advancing science, linking people
25th United European Gastroenterology Week Barcelona, Spain October 28 – November 1, 2017 Venue: Fira Gran Via
Final Programme
Celebrating
25 years
of UEG Week Join our Anniversary Activities: Anniversary Session & Celebration (Wednesday at 13:30 in Hall 7)
Art Exhibition showing the history of 25 years (walkway to Halls 6/7) Dedicated Anniversary Area in Hall 8.0: • Make a donation and take a piece of UEG Week home with you • Photobooth • Anniversary Wheel Get your pedometer watch at the Congress Material Counter Find out more, visit www.ueg.eu/week/25years
Table of Contents : UEG Week Final Programme
Table of Contents
5
Welcome Address
265 Ultrasound Learning Area
7
About UEG
269 Surgical Learning Area
8
Awards and Grants
275 UEG Evidence Based Medicine Course
13
Scientific Information
277 21th ESGENA Conference
21
Young GI Network
291 Common Interest Group Meetings
25
Scientific Programme Overview
293 Business Meetings
35
Postgraduate Teaching Programme
295 Industry Sponsored Symposia
46 67 94
Scientific Programme by Day Monday October 30, 2017 Tuesday October 31, 2017 Wednesday November 1, 2017
303 Congress Information 309 Metro Map of Barcelona 310 Acknowledgements
110 160 211
Poster Sessions by Day Monday October 30, 2017 Tuesday October 31, 2017 Wednesday November 1, 2017
313 List of Exhibitors and Exhibition Floor Plans 317 List of Reviewers 323 Index of Authors and Co-Authors
261 ESGE Learning Area
373 Floor Plans Fira Gran Via
Printed in accordance with the ʻEnvironmentally Compatible Printed Matterʼ guideline of the Austrian Eco-label. Druckerei Schmidbauer GmbH • UWNr. 897 (Eco-label license number 897)
3
Download the UEG Week App • Create your personal programme itinerary • Watch live-streamed sessions, find floorplans, Industry Sponsored Symposia, exhibitor profiles and more
and audience voting Participate in Q & A dedicated sessions via the app.
Q & A Tool The Q & A tool is available in the following session rooms:
• Hall 6 • Room A1 • Room A2 • Room C1
• Room C2 • Room F1 • Room F2 • Room F3
Audience Voting Tool The audience voting tool is available in the following session rooms:
Hall 6, Room C1 & C2 Room C1 & C2
Available at:
UEG Week App incl. Q&A Tool
Sat – Sun Mon – Tue
Welcome Address : UEG Week Final Programme
Welcome Address from the UEG President to the 25th UEG Week Barcelona 2017 Celebrating the 25th United European Gastroenterology Week at the heart of UEG’s activities.
Barcelona has proven to be a highly successful host city for UEG Weeks over the last years. The development of the scientific programme for the 25th UEG Week 2017 is now complete, and will contain some exciting new initiatives, which will ensure that postgraduate education and training in gastroenterology and hepatology remain at the ‘cutting edge’. High quality continued professional education have become of utmost importance since revalidation and re-licencing of medical practitioners becomes widely accepted. Although UEG Week is a congress firmly based in Europe, we are delighted to welcome increasing numbers of participants from around the world, this year from Asia, North and South America, the Middle East, Africa and Australia. Presentation of new research results from countries outside Europe enriches our programme and provides the opportunity for European investigators to develop new international research collaborations. While there is no doubt that UEG will continue to engage with advanced digital technologies to enhance e-learning,
notably through the expansion of our activities through online learning or the UEG Week Live concept, the need for clinicians and scientists to meet face to face and to discuss clinical innovations and research challenges is still the main focus. Do not miss this year’s highlight, the special anniversary session on Wednesday with updates on the major advances on gastroenterology and hepatology over the last 25 years! I warmly welcome you in Barcelona for the special anniversary of the 25th UEG Week 2017 which I am certain will be another resounding success.
Michael Manns UEG President
5
#uegweek
Engage and connect with the community or simply discover UEG Week at your fingertips wherever you are
#WeekChat CME Credits Any open questions? We are happy to help, visit us at the UEG Booth in Hall 8.0 or send an email to
[email protected]
About UEG and UEG Week : UEG Week Final Programme
About UEG and UEG Week
Mission & Goals The UEG’s mission is continually to improve standards of care in gastroenterology, and promote ever greater understanding of digestive and liver disease – among the public and medical experts alike. As part of that work, the UEG runs a number of education and training courses facilitated by highly respected experts. They also organise UEG Week – the largest and most prestigious meeting of its kind in Europe. UEG Week has been running since 1992, in a variety of major cities, and now attracts up to 14,000 people from across the world. UEG is committed to: • Raising awareness and expanding knowledge of GI and liver diseases among the public and medical profession, to deliver benefits for patients • Coordinating the activities of clinical and scientific associations in our field • Harmonising and improving clinical standards across Europe • Fostering basic and clinical research in the field, and raising the profile of this work worldwide • Promoting and delivering excellence in clinical and scientific education.
Organiser United European Gastroenterology GmbH House of European Gastroenterology Wickenburggasse 1 1080 Vienna, Austria T +43 1 997 16 39 F +43 1 997 16 39 10
[email protected] www.ueg.eu UEG Week Official Registration and Housing Agency Mondial Congress & Events Operngasse 20b 1040 Vienna Austria T +43 1 58804 0 F +43 1 58804 185
[email protected] [email protected]
UEG consisting of 16 Ordinary Member Societies and 47 National Societies is a vibrant organisation that constantly adapts to the changing requirements of scientific research and health care. For detailed information please visit the websites www.ueg.eu/about-ueg/structure/boards-committees and www.ueg.eu/about-ueg/who-we-are
Visit our social media profiles: Like us on Facebook at www.facebook.com/myUEG
Tweet us on @my_ueg 7
UEG Week Final Programme : Awards and Grants
Awards and Grants UEG Research Prize
Jesper Lagergren UEG Research Prize 2017 Stockholm, Sweden € 100,000 awarded for the most outstanding research programme The UEG Research Prize is awarded for excellence in basic science, translational or clinical research in the areas of gastroenterology, hepatology and related disciplines. The recipient’s previous work must have had an impact in its field and its quality must be internationally recognised. Jesper Lagergren is awarded the distinguished UEG Research Prize 2017 for his outstanding project ‘The aetiology, prevention and treatment of oesophageal cancer’. The overarching goal of his research is to improve clinical practice and to contribute with an improved prognosis to future patients’ survivorship. He is currently serving as Professor and Consultant of Surgery at the Department of Molecular Medicine and Surgery at the Karolinska Institutet in Stockholm, Sweden. Since 2016, he is also member of the Nobel Assembly. In parallel, he is Professor and Chair of Upper Gastrointestinal Cancer at King's College London and Honorary Consultant of Surgery at Guy's and St. Thomas' NHS Foundation Trust. He is leading collaborating research groups at Karolinska Institutet and King’s College.
8
Professor Jesper Lagergren is an internationally renowned surgeon. His research focuses on the causes, prevention and treatment of oesophageal and gastric cancer and related disorders, such as gastro-oesophageal reflux disease (GORD) and obesity. He has been author of nearly 300 peer reviewed scientific articles. The Prize money will support him to extend his research projects towards large-scale and well-designed studies and with these prerequisites given, Professor Lagergren aims to positively influence clinical decision-making. Award Ceremony at the Opening Session Monday, October 30, 2017 // 08:00 – 12:00 Hall 6 08:57 – 09:12 Project presentation and award ceremony Research Prize 2017: The aetiology, prevention and treatment of oesophageal cancer.
Awards and Grants : UEG Week Final Programme
UEG Lifetime Achievement Award
Anthony Axon UEG Lifetime Achievement Award 2017 Leeds, United Kingdom Recipients have proven lifelong excellence and leadership in the field The UEG Lifetime Achievement Award recognizes outstanding individuals whose pioneering and inventiveness throughout their careers have improved the Federation and inspired others. Professor Anthony Axon has been a clinical Gastroentero-logist for 40 years - safe, high quality clinical medicine has been the driving force in his practice, his teaching, research, and during his national and international activities. He was the first to draw attention to the requirement for effective disinfection in endoscopy, and to recognise the need for a closed disinfection system. As a pioneer in ERCP he chaired the committee that recommended the Cambridge endoscopic classification of chronic pancreatitis. He furthermore published on the early recognition and pathogenesis of GI cancer, the value of endoscopy in dyspepsia and in IBD. His investigations in gastritis, peptic ulcer and gastric cancer began before H pylori was identified and afterwards he became active in drawing attention to the pathological role of Hp, its diagnosis and treatment.
Professor Axon was elected ESGE President 2000-2002 and initiated an interest in quality, ethics and guidelines, areas that remain important ESGE activities today. During his Presidency of OMED (now WEO) from 2005-2008 the organisation thrived and has remained a vibrant contributor to world endoscopy since then. His involvement with UEG (former UEGF) started with his membership on the Scientific Committee 1996-1999 and culminated in his Chairmanship of UEGF Council 2006-2007. During his Presidency UEG has expanded its activities further and Professor Axon played a part in its success. Award Ceremony at the Opening Session Monday, October 30, 2017 // 08:00 – 12:00 Hall 6 09:34 – 09:44 Laudation and presentation of the award
9
UEG Week Final Programme : Awards and Grants
UEG Journal Best Paper Award
Clive H. Wilder-Smith UEG Journal Best Paper Award 2017 Bern, Switzerland Recognition of the first-named author for the best original research, published in the UEG Journal in 2016. UEG Journal provides an international forum for research in gastroenterology, publishing original articles, which describe basic research, translational and clinical studies of interest to gastroenterologists and researchers in related fields. In 2017, the UEG Journal continues to go from strength to strength with another impressive increase in Impact Factor, hitting 3.673 and a position of 21 out of 79 titles in the Gastroenterology and Hepatology category of the Journal Citation Reports®. With the Best Paper Award, we recognize the first named author of the best original scientific research, published in UEG Journal in the past year. The winning article is selected by the editors, presided over by Chief Editor Professor Jan Tack. The UEG Journal Best Paper Award 2017 is given to Clive H. Wilder-Smith (Managing Director of the Brain-Gut Research Group and Consultant at the Department of Preventive, Restorative and Paediatric Dentistry at Bern University, Switzerland) as the first author of the winning article: Gastro-oesophageal reflux is common in oligosymptomatic patients with dental erosion: A pH-impedance and endoscopic study. The article is available for download at ueg.sagepub.com As clinical gastroenterologist, Clive H. Wilder-Smith is practicing as senior partner in a private gastroenterology group practice and as consultant at BeauSite Clinic in Bern, Switzerland. Focusing on gastroenterology and pain in his research activities, he leads the Brain-Gut Research
10
Group, an international academic research institute with focus on gastroenterology, neuroimmunology, pain and metabolic syndrome and has an appointment as visiting professor at the School of Medicine of the University of California. Another strong interest of Clive H. Wilder-Smith lies in the beneficial effects of food and natural nutrition. As coordinator of ‘Food Intolerance Diagnostics’, he is part of a network which concentrates their research on the beneficial effects of food and natural nutrition and provides information, diagnostic services and treatment to individuals with adverse reactions to food. Clive H. Wilder-Smith is member of various renowned international associations and societies in the field of gastroenterology, nutrition and pain, reviewer of international gastroenterology and pain journals and has received over 30 international and national prizes for his research projects. He has published more than 120 original articles in journals, book chapters and over 200 abstracts from congress presentations. Award Ceremony at the Opening Session Monday, October 30, 2017 // 08:00 – 12:00 Hall 6 11:02 – 11:07 Presentation of the award UEG Journal Best Paper Award 2017: Gastro-oesophageal reflux is common in oligosymptomatic patients with dental erosion: A pH-impedance and endoscopic study
Awards and Grants : UEG Week Final Programme
Travel Grants UEG offers travel grants of € 1,000 to the presenters of the best abstracts submitted to UEG Week. 200 Grants are available to clinicians and scientists, 140 to basic scientists of 40 years of age or younger. Poster Champ Award Every day during lunch break, the highest scoring posters are presented in the interactive Poster Champ sessions at the e-poster terminals in the scientific centre. The best presenter of each session receives the Poster Champ Award. Awardees receive a certificate and free registration to next year’s UEG Postgraduate Teaching Programme. International Scholarship Award UEG awards 30 international scholarships to young gastroenterologists, aged 40 and below. Awardees receive € 1,000 to help cover travel expenses and free registration to UEG Week including the Postgraduate Training Programme. The scholarships are restricted to citizens of countries with a Human Development Index (HDI) of less than 0.8 according to the latest Human Development Report.
National Scholar Awards ª The National Scholar Award is designed to support promising young investigators at a junior level and to encourage them to work towards the more senior UEG Rising Star Award. The award recognises the highest scoring abstract, presented by a colleague below the age of 35, from every UEG National Member country. Top Abstract Prizes ª The presenting first authors of the top five accepted abstracts to UEG Week are awarded the Top Abstract Prize every year. The prize money of € 10,000 is to be spent on future research. In case of industry sponsored multi-centre studies, the author is required to waive the monetary part of the prize. Awarded abstracts must neither been previously presented at an international meeting nor been fully published. Oral Free Paper Prizes The best presenter of every Free Paper and Posters in the Spotlight session is awarded this prize. The winners are selected by the session chairs, who take the quality of research, the originality of the presented work as well as the presentation itself into account. Prize-winners receive a certificate of excellence.
Rising Star Awards ª Every year, the UEG National Societies Committee and the UEG Scientific Committee jointly select 6-8 clinical scientists as UEG Rising Stars. The selection is based on a track record of international quality research and on scientific independence. This initiative provides a durable platform for these young researchers to further improve and progress in their professional career.
International Scholars 2016
11
Wherever you are
e lecture esentations from th pr c ifi nt ie sc e th g on We brin Follow the livestream . en re sc ur yo to ly halls direct e latest GI d get updated on th the UEG website an and liver topics! .eu/week Visit www.live.ueg
ing Livestreams includ Q&A options
e Dynamic programm tly en rr cu on overview ns io ss se g streamin
Daily updates on our Social Wall
UEG Week 24/7 ed features all record e sessions from th previous days
Make ww.ueg.eu your mobile landing page for the complete congress experience
Scientific Information
UEG Week Final Programme : Scientific Information
Welcome by the Chair Scientific Committee
I would like to welcome all of you to the 25th UEG Week 2017 in Barcelona – the place to be for clinicians as well as for researchers!
This year's anniversary programme features the latest advances in clinical management, the best research in GI and liver disease and includes several different kinds of symposia and fora, where cutting edge gastroenterology and hepatology is being discussed. I would like to draw your attention to some of the highlights in 2017: • The UEG Week Scientific Centre – a place where all possibilities to present an abstract are united, featuring the UEG Week Hotspot, the e-poster lounges, the e-poster terminals as well as the poster exhibition.
• The Translational/Basic Science pathway including topics that will affect clinical practice within the foreseeable future, thereby being attractive for both, basic/translational scientists and clinicians.
• UEG Week is celebrating its 25th anniversary this year! On Wednesday there will be a special anniversary session dedicated to the past and the future of gastroenterology and hepatology in the UEG Week Scientific Centre, followed by a celebration, don't miss this!
• The Young GI Track, where sessions of special interest for young GI fellows will be highlighted in the programme. The mentoring programme for our young colleagues will be expanded additionally.
• Clinical trials revisited feature a recently published clinical trial, followed by a critical review and a panel discussion with experts in the field. • Posters in the Spotlight sessions, Poster Champ sessions and the Exemplary Clinical Cases promise exciting poster sessions. • Therapy updates, where the current state-of-the-art treatment options in some of the major GI and liver diseases are presented. • From guidelines to clinical practice sessions give you a concise update on European guidelines and their implementation in everyday clinical practice.
14
• Our clinically oriented one-day symposium within the meeting, entitled ‘Advances in Clinical Gastroenterology and Hepatology’, focusing on ‘Functional GI disorders and GORD’ this year. • The Today’s Science; Tomorrow’s Medicine initiative with this year's topic ‘Host microbiota crosstalk’, which will focus on research as well as clinical implications from one of the hottest research areas today: the role of gut microbiota in health and disease. • For the practical minded, we will again offer the popular Live Endoscopy sessions and we will further extend our Hands-on Training areas: A surgical section will complete the well-established endoscopy and ultrasound learning areas.
Scientific Information : UEG Week Final Programme
• Wednesday afternoon features the What’s new in…? session, which will again provide delegates with a comprehensive summary of recent changes in the management of major GI and liver diseases, as well as major scientific advances.
• As science remains the most important feature of our meeting, we have again worked hard to offer a large number of sessions devoted to original research. As you can easily understand from this, the 25th UEG Week is the place to be for you!
• With the Postgraduate Teaching Programme 2017, the 3-year curriculum is going to start again with year one, providing all major updates in GI & hepatology. A great mix of teaching methods with a focus on interactivity is employed. Magnus Simrén Chair of the UEG Scientific Committee
UEG Scientific Committee
Thank you!
15
Highlights recommended by the Scientific Chair Visit the Scientific Centre in Hall 7
hosting all possibilities to present an abstract
Thrilling symposia and debates at the UEG Week Hotspot
This extraordinary setting is home to Abstracts on Fire sessions revealing frontiers in research as well as Clinical trials revisited sessions and most controversial discussions.
Advances in Clinical Gastroenterology and Hepatology
This clinically oriented one-day symposium focuses on functional GI disorders and gastroesophageal reflux disease where substantial progress has been made and which has changed clinical practice.
Even more exciting poster formats Poster Champ Sessions Poster in the Spotlight Sessions Clinical Cases
Today’s Science; Tomorrow’s Medicine
This two day symposium on Host microbiota crosstalk presents the latest scientific advances in this fascinating research area and how these findings influence medicine today and tomorrow.
From guidelines to clinical practice sessions
Where experts discuss how to incorporate the latest European guidelines on major diseases into clinical practice.
Download the app to create your personal programme itinerary
Scientific Information : UEG Week Final Programme
Overview Scientific Programme
Saturday October 28, 2017
Sunday October 29, 2017
Monday October 30, 2017
Tuesday October 31, 2017
Wednesday November 1, 2017
Opening Session Postgraduate Teaching Programme
Symposia Translational/Basic Science Pathway Today’s Science; Tomorrow’s Medicine (TSTM)
Advances in Clinical GI and Hepatology
UEG Week Hotspot Live Endoscopy
Video Case Session
Free Paper Sessions Scientific Centre: Poster Exhibition / Poster Champ Sessions / Posters in the Spotlight Round Table Discussions ESGE Learning Area Ultrasound Learning Area Surgical Learning Area Business Meetings / Common Interest Groups Industry Sponsored Symposia Technical Exhibition 21st ESGENA Conference
17
UEG Week Final Programme : Scientific Information
Format Descriptions Postgraduate Teaching Programme (PGT) The UEG Week Postgraduate Teaching comprises two days of excellent ‘Continuing Medical Education’, focusing on the relevance for the clinical day-to-day business and provides profound updates of latest developments in GI and hepatology topics. The interactive session formats include tricky clinical cases, controversial debates and exciting video cases – a perfect mix for gastroenterologists in training and in practice as well as established GI physicians and general practitioners. In 2017, the PGT starts the second cycle of the three-year PGT Curriculum, which follows recommendations of the EBGH Blue Book and permits participants to get perfectly prepared for their professional career. Delegates can start the curriculum at any year of the cycle and will receive a certificate once they have completed all three years. PGT Syllabus contributions are available in the online programme, the UEG Week 2017 App and in our UEG Education Library at www.ueg.eu/education/library, where congress delegates can access recordings of all PGT sessions free of charge. The detailed curriculum and all learning objectives are available at www.ueg.eu/week/postgraduate-teaching. Please see further information on page 35 and following. Opening Session The opening session is held on Monday morning and includes official speeches and the opening of the scientific core programme, with a mixture of invited speakers and presentations of the best submitted abstracts. UEG awards the UEG Research Prize, the UEG Lifetime Achievement Award and the UEG Journal Best Paper Award at the opening session. Symposia Interdisciplinary symposia cover new approaches to diagnosis and treatment, and place major emphasis on innovative, technical advances in the non-invasive management of gastrointestinal and hepatic disorders and translational/basic science, including state-of-the-art lectures. Therapy updates on latest treatment options, guidelines in clinical practice, and the one-day symposium advances in clinical GI and hepatology on ‘Functional GI disorders and GORD’ on Wednesday present the hot topics in 2017. Translational/Basic Science Pathway These sessions include topics that will potentially affect clinical practice within the near future, thereby being 18
attractive for both basic/translational scientists and clinicians. Interactive Formats The UEG Scientific Committee continuously works on improving session formats used in the programme with the purpose of making symposia modern interactive experiences. We have once again more debates, where two speakers argue opposing cases, and more tandem talks, where experts present different aspects of the same problem. Symposia with a panel discussion at the end have also increased. All speakers will be on stage, take up controversial comments and discuss burning questions. Panel discussions are great for understanding what the speakers REALLY think! These discussions are always lively and informative – make sure you stay and see for yourself! Finally, we also continue to encourage wide use of cases to illustrate talks and anchor them in medical experience. For all these sessions we work hard to improve our Faculty instructions to increase interactivity with the audience, by interactive chairing and encouraging audience voting. Today’s Science; Tomorrow’s Medicine UEG Week hosts again the two-days ‘Today’s Science; Tomorrow’s Medicine’ initiative in the main programme. In 2017, the theme is ‘Host microbiota crosstalk’. Top class scientists have been invited to discuss how the current stage of knowledge is ready to be used in clinical practice, and to establish strategies to foster further progression of knowledge in this area. The Today’s Science; Tomorrow’s Medicine symposium is a combination of both, invited sessions featuring the world’s top scientists and Free Paper sessions where work is presented by young and established researchers. UEG Week Hotspot The UEG Week Hotspot is THE place to be at UEG Week 2017, where the most controversial sessions, hottest debates and interactive abstract discussions will take place. These sessions promise to be most intense! Heated discussions of the UEG ‘Abstracts on Fire’ (frontiers in research) and breaking news will be launched. Also featured at the Hotspot are the clinical trials revisited sessions, where the latest results from recent large clinical trials will be presented and discussed by experienced investigators. Do not miss to pass by this high-tech scientific environment and attend these exciting sessions taking place from Monday until Wednesday!
Scientific Information : UEG Week Final Programme
Live Endoscopy Live endoscopy is included in the core programme on Tuesday. Top international experts demonstrate cutting-edge techniques alongside basic procedures transmitted directly from the Evangelisches Hospital Düsseldorf to the auditorium. The use of multiple parallel cases and experienced chairs ensure interactive learning without unnecessary gaps.
Video Case Session The Video Case session is an excellent platform for brief information on recent issues of endoscopy. During this session short videos showing examples of new, unexpected or exceptional endoscopic practice are presented and briefly discussed. Thus, the Video Case session presents unusual cases or new technologies based on diagnostic and therapeutic endoscopy.
Free Paper Sessions The most important feature of UEG Week is science and we are constantly trying to attract the best science to our meeting. This is recognised in the core programme with a large number of Free Paper sessions devoted to original research, and an impressive number of mixed sessions where invited talks and free paper presentations alternate.
Round Table Discussions For each of these sessions we have invited four experts who will discuss common clinical situations based on a case presentation, scenario or specific problem. Four Round Table Discussions per day take place from Monday to Wednesday, 12:45-13:45, in the Rooms A2, A3, B2 and B3. No extra charge applies and no pre-booking is required. But come early as there are limited seats which will be filled on a first-come, first-served basis.
Posters in the Spotlight Posters in the Spotlight sessions boost science even further and have become a fixture at UEG Week. The Posters in the Spotlight are an excellent platform for in-depth scientific exchange with faculty and peers in a relaxed atmosphere and present an ideal opportunity to assist highly interactive and expert-led poster presentations. Poster Exhibition/E-Posters Poster sessions feature a very spacious room layout and poster format. Printed posters are displayed and changed daily from 09:00 – 17:00 (Mon & Tue) and 09:00 – 14:00 (Wed) in Hall 7. All accepted posters also have the opportunity to get published electronically in addition to the printed poster. All e-posters which were uploaded prior to UEG Week can be searched for and viewed on the six e-poster terminals in the poster exhibition, from Monday until Wednesday. E-posters allow all poster presenters to include interactive media files, such as radiology images, endoscopy videos, etc.
ESGE Learning Area The ESGE Learning Area incorporates different educational formats in order to provide both beginner endoscopists as well as proven experts a platform for skill enhancement and professional discourse. In cooperation with ESGENA, the Hands-on Training Centre gives practical insight into basic and advanced endoscopic techniques. Participants can test their skills under the guidance of expert doctor and nurse tutors. Lively talks between young experts and established senior discussants are held in the Lecture Theatre where debate on the how and why of current procedures prompts audience involvement. Video teaching is an essential part of endoscopy training. The DVD learning centre shows continuous films from the ESGE eLibrary and also includes videos contributed by the ASGE and JGES. The learning area is open to all delegates during the general opening hours of the congress. Please see further information on page 261 and following.
Poster Champ Sessions There will be four Poster Champ sessions in parallel from Monday until Wednesday from 12:30 – 13:30. 2-minutes presentations of the highest scoring posters are followed by 3-minutes Q&As from the chairs. The Poster Champ of each session will be awarded during the official award ceremony at the E-Poster Lounge I at 13:45 each day. All Poster Champs get a certificate and free registration to the Postgraduate Teaching Programme of next year’s UEG Week in Vienna. Poster Champ sessions take place at the e-poster terminals in Hall 7. Please see further information on page 109 and following.
The Ultrasound Learning Area (ULA) Please see further information on page 265 and following. Surgical Learning Area Please see further information on page 269 and following. Business Meetings > upon invitation only Association, board and committee meetings for elected (UEG) leadership. Please see further information on page 293.
19
UEG Week Final Programme : Scientific Information
Common Interest Group Meetings > open to all delegates Activities taking place outside of the core scientific programme and open to all UEG Week delegates. Please see further information on page 291. ESGENA Conference The Conference of the European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) is an associated meeting at the congress with separate scientific programme and registration. Please see further information on page 277.
Disclosure Policy UEG is committed to ensuring scientific rigour and objectivity in all of its educational activities. These include all aspects of the educational programme at UEG Week including those that are directly and jointly sponsored activities. All presenters, whether invited faculty or abstract presenters, are required to disclose to those organising and attending meetings any relevant financial or other relationship that may lead to a potential bias. UEG reserves the right to review the information disclosed for potential conflicts of interest. Please note that the sole responsibility for the content of each presentation lies with the presenting author.
Other Scientific Information The 25th UEG Week Barcelona 2017, Spain, October 28 – November 1, 2017, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 31 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/go/ internationalcme. Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Programme of The Royal College of Physicians and Surgeons of Canada. In order to obtain CME credits, UEG requires feedback on its educational activities. Therefore, we kindly ask all delegates to complete the online evaluation form after conclusion of the congress. The evaluation form is available as of Wednesday, November 1, 2017 via the congress app and on www.ueg.eu/myueg. The CME Certificate of EACCME will be available for download after completion of the online evaluation.
20
The UEG Scientific Committee requires all presenters to disclose any financial relationship with or any advisory role in the Biomedical Industry and the Biomedical Technology Industry during the past two years. These and any other potential conflicts of interest should be disclosed during introductory comments to the presentation. Invited speakers and oral abstract presenters are requested to disclose potential conflicts of interest on a PowerPoint slide to be shown immediately at the beginning of the presentation. Poster presenters are requested to disclose potential conflicts of interest at the bottom of their poster. Conflicts of interest may exist through a financial relationship or when the individual has the opportunity to influence the content of a presentation, and can involve grants, honoraria, shares, paid positions on advisory boards, etc. Conflicts of interest are frequent and expected, and do not preclude an individual from giving a presentation providing the conflict is disclosed. If there is any doubt about the relevance of a potential conflict of interest UEG requires all presenters to err on the safe side and to disclose it.
Young GI Network This initiative provides young delegates with the opportunity to network, exchange scientific ideas and discuss the congress programme with peers and senior experts. All delegates up to the age of 40 are invited to access the lounge and to participate in the activities. Young GI Lounge This comfortable area in Hall 8.0 is the place to meet for trainees and fellows at UEG Week. Form new collaborations over a cup of coffee, meet UEG Young Talent Group members and senior experts in the field, and attend special coaching sessions.
Opening hours Saturday October 28 09:00 – 17:00 Sunday October 29 09:00 – 17:00 Monday October 30 09:00 – 17:00 Tuesday October 31 09:00 – 17:00 Wednesday November 1 09:00 – 14:00
Mix and mingle in the
Young GI Lounge in Hall 8.0
New friends,
scientific exchange,
coaching sessions and coffee are waiting
for you!
Access is granted to UEG Week delegates below the age of 40 and dedicated Young GI Network mentors.
Join the Young GI Network on facebook
Find out more on www.ueg.eu/week
Scientific Information : UEG Week Final Programme
Young GI Network
Young GI Track This part of the UEG Week Pathways Tool will highlight sessions from the scientific programme at UEG Week that we consider of particular interest for junior congress delegates. The UEG Week Pathways Tool is available as part of the UEG Week App and as pdf on our website for download. Young GI Sessions Join our special coaching and information sessions which are aimed at junior delegates in particular. Registration is not required. Sunday, October 29 13:00 – 14:00 Young GI Lounge Check your CV: Tips and tricks from experts Monday, October 30 12:15 – 13:15 E-Poster Lounge 1 Moving GI education into the future: Current challenges, future needs 13:00 – 14:00 Young GI Lounge Visiting Fellowship Programme information meeting 15:45 – 17:15 E-Poster Lounge 2 Rising Stars in pancreatology from Europe and the USA Tuesday, October 31 13:00 – 14:00 Young GI Lounge Career Chat: Top advice from female leaders and their fellows 15:45 – 17:15 How to submit a good paper
E-Poster Lounge 1
For further details go to the UEG Week 2017 App or the online programme at www.ueg.eu/week/programme
Mentoring Programme Young congress participants have the possibility to network with senior experts and receive scientific guidance in small groups. Registration is required; remaining spots can be booked onsite in the Young GI Lounge on a firstcome, first-served basis. Monday, October 30 Tuesday, October 31
> 10:00 – 10:30 // 12:00 – 13:00 > 10:00 – 10:30 // 12:00 – 13:00
Meeting point for pre-registered delegates: 10:00, Young GI Lounge Young GI Network – Let's meet! This special event for young congress delegates takes place in Restaurante Bestial at the beach and provides an informal atmosphere to network with colleagues from all over the world. The event is limited to congress delegates and registration is required. Remaining tickets can be bought for € 15 at the congress registration counter on a first-come, first-served basis. Guests are asked to present their ticket and congress badge at the restaurant entrance. Sunday, October 29 19:00 – 24:00 Restaurante Bestial Barcelona, Ramon Trias Fargas, 2-4, 08005 Barcelona Young GI Network – Let’s tweet! Participate in the next round of moderated social media debates. Join in the discussion and ask the experts or express your point of view by including the hashtag #WeekChat. Sunday October 29 13:00 – 14:00 Twitter discussion: Transition from fellowship to faculty Expert: Björn Rembacken
Guided Poster Tours Review posters in your field of interest in small groups together with a senior expert. Registration is not required.
Tuesday October 31 17:15 – 18:00 Facebook discussion (Group ‘Young GI Network’): Career tips for PhD students Expert: Luigi Ricciardiello
Meet the Web Editors Meet the UEG Education Web Editorial Team each day in the lunch break at the UEG Education Booth in Hall 8.0.
Monday Tuesday Wednesday
October 30 October 31 November 1
12:30 – 13:30 12:30 – 13:30 12:30 – 13:30
Meeting point: Poster Service Desk (Hall 7) 23
We support your application for research funding in Horizon 2020! EU funding: What UEG can offer
Horizon 2020, the present EU Framework Programme for Research and Innovation, holds € 80bn support for researchers. JOIN OUR SESSION TO LEARN • about ways and options to have your ideas funded in Horizon 2020 • how your colleagues are managing their grants • how UEG can effectively support your application to EU funding Page 90
Find out more, visit www.ueg.eu/research
TUESDAY
October 31, 2017 15:45 – 17:15 Hall 8.0, Room E1
Scientific Programme Overview The scientific programme is as of September 12, 2017. Later changes are published in the online programme and in the UEG Week congress app.
UEG Week Final Programme : Scientific Programme Overview
Postgraduate Teaching Programme Overview Saturday, October 28, 2017
09:00 – 10:30
Hall 6 Voting Room
Room C1 Voting Room
Room C2 Voting Room
Room F3
Hall 8.0
Plenary I Early management of acute pancreatitis 10:30 – 11:00 Coffee Break
11:00 – 13:00
Video Case Session Video Case Session I: Diagnosis and management of biliary and pancreatic strictures
09:00 – 18:00
Parallel Sessions
ESGE Learning Area
Update on the management of pancreatic adenocarcinoma
H. pylori: From epidemiology to clinical management
Extraintestinal manifestations of IBD and co-morbidity
Surgical Learning Area Ultrasound Learning Area
13:00 – 14:00 Lunch Break
14:00 – 16:30
Video Case Session Video Case Session 2: Endoscopic stenting in the upper GI tract, endoscopy in IBD and lower GI bleeding
Parallel Sessions Management of gastro-oesophageal reflux disease (GORD)
Therapy update in GI cancers
Assessment of liver function: Pearls for the clinician
14:00 – 17:30 ESGENA
Sunday, October 29, 2017
08:30 – 10:30
Hall 6 Voting Room
}}
Room C1 Voting Room
Room C2 Voting Room
Room F3
Room F2
Advanced diagnostic endoscopy
Faecal incontinence: Mechanisms, diagnostic tests and treatment
Room A3
Parallel Sessions All you wanted to know about coeliac disease – but did not dare to ask!
Dyspepsia and gastroparesis: How to diagnose and treat?
The changing epidemiology of viral hepatitis
10:30 – 11:00 Coffee Break 11:00 – 13:00
Clinical Case Based Sessions Early management of IBD
Benign causes of oesophageal dysphagia
Optimising the outcome for patients with upper GI bleeding
Update on GI infections for the gastroenterologist
Management of early colorectal cancer
14:00 – 16:00
13:00 – 14:00 Lunch Break Plenary II Refractory IBD: How can we optimise the management? 16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia
26
Management of abdominal emergencies
Scientific Programme Overview : UEG Week Final Programme
Attention to time change on Sunday morning from 3:00 am to 2:00 am.
Missed a session? Watch it on www.ueg.eu/week/24-7
}} 17_08_Inserat_Week24_7_FP_86_5x85_RZ.indd 1 Room E4 Room E1
Room E2
Room E3
24.08.17 11:46 Hall
8.0
09:00 – 18:00
10:30 – 11:00 Coffee Break
Diagnostic work-up of a liver nodule
Malignant biliary obstruction: Diagnostic and therapeutic approach
Best clinical practice for patients with chronic intestinal failure
Management of non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)
09:00 – 18:30 ESGENA
13:00 – 14:00 Lunch Break
ESGE Learning Area Surgical Learning Area Ultrasound Learning Area
16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia
27
UEG Week Final Programme : Scientific Programme Overview
Scientific Programme Overview Monday, October 30, 2017 Hall 6
Room C1 Voting Room
}} Room C2 Voting Room
Room F3
Room F2
Room F1
Room A2
08:00 – 10:00
07:00 – 08:00 Industry Sponsored Symposia
Opening Session: Part 1
Opening Session: Part 2
Symposium
Symposium
Free Paper Session
Symposium
Symposium
Symposium
Adverse food reactions: How to diagnose and manage?
GORD from infancy to old age
Clinical trials in Crohn's disease
Optimising screening colonoscopy
Innovative therapeutic endoscopy in Japan and Europe
Fatty liver disease: Update 2017
RTD* 12:45 – 13:45
14:00 – 15:30
12:00 – 14:00
10:30 – 12:00
10:00 – 10:30 Coffee Break
Clinical management of cholan– giopathies
12:00 – 14:00 Lunch Break
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Best of DDW
Cancer and IBD
Management of early Barrett's neoplasia: When and how to resect or ablate?
Therapy update: Hepatocellular carcinoma (HCC) in 2017
How to manage malignant duodenal obstruction?
From guidelines to clinical practice: Functional bowel disorders
ERCP: The "difficult" patient
15:45 – 17:15
15:30 – 15:45 Coffee Break Symposium
Symposium
Symposium
Symposium
Free Paper Session
Symposium
Symposium
How to define therapeutic response in Crohn's disease?
The severly constipated patient not responding to standard therapies: What to do?
Managing collections in acute pancreatitis
Therapy update: Prevention and treatment of endoscopic complications
Clinical trials in ulcerative colitis
From guidelines to clinical practice: Coeliac disease
Alcoholic liver disease: Anything new?
17:45 – 19:15 Industry Sponsored Symposia
* RTD – Round Table Discussion / TSTM – Today’s Science; Tomorrow’s Medicine / FPS – Free Paper Session
28
Scientific Programme Overview : UEG Week Final Programme
}} Room A1
Scientific Centre (Hall 7) Room A3
Room B2
Room B3
Room E4
Room 7.1
Room E1
Room E2
Room E3
Room B5
E-Poster Lounge 1
E-Poster Lounge 2
Hotspot
Hall 8.0
07:00 – 08:00 Industry Sponsored Symposia
10:00 – 10:30 Coffee Break Symposium
Symposium
Free Paper Session
Translational/ Basic Science
TSTM*
Free Paper Session
Symposium
Free Paper Session
Free Paper Session
Free Paper Session
Posters in the Spotlight
Posters in the Spotlight
FPS*: Abstracts on Fire
Minimal invasive approach for pancreatohepato-biliary tumours
Hot topics from Latin America
Disease burden in IBD
Neurodegenerative diseases of the GI tract: From mechanism to therapy
Composition and functions of the healthy gut microbiota
Imaging, screening and surveillance of colorectal cancer
Multidisciplinary management of liver metastases in colorectal cancer
Advanced endoscopic treatment of upper GI neoplasia
Diagnosis and management of cirrhosis: Unmet needs
Bariatric surgery, obesity and weight loss
Therapeutic observations in IBD
Basic science models to understand human disease
Advances in endoscopic resection of early colorectal neoplasia
09:00 – 18:00
Symposium 12:15 – 13:15
ESGE Learning Area
RTD* 12:45 – 13:45
RTD* 12:45 – 13:45
RTD* 12:45 – 13:45
Pitfalls in the diagnosis of coeliac disease
Challenging cases of walledoff necrosis following acute pancreatitis
A young patient with chronic right lower quadrant pain
13:45 Poster Champ Award Ceremony
12:00 – 14:00 Lunch Break
12:00 – 14:00 Poster Sessions
Cross-cultural differences and challenges for a career choice in GI
Free Paper Session
Free Paper Session
Free Paper Session
Translational/ Basic Science
TSTM FPS*
Free Paper Session
Symposium
Free Paper Session
Free Paper Session
Free Paper Session
Posters in the Spotlight
Posters in the Spotlight
Symposium
Imaging and endoscopy in IBD
Late breaking abstracts I
Coeliac disease and wheatrelated disorder
The gut microbiome: A key regulator of serotonin synthesis in the gut-brain axis
New concepts in host-microbiota crosstalks
IBS: Searching for biomarkers
Hereditary colorectal cancer: From genes to clinic
Advances in endoscopic imaging: What does the future hold?
Challenges in pancreatic and biliary surgery
Drugs, liver and pancreas
Upper GI dysmotility: Understanding the symptoms and providing effective therapy
Colorectal neoplasia: Improving detection and outcome
Clinical trials revisited: Antibiotics in lower GI diseases – Should they be used?
Surgical Learning Area
Ultrasound Learning Area
15:30 – 15:45 Coffee Break Symposium
Free Paper Session
Free Paper Session
Translational/ Basic Science
TSTM*
Free Paper Session
Symposium
Free Paper Session
Free Paper Session
Free Paper Session
Symposium
Symposium
Symposium
H. pylori eradication: Unanswered questions
Late breaking abstracts II
ERCP: When the going gets tough
Immunotherapy in cancer
Microbiota crosstalk in health
Sporadic and hereditary colon cancer
How to treat duodenal adenomas?
Gluten-related disorders
General hepatology
Upper GI motility and brain-gut interactions
Moving GI education into the future: Current challenges, future needs
Rising Stars in pancreatology from Europe and the USA
Progress in the management of cholangiocarcinoma
17:45 – 19:15 Industry Sponsored Symposia
29
UEG Week Final Programme : Scientific Programme Overview
Scientific Programme Overview Tuesday, October 31, 2017 Hall 6
Room C1 Voting Room
}} Room C2 Voting Room
Room F3
Room F2
Room F1
Room A2
Room A1
Room A3
Room B2
Room B3
Room E4
Room 7.1
Room E1
08:30 – 10:00
07:00 – 08:00 Industry Sponsored Symposia
Live endoscopy
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Free Paper Session
Free Paper Session
Translational/ Basic Science
TSTM FPS*
Free Paper Session
Free Paper Session
Eosinophilic oesophagitis (EoE): European harmonisation
Chronic diarrhea: Diagnostic and therapeutic approach
Therapy update: Ulcerative colitis
Endoscopic and surgical interventions for metabolic disorders
From guidelines to clinical practice: Autoimmune liver disease
Pancreatic tumours: Diagnosis and treatment
Recurrences after colorectal EMR/ESD: How to avoid, how to treat?
Detection and removal of colorectal polyps: Latest techniques
Diagnosis and treatment of GORD
Understanding the basis for GI pain
Clinical implications of host microbiota interactions
The microbiome and IBD
Symptom patterns in functional GI disorders
Live endoscopy
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Free Paper Session
Free Paper Session
Translational/ Basic Science
TSTM*
Free Paper Session
Symposium
Perianal fistulising Crohn's disease: From pathophysiology to management
Treating patients with acute cholecystitis and cholangitis
Therapy update: Evidence for the efficacy of probiotics?
Optimising the diagnosis of IBS
From guidelines to clinical practice: Colorectal cancer
Evidence-based approach to achalasia
Lifestyle-related liver disease: Risks and management
Longterm management in IBD with biologics
Evidence-based management of Barrett's and oesophageal adenocarcinoma
Genetics of pancreatic disease and lessons for clinical practice
Gut microbiota and digestive disorders
H. pylori: Treatment and antibiotic resistance
Intestinal ultrasound: How and when?
RTD* 12:45 – 13:45
RTD* 12:45 – 13:45
RTD* 12:45 – 13:45
RTD* 12:45 – 13:45
Therapy-resistent reflux symptoms: What can we offer to the patient?
Autoimmune pancreatitis: Diagnostic and therapeutic challenges
Management of malignant dysphagia
Use and abuse of GI function tests
14:00 – 15:30
12:00 – 14:00
10:30 – 12:00
10:00 – 10:30 Coffee Break
12:00 – 14:00 Lunch Break
Live endoscopy
12:00 – 14:00 Lunch Break
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Free Paper Session
Free Paper Session
Translational/ Basic Science
TSTM*
Free Paper Session
Symposium
Management of dysplasia in ulcerative colitis
Proctology made easy
Therapy update: Faecal incontinence
How to manage early gastric cancer?
From guidelines to clinical practice: Pancreatic diseases
Malignant colorectal polyp: What to do?
The role of the GI microenvironment in IBS
Late breaking abstracts III
Impacts of biologics in IBD
Which GI diseases are inherited?
How to modulate the microbiome?
Optimising your colonoscopy practice
From fibrosis to cirrhosis: Diagnostic challenges and novel therapies
15:45 – 17:15
15:30 – 15:45 Coffee Break Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Symposium
Free Paper Session
Free Paper Session
Translational/ Basic Science
TSTM*
Free Paper Session
Symposium
Multidisciplinary management of complicated luminal Crohn's disease
Case finding and surveillance of Barrett's oesophagus
East meets West: Oesophageal cancer
Therapy update: Nutritional therapy in gastroenterology
Common mistakes in biliary obstruction management
From guidelines to clinical practice: Upper GI bleeding
Improved testing for upper and lower GI dysmotility
Update on diverticular disease
Potential future targets in IBD
Quality assurance in colonoscopy: Room for improvement?
Emerging biomarkers in GI cancer medicine
Microbiota: Future directions
Randomised controlled trials in functional lower GI disorders
EU funding: What UEG can offer
17:45 – 19:15 Industry Sponsored Symposia * RTD – Round Table Discussion / TSTM – Today’s Science; Tomorrow’s Medicine / FPS – Free Paper Session
30
Scientific Programme Overview : UEG Week Final Programme
}}
Scientific Centre (Hall 7)
Room E2
Room E3
Room B5
E-Poster Lounge 1
E-Poster Lounge 2
Hotspot
Hall 8.0
07:00 – 08:00 Industry Sponsored Symposia Free Paper Session
Free Paper Session
Free Paper Session
Acute and chronic pancreatitis: Risk factors and prevention
Progress in endoscopic diagnosis
New insights in microbiota: Gut and liver aspects
Symposium 08:30 – 10:00 09:00 – 10:00 Exemplary clinical cases I
09:00 – 10:00 Exemplary clinical cases II
Laryngopharyngeal reflux (LPR)
10:00 – 10:30 Coffee Break Free Paper Session
Free Paper Session
Free Paper Session
Posters in the Spotlight
Posters in the Spotlight
FPS*: Abstracts on Fire
Diverticular disease: From bench to bedside
Mechanisms of carcinogenesis in the pancreas
Microbiology and immunology of the small intestine
Pancreatic and biliary neoplasia: Basic and clinical observations
Advances in the management of functional GI disorders
Predicting and optimising IBD outcome
13:45 Poster Champ Award Ceremony
12:00 – 14:00 Lunch Break
12:00 – 14:00 Poster Sessions
Symposium 12:15 – 13:15 The role of academia in drug development
Free Paper Session
Free Paper Session
Free Paper Session
Posters in the Spotlight
Posters in the Spotlight
Symposium
H. pylori: From pathophysiology to the clinic
Pancreatic cancer: Risk factors and screening
Carcinogenesis and tumour progression in GI cancer
Optimising our diagnostic tools in gastroenterology and hepatology
How to improve the success rate in therapeutic endoscopy?
Clinical trials revisited: New drugs in liver diseases
09:00 – 18:00
ESGE Learning Area
Surgical Learning Area
Ultrasound Learning Area
15:30 – 15:45 Coffee Break Free Paper Session
Free Paper Session
Free Paper Session
Symposium
Autoimmune and cholestatic liver diseases: Novelties
From prevention to therapy of oesophagogastric cancer
Nerves and barrier function in health and disease
How to submit a good paper
FPS*: Abstracts on Fire Exemplary clinical cases III
Hepatobiliary and pancreatic malignancies: From bench to bedside
17:45 – 19:15 Industry Sponsored Symposia
31
UEG Week Final Programme : Scientific Programme Overview
Scientific Programme Overview
08:30 – 10:00
Wednesday, November 1, 2017
}}
Hall 6
Room F2
Room F1
Room A2
Room A1
Room A3
Symposium
Advances in Clinical GI & Hepatology
Symposium
Symposium
Symposium
Symposium
Update on new treatments in IBD
New therapeutic options for functional GI disorders
Resolving the enigma of coeliac disease
Quality in Endoscopy: How to use and interpret performance measures?
Pancreato-biliary EUS: How to do it better?
Viral hepatitis: Moving towards elimination
Symposium
Advances in Clinical GI & Hepatology
Symposium
Symposium
Symposium
Diagnostic and therapeutic challenges in pancreatology
Organic-functional overlap syndromes: Continuum or distinct diseases?
Patient education in IBD
Endoscopic resection of the difficult polyp
Management of advanced liver cirrhosis
14:00 – 15:30
12:00 – 14:00
10:30 – 12:00
10:00 – 10:30 Coffee Break
Video Case Session
12:00 – 14:00 Lunch Break
RTD* 12:45 – 13:45
Management of severe acute colitis
Endoscopic management of complications following upper GI surgery
Symposium
Advances in Clinical GI & Hepatology
Symposium
Symposium
Symposium
Symposium
IBD: What's new in 2017?
Treatment of GORD beyond acid inhibition
Endoscopy: What's new in 2017?
Hepatology: What's new in 2017?
Pancreatology: What's new in 2017?
H. pylori: What's new in 2017?
* RTD – Round Table Discussion / FPS – Free Paper Session
32
RTD* 12:45 – 13:45
Scientific Programme Overview : UEG Week Final Programme
}}
Scientific Centre (Hall 7)
Room B2
Room B3
Room E4
Room 7.1
Room E1
Room E2
Room E3
E-Poster Lounge 1
E-Poster Lounge 2
Hotspot
Hall 8.0
Symposium
Translational/Basic Science
Free Paper Session
Free Paper Session
Symposium
Free Paper Session
Free Paper Session
Posters in the Spotlight
Posters in the Spotlight
Symposium
Submucosal endoscopy: Indications, techniques and outcomes
Intestinal failure: Understanding the cause and treatment options
Endoscopic management of GI bleeding: What is new?
Long-term complications in IBD
Update on gastric precancerous conditions and lesions
Pathogenesis of IBD
Can colonic polyps be diagnosed in real time?
Detecting and removing colonic lesions
Clinical observations in oesophageal cancer
Controversies around serrated colorectal lesions
Symposium
Translational/Basic Science
Free Paper Session
Free Paper Session
Symposium
Free Paper Session
Free Paper Session
Posters in the Spotlight
Posters in the Spotlight
FPS*: Abstracts on Fire
Long-term adverse effects of bariatric surgery
Microbiota in liver disease
Hot topics in GORD and EoE
Safety and long-term outcomes with biologics in IBD
Therapeutic approaches targeting the tumour environment in pancreatic cancer: Hope or hype?
Endoluminal and transluminal interventions in the upper GI tract
Bugs in lower GI diseases
Bugs and viruses causing GI diseases
Progress in our understanding of colorectal inflammation and neoplasia
Diagnosis and treatment of upper GI diseases in children and adults
ESGE Learning Area
Symposium 12:30 – 13:30
Surgical Learning Area
10:00 – 10:30 Coffee Break
RTD* 12:45 – 13:45
RTD* 12:45 – 13:45
Diagnostic and therapeutic approach to patients with anal bloodloss
Infectious complications of liver cirrhosis
Symposium
Symposium
Symposium
Symposium
Colorectal cancer: What's new in 2017?
Neurogastroenterology and motility: What's new in 2017?
Upper GI cancer: What's new in 2017?
Diagnostic tools for GI diseases: What's new in 2017?
12:00 – 14:00 Lunch Break
13:45 Poster Champ Award Ceremony
12:00 – 14:00 Poster Sessions
25th UEG Week Anniversary Session: Major advances in gastroenterology and hepatology over the last 25 years
09:00 – 14:00
Ultrasound Learning Area
33
UEG Week Pathways
See at one glance which sessions are most relevant and interesting for your specialty
Choose among 198 sessions, up to 20 run in parallel each day. The UEG Week Pathways help you navigate through this huge choice, searching the online scientific programme by topic.
Available in the UEG Week App or visit www.ueg.eu/week/programme
Postgraduate Teaching Programme Overview Icons
Live Stream
Q&A
Audience Voting
Recorded Session
PGT Programme Committee Matthieu Allez, France Marianna Arvanitakis, Belgium Ian Jenkins, United Kingdom Dominique Thabut, France Herbert Tilg, Austria PGT Syllabus contributions are available in the online programme, the UEG Week App and in our UEG Education Library at www.ueg.eu/education/library.
UEG Week Final Programme : Postgraduate Teaching Programme
Saturday, October 28, 2017
Postgraduate Teaching Programme Saturday, October 28, 2017 Saturday, October 28, 2017
Plenary I 09:00 – 10:30 Early management of acute pancreatitis Chairs: Julia Mayerle, Germany Ross Carter, United Kingdom
Hall 6
09:00 – 09:30 IP001 Common mistakes in the initial management of acute pancreatitis Markus M. Lerch, Germany 09:30 – 10:00 IP002 Indications and techniques for endoscopic intervention in acute pancreatitis Djuna L. Cahen, The Netherlands 10:00 – 10:30 The complicated case Ross Carter, United Kingdom
IP003
Parallel Session 11:00 – 13:00 Hall 6 Video Case Session I: Diagnosis and management of biliary and pancreatic strictures Chairs: Marianna Arvanitakis, Belgium Thierry Ponchon, France 11:00 – 11:30 IP004 Endoscopic diagnosis and treatment of biliary stenosis Torsten Beyna, Germany 11:30 – 12:00 IP005 Endoscopic management of malignant hilar stenosis Andrea Tringali, Italy 12:00 – 12:30 EUS diagnosis of pancreatic lesions Peter Vilmann, Denmark
IP006
12:30 – 13:00 Endoscopic drainage of pancreacic ducts Myriam Delhaye, Belgium
IP007
36
Parallel Session 11:00 – 13:00 Room C1 Extraintestinal manifestations of IBD and co-morbidity Chairs: Severine Vermeire, Belgium James Lindsay, United Kingdom Tandem Talks 11:00 – 11:15 IP008 Epidemiology and genetics of extraintestinal manifestations: East meets West – the West Tine Jess, Denmark 11:15 – 11:30 IP009 Epidemiology and genetics of extraintestinal manifestations: East meets West – the East Siew Chien Ng, Hong Kong PRC 11:30 – 11:45 IP010 Dermatological extraintestinal manifestations: Clinical manifestations and diagnostic strategy Tim Raine, United Kingdom 11:45 – 12:00 IP011 Dermatological extraintestinal manifestations: Therapeutic considerations Stephan Vavricka, Switzerland 12:00 – 12:15 IP012 Athritis, arthralgias and metabolic bone disease: Clinical manifestations and diagnostic strategy Timothy Orchard, United Kingdom 12:15 – 12:30 IP013 Athritis, arthralgias and metabolic bone disease: Therapeutic considerations Martine De Vos, Belgium 12:30 – 12:45 IP014 Hepato-pancreatico-biliary extraintestinal manifestations: Clinical manifestations and diagnostic strategy Pascal Juillerat, Switzerland 12:45 – 13:00 IP015 Hepato-pancreatico-biliary extraintestinal manifestations: Therapeutic considerations Franck Carbonnel, France
Live Stream
Q&A
Audience Voting
Recorded Session
Postgraduate Teaching Programme : UEG Week Final Programme
Parallel Session 11:00 – 13:00 Room C2 H. pylori: From epidemiology to clinical management Chairs: John Atherton, United Kingdom Emad El-Omar, Australia
Parallel Session 14:00 – 16:30 Hall 6 Video Case Session 2: Endoscopic stenting in the upper GI tract, endoscopy in IBD and lower GI bleeding Chairs: Mario Dinis-Ribeiro, Portugal Lars Aabakken, Norway
11:00 – 11:30 IP016 The epidemiology of H. pylori infection and associated diseases Marcis Leja, Latvia
14:00 – 14:30 Esophageal stenting: Tips and tricks Manon C. W. Spaander, The Netherlands
IP024
11:30 – 12:00 IP017 H. pylori and extra-gastric diseases: Fact or fiction? Antonio Gasbarrini, Italy
14:30 – 15:00 Duodenal stenting: Tips and tricks Alessandro Repici, Italy
IP025
12:00 – 12:30 Testing for H. pylori: Who and how? Tamara Matysiak Budnik, France
IP018
15:00 – 15:30 Endoscopic management of lower GI bleeding Ian Gralnek, Israel
IP026
12:30 – 13:00 Optimal H. pylori treatment in 2017 Francis Megraud, France
IP019
15:30 – 16:00 Colonoscopic surveillance of IBD Helmut Neumann, Germany
IP027
Parallel Session 11:00 – 13:00 Room F3 Update on the management of pancreatic adenocarcinoma Chairs: Markus M. Lerch, Germany Marc G. H. Besselink, The Netherlands 11:00 – 11:30 IP020 Initial assessment of a pancreatic mass and biliary management Julia Mayerle, Germany
16:00 – 16:30 IP028 Endoscopic management of IBD related stenosis Edward Despott, United Kingdom Parallel Session 14:00 – 16:30 Room C1 Management of gastro-oesophageal reflux disease (GORD) Chairs: Albert Jan Bredenoord, The Netherlands Frank Zerbib, France
11:30 – 12:00 IP021 The limits of surgery for pancreatic adenocarcinoma Marc G.H. Besselink, The Netherlands
14:00 – 14:30 IP029 Pathophysiology: What is relevant for GORD management? André Smout, The Netherlands
12:00 – 12:30 Pain management and endoscopic palliation Asbjørn Drewes, Denmark
14:30 – 15:00 Supra-oesophageal GORD Radu Tutuian, Switzerland
IP030
15:00 – 15:30 Diagnostics: GORD phenotypes Sabine Roman, France
IP031
15:30 – 16:00 Medical management of GORD Jutta Keller, Germany
IP032
IP022
12:30 – 13:00 IP023 Chemotherapy for locally advanced and metastasized pancreatic adenocarcinoma Jean-Luc Van Laethem, Belgium
16:00 – 16:30 IP033 New surgical and endoscopic treatments for GORD Stephen Attwood, United Kingdom Live Stream
Q&A
Audience Voting
Recorded Session
37
Saturday, October 28, 2017
Saturday, October 28, 2017
UEG Week Final Programme : Postgraduate Teaching Programme
Saturday, October 28, 2017
Saturday, October 28, 2017
Parallel Session 14:00 – 16:30 Room C2 Therapy update in GI cancers Chairs: Thomas Seufferlein, Germany Rob Glynne-Jones, United Kingdom
Parallel Session 14:00 – 16:30 Room F3 Assessment of liver function: Pearls for the clinician Chairs: Laurent Castera, France Soo Aleman, Sweden
Debate 14:00 – 14:15 IP034 Adenocarcinoma of oesophagogastric junction and gastric cancer: We only need good quality surgery! Markus Schäfer, Switzerland
14:00 – 14:30 IP040 Assessment of liver function in acute liver failure Claire Francoz, France
14:15 – 14:30 IP035 Adenocarcinoma of oesophagogastric junction and gastric cancer: Neoadjuvant or perioperative treatment gives the best value for the patient! Michel Ducreux, France 14:30 – 15:00 Immunotherapy in GI cancer Markus Moehler, Germany
IP036
15:00 – 15:30 IP037 Colorectal cancer: Adjuvant treatment – according to molecular subtyping, immunoscore or simply TNM staging? Rob Glynne-Jones, United Kingdom 15:30 – 16:00 IP038 Colorectal cancer: Therapeutic strategies in metastatic colorectal cancer Dieter Hahnloser, Switzerland 16:00 – 16:30 IP039 Pancreatic ductal adenocarcinoma: Novel approaches in the adjuvant and palliative setting Jean-Luc Van Laethem, Belgium
14:30 – 15:00 IP041 Assessment of liver function in advanced chronic liver disease Jean-François Dufour, Switzerland Debates 15:00 – 15:15 IP042 How to diagnose liver cirrhosis in 2017: A liver biopsy is necessary! Karoline Lackner, Austria 15:15 – 15:30 IP043 How to diagnose liver cirrhosis in 2017: A liver biopsy is not necessary! Maja Thiele, Denmark 15:30 – 15:45 IP044 How to diagnose portal hypertension in 2017: Endoscopy and hepatic venous pressure gradient measurement are still necessary! Jaime Bosch, Spain 15:45 – 16:00 IP045 How to diagnose portal hypertension in 2017: Non-invasive tests are enough! Dominique Thabut, France Tandem Talks 16:00 – 16:15 IP046 How to assess liver function before surgery: Before general surgery Yves Panis, France 16:15 – 16:30 IP047 How to assess liver function before surgery: Before hepatic surgery Constantino Fondevila, Spain
38
Live Stream
Q&A
Audience Voting
Recorded Session
Sunday, October 29, 2017
Postgraduate Teaching Programme : UEG Week Final Programme
Postgraduate Teaching Programme Sunday, October 29, 2017 Parallel Session 08:30 – 10:30 Hall 6 All you wanted to know about coeliac disease – but did not dare to ask! Chairs: Knut E. A. Lundin, Norway Katri Kaukinen, Finland
09:30 – 10:00 Treatment options for gastroparesis Guillaume Gourcerol, France
IP056
10:00 – 10:30 Management of functional dyspepsia Tim Vanuytsel, Belgium
IP057
08:30 – 09:00 IP048 Diagnosis of coeliac disease: Clinical, serology, HLA, biopsy David Surendran Sanders, United Kingdom
Parallel Session 08:30 – 10:30 Room C2 The changing epidemiology of viral hepatitis Chairs: Michael Manns, Germany Maria Buti, Spain
09:15 – 09:30 IP050 Experimental diagnostic approaches: T-cell based assays Knut E. A. Lundin, Norway 09:30 – 10:00 Treatment of coeliac disease Carolina Ciacci, Italy
IP051
10:00 – 10:30 IP052 Follow-up of coeliac disease: What to do with non-responsive patients Jeremy Woodward, United Kingdom Parallel Session 08:30 – 10:30 Room C1 Dyspepsia and gastroparesis: How to diagnose and treat? Chairs: Jan Tack, Belgium Hans Törnblom, Sweden
Debate 08:30 – 08:45 IP058 Chronic hepatitis B: Do treatment criteria need to be expanded – Yes Thomas Berg, Germany 08:45 – 09:00 IP059 Chronic hepatitis B: Do treatment criteria need to be expanded – No Alessio Aghemo, Italy 09:00 – 09:30 IP060 How to manage hepatitis B reactivation in GI disease Rafael Esteban, Spain 09:30 – 10:00 Hepatitis E and immunosuppression Sven Pischke, Germany
IP061
10:00 – 10:30 IP062 Long term management of patients with chronic hepatitis B with nucleos(t)ide analogs (NUCs) Georgios Papatheodoridis, Greece
08:30 – 09:00 IP053 Functional dyspepsia and gastroparesis: Definitions, overlap and distinctions Daniel Pohl, Switzerland
Parallel Session 08:30 – 10:30 Room F3 Advanced diagnostic endoscopy Chairs: Horst Neuhaus, Germany Evelien Dekker, The Netherlands
Debate 09:00 – 09:15 IP054 Dyspepsia, nausea and vomiting: GI physiology tests are useful in clinical practice – Pro Jutta Keller, Germany
08:30 – 09:00 IP063 Current and future technologies for gastrointestinal endoscopy Jacques J. Bergman, The Netherlands
09:15 – 09:30 IP055 Dyspepsia, nausea and vomiting: GI physiology tests are useful in clinical practice – Con Heinz Florian Hammer, Austria Live Stream
Q&A
Audience Voting
Recorded Session
39
Sunday, October 29, 2017
Tandem Talks 09:00 – 09:15 IP049 Experimental diagnostic approaches: Antibody-based diagnosis Katri Kaukinen, Finland
UEG Week Final Programme : Postgraduate Teaching Programme
Tandem Talks 09:00 – 09:15 P064 Impact of advanced endoscopy on management of early GI neoplasia: Upper GI tract Krish Ragunath, United Kingdom 09:15 – 09:30 IP065 Impact of advanced endoscopy on management of early GI neoplasia: Lower GI tract Ana Wilson, United Kingdom Debate 09:30 – 09:45 Is cholangioscopy ready for prime time? Pro Torsten Beyna, Germany 09:45 – 10:00 Is cholangioscopy ready for prime time? Con Andrea Tringali, Italy
IP066
IP067
10:00 – 10:30 IP068 Progress in EUS based imaging and guided tissue sampling Marc Barthet, France Sunday, October 29, 2017
Parallel Session 08:30 – 10:30 Room F2 Faecal incontinence: Mechanisms, diagnostic tests and treatment Chairs: Anton Emmanuel, United Kingdom Søren Laurberg, Denmark 08:30 – 09:00 IP069 The continence mechanism and case-finding of the incontinent patient Anton Emmanuel, United Kingdom Debate 09:00 – 09:15 IP070 Physiological and radiological assessment of faecal incontinence: The tests are essential – Pro Henriette Heinrich, United Kingdom 09:15 – 09:30 IP071 Physiological and radiological assessment of faecal incontinence: The tests are essential – Con Søren Laurberg, Denmark 09:30 – 10:00 IP072 Conservative therapies: Should we use an algorithm or just try anything available? Satish Rao, USA
Sunday, October 29, 2017
Clinical Case Based Session 11:00 – 13:00 Early management of IBD Chairs: Ailsa Hart, United Kingdom Matthieu Allez, France Moderator: Stephan Vavricka, Switzerland
Hall 6
11:00 – 11:30 Case presentation: Ulcerative colitis Philip Hendy, United Kingdom
IP074
11:30 – 12:00 An overview of early ulcerative colitis Ailsa Hart, United Kingdom
IP075
12:00 – 12:30 Case presentation: Crohn’s disease Philip Hendy, United Kingdom
IP076
12:30 – 13:00 IP077 Prognostication and how it may inform management strategies in early Crohn’s disease Matthieu Allez, France Clinical Case Based Session 11:00 – 13:00 Benign causes of oesophageal dysphagia Chairs: Mark Fox, Switzerland Sabine Roman, France Moderator: Nathalie Rommel, Belgium 11:00 – 11:30 Case presentation: Achalasia Michael Hollenstein, Switzerland
Room C1
IP078
11:30 – 12:00 IP079 Clinical assessment and investigation of swallowing disorders Mark Fox, Switzerland 12:00 – 12:30 IP080 Case presentation: Eosinophilic esophagitis (EoE) Michael Hollenstein, Switzerland 12:30 – 13:00 IP081 Therapeutic management of benign oesophageal dysphagia Sabine Roman, France
10:00 – 10:30 IP073 Surgical and neuromodulation therapies: When should the GI refer and for what? Ronan O'Connell, Ireland
40
Live Stream
Q&A
Audience Voting
Recorded Session
Postgraduate Teaching Programme : UEG Week Final Programme
Clinical Case Based Session 11:00 – 13:00 Room C2 Optimising the outcome for patients with upper GI bleeding Chairs: Ian Gralnek, Israel Christopher John Hawkey, United Kingdom Moderator: Mostafa Ibrahim, Belgium
Clinical Case Based Session 11:00 – 13:00 Room F2 Management of early colorectal cancer Chairs: Simon Bach, United Kingdom Monique van Leerdam, The Netherlands Moderator: Cesare Hassan, Italy
11:00 – 11:30 IP082 Case presentation: Peptic ulcer bleeding due to NOAC Sarmed Sami, United Kingdom
11:00 – 11:30 IP090 Case presentation: Endoscopic resection of a malignant polyp in the colon Arthur Kooyker, The Netherlands
11:30 – 12:00 Bleeding peptic ulcer in 2017 Christopher John Hawkey, United Kingdom
11:30 – 12:00 Evaluation and resection of colonic lesions Monique van Leerdam, The Netherlands
IP083
12:00 – 12:30 IP084 Case presentation: Endoscopic management of gastric varices Sarmed Sami, United Kingdom 12:30 – 13:00 IP085 Management of gastric variceal haemorrhage: A sticky wicket? Ian Gralnek, Israel Clinical Case Based Session 11:00 – 13:00 Room F3 Update on GI infections for the gastroenterologist Chairs: Harry Sokol, France Christoph Högenauer, Austria Moderator: Edward Despott, United Kingdom 11:00 – 11:30 IP086 Case presentation: Acute severe hemorrhagic colitis Cecilia Landman, France
IP091
12:00 – 12:30 IP092 Case presentation: A patient with a small rectal cancer Arthur Kooyker, The Netherlands 12:30 – 13:00 Multimodality treatment of rectal cancers Simon Bach, United Kingdom
IP093
Clinical Case Based Session 11:00 – 13:00 Room A3 Management of abdominal emergencies Chairs: Josef Watfah, United Kingdom Marja A. Boermeester, The Netherlands Moderator: Tim Vanuytsel, Belgium 11:00 – 11:30 IP094 Case presentation: Acute abdomen and septic shock Jan Gooszen, The Netherlands
11:30 – 12:00 Management of infectious colitis Christoph Högenauer, Austria
IP087
11:30 – 12:00 Diagnostic work-up of the acute abdomen Marja A. Boermeester, The Netherlands
12:00 – 12:30 Case presentation: Relapsing colitis Cecilia Landman, France
IP088
12:00 – 12:30 IP096 Case presentation: Recurrent abdominal bleeding Jan Gooszen, The Netherlands
12:30 – 13:00 IP089 The clinical burden of clostridium difficile infection Harry Sokol, France
Live Stream
Q&A
Audience Voting
12:30 – 13:00 Initial management of the acute abdomen Josef Watfah, United Kingdom
Recorded Session
IP095
IP097
41
Sunday, October 29, 2017
Sunday, October 29, 2017
UEG Week Final Programme : Postgraduate Teaching Programme
Clinical Case Based Session 11:00 – 13:00 Room E4 Diagnostic work-up of a liver nodule Chairs: Dina Tiniakos, United Kingdom Jean-François Dufour, Switzerland Moderator: Christophe Moreno, Belgium 11:00 – 11:30 IP098 Case presentation: Liver nodules in non-cirrhotic liver Maria Guarino, Switzerland 11:30 – 12:00 To biopsy or not to biopsy a liver nodule? Dina Tiniakos, United Kingdom
IP099
12:00 – 12:30 IP100 Case presentation: Liver nodule in cirrhotic liver Maria Guarino, Switzerland 12:30 – 13:00 IP101 How to manage a liver nodule in a cirrhotic patient Jean-François Dufour, Switzerland
Sunday, October 29, 2017
Clinical Case Based Session 11:00 – 13:00 Room E1 Malignant biliary obstruction: Diagnostic and therapeutic approach Chairs: Paul Fockens, The Netherlands Torsten Beyna, Germany Moderator: Michael B Wallace, USA 11:00 – 11:30 Case presentation: Malignant biliary stricture Christian Gerges, Germany
IP102
11:30 – 12:00 IP103 Diagnostic approach to indeterminate biliary strictures Torsten Beyna, Germany 12:00 – 12:30 Case presentation: Benign biliary stricture Christian Gerges, Germany
IP104
12:30 – 13:00 IP105 The role of endoscopy in the treatment of (pre-)neoplastic biliary obstruction Paul Fockens, The Netherlands
Sunday, October 29, 2017
Clinical Case Based Session 11:00 – 13:00 Room E2 Best clinical practice for patients with chronic intestinal failure Chairs: André Van Gossum, Belgium Francisca Joly, France Moderator: Ioannis Papanikolaou, Greece 11:00 – 11:30 IP106 Case presentation: Intestinal adaptation of a very short gut Laure Billiauws, France 11:30 – 12:00 IP107 Chronic intestinal failure: How to promote intestinal rehabilitation André Van Gossum, Belgium 12:00 – 12:30 IP108 Case presentation: Liver abnormalities in case of short bowel syndrome Laure Billiauws, France 12:30 – 13:00 IP109 Prevention and treatment of home parenteral nutrition complications Francisca Joly, France Clinical Case Based Session 11:00 – 13:00 Room E3 Management of non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) Chairs: Helena Cortez-Pinto, Portugal Herbert Tilg, Austria Moderator: Alessio Aghemo, Italy 11:00 – 11:30 IP110 Case presentation: Non-alcoholic fatty liver disease (NAFLD) Pedro Marques Da Costa, Portugal 11:30 – 12:00 IP111 Epidemiology of ALD and NAFLD and how to differentiate between them. Implications for cardiovascular risk Helena Cortez-Pinto, Portugal 12:00 – 12:30 IP112 Case presentation: Alcoholic liver disease (ALD) Pedro Marques Da Costa, Portugal 12:30 – 13:00 IP113 Risk stratification and treatment for NAFLD and ALD Herbert Tilg, Austria
42
Live Stream
Q&A
Audience Voting
Recorded Session
Sunday, October 29, 2017
Postgraduate Teaching Programme : UEG Week Final Programme
Plenary II 14:00 – 16:00 Hall 6 Refractory IBD: How can we optimise the managment? Chairs: Iris Dotan, Israel Geert D'Haens, The Netherlands 14:00 – 14:30 IP114 Definition and mechanisms of treatment failure in clostridium difficile and ulcerative colitis Britta Siegmund, Germany
15:15 – 15:30 IP117 Optimal surgical-medical collaboration in dealing with refractory Crohn's disease: The surgical approach Yves Panis, France 15:30 – 15:45 IP118 Optimal surgical-medical collaboration in dealing with refractory ulcerative colitis: The medical approach Ailsa Hart, United Kingdom 15:45 – 16:00 IP119 Optimal surgical-medical collaboration in dealing with refractory ulcerative colitis: The surgical approach Janindra Warusavitarne, United Kingdom
Sunday, October 29, 2017
14:30 – 15:00 IP115 Taking the next step: What are the best options for patients failing second line therapy? Julian Panés, Spain
Tandem Talks 15:00 – 15:15 IP116 Optimal surgical-medical collaboration in dealing with refractory Crohn's disease: The medical approach Yoram Bouhnik, France
Improve your practical skills in Hall 8.0 Visit the ESGE (endoscopic training in cooperation with ESGENA), the Ultrasound and the Surgical Learning Areas. Find more information on pages 261–273
17_09_Inserat_UEGWEEK_FP_handson_136x62mm_RZ.indd 1 Live Stream Q&A Audience Voting Recorded
Session
14.09.17 11:3943
Keep on track with your training
Postgraduate Teaching Programme October 20–21, 2018 Vienna, Austria
Major updates
Enter the PGT 3-year curriculum! Experience two days of world-class continuing medical education for medical and surgical gastroenterologists in training and in practice. Join the 3-year cycle to get all major updates in GI & hepatology and you will be perfectly prepared for your professional career!
Increased interactivity
Full registration for UEG Week is not required.
Find out more, visit www.ueg.eu/week
Clinical cases
Scientific Programme by Day Overview Icons Live Stream Q&A Audience Voting Recorded Session
ª
Rising Star
ª
Top Abstract Prize
ª
National Scholar
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
Scientific Programme by Day Monday, October 30, 2017 Monday, October 30, 2017
Opening Session 08:00 – 10:00 Opening Session: Part I Chairs: Magnus Simrén, Sweden Michael Manns, Germany 08:00 – 08:05 Words of welcome Magnus Simrén, Sweden
Hall 6
IP120
08:05 – 08:25 IP121 How have prospective clincial trials changed the management of acute pancreatitis Marc G. H. Besselink, The Netherlands 08:25 – 08:37 OP001 DIAGNOSTIC YIELD OF “ARTIFICIAL INTELLIGENCE” -ASSISTED ENDOCYTOSCOPY FOR COLORECTAL POLYPS: A PROSPECTIVE STUDY ª Yuichi Mori, Japan; S.-E. Kudo; M. Misawa; K. Takeda; K. Ichimasa; Y. Ogawa; Y. maeda; T. Kudo; K. Wakamura; T. Hayashi; T. Baba; F. Ishida; H. Inoue; M. Oda; K. Mori 08:37 – 08:57 IP122 Inventing the future of minimally invasive therapies Jacques Marescaux, France 08:57 – 09:12 UEG Research Prize 2017 Jesper Lagergren, Sweden
IP123
09:12 – 09:22 Presidential address Michael Manns, Germany
IP124
09:22 – 09:34 OP002 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES INVERSION IN THE CTRB1-CTRB2 LOCUS TO MODIFY RISK FOR ALCOHOLIC AND NON-ALCOHOLIC CHRONIC PANCREATITIS ª Jonas Rosendahl, Germany; H. Kirsten; E. Hegyi; P. Kovacs; F. U. Weiss; H. Laumen; P. Lichtner; C. Ruffert; J.-M. Chen; E. Masson; S. Beer; C. Zimmer; K. Seltsam; A. PanEuropean Working Group on Alcoholic Chronic Pancreatitis; J. Mössner; C. Férec; P. Michl; J. P. H. Drenth; H. Witt; M. Scholz; M. Sahin-Tóth 09:34 – 09:39 Laudation UEG Lifetime Achievement Awardee Bjorn Rembacken, United Kingdom
46
IP125
09:39 – 09:44 UEG Lifetime Achievement Award 2017 Anthony Axon, United Kingdom
IP126
Tandem Talks 09:44 – 09:54 IP127 Host microbial crosstalk in IBD: The microbiologist's point of view Harry Sokol, France 09:54 – 10:04 IP128 Host microbial crosstalk in IBD: The immunologist's point of view Arthur Kaser, United Kingdom Opening Session 10:30 – 12:00 Opening Session: Part II Chairs: Magnus Simrén, Sweden Paul Fockens, The Netherlands 10:30 – 10:50 What's new in gastroenterology in 2017? C. Janneke van der Woude, The Netherlands
Hall 6
IP129
10:50 – 11:02 OP003 DIFFERENTIALLY O-GLYCOSYLATED CARBOXYL ESTER LIPASE CAUSES A MODY8-LIKE PHENOTYPE IN MICE ª Baris Mercanoglu, Germany; G. Wolters-Eisfeld; C. Güngör; J. R. Izbicki; M. Bockhorn 11:02 – 11:07 UEG Journal Best Paper Award 2017 Clive H. Wilder-Smith, Switzerland
IP130
11:07 – 11:27 What's new in endoscopy in 2017? Mario Dinis-Ribeiro, Portugal
IP131
11:27 – 11:39 OP004 BENEFITS OF H. PYLORI ERADICATION IN PREVENTING GASTRIC CANCER IN THE OLDER POPULATION: RESULTS FROM A POPULATION-BASED STUDY. ª Wai Keung Leung, Hong Kong PRC; I. O. Wong; E. W. Chan; A. Y. Wong; K. F. Yeung; L. Chen; I. C. Wong; K. S. Cheung 11:39 – 11:59 What's new in hepatology in 2017? Thomas Berg, Germany
IP132
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
Symposium 10:30 – 12:00 Room C1 Adverse food reactions: How to diagnose and manage? Chairs: Shanti Lynne Eswaran, USA Yvonne McKenzie, United Kingdom
Free Paper Session 10:30 – 12:00 Clinical trials in Crohn's disease Chairs: Raja Atreya, Germany Matthieu Allez, France
10:30 – 10:52 Allergies Alexander R. Moschen, Austria
IP133
10:30 – 10:42 State-of-the-art introduction Matthieu Allez, France
10:52 – 11:14 Carbohydrate intolerance Peter R. Gibson, Australia
IP134
11:14 – 11:36 Non-coeliac wheat sensitivity Umberto Volta, Italy
IP135
10:42 – 10:54 OP005 EFFECT OF DISEASE DURATION AND LOCATION ON CLINICAL REMISSION IN CROHN’S DISEASE PATIENTS TREATED WITH FILGOTINIB, A SELECTIVE JAK1 INHIBITOR: POST-HOC ANALYSIS FROM THE PHASE 2 FITZROY STUDY Séverine Vermeire, Belgium; A. Van der Aa; C. Jamoul; C. Tasset; P. Harrison; G. R. D'Haens
11:36 – 11:58 PANEL DISCUSSION
Symposium 10:30 – 12:00 GORD from infancy to old age Chairs: Sibylle Koletzko, Germany Frank Zerbib, France Tandem Talks 10:30 – 10:40 Clinical presentation in infants and children Carlo Di Lorenzo, USA 10:40 – 10:50 Clinical presentation in adults Radu Tutuian, Switzerland
Room C2
IP136
IP137
10:50 – 11:12 IP138 Is the pathophysiology of GORD age-dependent and if so, so what? Daniel Sifrim, United Kingdom Tandem Talks 11:12 – 11:22 Management of GORD in paediatric practice Carlo Di Lorenzo, USA
IP139
11:22 – 11:32 Management of GORD in adults Radu Tutuian, Switzerland
IP140
11:32 – 11:54 When should the surgeon step in? Stephen Attwood, United Kingdom
IP141
Live Stream
Q&A
Audience Voting
Room F3
IP142
10:54 – 11:06 OP006 EXPOSURE-RESPONSE TO SC USTEKINUMAB IN MODERATE –SEVERE CROHN’S DISEASE: RESULTS FROM THE IM-UNITI MAINTENANCE STUDY O. J. Adedokun; Z. Xu; C. Gasink; D. Jacobstein; P. Szapary; J. Johanns; L.-L. Gao; H. M. Davis; S. Hanauer; B. G. Feagan; S. Ghosh; William Sandborn, USA 11:06 – 11:18 OP007 SAFETY AND EFFICACY OF UPADACITINIB (ABT-494), AN ORAL JAK1 INHIBITOR, AS INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: RESULTS FROM CELEST William Sanborn, USA; B. Feagan; J. Panes; G. D’Haens; J.-F. Colombel; Q. Zhou; B. Huang; J. V. Enejosa; A. L. Pangan; A. P. Lacerda 11:18 – 11:30 OP008 EFFICACY AND SAFETY OF OPEN-LABEL MAINTENANCE THERAPY WITH SUBCUTANEOUS RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE Brian Feagan, Canada; J. Panés; M. Ferrante; A. Kaser; G. R. D'Haens; W. J. Sandborn; E. Louis; M. F. Neurath; D. Franchimont; O. Dewit; U. Seidler; K.-J. Kim; C. Selinger; S. J. Padula; I. Herichova; A. M. Robinson; K. Wallace; J. Zhao; A. Soaita; S. Visvanathan; D. Hall; W. O. Böcher 11:30 – 11:42 OP009 ENDOSCOPIC AND CLINICAL EFFICACY DEMONSTRATED WITH ORAL OZANIMOD IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE Brian Feagan, Canada; W. J. Sandborn; G. D'Haens; B. G. Levesque; B. E. Skolnick; C. Li; D. Penenberg; R. Aranda; A. Olson
Recorded Session
47
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
Monday, October 30, 2017
11:42 – 11:54 OP010 EXPOSURE-RESPONSE RELATIONSHIPS FOR THE EFFECT OF UPADACITINIB ON CLINICAL AND ENDOSCOPIC EFFICACY ENDPOINTS IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE – ANALYSIS OF CELEST STUDY Mohamed-Eslam Mohamed, USA; B. Klünder; A. P. Lacerda; A. A. Othman
11:15 – 11:30 IP150 Recent advances in colorectal endoscopic submucosal dissection (ESD): European curricula Alanna Ebigbo, Germany
Symposium 10:30 – 12:00 Room F2 Optimising screening colonoscopy Chairs: Cesare Hassan, Italy Brian P. Saunders, United Kingdom
11:45 – 12:00 IP152 EUS-guided gastroenterostomy: European current status and perspective Marc Barthet, France
10:30 – 10:52 Optimising bowel preparation Andrea May, Germany
IP143
10:52 – 11:14 IP144 Is adenoma detection rate the optimal quality parameter? Michal Filip Kaminski, Poland 11:14 – 11:36 IP145 Training and expertise in colonoscopy for doctors and nurses Matthew David Rutter, United Kingdom 11:36 – 11:58 New technologies Ian Gralnek, Israel
IP146
Symposium 10:30 – 12:00 Room F1 Innovative therapeutic endoscopy in Japan and Europe Chairs: Thierry Ponchon, France Haruhiro Inoue, Japan Tandem Talks 10:30 – 10:45 IP147 Cell sheet transplantation and steroid therapy to manage a severe stricture after circumferential mucosal resection in the oesophagus Naoyuki Yamaguchi, Japan 10:45 – 11:00 Biodegradable stents Manon C. W. Spaander, The Netherlands
IP148
11:00 – 11:15 IP149 Recent advances in colorectal endoscopic submucosal dissection (ESD): Technical advances Hironori Yamamoto, Japan
48
11:30 – 11:45 IP151 EUS-guided gastroenterostomy: Japanese current status and perspective Takao Itoi, Japan
Symposium 10:30 – 12:00 Fatty liver disease: Update 2017 Chairs: Frank Tacke, Germany Helen Reeves, United Kingdom
Room A2
Debate 10:30 – 10:40 IP153 Diagnosing NAFLD, NASH and ASH: We need a liver biopsy Dina Tiniakos, United Kingdom 10:40 – 10:50 IP154 Diagnosing NAFLD, NASH and ASH: We do not need a liver biopsy Laurent Castera, France 10:50 – 11:12 IP155 Long-term surveillance and management of patients with fatty liver disease Elisabetta Bugianesi, Italy 11:12 – 11:24 OP011 AN ESCHERICHIA COLI PATHOGEN ISOLATED FROM A NON-ALCOHOLIC STEATOHEPATITIS PATIENT PROMOTES THE DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN HIGH FAT DIET MICE Na Wu, China; J. Tan; J. Xu; Y. Song; F. Zhang; Y. L. Liu 11:24 – 11:36 OP012 DIET-DEPENDENT ACID LOAD IS ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE GENERAL POPULATION: THE ROTTERDAM STUDY Louise Alferink, The Netherlands; J. C. Kiefte- de Jong; N. S. Erler; J. D. Schoufour; E. J. Hoorn; M. A. Ikram; H. L. A. Janssen; H. J. Metselaar; O. H. Franco; S. Darwish Murad 11:36 – 11:58 An update on therapeutic options Vlad Ratziu, France
IP156
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
Symposium 10:30 – 12:00 Room A1 Minimal invasive approach for pancreato-hepato-biliary tumours Chairs: Marco J. Bruno, The Netherlands Robert Hawes, USA 10:30 – 10:52 Endoscopic ampullectomy Todd H. Baron, USA
IP157
10:52 – 11:14 EUS-guided and ERCP local therapy D. Nageshwar Reddy, India
IP158
11:14 – 11:36 IP159 Minimally invasive surgery: Robotic and laparoscopic surgery David Fuks, France 11:36 – 11:58 Local treatment for symptomatic liver cysts Marc Giovannini, France Symposium 10:30 – 12:00 Hot topics from Latin America Chairs: Michael Manns, Germany Enio Chaves Oliveira, Brazil
IP160
Room A3
10:30 – 10:52 IP161 Epidemiology of coeliac disease in Latin America Edgardo Smecuol, Argentina 10:52 – 11:14 Colonic diverticular disease treatment in 2017 Mauro Bafutto, Brazil
IP162
11:14 – 11:36 IP163 Diagnostic and therapeutic impact of colon capsule endoscopy in a real-life practice setting Eduardo Alfredo Gutiérrez Galiana, Uruguay 11:36 – 11:48 OP013 IN VIVO DETECTION OF COLONIC MUCOSA MICRO-INFLAMMATION BY CONFOCAL LASER ENDOMICROSCOPY PROBE (P-CLE) IN PATIENTS WITH IRRITABLE BOWEL SYNDROME. Carlos Robles-Medranda, Ecuador; M. Valero; J. Ospina; M. Puga-Tejada; G. Muñoz-Jurado; M. Soria; H. Alvarado-Escobar; R. Oleas-Narea; H. Pitanga-Lukashok 11:48 – 12:00 OP014 STRUCTURAL ANALYSIS OF VARIABILITY AND INTERACTION OF HELICOBACTER PYLORI ONCOGENIC EFFECTOR CAGA N-TERMINAL WITH PHOSPHATIDYLSERINE ª Cindy Ulloa, Colombia; M. D. P. Delgado; C. A. Jaramillo
Live Stream
Q&A
Audience Voting
Free Paper Session 10:30 – 12:00 Disease burden in IBD Chairs: Martine De Vos, Belgium Radislav Nakov, Bulgaria 10:30 – 10:42 State-of-the-art introduction Martine De Vos, Belgium
Room B2
IP164
10:42 – 10:54 OP015 IMPACT OF INTERVENTIONS FOR MODERATE TO SEVERE ULCERATIVE COLITIS ON HEALTH-RELATED QUALITY OF LIFE: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS Paschalis Paschos, Greece; A. Katsoula; O. Giouleme; M. Sarigianni; E. Athanasiadou; A. Tsapas 10:54 – 11:06 OP016 THE INCIDENCE OF MILD OPPORTUNISTIC SELF-REPORTED INFECTIONS IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES Lisa van Wijnen, The Netherlands; A. Wolters; M. J. Pierik; D. M. Jonkers; M. de Jong; A. Peters; A. A. M. Masclee; P. Steijlen; A. Tubergen 11:06 – 11:18 OP017 TREAT TO TARGET FOR CROHN’S DISEASE WITH ADALIMUMAB TREATMENT IS COST EFFECTIVE OVER 48 WEEKS: AN ECONOMIC ASSESSMENT OF THE CALM TRIAL Remo Panaccione, Canada; J.-F. Colombel; P. Bossuyt; M. Lukas; F. Baert; T. Vanásek; A. Danalıoğlu; G. Novacek; A. Armuzzi; W. Reinisch; S. Johnson; M. Davis; E. Neimark; J. Petersson; A. M. Robinson; R. Thakkar; W.-J. Lee; M. Skup 11:18 – 11:30 OP018 HEALTHCARE RESOURCE UTILIZATION AND QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS BY DISEASE SEVERITY: BASELINE DATA FROM ICONIC Subrata Ghosh, United Kingdom; L. Peyrin-Biroulet; F. Casellas; C. O'Shea; W. J. Lee; B. Pappalardo; J. Petersson 11:30 – 11:42 OP019 RISK FACTORS FOR POSTOPERATIVE INFECTION AFTER LOWER GASTROINTESTINAL SURGERY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: FINDINGS FROM A LARGE EPIDEMIOLOGICAL STUDY H. Liang; B. Jiang; Trevor Lissoos, USA; S. Manne; P. Dolin 11:42 – 11:54 OP020 DISEASE BURDEN AND FACTORS ASSOCIATED WITH ULCERATIVE COLITIS PROGRESSION IN SWEDEN J. Stålhammar; Per Hällström, Sweden; L. Agréus; H. Beydogan; L. Arnheim Dahlström; M. Skup; W.-J. Lee
Recorded Session
49
Monday, October 30, 2017
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
Translational Basic Science 10:30 – 12:00 Room B3 Neurodegenerative diseases of the GI tract: From mechanism to therapy Chairs: Nicolas Cenac, France Guy E. Boeckxstaens, Belgium
Free Paper Session 10:30 – 12:00 Room 7.1 Imaging, screening and surveillance of colorectal cancer Chairs: Jaroslaw Regula, Poland Elisabeth Waldmann, Austria
10:30 – 10:52 How do GI neurones develop? Pieter Vanden Berghe, Belgium
IP165
10:52 – 11:14 Mechanisms of neurodegeneration Keith A. Sharkey, Canada
IP166
11:14 – 11:36 IP167 Achalasia, pseudoobstruction, Hirschsprung's disease: Clinical aspects Roberto De Giorgio, Italy 11:36 – 11:58 Transplantation of neurons Nikhil Thapar, United Kingdom
IP168
Today's Science, Tomorrow's Medicine 10:30 – 12:00 Room E4 Composition and functions of the healthy gut microbiota Chairs: Manimozhiyan Arumugam, Denmark Antonio Gasbarrini, Italy 10:30 – 10:52 Composition of an healthy gut microbiota Mirjana Rajilic-Stojanovic, Serbia
IP169
10:52 – 11:14 Gut microbioita and immune development Dirk Haller, Germany
IP170
11:14 – 11:36 Gut microbiota and metabolism Fredrik Bäckhed, Sweden
IP171
11:36 – 11:58 The role of microbiota in human evolution Joel Doré, France
IP172
10:30 – 10:42 State-of-the-art introduction Jaroslaw Regula, Poland
IP173
10:42 – 10:54 OP021 DIFFERENCES IN ADENOMA AND PROXIMAL SERRATED POLYP DETECTION AND ITS EFFECT ON THE LONGTERM IMPACT OF A BIENNIAL FIT-BASED COLORECTAL CANCER SCREENING PROGRAM – A MICROSIMULATION STUDY Maxime Bronzwaer, The Netherlands; M. Greuter; A. Bleijenberg; J. IJspeert; E. Dekker; V. M. H. Coupé 10:54 – 11:06 OP022 HEAD-TO-HEAD COMPARISON OF DIAGNOSTIC PERFORMANCE OF NINE QUANTITATIVE FAECAL IMMUNOCHEMICAL TESTS FOR COLORECTAL CANCER SCREENING Anton Gies, Germany; K. Cuk; P. Schrotz-King; H. Brenner 11:06 – 11:18 OP023 ADENOMA DETECTION RATE ACCORDING TO AGE: COLONOSCOPY SCREENING SHOULD START AT 45 YEARS OLD David Karsenti, France; G. Tharsis; F. Venezia; P. Cattan; G. Tordjman; A. Gillet; K. Nahon-Uzan; J. Samama; M. Cavicchi 11:18 – 11:30 OP024 TAILORING COLONOSCOPY COLORECTAL CANCER SCREENING IN CHILDHOOD CANCER SURVIVORS: A MODELING STUDY Andrea Gini, The Netherlands; D. C. Hodgson; R. G. S. Meester; H. Keshavarz; S. Ahmed; I. Lansdorp-Vogelaar 11:30 – 11:42 OP025 FOLLOW UP OF COLORECTAL CANCER (CRC) PATIENTS INCLUDING 18FDGPET-CT (PET-CT): AN OPEN-LABEL MULTICENTER RANDOMIZED TRIAL (CLINICAL TRIAL: NCT 00624260). Iradj Sobhani, France; I. Baumgaertner; C. Tounigand; E. Ette; F. Brunetti; C. Gagniere; A. Luciani; I. Durand-Zaleski; S. Bastuji-Garin; G. ITEP Study 11:42 – 11:54 OP026 MRI TO PREDICT SUCCESSFUL SPHINCTER PRESERVATION AFTER PREOPERATIVE CHEMORADIOTHERAPY FOR DISTAL RECTAL TUMOURS. Doenja M. Lambregts, The Netherlands; J. Krdzalic; M. Maas; S. M. Engelen; J. J. van Griethuysen; G. L. Beets; R. G. H. Beets-Tan
50
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
Symposium 10:30 – 12:00 Room E1 Multidisciplinary management of liver metastases in colorectal cancer Chairs: Rodrigo Perez, Brazil Tamara Matysiak Budnik, France Tandem Talks 10:30 – 10:40 IP174 Imaging: MRI and PET-CT for all? The clinician's perspective Thomas Seufferlein, Germany 10:40 – 10:50 IP175 Imaging: MRI and PET-CT for all? The radiologist's perspective Andrew Plumb, United Kingdom 10:50 – 11:12 Strategy for liver limited metastasis Michel Ducreux, France
IP176
11:12 – 11:34 IP177 Surgery for liver metastasis: What can be achieved? Bernard Nordlinger, France 11:34 – 11:56 Loco-regional therapeutic approach Alban Denys, Switzerland
IP178
Free Paper Session 10:30 – 12:00 Room E2 Advanced endoscopic treatment of upper GI neoplasia Chairs: Alexander Meining, Germany Ping-Hong Zhou, China 10:30 – 10:42 State-of-the-art introduction Alexander Meining, Germany
IP179
10:42 – 10:54 OP027 LONG TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER IN ELDERLY PATIENTS Yu Sato, Japan; T. Michida; M. Kato; H. Saiki; Y. Tokuda; K. Yamamoto; N. Tatsumi; T. Ito 10:54 – 11:06 OP028 INCIDENCE OF SUBSEQUENT PRIMARY CANCERS AFTER ENDOSCOPIC RESECTION OF OESOPHAGEAL SQUAMOUS CELL CARCINOMAS Mitsuhiro Nikaido, Japan; S. Miyamoto; M. Muto; T. Setoyama; T. Horimatsu; H. Seno
Live Stream
Q&A
Audience Voting
11:06 – 11:18 OP029 SHOULD TAKING BIOPSY SAMPLES FROM APPARENTLY NON-CANCEROUS TISSUES AROUND THE LESION BE PERFORMED TO DETERMINE RESECTION MARGINS BEFORE GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION? Masayuki Shibata, Japan; N. Kawata; K. Takizawa; N. Kakushima; M. Tanaka; M. Yoshida; S. Ito; K. Imai; H. ishiwatari; K. Hotta; H. Matsubayashi; H. Ono 11:18 – 11:30 OP030 ARGON PLASMA COAGULATION FOR THE TREATMENT OF EARLY ESOPHAGEAL AND GASTRIC TUMORS IN HIGH-RISK PATIENTS: A RETROSPECTIVE, MULTICENTER, COLLABORATIVE STUDY Satoshi Tanabe, Japan; H. Nagase; Y. Sato; T. Sagawa; M. Murakami; K. Niimi; M. Fujishiro; J. Fujisaki; H. Doyama; N. Muguruma; Y. Takeda; K. Ishido; C. Katada 11:30 – 11:42 OP031 PHASE II STUDY OF COLD SNARE POLYPECTOMY FOR SUPERFICIAL NON-AMPULLARY DUODENAL EPITHELIAL TUMOR (D-CSP TRIAL) Kohei Takizawa, Japan; N. Kakushima; M. Tanaka; N. Kawata; M. Yoshida; K. Imai; S. Ito; H. ishiwatari; K. Hotta; H. Matsubayashi; K. Mori; H. Ono 11:42 – 11:54 OP032 ENDOSCOPIC AMPULLECTOMY FOR NON-INVASIVE AMPULLARY LESIONS: A SINGLE-CENTRE 10 YEAR RETROSPECTIVE COHORT STUDY Richard Lee, Australia; A. Huelsen; L. Hourigan Free Paper Session 10:30 – 12:00 Room E3 Diagnosis and management of cirrhosis: Unmet needs Chairs: Jasmohan S. Bajaj, USA Michael Trauner, Austria 10:30 – 10:42 State-of-the-art introduction Jasmohan S. Bajaj, USA
IP180
10:42 – 10:54 OP033 VON WILLEBRAND FACTOR ANTIGEN IS LINKED TO BACTERIAL TRANSLOCATION, INFLAMMATION, AS WELL AS PROCOAGULANT IMBALANCE AND PREDICTS COMPLICATIONS OF CIRRHOSIS INDEPENDENTLY OF PORTAL HYPERTENSION SEVERITY Mattias Mandorfer, Austria; P. Schwabl; R. Paternostro; K. Pomej; J. Thaler; C. Ay; M. Fritzer-Szekeres; P. Quehenberger; M. Trauner; M. Peck-Radosavljevic; T. Reiberger; A. Ferlitsch
Recorded Session
51
Monday, October 30, 2017
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
10:54 – 11:06 OP034 CLASS 1 OBESITY IS ASSOCIATED WITH INCREASED RISK FOR PORTAL VEIN THROMBOSIS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS: A NATIONWIDE ANALYSIS P. T. Kroener; J. E. Corral; Juan Gutierrez, Uruguay; M. A. D'assunção; I. Jovanovic; G. Schwingel; K. Mönkemüller
10:54 – 11:06 OP040 EROSIVE ESOPHAGITIS IS PREVALENT AND PREDICTABLE BY PRE-OPERATIVE GERDQ QUESTIONNAIRE IN OBESE INDIVIDUALS AND IS ASSOCIATED WITH THE NEED FOR CONTINUED PPI USE AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY A. I. Sharara; Hussein Rimmani, Lebanon; A. I. Al Abbas; B. Safadi; R. H. Shayto; H. Aridi; Y. Shaib; R. Alami
11:06 – 11:18 OP035 EVALUATION OF CONTROLLED ATTENUATED PARAMETER (CAP) FOR ASSESSMENT OF LIVER STEATOSIS IN AN UNSELECTED POPULATION: A SINGLE CENTER REAL LIFE EXPERIENCE Stephan Baumeler, Switzerland; I. Bergamin; B. Becker; W. Jochum; J. Neuweiler; D. Semela 11:18 – 11:30 OP036 A RANDOMIZED CONTROLLED TRIAL COMPARING NITAZOXANIDE PLUS LACTULOSE VERSUS LACTULOSE ALONE IN TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY. Sherief Abd-Elsalam, Egypt; R. badawi; N. Elwan; A. Elfert 11:30 – 11:42 OP037 DIAGNOSTIC ACCURACY OF ANATOMIC CT ANGIOGRAPHY-BASED VIRTUAL HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH PORTAL HYPERTENSION Xiaolong Qi, China; J. Hou; W. An; R. Qi; L. Wang; Y. Liu; C. Liu; C. Liu; Y. Xiang; J. Hui; Z. Liu; Y. Zhao; Y. Zhu; J. Huang; J. Chen; J. Zhao; W. Xiong; J. Dong; X. Qi; G. Si; B. Liu; J. Wei; J. Zhou; J. Tian; G. Li; X. He; Y. Yang; F. Liu; Z. Li; G. Chess 11:42 – 11:54 OP038 EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) ON MORTALITY AND COMPLICATIONS VIZ. SEPSIS, ENCEPHALOPATHY, HEPATORENAL SYNDROME, AND GASTROINTESTINAL BLEED IN SEVERE ALCOHOLIC HEPATITIS- A RANDOMIZED CONTROLLED STUDY. Abhinav Sharma, India; A. Setia; R. R. Rai Free Paper Session 10:30 – 12:00 Bariatric surgery, obesity and weight loss Chairs: Giles Major, United Kingdom Mario Morino, Italy 10:30 – 10:42 State-of-the-art introduction Mario Morino, Italy
Room B5
IP181
10:42 – 10:54 OP039 INTRAGASTRIC BALLOON-INDUCED WEIGHT LOSS PRIOR TO SURGERY IN SUPER-OBESE PATIENTS – A SINGLE CENTER EXPERIENCE Irina Mocanu, Portugal; A. Laranjo; S. Pires; N. Veloso; I. Medeiros; M. Rocha; S. Silva; M. Amaro; M. Carvalho 52
11:06 – 11:18 OP041 DEFECTS IN ENTEROENDOCRINE CELL DEVELOPMENT IN MORBIDLY OBESE HUMANS ARE NORMALIZED AFTER SLEEVE GASTRECTOMY Anne Christin Meyer-Gerspach, Switzerland; A. W. Moran; B. K. Wölnerhanssen; G. Burdyga; R. Peterli; M. Manz; M. Thumshirn; K. Daly; C. Beglinger; S. P. Shirazi-Beechey 11:18 – 11:30 OP042 A WEIGHT LOSS INTERVENTION REDUCES BOWEL SYMPTOMS: A PROSPECTIVE STUDY IN SUBJECTS WITH MORBID OBESITY Martin Aasbrenn, Norway; S. Lydersen; P. Gronaas Farup 11:30 – 11:42 OP043 DYNAMICS OF DECREASE OF ABDOMINAL FAT AFTER BARIATRIC SURGERY: A NONINVASIVE ASSESSMENT OVER 24 MONTHS BY MRI Anne Christin Meyer-Gerspach, Switzerland; B. K. Wölnerhanssen; D. Nabers; M. Moor; S. Borgwardt; R. Peterli; C. Beglinger; O. Bieri 11:42 – 11:54 OP044 FINAL RESULTS OF MULTI-CENTER, PROSPECTIVE, CONTROLLED TRIAL OF THE DUODENO-JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN OBESE PATIENTS: EFFICACY AND FACTORS PREDICTING A SUBOPTIMAL EFFECT Marek Benes, Czech Republic; P. Drastich; T. Hucl; J. Spicak Free Paper Session 10:30 – 12:00 Hotspot Abstracts on Fire: Advances in endoscopic resection of early colorectal neoplasia Chairs: Michael John Bourke, Australia Mathieu Pioche, France 10:30 – 10:40 OP045 UNDERWATER ENDOSCOPIC COLORECTAL POLYP RESECTION IS A SAFER AND MORE EFFECTIVE TECHNIQUE THAN GAS INSUFFLATION POLYPECTOMY FOR EVERYDAY CLINICAL PRACTICE Mauro Liggi, Italy; S. Cadoni; P. Gallittu; D. Mura; M. Koo
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
10:40 – 10:50 OP046 HAS THE SAFETY OF COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION BEEN MAINTAINED EVEN IN THE REGIONAL GENERAL HOSPITAL IN JAPAN? : A MULTICENTER PROSPECTIVE COHORT STUDY Yuko Hiraga, Japan; S. Tanaka; S. Oka; K. Boda; S. Nagata; M. Kunihiro; R. Higashi; T. Kuwai; A. Furudoi; K. Nakadoi; H. Kanao; M. Terasaki; H. Okanobu; M. Higashiyama; K. Chayama 10:50 – 11:00 OP047 WHAT ARE THE RESULTS OF RECTAL ESD IN FRANCE : A LARGE RETROSPECTIVE MULTICENTRE STUDY IN EXPERTS CENTERS Jeremie Albouys, France; M.-A. Guillaumot; V. Lepilliez; S. Chaussade; M. Pioche; S. Leblanc; M. Barret; R. Legros; F. Prat; J. Rivory; D. Sautereau; T. Ponchon; J. Jacques 11:00 – 11:10 OP048 EFFICACY OF TRACTION-ASSISTED COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION USING CLIP AND THREAD: A PROSPECTIVE RANDOMIZED STUDY Yasushi Yamasaki, Japan; Y. Takeuchi; N. Uedo; T. Kanesaka; R. Ishihara; H. Okada; H. Iishi 11:10 – 11:20 OP049 EFFICACY OF ENDOSCOPIC SUBMUCOSAL DISSECTION USING THE “CLIP-FLAP METHOD” FOR COLORECTAL TUMORS Katsumi Yamamoto, Japan; S. Hayashi; H. Saiki; T. Nishida; N. Tatsumi; T. Michida; T. Ito 11:20 – 11:30 OP050 EFFICACY AND SAFETY OF ENDOSCOPIC FULL-THICKNESS RESECTION IN THE COLORECTUM WITH THE FTRD SYSTEM– INTERIM RESULTS OF A GERMAN REGISTRY. Arthur Schmidt, Germany; B. Meier; A. Fischer; M. Wegener; T. Wiedbrauck; M. Repp; G. Fitzel; G. Hübner; D. Albers; B. Schumacher; A. Erhardt; K. Gutberlet; A. Bielich; D. Scholz; M. Caselitz; T. Frieling; M. Breidert; C. Rasch; K. Fellermann; K. Caca 11:30 – 11:40 OP051 MINIMISING THE RISK OF DELAYED BLEEDING IN COLONIC ENDOSCOPIC SUBMUCOSAL DISSECTION: IS THERE A ROLE FOR A NOVEL HAEMOSTATIC PEPTIDE? Sharmila Subramaniam, United Kingdom; K. Kandiah; A. Fujimoto; N. Yahagi; T. Uraoka; P. Bhandari 11:40 – 11:50 OP052 ENEMA OF MESENCHYMAL STEM CELL CULTURE SUPERNATANT PREVENTS RECTAL STRICTURE FORMATION AFTER CIRCUMFERENTIAL ENDOSCOPIC SUBMUCOSAL DISSECTION IN PIGS Momoko Tsuda, Japan; S. Ohnishi; T. Mizushima; S. Abiko; Y. Shimizu; N. Sakamoto
Live Stream
Q&A
Audience Voting
11:50 – 12:00 OP053 A NOVEL TEMPERATURE-RESPONSIVE, BIODEGRADABLE AND INJECTABLE COLLAGEN SOL FOR ENDOSCOPIC CLOSURE OF COLONIC PERFORATION HOLE: AN ANIMAL STUDY. Toshio Uraoka, Japan; S. Kinoshita; S. Yunoki; T. Narita; Y. Takatori; H. Mori; Y. Hirai; S. Banno; Y. Kubosawa; Y. Sunata; M. Shimoda; N. Yahagi Round Table Discussion 12:45 – 13:45 Clinical management of cholangiopathies Chair: Michael Trauner, Austria Experts: Olivier Chazouillères, France Annarosa Floreani, Italy Celso Matos, Belgium Michael Trauner, Austria
Room A2
Round Table Discussion 12:45 – 13:45 Room A3 Pitfalls in the diagnosis of coeliac disease Chair: Sibylle Koletzko, Germany Experts: Lars Agréus, Sweden Sibylle Koletzko, Germany Kalle Kurppa, Finland David Surendran Sanders, United Kingdom Round Table Discussion 12:45 – 13:45 Room B2 Challenging cases of walled-off necrosis following acute pancreatitis Chair: Thomas Rösch, Germany Experts: Ross Carter, United Kingdom Ulrike Denzer, Germany Thomas Rösch, Germany Hjalmar van Santvoort, The Netherlands Round Table Discussion 12:45 – 13:45 Room B3 A young patient with chronic right lower quadrant pain Chair: Dieter Hahnloser, Switzerland Experts: Alessandro Armuzzi, Italy Marja A. Boermeester, The Netherlands Shanti Lynne Eswaran, USA Dieter Hahnloser, Switzerland
Recorded Session
53
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
Symposium 12:45 – 13:30 Hotspot Cross-cultural differences and challenges for a career choice in GI Chair: Marianna Arvanitakis, Belgium 12:45 – 13:00 IP182 Trans-european training in GI: Getting the best by crossing frontiers Isabelle Cremers, Portugal 13:00 – 13:15 Training in GI outside Europe Naima Amrani, Morocco
IP183
13:15 – 13:30 IP184 Local issues regarding training in GI: Does everybody get the same? Marcel Tantau, Romania Symposium 14:00 – 15:30 Best of DDW Chairs: Michael Manns, Germany Sheila Eileen Crowe, USA
Hall 6
Monday, October 30, 2017
14:22 – 14:44 IP191 How can we prevent and detect early IBD related cancers? Laurence Egan, Ireland 14:44 – 15:06 Drug related cancers in IBD Vito Annese, Italy
IP192
15:06 – 15:28 IP193 IBD management in a patient with a recent cancer Krisztina Barbara Gecse, Hungary Symposium 14:00 – 15:30 Room C2 Management of early Barrett's neoplasia: When and how to resect or ablate? Chairs: Raf Bisschops, Belgium Marcia Irene Canto, USA Tandem Talks 14:00 – 14:10 IP194 Detection and characterisation of early Barrett's neoplasia; Endoscopy Krish Ragunath, United Kingdom
14:00 – 14:18 Liver John Vierling, USA
IP185
14:10 – 14:20 IP195 Detection and characterisation of early Barrett's neoplasia: Histopathology Michael Vieth, Germany
14:18 – 14:36 Oesophagus and upper GI John Y. Kao, USA
IP186
14:20 – 14:42 Optimising endoscopic resection Alexander Meining, Germany
14:36 – 14:54 IBD Dario Sorrentino, USA
IP187
14:54 – 15:12 Pancreatic disorders Rodger A. Liddle, USA
IP188
15:12 – 15:30 Oncology Linda Rabeneck, Canada
IP189
Symposium 14:00 – 15:30 Cancer and IBD Chairs: Franck Carbonnel, France Martine De Vos, Belgium 14:00 – 14:22 Who are the patients at risk? Laurent Beaugerie, France 54
Room C1
IP190
IP196
14:42 – 15:04 IP197 Ablation of neoplasia and non-neoplastic Barrett's epithelium Jacques J. Bergman, The Netherlands 15:04 – 15:26 Approach to local recurrence Pierre Henri Deprez, Belgium
IP198
Symposium 14:00 – 15:30 Room F3 Therapy update: Hepatocellular carcinoma (HCC) in 2017 Chairs: Alejandro Forner, Spain Helen Reeves, United Kingdom 14:00 – 14:22 HCC standard of care 2017 Arndt Vogel, Germany
IP199
14:22 – 14:44 Surgery and liver transplantation for HCC Patrizia Burra, Italy
IP200
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
14:44 – 15:06 Immunotherapy for HCC? Olivier Rosmorduc, France
IP201
15:06 – 15:28 IP202 Is there an increased risk of HCC after hepatitis C virus clearance? Maria Reig, Spain Symposium 14:00 – 15:30 Room F2 How to manage malignant duodenal obstruction? Chairs: Ulf Peter Neumann, Germany Bas L. A. M. Weusten, The Netherlands 14:00 – 14:22 Endoscopic stenting Peter D. Siersema, The Netherlands
IP203
14:22 – 14:44 EUS-guided creation of a gastroenteric bypass Takao Itoi, Japan
IP204
14:44 – 15:06 Surgery Giovanni Zaninotto, United Kingdom
IP205
15:06 – 15:30 PANEL DISCUSSION
Symposium 14:00 – 15:30 Room F1 From guidelines to clinical practice: Functional bowel disorders Chairs: Hans Törnblom, Sweden Fermin Mearín Manrique, Spain 14:00 – 14:22 Dietary management of IBS in adults Yvonne McKenzie, United Kingdom
IP206
14:22 – 14:44 Chronic constipation in adults Daniel Pohl, Switzerland
IP207
14:44 – 15:06 Management of constipation in children Carlo Di Lorenzo, USA
IP208
15:06 – 15:28 Hamonising European research on IBS Daisy Mae Jonkers, The Netherlands
IP209
Live Stream
Q&A
Audience Voting
Symposium 14:00 – 15:30 ERCP: The "difficult" patient Chairs: Marcel Tantau, Romania Marianna Arvanitakis, Belgium
Room A2
14:00 – 14:22 ERCP in pregnancy Jeanin E. van Hooft, The Netherlands
IP210
14:22 – 14:44 ERCP in the elderly Stefan Seewald, Switzerland
IP211
14:44 – 15:06 ERCP in the intensive care patient Robert Hawes, USA
IP212
Tandem Talks 15:06 – 15:16 ERCP in children: Indications Filippo Torroni, Italy 15:16 – 15:26 ERCP in children: Technique Guido Costamagna, Italy Free Paper Session 14:00 – 15:30 Imaging and endoscopy in IBD Chairs: Cathage Moran, Ireland Pascal Juillerat, Switzerland 14:00 – 14:12 State-of-the-art introduction Cathage Moran, Ireland
IP213
IP214
Room A1
IP215
14:12 – 14:24 OP054 EARLY MUCOSAL HEALING IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS TREATED WITH GOLIMUMAB PREDICTS FAVORABLE OUTCOMES: DATA FROM THE REAL LIFE BE-SMART COHORT. Peter Bossuyt, Belgium; F. Baert; F. D’Heygere; A. Nakad; E. Louis; F. fontaine; D. Franchimont; O. Dewit; P. Van Hootegem; S. Vanden Branden; G. Lambrecht; M. Ferrante 14:24 – 14:36 OP055 PREDICTION OF CLINICAL OUTCOMES IN CROHN’S DISEASE BY USING CONFOCAL LASER ENDOMICROSCOPY: A PROSPECTIVE MULTICENTER STUDY. Gian Eugenio Tontini, Italy; J. Mudter; M. Vieth; C. Günther; V. Milani; R. Atreya; T. Rath; A. Nägel; G. Hatem; G. C. Sturniolo; M. Vecchi; M. F. Neurath; P. R. Galle; A. Buda; H. Neumann
Recorded Session
55
Monday, October 30, 2017
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
14:36 – 14:48 OP056 HISTOLOGICAL PREDICTORS OF RELAPSE IN ULCERATIVE COLITIS: WHICH FEATURES MATTER MOST? Begona Gonzalez Suarez, USA; E. U. Yee; T. Zenlea; L. Rosenberg; K. S. Nande; J. D. Goldsmith; A. C. Moss
14:24 – 14:36 OP061 BACTERIAL MODULATION OF INTESTINAL INNATE ACTIVATION INDUCED BY WHEAT AMYLASE TRYPSIN INHIBITORS (ATIS) IN NOD-DQ8 MICE. Victor F. Zevallos, Germany; J. McCarville; A. Caminero; E. Verdu; D. Schuppan
14:48 – 15:00 OP057 DEVELOPMENT AND VALIDATION OF THE “MINI INDEX” (MUCOSAL INFLAMMATION -NON INVASIVE INDEX) FOR CROHN’S DISEASE ON A LARGE PROSPECTIVE PEDIATRIC COHORT ª A. Ben Shoham; Maarten Cozijnsen, The Netherlands; B. Kang; B.-H. Choe; Y. H. Choe; R. K. Russell; F. M. Ruemmele; J. C. Escher; L. de Ridder; S. Koletzko; J. Martin de Carpi; J. S. Hyams; T. D. Walters; A. M. Griffiths; D. Turner 15:00 – 15:12 OP058 LITTLE BENEFIT OF ENDOSCOPIC BASED THERAPEUTIC MANAGEMENT IN POSTOPERATIVE RECURRENT CROHN'S DISEASE: RESULTS OF A RETROSPECTIVE STUDY. Pauline Rivière, France; S. Vermeire; G. Van Assche; P. Rutgeerts; A. de Buck Van Overstraeten; A. Wolthuis; A. D'Hoore; M. Ferrante 15:12 – 15:24 OP059 TOFACITINIB FOR MAINTENANCE THERAPY IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS IN THE PHASE 3 OCTAVE SUSTAIN TRIAL: RESULTS BY LOCAL AND CENTRAL ENDOSCOPIC ASSESSMENTS Brian Feagan, Canada; S. Vermeire; W. J. Sandborn; W. Reinisch; J. Panés; D. Tarabar; C. Su; W. Niezychowski; H. Zhang; G. Friedman; D. Woodworth; B. E. Sands Free Paper Session 14:00 – 15:30 Late breaking abstracts I
Room A3
Free Paper Session 14:00 – 15:30 Room B2 Coeliac disease and wheat-related disorder Chairs: Kalle Kurppa, Finland Michael Schumann, Germany 14:00 – 14:12 State-of-the-art introduction Kalle Kurppa, Finland
IP216
14:12 – 14:24 OP060 GLUTEN INGESTION AND INTRADERMAL INJECTION OF PEPTIDES THAT ACTIVATE GLUTEN-SPECIFIC CD4+ T CELLS ELICIT A CYTOKINE SIGNATURE DOMINATED BY INTERLEUKIN-2 IN CELIAC DISEASE J. A. Tye-Din; J. J. Dzuris; A. K. Russell; S. Wang; K. E. Goldstein; L. J. Williams; Robert Anderson, USA
56
14:36 – 14:48 OP062 HLA-DQ:GLUTEN TETRAMER TEST IN BLOOD GIVES BETTER DETECTION OF CELIAC PATIENTS THAN BIOPSY AFTER 14-DAY GLUTEN CHALLENGE Vikas Sarna, Norway; G. I. Skodje; H. M. Reims; L. F. Risnes; S. Dahal-Koirala; L. Sollid; K. E. A. Lundin 14:48 – 15:00 OP063 RAPID HOME TESTS THAT REVEAL GLUTEN FREE DIET TRANSGRESSIONS Alfonso Rodriguez-Herrera, Spain; R. Domínguez-Flores; C. Sousa; A. Muñoz-Suano; M. Arévalo-Rodríguez; F. León; A. Cebolla 15:00 – 15:12 OP064 ‘CELIAC-LITE SCORE’: A PREDICTIVE SCORE OF RESPONSE TO A GLUTEN-FREE DIET IN PATIENTS WITH LYMPHOCYTIC ENTERITIS AND SUSPICION OF COELIAC DISEASE Fernando Fernández-Bañares, Spain; A. Carrasco; M. Rosinach; B. Arau; R. García-Puig; C. González; Y. Zabana; M. Esteve 15:12 – 15:24 OP065 EFFECTIVE GLUTEN DEGRADATION IN NON-COELIAC GLUTEN-SENSITIVE SUBJECTS BY ASPERGILLUS NIGER DERIVED ENZYME: A PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL Julia König, Sweden; S. Holster; M. J. Bruins; R. J. Brummer Translational Basic Science 14:00 – 15:30 Room B3 The gut microbiome: A key regulator of serotonin synthesis in the gut-brain axis Chairs: Robin Spiller, United Kingdom Muriel Derrien, France 14:00 – 14:22 IP217 Revealing the secrets of serotonin signalling in the gut Gary M Mawe, USA 14:22 – 14:44 IP218 The gut microbiome and host serotonin synthesis Mirjana Rajilic-Stojanovic, Serbia 14:44 – 15:06 IP219 The neurobiology of gut-brain axis disorders: Focus on serotonin and tryptophan metabolism Gerard Clarke, Ireland
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
15:06 – 15:28 IP220 Targeting the serotonin system in Irritable Bowel Syndrome: What have we learned?I Lesley Houghton, United Kingdom Today's Science, Tomorrow's Medicine 14:00 – 15:30 Room E4 TSTM Free Paper: New concepts in host-microbiota crosstalks Chairs: Johannes Roksund Hov, Norway Franco Scaldaferri, Italy 14:00 – 14:12 OP066 EXOSOMES RELEASED FROM INTESTINAL EPITHELIAL CELLS INFECTED WITH CROHN’S DISEASE-ASSOCIATED ADHERENT-INVASIVE E. COLI TRANSFER MIRNAS INTO RECIPIENT CELLS TO INHIBIT AUTOPHAGY ªª Anaïs Larabi, France; J. Carriere; G. Dalmasso; J. Delmas; N. Barnich; H. T. T. Nguyen 14:12 – 14:24 OP067 DIETARY EMULSIFIERS DIRECTLY IMPACT THE TRANSCRIPTOME OF A CROHN’S DISEASE-ASSOCIATED ESCHERICHIA COLI, INCREASING ITS ABILITY TO INDUCE INTESTINAL INFLAMMATION Benoit Chassaing, USA; A. T. Gewirtz 14:24 – 14:36 OP068 GUT DYSBIOSIS CAN LEAD TO VISCERAL HYPERSENSITIVITY AND DEPRESSION IN GERM-FREE RATS Lu Zhang, China; J. Zhang; S. Zhu; W. Zhang; L. Duan 14:36 – 14:48 OP069 INFLAMMATION MODULATION BY STOMACH MICROBIOTA VIA TLR2 /NF-κB SIGNALING PATHWAY IN HP-INDUCED GASTRIC CANCER ª Yini Dang, China; G. Zhang 14:48 – 15:00 OP070 CARD9 MEDIATES SUSCEPTIBILITY TO INTESTINAL PATHOGENS THROUGH MICROBIOTA MODULATION AND CONTROL OF BACTERIAL VIRULENCE. Bruno Lamas, France; M. L. Richard; M.-L. Michel; N. Waldschmitt; V. Zacharioudaki; M. Delacre; J. M. Natividad; G. Da Costa; J. Planchais; C. Bridonneau; P. Langella; M. Chamaillard; H. Sokol 15:00 – 15:12 OP071 A C-TYPE LECTIN TRIGGERS IMMUNE SURVEILLANCE BY INNATE LYMPHOID CELLS FOR ERADICATION OF ATTACHING-AND-EFFACING BACTERIA Nadine Waldschmitt, France; S. Kitamoto; T. Secher; V. Zacharioudaki; E. Floquet; M. Delacre; B. Lamas; P. Pham; A. Six; M. L. Richard; J.-C. Dagorn; P. Langella; G. Eberl; B. Ryffel; J. L. Iovanna; L. F. Poulin; H. Sokol; N. Kamada; M. Chamaillard
Live Stream
Q&A
Audience Voting
15:12 – 15:24 OP072 STUDY ON THE ANTI-INFLAMMATORY MECHANISMS OF ROSEBURIA INTESTINALIS MEDIATED BY INDUCING THE DIFFERENTIATION OF THE TREG CELLS VIA TLR5 OF THE INTESTINAL EPITHELIAL CELLS IN INFLAMMATORY BOWEL DISEASE Zhaohua Shen, China; C. Zhu; Y. Quan; W. Yuan; Z. Yang; S. Wu; X. Wang Free Paper Session 14:00 – 15:30 Room 7.1 IBS: Searching for biomarkers Chairs: Henriette Heinrich, United Kingdom Nathalie Vergnolle, France 14:00 – 14:12 State-of-the-art introduction Nathalie Vergnolle, France
IP221
14:12 – 14:34 IP222 SEARCHING FOR BIOLOGICAL FACTORS IN A BIOPSYCHOSOCIAL MODEL OF IRRITABLE BOWEL SYNDROME Yukari Tanaka, Japan 14:34 – 14:46 OP073 IBS PATIENTS HAVE LOWER LEVELS OF COLONIC MUCOSAL PRO-INFLAMMATORY CYTOKINES WHICH REMAIN STABLE OVER TIME Bradley Schmidt, USA; G. Saffouri; J. Chen; H. Lekatz; M. Grover; D. Knights; G. Farrugia; P. Kashyap 14:46 – 14:58 OP074 STRESS REGULATES SPECIFIC SEX-RELATED MOLECULAR ALTERATIONS IN EPITHELIAL BARRIER REGULATORY GENES IN THE JEJUNAL MUCOSA OF HEALTHY VOLUNTEERS Bruno Kotska Rodiño Janeiro, Spain; M. PIGRAU; A. Nieto; T. Pribic; L. Hernández; E. Salvo-Romero; B. Lobo Alvarez; A. M. González-Castro; M. Fortea; M. Gallart; C. Pardo-Camacho; I. de Torres; C. Martinez; D. Guagnozzi; T. Pérez-Berezo; F. Azpiroz; M. Vicario; J. Santos; C. Alonso Cotoner 14:58 – 15:10 OP075 ACUTE STRESS IMPACTS CLOCK GENES AND BARRIER INTEGRITY IN THE INTESTINAL MUCOSA IN HEALTH. Marc Pigrau Pastor, Spain; B. K. Rodiño Janeiro; E. Salvo Romero; A. Nieto; L. Hernández; T. Pribic; B. Lobo Alvarez; A. M. González-Castro; M. Fortea; C. Pardo-Camacho; D. Guagnozzi; C. Martinez; T. Pérez-Berezo; I. de Torres; F. Azpiroz; M. Vicario; C. Alonso Cotoner; J. Santos
Recorded Session
57
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
15:10 – 15:22 OP076 DIFFERENT RELATIONSHIPS BETWEEN INTESTINAL PARASITES AND BACTERIAL RICHNESS AND DIVERSITY IN INDIVIDUALS WITH IRRITABLE BOWEL SYNDROME AND HEALTHY CONTROLS Laura Rindom Krogsgaard, Denmark; L. O´Brien Andersen; T. Bech Johannesen; A. L. Engsbro; C. Rune Stensvold; N. Larsen; H. Vedel Nielsen; P. Bytzer Symposium 14:00 – 15:30 Room E1 Hereditary colorectal cancer: From genes to clinic Chairs: Yasmijn van Herwaarden, The Netherlands Luigi Ricciardiello, Italy 14:00 – 14:22 IP223 New colorectal cancer predisposing genes in 2017 Ian Tomlinson, United Kingdom 14:22 – 14:44 Genetic testing for whom? Karin Dahan, Belgium
IP224
14:44 – 15:06 IP225 Controversies in endoscopic surveillance strategies Michael Bretthauer, Norway 15:06 – 15:28 IP226 Surgical perspectives of hereditary colorectal cancer Gabriela Möslein, Germany Free Paper Session 14:00 – 15:30 Room E2 Advances in endoscopic imaging: What does the future hold? Chairs: Fabian Emura, Colombia Oliver Pech, Germany
Monday, October 30, 2017
14:36 – 14:48 OP079 THE MOLECULAR BASIS OF 5-AMINOLEVULINIC ACID (ALA) MEDIATED LASER-BASED PHOTODYNAMIC ENDOSCOPIC DIAGNOSIS (LPDED) FOR DIVERSE EARLY GASTRIC CANCER Hiroki Kurumi, Japan; K. Ogihara; T. Kanda; K. Yashima; K. Kawaguchi; K. Matsumoto; Y. Takeda; H. Isomoto 14:48 – 15:00 OP080 VISUALIZATION OF ABSORBED LIPID IN NORMAL DUODENAL EPITHELIUM BY MAGNIFYING ENDOSCOPY WITH NARROW-BAND IMAGING: AN OPEN-LABEL, RANDOMIZED, CONTROLLED STUDY Haruhiko Takahashi, Japan; K. Yao; T. Nagahama; M. Miyaoka; T. Ueki 15:00 – 15:12 OP081 APPLICATION OF VIRTUAL REALITY IN ENDOSCOPY Alexander Hann, Germany; B. Walter; S. Schmidt; A. Meining 15:12 – 15:24 OP082 ARE WE MISSING OPPORTUNITIES TO DIAGNOSE UPPER GASTROINTESTINAL CANCER AT ENDOSCOPY? Sue Priestley, United Kingdom; B. Ashall; V. Theis; A. Bassi Free Paper Session 14:00 – 15:30 Room E3 Challenges in pancreatic and biliary surgery Chairs: Johanna Laukkarinen, Finland Hjalmar van Santvoort, The Netherlands 14:00 – 14:12 State-of-the-art introduction Johanna Laukkarinen, Finland
IP228
IP227
14:12 – 14:24 OP083 INTERLEUKIN-13 RECEPTOR α2 PREDICTS PROGNOSIS IN SURGICALLY RESECTED PANCREATIC CANCER PATIENTS Toshio Fujisawa, Japan; H. Isayama
14:12 – 14:24 OP077 ENDOSCOPIC MACROSCOPIC TYPE IS A SIGNIFICANT PREDICTOR FOR HISTOLOGICAL TYPES OF EARLY GASTRIC CANCER Takashi Kanesaka, Japan; T. Nagahama; N. Uedo; H. Doyama; T. Ueo; K. Uchita; H. Ishikawa; K. Yao
14:24 – 14:36 OP084 PERFORMANCE OF A MULTIDISCIPLINARY TEAM IN PREDICTING AND MANAGING RESECTABLE PANCREATIC CANCER Shailendra Singh, USA; B. Rao; A. Gulati; M. Garg; A. Kulkarni; M. Mitre; K. Farah; S. Morrissey; M. Dhawan; S. Thakkar
14:00 – 14:12 State-of-the-art introduction Oliver Pech, Germany
14:24 – 14:36 OP078 IRREGULARLY BRANCHED MICROVESSELS ARE A RELIABLE MARKER FOR PREDICTING DEEP SUBMUCOSAL INVASION OF SUPERFICIAL ESOPHAGEAL CANCER WITH MAGNIFYING ENDOSCOPY Yoichiro Ono, Japan; Y. Takaki; K. Yao; S. Ishikawa; M. Miyaoka; T. Nagahama; H. Fumihito; T. Ueki; T. Matsui; H. Tanabe; A. Ohta; S. Haraoka; A. Iwashita; K. Mikami; T. Maekawa 58
14:36 – 14:48 OP085 DEFECTS IN PROTEIN PROCESSING MAY UNDERLIE THE DEVELOPMENT OF HEPATIC CYSTS IN PATIENTS WITH POLYCYSTIC LIVER DISEASE. Liyanne van de Laarschot, The Netherlands; S. A. B. Hermsen; T. F. Wijnants; E. S. Wills; H. J. Wessels; J. P. H. Drenth
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
14:48 – 15:00 OP086 A DEDICATED BILIARY THEATRE LIST IMPROVES EARLY DEFINITIVE MANAGEMENT AND REDUCES READMISSIONS IN ACUTE GALLSTONE PANCREATITIS Matthew Goldsworthy, United Kingdom; P. J. Gardiner; R. A. Adair; A. M. Smith; C. Macutkiewicz 15:00 – 15:12 OP087 GENERATION AND TRANSPLANTATION OF BIOENGINEERED BILE DUCTS FOR RECONSTRUCTION OF THE EXTRAHEPATIC BILIARY TREE Fotis Sampaziotis, United Kingdom; A. Justin; O. Tysoe; S. Sawiak; E. Godfrey; S. Upponi; N. L. Berntsen; L. Valestrand; T. H. Karlsen; E. Melum; A. Markaki; K. Saeb-Parsy; L. Vallier 15:12 – 15:24 OP088 A SYSTEMATIC REVIEW ON THE DEVELOPMENT OF MALIGNANCY IN 2904 PATIENTS WITH CONGENITAL CHOLEDOCHAL MALFORMATION Anneke ten Hove, The Netherlands; J. B. F. Hulscher; V. E. de Meijer; R. H. J. de Kleine Free Paper Session 14:00 – 15:30 Drugs, liver and pancreas Chairs: Carolina Ciacci, Italy Omid Sadr-Azodi, Sweden 14:00 – 14:12 State-of-the-art introduction Omid Sadr-Azodi, Sweden
Room B5
IP229
14:24 – 14:36 OP090 SCREENING RATE FOR HEPATITIS B VIRUS AMONG CANCER PATIENTS RECEIVING CHEMOTHERAPY IN TAIWAN: A NATIONWIDE POPULATION-BASED STUDY Wei Chih Sun, Taiwan; K.-H. LIN; H.-C. YU; W.-C. CHEN; W.-L. TSAI; H.-H. CHAN; P.-I. HSU; H.-C. LIN; P.-L. TANG; J.-S. CHENG 14:36 – 14:48 OP091 NODULAR REGENERATIVE HYPERPLASIA IN INFLAMMATORY BOWEL DISEASE: LOW IMPACT IN DAILY PRACTICE Melek Simsek, The Netherlands; B. Meijer; K. H. N. de Boer; C. J. J. Mulder 14:48 – 15:00 OP092 CAN MESALAZINE AFFECT THE PROGNOSIS OF ACUTE PANCREATITIS? EVIDENCE FROM THE INTESTINE L. Huang; W. Yang; Jing Li, China; Y. Tai; C. Ye; S. Tang; C. Tang Q&A
15:12 – 15:24 OP094 CLINICAL SIGNIFICANCE OF PATHOGENIC CTRC, CFTR AND SPINK1 MUTATIONS IN CHILDHOOD-ONSET PANCREATITIS (DATA ANALYSIS FROM APPLE STUDY) ª Balazs Nemeth, Hungary; A. Parniczky; C. Pienar; M. Sahin-Toth; P. Hegyi Symposium 14:00 – 15:30 Hotspot Clinical trials revisited: Antibiotics in lower GI diseases – Should they be used? Chair: Antonio Gasbarrini, Italy 14:00 – 14:15 IP230 Trial presentation: Randomised clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis Marja A. Boermeester, The Netherlands 14:15 – 14:30 Critical review Giovanni Barbara, Italy
IP231
14:30 – 14:45 PANEL DISCUSSION
14:12 – 14:24 OP089 A NOVEL IN VITRO TEST FOR CAUSALITY ASSESSMENT IN POLYMEDICATED PATIENTS WITH DRUG-INDUCED LIVER INJURY: CASES WITH DRUG RECHALLENGE Andreas Benesic, Germany; D. Dragoi; I. Rotter; M.-L. Buchholtz; A. Leitl; A. L. Gerbes
Live Stream
15:00 – 15:12 OP093 STATINS AND RISK OF ACUTE PANCREATITIS – A META-ANALYSIS OF OBSERVATIONAL STUDIES Goran Poropat, Croatia; L. Archibugi; T. Korpela; K. Cardenas-Jaen; E. de-Madaria; G. Capurso
Audience Voting
Giovanni Barbara, Italy Marja A. Boermeester, The Netherlands Charles H. Knowles, United Kingdom Anne Peery, USA 14:45 – 15:00 IP232 Trial presentation: Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant Irritable Bowel Syndrome Satish Rao, USA 15:00 – 15:15 Critical review Alexander Charles Ford, United Kingdom
IP233
15:15 – 15:30 PANEL DISCUSSION
Alexander Charles Ford, United Kingdom Jutta Keller, Germany Satish Rao, USA Jan Tack, Belgium
Recorded Session
59
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
Symposium 15:45 – 17:15 Hall 6 How to define therapeutic response in Crohn's disease? Chairs: Siew Chien Ng, Hong Kong PRC Raja Atreya, Germany
Monday, October 30, 2017
Symposium 15:45 – 17:15 Managing collections in acute pancreatitis Chairs: Markus M. Lerch, Germany Jacques Deviere, Belgium
Room C2
15:45 – 16:07 IP234 Therapeutic objectives: Clinical features and biomarkers Alessandro Armuzzi, Italy
15:45 – 16:07 IP242 Is there a need for early interventions for acute collections? Hjalmar van Santvoort, The Netherlands
16:07 – 16:29 IP235 The role of endoscopy in the assessment of therapeutic response Oliver Pech, Germany
16:07 – 16:29 IP243 Abdominal compartment syndrome: Diagnosis and treatment Sandra van Brunschot, The Netherlands
16:29 – 16:51 IP236 The role of imaging in the assessment of therapeutic response Francesca Maccioni, Italy
16:29 – 16:51 IP244 Timing and indications for interventions in walled-off necrosis: Do we need fine needle aspiration? Enrique de-Madaria, Spain
16:51 – 17:13 IP237 Are we ready for patient reported outcome measures? Johan Burisch, Denmark
16:51 – 17:13 IP245 Walled-off necrosis: Which technique is best and which route to choose? Ross Carter, United Kingdom
Symposium 15:45 – 17:15 Room C1 The severly constipated patient not responding to standard therapies: What to do? Chairs: Lin Chang, USA Robin Spiller, United Kingdom Tandem Talks 15:45 – 15:55 IP238 Diagnostic approach: The gastroenterologist's view Mark Fox, Switzerland
Symposium 15:45 – 17:15 Room F3 Therapy update: Prevention and treatment of endoscopic complications Chairs: Andrea May, Germany Pierre Eisendrath, Belgium 15:45 – 16:07 IP246 Polypectomy, endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) Alessandro Repici, Italy
15:55 – 16:05 Diagnostic approach: The radiologist's view Andrew Plumb, United Kingdom
IP239
16:05 – 16:27 Optimising medical and behavioral therapy José Maria Remes-Troche, Mexico
IP240
16:07 – 16:29 IP247 Peroral endoscopic myotomy (POEM) and pneumatic dilatation Guido Costamagna, Italy IP248
16:27 – 16:49 Surgical treatment options Emma Carrington, United Kingdom
IP241
16:29 – 16:51 ERCP D. Nageshwar Reddy, India 16:51 – 17:13 EUS-guided interventions Paul Fockens, The Netherlands
IP249
16:49 – 17:15 PANEL DISCUSSION
60
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
Free Paper Session 15:45 – 17:15 Room F2 Clinical trials in ulcerative colitis Chairs: Krisztina Barbara Gecse, The Netherlands Christoph Högenauer, Austria
Symposium 15:45 – 17:15 Room F1 From guidelines to clinical practice: Coeliac disease Chairs: Kalle Kurppa, Finland Edgardo Smecuol, Argentina
15:45 – 15:57 State-of-the-art introduction Christoph Högenauer, Austria
15:45 – 16:07 IP251 When to consider coeliac disease in primary care? Lars Agréus, Sweden
IP250
15:57 – 16:09 OP095 TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF ULCERATIVE COLITIS: OPEN-LABEL, LONG-TERM EXTENSION STUDY G. R. Lichtenstein; E. V. Loftus Jr; Stuart Bloom, United Kingdom; N. Lawendy; G. Friedman; H. Zhang; W. Wang; A. J. Thorpe; C. Nduaka; C. Su
16:07 – 16:29 Optimal diagnostic approach Michael Schumann, Germany
IP252
16:29 – 16:51 When to question the diagnosis? Sibylle Koletzko, Germany
IP253
16:09 – 16:21 OP096 SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH OZANIMOD, AN ORAL S1P RECEPTOR MODULATOR, IN MODERATE TO SEVERE ULCERATIVE COLITIS: TOUCHSTONE EXTENSION 2-YEAR FOLLOW-UP William Sandborn, USA; B. G. Feagan; G. D'Haens; S. Hanauer; D. C. Wolf; S. Vermeire; S. Ghosh; C. Li; D. Penenberg; A. Petersen; R. Aranda; A. Olson
16:51 – 17:13 Monitoring: Who and how? Katri Kaukinen, Finland
IP254
16:21 – 16:33 OP097 VEDOLIZUMAB DEMONSTRATES EARLY SYMPTOMATIC IMPROVEMENT IN ULCERATIVE COLITIS: A GEMINI 1 POST HOC ANALYSIS Brian Feagan, Canada; K. Lasch; J. M. Khalid; C. Cao; A. M. Wojtowicz; A. James; J.-F. Colombel 16:33 – 16:45 OP098 INDIGO NATURALIS IS EFFECTIVE FOR INDUCING CLINICAL REMISSION AND MUCOSAL HEALING IN PATIENTS WITH ULCERATIVE COLITIS (INDIGO STUDY) Makoto Naganuma, Japan; S. Sugimoto; K. Mitsuyama; T. Kobayashi; N. Yoshimura; K. Matsuoka; T. Hisamatsu; K. Watanabe; T. Abe; Y. Suzuki; T. Hibi; T. Kanai 16:45 – 16:45 OP099 SUBMUCOSAL INJECTION OF THE RNA OLIGONUCLEOTIDE STNM01 IN ACTIVE ULCERATIVE COLITIS INDUCES MUCOSAL HEALING AND REVERSES TISSUE REMODELING Raja Atreya, Germany; T. Kühbacher; M. J. Waldner; S. Hirschmann; O. Drvarov; R. A. Hashem; C. Maaser; T. Kucharzik; J. Dinter; J. Mertens; C. Schramm; B. Holler; J. Mössner; K. Suzuki; N. Yokoyama; S. Terai; H. Yoneyama; H. Asakura; T. Hibi; M. F. Neurath 16:45 – 16:57 OP100 EARLY RELAPSE OF ULCERATIVE COLITIS AFTER DISCONTINUATION OF TREATMENT IN PATIENTS RESPONDING TO GOLIMUMAB P. J. Hamlin; S. Sebastian; P. Irving; D. R. Gaya; C. Wheeler; A. Rose; G. Gillespie; Chris Probert, United Kingdom Live Stream
Q&A
Audience Voting
Symposium 15:45 – 17:15 Alcoholic liver disease: Anything new? Chairs: Markus Cornberg, Germany John Vierling, USA
Room A2
15:45 – 16:07 An easy diagnosis? Christophe Moreno, Belgium
IP255
16:07 – 16:29 Natural history Helena Cortez-Pinto, Portugal
IP256
16:29 – 16:41 OP101 TARGETING LIVER INFLAMMATION USING MINCLE-TARGETED LIPOSOMES AS A NOVEL DRUG DELIVERY SYSTEM ª M. Szachniewicz; M. Bartneck; F. Tacke; Ruchi Bansal, The Netherlands 16:41 – 16:53 OP102 IGA ANTIBODIES AGAINST FILAMENTOUS-ACTIN ARE FREQUENTLY DETECTED IN PATIENTS WITH CIRRHOSIS AND INDICATE A PROGRESSIVE DISEASE COURSE T. Tornai; B. Balogh; N. Sipeki; Z. Vitalis; I. Tornai; P. Antal-Szalmas; G. L. Norman; T. Bruns; Mária Papp, Hungary Debate 16:53 – 17:03 IP257 Steroids are still useful to treat acute acoholic hepatitis Alexandre Louvet, France 17:03 – 17:13 IP258 Steroids are contraindicated in acute acoholic hepatitis Patrizia Burra, Italy
Recorded Session
61
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
Symposium 15:45 – 17:15 Room A1 H. pylori eradication: Unanswered questions Chairs: Marcis Leja, Latvia Jan Bornschein, Germany 15:45 – 16:07 Optimal age to treat Xavier Calvet Calvo, Spain
IP259
16:07 – 16:29 IP260 Should every H. pylori positive person undergo eradication treatment? Peter Malfertheiner, Germany 16:29 – 16:51 IP261 Widespread use of antibiotics: The public health perspective Marcis Leja, Latvia 16:51 – 17:13 Do we need to test for resistance? Francis Megraud, France Free Paper Session 15:45 – 17:15 Late breaking abstracts II Free Paper Session 15:45 – 17:15 ERCP: When the going gets tough Chairs: Erwan Bories, France Michael John Bourke, Australia 15:45 – 15:57 State-of-the-art introduction Michael John Bourke, Australia
IP262
Room A3
Room B2
IP263
15:57 – 16:09 OP103 SELF-CONFORMABLE COVERED VS SELF-CONFORMABLE UNCOVERED METALLIC STENTS IN THE PALLIATIVE TREATMENT OF MALIGNANT EXTRA-HEPATIC BILIARY STRICTURE: A MULTICENTRIC RANDOMIZED STUDY Benedetto Mangiavillano, Italy; A. De Ceglie; R. Filiberti; A. Caruso; L. De Luca; S. Signorelli; M. Marini; P. Ravelli; A. Parodi; R. Conigliaro; M. Conio
Monday, October 30, 2017
16:21 – 16:33 OP105 UTILITY OF NEWLY DEVELOPED SHORT TYPE DOUBLE BALLOON ENDOSCOPY FOR ERCP IN POSTOPERATIVE PATIENTS WITH SURGICAL ANATOMIC VARIATIONS; A LARGE CASE SERIES Masaaki Shimatani, Japan; M. Tokuhara; M. Masuda; S. Miyamoto; M. Sakao; H. Miyoshi; T. Ikeura; M. Takaoka; K. Uchida; K. Okazaki 16:33 – 16:45 OP106 AN INTERNATIONAL, MULTICENTER, COMPARATIVE TRIAL OF EUS-GUIDED GASTROGASTROSTOMY-ASSISTED ERCP VERSUS ENTEROSCOPY-ASSISTED ERCP IN PATIENTS WITH ROUX-EN-Y GASTRIC BYPASS ANATOMY Majidah Bukhari, USA; A. A. Siddiqui; J. Nieto; R. Kunda; N. K. Ahuja; S. S. Irani; A. Shah; T. Kowalski; D. Loren; O. I. Brewer Gutierrez; O. Sanaei; L. Fayad; Y.-I. Chen; S. Ngamruengphong; V. Kumbhari; Y. Haito-Chavez; V. Singh; H. Dakour Aridi; M. A. Khashab 16:45 – 16:57 OP107 AN INTERNATIONAL MULTICENTER STUDY ON DIGITAL SINGLE OPERATOR CHOLANGIOSCOPY FOR THE MANAGEMENT OF DIFFICULT BILE DUCT STONES IN 407 PATIENTS Olaya Brewer Gutierrez, USA; S. Ngamruengphong; N. Bekkali; I. Raijman; R. Sturgess; D. V. Sejpal; H. D. Aridi; S. Sherman; R. J. Shah; R. Kwon; J. L. Buxbaum; C. Zulli; W. Wassef; D. G. Adler; V. Kushnir; A. Y. Wang; K. Krishnan; V. Kaul; D. Tzimas; C. J. DiMaio; S. Ho; B. T. Petersen; M. S. Lee; B. J. Elmunzer; G. Webster; Y. I. Chen; L. K. Dwyer; S. Inamdar; V. B. Patrick; A. Attwell; A. Hosmer; C. Ko; A. Maurano; A. Sarkar; L. J. Taylor; M. H. Gregory; D. S. Strand; A. Raza; S. Kothari; J. P. Harris; N. Kumta; A. Manvar; M. Topazian; Y. N. Lee; C. M. Spiceland; M. A. Bukhari; O. Sanaei; M. A. Khashab 16:57 – 17:09 OP108 ERCP WITH PANCREATOSCOPY-GUIDED LASER LITHOTRIPSY FOR CHRONIC PANCREATITIS COMPLICATED BY PANCREATIC DUCT STONES: A FIVE YEAR SINGLE CENTER EXPERIENCE Apostolos Malachias, Greece; D. Kypraios; S. Stavrinidis; S. L. Hatzinicolaou; D. Dimitroulopoulos; G. Sofianidis; D. Xinopoulos
16:09 – 16:21 OP104 CLINICAL EFFICACY OF ANTI-MIGRATION FEATURES IN FULLY-COVERED SELF-EXPANDABLE METALLIC STENTS FOR ANASTOMOTIC BILIARY STRICTURES AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE COHORT COMPARISON OF STANDARD AND ANTI-MIGRATION STENTS. Benoit Bordacahar, France; M. Barret; M.-A. Guillaumot; O. Scatton; F. Perdigao; S. Leblanc; S. Chaussade; F. Prat
62
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
Translational Basic Science 15:45 – 17:15 Immunotherapy in cancer Chairs: Markus Moehler, Germany Laurence Egan, Ireland 15:45 – 16:07 What is immunotherapy and how to study it? Pierre Coulie, Belgium
Room B3
15:57 – 16:19 IP273 New prevention strategy for colorectal cancer ~metformin chemoprevention Takuma Higurashi, Japan
IP264
16:19 – 16:31 OP109 LONG-TERM USE OF ASPIRIN IS MORE EFFECTIVE TO REDUCE THE INCIDENCES OF GASTROINTESTINAL CANCERS THAN NON-GASTROINTESTINAL CANCERS: A 10-YEAR POPULATION-BASED STUDY IN HONG KONG Kelvin Kf Tsoi, Hong Kong PRC; F. C. Chan; H. W. Hirai; J. J. Y. Sung
16:07 – 16:29 IP265 Manipulation of the immune system: Lessons learned from IBD Matthieu Allez, France 16:29 – 16:51 IP266 Cross-talk between microbiome and immunotherapy Patricia Lepage, France 16:51 – 17:13 Applications of immunotherapy in GI cancer Eric Van Cutsem, Belgium Today's Science, Tomorrow's Medicine 15:45 – 17:15 Microbiota crosstalk in health Chairs: Giovanni Barbara, Italy Dario Sorrentino, USA 15:45 – 16:07 Microbiota and the mucoepithelial system Malin Johansson, Sweden
IP267
Room E4
IP268
16:07 – 16:29 IP269 Rising Star: Gut microbiota and immune co-development Charlotte Hedin, Sweden 16:29 – 16:51 IP270 Microbiota and the neuroenteric/neuroendocrine systems Roberto De Giorgio, Italy 16:51 – 17:13 IP271 Microbial interactions – with the host and with each other Manimozhiyan Arumugam, Denmark Free Paper Session 15:45 – 17:15 Sporadic and hereditary colon cancer Chairs: Jaroslaw Regula, Poland Tomer Adar, USA 15:45 – 15:57 State-of-the-art introduction Jaroslaw Regula, Poland Live Stream
Q&A
Room 7.1
16:31 – 16:43 OP110 USE OF ASPIRIN AFTER CURATIVE SURGERY CAN REDUCE MORTALITY DUE TO COLORECTAL CANCER: A 10-YEAR POPULATION-BASED STUDY IN HONG KONG J. JY Sung, Hong Kong PRC; F. C. Chan; H. W. Hirai; K. Kf Tsoi 16:43 – 16:55 OP111 COLORECTAL CANCER INCIDENCE IN PATIENTS WITH LYNCH SYNDROME: FIRST REPORT OF A MULTICENTER NATION-WIDE STUDY Ariadna Sánchez García, Spain; M. Navarro; T. Ocaña; M. Pineda; L. Moreno; F. Rodriguez Moranta; A. Soriano Izquierdo; T. Ramon y Cajal; G. Llort; C. Yagüe; M. D. Pico Sala; R. Jover; A. Lopez Fernandez; E. Martinez de Castro; C. Alvarez Urturi; X. Bessa Casserras; L. Rivas; D. Rodríguez-Alcalde; A. Dacal Rivas; M. Herraiz; C. Garau Colom; L. Bujanda Fernández de Piérola; L. Cid Gómez; C. Poves; M. Garzon-Benavides; Á. E. Pizarro Moreno; I. Salces; M. Ponce; M. Carrillo Palau; E. Aguirre; E. Saperas Franch; A. Virgili; D. Fisas; V. Piñol; G. Jung; S. Carballal; L. Rivero Sánchez; M. Pellisé Urquiza; M. Serra; J. Balmana; G. Capella; J. Brunet; A. Castells; L. Moreira; F. Balaguer 16:55 – 17:07 OP112 CLINICAL AND MOLECULAR CHARACTERIZATION OF LYNCH-LIKE SYNDROME Maria Dolores Pico Sala, Spain; R. Jover; M. Giner-Calabuig; M. Alustiza; J. L. Soto; A. Castillejo; A. B. Sánchez; A. Sánchez García; F. Balaguer; L. Moreira; A. Castells; M. Pellisé Urquiza; T. Ramon y Cajal; M. Carrillo Palau; G. Llort; C. Yagüe; A. Lopez Fernandez; J. Balmana; E. Martinez de Castro; C. Alvarez Urturi; X. Bessa Casserras; L. Rivas; D. Rodríguez-Alcalde; A. Dacal Rivas; M. Herraiz; C. Garau Colom; L. Bujanda Fernández de Piérola; L. Cid Gómez; C. Poves; M. Garzon-Benavides; Á. E. Pizarro Moreno; A. Gomez; I. Salces; M. Ponce; E. Aguirre; E. Saperas Franch; V. Piñol; M. Serra
IP272
Audience Voting
Recorded Session
63
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
Symposium 15:45 – 17:15 How to treat duodenal adenomas? Chairs: Helmut Messmann, Germany Krish Ragunath, United Kingdom
Room E1
15:45 – 16:07 Endoscopic resection Bas L. A. M. Weusten, The Netherlands
IP274
16:07 – 16:29 Endoscopic papillectomy Robert Hawes, USA
IP275
16:29 – 16:51 How to manage local recurrence? Alexander Meining, Germany
IP276
16:51 – 17:13 Surgery Marco Del Chiaro, Sweden
IP277
Free Paper Session 15:45 – 17:15 Room E2 Gluten-related disorders Chairs: Imran Aziz, Sweden David Surendran Sanders, United Kingdom 15:45 – 15:57 State-of-the-art introduction David Surendran Sanders, United Kingdom
IP278
15:57 – 16:09 OP113 THE PREVALENCE OF NON-CELIAC GLUTEN SENSITIVITY IN PATIENTS WITH ABDOMINAL PAIN AND BLOATING M. Di Stefano; G. Di Fede; Irene Benedetti, Italy; M. Bresciani; C. Pedroni; A. Gabriele; M. Bergonzi; E. V. Pesatori; G. F. Manfredi; G. R. Corazza 16:09 – 16:21 OP114 PROSPECTIVE EVALUATION OF TRANSGLUTAMINASE ANTIBODY CUT-OFF LIMITS TO PREDICT SCREEN-DETECTED COELIAC DISEASE Ilma Rita Korponay-Szabo, Hungary; J. Gyimesi; G. Castillejo; S. Vriezinga; R. Auricchio; A. Chmielewska; K. Werkstetter; P. Crespo; C. Hartman; E. Martinez; P. Szillat; H. Szajewska; I. Polanco; R. Shamir; S. Koletzko; C. Ribes Koninckx; R. Troncone; M. L. Mearin Manrique 16:21 – 16:33 OP115 RECTO-SIGMOID SENSORIMOTOR ACTIVITY IN SELF-REPORTED NON-CELIAC GLUTEN SENSITIVITY: A COMPARISON WITH IRRITABLE BOWEL SYNDROME AND HEALTHY VOLUNTEERS. M. Di Stefano; I. Benedetti; E. V. Pesatori; G. F. Manfredi; Manuela Bergonzi, Italy; E. Pagani; B. Valvo; E. Miceli; G. R. Corazza
64
Monday, October 30, 2017
16:33 – 16:45 OP116 RISK OF LYMPHOMAS AND GASTROINTESTINAL CARCINOMAS AFTER A DIAGNOSIS OF CELIAC DISEASE BASED ON A NATIONWIDE POPULATION-BASED CASE-CONTROL STUDY. Tom van Gils, The Netherlands; P. Nijeboer; L. I. H. Overbeek; M. Hauptmann; D. A. R. Castelijn; G. Bouma; C. J. J. Mulder; F. E. van Leeuwen; D. de Jong 16:45 – 16:57 OP117 THE ROLE OF TMPRSS6 VARIANT RS855791 IN IRON-REFRACTORY IRON DEFICIENCY ANAEMIA (IRIDA) IN CELIAC DISEASE Nicola Imperatore, Italy; R. Tortora; L. De Falco; A. Iolascon; N. Gerbino; D. Nudo; L. Montesano; F. Nastro; N. Caporaso; A. Rispo 16:57 – 17:09 OP118 SAFETY AND TOLERABILITY, IMMUNOLOGICAL AND INTESTINAL EFFECTS, AND PHARMACOKINETICS (PK) OF DOSE TITRATION PRECEDING MAINTENANCE DOSES OF NEXVAX2® IN HLA-DQ2.5+ CELIAC DISEASE (CED) A. J. Daveson; H. Ee; J. M. Andrews; T. King; K. E. Goldstein; L. J. Williams; A. Treohan; M. P. Cooreman; Robert Anderson, USA Free Paper Session 15:45 – 17:15 General hepatology Chairs: Ivana Mikolasevic, Croatia Georgios Papatheodoridis, Greece 15:45 – 15:57 State-of-the-art introduction Georgios Papatheodoridis, Greece
Room E3
IP279
15:57 – 16:09 OP119 HIGH TUMOR RECURRENCE AFTER HEPATITIS C TREATMENT WITH ORAL DIRECT ACTING ANTIVIRALS IN PATIENTS WITH HISTORY OF HEPATOCELLULAR CARCINOMA IN COMPLETE REMISSION ª Beatriz Merchan Gomez, Spain; M. Maroto Castellanos; M. J. Devesa Medina; L. Redero Brioso; S. Izquierdo Rubio; E. Rey 16:09 – 16:21 OP120 BRG1 POSITIVELY REGULATES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY IN MICE. Baocai Wang, Germany; M. Lu; K. Benedikt; N. Hüser; S. Zhong; G. von Figura; D. Hartmann 16:21 – 16:33 OP121 HVPG AND TRANSIENT ELASTOGRAPHY ARE THE BEST PROGNOSTIC FACTOR IN PATIENTS WITH HEPATOCELLULAR CARCINOMA SUBMITTED TO HEPATIC RESECTION Bogdan Dumitru Procopet, Romania; E. Mois; A. Horhat; A. Bugariu; H. Stefanescu; F. Graur; M. Tantau; N. Al Hajjar
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
16:33 – 16:45 OP122 INNOVATIVE THERAPEUTIC EFFICACY OF A NOVEL REIC/DKK-3 EXPRESSING ADENOVIRAL VECTOR FOR HEPATOCELLULAR CARCINOMA Hiroaki Sawahara, Japan; H. Shiraha; D. Uchida; H. Kato; A. Oyama; M. Mandai; T. Mimura; M. Watanabe; M. Sakaguchi; T. Yagi; Y. Nasu; H. Kumon; H. Okada 16:45 – 16:57 OP123 EFFECT OF INTERFERON FREE DIRECT ACTING ANTIVIRAL THERAPY FOR HEPATITIS C VIRUS IN THE CARDIAC CONDUCTION SYSTEM Olga Neva López-García, Spain; D. García-Arribas; M. J. Devesa Medina; C. Olmos; J. Higueras Nafría; B. Merchan Gomez; S. Izquierdo Rubio; F. Cuenca Alarcón; M. Maroto Castellanos; E. Rey 16:57 – 17:09 OP124 NON-ALCOHOLIC STEATOHEPATITIS IS THE MOST RAPIDLY GROWING INDICATION FOR LIVER TRANSPLANTATION IN IRANIAN PATIENTS ª Ahad Eshraghian, Iran; S. Nikeghbalian; S. A. Taghavi; M. R. Fattahi; S. Ali Malek-Hosseini Free Paper Session 15:45 – 17:15 Room B5 Upper GI motility and brain-gut interactions Chairs: Fernando Azpiroz, Spain Henriette Heinrich, United Kingdom 15:45 – 15:57 State-of-the-art introduction Fernando Azpiroz, Spain
IP280
15:57 – 16:09 OP125 RESPONSES TO GASTRIC GAS IN PATIENTS WITH FUNCTIONAL GASTRODUODENAL DISORDERS ELBA NOEMI CABALLERO DE GARCIA, Spain; B. BENSLAIMAN SEYID-JEBARI; J. SERRA PUEYO
16:33 – 16:45 OP128 RELAMORELIN IN PATIENTS WITH DIABETIC GASTROPARESIS: EFFICACY AND SAFETY RESULTS FROM A PHASE 2B RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 12-WEEK STUDY (RM-131-009) Michael Camilleri, USA; R. W. McCallum; J. Tack; S. C. Spence; K. Gottesdiener; F. T. Fiedorek 16:45 – 16:57 OP129 THE ACCURACY OF ALCAT 5 IN DIAGNOSING NON-CELIAC GLUTEN SENSITIVITY IN FUNCTIONAL PATIENTS WITH ABDOMINAL PAIN AND BLOATING M. Di Stefano; Irene Benedetti, Italy; M. Bresciani; A. Gabriele; M. Deamici; E. V. Pesatori; G. F. Manfredi; M. Bergonzi; C. Torre; C. Pedroni; D. Iozzi; G. L. Marseglia; G. Di Fede 16:57 – 17:09 OP130 CHRONIC INTESTINAL PSEUDO-OBSTRUCTION IN CHILDREN: THE EARLY OUTCOMES OF THE NATIONAL PAEDIATRIC PSEUDOOBSTRUCTION DIAGNOSTIC SERVICE IN QUATERNARY CARE SETTING. Anna Rybak, United Kingdom; K. Larmour; E. Saliakellis; J. Brind; K. Lindley; F. Valitutti; O. Borrelli; N. Thapar Symposium 15:45 – 17:15 E-Poster Lounge 1 Moving GI education into the future: Current challenges, future needs Chairs: Heinz Florian Hammer, Austria Isabelle Cremers, Portugal 15:45 – 16:00 Translating the Blue Book into practice Ian Barrison, United Kingdom 16:00 – 16:15 PANEL DISCUSSION
16:09 – 16:21 OP126 INTRAGASTRIC FRUCTOSE INFUSION AND EMOTIONAL STATE INTERACT IN HOMEOSTATIC AND HEDONIC BRAIN REGIONS Julie Iven, Belgium; J. Biesiekierski; D. Zhao; E. Deloose; L. Van Oudenhove; J. Tack
16:15 – 16:30 How to assess effectiveness of education Heinz Florian Hammer, Austria
16:21 – 16:33 OP127 DDP-4 INHIBITOR, VILDAGLIPTIN INHIBITS GASTRIC ACCOMMODATION AND FOOD INTAKE IN HUMANS Alessandra ROTONDO, Belgium; J. Biesiekierski; I. Masuy; J. Tack
16:45 – 17:00 How to educate patients: New approaches C. Janneke van der Woude, The Netherlands
Live Stream
Q&A
Audience Voting
IP281
IP282
16:30 – 16:45 PANEL DISCUSSION
IP283
17:00 – 17:15 PANEL DISCUSSION
Recorded Session
65
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Scientific Programme by Day
Monday, October 30, 2017
Monday, October 30, 2017
Symposium 15:45 – 17:15 E-Poster Lounge 2 Rising Stars in pancreatology from Europe and the USA Chairs: Luigi Ricciardiello, Italy Linda Rabeneck, Canada
Symposium 15:45 – 17:15 Hotspot Progress in the management of cholangiocarcinoma Chair: Daniel Bléro, Belgium
15:45 – 15:50 Words of welcome Luigi Ricciardiello, Italy
15:45 – 15:48 Introduction Daniel Bléro, Belgium
IP292
15:50 – 15:53 IP285 Introduction of Marc Besselink, UEG Rising Star 2011 Thomas M. Gress, Germany
15:48 – 15:53 Diagnosis of early disease is challenging! Stefan Seewald, Switzerland
IP293
15:53 – 16:08 Multicenter research in acute pancreatitis Marc G. H. Besselink, The Netherlands
15:53 – 16:08
IP284
IP286
PANEL DISCUSSION
16:08 – 16:13 Cholangioscopy is not really useful! Jörg Albert, Germany
16:08 – 16:16 Questions and answers 16:16 – 16:19 IP287 Introduction of Vinciane Rebours, UEG Rising Star 2017 Luigi Ricciardiello, Italy
16:13 – 16:28 PANEL DISCUSSION
16:19 – 16:34 IP288 Effect of inflammation on pancreatic cancer development Vinciane Rebours, France
16:28 – 16:33 Endoscopy is only palliative! Andrea Tringali, Italy
16:34 – 16:42 Questions and answers
16:33 – 16:48
16:42 – 16:45 IP289 Introduction of Laura D. Wood, AGA Research Scholar Linda Rabeneck, Canada
16:48 – 16:53 Surgery – as always – is the only solution! Ulf Peter Neumann, Germany
16:45 – 17:00 IP290 Characterisation of the moment of invasion in pancreatic cancer Laura D. Wood, USA
16:53 – 17:08
66
IP295
PANEL DISCUSSION
17:00 – 17:08 Questions and answers 17:08 – 17:13 Closing remarks Linda Rabeneck, Canada
IP294
IP296
PANEL DISCUSSION
17:08 – 17:11 Conclusion Daniel Bléro, Belgium
IP297
IP291
ª Rising Star ª Top Abstract Prize ª National Scholar
Tuesday, October 31, 2017
Scientific Programme by Day : UEG Week Final Programme
Scientific Programme by Day Tuesday, October 31, 2017 Hall 6
Symposium 08:30 – 10:00 Room C1 Eosinophilic oesophagitis (EoE): European harmonisation Chairs: Stephen Attwood, United Kingdom Peter R. Gibson, Australia 08:30 – 08:52 Clinical presentation and epidemiology Albert Jan Bredenoord, The Netherlands
IP298
08:52 – 09:14 IP299 Diagnosis of EoO and PPI-responsive eosinophilia Alfredo Lucendo Villarin, Spain 09:14 – 09:36 IP300 Medical treatment: Today's standards and future options Stephan Miehlke, Germany Tandem Talks 09:36 – 09:46 IP301 Is dietary treatment a feasible option for children? Alexandra Papadopoulou, Greece 09:46 – 09:56 IP302 Is dietary treatment a feasible option for adults? Javier Molina Infante, Spain Symposium 08:30 – 10:00 Room C2 Chronic diarrhea: Diagnostic and therapeutic approach Chairs: Anne Peery, USA Vito Annese, Italy 08:30 – 08:52 Diagnostic approach Alexander Charles Ford, United Kingdom Live Stream
Q&A
Audience Voting
IP303
Tandem Talks 08:52 – 09:02 Microscopic colitis: Clinician's view Andreas Münch, Sweden
IP304
09:02 – 09:12 Microscopic colitis: Pathologist's view Cord Langner, Austria
IP305
09:12 – 09:34 Bile acid diarrhea Julian Walters, United Kingdom
IP306
09:34 – 09:56 Intestinal malabsorption Jutta Keller, Germany
IP307
Symposium 08:30 – 10:00 Room F3 Therapy update: Ulcerative colitis Chairs: Janindra Warusavitarne, United Kingdom Pierre Michetti, Switzerland 08:30 – 08:52 Management of acute severe colitis Geert D'Haens, The Netherlands
IP308
08:52 – 09:14 Optimal use of biologics in ulcerative colitis Walter Reinisch, Austria
IP309
09:14 – 09:36 Are we ready to use small molecules? Subrata Ghosh, Canada
IP310
09:36 – 09:58 Surgical options in ulcerative colitis Christianne Johanna Buskens
IP311
Symposium 08:30 – 10:00 Room F2 Endoscopic and surgical interventions for metabolic disorders Chairs: Jacques J. Bergman, The Netherlands Mario Morino, Italy 08:30 – 08:52 The endocrinologist's perspective Stephan Martin, Germany
IP312
08:52 – 09:14 Endoscopic options Jacques Deviere, Belgium
IP313
Recorded Session
67
Tuesday, October 31, 2017
Live Endoscopy 08:30 – 10:00 Live endoscopy Chairs: Thierry Ponchon, France Jeanin E. van Hooft, The Netherlands Christian Gerges, Germany Experts: Marc Barthet, France Philipp Bender, Germany Torsten Beyna, Germany Karel Caca, Germany Pierre Henri Deprez, Belgium Jennis Kandler, Germany Horst Neuhaus, Germany André Ragheb, Germany
UEG Week Final Programme : Scientific Programme by Day
09:14 – 09:36 Surgical options Ramon Vilallonga, Spain
IP314
09:36 – 10:00 PANEL DISCUSSION
Symposium 08:30 – 10:00 Room F1 From guidelines to clinical practice: Autoimmune liver disease Chairs: Tom Hemming Karlsen, Norway Marco Marzioni, Italy
Tuesday, October 31, 2017
09:46 – 09:56 IP323 Chemotherapy in advanced pancreatic cancer: Are the elderly fit for the novel regimens? Jean-Luc Van Laethem, Belgium Symposium 08:30 – 10:00 Room A1 Recurrences after colorectal endoscopic mucosal resection (EMR)/endoscopic submucosal dissection (ESD): How to avoid, how to treat? Chairs: Evelien Dekker, The Netherlands Edoardo Savarino, Italy
Tuesday, October 31, 2017
08:30 – 08:52 Autoimmune hepatitis Kalliopi Zachou, Greece
IP315
08:30 – 08:52 Risk factors for recurrence James Edward East, United Kingdom
IP324
08:52 – 09:14 Primary biliary cholangitis Annarosa Floreani, Italy
IP316
08:52 – 09:14 Optimising endoscopic resection Michael John Bourke, Australia
IP325
09:14 – 09:36 Primary sclerosing cholangitis Michael Trauner, Austria
IP317
09:14 – 09:36 Tips and tricks for treament of recurrence Michael B Wallace, USA
IP326
09:36 – 09:58 European registry on autoimmune hepatitis Rodrigo Liberal, United Kingdom
IP318
Symposium 08:30 – 10:00 Room A2 Pancreatic tumours: Diagnosis and treatment Chairs: Thomas M. Gress, Germany Rodger A. Liddle, USA 08:30 – 08:52 IP319 Pancreatic preneoplastic lesions under the microscope Caroline Verbeke, Sweden 08:52 – 09:14 IP320 Rising Star: Pancreatic cystic neoplasias: Diagnostic approach and when to resect? ª Stefano Crippa, Italy 09:14 – 09:36 IP321 Pancreatic neuroendcrine tumours: Can we follow-up and which ones need to be resected? Gabriele Capurso, Italy Tandem Talks 09:36 – 09:46 IP322 Chemotherapy in advanced pancreatic cancer: Moving towards more toxic chemotherapy regimens? Thomas Seufferlein, Germany
68
09:36 – 09:48 OP131 OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL ESOPHAGEAL CANCER IN AN ELDERLY POPULATION Toshiro Iizuka, Japan; D. Kikuchi; Y. Ochiai; S. Hoteya 09:48 – 10:00 OP132 BALLOON-ASSISTED ENDOSCOPY FACILITATES ENDOSCOPIC SUBMUCOSAL DISSECTION OF COLONOSCOPICALLY DIFFICULT SUPERFICIAL RIGHT COLON TUMORS Takeshi Yamashina, Japan; Y. Hayashi; H. Sakamoto; Y. Miura; S. Shinozaki; T. Yano; K. Sunada; A. K. Lefor; H. Yamamoto Free Paper Session 08:30 – 10:00 Room A3 Detection and removal of colorectal polyps: Latest techniques Chairs: Mihai Ciocirlan, Romania Michal Filip Kaminski, Poland 08:30 – 08:42 State-of-the-art introduction Michal Filip Kaminski, Poland
IP327
08:42 – 08:54 OP133 AUTOMATIC POLYP DETECTION IN COLONOSCOPY PROCEDURE USING DEEP LEARNING AND IMAGE PROCESSING TECHNIQUES Dror Zur, Israel; M. Zaltzhendler
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
08:54 – 09:06 OP134 IMPROVED DETECTION OF RIGHT-SIDED ADENOMAS BY G-EYE® COLONOSCOPY IN PATIENTS UNDERGOING COLORECTAL CANCER SCREENING- A PROSPECTIVE, RANDOMIZE, MULTICENTRE STUDY H. Shirin; B. Shpak; J. Epshtein; P. Vilmann; A. Hoffman; S. Sanduleanu; P. A. Testoni; S. Ishaq; D. N. Reddy; S. A. Gross; P. D. Siersema; H. Neumann; M. Goetz; D. Abramowich; M. Moshkowitz; M. Mizrahi; J. Hendel; J. W. Rey; R. de Ridder; E. Viale; H. Chaudhari; M. B. Pochapin; M. Yair; M. Shnell; S. Yaari; T. Stigaard; R. Simantov; N. Gluck; E. Israeli; S. Sloth; S. Matalon; A. Vilkin; A. Benson; A. Maliar; A. Waizbard; T. Hershcovici; E. Shachar; S. Rochberger; E. Tsvang; M. Braverman; H. Jacob; Y. Brachman; J. G. Karstensen; D. Teubner; R. Bogie; Ralf Kiesslich, Germany 09:06 – 09:18 OP135 A STANDARDIZED IMAGING PROTOCOL IS ACCURATE FOR THE ENDOSCOPIC PREDICTION OF DYSPLASIA WITHIN SESSILE SERRATED POLYPS ª David Tate, Australia; H. Awadie; M. Jayanna; L. Desomer; R. Lee; S. Heitman; K. Goodrick; D. McLeod; H. Mahajan; M. J. Bourke 09:18 – 09:30 OP136 RANDOMIZED CONTROLLED TRIAL OF THE USEFULNESS OF COLD SNARE POLYPECTOMY (CSP) FOR OUTPATIENTS Kensei Ohtsu, Japan; S. Sou; T. Noda; T. Karashima; T. Takeda; K. Imamura; R. sakemi; H. Terabe; Y. Morimitsu 09:30 – 09:42 OP137 IS COLD-SNARE POLYPECTOMY ALWAYS ADEQUATE FOR REMOVAL OF SMALL COLORECTAL POLYPS WITH ADVANCED HISTOLOGY? Yuichi Shimodate, Japan; M. Mizuno; J. Itakura; R. Takezawa; M. Kobayashi; T. Yamazaki; A. Doi; N. Nishimura; H. Mouri; K. Matsueda; H. Yamamoto 09:42 – 09:54 OP138 MANAGEMENT AND RISK FACTORS FOR INCOMPLETE RESECTION ASSOCIATED WITH COLD FORCEPS POLYPECTOMY FOR DIMINUTIVE COLORECTAL POLYPS: A SINGLE-INSTITUTION RETROSPECTIVE COHORT STUDY Naoki Asayama, Japan; S. Nagata; Y. Ogawa; H. Tamari; Y. Shimohara; T. Aoyama; A. Fukumoto; S. Mukai; M. Kaneko
Free Paper Session 08:30 – 10:00 Room B2 Diagnosis and treatment of GORD Chairs: Massimiliano di Pietro, United Kingdom Peter Banovcin, Slovak Republic 08:30 – 08:42 State-of-the-art introduction Massimiliano di Pietro, United Kingdom
IP328
08:42 – 08:54 OP139 COMPREHENSIVE QUANTITATIVE ANALYSIS OF RELATIONSHIP BETWEEN ACIDIC LARYNGOPHARYNGEAL REFLUX (LPR) AND SYMPTOMS AND SIGNS OF LARYNGEAL INJURY BY DUAL PHARYNGEAL AND ESOPHAGEAL 24-HOUR PH/IMPEDANCE MONITORING. Martin Ďuriček, Slovak Republic; P. Banovcin; T. Haličková; R. Hyrdel; M. Kollarik 08:54 – 09:06 OP140 ESOPHAGEAL MEAN NOCTURNAL BASELINE IMPEDANCE PREDICTS SYMPTOMATIC OUTCOME IN GERD EVEN WHEN ACID EXPOSURE TIME IS INCONCLUSIVE ON ESOPHAGEAL REFLUX MONITORING Arvind Rengarajan, USA; E. Savarino; A. Patel; S. Roman; R. Yadlapati; J. Pandolfino; C. P. Gyawali 09:06 – 09:18 OP141 HIGH RESOLUTION MANOMETRY IS SUPERIOR TO ENDOSCOPY AND RADIOLOGY IN ASSESSING AND GRADING SLIDING HIATAL HERNIA. A PROSPECTIVE COMPARISON WITH SURGICAL IN VIVO Salvatore Tolone, Italy; E. Savarino; G. Zaninotto; N. de Bortoli; I. Martinucci; M. Furnari; M. Frazzoni; L. Frazzoni; V. Savarino; L. Docimo 09:18 – 09:30 OP142 THE EFFECT OF BILE REFLUX ON BASELINE IMPEDANCE VALUE AND CHEMICAL CLEARANCE IN PATIENTS WITH NERD. Irene Martinucci, Italy; N. de Bortoli; M. Frazzoni; S. Tolone; L. Frazzoni; E. Marabotto; L. Macchia; R. Tutuian; S. Santi; V. Savarino; S. Marchi; E. Savarino 09:30 – 09:42 OP143 REDUCTION OF DAY TIME ACID GASTRO OESOPHAGEAL REFLUX BY TREATING INCREASED SUPRAGASTRIC BELCHING Etienne Glasinovic, United Kingdom; E. Wynter; J. Arguero; P. Hajek; D. Sifrim 09:42 – 09:54 OP144 POST-REFLUX SWALLOW-INDUCED PERISTALTIC WAVE INDEX AND MEAN NOCTURNAL BASELINE IMPEDANCE PREDICT HEARTBURN RESPONSE TO PROTON PUMP INHIBITORS BETTER THAN ACID EXPOSURE TIME IN GERD L. Frazzoni; Marco Della Coletta, Italy; M. Frazzoni; N. de Bortoli; S. Tolone; M. Furnari; I. Martinucci; S. Marchi; R. Conigliaro; L. Fuccio; V. Savarino; E. Savarino
Live Stream
Q&A
Audience Voting
Recorded Session
69
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
Translational Basic Science 08:30 – 10:00 Understanding the basis for GI pain Chairs: Nathalie Vergnolle, France Roberto De Giorgio, Italy
Room B3
08:30 – 08:52 Visceral nociception: Where can it go wrong? Ashley Blackshaw, United Kingdom
IP329
08:52 – 09:14 Rising Star: Neuroimmune mechanisms ª Nicolas Cenac, France
IP330
09:14 – 09:36 Gut microbiota brain interactions Keith A. Sharkey, Canada
IP331
09:36 – 09:58 IP332 How can knowledge of visceral pain mechanisms help patients? Guy E. Boeckxstaens, Belgium
Tuesday, October 31, 2017
Today's Science, Tomorrow's Medicine 08:30 – 10:00 Room E4 TSTM Free Paper: Clinical implications of host microbiota interactions Chairs: Alexander R. Moschen, Austria Krisztina Barbara Gecse, The Netherlands 08:30 – 08:42 OP145 ANALYSIS OF 1792 GUT METAGENOMES REVEALS MICROBIAL TREATMENT TARGETS FOR INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME Arnau Vich Vila, The Netherlands; F. Imhann; V. Collij; T. Gurry; A. Kurilshikov; S. Jankipersadsing; Z. Mujagic; M.-J. Bonder; X. Jiang; L. Franke; G. Dijkstra; E. A. M. Festen; J. Fu; R. Xavier; E. Alm; C. Wijmenga; D. M. Jonkers; A. Zhernakova; R. K. Weersma 08:42 – 08:54 OP146 IDENTIFICATION OF A MICROBIOTA BENEFICIAL AGAINST COLITIS AND COLITIS-ASSOCIATED CANCER E. Viennois; A. Pujada; A. T. Gewirtz; Benoit Chassaing, USA; D. Merlin 08:54 – 09:06 OP147 PROTECTIVE ROLE OF ESCHERICHIA COLI NISSLE 1917 ON INTESTINAL PERMEABILITY IN IRRITABLE BOWEL SYNDROME: AN IN VITRO STUDY. Daniele Fuschi, Italy; M. R. Barbaro; P. Dino; M. Carapelle; E. Capelli; C. Cremon; V. Stanghellini; G. Barbara
70
Tuesday, October 31, 2017
09:06 – 09:18 OP148 IS THE MICROBIOME IMPLICATED IN THE DEVELOPMENT OF GENUINE IRRITABLE BOWEL SYNDROME-TYPE SYMPTOMS IN INFLAMMATORY BOWEL DISEASE? David John Gracie, United Kingdom; O. Shutkever; C. Young; H. Wood; M. Taylor; P. J. Hamlin; A. C. Ford; P. Quirke 09:18 – 09:30 OP149 THE COMPLEMENT SYSTEM AS A REGULATOR OF THE HOST-MICROBIOTA RELATIONSHIP IN IBD ª Simon Reider, Austria; W. Posch; A. Pfister; R. Koch; D. Orth-Höller; R. Würzner; D. Wilflingseder; H. Tilg; A. R. Moschen 09:30 – 09:42 OP150 METABONOMIC AND MICROBIOTA PROFILE OF CROHN'S PATIENTS IS A PREDICTOR OF PRIMARY NON-RESPONSE TO ANTI-TNF THERAPY Nik Ding, Australia; M. Sarafian; A. Perdones-Montero; R. Misra; P. Hendy; L. Penez; E. Holmes; A. Hart 09:42 – 09:54 WITHDRAWN
OP151
Free Paper Session 08:30 – 10:00 Room 7.1 The microbiome and IBD Chairs: Arthur Kaser, United Kingdom Marianne Rebecca Spalinger, Switzerland 08:30 – 08:42 State-of-the-art introduction Arthur Kaser, United Kingdom
IP333
08:42 – 08:54 OP152 PANETH CELLS DYSFUNCTION AND DEATH IS DIRECTLY LINKED TO IFN-LAMBDA SIGNALING Claudia Günther, Germany; B. Buchen; H. Neumann; S. Wirtz; M. F. Neurath; C. Becker 08:54 – 09:06 OP153 THE STIMULATION OF MACROPHAGES WITH MICROBIAL-DERIVED COMPOUNDS SUPPORTS INCREASED IL-19 EXPRESSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND COLITIS MODELS A. Steinert; I. Linas; P. Hruz; M. Ibrahim; K. Radulovic; A. Schlitzer; L. Terracciano; A. Macpherson; Jan Hendrik Niess, Switzerland 09:06 – 09:18 OP154 CD1D MODULATES COLONIC INFLAMMATION IN NOD2−/− MICE BY ALTERING THE COMPOSITION OF INTESTINAL MICROBIOTA S.-N. Hong; Chansu Lee, Republic of Korea; Y.-H. Kim
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
09:18 – 09:30 OP155 ADAPTATION OF ADHERENT-INVASIVE E. COLI TO GUT ENVIRONMENT: IMPACT ON FLAGELLA EXPRESSION AND BACTERIAL VIRULENCE Gwladys Sevrin, France; S. Massier; B. Chassaing; A. Agus; J. Denizot; J. Delmas; E. Billard; N. Barnich
09:30 – 09:42 OP162 DO THE NEW ROME IV DIAGNOSTIC CRITERIA FOR OPIOID-INDUCED CONSTIPATION IDENTIFY PATIENTS WITH A GREATER BIOPSYCHOSOCIAL BURDEN? Anton Emmanuel, United Kingdom; V. Banerji; G. Hall; A. Lass; V. Andresen
09:30 – 09:42 OP156 IL-10-INDEPENDENT PROTECTIVE ACTIVITIES OF HUMANDERIVED CLOSTRIDIUM STRAINS IN EXPERIMENTAL COLITIS Akihiko Oka, USA; Y. Mishima; G. Bongers; A. Baltus; J. Herzog; B. Liu; S. Fukuda; K. Atarashi; K. Honda; D. Marshall; M. Hasse; L. San; R. B. Sartor
09:42 – 09:54 OP163 USERS OF WEAK OPIOIDS HAVE A SMALLER SPECTRUM OF CONSTIPATION SYMPTOMS, BUT A SIMILAR DEGREE OF BOTHER FROM CONSTIPATION, AS USERS OF POTENT OPIOIDS Viola Andresen, Germany; A. Lass; V. Banerji; G. Hall; A. V. Emmanuel
09:42 – 09:54 OP157 FAECAL MICROBIOTA IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE BEFORE AND AFTER THERAPY. Christine Olbjørn, Norway; M. C. Småstuen; E. Thiis-Evensen; B. Nakstad; C. Casén; M. H. Vatn; G. Perminow Free Paper Session 08:30 – 10:00 Room E1 Symptom patterns in functional GI disorders Chairs: Lesley Houghton, United Kingdom Giles Major, United Kingdom 08:30 – 08:42 State-of-the-art introduction Lesley Houghton, United Kingdom
IP334
08:42 – 08:54 OP158 ABDOMINAL DISTENTION SYMPTOMS WITHOUT FUNCTIONAL DYSPEPSIA OR IRRITABLE BOWEL SYNDROME ARE PERSISTENT: 10 YEAR FOLLOW-UP OF THE KALIXANDA STUDY. Jukka Ronkainen, Finland; P. Aro; L. Agréus; S.-E. Johansson; M. M. Walker; N. J. Talley 08:54 – 09:06 OP159 THE PREVALENCE OF ROME IV FUNCTIONAL DYSPEPSIA AND ITS IMPACT ON HEALTH IMPAIRMENT; RESULTS FROM A THREE-COUNTRY GENERAL POPULATION STUDY Imran Aziz, Sweden; O. S. Palsson; H. Törnblom; A. Sperber; W. E. Whitehead; M. Simrén 09:06 – 09:18 OP160 ROME III VERSUS ROME IV CRITERIA FOR IRRITABLE BOWEL SYNDROME: A COMPARISON OF CLINICAL CHARACTERISTICS IN A LARGE COHORT STUDY Lisa Vork, The Netherlands; Z. Z. R. M. Weerts; Z. Mujagic; J. Kruimel; M. Hesselink; D. Keszthelyi; D. M. Jonkers; A. A. M. Masclee 09:18 – 09:30 OP161 FACTOR ANALYSIS DEFINES DISTINCT UPPER AND LOWER SYMPTOM GROUPINGS COMPATIBLE WITH ROME IV IN A POPULATION-BASED STUDY Egbert Clevers, Belgium; W. E. Whitehead; O. S. Palsson; H. Törnblom; L. Van Oudenhove; J. Tack; M. Simrén Live Stream
Q&A
Audience Voting
Free Paper Session 08:30 – 10:00 Room E2 Acute and chronic pancreatitis: Risk factors and prevention Chairs: Jonas Rosendahl, Germany Sandra van Brunschot, The Netherlands 08:30 – 08:42 State-of-the-art introduction Jonas Rosendahl, Germany
IP335
08:42 – 08:54 OP164 ENDOSCOPIC ULTRASOUND-BASED MULTIMODAL EVALUATION OF THE PANCREAS FOR THE DIAGNOSIS OF EARLY CHRONIC PANCREATITIS Julio Iglesias-Garcia, Spain; J. Lariño Noia; A. Álvarez-Castro; L. Nieto; S. Lojo; S. Leal; J. E. Dominguez-Muñoz 08:54 – 09:06 OP165 THE IMPACT OF BARIATRIC SURGERY ON ACUTE PANCREATITIS MORTALITY AND OTHER OUTCOMES: A NATIONWIDE ANALYSIS Paul Thomas Kroener, USA; M. S. Abougergi; V. Popov; C. C. Thompson 09:06 – 09:18 OP166 THE OBESITY PARADOX IN ACUTE PANCREATITIS: AN INDIVIDUAL PATIENT DATA META-ANALYSIS Xavier Smeets, The Netherlands; I. Knoester; K. Grooteman; V. K. Singh; G. I. Papachristou; A. Duarte Rojo; G. Robles-Diaz; M. G. H. Besselink; H. van Santvoort; W. Kievit; H. van Goor; M. J. Bruno; J. P. H. Drenth; E. Van Geenen 09:18 – 09:30 OP167 STATIN CONSUMPTION IS ASSOCIATED TO A LOWER RISK OF POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS Enrique de-Madaria, Spain; K. Cárdenas-Jaén; A. B. Fernández-Laso; J. Millastre-Bocos; A. Torralba-Gallego; S. Martín-Arriero; E. Alfaro-Almajano; G. García-Rayado; E. Martínez-Moneo
Recorded Session
71
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
Tuesday, October 31, 2017
09:30 – 09:42 OP168 THE RISK FOR POST-ERCP PANCREATITIS AFTER INADVERTENT PANCREATIC DUCT CANNULATION CAN BE PREVENTED BY TEMPORARY PANCREATIC STENTING. A MULTICENTRE, PROSPECTIVE, RANDOMIZED TRIAL. Veit Phillip, Germany; A. Pukitis; A. Epstein; A. Hapfelmeier; D. Haf; M. Schwab; J. Rosendahl; A. Hofmeister; I. E. Demir; A. Weber; H. Algül
09:18 – 09:30 OP173 CAN ARTIFICIAL INTELLIGENCE FOR ENDOCYTOSCOPY PROVIDES FULLY AUTOMATED DIAGNOSIS OF HISTOLOGICAL HEALING IN ULCERATIVE COLITIS ? Yasuharu Maeda, Japan; S.-E. Kudo; Y. Mori; M. Misawa; K. Wakamura; S. Sasanuma; N. Ogata; Y. Ogawa; K. Takeda; K. Ichimasa; T. Hayashi; T. Kudo; F. Ishida; K. Ohtsuka
09:42 – 09:54 OP169 EXOCRINE PANCREATIC INSUFFICIENCY AFTER ACUTE PANCREATITIS: SYSTEMIC REVIEW AND META-ANALYSIS D. De la Iglesia-García; W. Huang; I. Baston Rey; J. Lariño Noia; J. Iglesias-Garcia; P. Szatmary; Q. M. Nunes; R. Mukherjee; J. Enrique Dominguez-Muñoz, Spain; R. Sutton
09:30 – 09:42 OP174 A PILOT INTERNATIONAL MULTICENTER RANDOMIZED CONTROLLED TRIAL OF CHROMOENDOSCOPY VERSUS AUTOFLUORESCENCE IMAGING FOR NEOPLASIA DETECTION IN PATIENTS WITH LONGSTANDING ULCERATIVE COLITIS (FIND-UC) Jasper Vleugels, The Netherlands; J. E. East; M. D. Rutter; L. K. Wanders; K. Ragunath; C. J. Rees; C. Y. Ponsioen; S. Samuel; F. Butt; T. Kuiper; S. van Eeden; E. Dekker
Free Paper Session 08:30 – 10:00 Room E3 Progress in endoscopic diagnosis Chairs: Tomas Hucl, Czech Republic Alexandre Oliveira Ferreira, Portugal
Tuesday, October 31, 2017
08:30 – 08:42 State-of-the-art introduction Tomas Hucl, Czech Republic
IP336
08:42 – 08:54 OP170 TERMINOLOGY AND DESCRIPTION OF VASCULAR LESIONS IN SMALL BOWEL CAPSULE ENDOSCOPY: AN INTERNATIONAL DELPHI CONSENSUS STATEMENT. Romain Leenhardt, France; C. LI; A. Koulaouzidis; F. Cavallaro; F. Cholet; R. Eliakim; I. Fernández-Urién; U. Kopylov; M. Mcalindon; A. Németh; J. N. Plevris; G. Rahmi; E. Rondonotti; J. C. Saurin; G. E. Tontini; E. Toth; D. E. Yung; P. Marteau; X. Dray 08:54 – 09:06 OP171 A PROSPECTIVE MULTICENTER SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL COMPARING FNA AND FNB IN THE DIAGNOSIS OF SOLID MASSESA PROSPECTIVE MULTICENTER SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL COMPARING FNA AND FNB IN THE DIAGNOSIS OF SOLID MASSES Qian Chen, China; B. Cheng; G. Wang; T. Jiang; L. Dou; J. Wang; Y. Li; Y. Zhang; B. Sun; H. Shan; Z. Deng; G. Xu; X. Yang 09:06 – 09:18 OP172 RANDOMIZED TRIAL COMPARING THE 22 GAUGE FRANSEEN BIOPSY AND 22 GAUGE ASPIRATION NEEDLES FOR EUS-GUIDED SAMPLING OF SOLID PANCREATIC MASS LESIONS Ji Young Bang, USA; S. Hebert-Magee; U. Navaneethan; M. Hasan; R. Hawes; S. Varadarajulu
72
09:42 – 09:54 OP175 MULTICENTRE EUROPEAN EVALUATION OF A NOVEL TECHNOLOGY (BLUE LIGHT IMAGING) IN THE OPTICAL DIAGNOSIS OF SMALL COLORECTAL POLYPS Sharmila Subramaniam, United Kingdom; K. Kandiah; P. Aepli; G. Wurm Johansson; E. J. Schoon; M. Stefanovic; P. Bhandari Free Paper Session 08:30 – 10:00 Room B5 New insights in microbiota: Gut and liver aspects Chairs: Mária Papp, Hungary Franco Scaldaferri, Italy 08:30 – 08:42 State-of-the-art introduction Mária Papp, Hungary
IP337
08:42 – 08:54 OP176 GUT MICROBIOTA INVOLVES IN NON-ALCOHOLIC FATTY LIVER DISEASE VIA AFFECTING INTRA-HEPATIC CD4+ T LYMPHOCYTE Lin Su, China; Z. Wu; J. Tan; J. Xu; Y. Song; Y. L. Liu 08:54 – 09:06 OP177 METHYL DONOR MOLECULES SUPPLEMENTATION IMPAIRS E. COLI COLONISATION BACTERIA BY MODULATING IGA PATHWAY Elodie Gimier, France; A. Agus; N. Barnich; J. Denizot 09:06 – 09:18 OP178 COMMD10 NEGATIVELY REGULATES LY6CHI MONOCYTE-DRIVEN INFLAMMATION AND PROMOTES BACTERIAL CLEARANCE BY KUPFFER CELLS DURING SEPSIS Nathan Gluck, Israel; S. Ben-Shlomo; O. Mouhadeb; C. Varol
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
09:18 – 09:30 OP179 IMPROVED HEMODYNAMIC AND LIVER FUNCTION MARKERS IN BILE-DUCT LIGATED RATS AFTER ADMINISTRATION OF B. PSEUDOCATENULATUM CECT7765 Isabel Gomez-Hurtado, Spain; P. Zapater; K. Portune; J. M. Gonzalez-Navajas; Y. Sanz; R. Frances 09:30 – 09:42 OP180 THE ROLE OF B LYMPHOCYTES WITHIN MESENTERIC ADIPOSE TISSUE IN NON-ALCOHOLIC FATTY LIVER DISEASE Zhe Wu, China; F. Zhang; J. Tan; J. Xu; Y. Song; Y. L. Liu 09:42 – 09:54 OP181 METABOLOMICS: IN THE SEARCH FOR NEW BIOMARKERS OF DECOMPENSATION AND INFECTION IN PATIENTS WITH CIRRHOSIS Petra Fischer, Romania; C. Moraru; A. Bugariu; C.-A. Grigoras; O. Farcau; H. Stefanescu; M. Tantau; C. Socaciu; B. D. Procopet Symposium 08:30 – 10:00 Laryngopharyngeal reflux (LPR) Chair: Daniel Sifrim, United Kingdom
Hotspot
08:30 – 08:33 Introduction Daniel Sifrim, United Kingdom
IP338
08:33 – 08:38 LPR doesn't exist André Smout, The Netherlands
IP339
08:38 – 08:53 PANEL DISCUSSION
08:53 – 08:58 LPR can be confidently diagnosed Radu Tutuian, Switzerland
IP340
08:58 – 09:13 PANEL DISCUSSION
09:13 – 09:18 If a PPI doesn't work, reflux testing is useless Frank Zerbib, France
IP341
09:18 – 09:33 PANEL DISCUSSION
09:33 – 09:38 Fundoplication is an option in resistant cases Serhat Bor, Turkey
IP342
09:38 – 09:53 PANEL DISCUSSION
09:53 – 09:56 Conclusion Daniel Sifrim, United Kingdom Live Stream
Q&A
Audience Voting
IP343
Live Endoscopy 10:30 – 12:00 Live endoscopy Chairs: Mario Dinis-Ribeiro, Portugal Tomas Hucl, Czech Republic Christian Gerges, Germany Experts: Marc Barthet, France Philipp Bender, Germany Torsten Beyna, Germany Karel Caca, Germany Pierre Henri Deprez, Belgium Jennis Kandler, Germany Horst Neuhaus, Germany André Ragheb, Germany
Hall 6
Symposium 10:30 – 12:00 Room C1 Perianal fistulising Crohn's disease: From pathophysiology to management Chairs: Antonino Spinelli, Italy Matthieu Allez, France 10:30 – 10:52 IP344 Pathophysiology of anal fistula Britta Siegmund, Germany, #B. Siegmund#, Germany Tandem Talks 10:52 – 11:02 Imaging assessment: MRI and ultrasound Francesca Maccioni, Italy
IP345
11:02 – 11:12 Surgical strategies Janindra Warusavitarne, United Kingdom
IP346
11:12 – 11:34 Medical therapy: Biologics and stem cells Julian Panés, Spain
IP347
11:34 – 11:46 OP182 ANTI-TNF THERAPY FOR RECTOVAGINAL FISTULAS COMPLICATING CROHN'S DISEASE: A GETAID STUDY Guillaume Le Baut, France; P. Seksik; G. Bouguen; A. Amiot; D. Laharie; R. Altwegg; F. Mathurin; C. Trang; L. Vuitton; M. Simon; C. Gilletta De Saint Joseph; L. Caillo; E. Del Tedesco; L. Plastaras; A. Aubourg; L. Peyrin-Biroulet; S. Viennot 11:46 – 11:58 OP183 HIGHER INFLIXIMAB AND ADALIMUMAB SERUM LEVELS CORRELATE WITH PERIANAL FISTULA CLOSURE IN CROHN’S DISEASE PATIENTS Anne Strik, The Netherlands; M. Lowenberg; C. Y. Ponsioen; C. J. Buskens; W. A. Bemelman; G. R. D'Haens
Recorded Session
73
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
Tuesday, October 31, 2017
Symposium 10:30 – 12:00 Room C2 Treating patients with acute cholecystitis and cholangitis Chairs: Lars Aabakken, Norway Tom Hemming Karlsen, Norway
Symposium 10:30 – 12:00 Optimising the diagnosis of IBS Chairs: Robin Spiller, United Kingdom Daniel Pohl, Switzerland
10:30 – 10:42 Case presentation: Part I Mostafa Ibrahim, Belgium
IP348
10:42 – 11:04 The role of endoscopy: When to drain? Marcel Tantau, Romania
IP349
Debate 10:30 – 10:40 IP357 Symptom-based criteria: Will Rome IV optimise the diagnosis of IBS? Pro Fermin Mearín Manrique, Spain
11:04 – 11:26 The role of surgery: When to operate? David Fuks, France
IP350
11:26 – 11:48 IP351 The role of interventional radiology: The era of minimal invasive approaches Andrea Phillips, United Kingdom
Tuesday, October 31, 2017
11:48 – 12:00 Case presentation: Part II Mostafa Ibrahim, Belgium
IP352
Symposium 10:30 – 12:00 Room F3 Therapy update: Evidence for the efficacy of probiotics? Chairs: Niek J. De Wit, The Netherlands Max Nieuwdorp, The Netherlands 10:30 – 10:52 Health claims for probiotics Henk van Loveren, The Netherlands
IP353
10:52 – 11:14 IP354 Antibiotic-associated diarrhea and clostridum difficile infection Gianluca Ianiro, Italy 11:14 – 11:36 Acute gastroenteritis Hania Szajewska, Poland
IP355
11:36 – 11:58 IBS Pali Hungin, United Kingdom
IP356
Room F2
10:40 – 10:50 IP358 Symptom-based criteria: Will Rome IV optimise the diagnosis of IBS? Con Alexander Charles Ford, United Kingdom 10:50 – 11:12 IP359 Psychological markers: How can they be used in the clinic? Lukas Van Oudenhove, Belgium 11:12 – 11:34 Biological markers: Ready for primetime? Daisy Mae Jonkers, The Netherlands
IP360
11:34 – 11:56 Future directions Lin Chang, USA
IP361
Symposium 10:30 – 12:00 Room F1 From guidelines to clinical practice: Colorectal cancer Chairs: Eric Van Cutsem, Belgium Yasmijn van Herwaarden, The Netherlands Tandem Talks 10:30 – 10:40 Early rectal cancer: Clinical case Mihai Ciocirlan, Romania 10:40 – 10:50 Early rectal cancer: Guidelines Rob Glynne-Jones, United Kingdom
IP362
IP363
10:50 – 11:00 PANEL DISCUSSION
Tandem Talks 11:00 – 11:10 IP364 Borderline resectable liver metastasis: Clinical case Bernard Nordlinger, France 11:10 – 11:20 IP365 Borderline resectable liver metastasis: Guidelines Eric Van Cutsem, Belgium
74
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
11:20 – 11:30
10:52 – 11:14 When does the pathologist come in? Karoline Lackner, Austria
IP374
IP366
11:14 – 11:36 Nutrition and the liver Shira Zelber-Sagi, Israel
IP375
IP367
11:36 – 11:58 Drugs versus life-style interventions Elisabetta Bugianesi, Italy
IP376
PANEL DISCUSSION
Tandem Talks 11:30 – 11:40 Stage two colon cancer: Clinical case Monique van Leerdam, The Netherlands 11:40 – 11:50 Stage two colon cancer: Guidelines Michel Ducreux, France 11:50 – 12:00 PANEL DISCUSSION
Symposium 10:30 – 12:00 Room A2 Evidence-based approach to achalasia Chairs: Albert Jan Bredenoord, The Netherlands Thomas Rösch, Germany Debate 10:30 – 10:40 IP368 High-resolution manometry is mandatory in all cases Sabine Roman, France 10:40 – 10:50 IP369 Conventional manometry or no manometry at all may suffice Radu Tutuian, Switzerland 10:50 – 11:12 Treatment of therapy-naive achalasia Guy E. Boeckxstaens, Belgium
IP370
11:12 – 11:34 IP371 Management of complex cases and therapeutic failures: Endoscopic approach Haruhiro Inoue, Japan 11:34 – 11:56 IP372 Management of complex cases and therapeutic failures: Surgical approach Mario Costantini, Italy Symposium 10:30 – 12:00 Room A1 Lifestyle-related liver disease: Risks and management Chairs: Dina Tiniakos, United Kingdom Vlad Ratziu, France 10:30 – 10:52 What should the clinician worry about? Helen Reeves, United Kingdom
Live Stream
Q&A
Audience Voting
Free Paper Session 10:30 – 12:00 Room A3 Long-term management in IBD with biologics Chairs: Joline de Groof, The Netherlands Tim Raine, United Kingdom 10:30 – 10:42 State-of-the-art introduction Tim Raine, United Kingdom
IP377
10:42 – 10:42 OP184 EFFICACY OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A POST-HOC ANALYSIS OF THE OBSERV-IBD COHORT OF THE GETAID Sara Tadbiri, France; M. Serrero; L. Peyrin-Biroulet; J. Filippi; B. Pariente; X. Roblin; A. Buisson; C. Stefanescu; C. Trang; R. Altwegg; P. Marteau; T. Vaysse; A. Bourrier; S. Nancey; D. Laharie; M. Allez; G. Savoye; J. Moreau; C. Gagniere; L. Vuitton; Y. Bouhnik; A. Amiot 10:42 – 10:42 OP185 HISTOLOGICAL FEATURES OF JOINT AND COLONIC INFLAMMATION IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH ANTI-TNFA ª S. Alivernini; Daniela Pugliese, Italy; B. Tolusso; L. Petricca; L. Bui; L. Guidi; G. L. Rapaccini; F. Federico; G. Ferraccioli; A. Armuzzi; E. Gremese 10:42 – 10:42 OP186 LONG-TERM EFFICACY AND SAFETY OF USTEKINUMAB IN REFRACTORY CROHN’S DISEASE PATIENTS: A MULTICENTER RETROSPECTIVE EXPERIENCE Pauline Wils, France; Y. Bouhnik; P. Michetti; B. Flourie; H. Brixi; A. Bourrier; M. Allez; B. Duclos; J.-C. Grimaud; A. Buisson; A. Amiot; M. Fumery; X. Roblin; L. Peyrin-Biroulet; J. Filippi; G. Bouguen; V. Abitbol; B. Coffin; M. Simon; D. Laharie; B. Pariente
IP373
Recorded Session
75
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
10:42 – 10:42 OP187 USEFULNESS OF COMBINATION THERAPY WITH ADALIMUMAB AND IMMUNOMODULATORS IN PATIENTS WITH CROHN’S DISEASE: A LARGE, MULTI-CENTRE COHORT STUDY Hiroki Tanaka, Japan; N. Kamata; A. Yamada; T. Fujii; K. Endo; T. Yoshino; S. Bamba; T. Sugaya; T. Kawaguchi; M. Ishii; S. Shinzaki; Y. Toya; Y. Yanai; Y. Yokoyama; J. Umeno; T. Okada; T. Kobayashi; M. Nojima; T. Hibi 10:42 – 10:42 OP188 SPACING OF INFLIXIMAB THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN CLINICAL REMISSION: PRELIMINARY RESULTS OF A RETROSPECTIVE MULTICENTRE FRENCH NATIONAL COHORT Gaspard Dufour, France; B. Pariente; R. Altwegg; L. Caillo; J.-C. Valats; M. Bismuth; J.-F. Bourgaux; L. Peyrin-Biroulet; P. Desreumaux; P. Pouderoux; P. Blanc; G. Pineton de Chambrun
Tuesday, October 31, 2017
10:42 – 10:42 OP189 HIGHER RATE OF CORTICORESISTANCE AND CORTICODEPENDENCE IN ELDERLY-ONSET UC PATIENTS DIAGNOSED <70 YEARS COMPARED TO ≥70 YEARS OF AGE: A POPULATION-BASED STUDY D. Duricova; H. Sarter; M. Fumery; A. Leroyer; C. Charpentier; Benjamin Pariente, France; L. Armengol-Debeir; L. Peyrin-Biroulet; C. Gower-Rousseau; G. Savoye Free Paper Session 10:30 – 12:00 Room B2 Evidence-based management of Barrett's and oesophageal adenocarcinoma Chairs: Jan Bornschein, Germany Marnix Jansen, United Kingdom 10:30 – 10:42 State-of-the-art introduction Jan Bornschein, Germany
IP378
10:42 – 10:54 OP190 INCIDENCE OF MALIGNANT PROGRESSION IN PERSISTENT NONDYSPLASTIC BARRETT'S ESOPHAGUS – A DUTCH NATIONWIDE COHORT STUDY Yonne Peters, The Netherlands; J. Honing; W. Kievit; C. Kestens; W. Pestman; I. D. Nagtegaal; P. D. Siersema 10:54 – 11:06 OP191 MULTICENTER FEASIBILITY STUDY OF COMBINED INJECTION AND ARGON PLASMA COAGULATION (HYBRID-APC) IN THE ABLATION THERAPY OF NEOPLASTIC BARRETT ESOPHAGUS Thomas Rösch, Germany; H. Manner; A. May; M. Knabe; G. Schachschal; H. Ehlken; H. Neuhaus; T. Beyna; J. J. G. H. M. Bergman; B. L. A. M. Weusten; O. Pech; S. Faiss; M. Anders; C. Ell
76
Tuesday, October 31, 2017
11:06 – 11:18 OP192 SAFETY OF THE SIX-SHOOTER MULTIBAND MUCOSECTOMY DEVICE FOR ENDOSCOPIC RESECTION IN BARRETT’S ESOPHAGUS IN 4327 RESECTIONS: A RETROSPECTIVE INTERNATIONAL MULTICENTER STUDY. Kamar Belghazi, The Netherlands; M. A. Everson; R. Haidry; P. Kandel; L. K. Mejia; M. J. Bourke; F. Bahin; B. L. A. M. Weusten; G. G. Ginsberg; G. Ma; A. D. Koch; R. V. Milano; S. Seewald; K. Ragunath; R. Bisschops; J. J. G. H. M. Bergman; R. E. Pouw 11:18 – 11:30 OP193 ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT’S EARLY NEOPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS Dennis Yang, USA; F. Zou; S. Xiong; J. J. Forde; P. V. Draganov 11:30 – 11:42 OP194 NEUTROPHIL LYMPHOCYTE RATIO AS PREDICTIVE MARKER OF SURVIVAL IN ESOPHAGEAL CANCER: SYSTEMATIC REVIEW AND META-ANALYSIS GiovannI Pirozzolo, Italy; S. S. Gisbertz; C. Castoro; M. I. van Berge Henegouwen; M. Scarpa 11:42 – 11:54 OP195 THE OPTIMAL TIME INTERVAL BETWEEN NEOADJUVANT CHEMORADIOTHERAPY AND ESOPHAGECTOMY: A NATIONWIDE STUDY Leonie van der Werf, The Netherlands; J. Dikken; E. van der Willik; M. I. van Berge Henegouwen; V. E. P. P. Lemmens; G. A. P. Nieuwenhuijzen; B. P. L. Wijnhoven; on behalf of the Dutch Upper GI Cancer Audit group Translational Basic Science 10:30 – 12:00 Room B3 Genetics of pancreatic disease and lessons for clinical practice Chairs: Julia Mayerle, Germany Marco J. Bruno, The Netherlands 10:30 – 10:52 IP379 Cystic fibrosis transmembrane conductance regulator (CFTR): Its physiological role and in the pathogenesis of pancreatitis Peter Hegyi, Hungary 10:52 – 11:14 IP380 CFTR gene mutations in pancreatitis and treatment options David C. Whitcomb, USA 11:14 – 11:36 IP381 Rising Star: Genetic susceptibility to acute and chronic pancreatitis ª Vinciane Rebours, France
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
11:36 – 11:58 IP382 Update on the genetic basis of familial pancreatic cancer Bill Greenhalf, United Kingdom Today's Science, Tomorrow's Medicine 10:30 – 12:00 Gut microbiota and digestive disorders Chairs: Alessio Aghemo, Italy Franck Carbonnel, France
Room E4
10:30 – 10:52 Gastric disorders Marcis Leja, Latvia
IP383
10:52 – 11:14 IBD Harry Sokol, France
IP384
11:14 – 11:36 IBS Magnus Simrén, Sweden
IP385
11:36 – 11:58 Liver and metabolic syndrome Herbert Tilg, Austria
IP386
Free Paper Session 10:30 – 12:00 Room 7.1 H. pylori: Treatment and antibiotic resistance Chairs: Giuseppe Losurdo, Italy Juozas Kupcinskas, Lithuania 10:30 – 10:42 State-of-the-art introduction Juozas Kupcinskas, Lithuania
IP387
10:42 – 10:54 OP196 HELICOBACTER PYLORI ERADICATION AND THE RISK OF GASTRIC CANCER: A POPULATION-BASED COHORT STUDY Eva Doorakkers, Sweden; J. Lagergren; L. Engstrand; N. Brusselaers 10:54 – 11:06 OP197 PAN-EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): FIRST-LINE TREATMENTS AND INTERIM ANALYSIS OF 20,000 PATIENTS Adrian Gerald McNicholl, Spain; O. P. Nyssen; D. S. Bordin; B. Tepeš; M. Á. Perez Aisa; B. Vaira; M. Caldas Álvarez; L. Bujanda Fernández de Piérola; M. Castro Fernández; F. Lerang; M. Leja; L. Rodrigo; T. Rokkas; L. Kupcinskas; J. Perez-Lasala; L. Virginijus Jonaitis; O. Shvets; A. Gasbarrini; H. Şimşek; A. Axon; G. M. Buzás; J. C. L. Machado; Y. Niv; J. Molina Infante; L. Boyanova; A. Goldis; V. Lamy; M. Katicic; K. Przytulski; C. Beglinger; M. Venerito; P. Bytzer; L. Capelle; T. Milosavljevic; L. Veijola; L. Vologzhanina; G. Fadeenko; I. Ariño; G. Fiorini; M. Caldas; M. Ramas; M. Garcia Donday; F. Megraud; C. O'Morain; J. P. Gisbert Live Stream
Q&A
Audience Voting
11:06 – 11:18 OP198 HELICOBACTER PYLORI ERADICATION THERAPY WITH VONOPRAZAN WAS MORE EFFECTIVE COMPARED TO PROTON PUMP INHIBITORS, AND THE EFFECT WAS NOT DISTURBED IN THE PATIENTS WITH LIFE STYLE-RELATED DISEASES Hiroyoshi Endo, Japan; Y. Takara; T. Matsunaga; H. Hidaka; S. Shirai; R. Shimoda; R. Iwakiri; K. Fujimoto 11:18 – 11:30 OP199 OPTIMIZED 14-DAY SEQUENTIAL VERSUS 10-DAY BISMUTH QUADRUPLE THERAPY CONTAINING HIGH DOSE ESOMEPRAZOLE IN THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI –A MULTICENTER RANDOMIZED TRIAL Jyh-Ming Liou, Taiwan; Y.-J. Fang; C.-C. Chen; M.-J. Bair; J.-T. Lin; M.-S. Wu 11:30 – 11:42 OP200 THE ABUNDANCE OF ANTIBIOTIC RESISTANCE GENES IN HUMAN GUTS AFTER H. PYLORI ERADICATION THERAPY ª S. Y. Malanin; D. D. Safina; D. R. Khusnutdinova; I. Y. Vasilyev; Tatiana Grigoryeva, Russian Federation; M. N. Siniagina; M. I. Markelova; E. A. Boulygina; S. R. Abdulkhakov; R. A. Abdulkhakov; V. M. Chernov 11:42 – 11:54 OP201 PAN-EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): BACTERIAL RESISTANCE OF 2,241 H. PYLORI ISOLATES. Adrian Gerald McNicholl, Spain; O. P. Nyssen; D. S. Bordin; B. Tepeš; M. Á. Perez Aisa; B. Vaira; M. Caldas Álvarez; L. Bujanda Fernández de Piérola; M. Castro Fernández; F. Lerang; M. Leja; L. Rodrigo; T. Rokkas; L. Kupcinskas; J. Perez-Lasala; L. Jonaitis; O. Shvets; A. Gasbarrini; H. Şimşek; A. Axon; G. M. Buzás; J. C. L. Machado; Y. Niv; L. Boyanova; A. Goldis; V. Lamy; M. Katicic; K. Przytulski; C. Beglinger; M. Venerito; P. Bytzer; L. Capelle; T. Milosavljevic; L. Veijola; J. Molina Infante; L. Vologzhanina; G. Fadeenko; I. Ariño; G. Fiorini; M. Ramas; M. Garcia Donday; F. Megraud; C. O'Morain; J. P. Gisbert Symposium 10:30 – 12:00 Intestinal ultrasound: How and when? Chairs: Odd Helge Gilja, Norway Giovanni Maconi, Italy
Room E1
10:30 – 10:52 IP388 The new European guidelines on intestinal ultrasound Odd Helge Gilja, Norway 10:52 – 11:14 IP389 What is the prognostic value of ultrasound in IBD? Giovanni Maconi, Italy
Recorded Session
77
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
11:14 – 11:36 IP390 Ultrasound in appendicitis and diverticulitis: A must or an option? Klaus Dirks, Germany 11:36 – 11:58 IP391 Any added value of elastography and contrast-enhanced ultrasound in Crohns disease? Kim Nylund, Norway Free Paper Session 10:30 – 12:00 Room E2 Diverticular disease: From bench to bedside Chairs: Anton Emmanuel, United Kingdom Nicolas Cenac, France 10:30 – 10:42 State-of-the-art introduction Anton Emmanuel, United Kingdom
IP392
Tuesday, October 31, 2017
10:42 – 10:54 OP202 CALCITONIN GENE-RELATED PEPTIDE INNERVATING ENTERIC PLEXUSES IS DOWNREGULATED IN DIVERTICULAR DISEASE: IMPLICATIONS FOR PATHOGENESIS ª Jaune Ieva Lukosiene, Lithuania; A. G. Pauza; K. Rysevaite-Kyguoliene; J. Kupcinskas; Z. Saladzinskas; A. Tamelis; N. Pauziene 10:54 – 11:06 OP203 IMMUNE ACTIVATION AND NERVE SPROUTING IN THE COLONIC MUCOSA OF PATIENTS WITH DIVERTICULAR DISEASE. Maria Raffaella Barbaro, Italy; C. Cremon; D. Fuschi; E. Scaioli; G. Marasco; M. Carapelle; E. Benatti; E. Capelli; A. Colecchia; D. Festi; V. Stanghellini; G. Barbara 11:06 – 11:18 OP204 PROLONGED RECURRENT ABDOMINAL PAIN IS ASSOCIATED WITH ON-GOING UNDERLYING MUCOSAL INFLAMMATION IN PATIENTS WHO HAD AN EPISODE OF ACUTE COMPLICATED DIVERTICULITS Adi Lahat, Israel; D. Necula; M. Yavzori; O. Picard; R. Eliakim; S. Ben-Horin 11:18 – 11:30 OP205 INCIDENCE OF COMPLICATED DIVERTICULAR DISEASE (ABSCESS AND PERFORATION): A POPULATION BASED COHORT STUDY FROM ENGLAND H. E. Otete; C. J. Crooks; J. West; David Humes, United Kingdom 11:30 – 11:42 OP206 COLONIC DIVERTICULA ARE NOT ASSOCIATED WITH MUCOSAL INFLAMMATION OR CHRONIC GASTROINTESTINAL SYMPTOMS Anne Peery, USA; T. Keku; C. Addamo; A. McCoy; C. Martin; J. Galanko; R. Sandler
78
Tuesday, October 31, 2017
11:42 – 11:54 OP207 UTILITY TO ENDOSCOPIC SUBMUCOSAL DISSECTION IN THE COLORECTAL TUMORS NEAR OR WITHIN DIVERTICULUM: CASE SERIES Victoria Alejandra Jimenez-Garcia, Japan; M. Yamada; H. Ikematsu; S. Abe; T. Sakamoto; T. Nakajima; T. Matsuda; Y. Saito Free Paper Session 10:30 – 12:00 Room E3 Mechanisms of carcinogenesis in the pancreas Chairs: Albrecht Neesse, Germany Corinne Bousquet, France 10:30 – 10:42 State-of-the-art introduction Albrecht Neesse, Germany
IP393
10:42 – 10:54 OP208 ENHANCED EXPRESSION OF K-RAS PROTEIN IN PANCREAS PROMOTES DEVELOPMENT OF CIGARETTE SMOKE INDUCED CHRONIC PANCREATITIS IN MICE. Jaroslaw Daniluk, Poland; U. Daniluk; J. Reszec; A. Dabrowski 10:54 – 11:06 OP209 EXPRESSION OF TN ANTIGEN CAUSES CHRONIC PANCREATITIS IN A TRANSGENIC MOUSE MODEL Baris Mercanoglu, Germany; K.-F. Karstens; C. Güngör; J. R. Izbicki; M. Bockhorn; G. Wolters-Eisfeld 11:06 – 11:18 OP210 LIPOXIN A4 INHIBITS PANCREATIC STELLATE CELL DIFFERENTIATION INTO PANCREATIC TUMOR STROMAL MYOFIBROBLASTS AND PANCREATIC TUMOR GROWTH IN VIVO M. Heinrich; Jonas Schnittert, The Netherlands; J. Prakash 11:18 – 11:30 OP211 PROTEIN FACTORS PRESENTED IN SERUM OF PANCREATIC CANCER PATIENTS ENHANCES THE MOTILITY OF CANCER CELLS – A NOVEL VIEW OF PANCREATIC CANCER CELL METASTASIS. ª Agata Poniewierska-Baran, Poland; K. Dąbkowski; T. Starzynska; M. Z. Ratajczak 11:30 – 11:42 OP212 ATM-DEFICIENCY GENERATES GENOMIC INSTABILITY IN PANCREATIC DUCTAL ADENOCARCINOMA AND SENSITIZES TOWARD THERAPEUTIC DNA-DAMAGE Lukas Perkhofer, Germany; A. Schmitt; E. Hessmann; D. A. A. Ruess; M. Lesina; A. Neese; B. Sipos; T. Seufferlein; H. C. Reinhardt; P.-O. Frappart; A. Kleger 11:42 – 11:54 OP213 COMBINED INHIBITION OF HISTONE DEACETYLASES AND SIRTUIN 1 LEADS TO PARTIAL REDIFFERENTIATION OF DUCTAL NEOPLASIA TOWARDS A MORE ACINAR PHENOTYPE IN MOUSE PANCREATIC TUMOR ORGANOIDS S. ZHANG; Xiaoping Zou, China
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
Free Paper Session 10:30 – 12:00 Room B5 Microbiology and immunology of the small intestine Chairs: Ashley Blackshaw, United Kingdom Johannes Roksund Hov, Norway 10:30 – 10:42 State-of-the-art introduction Ashley Blackshaw, United Kingdom
IP394
10:42 – 10:54 OP214 VERIFICATION OF IMMUNOGLOBULIN A REGULATION OF MICROFLORA AND PROTECTION OF INTESTINAL MUCOSA Naoya Tsugawa, Japan; T. Nagaishi; T. Watabe; N. Jose; A. Hosoya; Y. Kojima; T. Adachi; R. S. Blumberg; M. Watanabe 10:54 – 11:06 OP215 MONOCYTE-DERIVED MACROPHAGES RESTORE GUT MOTILITY IN POSTOPERATIVE ILEUS BY LIMITING ENTERIC NEURONAL DAMAGE M. Stakenborg; G. Farro; G. Goverse; V. De Simone; P. J. Gomez-Pinilla; Z. Lisowski; D. Laoui; J. Van Ginderachter; D. A. Hume; G. E. Boeckxstaens; Gianluca Matteoli, Belgium 11:06 – 11:18 OP216 VONOPRAZAN, A NOVEL ACTIVE POTASSIUM-COMPETITIVE ACID BLOCKER, AND RABEPRAZOLE INDUCE SMALL INTESTINAL DYSBIOSIS AND EXACERBATE THE NON-STEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED SMALL INTESTINAL ENTEROPATHY Yuji Nadatani, Japan; T. Watanabe; N. Sugimura; K. Otani; K. Taira; S. hosomi; Y. Nagami; F. Tanaka; N. Kamata; H. Yamagami; T. Tanigawa; M. Shiba; Y. Fujiwara 11:18 – 11:30 OP217 COMPOSITION OF MUCOSA-ASSOCIATED MICROBIOME ALONG THE ENTIRE GASTROINTESTINAL TRACT IN HUMANS Fanny E. R. Vuik, The Netherlands; G. M. Fuhler; S. R. Konstantinov; J. Dicksved; L. Engstrand; A. Van De Winkel; M. C. W. Spaander; E. J. Kuipers; M. P. Peppelenbosch 11:30 – 11:42 OP218 HYPOXIA DISRUPTS INTESTINAL BARRIER VIA REGULATING NHE8-TIGHT JUNCTION IN SEVERE ACUTE PANCREATITIS RAT MODELS Xiao Li, China; C. Geng; X. Lei; C. Wang 11:42 – 11:54 OP219 MODULATION OF THE ENDOCANNABINOID SYSTEM BY FATTY ACID AMIDE HYDROLASE, MONO- AND DIACYLGLYCEROL LIPASE INHIBITORS AS AN ATTRACTIVE TARGET FOR SECRETORY DIARRHEA THERAPY A. Wasilewski; A. Misicka; M. Sacharczuk; Jakub Fichna, Poland Live Stream
Q&A
Audience Voting
Free Paper Session 10:30 – 12:00 Hotspot Abstracts on Fire: Predicting and optimising IBD outcome Chairs: Walter Reinisch, Austria Catherine Reenaers, Belgium 10:30 – 10:40 OP220 ENRICHMENT OF CIRCULATING DOUBLE POSITIVE INTERLEUKIN-17 PRODUCING FOXP3+ CD4+ T CELL SUBSETS ARE ASSOCIATED WITH A HIGHER RISK OF FURTHER RELAPSE IN CROHN’S DISEASE IN REMISSION: AN OBSERVATIONAL, PROSPECTIVE MULTICENTER STUDY Gilles Boschetti, France; B. Flourie; X. Roblin; S. Paul; J. Bienvenu; G. Bommelaer; A. Buisson; E. Del Tedesco; C. Josson; S. Legastelois; S. Nancey 10:40 – 10:50 OP221 INFLIXIMAB TROUGH LEVELS ABOVE 7 μG/ML IN INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB: BETTER CONTROL OF INFLAMMATION WITHOUT INCREASED RISK OF INFECTION David Drobne, Slovenia; T. Kurent; S. Golob; P. Svegl; P. Rajar; S. Terzic; M. Kozelj; G. Novak; N. Smrekar; S. Plut; A. Smid; N. Sever; L. Strnisa; J. Brecelj; D. Urlep; J. Osredkar; M. Homan; R. Orel; B. Stabuc; I. Ferkolj 10:50 – 11:00 OP222 AN UPDATED ANALYSIS OF IN VITRO CYTOKINE INHIBITION PROFILES OF A NUMBER OF JANUS KINASE INHIBITORS AT CLINICALLY MEANINGFUL CONCENTRATIONS Martin Dowty, USA; T. H. Lin; L. Wang; J. M. Jussif; L. Li; E. Moy; J.-B. Telliez 11:00 – 11:10 OP223 IDENTIFICATION OF GENETIC SIGNATURES AND IMMUNE MECHANISMS THAT DEFINE THERAPEUTIC RESPONSE AND FAILURE TO ANTI-INTEGRIN THERAPY WITH VEDOLIZUMAB IN IBD PATIENTS Timo Rath, Germany; U. Billmeier; F. Ferrazzii; M. Vieth; A. Ekici; M. F. Neurath; R. Atreya 11:10 – 11:20 OP224 EXPANSION OF IL-23 RECEPTOR BEARING TNFR2+ T CELLS DRIVES RESISTANCE TO ANTI-TNF THERAPY IN CROHN`S DISEASE Heike Schmitt, Germany; U. Billmeier; W. Dieterich; T. Rath; S. Hirschmann; C. Neufert; K. Hildner; M. J. Waldner; J. Mudter; T. Münster; M. F. Neurath; R. Atreya
Recorded Session
79
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
11:20 – 11:30 OP225 SUPERIOR ENDOSCOPIC AND DEEP REMISSION OUTCOMES IN ADULTS WITH MODERATE TO SEVERE CROHN'S DISEASE MANAGED WITH TREAT TO TARGET APPROACH VERSUS CLINICAL SYMPTOMS: DATA FROM CALM Jean-Frederic Colombel, USA; R. Panaccione; P. Bossuyt; M. Lukas; F. Baert; T. Vanásek; A. Danalıoğlu; G. Novacek; A. Armuzzi; X. Hebuterne; S. Travis; S. Danese; W. Reinisch; W. J. Sandborn; P. Rutgeerts; D. Hommes; S. Schreiber; E. Neimark; B. Huang; Q. Zhou; J. Petersson; K. Wallace; A. M. Robinson; R. Thakkar; G. R. D'Haens 11:30 – 11:40 OP226 EFFICACY AND SAFETY OF A BRIDGING STRATEGY WITH CALCINEURIN INHIBITORS TO VEDOLIZUMAB IN PATIENTS WITH SEVERE ULCERATIVE COLITIS G. Pellet; C. Stefanescu; F. Carbonnel; L. Peyrin-Biroulet; X. Roblin; C. Allimant; M. Nachury; S. Nancey; J. Filippi; R. Altwegg; H. Brixi; G. Fotsing Makougang; S. Shili; David Laharie, France
Tuesday, October 31, 2017
11:40 – 11:50 OP227 A TREAT TO TARGET APPROACH DECREASES THE RATE OF CD-RELATED ADVERSE OUTCOMES VERSUS A CLINICAL APPROACH IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE: DATA FROM CALM Jean-Frederic Colombel, USA; R. Panaccione; P. Bossuyt; F. Baert; T. Vanásek; A. Danalıoğlu; G. Novacek; A. Armuzzi; X. Hebuterne; S. Travis; S. Danese; W. Reinisch; W. J. Sandborn; P. Rutgeerts; D. Hommes; S. Schreiber; E. Neimark; B. Huang; Q. Zhou; W. J. Lee; J. Petersson; K. Wallace; A. M. Robinson; R. B. Thakkar; G. D'Haens 11:50 – 12:00 OP228 PROFILE TRIAL: PREDICTING OUTCOMES FOR CROHN’S DISEASE USING A MOLECULAR BIOMARKER J. C. Lee; D. Biasci; Nurulamin Noor, United Kingdom; E. F. McKinney; T. Ahmad; N. R. Lewis; A. Hart; P. A. Lyons; M. Parkes; K. G. Smith Round Table Discussion 12:45 – 13:45 Room A2 Therapy-resistent reflux symptoms: What can we offer to the patient? Chair: André Smout, The Netherlands Experts: Pali Hungin, United Kingdom Sabine Roman, France André Smout, The Netherlands Giovanni Zaninotto, United Kingdom
80
Tuesday, October 31, 2017
Round Table Discussion 12:45 – 13:45 Room A3 Autoimmune pancreatitis: Diagnostic and therapeutic challenges Chair: Thomas M. Gress, Germany Experts: Luca Frulloni, Italy Thomas M. Gress, Germany Julia Mayerle, Germany Vinciane Rebours, France Round Table Discussion 12:45 – 13:45 Room B2 Management of malignant dysphagia Chair: Mark Ivo van Berge Henegouwen, The Netherlands Experts: Riccardo Rosati, Italy Peter D. Siersema, The Netherlands Eric Van Cutsem, Belgium Mark Ivo van Berge Henegouwen, The Netherlands Round Table Discussion 12:45 – 13:45 Use and abuse of GI function tests Chair: Mark Fox, Switzerland Experts: Fernando Azpiroz, Spain Mark Fox, Switzerland Jutta Keller, Germany Stuart Taylor, United Kingdom Symposium 12:45 – 13:30 The role of academia in drug development Chairs: Michael Manns, Germany Magnus Simrén, Sweden
Room B3
Hotspot
12:45 – 13:00 IP395 Breaking down borders between public and private research 13:00 – 13:15 IP396 How to turn a biotech company into big pharma John C. Martin, USA 13:15 – 13:30 IP397 Role of academia in drug development: View of the regulatory authority Joachim Musaus, United Kingdom
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
Career Chat 13:00 – 14:00 Young GI Lounge Top advice from female leaders and their fellows Chairs: Rebecca Clare Fitzgerald, United Kingdom Monika Maria Widlak, United Kingdom Experts: Marianna Arvanitakis, Belgium Siwan Thomas-Gibson, United Kingdom Severine Vermeire, Belgium Live Endoscopy 14:00 – 15:30 Live endoscopy Chairs: Guido Costamagna, Italy Jacques Deviere, Belgium Christian Gerges, Germany Experts: Marc Barthet, France Philipp Bender, Germany Torsten Beyna, Germany Karel Caca, Germany Pierre Henri Deprez, Belgium Jennis Kandler, Germany Horst Neuhaus, Germany André Ragheb, Germany
Hall 6
Symposium 14:00 – 15:30 Room C1 Management of dysplasia in ulcerative colitis Chairs: Willem A. Bemelman, The Netherlands Britta Siegmund, Germany
Symposium 14:00 – 15:30 Proctology made easy Chairs: Dieter Hahnloser, Switzerland Roger Leicester, United Kingdom
Room C2
14:00 – 14:22 Hemorrhoids Alexander Herold, Germany
IP403
14:22 – 14:44 Anal fissure Monica Millan, Spain
IP404
14:44 – 15:06 Anal warts Desmond C. Winter, Ireland
IP405
15:06 – 15:28 Perianal abscess Ibrahim Ethem Gecim, Turkey
IP406
Symposium 14:00 – 15:30 Room F3 Therapy update: Faecal incontinence Chairs: Emma Carrington, United Kingdom José Maria Remes-Troche, Mexico 14:00 – 14:22 IP407 Diagnostic work-up: What is the preferred strategy? Mark Scott, United Kingdom 14:22 – 14:44 Conservative treatment Henriette Heinrich, United Kingdom
IP408
IP398
IP409
14:10 – 14:20 Histopathological diagnosis Michael Vieth, Germany
IP399
14:44 – 15:06 Behavioural treatment Satish Rao, USA
IP400
15:06 – 15:28 Surgical treatment options Charles H. Knowles, United Kingdom
IP410
14:20 – 14:30 Endoscopic therapy and resection Brian P. Saunders, United Kingdom 14:30 – 14:40 Surgical therapy Antonino Spinelli, Italy
IP401
14:40 – 15:02 Surveillance strategies after ileal pouch Iris Dotan, Israel
IP402
Tandem Talks 14:00 – 14:10 Endoscopic diagnosis Tomas Hucl, Czech Republic
15:02 – 15:30 PANEL DISCUSSION
Live Stream
Q&A
Audience Voting
Recorded Session
81
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
Symposium 14:00 – 15:30 Room F2 How to manage early gastric cancer? Chairs: Mario Dinis-Ribeiro, Portugal Mark Ivo van Berge Henegouwen, The Netherlands 14:00 – 14:22 Endoscopic diagnosis and staging Fabian Emura, Colombia
IP411
14:22 – 14:44 Update on endoscopic treatment Helmut Messmann, Germany
IP412
14:44 – 15:06 IP413 Minimally invasive surgical and hyprid techniques Suzanne S. Gisbertz, The Netherlands
Tuesday, October 31, 2017
15:06 – 15:18 OP229 LYMPHATIC INVASION MAY BE MOST RELEVANT TO NODAL METASTASES IN EARLY-STAGE GASTRIC CANCERS: A RETROSPECTIVE ANALYSIS IN 65 CASES Teppei Akimoto, Japan; O. Goto; N. Ueki; H. Kawakubo; H. Noda; G. Ikeda; K. Higuchi; Y. Mitsunaga; H. Yamawaki; Y. Kodaka; A. Nakayama; M. Kato; A. Fujimoto; Y. Ochiai; T. Maehata; K. Suda; T. Uraoka; T. Kawagoe; S. Futagami; I. Fujita; M. Kaise; Y. Kitagawa; K. Iwakiri; N. Yahagi 15:18 – 15:30 OP230 CLINICAL CHARACTERISTICS AND MANAGEMENT OF PATIENTS WITH GASTRIC PRECANCEROUS LESIONS IN FRANCE: A LARGE 15-YEAR SINGLE CENTER RETROSPECTIVE STUDY. Matthieu Péron, France; N. Chapelle; A. Bourget; J.-F. Mosnier; S. Bruley Des Varannes; Y. Touchefeu; E. Coron; E. Cauchin; T. Matysiak Budnik Symposium 14:00 – 15:30 Room F1 From guidelines to clinical practice: Pancreatic diseases Chairs: Rodger A. Liddle, USA Philippe Lévy, France 14:00 – 14:22 Acute pancreatitis Djuna L. Cahen, The Netherlands
IP414
14:22 – 14:44 Chronic pancreatitis David C. Whitcomb, USA
IP415
14:44 – 15:06 Pancreatic cystic tumours Marco Del Chiaro, Sweden
IP416
82
Tuesday, October 31, 2017
15:06 – 15:28 Pancreatic cancer Michel Ducreux, France Symposium 14:00 – 15:30 Malignant colorectal polyp: What to do? Chairs: Gabriela Möslein, Germany Ian Jenkins, United Kingdom
IP417
Room A2
14:00 – 14:22 IP418 Clinically relevant information from the pathologist Iris D. Nagtegaal, The Netherlands Debates 14:22 – 14:32 IP419 Malignant colon polyp: Endoscopy or surgery? Endoscopy Michael Bretthauer, Norway 14:32 – 14:42 IP420 Malignant colon polyp: Endoscopy or surgery? Surgery Eloy Espin Basany, Spain 14:42 – 14:52 IP421 Malignant rectal polyp: Endoscopy or surgery or chemoradiotherapy? Endoscopy and chemoradiotherapy Marc Giovannini, France 14:52 – 15:02 IP422 Malignant rectal polyp: Endoscopy or surgery or chemoradiotherapy? Surgery Roel Hompes, United Kingdom 15:02 – 15:14 OP231 WATER EXCHANGE SIGNIFICANTLY IMPROVED ADENOMA DETECTION RATE AND RELATED MEASURES AND COLON CLEANLINESS IN PROPOFOL-SEDATED PATIENTS Felix Leung, USA; M. Koo; Y.-H. Hsieh; C.-W. Tseng; C.-T. Hu; L. Zhang; T. Dong; H. Jia; Y. Pan 15:14 – 15:26 OP232 COLONIC POST POLYPECTOMY BLEEDING IN PATIENTS ON NEW ORAL ANTI-COAGULANT – A CASE CONTROL STUDY. Long Yan Kelvin Lam, Hong Kong PRC; T. Y. T. Lam; J. Y. L. Ching; S. H. Wong; S. C. C. Ng; F. K. L. Chan Symposium 14:00 – 15:30 Room A1 The role of the GI microenvironment in IBS Chairs: Giovanni Barbara, Italy Daisy Mae Jonkers, The Netherlands 14:00 – 14:22 Bile acids Julian Walters, United Kingdom
IP423
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
14:22 – 14:44 Microbiota Muriel Derrien, France
IP424
14:44 – 15:06 Food Shanti Lynne Eswaran, USA
IP425
15:06 – 15:28 Gas Fernando Azpiroz, Spain
IP426
Free Paper Session 14:00 – 15:30 Late breaking abstracts III
Room A3
Free Paper Session 14:00 – 15:30 Impacts of biologics in IBD Chairs: Pascal Juillerat, Switzerland Julien Kirchgesner, France 14:00 – 14:12 State-of-the-art introduction Julien Kirchgesner, France
Room B2
IP427
14:12 – 14:24 OP233 MRI IMPROVEMENT AFTER ANTI-TNF THERAPY IS PREDICTIVE OF SUSTAINED CLINICAL REMISSION AND IS A POTENTIAL THERAPEUTIC TARGET IN CROHN’S DISEASE Anthony Buisson, France; L. Messadeg; G. Bouguen; F. GOUTORBE; J.-M. Reimund; M. Goutte; C. Sautel; A.-L. Boucher; I. Ticlete; C. Duron; J. Scanzi; M. Reymond; C. Allimant; M. Dapoigny; G. Bommelaer; B. Pereira; C. Hordonneau 14:24 – 14:36 OP234 EFFICACY OF ENDOSCOPIC PLACEMENT OF A DRUG-ELUTING PLATFORM WITH INFLIXIMAB FOR THE TREATMENT OF MUCOSAL LESIONS IN A RAT MODEL OF EXPERIMENTAL COLITIS. Ramon Bartolí, Spain; I. Bon; J. Boix; V. Moreno de Vega; N. D. De la Ossa; I. Marín; V. Lorenzo-Zúñiga 14:36 – 14:48 OP235 FINAL RESULTS ON EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT K. B. Gecse; Z. Vegh; Z. Kurti; M. Rutka; K. Farkas; P. A. Golovics; B. D. Lovasz; Lorant Gonczi, Hungary; J. Banai; L. Bene; B. Gasztonyi; T. Kristof; L. Lakatos; P. Miheller; F. Nagy; K. Palatka; M. Papp; A. Patai; A. Salamon; T. Szamosi; Z. Szepes; G. T. Toth; A. Vincze; T. Molnar; P. L. Lakatos
Live Stream
Q&A
Audience Voting
14:48 – 15:00 OP236 EFFICACY OF HEPATITIS B VIRUS VACCINATION IN NEWBORNS EXPOSED TO ANTI-TNF ALPHA IN UTERO Alison de Lima-Karagiannis, The Netherlands; S. Kanis; J. C. Escher; C. J. van der Woude 15:00 – 15:12 OP237 STRUCTURE AND BIOLOGICAL ACTIVITY OF INFLIXIMAB PRODUCTS Changsoo Lee, Republic of Korea; M. Jeong; J. Lee; S. Seo; S. Cho; W. Zhang; O. Jaquez 15:12 – 15:24 OP238 BODY WEIGHT AND RAPID CLEARANCE DETERMINE EARLY FORMATION OF ANTI-DRUG ANTIBODIES AGAINST INFLIXIMAB. Walter Reinisch, Austria; A. Eser; S. Schreiber; H. C. Kwon; D. R. Mould Translational Basic Science 14:00 – 15:30 Which GI diseases are inherited? Chairs: Carla Oliveira, Portugal Bill Greenhalf, United Kingdom
Room B3
14:00 – 14:22 When to refer a GI patient to a geneticist? Marc Tischkowitz, United Kingdom
IP428
14:22 – 14:44 Genetics and gastric cancer Carla Oliveira, Portugal
IP429
14:44 – 15:06 Genetics and colon cancer Emad El-Omar, Australia
IP430
15:06 – 15:28 The genetics of IBD: Status quo and beyond Vito Annese, Italy
IP431
Today's Science, Tomorrow's Medicine 14:00 – 15:30 How to modulate the microbiome? Chairs: Sibylle Koletzko, Germany Ed Kuijper, The Netherlands
Room E4
14:00 – 14:22 Diet and prebiotics Jan Tack, Belgium
IP432
14:22 – 14:44 Antibiotics Jasmohan S. Bajaj, USA
IP433
Recorded Session
83
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
14:44 – 15:06 Faecal microbiota transplantation (FMT) Giovanni Cammarota, Italy
IP434
15:06 – 15:28 IP435 How to optimise banking for faecal microbiota transplantation (FMT) Josbert Keller, The Netherlands Free Paper Session 14:00 – 15:30 Room 7.1 Optimising your colonoscopy practice Chairs: Bjorn Rembacken, United Kingdom Fatih Aslan, Turkey 14:00 – 14:12 State-of-the-art introduction Bjorn Rembacken, United Kingdom
IP436
Tuesday, October 31, 2017
14:12 – 14:24 OP239 RELATED FACTORS TO THE QUALITY OF COLON CLEANSING Carolina Mangas, Spain; E. Santana Rocamora; A. Suárez González; I. Portillo Villares; A. Seoane; M. Ponce; P. Diez; E. Quintero Carrion; M. Herraiz; M. Pellisé Urquiza; Á. Ferrández Arenas; V. Hernández; Á. E. Pizarro Moreno; R. Jover 14:24 – 14:36 OP240 IMPROVEMENT OF COLONOSCOPY PREPARATION BY AN AUTOMATED 4-DAY PATIENT GUIDANCE BY SMS; RESULTS FROM THE PERICLES-II STUDY Benjamin Walter, Germany; P. Klare; K. Strehle; J. Aschenbeck; L. Ludwig; N. Dikopoulos; B. Neu; S. Delius 14:36 – 14:48 OP241 A RANDOMIZED CONTROLLED TRIAL COMPARING WATER ASSISTED AND AIR INSUFFLATION COLONOSCOPY WITHOUT SEDATION Richard Azevedo, Portugal; C. Leitão; H. Ribeiro; J. Pinto; F. Pereira; A. Caldeira; R. Sousa; E. Pereira; J. Barros; A. Banhudo 14:48 – 15:00 OP242 NEW GENERATION FULL-SPECTRUM VERSUS STANDARD FORWARD-VIEWING COLONOSCOPY: A MULTICENTER, RANDOMIZED CONTROLLED, TANDEM COLONOSCOPY TRIAL Kinichi Hotta, Japan; T. Kudo; Y. Saito; H. Ikematsu; Y. Takeuchi; M. Shimatani; K. Kawakami; N. Tamai; K. Yoshimura; H. Ishikawa; K. Imai; Y. Mori; T. Matsuda; S.-E. Kudo 15:00 – 15:12 OP243 PERFORMANCE COMPARISON OF FULL-SPECTRUM VERSUS FORWARD-VIEWING COLONSCOPY: A RANDOMIZED CONTROLLED TRIAL. Martin Geyer, Switzerland; L. Dominik; F. Bannwart 84
Tuesday, October 31, 2017
15:12 – 15:24 OP244 IMPLEMENTATION OF AN OPTICAL DIAGNOSIS STRATEGY FOR DIMINUTIVE POLYPS INCLUDING SESSILE SERRATED LESIONS: TRAINING AND LONG-TERM QUALITY ASSURANCE Jasper Vleugels, The Netherlands; M. G. W. Dijkgraaf; Y. Hazewinkel; P. Fockens; E. Dekker; O. B. O. T. DISCOUNT study group Symposium 14:00 – 15:30 Room E1 From fibrosis to cirrhosis: Diagnostic challenges and novel therapies Chairs: Dominique Thabut, France Alexandre Louvet, France Debate 14:00 – 14:10 IP437 Staging of liver disease: Non-invasive methods are the gold-standard Laurent Castera, France 14:10 – 14:20 IP438 Staging of liver disease: Biopsies are still needed Karoline Lackner, Austria 14:20 – 14:42 Novel therapeutic options Frank Tacke, Germany
IP439
14:42 – 15:04 IP440 Regression of liver cirrhosis: Is this really possible? Maria Buti, Spain 15:04 – 15:26 IP441 Rising Star: The role of stabilin-1 in liver fibrogenesis and repair ª Shishir Shetty, United Kingdom Free Paper Session 14:00 – 15:30 Room E2 H. pylori: From pathophysiology to the clinic Chairs: Jose Carlos L. Machado, Portugal Chella Van der Post, The Netherlands 14:00 – 14:12 State-of-the-art introduction Jose Carlos L. Machado, Portugal
IP442
14:12 – 14:24 OP245 LONG-TERM EFFECTS OF H. PYLORI ERADICATION ON MOLECULAR ALTERATIONS RELATED TO GASTRIC CARCINOGENESIS Jiro Watari, Japan; Y. Michigami; C. Ito; K. Hara; T. Yamasaki; T. Okugawa; T. Kono; K. Tozawa; T. Tomita; Y. Ohda; T. Oshima; H. Fukui; H. Miwa
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
14:24 – 14:36 OP246 CLINICAL CHARACTERISTICS OF HELICOBACTER PYLORI NAÏVE NON-CARDIAC GASTRIC ADENOCARCINOMA. Sho Suzuki, Japan; N. Uedo; M. Arao; T. Iwatsubo; H. Nakahira; M. Kato; Y. Tounai; K. Hamada; Y. Yamasaki; N. Matsuura; S. Sichijo; T. Kanesaka; S. Yamamoto; T. Akasaka; N. Hanaoka; Y. Takeuchi; K. Higashino; R. Ishihara; Y. Tomita; H. Iishi 14:36 – 14:48 OP247 EPIGENETIC SILENCING OF AN AUTOPHAGY GENE BY HELICOBACTER PYLORI FACILITATES CARCINOGENIC TRANSFORMATION OF GASTRIC EPITHELIAL CELLS ª Jibran Sualeh Muhammad, Pakistan; S. Nanjo; T. Ando; S. Yamashita; T. Ushijima; T. Sugiyama 14:48 – 15:00 OP248 THE EPITHELIAL-MESENCHYMAL TRANSITION PROCESS OF NORMAL EPITHELIUM INFECTED BY HELICOBACTER PYLORI. ROLE OF FIBROBLASTS AND CANCER ASSOCIATED PROTEINS Gracjana Krzysiek-Maczka, Poland; A. Ptak-Belowska; A. Targosz; M. Strzalka; U. Szczyrk; T. Brzozowski 15:00 – 15:12 OP249 HELICOBACTER PYLORI INFECTION IS AN INDEPENDENT RISK FACTOR OF EARLY AND ADVANCED COLORECTAL NEOPLASM So Jung Lee, Republic of Korea; S. H. Kim; T. J. Kim; E. R. Kim; S. N. Hong; D. K. Chang; Y. H. Kim 15:12 – 15:24 OP250 HELICOBACTER PYLORI INFECTION ALLEVIATES THE ALLERGIC SYMPTOMS OF ATOPIC DERMATITIS IN A MOUSE MODEL VIA GENERATION OF CD4+CD25+FOXP3+ T CELLS Qian Xue, China; W. J. tong; X. Li Free Paper Session 14:00 – 15:30 Room E3 Pancreatic cancer: Risk factors and screening Chairs: Stefano Crippa, Italy Jonas Rosendahl, Germany 14:00 – 14:12 State-of-the-art introduction Jonas Rosendahl, Germany
IP443
14:12 – 14:24 OP251 INCREASING MORTALITY FROM PANCREATIC CANCER IN PORTUGAL – AN EPIDEMIOLOGICAL ANALYSIS OF 25 YEARS Pedro Marques Da Costa, Portugal; R. T. Marinho; H. Cortez-Pinto; L. Costa; J. Velosa 14:24 – 14:36 OP252 ADHERENCE TO FOOD GUIDELINES OF THE WORLD CANCER RESEARCH FUND & AMERICAN INSTITUTE FOR CANCER RESEARCH AND PANCREATIC CANCER RISK Jesse Fest, The Netherlands; R. Ruiter; M. A. Ikram; C. H. J. van Eijck; J. C. Kiefte-de Jong; B. H. Stricker Live Stream
Q&A
Audience Voting
14:36 – 14:48 OP253 SURVEILLANCE FOR PANCREATIC CANCER IN HIGHRISK INDIVIDUALS: FIRST-ROUND SCREENING RESULTS OF A MULTICENTRIC ITALIAN PROGRAM Salvatore Paiella, Italy; G. Capurso; G. Butturini; R. Pezzilli; S. Carrara; M. Falconi; M. Signoretti; M. Di Leo; I. Frigerio; C. Bassi; A. Zerbi 14:48 – 15:00 OP254 THE ROLE OF CYSTIC PRECURSOR LESIONS IN THE DEVELOPMENT OF PANCREATIC DUCTAL ADENOCARCINOMA IN CDKN2A-P16-LEIDEN MUTATION CARRIERS Isaura Ibrahim, The Netherlands; M. Wasser; Y. Wu; A. Inderson; W. De Vos Tot Nederveen Cappel; H. Morreau; F. Hes; R. A. Veenendaal; H. Putter; S. Feshtali; A. van Mil; N. Gruis; R. Tollenaar; W. Bergman; B. Bonsing; H. Vasen 15:00 – 15:12 OP255 CHARACTERIZATION OF GENETIC ALTERATIONS IN PANCREATIC CANCER HIGH RISK POPULATION Guy Rosner, Israel; E. Scapa; E. Santo; M. Ben-Yehoyada 15:12 – 15:24 OP256 DETECTION OF PANCREATIC CANCER BY URINE ELECTRIC NOSE ANALYSIS, A PROOF-OF-CONCEPT STUDY, 80 CASES Samuli Nissinen, Finland; A. Roine; L. Hokkinen; T. Rantanen; N. Oksala Free Paper Session 14:00 – 15:30 Room B5 Carcinogenesis and tumour progression in GI cancer Chairs: Ian Tomlinson, United Kingdom Albrecht Neesse, Germany 14:00 – 14:12 State-of-the-art introduction Ian Tomlinson, United Kingdom
IP444
14:12 – 14:24 OP257 HINOS PROMOTES A CD24+CD133+ LIVER CANCER STEM CELL PHENOTYPE AND TUMOR PROGRESSION THROUGH A TACE/ADAM17 DEPENDENT NOTCH SIGNALING PATHWAY Ronghua Wang, China 14:24 – 14:36 OP258 AUTOPHAGY INHIBITS PROTUMORAL EFFECTS INDUCED BY COLIBACTIN-PRODUCING COLORECTAL CANCER-ASSOCIATED ESCHERICHIA COLI Cécily Lucas, France; G. Dalmasso; M. Bonnet; P. Sauvanet; D. Pezet; N. Barnich; P. Rosenstiel; R. Bonnet; H. T. T. Nguyen
Recorded Session
85
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
14:36 – 14:48 OP259 INTERPLAY BETWEEN CD80 SIGNALLING AND MISMATCH REPAIR GENES EXPRESSION IN THE EARLY STAGES OF COLONIC CARCINOGENESIS Andromachi Kotsafti, Italy; M. Scarpa; M. Fassan; S. Morgan; A. Porzionato; C. Marchiori; P. BRUN; I. Angriman; M. Rugge; C. Castoro; I. Castagliuolo; M. Scarpa 14:48 – 15:00 OP260 BETA-6-INTEGRIN SERVES AS A NOVEL SERUM TUMOR MARKER AND THERAPEUTIC TARGET FOR COLORECTAL CARCINOMA S. Bengs; E. Becker; M. R. Spalinger; T. Raselli; S. Kasper; S. Lang; K. Atrott; C. Mamie; N. Britzen-Laurent; L. von Boehmer; A. K. R. Knuth; A. Tuomisto; M. J. Mäkinen; P. Hruz; M. Turina; A. Rickenbacher; H. Petrowsky; A. Weber; P. Frei; S. Vavricka; M. Halama; R. S. Croner; J. Christoph; G. Jenkins; D. Sheppard; M. Stürzl; M. Fried; G. Rogler; Michael Scharl, Switzerland
Tuesday, October 31, 2017
15:00 – 15:12 OP261 RESPONSIBLE GENES FOR CHARACTERISTICS OF THE INDUCED CANCER STEM-LIKE SPHERE CELLS OF HEPATOCELLULAR CARCINOMA Ryouichi Tsunedomi, Japan; K. Yoshimura; M. Nishiyama; S. Matsukuma; S. Kanekiyo; Y. Tokumitsu; S. Tomochika; Y. Tokuhisa; M. Iida; K. Sakamoto; N. Suzuki; S. Takeda; S. Yamamoto; S. Yoshino; S. Hazama; T. Ueno; H. Nagano
Tuesday, October 31, 2017
14:30 – 14:45 PANEL DISCUSSION
Jaime Bosch, Spain Elisabetta Bugianesi Vlad Ratziu, France Helen Reeves, United Kingdom 14:45 – 15:00 IP447 Trial presentation: A placebo-controlled trial of obeticholic acid in primary biliary cholangitis Joost P. H. Drenth, The Netherlands 15:00 – 15:15 Critical review Tom Hemming Karlsen, Norway
IP448
15:15 – 15:30 PANEL DISCUSSION
Joost P. H. Drenth, The Netherlands Tom Hemming Karlsen, Norway Marco Marzioni, Italy Michael Trauner, Austria Symposium 15:45 – 17:15 Hall 6 Multidisciplinary management of complicated luminal Crohn's disease Chairs: Tine Jess, Denmark James Lindsay, United Kingdom
15:12 – 15:24 OP262 IN VIVO EFFICACY OF LOCAL THERAPY WITH ADHESIVE WAFER CONTAINING ANTICANCER DRUG IN AN ORTHOTOPIC PANCREATIC CANCER MOUSE MODEL Eunhye Lee, Republic of Korea; J. H. Maeng; Y. H. Nan; K. Kim; S. Jeong; D. H. Lee
15:45 – 16:07 IP449 Imaging of complicated luminal Crohn's disease Stuart Taylor, United Kingdom
Symposium 14:00 – 15:30 Hotspot Clinical trials revisited: New drugs in liver diseases Chair: Heiner Wedemeyer, Germany
Tandem Talks 16:07 – 16:17 IP450 Management of ileal abscess: Medical therapy or surgery? Gastroenterologist's view Severine Vermeire, Belgium
14:00 – 14:15 IP445 Trial presentation: Elafibranor, an agonist of the peroxisome proliferator-activated receptor-α and -δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening Vlad Ratziu, France 14:15 – 14:30 Critical review Jaime Bosch, Spain
86
IP446
16:17 – 16:27 IP451 Management of ileal abscess: Medical therapy or surgery? Surgeon's view André D'Hoore, Belgium 16:27 – 16:37 IP452 Management of symptomatic ileal stricture: Gastroenterologist's view Yoram Bouhnik, France 16:37 – 16:47 IP453 Management of symptomatic ileal stricture: Surgeon's view Yves Panis, France
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
16:47 – 16:59 OP263 PATIENT-REPORTED OUTCOMES WITH UPADACITINIB IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: PHASE 2 RESULTS FROM CELEST STUDY Laurent Peyrin-Biroulet, France; E. Louis; E. V. Loftus Jr; N. Tundia; M. Fuldeore; A. Lacerda; J. Enejosa; A. Pangan
Symposium 15:45 – 17:15 East meets West: Oesophageal cancer Chairs: Hironori Yamamoto, Japan Riccardo Rosati, Italy
16:59 – 17:11 OP264 FECAL MICROBIOTA TRANSPLANT FOR CROHN’S DISEASE: A PROSPECTIVE, RANDOMIZED STUDY IN CHINESE POPULATION Zhenyu Yang, China; X. Wang; C. bu
15:45 – 16:07 Epidemiology and risk factors Isabelle Soerjomataram, France
IP459
16:07 – 16:29 Neo-adjuvant treatment Teresa Macarulla, Spain
IP460
Symposium 15:45 – 17:15 Room C1 Case finding and surveillance of Barrett's oesophagus Chairs: Jacques J. Bergman, The Netherlands Cord Langner, Austria Tandem Talks 15:45 – 15:55 IP454 Screening for Barrett's: Biomarkers and risk factors Jesper Lagergren, Sweden 15:55 – 16:05 Screening for Barrett's: Endoscopy Marcia Irene Canto, USA
IP455
16:05 – 16:17 OP265 A NOVEL, INTERACTIVE WEB-BASED EDUCATIONAL TOOL IMPROVES DETECTION AND DELINEATION OF BARRETT’S OESOPHAGUS RELATED NEOPLASIA (BORN): THE BORN PROJECT. Jacques J. Bergman, The Netherlands; O. Pech; K. Ragunath; D. Armstrong; G. Tytgat; J. Dent; L. Lundell; M. Vieth; P. Sharma 16:17 – 16:29 OP266 MANAGEMENT OF PATIENTS WITH BARRETT’S OESOPHAGUS: A COST-EFFECTIVENESS ANALYSIS Amir-Houshang Omidvari, The Netherlands; S. Kroep; I. Lansdorp-Vogelaar; A. Ali; W. D. Hazelton; E. Richmond; C. Y. Kong; J. H. Rubenstein; G. Luebeck; C. Hur; J. Inadomi Debate 16:29 – 16:39 IP456 Suspected Barrett's epithelium: Endoscopy is enough Raf Bisschops, Belgium 16:39 – 16:49 IP457 Suspected Barrett's epithelium: Histopathology is necessary Marnix Jansen, United Kingdom
Tandem Talks 16:29 – 16:39 Endoscopic treatment: East Naoyuki Yamaguchi, Japan 16:39 – 16:49 Endoscopic treatment: West Michael B Wallace, USA Tandem Talks 16:49 – 16:59 Surgical treatment: East Haruhiro Inoue, Japan
Room C2
IP461
IP462
IP463
16:59 – 17:09 IP464 Surgical treatment: West Mark Ivo van Berge Henegouwen, The Netherlands Symposium 15:45 – 17:15 Room F3 Therapy update: Nutritional therapy in gastroenterology Chairs: Antonio Gasbarrini, Italy Herbert Tilg, Austria 15:45 – 16:07 Pre-operative nutritional interventions André Van Gossum, Belgium
IP465
16:07 – 16:29 IP466 Acute pancreatitis: From nil by mouth to early feeding Stephan Bischoff, Germany 16:29 – 16:51 Nutritional interventions and cancer Francisca Joly, France
IP467
16:51 – 17:13 Intestinal failure Loris Pironi, Italy
IP468
16:49 – 17:11 IP458 Surveillance of known Barrett's: A rational approach Oliver Pech, Germany Live Stream
Q&A
Audience Voting
Recorded Session
87
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
Tuesday, October 31, 2017
Symposium 15:45 – 17:15 Room F2 Common mistakes in biliary obstruction management Chairs: Stefan Seewald, Switzerland Geoffroy Vanbiervliet, France
16:07 – 16:29 Disorders of oesophageal motility Mark Fox, Switzerland
IP478
16:29 – 16:51 Gastro-oesophageal reflux disease Edoardo Savarino, Italy
IP479
15:45 – 16:07 Pitfalls in the diagnostic work up Daniel Bléro, Belgium
IP469
16:07 – 16:29 How to prevent and manage infections Jörg Albert, Germany
IP470
Debate 16:51 – 17:01 IP480 High-resolution manometry is pivotal in the assessment of defecation disorders Satish Rao, USA
16:29 – 16:51 How to optimise endoscopic management Andrea Tringali, Italy
IP471
16:51 – 17:13 When to call the surgeon? Olivier Farges, France
IP472
Tuesday, October 31, 2017
Symposium 15:45 – 17:15 Room F1 From guidelines to clinical practice: Upper GI bleeding Chairs: Peter D. Siersema, The Netherlands Paul Fockens, The Netherlands 15:45 – 16:07 IP473 Non variceal upper GI bleeding: European guidelines Ian Gralnek, Israel 16:07 – 16:29 The patient with portal hypertension Mostafa Ibrahim, Belgium
IP474
16:29 – 16:51 IP475 The place of capsule endoscopy and enteroscopy Andrea May, Germany 16:51 – 17:13 The patient on anticoagulant therapy Cesare Hassan, Italy
IP476
Symposium 15:45 – 17:15 Room A2 Improved testing for upper and lower GI dysmotility Chairs: Sabine Roman, France Anton Emmanuel, United Kingdom 15:45 – 16:07 Swallowing disorders Nathalie Rommel, Belgium
88
IP477
17:01 – 17:11 IP481 High-resolution manometry is not essential in the assessment of defecation disorders Emma Carrington, United Kingdom Symposium 15:45 – 17:15 Update on diverticular disease Chairs: Ronan O'Connell, Ireland Julian Walters, United Kingdom
Room A1
15:45 – 16:07 Definition, epidemiology and risk factors Anne Peery, USA
IP482
16:07 – 16:29 Pathophysiology: What is new? Giovanni Barbara, Italy
IP483
16:29 – 16:51 IP484 Management of symptomatic uncomplicated diverticular disease Robin Spiller, United Kingdom 16:51 – 17:13 IP485 When to operate in recurrent uncomplicated diverticulitis? Desmond C. Winter, Ireland Free Paper Session 15:45 – 17:15 Potential future targets in IBD Chairs: Charlotte Hedin, Sweden Subrata Ghosh, Canada 15:45 – 15:57 State-of-the-art introduction Charlotte Hedin, Sweden
Room A3
IP486
15:57 – 16:09 OP267 MIR-9 INHIBITS GROWTH OF INTESTINAL EPITHELIAL CELLS AND PROMOTES EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CROHN’ S DISEASE AND MURINE COLITIS Ye Zhao, China; R. Shi
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
16:09 – 16:21 OP268 TARGETING NAD IMMUNOMETABOLISM AS NOVEL THERAPEUTIC STRATEGY IN IBD Romana Gerner, Austria; V. Klepsch; K. Arnhard; T. E. Adolph; S. Macheiner; C. Grander; N. Hermann-Kleiter; H. Oberacher; G. Baier; H. Tilg; A. R. Moschen
16:09 – 16:21 OP274 VARIATION BETWEEN PATHOLOGICAL MEASUREMENT AND ENDOSCOPIC ESTIMATED SIZE OF COLONIC POLYPS Catarina Atalaia Martins, Portugal; P. Marcos; S. Barbeiro; A. Fernandes; A. Santos; L. Eliseu; C. Gonçalves; I. Cotrim; H. Vasconcelos
16:21 – 16:33 OP269 BALANCING JAK/STAT-SIGNALING WITH TOFACITINIB IN MONOCYTES OF HEALTHY CONTROLS AND IBD PATIENTS ª Friederike Cordes, Germany; E. Lenker; T. Weinhage; D. Bettenworth; G. Varga; D. Foell
16:21 – 16:33 OP275 SHOULD WE RESECT AND DISCARD SMALL AND DIMINUTIVE POLYPS? S. Mifsud; E. L. Schembri; M. Muscat; Pierre Ellul, Malta
16:33 – 16:45 OP270 CHROMOFUNGIN, CGA47-66 DERIVED PEPTIDE, PROMOTES ALTERNATIVELY ACTIVATED MACROPHAGES, SUPPRESSES CLASSICALLY ACTIVATED MACROPHAGES AND IMPROVES EPITHELIAL BARRIER FUNCTIONS DURING COLITIS ª Nour Eissa, Canada; L. Kermarrec; C. N. Bernstein; J.-E. Ghia
16:33 – 16:45 OP276 APPROPRIATE INTERVALS TO LOOK FOR LOCAL RECURRENCE AFTER ENDOSCOPIC TREATMENT OF COLORECTAL NEOPLASMS. Yoriaki Komeda, Japan; H. Kashida; T. Sakurai; T. Nagai; S. Matsui; M. Kudo
16:45 – 16:57 OP271 A ROLE FOR THE NADPH OXIDASES NOX1 AND P22PHOX IN VEOIBD S. Lipinski; Florian Tran, Germany; B. Petersen; S. Stengel; M. Barann; M. Jentzsch; A. Franke; S. Schreiber; P. Rosenstiel 16:57 – 17:09 OP272 A NOVEL ORAL DOMAIN ANTIBODY TO TUMOUR NECROSIS FACTOR (TNF), ENGINEERED TO BE STABLE TO INTESTINAL PROTEASES, RESULTS IN HIGH CONCENTRATIONS OF ACTIVE COMPOUND DETECTED IN FAECES OF CROHN’S PATIENTS AFTER ORAL DOSING J. Robinson; S. Crowe; M. West; T. Carlton; L. Maggiore; G. Whale; J. Ritter; P. Irving; Suhail Nurbhai, United Kingdom
16:45 – 16:57 OP277 OPTICAL DIAGNOSIS OF T1 COLORECTAL CANCER AMONGST ACCREDITED ENDOSCOPISTS IN A NATIONWIDE BOWEL CANCER SCREENING PROGRAM Jasper Vleugels, The Netherlands; L. Koens; Y. Hazewinkel; P. Fockens; E. Dekker; O. B. O. T. DISCOUNT study group 16:57 – 17:09 OP278 TIME TO POLYPECTOMY COMPETENCY IN THE UK: RETROSPECTIVE ANALYSIS OF 1633 DOPYS FROM 131 TRAINEES Arun Rajendran, United Kingdom; S. Thomas-Gibson; P. Bassett; R. Rameshshanker; P. Dunckley; N. Sevdalis; A. Haycock Translational Basic Science 15:45 – 17:15 Room B3 Emerging biomarkers in GI cancer medicine Chairs: Rebecca Clare Fitzgerald, United Kingdom Massimo Rugge, Italy
Free Paper Session 15:45 – 17:15 Room B2 Quality assurance in colonoscopy: Room for improvement? Chairs: Michal Filip Kaminski, Poland Ana Wilson, United Kingdom
15:45 – 16:07 The biomarker roadmap Massimiliano di Pietro, United Kingdom
IP488
15:45 – 15:57 State-of-the-art introduction Michal Filip Kaminski, Poland
16:07 – 16:29 Upper GI cancer Kausilia K. Krishnadath, The Netherlands
IP489
16:29 – 16:51 Lower GI cancer Victor Moreno, Spain
IP490
IP487
15:57 – 16:09 OP273 SUSTAINED CHANGE IN COLONOSCOPY PRACTICE 3 YEARS AFTER INTRODUCTION OF QUALITY IMPROVEMENT IN COLONOSCOPY (QIC) BUNDLE Laura Jane Neilson, United Kingdom; J. E. East; P. T. Rajasekhar; S. Dunn; R. Bevan; S. Paremal; S. Esmaily; C. J. Rees
Live Stream
Q&A
Audience Voting
16:51 – 17:03 OP279 NOVEL COMBINATION OF CIRCULATING MICRORNAS FOR DETECTION OF EARLY GASTRIC CANCER Seiichiro Abe, Japan; J. Matsuzaki; K. Sudo; I. Oda; H. Katai; K. Kato; J. Kawauchi; S. Takizawa; H. Sakamoto; F. Takeshita; S. Niida; Y. Saito; T. Ochiya
Recorded Session
89
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
Tuesday, October 31, 2017
17:03 – 17:15 OP280 CIRCULATING TUMOR DNA FOR MONITORING COLORECTAL CANCER – RELATIONSHIP TO TISSUE METHYLATION, CANCER CHARACTERISTICS AND COMPLETENESS OF RESECTION Graeme Young, Australia; E. Symonds; D. Murray; S. Pedersen; S. Byrne; P. Rabbitt; R. Baker
16:21 – 16:33 OP283 EFFECT OF LACTOBACILLUS PARACASEI CNCM I-1572 ON SYMPTOMS, GUT MICROBIOTA, SHORT CHAIN FATTY ACIDS, AND IMMUNE ACTIVATION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED CLINICAL TRIAL. Cesare Cremon, Italy; S. Guglielmetti; A. M. Castellazzi; W. Fiore; M. Bellini; M. Cicala; M. R. Barbaro; L. Bellacosa; V. Stanghellini; G. Barbara
Today's Science, Tomorrow's Medicine 15:45 – 17:15 Microbiota: Future directions Chairs: Mirjana Rajilic-Stojanovic, Serbia Muriel Derrien, France
Room E4
15:45 – 16:07 IP491 Rising Star: Clinical implication of gut microbiome in primary sclerosing cholangitis (PSC) ª Johannes Roksund Hov, Norway 16:07 – 16:29 IP492 "Omics" in clinical practice: Between dreams and real needs Mirjana Rajilic-Stojanovic, Serbia Tuesday, October 31, 2017
16:29 – 16:51 Next-generation probiotics Max Nieuwdorp, The Netherlands
IP493
16:51 – 17:13 IP494 The future of FMT: Indications, techniques, regulatory issues Gianluca Ianiro, Italy Free Paper Session 15:45 – 17:15 Room 7.1 Randomised controlled trials in functional lower GI disorders Chairs: Philippe Van Hootegem, Belgium Daniel Keszthelyi, The Netherlands 15:45 – 15:57 State-of-the-art introduction Daniel Keszthelyi, The Netherlands
IP495
16:33 – 16:45 OP284 PATIENT-REPORTED OUTCOMES WITH NALDEMEDINE LONG-TERM TREATMENT OF OPIOID-INDUCED CONSTIPATION (OIC) IN SUBJECTS WITH CHRONIC NON-CANCER PAIN Jan Tack, Belgium; M. Camilleri; B. Cai; T. Yamada; J. C. Arjona Ferreira 16:45 – 16:57 OP285 RANDOMIZED CLINICAL TRIAL OF FOUR TREATMENTS FOR FAECAL INCONTINENCE AMONG ADULT COMMUNITY-DWELLING WOMEN: ASSESSMENT OF INDIVIDUAL EFFICACY OF ANORECTAL PHYSIOLOGY, THE IMPACT ON CLINICAL SEVERITY AND ON QUALITY OF LIFE Lluís Mundet, Spain; L. Rofes; O. Ortega; P. Clavé 16:57 – 17:09 OP286 THE EFFECT OF ZESPRI GREEN KIWIFRUIT ON DIGESTIVE FUNCTIONS IN CONSTIPATED PATIENTS: A MULTICENTRE, RANDOMIZED, CONTROLLED, SINGLE-BLIND, CROSS-OVER STUDY Cesare Cremon, Italy; J. Ansell; I. Pagano; B. Kuhn-Sherlock; L. Drummond; M. R. Barbaro; E. Capelli; L. Belacosa; V. Stanghellini; G. Barbara Symposium 15:45 – 17:15 EU funding: What UEG can offer Chairs: Michael Manns, Germany Arthur Kaser, United Kingdom
Room E1
Introduction 15:45 – 15:50 IP496 Importance of research coordination in European digestive health Michael Manns, Germany
15:57 – 16:09 OP281 PRELIMINARY RESULTS OF A RANDOMISED CONTROLLED TRIAL ON HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME (THE IMAGINE STUDY). Carla Flik, The Netherlands; Y. R. van Rood; W. Laan; A. Smout; B. L. A. M. Weusten; P. Whorwell; N. J. De Wit
15:50 – 16:05 IP497 Funding opportunities for digestive health research in Horizon 2020 Rebecca Breuer, Germany
16:09 – 16:21 OP282 INDIVIDUAL VERSUS GROUP HYPNOTHERAPY FOR IBS: A RANDOMIZED CONTROLLED TRIAL Jenny Lövdahl, Sweden; O. S. Palsson; G. Ringström; H. Törnblom; M. Simrén
16:05 – 16:20 Leading a Horizon 2020 research consortium Philip Rosenstiel, Germany
IP498
16:20 – 16:35 Winning a Marie-Curie fellowship Markus Tschurtschenthaler, Germany
IP499
90
Case studies and role models in digestive health research
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
16:35 – 16:50 Applying for an ERC grant Harry Sokol, France
IP500
16:50 – 17:00 Discussion and questions from the audience
UEG as facilitator for European digestive health research 17:00 – 17:10 IP501 How UEG can support your application to EU funding Arthur Kaser, United Kingdom 17:10 – 17:15 Discussion and questions from the audience Free Paper Session 15:45 – 17:15 Room E2 Autoimmune and cholestatic liver diseases: Novelties Chairs: Olivier Chazouillères, France Ewa Wunsch, Poland 15:45 – 15:57 State-of-the-art introduction Olivier Chazouillères, France
IP502
15:57 – 16:09 OP287 SURROGATE MARKERS FOR DISEASE PROGRESSION AND RISK FOR BILIARY NEOPLASIA IN PRIMARY SCLEROSING CHOLANGITIS Martti A. Färkkila, Finland; H. Mustonen; K. Jokelainen; J. Arola; H. Alfthan 16:09 – 16:21 OP288 DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 24 MONTHS OF OPEN-LABEL EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS Michael Trauner, Austria; F. Nevens; P. Andreone; G. Mazzella; S. Strasser; P. Invernizzi; J. P. H. Drenth; P. Pockros; J. Regula; A. Floreani; S. Hohenester; V. Luketic; M. Shiffman; K. van Erpecum; V. Vargas; C. Vincent; B. Hansen; C. Bowlus; L. MacConell; E. Smoot Malecha; D. Shapiro 16:21 – 16:33 OP289 DIFFERENTIAL EFFECTS OF FXR OR TGR5 ACTIVATION IN CHOLANGIOCARCINOMA PROGRESSION O. Erice; I. Labiano; A. Arbelaiz; A. Santos-Laso; P. Munoz-Garrido; A. Caro-Maldonado; N. Martin-Martin; A. Carracedo; E. Lozano; J. J. Marin; C. J. O'Rourke; J. B. Andersen; J. Llop; V. Gomez-Vallejo; D. Padro; A. Martin; M. Marzioni; L. Adorini; M. Trauner; L. Bujanda Fernández de Piérola; M. J. Perugorría; Jesus M. Banales, Spain 16:33 – 16:45 OP290 THE ROLE OF PNPLA3 (RS738409 C>G P.I148M) ALLELE DOSE ON BILE ACID COMPOSITION IN PRIMARY SCLEROSING CHOLANGITIS (PSC) Martti A. Färkkila, Finland; A. Tenca; H. Kautiainen Live Stream
Q&A
Audience Voting
16:45 – 16:57 OP291 CLINICAL EFFECT AND SAFETY OF ENDOSCOPIC RADIOFREQUENCY ABLATION FOR UNRESECTABLE EXTRAHEPATIC CHOLANGIOCARCINOMA-A PROSPECTIVE STUDY Jianfeng Yang, China; Y. zhou; Q. Lou; W. Gu; X. Zhang 16:57 – 17:09 OP292 PREDNISONE DOSAGE AND CHANCE OF REMISSION IN PATIENTS WITH AUTOIMMUNE HEPATITIS: AN INTERNATIONAL MULTICENTER COHORT STUDY Simon Pape, The Netherlands; T. J. Gevers; I. F. Mustafajev; F. F. van den Brand; C. M. van Nieuwkerk; G. Bouma; J. M. Vrolijk; J. Hartl; A. W. Lohse; C. Schramm; J. P. H. Drenth Free Paper Session 15:45 – 17:15 Room E3 From prevention to therapy of oesophago-gastric cancer Chairs: Juozas Kupcinskas, Lithuania Jurjen Boonstra, The Netherlands 15:45 – 15:57 State-of-the-art introduction Jurjen Boonstra, The Netherlands
IP503
15:57 – 16:09 OP293 LONG-TERM ASPIRIN AND RISK OF GASTRIC CANCER AFTER H. PYLORI ERADICATION: A POPULATION-BASED STUDY WITH PROPENSITY SCORE ANALYSIS Ka Shing Cheung, Hong Kong PRC; A. Y. Wong; E. W. Chan; L. Chen; I. C. Wong; W. K. Leung 16:09 – 16:21 OP294 GASTRIC INTESTINAL METAPLASIA IS SIGNIFICANTLY ASSOCIATED WITH POST ENDOSCOPY NON-CARDIA GASTRIC CANCER Yifat Snir, Israel; A. Vilkin; R. Gingold Belfer; D. Boltin; O. Sneh Arbib; I. Feldhamer; Y. Niv; I. Dotan; Z. Levi 16:21 – 16:33 OP295 ROLE OF MIR-20B-5P, MIR-451A-5P AND MIR-1468-5P IN GASTRIC CANCER Greta Streleckiene, Lithuania; J. Kupcinskas; S. Juzenas; R. Gedgaudas; V. Salteniene; A. Link; M. Leja; G. Kiudelis; L. Jonaitis; R. Lukosevicius; R. Inciuraite; G. Hemmrich-Stanisak; M. Hübenthal; A. Franke; P. Malfertheiner; L. Kupcinskas; J. Skieceviciene 16:33 – 16:45 OP296 AMOTL1 IS INVOLVED IN HIPPO PATHWAY BY PROMOTING YAP1 NUCLEAR LOCALIZATION TO DRIVE GASTRIC CARCINOGENESIS Yuhang Zhou, Hong Kong PRC; T. HUANG; J. Zhang; C. C. Wong; Y. Dong; A. S. L. Cheng; J. Yu; K. F. To; W. Kang
Recorded Session
91
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
16:45 – 16:57 OP297 PERIOPERATIVE CHEMOTHERAPY WITH DOCETAXEL, OXALIPLATIN AND FLUOROURACIL/LEUCOVORIN (FLOT) VERSUS EPIRUBICIN, CISPLATIN AND FLUOROURACIL OR CAPECITABINE (ECF/ECX) FOR RESECTABLE GASTRIC OR GEJ ADENOCARCINOMA (FLOT4-AIO): A RANDOMIZED PHASE 3 TRIAL. Nils Homann, Germany; H. Schmalenberg; H.-G. Kopp; G. M. Haag; K. B. Luley; W. Schmiegel; G. Folprecht; S. Probst; N. Prasnikar; P. Thuss-Patience; W. Fischbach; J. Trojan; M. Koenigsmann; C. Pauligk; T. O. Goetze; T. W. Kraus; A. Battmann; S. P. Moenig; W. Bechstein; T. Gaiser; A. Tannapfel; E. Jäger; M. Schuler; U. Lindig; M. Pohl; S. Kasper; R. D. Hofheinz; S.-E. Al-Batran 16:57 – 17:09 OP298 TUMOR ASSOCIATED MACROPHAGES AS NOVEL TARGETS FOR IMMUNOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA Silvia Calpe, The Netherlands; S. Hoefnagel; S. Bouchmal; C. del Sancho-Serra; D. Straub; K. K. Krishnadath
Tuesday, October 31, 2017
Free Paper Session 15:45 – 17:15 Room B5 Nerves & barrier function in health & disease Chairs: Roberto De Giorgio, Italy Johanna Sundin, Sweden 15:45 – 15:57 State-of-the-art introduction Roberto De Giorgio, Italy
IP504
15:57 – 16:09 OP299 ESTROGEN RECEPTOR BETA STIMULATION CONTROLS ENTERIC NEURON AND GLIAL CELL PROLIFERATION IN VITRO AND IN VIVO Francesca D'Errico, Belgium; G. Goverse; Y. Dai; W. Wu; E. Labeeuw; P. J. Gomez-Pinilla; M. Stakenborg; M. Warner; A. Di Leo; J.-Å. Gustafsson; G. Matteoli 16:09 – 16:21 OP300 CD90+ SUBPOPULATION OF FIBROBLASTS AS A MESENCHYMAL STEM CELL NICHE IN THE COLON Olga Karpus, The Netherlands; B. F. Westendorp; J. J. Koster; S. Meisner; V. Muncan; M. E. Wildenberg; G. R. van den Brink 16:21 – 16:33 OP301 INDIAN HEDGEHOG SUPPRESSES A STROMAL CELL DRIVEN INTESTINAL IMMUNE RESPONSE B. Florien Westendorp, The Netherlands; N. V. J. A. Büller; O. N. Karpus; W. A. van Dop; J. J. Koster; R. Versteeg; P. J. Koelink; C. Snel; S. Meisner; J. J. T. H. Roelofs; A. Uhmann; E. Ver Loren van Themaat; J. Heijmans; H. Hahn; V. Muncan; M. E. Wildenberg; G. R. van den Brink
92
Tuesday, October 31, 2017
16:33 – 16:45 OP302 SEMAPHORIN-3E PLAYS A ROLE IN TIGHT JUNCTION EPITHELIAL BARRIER MAINTENANCE IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS Laetitia Kermarrec, Canada; N. Eissa; C. N. Bernstein; J.-E. Ghia 16:45 – 16:57 OP303 ENDOPLASMIC RETICULUM STRESS INCREASES TRYPSIN-3 ACTIVITY IN ENTEROCYTES AND ALTERS BARRIER FUNCTION. Nuria Sola Tapias, France; A. Denadai-Souza; C. Rolland-Fourcade; C. Blanpied; G. Dietrich; C. Bonnart; A. Edir; C. Rolland; C. Deraison; N. Vergnolle; F. Barreau 16:57 – 17:09 OP304 INTESTINAL EPITHELIAL BARRIER DYSFUNCTION IN PATIENTS WITH CHRONIC INTESTINAL PSEUDO-OBSTRUCTION Elisa Boschetti, Italy; V. Bertakis; T. M. P. B. Karunaratne; A. Accarino; C. Malagelada; F. Azpiroz; R. Cogliandro; E. Bonora; P. CLAVENZANI; U. Volta; G. Caio; A. Gori; V. Stanghellini; R. De Giorgio Symposium 15:45 – 17:15 How to submit a good paper Chairs: Johan Burisch, Denmark Madalina Ilie, Romania
E-Poster Lounge 1
15:45 – 16:00 How to write a good research abstract Lukas Van Oudenhove, Belgium
IP505
16:00 – 16:15 IP506 Evidence Based Medicine: What can it do for you? Hania Szajewska, Poland 16:15 – 16:30 How to choose a journal for your paper C. Janneke van der Woude, The Netherlands
IP507
16:30 – 16:45 How to write a good discussion Emad El-Omar, Australia
IP508
16:45 – 17:15 PANEL DISCUSSION
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
Free Paper Session 15:45 – 17:15 Hotspot Abstracts on Fire: Hepatobiliary and pancreatic malignancies: From bench to bedside Chairs: Marcello Fabio Maida, Italy Eithne Costello-Goldring, United Kingdom 15:45 – 15:55 OP305 PREOPERATIVE ENDOSCOPIC VERSUS PERCUTANEOUS TRANSHEPATIC BILIARY DRAINAGE IN RESECTABLE PERIHILAR CHOLANGIOCARCINOMA: A MULTICENTER RANDOMIZED CONTROLLED TRIAL Eva Roos, The Netherlands; R. J. S. Coelen; J. K. Wiggers; E. A. J. Rauws; O. M. van Delden; B. Groot Koerkamp; J. N. M. IJzermans; C. H. J. van Eijck; J. de Jonge; R. J. Porte; C. I. Buis; C. H. Dejong; V. van Woerden; D. J. Gouma; M. G. H. Besselink; O. R. C. Busch; M. G. W. Dijkgraaf; T. M. van Gulik 15:55 – 16:05 OP306 IMPACT OF THE PREOPERATIVE GD-EOB-DTPA-ENHANCED MRI ON PROGNOSIS AFTER HEPATECTOMY IN THE PATIENTS WITH HEPATOCELLULAR CARCINOMA Masaharu Tada, Japan; E. Hatano; T. Okada; Y. Asano; N. Uyama; K. Suzumura; I. Nakamura; Y. Kondo; S. Hai; H. Sueoka; H. Iwama; A. Kurimoto; R. Ito; H. Nishida; K. Iida; J. Fujimoto 16:05 – 16:15 OP307 SAFETY AND EFFICACY OF TAE AND SIRT IN NET PATIENTS. Linde van Veenendaal, The Netherlands; A. Braat; M. Meier; K. Samsom; W. Verbeek; M. Vriens; G. Valk; W. Prevoo; M. Lam; M. Tesselaar 16:15 – 16:25 OP308 GEMCITABINE AND PLATINUM BASED CHEMOTHERAPY FOR THE FIRST LINE TREATMENT OF HEPATOCHOLANGIOCARCINOMA : AN AGEO MULTICENTER RETROSPECTIVE STUDY Maeva Salimon, France; C. Prieux-Klotz; D. Tougeron; T. Lecomte; M. Caulet; T. Matysiak Budnik; V. Hautefeuille; M. Tiako-Meyo; A. Zaanan; Y. Touchefeu
Live Stream
Q&A
Audience Voting
16:25 – 16:35 OP309 SQLE DRIVES HEPATOCARCINOGENESIS AND IS A THERAPEUTIC TARGET IN NONALCOHOLIC FATTY LIVER DISEASE-ASSOCIATED HEPATOCELLULAR CARCINOMA ª Dabin Liu, Hong Kong PRC; C. C. Wong; H. Chen; L. Fu; L. Zhao; C. Li; J. JY Sung; J. Yu 16:35 – 16:45 OP310 A XENOTRANSPLANTATION APPROACH USING HUMAN PLURIPOTENT STEM CELL-DERIVED PANCREATIC ORGANOIDS Meike Hohwieler, Germany; Z. Xiaofeng; P. C. Hermann; L. Perkhofer; T. Seufferlein; B. Böhm; Y. Ali; A. Kleger 16:45 – 16:55 OP311 FEASIBILITY OF WHOLE EXOME SEQUENCING AND GENOMIC PROFILING OF PANCREAS TUMOR TISSUE OBTAINED WITH A NOVEL FORK-TIPPED EUS GUIDED FINE NEEDLE CORE BIOPSY Pujan Kandel, USA; A. Nassar; G. Tranesh; C. Graddy; R. Bingham; B. Brahmbhatt; V. Gomez; M. Raimondo; T. Woodward; M. B. Wallace 16:55 – 17:05 OP312 USEFULNESS OF COMPLEMENTARY PANCREATIC JUICE CYTOLOGY IN AVOIDING UNNECESSARY SURGERY FOR PANCREATIC INTRA-DUCTAL PAPILLARY MUCINOUS NEOPLASM Mohammed Tag-Adeen, Japan; E. Ozawa; K. Ogihara; S. Iwatsu; Y. Akazawa; K. Ohnita; T. Adachi; Y. Sumida; K. Nakao 17:05 – 17:15 OP313 COMPARISON OF AMERICAN GASTROENTEROLOGICAL ASSOCIATION, INTERNATIONAL ASSOCIATION OF PANCREATOLOGY, AND AMERICAN COLLEGE OF RADIOLOGY GUIDELINES FOR DIAGNOSIS OF MALIGNANT PANCREATIC CYSTS Meir Mizrahi, USA; T. Kent; K. J. Mortele; J. Moser; J. Tseng; M. Callery; J. Cohen; T. Berzin; D. Pleskow; M. Sawhney
Recorded Session
93
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Scientific Programme by Day
Wednesday, November 1, 2017
Scientific Programme by Day Wednesday, November 1, 2017 Symposium 08:30 – 10:00 Update on new treatments in IBD Chairs: Iris Dotan, Israel Siew Chien Ng, Hong Kong PRC
Hall 6
Symposium 08:30 – 10:00 Resolving the enigma of coeliac disease Chairs: Katri Kaukinen, Finland Michael Schumann, Germany
Room F1
08:30 – 08:52 IP509 Inhibition of cell migration: Vedolizumab and beyond Raja Atreya, Germany
08:30 – 08:52 Gluten immune response and enteropathy Frits Koning, The Netherlands
IP517
08:52 – 09:14 IP510 Targetting of 12/23 and IL17 pathways: Benefits and limits Alexander R. Moschen, Austria
08:52 – 09:14 The role of genes in coeliac disease Sebo Withoff, The Netherlands
IP518
09:14 – 09:36 Environmental factors other than gluten Daniel Agardh, Sweden
IP519
09:14 – 09:36 IP511 Targetting cell activation: Small molecules and antibodies Matthieu Allez, France 09:36 – 09:58 Hematopietic and mesenchymal stem cells Julian Panés, Spain
IP512
09:36 – 09:58 IP520 Extraintestinal manifestation and associated autoimmune disorders Knut E. A. Lundin, Norway
Wednesday, November 1, 2017
Advances in Clinical GI & Hepatology 08:30 – 10:00 Room F2 New therapeutic options for functional GI disorders Chairs: Guy E. Boeckxstaens, Belgium Robin Spiller, United Kingdom
Symposium 08:30 – 10:00 Room A2 Quality in endoscopy: How to use and interpret performance measures? Chairs: Matthew David Rutter, United Kingdom Helmut Neumann, Germany
08:30 – 08:52 Functional dyspepsia Jan Tack, Belgium
IP513
08:30 – 08:52 Why performance measures are important Raf Bisschops, Belgium
08:52 – 09:14 Irritable bowel syndrome Lin Chang, USA
IP514
09:14 – 09:36 Functional heartburn and chest pain Daniel Sifrim, United Kingdom
IP515
Tandem Talks 08:52 – 09:02 IP522 What are the ESGE/UEG endoscopy performance measures? Upper GI and small bowel Cristiano Spada, Italy
09:36 – 09:58 Functional anorectal disorders Henriette Heinrich, United Kingdom
IP516
IP521
09:02 – 09:12 IP523 What are the ESGE/UEG endoscopy performance measures? Lower GI and pancreatobiliary Dirk Domagk, Germany 09:12 – 09:34 Endoscopy service performance measures Roland Valori, United Kingdom
IP524
09:34 – 09:56 IP525 Top tips for implementing performance measures and how to maximise their impact Siwan Thomas-Gibson, United Kingdom 94
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
Symposium 08:30 – 10:00 Room A1 Pancreato-biliary EUS: How to do it better? Chairs: Marc Giovannini, France Jeanin E. van Hooft, The Netherlands 08:30 – 08:52 IP526 Seeing is believing: Can elastography and contrast enhancement help? Pierre Eisendrath, Belgium 08:52 – 09:14 IP527 Tissue is the issue: How to improve tissue sampling Mariana Milashka, France 09:14 – 09:36 IP528 Ten mistakes to avoid when performing EUS-guided drainage Ulrike Denzer, Germany 09:36 – 09:48 OP314 LONG TERM OUTCOMES AND RE-INTERVENTION OF EUS-GUIDED BILIARY DRAINAGE FOR MALIGNANT BILIARY OBSTRUCTION Yousuke Nakai, Japan; H. Isayama; Y. Ito; H. Yagioka; N. Sasahira; N. Yamamoto; S. Matsubara; H. Kogure; S. Mizuno; N. Takahara; T. Hamada; K. Saito; R. Hakuta; K. Ishigaki; T. Takeda; T. Sato; T. Nakamura; M. Tada; K. Koike 09:48 – 10:00 OP315 EUS-GUIDED RADIOFREQUENCY ABLATION (RFA) FOR PANCREATIC NEUROENDOCRINE TUMOR (NET) AND PRE-MALIGNANT INTRADUCTAL PANCREATIC MUCINOUS TUMOR (IPMN) : FIRST RESULTS OF PROSPECTIVE MULTICENTER STUDY Marc Barthet, France; M. Giovannini; N. Lesavre; B. Napoléon; C. Boustiere; S. Koch; M. Gasmi; J.-M. Gonzalez Symposium 08:30 – 10:00 Room A3 Viral hepatitis: Moving towards elimination Chairs: Alessio Aghemo, Italy Soo Aleman, Sweden 08:30 – 08:52 IP529 How to identify asymptomatic viral hepatitis carriers? Charles Helsper, The Netherlands 08:52 – 09:14 IP530 Nucleos(t)ide analog (NUC) treatment of hepatitis B: Can we stop therapy? Markus Cornberg, Germany
Live Stream
Q&A
Audience Voting
09:14 – 09:36 Hepatitis C virus therapy: Still unmet needs? Alessio Aghemo, Italy
IP531
09:36 – 09:58 IP532 Long-term surveillance of patients after viral clearance Maria Reig, Spain Symposium 08:30 – 10:00 Room B2 Submucosal endoscopy: Indications, techniques and outcomes Chairs: Guido Costamagna, Italy Haruhiro Inoue, Japan 08:30 – 08:52 Peroral oesophageal endoscopic myotomy Albert Jan Bredenoord, The Netherlands
IP533
08:52 – 09:14 Peroral endoscopic myotomy of the pylorus Geoffroy Vanbiervliet, France
IP534
09:14 – 09:26 OP316 LIFE AFTER PERORAL ENDOSCOPIC MYOTOMY (POEM): QUALITY OF LIFE AND ITS ASSOCIATION WITH ECKARDT SCORE Y. Perbtani; J. Suarez; L. Mramba; D. Yang; Peter Draganov, USA 09:26 – 09:38 OP317 TECHNICAL FEASIBILITY OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR LOCAL FAILURE AFTER CHEMORADIOTHERAPY OR RADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA. Keiichiro Nakajo, Japan; T. Yano; Y. Yoda; K. Hori; K. Takashima; K. Shinmura; Y. Ohno; H. Ikematsu 09:38 – 10:00 Resection of submucosal tumours Ping-Hong Zhou, China
IP535
Translational Basic Science 08:30 – 10:00 Room B3 Intestinal failure: Understanding the cause and treatment options Chairs: André Van Gossum, Belgium Francisca Joly, France 08:30 – 08:52 Diagnostic assesment of intestinal failure Geert Wanten, The Netherlands
IP536
08:52 – 09:14 Physiology of nutrient absorption Kimberley K. Buhman, USA
IP537
Recorded Session
95
Wednesday, November 1, 2017
Wednesday, November 1, 2017
UEG Week Final Programme : Scientific Programme by Day
09:14 – 09:36 Current management of intestinal failure Tim Vanuytsel, Belgium
IP538
09:36 – 09:58 Building a better human intestine Michael A. Helmrath, USA
IP539
Free Paper Session 08:30 – 10:00 Room E4 Endoscopic management of GI bleeding: What is new? Chairs: Edward Despott, United Kingdom Madalina Ilie, Romania 08:30 – 08:42 State-of-the-art introduction Edward Despott, United Kingdom
IP540
08:42 – 08:54 OP318 MULTICENTRE RANDOMISED CONTROLLED TRIAL COMPARING THE EFFICACY AND SAFETY OF ADDING EARLY HEMOSTATIC POWDER APPLICATION TO ENDOSCOPIC AND MEDICAL TREATMENT IN THE MANAGEMENT OF ACUTE VARICEAL BLEEDING IN CIRRHOTIC PATIENTS. Mostafa Ibrahim, Belgium; A. El-Mikkawy; M. Abdel Hamid; H. Abdalla; A. Lemmers; I. Mostafa; J. Devière 08:54 – 09:06 OP319 HIGH EFFICACY OF OTSC AS FIRST-LINE ENDOSCOPIC TREATMENT IN PATIENTS WITH GASTROINTESTINAL BLEEDING: AN ITALIAN MULTICENTRIC EXPERIENCE IN A LARGE COHORT OF PATIENTS. Santi Mangiafico, Italy; S. Russo; M. Lupo; A. Caruso; G. Grande; F. P. Zito; H. Bertani; R. Conigliaro; A. Pisani; B. Germaná; G. Galloro; L. Pasquale; B. Mangiavillano; G. Bassotti; M. Mutignani; R. Manta
Wednesday, November 1, 2017
09:06 – 09:18 OP320 NEW USE OF LOW-DOSE ASPIRIN AND RISK OF UPPER AND LOWER GASTROINTESTINAL BLEEDING: ASSOCIATIONS BY CASE-FATALITY, HOSPITALISATION STATUS, BLEEDING LOCATION, ASPIRIN DOSE AND DURATION IN A LARGE OBSERVATIONAL STUDY IN THE UNITED KINGDOM L. Cea Soriano; M. Soriano-Gabarró; A. Lanas; Luis Alberto García Rodríguez, Spain 09:18 – 09:30 OP321 THE EFFICACY OF POLYGLYCOLIC ACID SHEETS AND FIBRIN GLUE FOR PREVENTING BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC NEOPLASMS (PAGER BUSTER TRIAL): INTENTION TO TREAT ANALYSIS OF A PROSPECTIVE MULTICENTER RANDOMIZED CONTROLLED TRIAL Yosuke Kataoka, Japan; Y. Tsuji; K. Hirasawa; K. Takimoto; T. Wada; S. Mochizuki; K. Ohata; K. Niimi; S. Ono; S. Kodashima; N. Yamamichi; M. Fujishiro; K. Koike
96
Wednesday, November 1, 2017
09:30 – 09:42 OP322 SIGNIFICANT REDUCTION OF POSTINTERVENTIONAL HAEMORRHAGE AFTER RESECTION OF LARGE DUODENAL ADENOMAS BY THE USE OF A HEMOSTATIC POWDER? Till Mueller, Germany; M. Knabe; J. Wetzka; C. Ell; A. May 09:42 – 09:54 OP323 EFFECT OF PROPHYLACTIC CLIP APPLICATION FOR THE PREVENTION OF POSTPOLYPECTOMY BLEEDING IN LARGE PEDUNCULATED COLONIC POLYPS: A RANDOMIZED, CONTROLLED MULTICENTER TRIAL Jeong-Seon Ji, Republic of Korea; K.-M. Lee; S.-W. Lee; D. B. Kim; T.-G. Gweon; H. Choi Free Paper Session 08:30 – 10:00 Room 7.1 Long-term complications in IBD Chairs: Alessandro Armuzzi, Italy Marianne Rebecca Spalinger, Switzerland 08:30 – 08:42 State-of-the-art introduction Alessandro Armuzzi, Italy
IP541
08:42 – 08:54 OP324 THE RISK OF PROXIMAL DISEASE EXTENSION IN PATIENTS WITH LIMITED ULCERATIVE COLITIS IN A PROSPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT – THE ECCO-EPICOM COHORT ª Johan Burisch, Denmark; J. Halfvarson; L. Kupcinskas; V. Hernández; I. Kaimakliotis; D. Valpiani; N. Pedersen; D. Duricova; L. Kievit; J. F. Dahlerup; M. Fumery; R. Salupere; N. Arebi; K. R. Nielsen; M. Giannotta; P. Oksanen; K. H. Katsanos; Z. Vegh; P. Ellul; D. Schwartz; S. Čuković-Čavka; R. D’Inca; S. Turcan; F. Magro; A. Goldis; E. Langholz; P. L. Lakatos; P. Munkholm 08:54 – 09:06 OP325 EARLY FIBROSTENOSIS IN CROHN’S DISEASE IS ASSOCIATED WITH MULTIPLE SUSCEPTIBILITY LOCI ON IMMUNOCHIP ANALYSIS Tom Holvoet, Belgium; P. Bossuyt; I. Cleynen; I. De Kock; P. Hindryckx; S. Vermeire; D. Laukens; M. De Vos 09:06 – 09:18 OP326 THE ROLE OF THE IKBA GENE FAMILY MEMBER NFKBIZ IN COLITIS ASSOCIATED CANCER Go Ito, Germany; D. Esser; J. Kuiper; R. Sheibani; S. Schreiber; P. Rosenstiel 09:18 – 09:30 OP327 RORGAMMA-T-EXPRESSING TREGS DRIVE GROWTH OF COLITIS-ASSOCIATED COLORECTAL CANCER BY CONTROLLING IL6 EXPRESSION OF DENDRITIC CELLS Angela Rizzo, Italy; M. Di Giovangiulio; E. Franzè; H.-J. Fehling; R. Carsetti; E. Giorda; G. Monteleone; M. C. Fantini
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
09:30 – 09:42 OP328 NEW METHYLATION BIOMARKER PANEL FOR EARLY DIAGNOSTIC OF DYSPLASIA OR CANCER IN HIGH RISK INFLAMMATORY BOWEL DISEASE PATIENTS Daniel Azuara Garcia, Spain; S. Aussó; F. Rodriguez Moranta; J. Guardiola; X. Sanjuan; T. Lobaton; J. Boadas; E. Guinó; V. Moreno; G. Capella; J. de Oca 09:42 – 09:54 OP329 INCIDENT CANCER IN INFLAMMATORY BOWEL DISEASE IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY Livia Biancone, Italy; A. Armuzzi; M. L. Scribano; F. Castiglione; R. D'inca; C. Papi; M. Vecchi; G. Riegler; F. Mocciaro; A. Ruffa; B. Neri; S. Festa; W. Fries; P. Alvisi; M. Daperno; G. Meucci; L. guidi; L. Spina; S. Renna; E. calabrese; F. Rogai; S. Ardizzone; A. Rossi; A. Orlando; F. Pallone Symposium 08:30 – 10:00 Room E1 Update on gastric precancerous conditions and lesions Chairs: Fatima Carneiro, Portugal Emad El-Omar, Australia 08:30 – 08:52 Time for a new classification of gastritis? Peter Malfertheiner, Germany
IP542
08:52 – 09:14 IP543 Is there a place for subtyping intestinal metaplasia? Maria Blanca Piazuelo, USA Debate 09:14 – 09:24 IP544 Targeted biopsies suffice: The endoscopist's view Mario Dinis-Ribeiro, Portugal 09:24 – 09:34 IP545 Random biopsies are required: The pathologist's view Massimo Rugge, Italy 09:34 – 09:56 IP546 Guidelines on management of precancerous lesions: Where do we stand? Ernst J. Kuipers, The Netherlands Free Paper Session 08:30 – 10:00 Pathogenesis of IBD Chairs: Andreas Sturm, Germany Mathieu Uzzan, France 08:30 – 08:42 State-of-the-art introduction Andreas Sturm, Germany
Live Stream
Q&A
Room E2
IP547
Audience Voting
08:42 – 08:54 OP330 THE UBIQUITIN-LIKE PROTEIN UBIQUITIN D IS UP-REGULATED BY SYNERGY OF NOTCH AND PRO-INFLAMMATORY CYTOKINES IN THE INFLAMED INTESTINAL EPITHELIA OF IBD PATIENTS. Ami Kawamoto, Japan; G. Ito; T. Nakata; S. Fujii; K. Suzuki; F. Ishibashi; H. Shimizu; S. Nagata; S. Anzai; R. Kuno; K. Kuwabara; M. Kawai; J. Takahashi; M. Hama; K. Tsuchiya; T. Nakamura; R. Okamoto; M. Watanabe 08:54 – 09:06 OP331 WNT5B UP-REGULATION IN THE MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE COULD CONTRIBUTE TO THE REGENERATION OF INTESTINAL EPITHELIUM Isabella Dotti, Spain; E. Ferrer-Picón; N. Planell; E. H. van Herk; M. Cuatrecasas; J. Panés; A. Salas 09:06 – 09:18 OP332 NOVEL HUMAN GUT XENOGRAFT MOUSE MODEL FOR INTESTINAL FISTULAS ª Ramona Sonja Bruckner, Switzerland; N. Marsiano; E. Nissim-Eliraz; E. Nir; M. Leutenegger; C. Gottier; S. Lang; M. R. Spalinger; G. Rogler; S. Yagel; M. Scharl; N. Y. Shpigel 09:18 – 09:30 OP333 REPROGRAMMED ATOH1+ INTESTINAL EPITHELIAL CELLS CONTRIBUTE TO REGENERATE DAMAGED COLONIC MUCOSA IN DSS-INDUCED COLITIS ª Fumiaki Ishibashi, Japan; H. Shimizu; A. Kawamoto; G. Ito; T. Nakata; S. Fujii; K. Suzuki; R. Kuno; S. Anzai; K. Kuwabara; M. Kawai; J. Takahashi; M. Hama; S. Nagata; K. Tsuchiya; T. Nakamura; R. Okamoto; M. Watanabe 09:30 – 09:42 OP334 THE ROLE OF PH-SENSING RECEPTOR TDAG8 (GPR65) IN INTESTINAL INFLAMMATION I. Tcymbarevich; Jesus Cosin Roger, Switzerland; S. M. Richards; K. Baebler; M. R. Spalinger; G. Russo; K. Atrott; I. Frey-Wagner; C. A. Wagner; B. Misselwitz; K. Seuwen; G. Rogler; C. de Vallière 09:42 – 09:54 OP335 PRO-INFLAMMATORY HUMAN CD11C+ MACROPHAGES, BUT NOT THEIR TOLEROGENIC CD11CDIM OR CD11CCOUNTERPARTS, ARE EXPANDED IN THE INFLAMED MUCOSA FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE. David Bernardo, Spain; I. Mora-Gutierrez; A. C. Marín; A. Montalban-Arques; S. Fernandez-tome; A. Diaz-Guerra; R. Caminero-Fernandez; S. Casabona; P. Miranda; F. Casals; M. Caldas Álvarez; M. Jimenez; F. de la Morena; C. Santander; M. Chaparro; J. P. Gisbert
Recorded Session
97
Wednesday, November 1, 2017
Wednesday, November 1, 2017
UEG Week Final Programme : Scientific Programme by Day
Wednesday, November 1, 2017
Free Paper Session 08:30 – 10:00 Room E3 Can colonic polyps be diagnosed in real time? Chairs: Michael B. Wallace, USA Bjorn Rembacken, United Kingdom
Symposium 08:30 – 10:00 Hotspot Controversies around serrated colorectal lesions Chair: James Edward East, United Kingdom
08:30 – 08:42 State-of-the-art introduction Michael B. Wallace, USA
08:30 – 08:33 Introduction James Edward East, United Kingdom
IP548
08:42 – 08:54 OP336 DOES CHROMOENDOSCOPY REDUCE COLORECTAL NEOPLASIA DURING SURVEILLANCE IN LYNCH SYNDROME? A RANDOMIZED TRIAL Jasmijn Haanstra, The Netherlands; E. Dekker; A. Cats; F. M. Nagengast; J. Hardwick; S. Vanhoutvin; W. De Vos Tot Nederveen Cappel; H. Vasen; J. Kleibeuker; J. J. Koornstra 08:54 – 09:06 OP337 LEAVING COLORECTAL POLYPS IN PLACE CAN BE ACHIEVED WITH HIGH ACCURACY USING BLUE LIGHT IMAGING (BLI) Helmut Neumann, Germany; H. Neumann Sen; F. Thieringer; F. Rahman; G. E. Tontini; P. R. Galle 09:06 – 09:18 OP338 A STUDY ON DIAGNOSTIC ABILITY TO DISTINGUISH BETWEEN ADENOMAS AND INVASIVE COLORECTAL CANCERS USING COMPUTER-AIDED ENDOCYTOSCOPY Kenichi Takeda, Japan; S.-E. Kudo; Y. Mori; M. Misawa; S. Kataoka; Y. maeda; Y. Ogawa; K. Ichimasa; T. Kudo; K. Wakamura; T. Baba; E. Hidaka; F. Ishida; H. Inoue; M. Oda; K. Mori 09:18 – 09:30 OP339 ENDOSCOPIC AND MOLECULAR CHARACTERISTICS IN COLORECTAL SERRATED LESIONS REPRESENT SUBCLASSES OF THE SERRATED NEOPLASIA PATHWAY Hironori Aoki, Japan; E. Yamamoto; H.-O. Yamano; H.-O. Matsushita; K. Yoshikawa; R. Takagi; E. Harada; Y. Tanaka; T. Harada; T. Sugai; H. Suzuki
Wednesday, November 1, 2017
09:30 – 09:42 OP340 CLASSIFICATION OF CELL NUCLEI MORPHOLOGY OF EC FINDINGS IN COLORECTAL ENDOCYTOSCOPY Kenichi Suzuki, Japan; S.-E. Kudo; T. Kudo; Y. Mori; K. Wakamura; M. Misawa; Y. Ogawa; Y. maeda; K. Takeda; H. Nakamura; T. Hayashi; T. Baba; F. Ishida 09:42 – 09:54 OP341 COMPUTER-AIDED DIAGNOSTIC SYSTEM USING ARTIFICIAL INTELLIGENCE FOR PREDICTING THE NBI INTERNATIONAL COLORECTAL ENDOSCOPIC CLASSIFICATION OF COLORECTAL TUMORS Jeong-Sik Byeon, Republic of Korea; E. M. Song; S. H. Lee; K. J. Change; S. W. Hwang; S. H. Park; D.-H. Yang; B. D. Ye; S.-J. Myung; S.-K. Yang; B. H. Park; N. K. Kim; J. B. Seo 98
IP549
08:33 – 08:38 IP550 With proper technique and equipment you detect all serrated lesions Michael Bretthauer, Norway, 08:38 – 08:53 PANEL DISCUSSION
08:53 – 08:58 All serrated lesions need sub-classification Iris D. Nagtegaal, The Netherlands
IP551
08:58 – 09:13 PANEL DISCUSSION
09:13 – 09:18 IP552 All serrated lesions should be endoscopically removed Michal Filip Kaminski, Poland 09:18 – 09:33 PANEL DISCUSSION
09:33 – 09:38 IP553 Short surveillance intervals are needed for patients with serrated lesions Cesare Hassan, Italy 09:38 – 09:53 PANEL DISCUSSION
09:53 – 09:56 Conclusion James Edward East, United Kingdom
IP554
Symposium 10:30 – 12:00 Hall 6 Diagnostic and therapeutic challenges in pancreatology Chairs: Peter Hegyi, Hungary Philippe Lévy, France 10:30 – 10:52 Drug-induced pancreatitis Luca Frulloni, Italy
IP555
Debate 10:52 – 11:02 IP556 Diagnosis and definition of early chronic pancreatitis: Is EUS all we need? Pro Maria Chiara Petrone, Italy
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
11:02 – 11:12 IP557 Diagnosis and definition of early chronic pancreatitis: Is EUS all we need? Con Celso Matos, Belgium Tandem Talks 11:12 – 11:22 IP558 Pancreatic duct stones in chronic pancreatitis: Interventional treatment Jacques Deviere, Belgium 11:22 – 11:32 IP559 Pancreatic duct stones in chronic pancreatitis: When does surgery come in? Ross Carter, United Kingdom 11:32 – 11:54 IP560 Screening for pancreatic cancer in chronic pancreatitis: Should we do it at all and how? Maiken Thyregod Joergensen, Denmark Advances in Clinical GI & Hepatology 10:30 – 12:00 Room F2 Organic-functional overlap syndromes: Continuum or distinct diseases? Chairs: Umberto Volta, Italy Albert Jan Bredenoord, The Netherlands 10:30 – 10:52 Eosinophilic oesophagitis, GORD or both? Javier Molina Infante, Spain
IP561
10:52 – 11:14 Non-coeliac gluten sensitivity or IBS? Katri Kaukinen, Finland
IP562
11:14 – 11:36 IBS-like symptoms in IBD in remission Magnus Simrén, Sweden
IP563
11:36 – 11:58 Painful diverticuli or IBS? Giovanni Barbara, Italy
IP564
Video Case Session 10:30 – 12:00 Video Case Session Chairs: Lars Aabakken, Norway Helmut Neumann, Germany
Room F1
10:30 – 10:36 VC01 SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION OF A LARGE OESOPHAGEAL LEIOMYOMA Mayenaaz Sidhu, Australia; D. J. Tate; M. J. Bourke
Live Stream
Q&A
Audience Voting
10:36 – 10:42 VC02 TEMPORARY BILIARY METAL STENT PLACEMENT IN THE CYSTIC DUCT AS AN AID TO CHOLANGIOSCOPY-GUIDED LASER LITHOTRIPSY OF MIRIZZI SYNDROME (MS). Ramon Sanchez-Ocana, Spain; M. Jimenez-Palacios; P. Gil-Simon; C. De la Serna-Higuera; M. Perez-Miranda 10:42 – 10:49 VC03 METACHRONOUS DEPLOYMENT OF FOUR PLASTIC AND FOUR METALLIC STENTS IN THE PATIENT WITH HILAR BILE DUCT CARCINOMA SUCCESSFULLY ACHIEVED ONLY VIA ENDOSCOPIC PROCEDURE. Hirofumi Kawamoto, Japan 10:49 – 10:55 VC04 CHRONIC TRACHEOESOPHAGEAL FISTULA SUCCESSFULLY TREATED USING AMPLATZER SEPTAL OCCLUDER Michele Amata, Italy; C. Gandolfo; L. De Monte; A. Granata; D. Ligresti; L. Barresi; I. Tarantino; M. Traina 10:55 – 11:01 VC05 A NOVEL SCISSOR AND LOOP TECHNIQUE FOR ENDOSCOPIC RESECTION AND CLOSURE OF ESD DEFECTS: A VIDEO ABSTRACT ON THE RESECTION OF A GASTRIC SUBMUCOSAL TUMOUR Kesavan Kandiah, United Kingdom; S. Subramaniam; D. Poller; A. Higginson; P. Bhandari 11:01 – 11:07 VC06 RENDEZVOUS BILIARY RECANALIZATION OF COMPLETE BILIARY OBSTRUCTION WITH DIRECT PERORAL AND PERCUTANEOUS TRANSHEPATIC CHOLANGIOSCOPY Majidah Bukhari, USA; Y. Haito-Chavez; S. Ngamruengphong; O. I. Brewer Gutierrez; Y.-I. Chen; M. A. Khashab 11:07 – 11:13 VC07 EUS GUIDED CONTINUOUS CATHETER THROMBOLYSIS OF PORTAL VENOUS SYSTEM Malay Sharma, India; S. Jindal; P. somani; K. Sampath; V. V. Mahesh 11:13 – 11:19 VC08 PER RECTAL ENDOSCOPIC MYOTOMY (PREM) FOR PEDIATRIC HIRSCHSPRUNG’S DISEASE Amol Bapaye, India; M. R. Mahadik; R. Pujari; S. Date; N. Dubale; T. K. Bharadwaj; S. G. Vare; J. A. Bapaye 11:19 – 11:26 VC09 COMBINED LAPAROSCOPIC AND ENDOSCOPIC FULL THICKNESS RESECTION APPROACH FOR GASTRO-INTESTINAL STROMAL TUMOR (GIST). SERIES OF 3 CASES WITH VIDEO. Jean-Michel Gonzalez, France; L. Beyer; S. Berdah; M. Barthet
Recorded Session
99
Wednesday, November 1, 2017
Wednesday, November 1, 2017
UEG Week Final Programme : Scientific Programme by Day
11:26 – 11:34 VC10 TRACTION STRATEGY WITH CLIPS AND RUBBER BAND ALLOWS COMPLETE EN BLOC ENDOSCOPIC SUBMUCOSAL DISSECTION OF LATERALLY SPREADING TUMORS INVADING THE APPENDIX. Mathieu Pioche, France; J. Jacques; J. Rivory; J. C. Saurin; R. Legros; T. Ponchon Symposium 10:30 – 12:00 Patient education in IBD Chairs: Matthieu Allez, France Britta Siegmund, Germany 10:30 – 10:52 How to communicate at the time of diagnosis Alessandro Armuzzi, Italy
Room A2
IP565
IP567
Tandem Talks 11:36 – 11:46 IP568 Patient empowerment: The patient´s perspective Luisa Avedano, Belgium 11:46 – 11:56 IP569 Patient empowerment: The physician´s perspective Subrata Ghosh, Canada Symposium 10:30 – 12:00 Endoscopic resection of the difficult polyp Chairs: Michael John Bourke, Australia Ana Wilson, United Kingdom
Room A1
Wednesday, November 1, 2017
10:30 – 10:52 Endoscopic mucosal resection (EMR) Thierry Ponchon, France
IP570
10:52 – 11:14 Endoscopic submucosal dissection (ESD) Hironori Yamamoto, Japan
IP571
11:14 – 11:36 Full-thickness resection Alanna Ebigbo, Germany
IP572
11:36 – 11:58 Combined endoscopic-laparoscopic resection Dieter Hahnloser, Switzerland
IP573
100
Symposium 10:30 – 12:00 Management of advanced liver cirrhosis Chairs: Dominique Thabut, France Patrizia Burra, Italy
Room A3
10:30 – 10:52 Prevention and treatment of encephalopathy John Vierling, USA
IP574
10:52 – 11:14 IP575 Nutritional therapy: Between evidence and common sense Claire Francoz, France
10:52 – 11:14 IP566 How to improve adherence: Apps, e-health, etc. Pierre Michetti, Switzerland 11:14 – 11:36 How to develop an educational program Jacques Moreau, France
Wednesday, November 1, 2017
11:14 – 11:36 IP576 Primary and secondary prevention of variceal bleeding Juan Carlos Garcia Pagan, Spain 11:36 – 11:58 Hepatorenal syndrome Thomas Reiberger, Austria
IP577
Symposium 10:30 – 12:00 Room B2 Long-term adverse effects of bariatric surgery Chairs: Ramon Vilallonga, Spain Robert Hawes, USA 10:30 – 10:52 Dysphagia after restrictive procedures Edoardo Savarino, Italy
IP578
10:52 – 11:14 GORD and dumping Mario Morino, Italy
IP579
11:14 – 11:36 Nutrient deficiencies Loris Pironi, Italy
IP580
11:36 – 11:58 The role of endoscopy in long-term follow-up Todd H. Baron, USA
IP581
Translational Basic Science 10:30 – 12:00 Microbiota in liver disease Chairs: Stephan Bischoff, Germany Max Nieuwdorp, The Netherlands
Room B3
10:30 – 10:52 IP582 Role of microbiota in liver inflammation and fibrosis Antonio Gasbarrini, Italy
ª Rising Star ª Top Abstract Prize ª National Scholar
Scientific Programme by Day : UEG Week Final Programme
10:52 – 11:14 Role of microbiota in liver cancer Antonio Moschetta, Italy
IP583
11:14 – 11:36 IP584 The paradoxical effect of antibiotics on microbiota Jasmohan S. Bajaj, USA 11:36 – 11:48 OP342 LONG TERM PROTON PUMP INHIBITOR USE INCREASES INTESTINAL DYSBIOSIS, GUT PERMEABILITY, INFLAMMATION AND MORTALITY IN PATIENTS WITH LIVER CIRRHOSIS Angela Horvath, Austria; F. Rainer; M. Bashir; B. Leber; B. Schmerboeck; H. Grønbæk; H. J. Møller; T. Madl; A. Groselj-Strele; P. Fickert; P. Stiegler; V. Stadlbauer 11:48 – 12:00 OP343 CO-ADMINISTRATION OF PROBIOTIC WITH OMEGA-3 FATTY ACIDS IN NAFLD MANAGEMENT: EVIDENCE FROM ANIMALS TO RANDOMIZED CLINICAL STUDIES ª Nazarii Kobyliak, Ukraine; T. Falalyeyeva; G. Mykhalchyshyn; O. Dynnyk; D. Kyriienko; I. Komisarenko Free Paper Session 10:30 – 12:00 Hot topics in GORD and EoE Chairs: Martin Ďuriček, Slovak Republic Stephan Miehlke, Germany 10:30 – 10:42 State-of-the-art introduction Stephan Miehlke, Germany
Room E4
IP585
10:42 – 10:54 OP344 ORAL ALGINATE SOLUTION REDUCES SENSITIVITY TO ESOPHAGEAL ACID PERFUSION IN PATIENTS WITH HEARTBURN. INTERIM REPORT OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY Joanne Li Shen Ooi, United Kingdom; P. Woodland; D. Sifrim 10:54 – 11:06 OP345 SYMPTOM ASSOCIATION PROBABILITY DETERMINES THE OUTCOME OF BACLOFEN THERAPY IN REFRACTORY GASTRO-OESOPHAGEAL REFLUX DISEASE Ans Pauwels, Belgium; E. Deloose; V. Boecxstaens; C. Broers; T. Vanuytsel; J. Tack 11:06 – 11:18 OP346 GASTRO-ESOPHAGEAL REFLUX AFTER PERORAL ENDOSCOPIC MYOTOMY AS COMPARED WITH HELLER’S MYOTOMY: A SYSTEMATIC REVIEW WITH META-ANALYSIS. Alessandro Repici, Italy; L. Fuccio; R. Maselli; F. Mazza; L. Correale; D. Mandolesi; C. Bellisario; A. Sethi; M. Kashab; T. Rösch; C. Hassan
Live Stream
Q&A
Audience Voting
11:18 – 11:30 OP347 ESSENTIAL ROLE OF INTERLEUIKIN-33-INDUCED INNATE LYMPHOID CELLS IN DEVELOPMENT OF EOSINOPHILIC ESOPHAGITIS IN MICE Naoki Oshima, Japan; S. Ishihara; H. Sonoyama; N. Yamashita; N. Fukuba; Y. Mishima; I. Moriyama; K. Kawashima; N. Ishimura; Y. Kinoshita 11:30 – 11:42 OP348 EFFICACY AND SAFETY OF BUDESONIDE ORODISPERSIBLE TABLETS IN ACTIVE EOSINOPHILIC OESOPHAGITIS: RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PIVOTAL, EUROPEAN MULTICENRE TRIAL (EOS-1) Alex Straumann, Switzerland; A. J. Lucendo Villarin; S. Miehlke; M. Vieth; C. Schlag; U. von Arnim; J. Molina-Infante; D. Hartmann; A. J. Bredenoord; C. Ciriza de Los Rios; S. Schubert; S. Brueckner; A. Madisch; J. Hayat; J. Tack; A. Schoepfer; R. Greinwald; R. Mueller; S. Attwood 11:42 – 11:54 OP349 LONG-TERM TREATMENT OF EOSINOPHILIC OESOPHAGITIS WITH SWALLOWED TOPICAL CORTICOSTEROIDS: DEVELOPMENT AND EVALUATION OF A THERAPEUTIC CONCEPT Thomas Greuter, Switzerland; C. Bussmann; E. Safroneeva; A. Schoepfer; L. Biedermann; S. Vavricka; A. Straumann Free Paper Session 10:30 – 12:00 Room 7.1 Safety and long-term outcomes with biologics in IBD Chairs: Johan Burisch, Denmark Laurent Beaugerie, France 10:30 – 10:42 State-of-the-art introduction Laurent Beaugerie, France
IP586
10:42 – 10:54 OP350 PYRAMID REGISTRY: LONG-TERM SAFETY OF ADALIMUMAB BY AGE IN PATIENTS WITH CROHN’S DISEASE Jean-Frederic Colombel, USA; G. D'Haens; W. Reinisch; E. V. Loftus Jr; R. Panaccione; J. Satsangi; G. Alperovich; S. Berg; J. Kalabic; M. Bereswill; J. Petersson; A. M. Robinson 10:54 – 11:06 OP351 EXPOSURE TO COMBINATION THERAPY WITH THIOPURINES AND ANTI-TNF AGENTS IS ASSOCIATED WITH REDUCED INCIDENCE OF ACUTE ARTERIAL EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A NATIONWIDE FRENCH COHORT STUDY. Julien Kirchgesner, France; N. N. Andersen; F. Carrat; M. Schwarzinger; T. Jess; L. Beaugerie
Recorded Session
101
Wednesday, November 1, 2017
Wednesday, November 1, 2017
UEG Week Final Programme : Scientific Programme by Day
11:06 – 11:18 OP352 PYRAMID REGISTRY: LONG-TERM SAFETY AND EFFECTIVENESS OF ADALIMUMAB BY BASELINE IMMUNOMODULATOR USE IN PATIENTS WITH CROHN’S DISEASE Walter Reinisch, Austria; R. Panaccione; G. R. D'Haens; E. V. Loftus Jr; J. Satsangi; J.-F. Colombel; G. Alperovich; S. Berg; J. Kalabic; M. Bereswill; J. Petersson; A. M. Robinson 11:18 – 11:30 OP353 INTEGRATED SAFETY ANALYSES OF TOFACITINIB IN ULCERATIVE COLITIS CLINICAL TRIALS William Sandborn, USA; J. Panés; G. D’Haens; B. E. Sands; C. Su; M. Moscariello; T. V. Jones; R. Pedersen; G. Friedman; N. Lawendy; G. Chan 11:30 – 11:42 OP354 LONG-TERM HEALTH OUTCOMES OF 1000 CHILDREN BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE IN THE ANTI-TNF ERA Shannon Kanis, The Netherlands; S. Modderman; J. C. Escher; R. Beukers; K. H. N. (. de Boer; A. Bodelier; A. Depla; G. Dijkstra; A.-B. Van Dijk; L. P. L. Gilissen; F. Hoentjen; J. M. Jansen; J. Kuijvenhoven; N. Mahmmod; R. Mallant; A. E. Van Der Meulen – De Jong; A. Noruzi; B. Oldenburg; L. E. Oostenbrug; R. J. Ouwendijk; M. J. Pierik; M. Romberg Camps; W. J. Thijs; R. West; A. Lima; C. J. van der Woude 11:42 – 11:54 OP355 SAFETY OF HERPES ZOSTER VACCINATION AMONG INFLAMMATORY BOWEL DISEASE PATIENTS BEING TREATED WITH ANTI-TNF MEDICATIONS C. Trivedi; Y. Shah; Nabeel Khan, USA Symposium 10:30 – 12:00 Room E1 Therapeutic approaches targeting the tumour environment in pancreatic cancer: Hope or hype? Chairs: Caroline Verbeke, Norway Eike Gallmeier, Germany
Wednesday, November 1, 2017
10:30 – 10:52 IP587 Stromal targets in human pancreatic ductal adenocarcinoma Eithne Costello-Goldring, United Kingdom 10:52 – 11:14 IP588 Pharmacological targeting of dysregulated pathways in cancer associated fibroblasts Corinne Bousquet, France 11:14 – 11:36 IP589 Rising Star: Stromal remodelling in vivo-therapeutic and biological implications ª Albrecht Neesse, Germany
102
Wednesday, November 1, 2017
11:36 – 11:48 OP356 THE CONTRIBUTION OF LYMPHOTOXIN TO PANCREATIC CARCINOGENESIS – FROM PANINS TO TUMOR DEVELOPMENT Gitta Maria Seleznik, Switzerland; T. Reding; C. Waschkies; D. Lenggenhager; A. Gupta; E. Diamantis; A. Perren; M. Heikenwälder; R. Graf 11:48 – 12:00 OP357 RELA/NF-κB CONTROLLED ONCO-IMMUNO CROSSTALK IN PANCREATIC CANCER – ROLE OF CCL20 AND CX3CL1 IN APOPTOSIS RESISTANCE Claudia Geismann, Germany; F. Grohmann; S. Schreiber; A. Arlt Free Paper Session 10:30 – 12:00 Room E2 Endoluminal and transluminal interventions in the upper GI tract Chairs: Geoffroy Vanbiervliet, France Myriam Delhaye, Belgium 10:30 – 10:42 State-of-the-art introduction Geoffroy Vanbiervliet, France
IP590
10:42 – 10:54 OP358 ENDOLUMINAL AND INTRACAVITAL VACUUM COMBINED WITH STENT-OVER-SPONGE (SOS) TREATMENT FOR FOREGUT PERFORATIONS AND LEAKS Piero V Valli, Switzerland; J. Mertens; A. Kroeger; P. M. Schneider; C. Gutschow; C. Gubler; P. Bauerfeind 10:54 – 11:06 OP359 INTRADUCTAL BILIARY OR PANCREATIC ABLATION DURING ENDOSCOPIC AMPULLECTOMY MAY REDUCE THE LONG-TERM RECURRENCE RATE. ª Enrique Perez-Cuadrado-Robles, Belgium; H. Piessevaux; T. Moreels; R. Yeung; T. Aouattah; A. Jouret-Mourin; M. Komuta; P. H. Deprez 11:06 – 11:18 OP360 EFFECT OF SUBMUCOSAL INJECTION IN ENDOSCOPIC PAPILLECTOMY OF AMPULLARY TUMOR: A PROPENSITY ANALYSIS Kwang Hyun Chung, Republic of Korea; S. H. Lee; J. H. Choi; J. W. Kang; J. K. Ryu; Y.-T. Kim 11:18 – 11:30 OP361 EUS-GUIDED GASTROENTEROSTOMY: A LARGE MULTICENTER STUDY COMPARING THE DIRECT AND BALLOON-ASSISTED TECHNIQUES Y.-I. Chen; R. Kunda; A. C. Storm; C. C. Thompson; J. Nieto; A. A. Siddiqui; T. James; M. A. Bukhari; O. I. Brewer Gutierrez; M. I. Canto; V. K. Singh; T. H. Baron; Mouen A. Khashab, USA
ª Rising Star ª Top Abstract Prize ª National Scholar
Wednesday, November 1, 2017
Scientific Programme by Day : UEG Week Final Programme
11:30 – 11:42 OP362 MINIMALLY INVASIVE SURGERY VERSUS ENDOSCOPY RANDOMIZED (MISER) TRIAL FOR NECROTIZING PANCREATITIS Ji Young Bang, USA; J. P. Arnoletti; B. A. Holt; U. Navaneethan; M. Hasan; C. M. Wilcox; R. Hawes; S. Varadarajulu 11:42 – 11:54 OP363 LUMEN APPOSING METAL STENTS ARE COST-EFFECTIVE WHEN COMPARED WITH PLASTIC STENTS IN THE MANAGEMENT OF PANCREATIC WALLED-OFF NECROSIS O. I. Brewer Gutierrez; Y. I. Chen; A. Barkun; V. Adam; Lea Fayad, USA; G. Bai; V. K. Singh; M. A. Bukhari; O. Sanaei; B. J. Elmunzer; T. H. Baron; S. Ngamruengphong; M. I. Canto; A. Repici; M. A. Khashab Free Paper Session 10:30 – 12:00 Bugs in lower GI diseases Chairs: Giovanni Cammarota, Italy Charlotte Hedin, Sweden
10:54 – 11:06 OP365 1-DAY OR 5-DAY FECAL SAMPLES, WHICH ONE IS MORE BENEFICIAL TO BE USED FOR DNA-BASED GUT MICROBIOTA STUDY T. Su; Shujie Chen, China 11:06 – 11:18 OP366 THE IN-HOSPITAL MORTALITY RATE FOR CLOSTRIDIUM DIFFICILE INFECTION HAS DECREASED OVER THE PAST DECADE IN THE UNITED STATES: A NATIONWIDE ANALYSIS Paul Thomas Kroener, USA; P. Jirapinyo; M. S. Abougergi; C. C. Thompson 11:18 – 11:30 OP367 SINGLE-INFUSION FECAL MICROBIOTA TRANSPLANTATION IS NOT EFFECTIVE IN TREATING SEVERE CLOSTRIDIUM DIFFICILE INFECTION Gianluca Ianiro, Italy; L. Masucci; C. Simonelli; M. Sanguinetti; A. Gasbarrini; G. Cammarota
Q&A
Free Paper Session 10:30 – 12:00 Hotspot Abstracts on Fire: Diagnosis and treatment of upper GI diseases in children and adults Chairs: Anne Christin Meyer-Gerspach, Switzerland Michael Farthing, United Kingdom
IP591
10:42 – 10:54 OP364 EVALUATION OF MULTIPLEX PCR FOR DIAGNOSIS OF GASTROINTESTINAL TUBERCULOSIS ª N. Berry; Sarthak Malik, India; K. Sharma; S. K. Sinha; N. Dhaka; R. Kochhar; K. Vaiphei
Live Stream
11:42 – 11:54 OP369 INTRODUCTION OF MOLECULAR STOOL TESTING FOR PATIENTS WITH GASTROENTERITIS IS ASSOCIATED WITH INCREASED INCIDENCE AND ANTIBIOTIC TREATMENT OF BLASTOCYSTIS AND DIENTAMOEBA Alwin Schierenberg, The Netherlands; P. C. J. Bruijning-Verhagen; M. D. Nipshagen; J. Kusters; S. van Delft; M. J. M. Bonten; N. J. De Wit
Audience Voting
10:30 – 10:40 OP370 THE RESULTS OF ENDOSCOPIC AND SURGICAL TREATMENT FOR ACHALASIA IN ENGLAND BETWEEN 2005 AND 2016 Phil Harvey, United Kingdom; B. Coupland; J. Mytton; F. Evison; P. Patel; N. Trudgill 10:40 – 10:50 OP371 Spectrum of histopathologic patterns among achalasia subtypes Nao Nakajima, Japan; H. Sato; K. Takahashi; G. Hasegawa; K.-I. Mizuno; S. Hashimoto; Y. Sato; S. Terai 10:50 – 11:00 OP372 THE TAUROLIDINE-CITRATE-HEPARIN CATHETER LOCK REDUCES CATHETER-RELATED BLOODSTREAM INFECTIONS IN INTESTINAL FAILURE PATIENTS RECEIVING HOME PARENTERAL SUPPORT: A RANDOMISED AND PLACEBO-CONTROLLED TRIAL. Siri Tribler, Denmark; C. F. Brandt; A. H. Petersen; J. H. Petersen; K. A. Fuglsang; M. Staun; P. Brøbech; C. E. Moser; P. B. Jeppesen 11:00 – 11:10 OP373 REDUCING FODMAP CONTENT IN THE BREASTFEEDING MOTHER’S DIET ALLEVIATES THE SYMPTOMS OF INFANTILE COLIC: A RANDOMISED CONTROLLED DOUBLE-BLIND CROSSOVER STUDY Marina Iacovou, Australia; P. R. Gibson; J. G. Muir
Recorded Session
103
Wednesday, November 1, 2017
10:30 – 10:42 State-of-the-art introduction Giovanni Cammarota, Italy
Room E3
11:30 – 11:42 OP368 FAECAL MICROBIOTA TRANSFER IN IRRITABLE BOWEL SYNDROME – CLINICAL OUTCOMES OF A RANDOMISED PLACEBO-CONTROLLED TRIAL ª Savanne Holster, Sweden; D. Repsilber; R. J. Brummer; J. König
UEG Week Final Programme : Scientific Programme by Day
11:10 – 11:20 OP374 COMPARISON OF TWO STRATEGIES FOR PREVENTION OF REBLEEDING AMONG CHILDREN WITH PEPTIC ULCER Oana Belei, Romania; L. Olariu; C. Jinca; T. Marcovici; O. Marginean 11:20 – 11:30 OP375 EXPLOITING THE MECHANISM OF GASTROPROTECTION BY ADIPONECTIN IN MICE FED A HIGH FAT DIET AND CHALLENGED BY ETHANOL. RELEVANCE TO ETHANOL CONSUMPTION IN HUMAN OBESITY. A. Szlachcic; J. Majka; M. Magierowski; D. Wojcik; M. Surmiak; K. Magierowska; S. Kwiecien; G. Ginter; Tomasz Brzozowski, Poland 11:30 – 11:40 OP376 PAN-EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): INTERIM ANALYSIS OF 4,417 SECOND-LINE TREATMENTS A. G. McNicholl; Olga P. Nyssen, Spain; D. S. Bordin; B. Tepeš; M. Á. Perez Aisa; B. Vaira; M. Caldas Álvarez; L. Bujanda Fernández de Piérola; M. Castro Fernández; F. Lerang; M. Leja; L. Rodrigo; T. Rokkas; L. Kupcinskas; J. Perez-Lasala; L. Jonaitis; O. Shvets; A. Gasbarrini; H. Şimşek; A. Axon; G. M. Buzás; J. C. L. Machado; Y. Niv; L. Boyanova; A. Goldis; V. Lamy; M. Katicic; K. Przytulski; C. Beglinger; M. Venerito; P. Bytzer; L. Capelle; T. Milosavljevic; L. Veijola; J. Molina Infante; L. Vologzhanina; G. Fadeenko; I. Ariño; G. Fiorini; M. Ramas; M. Garcia Donday; F. Megraud; C. O'Morain; J. P. Gisbert 11:40 – 11:50 OP377 CAPSULE ENDOSCOPY IN INTESTINAL LYMPHAGIECTASIA: A NOVEL ENDOSCOPIC CLASSIFICATION AND ITS CLINICAL CORRELATION Kuiliang Liu, China; W. Shen; J. Wu
Wednesday, November 1, 2017
11:50 – 12:00 OP378 LONG-TERM OUTCOMES OF PATIENTS WITH EARLY GASTRIC CANCER DIAGNOSED AS PATHOLOGICAL EXTRA-INDICATED LESION AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION Kenji Ishido, Japan; T. Yano; S. Tanabe; T. Wada; M. Azuma; C. Katada; W. Koizumi
104
Wednesday, November 1, 2017
Round Table Discussion 12:45 – 13:45 Room A2 Management of severe acute colitis Chair: Iris Dotan, Israel Experts: Willem A. Bemelman, The Netherlands Franck Carbonnel, France Iris Dotan, Israel Geert D'Haens, The Netherlands
Round Table Discussion 12:45 – 13:45 Room A3 Endoscopic management of complications following upper GI surgery Chair: Todd H. Baron, USA Experts: Todd H. Baron, USA Andrea May, Germany Alessandro Repici, Italy Riccardo Rosati, Italy Round Table Discussion 12:45 – 13:45 Room B2 Diagnostic and therapeutic approach to patients with anal bloodloss Chair: Roger Leicester, United Kingdom Experts: Alexander Herold, Germany Ian Jenkins, United Kingdom Roger Leicester, United Kingdom Monica Millan, Spain Round Table Discussion 12:45 – 13:45 Infectious complications of liver cirrhosis Chair: Claire Francoz, France Experts: Claire Francoz, France Thomas Reiberger, Austria Frank Tacke, Germany Jonel Trebicka, Germany
Room B3
ª Rising Star ª Top Abstract Prize ª National Scholar
Wednesday, November 1, 2017
Scientific Programme by Day : UEG Week Final Programme
Symposium 12:30 – 13:30 Hotspot 25th UEG Week Anniversary Session: Major advances in gastroenterology and hepatology over the last 25 years Chair: Michael Farthing, United Kingdom
Symposium 14:00 – 15:30 Hall 6 IBD: What's new in 2017? Chairs: C. Janneke van der Woude, The Netherlands Julian Panés, Spain
12:30 – 12:35 Introduction by the UEG President Michael Manns, Germany
IP592
14:00 – 14:22 Microbiota Harry Sokol, France
IP601
12:35 – 12:40 IBD and biologics: A happy marriage! Julian Panés, Spain
IP593
14:22 – 14:44 Pathophysiology Arthur Kaser, United Kingdom
IP602
12:40 – 12:45 Hepatitis C virus: Discovery and extinction Michael Manns, Germany
IP594
14:44 – 15:06 New drugs Raja Atreya, Germany
IP603
12:45 – 12:50 H. pylori: The Nobel bug John Atherton, United Kingdom
IP595
15:06 – 15:28 Surgery Willem A. Bemelman, The Netherlands
IP604
12:50 – 12:55 Endoscopy: A technical revolution Paul Fockens, The Netherlands
IP596
13:00 – 13:05 IP598 GI oncology: A successful multidisciplinary endeavour Thomas Seufferlein, Germany 13:05 – 13:10 IP599 Gastroesophageal reflux disease: Reducing acid and complications Rebecca Clare Fitzgerald, United Kingdom 13:10 – 13:15 IP600 Laparoscopic surgery: A diagnostic and therapeutic success story! Mario Morino, Italy 13:15 – 13:30 PANEL DISCUSSION
Room F2
14:00 – 14:22 What is wrong with PPI-nonresponders? Daniel Sifrim, United Kingdom
IP605
14:22 – 14:44 Laparoscopic fundoplication Mario Costantini, Italy
IP606
14:44 – 15:06 Endoscopic anti-reflux procedures Nicole Bouvy, The Netherlands
IP607
15:06 – 15:28 IP608 Magnets, pacemakers and other new approaches Stephen Attwood, United Kingdom Wednesday, November 1, 2017
12:55 – 13:00 IP597 Treating diarrhoea in children: A global life-saver Sibylle Koletzko, Germany
Advances in Clinical GI & Hepatology 14:00 – 15:30 Treatment of GORD beyond acid inhibition Chairs: Frank Zerbib, France Serhat Bor, Turkey
“Looking into the crystal ball: The future in gastroenterology and hepatology looks bright!”
Live Stream
Q&A
Audience Voting
Recorded Session
105
UEG Week Final Programme : Scientific Programme by Day
Symposium 14:00 – 15:30 Endoscopy: What's new in 2017? Chairs: Lars Aabakken, Norway Thierry Ponchon, France
Room F1
14:00 – 14:22 Upper GI Mario Dinis-Ribeiro, Portugal
IP609
14:22 – 14:44 Lower GI Brian P. Saunders, United Kingdom
IP610
14:44 – 15:06 ERCP Ioannis Papanikolaou, Greece
IP611
15:06 – 15:28 EUS Maria Chiara Petrone, Italy
IP612
Symposium 14:00 – 15:30 Hepatology: What's new in 2017? Chairs: Dominique Thabut, France Olivier Rosmorduc, France
Room A2
14:00 – 14:22 Viral hepatitis Heiner Wedemeyer, Germany
IP613
14:22 – 14:44 Autoimmune and cholestatic diseases Marco Marzioni, Italy
IP614
14:44 – 15:06 Cirrhosis Jonel Trebicka, Germany
IP615
15:06 – 15:28 Hepatocellular carcinoma Alejandro Forner, Spain
IP616
Wednesday, November 1, 2017 106
Wednesday, November 1, 2017
Symposium 14:00 – 15:30 Pancreatology: What's new in 2017? Chairs: Vinciane Rebours, France Thomas Seufferlein, Germany
Room A1
14:00 – 14:22 IP617 Rising Star: Management of acute pancreatitis: Nothing is what it seems ª Enrique de-Madaria, Spain 14:22 – 14:44 Chronic pancreatitis David C. Whitcomb, USA
IP618
14:44 – 15:06 Neuroendocrine pancreatic tumours Gabriele Capurso, Italy
IP619
15:06 – 15:28 Pancreatic cancer Eike Gallmeier, Germany
IP620
Symposium 14:00 – 15:30 H. pylori: What's new in 2017? Chairs: Emad El-Omar, Australia John Atherton, United Kingdom
Room A3
14:00 – 14:22 What’s new in ‘omics’ and pathogenesis? Jose Carlos L. Machado, Portugal
IP621
14:22 – 14:44 What’s new in diagnostics? Francis Megraud, France
IP622
14:44 – 15:06 What’s new in treatment? Xavier Calvet Calvo, Spain
IP623
15:06 – 15:28 The way to the vaccine Peter Malfertheiner, Germany
IP624
ª Rising Star ª Top Abstract Prize ª National Scholar
Wednesday, November 1, 2017
Scientific Programme by Day : UEG Week Final Programme
Symposium 14:00 – 15:30 Room B2 Colorectal cancer: What's new in 2017? Chairs: Rob Glynne-Jones, United Kingdom André D'Hoore, Belgium
Symposium 14:00 – 15:30 Upper GI cancer: What's new in 2017? Chairs: Tamara Matysiak Budnik, France Ernst J. Kuipers, The Netherlands
Room E4
IP625
14:00 – 14:22 New TNM classification Fatima Carneiro, Portugal
IP633
14:00 – 14:22 Molecular classification of colorectal cancer Rodrigo Dienstmann, Spain
IP626
14:22 – 14:44 Early diagnosis in primary care Gregory Rubin, United Kingdom
IP634
14:22 – 14:44 Liquid biopsy Federica Di Nicolantonio, Italy
IP627
14:44 – 15:06 Progress in neo-adjuvant treatment Tamara Matysiak Budnik, France
IP635
14:44 – 15:06 Organ sparing treatment for rectal cancer Rodrigo Perez, Brazil 15:06 – 15:28 Immunotherapy in colorectal cancer Ramon Salazar, Spain
IP628
Tandem Talks 15:06 – 15:16 Endoscopic treatment Fabian Emura, Colombia
14:00 – 14:22 Basic neurogastroenterology Gary M. Mawe, USA
IP629
14:22 – 14:44 Brain-gut interactions Asbjørn Drewes, Denmark
IP630
14:44 – 15:06 Disease mechansims Nathalie Vergnolle, France
IP631
15:06 – 15:28 Diagnostic tests Guillaume Gourcerol, France
IP632
Live Stream
Q&A
Audience Voting
15:16 – 15:26 Surgical treatment Riccardo Rosati, Italy
IP637
Symposium 14:00 – 15:30 Room E1 Diagnostic tools for GI diseases: What's new in 2017? Chairs: Marianna Arvanitakis, Belgium Joost P. H. Drenth, The Netherlands 14:00 – 14:22 Radiology Andrew Plumb, United Kingdom
IP638
14:22 – 14:44 Endoscopy Marco J. Bruno, The Netherlands
IP639
14:44 – 15:06 Histopathology Cord Langner, Austria
IP640
15:06 – 15:28 Biomarkers Rebecca Clare Fitzgerald, United Kingdom
IP641
Recorded Session
Wednesday, November 1, 2017
Symposium 14:00 – 15:30 Room B3 Neurogastroenterology and motility: What's new in 2017? Chairs: Lesley Houghton, United Kingdom Guillaume Gourcerol, France
IP636
107
Visit the Scientific Centre in Hall 7, hosting all possibilities to present your abstract
Poster in the Spotlight Clinical Cases Poster of Excellence
Poster Exhibition
Abstracts on Fire
View the programme schedule directly in the UEG Week App (www.ueg.eu/app) and on www.ueg.eu/week
Poster Sessions by Day Overview Icons
Posters are displayed from Monday, October 30 until Wednesday, November 1 in the poster exhibition in Hall 7. The posters are changed daily and are at display during the following times:
Monday Tuesday Wednesday
October 30 09:00 – 17:00 October 31 09:00 – 17:00 November 1 09:00 – 14:00
Four Poster Champ Sessions run in parallel from Monday until Wednesday from 12:30 – 13:30. 2-minutes presentations of the highest scoring posters will be given at the e-poster terminals in the poster exhibition, followed by 3-minutes Q&As from the chairs.
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Champs are awarded in the following categories: 1. Upper gastrointestinal diseases 2. Lower gastrointestinal diseases 3. Liver, biliary and pancreatic diseases 4. Surgery, endoscopy and imaging Poster Champ sessions are open to all delegates. All UEG Week 2017 attendees are kindly invited to join these sessions and the Poster Champ award ceremony held in E-Poster Lounge I at 13:45 every day. Posters in the Spotlight will be presented additionally in dedicated sessions held daily in the E-Poster Lounge I and II.
Poster Sessions
Monday, October 30, 2017
Poster Sessions by Day Monday, October 30, 2017 Posters in the Spotlight 10:30 – 12:00 E-Poster Lounge 1 Therapeutic observations in IBD Chairs: James Lindsay, United Kingdom Krisztina Barbara Gecse, The Netherlands P0405 DIRECT INTESTINAL PH-TRANSIT ASSESSMENT IN PATIENTS WITH ULCERATIVE COLITIS AS A STRATEGY FOR PREDICTING SUCCESS OF REGIONAL DELIVERY OF TOPICALLY-ACTING DRUGS P0376 CELL THERAPY FOR PERIANAL CROHN'S DISEASE
Visit the E-Poster Terminals & Poster Champ Sessions Find posters also electronically on the e-poster terminals in the UEG Week Scientific Centre (Hall 7). Additionally 4 Poster Champ Sessions run in parallel each day from 12:30 – 13:30 in the poster exhibition and a Poster Champ will be selected out of the Posters of Excellence in each category.
P0407 COMPARATIVE EFFICACY AND SAFETY OF TOFACITINIB AND BIOLOGICS AS INDUCTION THERAPY FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS P0374 CHANGES IN THERAPEUTIC STRATEGY AND OUTCOMES IN NEWLY DIAGNOSED PATIENT WITH CROHN'S DISEASE IN THE BIOLOGICAL ERA IN HUNGARY: A NATIONWIDE STUDY BASED ON THE NATIONAL HEALTH INSURANCE FUND DATABASE P0396 INTEGTRATING PSYCHOLOGICAL SUPPORT INTO ROUTINE CARE FOR PEOPLE WITH INFLAMMATORY BOWEL DISEASE. P0399 ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY Posters in the Spotlight 10:30 – 12:00 E-Poster Lounge 2 Basic science models to understand human disease Chairs: Nathalie Vergnolle, France Gary M Mawe, USA P0312 THE EFFECTS OF GLIAL -DERIVED NEUROTROPHIC FACTOR PRODUCED BY ENTERIC GLIAL CELLS ON DENDRITIC CELL AND ITS ROLES IN DEXTRAN SULPHATE SODIUM INDUCED COLITIS
E-Posters will be published on www.ueg.eu/week/24-7
P0300 REGULATORY B CELLS CONTRIBUTE TO THE ALLEVIATION OF COLITIS INDUCED BY DEXTRAN SULPHATE SODIUM AFTER H.PYLORI INFECTION
Poster Sessions : UEG Week Final Programme
P0333 ORMDL PROTEINS: CRITICAL REGULATORS OF FINE-TUNING OF THE UNFOLDED PROTEIN RESPONSE IN INTESTINAL INFLAMMATION P0473 POTENTIAL REGULATORY EFFECTS OF CORTICOTROPIN-RELEASING FACTOR ON TIGHT JUNCTION-RELATED INTESTINAL EPITHELIAL PERMEABILITY ARE PARTIALLY MEDIATED THROUGH CK8 UPREGULATION P0005 EFFECTS OF INTERNAL AND EXTERNAL BILIARY DRAINAGE ON THE EXPRESSION OF INTESTINAL BILE ACID RECEPTOR AND TLR4/NOD2 IN MICE WITH OBSTRUCTIVE JAUNDICE P0097 EXPDF IMPACTS PANCREATIC DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELL DERIVED PANCREATIC ORGANOIDS Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 1 Poster Champ Session: Upper gastrointestinal diseases Chairs: Niek J. De Wit, The Netherlands Fatima Carneiro, Portugal
P0512 REAL-LIFE ANALYSIS OF FREQUENCY, LOCATIONS AND BLEEDING SOURCES IN UNSELECTED EMERGENCY PATIENTS DURING NON-VITAMIN K ANTICOAGULANT (NOAC) THERAPY AND COMPARISON TO CONTROLLED APPROVAL STUDIES P0529 RELEVANCE OF SLEEP DISTURBANCE TO FUNCTIONAL GASTROINTESTINAL SYMPTOMS, CLINICAL CHARACTERISTICS, AND PSYCHOLOGICAL DISTRESS P0534 A PHASE 1 STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF SINGLE DOSE APT-1011 ADMINSTERED UNDER FED OR FASTED CONDITIONS OR AT BEDTIME IN A RANDOMISED THREE-WAY, CROSSOVER DESIGN P0643 FEATURES OF CHRONIC GASTRITIS CAUSED BY CO-INFECTION OF HELICOBACTER PYLORI AND EPSTEIN-BARR VIRUS IN PEDIATRIC PATIENTS P0519 ESOPHAGEAL REFLUX BURDEN IN RELATIONSHIP TO ESOPHAGOGASTRIC JUNCTION (EGJ) AND ESOPHAGEAL BODY FUNCTION ON HIGH RESOLUTION MANOMETRY (HRM)
P0627 FOOD-DERIVED MICRORNA AND INFLUENCE ON THE FECAL MICRORNA EXPRESSION
P0531 DETERMINANT FACTORS OF QUALITY OF LIFE IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
P0555 A DEDICATED BARRETT'S OESOPHAGUS ENDOSCOPY LIST IMPROVES THE ACCURACY OF ENDOSCOPIC REPORTING AND QUALITY OF BIOPSIES
Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 2 Poster Champ Session: Liver, biliary and pancreatic diseases Chairs: Albrecht Neesse, Germany Philippe Lévy, France
P0497 THE ONCOGENIC MIR-491-5P/MIR-875-5P-NOTCH3PHLDB2 AXIS IN GASTRIC TUMORIGENESIS P0597 EFFICACY OF THREE-IN-ONE CAPSULE BISMUTH QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN CLINICAL PRACTICE IN A MULTINATIONAL PATIENT POPULATION P0521 MOTILITY PATTERNS AFTER PER-ORAL ENDOSCOPIC MYOTOMY (POEM) IN PATIENTS WITH ACHALASIA P0603 ROLE OF POLYMORPHISMS IN TLR1 AND PRKAA1 GENES IN THE DEVELOPMENT OF ATROPHIC GASTRITIS AND GASTRIC CANCER
Poster in the Spotlight
Poster of Excellence
P0004 THE PROTECTIVE EFFECTS OF GROUP 3 INNATE LYMPHOID CELLS ON HEPATITIS B VIRUS RELATED LIVER FIBROSIS COULD BE IMPAIRED BY TH17 CELLS P0063 EPIGENETIC INACTIVATION OF METALLOTHIONEIN 1G IN PATIENTS WITH HEPATOCELLULAR CARCINOMA P0037 RIFAXIMIN-? IS ASSOCIATED WITH REDUCTIONS IN EMERGENCY DEPARTMENT RESOURCE USE IN UK PATIENTS WITH HEPATIC ENCEPHALOPATHY: REAL WORLD EVIDENCE FROM THE IMPRESS STUDY
Clinical Case Session
111
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
P0083 ERCP WITH SHORT-TYPE SINGLE BALLOON ENTEROSCOPE IN PATIENTS WITH SURGICALLY ALTERED PATIENTS Monday, October 30, 2017
P0057 OPTIMAL NUMBER OF MEASUREMENTS IN REAL-TIME SHEAR WAVE ELASTOGRAPHY TO ASSESS LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION P0125 CONCOMITANT PANCREATIC CANCERS ARISING ADJACENT TO INDEX INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS SHARE IDENTICAL KRAS MUTATIONS AND ARE ASSOCIATED WITH A FAVORABLE PROGNOSIS. P0007 THE EMERGING ROLE OF ZBP-89 IN SENSITIZING HEPATIC CANCER STEM CELLS TO SORAFENIB P0104 EARLY OR LATE CHOLECYSTECTOMY IN MILD GALLSTONE PANCREATITIS? RESULTS FROM RANDOMIZED TRIAL P0116 AUTOIMMUNE PANCREATITIS CLASSIFIED AS NOT-OTHERWISE SPECIFIED (NOS) ACCORDING TO THE INTERNATIONAL CONSENSUS DIAGNOSTIC CRITERIA: CLINICAL FEATURES AND OUTCOMES IN 47 PATIENTS. P0121 GALECTIN-1 EXPRESSED IN PANCREATIC STELLATE CELLS PROMOTES TUMOR PROGRESSION IN PANCREATIC CANCER VIA UPREGULATION OF SDF-1 AND ACTIVATION OF NF-?B P0129 VERIFICATION OF INTERNATIONAL CONSENSUS GUIDELINES 2012 – SURGICAL INDICATION FOR BRANCH DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS (BD-IPMN) WITH WORRISOME FEATURES P0017 THE ROLE OF GENETIC FACTORS IN NON-OBESE NASH PATIENTS Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 3 Poster Champ Session: Lower gastrointestinal diseases Chairs: Yasmijn van Herwaarden, The Netherlands Franco Scaldaferri, Italy P0367 INCIDENTAL FINDINGS AT CT ENTEROGRAPHY IN PATIENTS WITH CROHN'S DISEASE: CLINICAL SIGNIFICANCE AND IMPACT ON TARGETED THERAPY
112
P0470 A NEW SCORING MODEL FOR PREDICTING ADVANCED COLORECTAL NEOPLASIA IN ASYMPTOMATIC SCREENING POPULATION AND COMPARISON WITH THE MODIFIED ASIA-PACIFIC COLORECTAL SCREENING SCORE P0446 MITOCHONDRIAL GLUTAMATE TRANSPORTER (SLC25A22) MEDIATES DNA AND HISTONE HYPERMETHYLATION AND PROMOTES THE TUMORIGENICITY OF KRAS-MUTANT COLORECTAL CANCER P0320 EPIDEMIOLOGY OF MICROSCOPIC COLITIS IN NOTTINGHAM: A CONTEMPORARY COHORT STUDY P0436 WORLD ENDOSCOPY ORGANISATION CONSENSUS STATEMENTS ON POST-COLONOSCOPY/POST-IMAGING COLORECTAL CANCER P0481 THE DIAGNOSTIC VALUE OF BALLOON EXPLUSION TEST AND COLON TRANSIT TEST AND AGREEMENT WITH FINDINGS FROM HIGH RESOLUATION ANORECTAL MANOMETRYIN PATIENTS WITH DYSSYNERGIA DEFECATION P0469 LONG-TERM COLONOSCOPIC SURVEILLANCE BETWEEN PATIENTS WITH UNRESECTED DIMINUTIVE POLYPS AND THOSE WITH COLORECTAL ADENOMAS > 5MM IN SIZE RESECTED AT INITIAL COLONOSCOPY P0360 DOUBLE-BALLOON ENDOSCOPIC EVALUATION OF FECAL CALPROTECTIN AS A BIOMARKER FOR SMALL INTESTINAL INFLAMMATION IN CROHN'S DISEASE P0408 CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH C. DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE: BEZLOTOXUMAB VERSUS PLACEBO P0428 THE PROPHYLACTIC CLIP APPLICATION BEFORE SNARE POLYPECTOMY DECREASES IMMEDIATE POST-POLYPECTOMY BLEEDING IN LARGE PEDUNCULATED POLYPS. P0451 THE POSSIBILITIES OF APPLICATION OF METABOLIC PROFILES OF BLOOD SERUM AND RED BLOOD CELLS IN DIAGNOSING OF COLORECTAL CANCER P0416 ALTERED INTESTINAL EXPRESSION PROFILES OF ANTI-MICROBIAL GENES IN IRRITABLE BOWEL SYNDROME ARE LINKED TO BACTERIAL COMPOSITION AND IMMUNE ACTIVATION
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 4 Poster Champ Session: Surgery, endsocopy and imaging Chairs: Mariana Milashka, France Myriam Delhaye, Belgium P0293 EARLY VERSUS DELAYED CLOSURE OF TEMPORARY LOOP ILEOSTOMY AFTER COLORECTAL SURGERIES: A PROSPECTIVE RANDOMIZED STUDY P0271 LONG-TERM OUTCOMES OF ENDOSCOPIC ULTRASOUND-GUIDED RIGHT INTRAHEPATIC DUCT DRAINAGE WITH TRANSMURAL COVERED METAL STENT. P0262 SINGLE INCISION LAPAROSCOPIC ASSISTED DOUBLE BALLOON ENTEROSCOPY: A NOVEL TECHNIQUE TO MANAGE SMALL BOWEL PATHOLOGY P0203 VASCULAR AND PIT-PATTERN ANALYSIS ACCORDING TO KUDO, SANO AND NICE CLASSIFICATIONS SIGNIFICANTLY IMPROVES AFTER AN IMAGE-BASED TRAINING PROGRAM P0275 PROSPECTIVE RANDOMIZED STUDY FOR EFFICACY OF AN DOUBLE BARE STENT COMPARED A DOUBLE COVERED STENT IN MALIGNANT COLORECTAL OBSTRUCTION P0259 EUS-GUIDED RADIOFREQUENCY ABLATION OF DIFFICULT SITES IN THE LIVER: A PRECLINICAL STUDY. P0225 PERIOPERATIVE MANAGEMENT OF ORAL ANTICOAGULANTS WITHOUT HEPARIN BRIDGING THERAPY FOR PATIENTS UNDERGOING ENDOSCOPIC SURGERY: A PILOT STUDY P0242 EXPERT VALIDATION OF A NOVEL MECHANICAL CUTTING PAPILLA P0244 VISUALIZATION OF INTRA-AMPULLARY CHOLEDOCHOCELE WITH CONTRAST MEDIUM FOR EVALUATING TECHNICAL DIFFICULTY IN ERCP
P0233 INCIDENCE AND RISK FACTORS FOR PANCREATITIS IN EMERGENCY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY: A PROSPECTIVE MULTICENTER STUDY P0252 RANDOMIZED TRIAL COMPARING THE LUMEN-APPOSING METAL STENTS (LAMS) AND PLASTIC STENTS FOR EUS-GUIDED DRAINAGE OF WALLED-OFF NECROSIS (WON) Posters in the Spotlight 14:00 – 15:30 E-Poster Lounge 1 Upper GI dysmotility: Understanding the symptoms and providing effective therapy Chairs: Nathalie Rommel, Belgium Guillaume Gourcerol, France P0527 CHRONIC POSTSTROKE OROPHARYNGEAL DYSPHAGIA IS ASSOCIATED WITH IMPAIRED CORTICAL ACTIVATION TO PHARYNGEAL SENSORY INPUTS. P0522 WHAT IS THE EFFECT OF MYOTOMY SITE ON PER-ORAL ENDOSCOPIC MYOTOMY? COMPARISON OF ANTERIOR AND POSTERIOR MYOTOMY P0528 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH JEJUNAL EXTENSION FOR GASTROPARESIS: THE ULTIMATE SOLUTION? P0516 INFLUENCE OF PRUCALOPRIDE ON SECONDARY PERISTALSIS IN REFLUX PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY P0518 PER-ORAL ENDOSCOPIC MYOTOMY IN TREATMENT NAÏVE VERSUS PRIOR TREATMENT FAILURE CASES – OUTCOME IN OVER 500 PATIENTS P0640 OUTCOMES OF PER-ORAL ENDOSCOPIC MYOTOMY IN CHILDREN WITH ACHALASIA CARDIA
P0258 THE SUCCESS RATE OF DOUBLE BALLOON ENDOSCOPIC CHOLANGIOGRAPHY IN PATIENTS WHO UNDERWENT THEIR INITIAL SURGERY AS INFANT IS SIGNIFICANTLY LOWER THAN OTHER PATIENTS
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
113
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
Posters in the Spotlight 14:00 – 15:30 E-Poster Lounge 2 Colorectal neoplasia: Improving detection and outcome Chairs: Rob Glynne-Jones, United Kingdom Bjorn Rembacken, United Kingdom P0456 CORRELATION OF ELECTRICAL AND VISCOELASTIC PARAMETERS OF ERYTHROCYTES WITH FATTY ACID COMPOSITION OF THEIR MEMBRANES AND SERUM IN PATIENTS WITH COLORECTAL CANCER Iana Prudnikova, Russian Federation P0438 INCIDENCE OF FECAL OCCULT BLOOD TEST INTERVAL CANCERS IN COLORECTAL CANCER SCREENING; A SYSTEMATIC REVIEW AND META-ANALYSIS Els Wieten, The Netherlands P0467 WAIT-AND-SEE STRATEGY IN LOW RECTAL CANCER João Cortez-Pinto, Portugal P0184 ACHIEVING ADEQUATE LEVEL BOWEL PREPARATION WITH EVENING/MORNING OR MORNING-ONLY SPLIT-DOSING REGIMENS OF NER1006 VERSUS STANDARD 2L PEG WITH ASCORBATE: POST HOC ANALYSIS OF A PHASE 3 TRIAL Raf Bisschops, Belgium P0176 PREDICTORS OF ADENOMA DETECTION AT COLONOSCOPY AFTER BOWEL SCOPE SURVEILLANCE: RESULTS FROM A UK PILOT SCREENING CENTRE Keith Siau, United Kingdom P0209 REAL TIME MORPHOLOGIC CHANGE ON NUCLEUS & MITOCHONDRIA OF COLON CANCER CELL BY IRREVERSIBLE ELECTROPORATION: DETECTED BY PROBE BASED MULTIPHOTON MICROSCOPY Seong Ji Choi, Republic of Korea Poster Session 09:00 – 17:00 Liver and Biliary I
P0002 NATURAL KILLER CELLS MAY BE THE KEY FACTOR FOR THE AMELIORATION OF THE LIVER FIBROSIS AFTER MESENCHYMAL CELL TRANSPLANTATION Munkhtsetseg Banzragch, Turkey; T. Akkoc; N. Zibandeh; M. U. Ugurlu; T. Akkoc; D. Genc; C. A. Celikel; D. G. Duman P0003 SERPINB3 INVOLVEMENT IN THE STIMULATION OF MACROPHAGE ACTIVATION MARKER SCD163 IN HCV INFECTED PATIENTS Andrea Martini, Italy; A. Cappon; A. Biasiolo; C. Turato; P. Pontisso P0004 THE PROTECTIVE EFFECTS OF GROUP 3 INNATE LYMPHOID CELLS ON HEPATITIS B VIRUS RELATED LIVER FIBROSIS COULD BE IMPAIRED BY TH17 CELLS Si-Qi Wang, China; W. Ma; L.-S. Cheng; W. Jiang P0005 EFFECTS OF INTERNAL AND EXTERNAL BILIARY DRAINAGE ON THE EXPRESSION OF INTESTINAL BILE ACID RECEPTOR AND TLR4/NOD2 IN MICE WITH OBSTRUCTIVE JAUNDICE S. Li; Shaohua Shen, China; T. Zhang; W. LI P0006 ALTERED SMALL INTESTINAL MICROBIOTA TOWARD FAMILY LACTOBACILLACEAE IN MIR-21 KNOCKOUT MICE A. Santos; M. B. Afonso; P. M. Rodrigues; R. S. Ramiro; I. Gordo; Rui Castro, Portugal; C. M. P. Rodrigues P0007 THE EMERGING ROLE OF ZBP-89 IN SENSITIZING HEPATIC CANCER STEM CELLS TO SORAFENIB Nuozhou Wang, Hong Kong PRC; Y. Liu; J. Ren; J. Yu; R. Ho; P. B. Lai; G. G. Chen Microbiology P0008 PROTECTIVE EFFECT OF AKKERMANSIA MUCINIPHILA AGAINST IMMUNE-MEDIATED LIVER INJURY IN A MOUSE MODEL W. Wu; D. Shi; D. Fang; Xingkang He, China; L. Li
Hall 7
P0009 CLINICAL OBSERVATION ON THE TREATMENT OF NONALCOHOLIC FATTY LIVER WITH PROBIOTICS Wei Wang, China
P0001 ALTERATIONS OF THE NO-CGMP PATHWAY IN THIOACETAMIDE-INDUCED LIVER FIBROSIS/CIRRHOSIS IN RATS Denise Schaffner, Germany; A. Lazaro; I. Merfort; P. Hasselblatt; P. Deibert; W. Kreisel
P0010 FAECALIBACTERIUM ASSOCIATED WITH GUT-PERMEABILITY IN NONALCOHOLIC FATTY LIVER DISEASE Takaomi Kessoku, Japan; K. Imajo; Y. Honda; T. Kato; Y. Ogawa; W. Tomeno; T. Higurashi; M. Yoneda; M. Shimakawa; Y. Tanaka; T. Kawahara; S. Saito; H. Usuda; K. Wada; A. Nakajima
Molecular biology, inflammation and fibrosis
114
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0011 GUT MICROBIOTA COMPOSITION IN EXPERIMENTAL MOUSE MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASE Bangzhou Zhang, China; L. Fan; J. Ren Metabolic/genetic disorders P0012 PREVALENCE OF METABOLIC SYNDROME AND LIVER STEATOSIS IN A PROSPECTIVE MULTICENTER STUDY OF PATIENTS REFERRED FOR HYPERFERRITINEMIA Agustin Castiella Eguzkiza, Spain; E. Zapata; I. Urreta; L. Zubiaurre; P. Otazua; J. M. Alustiza; E. Salvador; G. Letamendi; B. Arrizabalaga; L. Mendibil; J. I. Emparanza P0013 LIVER IRON CONCENTRATION IN PATIENTS REFERRED FOR HYPERFERRITINEMIA. MULTICENTRE ANALYSIS OF THE DIFFERENT GROUPS ACCORDING TO HFE MUTATIONS AND TRANSFERRIN SATURATION INDEX. Agustin Castiella Eguzkiza, Spain; E. Zapata; I. Urreta; L. Zubiaurre; P. Otazua; J. M. Alustiza; M. D. De Juan; E. Salvador; G. Letamendi; B. Arrizabalaga; A. iribarren; L. Mendibil; J. I. Emparanza P0014 LIVER IRON CONCENTRATION IN THE METABOLIC SYNDROME WITH HYPERFERRITINEMIA (DYSMETABOLIC HYPERFERRITINEMIA). RESULTS FROM A PROSPECTIVE COHORT OF 312 PATIENTS. Agustin Castiella Eguzkiza, Spain; E. Zapata; I. Urreta; L. Zubiaurre; P. Otazua; J. M. Alustiza; E. Salvador; G. Letamendi; B. Arrizabalaga; L. Mendibil; J. I. Emparanza P0015 INTERLEUKIN-25 PROTECTS AGAINST HIGH-FAT DIET-INDUCED HEPATIC STEATOSIS IN MICE BY INDUCING IL-25 AND M2A KUPFFER CELL PRODUCTION An-Jiang Wang, China; X.-L. Zheng; B.-M. Li; H.-Y. Xiao; J.-B. Hong; X. Zhu P0016 LONG TERM BENEFIT OF STATINS USED FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) A.-I. Suceveanu; Adrian Suceveanu, Romania; I. R. Parepa; D. Catrinoiu; F. Voinea; L. Mazilu P0017 THE ROLE OF GENETIC FACTORS IN NON-OBESE NASH PATIENTS Fehmi Ates, Turkey P0018 EVALUATION OF THE RELATIONSHIP OF LEVELS OF C-REACTIVE PROTEIN AND HOMOCYSTEIN IN PATIENTS WITH ABDOMINAL OBESITY AND PATHOLOGICAL CHANGES IN THE LIVER DEFINED BY BIOPROGNOSTIC TEST STEATOSCREEN. Ekaterina Chernetcova, Russian Federation; N. Denisov Poster in the Spotlight
Poster of Excellence
P0019 INVESTIGATION OF THE RELATIONSHIP BETWEEN THE THICKNESS OF THE INTIMA-MEDIA COMPLEX OF COMMON CAROTID ARTERIES AND PATHOLOGICAL CHANGES IN THE LIVER IN PATIENTS WITH ABDOMINAL OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE. Ekaterina Chernetcova, Russian Federation; N. Denisov; V. Grinevich; Y. Kravchuk; K. Ivashkin; L. Kornouchova P0020 OVEREXPRESSION OF HEPASSOCIN IN DIABETIC PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE MAY FACILITATE INCREASED HEPATIC LIPID ACCUMULATION. Sherief Abd-Elsalam, Egypt; S. Khodeir; S. Abou Saif; G. Abdelmoemen P0021 Mesenteric adipose tissue protects against non-alcoholic fatty liver disease by improving intestinal barrier Z. Wu; J. Tan; F. Zhang; Jun Xu, China; Y. Song; Y. L. Liu P0022 DIAGNOSTIC ACCURACY OF SHEAR WAVE ULTRASOUND ELASTOGRAPHY FOR EARLY DETECTION OF NON ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS. Asmaa Gameel, Egypt; E. M. Elhadidy; A. A. Mousa; M. M. Elrakhawy P0023 WITHDRAWN P0024 A NOVEL TOOL FOR THE NON-INVASIVE QUANTITATIVE ASSESSMENT OF HEPATIC STEATOSIS USING B-MODE IMAGE-GUIDED ULTRASOUND ATTENUATION IMAGING: A PROSPECTIVE STUDY Yudai Fujiwara, Japan; H. Kuroda; T. Abe; Y. Mikami; T. Oguri; S. Noguchi; N. Kamiyama; Y. Takikawa Cirrhosis and complications: Basic aspects P0025 SERUM FERRITIN SPECIFICITY IN PREDICTING EARLY MORTALITY OF PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS I. Valantiene; Andrius Kederys, Lithuania; J. Kupcinskas; J. Kondrackiene; J. Šumskienė; V. Petrenkiene; L. Kupcinskas P0026 PLASMA RETICULON 4 PROTEIN IS ASSOCIATED WITH PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS Sigita Gelman, Lithuania; V. Salteniene; A. Pranculis; L. Kupcinskas
Clinical Case Session
115
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0027 MICRORNAS IN ASCITES AS POTENTIAL BIOMARKERS FOR PERITONEAL CARCINOMATOSIS AND PERITONITIS P. Schindler; J. Kupcinskas; S. Juzenas; J. Skieceviciene; V. Salteniene; C. Schulz; J. Weigt; P. Malfertheiner; Alexander Link, Germany
P0036 HAEMOSTASIS IN PORTAL VEIN IN CIRRHOSIS: ROLE OF LOCAL ENDOTHELIAL DAMAGE S. Shalaby; P. Simioni; E. Campello; S. Gavasso; A. Zanetto; F. D'Amico; E. Gringeri; U. Cillo; M. Battistel; Patrizia Burra, Italy; M. Senzolo
P0028 ALTERATIONS IN GUT VASCULAR BARRIER IN EXPERIMENTAL PORTAL HYPERTENSION Marcel Sorribas Olivera, Switzerland; I. Spadoni; M. Rescigno; R. Wiest
P0037 RIFAXIMIN-Α IS ASSOCIATED WITH REDUCTIONS IN EMERGENCY DEPARTMENT RESOURCE USE IN UK PATIENTS WITH HEPATIC ENCEPHALOPATHY: REAL WORLD EVIDENCE FROM THE IMPRESS STUDY M. Hudson; Paola Di Maggio, United Kingdom; R. Cipelli; R. Aspinall
P0029 INHIBITION OF CYCLOOXYGENASE-2 AMELIORATES SPLENOMEGALY IN CIRRHOTIC RATS C. Tang; L. Zhang; Shihang Tang, China; X. Jia; J. Gao P0030 EPITHELIAL BARRIER DESTABILIZATION AND REGULATION OF P53 – A POSSIBLE BACTERIAL DEFENSE MECHANISM IN SPONTANEOUS BACTERIAL PERITONITIS? Marika Haderer, Germany; L. Wächter; E. Aschenbrenner; K. Pollinger; J. Middendorf; S. Schlosser; C. Kunst; M. Müller-Schilling P0031 INTESTINAL EPITHELIAL BARRIER IN EXPERIMENTAL LIVER CIRRHOSIS – A ROLE FOR BILE SALTS IN THE MUCUS LAYER M. Sorribas Olivera; Y. Noser; A. Albillos; Reiner Wiest, Switzerland P0032 CAPSAICIN AND SULFORAPHANE PREVENT THE ADVANCEMENT OF LIVER FIBROSIS IN AN EXPERIMENTAL MODEL OF LIVER CIRRHOSIS Edgar Mendivil, Mexico; A. Sandoval-Rodriguez; A. Dominguez-Rosales; L. Zuñiga-Ramos; J. Armendariz-Borunda Cirrhosis and complications: Clinical aspects P0033 DIAGNOSIS OF GASTRIC VARICES BY ENDOSCOPIC ULTRASONOGRAPHY USING COLOR DOPPLER Takahiro Sato, Japan P0034 PORTAL HYPERTENSIVE COLOPATHY BUT NOT ILEOPATHY IS COMMON IN EGYPTIANS WITH LIVER CIRRHOSIS A. Farag; Mohamed-Naguib Wifi, Egypt; M. Fawzi; A. Nageeb; M. Alboraie P0035 PREDICTIVE FACTORS FOR THE DEVELOPMENT OF ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH GASTROINTESTINAL BLEEDING C. Cojocariu; Stefan Chiriac, Romania; A.-V. Trifan; C. Stanciu 116
P0038 PREDICTING FACTORS FOR HOSPITAL READMISSON AFTER THE FIRST EPISODE OF HEPATIC ENCEPHALOPATHY Marco Silva, Portugal; A. Peixoto; H. Cardoso; S. Lopes; G. Macedo P0039 SAFETY, EFFICACY AND RISK OF COMPLICATIONS FOR CIRRHOTIC HCV PATIENTS WITH THROMBOCYTOPENIA AND HYPOALBUMINEMIA TREATED WITH OMBITASVIR/PARITAPREVIR/R+DASABUVIR+RIBAVIRIN – A REAL LIFE COHORT Carmen-Cristina Ester, Romania; L. Gheorghe; S. Iacob; C. Cijevschi; A.-V. Trifan; C. Stanciu; I. Sporea; R. Sirli; M. Curescu; C. Brisc; A. Goldis; V. Arama; F. A. Caruntu; I. Rogoveanu; A. Seicean; I. SIMIONOV; R. Vadan; I. Pirvulescu; C. Pietrareanu; R. A. Iacob; C. Gheorghe; M. Diculescu P0040 WITHDRAWN P0041 REAL WORLD IMPACT OF RIFAXIMIN-Α USE IN HEPATIC ENCEPHALOPATHY PATIENTS WITH ADVANCED LIVER DISEASE OR CONTINUED ALCOHOL MISUSE: A POST-HOC ANALYSIS OF THE IMPRESS STUDY M. Hudson; Paola Di Maggio, United Kingdom; R. Cipelli; R. Aspinall P0042 BACTERIAL INFECTION IN PATIENTS WITH DECOMPENSATED CIRRHOSIS – A PREDICTOR OF LONG-TERM MORTALITY INDEPENDENT OF DISEASE´S SEVERITY Mafalda Sousa, Portugal; S. Fernandes; J. Silva; A. Ponte; J. Rodrigues; J. C. Silva; L. Proença; J. Carvalho P0043 A PROPORTIONALLY GREATER ELEVATION IN LIVER TRANSPLANT CANDIDACY IN PATIENTS WITH NAFLD AND PORTAL VEIN THROMBOSIS Metin Basaranoglu, Turkey
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0044 RISK FACTORS AND PREDICTIVE MODEL FOR THE DEVELOPMENT OF MULTIDRUG RESISTANT BACTERIAL INFECTIONS AND THE IMPACT ON PROGNOSIS IN HOSPITALIZED DECOMPENSATED LIVER CIRRHOSIS PATIENTS Rui Morais, Portugal; S. Rodrigues; H. Cardoso; M. Silva; A. Peixoto; E. Moniz; A. L. Santos; I. Pita; R. Liberal; R. Gaspar; E. Rodrigues-Pinto; G. Macedo Viral hepatitis C: Clinical aspects P0045 EFFECT OF TREATMENT OF CHRONIC HEPATITIS C WITH SOFOSBUVIR AND DACLATASVIR IN PATIENTS OLDER THAN 60 YEARS Karim Elnoemany, Egypt; M. Badr P0046 EGY FIBRO-MARK: A PANEL OF ACCURATE LABORATORY PARAMETERS FOR THE IDENTIFICATION HEPATIC FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C Dalia Omran, Egypt; A. M. Attallah; M. Omran; R. Zayed; S. Saif; A. Farid; M. Hassany; A. Yosry P0047 EXTRACELLULAR MATRIX PROTEINS CIRCULATING LEVELS SUBSTANTIATE THE EFFECT OF IL-28B RS12979860 T ALLELE ON FIBROSIS STAGE OF CHRONIC HEPATITIS C TYPE 4 Dalia Omran, Egypt; A. M. Attallah; M. Omran; R. Zayed; R. El Essawey; S. Saif; A. Farid; M. Hassany; A. Yosry P0048 REAL-WORLD EFFECTIVENESS OF FIVE DIFFERENT DIRECT ACTING ANTIVIRAL REGIMENS FOR TREATMENT OF CHRONIC HEPATITIS C WITH NORMAL LIVER ENZYMES: SINGLE CENTER EGYPTIAN EXPERIENCE M. El Kassas; Mohamed Alboraie, Egypt; M. Salah; A. Eltahan; Y. Abdellatif; I. Kabbash; A. Fouad; M. Eltabbakh; Z. Ali-Eldin; M.-N. Wifi; M. El-Serafy; K. Elsaeed; Y. Elshazly; W. Doss P0049 THE SAFETY AND EFFICACY OF THE COMBINATION OF DACLATASVIR, ASUNAPREVIR, AND BECLABUVIR IN THE TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE 1 INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS. Ali Mahmoud Ahmed, Egypt; M. F. Doheim; O. M. Mattar; N. A. Sherif; D. H. Truong; P. T. L. Hoa; K. Hirayama; N. T. Huy P0050 GENETIC EPIDEMIOLOGY OF HCV INFECTION IN UPPER &LOWER EGYPT: A MULTICENTRE FAMILY BASED STUDY Mahmoud El-Bendary, Egypt; M. Neamatallah; E. Kamel; H. Elalfy; T. Besheer; H. Elsayed; Y. Ellazeik; A. A. Elmorsy; M. El-Setouhy; A.-H. Eladl; G. Esmat; Poster in the Spotlight
Poster of Excellence
P0051 RED BLOOD CELL DISTRIBUTION WIDTH (RDW) AS NON INVASIVE PREDICTOR OF LIVER FIBROSIS IN CHRONIC HEPATITIS C PATIENTS GENOTYPE 4. Mahmoud El-Bendary, Egypt; K. Farid; D. El-Barber; M. Elnagar P0052 CANCER INCIDENCE IN VARIOUS ORGANS OTHER THAN THE LIVER FOLLOWING DIRECT-ACTING ANTIVIRAL (DAA) THERAPY FOR HEPATITIS C Bunji Endoh, Japan; N. Esaka; S. Katsushima; K. Chikugo; S. Nakano; T. Shimogama; S. Iwamoto; K. Kasahara; T. Komeda P0053 OPTIMIZATION OF DIRECT ANTI-VIRAL AGENT TREATMENT SCHEDULE: FOCUS ON HCV GENOTYPE 3 R. Granata; Filomena Morisco, Italy; S. Camera; A. Ippolito; M. Milella; F. Conti; C. Masetti; A. Smedile; P. Tundo; T. Santantonio; M. R. Valvano; A. Termite; P. Gatti; V. Messina; A. Iacobellis; M. Librandi; N. Caporaso; A. Andriulli P0054 IS THERE AN INCREASE IN THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS WITH HEPATITIS C TREATED WITH THE DIRECT-ACTING ANTIVIRALS? Joana C. Branco, Portugal; R. Carvalho; S. Alberto; A. Martins Immunology, autoimmune liver disease P0055 MIRNA-506 PROMOTES PRIMARY BILIARY CHOLANGITIS-LIKE FEATURES IN CHOLANGIOCYTES AND IMMUNE ACTIVATION O. Erice; P. Munoz-Garrido; J. Vaquero; M. J. Perugorría; M. G. Fernandez-Barrena; E. Saez; A. Santos-Laso; A. Arbelaiz; R. Jimenez-Agüero; J. Fernandez-Irigoyen; E. Santamaria; V. Torrano; A. Carracedo; M. Ananthanarayanan; M. Marzioni; J. Prieto; U. H. W. Beuers; R. Elferink; N. LaRusso; L. Bujanda Fernández de Piérola; J. J. Marin; Jesus M. Banales, Spain Imaging, radiology (incl. interventional radiology) P0056 CLINICAL EXPERIENCE IN THE USE OF TRANSJUGULAR LIVER BIOPSY WITH TRU-CUT NEEDLE: A RETROSPECTIVE EVALUATION OF 265 CASES Armando Peixoto, Portugal; M. Silva; A. L. Santos; P. Costa-Moreira; I. Pita; S. Rodrigues; S. Lopes; G. Macedo
Clinical Case Session
117
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0057 OPTIMAL NUMBER OF MEASUREMENTS IN REAL-TIME SHEAR WAVE ELASTOGRAPHY TO ASSESS LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION Hiroshi Numao, Japan; K. Shimaya; M. Ryoma; S. Igarashi; K. Hasui; K. Kanazawa; M. Munakata; N. Hanabata P0058 APPARENT DIFFUSION COEFFICIENT IN EVALUATING THERAPEUTIC EFFICACY AFTER RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA: PROMISING RESULTS E. Emara; R. Mousa; M. Ghalab; Mohamed Hassan Emara Elzanan, Egypt; M. Balbaa; M. Talaat P0059 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IMPACT ON RESULTS OF SHEAR WAVE ELASTOGRAPHY FOR HEPATIC FIBROSIS STAGING Alexey Katrich, Russian Federation; A. Okhotina; O. Ponkina; N. Ryabin P0060 FEASIBILITY AND REPRODUCIBILITY OF NON-INVASIVE LIVER AND PANCREATIC STIFFNESS ASSESSMENT IN A COHORT OF PATIENTS WITH ALCOHOL-RELATED LIVER DISEASE Clara Benedetta Conti, Italy; N. Weiler; M. Fraquelli; G. Casazza; D. Conte; M. Colombo; S. Zeuzem; M. Friedrich-Rust Liver neoplasia: Basic P0061 EXOSOMIC MIR-224 REGULATED TUMOR INVASION AND MIGRATION THROUGH IL-6/STAT3 PATHWAY IN HEPATOCELLULAR CARCINOMA Fangmei An, China; D. Chen; Q. Zhan; M. Xia; X. Wu P0062 ª EXPRESSION ANALYSIS OF LIVER-SPECIFIC CIRCULATING MICRORNAS IN HCV-INDUCED HEPATOCELLULAR CARCINOMA IN EGYPTIAN PATIENTS Lobna Mourad, Egypt; E. El-Ahwany; M. Zoheiry; H. Abu-Taleb; M. Hassan; A. Abdel Rehim; M. Hassan; S. Zada P0063 EPIGENETIC INACTIVATION OF METALLOTHIONEIN 1G IN PATIENTS WITH HEPATOCELLULAR CARCINOMA Xiaoxing LI, China; N. Zhang; L. XU; G. Zhao P0064 THE FXR RECEPTOR PATHWAY IN HEPATOCELLULAR ADENOMA AND FOCAL NODULAR HYPERPLASIA, A PRELIMINARY EXPERIENCE Belle van Rosmalen, The Netherlands; M. Visentin; J. Verheij; M. Bieze; B. Stieger; T. M. van Gulik 118
P0065 CUX1 CONTROLS ENDOPLASMIC RETICULUM STRESS AND AUTOPHAGY RELATED CELL DEATH Giulia Metzger, Germany; P. Di Fazio; D. Bartsch; T. M. Gress; T. T. Wissniowski P0066 CUX1 CONFERS RESISTANCE TO APOPTOTIC CELL DEATH IN LIVER CANCER CELLS Elena Hofmann, Germany; P. Di Fazio; D. Bartsch; T. M. Gress; T. T. Wissniowski P0067 SERUM SQUAMOUS CELL CARCINOMA ANTIGEN LEVEL IN CIRRHOTIC CHRONIC HEPATITIS C PATIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA Walid Ellakany, Egypt Liver neoplasia: Clinical P0068 HEPATOCELLULAR CARCINOMA MULTIDISCIPLINARY CLINIC – CAIRO UNIVERSITY (HMC-CU) SCORE; A NEW SIMPLE SCORE FOR EARLY DIAGNOSIS OF HCC A. Omar; Dalia Omran, Egypt; M. Mahmoud; T. El Baz; E. Medhat; A. Hosny; A. Salah; H. Shousha P0069 MULTIPLE BIPOLAR RADIOFREQUENCY ABLATION IN TREATMENT OF MEDIUM TO LARGE HEPATOMAS – EXPERIENCE IN A REGIONAL HOSPITAL Po-Jen Hsieh, Taiwan; C.-L. Yen P0070 RECENT TRENDS IN HEPATOCELLULAR ADENOMAS: CLINICAL FEATURES, DIAGNOSIS AND OUTCOMES Marco Silva, Portugal; A. Peixoto; R. Coelho; H. Cardoso; G. Macedo P0071 LASER ABLATION IS SUPERIOR TO TACE IN LARGE SIZED HEPATOCELLULAR CARCINOMA: A CASE–CONTROL STUDY Silvia Camera, Italy; G. G. Di Costanzo; R. Tortora; M. Guarino; V. Cossiga; A. Vitiello; G. Cordone; N. Caporaso; F. Morisco; I. L. C. Italian Liver Cancer Group P0072 ENDOSCOPIC ULTRASOUND GUIDED BIOPSY FOR LIVER MASS USING CORE BIOPSY NEEDLE H. K. Chon; Tae Hyeon Kim, Republic of Korea; K. H. Choi P0073 COMPARISON OF METHODS TO ESTIMATE LIVER FUNCTION IN NEWLY-DIAGNOSED HEPATOCELLULAR CARCINOMA PATIENTS WITH ASCITES YoungSun Ko, Republic of Korea
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0074 DIAGNOSTIC AND PROGNOSTIC ROLE OF SQUAMOUS CELL CARCINOMA ANTIGEN IN HEPATOCELLULAR CARCINOMA: SEROLOGICAL AND TISSUE DETERMINATION Filippo Pelizzaro, Italy; L. Ferrara; R. Cardin; M. Piciocchi; G. Peserico; P. Todesca; A. Imondi; C. Pozzan; F. Farinati
P0082 ALCOHOL CONSUMPTION CAN REDUCE THE RISK OF GALLSTONE DISEASE: A SYSTEMATIC REVIEW WITH DOSE-RESPONSE META-ANALYSIS OF CASE-CONTROL AND COHORT STUDIES. Byung Hyo Cha, United Arab Emirates; M.-J. Jang
P0075 ADHERENCE TO BARCELONA CLINIC LIVER CANCER GUIDELINES IN FIELD-PRACTICE: RESULTS OF PROGETTO EPATOCARCINOMA CAMPANIA. F. Morisco; Maria Guarino, Italy; A. Vitiello; R. Tortora; G. de Stefano; C. Coppola; A. Salomone Megna; F. Izzo; G. Nardone; L. E. Adinolfi; G. D'Adamo; G. B. Gaeta; V. Messina; P. Guido; G. Francica; V. De Girolamo; N. Coppola; M. Persico; G. G. Di Costanzo
P0083 ERCP WITH SHORT-TYPE SINGLE BALLOON ENTEROSCOPE IN PATIENTS WITH SURGICALLY ALTERED PATIENTS Mitsuhiro Kida, Japan; H. Yamauchi; Y. Kawaguchi; E. Miyata; R. Hasegawa; T. Kaneko; K. Okuwaki; T. Iwai; H. Kikuchi; H. Imaizumi; W. Koizumi
Liver health services research P0076 A QUESTIONNAIRE SURVEY ON QUALITY OF LIFE WITH ANXIETY AND DEPRESSION SELF-RATING IN PATIENTS OF LIVER CIRRHOSIS Yuanyuan Zhang, China; X. Li; N. Cui; Y. L. Liu
P0084 CHOLECYSTECTOMY FOLLOWING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY AND DUCT CLEARANCE FOR CHOLEDOCHOLITHIASIS; A SINGLE CENTRE EXPERIENCE FROM UNITED KINGDOM. Fahd Rana, United Kingdom; D. Majumdar; P. Sambaiah; D. Craig; J. Greenaway; V. Mitra Biliary neoplasia: Clinical
P0077 THE IMPORTANCE OF INDIVIDUAL CORRECTION OF EATING BEHAVIOR IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE Yana Nikiforova, Ukraine
P0085 THE DEVELOPMENT OF MULTI-LAYER DRUG ELUTING MEMBRANE USING ULTRASONIC SPRAY COATING TECHNIQUE Jin-Seok Park, Republic of Korea; D. H. Lee
P0078 NON-GOVERNMENTAL HCV SCREENING IN A VILLAGE IN NILE DELTA IN DAAS ERA IN EGYPT Ahmed Sadek, Egypt; A. Salem; W. Wafy; A. Abdelfattah
P0086 THE ANTI-TUMOR EFFECT OF PACLITAXEL, GEMCITABINE AND MITOMYCIN C ELUTING MEMBRANE IN ANIMAL MODEL Jin-Seok Park, Republic of Korea; D. H. Lee; S. Jeong
P0079 EARLY DIAGNOSTICS OF NAFLD: ANALYSIS OF RISK FACTORS AND SCREENING USING ELASTOMETRY. ASSOTIATION BETWEEN THE PREVALENCE STEATOSIS AND COMPONENT COMPOSITION OF THE BODY. Igor Bakulin, Russian Federation; L. Belousova; L. Evdokimova; M. Serkova; S. Ivanov; D. Korostelev Cholestasis and gallstones: Clinical P0080 SALVAGE TECHNIQUE USING A MICRO GUIDEWIRE FOR DIFFICULT BILIARY CANNULATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY Akihiro Mori, Japan; S. Ito; S. Hayashi; T. Shibuya; M. Sawada; H. Hachiya; T. Yumura; N. Ohashi P0081 ERCP IN VERY ELDERLY PATIENTS AGE 85 OR OLDER. Mohammad Taghi Ayoubi Khajekini, Italy; F. Castellino; N. Leone; M. Berrutti; G. Sansoè; L. Framarin; A. Repici
Poster in the Spotlight
Poster of Excellence
P0087 ADVANCES IN CYTOLOGY FOR THE EARLY DIAGNOSIS OF PANCREATICO-BILIARY MALIGNANCY Christopher Meredith, Australia; P. Irandoost; P. Baird P0088 IMPACT OF PALLIATIVE BILIARY DRAINAGE BETWEEN METAL STENT AND PLASTIC STENT ON SURVIVAL RATE IN UNRESECTABLE DISTAL MALIGNANT BILIARY STRICTURE IN SOUTH OF THAILAND Tanawat Pattarapuntakul, Thailand; B. Ovartlanporn; N. Netinatsunton P0089 PROGNOSTIC VALUE OF EARLY CA19-9 RESPONSE DURING CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT BILIARY TRACT CANCER Naminatsu Takahara, Japan; Y. Nakai; K. Saito; T. Nakamura; T. Sato; T. Takeda; R. Uchino; S. Mizuno; H. Kogure; S. Matsubara; M. Tada; H. Isayama; K. Koike
Clinical Case Session
119
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0090 BILIARY DRAINAGE IN PATIENTS WITH UNRESECTABLE PERIHILAR CHOLANGIOCARCINOMA HAS A VERY HIGH COMPLICATION AND FAILURE RATE. Marcia Gaspersz, The Netherlands; J. L. A. van Vugt; E. Roos; R. J. S. Coelen; J. Vugts; E. Belt; J. de Jonge; W. Polak; J. W. Poley; F. E. J. A. Willemssen; L. Hol; T. M. van Gulik; J. N. M. IJzermans; B. Groot Koerkamp P0091 BRUSH CYTOLOGY GUIDED BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY OF BILIARY STRICTURES Armando Peixoto, Portugal; P. Pereira; M. Silva; F. Vilas-Boas; E. Rodrigues-Pinto; P. Moutinho-Ribeiro; J. Lopes; G. Macedo P0092 WITHDRAWN P0093 UNILATERAL VERSUS BILATERAL STENT-IN-STENT PLACEMENT OF METAL STENTS FOR MALIGNANT HILAR BILIARY OBSTRUCTION Haruka Toyonaga, Japan; Y. Taniguchi; T. Inokuma Biliary health services research P0094 CLINICAL ASSESSMENT OF THE SAFETY AND EFFICACY OF A NOVEL BIODEGRADABLE STENT IN PATIENTS WITH BILIARY OBSTRUCTION: A PILOT STUDY Hairol Othman, Malaysia; N. Y. Yaacob; E. J. Roslan; R. Jarmin; Z. Mohamed Poster Session 09:00 – 17:00 Pancreas I
Hall 7
Cell biology/secretion/enzymology/physiology P0095 TOLL-LIKE RECEPTOR 5 IS ESSENTIAL FOR THE ACTIVATION OF LIVER AND PANCREATIC STELLATE CELLS Isabell Böhm, Germany; D. Bartsch; T. M. Gress; M. Buchholz; T. T. Wissniowski; P. Di Fazio P0096 THE IMPAIRED FUNCTION OF THE PLASMA MEMBRANE CA2+ PUMP RESULTS IN CA2+ OVERLOAD AND CELL DAMAGE IN CFTR KNOCK OUT PANCREATIC DUCTAL CELLS Tamara Madacsy, Hungary; J. Fanczal; A. Schmidt; P. Pallagi; Z. Rakonczay; P. Hegyi; Z. Rázga; M. A. Gray; M. Hohwieler; A. Kleger; J. Maléth
120
P0097 EXPDF IMPACTS PANCREATIC DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELL DERIVED PANCREATIC ORGANOIDS M. Breunig; M. Hohwieler; T. Seufferlein; Alexander Kleger, Germany P0098 MELATONIN METABOLITE; N1-ACETYL-N2-FORMYL-5METHOXYKYNURAMINE STIMULATES PANCREATIC ENZYME SECRETION VIA CCK RELEASE. STUDY ON THE RATS. Jolanta Maria Jaworek, Poland P0099 INVESTIGATION OF THE FUNCTION OF TRPM2 IN MOUSE PANCREATIC ACINAR CELLS Júlia Fanczal, Hungary; P. Biró; T. Madacsy; P. Hegyi; J. Maléth P0100 INVESTIGATION OF THE PANCREATIC DUCTAL ION SECRETION IN PANCREATIC DUCTAL ORGANOID CULTURES Réka Molnár, Hungary; L. Alsardi; J. Fanczal; T. Madacsy; P. Hegyi; J. Maléth P0101 INVESTIGATION OF THE ORAI1 MEDIATED CA2+ ENTRY IN MOUSE PANCREATIC DUCTAL CELLS Marietta Görög, Hungary; A. Grassalkovich; A. Balázs; P. Pallagi; P. Hegyi; J. Maléth Pancreatitis, acute P0102 ACUTE PANCREATITIS OF UNKNOWN ORIGIN AND IDIOPATHIC JUVENILE PANCREATITIS IN SWEDEN Miroslav Vujasinovic, Sweden; F. Lindgren; S. Haas; R. Valente; S. Ghazi; N. Kartalis; R. Pozzi; M. Del Chiaro; P. Bauer; C. Verbeke; H. Witt; U. Arnelo; J.-M. Löhr P0103 THE FACTORS FOR PREDICTING HOSPITAL MORTALITY IN EARLY STAGE OF SEVERE ACUTE PANCREATITIS. Masayasu Horibe, Japan; M. Sasaki; M. Sanui; H. Sawano; T. Goto; T. Ikeura; T. Hamada; E. Iwasaki; T. Kanai; T. Mayumi P0104 EARLY OR LATE CHOLECYSTECTOMY IN MILD GALLSTONE PANCREATITIS? RESULTS FROM RANDOMIZED TRIAL Rozh Noel, Sweden; U. Arnelo; L. Enochsson; G. Sandblom P0105 COMPARISON OF PREDICTIVE SYSTEMS TO PREDICT DEATH, SEVERE AND MILD ACUTE PANCREATITIS ACCORDING TO THE REVISED ATLANTA CLASSIFICATION Rubén Pique Becerra, Spain; F. J. García Alonso; F. García Durán; M. Hernández Tejero; A. Granja Navacerrada; P. Bernal Checa; P. Bernal Checa; F. Bermejo
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0106 PANCREATIC DUCT ASCARIASIS Piyush Somani, India; M. Sharma P0107 LARGE VOLUME FLUID RESUSCITATION IN PATIENTS WITH SEVERE ACUTE PANCREATITIS IS ASSOCIATED WITH REDUCED MORTALITY: A MULTI-CENTRE RETROSPECTIVE STUDY Takahiro Yamashita, Japan; M. Horibe; M. Sanui; M. Sasaki; H. Sawano; T. Goto; T. Ikeura; T. Hamada; T. Oda; T. Mayumi P0108 SERUM PHOSPHATE AS A PROGNOSTIC FACTOR IN POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS Young Hoon Choi, Republic of Korea; D. K. Jang; Y.-T. Kim; J. K. Ryu; W. H. Paik; J. W. Kang; J. H. Choi; S. H. Lee P0109 BISAP AND RANSON AS PREDICTORS OF SEVERE ACUTE PANCREATITIS AND MORTALITY IN A EUROPEAN COHORT. Francisco Valverde López, Spain; E. Fernández-Fernández; R. Jiménez-Rosales; A. M. Matas-Cobos; E. Ortega-Suazo; E. Redondo-Cerezo
P0111 LACTATE AND OTHER BIOMARKERS AS PREDICTORS OF SEVERE ACUTE PANCREATITIS IN A EUROPEAN COHORT. Francisco Valverde López, Spain; E. Fernández-Fernández; F. Vadillo-Calles; A. M. Matas-Cobos; P. Abellán-Alfocea; E. Redondo-Cerezo P0112 COTTON VS. REVISED ATLANTA CRITERIA TO DEFINE SEVERITY OF POST-ERCP PANCREATITIS Xavier Smeets, The Netherlands; A. C. Tan; J. P. H. Drenth; E. Van Geenen P0113 RISKS FACTORS AND OUTCOMES OF INFECTED PANCREATIC NECROSIS: RESULTS FROM A COHORT OF 148 PATIENTS ADMITTED IN ICU FOR SEVERE ACUTE PANCREATITIS. Charlotte Garret, France; M. Péron; A. Le Thuaut; M. Le Rhun; C. Guitton; J. Gournay; J. Reignier; E. Coron
Poster in the Spotlight
Poster of Excellence
Pancreatitis, chronic (including hereditary disorders) P0116 AUTOIMMUNE PANCREATITIS CLASSIFIED AS NOT-OTHERWISE SPECIFIED (NOS) ACCORDING TO THE INTERNATIONAL CONSENSUS DIAGNOSTIC CRITERIA: CLINICAL FEATURES AND OUTCOMES IN 47 PATIENTS. N. de Pretis; A. Brandolese; L. Brozzi; F. Vieceli; A. Amodio; Martina Ruffini, Italy; S. Crinò; A. Gabbrielli; L. Frulloni P0117 698 CASES OF PANCREATIC DISEASES TREATED BY EPDBD (ENDOSCOPIC PANCREATIC DUCT BALLOON DILATION) – ITS USEFULNESS AND SAFETY Tadao Tsuji, Japan P0118 ENDOSCOPIC ULTRASOUND AS A PREDICTOR AND GUIDE TO SUCCESSFUL ENDOTHERAPY IN CHRONIC PANCREATITIS Malay Sharma, India; P. Somani
P0110 POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS: MORBIDITY AND PREDICTORS OF SEVERITY Ehab El-Hanafy, Egypt; A. El Nakeeb
P0114 EARLY PREDICTORS AND OUTCOMES OF FLUID SEQUESTRATION IN ACUTE PANCREATITIS Sundeep Goyal, India
P0115 LONGER CANNULATION TIME AND PANCREATIC GUIDEWIRE DURING ERCP CAN BE A GOOD CANDIDATE FOR PROPHYLACTIC PANCREATIC STENT TO PREVENT POST-ERCP PANCREATITIS: A MATCHED PROPENSITY ANALYSIS Shiro Hayashi, Japan; T. Nishida; R. Tomita; Y. Higaki; H. Shimakoshi; A. Shimoda; N. Osugi; A. Sugimoto; K. Takahashi; D. Nakamatsu; K. Mukai; T. Matsubara; M. Yamamoto; K. Fukui; M. Inada
P0119 UTILITY OF SERUM APOPTOSIS INHIBITOR OF MACROPHAGE FOR DIFFERENTIATING IGG4-RELATED DISEASE FROM MALIGNANT DISEASE Shiroh Tanoue, Japan; S. Hashimoto; S. Arima; Y. Nasu; F. Sasaki; S. Kanmura; A. Ido P0120 ENDOSONOGRAPHY FOR SUSPECTED PANCREATIC NEOPLAMS: OUTCOME AND FOLLOW-UP OF PANCREATIC LESIONS IN THE SETTING OF A NORMAL OR INFLAMED PANCREAS Francesco Vitali, Germany; D. Strobel; S. Heinrich; L. Frulloni; L. Pfeifer; R. S. Goertz; M. F. Neurath; D. Wildner Pancreatic cancer: Basic P0121 GALECTIN-1 EXPRESSED IN PANCREATIC STELLATE CELLS PROMOTES TUMOR PROGRESSION IN PANCREATIC CANCER VIA UPREGULATION OF SDF-1 AND ACTIVATION OF NF-ΚB T. Yu; Dong Qian, China
Clinical Case Session
121
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0122 WHOLE-GENOME SEQUENCING OF PANCREATIC TUMOR BY NEXT-GENERATION SEQUENCING USING EUS-FNA SPECIMENS Miho Matsukawa, Japan; M. Nishimura; Y. Fujii P0123 PTPN11 DRIVES TUMOR DEVELOPMENT AND DEFINES A NOVEL THERAPEUTIC TARGET IN KRAS-MUTANT CANCERS Dietrich Alexander Ruess, Germany; G. J. Heynen; K. Ciecielski; H. Algül P0124 CIRCHIPK3 PROMOTES PANCREATIC CARCINOMA CELLS BXPC3 PROLIFERATION BY TARGETING MIR-124/ IL6R/STAT3 PATHWAY Genwen Chen, China; Y. Zhang; J. Sun P0125 CONCOMITANT PANCREATIC CANCERS ARISING ADJACENT TO INDEX INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS SHARE IDENTICAL KRAS MUTATIONS AND ARE ASSOCIATED WITH A FAVORABLE PROGNOSIS. Yuko Omori, Japan; Y. Ono; M. Tanino; H. Karasaki; T. Shinohara; S. Tanaka; H. Maguchi; Y. Mizukami P0126 POLYMORPHISM OF TP53 GENE, LEVELS OF INSULIN AND PROINFLAMMATORY CYTOKINES IN PATIENTS WITH PANCREATIC CANCER T. I. Romanova; Irina Grigoreva, Russian Federation; V. N. Maximov; O. V. Efimova; Y. I. Ragino; T. S. Suvorova; N. L. Tov P0127 VALIDATION OF SERUM/PLASMA METABOLOMIC BIOMARKERS AGAINST PANCREATIC CANCER BY QUANTITATIVE TARGETED GC/MS/MS Takashi Kobayashi, Japan; Y. Hirata; M. Yoshida; S. Nishiumi; K. Honda Pancreatic cancer: Clinical P0128 COMBINED HISTO-CYTOLOGICAL ANALYSIS OF EUSFNA SAMPLES FROM SOLID LESIONS USING STANDARD FNA NEEDLES GIVES BETTER DIAGNOSTIC YIELD AND ACCURACY Ashwini Banerjee, United Kingdom; A. Cairns; L. Sanni; B. Paranandi; M. Huggett P0129 VERIFICATION OF INTERNATIONAL CONSENSUS GUIDELINES 2012 – SURGICAL INDICATION FOR BRANCH DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS (BD-IPMN) WITH WORRISOME FEATURES Yasuhiro Shimizu, Japan; H. Yamaue; H. Maguchi; S. Hirono; S. Hijioka; K. Hara; T. Sano; Y. Senda; S. Natsume; A. Yanagisawa 122
P0130 USE OF A NOVEL THROUGH-THE-NEEDLE MICRO-BIOPSY FORCEPS IN DIAGNOSING PANCREATIC CYSTS – A MULTICENTER FEASIBILITY STUDY Bojan Kovacevic, Denmark; J. G. Karstensen; R. F. Havre; K. D.-C. Pham; M. Giovannini; E. Dabizzi; P. G. Arcidiacono; E. Vazquez Sequeiros; P. Klausen; C. V. Rift; J. P. Hasselby; A. Toxværd; E. Kalaitzakis; C. P. Hansen; P. Vilmann P0131 PANCREATIC DUCTAL CYTOLOGY: AN UNDERUSED DIAGNOSTIC TOOL Armando Peixoto, Portugal; P. Pereira; E. Rodrigues-Pinto; F. Vilas-Boas; J. Lopes; G. Macedo P0132 ANALYSIS OF PROGNOSTIC FACTORS IN PANCREATIC METASTASES, A MULTICENTER RETROSPECTIVE ANALYSIS Takashi Ito, Japan; R. Takada; S. Omoto; M. Tsuda; D. Masuda; H. Kato; H. Ishii; I. Moriyama; K. Tanaka; H. Kawamoto; S. Yazumi P0133 LUNG METASTASIS IN PANCREATIC CANCER: SHOULD STAGING CHEST CT BE ROUTINELY PERFORMED? Shailendra Singh, USA; B. Rao; S. Umar; M. Chowdhry; A. Kulkarni; K. Farah; S. Morrissey; M. Dhawan; S. Thakkar P0134 VALUE OF EUS IN EARLY DETECTION OF TUMOR LESION IN THE REMNANT PANCREAS Hirotsugu Maruyama, Japan; A. Shimizu; T. Minami; N. Hirano; K. Hanada P0135 PATIENTS WITH INTRADUCTAL PAPILLARY MUCIONOUS NEOPLASMS OF PANCREAS (IPMNS) ARE AT INCREASED RISK OF RENAL CELL CARCINOMA, PROSTATE, COLORECTAL AND BREAST CANCER: A SINGLE CENTER ITALIAN EXPERIENCE Nikola Panic, Italy; M. Bulajic; F. Macchini; S. Solito; S. Boccia; E. Leoncini; D. Berretti; S. Pevere; S. Vadala; M. Marino; E. Pinese; M. Zilli P0136 CLINICAL CHARACTERISTICS OF SECOND PRIMARY PANCREATIC CANCER Jung Hyun Jo, Republic of Korea; I. R. Cho; H. S. Lee; M. J. Chung; S. Bang; S. W. Park; S. Y. Song; J.-B. Chung; J. Y. Park P0137 ADEQUACY ASSESSMENT OF EUS-FNAB SAMPLES OF PANCREATIC CANCER FOR “PRECISION MEDICINE”: A COMPARISON OF 22-GAUGE AND 25-GAUGE NEEDLES Naohiko Yoshizawa, Japan; R. Yamada; H. Miura; T. Takeuchi; T. Harada; H. Inoue; H. Okuse; T. Sakuno; M. Nakamura; Y. Hamada; M. Katsurahara; K. Tanaka; N. Horiki; Y. Takei
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
Poster Session 09:00 – 17:00 Endoscopy and Imaging I
Hall 7
Endoscopy, upper GI P0138 FEASIBILITY OF GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION WITH CONTINUOUS LOW-DOSE ASPIRIN FOR PATIENTS ON DUAL ANTIPLATELET THERAPY Hideaki Harada, Japan; S. Suehiro; D. Murakami; R. Nakahara; T. Ujihara; T. Shimizu; Y. Katsuyama; K. Hayasaka P0139 OUTCOMES OF PERORAL ENDOSCOPIC MYOTOMY FOR TREATMENT OF ESOPHAGEAL ACHALASIA WITH A MEDIAN FOLLOW-UP OF 4 YEARS Quan-Lin Li, China; Q.-N. Wu; X.-C. Zhang; P.-H. Zhou P0140 PATIENTS WITH CHRONIC GASTROINTESTINAL ISCHEMIA HAVE AN ALTERED SUBLINGUAL MICROCIRCULATION Jihan Harki, The Netherlands; M. Suker; M. S. Tovar Doncel; L. J. D. van Dijk; D. van Noord; C. H. J. van Eijck; M. J. Bruno; E. J. Kuipers; C. Ince P0141 CONVENTIONAL NARROW BAND IMAGING HAS GOOD CORRELATION WITH OLGA STAGING OF GASTRITIS A. Gawish; A. Elbahrawy; S. Mabrouk; Mohamed Abdellah, Egypt; M. El Fayoumie; A. Aboelfotoh; M. Eldahshan; F. Al Ghamry P0142 SAFETY ADVANTAGE OF THE NEW DEVICE (SPLASH-M KNIFE®) FOR ENDOSCOPIC SUBMUCOSAL DISSECTION OF EARLY GASTRIC CANCER Mitsuru Esaki, Japan; K. Hayashi; S. Suzuki; C. Kusano; S. Itonaga; S. Abe; Y. Hayashi; A. Yokoyama; T. Hosokawa; H. Ogino; H. Akiho; T. Gotoda P0143 INTUBATION FAILURE DURING GASTROSCOPY – INCIDENCE, PREDICTORS AND FOLLOW-UP FINDINGS Keith Siau, United Kingdom; J. Li; N. C. Fisher; C. J. J. Mulder; S. Ishaq P0144 DIAGNOSTIC CAPABILITY OF ENDOSCOPY FOR HELICOBACTER PYLORI INFECTION Yoshii Shinji, Japan; K. Mabe; M. Kato; N. Sakamoto P0145 A RETROSPECTIVE AUDIT OF OUTCOMES AND CURRENT CLINICAL PRACTICE POST-BALLOON TAMPONADE FOR ACUTE SEVERE VARICEAL BLEEDING: HAVE THINGS IMPROVED OVER TIME? Charlotte Keung, Australia; A. Jackson; M. Swan Poster in the Spotlight
Poster of Excellence
P0146 CONSCIOUS SEDATION FOR ENDOSCOPIC SUBMUCOSAL RESSECTION BY USING DEXMEDETOMIDINE Masaya Esaki, Japan; M. Hattori; I. Matsuzaki; K. Hirose; C. Izumi; M. Yoshikawa; H. Yamauchi; S. Nakazawa P0147 DIAGNOSTIC ACCURACY OF BLUE LASER IMAGING WITH MAGNIFYING ENDOSCOPY FOR INVASION DEPTH OF SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA. Tomohiro Ueda, Japan; O. Dohi; K. Ogita; S. Takayama; K. Terasaki; T. Nakano; N. Iwai; T. Okayama; N. Yoshida; K. Katada; K. Kamada; K. Uchiyama; O. Handa; T. Ishikawa; T. Takagi; H. Konishi; Y. Naito; Y. Itoh P0148 IMPACT OF NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY (NCLE) IN IMPROVING DIAGNOSIS OF PANCREATIC CYSTIC NEOPLASMS: SINGLE CENTER EXPERIENCE F. Shariati; E. Verter; M. Lucas; C. Molina; J. Adams; Virendra Joshi, USA P0149 FULL-SPECTRUM ENDOSCOPY FOR UPPER GASTROINTESTINAL SCREENING INCLUDING PRECISE OBSERVATION OF THE AMPULLA OF VATER AND THE ANAL SIDE OF THE PYLORIC RING Hyuga Yamada, Japan; T. Shibata; T. Kawamura; N. Horiguchi; M. Okubo; T. Tahara; M. Nagasaka; Y. Nakagawa; N. Ohmiya P0150 PREDICTIVE FACTORS OF PROCEDURAL DIFFICULTIES IN ENDOSCOPIC SUBMUCOSAL DISSECTION OF EARLY-STAGE GASTRIC CANCER Hyuga Yamada, Japan; T. Shibata; T. Kawamura; N. Horiguchi; M. Okubo; T. Tahara; M. Nagasaka; Y. Nakagawa; N. Ohmiya P0151 LOCATION FEATURES OF EARLY GASTRIC CANCER TREATED WITH ENDOSCOPIC SUBMUCOSAL DISSECTION Cheol Woong Choi, Republic of Korea; D. H. Kang; H. W. Kim; S. J. Kim; J. S. Lee; C. W. Yeo; S. H. Choi; H. J. Kim; J. H. Ko P0152 A STUDY OF THE RECOGNITION OF ENDOSCOPIC IMAGES BY MACHINE LEARNING WITH CONVOLUTIONAL NEURAL NETWORK AND DEEP LEARNING Ryoichi Yamakawa, Japan; M. Harada; K. Kawauchi; S. Nuzuki; M. Iwata
Clinical Case Session
123
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0153 CONVENTIONAL VERSUS TRACTION-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC NEOPLASMS (CONNECT-G): A MULTICENTER, RANDOMIZED CONTROLLED TRIAL Sho Suzuki, Japan; M. Yoshida; K. Takizawa; Y. Koike; S. Nonaka; Y. Yamasaki; T. Minagawa; C. Sato; C. Takeuchi; K. Watanabe; K. Miura; H. Morimoto; T. Yano; K. Sudo; K. Mori; T. Gotoda; H. Ono P0154 MACHINE LEARNING-BASED AUTOMATIC DETECTION SYSTEM FOR DEMARCATION LINE OF GASTRIC CANCER WITH NBI IMAGES Naoya Ishida, Japan; N. Yagi; H. Kitae; A. Tomie; H. Ichikawa; S. Hiwa; T. Hiroyasu P0155 ENDOSCOPIC TREATMENT OF FISTULAS AFTER SLEEVE GASTRECTOMY: ASSESSMENT FOR SWITCHING TOWARDS INTERNAL DRAINAGE IN A REFERENCE CENTER Diane Lorenzo, France; T. Guilbaud; J.-M. Gonzalez; A. Benezech; S. Berdah; T. Bège; M. Barthet P0156 CLOSURE BY USING OVER-THE-SCOPE CLIPS AFTER ENDOSCOPIC FULL-THICKNESS RESECTION Jintao Guo, China P0157 EFFICACY OF ORAL MIXTURE OF HYDROCORTISONE SODIUM SUCCINATE AND ALUMINUM PHOSPHATE GEL FOR THE PREVENTION OF STRICTURE AFTER ≥2/3 CIRCUMFERENTIAL ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR ESOPHAGEAL CANCER---A SINGLE CENTER PILOT STUDY FROM CHINA Yonghui Huang, China; X. Yan; H. Chang; Y. Zhang; W. Yao; K. Li P0158 LONG-TERM OUTCOMES OF COLD POLYPECTOMY FOR NONAMPULLARY DUODENAL ADENOMAS Daisuke Maruoka, Japan; M. Arai; N. Akizue; K. Okimoto; T. Matsumura; T. Nakagawa; T. Katsuno; N. Kato P0159 ENDOSCOPIC TREATMENT OF BOERHAAVE SYNDROME: A SURPRISINGLY QUICK HEALING Georgios Sakizlis, Greece; D. Karagiannis P0160 ARTIFICIAL INTELLIGENCE DIAGNOSIS OF HELICOBACTER PYLORI INFECTION USING LINKED COLOR IMAGING Hirotaka Nakashima, Japan; H. Kawahira; H. Kawachi; N. Sakaki
124
P0161 ENDOSCOPIC GRADING FOR GASTRIC INTESTINAL METAPLASIA (EGGIM): A MULTICENTRE VALIDATION STUDY Gianluca Esposito, Italy; P. Pimentel-Nunes; S. Angeletti; R. Castro; D. Libanio; G. Galli; E. Lahner; E. Di Giulio; B. Annibale; M. Dinis-Ribeiro P0162 PERCUTANEOUS TRANSESOPHAGEAL GASTROTUBING (PTEG) IN THE DECOMPRESSION TREATMENT FROM THE GASTROINTESTINAL TRACT AS THE IDEAL PALLIATIVE CARE FOR THE PATIENTS WITH MALIGNANT DISEASE Masato Murakami, Japan; K. Nishino; T. Okamoto; S. Murakami; K. Mori; B. Murakami; M. Azuma; S. Tanabe; M. Kida; W. Koizumi P0163 COMPARISON OF PERCUTANEOUS ENDOSCOPIC VERSUS RADIOLOGIC GASTROSTOMY IN TERMS OF INDICATIONS, EFFICACY, COMPLICATIONS; A RETROSPECTIVE ANALYSIS Denise Strijbos, The Netherland; D. Keszthelyi; L. P. L. Gilissen; M. W. de Haan; C. van der Leij; R. de Ridder; J. Kruimel; J. Conchillo; A. A. M. Masclee P0164 WITHDRAWN P0165 COMPREHENSIVE EVALUATION OF THE LEARNING CURVE FOR PERORAL ENDOSCOPIC MYOTOMY: LESSONS FROM 1346 PATIENTS Zu-Qiang Liu, China; X.-C. Zhang; Q.-L. Li; P.-H. Zhou P0166 CLINICAL CURATIVE EFFECT ANALYSIS OF 162 GASTRIC STROMAL TUMORS RESECTED BY ENDOSCOPIC TREATMENTS Li Liu, China; W. Liu; Z. Fan P0167 GASTROENTEROLOGY REGISTRAR OF THE WEEK: A SOLUTION FOR AUGIB ENDOSCOPY TRAINING? Shivkumar Budihal, United Kingdom; P. Wurm P0168 HIGH PERCENTAGE OF VISIBLE LESIONS IN PATIENTS WITH BARRETT’S ESOPHAGUS REFERRED WITH DYSPLASIA IN RANDOM BIOPSIES. Irma Noordzij, The Netherlands; W. L. Curvers; I. van Lijnschoten; C. J. Huysentruyt; E. J. Schoon P0169 ENDOSCOPIC MANAGEMENT OF BENIGN ESO-RESPIRATORY FISTULAS Antoine Debourdeau, France; J.-M. Gonzalez; A. Benezech; M. Barthet P0170 CLINICAL UTILITY OF NARROW BAND IMAGING MAGNIFYING ENDOSCOPY FOR MM/SM1 ESOPHAGEAL SQUAMOUS CELL CARCINOMA Masazumi Inoue, Japan; T. Omori; K. Nastu; K. Aiura
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0171 PER-ORAL ENDOSCOPIC PYLOROMYOTOMY (POEP) IN THE TREATMENT OF REFRACTORY GASTROPARESIS – A SINGLE CENTRE EXPERIENCE Rastislav Hustak, Czech Republic; Z. Vackova; J. Spicak; L. Jurgoš; J. Martinek P0172 BLUE LIGHT IMAGING FOR BARRETT'S NEOPLASIA CLASSIFICATION (BLINC): THE DEVELOPMENT AND VALIDATION OF A NEW ENDOSCOPIC CLASSIFICATION SYSTEM TO IDENTIFY BARRETT'S NEOPLASIA Sharmila Subramaniam, United Kingdom; K. Kandiah; F. Chedgy; R. Bhattacharyya; P. Basford; G. Longcroft-Wheaton; P. Bhandari P0173 TREATMENT OF MULTIPLE GASTROINTESTINAL SUBMUCOSAL TUMORS BY SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION Jingzheng Liu, China; W. Qin; Y. Huang; Z. Ren; P. Zhou P0174 COMPARISON OF THE LINKED COLOR IMAGING (LCI) TECHNOLOGY AND CHROMOENDOSCOPY WITH ACETIC ACID FOR DIAGNOSIS OF BARRETT’S ESOPHAGUS Helmut Neumann, Germany; H. Neumann Sen; P. Grimminger; F. Corvinus; F. Rahman; F. Thieringer; G. E. Tontini; P. R. Galle Endoscopy, colon P0175 ALBERTA FAMILY PRACTICE ELECTRONIC ENDOSCOPY STUDY (AFPEE) Michael Kolber, Canada; L. Green; N. Olivier; R. Torrie; O. Babenko P0176 PREDICTORS OF ADENOMA DETECTION AT COLONOSCOPY AFTER BOWEL SCOPE SURVEILLANCE: RESULTS FROM A UK PILOT SCREENING CENTRE A. Yew; Keith Siau, United Kingdom; S. Jewes; A. Veitch; S. Ishaq; M. Brookes; B. McKaig; A. Veitch; S. Shetty; A. Murugananthan P0177 COLD SNARE POLYPECTOMY WITH SUBMUCOSAL PRE-LIFT VERSUS ENDOSCOPIC MUCOSAL RESECTION FOR 6-10MM COLORECTAL POLYPS: A RANDOMIZED NON-INFERIORITY TRIAL. V. Papastergiou; M. Fragkaki; I. Dimas; A. Mpitouli; E. Vardas; A. Theodoropoulou; N. Mathou; A. Giannakopoulos; K. Karmiris; D. Apessou; L. Giannikaki; G. Chlouverakis; K. Paraskeva; Grigorios Paspatis, Greece
Poster in the Spotlight
Poster of Excellence
P0178 COLONOSCOPIC POLYPECTOMY PRACTICE AMONGST SPANISH CLINICAL GASTROENTEROLOGISTS. RESULTS OF A NATIONAL SURVEY FROM THE SPANISH ENDOSCOPY SOCIETY ENDOSCOPIC RESECTION GROUP. Carla Jerusalen Gargallo Puyuelo, Spain; E. Albéniz Arbizu; M. Fraile González; C. Guarner Argente; M. Pellisé Urquiza; M. A. Alvarez; F. Ramos; M. Rodriguez Tellez; D. Martínez-Ares; J. Santiago; A. Sanchez Yague; F. Gonzalez Huix; J. Merlo P0179 ASSESSMENT OF TRAINING NEEDS AND DEVELOPMENT OF A SIMULATION BASED TRAINING PROGRAMME FOR SEMI-AUTOMATED ROBOTIC COLONOSCOPY M. Kopczynska; R. Hopps; S. Smits; N. Warren; S. Goddard; X. Ye; Sunil Dolwani, United Kingdom P0180 WHITE OPAQUE SUBSTANCE, A NEW OPTICAL MARKER ON MAGNIFYING ENDOSCOPY: USEFULNESS IN DIAGNOSING COLORECTAL EPITHELIAL NEOPLASMS Kazutomo Yamasaki, Japan; T. Hisabe; K. Yao; H. Ishihara; T. Ueki; T. Matsui; H. Tanabe; A. Iwashita P0181 WITHDRAWN P0182 NARROW BAND IMAGING OPTICAL DIAGNOSIS OF SMALL COLORECTAL POLYPS. LEARNING CURVE AND SUBSEQUENT DIAGNOSTIC ACCURACY IN UNEXPERIENCED EVALUATORS Francisco Javier Garcia-Alonso, Spain; I. Manzano Santamaría; A. Guardiola Arévalo; A. Bermejo; M. Molinero García; S. Sevo Spahiu; L. García Martín; I. Gómez-Pastrana; I. Carrascosa del Álamo; G. Martínez Izquierdo; M. J. Motta Molina; A. Gutiérrez Martín; M. Alguacil Cuéllar; A. Zubillaga de Diego; F. J. Parra Villanueva; P. Plaza Roig; M. J. Reyes Larriba; A. Posada Restrepo; F. Bermejo P0183 HIGH CLEANSING EFFICACY OF NER1006 ALSO IN THE ELDERLY: POST HOC SUBGROUP ANALYSIS OF RANDOMISED PHASE 3 TRIALS Rodrigo Jover, Spain; R. Ng Kwet Shing; P. Uebel P0184 ACHIEVING ADEQUATE LEVEL BOWEL PREPARATION WITH EVENING/MORNING OR MORNING-ONLY SPLIT-DOSING REGIMENS OF NER1006 VERSUS STANDARD 2L PEG WITH ASCORBATE: POST HOC ANALYSIS OF A PHASE 3 TRIAL Raf Bisschops, Belgium; L. Clayton
Clinical Case Session
125
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0185 ASSESSMENT OF COLONOSCOPY QUALITY IN CLINICAL PRACTICE COMPARED WITH EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY PERFORMANCE INDICATORS Ervin Toth, Sweden; R. Jover; C. Spada; A. Agrawal; P. Amaro; L. Brink; W. Fischbach; M. Hünger; A. Ono; L. Petruzziello; A. Naidoo; J. F. Riemann
P0193 EFFICACY OF CIMETROPIUM BROMIDE ON POLYP DETECTION DURING COLONOSCOPIC WITHDRAWAL: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CLINICAL TRIAL Dae Hwan Kang, Republic of Korea; H. W. Kim; C. W. Choi; S. J. Kim; J. S. Lee; H. S. Nam; S. H. Choi; B. J. Kwon; C. W. Yeo
P0186 SEDATION IN GASTROINTESTINAL ENDOSCOPY: CURRENT PRACTICES OF GREEK GASTROENTEROLOGISTS Adonis Protopapas, Greece; E. Stournaras; G. Neokosmidis; A. Protopapas
P0194 ADHERENCE TO EUROPEAN SOCIETY OF GASTROENTEROLOGY ENDOSCOPY (ESGE) POLYPECTOMY GUIDELINES: AN IRISH EXPERIENCE. Neil O'Morain, Ireland; V. parihar; O. O'Dwyer; P. Maheshwari; L. Kumar; S. Fennessy; N. Breslin; B. Ryan; D. McNamara
P0187 QUALITY MEASURE IN COLONOSCOPY: IMPLEMENTATION OF COLONOSCOPY QUALITY MONITORING IN A BELGIAN UNIVERSITY HOSPITAL. Sohaib Ouazzani, Belgium; A. Lemmers; F. Martinez; M. Delhaye; M. Arvanitakis; O. Le Moine; P. Demetter; J. Deviere; P. Eisendrath P0188 LARGE RECTAL ADENOMAS - EMR VERSUS ESD: WHAT IS THE BEST APPROACH? Hubertus Heinrich Nietsch, Germany P0189 COMPUTED TOMOGRAPHY COLONOGRAPHY VERSUS COLONOSCOPY FOR THE DIAGNOSIS OF COLORECTAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS Ralph Duarte, Brazil; W. M. Bernardo; C. M. Sakai; G. L. R. Silva; H. G. Guedes; R. Kuga; E. Ide; R. K. Ishida; P. Sakai; E. G. H. de Moura P0190 AUTOMATED POLYP DETECTION FOR COLONOSCOPY USING DEEP LEARNING TECHNOLOGY: PRELIMINARY RESULTS. Masashi Misawa, Japan; S.-E. Kudo; Y. Mori; K. Takeda; K. Ichimasa; Y. maeda; Y. Ogawa; S. Kataoka; H. Nakamura; T. Ishigaki; Y. Yagawa; S. Matsudaira; N. Toyoshima; N. Ogata; T. Kudo; T. Hayashi; K. Wakamura; T. Baba; F. Ishida; H. Itoh; H. Roth; M. Oda; K. Mori P0191 MOTORIZED SPIRAL COLONOSCOPY (MSC) – A FIRST FEASIBILITY TRIAL Torsten Beyna, Germany; M. Schneider; D. Pullmann; H. Neuhaus P0192 TREATMENT OUTCOMES OF COLD FORCEPS POLYPECTOMY FOR PATIENTS WITH DIMINUTIVE POLYPS: A PROSPECTIVE FOLLOW-UP STUDY Hiroshi Hasegawa, Japan; S. Bamba; H. Ban; H. Imaeda; A. Nishida; O. Inatomi; M. Sasaki; M. Sugimoto; A. Andoh
126
P0195 WOMEN AWAKE FASTER THAN MEN AFTER EEG MONITORED PROPOFOL SEDATION – FIRST PROSPECTIVE OBSERVATIONAL STUDY OF GENDER DIFFERENCES IN PROPOFOL DOSES AND RECOVERY TIMES FOR COLONOSCOPY Andrea Riphaus, Germany; M. Slottje; J. Bulla; C. Keil; C. Mentzel; V. Limbach; B. Schultz; C. Unzicker P0196 EFFECT OF PREOPERATIVE COLONOSCOPIC TATTOOING USING BOTH SIDE INJECTION OF INDOCYANINE GREEN FOR IMPROVEMENT OF LYMPH NODE HARVEST IN COLORECTAL CANCER Hyung Wook Kim, Republic of Korea; J. S. Lee; D. H. Kang; C. W. Choi; S. J. Kim; H. S. Nam; D. G. Ryu; C. W. Yeo; S. H. Choi; B. J. Kwon P0197 THE EFFICACY OF COLD SNARE POLYPECTOMY IN ACHIEVING COMPLETE RESECTION OF SUBCENTIMETRE COLORECTAL POLYPS: A MULTICENTRE RANDOMISED CONTROLLED TRIAL (CRESCENT STUDY) Takuji Kawamura, Japan; Y. Takeuchi; S. Asai; I. Yokota; E. Akamine; M. Kato; T. Akamatsu; K. Tada; Y. Komeda; M. Iwatate; K. Kawakami; M. Nishikawa; D. Watanabe; A. Yamauchi; N. Fukata; M. Shimatani; M. Ooi; K. Fujita; Y. Sano; H. Kashida; S. Hirose; H. Iwagami; N. Uedo; S. Teramukai; K. Tanaka P0198 EFFICACY OF PLATELET-RICH PLASMA (PRP) ON ENDOSCOPIC RESECTION TECHNIQUES: CLINICAL STUDY IN 15 PATIENTS Vicente Lorenzo-Zúñiga García, Spain; V. Moreno de Vega; I. Marín; N. Caballero; R. Bartolí; I. Bon; J. Boix P0199 INTERVENTIONS AND COSTS ASSOCIATED WITH SIVA-DEFINED ADVERSE EVENTS DURING PROCEDURAL SEDATION IN FIVE COUNTRIES Rhodri Saunders, Germany; J. Davis; R. Weissbrod; D. Whitaker; P. Kranke; J. R. Lightdale
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0200 COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (CR-ESD), KNIFE-ASSISTED SNARE RESECTION (KAR) AND RECURRENCE RATE: A WESTERN EUROPEAN EXPERIENCE IN SPAIN. José Marín-Gabriel, Spain; J. B. Díaz Tasende; P. Cancelas-Navia; S. Rodríguez-Muñoz; A. J. Del Pozo-García; M. Alonso-Riaño; Y. Rodríguez-Gil; C. Ibarrola-de Andrés; G. Castellano-Tortajada P0201 ASSOCIATION BETWEEN SIZE, LOCATION AND HISTOLOGICAL CHARACTERISTICS OF COLORECTAL LATERALLY SPREADING TUMORS. F. L. Mota; J. F. Loureiro; Lucas Da Costa, Brazil P0202 SAFE AND SUCCESSFUL RESECTION OF DIFFICULT GI LESIONS USING A NOVEL SINGLE-STEP FULL-THICKNESS RESECTION DEVICE (FTRD) Piero V Valli, Switzerland; J. Mertens; P. Bauerfeind
P0208 AN INNOVATIVE 3D COLONOSCOPE SHAPE IMAGING SYSTEM BASED ON FIBER BRAG GRATING ARRAY I. K. Yoo; B. Keum; Woojung Kim, Republic of Korea; S. J. Choi; G. Min; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; Y. T. Jeen; H. J. Chun; H. S. Lee; C. D. Kim; J. M. Lee; J. Kim; M. S. Jang; S. Yang P0209 REAL TIME MORPHOLOGIC CHANGE ON NUCLEUS & MITOCHONDRIA OF COLON CANCER CELL BY IRREVERSIBLE ELECTROPORATION: DETECTED BY PROBE BASED MULTIPHOTON MICROSCOPY I. K. Yoo; B. Keum; W. Kim; Seong Ji Choi, Republic of Korea; G. Min; J. M. Lee; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; Y. T. Jeen; H. J. Chun; H. S. Lee; C. D. Kim P0210 WITHDRAWN
P0203 VASCULAR AND PIT-PATTERN ANALYSIS ACCORDING TO KUDO, SANO AND NICE CLASSIFICATIONS SIGNIFICANTLY IMPROVES AFTER AN IMAGE-BASED TRAINING PROGRAM Federico Desideri, Italy; G. Esposito; S. Angeletti; F. Iacopini; M. Haefner; E. Di Giulio P0204 YIELD OF 2ND SURVEILLANCE COLONOSCOPY IN “INTERMEDIATE RISK” PATIENTS. COULD SURVEILLANCE INTERVALS BE REFINED? M. Balakrishnan; B. Adeoti; S. Cerys; S. Catnach; A. King; B. Macfarlane; Jonathan Landy, United Kingdom
P0211 LARGE (>30MM) POLYP ENDOSCOPIC MUCOSAL RESECTION: OUTCOMES AND PREDICTORS OF SUCCESS Keith Siau, United Kingdom; E. Karunadasa; A. Kawesha; S. Ishaq P0212 PROSPECTIVE RANDOMIZED CONTROLLED TRIAL COMPARING EFFICACY OF 1-L PEG-ASC WITH PRUCALOPRIDE AND 2-L PEG-ASC FOR BOWEL PREPARATION Seong Ji Choi, Republic of Korea; Y. T. Jeen; G. Min; W. Kim; J. M. Lee; I. K. Yoo; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; B. Keum; H. S. Lee; H. J. Chun; C. D. Kim
P0205 SAFETY OF COLD SNARE COLON POLYPECTOMY IN PATIENTS ON ANTITHROMBOTIC MEDICATION Mio Matsumoto, Japan
P0213 IMPROVING SURVEILLANCE FOLLOW UP RATES AFTER COLONOSCOPY ENDOSCOPIC MUCOSAL RESECTION: A QUALITY IMPROVEMENT PROJECT Monia Werlang, USA; P. Kandel; I. Ahn; B. Brahmbhatt; M. Raimondo; E. Bouras; T. Woodward; M. B. Wallace; V. Gomez
P0206 OPTICAL ENHANCEMENT FOR THE IN VIVO PREDICTION OF COLORECTAL POLYP HISTOLOGY Entcho Klenske, Germany; C. Neufert; A. Nägel; S. Zopf; M. F. Neurath; T. Rath
P0214 META-ANALYSIS SUGGESTS: INSPECT TWICE TO INCREASE RIGHT COLON ADENOMA DETECTION RATE Konstantinos Triantafyllou, Greece; P. Gkolfakis; G. Tziatzios; G. D. Dimitriadis
P0207 BLUE LASER IMAGING OPTICAL DIAGNOSIS OF COLORECTAL POLYPS: ACCURACY OF THE NICE, SANO AND WASP CLASSIFICATIONS Sophie Ribiere, France; J. Dreanic; M. Barret; M. Camus; M. Dior; B. Brieau; S. Leblanc; F. Prat; R. Coriat; S. Chaussade
P0215 ENDOSCOPIC FULL-THICKNESS RESECTION FOR T1 EARLY RECTAL CANCER: A CASE SERIES (WITH VIDEO). S. Vavassori; Paola Soriani, Italy; G. E. Tontini; H. Neumann; G. De Nucci; D. De Toma; B. Bruni; L. Pastorelli; M. Vecchi; P. Lagoussis
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
127
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0216 UNTUTORED LEARNING CURVE ANALYSIS FOR COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION: PREDICTIVE FACTORS FOR COMPLEX TECHNIQUE F. Ramos-Zabala; Jorge Vásquez-Guerrero, Spain; A. Alzina-Pérez; M. García-Mayor; A. Domínguez-Pino; J. M. Cárdenas-Rebollo; F. J. Pérez-Rodríguez; J. Rodríguez-Pascual; L. Moreno-Almazán P0217 PERSISTENT PAIN AFTER COLONIC ENDOSCOPIC MUCOSAL RESECTION: PREDICTORS, A MANAGEMENT ALGORITHM AND OUTCOMES Lobke Desomer, Australia; D. J. Tate; H. Awadie; L. Pillay; G. Ahlenstiel; M. J. Bourke P0218 QUALITY OF SINGLE SESSION COLONOSCOPIC EXAMINATIONS INTENDING TO REMOVE ALL NEOPLASTIC POLYPS USING COLD POLYPECTOMY IN OUTPATIENT SETTING: RESULTS FROM CLINICAL PRACTICE DATA OF SINGLE CANCER CENTER HOSPITAL IN JAPAN Kinichi Hotta, Japan; K. Imai; S. Ito; Y. Kishida; M. Yoshida; N. Kawata; N. Kakushima; K. Takizawa; M. Tanaka; H. ishiwatari; H. Matsubayashi; H. Ono P0219 META-ANALYSIS AND OWN EXPERIENCE IN THE TREATMENT OF RECTO-UROGENITAL FISTULA USING THE OVER-THE-SCOPE CLIP (OTSC) Martin Raithel, Germany; M. Vetter; A. Braun; T. Vasilakis; A. F. Hagel P0220 QUALITY INDICATORS FULFILLMENT AT QUALISCOPIA STUDY Carolina Mangas, Spain; E. Santana Rocamora; A. Suárez González; I. Portillo Villares; A. Seoane; M. Ponce; P. Diez; E. Quintero Carrion; M. Herraiz; M. Pellisé Urquiza; Á. Ferrández Arenas; V. Hernández; Á. E. Pizarro Moreno; R. Jover P0221 ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) IN THE COLORECTUM: FEASIBILITY IN AN EUROPEAN SINGLE CENTER CASE SERIES. Regina Maria Lackermeier, Germany; M. Meiborg; S. Schürle; C. Aubele; E. Tsegai-Eh; M. Edelmann; H.-R. Kitterer; S. Leykauf; M. Hack; G. Kleber P0222 CLINICAL USABILITY QUANTIFICATION OF A REAL-TIME POLYP DETECTION METHOD IN VIDEOCOLONOSCOPY Q. Angermann; J. Bernal; C. Sánchez-Montes; M. Hammami; G. Fernández-Esparrach; O. Romain; J. Sánchez; X. Dray; Aymeric Histace, France
128
P0223 RESECT AND DISCARD/DIAGNOSE AND DISREGARD STRATEGY FOR COLONIC POLYPS: ARE WE READY TO START IT? Richard Azevedo, Portugal; J. Pinto; H. Ribeiro; F. Pereira; C. Leitão; A. Caldeira; E. Pereira; R. Sousa; J. Barros; A. Banhudo P0224 THE EFFICACY AND SAFETY OF JUMBO FORCEPS BIOPSY USING NARROW-BAND IMAGING ENDOSCOPY IN PATIENTS WITH DIMINUTIVE POLYPS Takuya Yamada, Japan; T. Kuwai; T. Toyokawa; H. Iwase; T. Kudo; N. Esaka; H. Ota; H. Yamashita; Y. Hosoda; N. Watanabe; N. Harada P0225 PERIOPERATIVE MANAGEMENT OF ORAL ANTICOAGULANTS WITHOUT HEPARIN BRIDGING THERAPY FOR PATIENTS UNDERGOING ENDOSCOPIC SURGERY: A PILOT STUDY Shouko Ono, Japan; M. Kato; M. Kato; K. Matsuda; M. Tsuda; S. Abiko; S. Miyamoto; K. Yamamoto; T. Kudo; Y. Shimizu; N. Sakamoto P0226 ENDOSCOPIC FEATURE OF DEPRESSED TYPE COLORECTAL NEOPLASMA IN MAGNIFYING ENDOSCOPY AND ENDOCYTOSCOPY Shinei Kudo, Japan; K. Mochizuki; T. Okumura; S. Matsudaira; Y. Kouyama; K. Ichimasa; N. Toyoshima; Y. Mori; M. Misawa; N. Ogata; T. Kudo; T. Hisayuki; T. Hayashi; K. Wakamura; E. Hidaka; T. Baba; S. Hamatani; F. Ishida P0227 COLONOSCOPY INDICATION INFLUENCE ON THE COMPLIANCE OF QUALITY INDICATORS Carolina Mangas, Spain; E. Santana Rocamora; A. Suárez González; I. Portillo Villares; A. Seoane; M. Ponce; P. Diez; E. Quintero Carrion; M. Herraiz; M. Pellisé Urquiza; Á. Ferrández Arenas; V. Hernández; Á. E. Pizarro Moreno; R. Jover Endoscopy, ERCP P0228 THERAPEUTIC ERCP USING A SHORT SINGLE-BALLLOON ENTEROSCOPE IN PATIENTS WITH SURGICALLY ALTERED ANATOMY Kaori Masu, Japan; K. Ito; T. Ohira; S. Koshita; Y. Kanno; T. Ogawa P0229 USEFULNESS OF SPYGLASS PERORAL CHOLANGIOSCOPY FOR THE DIAGNOSIS AND TREATMENT OF BILEDUCT DISORDERS: EXPERIENCE FROM A LARGE-VOLUME CENTER Xiaowei Tang, China; D. Zhang; C. Xu; X. Zhang
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0230 DIAGNOSTIC AND THERAPEUTIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) IN INFANT AND CHILDREN: A LARGE RETROSPECTIVE STUDY Xiaowei Tang, China; D. Zhang; C. Xu; X. Zhang P0231 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PATIENTS WITH SURGICALLY ALTERED GASTROINTESTINAL ANATOMY: 11 YEARS’ EXPERIENCE AT A LARGE CENTER IN CHINA Xiaowei Tang, China; D. Zhang; C. Xu; X. Zhang P0232 IMPACT OF HIGH DEFINITION, NEAR FOCUS-IMAGING AND SYDNEY RECURRENCE TOOL (SERT) AFTER COLORECTAL ENDOSCOPIC MUCOSAL RESECTION: A PROPENSITY SCORE ANALYSIS. Daniela Guerrero Vinsard, USA; R. Lennon; P. Kandel; L. K. Mejia; R. Bingham; T. Woodward; V. Gomez; M. Raimondo; E. Bouras; M. B. Wallace P0233 INCIDENCE AND RISK FACTORS FOR PANCREATITIS IN EMERGENCY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY: A PROSPECTIVE MULTICENTER STUDY Nakai Yoshitaka, Japan; K. Kusumoto; Y. Itokawa; B. Endoh; K. Chikugo; A. Suzuki; T. Kawakami; T. Suzuki; O. Inatomi; S. Bamba; T. Kusaka; H. Kokuryu; Y. Mizumoto; K. Tanaka P0234 WALLED-OFF NECROSIS (WON): OUTCOMES OF AN ALGORITHMIC APPROACH TO NECROSECTOMY Ji Young Bang, USA; U. Navaneethan; M. Hasan; R. Hawes; S. Varadarajulu P0235 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN THE MANAGEMENT OF PANCREAS DIVISUM ASSOCIATED WITH RECURRENT ACUTE PANCREATITIS IN CHILDREN: EXPERIENCE FROM A SINGLE CENTER IN CHINA G.-X. Cui; J. Yang; X. Tang; J. Yang; Xiaofeng Zhang, China P0236 ENDOSCOPIC BILIARY SPHINCTEROTOMY IN MALIGNANT BILIARY OBSTRUCTION: IS IT INDICATED IN CASE OF STENT PLACEMENT? A META-ANALYSIS Benedetto Mangiavillano, Italy; A. Montale; L. Frazzoni; M. Bianchetti; A. Repici; L. Fuccio
P0237 ENDOSCOPIC PANCREATIC SPHINCTEROTOMY COMBINED WITH PANCREATIC DUCT STENT CAN EFFECTIVELY PREVENT RECURRENCE OF ACUTE RECURRENT PANCREATITIS CAUSED BY BILIARY MICROLITHIASIS --- A SINGLE-CENTER STUDY FROM BEIJING, CHINA. Yonghui Huang, China; X. Yan; W. Liu; Y. Zhang; W. Yao; K. Li P0238 OUTCOME OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PATIENTS WITH PERIAMPULLARY DIVERTICULUM Muhammad Asif Baig, Pakistan; M. Salih; N. H. Shah; M. Fatima P0239 COMPARISON OF DIGITAL VS FIBEROPTIC CHOLANGIOSCOPY IN PATIENTS REQUIRING EVALUATION OF BILE DUCT DISEASE OR TREATMENT OF BILIARY STONES. I. D. Dimas; E. Vardas; M. Fragkaki; A. Mpitouli; E. Voudoukis; A. Theodoropoulou; Grigorios Paspatis, Greece P0240 EMERGENCY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN SUPER-ELDERLY PATIENTS WITH SEVERE ACUTE CHOLANGITIS: CAN WE PERFORM THE PROCEDURE SAFELY? Shuhei Shintani, Japan; T. Imai; Y. Yokota; Y. Sato; H. Inoue; H. Tanabe; H. Bamba; Y. Komai; O. Inatomi; A. Andoh P0241 EFFICACY AND SAFETY OF ENDOBILIARY RADIOFREQUENCY ABLATION FOR THE ERADICATION OF RESIDUAL NEOPLASIA AFTER ENDOSCOPIC AMPULLECTOMY. RESULTS OF A MULTICENTER PROSPECTIVE STUDY Marine Camus, France; B. Napoléon; A. Vienne; M. Le Rhun; S. Leblanc; M. Barret; N. Kaddour; F. Robin; S. Chaussade; F. Prat P0242 EXPERT VALIDATION OF A NOVEL MECHANICAL CUTTING PAPILLA Sophia van der Wiel, The Netherlands; A. D. Koch; M. J. Bruno P0243 MEDICO-LEGAL CLAIMS IN GASTROINTESTINAL ENDOSCOPY: DOES PROCEDURE RISK RELATE TO SUCCESSFUL OUTCOMES? Shivkumar Budihal, United Kingdom; J. F Mayberry P0244 VISUALIZATION OF INTRA-AMPULLARY CHOLEDOCHOCELE WITH CONTRAST MEDIUM FOR EVALUATING TECHNICAL DIFFICULTY IN ERCP Noriyuki Nishino, Japan
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
129
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0245 ENDOTHERAPIES FOR DUCT-TO-DUCT BILIARY ANASTOMOTIC STRICTURE AFTER LIVER TRANSPLANTATION (BASALT STUDY GROUP): INTERIM ANALYSIS AND MEDIUM-TERM OUTCOMES OF A RETROSPECTIVE NATIONWIDE ITALIAN SURVEY. P. Cantù; I. Parzanese; R. Rosa; G. Santi; F. Barbaro; E. Forti; G. Lombardi; E. Nadal; V. Boarino; A. Pisani; A. Di Sario; H. Bertani; M. Bulajic; D. Ghinolfi; T. Staiano; D. Ligresti; L. Barresi; G. Catalano; A. Baldan; A. Cerofolini; L. De Carlis; M. Monteleone; A. Tringali; G. Costamagna; M. Mutignani; A. Fantin; A. Merighi; S. Traini; R. Conigliaro; M. Zilli; F. Filipponi; E. Masci; I. Tarantino; M. Traina; M. Salizzoni; P. Ravelli; L. Rodella; V. Mazzaferro; M. F. Donato; U. Maggi; L. Caccamo; G. Paone; P. Reggiani; G. E. Rossi; D. Conte; Roberto Penagini, Italy Endosonography P0246 COMPARATIVE EVALUATION OF TWO PORCINE EX-VIVO MODELS FOR TRAINING IN ENDOSCOPIC ULTRASOUND-GUIDED DRAINAGE OF PANCREATIC FLUID COLLECTIONS Frederick Moryoussef, France; S. Leblanc; A. Bertucat; A. Laquière; E. Coron; L. Mangialavoria; J. C. Duchmann; Y. Le Baleur; F. Prat P0247 A COMPARATIVE STUDY OF SUCTION METHODS DURING ENDOSCOPIC ULTRASOUND-GUIDED FINE-NEEDLE ASPIRATION (CONVENTIONAL SUCTION VERSUS CAPILLARY SUCTION) Keisuke Yamakita, Japan; Y. Kitano; H. Iwamoto; K. Takahashi; K. Wada; S. Otake; Y. Ota; Y. Tamaki; M. Okada; K. Aso; Y. Makino P0248 A PROSPECTIVE COMPARISON OF EUS-GUIDED TISSUE ACQUISITION USING A 25G-GAUGE CORE BIOPSY NEEDLE WITHOUT AND WITH A STYLET FOR INTRAABDOMINAL SOLID MASS LESIONS Jin-Hong Kim, Republic of Korea; M. J. Yang; J. C. Hwang; B. M. Yoo P0249 DIAGNOSTIC EFFICACY OF ENDOSCOPIC ULTRASOUND-GUIDED FINE-NEEDLE ASPIRATION FOR A PANCREATIC MASS USING THE CELL BLOCK METHOD WITHOUT RAPID ON-SITE CYTOLOGY Kaori Masu, Japan; K. Ito; Y. Noda; S. Koshita; Y. Kanno; T. Ogawa; T. Sawai P0250 A COMPARATIVE STUDY BETWEEN EUS-GUIDED BILIARY DRAINAGE AND PERCUTANEOUS BILIARY DRAINAGE IN PATIENTS WITH MALIGNANT BILIARY OBSTRUCTION AND FAILED ERCP Lei Lu, China; J. Yang; H. Jin; X. Tang; J. Yang; X. Zhang 130
P0251 A PROSPECTIVE COMPARATIVE STUDY OF EFFICACY OF EUS GUIDED FNA VERSUS ERCP GUIDED BRUSH CYTOLOGY IN ATTAINMENT OF HISTOPATHOLOGY OF DISTAL CBD MASSES. Pankaj N. Desai, India; M. Kabrawala P0252 RANDOMIZED TRIAL COMPARING THE LUMEN-APPOSING METAL STENTS (LAMS) AND PLASTIC STENTS FOR EUSGUIDED DRAINAGE OF WALLED-OFF NECROSIS (WON) Ji Young Bang, USA; M. Hasan; U. Navaneethan; R. Hawes; S. Varadarajulu P0253 TRANS AORTIC ENDOSCOPIC ULTRASOUND GUIDED FNA IN THE DIAGNOSIS OF LUNG CANCERS AND MEDIASTINAL LYMPH NODES Piyush Somani, India; M. Sharma P0254 ULTRASOUND-GUIDED ENDOSCOPIC TRANSGASTRIC DRAINAGE OF PANCREATIC FLUID COLLECTIONS Marco Silva, Portugal; S. Lopes; A. Peixoto; F. Vilas-Boas; P. Moutinho-Ribeiro; G. Macedo P0255 ENDOSCOPIC ULTRASOUND-GUIDED TISSUE SAMPLING WITH A NEW 20G BIOPSY NEEDLE FOR THE CHARACTERIZATION OF GASTROINTESTINAL SUBEPITHELIAL LESIONS Filippo Antonini, Italy; G. Delconte; L. Fuccio; G. De Nucci; C. Fabbri; E. Armellini; L. Frazzoni; A. Fornelli; A. Magarotto; E. Mandelli; P. Occhipinti; E. Masci; G. Manes; G. Macarri P0256 COMPARISON OF NATURAL COURSE VERSUS EUS-GUIDED ETHANOL ABLATION FOR PANCREATIC CYSTIC LESIONS J. H. Choi; Sang Hyub Lee, Republic of Korea; Y. H. Choi; J. W. Kang; W. H. Paik; D.-W. Ahn; J. K. Ryu; Y.-T. Kim P0257 RANDOMIZED TRIAL COMPARING THE FRANSEEN AND FORK-TIP NEEDLES FOR EUS-GUIDED FINE NEEDLE BIOPSY Ji Young Bang, USA; S. Hebert-Magee; M. Hasan; U. Navaneethan; R. Hawes; S. Varadarajulu Enteroscopy P0258 THE SUCCESS RATE OF DOUBLE BALLOON ENDOSCOPIC CHOLANGIOGRAPHY IN PATIENTS WHO UNDERWENT THEIR INITIAL SURGERY AS INFANT IS SIGNIFICANTLY LOWER THAN OTHER PATIENTS Kensuke Yokoyama, Japan; T. Yano; J. Ushio; K. Tamada; A. K. Lefor; H. Yamamoto P0259 EUS-GUIDED RADIOFREQUENCY ABLATION OF DIFFICULT SITES IN THE LIVER: A PRECLINICAL STUDY. Nuta Junya, Japan; T. Tamura; M. Itonaga; R. Shimizu; Y. Ida; M. Kitano
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0260 CYANOACRYLATE INJECTION THERAPY OF SMALL BOWEL VARICES BY DOUBLE-BALLOON ENTEROSCOPY (DBE): A TERTIARY CENTRE EXPERIENCE Alberto Murino, United Kingdom; N. Koukias; E. Vlachou; K. Planche; D. Patch; E. J. Despott P0261 MAGNIFYING NARROW-BAND IMAGING FINDINGS EFFICACY FOR INFLAMMATORY ACTIVITY EVALUATION IN SMALL INTESTINAL CROHN’S DISEASE WHEN USING NEWLY DEVELOPED MAGNIFYING ENTEROSCOPY: A PILOT STUDY. Noriyuki Ogata, Japan; K. Ohtsuka; S. Sasanuma; M. Misawa; Y. Mori; T. Kudo; T. Hisayuki; T. Hayashi; K. Wakamura; S.-E. Kudo P0262 SINGLE INCISION LAPAROSCOPIC ASSISTED DOUBLE BALLOON ENTEROSCOPY: A NOVEL TECHNIQUE TO MANAGE SMALL BOWEL PATHOLOGY Ioannis Stasinos, United Kingdom; N. Kamperidis; R. Rameshshanker; A. Murino; C. Fraser; J. Warusavitarne; A. Humphries Capsule endoscopy P0263 GASTRIC EMPTYING IN CROHN’S DISEASE – EVALUATION BY SMALL BOWEL CAPSULE ENDOSCOPY Ana Maria Singeap, Romania; A.-V. Trifan; S. Chiriac; I. Girleanu; T. Cuciureanu; C. Stanciu P0264 META-ANALYSIS SHOWS THAT PURGATIVE PREPARATION INCREASES SMALL BOWEL VIDEO CAPSULE ENDOSCOPY DIAGNOSTIC YIELD AND IMPROVES THE QUALITY OF SMALL BOWEL MUCOSA VISUALIZATION P. Gkolfakis; G. Tziatzios; G. D. Dimitriadis; Konstantinos Triantafyllou, Greece P0265 INTER-OBSERVER AGREEMENT IN BROTZ CLEANING SCALES FOR CAPSULE ENDOSCOPY Mafalda Sousa, Portugal; R. Pinho; A. Ponte; J. Silva; J. Rodrigues; J. C. Silva; A. Rodrigues; L. Proença; J. Carvalho P0266 PILOT STUDY OF THE EFFECTS OF IMAGE QUALITY ON LESION VISUALISATION IN SMALL BOWEL CAPSULE ENDOSCOPY Diana Yung, United Kingdom; X. Dray; E. Toth; E. Rondonotti; R. Sidhu; U. Kopylov; M. Mcalindon; M. Pennazio; J. N. Plevris; A. Koulaouzidis
Poster in the Spotlight
Poster of Excellence
P0267 EVALUATION OF A NEW PAN ENTERIC CAPSULE SYSTEM IN PATIENTS WITH SUSPECTED OR ESTABLISHED INFLAMMATORY BOWEL DISEASE – ASSESSING THE SYSTEM FUNCTIONALITY TO VISUALIZE AND ASSESS THE SMALL AND LARGE BOWELS Rami Eliakim, Israel; C. Spada; I. Fernández-Urién Sainz; H. Yanai; A. Lahat; Y. Ron; S. Pecere; G. Costamagna; A. Schwartz; I. Eyal; A. Lapidus; S. N. Adler Biliary and pancreatic stenting P0268 THE UTILITY OF A NOVEL TRANSPAPILLARY DILATION TECHNIQUE WITH A DIATHERMIC CATHETER FOR SEVERE MAIN PANCREATIC DUCT STRICTURE DUE TO CHRONIC PANCREATITIS Shin Kato, Japan; M. Kuwatani; R. Sugiura; I. Sano; K. Kawakubo; N. Sakamoto P0269 CLINICAL OUTCOMES OF BILIARY DRAINAGE DURING NEOADJUVANT CHEMOTHERAPY/ CHEMORADIOTHERAPY IN MULTICENTER PANCREATIC CANCER STUDIES: METAL STENT VERSUS PLASTIC STENT Masaki Kuwatani, Japan; T. Nakamura; T. Hayashi; Y. Kimura; M. Ono; K. Yamakita; T. Goto; K. Takahashi; M. Motoya; H. MAGUCHI; S. Hirano; N. Sakamoto P0270 OUTCOME OF ENDOSCOPIC REINTERVENTION FOR MALIGNANT HILAR OBSTRUCTION TREATED BY STENTIN-STENT DEPLOYMENT Dae Hwan Kang, Republic of Korea; H. W. Kim; C. W. Choi; S. J. Kim; J. S. Lee; C. W. Yeo; H. S. Nam; S. H. Choi; J. H. Ko; B. J. Kwon; D. G. Ryu P0271 LONG-TERM OUTCOMES OF ENDOSCOPIC ULTRASOUND-GUIDED RIGHT INTRAHEPATIC DUCT DRAINAGE WITH TRANSMURAL COVERED METAL STENT. Dong Hui Cho, Republic of Korea; D. H. Park; D. Oh; T. J. Song; S. S. Lee; D. W. Seo; S. K. Lee; M.-H. Kim P0272 UTILITY OF EUS-GUIDED HEPATICOGASTROSTOMY WITH ANTEGRADE STENTING FOR MALIGNANT BILIARY OBSTRUCTION OF ERCP INABILITY Hajime Imai, Japan; M. Takenaka; M. Kudo P0273 EUS-GUIDED GALLBLADDER DRAINAGE REDUCES LATE ADVERSE EVENT AND NEED FOR RE-INTERVENTION COMPARED WITH PERCUTANEOUS CHOLECYSTOSTOMY IN PATENTS WHO ARE NOT ELIGIBLE FOR SURGERY Dong Hui Cho, Republic of Korea; S. S. Lee; D. Oh; T. J. Song; D. H. Park; D. W. Seo; S. K. Lee; M.-H. Kim
Clinical Case Session
131
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0274 ENDOSCOPIC TREATMENT OF ANASTOMOTIC BILIARY STRICTURES IN PATIENTS WITH LIVING DONOR LIVER TRANSPLANTATION: MULTIPLE PLASTIC STENTS VS FULLY COVERED SELF-EXPANDABLE METALLIC STENTS A. T. Eminler; Erkan Parlak, Turkey; A. S. Koksal; B. Toka; M. I. Uslan
P0281 OUTCOMES OF PATIENTS UNDERGOING PLACEMENT OF FULLY COVERED SELF EXPANDING METAL STENTS FOR MALIGNANT OESOPHAGEAL STRICTURES Martin Everson, United Kingdom; C. Magee; P. Galloway; A. Nelson; R. Sweis; M. Banks; S. Bown; D. Graham; L. Lovat; R. Haidry
Enteral dilatation and stenting (oesophagus, stomach, duodenum, colon)
Poster Session 09:00 – 17:00 Surgery I
P0275 PROSPECTIVE RANDOMIZED STUDY FOR EFFICACY OF AN DOUBLE BARE STENT COMPARED A DOUBLE COVERED STENT IN MALIGNANT COLORECTAL OBSTRUCTION Alexandr Vodoleev, Russian Federation; V. Duvanskiy; V. Malyuga P0276 THE FEASIBILITY OF NEW ENDOSCOPIC GASTROINTESTINAL BYPASS STENT FOR WEIGHT REDUCTION: EXPERIMENTAL STUDY S. J. Choi; Chang Duck Kim, Republic of Korea; W. Kim; G. Min; J. M. Lee; I. K. Yoo; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; B. Keum; Y. T. Jeen; H. J. Chun; H. S. Lee P0277 LONG TERM EFFICACY OF AN ENDOSCOPIC DILATION PROGRAM ON POST-RADIATION AND ANASTOMOTIC FARINGO-ESOPHAGIC STRICTURES Diana Martins, Portugal; S. Pires; C. Camila Dias; P. Pimentel-Nunes; R. Silva; M. Dinis-Ribeiro P0278 OUTCOME AFTER THE USE OF SX-ELLA DANIS BLEEDING STENTS FOR REFRACTORY VARICEAL BLEEDING – A VIENNA MULTICENTER EXPERIENCE Nikolaus Pfisterer, Austria; T. Pachofszky; W. Dolak; M. Schöniger-Hekele; B. Schuster; B. Tribl; M. Mandorfer; P. Schwabl; F. Riedl; T. Bucsics; K. König; L. Kramer; M. Gschwantler; C. Madl; M. Trauner; T. Reiberger P0279 A NOVEL METHOD WITH SELF-EXPANDABLE METALLIC STENT FASTENED WITH CLIP AND LOOP FOR THE TREATMENT OF ANASTOMOTIC STRICTURE AFTER SUBTOTAL GASTRECTOMY Joon Koo Kang, Republic of Korea; S. G. LIm; K. M. Lee; S. J. Shin; B. M. Yoo; J.-H. Kim; C.-K. Noh P0280 EFFICACY AND TOLERABILITY OF BIODEGRADABLE STENTS FOR RECURRENT BENIGN OESOPHAGEAL STRICTURES: THE LEEDS EXPERIENCE Nicolas Rabb, United Kingdom; H. Procter; N. Burr; V. Appleby; S. Everett
132
Hall 7
Oesophagus / stomach / duodenum P0282 COMBINED RESECTION IN ESOPHAGEAL CANCER: MYTH OR REALITY. Dmitry Rusanov, Russian Federation; K. Pavelets; M. Antipova; M. Protchenkov; M. Pavelets; U. Drozd; A. Sokolova; G. Florovsky P0283 INFLUENCE OF CONTINUOUS ADMINISTRATION OF LOW-DOSE ASPIRIN FOR INTRAOPERATIVE BLEEDING ON GASTRIC ENDOSCOPIC GASTRIC DISSECTION: A PROPENSITY SCORE MATCHING ANALYSIS Yohei Horikawa, Japan; N. Mimori; H. Mizutamari; Y. Kato; S. Fushimi; S. Okubo; S. Sato P0284 WEEKDAY OF CANCER SURGERY IN RELATION TO PROGNOSIS Pernilla Lagergren, Sweden; F. Mattsson; J. Lagergren P0285 IMPACT OF POSTOPERATIVE COMPLICATIONS AND PERIOPERATIVE ONCOLOGICAL TREATMENTS FOR GASTRIC CANCER PATIENTS AFTER GASTRECTOMY Satoshi Kamiya, Sweden; F. Klevebro; I. Rouvelas; M. Lindblad; L. Lundell; M. Nilsson P0286 ENDOSCOPIC PAPILLECTOMY OF DUODENAL PAPILLARY TUMOR: A REPORT OF 75 CASES Zikai Wang, China; E. Linghu; F. Cai; Y. Yang; G. Sun; M. Li; S. Li; X. Wang; J. Meng; H. Du; J. Zhu; W. Li Small bowel / colorectal and anal P0287 PROPHYLACTIC COLECTOMY WITH EXTENDED INDICATION OF RECTAL PRESERVATION IN RELATED APC FAMILIAL ADENOMATOUS POLYPOSIS: SYSTEMATIC ADENOMA TREATMENT DRAMATICALLY CHANGES THE NATURAL HISTORY OF POLYPOSIS Arnaud Pasquer, France; G. Poncet; M. Pioche; J. Rivory; O. Vinet; N. Benech; J. C. Saurin
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0288 ANAL PROBLEMS DURING PREGNANCY AND POSTPARTUM: A PROSPECTIVE COHORT STUDY. Kymentie Ferdinande, Belgium; Y. Dorreman; K. Roelens; W. Ceelen; D. De Looze
P0296 LAPAROSCOPIC COMPLETE LATERAL LYMPH NODE DISSECTION FOR LOW RECTAL CANCER Takashi Kinoshita, Japan; K. Komori; T. Oshiro; A. Ouchi; Y. Shimizu
P0289 SURGICAL TREATMENT OF DIVERTICULITIS AND ITS COMPLICATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROL TRIALS. Ali Mahmoud Ahmed, Egypt; A. T. Moahammed; O. M. Mattar; E. M. Mohamed; E. A. Faraag; A. M. AlSafadi; N. T. Huy; K. Hirayama
P0297 TRANSGASTRIC-NOTES SIGMOID RESECTION IN AN ANIMAL SURVIVAL MODEL USING THE ANUBIS-SYSTEM Joern Bernhardt, Germany; H. Steffen; P. Koehler; S. Schneider-Koriath; K. Ludwig
P0290 ª NLR AND PLR IN DIAGNOSING SYNCHRONOUS LIVER AND LYMPH NODE METASTASES IN PATIENTS WITH CRC Milica Stojkovic Lalosevic, Serbia; A. Pavlovic Markovic; V. Markovic; I. Dimitrijevic; M. Stojkovic; S. Kiurski; Z. Krivokapic P0291 DEVELOPING AND VALIDATING OF RAMATHIBODI APPENDICITIS SCORE (RAMA-AS) FOR DIAGNOSIS OF APPENDICITIS IN SUSPECTED APPENDICITIS PATIENTS Chumpon Wilasrusmee, Thailand; B. Siribumrungwong; S. Phuwapraisirisan; N. Poprom; A. Thakkinstian P0292 IS HAEMORRHOIDECTOMY SAFE IN PATIENTS WITH ULCERATIVE COLITIS? Seong-Dae Lee, Republic of Korea; Y. S. Choi; E.-J. Lee; J. B. Lee; D. S. Lee; E. G. Youk; D. H. Lee; D. S. Kim P0293 EARLY VERSUS DELAYED CLOSURE OF TEMPORARY LOOP ILEOSTOMY AFTER COLORECTAL SURGERIES: A PROSPECTIVE RANDOMIZED STUDY Siva Gavini, India; V. Vutukuru; D. Annareddy; C. Chandramaliteeswaran; V. Dasari; N. Pagadala Laparoscopic techniques P0294 FULL-SCALE INTRODUCTION OF RADICAL LAPAROSCOPIC SURGERY FOR INGUINAL HERNIA EMPLOYING THE TRANSABDMINAL PREPERITONEAL (TAPP) REPAIR AND EARLY OUTCOMES Takuya Saito, Japan; T. Sano; S. Komatsu; T. Arikawa; S. Ishiguro; K. Komaya P0295 EFFECTIVENESS OF PURE LAPAROSCOPIC LEFT COLECTOMY WITH PRIMARY ANASTOMOSIS AND LOOP ILEOSTOMY FOR THE TREATMENT OF COMPLICATED HINCHEY 3 DIVERTICULITIS Francesco Roscio, Italy; A. De Luca; I. Scandroglio
Poster in the Spotlight
Poster of Excellence
P0298 ASCITES, COMPLEX ADNEXAL MASSES AND RAISED CA-125 IN POST-MENOPAUSAL WOMEN: OVARIAN CANCER OR TUBERCULOSIS? Sonda Jardak, Tunisia; H. Kchir; N. Maamouri; H. Chaabouni; N. Ben Mami Poster Session 09:00 – 17:00 IBD I
Hall 7
Basic/pathogenesis/pathology P0299 INSULINLIKE GROWTH FACTOR IGF-I AND INFLAMMATORY RESPONSE IN THE COLONIC MUCOSA IN ULCERATIVE COLITIS Vladimir Pavlenko, Russian Federation; F. Urusova; G. Eseneeva; A. Pavlenko; N. Korablina P0300 REGULATORY B CELLS CONTRIBUTE TO THE ALLEVIATION OF COLITIS INDUCED BY DEXTRAN SULPHATE SODIUM AFTER H.PYLORI INFECTION Xia Li, China; N. Wang; Q. Xue; J. Tan; J. Wang P0301 FUNGAL COMPOSTION AND FUNGI-BACTERIA CORRELATION IN IBD PATIENTS WITH DIFFERENT TREATMENT STRATEGIES Jun Xu, China; Z. Wu; Y. Song; N. Wu; F. Zhang; H. X. Ren; N. Chen; Y. L. Liu P0302 INVESTIGATING THE MICROBIOME IN A PHASE 1B STUDY OF ANDECALIXIMAB IN ULCERATIVE COLITIS Brandon LaMere, USA; E. R. Wendt; B. Kanwar; S. V. Lynch P0303 MUCOSAL CYTOKINE PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: A LASER CAPTURE MICRODISSECTION APPROACH Giuseppe Mazzarella, Italy; V. Rotondi Aufiero; P. Marena; A. Venezia; R. Melina; N. Giardullo; B. Perugini; F. S. Taccone; S. Iaquinto; G. Iacomino; G. Iaquinto
Clinical Case Session
133
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
P0304 ALTERATIONS IN THE MUCOSA-ASSOCIATED FUNGAL MICROBIOTA IN PATIENTS WITH ULCERATIVE COLITIS Xinyun Qiu, China; H. Zhang Monday, October 30, 2017
P0305 CD16 POSITIVE CELLS, EXPRESSING WNT LIGANDS, ACCUMULATE IN THE MUCOSA AND MEDIATE INTESTINAL FIBROSIS. Dolores Ortiz Masia, Spain; P. Salvador; D. Macias-Ceja; S. Coll-Puig; L. Gisbert-Ferrándiz; C. Hernández; S. Calatayud; M. D. Barrachina P0306 CHARACTERIZATION OF GUT MICROBIOME ASSOCIATED WITH IMPROVEMENT OF ULCERATIVE COLITIS AFTER ANTIBIOTIC COMBINATION THERAPY USING FECAL METAGENOMIC ANALYSIS Kimitoshi Kato, Japan; T. Sekizuka; T. Sugiyama; Y. Ishii; M. Kuroda; T. Ohkusa P0307 GLP-1 EXPRESSING ENTEROENDOCRINE CELL NUMBERS ARE REDUCED AT THE SITE OF ACTIVE DISEASE IN VARIOUS MOUSE MODELS OF INTESTINAL INFLAMMATION Eva Rath, Germany; N. Waldschmitt; M. Ahmed; S. Khaloian Sarnaghi; M. Schaubeck; G. Hörmannsperger; J. Planchais; H. Sokol; D. Haller P0308 ª ACTIVE ULCERATIVE COLITIS IS CHARACTERIZED BY THE FORMATION OF THROMBOGENIC TISSUE FACTOR-EXPRESSING NEUTROPHIL EXTRACELLULAR TRAPS I. Angelidou; A. Mitsios; Akrivi Chrysanthopoulou, Greece; K. Kambas; A. Arampatzioglou; E. Dellaporta; S. Arelaki; V. Dalla; K. Ritis; G. Kouklakis; P. Skendros P0309 IMPAIRED MITOCHONDRIAL PROTEOSTASIS IS ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION AND INDUCES PHENOTYPIC TRANSITION OF LGR5+ STEM CELLS INTO PANETH CELLS Sevana Khaloian Sarnaghi, Germany; E. Rath; N. Waldschmitt; I. Gosch; E. Berger; D. Haller P0310 METABONOMIC PROFILING OF ULCERATIVE COLITIS PATIENTS; RESULTS FROM AN INCEPTION COHORT TIME SERIES ANALYSIS Ravi Misra, United Kingdom; M. Sarafian; N. S. Ding; E. Holmes; O. Faiz; N. Arebi P0311 BASELINE CLINICAL AND ENDOSCOPIC FEATURES OF ULCERATIVE COLITIS PATIENTS ARE RELEVANT GUIDE FOR SELECTING RESPONDERS TO SELECTIVE DEPLETION OF MYELOID LINEAGE LEUCOCYTES AS REMISSION INDUCTION THERAPY Tomotaka Tanaka, Japan; M. Akagi; H. Goishi; T. Iiboshi; T. Kajihara; T. Miura 134
P0312 THE EFFECTS OF GLIAL -DERIVED NEUROTROPHIC FACTOR PRODUCED BY ENTERIC GLIAL CELLS ON DENDRITIC CELL AND ITS ROLES IN DEXTRAN SULPHATE SODIUM INDUCED COLITIS Yu Huan, China P0313 DETERMINANTS OF REDUCED GENETIC CAPACITY FOR BUTYRATE SYNTHESIS BY THE GUT MICROBIOME IN CROHN’S DISEASE AND ULCERATIVE COLITIS Emilio Laserna-Mendieta, Ireland; A. G. Clooney; J. F. Carretero-Gomez; J. Nolan; C. Hill; C. G. Gahan; S. A. Joyce; C. Moran; D. Sheehan; F. Shanahan; M. J. Claesson P0314 A COMBINED ADMINISTRATION OF AMPICILLIN AND VANCOMYCIN INDUCES MILD COLITIS WITH DECREASED DIVERSITY OF GUT MICROBIOTA AND PERTURBATION OF GLUTAMINE AND SHORT CHAIN FATTY ACID METABOLISMS. Akira Sonoda, Japan; N. Sachi; Y. Gendo; T. Ozaki; N. Kamiyama; S. Hidano; K. Mizukami; T. Okimoto; K. Murakami; T. Kobayashi P0315 ANTI-INFLAMMATORY EFFECTS OF G PROTEIN-COUPLED RECEPTOR 18 – A NOVEL POTENTIAL THERAPEUTIC TARGET IN INFLAMMATORY BOWEL DISEASE Adam Fabisiak, Poland; N. Fabisiak; M. Zielińska; A. Mokrowiecka; E. Malecka-Panas; R. Kordek; K. Kieć-Kononowicz; J. Fichna P0316 THE MECHANISM OF PROTECTIVE ROLE OF D3 DOPAMINE RECEPTORS IN PATHOGENESIS OF ULCERATIVE COLITIS A. Prysiazhniuk; T. Dovbynchuk; Y. Holota; I. Vareniuk; L. Garmanchuk; Ganna Tolstanova, Ukraine P0317 INFLAMMATION AT DISTAL ILEOCAECAL RESECTION MARGINS INCREASE THE RISK OF POSTOPERATIVE CROHN’S RECURRENCE Karin Wasmann, The Netherlands; J. van Amesfoort; L. Koens; W. A. Bemelman; C. J. Buskens P0318 APPLICATION OF NEW SINGLE NUCLEOTIDE POLYMORPHISMS TO THE IDENTIFICATION OF ADHERENT-INVASIVE E. COLI (AIEC) Carla Camprubí-Font, Spain; M. Lopez-Siles; M. Ferrer-Guixeras; L. Niubo-Carulla; C. Abellà-Ametller; L. J. Garcia-Gil; M. Martinez-Medina
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0319 LIPOSOMAL FORMULATION AS A NEW DRUG DELIVERY SYSTEM FOR CROHN’S DISEASE – VALIDATION IN THE MOUSE MODEL OF TNBS-INDUCED COLITIS Julia Krajewska, Poland; P. Pietruszka; D. Tomczyk; J. Fichna Aetiology/epidemiology P0320 EPIDEMIOLOGY OF MICROSCOPIC COLITIS IN NOTTINGHAM: A CONTEMPORARY COHORT STUDY Nina Lewis, United Kingdom; T. Archer; P. Kaye P0321 EXTRA-INTESTINAL MANIFESTATIONS AT DIAGNOSIS IN PAEDIATRIC- AND ELDERLY-ONSET ULCERATIVE COLITIS ARE ASSOCIATED WITH A MORE SEVERE DISEASE OUTCOME: A POPULATION-BASED STUDY D. Duricova; A. Leroyer; G. Savoye; H. Sarter; B. Pariente; D. Aoucheta; L. Armengol-Debeir; D. Ley; D. Turck; L. Peyrin-Biroulet; C. Gower-Rousseau; Mathurin Fumery, France P0322 LONG-TERM NATURAL HISTORY OF MICROSCOPIC COLITIS: A POPULATION-BASED STUDY Julien Loreau, France; D. Duricova; C. Gower-Rousseau; G. Savoye; H. Sarter; C. Yzet; M. Kohut; F. Brazier; D. Chatelain; E. Nguyen-Khac; J.-L. Dupas; M. Fumery P0323 IBD-INFO QUESTIONNAIRE: A MULTICENTER FRENCH UP-TO-DATE SURVEY OF PATIENT KNOWLEDGE IN INFLAMMATORY BOWEL DISEASE Pauline Danion, France; A. Buisson; X. Roblin; N. Mathieu; A.-L. Charlois; N. Williet; E. Del Tedesco; B. Flourie; S. Nancey; G. Boschetti
P0326 OPIATE USE IN INFLAMMATORY BOWEL DISEASE. PRESCRIPTION TRENDS AND MORTALITY IN AN ENGLISH PRIMARY CARE COHORT FROM 1990-2014. Nick Burr, United Kingdom; C. Smith; R. West; M. A. Hull; V. Subramanian P0327 PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE AN INCREASE RISK OF PERIODONTITIS CORRELATED WITH DISEASE ACTIVITY O. Fumery; C. Yzet; K. Agossa; J. Braux; J. Loreau; F. Brazier; S. Dapke; B. Devauchelle; S. Testelin; E. Nguyen-Khac; J.-L. Dupas; Mathurin Fumery, France Genetics P0328 DETECTION OF MUTATIONS IN NOD2/CARD15 GENE IN ARAB PATIENTS WITH CROHN’S DISEASE Iqbal Siddique, Kuwait; I. Khan; R. Sulaiman; N. Kadungothayil; M. Al-Tarrah; A. S. Mustafa P0329 GENETIC ASSOCIATIONS OF INFLAMMATORY BOWEL DISEASE IN SRI LANKA: A CASE-CONTROL STUDY OF PHENOTYPES AND SELECTED GENETIC POLYMORPHISMS Madunil Niriella, Sri Lanka; K. S. Kodisinghe; A. P. De Silva; N. Rajapakshe; S. D. Nanayakkara; D. P. Luke; T. M. De Silva; N. M. Navarathne; U. Kalubovila; R. S. Kumarasena; V. H. Dissanayake; R. W. Jayasekara; H. J. de Silva P0330 VDR GENE BSM I POLYMORPHISM AND ULCERATIVE COLITIS Daria Kuznetsova, Russian Federation; A. Razumov; M. Merzlyakov; G. Vavin
P0324 IMPACT OF PRIMARY SCLEROSING CHOLANGITIS ON THE DISEASE COURSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – EVIDENCE FROM A LARGE RETROSPECTIVE STUDY WITH MATCHED COHORTS Friederike Cordes, Germany; T. Laumeyer; M. Brückner; T. M. Nowacki; J. Gerß; T. Kucharzik; D. Bettenworth
P0331 GENETIC AND SEROLOGICAL PROFILE AS MARKERS OF DISEASE SUSCEPTIBILITY IN SIBLINGS OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE Giulia D'Arcangelo, Italy; M. Bramuzzo; G. Catassi; C. Romano; E. Miele; G. Morabito; S. Pellegrino; C. Cuzzupè; C. Strisciuglio; S. Martelossi; S. Cucchiara; M. Aloi
P0325 UNCHANGED SURGERY AND HOSPITALIZATION RATES IN AN EAST-WEST EUROPEAN INCEPTION COHORT DESPITE DIFFERENCES IN USE OF BIOLOGICALS – 5-YEAR FOLLOW-UP OF THE ECCO-EPICOM COHORT Johan Burisch, Denmark; E. Langholz; A. Goldis; R. D’Inca; L. Kupcinskas; V. Hernández; D. Valpiani; D. Duricova; Z. Vegh; L. Kievit; I. Kaimakliotis; J. F. Dahlerup; R. Salupere; J. Halfvarson; K. R. Nielsen; M. Giannotta; K. H. Katsanos; N. Pedersen; P. Ellul; M. Fumery; D. Schwartz; S. Turcan; S. Čuković-Čavka; P. Oksanen; F. Magro; N. Arebi; P. L. Lakatos; P. Munkholm
P0332 ROLE OF DNMT3A IN INTESTINAL EPITHELIAL CELLS Antonella Fazio, Germany; J. Kuiper; A. Sinha; R. Sheibani-Tezerji; P. Rosenstiel
Poster in the Spotlight
Poster of Excellence
P0333 ORMDL PROTEINS: CRITICAL REGULATORS OF FINE-TUNING OF THE UNFOLDED PROTEIN RESPONSE IN INTESTINAL INFLAMMATION M. Jentzsch; M. Falk-Paulsen; A. Luzius; Stephanie Stengel, Germany; J. Kuiper; B. Messner; F. Tran; K. Aden; P. Rosenstiel
Clinical Case Session
135
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Diagnosis and monitoring
Monday, October 30, 2017
P0334 THE USE OF LÉMANN SCORE TO EVALUATE THE DAMAGE TO THE DIGESTIVE TRACT CAUSED BY CROHN’S DISEASE IN AN EGYPTIAN COHORT Hussein Saad, Egypt; O. E. Salem; M. A. Salem; M. E. Ibrahim; S. M. El Kady P0335 FINAL RESULTS ON IMMUNOGENICITY PROFILE AND PREDICTORS OF ADA DEVELOPMENT OF BIOSIMILAR INFLIXIMAB DURING THE FIRST 12 MONTHS OF THE THERAPY: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT Petra Anna Golovics, Hungary; B. D. Lovasz; Z. Kurti; M. Rutka; Z. Vegh; K. B. Gecse; K. Farkas; J. Banai; L. Bene; L. Gonczi; B. Gasztonyi; T. Kristof; L. Lakatos; P. Miheller; K. Palatka; A. Patai; M. Papp; A. Salamon; T. Szamosi; Z. Szepes; G. T. Toth; A. Vincze; E. Biro; T. Molnar; P. L. Lakatos P0336 RECONSIDERING THE PROGNOSTIC VALUE OF TRADITIONAL SEROLOGIC ANTIBODIES IN CROHN’S DISEASE – IMMUNOGLOBULIN CLASSES TO TAKE THE CENTRE STAGE Nora Sipeki, Hungary; B. Suga; G. L. Norman; Z. Shums; G. L. Veres; P. L. Lakatos; P. Antal-Szalmas; M. Papp P0337 UTILITY OF MAGNETIC RESONANCE EVALUATION FOR SMALL BOWEL ENDOSCOPIC HEALING IN PATIENTS WITH CROHN’S DISEASE Kento Takenaka, Japan; K. Ohtsuka; Y. Kitazume; T. Fujii; K. Matsuoka; M. Kimura; M. Nagahori; M. Watanabe P0338 USEFULNESS OF DOUBLE BALLOON ENDOSCOPY IN DIAGNOSIS AND TREATMENT OF SMALL BOWEL CROHN'S DISEASE Ali Madian, Egypt; M. Matsuura; A. Elbahrawy; H. Nakase; T. Chiba; M. N. Rafat P0339 AGE AND SMOKING KEY TO ADHERENCE IN INFLAMMATORY BOWEL DISEASE: LOW ADHERENCE CAN SERIOUSLY LIMIT DRUG EFFECTIVENESS IN YOUNGS Carla Jerusalen Gargallo Puyuelo, Spain; P. Alarcon; E. Alfambra; T. Arroyo Villarino; J. M. Nerin de la Puerta; A. Lué; F. Gomollon P0340 IS THE CDMRIS USEFUL TO MONITOR PATIENTS WITH CROHN’S DISEASE BY MAGNETIC RESONANCE IMAGING? Catherine Le Berre, France; M. Tahora; C. Trang; M. Flamant; P. Hallouin; S. Bruley Des Varannes; A. Bourreille; E. Frampas
136
P0341 CONCORDANCE OF STOOL FREQUENCY AND ABDOMINAL PAIN MEASURES WITH SIMPLE ENDOSCOPIC SCORE FOR CROHN'S DISEASE James Lewis, USA; P. Rutgeerts; G. D'Haens; J.-F. Colombel; W. Sandborn; W. Reinisch; J. Butler; J. F. Maa; A. M. Robinson P0342 DECREASED CD8+CD28+/CD8+CD28- T CELLS’ RATIO CAN PREDICT THE POOR OUTCOME SENSITIVELY FOR PATIENTS WITH COMPLICATED CROHN’S DISEASE S.-X. Dai; H.-X. Gu; Q.-Y. Lin; Y.-K. Wu; X.-Y. Wang; S.-Z. Huang; T.-S. Xing; M.-H. Chen; Q.-F. Zhang; Zhong-Wen Zheng, China; W. Sha P0343 BOWEL PREPARATION QUALITY OF NER1006 VERSUS STANDARD 2L PEG WITH ASCORBATE AS ASSESSED BY COLONOSCOPISTS AT SITE: A POST HOC ANALYSIS FROM A RANDOMISED CONTROLLED TRIAL Jonathan Manning, United Kingdom; L. Clayton; V. Lorenzo-Zúñiga García P0344 BOWEL PREPARATION QUALITY OF NER1006 VERSUS ORAL TRISULFATE SOLUTION AS ASSESSED BY COLONOSCOPISTS AT SITE: A POST HOC ANALYSIS FROM A RANDOMISED CONTROLLED TRIAL Richard Ng Kwet Shing, United Kingdom; P. Bekal P0345 BOWEL PREPARATION QUALITY OF NER1006 VERSUS SODIUM PICOSULFATE + MAGNESIUM CITRATE AS ASSESSED BY COLONOSCOPISTS AT SITE: A POST HOC ANALYSIS FROM A RANDOMISED CONTROLLED TRIAL Stephen Lewis, United Kingdom; J. P. H. Drenth; C. Santander; C. Pediconi; B. Amlani; A. Repici P0346 LOW VITAMIN D LEVELS ARE RELATED TO CLINICAL ACTIVITY, MUCOSAL INFLAMMATION, AND INTESTINAL FIBROSTENOSIS IN CROHN’S DISEASE. Tsunaki Sawada, Japan; O. Watanabe; M. Nakamura; T. Yamamura; M. Matsushita; M. Saito; R. matsuura; Y. Mizutani; Y. Niwa; E. Ishikawa; G. Uchida; H. Otsuka; H. Suzuki; T. Nishikawa; T. Ishida; T. Kuno; S. Hattori; K. Yamada; T. Ishikawa; K. Furukawa; K. Funasaka; E. Ohno; R. Miyahara; H. Kawashima; H. Goto; Y. Hirooka P0347 PATIENT SATISFACTION WITH HOME MONITORING OF DISEASE ACTIVITY AND FECAL CALPROTECTIN IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE- INTERIM ANALYSIS OF 68 PATIENTS Petra Weimers, Denmark; D. Marker; D. V. Ankersen; J. Burisch; P. Munkholm
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0348 SKELETAL MUSCLE ATROPHY IS A PREDICTIVE FACTOR FOR INTESTINAL RESECTION IN PATIENTS WITH CROHN'S DISEASE Shigeki Bamba, Japan; M. Sasaki; A. Takaoka; A. Nishida; O. Inatomi; M. Sugimoto; A. Andoh P0349 A PROSPECTIVE STUDY TO PREDICT A MILD COURSE OF CROHN’S DISEASE AN INTERIM ANALYSIS OF THE PROGNOS STUDY Wolfgang Kruis, Germany; L. Leifeld; N. Hoepffner; M. Hoesl; P. Jessen; M. Mroß; T. Klugmann; S. Ceplis-Kastner; B. Reimers; B. Bokemeyer P0350 USEFULNESS OF REPEATING TESTING FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD). CORRELATION BETWEEN TUBERCULIN SKIN TEST (TST)/BOOSTER AND QUANTIFERON-TB (QFT) Ana María Fuentes Coronel, Spain; P. Fradejas Salazar; C. López Ramos; C. Ochoa Sangrador; G. Rascarachi; L. Julian Gómez; C. Bailador; E. Martín; P. Conde; M. García; F. Fernández; R. Castillo; S. Rodríguez P0351 MAGNETIC RESONANCE ENTEROGRAPHY GLOBAL SCORE ALLOWS FOR ACCURATE QUANTIFICATION OF SMALL BOWEL INFLAMMATION IN CROHN’S DISEASEA COMPARISON WITH CAPSULE ENDOSCOPY E. Klang; M. M. Amitai; A. Lahat; D. Yablecovitch; S. Neuman; N. Levhar; N. Rozendorn; B. Avidan; S. Ben-horin; R. Eliakim; Uri Kopylov, Israel P0352 WHICH ONE IS BETTER FOR ASSESSMENT OF ESTABLISHED CROHN’S DISEASE BY CAPSULE ENDOSCOPY: THE LEWIS SCORE OR THE CAPSULE ENDOSCOPY CROHN'S DISEASE ACTIVITY INDEX? D. Yablecovitch; A. Lahat; S. Neuman; N. Levhar; B. Avidan; S. Ben-Horin; R. Eliakim; Uri Kopylov, Israel P0353 CONCORDANCE BETWEEN TUBERCULIN SKIN TEST AND INTERFERON GAMMA RELEASE ASSAY FOR LATENT TUBERCULOSIS SCREENING IN INFLAMMATORY BOWEL DISEASE (META-ANALYSIS). Saad Alrajhi, Canada; P. Germain; W. Afif; M. Martel P0354 THIOPURINE MAINTENANCE THERAPY FOR IBD: WHICH IS THE BEST METHOD TO MEASURE MEDICATION ADHERENCE? Alvin Ochieng, United Kingdom; V. George; C. Selinger
Poster in the Spotlight
Poster of Excellence
P0355 ROLE FOR THERAPEUTIC DRUG MONITORING IN ASSESSING SECONDARY LOSS OF RESPONSE TO MAINTENANCE ANTI-TNFA THERAPY IN INFLAMMATORY BOWEL DISEASE. Donal Tighe, Ireland; R. Hession; A. Naqeem; S. Smith; A. O'Connor; N. Breslin; B. Ryan; D. McNamara P0356 COMPARATIVE ACCURACY OF BOWEL ULTRASOUND VERSUS MAGNETIC RESONANCE ENTEROGRAPHY AND COLONOSCOPY IN ASSESSING DISEASE ACTIVITY AND COMPLICATIONS AND INFLUENCING THE DECISION-MAKING PROCESS IN CROHN’S DISEASE Mariangela Allocca, Italy; G. Fiorino; C. Bonifacio; F. Furfaro; D. Gilardi; S. Radice; L. Peyrin-Biroulet; S. Danese P0357 DIAGNOSTIC DELAY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – A STUDY OF THE AUSTRIAN IBD STUDY GROUP (ATISG) Gottfried Novacek, Austria; H. P. Gröchenig; T. Haas; H. H. Wenzl; P. Steiner; R. Koch; T. Feichtenschlager; G. Eckhardt; A. Mayer; A. Kirchgatterer; O. Ludwiczek; R. Platzer; P. Papay; J. Gartner; H. Fuchssteiner; W. Miehsler; P.-G. Peters; G. Reicht; H. Vogelsang; C. Dejaco; T. Waldhör P0358 IDENTIFICATION OF NON-INVASIVE BIOMARKERS TO DETECT ILEAL CEACAM-6 OVEREXPRESSION AND ADHERENT AND INVASIVE E. COLI (AIEC) INFECTION IN CROHN’S DISEASE PATIENTS: RESULTS FROM THE CEALIVE MULTICENTER STUDY Emilie Vazeille, France; X. Hebuterne; M. Fumery; B. Pariente; S. nancey; P. SEKSIK; L. Peyrin-Biroulet; M. Allez; A. Dubois; N. Ballet; J. Filippi; J.-L. Dupas; M. Nachury; G. Boschetti; M. Goutte; G. Bommelaer; B. Pereira; N. Barnich; A. Buisson P0359 INCREASED LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH ULCERATIVE COLITIS IN REMISSION Magdalena Panek-Jeziorna, Poland; M. Jasinska; B. Marczak-Karpina; A. Mulak P0360 DOUBLE-BALLOON ENDOSCOPIC EVALUATION OF FECAL CALPROTECTIN AS A BIOMARKER FOR SMALL INTESTINAL INFLAMMATION IN CROHN’S DISEASE Rinzaburo Matsuura, Japan; O. Watanabe; M. Nakamura; T. Yamamura; M. Matsushita; M. Saito; Y. Mizutani; T. Sawada; Y. Niwa; E. Ishikawa; G. Uchida; H. Otsuka; H. Suzuki; T. Nishikawa; T. Ishida; T. Kuno; S. Hattori; K. Yamada; T. Ishikawa; K. Furukawa; K. Funasaka; E. Ohno; H. Kawashima; R. Miyahara; Y. Hirooka; H. Goto
Clinical Case Session
137
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0361 CLINICIANS’ ATTITUDES TO PHOTO PROTECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMUNOSUPPRESSION Catriona Gallagher, Ireland; M. Hussey; D. Tighe; A. Ridge; M. Kennedy; Y. Bailey; D. Kevans; A. M. Tobin; D. McNamara P0362 HOME MONITORING OF DISEASE ACTIVITY AND FECAL CALPROTECTIN IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE – INTERIM ANALYSIS OF 68 PATIENTS Dorit Ankersen, Denmark; D. Marker; P. Weimers; J. Burisch; P. Munkholm P0363 S100A4 PROTEIN IN INFLAMMATORY BOWEL DISEASE: RESULTS OF A SINGLE CENTRE PROSPECTIVE STUDY P. Moravkova; Darina Kohoutova, Czech Republic; J. Vavrova; J. Bures P0364 SEVERE VITAMIN D DEFICIT IN ACTIVE INFLAMMATORY BOWEL DISEASE G. Burrelli Scotti; M. T. Afferri; A. De Carolis; V. Vaiarello; V. Fassino; S. Minisola; Piero Vernia, Italy P0365 MAGNETIC RESONANCE OF THE SMALL BOWEL WITH EARLY (70S) AND LATE (7MINS) PHASE POST GADOLINIUM IMAGING TO IDENTIFY FIBROSIS IN STRICTURING SMALL BOWEL CROHN’S DISEASE. Roisin Stack, Ireland; C. O'Brien; T. Nuzum; S. Cummins; N. O'Morain; A. O'Connor; N. Breslin; B. Ryan; I. Murphy; D. McNamara P0366 GASTRODUODENAL INVOLVEMENT IN PATIENTS WITH CROHN'S DISEASE – UPPER ENDOSCOPY ONLY IN SYMPTOMATIC PATIENTS? Mafalda Sousa, Portugal; L. Proença; J. Silva; A. Ponte; J. Rodrigues; J. C. Silva; J. Carvalho P0367 ª INCIDENTAL FINDINGS AT CT ENTEROGRAPHY IN PATIENTS WITH CROHN'S DISEASE: CLINICAL SIGNIFICANCE AND IMPACT ON TARGETED THERAPY Rui Morais, Portugal; S. Lopes; I. Pita; F. Magro; G. Macedo P0368 CLINICAL SIGNIFICANCE OF ASYMPTOMATIC CLOSTRIDIUM DIFFICILE CARRIAGE IN PATIENTS ON IMMUNOMODULATOR FOR INFLAMMATORY BOWEL DISEASE Siu Tong Law, Hong Kong PRC; W. M. Yip; K. K. Li
138
P0369 BOWEL ULTRASOUND IS USEFUL IN DISEASE MONITORING OF ULCERATIVE COLITIS PATIENTS: FIRST ANALYSIS FROM THE TRUST&UC STUDY IN GERMANY Christian Maaser, Germany; F. Petersen; U. Helwig; A. Rössler; D. Lang; S. Rath; T. Kucharzik; on behalf of the TRUST&UC study group P0370 THE GUT MICROBIOME IN IBD IS CHARACTERIZED BY IMPAIRED METABOLIC COOPERATIVITY AND CAN BE RESTORED UPON ANTI-TNFα THERAPY Konrad Aden, Germany; A. Rehman; W. H. Pan; S. Waschina; J. Zimmermann; J. Bethge; A. Franke; S. Nikolaus; J. O. Schröder; R. Zeuner; C. Kaleta; S. Schreiber; P. Rosenstiel P0371 SELF-MONITORING OF THE COLONIC INFLAMMATORY BOWEL DISEASE BY A RAPID HOME BASED FEACAL CALPROTECTIN TEST AND A SYMPTOM QUESTIONNAIRE Anna-Maija Puolanne, Finland; M. A. A. Färkkila; K.-L. Kolho P0372 CLINICAL CHARACTERISTICS IN ULCERATIVE COLITIS PATIENTS WITH COLITIS ASSOCIATED DYSPLASIA/CANCER AND SPORADIC TUMOR Makoto Mutaguchi, Japan; M. Naganuma; Y. Iwao; T. Fukuda; S. Sugimoto; K. Nanki; S. Mizuno; H. Ogata; T. Kanai Treatment-medical P0373 CAN WE PREDICT THE LACK OF RESPONSE TO CYCLOSPORINE AS SECOND LINE THERAPY IN PATIENTS WITH ACUTE SEVERE COLITIS REFRACTORY TO CORTICOSTEROIDS? Hammami Aya, Tunisia; B. S. Aida; H. Bassem; J. Hanen; E. Nour; B. M. Imed; A. Salem; B. Ahlem; K. Mehdi; J. Ali P0374 CHANGES IN THERAPEUTIC STRATEGY AND OUTCOMES IN NEWLY DIAGNOSED PATIENT WITH CROHN’S DISEASE IN THE BIOLOGICAL ERA IN HUNGARY: A NATIONWIDE STUDY BASED ON THE NATIONAL HEALTH INSURANCE FUND DATABASE Zsuzsanna Kurti, Hungary; L. Gonczi; Z. Vegh; P. A. Golovics; P. Fadgyas-Freyler; J. Gimesi-Orszagh; G. Korponai; B. D. Lovasz; K. B. Gecse; P. L. Lakatos P0375 RELATIVE FREQUENCY OF RELAPSES IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE TREATED WITH MESENCHYMAL STROMAL CELLS – 5 YEARS OF FOLLOW UP O. Knyazev; A. Kagramanova; Nina Fadeeva, Russian Federation; A. Lishchinskaya; I. Ruchkina; A. Konoplyannikov; A. Parfenov
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0376 CELL THERAPY FOR PERIANAL CROHN'S DISEASE O. Knyazev; A. Kagramanova; N. Fadeeva; A. Lishchinskaya; Nikita Belyakov, Russian Federation; A. Konoplyannikov; A. Parfenov P0377 DYNAMICS OF PROINFLAMMATORY CYTOKINES IN PATIENTS WITH CROHN'S DISEASE TREATED WITH MESENCHYMAL STROMAL CELLS OF BONE MARROW AND AZATHIOPRINE O. Knyazev; Nina Fadeeva, Russian Federation; K. Noskova; A. Kagramanova; A. Konoplyannikov; R. Gudkova; E. Dobrolyubova; A. Parfenov P0378 EFFICACY AND SAFETY OF RECTAL 5-AMINOSALICYLIC ACID VERSUS CORTICOSTEROIDS IN ACTIVE DISTAL ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS Xiaojing Zhao, China; H. Zhang P0379 A PROTEASE-STABILISED ORAL DOMAIN ANTIBODY TO TNF DELIVERS HIGH CONCENTRATIONS OF ACTIVE COMPOUND IN ILEAL FLUID OF SUBJECTS WITH AN ILEOSTOMY J. Robinson; S. Crowe; G. Whale; K. Roberts; M. West; J. Ritter; P. Irving; Suhail Nurbhai, United Kingdom P0380 ULCERATIVE COLITIS (UC) WITH IBS – LIKE DISORDERS: PARTICULAR QUALITIES OF CLINICAL MANIFESTATIONS AND MEDICAL THERAPY. Ekaterina Dobrolyubova, Russian Federation; I. Ruchkina; A. Parfenov; O. Knyazev P0381 A PROSPECTIVE RANDOMISED STUDY: ELECTROACUPUNCTURE VS. SHAM PROCEDURE FOR THE TREATMENT OF FATIGUE IN PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DIASE Diana Horta, Spain; M. Sanchez-Lloansi; A. Lira; A. Villoria; M. Teggiachi; D. Garcia; T. Torres; M. Calatayud; A. Figuerola; X. Calvet P0382 EFFICACY AND SAFETY OF GOLIMUMAB IN CROHN’S DISEASE : A FRENCH NATIONAL RETROSPECTIVE STUDY Chloé Martineau, France; B. Flourie; P. Wils; T. Vaysse; R. Altwegg; A. Buisson; A. Amiot; G. Pineton de Chambrun; V. Abitbol; M. Fumery; X. Hebuterne; S. Viennot; D. Laharie; L. Beaugerie; S. Nancey; H. Sokol P0383 BIOLOGICS AND BIOSIMILARS: WHAT MATTERS TO PHYSICIANS? A. Molinari; A. Loaiza-Bonilla; David Charles, USA
Poster in the Spotlight
Poster of Excellence
P0384 ARE STEROIDS STILL USEFUL IN THOSE INFLAMMATORY BOWEL DISEASE PATIENTS UNDER IMMUNOSUPPRESSION? A RETROSPECTIVE POPULATION-BASED STUDY L. Arias García; G. Hontoria Bautista; E. Badia Aranda; F. Saez-Royuela Gonzalo; F. Gomollon; Beatriz Sicília Aladrén, Spain P0385 ADALIMUMAB LONG-TERM EFFECTIVENESS IN ADALIMUMAB-NAIVE PATIENTS WITH CROHN'S DISEASE: FINAL DATA FROM PYRAMID REGISTRY Edward Loftus Jr, USA; G. D'Haens; W. Reinisch; J. Satsangi; R. Panaccione; S. Berg; G. Alperovich; M. Bereswill; J. Kalabic; M. Skup; J. Petersson; A. M. Robinson P0386 EFFECT OF ADALIMUMAB ON CLINICAL AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES BY DISEASE SEVERITY AND PRIOR TUMOUR NECROSIS FACTOR INHIBITOR USE IN PATIENTS WITH ULCERATIVE COLITIS IN A CLINICAL PRACTICE SETTING: SUBGROUP ANALYSES FROM INSPIRADA Simon Travis, United Kingdom; B. G. Feagan; L. Peyrin-Biroulet; R. Panaccione; S. Danese; J. Petersson; A. Lazar; A. M. Robinson; N. Chen; M. Skup; W.-J. Lee P0387 SUBCUTANEOUS ADMINISTRATION OF A NOVEL FORMULATION OF CT-P13 (INFLIXIMAB BIOSIMILAR) IS SAFE AND ACHIEVES PROJECTED THERAPEUTIC DRUG LEVELS: A PHASE I STUDY IN HEALTHY SUBJECTS R. Westhovens; D. H. Yoo; S. Schreiber; W. Reinish; S. Ben-Horin; B. D. Ye; J. W. Kim; Sang Joon Lee, Republic of Korea; Y. J. Jung; J. H. Suh; S. Kim; D. H. Kwak P0388 REAL-WORLD HEALTHCARE UTILISATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE NEWLY TREATED WITH VEDOLIZUMAB AND ANTI-TUMOUR NECROSIS FACTOR AGENTS Mark Osterman, USA; A. Afzali; X. Song; N. Shi; M. Skup; W.-J. Lee P0389 SAFETY OF ANTI-TNF TREATMENT IN ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE Luís Maia, Portugal; P. Lago; Â. Rodrigues; M. S. Rodrigues; C. Caetano; D. Ferreira; M. Rocha; I. Pedroto P0390 SWITCHING FROM REFERENCE INFLIXIMAB TO CT-P13 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: 12 MONTHS RESULTS Maria Fernanda Guerra Veloz, Spain; F. Argüelles Arias; R. Perea Amarillo; L. Castro Laria; B. Maldonado Pérez; D. Chaaro; A. Benítez Roldan; V. Merino; G. Ramirez; A. Caunedo Álvarez; M. Romero Gómez
Clinical Case Session
139
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0391 CLINICAL RESPONSE TO VEDOLIZUMAB IN IBD PATIENTS IS ASSOCIATED WITH THE CONCOMITANT USE OF IMMUNOMODULATORS Ioanna Parisi, United Kingdom; R. Vega; L. Whitley; S. Bloom; S. McCartney P0392 CORRELATION OF RELATIONSHIP BETWEEN INFLIXIMAB AND ADALIMUMAB TROUGH AND ANTIBODY LEVELS WITH CLINICAL RESPONSE RATES AT COMPLETION OF INDUCTION THERAPY Donal Tighe, Ireland; S. Smith; A. O'Connor; B. Ryan; N. Breslin; D. McNamara P0393 BUDESONIDE IS SUPERIOR TO MESALAZINE AND PLACEBO FOR INDUCTION OF REMISSION IN LYMPHOCYTIC COLITIS Stephan Miehlke, Germany; D. Aust; E. Mihaly; P. Armerding; G. Boehm; O. K. Bonderup; F. Fernández-Bañares; J. Kupcinskas; L. K. Munck; K.-U. Rehbehn; T. Nacak; R. Greinwald; A. Münch P0394 PREGNANCY OUTCOMES IN THE TOFACITINIB ULCERATIVE COLITIS OCTAVE STUDIES U. Mahadevan; Daniel C. Baumgart, Germany; M. C. Dubinsky; N. Lawendy; G. Friedman; G. G. Konijeti; H. P. Gröchenig; T. V. Jones; A. Marren; A. J. Thorpe; C. Nduaka; C. Su P0395 SAFETY AND EFFICACY OF GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS IN 363 PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO HAVE SPECIAL SITUATIONS: AN INTERIM ANALYSIS OF A POST-MARKETING SURVEILLANCE STUDY Satoshi Motoya, Japan; H. Tanaka; T. Shibuya; T. Osada; H. Hongo; T. Kimura; D. Saito; A. Sakuraba; C. Mizuno; A. Ito; T. Kobayashi; D. Abukawa; S. Kokuma; E. Hosoi P0396 INTEGTRATING PSYCHOLOGICAL SUPPORT INTO ROUTINE CARE FOR PEOPLE WITH INFLAMMATORY BOWEL DISEASE. T. Lores; Charlotte Goess, Australia; C. Hrycek; R. Grafton; J. Hughes; L. Cronin; A. Mikocka-Walus; A. Chur-Hansen; A. L. Burke; K. L. Collins; J. M. Andrews P0397 LONG-TERM EFFICACY, SAFETY, AND IMMUNOGENICITY DATA FROM A PHASE III CONFIRMATORY STUDY COMPARING GP2017, A PROPOSED BIOSIMILAR, WITH REFERENCE ADALIMUMAB A. Blauvelt; J.-P. Lacour; J. F. Fowler; E. Schuck; Julia Jauch-Lembach, Germany; A. Balfour; C. L. Leonardi
140
P0398 PREDICTIVE FACTORS OF RESPONSE TO GRANULOCYTE – MONOCYTE APHERESIS IN INFLAMMATORY BOWEL DISEASE Iago Rodríguez – Lago, Spain; J. M. Benítez-Cantero; V. García-Sánchez; L. Sempere; A. Gutiérrez; I. Galdona; A. Rodríguez-Pescador; E. Fernández; I. Lafuente; A. Loroño; J. L. Cabriada P0399 ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY William J. Sandborn, USA; B. R. Bhandari; C. Randall; Z. Younes; T. Romańczyk; H. Chai; M. McKevitt; S. Zhao; B. Kanwar; J. Sundy; S. Keshav; S. Danese P0400 ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR CROHN’S DISEASE: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY Stefan Schreiber, Germany; C. Siegel; K. Friedenberg; U. Seidler; B. R. Bhandari; Z. Younes; K. Wang; M. McKevitt; S. Zhao; B. Kanwar; J. Sundy; S. D. Lee; E. V. Loftus Jr P0401 TUBERCULIN SKIN TEST CONVERSION RATE IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING ANTI-TNF ALPHA AGENTS M. Fragkaki; A. Mpitouli; I. Dimas; Grigorios Paspatis, Greece; K. Karmiris P0402 THE TEMPORAL EVOLUTION OF IMMUNOGENICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH ADALIMUMAB Bella Ungar, Israel; T. Engel; D. Yablecovich; A. Lahat; A. Lang; B. Avidan; O. Har-Noy; N. Levhar; L. Selinger; S. Neuman; O. Haj Natour; M. Yavzori; E. Fudim; O. Picard; U. Kopylov; Y. Chowers; T. Naftali; E. Broide; E. Shachar; R. Eliakim; S. Ben-Horin P0403 GOLIMUMAB IN ULCERATIVE COLITIS. REAL-LIFE PROSPECTIVE COHORT STUDY FROM A SINGLE REFERRAL CENTRE OF MIDDLE ITALY Laurino Grossi, Italy; V. Vecchione; S. Cocciolillo; R. Tavani; M. Di Berardino; A. Sepe; C. Di Giacomo; N. Russo; V. D'Addetta; L. Marzio P0404 FIVE-YEAR SAFETY DATA FROM THE OBSERVATIONAL POSTMARKETING ULCERATIVE COLITIS STUDY, A EUROPEAN REGISTRY FOR ADULTS WITH ULCERATIVE COLITIS TREATED WITH ORIGINATOR INFLIXIMAB OR STANDARD THERAPY Julian Panés, Spain; J. Lindsay; N. Teich; S. Lindgren; J.-F. Colombel; F. Cornillie; H. A. Flynn; S. Huyck; P. Stryszak; R. Yao; G. Philip; W. Reinisch
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0405 DIRECT INTESTINAL PH-TRANSIT ASSESSMENT IN PATIENTS WITH ULCERATIVE COLITIS AS A STRATEGY FOR PREDICTING SUCCESS OF REGIONAL DELIVERY OF TOPICALLY-ACTING DRUGS Ck Yao, Australia; R. E. Burgell; K. M. Taylor; M. G. Ward; J. S. Barrett; J. G. Muir; P. R. Gibson P0406 HIGHER EXPOSURE TO GOLIMUMAB IS ASSOCIATED WITH ENDOSCOPIC RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE GO-KINETIC TRIAL Sophie Berends, The Netherlands; A. Strik; R. Mathot; G. R. D'Haens; M. Lowenberg P0407 COMPARATIVE EFFICACY AND SAFETY OF TOFACITINIB AND BIOLOGICS AS INDUCTION THERAPY FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS David Rubin, USA; A. O. Ashaye; Y. Zhang; Y. Xu; K. Fahrbach; L. A. Chen; A. Manuchehri; C. Kayhan; J. Woolcott; J. C. Cappelleri P0408 CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH C. DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE: BEZLOTOXUMAB VERSUS PLACEBO Ciaran Kelly, USA; M. Wilcox; H. Glerup; N. Aboo; K. Eves; D. Mary Beth P0409 SIMILAR TRIAL - EFFICACY OF INFLIXIMAB-BIOSIMILAR COMPARED TO INFLIXIMAB-BIOLOGICAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN REMISSION – A RANDOMIZED, CONTROLLED, DOUBLE BLIND, PHASE 4 NONINFERIORITY TRIAL Adrian Volkers, The Netherlands; J. M. Jansen P0410 WITHDRAWN P0411 ENCAPSULATED FECAL MICROBIOTA TRANSFER IN PATIENTS WITH CHRONIC, ANTIBIOTIC–REFRACTORY POUCHITIS A. Steube; M. Vital; A. Sturm; C. Buening; Andreas Stallmach, Germany; D. Pieper P0412 HISTOLOGIC MEASURES OF MUCOSAL HEALING CORRELATE WITH ENDOSCOPIC MEASURES OF DISEASE ACTIVITY AT BASELINE AND FOLLOWING INDUCTION THERAPY WITH THE JAK1 INHIBITOR FILGOTINIB IN ACTIVE CROHN’S DISEASE: RESULTS FROM FITZROY STUDY Walter Reinisch, Austria; G. R. D'Haens; G. De Hertogh; A. Van der Aa; J. Zhang; C. Tasset; C. Yun; A. Serone; B. G. Feagan; W. J. Sandborn; S. Vermeire
Poster in the Spotlight
Poster of Excellence
P0413 RESPONSE AND REMISSION AFTER 16 WEEKS OF USTEKINUMAB– AN ALL PATIENTS ANALYSIS FROM THE UNITI CROHN’S STUDIES Jean-Fred Colombel, USA; S. Sloan; C. Gasink; L.-L. Gao; D. Jacobstein; S. D. Lee; S. R. Targan P0414 REAL-WORLD PATTERNS OF TREATMENT DISCONTINUATION, FLARES, AND HOSPITALISATIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS WITHIN 12 MONTHS OF INITIATION OF VEDOLIZUMAB OR INFLIXIMAB Haridarshan Patel, United Kingdom; M. Raluy Callado; A. Berger; R. Curtis; M. J. Khalid Poster Session 09:00 – 17:00 Other Lower GI Disorders I
Hall 7
Lower GI Immunology, immunity, inflammation (NOT IBD) P0415 OXIDATIVE STRESS ENHANCES THE ANTIGEN PRESENTING FUNCTION OF COLONIC EPITHELIAL CELLS BY INDUCING CD80 IN THE EARLY STAGES OF COLONIC CARCINOGENESIS Chiara Marchiori, Italy; A. Kotsafti; I. Angriman; C. Castoro; A. Porzionato; P. BRUN; M. Scarpa; I. Castagliuolo; M. Scarpa P0416 ALTERED INTESTINAL EXPRESSION PROFILES OF ANTI-MICROBIAL GENES IN IRRITABLE BOWEL SYNDROME ARE LINKED TO BACTERIAL COMPOSITION AND IMMUNE ACTIVATION Johanna Sundin, Sweden; S. M. P. Bennet; M. K. Magnusson; J. Tap; M. Derrien; B. Le Nevé; J. Doré; H. Törnblom; M. Simrén; L. Öhman P0417 THE EXPOSURE OF ANTIBIOTICS IS ASSOCIATED WITH INCREASED RISK OF COLORECTAL CANCER- A SYSTEMATIC REVIEW AND META-ANALYSIS Xingkang He, China; W. wu; Y. Ding; L. Sun P0418 EFFECT OF INTERNAL AND EXTERNAL BILIARY DRAINAGE ON INTESTINAL MUCOSAL BARRIER FUNCTION IN BILIARY OBSTRUCTION RATS Shuling Li, China; X. Su; K. Luo; C. Ge; W. Li P0419 COMPARATIVE EFFECT OF XYLOGLYCAN ASSOCIATIONS WITH COMPOUNDS FROM ANIMAL OR ALGAE ORIGIN ON LPS-INDUCED ENTERITIS IN RATS Helene Eutamene, France; C. Harkat; V. Theodorou
Clinical Case Session
141
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Lower GI infections
Monday, October 30, 2017
P0420 RISK FACTORS ASSOCIATED WITH RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION IN THE ELDERLY Min Su You, Republic of Korea; D. H. Lee P0421 CLINICAL CHARACTERISTICS OF CYTOMEGALOVIRUS COLITIS: 15 YEAR-EXPERIENCE IN A TERTIARY MEDICAL CENTER Puo-Hsien Le, Taiwan; R.-C. Wu; C.-T. Chiu; C.-J. Kuo; M.-Y. Su; C.-J. Lin; J.-T. Hsu P0422 FIRST CASE SERIES OF FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN BALTIC COUNTRIES Rolandas Gedgaudas, Lithuania; M. Urba; V. Petkevicius; L. Jonaitis; G. Kiudelis; L. Kupcinskas; J. Kupcinskas P0423 A RANDOMISED CONTROLLED TRIAL OF RIFAXIMIN TO PREVENT RELAPSE OF CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHOEA AFTER RESOLUTION WITH STANDARD THERAPY Giles Major, United Kingdom; L. Bradshaw; N. Boota; K. Sprange; A. Jawhari; M. Diggle; A. Montgomery; R. Spiller P0424 A SYSTEMATIC REVIEW AND META-ANALYSIS OF IN-HOSPITAL DELAY BEFORE SURGERY AS A RISK FACTOR FOR COMPLICATIONS IN PATIENTS WITH ACUTE APPENDICITIS. Stefan van Dijk, The Netherlands; A. Van Dijk; M. G. W. Dijkgraaf; M. A. Boermeester P0425 VANCOMYCIN FOLLOWED BY FECAL MICROBIOTA TRANSPLANTATION VERSUS VANCOMYCIN FOR INITIAL CLOSTRIDIUM DIFFICILE INFECTION: AN OPEN-LABEL RANDOMISED CONTROLLED TRIAL Siew Chien Ng, Hong Kong PRC; S. H. Wong; R. N. Lui; K. Cheung; J. Y. L. Ching; W. Tang; M. Kyaw; Z. Tao; K. T. Ho; M. Ip; P. Chan; F. K. L. Chan; J. J. Y. Sung; J. C. Wu; L. Y. K. Lam P0426 A 10-YEAR REVIEW OF ABDOMINAL TUBERCULOSIS EXPERIENCE IN A MULTI-ETHNIC SECONDARY CARE POPULATION U. Shivaji; T. Critchlow; S. Pathmakanthan; S. Ghosh; M. Iacucci; N. Sharma; R. Cooney; T. Iqbal; P. Glynn; Neeraj Bhala, United Kingdom
142
P0427 INCREASING INCIDENCE OF CLOSTRIDIUM DIFFICILE INFECTION AND THE USE OF PROTON-PUMP INHIBITORS: RESULTS FROM A TERRITORY-WIDE POPULATION STUDY IN HONG KONG Sunny Wong, Hong Kong PRC; J. Ho; R. Dai; L. Y. K. Lam; S. C. C. Ng; J. C. Wu; J. J. Y. Sung; W. Wu Lower GI bleeding P0428 THE PROPHYLACTIC CLIP APPLICATION BEFORE SNARE POLYPECTOMY DECREASES IMMEDIATE POST-POLYPECTOMY BLEEDING IN LARGE PEDUNCULATED POLYPS. Jae Seung Soh, Republic of Korea; S. H. Park; Y. Song; K.-J. Kim P0429 DOES CONTINUATION OF WARFARIN BECOME A PERIPROCEDURAL ALTERNATIVE METHOD TO HEPARIN REPLACEMENT IN COLONIC POLYPECTOMY / ENDOSCOPIC MUCOSAL RESECTION? Itaru Saito, Japan; S. Ono; Y. Takeda; K. Takemura; H. Doyama; Y. Tsuji; K. Niimi; S. Kodashima; N. Yamamichi; M. Fujishiro; K. Koike P0430 EFFECTS OF HEPARIN BRIDGING THERAPY ON POST-POLYPECTOMY BLEEDING AND THROMBOEMBOLIC RISKS IN PATIENT UNDERGOING COLONOSCOPIC POLYPECTOMY Noriyuki Hayashi, Japan; H. Kataoka; T. Katano; K. Ozeki; Y. okamoto; T. Mizoshita; T. Shimura; E. Kubota; S. Tanida; T. Joh P0431 ARTERIOSCLEROSIS IS A SIGNIFICANT CONTRIBUTOR TO COLON DIVERTICULUM RECURRENT BLEEDING Taiki Aoyama, Japan; S. Nagata; T. Sakamoto; Y. Shimohara; H. Tamari; Y. Ogawa; K. Shigita; N. Asayama; A. Fukumoto; S. Mukai P0432 EARLY VERSUS STANDARD COLONOSCOPY – A RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH ACUTE LOWER GASTRO-INTESTINAL BLEEDING: RESULTS OF THE BLEED STUDY Inge van Rongen, The Netherlands; B. Thomassen; L. Perk P0433 THE COMPARISON OF DIRECT ORAL ANTICOAGULANTS (DOAC) AND WARFARIN FOR ANTICOAGULATION IN THE PATIENTS WITH GASTROINTESTINAL BLEEDING Kentaro Kojima, Japan; N. Toda; J. Arai; K. Kurokawa; C. Shibata; S. Kurosaki; K. Funato; M. Kondo; T. Ohki; M. Seki; K. Tagawa
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
Lower GI malignant disease-epidemiology P0434 WITHDRAWN P0435 INCREASED INCIDENCE OF OVARIAN CANCER FOLLOWING COLORECTAL CANCER: A KOREAN NATIONWIDE COHORT STUDY Dong Woo Shin, Republic of Korea; D. H. Lee; H. S. Kim P0436 WORLD ENDOSCOPY ORGANISATION CONSENSUS STATEMENTS ON POST-COLONOSCOPY/POST-IMAGING COLORECTAL CANCER Iosif Beintaris, United Kingdom; S. Sanduleanu; H. M. Chiu; D. Corley; M. Cuatrecasas; E. Dekker; A. Forsberg; U. Haug; M. F. Kaminski; T. Matsuda; G. A. Meijer; E. Morris; A. Plumb; L. Rabeneck; D. Robertson; R. Schoen; H. Singh; J. Tinmouth; R. Valori; G. Young; M. D. Rutter P0437 EXCESS RISK OF SECOND PRIMARY CANCERS IN YOUNG-ONSET COLORECTAL CANCER SURVIVORS Xingkang He, China; W. wu; L. Sun; Y. Ding; J. Si P0438 INCIDENCE OF FECAL OCCULT BLOOD TEST INTERVAL CANCERS IN COLORECTAL CANCER SCREENING; A SYSTEMATIC REVIEW AND META-ANALYSIS Els Wieten, The Netherlands; E. Schreuders; E. J. Grobbee; D. Nieboer; I. Lansdorp-Vogelaar; M. J. Bruno; E. J. Kuipers; M. C. W. Spaander P0439 MEASURES OF BODY COMPISITION AND GENDER DIFFERENCES IN RISK FOR COLORECTAL CANCER – A POPULATION-BASED COHORT STUDY Anna Forsberg, Sweden; F. Sköldberg; P. Thelin Schmidt; A. Carlsson; K. Önnerhag; H. Hagström; A. Andreasson Lower GI malignant disease, pathogenesis P0440 TH17 CELLS INDUCE EPITHELIAL-MESENCHYMAL TRANSITION VIA IL-17/PI3K/AKT/SNAIL PATHWAY IN COLORECTAL CANCER Quan-Lin Li, China; X.-Y. Xu; P.-H. Zhou P0441 MICRORNA EXPRESSION PROFILE IN RECTAL CANCER Jan Král, Czech Republic; V. Rusnakova; L. Langerova; V. Korenkova; P. Vodicka; J. Spicak; J. Slyskova P0442 MUSCARINIC-3 RECEPTOR TARGETED MIRNAS ARE INVOLVED IN BILE ACID INDUCED PROLIFERATION ON H508 COLON CANCER CELL LINE Fatih Tekin, Turkey; C. Aktan; N. Oruc; O. Ozutemiz Poster in the Spotlight
Poster of Excellence
P0443 COLORECTAL CANCER AND DYSLIPIDAEMIA: CAUSE OR CONFOUNDING? A MENDELIAN RANDOMIZATION STUDY Gemma Ibáñez, Spain; A. Díez-Villanueva; M. Riera-Ponsati; E. Guinó; B. Pérez-Gómez; M. Bustamante; V. Martin; J. Llorca; P. Amiano; E. Ardanaz; A. Tardón; J. J. Jimenez-Moleon; R. Peiró; J. Alguacil; C. Navarro; P. Pablo Fernández Navarro; A. Espinosa; V. Verónica Dávila-Batista; A. J. Molina; C. Palazuelos; G. Castaño-Vinyals; N. Aragonés; M. Kogevinas; M. Pollán; V. Moreno P0444 LINC00152 LONG NON-CODING RNA FACILITATES CELL PROLIFERATION IN SW480 COLON CARCINOMA CELLS THROUGH REGULATION OF CELL CYCLE AND WNT SIGNALING PATHWAY Orsolya Galamb, Hungary; B. K. Bartak; A. Kalmár; A. Sebestyén; T. Dankó; C. Tolnai-Kriston; G. Valcz; K. Szigeti; Z. B. Nagy; G. Barna; Z. Tulassay; P. Igaz; B. Molnar P0445 GENETIC PROFILE OF POLYPS AND RISK OF ADVANCED METACHRONOUS LESIONS Oscar Murcia, Spain; M. Juárez; E. Hernández-Illán; M. Rodríguez-Soler; C. Egoavil; C. Alenda; A. Martínez-García; C. Mangas; M. Giner-Calabuig; M. Alustiza; J. R. Aparicio; F. A. Ruiz; J. F. Martínez; J. A. Casellas; J. L. Soto; P. Zapater; R. Jover P0446 MITOCHONDRIAL GLUTAMATE TRANSPORTER (SLC25A22) MEDIATES DNA AND HISTONE HYPERMETHYLATION AND PROMOTES THE TUMORIGENICITY OF KRAS-MUTANT COLORECTAL CANCER Chi Chun Wong, Hong Kong PRC; J.-L. Wu; J. Xu; W. Kang; Y. Qian; H. Chen; X. Li; Z. Cai; J. Jao-yiu Sung; J. Yu P0447 FOLLISTATIN-LIKE PROTEIN 1 SUSTAINS COLON CANCER CELL GROWTH AND SURVIVAL Gerolamo Bevivino, Italy; V. De Simone; R. Izzo; M. Di Giovangiulio; S. Sedda; E. Franzè; A. Rizzo; P. Rossi; C. Stolfi; G. Monteleone P0448 TP53 MUTATION ACQUIRES HIGHER MALIGNANT POTENTIAL IN HUMAN COLON CANCER CELLS Sho Watanabe, Japan; K. Tsuchiya; T. Shirasaki; S. Hibiya; S. Ooshima; T. Nakamura; M. Watanabe; R. Nishimura; R. Okamoto P0449 PROTECTIVE EFFECT OF OPIOID RECEPTOR ACTIVATION IN THE DEVELOPMENT OF COLITIS-ASSOCIATED COLORECTAL CANCER IN MICE Agata Jarmuz, Poland; D. Jacenik; H. Zatorski; R. Kordek; W. M. Krajewska; J. Fichna; M. Zielińska
Clinical Case Session
143
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Lower GI malignant disease, diagnosis/histopathology
Monday, October 30, 2017
P0450 INCREASED HMGB1 EXPRESSION CORRELATES WITH HIGHER EXPRESSION OF C-IAP2 AND PERK IN COLORECTAL CANCER Wenjia Zhang, China; M. Xia; F. an; Q. Zhan; W. Tian P0451 THE POSSIBILITIES OF APPLICATION OF METABOLIC PROFILES OF BLOOD SERUM AND RED BLOOD CELLS IN DIAGNOSING OF COLORECTAL CANCER Margarita Kruchinina, Russian Federation; A. A. Gromov; Y. I. Prudnikova; S. A. Kurilovich; V. N. Kruchinin; M. V. Shashkov; A. S. Sokolova; S. E. Peltec P0452 THE MICRORNAS EXPRESSION PROFILES OF MULTIPLE COLORECTAL TUMORS Yoshihito Nakagawa, Japan; Y. Akao; T. Tahara; T. Shibata; M. Nagasaka; N. Ohmiya P0453 UTILITY OF MEAN PLATELET VOLUME, PLATELETCRIT, PLATELET-LYMPHOCYTE RATIO AND NEUTROPHIL-LYMPHOCYTE RATIO IN THE DIFFERENTIATION OF COLON CANCER AND COLONIC POLYPS IN OLDER PATIENTS Fatih Karakaya, Turkey; Ç. Kalkan; I. Soykan P0454 IMPROVING THE SELECTION OF COMPLETE RESPONDERS FOR WATCHFUL WAITING AFTER CHEMORADIOTHERAPY FOR RECTAL CANCER: WHAT CAN WE LEARN FROM THE ‘MISSED’ PATHOLOGIC COMPLETE RESPONDERS AFTER SURGERY? Doenja M. Lambregts, The Netherlands; M. Maas; M. van der Sande; B. Hupkens; M. Martens; F. Bakers; R. G. H. Beets-Tan; S. O. Breukink; G. L. Beets P0455 RADIOMICS AS A NOVEL TOOL FOR PRE-TREATMENT RESPONSE PREDICTION IN RECTAL CANCER J. J. M. van Griethuysen; S. Trebeschi; Doenja M. Lambregts, The Netherlands; M. Lahaye; F. Bakers; R. F. A. Vliegen; E. Voest; G. L. Beets; R. G. H. Beets-Tan; H. J. W. L. Aerts P0456 CORRELATION OF ELECTRICAL AND VISCOELASTIC PARAMETERS OF ERYTHROCYTES WITH FATTY ACID COMPOSITION OF THEIR MEMBRANES AND SERUM IN PATIENTS WITH COLORECTAL CANCER Iana Prudnikova, Russian Federation P0457 CLINICOPATHOLOGICAL STUDY OF LATERALLY SPREADING TUMORS OF THE COLORECTUM. Masahiro Iwabuchi, Japan; M. Sugimura; S. Toda; K. Ukai
144
P0458 POST INVESTIGATION COLORECTAL CANCER RATES INCLUDING POST COLONOSCOPY COLORECTAL CANCER RATES IN A DISTRICT GENERAL HOSPITAL: THE POOLE EXPERIENCE MARCH 2015 TO FEBRUARY 2017. Sally Davina Parry, United Kingdom; T. Deacy; E. J. Williams P0459 RISK OF DETECTION OF GASTROINTESTINAL NEOPLASMS AND DEATH IN SYMPTOMATIC PATIENTS WITH A POSITIVE FECAL IMMUNOCHEMICAL TEST WITHOUT COLORECTAL CANCER Noel Pin, Spain; M. J. Iglesias; D. Remedios; P. Vega; J. Cubiella Lower GI malignant disease, management P0460 LONG-TERM OUTCOMES OF TRANSANAL COLORECTAL TUBE PLACEMENT FOR DISTAL STAGE II/III COLORECTAL CANCER WITH ACUTE COLORECTAL OBSTRUCTION Tomonori Yamada, Japan; Y. Okuda; R. Yamaguchi; E. Sakamoto; Y. Hirata; T. Shimura P0461 FACTORS ASSOCIATED WITH THE TECHNICAL DIFFICULTY OF DOUBLE-WIRE WOVEN UNCOVERED SELF-EXPANDABLE METALLIC STENT PLACEMENT FOR MALIGNANT COLORECTAL OBSTRUCTION Kenji Tominaga, Japan; I. Maetani; S. Yoshida; H. Isayama; T. Yamada; Y. Sumida; R. Kyo; T. Kuwai; M. Tomita; Y. Kushiyama; M. Kikkawa; S. Saito; Y. Saida P0462 PROGNOSIS AND CLINICOPATHOLOGICAL FACTORS OF PATIENTS WHO SELECTED THE FOLLOW-UP OPTION AMONG HIGH-RISK T1 COLORECTAL CANCER PATIENTS AFTER ENDOSCOPIC RESECTION BASED ON JAPANESE CLINICAL PRACTICE GUIDELINE: A RETROSPECTIVE OBSERVATIONAL STUDY. Yoshitaka Nishikawa, Japan; T. Horimatsu; S. Minamiguchi; H. Seno; Y. Sakai; T. Nakayama P0463 LONG-TERM OUTCOMES AFTER TREATMENT FOR T1 CARCINOMA OF LATERALLY SPREADING TUMORS: – A MULTICENTER RETROSPECTIVE STUDY OF HIROSHIMA GI ENDOSCOPY RESEARCH GROUPKen Yamashita, Japan; S. Tanaka; S. Oka; S. Nagata; T. Kuwai; A. Furudoi; T. Tamura; M. Kunihiro; H. Okanobu; K. Nakadoi; H. Kanao; M. Higashiyama; Y. Tamaru; F. Shimamoto; K. Chayama
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Monday, October 30, 2017
Poster Sessions : UEG Week Final Programme
P0465 COMPLETE ENDOSCOPIC MUCOSAL RESECTION OF MALIGNANT COLONIC SESSILE POLYPS AND CLINICAL OUTCOME OF 51 CASES. M. Fragkaki; E. Chliara; I. Dimas; A. Mpitouli; E. Vardas; A. Theodoropoulou; K. Karmiris; E. Voudoukis; L. Giannikaki; Grigorios Paspatis, Greece P0466 IMPACT OF EVALUATION OF PRECISION CHEMOTHERAPY FOR COLORECTAL CANCER (CRC) BASED ON COLLAGEN GEL DROPLET-EMBEDDED DRUG SENSITIVITY TEST (CD-DST). Takumi Ochiai, Japan; K. Nishimura; T. Watanabe; M. Kitajima; A. Nakatani; K. Nagayasu; N. Sakuyama; T. Sato; K. Kishine; Y. Abe; C. Hara; K. Fujiwara; I. Nagaoka P0467 WAIT-AND-SEE STRATEGY IN LOW RECTAL CANCER João Cortez-Pinto, Portugal; R. Oom; I. Rosa; C. Travancinha; G. Fernandez; I. Marques; I. Miguel; J. Freire; J. Pereira da Silva; J. Venâncio; L. d´Orey; L. Mirones; M. Limbert; P. Chaves; P. Pereira; R. Fonseca; R. Barroca; T. Ferreira; T. Marques; A. Dias Pereira P0468 LONG-TERM COLONOSCOPIC SURVEILLANCE BETWEEN PATIENTS AFTER SURGICAL RESECTIONS OF COLORECTAL INVASIVE CANCER AND THOSE AFTER ENDOSCOPIC RESECTIONS OF COLORECTAL ADENOMA AND INTRAMUCOSAL CANCER Seiji Kimura, Japan; M. Tanaka P0469 LONG-TERM COLONOSCOPIC SURVEILLANCE BETWEEN PATIENTS WITH UNRESECTED DIMINUTIVE POLYPS AND THOSE WITH COLORECTAL ADENOMAS > 5MM IN SIZE RESECTED AT INITIAL COLONOSCOPY Seiji Kimura, Japan; M. Tanaka P0470 A NEW SCORING MODEL FOR PREDICTING ADVANCED COLORECTAL NEOPLASIA IN ASYMPTOMATIC SCREENING POPULATION AND COMPARISON WITH THE MODIFIED ASIA-PACIFIC COLORECTAL SCREENING SCORE Masau Sekiguchi, Japan; T. Matsuda; Y. Kakugawa; M. Matsumoto; Y. Saito
Poster in the Spotlight
Poster of Excellence
IBS /Lower GI motility: Brain-gut and gut-brain axes, neuro-hormonal, neural-immune and visceral sensitivity P0471 ASSOCIATION BETWEEN PARAMETERS OF THE RECTOANAL INHIBITORY REFLEX AND THRESHOLD FOR FIRST RECTAL SENSATION ESTABLISHED BY HIGH-RESOLUTION ANORECTAL MANOMETRY (HRAM) AND ITS SIGNIFICANCE FOR FECAL INCONTINECE DIAGNOSTICS Olga Storonova, Russian Federation; A. Trukhmanov; V. T. Ivashkin P0472 AVOIDANT COPING AND SOMATIZATION PARTLY EXPLAIN THE RELATIONSHIP BETWEEN NEUROTICISM AND GASTROINTESTINAL SYMPTOM BURDEN Michael P. Jones, Australia; A. P. Beath; A. Ejova; P. Mahoney; J. M. Koch P0473 POTENTIAL REGULATORY EFFECTS OF CORTICOTROPIN-RELEASING FACTOR ON TIGHT JUNCTION-RELATED INTESTINAL EPITHELIAL PERMEABILITY ARE PARTIALLY MEDIATED THROUGH CK8 UPREGULATION Yue Hu, China; B. Lv P0474 REGULATING EFFECTS OF TONGXIE-YAOFANG FORMULA ON COLONIC EPITHELIAL SECRETION IN RATS WITH DIARREHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME Y. Cheng; Zhan Qiang, China; Z. Q. Lin; S. Jing; L. X. Ling P0475 DIOSMECTITE CHRONIC TREATMENT SUPPRESSES GUT VISCERAL HYPERSENSITIVITY AND INTESTINAL TRANSIT ACCELERATION INDUCED BY CHRONIC STRESS IN RAT. Helene Eutamene, France; C. Beaufrand; H. Mathiex-Fortunet; V. Theodorou P0476 METABOLOMIC SIGNATURE OF THE POSTPRANDIAL EXPERIENCE Carolina Malagelada, Spain; T. Pribic; N. Cañellas; J. Gomez; N. Amigo; B. Ciccantelli; A. Accarino; J. R. Malagelada; F. Azpiroz P0477 NEGATIVE EFFECTS OF BIFIDOBACTERIUM BIFIDUS ON THE RAT WITH COLONIC VISCERAL HYPERSENSITIVITY INDUCED BY ACETIC ACID PERFUSION X. Wang; Weifang Zhang, China; K. Wang; L. Zhang; Q. Sun; L. Duan Lower GI motility disorders: Clinical P0478 EFFECTS OF PREBIOTICS AND SYNBIOTICS ON FUNCTIONAL CONSTIPATION Ting Yu, China; L. Lin
Clinical Case Session
145
Monday, October 30, 2017
P0464 ASSESSMENT OF THE EFFECTS OF A PACLITAXEL-ELUTING SELF-EXPANDING METAL STENT ON NAÏVE PORCINE BILIARY TISSUE John Favreau, USA; G. Haber; S. Alkaade; M. Arain; T. H. Baron; S. Branch; P. V. Draganov; J. H. Lee; D. K. Mullady; B. T. Petersen; R. J. Shah; S. Sherman; D. Amos; R. Bennett; J. Hemerick; S. Dassner; A. Foss; D. Ross; A. Pearlman; J. Saunders; M. Rivera-Bermudez; C. O. Clerc; L. Swanson; J. Scutti
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0479 EFFICACY AND PREDICTORS FOR BIOFEEDBACK THERAPEUTIC OUTCOME IN PATIENTS WITH DYSSYNERGIC DEFECATION Ting Yu, China; L. Lin P0480 THE PREVALENCE OF DELAYED OROCECAL TRANSIT TIME AND SMALL INTESTINAL BACTERIAL OVERGROWTH IN PATIENTS WITH FUNCTIONAL CONSTIPATION Ting Yu, China
Diverticular disease P0488 DIVERTICULITIS IN THE SIGMOID COLON HAS THE HIGHEST RISK FOR INTESTINAL COMPLICATION OF COLONIC DIVERTICULITIS IN JAPANESE PATIENTS Hiroshi Takayama, Japan; Y. Shimodate; A. Doi; N. Nishimura; H. Mouri; K. Matsueda; H. Yamamoto; M. Mizuno
P0481 THE DIAGNOSTIC VALUE OF BALLOON EXPLUSION TEST AND COLON TRANSIT TEST AND AGREEMENT WITH FINDINGS FROM HIGH RESOLUATION ANORECTAL MANOMETRYIN PATIENTS WITH DYSSYNERGIA DEFECATION Ting Yu, China
P0489 A VARIANT OF COL3A1 (RS3134646) IS ASSOCIATED WITH RISK OF DEVELOPING DIVERTICULOSIS IN CAUCASIAN MALES M. C. Reichert; Juozas Kupcinskas, Lithuania; M. Krawczyk; C. Jüngst; B. Appenrodt; S. N. Weber; V. Zimmer; A. Tamelis; J. I. Lukosiene; N. Pauziene; G. Kiudelis; L. Jonaitis; C. Schramm; T. Goeser; M. Glanemann; L. Kupcinskas; F. Lammert
P0482 DA-9701 IMPROVES COLONIC TRANSIT TIME AND SYMPTOMS IN PATIENTS WITH FUNCTIONAL CONSTIPATION: A PROSPECTIVE STUDY S.-Y. Kim; Hyun Sun Woo, Republic of Korea; S. H. Choi; D. K. Park; K. A. Kwon; J.-W. Chung; Y. J. Kim; J. H. Kim; S. J. Kim; K. O. Kim
P0490 THE USE OF ENDOSCOPIC CLASSIFICATION “DICA” MAY HAVE A SIGNIFICANT COST-SAVING ON THE BURDEN OF DIVERTICULAR DISEASE OF THE COLON A. Tursi; W. Elisei; M. Picchio; G. Nasi; A. M. Mastromatteo; F. Di Mario; E. Di Rosa; M. A. Brandimarte; C. Cassieri; P. G. Lecca; Giovanni Brandimarte, Italy
Irritable bowel syndrome: Classification and diagnosis P0483 INDEPENDENT VALIDATION OF THE ROME IV CRITERIA FOR IRRITABLE BOWEL SYNDROME REVEALS THEIR MODEST PERFORMANCE AND RESTRICTIVE NATURE. Orla Craig, United Kingdom; C. Black; L. Houghton; A. C. Ford P0484 WHAT DETERMINES WHETHER INDIVIDUALS WITH IRRITABLE BOWEL SYNDROME IN THE GENERAL POPULATION SEEK MEDICAL CARE FOR THEIR DISORDER? Navkiran Jossan, Sweden; H. Törnblom; M. Simrén; I. Aziz; O. S. Palsson; A. Sperber; W. E. Whitehead P0485 PERFORMANCE OF A DIAGNOSTIC ALGORITHM FOR FUNCTIONAL GASTROINTESTINAL DISORDERS. Ecushla Linedale, Australia; A. Mikocka-Walus; P. R. Gibson; J. M. Andrews P0486 SCOTTISH GUT MOTILITY DISORDER CLINIC: REVIEW OF ACTIVITY OVER 1 YEAR PERIOD. Francesca Moroni, United Kingdom; M. P. Eugenicos P0487 ALTERED EXPRESSION OF MEMBRANE TRANSPORTERS IN COLONIC MUCOSA OF PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) AND POST-INFECTIOUS (PI)IBS COMPARED TO HEALTHY SUBJECTS Rebecca Wall, Sweden; T. M. Marques; H. Edebol-Carlman; J. Sundin; R. Vumma; I. Rangel; R. J. Brummer 146
P0491 NATURAL HISTORY OF SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE: A 13-YEAR PROSPECTIVE STUDY A. Tursi; S. Scida; C. Miraglia; C. Scarpignato; M. Franceschi; W. Elisei; M. Picchio; G. Brandimarte; Francesco Di Mario, Italy P0492 IMPACT OF TREATMENTS ON FECAL MICROBIOTA AND FECAL METABOLIC PROFILING IN SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE OF THE COLON Antonio Tursi, Italy; P. Mastromarino; D. Capobianco; W. Elisei; L. Laghi; C.-L. Zhu; M. Picchio; G. Giorgetti; F. Fabiocchi; F. Di Mario; G. Brandimarte P0493 5-YEARS ITALIAN REGISTER OF DIVERTICULOSIS AND DIVERTICULAR DISEASE (REMAD): A LOW PROGRESSION RATE OF DISEASE DURING THE FIRST YEAR OF FOLLOW-UP Marilia Carabotti, Italy; R. Cuomo; G. Barbara; F. Pace; P. Andreozzi; R. Benini; B. Annibale P0494 CLINICAL FEATURES ASSOCIATED WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE AND DIVERTICULITIS PATIENTS: RESULTS FROM THE ITALIAN REGISTER OF DIVERTICULAR DISEASE (REMAD) Marilia Carabotti, Italy; R. Cuomo; G. Barbara; F. Pace; P. Andreozzi; R. Benini; B. Annibale
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0495 FEATURES OF ABDOMINAL PAIN MAY DISTINGUISH PATIENTS WITH PREVIOUS DIVERTICULITIS FROM PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICOLAR DISEASE: RESULTS FROM THE ITALIAN REGISTER OF DIVERTICULAR DISEASE (REMAD). Paolo Andreozzi, Italy; B. Annibale; G. Barbara; F. Pace; M. Carabotti; C. Cremon; R. Benini; R. Cuomo
P0502 THE OBESTATIN/G PROTEIN-COUPLED RECEPTOR 39 SYSTEM REGULATES PEPSINOGEN I SECRETION IN HUMAN STOMACH B. Otero-Alen; S. Leal-López; L. S. Estevez-Perez; M. Otero-Alen; J. Baltar-Boileve; J. Enrique Dominguez-Muñoz, Spain; R. Gallego-Gomez; T. Garcia-Caballero; J. P. Perez-Camiña; Y. Pazos-Randulfe
P0496 MUSCULAR INFLAMMATORY STATE AND PHENOTYPIC SWITCH IN DIVERTICULOSIS AND COMPLICATED DIVERTICULAR DISEASE L. Pallotta; A. Scirocco; A. Ignazzi; M. A. Maselli; M. Carabotti; A. Cicenia; G. De Toma; F. Pezzolla; E. S. Corazziari; Carola Severi, Italy
P0503 SERUM EXOSOMAL MIRNAS EXPRESSION AS NOVEL BIOMARKERS FOR DETECTION OF ESOPHAGEAL ADENOCARCINOMA Han Chen, China
Poster Session 09:00 – 17:00 Hall 7 Oesophageal, Gastric and Duodenal Disorders I
P0504 COMPARATIVE STUDY BETWEEN THE EFFICACY OF REBAMIPIDE, SUCRALFATE AND PANTOPRAZOLE IN TREATMENT OF POST BANDING VARICEAL ULCERS M. Yousry; A. A. Wahib; Gamal Soliman, Egypt
Cell/molecular biology/pathology P0497 THE ONCOGENIC MIR-491-5P/MIR-875-5P-NOTCH3PHLDB2 AXIS IN GASTRIC TUMORIGENESIS Tingting Huang, Hong Kong PRC; Y. Zhou; J. Zhang; C. C. Wong; Y. Dong; A. S. L. Cheng; J. Yu; K. F. To; W. Kang P0498 FOXF2 SUPPRESSES WNT SIGNALING PATHWAY IN GASTRIC CARCINOGENESIS THROUGH TRANSCRIPTIONALLY UPREGULATING E3 LIGASE IRF2BPL AND PROMOTING β-CATENIN DEGRADATION Yujuan Dong, Hong Kong PRC; A. Higashimori; Y. Zhang; S. S. M. Ng; T. Arakawa; F. K. L. Chan; J. J. Y. Sung; J. Yu P0499 CLINICOPATHOLOGICAL AND COMPREHENSIVE ANALYSIS BY NEXT GENERATION SEQUENCING IN GASTRIC ADENOCARCINOMA WITH ENTEROBLASTIC DIFFERENTIATION Yoichi Akazawa, Japan; T. Saito; T. Hayashi; Y. Yanai; S. Tsuyama; K. Akaike; T. Murakami; T. Yao P0500 CO-OCCURRENCE OF MODERATE RISK ALLELES IN THE GERMLINE OF FAMILIAL INTESTINAL GASTRIC CANCER SYNDROME Joana Carvalho, Portugal; C. São José; H. Pinheiro; P. Oliveira; J. Senz; S. Hansford; A. S. Valente; D. Lemos; V. Pascale; F. Roviello; D. Huntsman; C. Oliveira P0501 PREVENTION OF STENOSIS WITH ENDOSCOPIC TRANSPLANTATION OF CULTURED AUTOLOGOUS ORAL MUCOSAL EPITHELIAL CELL SHEETS AFTER ESOPHAGEAL ENDOSCOPIC SUBMUCOSAL DISSECTION Daisuke Murakami, Japan; H. Harada; S. Suehiro; T. Ohki; M. Yamato Poster in the Spotlight
Poster of Excellence
Upper GI and small intestinal bleeding
P0505 MULTICENTRE EVALUATION OF FIRST-LINE ENDOSCOPIC TREATMENT WITH THE OTSC IN ACUTE NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING AND COMPARISON WITH THE ROCKALL COHORT – THE FLETROCK-STUDY Edris Wedi, Germany; A. Fischer; J. Hochberger; C. Jung; H.-J. Richter-Schrag P0506 A NEW PREDICTION RULE FOR UPPER GASTROINTESTINAL BLEEDING USING THE GLASGOW BLATCHFORD SCORE AND CT NUMBER Mari Tsudome, Japan; K. Fujita; A. Sugahara P0507 FIBRIN GLUE CAN PREVENT BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION. Lianzhen Yu, China; Y. Wang P0508 WITHDRAWN P0509 A COMPARATIVE STUDY OF THERAPEUTIC EFFECT BY VONOPRAZAN AND ESOMEPRAZOLE ON BLEEDING AFTER GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION Yuhei Sakata, Japan; T. Yamazaki; Y. Yasui; K. Yamamoto; M. Suo; A. Kimura; A. Nakata; M. Yamamura; T. Suekane; T. Nakai; E. Sasaki; K. Sano; K. Watanabe; Y. Kawasaki; K. Kioka; H. Nebiki
Clinical Case Session
147
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0510 OUTCOMES FROM AN INTERNATIONAL MULTICENTRE REGISTRY OF PATIENTS WITH GASTROINTESTINAL BLEEDING UNDERGOING ENDOSCOPIC TREATMENT WITH HEMOSPRAY Durayd Alzoubaidi, United Kingdom; S. Gulati; A. Murino; L. H. Eusebi; D. Graham; A. Haji; J. J. G. H. M. Bergman; M. Goetz; E. J. Despott; M. Banks; B. Hayee; R. Haidry
P0517 EFFECTS OF PRIOR JEJUNAL FEEDING ON GASTRIC EMPTYING AND SYMPTOMS IN PATIENTS WITH DIABETIC GASTROPARESIS (J4G STUDY): A RANDOMIZED, DOUBLE BLIND CONTROLLED CLINICAL TRIAL Helen Parker, United Kingdom; L. Carneiro; C. L. Hoad; E. Tucker; J. R. White; L. Marciani; P. Mansell; T. Gazis; M. M. Walker; B. Scurry; M. Fox
P0511 RISK FACTORS OF GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVED DUAL ANTIPLATELET THERAPY Worapoth Yingyongthawat, Thailand; A. Pulsombat
P0518 PER-ORAL ENDOSCOPIC MYOTOMY IN TREATMENT NAÏVE VERSUS PRIOR TREATMENT FAILURE CASES – OUTCOME IN OVER 500 PATIENTS Zaheer Nabi, India; M. Ramchandani; R. Chavan; S. Darisetty; R. Kalapala; D. N. Reddy
P0512 REAL-LIFE ANALYSIS OF FREQUENCY, LOCATIONS AND BLEEDING SOURCES IN UNSELECTED EMERGENCY PATIENTS DURING NON-VITAMIN K ANTICOAGULANT (NOAC) THERAPY AND COMPARISON TO CONTROLLED APPROVAL STUDIES Martin Raithel, Germany; H. Albrecht; L. S. Maass; S. Peter; A. K. Kluger; M. F. Neurath; A. F. Hagel Functional upper GI disorders: Basic P0513 REDUCED INTERSTITIAL CELLS OF CAJAL DENSITY AND INCREASED INTRAEPITHELIAL LYMPHOCYTES ARE ASSOCIATED WITH DEVELOPMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN POST-INFECTIOUS IBS MOUSE MODEL Binrui Chen, China; L. Du; H. He; S. Zhu; J. J. Kim; N. Dai P0514 CLINICAL CHARACTERISTICS OF FUNCTIONAL DYSPEPSIA PATIENTS DEPENDING ON WHETHER THEY ARE CHEMOSENSITIVE OR NOT V. Hammer; Katharina Hammer, Austria; M. Führer; J. Hammer P0515 NUCLEAR LORICRIN AND A DYSREGULATION OF BARRIER PROTEINS OBSERVED IN GASTRO-OESOPHAGEAL REFLUX DISEASE AFFECTED OESOPHAGEAL EPITHELIUM Lisa McGinty, United Kingdom; J. Ooi; P. Woodland; D. Kelsell; D. Blaydon Upper GI motility disorders: Clinical P0516 INFLUENCE OF PRUCALOPRIDE ON SECONDARY PERISTALSIS IN REFLUX PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY Chien-Lin Chen, Taiwan; W.-Y. Lei; C.-H. Yi; T.-T. Liu; J.-S. Hung
P0519 ESOPHAGEAL REFLUX BURDEN IN RELATIONSHIP TO ESOPHAGOGASTRIC JUNCTION (EGJ) AND ESOPHAGEAL BODY FUNCTION ON HIGH RESOLUTION MANOMETRY (HRM) Arvind Rengarajan, USA; S. Roman; E. Savarino; R. Yadlapati; M. Tye; F. Mion; J. Pandolfino; C. P. Gyawali P0520 MEASURING THE ACTIVE AND PASSIVE CHARACTERISTICS OF CONTRACTILE SMOOTH MUSCLE IN PORCINE INTESTINE MODEL G. Min; W. Kim; S. J. Choi; I. K. Yoo; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; B. Keum; Hong Sik Lee, Republic of Korea; H. J. Chun; C. D. Kim; Y. T. Jeen P0521 ª MOTILITY PATTERNS AFTER PER-ORAL ENDOSCOPIC MYOTOMY (POEM) IN PATIENTS WITH ACHALASIA Zuzana Vackova, Czech Republic; J. Krajciova; L. Zdrhova; P. Loudova; P. Stirand; T. Hucl; J. Spicak; J. Martinek P0522 WHAT IS THE EFFECT OF MYOTOMY SITE ON PER-ORAL ENDOSCOPIC MYOTOMY? COMPARISON OF ANTERIOR AND POSTERIOR MYOTOMY Fatih Aslan, Turkey; Z. Akpinar; D. A. Yurtlu; C. Cekic; B. Unsal; S. Bor P0523 LONG – TERM RESULTS OF PERORAL ENDOSCOPIC MYOTOMY (POEM) FOR ACHALASIA Zuzana Rabekova, Czech Republic; Z. Vackova; V. Lanska; J. Spicak; P. Stirand; T. Hucl; E. Kieslichova; J. Martinek Functional upper GI disorders: Clinical P0524 BEER EFFECTS ON POSTPRANDIAL DIGESTIVE SYMPTOMS AND GASTROESOPHAGIC PHYSIOLOGY Blanca Serrano Falcón, Spain; M. Megía Sánchez; A. Ruiz de León; E. Rey P0525 WITHDRAWN
148
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0526 DUODENAL PATHOLOGY IN PATIENTS WITH RUMINATION SYNDROME – EOSINOPHILIA AND INTRAEPITHELIAL LYMPHOCYTOSIS Magnus Halland, USA; N. J. Talley; J. A. Murray; R. Cameron; M. M. Walker P0527 CHRONIC POSTSTROKE OROPHARYNGEAL DYSPHAGIA IS ASSOCIATED WITH IMPAIRED CORTICAL ACTIVATION TO PHARYNGEAL SENSORY INPUTS. Omar Ortega, Spain; C. Cabib; N. Vilardell; L. Mundet; P. Clavé; L. Rofes P0528 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH JEJUNAL EXTENSION FOR GASTROPARESIS: THE ULTIMATE SOLUTION? Denise Strijbos, The Netherlands; D. Keszthelyi; J. Kruimel; L. P. L. Gilissen; R. de Ridder; J. Conchillo; A. A. M. Masclee P0529 RELEVANCE OF SLEEP DISTURBANCE TO FUNCTIONAL GASTROINTESTINAL SYMPTOMS, CLINICAL CHARACTERISTICS, AND PSYCHOLOGICAL DISTRESS Wei-Yi Lei, Taiwan; C.-L. CHEN; S.-H. Wen; C.-H. Yi; T.-T. Liu; J.-S. Hung P0530 ESOPHAGEAL SYMPTOMS ARE COMMON AND RELATED TO OTHER FUNCTIONAL GASTROINTESTINAL DISORDERS (FGIDS) IN A WESTERN POPULATION Axel Josefsson, Sweden; O. S. Palsson; M. Simrén; A. Sperber; H. Törnblom; W. E. Whitehead Eosinophilic oesophagitis P0531 DETERMINANT FACTORS OF QUALITY OF LIFE IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS Alfredo J Lucendo Villarin, Spain; L. Arias-González; J. Molina-Infante; Á. Arias P0532 THE ASSOCIATION BETWEEN ATOPIC MANIFESTATIONS AND EOSINOPHILIC ESOPHAGITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS Alfredo J Lucendo Villarin, Spain; J. González-Cervera; Á. Arias; O. Redondo-González; I. T. Terreehorst; M. M. Cano-Mollinedo P0533 WITHDRAWN
Poster in the Spotlight
Poster of Excellence
P0534 A PHASE 1 STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF SINGLE DOSE APT-1011 ADMINSTERED UNDER FED OR FASTED CONDITIONS OR AT BEDTIME IN A RANDOMISED THREE-WAY, CROSSOVER DESIGN G. M. Comer; Brian Meltzer, USA P0535 EOSINOPHILLIC ESOPHAGITIS: RATIONALISING THERAPY Martin Everson, United Kingdom; I. Parisi; S. Mankodi; A. Shah; D. Grant; M. Rodriguez-Justo; M. R. Novelli; R. Sweis P0536 ESOMEPRAZOLE, RABEPRAZOLE AND PANTOPRAZOLE ARE EQUALLY EFFECTIVE IN INDUCING ENDOSCOPIC AND HISTOLOGIC REMISSION IN PATIENTS WITH PROTON PUMP INHIBITOR-RESPONSE ESOPHAGEAL EOSINOPHILIA M. Della Coletta; S. Tolone; N. de Bortoli; O. Bartolo; G. Bodini; E. Marabotto; P. Zentilin; A. Mauro; R. Penagini; V. Savarino; Edoardo Savarino, Italy Reflux disease, diagnosis P0537 THE « GARD (GASTRO-ESOPHAGEAL ANTI-REFLUX DEVICE»: A NEW ENDOSCOPIC MEDICAL DEVICE TO DIAGNOSE, MANAGE AND TREAT GERD. Norman Godin, Switzerland P0538 SYMPTOM PATTERNS AND TYPES OF GASTROESOPHAGEAL REFLUXES SIGNIFICANTLY DIFFER IN GROUPS OF EROSIVE ESOPHAGITIS AND NON-EROSIVE FORM OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS. Mariya Konovalova, Russian Federation; S. Morozov; V. Isakov P0539 LARYNGEAL DISORDERS AND CHRONIC COUGH IN ADULTS WITH AND WITHOUT EROSIVE ESOPHAGITIS: A CASE-CONTROL STUDY IN ALBANIA Bledar Kraja, Albania; I. Këlliçi; I. Mone; F. Kraja; S. Prifti; G. Burazeri P0540 ASSESSMENT OF EXHALED BREATH CONDENSATE FOR NON-INVASIVE DIAGNOSIS OF GASTROESOPHAGEAL REFLUX DISEASE IN CORRELATION WITH MII-PH AND PEPTEST Stefan Konecny, Czech Republic; J. Dolina; M. Doubkova; J. Skrickova; D. Kindlova; E. Pokojova; P. Durc; J. Lacna; M. Gregus; F. Foret; P. Kuban
Clinical Case Session
149
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0541 GASTRIN 17 MEASUREMENTS IN SINGLING OUT PATIENTS WITH DIFFERENT PATTERNS OF REFLUXATE: A PILOT STUDY USING IMPEDANCE-PH AS REFERENCE STANDARD Marco Della Coletta, Italy; E. Savarino; N. de Bortoli; S. Speroni; S. Landi; S. Grillo; A. Bertelè; N. Dal Bò; F. Di Mario
Barrett's oesophagus: Basic
Reflux disease, treatment
P0549 REMODELING BARRETT’S METAPLASIA IN A NOVEL IN VIVO HUMANORGANOID MODEL Ana Correia, The Netherlands; M. Read; S. Calpe; N. Clemons; D. Liu; C. Duong; W. Phillips; K. Kausilia Krishnadath
P0542 ANTI REFLUX MUCOSECTOMY (ARMS) FOR REFRACTORY GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) – ARE WE THERE YET? Rahul Shah, India; A. P. MAYDEO; V. Dhir P0543 A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE 26-WEEK STUDY ON THE EFFECTS OF DEXLANSOPRAZOLE AND ESOMEPRAZOLE ON BONE HOMEOSTASIS IN HEALTHY POSTMENOPAUSAL WOMEN K. E. Hansen; J. W. Nieves; S. Nudurupati; D. C. Metz; Maria Perez, USA P0544 ALGINATE EFFECT ON POSTPRANDIAL REFLUXES AND PH OF STOMACH CONTENT: RESULTS OF PH-IMPEDANCE MONITORING COMBINED WITH STOMACH PH MONITORING IN REFLUX PATIENTS I. Paliy; S. Zaika; Oleh Ksenchyn, Ukraine P0545 EFFICACY OF S-PANTOPRAZOLE 10 MG IN THE SYMPTOM CONTROL OF NON-EROSIVE REFLUX DISEASE: A PHASE III PLACEBO-CONTROLLED TRIAL Myung-Gyu Choi, Republic of Korea; Y. K. Cho; Y.-T. Bak; P.-L. Rhee; S. G. Kim; H.-Y. Jung; S. Y. Seol P0546 TAILORED THERAPY GUIDED BY MULTICHANNEL INTRALUMINAL IMPEDANCE PH MONITORING FOR REFRACTORY NON EROSIVE REFLUX DISEASE: PRELIMINARY EXPERIENCE N. Ranaldo; Giuseppe Losurdo, Italy; A. Morelli; A. Iannone; M. Barone; M. Principi; E. Ierardi; A. Di Leo Reflux disease, complications P0547 STW5 MODULATES TIGHT-JUNCTION GENE AND PROTEIN EXPRESSIONS IN REFLUX-ESOPHAGITIS – POSSIBLE RELEVANCE FOR TUMORIGENESIS H. Abdel-Aziz; Gudrun Ulrich-Merzenich, Germany; A. Shcherbakova; O. Kelber
150
P0548 THE EFFECT OF SPECIFIC REFLUXATE COMPONENTS ON BILE RECEPTOR SIGNALING AND DEVELOPMENT OF METAPLASTIC BARRETT-LIKE GLANDS IN MICE. D. Straub; L. Mari; S. van de Graaf; Kausilia K. Krishnadath, The Netherlands
P0550 GASTRIC CARDIA GLANDS MANIFEST APPARENT BROAD DIFFERENTIATION POTENTIAL, AS EVIDENCED BY HOXA13 EXPRESSION, IMPLICATIONS FOR THE ORIGIN OF BARRETT’S ESOPHAGUS Vincent Janmaat, The Netherlands; M. J. M. Smits; M. J. Bruno; M. C. W. Spaander; M. P. Peppelenbosch P0551 ACTIVE HUMAN PAPILLOMAVIRUS INVOLVEMENT IN BARRETT’S DYSPLASIA AND OESOPHAGEAL ADENOCARCINOMA IS CHARACTERIZED BY WILD-TYPE P53 AND ABERRATIONS OF THE RETINOBLASTOMA PROTEIN PATHWAY Shan Rajendra, Australia; T. Yang; W. Xuan; P. Sharma; D. Pavey; C. S. Lee; S. Le; J. Collins; B. Wang P0552 CHARACTERIZING DIPEPTIDYL PEPTIDASE SPECIFIC ACTIVITY IN HUMAN BARRETT’S OESOPHAGUS AND IN A PANEL OF OESOPHAGEAL METAPLASIA, DYSPLASIA AND CANCER CELL LINES S. Jaenisch; D. J. Hussey; D. Watson; C. A. Abbott; M. Squire; Roger Yazbeck, Australia P0553 AN ANTI-INFLAMMATORY ENVIRONMENT CHARACTERISES BARRETT'S OESOPHAGUS ASSOCIATED ADENOCARCINOMAS AND INFLUENCES PATIENT SURVIVAL Karl-Frederick Karstens, Germany; J. Kempski; A. Giannou; S. Steurer; G. Wolters-Eisfeld; T. Rösch; J. R. Izbicki; A. W. Lohse; N. Gagliani; S. Huber P0554 DIFFERENT GLAND PHENOTYPES ARE CLONALLY RELATED IN BARRETT'S EOSOPHAGUS AND GLAND PHENOTYPIC DIVERSITY IS INCREASED IN PATIENTS WHO HAVE PROGRESSED TO DYSPLASIA. J. Evans; E. Carlotti; M. Rodriguez-Justo; S. L. Preston; N. Wright; T. Graham; M. Jansen; Stuart McDonald, United Kingdom
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
Barrett's oesophagus: Clinical
P0563 RISK FACTORS FOR THE DEVELOPMENT OF DYSPLASTIC SQUAMOUS EPITHELIUM IN THE ESOPHAGUS Chikatoshi Katada, Japan; T. Yokoyama; T. Yano; I. Oda; Y. Shimizu; S. Tanabe; H. Doyama; T. Koike; K. Takizawa; M. Hirao; H. Okada; T. Yoshii; K. Konishi; T. Yamanouchi; T. Tsuda; T. Omori; N. Kobayashi; H. Ishikawa; A. Yokoyama; M. Muto
P0555 A DEDICATED BARRETT’S OESOPHAGUS ENDOSCOPY LIST IMPROVES THE ACCURACY OF ENDOSCOPIC REPORTING AND QUALITY OF BIOPSIES Hannah Al-Hasani, United Kingdom; T. Sharp; S. M. Ha; L. Matsuka; N. Siddique P0556 ADHERENCE TO QUALITY INDICATORS AND SURVEILLANCE GUIDELINES IN THE MANAGEMENT OF BARRETT’S ESOPHAGUS: A RETROSPECTIVE ANALYSIS D. Westerveld; V. Khullar; M. B. Riverso; Y. Perbtani; M. Agarwal; J. J. Forde; J. Chakraborty; T. S. Brar; F. Ayoub; A. Gupte; C. E. Forsmark; P. V. Draganov; Dennis Yang, USA P0557 EXPRESSION OF TGF-B AND CD-44 IN AGE SPECIFIC SUBGROUP OF PATIENTS WITH ADENOCARCINOMA OF GASTRIC CARDIA Nazar Lukavetskyy, Ukraine; T. Fetsych P0558 BARRETT’S OESOPHAGUS PROFILE AND OUTCOMES IN A LARGE COHORT Nir Bar, Israel; N. Fliss Isacov; M. Nisim; R. Kariv P0559 THE EFFICACY OF ENDOSCOPIC MUCOSAL RESECTION IN MANAGING EARLY NEOPLASIA IN BARRETT’S OESOPHAGUS, EXPERIENCES OF A TERTIARY REFERRAL CENTER IN THE UK Balint Eross, United Kingdom; C. Clisby; B. Foria; C. Gordon P0560 ADHERENCE TO BARRETT’S ESOPHAGUS SURVEILLANCE GUIDELINES: A SYSTEMATIC REVIEW AND META-ANALYSIS Carlijn Roumans, The Netherlands; E. W. Steyerberg; D. Rizopoulos; I. Lansdorp-Vogelaar; M. C. W. Spaander; M. J. Bruno Oesophageal neoplasia: Clinical P0561 LONG-TERM OUTCOMES OF ENDOSCOPIC RESECTION VERSUS SURGICAL RESECTION FOR MM-SM1 ESOPHAGUS SQUAMOUS CELL CARCINOMA. Kenji Yamauchi, Japan; M. Iwamuro; Y. Obayashi; Y. Baba; H. Sakae; T. Gotoda; Y. Kouno; H. Kanzaki; S. Kawano; Y. Kawahara; H. Okada P0562 ESOPHAGEAL REFLUX DISEASE AND ESOPHAGEAL SQUAMOUS CELL CANCER IN PATIENTS WITH FANCONI ANEMIA UNDERGOING ENDOSCOPIC SURVEILLANCE David Itskoviz, Israel; H. Tamary; T. Krasnov; N. Sahar; N. Zevit; O. Ben-Bassat; Y. Leibovici Wiseman; D. Boltin; Y. Goldberg; Z. Levi Poster in the Spotlight
Poster of Excellence
P0564 EVALUATION OF THE RISK OF METACHRONOUS SQUAMOUS CELL CARCINOMA OF THE OESOPHAGUS AND THE HEAD AND NECK AFTER ENDOSCOPIC RESECTION FOR SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS BASED ON THE GENETIC POLYMORPHISMS OF ADH1B AND ALDH2. Satoshi Abiko, Japan; Y. Shimizu; T. Mizushima; M. Kato; K. Matsuda; S. Miyamoto; M. Tsuda; K. Yamamoto; S. Ono; T. Kudo; N. Sakamoto P0565 IS IT FEASIBLE TO TREAT ESOPHAGEAL SQUAMOUS CELL CARCINOMA WITH CLINICAL DEPTH OF MM/SM1 BY ENDOSCOPIC RESECTION? Ken Namikawa, Japan; T. Yoshio; A. Ishiyama; T. Tsuchida; J. Fujisaki P0566 TRIAMCINOLONE INJECTION AND SHIELDING WITH POLYGLYCOLIC ACID SHEETS AND FIBRIN GLUE FOR THE PREVENTION OF POSTOPERATIVE STRICTURE AFTER ESOPHAGEAL ENDOSCOPIC SUBMUCOSAL DISSECTION: A RETROSPECTIVE COMPARISON OF TWO PILOT STUDIES AND A HISTORICAL COHORT Yoshiki Sakaguchi, Japan; Y. Tsuji; Y. Kataoka; I. Saito; K. Niimi; S. Ono; S. Kodashima; M. Fujishiro; K. Koike P0567 MULTICENTRIC ASSESSMENT OF THE ENDOSCOPIC MANAGEMENT OF SUPERFICIAL ESOPHAGEAL SQUAMOUS-CELL CARCINOMA IN WESTERN POPULATION. Arthur Berger, France; G. Rahmi; G. Perrod; M. Pioche; J.-M. Canard; E. Cesbron Métivier; J. Boursier; E. Samaha; A. Vienne; V. Lepilliez; C. Cellier P0568 CURATIVE CONDITIONS AFTER ENDOSCOPIC RESECTION FOR MM/SM1 OESOPHAGEAL SQUAMOUS CELL CARCINOMA BASED ON LONG-TERM OUTCOMES Takeshi Mizumoto, Japan; S. Oka; S. Tanaka; T. Hiyama; K. Kuroki; M. Kurihara; Y. Yoshihuku; Y. Sanomura; Y. Urabe; K. Chayama
Clinical Case Session
151
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Gastroduodenal neoplasia: Clinical
Monday, October 30, 2017
P0569 ENDOSCOPIC SUBMUCOSAL DISSECTION COMPARED TO LAPAROSCOPIC GASTRECTOMY FOR TREATMENT OF EARLY GASTRIC CANCER – A PROSPECTIVE RANDOMIZED TRIAL Philip Wai Yan Chiu, Hong Kong PRC; A. Y. Teoh; E. Ng; V. Wong; H. C. Yip; J. C. Wu; S. Liu; S. K. Wong; F. K. L. Chan; J. JY Sung; J. Y. Lau P0570 PREVALENCE OF PRE-MALIGNANT LESIONS IN BIOPSIES TAKEN FROM GASTRIC MUCOSA ENDOSCOPICALLY NORMAL OR WITH GASTRITIS Victor Yep-Gamarra, Peru; P. Rojas-Perez; A. Aldave; C. Rodriguez-Ulloa; C. Díaz-Veléz; H. Mariños; H. Calvo; J. Pelaez; G. Flores-Trujillo P0571 CORRELATION BETWEEN THE COMBINATION OF HELICOBACTER PYLORI ANTIBODY AND PEPSINOGEN AND OLGA/OLGIM STAGING FOR RISK ASSESSMENT OF GASTRIC PRECANCEROUS LESIONS Xiaoteng Wang, China; B. Lv; Z. Ji P0572 ENDOSCOPIC MUCOSAL RESECTION FOR SPORADIC NON AMPULLARY DUODENAL ADENOMA (SDA) : CAN WE REDUCE THE RISK OF RECURRENCE AND COMPLICATIONS IN TERTIARY CENTERS? Solene Hoibian, France; E. Bories; F. Caillol; C. Pesenti; J. P. Ratone; J.-M. Gonzalez; M. Giovannini; M. Barthet P0573 CAN BE THE PATIENT WITH NON-CURATIVE ESD FOR EARLY GASTRIC CANCER RESCUED BY SURGERY AFTER RECURRENCE? Kohei Takizawa, Japan; W. Hatta; T. Gotoda; N. Kawata; M. Nakagawa; A. Takahashi; M. Esaki; A. Mitoro; S. Yamada; K. Tanaka; M. Matsuda; J. Takada; Y. Yoshifuku; H. Ito; K. Ohnita; R. Shimoda; S. Hoteya; T. Oyama; T. Shimosegawa P0574 BLEEDING AFTER ENDOSCOPIC RESECTION FOR EARLY GASTRIC LESIONS IN PATIENTS ON ANTITHROMBOTIC THERAPY Tomoyuki Nagai, Japan; S. Matsui; H. Kashida; Y. Komeda; T. Sakurai; M. Kudo P0575 FACTORS AFFECTING CURATIVE ENDOSCOPIC RESECTION OF EARLY GASTRIC CANCER IN THE ENVIRONMENT OF POPULATION-BASED SCREENING Yoon Gwon Mun, Republic of Korea; H. H. Lee; D. H. Kang; J. M. Park; K. Y. Song; M.-G. Choi
152
P0576 USEFULNESS OF OPERATIVE LINK ON GASTRITIS ASSESSMENT (OLGA) AND OPERATIVE LINK ON GASTRIC INTESTINAL METAPLASIA (OLGIM) FOR DIAGNOSIS OF HELICOBACTER PYLORI-ASSOCIATED GASTRIC CANCER REGARDLESS OF TISSUE TYPE IN KOREA ChangYong Yun, Republic of Korea; N. Kim; Y.-J. Hwang; H. Lee; M. Kwon; J. Lee; Y. J. Choi; H. Yoon; C. M. Shin; Y. S. Park; D. H. Lee P0577 BODY MASS INDEX AND DIGESTIVE CANCER MORTALITY IN THE KOREAN GENERAL POPULATION : A NATIONWIDE COHORT STUDY Pumsoo Kim, Republic of Korea; Y. J. Kim; M. K. Baeg; S. H. Jeong; S.-W. Yi P0578 RISK FACTORS FOR LYMPH NODE METASTASIS OF ULCERATIVE TYPE INTRAMUCOSAL EGC Taewan Kim, Republic of Korea; T. J. Kim; H. Lee; J. H. Lee; J. J. Kim P0579 THE FEASIBILITY STUDY USING KUMC ROBOTIC MANIPULATOR IN ENDOSCOPIC SUBMUCOSAL DISSECTION G. Min; S. J. Choi; W. Kim; J. M. Lee; I. K. Yoo; S. H. Kim; J. M. Lee; Hyuk Soon Choi, Republic of Korea; E. S. Kim; B. Keum; H. S. Lee; H. J. Chun; C. D. Kim; Y. T. Jeen P0580 DEVELOPMENT OF NOVEL ENDOSCOPIC IRREVERSIBLE ELECTROPORATION ABLATION DEVICE G. Min; S. J. Choi; W. Kim; I. K. Yoo; S. H. Kim; J. M. Lee; Hyuk Soon Choi, Republic of Korea; E. S. Kim; B. Keum; H. S. Lee; H. J. Chun; C. D. Kim; Y. T. Jeen P0581 DIAGNOSIS OF MICROVASCULAR PATTERN IS MORE IMPORTANT THAN MICROSURFACE PATTERN TO DELINEATE GASTRIC CANCERS DETECTED AFTER H. PYLORI ERADICATION BY MAGNIFYING ENDOSCOPY. Takehiro Iwasaki, Japan; K. Uchita; K. Kojima; S. Iwamura P0582 ENDOSCOPIC SMALL CAPACITY FORCEPS INCREASE THE PATHOLOGICAL DIAGNOSIS OF GASTRIC INDEFINITE NEOPLASIA Yasumasa Matsuo, Japan; H. Yasuda; M. Kato; H. Kiyokawa; M. Ozawa; Y. Sato; Y. Ikeda; M. Yamashita; T. Fujino; H. Yamamoto; M. Takagi; F. Itoh
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
Gastroduodenal neoplasia: Basic P0583 THE ROLE OF STRESS AND NITROSAMINES IN THE DEVELOPMENT OF GASTRIC CANCER: A NEW MODEL OF ADENOCARCINOMA FORMATION WITH METASTASES IN RATS Alexandr Khorovodov, Russian Federation; I. Agranovich; N. Shushunova; N. Navolokin; A. Telegin; A. Shnitenkova; M. Sagatova; I. Trishkina; M. Ulanova; E. Borisova; O. Semyachkina-Glushkovskaya P0584 WITHDRAWN P0585 RELEVANCE OF PTGS1 AND PTGS2 GENE POLYMORPHISMS TO GASTRIC CANCER RISK AND PHENOTYPE IN CAUCASIANS. María Asunción García-González, Spain; L. Bujanda Fernández de Piérola; E. Quintero Carrion; M. Strunk; F. Sopeña-Biarge; S. Santolaria; R. Benito; E. Piazuelo; C. Thomson; Á. Pérez-Aísa; M. Badía; D. Nicolás-Pérez; E. Hijona; J. Espinel; R. Campo; M. Pellisé; M. Manzano; F. Geijo; F. González-Huix; M. Zaballa; J. Espinós; L. Titó; L. Barranco; Á. Lanas P0586 GASTRIC JUICE FREE AMINO ACID PROFILING AS A METHOD FOR DISCOVERING POTENTIAL BIOMARKERS OF GASTRIC CANCER Jian Liu, China; Y. L. Zhou; R. S. Lin; Y. Xue; E. X. Yan; M. L. Meng; J. B. Suo; J. J. Lu
Poster Session 09:00 – 17:00 H. Pylori I
Hall 7
Epidemiology/natural history P0590 HELICOBACTER PYLORI INFECTION ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE: A LARGESCALE COHORT STUDY Taewan Kim, Republic of Korea; T. J. Kim; H. Lee; J. J. Kim P0591 HELICOBACTER PYLORI INFECTION STATUS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS Seiya Kato, Japan; T. Yamada; Y. Fujii; A. Shoji; R. Kiyota; K. Shinkai; T. Tashiro; A. Ishihara; T. Iwasaki; S. Tanaka; H. Hasegawa; Y. Sakakibara; S. Nakazuru; H. Ishida; E. Mita P0592 HELICOBACTER PYLORI INFECTION REDUCES THE RISK OF BARRETT’S OESOPHAGUS AND IT IS INDEPENDENT FROM THE GEOGRAPHICAL LOCATION, A META-ANALYSIS Balint Eross, Hungary; N. Farkas; K. Márta; P. Hegyi P0593 THE IMPACT OF HELICOBACTER PYLORI ON MORTALITY AND OTHER OUTCOMES IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: A NATIONWIDE ANALYSIS Paul Thomas Kroener, USA; M. S. Abougergi; V. Popov; C. C. Thompson Treatment
P0587 THE ASSOCIATION BETWEEN MMP-2/9 AND TYPE IV COLLAGEN AND THE LEVELS OF AROMATIC AMINO ACIDS IN GASTRIC JUICE OF GASTRIC CANCER PATIENTS Jian Liu, China; Y. L. Zhou; R. S. Lin; Z. Jin; J. Y. Han; Y. Xue; E. X. Yan; M. L. Meng
P0594 ERADICATION THERAPY FOR HELICOBACTER PYLORI – AN IMPORTANT TOOL TO IMPROVE THE HEART FUNCTION IN PATIENTS WITH CORONARY HEART DISEASE. Andra-Iulia Suceveanu, Romania; A. P. Suceveanu; I. R. Parepa; F. F. Voinea; D. Catrinoiu; L. Mazilu
P0588 MISSING RATE OF GASTRIC CANCER DURING UPPER GASTROINTESTINAL ENDOSCOPY AND INFLUENCE ON THE NATURAL HISTORY OF THE DISEASE Rosario Salmoral, Spain; J. Rodriguez-Sanchez; F. Martín Dávila; B. López Viedma; P. Olivencia Palomar; E. De la Santa Belda; J. Olmedo Camacho
P0595 RANDOMIZED CONTROLLED STUDY OF A NOVEL TRIPLE NITAZOXANIDE (NTZ) CONTAINING THERAPEUTIC REGIMEN VERSUS THE TRADITIONAL REGIMEN FOR ERADICATION OF HELICOBACTER PYLORI INFECTION. Sherief Abd-Elsalam, Egypt; M. A. H. Shehata; H. Elmesseri; R. Talaat
P0589 INTERFERENCE OF PG2 TATA BOX REGION WITH THE SERUM PG2 LEVEL IN GASTRIC CANCER V. De Re; R. Magris; M. De Zorzi; S. Maiero; L. Caggiari; M. Fornasarig; O. Repetto; E. Buscarini; F. Di Mario; Renato Cannizzaro, Italy
P0596 PREVIOUS INTAKE OF MACROLIDES PREDICTS FAILURE TO ERADICATE HELICOBACTER PYLORI WITH CLARITHROMYCIN-CONTAINING REGIMENS. P. Muñoz-Gómez; A. Jordán-Castro; M. Abanades-Tercero; J. Blanco-González; Julio Valle-Muñoz, Spain
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
153
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
P0597 EFFICACY OF THREE-IN-ONE CAPSULE BISMUTH QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN CLINICAL PRACTICE IN A MULTINATIONAL PATIENT POPULATION Stephan Miehlke, Germany; D. Frederking; T. Guenther; E. Glocker; B. Eisele; V. Andresen; S. Schroeder; A. Morgner
P0604 ASSOCIATION BETWEEN GASTRIC ADENOCARCINOMA OF THE FUNDIC GLAND TYPE AND H.PYLORI INFECTION Mayu Matsueda, Japan; H. Kinugasa; K. Miyahara; M. Nakagawa Poster Session 09:00 – 17:00 Small Intestinal I
Hall 7
P0598 ERADICATION OF HELICOBACTER PYLORI INFECTION WITH A COMBINATION FORMULATION OF BISMUTH, METRONIDAZOLE AND TETRACYCLINE WITH ESOMEPRAZOLE: A REAL-LIFE STUDY Elena Pérez Arellano, Spain; M. I. Rodriguez Garcia; A. B. Galera; E. De La Morena
Coeliac disease (adult)
P0599 COST EFFECTIVENESS OF HELICOBACTER PYLORI POPULATION SCREENING: ECONOMIC EVALUATION ALONGSIDE A RANDOMIZED CONTROLLED TRAIL WITH 13-YEARS FOLLOW-UP (THE HEP-FYN STUDY) Maria Bomme Høgh, Denmark; C. Kronborg; J. M. Hansen; M. Wildner-Christensen; J. Hallas; O. B. Schaffalitzky de Muckadell
P0606 HEPATIC ABNORMALITIES ASSOCIATED WITH CELIAC DISEASE Dalila Tagzout, Algeria; A. Tebaibia; N. Oumnia; N. Benfenatki
P0600 A SEVEN DAY TRIPLE THERAPY CONTAINING A POTASSIUM-COMPETITIVE ACID BLOCKER COMPARED WITH PROTON PUMP INHIBITORS, AMOXICILLIN AND CLARITHROMYCIN FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION IN JAPAN: A SINGLE CLINIC RETROSPECTIVE STUDY Sadamoto Yojiro, Japan P0601 AN OPEN-LABEL, RANDOMIZED CONTROLLED TRIAL OF VONOPRAZAN VERSUS ESOMEPRAZOLE AS PART OF FIRST-LINE TRIPLE THERAPY FOR HELICOBACTER PYLORI INFECTION Hiroyuki Tamaki, Japan; M. Morita; A. Omura; T. Noda; A. Kubo; C. Ogawa; T. Matsunaka; M. Shibatoge P0602 THE IMPACT OF AMOXICILLIN RESISTANCE ON THE EFFICACY OF AMOXICILLIN-CONTAINING REGIMENS FOR HELICOBACTER PYLORI ERADICATION- A POST-HOC ANALYSIS OF FIVE RANDOMIZED TRIALS Jyh-Ming Liou, Taiwan; M.-J. Chen; J.-T. Lin; M.-S. Wu
H. pylori-associated malignancy P0603 ROLE OF POLYMORPHISMS IN TLR1 AND PRKAA1 GENES IN THE DEVELOPMENT OF ATROPHIC GASTRITIS AND GASTRIC CANCER Vytenis Petkevicius, Lithuania; G. Dargiene; M. Leja; A. Link; L. Jonaitis; G. Kiudelis; G. Streleckiene; J. Skieceviciene; L. Kupcinskas; P. Malfertheiner; J. Kupcinskas
154
P0605 MUCIN EXPRESSION IN THE SMALL BOWEL OF CELIAC DISEASE – A SYSTEMATIC REVIEW AND META-ANALYSIS Yaron Niv, Israel; R. Shamir
P0607 CELIAC DISEASE ASSOCIATED WITH VASCULAR THROMBOSIS Dalila Tagzout, Algeria; A. Tebaibia; N. Oumnia; N. Benfenatki P0608 DIFFERENT PROFILES OF TLR 2,4, 7 AND 9 MRNA IN PBMC AND BIOPSY SPECIMENS OF PATIENTS WITH CELIAC DISEASE H. Ghasiyari; Mohammad Rostami-Nejad, Iran; D. Amani; M. A. Pourhosseingholi; E. Aghamohammadi; K. Rostami; H. Asadzadeh; M. R. Zali P0609 STUDY OF BONE DENSITY IN CELIAC DISEASE A. Ravaux; G. Malamut; Christophe Cellier, France P0610 GLUTEN-FRIENDLY BREAD (GFB) INCREASES GUT MUCUS PRODUCTION AND MONOLAYER PERMEABILITY IN VITRO. G. Corona; M. Henderson; T. Bergillos-Meca; M. Roul; D. Musaico; C. Lamacchia; Adele Costabile, United Kingdom P0611 IMMUNOHISTOCHEMICAL LYMPHOCYTE PATTERN OF NON CELIAC GLUTEN SENSITIVITY MAY SUPPORT THE INVOLVEMENT OF INNATE IMMUNITY Giuseppe Losurdo, Italy; F. Pezzuto; C. Covelli; F. Fortarezza; A. Marra; A. Iannone; A. Amoruso; M. Barone; M. Principi; E. Ierardi; A. Di Leo
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P0612 FUNCTIONAL DYSPEPSIA SYMPTOMS ARE STRONGLY ASSOCIATED WITH COELIAC DISEASE: RESULTS FROM A POPULATION-BASED STUDY Michael Potter, Australia; M. M. Walker; M. P. P. Jones; N. Koloski; G. Brogan; S. Keely; N. J. Talley P0613 MALE GENDER AND UNDERWEIGHT ARE ASSOCIATED WITH OSTEOPOROSIS IN PATIENTS WITH NEW DIAGNOSIS OF COELIAC DISEASE Gloria Galli, Italy; E. Lahner; L. Conti; G. Esposito; M. C. Sacchi; E. Di Giulio; B. Annibale P0614 SELF-REPORTED WHEAT SENSITIVITY IN AN AUSTRALIAN POPULATION STUDY Michael Potter, Australia; M. M. Walker; M. P. P. Jones; N. Koloski; G. Brogan; S. Keely; N. J. Talley Malabsorption syndromes and food enteropathies (adult) P0615 INSUFFICIENCY OF THE SMALL INTESTINAL ENZYMES MAY BE ONE OF THE CAUSES OF FUNCTIONAL BOWEL DISEASE. Olga Akhmadullina, Russian Federation; A. Parfenov; N. Belostotsky; E. Sabelnikova; S. Bykova; S. Khomeriki P0616 WHEAT PROTEIN ALLERGY OR SENSITIZATION TO WHEAT PROTEIN IN A CELIAC POPULATION. C. Caruso; V. Gerardi; A. Armuzzi; L. Guidi; A. Papa; S. Ennas; A. Romano; G. Rapaccini; Italo De Vitis, Italy P0617 A QUESTIONNAIRE BASED SYMPTOM EVALUATION STUDY IN 381 PATIENTS DIAGNOSED WITH BILE ACID MALABSORPTION BY SEHCAT FROM 2003 TO 2016 Helene Rask Clausen, Denmark; B. Damsgaard; J. F. Dahlerup; J. Agnholt; S. P. Jørgensen; K. Krogh P0618 EFFICACY OF PERCUTANEOUS ENDOSCOPIC GASTRO-JEJUNOSTOMY (PEG-J) DECOMPRESSION THERAPY FOR PATIENTS WITH CHRONIC INTESTINAL PSEUDO-OBSTRUCTION (CIPO) Hidenori Ohkubo, Japan; T. Higurashi; J. Arimoto; A. Nakajima P0619 DIFFERENT ORAL GLUTEN LOADS INDUCE AN INFLAMMATORY AND ANTIOXIDANT RESPONSE IN HEALTHY VOLUNTEERS M. Di Stefano; Irene Benedetti, Italy; E. V. Pesatori; G. F. Manfredi; M. Deamici; M. Bergonzi; E. Pagani; C. Torre; G. Testa; B. Valvo; E. Miceli; G. L. Marseglia; G. R. Corazza
Poster in the Spotlight
Poster of Excellence
Poster Session 09:00 – 17:00 Nutrition I
Hall 7
Obesity P0620 THERAPEUTIC ACTION OF KETOGENIC ENTERAL NUTRITION IN OBESE AND OVERWEIGHT PATIENTS: A RETROSPECTIVE INTERVENTIONAL STUDY Cinzia Papadia, United Kingdom; P. Basset; G. Cappello; R. Shidrawi P0621 ANALYSIS OF LONG-TERM WEIGHT REGAIN IN OBESE PATIENTS TREATED WITH INTRAGASTRIC BALLOON Bruno Sander, Brazil; M. Galvao Neto; J. I. B. Scarparo; E. Grecco; T. F. Souza; M. P. Sander; D. S. Paiva; L. R. Alberti; V. N. Arantes P0622 LONG TERM EFFECT OF DUODENAL-JEUJENAL BYPASS LINEAR IMPLANTATION ON WEIGHT REDUCTION AND GLYCEMIC CONTROL Sigal Fishman, Israel; L. Mlynarsky; L. Ben-Haim; J. Rutenberg; M. Shnell; E. Santo P0623 SYNBIOTIC (INULIN, LACTOBACILLUS, BIFIDOBACTERIUM AND SACCHAROMYCES BOULARDII) IMPROVES FATTY LIVER DISEASE BY VIRTUE OF ITS ACTION ON LIPID PROFILES, LEPTIN, ADIPONECTIN, AND INFLAMMATORY BIOMARKERS T. M. M. Falalyeyeva; Nazarii Kobyliak, Ukraine; O. Tsyryuk; I. Prybytko; T. Beregova; L. Ostapchenko P0624 IMPROVED EMPLOYEMENT OF INTRAGASTRIC BALLOON FOR WEIGHT LOSS: A PRELIMINARY ANALYSIS S. H. Kim; Hoon Jai Chun, Republic of Korea; H. S. Choi; E. S. Kim; B. Keum; Y. T. Jeen; H. S. Lee; C. D. Kim P0625 IS RE-IMPLANTATION OF THE DUODENAL-JEJUNAL BYPASS LINER VIABLE? S. Guenthert; A. Dienethal; Jürgen Stein, Germany P0626 THE COMPARATIVE EFFICACY OF OBESITY TREATMENTS IN YOUNG PEOPLE – A SYSTEMATIC REVIEW AND META ANALYSIS Subothini Selvendran, United Kingdom; N. Penney; N. Aggarwal; A. Darzi; S. Purkayastha
Clinical Case Session
155
Monday, October 30, 2017
Monday, October 30, 2017
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
Nutrients and gut function
Enteral and parenteral nutrition
P0627 FOOD-DERIVED MICRORNA AND INFLUENCE ON THE FECAL MICRORNA EXPRESSION J. Link; C. Langner; A. Canbay; P. Malfertheiner; Alexander Link, Germany
P0635 USE OF ALTERNATIVE LIPID EMULSION IN NON-CRITICALLY ILL PATIENTS IN ACUTE HOSPITAL SETTING Ennaliza Salazar, Singapore; P. Ghosh; V. Tan; T. Pang; B. Y. Poh; L. B. Tan; K. L. Loy; J. N. C. Chong; D. H. L. Ng; K. L. Ling; Y. T. Wang
P0628 NEUROMEDIN U BLOCKS GASTRIC EMPTYING THROUGH VAGAL-DEPENDENT MECHANISMS AND IMPROVES ORAL GLUCOSE TOLERANCE Anne-Charlotte Jarry, France; N. Merah; M.-N. Fiamma; L. Bodineau; A. Bado; J. Le Beyec; M. Le Gall P0629 LOW FODMAP DIET & PREBIOTIC GALACTOOLIGOSACCHARIDES IMPROVE IRRITABLE BOWEL SYNDROME SYMPTOMS AND RESPONSE TO LOW FODMAP DIET IS PREDICTED BY URINE METABOLOME, STOOL SHORTCHAIN FATTY ACIDS AND VOLATILE ORGANIC COMPOUNDS: A RANDOMISED CONTROLLED TRIAL B. Wilson; R. Hough; T. Kanno; M. Rossi; G. Parkes; Q. Aziz; S. Anderson; Peter Irving, United Kingdom; M. Lomer; A. J. Mason; C. S. J. Probert; K. Whelan P0630 THE ANALYSIS OF PROTEIN CONSUMPTION PATTERNS IN PATIENTS WITH SIBO Vladimir Pilipenko, Russian Federation; V. Isakov; A. Vlasova P0631 LOW FODMAP DIET IMPROVES SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH RADIATION INDUCED SMALL BOWEL DISEASE: A PILOT STUDY Trine Larsen, Norway; T. Hausken; S. O. Ystad; N. Hovdenak; B. Mueller; G. A. Lied P0632 DIET SUPPLEMENTED WITH MEDIUM- AND LONGCHAIN FATTY ACIDS DOES NOT AFFECT LOWER GI MOTILITY AND VISCERAL PAIN IN RATS Paula Mosinska, Poland; M. Martin-Ruiz; R. Abalo; J. Fichna P0633 INTESTINAL ADAPTATIONS AFTER SUBTOTAL PANCREATECTOMY IN MICE MAY CONTRIBUTE TO POSTPRANDIAL HYPERGLUCAGONEMIA Anne-Charlotte Jarry, France; G. Guillemain; J. Le Beyec; A. Bado; J.-F. Gauthier; B. Blondeau; J.-P. Riveline; M. Le Gall
P0636 COMPLICATIONS AND EARLY MORTALITY IN PERCUTANEOUS ENDOSCOPIC GASTROSTOMY PLACEMENT IN LOMBARDY: A MULTICENTER PROSPECTIVE STUDY Andrea Anderloni, Italy; F. Barzaghi; G. Meucci; R. Marino; L. Amato; M. Frigerio; V. Saladino; A. Toldi; G. Manfredi; A. E. Redaelli; M. Feliziani; G. De Roberto; F. Boni; G. Scacchi; D. Mosca; M. Devani; M. Arena; M. Massidda; P. Zanoni; C. Ciscato; V. Casini; P. Beretta; E. Forti; R. Salerno; V. Caramia; G. Lollo; M. Bianchetti; C. Tomba; M. Di Leo; A. Repici; M. Soncini; G. Maconi; G. Manes; R. Gullotta P0637 MEDICAL REGISTRAR REPORTING OF CHEST XRAYS FOR NASOGASTRIC TUBE POSITION: HOW CAN IT BE MADE SAFER? Maeve Tierney, United Kingdom; Z. Leach; C. Sibley; C. Rutter; C. Pither; T. Smith P0638 MICRONUTRIENT MONITORING IN HOME PARENTERAL NUTRITION PATIENTS: AN AUDIT OF PRACTICE IN A REGIONAL REFERRAL CENTRE Maeve Tierney, United Kingdom; L. Bakewell; E. Buse; C. Rutter; C. Pither; T. Smith P0639 CLINICAL NUTRITION – ARE WE IGNORANT OR NEGLIGENT? Tau Ming Aaron Gan, Singapore; R. Asokkumar; E. Salazar Poster Session 09:00 – 17:00 Paediatric: Upper GI
Hall 7
Paediatric oesophageal disorders P0640 OUTCOMES OF PER-ORAL ENDOSCOPIC MYOTOMY IN CHILDREN WITH ACHALASIA CARDIA Zaheer Nabi, India; M. Ramchandani; R. Chavan; R. Kalapala; D. N. Reddy; S. Darisetty
P0634 QUALITY, VIABILITY AND COMPOSITION OF THE MULTISPECIES PROBIOTIC VSL#3 Diego Mora, Italy; S. Colombo; G. Della Scala; G. Gargari; S. Arioli; W. M. de Vos
156
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Monday, October 30, 2017
Poster Sessions : UEG Week Final Programme
P0641 HIGH RATE OF HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE IN ARMENIAN CHILDREN WITH GASTRODUODENAL DISEASE T. Shahinyan; Gayane Amaryan, Armenia; M. Hovsepyan; C. Braegger P0642 GASTRIC MICROBIOTA OF CHILDREN WITH CHRONIC GASTRITIS Elena Kornienko, Russian Federation; N. Parolova; P. Zykov P0643 FEATURES OF CHRONIC GASTRITIS CAUSED BY CO-INFECTION OF HELICOBACTER PYLORI AND EPSTEIN-BARR VIRUS IN PEDIATRIC PATIENTS Eugeny Spivak, Russian Federation; R. Levit P0644 HELICOBACTER PYLORI INFECTION AND SPECIFIC IMMUNOGLOBULIN E ANTIBODIES TO FOOD ALLERGENS IN SYMPTOMATIC CHILDREN ADMITTED IN A DIGESTIVE ENDOSCOPY UNIT. Victoria Hurduc, Romania; B. Luiza; P. Doina P0645 CURRENT STATUS OF THE FIRST AND SECOND LINE THERAPY FOR HELICOBACTER PYLORI INFECTION IN SYMPTOMATIC CHILDREN: A SINGLE CENTER STUDY Victoria Hurduc, Romania; B. Luiza; P. Doina
P0646 GUT MICROBIOTA ALTERATIONS UNDER OLIGOFRUCTOSE-ENRICHED INULIN ADMINISTRATION IN PAEDIATRIC COELIAC DISEASE PATIENTS ON A GLUTEN-FREE DIET:A RANDOMIZED CONTROLLED TRIAL Urszula Krupa-Kozak, Poland; N. Drabińska; L. H. Markiewicz; E. Jarocka-Cyrta P0647 WITHDRAWN P0648 EVALUATING GLUTEN IMMUNOGENIC PEPTIDES AS NON-INVASIVE MARKER OF GLUTEN-FREE DIET ADHERENCE IN PAEDIATRIC CELIAC DISEASE Alfonso Rodriguez-Herrera, Spain; I. Comino; V. Segura; J. Diaz; A. Muñoz-Suano; A. Cebolla; C. Sousa; The DELIAC Group P0649 INTUSSUSCEPTION IN CHILDREN WITH NEWLY DIAGNOSED CELIAC DISEASE: PREVALENCE AND NATURAL HISTORY Ujjal Poddar, India; V. V. Borkar; A. Thakral; J. Agarwal; A. Srivastava; S. K. Yachha; S. Kumar Poster of Excellence
Malabsorption syndromes, food enteropathies and other small intestinal disorders (paediatric) P0651 META-ANALYSIS: PROTON PUMP INHIBITORS MODERATELY INCREASE THE RISK OF SMALL INTESTINAL BACTERIAL OVERGROWTH Tingting Su, China; S. Chen P0652 CLINICAL SIGNIFICANCE OF TRANSFORMING GROWTH FACTOR – β1 AND TUMOR NECROSIS FACTOR – α IN CHILDREN WITH FOOD PROTEIN INDUCED ENTEROCOLITIS SYNDROME. Oltinoy Kamilova, Uzbekistan; A. N. Aripov; S. S. Sultankhodjaeva; S. I. Geller; D. X. Dustmuxamedova; Z. S. Xudoyorova; M. Rustamova Paediatric nutrition P0653 THE ROLE OF GTS1 & GTM1 GENE POLYMORPHISMS IN NEWBORNS’ OBESITY RISK Cristina Oana Marginean, Romania; C. Marginean; L. E. Melit; C. Banescu; M. O. Marginean P0654 SARCOPENIA IN CHILDREN WITH INTESTINAL TRANSPLANTATION R. Hegarty; J. Hind; Dhamyanthi Thangarajah, United Kingdom
Coeliac disease (paediatric)
Poster in the Spotlight
P0650 WITHDRAWN
P0655 GENETIC PREDISPOSITION TO PRIMARY LACTOSE INTOLERANCE AND ITS INFLUENCE ON CHILDREN’S QUALITY OF LIFE AND DAIRY INTAKE Corina Pienar, Romania; E. Seclaman; M. Lazarescu; R. Costachescu; S. A. Popescu; I. Sporea; I. Ciuca; L. Pop Poster Session 09:00 – 17:00 Clinical Cases I
Hall 7
Liver / Biliary / Pancreas CC001 HEPATIC GLYCOGENOSIS ASSOCIATED WITH TYPE 1 DIABETES MELLITUS – A RARE ENTITY IN THE 21ST CENTURY Marta Patita, Portugal; R. Barosa; G. Nunes; H. Coelho; M. J. Brito; A. Alves de Matos; J. Fonseca; C. Fonseca CC002 CASE OF PORPHIRIA ACUTE INTERMITTENT. ENTITY OF DIFFICULT DIAGNOSIS. J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain
Clinical Case Session
157
Monday, October 30, 2017
Paediatric H. pylori
UEG Week Final Programme : Poster Sessions
Monday, October 30, 2017
Monday, October 30, 2017
CC003 A CASE OF GENOTYPE-4 ACUTE HEPATITIS E IN KOREAN Kyoung Min Sohn, Republic of Korea; I.-S. Choi; G. Y. Jeong; Y. J. Jeon
CC013 DIGITAL CHOLANGIOSCOPY FOR THE DIAGNOSIS OF A RARE CAUSE OF PAINLESS JAUNDICE Bjoern Lewerenz, Germany; W. Schepp
CC004 ELEVATED LIVER ENZYMES IN A PATIENT RECEIVING ANTIRETROVIRAL THERAPY – A DIAGOSTIC CHALLENGE Marta Patita, Portugal; R. Barosa; G. Nunes; D. Gonçalves; M. J. Aleixo; M. J. Brito; C. Fonseca
CC014 PANCREATIC METASTASIS IN AN EPIDERMOID LUNG NEOPLASIA Isabel Leyre Pinazo Martínez, Spain; J. Mostazo Torres; M. Vilchez Jaimez
CC005 A RARE CASE OF HYPERSENSITIVITY CHOLESTASIS Ravindra Lakshman Satarasinghe, Sri Lanka; B. M. Dayananda; K. Weerasinghe
CC015 INCIDENTALOMA: DIAGNOSIS OF AMPULOMA AFTER EXTENSION STUDY OF CA UTERINE. J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martínez, Spai
CC006 AN UNUSUAL FINDING ON LIVER BIOPSY – GIANT CELL HEPATITIS Thomas Garvey, United Kingdom; D. Galloway; A. Winstanley; A. O'Brien; D. Joshi CC007 LIVER TRANSPLANTATION FOR MALIGNANT MUCINOUS CYSTIC NEOPLASM OF THE LIVER: THE FIRST PUBLISHED CASE Peter Macinga, Czech Republic; J. Mendl; L. Bajer; E. Sticova; J. Fronek; P. Trunecka; J. Spicak; T. Hucl CC008 A HEPATOCELLULAR CARCINOMA WITH GUILLAIN-BARRE SYNDROME IN A YOUNG ADULT Khellaf Amalou, Algeria; F. Belghanem; D. Kezzoula; F. Yahiaoui; A. Bousseloub CC009 LIVER NODULE AND ELEVATED ALPHA-FETOPROTEIN: BEYOND THE HEPATOCELLULAR CARCINOMA Marta Gravito-Soares, Portugal; E. Soares; D. Gomes; R. Ferreira; M. A. Cipriano; L. Tomé CC010 DUODENAL BULB INVASION BY AN HEPATOCELLULAR CARCINOMA MIMICS ACUTE CHOLECYSTITIS WITH CHOLECYSTODUODENAL FISTULA. Pedro Marques Da Costa, Portugal; J. Lopes; R. Luís; E. Vitorino; I. Leite; J. Coutinho; L. Carrilho Ribeiro; J. Velosa CC011 DIFFUSE HEPATOCELLULAR CARCINOMA IN A HIVINFECTED PATIENT – COMPLETE RESPONSE TO SORAFENIB Gonçalo Nunes, Portugall; R. Barosa; M. Patita; M. J. Aleixo; M. Ramalho; J. Fonseca; C. Fonseca CC012 ENDOBILIARY RADIOFREQUENCY ABLATION OF MALIGNANT BILIARY OBSTRUCTION: A SINGLE-CENTRE EXPERIENCE Hairol Othman, Malaysia; M. F. Che Ani; Z. Zuhdi; R. Jarmin; A. Azman 158
CC016 A COMPRESSIVE SEROUS CYSTADENOCARCINOMA OF THE PANCREAS REVEALED BY A DIGESTIVE HEMORRHAGE: ABOUT AN EXCEPTIONAL CASE Chu Mohammed Zakaria, Morocco; I. Zahi; W. Khannoussi; E. M. amine; G. Kharrasse CC017 A CASE OF NON FUNCTIONAL PANCREATIC PARAGANGLIOMA Stefano Rizza, Italy; L. Venezia; P. Cortegoso Valdivia; C. G. De Angelis Surgery / Endoscopy / Imaging CC018 SPONTANEOUS CHOLEDOCHO DUODENAL FISTULA WITH TUBERCULOUS DUODENAL ULCERATION: A RARE CAUSE OF UPPER GASTROINTESTINAL BLEEDING Patrícia Santos, Portugal; C. Freitas; M. Moura; L. Meireles; M. Camacho; A. Sá; A. Valente; J. Velosa CC019 GASTRIC OUTLET OBSTRUCTION DUE TO DISPLACEMENT OF AN INTRAGASTRIC BALLOON DEVICE Pedro Marques Da Costa, Portugal; M. Verdelho Machado; A. O. Ferreira; A. Marques; L. Carrilho Ribeiro; J. Velosa CC020 THE FIRST CASE OF ENDOSONOGRAPHY BIOPSY FOR LEIOMYOMA OF INFRARENAL INFERIOR VENA CAVA Tatiana Silina, Russian Federation; A. V. Chizhikov; N. Y. Mishakina; K. V. Kirsanov; V. I. Vladimirova; A. P. Raksha; T. N. Starostina; A. V. Sazhin Lower GI CC021 MUCINOUS ADENOCARCINOMA OF PERIANAL FISTULA IN A PATIENT WITH ULCERATIVE COLITIS Vlasta Orsic Fric, Croatia; V. Borzan; B. Borzan
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Monday, October 30, 2017
Poster Sessions : UEG Week Final Programme
CC023 IMPACTED RING CAUSING COLONIC OBSTRUCTION : A CASE REPORT S.-J. Boo; H. S. Jang; S. T. Kim; S. J. Ko; S.-Y. Na; S. U. Jeong; Eun Kwang Choi, Republic of Korea; H. U. Kim; B.-C. Song CC024 A RARE CASE WITH RECURRENT DIARRHEA: GOOD SYNDROME V. Asoglu; H. Goze; A. R. Soylu; Hüseyin Tezel, Turkey; G. Ünsal; H. Ümit CC025 A RARE CASE PRESENTING WITH ABDOMINAL PAIN: EOSINOPHILIC GASTROENTERITIS V. Asoglu; S. Orman; A. R. Soylu; G. Ünsal; Hüseyin Tezel, Turkey; H. Ümit CC026 EXCLUSIVE ABDOMINAL LYMPHADENOMEGALY: A RARE PRESENTATION OF SARCOIDOSIS Abadia Matoso, Brazil; M. Simão Ferreira; L. E. Zumpano CC027 UNUSUAL PRESENTATION OF A DIGESTIVE MANTLE CELL LYMPHOMA. Khellaf Amalou, Algeria; D. Kezzoula; F. Belghanem; S. Bouchnafa; F. Yahiaoui; A. Bousseloub CC028 LIVER ABSCESS AS THE FIRST MANIFESTATION OF RECTAL ADENOCARCINOMA WITHOUT METASTASIS Adam Nagy, Hungary; A. V. Patai; A. Kocsis; T. Micsik; H. Székely; J. Lohinszky; V. Lehoczki; B. Molnar; P. Igaz CC029 SYNCHRONOUS MULTIPLE LYMPHOMATOUS POLYPOSIS AND ADENOCARCINOMA IN THE COLON : A CASE REPORT S.-J. Boo; Hoe Soo Jang, Republic of Korea; S. T. Kim; S. J. Ko
Upper GI CC032 LYMPHOCYTIC OESOPHAGITIS – EMERGING CLINICAL ENTITY Ayman Bannaga, United Kingdom; R. Iriarte; B. Disney CC033 MASSIVE GASTRIC POLYPOSIS – DIAGNOSTIC CHALLENGE Joana Castela, Portugal; G. Esteves; R. Casaca; P. Chaves; C. Albuquerque; I. Claro; A. Dias Pereira CC034 BAFFLING CAUSE OF UPPER GASTROINTESTINAL BLEED Amit Soni, India; N. S. Malhi CC035 ACUTE GASTROINTESTINAL BLEEDING CAUSED BY GASTRITIS CYSTICA PROFUNDA IN AN UNOPERATED STOMACH – A CHALLENGING CASE Joana Rita Carvalho, Portugal; L. C. Meireles; I. Goulart; A. C. Quadros; P. M. dos Santos; F. Serejo; C. Ferreira; J. Velosa CC036 ESOPHAGEAL RUPTURE (BOERHAAVE SYNDROME) AS A FIRST CLINICAL EVENT IN YOUNG ADULT Maria Stafylidou, Greece; A. Gagalis; P. Saripoulos; A. Kalambakas; G. Tzatzagou CC037 LUPUS ENTERITIS AS AN INITIAL PRESENTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS Patrícia Santos, Portugal; S. Fernandes; L. Correia; H. Cortez Pinto; J. Velosa CC038 A TALE OF TWO LYMPHOMAS Vikrant Parihar, Ireland; P. Crotty; D. McNamara CC039 JEJUNAL VARICEAL BLEEDING SUCCESSFULLY TREATED WITH TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT: A CASE REPORT Fabiana Capuano, Italy; C. Cusumano; N. Passigato; D. Costa; S. Di Stefano; C. Perini; G. Vettori; A. Colecchia; L. Frulloni
CC030 AN UNUSUAL CAUSE OF ANORECTAL DISCHARGE Rafaela Loureiro, Portugal; V. Pavão Borges; C. Bernardes; J. Saiote
CC040 NEUROMUSCULAR AND VASCULAR HAMARTOMA AS A RARE CAUSE OF RECURRENT GASTROINTESTINAL BLEEDING Marta Patita, Portugal; J. Félix; M. Allen; M. M. Mafra; L. Gargaté; P. Pinto Marques
CC031 A CASE OF DOUBLE TROUBLE: DIARRHEA IN A PATIENT WITH DIFFUSE LARGE B CELL LYMPHOMA Harshal Mandavdhare, India; R. Agarwala; R. Nada; G. Prakash; V. Suri; V. Sharma
CC041 AN OCCULT CAUSE OF OBSCURE GASTROINTESTINAL BLEEDING Rui Morais, Portugal; R. Coelho; A. Andrade; A. C. Nunes; M. Marques; H. Cardoso; C. Fernandes; R. Melo; G. Macedo
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
159
Monday, October 30, 2017
CC022 TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY WITH GASTROINTESTINAL ONSET: PRESENTATION OF TWO CASES Radislav Nakov, Bulgaria; S. Sarafov; V. Nakov; M. Gospodinova; L. Tankova; V. Gerova; A. Borizanova; T. Todorov; A. Kirov; A. Todorova; I. Tournev; B. Vladimirov
Poster Sessions
Tuesday, October 31, 2017
Poster Sessions by Day Tuesday, October 31, 2017
Focus on original research: Posters in the Spotlight
Posters in the Spotlight 10:30 – 12:00 E-Poster Lounge 1 Pancreatic and biliary neoplasia: Basic and clinical observations Chairs: Marco Del Chiaro, Sweden Eike Gallmeier, Germany P0788 HENT1 & DPD EXPRESSION IN EUS-FNAB SAMPLES OF PANCREATIC DUCTAL ADENOCARCINOMA: TECHNICAL FEASIBILITY AND PROGNOSTIC SIGNIFICANCE OF GEMCITABINE+S1-BASED CHEMORADIOTHERAPY P0784 PRESENTATION SYMPTOMS AND RISK FACTORS ARE ASSOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH PROGNOSIS OF PANCREATIC CANCER. P0793 RAPID ON SITE EVALUATION (ROSE): AN ESSENTIAL TOOL IN ECHO-ENDOSCOPIC (EUS) STUDY OF SOLID LESIONS OF THE PANCREAS P0749 THE OUTCOMES OF ERCP FOR THE PALLIATION OF MALIGNANT JAUNDICE IN ENGLAND BETWEEN 2001 AND 2015
Up to 6 posters featuring hot topic research will be presented in the Posters in the Spotlight Sessions at the e-poster terminal in the E-Poster Lounges in Hall 7. A following discussion is led by two moderators and experts in the field. At the end of each session, the Oral Free Paper Prize will be awarded to the best presenter.
P0770 IMAGING IN CHRONIC PANCREATITIS – DATA FROM THE SCANDINAVIAN BALTIC PANCREAS CLUB DATABASE Posters in the Spotlight 10:30 – 12:00 E-Poster Lounge 2 Advances in the management of functional GI disorders Chairs: Henriette Heinrich, United Kingdom Imran Aziz, Sweden P1178 GASTRIC PERORAL ENDOSCOPIC MYOTOMY (G-POEM) AS TREATMENT FOR FUNCTIONAL DELAYED GASTRIC EMPTYING: INITIAL ASIAN EXPERIENCE P1191 THE MUCOSAL INTEGRITY IN PHENOTYPES OF GASTROESOPHAGEAL REFLUX DISEASE AND FUNCTIONAL HEARTBURN
E-Posters will be published on www.ueg.eu/week/24-7
P1204 LOW-FODMAP DIET RESULTED EFFECTIVE IN REDUCING SYMPTOM PERCEPTION IN PATIENTS WITH FUNCTIONAL HEARTBURN
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P1140 EFFECT OF FAECAL MICROBIOTA TRANSPLANTATION ON GUT BACTERIAL FERMENTATION PRODUCTS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME P1149 ORAL ?-GALACTOSIDASE IMPROVES GASTROINTESTINAL TOLERANCE TO A DIET HIGH IN GALACTO-OLIGOSACCHARIDES: ADJUNCT THERAPY TO A LOW FODMAP DIET IN IRRITABLE BOWEL SYNDROME Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 1 Poster Champ Session: Upper gastrointestinal diseases Chairs: Jan Bornschein, Germany Jose Carlos L. Machado, Portugal P1157 A CASE-CONTROL STUDY ON THE RISK OF UPPER GASTROINTESTINAL MUCOSAL INJURIES IN SUBJECTS PRESCRIBED NSAIDS AND ANTI-THROMBOTIC DRUGS USING THE LARGE ORGANIZED DATABASE OF CLAIMS IN JAPAN (APPROXIMATELY 3.7 MILLION OF POPULATION ON AN ACCUMULATED BASIS)
P1245 FUNDING DISPARITIES IN DIGESTIVE CANCER RESEARCH IN THE UNITED STATES P1253 THE TRANSITION OF HELICOBACTER PYLORI ERADICATION IN OUR INSTITUTION P1256 COMPARISON OF HELICOBACTER PYLORI ERADICATION RATES :VONOPRAZAN VS. PROTON PUMP INHIBITOR P1275 CELIAC DISEASE AND POSITIVE IGA TISSUE TRANSGLUTAMINASE IN PATIENTS WITH DISTAL RADIUS AND ANKLE FRACTURE: A CASE-CONTROL STUDY P1300 INTRAGASTRIC BALLOON: A LARGE BRAZILIAN MULTICENTRIC STUDY OVER 10,000 CASES AND 20 YEARS OF EXPERIENCE Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 2 Poster Champ Session: Liver, biliary and pancreatic diseases Chairs: Corinne Bousquet, France Stefano Crippa, Italy
P1171 THE NORMATIVE VALUES OF A NEW 36 CHANNELS WATER PERFUSION ESOPHAGEAL MOTILITY CATHETER
P0664 STEM CELL TRANSPLANTATION IMPROVES SURVIVAL, QUALITY OF LIFE AND SYNTHETIC FUNCTIONS OF THE LIVER IN PATIENTS WITH END STAGE LIVER DISEASE
P1172 LOW-VOLUME MULTIPLE RAPID SWALLOW BETTER DISTINGUISH PERISTALTIC ESOPHAGEAL RESERVE COMPARED TO HIGH-VOLUME RAPID DRINKING TEST
P0778 AUTOPHAGY IS ESSENTIAL FOR PANCREATIC CANCER DEVELOPMENT IN A NEW HUMANIZED GENETICALLY-MODIFIED ADULT MOUSE MODEL
P1190 A LESS COMPETENT OESOPHAGO-GASTRIC JUNCTION IS ASSOCIATED WITH OESOPHAGEAL ACID HYPERSENSITIVITY EVEN IN HEALTHY CONTROLS
P0665 PERIPHERAL BLOOD MONONUCLEAR CELL TRANSPLANTATION STIMULATES HEPATOCYTES PROLIFERATION IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS
P1217 SAFETY AND EFFICACY OF CHEMORADIOTHERAPY AFTER ENDOSCOPIC RESECTION IN PATIENTS WITH SUPERFICIAL ESOPHAGEAL SQUAMOUS-CELL CARCINOMA.
P0689 NESTED CASE-CONTROL STUDY FOR RISK FACTORS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS
P1221 ENDOSCOPIC CRYOBALOON ABLATION IS SAFE, WELL-TOLERATED AND HIGHLY EFFECTIVE IN THE ERADICATION OF ESOPHAGEAL SQUAMOUS CELL NEOPLASIA.
P0753 DEVELOPMENT OF AUTOIMMUNE PANCREATITIS IS INDEPENDENT OF P21 MEDIATED PANCREATIC INFLAMMATION
P1240 HOXC10 IS UPREGULATED IN HUMAN GASTRIC CANCER AND PROMOTES CELL G1-S TRANSFORMATION AND PROLIFERATION THROUGH DIRECT TRANSCRIPTIONAL REPRESSION OF P21 Poster in the Spotlight
Poster of Excellence
P0785 PLASMA DNA GENOTYPING USING DIGITAL PCR FOR SURVEILLANCE OF PANCREATIC CANCER IN HIGH-RISK INDIVIDUALS
Clinical Case Session
161
Tuesday, October 31, 2017
P1137 HEALTHCARE PROFESSIONALS FAIL TO PROVIDE ADEQUATE COUNSELLING AND SUPPORT ABOUT OPIOID-INDUCED CONSTIPATION TO STRONG-OPIOID USERS
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0669 ROLE OF BISPHENOL A AS AN ENVIRONMENTAL FACTOR IN THE PROMOTION OF NON-ALCOHOLIC FATTY LIVER DISEASE: IN VITRO AND IN VIVO STUDY
P0982 COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE: RISK FACTORS IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY
P0674 AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE IS A RISK FACTOR TO HAVE A LARGER LIVER VOLUME COMPARED WITH PATIENTS WITH COMBINED POLYCYSTIC LIVER DISEASE AND AUTOSOMAL POLYCYSTIC KIDNEY DISEASE: RESULTS OF THE PLD REGISTRY
P0990 RISK OF SERIOUS INFECTION IN HEALTHCARE WORKER WITH INFLAMMATORY BOWEL DISEASE: A CASE-CONTROL STUDY OF THE GETAID
P0731 A PROPOSAL FOR MODIFICATION OF BARCELONA CLINIC LIVER CANCER SYSTEM FOR HEPATOCELLULAR CARCINOMA STAGING BASED ON KOREAN MULTICENTER REGISTRY DATABASE P0690 SEPSIS-3 CRITERIA ARE MORE ACCURATE THAN SIRS CRITERIA IN PREDICTING IN-HOSPITAL MORTALITY IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS
Tuesday, October 31, 2017
P0742 SYSTEMATIC REVIEW AND META-ANALYSIS OF TRANSABDOMINAL AND ENDOSCOPIC ULTRASOUND FOR GALLBLADDER POLYPS P0672 IDENTIFICATION AND IN SILICO CHARACTERIZATION OF SIX NOVEL GANAB MUTATIONS IN POLYCYSTIC LIVER DISEASE. Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 3 Poster Champ Session: Lower gastrointestinal diseases Chairs: Laurence Egan, Ireland Ian Jenkins, United Kingdom
P0956 PATHOBIONT-FREE MICROBIOTA PROTECTS AGAINST GUT INFLAMMATION INDUCED BY AN INNATE IMMUNE DEFICIENCY OR DIETARY PERTURBANT OF THE MICROBIOTA P0967 FIRST ANALYSIS FROM UK IBD TWIN BIOBANK; 16S RRNA GENE SEQUENCING IDENTIFIES REDUCED DIVERSITY IN ACTIVE IBD AND TAXA ASSOCIATED WITH ACTIVE DISEASE PHENOTYPE TO LEVEL OF SPECIES P0974 DISTINCT GUT MICROBIOTA PROFILES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE COLITIS
162
P0995 THE DIAGNOSTIC UTILITY OF LINKED-COLOR IMAGING IN THE EVALUATION OF MUCOSAL INFLAMMATION IN PATIENTS WITH ULCERATIVE COLITIS P1003 FAECAL CALPROTECTIN AND MAGNETIC RESONANCE IMAGING ARE RELIABLE TOOL TO DETECT ENDOSCOPIC POSTOPERATIVE RECURRENCE IN CROHN'S DISEASE P1012 MMP3 (METALLOPROTEINASE 3): A NEW MARKER FOR ASSESSING LOSS OF RESPONSE TO INFLIXIMAB IN IBD P1030 INDIRECT TREATMENT COMPARISON OF USTEKINUMAB VERSUS OTHER BIOLOGICS IN MODERATE-TO-SEVERE CROHN'S DISEASE PATIENTS HAVING FAILED ANTI-TNF THERAPY? A 1-YEAR TREATMENT SEQUENCE ANALYSIS INCLUDING DELAYED RESPONDERS P1032 EFFICACY AND TOLERABILITY OF INITIATING, OR SWITCHING TO, INFLIXIMAB BIOSIMILAR CT-P13 IN INFLAMMATORY BOWEL DISEASE (IBD): A LARGE SINGLE-CENTRE EXPERIENCE P1058 A UNITED STATES CLAIMS DATABASE ANALYSIS COMPARING SAFETY, MEDICAL RESOURCE UTILIZATION, AND TREATMENT COSTS ASSOCIATED WITH THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE BY DRUG CLASS Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 4 Poster Champ Session: Surgery, endsocopy and imaging Chairs: Sandra van Brunschot, The Netherlands Jörg Albert, Germany P0944 PARADIGM SHIFT? SHOULD A LYMPHADENECTOMY ROUTINELY BE PERFORMED ALSO AMONG GALLBLADDER CANCER PATIENTS WITH T1A DISEASE? P0921 COLON CAPSULE ENDOSCOPY MAY REDUCE COLONOSCOPY MISS RATE – A MULTICENTER STUDY
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P0895 PROSPECTIVE STUDY OF EARLY PRECUT VS. UTMOST PRECUT WITH PANCREATIC STENT IN INITIAL PANCREATIC DUCT CANNULATION
Posters in the Spotlight 14:00 – 15:30 E-Poster Lounge 1 Optimising our diagnostic tools in gastroenterology and hepatology Chairs: Stuart Taylor, United Kingdom Oliver Pech, Germany
P0924 ENDOSCOPIC ULTRASONOGRAPHY-GUIDED BILIARY DRAINAGE WITHOUT DILATION DEVICE USING A THIN DELIVERY-SYSTEM STENT: A PRECLINICAL STUDY
P1115 PROSPECTIVE COMPARISON OF THE NOVEL FULL SPECTRUM ENDOSCOPY (FUSE) AND ADVANCED HIGH DEFINITION-WHITE LIGHT ENDOSCOPY FOR DETECTION OF POLYPS IN ROUTINE PRACTICE
P0794 ESOPHAGEAL FISTULA HEALING BY MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES IN A THERMORESPONSIVE GEL: A PRE-CLINICAL PORCINE STUDY
P1005 VALUE OF 75SEHCAT IN THE DIAGNOSIS OF BILE ACID MALABSORPTION IN CROHN´S DISEASE WITH CHRONIC DIARRHOEA
P0796 IMPROVEMENT IN HEPATIC TRANSAMINASES OVER 12 MONTHS AFTER SINGLE PROCEDURE DUODENAL MUCOSAL RESURFACING IN TYPE 2 DIABETES PATIENTS
P0714 UTILITY OF A NEW FUNCTION IN 3D SIM-NAVIGATOR: ELECTRIC FIELD, WHICH INDICATES THE PREDICTED ABLATIVE AREA
P0919 A NOVEL CAPSULE TECHNOLOGY PLATFORM FOR SPECIFIC LOCALIZED COLON DRUG DELIVERY
P0713 STAGING HEPATIC STEATOSIS IN NONALCOHOLIC FATTY LIVER DISEASE BY QUANTITATIVE CONVENTIONAL ULTRASOUND IMAGING, VALIDATED WITH HISTOPATHOLOGY
P0946 EFFECT OF TRICLOSAN-COATED SUTURE USE ON THE INCIDENCE OF SUPERFICIAL INCISIONAL SURGICAL SITE INFECTIONS AFTER GASTROENTEROLOGIC SURGERY: A PROPENSITY SCORE MATCHING RETROSPECTIVE STUDY P0948 NOVEL ENDOSCOPIC REPAIR TECHNIQUE FOR GASTROINTESTINAL LEAKS AND PERFORATIONS USING NEGATIVE PRESSURE THERAPY WITH OPEN-PORE POLYURETHANE-FOAM AND FILM DRAINAGE
P0920 COLON CAPSULE ENDOSCOPY: HOW DOES INADEQUATE PROCEDURE CLEANSING CORRELATE WITH PROCEDURE ACCURACY? P0846 DEVELOPMENT OF A NEW ENDOSCOPIC CLASSIFICATION AND FIRST INTERNATIONAL VALIDATION (FACILE GROUP) OF COLONIC LESIONS USING ADVANCED IMAGING MODALITIES IN IBD PATIENTS
P0820 USEFULNESS OF LINKED COLOR IMAGING (LCI) FOR RECOGNITION OF EARLY GASTRIC CANCER AND GASTRIC ADENOMA P0824 ENDOSCOPIC SUBMUCOSAL TUNNEL DISSECTION FOR LESSER GASTRIC CURVATURE SUPERFICIAL NEOPLASMS
Posters in the Spotlight 14:00 – 15:30 E-Poster Lounge 2 How to improve the success rate in therapeutic endoscopy? Chairs: Stefan Seewald, Switzerland Mostafa Ibrahim, Belgium P0859 NON-GRANULAR LATERALLY SPREADING COLONIC LESIONS ?20MM (LSL) ARE SMALLER AND MORE COMMONLY MULTIPLE THAN GRANULAR LSL; IMPLICATIONS OF A COLONIC MUCOSAL PHENOTYPE' FOR PRACTITIONERS OF ENDOSCOPIC RESECTION P0862 THE SMSA POLYP SCORE RELIABLY PREDICTS ROBUST ENDPOINTS OF ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL LATERALLY SPREADING LESIONS.
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
163
Tuesday, October 31, 2017
P0910 DETERMINATION OF INTRACYSTIC GLUCOSE CONCENTRATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PANCREATIC CYSTS: A PROSPECTIVE STUDY.
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0890 MOST ADVANCED ENDOSCOPY TRAINEES DO NOT MEET COMPETENCE FOR NATIVE PAPILLAE CANNULATION IN ERCP: RESULTS FROM A PROSPECTIVE MULTICENTER STUDY P0896 POST-ERCP BLEEDING IN THE ERA OF MULTIPLE ANTIPLATELET AGENTS P0926 EFFICACY OF SELF-EXPANDABLE METALLIC STENT PLACEMENT IN THE MANAGEMENT OF ANASTOMOTIC STRICTURE AFTER ORTHOTOPIC LIVER TRANSPLANTATION P0930 CLINICAL FAILURE IN COLONIC STENTING FOR MALIGNANT LARGE BOWEL OBSTRUCTION: OUTCOMES AND RISK FACTORS IN 172 PROCEDURES Poster Session 09:00 – 17:00 Liver & Biliary II
Hall 7
Tuesday, October 31, 2017
Molecular biology, inflammation and fibrosis P0656 HYPOXIA CAUSES HEPATIC STELLATE CELLS ACTIVATION IN THE ABSENCE OF CUX1 Eva Becker, Germany; P. Di Fazio; J. Hänze; T. M. Gress; D. Bartsch; T. T. Wissniowski P0657 HEPATIC FIBROBLAST GROWTH FACTOR-21 AND OMENTIN-1 MRNA LEVELS IN MORBIDLY OBESE WOMEN WITH NON-ALCOHOLIC FATTY LIVER DISEASE M. Kukla; Marek Waluga, Poland; M. Żorniak; M. Kajor; Ł. Liszka; M. Dyaczyński; G. Kowalski; R. J. Buldak; M. Hartleb P0658 LOUREIRIN B INHIBITS THE PROLIFERATION OF HEPATIC STELLATE CELLS VIA DOWN-REGULATING FRIZZLED-4 Zhengji Song, China P0659 MACROPHAGE CONTRIBUTES TO STEATOHEPATITIS THROUGH MEDIATING INFLAMMATORY CYTOKINES, AUTOPHAGY AND THE CROSSTALK WITH HEPATOCYTES Jennie Ka Ching Lau, Hong Kong PRC; X. Zhang; E. S. Chu; J. Yu P0660 NEWLY SYNTHESIZED BILE ACID DERIVATIVES PREVENT LIVER STEATOSIS IN VITRO THROUGH TARGETING OF NR1 SUBFAMILY NUCLEAR RECEPTORS H. M. D. S. Brito; M. Batista; M. Silva; J. Salvador; Rui Castro, Portugal; C. M. P. Rodrigues
164
P0661 DISSECTING AUTOPHAGY IN A NAFL/NASH MOUSE AND HUMAN MODEL Sophia Polte, Germany; T. T. Wissniowski; T. M. Gress; D. Bartsch; K. Okamoto; T. Matono; T. Stiewe; M. Wanzel; P. Di Fazio P0662 MODULATION OF MITOCHONDRIAL DYNAMICS BY MIRNAS IN NAFLD André Lopes Simão, Portugal; M. B. Afonso; P. M. Rodrigues; A. J. Amaral; M. Gama-Carvalho; A. Zorzano; C. M. P. Rodrigues; R. E. Castro Regeneration, stem cells and nutrition P0663 ª GRANULOCYTE COLONY STIMULATING FACTOR IN DECOMPENSATED LIVER DISEASE – OUR EXPERIENCE IN A TERTIARY HOSPITAL IN NEPAL Sabin Thapaliya, Nepal P0664 TITLE: STEM CELL TRANSPLANTATION IMPROVES SURVIVAL, QUALITY OF LIFE AND SYNTHETIC FUNCTIONS OF THE LIVER IN PATIENTS WITH END STAGE LIVER DISEASE M. Albadry; M.-E. Amer; W. A. E. Mostafa; H. A. Bayomi; A. El Shafie; Mohamed Alboraie, Egypt P0665 PERIPHERAL BLOOD MONONUCLEAR CELL TRANSPLANTATION STIMULATES HEPATOCYTES PROLIFERATION IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS Guzel R. Burganova, Russian Federation; S. R. Abdulkhakov; I. M. Gazizov; A. A. Gumerova; M. A. Titova; R. Deev; A. P. Kiyasov Metabolic/genetic disorders P0666 ASSOCIATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME IN APPARENTLY HEALTHY KOREAN ADULTS Kyoung Min Sohn, Republic of Korea; Y. J. Jeon P0667 LEAN-NAFLD IS THE STRONGEST PREDICTOR OF FUTURE OBESITY AMONG URBAN ADULT SRI LANKANS: RESULTS FROM A PROSPECTIVE, COMMUNITY COHORT FOLLOW-UP STUDY Madunil Niriella, Sri Lanka; S. T. De Silva; A. Kasthuriratna; A. G. Ranasinghe; A. S. Dassanayake; A. P. De Silva; A. Pathmeswaran; A. R. Wickramasinghe; N. Kato; H. J. de Silva P0668 THE USE OF THE FATTY LIVER INDEX TO DETERMINE THE PREVALENCE OF FATTY LIVER DISEASE (HEPATIC STEATOSIS) IN AN IRISH POPULATION Laura Reynolds, Ireland; L. Rabbitt; C. Goulding
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P0669 ROLE OF BISPHENOL A AS AN ENVIRONMENTAL FACTOR IN THE PROMOTION OF NON-ALCOHOLIC FATTY LIVER DISEASE: IN VITRO AND IN VIVO STUDY Marcello Dallio, Italy; A. G. Gravina; M. Masarone; S. Errico; C. Nicolucci; R. Di Sarno; C. Tuccillo; D. Sgambato; M. Romano; M. Persico; N. Diano; C. Loguercio; A. Federico P0670 ASSESSMENT OF FATTY PANCREAS IN PATIENTS WITH NON–ALCOHOLIC FATTY LIVER DISEASE Tamara Alempijevic, Serbia; S. Dragasevic; S. Zgradic; M. Stojkovic Lalosevic; B. Milicic; D. Popovic; T. Milosavljevic P0671 SERUM THYROID STIMULATING HORMONE IS INDEPENDENTLY ASSOCIATED WITH HEPATIC STEATOSIS AND STEATOHEPATITIS IN EUTHYROID SUBJECTS Ahad Eshraghian, Iran; S. Nikeghbalian; B. Geramizadeh; S. Ali Malek-Hosseini
P0674 AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE IS A RISK FACTOR TO HAVE A LARGER LIVER VOLUME COMPARED WITH PATIENTS WITH COMBINED POLYCYSTIC LIVER DISEASE AND AUTOSOMAL POLYCYSTIC KIDNEY DISEASE: RESULTS OF THE PLD REGISTRY René van Aerts, The Netherlands; M. de Jong; W. Kievit; F. Nevens; H. Kim; C. Ahn; J. P. H. Drenth P0675 CARDIOVASCULAR RISK DEVELOPMENT MODEL FOR THE (ATYPICAL) PATIENT WITH NON-ALCOHOLIC FATTY LIVER DISEASE Mihai Alexandru Munteanu, Romania; G. Nagy; M. Gordan; S. Valean; P. A. Mircea
P0679 EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) ON MORTALITY AND COMPLICATIONS VIZ. SEPSIS, ENCEPHALOPATHY, HEPATORENAL SYNDROME, AND GASTROINTESTINAL BLEED IN SEVERE ALCOHOLIC HEPATITIS- A RANDOMIZED CONTROLLED STUDY. Abhinav Sharma, India P0680 ALCOHOLIC LIVER DISEASE/NON ALCOHOLIC FATTY LIVER DISEASE INDEX(ANI): HOW TO DISTINGUISH ALCOHOLIC FROM NON ALCOHOLIC LIVER DISEASE WITHOUT HISTOLOGY Rui Gaspar, Portugal; J. Santos-Antunes; S. Rodrigues; F. Carneiro; G. Macedo P0681 TO DRINK OR NOT TO DRINK? A PROSPECTIVE COHORT STUDY ON THE EFFECTS OF ONE MONTH ALCOHOL ABSTINENCE IN MODERATE DRINKERS Isabelle Munsterman, The Netherlands; M. Groefsema; G. Weijers; W. Klein; D. W. Swinkels; J. P. H. Drenth; A. Schellekens; E. Tjwa P0682 PROBIOTICS REDUCE ETHANOL-INDUCED HEPATIC INJURY BY MODULATING GUT MICROBIOTA AND INTESTINAL BARRIER INTEGRITY IN MICE Yu Zhang, China; G. Chen; J. Sun P0683 THE OVERWEIGHT ROLE IN THE OCCURRENCE OF HEPATOTOXIC REACTIONS DURING CHEMOTHERAPY OF ACUTE LEUKEMIA Igor Skrypnyk, Ukraine; G. Maslova
Clinical Case Session
165
Tuesday, October 31, 2017
Hepatotoxicity/alcohol
P0673 DIFFERENCES BETWEEN BY-PASS AND SLEEVE GASTRECTOMY ON CLINICAL AND LABORATORY STATUS 6 AND 12 MONTHS AFTER INTERVENTION IN BARIATRIC SUBJECTS Daniele Macor, Italy; S. Palmisano; F. Masutti; V. Lanzlotti; R. Patti; R. M. Buonocore; C. Abazia; N. De Manzini; L. S. Croce'; C. Tiribelli
Poster of Excellence
P0677 THE IMPORTANCE OF FIBROSIS SCORES AND TRANSIENT ELASTOGRAPHY IN NAFLD EVOLUTION Daniela Neagoe, Romania; A. Amzolini; G. Ianosi; M. Popescu; A. Farmazon; S. Ianosi; A. Turculeanu P0678 EFFECTS OF UDCA AND STATIN COMBINATIONS ON LIPID PROFILE IN NAFLD PATIENTS Sergey Vyalov, Russian Federation
P0672 IDENTIFICATION AND IN SILICO CHARACTERIZATION OF SIX NOVEL GANAB MUTATIONS IN POLYCYSTIC LIVER DISEASE. Liyanne van de Laarschot, The Netherlands; R. H. M. te Morsche; A. Hoisschen; W. R. Cnossen; H. Venselaar; J. M. Banales; J. P. H. Drenth
Poster in the Spotlight
P0676 DEVELOPMENT AND VALIDATION OF AN AUTOMATED SYSTEM FOR ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS IN ROUTINE HISTOLOGICAL IMAGES FROM PATIENTS WITH NAFLD Roberta Forlano, United Kingdom; B. H. Mullish; J. Maurice; N. Giannakeas; N. Angkathunyakul; J. Lloyd; A. Tzallas; M. Tsipouras; M. Yee; S. Taylor-Robinson; R. D. Goldin; M. Thursz; P. Manousou
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0684 RESEARCH ON FERROPTOSIS IN HEPATOCYTE INJURY INDUCED BY ALCOHOLIC. Y. Wu; Ting Liu, China; G. Zhang P0685 AMANITA PHALLOIDES HEPATOTOXICITY: 20-YEAR EXPERIENCE IN A GASTROENTEROLOGY INTENSIVE CARE UNIT Catarina Atalaia Martins, Portugal; J. Carvalheiro; R. Ferreira; P. Amaro; M. Ferreira; L. Tomé P0686 BINGE DRINKING AMONG YOUNG STUDENTS IS A RISK FACTOR FOR THE DEVELOPMENT OF ALCOHOL USE DISORDER: RESULTS FROM A CROSS-SECTIONAL STUDY. G. Addolorato; Gabriele Vassallo, Italy; G. Antonelli; M. Antonelli; C. Tarli; A. Mirijello; C. Mosoni; M. M. Rando; L. Sestito; M. Barbara; M. F. Maida; C. Cammà; A. Gasbarrini P0687 LOW LYSOPHOSPHATIDYLCHOLINE LEVELS MAY PREDICT SEVERE ALCOHOLIC HEPATITIS P. Fischer; Adelina Horhat, Romania; C. Hebristean; B. D. Procopet; M. Tantau; C. Socaciu; H. Stefanescu Tuesday, October 31, 2017
Cirrhosis and complications: Clinical aspects P0688 APPLICATION OF THE ICA-AKI CRITERIA IN THE DIAGNOSIS OF ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS Richard Azevedo, Portugal; J. Pinto; H. Ribeiro; F. Pereira; C. Leitão; A. Caldeira; E. Pereira; R. Sousa; A. Banhudo P0689 NESTED CASE-CONTROL STUDY FOR RISK FACTORS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS Lan Ting Yuan, Taiwan; S.-K. Chuah; S.-C. Yang; C.-M. Liang; C.-K. Wu; W.-C. Tai; T.-H. Hung; S.-H. Nguang; J.-W. Wang; K.-L. Tseng; M.-K. Ku; P.-I. Hsu; D.-C. Wu; C.-N. Hsu P0690 SEPSIS-3 CRITERIA ARE MORE ACCURATE THAN SIRS CRITERIA IN PREDICTING IN-HOSPITAL MORTALITY IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS Salvatore Piano, Italy; M. Tonon; G. Chies; A. Romano; E. Vettore; M. Stanco; C. Pilutti; A. Brocca; P. Angeli P0691 A SUBCLINICAL HIGH TRICUSPID REGURGITATION PRESSURE GRADIENT IS A RISK FACTOR FOR SURVIVAL AFTER LIVING DONOR LIVER TRANSPLANTATION Atsushi Ohyama, Japan; A. Takaki; Y. Umeda; T. Yasunaka; R. Yoshida; D. Nobuoka; F. Ikeda; H. Okada; H. Onishi; H. Shiraha; S. Nakamura; T. Yagi P0692 WITHDRAWN 166
P0693 CARVEDILOL VERSUS PROPRANOLOL EFFECT IN THE PRIMARY PROPHYLAXIS OF VARICEAL BLEEDING IN CIRRHOTIC PATIENTS WITH PORTAL VEIN THROMBOSIS Irina Girleanu, Romania; A.-V. Trifan; C. Cojocariu; A. M. Singeap; C. Sfarti; O. Stoica; S. Chiriac; T. Cuciureanu; C. Stanciu P0694 ASSESSMENT OF PROGNOSTIC PERFORMANCE OF ALBI, CHILD-PUGH AND MELD SCORES IN PATIENTS WITH LIVER CIRRHOSIS COMPLICATED WITH ACUTE UPPER GASTROINTESTINAL BLEEDING Sofia Xavier, Portugal; R. Villas-Boas; P. Boal Carvalho; J. Magalhães; C. Marinho; J. Cotter P0695 PROTON PUMP INHIBITORS IN CIRRHOTIC PATIENTS: IT’S URGENT TO RETHINK THEIR USE! Tiago Cúrdia Gonçalves, Portugal; S. Monteiro; S. Xavier; M. Barbosa; P. Boal Carvalho; J. Magalhães; C. Marinho; J. Cotter P0696 WITHDRAWN P0697 CRITICAL FLICKER FREQUENCY TEST PREDICTS THE FIRST EPISODE OF OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS Endrit Shahini, Italy; M. Barone; A. Iannone; M. T. Viggiani; V. Corvace; M. Principi; A. Di Leo P0698 OMNIPRESENCE OF LIVER FIBROSIS, BUT PORTAL HYPERTENSION ONLY IN SELECTED ADULT FONTAN PATIENTS Isabelle Munsterman, The Netherlands; T. Duijnhouwer; R. van Kimmenade; C. Bronkhorst; J. P. H. Drenth; A. van Dijk; E. Tjwa P0699 A RANDOMIZED DOUBLE BLIND CONTROLLED TRIAL ON THE EFFECT OF LACTOBACILLUS RHAMNOSUS GG IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY Endrit Shahini, Italy; M. Barone; A. Iannone; M. T. Viggiani; V. Corvace; M. Principi; A. Di Leo Viral hepatitis: Basic aspects P0700 ASSOCIATIONS OF GENETIC POLYMORPHISM OF TOLLLIKE RECEPTOR 3(TLR-3) AND SEX- LINKED TOLL- LIKE RECEPTOR 7 (TLR-7) ALLELES WITH THE HEPATITIS C VIRUS INFECTION OUTCOME IN EGYPTIAN POPULATION :A MULTICENTRE FAMILY BASED STUDY Mahmoud El-Bendary, Egypt; M. Neamatallah; H. Elalfy; T. Besheer; A. Elkholy; M. El-Diasty; M. Elsareef; M. Zahran; B. El-Aarag; M. El-Setouhy; A.-H. Eladl; G. Esmat;
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
Viral hepatitis C: Clinical aspects P0702 EFFICACY AND SAFETY OF DIRECT ACTING ANTIVIRAL DRUGS IN EARLY TREATMENT OF HCV GENOTYPE 4 POST-LIVING DONOR LIVER TRANSPLANTATION Ehab Fawzy, Egypt; A. M. Moussa; I. M. Fawzy; M. Elbadry P0703 OPTIMIZATION OF DAA TREATMENT SCHEDULE: FOCUS ON HCV GENOTYPE 3 F. Morisco; R. Granata; S. Camera; Federica Morando, Italy; A. Ippolito; M. Milella; F. Conti; C. Masetti; A. Smedile; P. Tundo; T. Santantonio; M. R. Valvano; A. Termite; P. Gatti; V. Messina; A. Iacobellis; M. Librandi; N. Caporaso; A. Andriulli P0704 IMPROVEMENT OF LIVER STIFFNESS VALUES MEASURED BY TRANSITION ELASTOGRAPHY AFTER CHRONIC HEPATITIS C TREATMENT WITH DIRECT ACTION ANTIVIRALS AND EVOLUTIVE CORRELATION OF THROMBOCYTOPENIA AND PRESENCE OF ESOPHAGEAL VARICES Miguel Perez Ferrer, Spain; I. Maestro Prada; A. McGee; J. L. Castro Urda; L. A. Castillo Hererra; C. Garcia Ramos P0705 8 VERSUS 12 WEEKS OF LEDIPASVIR/SOFOSBUVIR REGIMEN IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION Joana Rita Carvalho, Portugal; P. Alexandrino; F. Serejo; R. T. Marinho; F. Ramalho; B. Rodrigues; P. Ferreira; M. S. Dias; H. Cortez-Pinto; C. Baldaia; A. J. Pedro; L. X. de Brito; L. Carrilho Ribeiro; N. Fatela; J. Velosa P0706 CLINICAL FEATURES OF PATIENTS DEVELOPING HCC AFTER ACHIEVING SVR WITH DAA AGAINST CHRONIC HEPATITIS C Koji Ishida, Japan; T. Nakatani; Y. Motokawa; F. Tomooka; A. Shibamoto; Y. Fujimoto; Y. Aihara; S. Nagamatu; M. Uejima; H. Matuo; E. Kikuchi P0707 EARLY OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS C VIRUS TREATED WITH DIRECT-ACTING ANTIVIRALS Seikan Hai, Japan; E. Hatano; T. Okada; Y. Asano; N. Uyama; K. Suzumura; M. Tada; I. Nakamura; K. Iida; H. Sueoka; H. Iwama; A. Kurimoto; R. Ito; H. Nishida; J. Fujimoto
Poster in the Spotlight
Poster of Excellence
P0708 EFFICACY AND SAFETY OF SOFOSBUVIR AND RIBAVIRIN IN HCV POSITIVE PATIENTS WITH RENAL IMPAIRMENT Muhammad Osama Butt, Pakistan P0709 CHRONIC HEPATITIS C A MAJOR HEALTH – RELATED QUALITY OF LIFE BURDEN IN COMPANSATED CIRRHOTIC PATIENTS. Tudor Cuciureanu, Romania; A. M. Singeap; I. Girleanu; S. Chiriac; A.-V. Trifan P0710 SOFOSBUVIR IN COMBINATION WITH RIBAVIRIN IN GENOTYPE 3 HEPATIITS C PATIENTS WITH CIRRHOSIS. AN EXPERIENCE FROM TERTIARY CARE HOSPITAL Ali Langhah, Pakistan P0711 RECURRENCE OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS AND HCC TREATED WITH PARITAPREVIR/ OMBITASVIR /RITONAVIR, DASABUVIR WITH RIBAVIRIN: A NATIONAL COHORT STUDY Doina Proca, Romania; C. M. Preda; C.-R. Baicus; C. P. Popescu; M. Manuc; C. S. Pop; T. Voiosu; E. Ceausu; M. Diculescu; A. Oproiu Imaging, radiology (incl. interventional radiology) P0712 SHEAR WAVE ELASTOGRAPHY FOR THE DIAGNOSIS OF ESOPHAGOGASTRIC VARICES Hiroko Iijima, Japan; T. Nishimura; C. Nakano; T. Aoki; Y. Miyamoto; N. Ishii; Y. Yuri; K. Hasegawa; R. Takata; K. Yo; A. Ishii; T. Takashima; Y. Sakai; N. Aizawa; N. Ikeda; H. Nishikawa; Y. Iwata; H. Enomoto; S. Nishiguchi; J. Fujimoto P0713 STAGING HEPATIC STEATOSIS IN NONALCOHOLIC FATTY LIVER DISEASE BY QUANTITATIVE CONVENTIONAL ULTRASOUND IMAGING, VALIDATED WITH HISTOPATHOLOGY G. Weijers; Isabelle Munsterman, The Netherlands; A. Meel – van den Abeelen; J. M. Thijssen; J. P. H. Drenth; E. Tjwa; C. de Korte P0714 UTILITY OF A NEW FUNCTION IN 3D SIM-NAVIGATOR: ELECTRIC FIELD, WHICH INDICATES THE PREDICTED ABLATIVE AREA Azusa Sakamoto, Japan; T. Kimura; T. Matsumae; G. Tanke; H. Yoshida; M. Taki; M. Fukuhara; S. Henmi; T. Yamashina; Y. Sawai; S. Saito; N. Nishijima; A. Nasu; H. Komekado; M. Asada; T. Tsumura; T. Maruo; R. Kita; Y. Osaki
Clinical Case Session
167
Tuesday, October 31, 2017
P0701 ACTIVATED HEPATIC STELLATE CELLS CAN DIRECTLY INDUCE PATHOGENIC TH17 CELLS IN CHRONIC HEPATITIS B VIRUS INFECTION Yun Liu, China; W. Jiang
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0715 ATTENUATION COEFFICIENT MEASUREMENT (ACM) AS NOVEL REAL TIME ULTRASOUND ALTERNATIVE TO CAP (FIBROSCAN) O. Dynnyk; N. Marunchyn; Nazarii Kobyliak, Ukraine; O. Fedusenko; V. Gurianov P0716 HOW DIFFERENT IS THE PERFORMANCE OF CEUS IN CIRRHOTIC VS. NON-CIRRHOTIC PATIENTS? Tudor Moga, Romania; C. S. Ivascu; C. G. Foncea; D. Gherhardt; R. Sirli; S. A. Popescu; M. Danila; I. Sporea Liver neoplasia: Basic P0717 CUX1 IN LIVER CANCER: EXPERIMENTAL STUDY IN HYPOXIA MODEL Sophie Blümel, Germany; T. T. Wissniowski; J. Hänze; T. M. Gress; D. Bartsch; P. Di Fazio P0718 S-ADENOSYLMETHIONINE AFFECTS CELL CYCLE PATHWAYS AND SUPRESSES PROLIFERATION IN LIVER CELLS Lu Yan, China; G. Zhang; Y. Chen Tuesday, October 31, 2017
P0719 BRG1 PROMOTES HEPATOCARCINOGENESIS BY MODULATING CYCLINB, D, E AND MATRIX METALLOPROTEINASE 7 Benedikt Kaufmann, Germany; B. Wang; M. Lu; N. Hüser; H. Friess; G. von Figura; D. Hartmann P0720 PROGNOSTIC ROLE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN HEPATOCELLULAR CARCINOMA (HCC) Nour Elleuch, Tunisia; S. jardak; A. Sabbek; A. Ben Slama; H. Jaziri; E. Hammami; B. Ahlem; K. Mehdi; J. Ali P0721 REIC/DKK-3 PROTEIN CONCENTRATION INDUCE THE POSITIVE EFFECT TO THE MORTALITY OF HEPATOCELLULAR CARCINOMA Atsushi Ohyama, Japan; D. Uchida; H. Shiraha; H. Sawahara; H. Kato; H. Okada P0722 SURGICAL OUTCOME OF PATIENTS WITH FIBROLAMELLAR HEPATOCELLULAR CARCINOMA. DOES IT DIFFERS FROM COMMON HEPATOCELLULAR CARCINOMA ? Ehab El-Hanafy, Egypt P0723 WITHDRAWN
Liver neoplasia: Clinical P0724 MICROWAVE VERSUS RADIOFREQUENCY THERMAL ABLATION OF HEPATOCELLULAR ADENOMA : SAFETY AND EFFICACY. H. El Alfy; T. Besheer; K. Farid; A. Mohammed El Sayed Ahmed El Nakib; A. El Shabrawi; A. Elbadrawy; A. El morsy; K. Zalata; Mahmoud Abd el_Aziz, Egypt P0725 METABOLIC DISORDERS ACROSS HEPATOCELLULAR CARCINOMA IN ITALY. F. Morisco; M. Guarino; M. R. Valvano; Valentina Cossiga, Italy; F. Farinati; E. G. Giannini; F. Ciccarese; F. Piscaglia; G. L. Rapaccini; M. Di Marco; E. Caturelli; M. Zoli; F. Borzio; R. Sacco; C. Cammà; M. Felder; L. Benvengù; A. Gasbarrini; G. Svegliati Baroni; F. G. Foschi; G. Missale; A. Masotto; R. Virdone; N. Caporaso; F. Trevisani P0726 LIVER VOLUME AS A PREDICTOR OF RISK FOR HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C PATIENTS Namkyu Kang, Republic of Korea; J. W. Chung; J.-W. Kim P0727 HAND AND FOOT SYNDROME AS A PREDICTOR OF OUTCOME IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB Masanori Ochi, Japan; A. Okawara; N. Kakinoki; T. Kamoshida; S. Hirai P0728 WITHDRAWN P0729 UNUSUAL METASTASIS OF HEPATOCELLULAR CARCINOMA Ibtissam Nakhcha, Morocco; I. Benelbarhdadi; F. Z. Ajana P0730 EPIDEMIOLOGICAL STUDY OF HISTOLOGICALLY PROVEN ADVANCED HEPATOCHOLANGIOCARCINOMA : AN AGEO MULTICENTER RETROSPECTIVE STUDY IN FRANCE Maeva Salimon, France; C. Prieux-Klotz; D. Tougeron; T. Lecomte; M. Caulet; T. Matysiak Budnik; V. Hautefeuille; M. Tiako-Meyo; A. Zaanan; Y. Touchefeu P0731 A PROPOSAL FOR MODIFICATION OF BARCELONA CLINIC LIVER CANCER SYSTEM FOR HEPATOCELLULAR CARCINOMA STAGING BASED ON KOREAN MULTICENTER REGISTRY DATABASE Jaeyoun Cheong, Republic of Korea; H. Cho P0732 HEPATIC LYMPHOMAS: A RARE ENTITY Rui Gaspar, Portugal; A. Andrade; J. Santos-Antunes; R. Liberal; F. Carneiro; G. Macedo
168
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
Bile acids, transport, cholestasis, gallstones: Basic
Biliary neoplasia: Clinical
P0733 USE OF BILE ACIDS AS A REGULATOR OF GUT MICROBIOTA. Kihyun Ryu, Republic of Korea; Y. Choi; H. Koo; K. Song; S. Kim; T. Lee; K. Huh; Y. Kang; M. Kang; S. Han; J. Jeong
P0740 KML001, AN ORAL ARSENIC COMPOUND, AS PALLIATIVE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCERS AFTER FAILURE OF GEMCITABINE BASED CHEMOTHERAPY Jung Hyun Jo, Republic of Korea; I. R. Cho; H. S. Lee; M. J. Chung; J. Y. Park; S. Bang; S. W. Park; J.-B. Chung; S. Y. Song
Cholestasis and gallstones: Clinical P0735 IS COMPLETE STONE REMOVAL FOR CHOLEDOCHOLITHIASIS ALWAYS NECESSARY IN EXTREMELY ELDERLY PATIENTS? Naoko Okuda, Japan; S. Sugimoto; H. Nakamura; H. Hisada; T. Temma; Y. Hashimoto; S. Hayashi; T. Ito; M. Takami; M. Yamamura; J. Oyamada; A. Kamei P0736 THE EVALUATION OF TRANSPAPILLARY ENDOSCOPIC GALLBLADDER DRAINAGE WITH THE USE OF INTRADUCTAL ULTRASONOGRAPHY Kenji Hayasaka, Japan; T. Ujihara; R. Nakahara; D. Murakami; T. Shimizu; S. Suehiro; Y. Katsuyama; H. Harada P0737 THE RENDEZVOUS PROCEDURE FOR THE MANAGEMENT OF BILE DUCT INJURIES AFTER CHOLECYSTECTOMY: SHORT AND LONG TERM OUTCOMES AND PREDICTORS FOR SUCCESS. Anne Marthe Schreuder, The Netherlands; K. A. Booij; P. R. de Reuver; O. M. van Delden; K. P. van Lienden; M. G. H. Besselink; O. R. C. Busch; D. J. Gouma; E. A. J. Rauws; T. M. van Gulik P0738 CHOLECYSTECTOMY AFTER ERCP CLEARANCE OF COMMON BILE DUCT STONES: DOES TIMING MATTERS?. A PROSPECTIVE RANDOMIZED STUDY Ehab Atif, Egypt; E. A. Elhanafy; A. Elnakeeb P0739 TRANSRECTAL GALLBLADDER PRESERVING CHOLECYSTOLITHOTOMY AND POLYPECTOMY BY PURE NOTES Bingrong Liu, China
Poster in the Spotlight
Poster of Excellence
P0741 ENDOSCOPIC DRAINAGE OF MALIGNANT STENOSIS OF THE BILIARY CONFLUENCE : HOW MANY SEGMENTS SHOULD BE DRAINED TO IMPROVE THE PATIENT SURVIVAL? Fabrice Caillol, France; E. Bories; C. Zemmour; C. Pesenti; J. P. Ratone; M. Giovannini P0742 SYSTEMATIC REVIEW AND META-ANALYSIS OF TRANSABDOMINAL AND ENDOSCOPIC ULTRASOUND FOR GALLBLADDER POLYPS Sarah Wennmacker, The Netherlands; M. P. Lamberts; M. Di Martino; J. P. H. Drenth; K. S. Gurusamy; C. J. H. M. van Laarhoven P0743 DIAGNOSTIC VALUE OF CONTRAST-ENHANCED ULTRASONOGRAPHY IN HIGH MECHANICAL INDEX CONTRAST MODE FOR POLYPOID LESIONS OF THE GALLBLADDER Haruo Miwa, Japan; K. Numata; A. Hirotani; K. Sanga; Y. Gouda; K. Irie; T. Ishii; T. Kaneko; K. Sugimori; S. Maeda P0744 ASSOCIATION OF CIRCULATING ADIPONECTIN LEVELS AND TUMOR STAGE IN BILIARY TRACT CANCER Aida Saray, Bosnia And Herzegovina; B. Gogov; N. Zubcevic; D. Prohic; A. Mehmedović; A. Puhalović P0745 PRETREATMENT BODY MASS INDEX AND WEIGHT CHANGE DURING INITIAL PERIOD OF CHEMOTHERAPY AFFECT SURVIVAL OUTCOME IN ADVANCED BILIARY TRACT CANCER PATIENTS Jinwoo Kang, Republic of Korea; S. H. Lee; Y. H. Choi; J. H. Choi; J. K. Ryu; Y.-T. Kim P0746 THROUGH THE CATHETER BIOPSY METHOD FOR BILIARY CARCINOMA Toru Okuzono, Japan P0747 THE DEVELOPMENT OF A RISK SCORE TO PREDICT ADVERSE OUTCOMES OF EXPLORATORY SURGERY IN PERIHILAR CHOLANGIOCARCINOMA Marcia Gaspersz, The Netherlands; S. Buettner; J. L. A. van Vugt; R. J. S. Coelen; J. Vugts; E. Belt; J. de Jonge; W. Polak; F. E. J. A. Willemssen; T. M. van Gulik; J. N. M. IJzermans; B. Groot Koerkamp
Clinical Case Session
169
Tuesday, October 31, 2017
P0734 MIRNA-21 IS OVEREXPRESSED IN PRIMARY BILIARY CHOLANGITIS AND MEDIATES LIVER INJURY AND NECROPTOSIS IN EXPERIMENTAL CHOLESTASIS M. B. B. Afonso; P. M. Rodrigues; André Simão, Portugal; M. M. Gaspar; T. Carvalho; P. Borralho; J. M. Banales; R. E. Castro; C. M. P. Rodrigues
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0748 A NEW PROGNOSTIC MODEL FOR PATIENTS WITH PERIHILAR CHOLANGIOCARCINOMA J. L. A. van Vugt; Marcia Gaspersz, The Netherlands; R. J. S. Coelen; E. Roos; J. de Jonge; W. Polak; O. R. C. Busch; M. G. H. Besselink; C. Y. Nio; F. E. J. A. Willemssen; J. N. M. IJzermans; D. van Klaveren; T. M. van Gulik; B. Groot Koerkamp P0749 THE OUTCOMES OF ERCP FOR THE PALLIATION OF MALIGNANT JAUNDICE IN ENGLAND BETWEEN 2001 AND 2015 Phil Harvey, United Kingdom; S. Baldwin; J. Mytton; F. Evison; P. Patel; N. Trudgill Poster Session 09:00 – 17:00 Paediatric: Liver, Biliary and Pancreas
Hall 7
Tuesday, October 31, 2017
P0750 EARLY DEVELOPMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN GENETICALLY PREDISPOSED CHILDREN WITH OVERWEIGHT AND OBESITY DOES NOT COINCIDE WITH METABOLIC DERANGEMENTS Kylie Karnebeek, The Netherlands; J. Plat; A. Vreugdenhil P0751 TWO-DIMENSIONAL SHEAR WAVE ELASTOGRAPHY IN CHILDREN: WHAT IS THE NUMBER OF LIVER STIFFNESS MEASUREMENTS NEEDED FOR A HIGH QUALITY EVALUATION? Corina Pienar, Romania; P.-I. Velea; D. Gherhardt; I. Ciuca; C. Paul; O. Belei; S. A. Popescu; I. Sporea
Hall 7
Pancreatitis, experimental P0752 PERCUTANEOUS EMBOLIZATION OF VISCERAL ARTERY PSEUDO-ANEURYSMS – A TERTIARY CENTER EXPERIENCE Radhika Chavan, India; J. Singh; Z. Nabi; R. Kalapala; D. N. Reddy P0753 DEVELOPMENT OF AUTOIMMUNE PANCREATITIS IS INDEPENDENT OF P21 MEDIATED PANCREATIC INFLAMMATION G. M. Seleznik; T. Reding; L. Peter; Anurag Gupta, Switzerland; S. Sonda; C. Verbeke; E. Dejardin; M. Heikenwälder; R. Graf
170
P0755 MITOCHONDRIAL FUNCTION AND DISTRIBUTION IN PANCREATIC DUCTAL EPITHELIAL CELLS Emese Tóth, Hungary; J. Maléth; R. Erdős; Z. Rázga; L. Tretter; G. Horváth; Z. Rakonczay; P. Hegyi Pancreatitis, acute
Paediatric liver disease
Poster Session 09:00 – 17:00 Pancreas II
P0754 GRANULOCYTES DRIVE PANCREATITIS IN A NOVEL MODEL OF INTERLEUKIN-17A-INDUCED PANCREATITIS VIA PEPTIDYL ARGININE DEIMINASE-DEPENDENT EXTRACELLULAR TRAP FORMATION Moritz Leppkes, Germany; C. Maueröder; S. Hirth; C. Günther; S. Nowecki; U. Billmeier; S. Paulus; M. Biermann; L. E. Munoz; M. Hoffmann; D. Wildner; A. L. Croxford; A. Waisman; D. E. Jenne; J. Mayerle; M. M. Lerch; G. Schett; S. Wirtz; M. F. Neurath; M. Herrmann; C. Becker
P0756 RELATIONSHIP BETWEEN NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN-CONTAINING PROTEIN 2 VARIANTS AND SEVERITY OF ACUTE PANCREATITIS Muhsin Murat Muhip Harputluoglu, Turkey; M. Ozbek; B. Otlu; U. Demirel; M. Aladag; M. A. Erdogan; Y. Atayan; B. Barut; B. Sarici; O. Yener P0757 DETERMINANTS OF SEVERITY IN ACUTE PANCREATITIS - A NATION-WIDE PROSPECTIVE MULTICENTER STUDY Hanna Sternby, Sweden; F. Bolado; H. J. Canaval-Zuleta; C. Marra-López; A. I. Hernando-Alonso; A. del-Val-Antonana; G. García-Rayado; R. Rivera Irigoin; F. J. Grau-Garcia; L. Oms; J. Millastre-Bocos; I. Pasqual-Moreno; D. Martínez-Ares; J. A. Rodriguez-Oballe; A. Lopez-Serrano; M. Ruiz-Rebollo; A. Viejo-Almanzor; P. Zapater; E. de-Madaria P0758 A LUMEN APPOSING METAL STENT WITH ANTI-REFLUX VALVE FOR ENDOSCOPIC ULTRASOUND-GUIDED DRAINAGE OF PSEUDOCYST AND WALLED-OFF NECROSIS. In Rae Cho, Republic of Korea; M. J. Chung; J. H. Jo; H. S. Lee; J. Y. Park; S. Bang; S. W. Park; S. Y. Song; J.-B. Chung P0759 THE PREDICTORS OF STEP UP APPROACH USING ENDOSCOPIC ULTRASOUND-GUIDED TRANSMURAL DRAINAGE FOR WALLED-OFF NECROSIS Hideyuki Shiomi, Japan; A. Sakai; T. Ezaki; T. Nakagawa; T. Kobayashi; Y. Shiomi; A. Masuda; Y. Okabe; T. Azuma P0760 THE ANALYSIS OF CLINICAL FEATURES AND RISK FACTOR OF RECURRENCE AFTER THE FIRST ATTACK OF ACUTE PANCREATITIS N. Gao; C. Jiao; C. Ma; M. Li; Weichang Chen, China
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P0762 A NEW IL13/IFNγ RATIO PREDICTS SEVERITY IN ACUTE PANCREATITIS A. Rodriguez-Nicolas; A. Martinez-Chamorro; M. P. Jimenez-Gamiz; A. M. Matas-Cobos; F. Ruiz-Cabello; Eduardo Redondo-Cerezo, Spain P0763 CORRELATION BETWEEN POST-ERCP SERUM AMYLASE LEVELS AND CT FINDINGS IN ERCP-INDUCED PANCREATITIS: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY Osamu Inatomi, Japan; S. Bamba; Y. Nakai; K. Kusumoto; B. Endoh; A. Suzuki; T. Suzuki; T. Kawakami; S. Oota; A. Inoue; Y. Itokawa; K. Chikugo; A. Andoh; Y. Mizumoto; K. Tanaka P0764 CLINICAL EFFIACY AND SAFETY OF EUS-GUIDED LUMEN-APPOSING METAL STENT ASSISTED PANCREATIC WALL-OFF NECROSIS DRAINAGE : A REAL-LIFE EXPERIENCE IN A TERTIARY HOSPITAL Siu Tong Law, Hong Kong PRC; C. De La Serna Higuera; M. Perez-Miranda; P. Gil P0765 RECTAL INDOMETHACIN IS PROTECTIVE AGAINST POST-ERCP PANCREATITIS IN HIGH-RISK AND AVERAGE-RISK POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS Xingkang He, China; W. Wu; Y. Ding; W. Zheng; L. Sun; J. Si P0766 THE IMPACT OF THE SPECIALISTIC GASTROENTEROLOGIC UNIT ON THE OUTCOME OF ACUTE PANCREATITIS (AP) IN THE VENETO REGION (NORTH-EAST OF ITALY) Lucas Giovanni Cavallaro, Italy; B. Germaná; A. Giacomin; L. Frulloni; A. Gabbrielli; F. Farinati; M. Saia P0767 COMPARISON OF CLINICAL COURSE AND OUTCOME OF ACUTE PANCREATITIS, RECURRENT ACUTE PANCREATITIS, ACUTE ON CHRONIC PANCREATITIS. N. Berry; Dibya Sharma, India; J. Samanta; N. Dhaka; S. K. Sinha; R. Kochhar; R. Prasada; V. Gupta; T. Yadav P0768 ACUTE PANCREATITIS IN PATIENTS WITH IPMNS: RETROSPECTIVE STUDY OF 346 PATIENTS OBSERVED FROM 2009 TO 2016 Lorenzo Brozzi, Italy; A. Amodio; F. De Marchi; R. Teresa Marzia; I. Breoni; P. Campagnola; S. F. Crinó; A. Gabbrielli; L. Frulloni
Poster in the Spotlight
Poster of Excellence
P0769 APOLIPOPROTEIN B AND A-I RATIO PREDICTS SEVERE ACUTE PANCREATITIS Jae-Woo Kim, Republic of Korea; K. J. Lee Pancreatitis, chronic (including hereditary disorders) P0770 IMAGING IN CHRONIC PANCREATITIS – DATA FROM THE SCANDINAVIAN BALTIC PANCREAS CLUB DATABASE Trond Engjom, Norway; F. G. Erchinger; E. Tjora; G. Dimcevski P0771 OSTEOPATHY IS COMMON IN PATIENTS WITH CHRONIC PANCREATITIS, BUT IS NOT RELATED WITH VITAMIN D AND FECAL ELASTASE LEVELS (P-BONE STUDY). Serena Stigliano, Italy; A. Waldthaler; E. Martínez-Moneo; S. Robinson; M. Malvik; A. Hedstrom; A. Kaczka; M. Scholdei; G. Delle Fave; P. Simon; G. Capurso P0772 NATURAL HISTORY OF PANCREATITIS ASSOCIATED WITH SPINK1 MUTATIONS Nelly Muller, France; O. Hentic; F. Maire; P. Ruszniewski; P. Lévy; V. Rebours P0773 EXOCRINE FUNCTION, NUTRITION AND ENZYME TREATMENT IN THE SCANDINAVIAN BALTIC PANCREAS CLUB DATABASE – PRELIMINARY DATA Friedemann Georg Erchinger, Norway; T. Engjom; E. Tjora; G. Dimcevski P0774 FLUID AND HCO3- SECRETION AND CFTR ACTIVITY IS INHIBITED BY CIGARETTE SMOKE EXTRACT IN GUINEA PIG PANCREATIC DUCTAL CELLS David Talas, Hungary; P. Pallagi; V. Venglovecz; E. Gál; K. Tóth; A. Schnúr; J. Maléth; D. Csupor; Z. Rakonczay; P. Hegyi Pancreatic cancer: Basic P0775 HISTOLOGICAL DIAGNOSIS WITH RAPID ON-SITE EVALUATION IN ENDOSCOPIC ULTRASOUND-GUIDED FINE-NEEDLE ASPIRATION OF PANCREATIC SOLID LESIONS Takashi Hirayama, Japan; K. Hara; N. Mizuno; S. Hijioka; T. Kuwahara; N. Okuno; Y. Niwa P0776 WITHDRAWN P0777 THE NOVEL ROLE OF GASTROKINE, A GASTRIC TUMOR SUPPRESSOR PROTEIN, IN PANCREATIC CARCINOGENESIS Sabrina Steiner, Switzerland; G. M. Seleznik; T. Reding; A. Gupta; D. Lenggenhager; M. Heikenwälder; R. Graf
Clinical Case Session
171
Tuesday, October 31, 2017
P0761 CROSSTALK BETWEEN INFLAMMATION AND COAGULATION IN PANCREATITIS-INDUCED ACUTE RENAL FAILURE Serhii Chuklin, Ukraine; S. Chooklin; B. Pidhirnyy
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0778 AUTOPHAGY IS ESSENTIAL FOR PANCREATIC CANCER DEVELOPMENT IN A NEW HUMANIZED GENETICALLY-MODIFIED ADULT MOUSE MODEL C. Tang; Xintong Jia, China; R. Luo; Q. Tu; X. Zhao P0779 HIPEC IN GI CANCERS. IS HYPERTHERMIA FRIEND OR FOE? V. Cesna; A. Sukovas; S. Paskauskas; G. Barauskas; Z. Dambrauskas; Antanas Gulbinas, Lithuania P0780 CACHEXIA INVOLVEMENT IN THE LOCAL SPREAD OF PANCREATIC DUCTAL ADENOCARCINOMA L. Petrusel; R. Suharoschi; I. Rusu; C. Pojoga; R. Seicean; Andrada Seicean, Romania P0781 THE INTRACELLULAR CYTOSKELETON MARKER IS OVEREXPRESSED IN PANCREATIC DUCTAL ADENOCARCINOMA L. Petrusel; R. Suharoschi; T. Zaharie; I. Rusu; C. Pojoga; R. Seicean; Andrada Seicean, Romania Pancreatic cancer: Clinical Tuesday, October 31, 2017
P0782 QUALITY OF LIFE DURING CHEMOTHERAPY IN JAPANESE PATIENTS WITH UNRESECTABLE ADVANCED PANCREATIC CANCER Kaoru Shibayama, Japan; F. Koga; S. Nakashita; N. Oza; T. Otsuka; N. Ureshino; Y. Kawaguchi P0783 C-REACTIVE PROTEIN (CRP) LEVEL IS AN INDICATOR OF THE THERAPEUTIC EFFECT OF TREATMENT RESPONSE TO ENDOSCOPIC ULTRASOUND-GUIDED CELIAC NEUROLYSIS (EUS-CPN) IN PATIENTS WITH PANCREATIC CANCER (PC) PAIN Gen Kimura, Japan; Y. Hashimoto; K. Umemoto; K. Watanabe; M. Sasaki; H. Takahashi; H. Imaoka; I. Oono; S. Mitsunaga; M. Ikeda P0784 PRESENTATION SYMPTOMS AND RISK FACTORS ARE ASSOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH PROGNOSIS OF PANCREATIC CANCER. G. Capurso; C. Stornello; Livia Archibugi, Italy; S. Stigliano; M. Signoretti; M. Milella; V. Barucca; C. Capalbo; G. Delle Fave P0785 PLASMA DNA GENOTYPING USING DIGITAL PCR FOR SURVEILLANCE OF PANCREATIC CANCER IN HIGH-RISK INDIVIDUALS Yusuke Mizukami, Japan; Y. Ono; H. Karasaki; K. Koizumi; T. Okada; J. Sasajima; M. Yamada; S. Asahara; K. Kawakubo; H. Maguchi
172
P0786 TREATMENT EFFICACY AND ADVERSE EVENTS OF GEMCITABINE PLUS NAB-PACLITAXEL USED FOR METASTATIC PANCREATIC CANCER : A RETROSPECTIVE COHORT STUDY In Rae Cho, Republic of Korea; J. H. Jo; H. S. Lee; M. J. Chung; J. Y. Park; S. W. Park; S. Y. Song; J.-B. Chung; S. Bang P0787 IMPACT OF PREOPERATIVE EUS-FNA ON PERITONEAL RECURRENCE AND SURVIVAL IN PATIENTS WITH PANCREATIC CANCER Sun Hwa Kim, Republic of Korea; S. J. Lee; K. H. Lee; J. K. Lee; K. T. Lee; J. K. Park P0788 HENT1 & DPD EXPRESSION IN EUS-FNAB SAMPLES OF PANCREATIC DUCTAL ADENOCARCINOMA: TECHNICAL FEASIBILITY AND PROGNOSTIC SIGNIFICANCE OF GEMCITABINE+S1-BASED CHEMORADIOTHERAPY Reiko Yamada, Japan; S. Isaji; H. Inoue; A. Hayasaki; Y. Murata; M. Kishiwada; H. Miura; T. Takeuchi; T. Harada; N. Yoshizawa; H. Okuse; T. Sakuno; M. Nakamura; M. Katsurahara; Y. Hamada; K. Tanaka; N. Horiki; Y. Takei P0789 EVALUATION OF THE EFFICACY OF ENDOSCOPIC SPHINCTEROTOMY IN THE TREATMENT OF SYMPTOMATIC IPMN WITHOUT WORRISOME FEATURES. A MULTICENTER FRENCH RESTROSPECTIVE STUDY Jean-Michel Gonzalez, France; D. Lorenzo; J. P. Ratone; A. Culetto; P. Lévy; M. Giovannini; M. Barthet P0790 STATIN USE DECREASES THE RISK OF PANCREATIC CANCER OCCURRENCE: A META-ANALYSIS Livia Archibugi, Italy; P. G. Arcidiacono; G. Delle Fave; G. Capurso P0791 AN IMPROVED DIGITAL POLYMERASE CHAIN REACTION PROTOCOL TO CAPTURE LOW-COPY KRAS MUTATIONS IN PLASMA CELL-FREE DNA BY RESOLVING “SUBSAMPLING” ISSUES Yusuke Ono, Japan; A. Sugitani; H. Karasaki; M. Ogata; R. Nozaki; J. Sasajima; Y. Mizukami P0792 ANALYSIS OF CLINICAL PREDICTIVE FACTORS AFFECTING THE OUTCOME OF 2ND LINE CHEMOTHERAPY FOR THE PATIENT OF ADVANCED PANCREATIC CANCER Jeung Eun Lee, Republic of Korea; H. S. Lee; M. J. Chung; J. Y. Park; S. Bang; S. W. Park; S. Y. Song
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
Poster Session 09:00 – 17:00 Endoscopy and Imaging II
Hall 7
Endoscopy, upper GI P0794 ESOPHAGEAL FISTULA HEALING BY MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES IN A THERMORESPONSIVE GEL: A PRE-CLINICAL PORCINE STUDY A. A K Silva; S. Perretta; G. Perrod; L. Pidial; V. Lindner; C. Wilhelm; B. Dallemagne; F. gazeau; C. Cellier; O. Clément; Gabriel Rahmi, France P0795 REAL-TIME MULTIPHOTON MORPHOLOGICAL IMAGING FOR DIAGNOSING GASTRIC ATYPICAL HYPERPLASIA AND ADENOCARCINOMA K. He; L. Zhao; M. Wang; X. Wang; L. Liu; Zhining Fan, China P0796 IMPROVEMENT IN HEPATIC TRANSAMINASES OVER 12 MONTHS AFTER SINGLE PROCEDURE DUODENAL MUCOSAL RESURFACING IN TYPE 2 DIABETES PATIENTS Annieke van Baar, The Netherlands; M. Nieuwdorp; L. Crenier; R. Batterham; F. Holleman; P. Vignolo; G. Costamagna; J. Deviere; R. Haidry; L. Rodríguez; M. Galvao Neto; J. J. G. H. M. Bergman; G. Mingrone P0797 UPPER GASTROINTESTINAL ENDOSCOPIC FINDINGS IN ASYMPTOMATIC HEALTHY INDIVIDUALS WITH NORMAL AND DECREASED SERUM PEPSINOGENS FROM THE GISTAR PILOT STUDY Ilze Kikuste, Latvia; J. Young Park; R. Murillo; S. Parshutin; I. Polaka; A. Kirsners; R. Herrero; M. Leja P0798 REBAMIPIDE SOLUTION AS A NOVEL SUBMUCOSAL INJECTION PROMOTES HEALING SPEED AND QUALITY OF ESD-INDUCED ULCER BY SUPRESSING FIBROSIS. Ai Fujimoto, Japan; T. Nishizawa; M. Shimoda; O. Goto; Y. Ochiai; T. Maehata; T. Akimoto; Y. Mitsunaga; M. Kato; A. Nakayama; M. Sasaki; T. Uraoka; N. Yahagi P0799 EFFECT OF ILAPRAZOLE ON THE HEALING OF ENDOSCOPIC SUBMUCOSAL DISSECTION-INDUCED GASTRIC ULCER: INTERIM ANALYSIS OF RANDOMIZED, MULTICENTER STUDY C. S. Bang; Woon Geon Shin, Republic of Korea; G. H. Baik; H. Y. Kim; S.-H. Kae; H. J. Jang; M. H. Choi Poster in the Spotlight
Poster of Excellence
P0800 THE EFFECT OF VONOPRAZAN FOR ENDOSCOPIC SUBMUCOSAL DISSECTION-INDUCED ULCERATION AND POSTOPERATIVE BLEEDING. Go Ikeda, Japan; N. Ueki; S. Futagami; S. Agawa; H. Noda; K. Higuchi; T. Akimoto; Y. Maruki; H. Yamawaki; Y. Kodaka; T. Kawagoe; K. Miyake; M. Kaise; K. Iwakiri P0801 INFLUENCE OF ANTITHROMBOTIC THERAPY ON DELAYED BLEEDING AFTER GASTRIC ESD: A RETROSPECTIVE ANALYSIS IN 665 CASES Hiroto Noda, Japan; N. Ueki; T. Akimoto; G. Ikeda; K. Higuchi; S. Agawa; Y. Maruki; H. Yamawaki; Y. Kodaka; T. Kawagoe; K. Miyake; S. Futagami; K. Iwakiri P0802 LOW DOSE ASPIRIN DELAYS THE ULCER HEALING AND INCREASES THE RISK OF POSTOPERATIVE BLEEDING AFTER GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION THROUGH THE DUODENOGASTRIC REFLUX Nobue Ueki, Japan; S. Futagami; T. Akimoto; S. Agawa; G. Ikeda; H. Noda; K. Higuchi; Y. Maruki; H. Yamawaki; Y. Kodaka; T. Kawagoe; K. Miyake; M. Kaise; K. Iwakiri P0803 NARROW-BAND IMAGING (NBI) ENDOSCOPY WITH DUAL FOCUS MAGNIFICATION FOR CHARACTERIZATION OF GASTRIC NON-NEOPLASTIC AND NEOPLASTIC LESIONS Roman Kuvaev, Russian Federation; S. Kashin; A. Aleshicheva; E. Kraynova; A. Nadezhin; E. Nikonov P0804 TRANSPLANTATION OF AUTOLOGOUS ESOPHAGUS MUCOSA TO PREVENT STRICTURE AFTER CIRCUMFERENTIAL ENDOSCOPIC SUBMUCOSAL DISSECTION OF EARLY SQUAMOUS CELL Liao ZhongLi, China; F. ChaoQiang; Y. Xin; P. Xue; Z. Xia; Y. Jin; X. Xia; B. JianYing P0805 ENDOSCOPIC CLOSURE OF POST-SURGICAL FISTULAS OR PERFORATIONS WITH OVER-THE-SCOPE-CLIP Patrícia Santos, Portugal; D. Reis; C. Noronha Ferreira; J. Lopes; L. Carrilho Ribeiro; J. Velosa P0806 A PROSPECTIVE STUDY USING A NEW DEVICE FOR ENDOSCOPIC RESECTION OF EARLY NEOPLASIA IN BARRETT’S ESOPHAGUS Roos Pouw, The Netherlands; T. Beyna; K. Belghazi; A. D. Koch; E. J. Schoon; R. Haidry; B. L. A. M. Weusten; R. Bisschops; N. J. Shaheen; M. B. Wallace; N. E. Marcon; K. Wang; C. Leggett; J. Ortiz Fernandez-Sordo; K. Ragunath; M. di Pietro; O. Pech; H. Neuhaus; J. J. G. H. M. Bergman
Clinical Case Session
173
Tuesday, October 31, 2017
P0793 RAPID ON SITE EVALUATION (ROSE): AN ESSENTIAL TOOL IN ECHO-ENDOSCOPIC (EUS) STUDY OF SOLID LESIONS OF THE PANCREAS Rui Gaspar, Portugal; P. Moutinho-Ribeiro; V. Magno Pereira; M. Silva; A. Peixoto; S. Lopes; F. Vilas-Boas; H. Barroca; J. Lopes; F. Carneiro; G. Macedo
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0807 COST–EFFECTIVE ANALYSIS COMPARING STANDARD BIOPSY VS. DIGITAL BIOPSY BY CONFOCAL ENDOMICROSCOPY Carlos Robles-Medranda, Ecuador; M. Valero; J. Ospina; M. Puga-Tejada; H. Alvarado-Escobar; M. Soria; H. Pitanga-Lukashok P0808 GASTRIC PER-ORAL ENDOSCOPIC PYLOROMYOTOMY (G-POEM) IN THE TREATMENT OF REFRACTORY GASTROPARESIS: EXPERIENCE OF THE FIRST 9 CASES IN A MEXICO. Oscar Hernandez Mondragon, Mexico; R. Palos Cuellar; G. Blanco Velasco; J. M. Blancas-Valencia; M. L. Hernandez Reyes
P0815 PREDICTIVE RISK MODEL FOR POST-ENDOSCOPIC SUBMUCOSAL DISSECTION ULCER BLEEDING OF STOMACH Yeon Hwa Choe, Republic of Korea; S. K. Shin; E. H. Kim; Y. C. Lee; S. K. Lee; J. Park P0816 USEFULNESS OF DUAL RED IMAGING IN ESOPHAGEAL AND GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION. Tomoaki Yamasaki, Japan; K. Yamamoto; Y. Yasui; Y. Sakata; M. Suo; T. Ochiai; A. Kimura; A. Nakata; M. Yamamura; N. Hirata; T. Suekane; E. Sasaki; K. Sano; K. Watanabe; H. Nebiki
Tuesday, October 31, 2017
P0809 ENDOSCOPIC MANAGEMENT OF FOREIGN BODIES IN THE UPPER GASTROINTESTINAL TRACT: A RETROSPECTIVE STUDY OF 1294 CASES Chong Geng, China; X. Li; X. Lei; C. Wang
P0817 EFFICACY OF BLUE LIGHT IMAGING USING LED LIGHT SOURCE FOR DIAGNOSIS OF EARLY GASTRIC CANCER Osamu Dohi, Japan; Y. Naito; S. Takayama; K. Ogita; K. Terasaki; T. nakano; N. Iwai; T. ueda; T. Okayama; N. Yoshida; K. Kamada; K. Uchiyama; T. Ishikawa; T. Takagi; O. Handa; H. Konishi; Y. Itoh
P0810 CLINICAL OUTCOMES AFTER ENDOSCOPIC RESECTION FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA COMPARING THE CASES WITH MM AND SM1 INVASION. S. Yoshimizu; Toshiyuki Yoshio, Japan; K. Namikawa; A. Ishiyama; T. Tsuchida; J. Fujisaki
P0818 RISK FACTORS OF COMPLICATION RELATED TO ENDOSCOPIC MANAGEMENT OF FOREIGN BODIES IN THE ESOPHAGUS: A PROSPECTIVE STUDY IN 595 CASES FROM MULTIPLE CENTERS IN CHINA L. Wang; Liangjing Wang, China
P0811 GASTRIC ESD IN AN ANIMAL SURVIVAL MODEL USING THE ANUBIS-SYSTEM Joern Bernhardt, Germany; H. Steffen; P. Koehler; S. Schneider-Koriath; K. Ludwig
P0819 BIOPSY STRATEGIES FOR ENDOSCOPICS SCREENING OF PRE-MALIGNANT GASTRIC LESIONS Zhang Meng, China
P0812 USEFULNESS OF NARROW BAND IMAGING WITH MAGNIFYING ENDOSCOPY AS A SCREENING TEST FOR GASTRIC CANCER Tatsuo Morinushi, Japan
P0820 USEFULNESS OF LINKED COLOR IMAGING (LCI) FOR RECOGNITION OF EARLY GASTRIC CANCER AND GASTRIC ADENOMA Nobuaki Yagi, Japan; H. kitae; A. Tomie; T. Yasuda; T. Omatsu; Y. Nakahata; T. Kurobe; A. Obora; T. Kojima
P0813 DIAGNOSTIC LIMITATIONS OF MAGNIFYING ENDOSCOPY WITH NARROW BAND IMAGING (ME-NBI) IN EARLY GASTRIC CANCER Kohei Matsumoto, Japan; H. Ueyama; K. Matsumoto; Y. Akazawa; H. Komori; M. Hojo; A. Nagahara; T. Yao; S. Watanabe
P0821 GASTROINTESTINAL STROMAL TUMORS SHOULD BE RESECTED EVEN IN A SMALL SIZE – A RETROSPECTIVE ANALYSIS IN 33 CASES Osamu Goto, Japan; T. Akimoto; Y. Mitsunaga; A. Fujimoto; Y. Ochiai; T. Maehata; H. Kawakubo; H. Takeuchi; Y. Kitagawa; N. Yahagi
P0814 BEST PRACTICE IN PLACEMENT OF PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH JEJUNAL EXTENSION TUBE FOR CONTINUOUS INFUSION OF LEVODOPA CARBIDOPA INTESTINAL GEL IN THE TREATMENT OF ADVANCED PARKINSON'S DISEASE: THE ROLE OF GASTROENTEROLOGIST Antonietta Gerarda Gravina, Italy; I. Apicella; V. M. Ormando; M. R. Amato; M. I. Russo; M. Romano; P. Esposito
P0822 LONG-TERM OUTCOMES OF PERORAL ENDOSCOPIC MYOTOMY FOR ACHALASIA IN PATIENTS OLDER THAN 70 YEARS Junyu Zhu, China; Q.-L. Li; P.-H. Zhou
174
P0823 POST-POEM ESOPHAGITIS – REAL REFLUX ESOPHAGITIS OR JUST A HEALING PROCESS? Denisa Erhartova, Czech Republic; J. Krajciova; Z. Vackova; Z. Rabekova; P. Stirand; T. Hucl; J. Spicak; J. Martinek
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P0825 PROPOFOL SEDATION DURING GASTROINTESTINAL ENDOSCOPY INDUCES EUPHORIA IN A LARGE SUBSET OF PATIENTS. Thorsten Brechmann, Germany; C. Maier; M. Kaisler; J. Vollert; W. Schmiegel; S. Pak; N. Scherbaum; F. Rist; A. Riphaus P0826 ENDOSCOPIC SUBMUCOSAL DISSECTION FOR UPPER GI SUBMUCOSAL TUMOURS Halim Awadie, Australia; D. J. Tate; A. Klein; L. Desomer; M. Ma; S. Heitman; N. J. Burgess; E. Y. T. Lee; V. Kwan; M. J. Bourke P0827 COMPARING APPROACHES TO SELF-EXPANDING METALLIC STENTS INSERTION Leanne Mooney, United Kingdom; N. Church; R. Sinha; C. Basquill P0828 CAUSTIC INJURIES OF THE SUPERIOR GASTROINTESTINAL TRACT: 15 YEARS OF EXPERIENCE Marta Rocha, Portugal; T. Moreira; M. Salgado; L. Maia; S. Barrias; I. Pedroto P0829 NOVEL IMAGE ENHANCEMENT TECHNOLOGY USING LINKED COLOR IMAGING WITH ACETIC ACID INDIGOCARMINE MIXTURE FOR DIAGNOSIS OF EARLY GASTRIC NEOPLASM Yoshiro Kawahara, Japan; H. Kanzaki; S. Kawano; M. Iwamuro; Y. Kono; T. Gotoda; H. Sakae; Y. Baba; Y. Obayashi; Y. Okamoto; H. Okada P0830 THE SAFETY AND EFFECTIVENESS OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC NEOPLASMS IN PATIENTS AGED 85 YEARS OR OLDER Yuki Sumida, Japan; T. Kuwai; K. Tao; S. Funaki; Y. Miyasako; T. Takasago; T. Nishimura; R. Miura; H. Imagawa; T. Yamaguchi; A. Yamaguchi; H. Kouno; H. Kohno; S. Ishaq Endoscopy, colon P0831 RESULTS FROM THE FIRST UK VIRTUAL COMPLEX POLYP MDM Amit Chattree, United Kingdom; M. Rutter
Poster in the Spotlight
Poster of Excellence
P0832 DIFFERENCES IN DISTRIBUTION OF SIZE, SHAPE AND SERRATED HISTOLOGY OF COLORECTAL ADENOMAS BETWEEN ENDOSCOPISTS WITH LOW (<20%) AND HIGH (≥20%) ADENOMA DETECTION RATE Daniela Penz, Austria; E. Waldmann; A. Hinterberger; B. Majcher; A. Dokladanska; A. Szymanska; M. Trauner; M. Ferlitsch P0833 PREDICTIVE FACTORS FOR TECHNICALLY DIFFICULT ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD). IMPLICATIONS FOR CASE SELECTION: A SPANISH PROSPECTIVE MULTICENTER COHORT STUDY. José Marín-Gabriel, Spain; F. Ramos-Zabala; F. Mugica; A. Herreros de Tejada; E. Albéniz Arbizu; J. De la Peña Garcia; O. Nogales Rincón; A. Sanchez Yague; M. G. Fernández-Esparrach; C. Dolz Abadia; A. Alvarez Delgado; H. Cortés-Pérez; C. Guarner Argente; A. J. Del Pozo-García; J. B. Díaz Tasende P0834 EPOCH-MAKING TECHNIQUE OF FULL-THICKNESS RESECTION FOR THE COLORECTAL TUMOR BY USING LAPAROSCOPY ENDOSCOPY COOPERATIVE SURGERY (LECS) Yoshiro Tamegai, Japan; Y. Fukunaga; A. Chino; S. Saito; J. Fujisaki; M. Ueno P0835 WITHDRAWN P0836 HIGH INCIDENCE OF MINOR ADVERSE EVENTS AFTER ENDOSCOPIC MUCOSAL RESECTION OR SUBMUCOSAL DISSECTION FOR COLORECTAL NEOPLASMS Yelim Song, Republic of Korea; J.-S. Byeon; K.-J. Kim; D.-H. Yang; S. W. Hwang; E. M. Song; S. H. Park P0837 DEVELOPING PATIENT REPORTED EXPERIENCE MEASURES FOR GI ENDOSCOPY: RESULTS OF PATIENT INTERVIEWS Laura Jane Neilson, United Kingdom; L. Sharp; J. Patterson; P. Hewitson; C. von Wagner; C. J. Rees P0838 RANDOMIZED CONTROLLED TRIAL OF ABDOMINAL VIBRATION STIMULATION AND WALKING EXERCISE FOR BOWEL CLEANSING PRIOR TO COLONOSCOPY Choong-Kyun Noh, Republic of Korea; J. K. Kang; K. M. Lee; S. J. Shin; S. G. LIm; K. J. Lee P0839 COMPARATIVE STUDY OF ELECTRICAL AND RHEOLOGICAL PROPERTIES OF DIFFERENT SOLUTIONS TO PERFORM SUBMUCOSAL INJECTION Ignacio Bon, Spain; V. Lorenzo-Zúñiga; V. Moreno de Vega; A. Rodríguez; N. D. De la Ossa; I. Marín; J. Boix; R. Bartolí
Clinical Case Session
175
Tuesday, October 31, 2017
P0824 ENDOSCOPIC SUBMUCOSAL TUNNEL DISSECTION FOR LESSER GASTRIC CURVATURE SUPERFICIAL NEOPLASMS D. Shi; Rui Li, China; W. chen; X. Wang; C. Ma; D. Zhang
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0840 PATIENT SATISFACTION RELATED TO QUALITY OF INFORMATION GIVEN THROUGHOUT COLONOSCOPY Sara Sjöblom, Sweden; S. Jakobsson; J. Ryhlander; M. Simrén; P.-O. Stotzer; G. Ringström P0841 THE INCIDENCE OF SYNCHRONOUS ADVANCED NEOPLASIA OF RECTAL LATERALLY SPREADING TUMORS WITH A SKIRT Shozo Osera, Japan; T. Shinohara; A. Kudo; T. Yamada; T. Momoi; H. Fukushima; M. Furutake; A. Tomori; T. Hisa P0842 EVALUATION OF MUCOSAL HEALING WITH SHIELDS BASED ON DIFFERENT HYDROGELS IN A RAT MODEL OF THERMAL INJURY Ignacio Bon, Spain; R. Bartolí; V. Moreno de Vega; J. Boix; N. D. De la Ossa; I. Marín; V. Lorenzo-Zúñiga
Tuesday, October 31, 2017
P0843 EFFICACY OF ENDOSCOPIC PLACEMENT OF A DRUGELUTING PLATFORM WITH DIFFERENT ANTITUMORAL AGENTS TO EVALUATE ACUTE NECROSIS IN AN AZOXYMETHANE-INDUCED COLONIC TUMOURS IN RATS. Ramon Bartolí, Spain; I. Bon; V. Moreno de Vega; J. Boix; N. D. De la Ossa; I. Marín; V. Lorenzo-Zúñiga
P0848 THE ROLE OF PROBE CONFOCAL LASER ENDOMICROSCOPY WITH IMAGE ENHANCED ENDOSCOPY IN CHARACTERISATION AND ENDOSCOPIC RESECTION OF DYSPLASTIC LESIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS. Marietta Iacucci, United Kingdom; X. Gui; S. Ghosh P0849 THE SAFETY AND EFFECTIVENESS OF COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION USING A SCISSORS-TYPE KNIFE IN ELDERLY PATIENTS Toshio Kuwai, Japan; T. Yamaguchi; H. Imagawa; S. Funaki; K. Tao; R. Miura; T. Takasago; Y. Sumida; Y. Miyasako; A. Yamaguchi; H. Kouno; H. Kohno; S. Ishaq P0850 QUALITY IN COLONOSCOPY; HAVE YOU REALLY GOT TO THE CAECUM? Shivkumar Budihal, United Kingdom P0851 DETECTION AND CHARACTERIZATION OF SSA/PS DURING SURVEILLANCE COLONOSCOPY IN LONG STANDING IBD USING ADVANCED ENDOSCOPIC TECHNIQUES. Marietta Iacucci, United Kingdom; O. Akinola; R. Panaccione; G. G. Kaplan; X. Gui; S. Urbanski; S. Ghosh
P0844 A THREE-DIMENSIONAL IMAGING SYSTEM IMPROVES THE ENDOSCOPIC VISIBILITY OF NON-POLYPOID COLORECTAL NEOPLASMS Tomoaki Matsumura, Japan; D. Maruoka; K. Okimoto; N. Akizue; T. Nakagawa; H. Ishigami; M. Arai; N. Kato
P0852 IN VIVO HISTOLOGICAL PREDICTION OF COLORECTAL POLYPS USING FICE TECHNOLOGY João Cortez-Pinto, Portugal; J. Moleiro; I. Marques; R. Barosa; J. Castela; J. Pereira da Silva; S. Faias; S. Mão de Ferro; P. Lage; A. Dias Pereira
P0845 PAIN DURING COLONOSCOPY: DIFFERENCES BETWEEN PATIENTS’ EXPERIENCES AND CAREGIVERS’ ASSESSMENT Jessica Ryhlander, Sweden; G. Ringström; M. Simrén; S. Sjöblom; P.-O. Stotzer; S. Jakobsson
P0853 POLYP DETECTION RATES IN COLONOSCOPIES PERFORMED UNDER GENERAL ANAESTHETIC COMPARED TO CONVENTIONAL SEDATION Ben Perren, United Kingdom; A. S. Bancil; A. G. Lim; P. Youd; S. J. Moodie; P. Patel
P0846 DEVELOPMENT OF A NEW ENDOSCOPIC CLASSIFICATION AND FIRST INTERNATIONAL VALIDATION (FACILE GROUP) OF COLONIC LESIONS USING ADVANCED IMAGING MODALITIES IN IBD PATIENTS Marietta Iacucci, United Kingdom; K. McQuaid; T. Uraoka; T. Matsumoto; V. Subramanian; Y. Iwao; M. Lowerison; B. C. Lethebe; S. Sanduleanu; S. Ghosh; R. Kiesslich P0847 GENDER DIFFERENCES IN ACCEPTANCE OF COLORECTAL CANCER SCREENING: PAIN AS THE EXPLENATION Benedicte Kirkøen, Norway; P. Berstad; E. Botteri; E. Dalén; J. A. Nilsen; G. Hoff; T. de Lange; T. Bernklev
176
P0854 PATIENT AND PHYSICIANS RELATED FACTORS ASSOCIATED WITH A HIGH ADENOMA DETECTION RATE IN ROUTINE COLONOSCOPY. Maryan Cavicchi, France; G. Tharsis; P. Burtin; P. Cattan; F. Venezia; G. Tordjman; A. Gillet; J. Samama; K. Nahon-Uzan; D. Karsenti P0855 EFFICIENCY OF COLONOSCOPY IN CASE OF POSITIVE FECAL IMMUNOCHEMICAL TEST: ONE-YEAR EXPERIENCE AND RESULTS ON 391 PATIENTS IN ROUTINE PRACTICE IN FRANCE. Maryan Cavicchi, France; G. Tharsis; P. Burtin; P. Cattan; F. Venezia; G. Tordjman; A. Gillet; J. Samama; K. Nahon-Uzan; D. Karsenti
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P0857 TWO LITERS OF POLYETHYLENE GLYCOL (PEG) WITH 15 MG OF BISACODYL VERSUS 4 LITERS OF PEG FOR BOWEL PREPARATION TO COLONOSCOPY. PROSPECTIVE RANDOMIZED STUDY. PRELIMINARY RESULTS El Mekkaoui Amine, Morocco; Z. Abdelkrim; E. M. Aziz; W. Khannoussi; G. Kharrasse; Z. Ismaili P0858 COLONOSCOPY ON THE LEFT, RIGHT? Irina Mocanu, Portugal; A. Laranjo; S. Pires; N. Veloso; L. Gonçalves; R. Godinho; I. Medeiros P0859 NON-GRANULAR LATERALLY SPREADING COLONIC LESIONS ≥20MM (LSL) ARE SMALLER AND MORE COMMONLY MULTIPLE THAN GRANULAR LSL; IMPLICATIONS OF A ‘COLONIC MUCOSAL PHENOTYPE’ FOR PRACTITIONERS OF ENDOSCOPIC RESECTION David Tate, Australia; H. Awadie; L. Desomer; M. Sidhu; K. Goodrick; N. G. Burgess; M. J. Bourke P0860 WIDE-FIELD PIECEMEAL COLD SNARE POLYPECTOMY OF LARGE SESSILE SERRATED POLYPS WITHOUT A SUBMUCOSAL INJECTION IS SAFE David Tate, Australia; H. Awadie; F. Bahin; L. Desomer; R. Lee; S. Heitman; K. Goodrick; M. J. Bourke P0861 THE PROSPECTIVE OBSERVATION STUDY FOR OVER 10MM COLORECTAL LESIONS ENDOSCOPICALLY RESECTED USING BIPOLAR SNARE Hiroshi Nakamura, Japan; H. Ikematsu; N. Okamoto; R. Ito; D. Sato; T. Minamide; Y. Yamamoto; K. Takashima; T. Hombu; K. Nakajo; T. Kadota; Y. Yoda; K. Hori; Y. Oono; T. Yano P0862 THE SMSA POLYP SCORE RELIABLY PREDICTS ROBUST ENDPOINTS OF ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL LATERALLY SPREADING LESIONS. Mayenaaz Sidhu, Australia; D. J. Tate; L. Desomer; G. Brown; A. Moss; S. Raftopoulos; S. Zanati; R. Singh; S. Williams; E. lee; M. J. Bourke
P0864 AUTOLOGOUS BLOOD, A NOVEL AGENT FOR PREOPERATIVE COLONIC LOCALIZATION: A SAFETY AND EFFICACY COMPARISON STUDY E. J. Kim; J.-W. Chung; S.-Y. Kim; J. H. Kim; Y. J. Kim; Kyung Oh Kim, Republic of Korea; K. A. Kwon; D. K. Park; S. W. Park; J.-H. Baek P0865 SUBMUCOSAL INVASION IN COLORECTAL LATERALLY SPREADING TUMORS (LST) AND ABILITY OF THE ENDOSCOPIST FOR CANCER DETECTION Heithem Soliman, France; B. Brieau; M.-A. Guillaumot; S. Leblanc; R. coriat; F. Prat; S. Chaussade P0866 ETHNIC VARIATION OF COLONIC POLYPS: FINDINGS FROM AN INTERNATIONAL HOSPITAL FOR MEDICAL TOURISM IN THAILAND S. Techapaitoon; V. Permpoon; Krit Pongpirul, USA P0867 ARE WE READY FOR COLONIC ESD IN FRANCE? Jérémie Jacques, France; J. Albouys; A. Charissoux; J. Rivory; D. Sautereau; T. Ponchon; R. Legros; M. Pioche P0868 RISK OF COLORECTAL NEOPLASM IN PATIENTS WITH ACROMEGALY -A CASE-CONTROL STUDYYorinari Ochiai, Japan; T. Iizuka; N. Inoshita; S. Yamada; S. Hoteya P0869 COMPARISON OF WHITE LIGHT COLONOSCOPY AND A NOVEL ROBOTIC COLONOSCOPE IN THE ASSESSMENT OF ULCERATIVE COLITIS S. Pallotta; E. Tumino; G. Manes; S. Ardizzone; R. Sacco; Francesca Iannuzzi, Italy; R. de Franchis P0870 WHAT IS THE CONCORDANCE FOR THE DIAGNOSIS OF LATERALLY SPREADING-TYPE LESIONS (LST) AMONGST WESTERN AND JAPANESE EXPERT ENDOSCOPISTS? Bairavi Manorahan, United Kingdom; A. Jimenez; S. Sansone; M. Yamada; M. San Juan; N. Gonzalez; E. Albéniz Arbizu; M. A. Bianco; R. Bisschops; K. Homma; H. Ikematsu; Y. Morita; T. Uraoka; K. Ragunath; A. Parra-Blanco
P0863 USE OF ACETIC ACID FOR EVALUATING SESSILE SERRATED ADENOMA/POLYP: A PILOT STUDY Shunsuke Yamamoto, Sweden; M. Shafazand
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
177
Tuesday, October 31, 2017
P0856 WITHDRAWN
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0871 CLINICAL USEFULNESS OF THE SMSA DIFFICULTY SCORE AND COMPARISON WITH A SUBJECTIVE SCORE FOR THE MANAGEMENT OF LARGE NON-PEDUNCULATED COLORECTAL LESIONS. A MULTICENTER STUDY FROM THE SPANISH ENDOSCOPY SOCIETY ENDOSCOPIC RESECTION GROUP. Eduardo Albéniz Arbizu, Spain; M. Fraile González; C. Guarner Argente; D. Martínez-Ares; B. Ibañez Beroiz; A. Herreros de Tejada; J. Santiago; M. A. Alvarez; X. Bessa Casserras; M. Rullan; O. Nogales Rincón; F. Ramos-Zabala; E. Valdivielso Cortazar; R. Pardeiro Pertega; P. Alonso; J. Cobian; F. Mugica; C. J. Gargallo Puyuelo; A. Elosua; J. de la Peña; J. G. Martinez-Cara; E. Redondo Cerezo; M. Pellisé Urquiza; L. Rivero Sánchez; A. Huerta; J. Gonzalez Santiago; A. Alvarez Delgado; J. Espinós; A. Repiso Ortega; F. J. Navajas; J. Carbo Perseguer; J. Merlo; M. Rodriguez Tellez; V. A. Jimenez-Garcia; F. Sabado; E. Saperas Franch; P. Huelin Alvarez; M. Concepcion-Martin; Spanish Endoscopy Society Endoscopic Resection Group members
Tuesday, October 31, 2017
P0872 NARROW BAND IMAGING GUIDED BIOPSY IMPROVES THE YIELD OF HISTOLOGY FOR THE DIAGNOSIS OF GASTROINTESTINAL TUBERCULOSIS (GITB) N. Berry; Saroj Sinha, India; S. Malik; R. Kochhar; K. Vaiphei; K. Sharma; N. Dhaka; A. Koshi P0873 EFFICACY AND SAFETY OF ENDOSCOPIC RESECTION OF LARGE COLORECTAL ADENOMAS – CLINICAL EXPERIENCE OF A TERTIARY REFERRAL CENTER L. Mlynarsky; S. Zelber-Sagi; E. Miller; Revital Kariv, Israel P0874 COLORECTAL MUCOSAL DEFECT CLOSURE FOLLOWING ENDOSCOPIC MUCOSAL RESECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS Carolina Palmela, Portugal; P. Marques Da Costa; A. O. Ferreira P0875 RECTAL ESD IN VERY OLD PATIENTS (>80 YEARS) : A FRENCH MULTICENTER RETROSPECTIVE STUDY Romain Legros, France; J. Albouys; M.-A. Guillaumot; V. Lepilliez; S. Chaussade; M. Pioche; S. Leblanc; M. Barret; F. Prat; J. Rivory; D. Sautereau; T. Ponchon; J. Jacques P0876 COLONOSCOPY SPLIT-DOSE PROTOCOL IMPLEMENTATION: A SINGLE-CENTRE EXPERIENCE Carolina Palmela, Portugal; C. Gomes; M. P. Costa Santos; M. Rocha; S. Pereira; D. Tavares; R. Ribeiro; A. O. Ferreira; E. Barjas; M. Cravo
178
P0877 EQUAL ADENOMA DETECTION RATE IN COLONOSCOPIES OF PATIENTS WITH SPINAL CORD INJURY AND CONTROLS – A CASE-CONTROL STUDY. A. Blanco Belver; M. Aach; W. Schmiegel; T. A. Schildhauer; R. Meindl; Thorsten Brechmann, Germany P0878 RISK FACTORS AND PRACTICAL CONSEQUENCES OF COLORECTAL ESD CONVERSION TO EMR AT A WESTERN REFERRAL CENTER IN DAILY PRACTICE. Enrique Perez-Cuadrado-Robles, Belgium; H. Piessevaux; T. Moreels; P. H. Deprez P0879 CONTRIBUTION OF COLONOSCOPY IN ELDERLY PATIENTS OLDER THAN 70 YEARS Amine El Mekkaoui, Morocco; A. Taiymi; A. Zazour; W. Khannoussi; G. Kharrasse; Z. Ismaili P0880 ENDOSCOPIC CLOSURE OF ACUTE IATROGENIC PERFORATIONS OF THE GASTROINTESTINAL TRACT AND PREDICTORS OF NEED FOR EARLY SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSIS Ahmed Gabr, United Kingdom; N. Ammar; M. El Houssine; M. Rutter P0881 REAL-TIME HISTOLOGICAL CHARACTERIZATION OF COLORECTAL POLYPS – THE IMPACT OF TRAINING Joana Castela, Portugal; J. Cortez-Pinto; S. Mão de Ferro; I. Rosa; S. Ferreira; J. Pereira da Silva; I. Claro; S. Faias; P. Lage; A. Dias Pereira P0882 “O-RING SIGN” AS A NOVEL COLONOSCOPIC FINDING WITH NARROW-BAND IMAGING FOR DETECTING DEPRESSED-TYPE COLORECTAL LESIONS Takahiro Fujii, Japan P0883 THE LEARNING CURVE FOR COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) BETWEEN EXPERT AND TRAINEE ENDOSCOPIST Naohiko Akimoto, Japan; K. Mitsui; T. Teramoto; S. Fujimori; K. Iwakiri Endoscopy, ERCP P0884 LARGE BALLOON DILATATION VERSUS MECHANICAL LITHOTRIPSY AFTER ENDOSCOPIC SPHINCTEROTOMY IN MANAGEMENT OF LARGE COMMON BILE DUCT STONES AMONG CIRRHOTIC PATIENTS M. I. Radwan; Mohamed Hassan Emara Elzanan, Egypt; I. M. Ibrahim; M. E. Morsy
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P0886 A NOVEL METHOD OF PREVENTING DUODENOBILIARY REFLUX BY MEANS OF SUSPENDED OVERLENGTH BILIARY STENTS IN PATIENTS WITH BILIARY STRICTURE Yonghui Huang, China; X. Yan; H. Chang; Y. Zhang; W. Yao; K. Li P0887 DUODENOSCOPES AND LINEAR ECHOENDOSCOPES ARE CONTAMINATED WITH DIGESTIVE TRACT BACTERIA: NATIONWIDE PERSISTENT HIGH PREVALENCE IN THE THE NETHERLANDS Arjan Rauwers, The Netherlands; A. F. Voor in ’t holt; W. De Groot; J. G. Buijs; B. E. Hansen; M. C. Vos; M. J. Bruno P0888 TECHNICAL EVOLUTION OF A NEWLY-DEVELOPED DIGITAL CHOLANGIO/PANCREATO-SCOPY (SPYGLASS DS) FOR PREOPERATIVE EVALUATION OF PANCREATOBILIARY NEOPLASM Kei Ito, Japan; S. Koshita; T. Ogawa; Y. Kanno; K. Masu; H. Kusunose; T. Sakai; T. Murabayashi; S. Hasegawa; F. Kozakai; Y. Noda P0889 ACUTE PANCREATITIS AND HYPERAMYLASAEMY DEVELOPMENT AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPY – CHALLENGES AND PREVENTION Plamen Petrov, Bulgaria; B. Petrov; T. Vukova P0890 MOST ADVANCED ENDOSCOPY TRAINEES DO NOT MEET COMPETENCE FOR NATIVE PAPILLAE CANNULATION IN ERCP: RESULTS FROM A PROSPECTIVE MULTICENTER STUDY Sachin Wani, USA; M. Hall; V. Simon; S. Han; D. Early; R. Keswani P0891 SIMILAR POST-ERCP PANCREATITIS RATES IN ENDOSCOPIST- VS ASSISTANT-CONTROLLED WIRE-GUIDED BILE DUCT CANNULATION: A SINGLE CENTRE OBSERVATIONAL STUDY Maxworth Hu, United Kingdom; A. Bhagwat; M. Hayat
Poster in the Spotlight
Poster of Excellence
P0892 CONFIRMATION OF THE EFFECT OF AN ANTAGONIST TO CONSCIOUS SEDATION ON THE PREVENTION OF ASPIRATION PNEUMONIA AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY Yoko Taya, Japan; M. Kuwatani; K. Sakurai; R. Sasaki; S. Tsunematsu; M. Matsumoto; U. Baba; Y. Tsukamoto; S. Muto; T. Kimura P0893 PREVENTION OF POST-ERCP PANCREATITIS: RESULTS OF AN AGGRESSIVE HYDRATION PROTOCOL Pedro Marcos, Portugal; C. Atalaia-Martins; S. Barbeiro; I. Cotrim; C. Gonçalves; L. Eliseu; H. Vasconcelos P0894 ERCP CYTOLOGY YIELD – DOES THE BRUSH MATTER? Irina Mocanu, Portugal; A. Laranjo; S. Pires; N. Veloso; L. Gonçalves; R. Godinho; I. Medeiros P0895 PROSPECTIVE STUDY OF EARLY PRECUT VS. UTMOST PRECUT WITH PANCREATIC STENT IN INITIAL PANCREATIC DUCT CANNULATION Eun Taek Park, Republic of Korea; B. C. Yun; S. U. Lee; B. H. Han P0896 POST-ERCP BLEEDING IN THE ERA OF MULTIPLE ANTIPLATELET AGENTS Hyoung-Chul Oh, Republic of Korea; I. El Hajj; J. Easler; E. Fogel; J. Watkins; L. McHenry; G. Lehman; J. S. Choi; H. Kang; S. Sherman P0897 PROSPECTIVE COMPARISON OF DIGITAL SPYGLASS DIRECT VISUALIZATION SYSTEM VS DIRECT PERORAL CHOLANGIOSCOPY USING A MULTIBENDING ENDOSCOPE AS A SINGLE-OPERATOR CHOLANGIOSCOPY FOR MANAGING BILIARY LESIONS Yun Nah Lee, Republic of Korea; J. H. Moon; H. J. Choi; H. K. Kim; T. H. Lee; H. W. Lee; M. H. Choi; S.-W. Cha; Y. D. Cho; S.-H. Park P0898 WITHDRAWN P0899 THE DILEMMA OF MANAGMENT BORDERLINE COMMON BILE DUCT STONE. DOES STONE SIZE MATTER? : A PROSPECTIVE RANDOMIZED STUDY. Ehab Abdellatif, Egypt; E. Elhanafy; A. Elnakeeb P0900 PROSPECTIVE STUDY ON METHODS AND SUCCESS OF BILIARY CANNULATION OF 458 VIRGIN PAPILLAS – QUALITY ASSURANCE OF ERCP AT OUR DEPARTMENT Á. Orbán-Szilágyi; K. Lorinczy; K. Rábai; M. Horváth; F. Zsigmond; Tibor Gyökeres, Hungary
Clinical Case Session
179
Tuesday, October 31, 2017
P0885 SAFETY AND EFFICACY OF ENDOSCOPIST-DIRECTED BALANCED PROPOFOL SEDATION (BPS) DURING ENDOSCOPIC RETROGRADE CHOLANGIO-PANCREATOGRAPHY (ERCP) Alon Lapidus, Israel; I. M. Gralnek; A. Suissa; A. Klein; K. A. Yassin; I. Khamaysi
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0901 RISK FACTORS FOR POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS: A PROSPECTIVE MULTICENTER STUDY Azumi Suzuki, Japan; B. Endoh; K. Chikugo; T. Kawakami; T. Suzuki; N. Yoshitaka; K. Kusumoto; Y. Itokawa; O. Inatomi; S. Bamba; K. Uno; Y. Mizumoto; K. Tanaka P0902 USEFULNESS OF AMY MEASUREMENTS AT 2 HOURS AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PREDICTING THE SEVERITY OF POST-ERCP PANCREATITIS, MULTICENTER PROSPECTIVE STUDY, SOSUI. Kawakami Takumi, Japan; T. Suzuki; H. Sato; N. Yoshida; Y. Nakai; K. Kusumoto; Y. Itokawa; A. Suzuki; B. Endoh; K. Chikugo; O. Inatomi; S. Bamba; Y. Mizumoto; K. Tanaka Endosonography P0903 ENDOSCOPIC ULTRASOUND-BASED TRANSDUODENAL CHOLECYSTOLITHOTOMY VIA DOUBLE-FLANGED FULLY COVERED METAL STENT WITH HOT STENT DELIVERY Siyu Sun, China Tuesday, October 31, 2017
P0904 QUANTITATIVE ENDOSCOPIC ULTRASOUND ELASTOGRAPHY IN THE DIFFERENTIAL DIAGNOSIS OF PANCREATIC SOLID TUMORS Helena Ribeiro, Portugal; C. Leitão; J. Pinto; R. Azevedo; F. Pereira; R. Sousa; A. I. L. Pires Caldeira; E. Pereira; A. Banhudo P0905 IS ENDOSCOPIC ULTRASONOGRAPHY EXAMINATION USEFUL BEFORE ENDOSCOPIC SUBMUCOSAL DISSECTION IN PATIENTS OF SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA? Yin Yi Chu, Taiwan; S. C. Ng; J. M. Lien; C. T. Chiu P0906 COMPARISON OF DIAGNOSTIC PERFORMANCES FOR THE EVALUATION OF SUSPECTED MALIGNANT BILIARY STRICTURE AMONG SAME SESSION EUS-AND ERCP-GUIDED TISSUE SAMPLING Seong Jae Yeo, Republic of Korea; C. M. Cho; M. K. Jung; A. N. Seo; H. I. Bae P0907 PREVALENCE OF POSTERIOR MEDIASTINAL LYMPHADENOPATHIES IN PATIENTS UNDERGOING ENDOSCOPIC ULTRASONOGRAPHY FOR NON-MALIGNANT INDICATIONS: A PORTUGUESE SINGLE-CENTRE PROSPECTIVE STUDY Joana Veloso do Carmo, Portugal; S. C. Marques; M. Bispo; C. Chagas
180
P0908 ACCURACY OF ENDOSCOPIC ULTRASOUND IN GASTRIC ADENOCARCINOMA PATIENT SELECTION FOR NEOADJUVANT THERAPY Juliana Costa, Portugal; J. B. Soares; B. Gonçalves; S. Carvalho; R. Gonçalves P0909 IS IT USEFULL TO REPEAT ENDOSCOPIC ULTRASOUND WITH FINE NEEDLE ASPIRATION OF PANCREATIC CYSTIC LESIONS? A RETROSPECTIVE STUDY Sandra Faias, Portugal; J. Pereira Silva; I. Marques; R. Fonseca; A. Dias Pereira P0910 DETERMINATION OF INTRACYSTIC GLUCOSE CONCENTRATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PANCREATIC CYSTS: A PROSPECTIVE STUDY. A. Cantamessa; M. Bruno; S. Gaia; G. Saracco; Claudio De Angelis, Italy P0911 WITHDRAWN P0912 UTILITY OF LIQUID BASED CYTOLOGY IN EUS-FNA SAMPLES FOR THE PANCREATIC LESIONS Yusuke Ishida, Japan; Y. Okabe; T. Taira; T. Sakaue; M. Fukahori; M. Yasumoto; T. Ushijima; Y. Naito; O. Tsuruta; T. Torimura P0913 ANTIBIOTIC PROPHYLAXIS AFTER PANCREATIC CYST PUNCTURE – LESS IS MORE? ONE-TIME VERSUS EXTENDED CIPROFLOXACIN PROTOCOL. Irina Mocanu, Portugal; R. Barosa; M. Patita; G. Nunes; P. Pinto Marques P0914 EUS-GUIDED FNA IN THE STUDY OF THE ADRENAL GLAND: NATIONAL RETROSPECTIVE MULTICENTER STUDY Albert Martin-Cardona, Spain; G. Fernández-Esparrach; J. C. Súbtil Íñigo; J. Iglesias Garcia; M. Garcia-Guix; A. Barturen Barroso; A. Z. Gimeno García; J. Miguel Esteban; A. Pardo Balteiro; A. J. Velasco Guardado; E. Vazquez Sequeiros; C. Loras Alaustrey; B. Martinez Moreno; A. Castellot; C. Huertas Nadal; M. Martínez Lapiedra; A. Sanchez Yague; Á. Terán Lantarón; V. Jair Morales; M. T. Betes Ibáñez; D. de la Iglesia Garcia; C. Sánchez-Montes; M. D. Lozano Escario; J. Lariño Noia; A. Gines; J. B. Gornals P0915 RELIABILITY OF GIST'S PRE-TREATMENT RISK ASSESSMENT CLASSIFICATION WITH EUS-FNB BY USING DESIGNED CORE NEEDLES Roberto Grassia, Italy; P. Capone; F. Cereatti; E. Iiritano; K. Vjero; M. Martinotti; G. Tanzi; F. Buffoli
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
Capsule endoscopy P0917 DEVELOPMENT AND VALIDATION OF A HIGHLY SENSITIVE AND SPECIFIC AUTOMATED ALGORITHM TO EVALUATE THE ABUNDANCE OF BUBBLES IN SMALL BOWEL CAPSULE ENDOSCOPY Olivia Pietri, France; G. Rezgui; A. Histace; M. Camus; I. Nion-Larmurier; E. Abou Ali; C. Li; A. Becq; O. Romain; U. Chaput; P. Marteau; C. Florent; X. Dray P0918 AGE AND GASTRIC EMPTYING TIME ARE PREDICTIVE FACTORS FOR INCOMPLETE CAPSULE ENDOSCOPY: RESULTS OF A MULTIVARIATE ANALYSIS IN A LARGE STUDY POPULATION. E. Macías; Ignacio Fernández-Urién Sainz, Spain; J. F. Juanmartiñena; I. Elizalde; A. Borda; G. Ezpeleta; J. J. Vila P0919 A NOVEL CAPSULE TECHNOLOGY PLATFORM FOR SPECIFIC LOCALIZED COLON DRUG DELIVERY Nadir Arber, Israel; H. Elizabeth; S. Doron; G. Nathan; J.-D. Maayan; L. Jesse; M. Alaa; S. Benny; G. Ian; R. Tova; L. Evgenya P0920 COLON CAPSULE ENDOSCOPY: HOW DOES INADEQUATE PROCEDURE CLEANSING CORRELATE WITH PROCEDURE ACCURACY? Shay Perek, Israel; S. Farkash; N. Schwartz P0921 COLON CAPSULE ENDOSCOPY MAY REDUCE COLONOSCOPY MISS RATE – A MULTICENTER STUDY Shay Perek, Israel; N. Schwartz Biliary and pancreatic stenting P0922 ENDOSCOPIC MANAGEMENT OF POSTOPERATIVE PANCREATIC FISTULAS AFTER DISTAL PANCREATECTOMY OR ENUCLEATION Marine Camus, France; S. Chaouch; S. Leblanc; S. Gaujoux; F. Paye; P. Balladur; J. C. Vaillant; F. Menegaux; P. P. Massault; M. Barret; R. coriat; S. Chaussade; B. Dousset; F. Prat
Poster in the Spotlight
Poster of Excellence
P0923 EFFICIENCY OF PANCREATIC STENTS IN DIFFICULT CANNULATION – A RETROSPECTIVE SINGLE – CENTER STUDY Vasile Sandru, Romania; M. Ilie; O. M. Plotogea; E. Rinja; I. Moroi; B. Ungureanu; G. Constantinescu P0924 ENDOSCOPIC ULTRASONOGRAPHY-GUIDED BILIARY DRAINAGE WITHOUT DILATION DEVICE USING A THIN DELIVERY-SYSTEM STENT: A PRECLINICAL STUDY Itonaga Masahiro, Japan; M. Kitano; Y. Kawaji; H. Abe; T. Tamura; N. Junya; K. Hatamaru; H. IMAI; S. Omoto; K. Yamao; K. Minaga; K. Kamata; T. Miyata; M. Takenaka; M. Kudo P0925 TREATMENT WITH FULLY-COVERED METAL STENTS OF POST-SPHINCTEROTOMY EARLY AND LATE BLEEDING P. Gambitta; S. Pallotta; A. D'Alessandro; F. Iannuzzi; E. Bareggi; Alessandro Ballerini, Italy P0926 EFFICACY OF SELF-EXPANDABLE METALLIC STENT PLACEMENT IN THE MANAGEMENT OF ANASTOMOTIC STRICTURE AFTER ORTHOTOPIC LIVER TRANSPLANTATION Sunguk Jang, USA; M. Parsi; R. Lopez; A. Bhatt; J. J. Vargo P0927 “DISCONNECTED PANCREATIC DUCT” FOLLOWING EUS GUIDED DRAINAGE OF PANCREATIC FLUID COLLECTION – IS IT CLINICALLY RELEVANT? LONG-TERM FOLLOW UP FROM A LARGE VOLUME TERTIARY CARE CENTRE. Sundeep Lakhtakia, India; J. Basha; P. Pal; R. Gupta; M. Ramchandani; S. Kumar; R. Kalapala; M. Tandan; Z. Nabi; P. M. Reddy; G. V. Rao; D. N. Reddy P0928 FULLY COVERED SELF-EXPANDABLE METAL STENT IN THE MANAGEMENT OF DUODENAL RETROPERITONEAL PERFORATIONS DURING ERCP: A SINGLE CENTER EXPERIENCE M. Pizzicannella; G. Andrisani; M. Martino; R. Rea; M. Pandolfi; Francesco Maria Di Matteo, Italy Enteral dilatation and stenting (oesophagus, stomach, duodenum, colon) P0929 EFFICACY AND ONCOLOGIC SAFTY OF ENDOSCOPIC DUODENAL STENTING IN PATIENTS WITH ADVANCED PANCREATIC CANCER Takashi Sakuno, Japan; H. Inoue; R. Yamada; T. Harada; M. Nakamura; M. Katsurahara; Y. Hamada; K. Tanaka; N. Horiki; Y. Takei
Clinical Case Session
181
Tuesday, October 31, 2017
P0916 TECHNICAL FEASIBILITY AND SAFETY OF ENDOSCOPIC ULTRASOUND (EUS)-GUIDED FIDUCIAL MARKER PLACEMENT USING A NOVEL SYSTEM WITH PRE-LOADED 22-GAUGE NEEDLES IN PANCREATIC CANCER PATIENTS Eun Ji Shin, USA; S.-H. Kim; M. A. Khashab; M. I. Canto
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0930 CLINICAL FAILURE IN COLONIC STENTING FOR MALIGNANT LARGE BOWEL OBSTRUCTION: OUTCOMES AND RISK FACTORS IN 172 PROCEDURES Rei Ishibashi, Japan; S. Yoshida; A. Narita; T. Shimpoh; N. Takahara; A. Nakada; M. Tsuboi; M. Hata; Y. Nakai; Y. Hirata; K. Koike
P0937 PREDICTORS OF POSTOPERATIVE LYMPHOPAENIA AFTER SURGERY FOR ESOPHAGEAL AND ESOPHAGO-GASTRIC JUNCTION CANCER Ottavia De Simoni, Italy; S. Mocellin; P. Moroni; L. M. Saadeh; F. Cavallin; R. Alfieri; M. Cagol; C. Castoro; M. Scarpa
P0931 THE CLINICAL EFFICACY OF MITOMYCIN-C INJECTION THERAPY IN REFRACTORY BENIGN ESOPHAGEAL STENOSIS: A PRELIMINARY STUDY Sun Gyo Lim, Republic of Korea; J.-H. Kim; K. M. Lee
P0938 FLEXIBLE ENDOSCOPIC TREATMENT FOR ZENKER’S DIVERTICULUM OF HIGH ANESTHETIC RISK PATIENTS WITH THE SB KNIFE. TERTIARY CENTRE CENTRE EXPERIENCE Sauid Ishaq, United Kingdom; A. Antonello; A. Aziz; L. Priestnall; T. Kuwai; S. Kong; F. Walji; K. Siau; A. Gait; C. J. J. Mulder
P0932 TREATMENT WITH MULTIPLE REABSORBABLE STENTS OF COMPLETE AND PARTIAL LOWER GI ANASTOMOSIS DEHISCENCE AND STENOSIS P. Gambitta; S. Pallotta; F. Iannuzzi; E. Bareggi; Alessandro Ballerini, Italy; A. D'Alessandro
Tuesday, October 31, 2017
P0933 EVALUATION OF FACTORS ASSOCIATED TO A SUCCESSFUL DILATION IN POST-ESD STRICTURES Enrique Perez-Cuadrado-Robles, Belgium; H. Piessevaux; T. Moreels; R. C. P. Yeung; E. Danse; P. H. Deprez P0934 EFFECTIVENESS OF REPEATED DILATIONS IN THE MANAGEMENT OF ESOPHAGEAL BENIGN STRICTURES Alban Benezech, France; A. Debourdeau; J.-M. Gonzalez; M. Barthet P0935 EFFICACY AND SAFETY OF NEWLY DEVELOPED ENDOSCOPIC COLONIC STENTS WITH AN INCREASED EXPANDABLE FORCE: A RETROSPECTIVE COMPARISON WITH CONVENTIONAL COLONIC STENTS Tomoyuki Nishimura, Japan; T. Kuwai; H. Kohno; H. Kouno; A. Yamaguchi; T. Yamaguchi; H. Imagawa; Y. Miyasako; Y. Sumida; T. Takasago; R. Miura; K. Tao; S. Funaki; S. Ishaq Poster Session 09:00 – 17:00 Surgery II
Hall 7
Oesophagus / stomach / duodenum P0936 PERORAL ENDOSCOPIC MYOTOMY FOR THE CASES IN WHICH HELLER-DOR OPERATION WERE INEFFECTIVE Hironari Shiwaku, Japan; K. Yamashita; N. Kore-eda; T. Ohmiya; H. Okada; F. Yoshimura; S. Nimura; H. Inoue; S. Hasegawa
182
P0939 INCREASING LYMPH NODE RETRIEVAL IN ESOPHAGECTOMY, OUTCOMES OF THE DUTCH UPPER GASTROINTESTINAL CANCER AUDIT Leonie van der Werf, The Netherlands; J. Dikken; M. I. van Berge Henegouwen; V. E. P. P. Lemmens; G. A. P. Nieuwenhuijzen; B. P. L. Wijnhoven; on behalf of the Dutch Upper GI Cancer Audit group P0940 COLONIC INTERPOSITION AFTER OESOPHAGECTOMY IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE INFLUENCE OF CONDUIT CHOICE AND ROUTE ON OUTCOME Jade Brown, United Kingdom; D. Chan; W. Lewis; G. Clark; G. Blackshaw; A. Foliaki Hepatobiliary / pancreas / spleen P0941 THE ROLE OF LIVER RESECTION AFTER CHEMOTHERAPY FOR SYNCHRONOUS COLORECTAL LIVER METASTASIS Akira Ouchi, Japan; Y. Shimizu; K. Komori; Y. Senda; T. Kinoshita; S. Natsume; T. Ooshiro P0942 SURGICAL OUTCOME OF HEPATOPANCREATODUODENECTOMY ASSOCIATED WITH HEMIHEPATECTOMY OR MORE EXTENDED LIVER RESECTION FOR BILIARY CANCERS Tsuyoshi Sano, Japan; K. Komaya; T. Arikawa; T. Saito; S. Ishiguro; S. Komatsu; Y. Senda; S. Natsume; Y. Shimizu; M. Esaki; K. Shimada P0943 PERIOPERATIVE ADMINISTRATION OF BROAD-SPECTRUM ANTIBIOTICS COVERING ENTEROBACTERIACEAE DECREASE THE INCIDENCE OF SURGICAL SITE INFECTION FOLLOWING PANCREATODUODENECTOMY Kimitaka Tanaka, Japan; Y. Nakanishi; T. Asano; T. Noji; T. Nakamura; T. Tsuchikawa; K. Okamura; T. Shichinohe; S. Hirano
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P0945 RECTAL SWAB CULTURE CAN DIRECT ANTIMICROBIAL PROPHYLAXIS AND PREDICT THE RISK OF INFECTIOUS COMPLICATIONS AFTER PANCREATICODUODENECTOMY. M. De Pastena; Salvatore Paiella, Italy; D. Ciprani; G. Marchegiani; A. M. Azzini; E. Concia; R. Salvia; C. Bassi Postoperative complications P0946 EFFECT OF TRICLOSAN-COATED SUTURE USE ON THE INCIDENCE OF SUPERFICIAL INCISIONAL SURGICAL SITE INFECTIONS AFTER GASTROENTEROLOGIC SURGERY: A PROPENSITY SCORE MATCHING RETROSPECTIVE STUDY Kanefumi Yamashita, Japan; S. Takeno; S. Hoshino; H. Shiwaku; S. Hasegawa P0947 COMPARISON OF POSTOPERATIVE CONDITIONS BETWEEN ESOPHAGOGASTROSTOMY WITH THE DOUBLE-FLAP TECHNIQUE AND THAT WITH A CIRCULAR STAPLER IN LAPAROSCOPIC PROXIMAL GASTRECTOMY Masato Hayashi, Japan; H. Kawakubo; S. Mayanagi; K. Fukuda; R. Nakamura; K. Suda; N. Wada; Y. Kitagawa P0948 NOVEL ENDOSCOPIC REPAIR TECHNIQUE FOR GASTROINTESTINAL LEAKS AND PERFORATIONS USING NEGATIVE PRESSURE THERAPY WITH OPEN-PORE POLYURETHANE-FOAM AND FILM DRAINAGE Gunnar Loske, Germany; F. Rucktaeschel; T. Schorsch; C. T. Mueller P0949 INFLUENCE OF THE HYBRID METHOD OF DETOXICATION ON BLOOD CLARIFICATION EFFECTIVENESS AT PATIENTS WITH THE MULTIORGAN FAILURE Khasan Khalikulov, Uzbekistan; B. A. Saidkhanov; D. B. Saidkhanova
Poster of Excellence
P0951 COMPARATIVE EVALUATION OF LAPAROSCOPIC SINGLE-PORT (SILS) CHOLECYSTECTOMY AND LAPAROSCOPIC FOUR-PORT CHOLECYSTECTOMY Aftandil Alekberzade, Russian Federation; N. Krylov; E. Lipnitsky P0952 LAPAROSCOPIC SURGERY’S 100 MOST INFLUENTIAL MANUSCRIPTS: A BIBLIOMETRIC ANALYSIS Katie Mellor, United Kingdom; A. Powell; W. Lewis P0953 BASELINE CHARACTERISTICS IN LAPAROSCOPIC SIMULATOR PERFORMANCE Ninos Oussi, Sweden; P. Renman; E. Georgiou; L. Enochsson P0954 PERITONEAL TUBERCULOSIS: EPIDEMIOLOGICAL DATA, CLINICAL AND EVOLUTIVE ASPECTS ACCORDING TO THE EXPERIENCE OF A TUNISIAN CENTER Wafa Ben Ameur, Tunisia; J. Hanen; E. Hammami; E. Nour; M. Kssia; B. Ahlem; A. Salem; A. Ben Slama; J. Ali P0955 ABDOMINAL TUBERCULOSIS: A RETROSPECTIVE SERIES OF 150 CASES Sonda Jardak, Tunisia; H. Kchir; N. Maamouri; H. Chaabouni; N. Ben Mami Poster Session 09:00 – 17:00 IBD II
Hall 7
Basic/pathogenesis/pathology P0956 PATHOBIONT-FREE MICROBIOTA PROTECTS AGAINST GUT INFLAMMATION INDUCED BY AN INNATE IMMUNE DEFICIENCY OR DIETARY PERTURBANT OF THE MICROBIOTA Benoit Chassaing, USA; A. T. Gewirtz P0957 WITHDRAWN
P0950 CARDIAC SEPTAL DEFFECT OCCLUDER DEVICE FOR ENDOSCOPIC TREATMENT OF GASTRO-CUTANEOUS AND GASTRO-PULMONARY LEAKS AFTER BARIATRIC SURGERY Alberto J. Baptista, Venezuela; W. Bandel; A. Gelrud; A. Salinas; L. C. Sabagh; A. Ospina; M. A. Guzman; J. F. Piñerúa Gonsálvez; H. Rass; A. Oropeza; M. Antor
Poster in the Spotlight
Laparoscopic techniques
P0958 ISOLATION AND CHARACTERIZATION OF LAMINA PROPRIA MONONUCLEAR CELLS FROM HUMAN COLONIC MUCOSA Sanja Musladin, Croatia; I. Zlatar; L. Pribolšan; K. Ilić; P. Nikolić; M. Antolić; S. Čužić; G. Aralica; L. Patrlj; R. Kliček; M. Bosnar; V. Eraković Haber P0959 FACTORS ASSOCIATED WITH DISABILITY IN INFLAMMATORY BOWEL DISEASE: OUTPATIENT CROSS–SECTIONAL STUDY Juliana Costa, Portugal; D. Matos; J. B. Soares; R. Costa; B. Arroja; R. Gonçalves
Clinical Case Session
183
Tuesday, October 31, 2017
P0944 PARADIGM SHIFT? SHOULD A LYMPHADENECTOMY ROUTINELY BE PERFORMED ALSO AMONG GALLBLADDER CANCER PATIENTS WITH T1A DISEASE? N. Köhn; R. Warschkow; D. Nussbaum; D. Candinas; B. Gloor; B. Schmied; D. Blazer; Mathias Worni, Switzerland
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0960 BIOLOGIC THERAPY REDUCES T CELL ACTIVATION IN PATIENTS WITH CROHN'S DISEASE. Leticia Garcia, Brazil; A. E. Z. Carvalho; E. A. Rosseto; C. C. V. Nora; F. S. Flaquer; C. L. P. Mangueira; L. V. Rizzo; K. I. L. de Carvalho P0961 CHANGES OF THE MUCOSAL COLON MICROFLORA ARE CAUSE OF INFLAMMATION AT THE PATIENTS WITH ULCERATIVE COLITIS Artem Kasianov, Russian Federation; A. Fedotova; M. Logacheva; K. Klimina; A. Zhurov; I. Ruchkina; A. Parfenov; O. Knyazev; N. Fadeeva P0962 COLONIC INFLAMMATION DELAYS DEVELOPMENT OF STREPTOZOTOCIN-INDUCED DIABETES IN MICE THROUGH MODULATION OF ENDOGENOUS INCRETIN SYSTEM Hubert Zatorski, Poland; M. Sałaga; M. Zielińska; J. Fichna
Tuesday, October 31, 2017
P0963 EOSINOPHILS-ASSOCIATED CYTOKINES AS INFLAMMATORY BOWEL DISEASE BIOMARKERS Katarzyna Neubauer, Poland; M. Matusiewicz; I. Bednarz-Misa; S. Górska; A. Gamian; M. Krzystek-Korpacka P0964 MACROPAHGE IL10 SIGNALING IS REQUIRED FOR THE THERAPEUTIC EFFECT OF ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE Pim Koelink, The Netherlands; F. M. Bloemendaal; L. Westera; A. B. van 't Wout; A. K. Gloudemans; B. Li; T. L. Geiger; M. E. Wildenberg; G. R. van den Brink P0965 LONG-TERM CONSEQUENCES OF ANTIBIOTIC THERAPY: ROLE OF SCFAS AND INTESTINAL BARRIER INTEGRITY Yuliia Holota, Ukraine; A. Bazan; V. Stetska; N. Dziubenko; T. Dovbynchuk; T. Chervinska; L. Zakordonets; T. Serhiychuk; I. Kaji; G. Tolstanova P0966 THE ROLE OF TLR2-MEDIATED TREG/TH17 IMBALANCE IN THE PATHOGENESIS OF ULCERATIVE COLITIS Y. F. Xie; J. Y. Hao; Y. H. Pang; Y. H. Ma; Z. R. Li; X. Q. He; Xin Juan Liu, China P0967 FIRST ANALYSIS FROM UK IBD TWIN BIOBANK; 16S RRNA GENE SEQUENCING IDENTIFIES REDUCED DIVERSITY IN ACTIVE IBD AND TAXA ASSOCIATED WITH ACTIVE DISEASE PHENOTYPE TO LEVEL OF SPECIES H. Gordon; Marcus Harbord, United Kingdom; J. Marchesi; W. Blad; T. R. Orchard; J. McDonald
184
P0968 CD4+ T CELLS OF IBD PATIENTS ARE CHARACTERIZED BY AN INCREASED EXPRESSION OF THE NUCLEOTIDE RECEPTOR P2Y2, WHICH IMPACTS RELEVANTLY ON PRO-INFLAMMATORY SIGNALING CASCADES. J. Panteleev-Ivlev; S. Zundler; R. Atreya; M. F. Neurath; Imke Atreya, Germany P0969 HIF-1α STABILIZATION THROUGH HYDROXYLASE INHIBITION AMELIORATES DSS-INDUCED COLITIS AND INDUCES AUTOPHAGY Jesus Cosin Roger, Switzerland; S. Simmen; H. Melhem; K. Atrott; I. Frey-Wagner; M. Hausmann; C. De Valliere; M. R. Spalinger; P. Spielmann; R. H. Wenger; J. Zeitz; S. Vavricka; G. Rogler; P. A. Ruiz P0970 PROTECTIVE EFFECT AND ACTION MECHANISM OF APOCYNIN IN IBD MOUSE MODEL Seung-Joo Nam, Republic of Korea; S.-I. Kim; W. Chun; J. M. Park; S. C. Park; D. H. Choi; C. D. Kang; S. J. Lee P0971 THE USE OF RAPID EVAPORATIVE IONISATION MASS SPECTROMETRY (REIMS) IN FAECAL SAMPLES TO IDENTIFY INFLAMMATORY BOWEL DISEASE Sam Tristan Richmond Powles, United Kingdom; L. W. L. Chong; S. J. Cameron; L. C. Hicks; Z. Takats; H. R. T. Williams; T. R. Orchard P0972 THE PATHOGENIC MECHANISM OF ARYL HYDROCARBON RECEPTOR MEDIATED ABNORMAL DIFFERENTIATION OF INTESTINAL ILC3/ILC1 IN CROHN'S DISEASE Xiaojing Zhao, China; H. Zhang P0973 PREVALENCE AND GENETIC DIFFERENCES IN ADHESION-RELATED GENES AMONG COMMENSAL AND ADHERENT-INVASIVE E. COLI STRAINS Carla Camprubí-Font, Spain; A. Segú-Roig; N. Maeso-Sánchez; M. López-Siles; M. Martinez-Medina P0974 DISTINCT GUT MICROBIOTA PROFILES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE COLITIS Lukas Bajer, Czech Republic; M. Kverka; M. Kostovcik; P. Macinga; J. Dvorak; Z. Stehlikova; J. Brezina; J. Spicak; P. Drastich P0975 WITHDRAWN P0976 HYPOXIA INDUCIBLE FACTOR (HIF)-1 ACCELERATES EPITHELIAL WOUND HEALING THROUGH INTEGRIN REGULATION B. J. Goggins; K. Minahan; D. Knight; J. Horvat; M. M. Walker; Simon Keely, Australia
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P0978 BACTERIAL TRANSLOCATION CONTINUES IN ULCERATIVE COLITIS DESPITE MUCOSAL HEALING AND CONTINUED CLINICAL REMISSION Alan Steel, United Kingdom Aetiology/epidemiology P0979 EFFECT OF FIBER AND FAT CONSUMPTION ON DISEASE ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Ioanna Pefkianaki, Greece; I. Mouzas; I. Koutroubakis P0980 PROGRESSION IN CROHN’S DISEASE BEHAVIOUR IN A PROSPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT – THE ECCO-EPICOM COHORT Johan Burisch, Denmark; A. Goldis; F. Magro; S. Turcan; R. D’Inca; S. Čuković-Čavka; D. Schwartz; P. Ellul; Z. Vegh; P. Oksanen; M. Giannotta; K. R. Nielsen; N. Arebi; R. Salupere; M. Fumery; J. F. Dahlerup; D. Christodoulou; L. Kievit; D. Duricova; N. Pedersen; D. Valpiani; I. Kaimakliotis; V. Hernández; L. Kupcinskas; J. Halfvarson; E. Langholz; P. L. Lakatos; P. Munkholm P0981 CHANGES IN GUT MICROBIOTA COMPOSITION CORRELATE WITH SHORT TERM CHANGES IN FACEAL CALPROTECTIN AND CRP IN PATIENTS WITH CROHN’S DISEASE Derek Chan, United Kingdom; D. Kumar; M. Mendall P0982 COLORECTAL CANCER IN INFLAMMATORY BOWEL DISEASE: RISK FACTORS IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY Livia Biancone, Italy; A. Armuzzi; M. L. Scribano; R. D'inca; C. Papi; L. Spina; L. Guidi; F. Moccisro; P. Alvisi; A. Ruffa; B. Neri; W. Fries; G. Riegler; M. Daperno; F. Castiglione; S. Renna; S. Festa; E. Calabrese; G. Meucci; F. Rogai; S. Ardizzone; A. Rossi; A. Orlando; F. Pallone
P0983 EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE IN SPAIN: INTERIM ANALYSIS OF THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU Maria Chaparro, Spain; J. L. Cabriada; M. J. Casanova; D. Ceballos; M. Esteve; H. Fernández Rosaenz; M. Barreiro-de Acosta; V. García-Sánchez; D. Ginard; F. Gomollon; R. Lorente Poyatos; P. Nos; S. Riestra Menéndez; M. Rivero Tirado; P. Robledo Andrés; C. Rodríguez; B. Sicília Aladrén; E. A. Torrella Cortes; F. Rodríguez-Artalejo; J. P. Gisbert; On behalf of the EpidemIBD group P0984 IMPACT OF ANORECTAL COMPLAINTS ON QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – A SURVEY OF THE DUTCH NATIONAL CROHN’S AND COLITIS ORGANISATION. Paul Vollebregt, The Netherlands; A. A. van Bodegraven; M. L. Markus-de Kwaadsteniet; D. van der Horst; R. J. Felt-Bersma P0985 CURRENT UNDERSTANDING OF POUCH MICROBIOTA IN HEALTH AND DISEASE; A SYSTEMATIC REVIEW Jonathan Segal, United Kingdom; S. Oke; G. Hold; A. Hart P0986 LIVE-VACCINES AND BREASTFEEDING IN NEWBORN EXPOSED IN UTERO TO ANTI TNF: A MULTICENTER FRENCH STUDY IN INFLAMMATORY BOWEL DISEASE Sihem Bendaoud, France; S. Nahon; L. Beaugerie; J.-M. Gornet; B. Pariente; L. Peyrin-Biroulet; V. Abitbol; M. Boualit; R. Altwegg; A. Buisson; C. Baudry; L. Plastaras; F. Heluwaert; M. Amil; M. Antoni; K. Bideau; V. Quentin; G. Pineton de Chambrun; R. Faroux; F. Skinazi; C. LOCHER; E. Cuillerier; A. Boureille; A. Aubourg; I. Rosa; M. Simon Diagnosis and monitoring P0987 OUTCOME OF ENDOSCOPIC ALLY RESECTED DYSPLASIC LESIONS IN ULCERATIVE COLITIS Houria Saoula, Algeria; A. F. Boutaleb; H. Mahiou; M. Aissaoui; Y. Zmiri; N. Hamidouche; R. Osmane; Y. Aissat; A. Mitiche; L. Gamar; K. Belhocine; N. Bounab; T. Boucekkine; L. Kecili; S. Berkane; Z. Amir; M. Nakmouche P0988 CYTOMEGALOVIRUS INFECTION IS ASSOCIATED WITH A POOR OUTCOME IN PATIENTS WITH ULCERATIVE COLITIS TREATED BY VEDOLIZUMAB Xavier Roblin, France; L. Brichet; S. Pillet; E. del Tedesco; J. M. Phelip; B. Pozzetto; N. Williet
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
185
Tuesday, October 31, 2017
P0977 EFFECTS OF TIME ON URINARY METABOLIC SIGNATURES IN INFLAMMATORY BOWEL DISEASE Lucy Hicks, United Kingdom; S. T. R. Powles; L. W. L. Chong; J. Swann; E. Holmes; H. R. T. Williams; T. R. Orchard
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P0989 F-CALPROTECTIN USE IN INFLAMMATORY BOWEL DISEASE IS CHARACTERISED BY IMPROVED DIAGNOSTIC ACCURACY, LESS PATIENT HARM AND DECREASED COSTS, COMPARED WITH CONVENTIONAL SEROLOGICAL MARKERS AND COLONOSCOPY. THE SPANISH SCENARIO. Barbara Mascialino, Sweden; A. A. Vora P0990 RISK OF SERIOUS INFECTION IN HEALTHCARE WORKER WITH INFLAMMATORY BOWEL DISEASE: A CASE-CONTROL STUDY OF THE GETAID Charlotte Gagniere, France; A. Bourrier; P. Seksik; J.-M. Gornet; O. Dewit; S. Nancey; R. Altwegg; V. Abitbol; D. Laharie; C. Reenaers; A. Buisson; M. Nachury; S. Viennot; L. Vuitton; C. Stefanescu; P. Marteau; G. Bouguen; J. Cosnes; A. Amiot P0991 CORRELATION BETWEEN INFLAMMATORY BIOMARKERS AND ENDOSCOPIC SCORES IN ULCERATIVE COLITIS: THUS EXTENSION MAKES THE DIFFERENCE? Cátia Arieira, Portugal; F. Dias de Castro; M. J. Moreira; J. Cotter Tuesday, October 31, 2017
P0992 IBD – IS IT A RISK FACTOR FOR THE DIAGNOSIS OF HEPATIC STEATOSIS? Cátia Arieira, Portugal; S. Monteiro; S. Xavier; F. Dias de Castro; J. Magalhães; M. J. Moreira; J. Cotter P0993 BONE HEALTH IN CROHN'S DISEASE IN THE ERA OF TNF-ALPHA INHIBITORS Shahrad Hakimian, USA; J. Kheder; D. Cave; B. Hyatt P0994 THE AVAILABILITY OF INFLIXIMAB TROUGH LEVELS IN IBD PATIENTS ON MAINTENANCE THERAPY DEEPLY IMPACTS THERAPEUTIC DECISION-MAKING Triana Lobaton, Spain; F. Cañete; A. Teniente; E. Cabré; M. Mañosa; E. Martínez; E. Domènech P0995 THE DIAGNOSTIC UTILITY OF LINKED-COLOR IMAGING IN THE EVALUATION OF MUCOSAL INFLAMMATION IN PATIENTS WITH ULCERATIVE COLITIS Hitomi Hamamoto, Japan; S. Kanmura; S. Arima; Y. Nasu; S. Tanoue; F. Sasaki; S. Hashimoto; A. Ido P0996 WHAT SITUATIONS PRODUCE PSYCHOLOGICAL MALAISE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? PERCEPTIONS FROM PHYSICIANS AND PATIENTS. THE ENMENTE PROJECT Manuel Barreiro-de Acosta, Spain; A. Panadero; M. Cañas; L. Carmona; Y. Modino; J. Guardiola; L. Cea-Calvo; B. Juliá De Páramo; C. Romero; M. Gobbo; I. Marín-Jiménez 186
P0997 EVALUATION OF LISA-TRACKER IMMUNOASSAY INFLIXIMAB AND ANTI-INFLIXIMAB FOR THE THERAPEUTIC DRUG MONITORING OF SB2. A.-E. Berger; A. Haccourt; J. Salameh; X. Roblin; Stéphane Paul, France P0998 THE MEASURE OF TROUGH LEVELS OF INFLIXIMAB IS LINKED TO THERAPEUTIC RESPONSE IN IBD PATIENTS. Xavier Roblin, France; A.-E. Berger; G. Boschetti; B. Flourie; S. Nancey; S. Paul P0999 SMOKING STATUS INFLUENCES FECAL VOLATILE ORGANIC COMPOUNDS COMPOSITION J. de Swart; N. van Gaal; D. J. C. Berkhout; Sofie Bosch, The Netherlands; T. G. J. de Meij; K. H. N. de Boer P1000 CLOSTRIDIUM DIFFICILE INFECTION AND IBD PATIENTS IN ONE CLINICAL CENTER Antonia Atanassova, Bulgaria; A. Georgieva P1001 DEVELOPMENT OF A NEW SCORE PREDICTIVE OF SUSTAINED CLINICAL REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER INFLIXIMAB-AZATHIOPRINE COMBOTHERAPY. B. Sivard; N. Williet; J.-M. Phelip; E. Del Tedesco; S. Paul; Xavier Roblin, France P1002 LOWER GI SYMPTOMS IN YOUNG PATIENTS: CAN SYMPTOMS AND NON-INVASIVE TESTS BE USED SYSTEMATICALLY TO AVOID UNNECESSARY COLONOSCOPIES? Alaa Alakkari, Ireland; B. Ryan P1003 FAECAL CALPROTECTIN AND MAGNETIC RESONANCE IMAGING ARE RELIABLE TOOL TO DETECT ENDOSCOPIC POSTOPERATIVE RECURRENCE IN CROHN’S DISEASE Anthony Buisson, France; P. Baillet; G. Cadiot; M. Goutte; F. Goutorbe; H. Brixi; C. Hoeffel; C. Allimant; M. Reymond; H. Obritin-Guilhen; G. Bommelaer; B. Pereira; C. Hordonneau P1004 SMALL BOWEL PREPARATION IN PATIENTS WITH CROHN'S DISEASE: THE POLYETHYLENE-GLYCOL IS NO LONGER USEFUL Ludovic Lagin, France; A. Bourreille; M. Flamant; M. Freyssinet; C. Le Berre; S. Bruley Des Varannes; C. Trang P1005 VALUE OF 75SEHCAT IN THE DIAGNOSIS OF BILE ACID MALABSORPTION IN CROHN´S DISEASE WITH CHRONIC DIARRHOEA Beatriz Gros, Spain; L. Mena; J. M. Benítez-Cantero; E. Carmona; E. Iglesias-Flores; F. R. Maza; R. Medina; V. García-Sánchez
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P1006 CLINICAL USEFULNESS OF ENDOSCOPIC ASSESSMENT IN ULCERATIVE COLITIS USING LINKED COLOR IMAGING: A PRELIMINARY PILOT STUDY WITH 10 PATIENTS Kohei Yamanouchi, Japan; R. Iwakiri; R. Shimoda; Y. Sakata; N. Tsuruoka; S. Shirai; K. Yamamoto; K. Akutagawa; T. Noda; H. Endo; K. Fujimoto
P1014 PERFORMANCE OF THE BÜHLMANN QUANTUM BLUE® ADALIMUMAB RAPID TEST DEDICATED FOR THERAPEUTIC DRUG MONITORING OF SERUM ADALIMUMAB TROUGH LEVELS T. Schuster; M. Wieser; S. Kräuchi; R. Sokoll; F. Bantleon; J. Weber; Michael Schneider, Switzerland; A. P. Abel
P1007 THE ROLE OF SENSE OF COHERENCE IN DETERMINING HEALTH RELATED QUALITY OF LIFE AND DISABILITY IN INFLAMMATORY BOWEL DISEASE Gary Wild, Canada; M. Vitagliano; I. Albanese; K. Shirlow
P1015 ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIMUMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN’S DISEASE PATIENTS. Gaia Pellegatta, Italy; S. Lo Pumo; G. Bodini; I. Baldissarro; E. G. Giannini; V. Savarino; A. Jain; E. Savarino
P1009 INFLIXIMAB TROUGH LEVELS AND ANTIBODIES TO INFLIXIMAB IN ASSOCIATION WITH DISEASE ACTIVITY AND MUCOSAL HEALING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Eleni Orfanoudaki, Greece; M. Gazouli; K. Foteinogiannopoulou; E. Theodoraki; E. Legaki; I. Koutroubakis
P1016 ULTRASONOGRAPHIC RESPONSE TO ANTI-TNFS IS ASSOCIATED WITH BETTER OUTCOMES IN CROHN’S DISEASE Emma Calabrese, Italy; F. Zorzi; E. Lolli; S. Onali; M. C. Fantini; L. Biancone; G. Monteleone P1017 CONTINUOUS MONITORING WITH THE TELEMEDICINE TOOL MYIBDCOACH SHOWS AN ASSOCIATION BETWEEN NOVEL STRESS AND INFLAMMATORY BOWEL DISEASE FLARES Dion Wintjens, The Netherlands; M. de Jong; A. E. Van Der Meulen – De Jong; M. Romberg Camps; M. Becx; M. H. Verwey; B. Winkens; A. A. M. Masclee; D. M. Jonkers; M. J. Pierik
P1010 COMPARATIVE INVESTIGATION OF ENTEROBACTERIA BUSH IN ULCERATIVE COLITIS PATIENTS, AND THEIR CONSANGUINEOUS, AND NON-CONSANGUINEOUS RELATIVES Katsuyuki Fukuda, Japan
P1018 STRAIN ELASTOGRAPHY AND DIFFERENTIAL DIAGNOSIS OF INFLAMMATORY AND FIBROTIC STRICTURES IN CROHN’S DISEASE Larisa Orlova, Russian Federation; T. V. Samsonova; I. Khalif; M. Shapina; P. Evgrafov
P1011 EVALUATION OF PET-MRI AND FECAL BIOMARKERS TO MONITOR DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS. Jost Langhorst, Germany; J. H. Boone; A. K. Koch; A. Rueffer; G. Dobos; K. Beiderwellen; T. Lauenstein; Y. Li; L. Umutlu
P1019 THE INFLAMMATORY BOWEL DISEASE DISABILITY INDEX IN INFLAMMATORY BOWEL DISEASE : RELATIONSHIP WITH DISEASE CHARACTERISTICS AND QUALITY OF LIFE IN A COHORT OF SICILIAN PATIENTS G. C. Morreale; E. Gianquinto; V. Calvaruso; M. G. Cilluffo; B. Scrivo; Maria Cappello, Italy
P1012 MMP3 (METALLOPROTEINASE 3): A NEW MARKER FOR ASSESSING LOSS OF RESPONSE TO INFLIXIMAB IN IBD Brigida Barberio, Italy; R. D'inca; L. Digiglio; S. Facchin; M. Piciocchi; R. Cardin; M. G. Vettorato; M. Dalla Gasperina; A. Rigo; G. C. Sturniolo
P1020 DIPEPTIDYL PEPTIDASE 4 (DPP-4): A BIOMARKER OF DISEASE ACTIVITY AND PROGNOSIS IN INFLAMMATORY BOWEL DISEASE Pedro Pinto-Lopes, Portugal; J. Afonso; G. Macedo; F. Magro
P1013 USEFULNESS OF A MULTIDISCIPLINARY APPROACH COMBINING BOTH RHEUMATOLOGY AND GASTROENTEROLOGY FOR THE ASSESSMENT AND TREATMENT OF INFLAMMATORY BOWEL DISEASE PATIENTS Manuel Barreiro-de Acosta, Spain; E. Pérez-Pampín; R. Ferreiro Iglesias; R. Mejuto; A. Mera; J. E. Dominguez-Muñoz Poster in the Spotlight
Poster of Excellence
P1021 ROLE OF PET-CT TO ASSESS DISEASE ACTIVITY IN ULCERATIVE COLITIS AND ITS CORRELATION WITH CLINICAL CRITERIA, ENDOSCOPY AND FECAL BIOMARKERS Neha Berry, India; S. K. Sinha; A. Bhattacharya; K. Prasad; C. Vaishnavi; K. Vaiphei; J. Samanta; R. Prasada; N. Dhaka; R. Kochhar
Clinical Case Session
187
Tuesday, October 31, 2017
P1008 FAECAL AMINO ACID PROFILES AS NOVEL NON-INVASIVE BIOMARKERS FOR THE DETECTION OF PAEDIATRIC INFLAMMATORY BOWEL DISEASE: A METABOLOMIC APROACH. Sofie Bosch, The Netherlands; N. van Gaal; R. Zuurbier; E. Struijs; A. Bakkali; K. H. N. (. de Boer; T. G. J. de Meij
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P1022 CLINICAL PERSPECTIVE ON DRUG MONITORING WITH AN INFLIXIMAB RAPID QUANTIFICATION ASSAY F. Magro; Joana Afonso, Portugal; S. Lopes; R. Coelho; R. Gonçalves; P. Caldeira; P. Lago; M. H. Tavares Sousa; J. Ramos; A. R. Gonçalves; P. Ministro; I. Rosa; T. Meira; A. Andrade; J. B. Soares; D. Carvalho; P. Sousa; A. Vieira; C. Camila Dias P1023 THE IMPACT OF AN INFLAMMATORY BOWEL DISEASE EDUCATION CLINIC ON PATIENT OUTCOMES AND RESOURCE UTILISATION Wei On, United Kingdom; B. Collins; H. Stanley; A. Westhoff; S. Tynan; D. McClements; V. Theis; J. McLindon; R. Chandy; A. Bassi
P1029 MOLECULAR SURROGATES OF HISTOLOGIC ACTIVITY IN CROHN’S DISEASE Calixte Monast, USA; K. Li; E. Myshkin; C. Brodmerkel; J. Friedman; F. Baribaud P1030 INDIRECT TREATMENT COMPARISON OF USTEKINUMAB VERSUS OTHER BIOLOGICS IN MODERATE-TO-SEVERE CROHN'S DISEASE PATIENTS HAVING FAILED ANTI-TNF THERAPY – A 1-YEAR TREATMENT SEQUENCE ANALYSIS INCLUDING DELAYED RESPONDERS Laura Mesana, United Kingdom; M. Pacou; D. Naessens; S. Sloan; A. Gauthier
Tuesday, October 31, 2017
P1024 EMERGING ROLE OF IL-33/ST2 LEVELS IN PREDICTING MUCOSAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS. Loris Riccardo Lopetuso, Italy; V. Petito; C. Graziani; T. T. Pizarro; F. Scaldaferri; A. Gasbarrini
P1031 INDIRECT TREATMENT COMPARISON OF USTEKINUMAB VERSUS OTHER BIOLOGICS IN MODERATE-TO-SEVERE CROHN'S DISEASE PATIENTS HAVING FAILED CONVENTIONAL THERAPY – A 1-YEAR TREATMENT SEQUENCE ANALYSIS INCLUDING DELAYED RESPONDERS Laura Mesana, United Kingdom; M. Pacou; D. Naessens; S. Sloan; A. Gauthier
P1025 INFLIXIMAB TROUGH LEVELS IN THE INDUCTION PHASE ARE ASSOCIATED WITH PROLONGED REMISSION IN CROHN´S DISEASE PATIENTS. María Dolores Martín-Arranz, Spain; M. Jaquotot Herranz; E. Martín-Arranz; A. Martínez Feito; M. Díaz-Almirón; C. Suárez Ferrer; J. Poza Cordon; S. Gómez Senent; L. García Ramirez; M. P. Aracelia; D. Pascual-Salcedo
P1032 EFFICACY AND TOLERABILITY OF INITIATING, OR SWITCHING TO, INFLIXIMAB BIOSIMILAR CT-P13 IN INFLAMMATORY BOWEL DISEASE (IBD): A LARGE SINGLE-CENTRE EXPERIENCE Ragu Prakash Ratnakumaran, United Kingdom; N. To; D. Gracie; C. Selinger; T. Clark; N. Carey; G. Dowson; K. Leigh; L. Bourner; A. C. Ford; P. J. Hamlin
P1026 CORRELATION BETWEEN CLINICAL, ENDOSCOPIC AND HISTOLOGICAL ACTIVITY IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDY Benedetto Neri, Italy; A. Ruffa; S. Romeo; E. Grasso; F. Zorzi; G. Palmieri; L. Biancone
P1033 SAFETY AND EFFICACY OF HELICOBACTER PYLORI ERADICATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Shinichiro Shinzaki, Japan; T. Fujii; S. Bamba; T. Kobayashi; H. Tanaka; T. Yoshino; A. Yamada; N. Kamata; T. Hibi
Treatment-medical P1027 THE RELATIONSHIP BETWEEN SERUM INFLIXIMAB AND ADALIMUMAB CONCENTRATIONS AND THEIR CORRESPONDING ANTI-DRUG ANTIBODY LEVELS: ANALYSIS OF OVER 50,000 PATIENT RESULTS USING LAB DEVELOPED CHEMILUMINESCENT IMMUNOASSAYS Kelly Chun, USA; J. Yang P1028 REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB M. Raluy Callado; R. Carroll; R. Curtis; M. J. Khalid; Haridarshan Patel, United Kingdom
188
P1034 EFFECTIVENESS OF IMMUNOSUPPRESSORS IN CROHN'S DISEASE Linda Kecili, Algeria; N. Kaddache; L. Si Salah; A. Rebiha; S. Khouitar; K. Soualah; H. Bellimi; F. Ihaddadene; R. Benbaya; K. Bouchaoui; A. Tata; B. Bahaz; T. Boucekkine; S. Berkane P1035 EVALUATION OF PHARMACOKINETIC PROFILES OF SB2 AS A BIOSIMILAR OF REFERENCE INFLIXIMAB D. Shin; J. W. Kang; S. Park; Y. Lee; Sora Lee, Republic of Korea P1036 INFLIXIMAB DOSE BANDING SHORTENS LENGTH OF STAY OF INFLAMMATORY BOWEL DISEASE PATIENTS Julien Ollivier, France; F. Poullenot; A. Berroneau; S. Djabarouti; F. Xuereb; F. Zerbib; D. Laharie; D. Breilh
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P1038 HIGH DOSE INTRAVENOUS IRON ISOMALTOSIDE IN PATIENTS WITH GASTROINTESTINAL DISEASES R. Derman; J. F. Dahlerup; Walter Reinisch, Austria P1039 EFFICACY AND SAFETY OF GOLIMUMAB IN ULCERATIVE COLITIS. PRELIMINARY DATA FROM A MULTICENTER ITALIAN STUDY Fabrizio Bossa, Italy; M. R. Valvano; C. Giuseppe; A. Lauria; N. Buccianti; E. Vinci; E. Shaini; M. Mendolaro; L. Grossi; S. Mazzuoli; A. Rispo; G. Pranzo; L. Sebkova; A. Tursi; A. Miranda; M. Patturelli; R. Spagnuolo; C. Ricciardelli; C. Sgarro; P. Paese; G. Inserra; A. Azzarone; W. Fries; A. C. Privitera; M. Principi; M. Cappello; A. Andriulli P1040 OUTCOMES OF PATIENTS IN REMISSION WITH INFLAMMATORY BOWEL DISEASE WITH UNDETECTABLE INFLIXIMAB TROUGH LEVELS AND POSITIVE ANTIBODIES TO INFLIXIMAB. Gloria Shwe Zin Tun, United Kingdom; R. W. Downey; K. Robinson; A. Wright; L. Marshall; M. F. Hale; A. J. Lobo P1041 PHARMACOKINETIC SIMILARITY OF ABP 710 TO INFLIXIMAB: RESULTS FROM A RANDOMISED, SINGLE-BLIND, SINGLE-DOSE, PARALLEL-GROUP STUDY IN HEALTHY SUBJECTS Vincent Chow, USA; N. Zhang; P. Kaur; A. Kaliyaperumal; E. Krishnan P1042 EPIDEMIOLOGY AND BURDEN OF COMPLEX PERIANAL FISTULAS IN PATIENTS WITH CROHN DISEASE– A SYSTEMATIC LITERATURE REVIEW J. Panés; Haridarshan Patel, United Kingdom; E. Rupniewska; S. Khan; D. Bojic; M. J. Khalid; W. Reinisch P1043 VITAMIN D IS RELATED TO THE EFFECTS OF ANTI-TNF TREATMENT IN CROHN´S DISEASE PATIENTS Mauro Bafutto, Brazil; M. B. G. Costa; K. T. P. E. Silva; J. P. V. Costa; C. C. S. O. Reviglio; E. C. Oliveira; J. R. Filho P1044 WITHDRAWN Poster in the Spotlight
Poster of Excellence
P1045 CLINCAL EFFECTIVENESS OF GOLIMUMAB IN CROHN’S DISEASE – AN OBSERVATIONAL STUDY BASED ON THE SWEDISH NATIONAL QUALITY REGISTRY FOR INFLAMMATORY BOWEL DISEASE Sara Rundquist, Sweden; C. Eriksson; L. Nilsson; L. Angelison; S. Jäghult; J. Björk; O. Grip; H. Hjortswang; H. Strid; P. Karlén; S. Montgomery; J. Halfvarson P1046 EARLY IMPROVEMENT IN QUALITY OF LIFE IN PATIENTS WITH LUMINAL CROHN´S DISEASE TREATED WITH ADALIMUMAB. DATA FROM RAPIDA TRIAL Francesc Casellas, Spain; M. Barreiro-de Acosta; M. Esteve; L. Castro-Laria; R. Vicente; D. Ceballos; A. Echarri; M. Martín-Arranz; D. Busquets; J. Llaó; M. Navarro-Llavat; J. Huguet; F. Argüelles-Arias; J. Boudet; L. Rodríguez-San Pedro; G. Díaz; R. Casado; I. Marín-Jiménez P1047 EVALUATION OF QUALITY OF LIFE IN IBD PATIENTS TREATED WITH ANTI-TNFα THERAPY Greta Lorenzon, Italy; R. Caccaro; G. Girardin; B. Barberio; A. Rigo; E. Savarino; G. C. Sturniolo; R. D'inca P1048 ENDOSCOPIC AND HISTOLOGIC FINDINGS CORRELATE WITH FREE INFLIXIMAB FOUND IN UNINFLAMED TISSUE IN IBD PATIENTS Haggai Bar-Yoseph, Israel; A. Blatt; S. Pressman; S. Gerassy; B. Ungar; S. Ben-Horin; Y. Chowers P1049 WITHDRAWN P1050 LONG-TERM OUTCOMES OF MAINTENANCE ANTIBIOTIC THERAPY IN CHRONIC ANTIBIOTIC-DEPENDENT POUCHITIS Stephanie Poo, United Kingdom; J. Segal; S. McLaughlin; O. Faiz; S. Clark; A. Hart P1051 ANTIBODIES TO INFLIXIMAB OCCUR THROUGHOUT TREATMENT BUT DEVELOPMENT IS DELAYED BY IMMUNOSUPPRESSION. Robert Downey, United Kingdomm; G. S. Z. Tun; K. Swallow; G. Wild; A. Wright; K. Robinson; L. Marshall; R. Sargur; M. F. Hale; A. J. Lobo P1052 A DRUG-RESISTANT ASSAY CAN BETTER DIRECT THE NEED FOR ADALIMUMAB DOSE-ESCALATION AFTER INDUCTION THERAPY IN ANTI-TNF NAÏVE PATIENTS WITH CROHN’S DISEASE Gitte Moors, Belgium; B. Verstockt; S. Bian; S. Tops; V. Ballet; G. Van Assche; S. Vermeire; A. Gils; M. Ferrante
Clinical Case Session
189
Tuesday, October 31, 2017
P1037 RAPIDITY OF ONSET OF RESPONSE TO ADALIMUMAB (ADA) IN LUMINAL CROHN´S DISEASE (CD). DATA FROM RAPIDA TRIAL Ignacio Marín-Jiménez, Spain; F. Casellas; M. Esteve; L. Castro-Laria; S. García-López; D. Ceballos; A. Echarri; M. Martín-Arranz; D. Busquets; J. Llaó; M. Navarro-Llavat; J. Huguet; F. Argüelles-Arias; R. Vicente; L. Rodríguez-San Pedro; G. Díaz; R. Casado; M. Barreiro-de Acosta
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P1053 ADHERENCE TO MAINTENANCE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEFORE AND AFTER THE INTRODUCTION OF THE SHARED MEDICATION RECORD Klaus Roelsgaard, Denmark P1054 CLINICAL EFFICACY AND SAFETY OF GOLIMUMAB IN BIOLOGIC NAÏVE AND EXPERIENCED PATIENTS WITH ACTIVE ULCERATIVE COLITIS NON-RESPONDER OR INTOLERANT TO CONVENTIONAL THERAPIES. Beatrice Orlandini, Italy; E. Capoferro; S. Bagnoli; G. Dragoni; A. Geccherle; F. Rogai P1055 ENDOSCOPIC FOLLOW-UP AND THERAPEUTIC ATTITUDE AFTER ILEOCOLONIC RESECTION IN A NATIONWIDE SPANISH COHORT OF CROHN’S DISEASE PATIENTS. PRACTICROHN STUDY M Barreiro-de Acosta, Spain; V. García-Sánchez; A. Gutiérrez; M. D. Martín Arranz; L. Cea-Calvo; C. Romero; B. Juliá De Páramo; E. Domènech Tuesday, October 31, 2017
P1056 ETROLIZUMAB TREATMENT IMPROVES HISTOLOGICAL ACTIVITY AS ASSESSED BY BOTH THE ROBARTS HISTOPATHOLOGY AND NANCY HISTOLOGICAL INDICES L. Peyrin-Biroulet; B. G. Feagan; G. de Hertogh; D. T. Rubin; R. Maciuca; J. McBride; Udaysankar Arulmani, USA; A. Scherl P1057 GO-COLITIS: EFFICACY AND QUALITY OF LIFE DURING GOLIMUMAB MAINTENANCE IN UK PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS D. R. Gaya; P. Irving; S. Sebastian; P. J. Hamlin; C. Wheeler; A. Rose; G. Gillespie; Chris Probert, United Kingdom P1058 A UNITED STATES CLAIMS DATABASE ANALYSIS COMPARING SAFETY, MEDICAL RESOURCE UTILIZATION, AND TREATMENT COSTS ASSOCIATED WITH THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE BY DRUG CLASS G. H. Long; A. Tatro; Young Oh, USA; S. R. Reddy; A. N. Ananthakrishnan P1059 CAN EARLY DRUG AND ANTI-INFLIXIMAB-ANTIBODY LEVELS PREDICT PRIMARY NON RESPONSE TO INFLIXIMAB THERAPY? H. Bar-Yoseph; Y. Chowers; N. Levhar; L. Selinger; U. Manor; M. Yavzori; E. Fudim; O. Picard; U. Kopylov; R. Eliakim; S. Ben-Horin; Bella Ungar, Israel
190
P1060 TREATMENT EXPERIENCE WITH TOPICAL PRODUCTS FOR ULCERATIVE COLITIS – THE PATIENT´S PERSPECTIVE IN EUROPE AND THE USA T. Bayrhoffer; A. Thompson; Thomas Knittel, Sweden P1061 SELF-MANAGEMENT IN INFLAMMATORY BOWEL DISEASE: A PERSPECTIVE OF NURSES AND PHYSICIANS Siepke van den Burg, The Netherlands; N. M. S. Peek; A. E. Van Der Meulen – De Jong; J. P. W. Maljaars P1062 DISTINCT PATTERNS OF SHORT CHAIN FATTY ACIDS IN PATIENTS WITH ULCERATIVE COLITIS EXPERIENCING A FLARE DURING TREATMENT WITH MESALAMINE OR A HERBAL COMBINATION OF MYRRH, CHAMOMILE FLOWERS AND COFFEE CHARCOAL Jost Langhorst, Germany; A. K. Koch; A. Rueffer; G. Dobos P1063 GRANULOCYTE-MONOCYTE APHERESIS (GMA) IN DIFFICULT- TO-TREAT INFLAMMATORY BOWEL DISEASE (IBD). A SINGLE-CENTER REAL-LIFE EXPERIENCE. Alessandro Caroli, Italy; F. Lamboglia; I. Franceschet; C. Pozzan; D. Checchin; F. Bortoluzzi; R. Cappuccio; A. Vitalba P1064 SYNERGISTIC AND ADDITIVE EFFECTS OF MYRRH, CHAMOMILE AND COFFEE CHARCOAL – COMPONENTS OF A TRADITIONAL HERBAL MEDICINE ENHANCE ANTISPASMODIC AND CYTOKINE/CHEMOKINE-INHIBITING ACTIVITY OF THE HERBAL COMBINATION Cica Vissiennon, Germany; S. Paulo; D. Hammoud; K.-H. Goos; K. Nieber; J. Arnhold P1065 ARE TROUGH LEVELS OF ANTI-TNF DRUGS RELATED WITH TREATMENT FAILURE AND DURATION OF TREATMENT? J. González-López; Manuel Barreiro-de Acosta, Spain; C. Llamas; J. E. Dominguez-Muñoz; J. M. Giráldez-Montero; R. Ferreiro Iglesias; M. J. Lamas-Díaz P1066 IMMUNOSUPPRESSIVE CO-TREATMENT WITH INFLIXIMAB AND ADALIMUMAB IS NOT SUPERIOR TO ANTI-TNF MONOTHERAPY TO PREVENT TREATMENT FAILURE AND TREATMENT DISCONTINUATION IN ULCERATIVE COLITIS. S. Vieujean; E. Louis; Catherine Reenaers, Belgium P1067 EFFICACY AND SAFETY OF ADALIMUMAB AFTER INFLIXIMAB FAILURE IN PEDIATRIC ULCERATIVE COLITIS: A REAL-LIFE EXPERIENCE FROM THE SIGENP-IBD REGISTRY Marina Aloi, Italy; M. Bramuzzo; S. Arrigo; C. Romano; D. Iacorte; S. Gatti; M. T. Illiceto; F. Zucconi; D. Dilillo; G. Zuin; D. Knafelz; A. Ravelli; G. D'Arcangelo; P. Alvisi
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
Poster Session 09:00 – 17:00 Paediatric: Lower GI
Hall 7
Paediatric and adolescent IBD P1069 SUBCUTANEOUS USTEKINUMAB PROVIDED CLINICAL AND BIOLOGICAL BENEFIT FOR 9/12 REFRACTORY PEDIATRIC CROHN'S DISEASE Christine Martinez-Vinson, France; J.-P. Hugot; M. Bellaiche; J. Viala P1070 TROUGH LEVELS TO INFLIXIMAB AT W6 ARE PREDICTIVE OF REMISSION AT W14, IN PEDIATRIC CROHN DISEASE. Christine Martinez-Vinson, France; O. Courbette; C. Aupiais; J. Viala; J.-P. Hugot P1071 INFLIXIMAB INDUCED PSORIASIS IN A COHORT OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE : A 12 YEARS FOLLOW-UP STUDY. Christine Martinez-Vinson, France; O. Courbette; C. Aupiais; J. Viala; J.-P. Hugot P1072 PLATELET ABNORMALITIES AND ANEMIA IN PAEDIATRIC IBD: ARE THEY LINKED? Martina Votto, Italy; F. Viviano; F. Viola P1073 RELATIONSHIP BETWEEN CLINICAL COURSE OF ULCERATIVE COLITIS (UC) DURING PREGNANCY AND OUTCOMES OF PREGNANCY: A RETROSPECTIVE EVALUATION STUDY Ayumi Ito, Japan; O. Teppei; T. Katutishi P1074 USE OF STEROIDS IN ADULTS AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE IN THE BIOLOGICS ERA Ioanna Parisi, United Kingdom; L. Whitley; C. Murray; F. Kiparissi; F. Rahman; S. Mehta; E. Seward; D. Graham; H. Kwok; S. McCartney
P1075 REMISSION INDUCTION IN CORTICOSTEROID NAÏVE CHILDREN AND ADOLESCENTS WITH ULCERATIVE COLITIS BY ADSORPTIVE LEUCOCYTAPHERESIS AS MONOTHERAPY OR IN COMBINATION WITH A LOW DOSE PREDNISOLONE AFTER FAILURE OF FIRST-LINE MEDICATIONS Tomotaka Tanaka, Japan; M. Akagi; T. Iiboshi; H. Goishi; T. Kajihara; T. Miura P1076 EARLY SCREENING FOR INFLAMMATORY BOWEL DISEASE IN CHILDREN WITH AUTOIMMUNE LIVER DISEASE Dhamyanthi Thangarajah, United Kingdom; E. Cernat; B. Vadamalayan; D. Hadzic; M. Samyn P1077 CLINICAL AND LABORATORY VARIABLES THAT PREDICT CLINICAL AND ENDOSCOPIC REMISSION IN CHILDREN WITH CROHN’S DISEASE TREATED WITH INFLIXIMAB Giulia D'Arcangelo, Italy; S. Oliva; F. Tarani; F. Viola; F. Civitelli; S. Cucchiara; M. Aloi Poster Session 09:00 – 17:00 Other Lower GI Disorders II
Hall 7
Lower GI bleeding P1078 THALIDOMIDE FOR THE TREATMENT OF REFRACTORY GASTROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIAS Xia Wang, China; Q. Wang; H. Huang; W. Lu P1079 NEWLY DEVELOPED ENDOSCOPIC DETACHABLE SNARE LIGATION THERAPY FOR COLONIC DEVERTICULAR HEMORRHAGE: A MULTICENTER PHASE II TRIAL Katsumasa Kobayashi, Japan; T. Narasaka; D. Akutsu; M. Nishi; M. Wakayama; Y. Hiroshima; S. Endo; T. Mamiya; S. Hirai; K. Ikezawa; H. Ishida; M. Hirose; T. Yamada; H. Suzuki; T. Kaneko; Y. Mizokami; I. Hyodo P1080 RISK FACTORS FOR EARLY AND LATE RE-BLEEDING IN PATIENTS WITH COLONIC DIVERTICULAR BLEEDING Yoshinori Sato, Japan; H. Yasuda; S. Nakatsu; M. Yamashita; Y. Matsuo; H. Yamamoto; F. Itoh P1081 ACUTE LOWER GASTROINTESTINAL BLEEDING – IS NOBLADS THE ANSWER? Sofia Xavier, Portugal; J. Magalhães; J. Cotter P1082 COLORECTAL CANCERS (CRCS) DEPENDING ON THE SCREENING INTERVAL IN IBARAKI, JAPAN Yoko Saitoh, Japan; H. H. Suzuki; I. Hyodo
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
191
Tuesday, October 31, 2017
P1068 LOW FODMAP DIET IMPROVE DISEASE ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Giorgia Bodini, Italy; E. G. Giannini; V. Savarino; M. Crespi; S. Lo Pumo; C. Zanella; I. Baldissarro; E. Savarino
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P1083 ANALYSIS OF THE CONCENTRATION OF FIT FOR COLORECTAL CANCERS FROM THE SCREENING (2000-2014) IN IBARAKI, JAPAN Yoko Saitoh, Japan; I. Hyodo; H. Suzuki; M. Kaneko Lower GI malignant disease-epidemiology P1084 COLONOSCOPY SURVEILLANCE DETECTS A HIGH PREVALENCE OF ADVANCED COLORECTAL NEOPLASIA AND SERRATED POLYPOSIS SYNDROME IN HODGKIN LYMPHOMA SURVIVORS Lisanne Rigter, The Netherlands; M. C. W. Spaander; B. M. Aleman; T. M. Bisseling; L. M. G. Moons; A. Cats; P. J. Lugtenburg; C. P. Janus; E. J. Petersen; J. M. Roesink; R. W. van der Maazen; P. Snaebjornsson; E. J. Kuipers; M. J. Bruno; E. Dekker; G. A. Meijer; J. P. de Boer; F. E. van Leeuwen; M. E. van Leerdam
Tuesday, October 31, 2017
P1085 INCIDNCE OF PROSTATE CANCER IN COLORECTAL CANCER PATIENTS: NATIONWIDE RETROSPECTIVE COHORT STUDY Hyun Soo Kim, Republic of Korea; D. H. Lee; K. D. Han; D. W. Shin; Y. J. Choi; H. Yoon; N. Kim P1086 SITE AND STAGE DISTRIBUTION OF SCREEN DETECTED AND CLINICALLY DETECTED COLORECTAL CANCERS IN THE THE NETHERLANDS Esther Toes-Zoutendijk, The Netherlands; A. Kooyker; M. A. Elferink; V. Lemmens; M. E. van Leerdam; I. Lansdorp-Vogelaar P1087 LOCATION AND SEX PREDOMINANCE OF MISMATCH REPAIR DEFICIENT COLORECTAL CANCER IN IVORY COAST DIFFER FROM ITS EUROPEAN COUNTERPART Lucie Bienfait, Belgium; B. Doukoure; N. D'Haene; I. Salmon; P. Demetter; L. Verset P1088 ROUTINE MOLECULAR ANALYSIS FOR LYNCH SYNDROME IN PATIENTS WITH ADVANCED ADENOMA OR COLORECTAL CANCER WITHIN A NATIONAL SCREENING PROGRAM FOR COLORECTAL CANCER. Anne Goverde, The Netherlands; W. NM Dinjens; M. J. Bruno; R. M. W. Hofstra; M. Doukas; M. M. van der Weiden; H. J. Dubbink; A. Wagner; M. C. W. Spaander P1089 COLORECTAL CANCER SCREENING PROGRAMS AND THE RATE OF SURGICAL ONCOLOGY PROCEDURES IN THE VENETO REGION (ITALY): ARE FOLLOW-UP COLONOSCOPIES REALLY NEEDED? E. Rosa-Rizzotto; M. Saia; Diego Caroli, Italy; G. Ennio; B. Germaná; F. Monica; P. Pilati; F. De Lazzari 192
P1090 ETHNIC VARIATION IN ADENOMA DETECTION IN THE UK FLEXIBLE SIGMOIDOSCOPY BOWEL CANCER SCREENING PROGRAMME Dennis Lim, United Kingdom; S. Mellor; S. Szarvas-Jones; D. Bools; H. Whitsey; B. Miri; A. Mapiye; P. Wurm; R. J. Robinson Lower GI malignant disease, pathogenesis P1091 DEAD BOX POLYPEPTIDE 27 PROMOTES TUMORIGENICITY IN COLORECTAL CANCER THROUGH ACTIVATING NUCLEAR FACTOR KAPPA B PATHWAY AND ITS EXPRESSION IS ASSOCIATED WITH POOR SURVIVAL IN PATIENTS Huarong Chen, Hong Kong PRC; J. Tang; C. C. Wong; J. Fang; J. J. Y. Sung; J. Yu P1092 CLINICOPATHOLOGICAL STUDY OF SERRATED LESIONS OF THE COLORECTUM. Mikako Sugimura, Japan; M. Iwabuchi; K. Ukai P1093 IN SITU DETECTION OF MIGRATING COLORECTAL CANCER CELL-RELEASED LARGE EXTRACELLULAR EXOSOME CLUSTERS G. Valcz; E. I. Buzás; T. Krenács; Arpad V. Patai, Hungary; Á. Nagy; L. Homolya; G. Török; Z. Szállási; K. Dede; S. Spisák; Z. Tulassay; P. Igaz; B. Molnar P1094 ALTERED ARGININE METABOLISM IN HYPERPROLIFERATIVE INTESTINAL EPITHELIAL CELLS: A POTENTIAL ROLE IN TUMORIGENESIS AND WOUND HEALING. Jonathan van der Meer, The Netherlands; W. L. Smit; B. J. Meijer; C. N. Spaan; T. B. M. Hakvoort; M. A. Boermeester; G. R. van den Brink; V. Muncan P1095 ENHANCED COLONIC TUMORIGENESIS IN TLR4-DEFICIENT MICE IS ASSOCIATED TO IMPAIRMENT OF ANTIGEN PRESENTATION BY EPITHELIAL CELLS Melania Scarpa, Italy; I. Castagliuolo; C. Marchiori; S. Morgan; A. Kotsafti; P. BRUN; A. Porzionato; I. Angriman; C. Castoro; M. Scarpa P1096 ENDOSCOPIC FOLLOW UP CAN SELECT PATIENTS FOR MULTI-GENE TESTING IN ATTENUATED ADENOMATOUS POLYPOSIS WITH NO APC OR MUTYH IDENTIFIED MUTATIONS. Renato Cannizzaro, Italy; R. Magris; G. Cini; M. Quaia; S. Maiero; E. Canton; A. Viel; M. Fornasarig P1097 GLOBAL DNA HYPOMETHYLATION ALONG THE COLORECTAL NORMAL-ADENOMA-CANCER SEQUENCE Krisztina Szigeti, Hungary; O. Galamb; A. Kalmár; G. Valcz; E. Markus; Z. Tulassay; B. Wichmann; P. Igaz; B. Molnar
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Poster Sessions : UEG Week Final Programme
P1098 CIRCULATING MIRNA CHANGES IN HUMAN COLORECTAL CANCER DEVELOPMENT AND IN ANIMAL MODEL Zsofia Brigitta Nagy, Hungary; B. K. Bartak; A. Kalmár; B. Wichmann; O. Galamb; E. Markus; K. Szigeti; Á. Nagy; P. Igaz; Z. Tulassay; B. Molnar
P1105 ENDOSCOPIC OBSERVATIONS OF MICROSURFACE STRUCTURES MAY REFLECT MOLECULAR SUBCLONES IN COLORECTAL TUMORS Eiichiro Yamamoto, Japan; H. Aoki; H. Yamano; H. Suzuki; H. Nakase
P1099 RHOA: THE KEY SIGNALING PATHWAY OF MICRORNA-126 IN SUPPRESSING THE EPITHELIAL-MESENCHYMAL TRANSITION, PROLIFERATION, MIGRATION AND INVASION OF COLORECTAL CANCER CELLS M.-Y. Huang; W. Yuan; S. Wu; Zhaohua Shen, China; Z. Yang; Y. Quan; C. Zhu; K. Tang; X. Wang
P1106 THE DIAGNOSTIC VALUE OF HYPOXIA INDUCED EXOCELLULAR VESICLES IN COLORECTAL CANCER PATIENT PLASMA A. Abols; Daiga Santare, Latvia; R. Toleikiene; E. Zandberga; R. Vangravs; M. Takatalo-Laine; M. Palviainen; P. Siljander; M. Leja; A. Line
P1100 DNA METHYLATION CHANGES PRECEDE AND CONTRIBUTE TO SPORADIC MUTATIONS IN COLORECTAL ADENOMA AND CANCER DEVELOPMENT THROUGH INDUCED GENOMIC INSTABILITY Bela Molnar, Hungary; O. Galamb; B. Péterfia; B. Wichmann; A. Kalmár; Z. B. Nagy; B. K. Bartak; K. Szigeti; E. Markus; Z. Tulassay
P1107 THE GENESIS STUDY: GENETIC BIOPSY FOR PREDICTION OF SURVEILLANCE INTERVALS AFTER ENDOSCOPIC RESECTION OF COLONIC POLYPS A. W. Berger; K. Raedler; C. Langner; L. Ludwig; N. Dikopoulos; K. F. Becker; J. Slotta-Huspenina; M. Quante; D. Schwerdel; L. Perkhofer; A. Kleger; E. Zizer; F. Oswald; T. Seufferlein; Alexander Meining, Germany
P1101 MIR-126 REGULATES TUMOR GROWTH AND METASTASIS IN COLORECTAL CANCER BY RECRUITING TUMOR ASSOCIATED MACROPHAGES THROUGH PARACRINE SIGNALING OF CXCL12 Shuai Wu, China; Z. shen; M.-Y. Huang; W. Yuan; Y. Quan; C. Zhu; Z. Yang; X. Wang
P1108 QUANTITY, FRAGMENT LENGTH AND GLOBAL DNA METHYLATION LEVEL ALTERATIONS OF CIRCULATING CELL-FREE DNA IN COLORECTAL ADENOMA, CANCER AND INFLAMMATORY BOWEL DISEASES Eszter Markus, Hungary; A. Kalmár; O. Galamb; K. Szigeti; B. K. Bartak; Z. B. Nagy; B. Wichmann; Z. Tulassay; P. Igaz; B. Molnar
Lower GI malignant disease, diagnosis/histopathology P1102 THE EFFICACY OF NEXT-GENERATION OF IMAGE ENHANCED COLONOSCOPY (BLUE LASER IMAGING) IN THE DETECTION OF COLONIC LESIONS : A PILOT STUDY Ryo Shimoda, Japan; Y. Sakata; N. Tsuruoka; S. Shirai; T. Noda; H. Endo; K. Akutagawa; R. Iwakiri; K. Fujimoto P1103 COLORECTAL CANCER SCREENING COLONOSCOPY – ABSENT DISTAL POLYPS IN ADVANCED PROXIMAL NEOPLASIA Rajan Patel, United Kingdom; M. Hussein; L. Polak; A. Kumar; S. Samanta P1104 STUDIES ON CLINICOPATHOLOGICAL CHARACTERISTICS AND THE LONG-TERM PROGNOSIS OF DEPRESSED-TYPE COLORECTAL CARCINOMAS. Shinei Kudo, Japan; T. Kurata; K. Ichimasa; Y. Kouyama; S. Matsudaira; N. Toyoshima; Y. Mori; M. Misawa; N. Ogata; T. Kudo; T. Hisayuki; T. Hayashi; K. Wakamura; E. Hidaka; T. Baba; F. Ishida
Poster in the Spotlight
Poster of Excellence
P1109 ANALYSIS OF SFRP1, SFRP2, SDC2 AND PRIMA1 PROMOTER METHYLATION IN CELL-FREE PLASMA DNA FOR NON-INVASIVE DETECTION OF COLORECTAL ADENOMA AND CANCER Barbara Kinga Bartak, Hungary; A. Kalmár; B. Péterfia; A. V. Patai; O. Galamb; G. Valcz; B. Wichmann; Z. B. Nagy; E. Markus; K. Szigeti; Á. Nagy; Z. Tulassay; P. Igaz; B. Molnar P1110 URINE-NMR METABOLOMICS FOR SCREENING OF ADVANCED COLORECTAL ADENOMA AND EARLY STAGE COLORECTAL CANCER Eun-Ran Kim, Republic of Korea; H. N. Kwon; S. H. Kim; N. Y. Paik; S.-N. Hong; T. J. Kim; D. K. Chang; J. J. Kim; S. H. Park; Y.-H. Kim P1111 VALIDATION OF THE UTILITY OF A FAECAL IMMUNOCHEMICAL TEST FOR HAEMOGLOBIN (FIT) IN PATIENTS PRESENTING TO PRIMARY CARE WITH NEW BOWEL SYMPTOMS Jayne Digby, United Kingdom; J. A. Strachan; C. G. Fraser; R. Steele; C. Mowat
Clinical Case Session
193
Tuesday, October 31, 2017
Tuesday, October 31, 2017
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P1112 NEW FECAL IMMUNOASSAY TEST (FIT) FOR THE COLORECTAL CANCER SCREENING IN ILE DE FRANCE: IMPACT OF AGE, GENDER AND HEMOGLOBIN LEVEL S. Bercier; A. Liautaud; A. Kaufmanis; C. Vincelet; A. Bernoux; H. Aithadad; H. Delattre; G. Lemab; A. Koivogui; T. Letrung; Z. Brixie; Iradj Sobhani, France Lower GI malignant disease, management P1113 ARTIFICIAL INTELLIGENCE CAN PREDICT THE PRESENCE OF LYMPH NODE METASTASIS IN T1 COLORECTAL CANCER Katsuro Ichimasa, Japan; S.-E. Kudo; Y. Mori; M. Misawa; S. Matsudaira; Y. Kouyama; T. Baba; K. Wakamura; T. Hayashi; T. Hisayuki; T. Kudo; N. Toyoshima; H. Nakamura; T. Ishigaki; Y. Yagawa; K. Takeda; Y. Maeda; Y. Ogawa; S. Hamatani; H. Miyachi; F. Ishida P1114 RISK FACTORS OF ADVANCED METACHRONOUS NEOPLASM IN COLONOSCOPIC SURVEILLANCE AFTER COLON CANCER RESECTION Kwangwoo Nam, Republic of Korea; J. E. Shin; K. B. Bang; H. D. Shin; H. Namgung; D. G. Park Tuesday, October 31, 2017
P1115 PROSPECTIVE COMPARISON OF THE NOVEL FULL SPECTRUM ENDOSCOPY (FUSE) AND ADVANCED HIGH DEFINITION-WHITE LIGHT ENDOSCOPY FOR DETECTION OF POLYPS IN ROUTINE PRACTICE Alvaro Martinez- Alcala García, Spain; F. J. Martínez-Alcala; C. Martínez- Alcalá; K. Thakar; R. Madero; K. Mönkemüller; F. Martínez Alcalá P1116 UNDERWATER ENDOSCOPIC MUCOSAL RESECTION FOR NON-PENDULATED COLORECTAL LESIONS. IS THE DISTAL CAP REALLY NECESSARY? L. H. Lenz Tolentino; Caterina Pennacchi, Brazil; J. F. de Oliveira; E. Q. Mendonça; M. Minata; E. Gonzalez; G. de Paulo; S. Geiger; M. Sorbello; M. Simas de Lima; F. Kawaguti; B. D. C. Martins; E. R. Baba; A. V. Safatle-Ribeiro; C. C. Gusmon; R. Uemura; A. Tellian; F. Rolim; C. Hashimoto; U. Ribeiro Jr.; F. Maluf-Filho P1117 ADENOMA DETECTION RATE INFLUENCES RISK PREDICTION OF METACHRONOUS ADVANCED COLORECTAL NEOPLASIA IN LOW-RISK PATIENTS Sun Hwa Kim, Republic of Korea; S. J. Lee; T. J. Kim; E. R. Kim; S. N. Hong; D. K. Chang; Y.-H. Kim P1118 EXPERIENCE OF PER ANAL ENDOSCOPIC MYECTOMY (PAEM) Takashi Toyonaga, Japan; Y. Ohara; S. Tanaka; H. Takihara; S. Baba; F. Kawara; T. Ishida; Y. Morita; E. Umegaki 194
P1119 LOCAL RECURRENCE AFTER ENDOSCOPIC MUCOSAL RESECTION FOR HIGH-RISK LESIONS: MAY WE BETTER PLAN THE ENDOSCOPIC FOLLOW-UP ACCORDING TO PROCEDURAL, MORPHOLOGICAL AND HISTOLOGICAL CHARACTERISTICS? Cinzia Quondamcarlo, Italy; C. Lucidi; R. Lapenta P1120 TREATMENT STRATEGY FOR LOCAL RECURRENCES AFTER ENDOSCOPIC RESECTION OF COLORECTAL NEOPLASMS Sayo Ito, Japan; K. Hotta; K. Imai; Y. Yamaguchi; Y. Kishida; K. Takizawa; N. Kakushima; M. Tanaka; N. Kawata; M. Yoshida; H. ishiwatari; H. Matsubayashi; H. Ono P1121 A COMPARATIVE STUDY ON EFFICACY OF CHEMOTHERAPY AFTER ENDOSCOPIC COLONIC STENTING VS. THAT AFTER COLONIC SURGERY IN THE MANAGEMENT OF OBSTRUCTIVE COLORECTAL CANCER Norihiro Hanabata, Japan; Y. Sasaki; K. Kanazawa; S. Igarashi; K. Hasui; K. Shimaya; H. Numao; M. Munakata; S. Fukuda P1122 A NEW MANEUVER TO PLACE A THROUGH-THE-SCOPE STENT IN A MALIGNANT COLONIC STRICTURE INACCESSIBLE WITH A STANDARD-CALIBER COLONOSCOPE: "OVER-THE-CATHETER" COLONOSCOPE REPLACEMENT TECHNIQUE Yoichiro Iboshi, Japan; Y. Sumida; N. Harada; H. Tsuru; M. Tomonori; M. Wada; T. Osoegawa; M. Nakamuta; E. Ihara P1123 RESULT OF THE FIRST ROUND OF THE COLORECTAL CANCER SCREENING PROGRAMME IN THE BALEARIC ISLANDS (SPAIN) Monica Florido, Spain; M. Novella; M. Heredia; E. Miro; C. Sanchez-Contador; J. Gelabert; S. P. Ortega; E. Y. Iyo; J. Reyes; P. Garcia-Cortes; J. A. Lucero; Z. Salman; C. Rodriguez; A. Ruiz; M. J. Garcia IBS/Lower GI motility: Transmitters/signals/receptors/ enteric nervous system P1124 ADVANCED GLYCATION END PRODUCTS IMPAIR CA2+ HANDLING IN COLON SMOOTH MUSCLE CELLS VIA CAMP/PKA PATHWAY Ting Yu, China; L. Lin P1125 ENTEROENDOCRINE, MUSASHI 1, AND NEUROGENIN 3 CELLS IN THE LARGE INTESTINE OF THAI PATIENTS WITH IRRITABLE BOWEL SYNDROME Magdy El-Salhy, Norway; T. Patcharatrakul; J. G. Hatlebakk; T. Hausken; O. H. Gilja; S. Gonlachanvit
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P1127 IBEROGAST PREVENTS CHANGES IN INTESTINAL PERMEABILITY INDUCED BY PSYCHOLOGICAL STRESS IN MICE. P. Aubert; J. Chevalier; T. Durand; A. Bessard; O. Kelber; H. Abdel-Aziz; Michel Neunlist, France P1128 WITHDRAWN P1129 ALTERING SPHINGOSINE-1-PHOSPHATE WITH AGING INDUCES MOTILITY DYSFUNCTION OF COLON SMOOTH MUSCLE BY BKCA UPREGULATION IN RATS Shen Xiaoxue, China P1130 DIABETES-RELATED ALTERATIONS IN THE EXPRESSION OF THE INFLAMMATORY CYTOKINES, TUMOR NECROSIS FACTOR ALPHA AND INTERLEUKIN 6 IN THE MYENTERIC GANGLIA AND ITS MICROENVIRONMENT OF DIFFERENT INTESTINAL SEGMENTS Lalitha Chandrakumar, Hungary; D. Mezei; B. P. Barta; Z. Szalai; N. Bódi; M. Bagyánszki P1131 ROLE OF SEMAPHORIN 3A IN THE POSTNATAL DEVELOPMENT OF THE ENTERIC NERVOUS SYSTEM Jacques Gonzales, France; C. Le Berre; E. Dikkongue; M. Neunlist; H. Boudin Lower GI motility disorders: Clinical P1132 A POPULATION-BASED STUDY ON BOWEL HABITS IN A PORTUGUESE COMMUNITY: PREVALENCE OF CONSTIPATION Marco Silva, Portugal; S. Gomes; J. Silva; M. Fazendeiro; M. Ribeiro; A. Peixoto; R. Gaspar; R. Morais; J. A. Sarmento; G. Macedo P1133 DIAGNOSTIC DISCORDANCE BETWEEN TESTS OF EVACUATION : A PROSPECTIVE STUDY Dan Carter, Israel; E. Bardan; M. Beer-Gabel P1134 DIAGNOSTIC USE OF ENDOSCOPIC FULL-THICKNESS WALL RESECTION (EFTR) IN PATIENTS WITH SYMPTOMS OF CHRONIC INTESTINAL PSEUDO-OBSTRUCTION (CIPO) Piero V Valli, Switzerland; D. Pohl; M. Fried; R. Caduff; P. Bauerfeind Poster in the Spotlight
Poster of Excellence
P1135 TRANS-ABDOMINAL INTERFERENTIAL ELECTRICAL STIMULATION IS EFFECTIVE IN MANAGING REFRACTORY LOWER GASTROINTESTINAL DYSMOTILITY DISORDERS. Judith Moore, Australia; P. R. Gibson; R. E. Burgell P1136 YH12852, A NOVEL AND HIGHLY SELECTIVE 5-HYDROXYTRYPTAMINE 4 RECEPTOR AGONIST, INCREASES STOOL FREQUENCY IN HEALTHY VOLUNTEERS AND PATIENTS WITH FUNCTIONAL CONSTIPATION: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO/ACTIVE-CONTROLLED PHASE 1/2A TRIAL S. J. Moon; H. G. Yoo; Seoungoh Lee, Republic of Korea; S. B. Jang; M. K. Kim; H. Na; H. Lee P1137 HEALTHCARE PROFESSIONALS FAIL TO PROVIDE ADEQUATE COUNSELLING AND SUPPORT ABOUT OPIOID-INDUCED CONSTIPATION TO STRONG-OPIOID USERS Viola Andresen, Germany; V. Banerji; G. Hall; A. Lass; A. V. Emmanuel P1138 THREE-DIMENSIONAL HIGH-RESOLUTION ANORECTAL MANOMETRY IN CHILDREN AFTER SURGERY FOR ANORECTAL DISORDERS Marcin Banasiuk, Poland; A. Banaszkiewicz; M. Dziekiewicz; A. Kamiński; P. Albrecht Irritable bowel syndrome: Treatment P1139 UK CLINICAL EXPERIENCE AT 52 WEEKS WITH LINACLOTIDE FOR IRRITABLE BOWEL SYNDROME WITH CONSTIPATION Anton Emmanuel, United Kingdom; J. McLaughlin; Y. Yiannakou; S. McLain-Smith P1140 EFFECT OF FAECAL MICROBIOTA TRANSPLANTATION ON GUT BACTERIAL FERMENTATION PRODUCTS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME Tarek Mazzawi, Norway; J. Valeur; T. Hausken; M. El-Salhy; J. G. Hatlebakk; G. A. Lied P1141 HEALTHCARE RESOURCE USE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA BASED ON A SURVEY OF PHYSICIANS IN THE UNITED KINGDOM Anne Marciniak, United Kingdom; D. Collomb; S. Baker; R. Goosey
Clinical Case Session
195
Tuesday, October 31, 2017
P1126 SUBJECT GLOBAL SATISFACTION SCORE TO ASSESS OVERALL EFFECT OF NALDEMEDINE COMPARED WITH PLACEBO ON CONSTIPATION AND ABDOMINAL SYMPTOMS IN SUBJECTS WITH CHRONIC NON-CANCER PAIN AND OPIOID-INDUCED CONSTIPATION Jan Tack, Belgium; M. Camilleri; B. Cai; T. Yamada; J. C. Arjona Ferreira
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P1142 RANDOMISED PLACEBO CONTROLLED ESCITALOPRAM INTERVENTION IN IBS WITH PANIC DISORDER: EVALUATION BY GSRS AND BY EXPERIENCE SAMPLING METHOD Lisa Vork, The Netherlands; M. Drukker; Z. Mujagic; D. Keszthelyi; J. van Os; A. A. M. Masclee; C. Leue; J. Kruimel P1143 LINACLOTIDE ACCELERATES COLONIC TRANSIT AND IMPROVES COLONIC CONTRACTILITY IN IBS WITH CONSTIPATION Adam Farmer, United Kingdom; A. R. Hobson P1144 RELATIONSHIP BETWEEN RIFAXIMIN THERAPY AND SEHCAT TEST IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME OR FUNCTIONAL DIARRHEA. Alexandra Ruiz Cerulla, Spain; S. Maisterra; C. Arajol; P. Gilabert; K. Serra; O. Puig; P. Notta; F. Rodriguez-Moranta; L. Rodriguez-Alonso; E. Sanchez-Pastor; J. Guardiola
Ano-rectal disorders other than IBD or motility-related P1150 A SYSTEMATIC REVIEW AND META-ANALYSIS TO DETERMINE WHETHER BALLOON EXPULSION TESTING MIGHT BE AN APPROPRIATE INITIAL OFFICE-BASED TEST FOR DYSSYNERGIC DEFECATION Eric Shah, USA; J. Farida; W. D. Chey P1151 PREVALENCE OF ANAL SQUAMOUS INTRAEPITHELIAL LESIONS IN LIVER TRANSPLANTED PATIENTS. Andreia Albuquerque, Portugal; H. Pessegueiro Miranda; J. Lopes; J. Gandara; S. Rodrigues; R. Gaspar; R. Morais; R. Ramalho; E. Rodrigues-Pinto; H. Cardoso; H. Barroca; C. Camila Dias; F. Carneiro; G. Macedo Poster Session 09:00 – 17:00 Hall 7 Oesophageal, Gastric and Duodenal Disorders II Immunity and inflammation (not H. pylori)
Tuesday, October 31, 2017
P1145 FECAL MICROBIOTA TRANSPLANTATION FOR PATIENTS WITH POST-INFECTIOUS OR ANTIBIOTIC-INDUCED IRRITABLE BOWEL SYNDROME: RESULTS FROM A PROSPECTIVE PILOT STUDY Yvette van Beurden, The Netherlands; A. E. Budding; E. M. Terveer; J. J. Keller; E. J. Kuijper; C. M. J. E. Vandenbroucke-Grauls; C. J. J. Mulder
P1152 IMMUNOHISTOCHEMICAL EXPRESSION OF DIAMINE OXIDASE IN THE UPPER GASTROINTESTINAL TRACT OF PATIENTS WITH GASTROINTESTINALLY MEDIATED FOOD ALLERGY Thomas Vasilakis, Germany; R. J. Rieker; J. Heinrich; A. Missbichler; A. F. Hagel; J. Kressel; M. Raithel
P1146 CONSECUTIVE WEEKS OF INADEQUATE RELIEF: A POST HOC ANALYSIS OF THE POOLED ELUXADOLINE PHASE 3 STUDIES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME D. Collomb; A. Marciniak; Y. Mo; D. A. Andrae; Gwen Wiseman, United Kingdom
P1153 PREVALENCE OF ATROPHIC GASTRITIS IN GENERAL POPULATION: A GASTROPANEL®- BASED STUDY, COMPARED WITH OLGA HISTOLOGICAL CLASSIFICATION Francesco Di Mario, Italy; S. Grillo; S. Cesario; C. Miraglia; S. Scida; S. Landi; P. Crafa; R. Cannizzaro; G. grande; V. Corrente; M. Franceschi; M. Riccò; L. Franzoni; C. Scarpignato; M. Rugge
P1147 CLINICAL RESPONSE AND DISCONTINUATION OVER TIME IN PHASE 3 TRIALS OF ELUXADOLINE FOR IRRITABLE BOWEL SYNDROME WITH DIARRHOEA Anne Marciniak, United Kingdom; R. T. Carson; J. L. Abel; D. A. Andrae; K. Fust; D. Becker P1148 THE LOW FODMAP DIET REDUCES CAECAL FERMENTATION COMPARED TO TRADITIONAL DIETARY ADVICE: A RANDOMISED CONTROLLED TRIAL Adam Farmer, United Kingdom; N. Saini; A. R. Hobson P1149 ORAL A-GALACTOSIDASE IMPROVES GASTROINTESTINAL TOLERANCE TO A DIET HIGH IN GALACTO-OLIGOSACCHARIDES: ADJUNCT THERAPY TO A LOW FODMAP DIET IN IRRITABLE BOWEL SYNDROME Caroline Tuck, Australia; K. M. Taylor; J. S. Barrett; P. R. Gibson; J. G. Muir 196
P1154 IMPROVEMENT OF SYMPTOMS IN PATIENTS AFFECTED BY CHRONIC ATROPHIC GASTRITIS: A TWO-YEAR PROSPECTIVE STUDY BY USING L-CYSTEINE G. Masciangelo; L. Franzoni; C. Miraglia; P. Crafa; S. Scida; M. Franceschi; R. Cannizzaro; N. Dal Bò; C. Scarpignato; M. Rugge; Francesco Di Mario, Italy P1155 PROGNOSTIC SIGNIFICANCE OF SERUM INFLAMMATORY MARKERS IN GASTRIC CANCER Arfon Powell, United Kingdom; D. Parkinson; N. Patel; C. Brown; W. Lewis
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P1156 ANALYSIS OF REBLEEDING PATIENTS IN UPPER GASTROINTESTINAL BLEEDING IN A SINGLE CENTER SERIES R. Jiménez-Rosales; E. Ortega-Suazo; P. Abellán-Alfocea; F. Valverde López; J. G. Martinez-Cara; Eduardo Redondo Cerezo, Spain P1157 A CASE-CONTROL STUDY ON THE RISK OF UPPER GASTROINTESTINAL MUCOSAL INJURIES IN SUBJECTS PRESCRIBED NSAIDS AND ANTI-THROMBOTIC DRUGS USING THE LARGE ORGANIZED DATABASE OF CLAIMS IN JAPAN (APPROXIMATELY 3.7 MILLION OF POPULATION ON AN ACCUMULATED BASIS) Nobuyuki Sugisaki, Japan; R. Iwakiri; K. Fujimoto P1158 GASTROINTESTINAL BLEEDING UNDER ANTICOAGULATION THERAPY: SYSTEMATIC REVIEW OF THE REBLEEDING RISK, ITS REVERSIBILITY PROFILE AND RISK STRATIFICATION TO SELECT PATIENTS FOR LEFT ATRIAL APPENDAGE OCCLUSION. Alia Hadefi, Belgium; A. Aminian; A. Bondue; J. Devière; A. Lemmers P1159 AN AUDIT INTO THE MANAGEMENT OF BLEEDING PEPTIC ULCER DISEASE Keith Siau, United Kingdom; A. Vijayasingam P1160 COMPARISON OF SCORING SYSTEMS FOR NON-VARICEAL UPPER GI BLEEDING; FOCUS ON THE SIMPLE PREDICTION SYSTEM, AIMS65 Min Seong Kim, Republic of Korea; J. Choi; W. C. Shin P1161 COMPARISON OF RISK-SCORING SYSTEMS IN PREDICTING NEEDS OF INTERVENTION AND CLINICAL OUTCOMES OF UPPER GASTROINTESTINAL BLEEDING Marie Ooi, Australia; W. Low; R. Bryant; N. Q. Nguyen P1162 STEROID ADMINISTRATION IS AN INDEPENDENT RISK FACTOR FOR REBLEEDING IN HEMORRHAGIC DUODENAL ULCER WITH A DOSE-RESPONSE RELATION Waku Hatta, Japan; Y. Kondo; T. Koike; T. Kanno; N. Ara; K. Asanuma; N. Asano; A. Imatani; T. Shimosegawa P1163 EFFICACY AND SAFETY OF BIO-INSERT MINERAL SMECTITE IN CONTROLLING GASTROINTESTINAL HEMORRHAGE: AN ANIMAL PILOT STUDY J. Wang; L. Zhao; M. Wang; L. Liu; Z. Fan; Xiang Wang, China
Poster in the Spotlight
Poster of Excellence
P1164 PREDICTORS OF LIFE THREATENING MUCOSAL ULCERATION AFTER VARICEAL SCLEROTHERAPY Amr Hanafy, Egypt Community dyspepsia P1165 IMPACT OF SLEEP DISORDER IN PATIENTS WITH FUNCTIONAL DYSPEPSIA Kyuchan Huh, Republic of Korea; J. K. Park; K. W. Jung; C. M. Shin; J. W. Kim P1166 PREVALENCE OF DYSPEPSIA IN INDIVIDUALS WITH GASTRO-OESOPHAGEAL REFLUX-TYPE SYMPTOMS IN THE COMMUNITY: A META-ANALYSIS L. H. Eusebi; Ragu Prakash Ratnakumaran, United Kingdom; M. L. Artesiani; F. Bazzoli; A. C. Ford Upper GI nerve-gut and motility: Brain-gut and gutbrain axes, neuro-hormonal, neural-immune and visceral sensitivity P1167 PSYCHOSOCIAL PREDICTORS OF LATER GASTROINTESTINAL SYMPTOMS Michael P. Jones, Australia; N. Koloski; L. Van Oudenhove; A. Ejova; N. J. Talley P1168 AN INCREASED PREVALANCE OF NEURODEGENERATIVE/DEMYELINATING PROCESS IN PATIENTS WITH ESOPHAGEAL ACHALASIA – A PROSPECTIVE STUDY Martin Jerie, Czech Republic; Z. Vackova; H. Svecová; E. Meluzinova; J. Krajciova; Z. Vojtech; J. Spicak; J. Vymazal; J. Martinek P1169 HIGH RESTING PARASYMPATHETIC CARDIAC VAGAL TONE CONFERS A UNIQUE FUNCTIONAL BRAIN NETWORK DURING ACUTE OESOPHAGEAL PAIN James Ruffle, United Kingdom; S. J. Coen; V. Giampietro; S. C. R. Williams; A. D. Farmer; Q. Aziz Upper GI motility disorders: Clinical P1170 RAPID DRINK CHALLENGE (RDC) TEST DURING OESOPHAGEAL HIGH RESOLUTION MANOMETRY (HRM) IN PATIENTS WITH OESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTION Dario Biasutto, France; F. Mion; A. Garros; S. Roman P1171 ª THE NORMATIVE VALUES OF A NEW 36 CHANNELS WATER PERFUSION ESOPHAGEAL MOTILITY CATHETER S. Bor; Sezgi Kipcak, Turkey
Clinical Case Session
197
Tuesday, October 31, 2017
Upper GI and small intestinal bleeding
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P1172 LOW-VOLUME MULTIPLE RAPID SWALLOW BETTER DISTINGUISH PERISTALTIC ESOPHAGEAL RESERVE COMPARED TO HIGH-VOLUME RAPID DRINKING TEST Irene Martinucci, Italy; N. de Bortoli; S. Tolone; M. Furnari; M. Frazzoni; L. Frazzoni; L. Fuccio; M. Bellini; V. Savarino; R. Penagini; S. Marchi; E. Savarino P1173 HIGH-VOLUME RAPID DRINKING TEST BETTER DISTINGUSH ESOPHAGEAL BODY INHIBITION COMPARED TO LOW-VOLUME MULTIPLE RAPID SWALLOWS Irene Martinucci, Italy; N. de Bortoli; S. Tolone; M. Furnari; M. Frazzoni; L. Frazzoni; L. Fuccio; M. Bellini; V. Savarino; R. Penagini; S. Marchi; E. Savarino P1174 ESOPHAGEAL BOLUS FLOW METRICS ON PRESSURE FLOW ANALYSIS (PFA) OF ESOPHAGEAL HIGH RESOLUTION IMPEDANCE MANOMETRY (HRIM) IN GASTROESOPHAGEAL REFLUX DISEASE (GERD) Stephen Hasak, USA; A. Manolakis; R. Badillo; A. Ding; A. Pauwels; J. Tack; N. Rommel; T. Omari; C. P. Gyawali Tuesday, October 31, 2017
P1175 PROVOCATIVE TESTING INCREASES THE DIAGNOSTIC YIELD OF HIGH RESOLUTION OESOPHAGEAL MANOMETRY IN PATIENTS WITH OESOPHAGEAL DIVERTICULA. Fabien Wuestenberghs, Belgium; C. A. Melchior; A. M. Leroi; G. Gourcerol P1176 EVALUATION OF ESOPHAGOGASTRIC JUNCTION CONTRACTILITY AFTER DIFFERENT TREATMENTS FOR ACHALASIA Salvatore Tolone, Italy; E. Savarino; N. de Bortoli; M. Frazzoni; M. Furnari; L. Frazzoni; V. Savarino; L. Docimo; L. Swanström P1177 MULTIPLE RAPID SWALLOWING IN JACKHAMMER ESOPHAGUS PATIENTS: EVIDENCE FOR ALTERED NEURAL CONTROL. Aurelio Mauro, Italy; S. Tolone; E. Savarino; N. de Bortoli; M. Franchina; R. Penagini Functional upper GI disorders: Clinical P1178 GASTRIC PERORAL ENDOSCOPIC MYOTOMY (G-POEM) AS TREATMENT FOR FUNCTIONAL DELAYED GASTRIC EMPTYING: INITIAL ASIAN EXPERIENCE Mingyan Cai, China; J. Xu; P.-H. Zhou P1179 EFFECTIVENESS OF CAP-ASSISTED DEVICE IN THE ENDOSCOPIC MANAGEMENT OF FOOD BOLUS OBSTRUCTION IN THE UPPER ESOPHAGUS. Marie Ooi, Australia; E. J. Young; N. Q. Nguyen 198
P1180 DO THE ENDOSCOPIC FINDINGS OF GASTRITIS BRING THE FD SYMPTOMS? Yuji Shimada, Japan; S. Sato; K. tomishima; Y. Kanemitsu; H. Tsuzura; A. Murata; N. Amano; S. Sato; T. Genda; K. Iijima; M. Kusano; A. Nagahara P1181 IMPACT OF EPIGASTRIC PAIN SYNDROME ACCOMPANYING PANCREATIC ENZYME ABNORMALITIES EXHIBITED RAPID EARLY PHASE OF GASTRIC EMPTYING AND EARLY CHRONIC PANCREATITIS USING ENDOSONOGRAPHY Kumiko Kirita, Japan; S. Futagami; S. Agawa; G. Ikeda; H. Noda; K. Higuchi; T. Akimoto; Y. Maruki; H. Yamawaki; Y. Kodaka; N. Ueki; T. Kawagoe; K. Iwakiri P1182 ENDOSCOPIC AUTOLOGOUS TRANSPLANTATION OF ESOPHAGEAL MUCOSA FOR TREATING THE REFRACTORY CAUSTIC ESOPHAGEAL STRICTURE K. He; L. Zhao; S. Bu; L. Liu; M. Wang; X. Wang; Zhining Fan, China P1183 FUNCTIONAL DYSPEPSIA IS STRONGLY ASSOCIATED WITH OBSTRUCTIVE SLEEP APNOEA – A CASE CONTROL STUDY Rashid Lui, Hong Kong PRC; P. Cheong; C. K. Cheung; Y. Chan; K. Yuen; F. Fang; J. C. Wu P1184 INDIVIDUAL ASSESSMENT OF GASTRIC ACID PRODUCTION BY MEANS OF A NON-INVASIVE TEST: RELATIONSHIP BETWEEN MAXIMAL ACID OUTPUT AND PEPSINOGEN I LEVELS F. Di Mario; S. Scida; Chiara Miraglia, Italy; L. Franzoni; M. Franceschi; A. Bertelè; R. Cannizzaro; N. Dal Bò; E. Savarino; N. de Bortoli; M. Rugge; C. Scarpignato Reflux disease, epidemiology P1185 THE DISCREPANCY BETWEEN THE ACID REGURGITATION SYMPTOMS AND ENDOSCOPIC GERD GRADE IN DIABETES MELLITUS PATIENTS. Kosuke Sakitani, Japan; N. Suzuki P1186 SARCOPENIA AS A LEADING RISK FACTOR FOR EROSIVE ESOPHAGITIS: A LARGE-SCALE CROSS-SECTIONAL STUDY Taewan Kim, Republic of Korea; T. J. Kim; H. Lee; J. J. Kim P1187 FOOD RATE (FREQUENCY AND TIME SPENT IN EATING) IN PATIENTS WITH MORBID OBESITY. DIFFERENCES AND SIMILARITIES BETWEEN MEN AND WOMEN. J. Perez de la Serna; A. Ruiz de León; Sonia Ayllón Cano, Spain; C. Sevilla Mantilla; A. Sánchez Pernaute; E. Rey; B. Merchan Gomez
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
Reflux disease, pathogenesis P1189 THE INFLUENCES OF VISCERAL FAT AREA ON THE SITES OF ESOPHAGEAL MUCOSAL BREAKS AND SYMPTOM SEVERITIES IN SUBJECTS WITH GASTROESOPHAGEAL REFLUX DISEASES E. Cho; Jae Hak Kim, Republic of Korea P1190 A LESS COMPETENT OESOPHAGO-GASTRIC JUNCTION IS ASSOCIATED WITH OESOPHAGEAL ACID HYPERSENSITIVITY EVEN IN HEALTHY CONTROLS Christian Lottrup, Denmark; A. L. Krarup; P. Ejstrud; B. P. McMahon; A. M. Drewes P1191 THE MUCOSAL INTEGRITY IN PHENOTYPES OF GASTROESOPHAGEAL REFLUX DISEASE AND FUNCTIONAL HEARTBURN Pelin Ergun, Turkey; S. Kipcak; S. Bor P1192 PEPSIN AND PH LEVELS OF HUMAN GASTRIC JUICES IN GASTROESOPHAGEAL REFLUX DISEASE SUBGROUPS AND FUNCTIONAL HEARTBURN Pelin Ergun, Turkey; S. Kipcak; P. Dettmar; A. Woodcock; S. Bor P1193 NON INVASIVE DIAGNOSIS OF UPPER GI DISEASES IN A PRIMARY CARE SETTING: A STUDY ON 1,900 PATIENTS F. Di Mario; S. Cesario; Simone Grillo, Italy; S. Landi; G. Baldassarre; R. Cannizzaro; P. Crafa; M. Riccò; L. Franzoni; C. Miraglia; S. Scida; C. Scarpignato; M. Rugge; M. F. Roberti P1194 CHANGES IN ANTHROPOMETRIC AND METABOLIC PARAMETERS RELATED TO GASTROESOPHAGEAL REFLUX DISEASE IN NON-OBESE CASES S. Yavuz; Özlem Gül Utku, Turkey; A. Gungunes; N. Dindar Badem; B. Ergul; D. Oğuz Reflux disease, diagnosis P1195 PROXIMAL ESOPHAGEAL BASELINE IMPEDANCE LEVELS ARE ABLE TO DISCRIMINATE BETWEEN SCLERODERMA PATIENTS WITH AND WITHOUT ESOPHAGEAL INVOLVEMENT Marco Della Coletta, Italy; P. Zentilin; E. Marabotto; S. Tolone; N. de Bortoli; G. Bodini; V. Savarino; E. Savarino Poster in the Spotlight
Poster of Excellence
P1196 GASTRIN-17 AS A NON-INVASIVE MARKER OF EARLY GERD RELAPSE: A PROSPECTIVE ONE-YEAR STUDY Francesco Di Mario, Italy; S. Speroni; S. Scida; C. Miraglia; V. Corrente; M. Franceschi; E. Savarino; N. de Bortoli; A. Tursi; G. Brandimarte; L. Franzoni; C. Scarpignato P1197 THE DIAGNOSTIC VALUE OF ESOPHAGEAL MUCOSAL AND BASELINE IMPEDANCE MEASUREMENTS IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE Sezgi Kipcak, Turkey; P. Ergun; S. Bor P1198 ENDOSCOPIC-HISTOPATHOLOGIC ESOPHAGEAL FINDINGS IN ATROPHIC BODY GASTRITIS PATIENTS WITH GASTRO-ESOPHAGEAL REFLUX SYMPTOMS Marilia Carabotti, Italy; G. Esposito; E. Lahner; E. Pilozzi; G. Galli; G. Ranazzi; E. Di Giulio; B. Annibale P1199 CLINICAL PRESENTATION RISK FACTORS AND ENDOSCOPICAL FEATURES IN GERD: A COMPARATIVE STUDY BETWEEN GERD AND DYSPEPTIC SUBJECTS ON A SAMPLE OF 2300 PEOPLE IN A PRIMARY CARE SETTING Francesco Di Mario, Italy; T. B. Tene Fokam; S. Landi; S. Cesario; S. Grillo; S. Scida; C. Miraglia; E. Savarino; N. de Bortoli; L. Franzoni; G. grande; C. Scarpignato Reflux disease, treatment P1200 REAL-WORLD RESPONSE OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE TO EMPIRICAL TREATMENT WITH PROTON PUMP INHIBITORS: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY IN CHINA B. Lu; L. Zhang; J. Wang; B. Wang; X. Zou; J. Qian; D. Chen; X. Wang; B. Wu; Duowu Zou, China P1201 WIRELESS ELECTRICAL STIMULATION FOR MANAGING GASTROESOPHAGEAL REFLUX DISEASE IN THE RABBIT MODEL M. Wang; L. Zhao; L. Liu; X. Wang; Zhining Fan, China P1202 SYSTEMATIC REVIEW AND META-ANALYSIS OF OUTCOMES AFTER LAPAROSCOPIC ANTI-REFLUX SURGERY RELATED TO OBESITY Tarig Abdelrahman, United Kingdom; A. Latif; D. Chan; N. Patel; C. Brown; W. Lewis; T. Havard; X. Escofet P1203 GASTROESOPHAGEAL REFLUX DISEASE REFRACTORY TO PROTON PUMP INHIBITOR THERAPY. INCOMPLETE ACID INHIBITION OR DIAGNOSTIC ERROR? Julio Perez de la Serna, Spain; A. Ruiz de León; C. Sevilla Mantilla; A. Zataraín Valles; O. N. López García; E. Rey; B. Merchan Gomez
Clinical Case Session
199
Tuesday, October 31, 2017
P1188 ONE DRINK CAN INCREASE A RISK FOR ESOPHAGEAL, STOMACH AND COLORECTAL CANCER IN A COHORT OF 23,323,730 KOREAN ADULTS Yoon Jin Choi, Republic of Korea; D. H. Lee
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P1204 LOW-FODMAP DIET RESULTED EFFECTIVE IN REDUCING SYMPTOM PERCEPTION IN PATIENTS WITH FUNCTIONAL HEARTBURN Irene Martinucci, Italy; E. Savarino; G. Guidi; K. Nardi; S. Tolone; M. Frazzoni; L. Fuccio; L. Frazzoni; M. Bellini; V. Savarino; S. Marchi; N. de Bortoli Barrett's oesophagus: Clinical P1205 GENDER DIFFERENCES IN NEOPLASTIC PROGRESSION IN BARRETT'S ESOPHAGUS: A MULTICENTER PROSPECTIVE COHORT STUDY Carlijn Roumans, The Netherlands; A. Treling; D. Rizopoulos; E. W. Steyerberg; M. J. Bruno; M. C. W. Spaander P1206 SINGLE SESSION FOCAL CRYOBALLOON ABLATION THERAPY IS SAFE AND EFFECTIVE IN THE TREATMENT OF DYSPLASTIC BARRETT’S ESOPHAGUS Sanne van Munster, The Netherlands; A. Overwater; J. J. G. H. M. Bergman; B. L. A. M. Weusten Tuesday, October 31, 2017
P1207 CRYOBALLOON ABLATION OF DYSPLASTIC BARRETT’S ESOPHAGUS CAUSES SHORTER DURATION AND LESS SEVERE POST-PROCEDURAL PAIN AS COMPARED TO RADIOFREQUENCY ABLATION Sanne van Munster, The Netherlands; A. Overwater; J. J. G. H. M. Bergman; B. L. A. M. Weusten P1208 COMPARATIVE OUTCOMES OF RADIOFREQUENCY ABLATION FOR BARRETT’S OESOPHAGUS WITH DIFFERENT BASELINE HISTOLOGY Wei Keith Tan, United Kingdom; A. Rattan; T. Nuckcheddy; B. Alias; V. Sujendran; M. di Pietro P1209 IS IT REASONABLE TO PROPOSE AN ENDOSCOPIC MUCOSAL RESECTION FOR BARRET’S OESOPHAGUS WITH HIGH GRADE DYSPLASIA ON THE BIOPSIES ? Jean-Michel Gonzalez, France; J.-P. Casanova; A. Benezech; E. Bories; S. Garcia; M. Giovannini; M. Barthet Oesophageal neoplasia: Basic P1210 CD4+ AND CD8+ LYMPHOCYTE RATE AND PDL-1 LEUKOCYTE EXPRESSION ARE PREDICTIVE OF CLINICAL COMPLETE RESPONSE AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR SQUAMOUS CELL CANCER OF THE THORACIC OESOPHAGUS M. Fassan; F. Cavallin; V. Guzzardo; Andromachi Kotsafti, Italy; R. Alfieri; M. Cagol; M. Scarpa; V. Chiarion Sileni; I. Castagliuolo; M. Rugge; C. Castoro; M. Scarpa 200
P1211 IDENTIFICATION OF THREE DISTINCT BIOLOGICAL SUBTYPES IN ESOPHAGEAL AND JUNCTIONAL ADENOCARCINOMA BY RNA SEQUENCING Sanne Hoefnagel, The Netherlands; B. Scicluna; S. Calpe; C. del Sancho-Serra; K. K. Krishnadath P1212 CLINICAL VALUE OF LONG NONCODING RNA TRPM2AS EXPRESSION IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA Hairong Xu, China; G. Yao; L. Lin P1213 ROLE OF CD80 EXPRESSION IN INFLAMMATORY-RELATED ESOPHAGEAL CARCINOGENESIS Melania Scarpa, Italy; L. Dall'Olmo; M. Fassan; A. Porzionato; A. Kotsafti; V. Macchi; R. Alfieri; S. Realdon; M. Rugge; I. Castagliuolo; C. Castoro; M. Scarpa P1214 TUMOR MICROENVIRONMENT IN ESOPHAGEAL ADENOCARCINOMA: NUCLEAR P53 OVER-EXPRESSION IS ASSOCIATED TO WORSE DISEASE FREE SURVIVAL Andromachi Kotsafti, Italy; M. Fassan; L. M. Saadeh; V. Guzzardo; M. Scarpa; F. Cavallin; M. Agostini; M. Cagol; R. Alfieri; M. Rugge; I. Castagliuolo; C. Castoro; M. Scarpa P1215 PHARMACOLOGICAL INHIBITION OF MONOCARBOXYLATE TRANSPORTER 1 INDUCES APOPTOSIS IN METASTATIC ESOPHAGEAL ADENOCARCINOMA CELLS Eduardo Chueca Lapuente, Spain; A. Valero Torres; S. Arechavaleta Tabuenca; M. Á. Sáenz; M. A. García-González; C. Hörndler; A. Lanas; E. Piazuelo Oesophageal neoplasia: Clinical P1216 THE PREDICTIVE FACTOR FOR PERFORATION IN ESOPHAGEAL ESD Yasuaki Nagami, Japan; M. Ominami; M. Shiba; S. Fukunaga; F. Tanaka; N. Kamata; H. Yamagami; T. Tanigawa; T. Watanabe; Y. Fujiwara P1217 SAFETY AND EFFICACY OF CHEMORADIOTHERAPY AFTER ENDOSCOPIC RESECTION IN PATIENTS WITH SUPERFICIAL ESOPHAGEAL SQUAMOUS-CELL CARCINOMA. Takuya Wada, Japan; C. Katada; M. Azuma; T. Yano; S. Tanabe; W. Koizumi; H. Moriya; K. Yamashita; S. Komori; K. Ishido P1218 SAFETY, EFFICACY AND OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR THE TREATMENT OF EARLY BARRETT’S NEOPLASIA Masami Omae, Sweden; M. Konradsson; P. Elbe; M. Nilsson; M. Lindblad; I. Rouvelas; F. Baldaque-Silva
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P1220 CLINICAL OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL ESOPHAGEAL NEOPLASMS OF PATIENTS WITH HEAD AND NECK CANCER J. F. D. Oliveira; E. Q. Mendonça; B. D. C. Martins; F. Kawaguti; M. S. de Lima; S. Geiger; Caterina Pennacchi, Brazil; C. C. Gusmon; R. Uemura; E. R. Baba; A. V. Safatle-Ribeiro; L. H. Lenz Tolentino; G. de Paulo; M. Sorbello; M. Minata; R. N. Moura; U. Ribeiro Jr.; F. Maluf-Filho P1221 ENDOSCOPIC CRYOBALOON ABLATION IS SAFE, WELLTOLERATED AND HIGHLY EFFECTIVE IN THE ERADICATION OF ESOPHAGEAL SQUAMOUS CELL NEOPLASIA. Ke Yan, China; S. van Munster; C. Jian; L. Fugang; Z. Deli; W. Li; S. He; Y. Zhang; D. Lizhou; Y. Liu; L. Xudong; L. Xue; L. Ning; S. Dawsey; J. J. G. H. M. Bergman; B. L. A. M. Weusten; G. Wang P1222 THE ENDOSCOPIC TREATMENT STRATEGY FOR SUPERFICIAL ESOPHAGEAL CANCER Naoyuki Yamaguchi, Japan P1223 DIAGNOSIS OF TUMORS IN THE CERVICAL AND UPPER THORACIC ESOPHAGUS: EFFICACY OF ENDOSCOPIC ULTRASONOGRAPHY USING A JELLY-FILLING METHOD WITH WATER-SOLUBLE LUBRICATING JELLY Noriko Matsuura, Japan; N. Hanaoka; R. Ishihara; S. Yamamoto; T. Akasaka; Y. Takeuchi; K. Higashino; N. Uedo; H. Iishi Gastroduodenal neoplasia: Clinical P1224 OPTIMAL SURGERY TIME AFTER ENDOSCOPIC RESECTION IN EARLY GASTRIC CANCER : LONG-TERM FOLLOW-UP STUDY FOR SURGICAL AND ONCOLOGICAL SAFETY Jae Hwang Cha, Republic of Korea; J.-H. Kim; S. H. Choi; D. H. Jung; J. J. Park; Y. H. Youn; H. Park; H.-I. Kim; J.-H. Cheong; W. J. Hyung; S. H. Noh P1225 THE POINT TO DISTINGUISH EARLY GASTRIC CANCER FROM DEPRESSION TYPE OF GASTRIC INTESTINAL METAPLASIA. Toshiyuki Wakatsuki, Japan; S. Furutachi; H. Yamashita
Poster in the Spotlight
Poster of Excellence
P1226 IRON DEFICIENCY ANEMIA – ARE THERE ANY PREDICTORS OF GASTROINTESTINAL MALIGNANCY? Sofia Xavier, Portugal; J. Magalhães; J. Cotter P1227 IMPROVEMENT OF DETECTION RATE OF EARLY GASTRIC CANCER BY A TRAIN-THE-TRAINER (TTT) COURSE IN CHINA: A PROSPECTIVE CONTROLLED STUDY Jian-Wei Hu, China; M.-Y. Cai; Q. Shi; B.-Q. Zhu; Y. Huang; W. Qin; Z. Ren; J.-Z. Liu; J.-J. Lian; Z. Zhang; P.-H. Zhou; K. Yao P1228 COMPARISON OF ENDOSCOPIC SUBMUCOSAL DISSECTION AND SURGERY FOR THE TREATMENT OF EARLY GASTRIC CANCER: SINGLE CENTER LONG TERM OUTCOME STUDY Hye in Jung, Republic of Korea; S. J. Kim; I. T. So; J. H. Choi; Y. J. Lee; H. J. Lee; K. B. Cho; K. S. Park; S. W. Ryu; Y. G. Son; J. Y. Lee P1229 HEMATOLOGISTS SHOULD ORDER ENDOSCOPIC EXAMINATION TO EXPERTS OF ENDOSCOPY IN CASE OF ENDOSCOPIC CHECK-UP OF GASTROINTESTINAL MALIGNANT LYMPHOMA. Takuji Yamasaki, Japan; T. Sakurai; J. Mitobe; M. Mitsunaga; M. Saruta P1230 SURVIVAL BENEFITS OF GASTRECTOMY IN PATIENTS WITH STAGE IV GASTRIC CANCER: A POPULATION-BASED STUDY Xingkang He, China; W. wu; Y. Ding; Z. Jin; L. Sun; J. Si P1231 DEVELOPMENT OF AND EXPERIENCE WITH AN INSULATED SCISSORS-TYPE KNIFE (SB KNIFE) Makoto Kobayashi, Japan P1232 GASTROINTESTINAL LYMPHOMAS Rui Gaspar, Portugal; A. Andrade; J. Santos-Antunes; R. Liberal; F. Carneiro; G. Macedo P1233 THE EFFECT OF OBESITY ON EARLY GASTRIC CANCER IN PATIENTS UNDERGOING ENDOSCOPIC TREATMENT Sun Jin, Republic of Korea; S. Y. Nam; S. W. Jeon; Y.-H. Kwon; H. S. Lee P1234 COMPARATIVE STUDY OF THE ENDOSCOPIC ULTRASONOGRAPHY-GUIDED FINE-NEEDLE ASPIRATION VS MUCOSAL-INCISION ASSISTED BIOPSY FOR THE HISTOLOGICAL DIAGNOSIS OF GASTROINTESTINAL SUBEPITHELIAL TUMORS. Takashi Osoegawa, Japan; N. Harada; E. Ihara; Y. Iboshi; Y. Sumida; M. Nakamuta; Y. Ogawa
Clinical Case Session
201
Tuesday, October 31, 2017
P1219 ENDOSCOPIC EVALUATION AT THE PRIMARY SITE OF CT1 ESOPHAGEAL CANCER AFTER PROTON BEAM THERAPY AND CLINICAL RESULTS OF SALVAGE ENDOSCOPIC THERAPY FOR LOCAL RECURRENCE Daiki Satou, Japan; A. Motegi; T. Kojima; H. Bando; K. Hori; T. Kadota; Y. Yoda; K. Shinmura; Y. Oono; H. Ikematsu; S. Zenda; T. Akimoto; T. Yano
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P1235 CLINICAL TRENDS AND BURDEN OF DEATH IN GASTRIC CANCER: A SIX YEARS SURVEY Pellegrino Crafa, Italy; S. Landi; S. Grillo; M. Franceschi; A. Noto; S. Scida; C. Miraglia; L. Franzoni; V. Corrente; R. Cannizzaro; G. M. Cavestro; M. Rugge; F. Di Mario; P. Caruana; C. Mancini
Upper GI / Intestinal health services research
Gastroduodenal neoplasia: Basic
P1244 WHAT IS THE YIELD OF ROUTINE D2 BIOPSIES IN THOSE PRESENTING WITH WEIGHT LOSS AT GASTROSCOPY? Mehmet Yalchin, United Kingdom; S. Zonoozi; M. Hussein; N. Jayasooriya; K. Besherdas
P1236 GASTRIC ADENOCARCINOMA OF FUNDIC GLAND TYPE: CANCER GENOMIC DATA Hiroya Ueyama, Japan; T. Hayashi; T. Saito; Y. Akazawa; H. Komori; K. Matsumoto; K. Matsumoto; M. Hojo; A. Nagahara; T. Yao; S. Watanabe P1237 LNCRNA-HOTAIR INDUCES THE UBIQUITINATION OF RUNX3 IN GASTRIC CANCER Shujie Chen, China; M. Xue; L. Chen; L. Wang
Tuesday, October 31, 2017
P1238 CAB39L FUNCTIONS AS A TUMOUR SUPPRESSOR IN GASTRIC CANCER THROUGH LKB1-MEDIATED AMPK ACTIVATION Weilin Li, Hong Kong PRC; C. C. Wong; Y. Dong; J. Xu; Y. Qian; W. Kang; P. W. Y. Chiu; E. Ng; J. Yu P1239 FUNCTIONAL CHARACTERIZATION AND CLINICAL SIGNIFICANCE OF PKNOX2, A NOVEL TUMOR SUPPRESSOR IN GASTRIC CANCER Li Zhang, Hong Kong PRC; C. C. Wong; W. Li; J. Xu; L. Cao; J. Yu P1240 HOXC10 IS UPREGULATED IN HUMAN GASTRIC CANCER AND PROMOTES CELL G1-S TRANSFORMATION AND PROLIFERATION THROUGH DIRECT TRANSCRIPTIONAL REPRESSION OF P21 Liangjing Wang, China; Z. Jin; S. Chen; S. Lai; X. He; J. Si P1241 RECOVERY OF GASTRIC FUNCTION IN CHRONIC ATROPHIC GASTRITIS BY USING L-CYSTEINE: A 3 YEARS STUDY Francesco Di Mario, Italy; L. Franzoni; S. Grillo; S. Landi; C. Miraglia; S. Scida; M. Riccò; G. Grande; M. Franceschi; M. P. Panozzo; A. Antico; R. Cannizzaro; G. M. Cavestro; M. Rugge; C. Scarpignato P1242 ANDROGEN RECEPTOR DIRECTLY REGULATES CELL CYCLE-RELATED KINASE TO PROMOTE GASTROCARCINOGENESIS Guijun Zhao, China; X. LI; L. XU; N. Zhang
202
P1243 FLYING OFF COURSE WITH A 2WW DIRECT ACCESS TO TEST PILOT: NOTTINGHAM'S EXPERIENCE OF THE SUSPECTED UPPER GASTRO-INTESTINAL CANCER PATHWAY CHANGE WITH GP VETTING AND OGD BOOKING Nina Lewis, United Kingdom; J. Catton; E. James
P1245 FUNDING DISPARITIES IN DIGESTIVE CANCER RESEARCH IN THE UNITED STATES Peter Liang, USA; K. O'Connell; M. Du Poster Session 09:00 – 17:00 H. Pylori II
Hall 7
Pathogenesis: Microbial factors P1246 HELICOBACTER PYLORI ERADICATION MODULATES ABERRANT CPG ISLAND HYPERMETHYLATION IN GASTRIC CARCINOGENESIS Jeongmin Choi, Republic of Korea; S. G. Kim; B. G. Kim; S.-J. Koh; J. W. Kim; K. L. Lee Pathogenesis: Host factors/immunology/inflammation P1247 CURCUMIN DOWNREGULATES INTERLEUKIN (IL)-17 BY INCREASING THE EXPRESSION OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) IN HELICOBACTER PYLORI-INFECTED HUMAN GASTRIC MUCOSA Tiziana Larussa, Italy; R. Liparoti; S. Gervasi; E. Suraci; R. Marasco; M. Imeneo; F. Luzza P1248 ALTERATIONS IN SALIVARY MICROBIOTA IN SUBJECTS WITH HELICOBACTER PYLORI-ASSOCIATED GASTRITIS Wai Keung Leung, Hong Kong PRC; K. S. Lau; T. S. Tong; K.-M. Chu; P. C. Sham P1249 EFFECT OF ALCOHOL DRINKING ON SEROCONVSERSION IN HELICOBACTER PYLORI-SERONEGATIVE KOREANS Ji Hye Kim, Republic of Korea; S.-Y. Lee; H. G. Kwon; S. P. Lee; J. H. Kim; I.-K. Sung; H. S. Park; C. S. Shim
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P1250 AUTOIMMUNE GASTRITIS WITH PREVIOUS O CONCURRENT H. PYLORI INFECTION PRESENTS DISTINCT FUNCTIONAL AND MORPHOLOGICAL FEATURES. Gemma Maddalo, Italy; V. Pilotto; C. Orlando; M. Pizzi; M. Fassan; D. Basso; M. Rugge; F. Farinati
P1258 MAY PROBIOTICS MONOTHERAPY ERADICATE HELICOBACTER PYLORI? A SYSTEMATIC REVIEW WITH POOLED-DATA ANALYSIS Giuseppe Losurdo, Italy; R. Cubisino; M. Barone; M. Principi; E. Ierardi; A. Di Leo
P1251 THE INVESTIGATION OF MIR-155, MIR-21, MIR-146A AND MIR-223 EXPRESSIONS IN HELICOBACTER PYLORİ POSITIVE AND NEGATIVE INDIVIDUALS N. Uyar Alpaslan; Enver Ucbilek, Turkey; İ. Ö. Barlas; O. Sezgin; S. Yaraş
P1259 EFFECTIVENESS AND SAFETY OF PYLERA® IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A LARGE, PROSPECTIVE, REAL LIFE STUDY A. Tursi; M. Franceschi; L. Allegretta; E. Savarino; R. De Bastiani; W. Elisei; G. Baldassarre; A. Ferronato; S. Scida; C. Miraglia; A. Penna; C. Licci; G. L. Rizzo; P. Giuseppe; C. Cassieri; G. Brandimarte; M. Picchio; Francesco Di Mario, Italy
Treatment P1253 THE TRANSITION OF HELICOBACTER PYLORI ERADICATION IN OUR INSTITUTION Masayoshi Ono, Japan; T. Kitagataya; Y. Shimoda; J. Ito; T. Kudo; K. Hatanaka; Y. Yamamoto; H. Naruse P1254 ERADICATION OF H. PYLORI INFECTION IN PATIENTS NAÏVE TO TREATMENT USING CONCOMITANT THERAPY OR BISMUTH QUADRUPLE THERAPY (THREE-IN-ONE PILL): A REAL LIFE OBSERVATIONAL STUDY Antonietta Gerarda Gravina, Italy; G. Nardone; A. Miranda; D. Sgambato; A. Rocco; G. Visciola; D. Compare; M. Dallio; L. Granata; M. R. Romito; M. Martorano; C. Mucherino; P. Rocco; A. Federico; C. Loguercio; M. Romano P1255 CYP3A5 GENOTYPE STATUS AFFECTS OUTCOME OF FIRST-LINE VONOPRAZAN-CONTAINED HELICOBACTER PYLORI ERADICATION THERAPY Mitsushige Sugimoto, Japan; H. Ban; A. Otsuki; H. Itoi; O. Inatomi; A. Andoh P1256 COMPARISON OF HELICOBACTER PYLORI ERADICATION RATES :VONOPRAZAN VS. PROTON PUMP INHIBITOR Naoko Kozawa, Japan; T. Mochida; A. Igarashi; C. Kamitsuma; J. Tsuchiya; M. Ike; K. Yasuda; M. Kaneshiro; H. Ikemiyagi; Y. Fukami; K. Yoshino; S. Sakita P1257 CAN TWO WEEK BISMUTH BASED QUADRUPLE THERAPY FOR RESISTANT H.PYLORI INFECTION STILL BE USED IN THE UK? Hugh Logan-Ellis, United Kingdom; L. Bensaid; R. P. H. Logan Poster in the Spotlight
Poster of Excellence
P1260 COMPARISON OF CLARITHROMYCIN- AND LEVOFLOXACIN-CONTAINING TRIPLE THERAPIES FOR FIRST LINE HELICOBACTER PYLORI ERADICATION IN IRAN H. Fakheri; A. Sadoogh; Sepehr Tirgar Fakheri, Iran P1261 EFFICACY AND TOLERABILITY OF REBAMIPIDE IN TRIPLE THERAPY FOR ERADICATION OF HELICOBACTER PYLORI: A RANDOMIZED CLINICAL TRIAL Sergey Vyalov, Russian Federation Poster Session 09:00 – 17:00 Small Intestinal II
Hall 7
Small intestinal immunology, immunity and inflammation P1262 OBSERVER AGREEMENT FOR DIAGNOSIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH MICROVILLI ATROPHY IN THE TERMINAL ILEUM Yuusaku Sugihara, Japan; S. Hiraoka; N. Fujii; S. Takashima; Y. Yamasaki; D. Takei; T. Inokuchi; M. Takahara; Y. Morito; S. Takahashi; K. Kuwaki; K. Harada; T. Tanaka; H. Okada P1263 EPIGALLOCATECHIN-3-GALLATE FROM GREEN TEA AMELIORATE 5-FLUROURACIL-INDUCED INTESTINAL MUCOSITIS J. M. Lee; G. Min; W. Kim; S. J. Choi; I. K. Yoo; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; B. Keum; H. J. Chun; H. S. Lee; Yoon Tae Jeen, Republic of Korea; C. D. Kim; K. C. Yoon P1264 INCREASED SUSCEPTIBILITY TO ENTEROPATHOGENIC BACTERIA BY PROTON PUMP INHIBITORS IN THE MURINE MODEL OF FOOD POISONING Eiichiro Yasutomi, Japan; N. Hoshi; J. Inoue; S. Adachi; T. Otsuka; D. Watanabe; Y. Ku; H. Yamairi; M. Ooi; S. Fukuda; M. Yoshida; T. Azuma
Clinical Case Session
203
Tuesday, October 31, 2017
P1252 INTERLEUKIN LEVEL IN PATIENTS INFECTED WITH CAGA(+) AND CAGA(-) STRAINS OF HELICOBACTER PYLORI N. V. Baryshnikova; Yury P. Uspenskiy, Russian Federation; A. Suvorov
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
P1265 EXPRESSION OF AMINO ACID TRANSPORTERS IN ANTITUMOR AGENT-INDUCED GASTROINTESTINAL MUCOSAL INJURIES Masaru Kodo, Japan; R. Kawashima; W. Koizumi; T. Ichikawa P1266 A MUCOUS DEPENDENT MECHANISM OF ACETYL SALICYLIC ACID- INDUCED SMALL INTESTINAL MUCOSAL INJURY IN RATS. Yosuke Suyama, Japan; O. Handa; S. Takayama; R. Mukai; A. Majima; Y. Onozawa; A. Fukui; T. Okayama; K. Kamada; K. Katada; K. Uchiyama; T. Ishikawa; T. Takagi; Y. Naito; Y. Itoh P1267 ANTIBIOTIC-INDUCED DYSBIOSIS IN THE MOUSE SMALL INTESTINE PROMOTES ALLERGIC SENSITISATION G. Burns; B. J. Goggins; K. Minahan; P. Foster; N. J. Talley; M. M. Walker; J. Horvat; Simon Keely, Australia
Tuesday, October 31, 2017
P1268 PREBIOTIC EFFECTS ON HEALTHY AND CHEMOTHERAPY-INDUCED SMALL BOWEL INJURY IN RATS Roger Yazbeck, Australia; R. J. Lindsay; M. S. Geier; R. N. Butler; S. Jaenisch; G. S. Howarth P1269 THE RELATION OF CHEMOKINE RECEPTOR CXCR3 AND GUT-HOMING MARKERS ON SMALL INTESTINAL LAMINA PROPRIA T-LYMPHOCYTES IN CROHN’S DISEASE PATIENTS. Anh Do, Australia; A. Shah; E. Shanahan; P. Gashemi; T. Hansen; N. Koloski; S. Keelly; N. J. Talley; G. Holtmann Microbiology P1270 METHODOLOGICAL QUALITY OF CLINICAL PRACTICE GUIDELINES ON PROBIOTICS IN ACUTE GASTROENTRITIS IN CHILDREN USING THE APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION II INSTRUMENT (AGREEII) Aldo Maruy Saito, Peru; J. C. Herrera Rodriguez; R. Rojas Galarza P1271 COMBINATION OF TWO IN VITRO MODELS TO STUDY THE IMPACT OF CHRONIC CO-EXPOSURE OF A PESTICIDE WITH A PREBIOTIC ON THE INTESTINAL ENVIRONMENT Marina Requile, France; D. O. Gonzalez Alvarez; S. Delanaud; L. Rhazi; V. Bach; F. Depeint; H. Khorsi-Cauet
P1273 SYSTEMATIC REVIEW AND META-ANALYSIS: PREVALENCE OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN CHRONIC LIVER DISEASE Ayesha Shah, Australia; P. Ghasemi; E. Shanahan; G. MacDonald; L. Fletcher; M. Morrison; M. P. P. Jones; G. Holtmann P1274 IS THERE AN ASSOCIATION BETWEEN ENTERIC METHANE (CH4) PRODUCTION AND SYMPTOMS IN PATIENTS WITH UNEXPLAINED GI SYMPTOMS? Ayesha Shah, Australia; P. Ghasemi; M. Morrison; L. Fletcher; G. Holtmann; T. Hansen Coeliac disease (adult) P1275 CELIAC DISEASE AND POSITIVE IGA TISSUE TRANSGLUTAMINASE IN PATIENTS WITH DISTAL RADIUS AND ANKLE FRACTURE: A CASE-CONTROL STUDY Anja Hjelle, Norway; P. F. Mielnik; G. S. Tell; K. E. A. Lundin; R. M. Nilsen; E. Apalset P1276 INTERLEUKIN 1BETA, CLAUDIN AND OCCLUDIN CONCENTRATIONS IN SERUM AND AUTONOMIC NERVOUS SYSTEM ACTIVITY AMONG NEUROLOGICAL ASYMPTOMATIC CELIAC DISEASE PATIENTS – PILOT STUDY Malgorzata Zwolinska-Wcislo, Poland; M. Przybylska-Feluś; A. Furgała; B. Brzozowski; O. Kaczmarczyk; K. Gil; T. Mach P1277 WIDE HETEROGENEITY AND HIGH MORTALITY IN UNDEFINED AND NON-COELIAC REFRACTORY SPRUE: A RETROSPECTIVE EVALUATION OF 7 CASES Annalisa Schiepatti, Italy; F. Biagi; M. Zuffada; G. Maiorano; G. R. Corazza P1278 ª EVERYDAY LIFE RESTRICTIONS CAUSED BY LONGTERM TREATED CELIAC DISEASE: PREVALENCE AND ASSOCIATED FACTORS Laura Kivelä, Finland; S. Alin; S. Kröger; K. Kaukinen; K. Kurppa P1279 SYSTEMATIC REVIEW OF THE ECONOMIC BURDEN OF COELIAC DISEASE T. Boulanger; Aliki Taylor, United Kingdom; D. A. Leffler; E. S. Mearns; M. Gerber
P1272 THE DIET FEATURES OF DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME PATIENTS WITH SMALL INTESTINAL BOWEL OVERGROWTH H. Wei; Z. Liu; K. Wang; W. Zheng; Liping Duan, China 204
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
P1281 PROTON PUMP INHIBITORS AS RISK FACTOR FOR METABOLIC SYNDROME AND HEPATIC STEATOSIS IN PATIENTS WITH CELIAC DISEASE ON GLUTEN FREE-DIET Nicola Imperatore, Italy; R. Tortora; A. Testa; N. Gerbino; M. Di Palma; V. Di Martino; N. Caporaso; A. Rispo P1282 HOW MANY HOURS DO STABLE COELIAC PATIENTS TAKE UP IN GASTROENTEROLOGY OUT-PATIENT CLINICS? Mehmet Yalchin, United Kingdom; R. Eckersley; T. Coysh; S. Mann P1283 MONITORING PATIENTS WITH COELIAC DISEASE: WHO ACTUALLY NEEDS A DEXA SCAN? Mehmet Yalchin, United Kingdom; R. Eckersley; T. Coysh; S. Mann P1284 CELIAC DISEASE AND ADHERENCE TO THE GLUTEN-FREE DIET: A 30-YEAR FOLLOW UP STUDY Federica Branchi, Italy; M. Bravo; L. Norsa; F. Ferretti; M. T. Bardella; D. Conte; L. Elli Malabsorption syndromes and food enteropathies (adult) P1285 PATIENTS WITH SHORT BOWEL SYNDROME STRATIFIED BY BASELINE PARENTERAL SUPPORT VOLUME: POST HOC ANALYSIS OF THE CLINICAL EFFECT OF TEDUGLUTIDE Palle Bekker Jeppesen, Denmark; S. M. Gabe; D. L. Seidner; H.-M. Lee; C. Olivier P1286 POST HOC ANALYSIS OF THE RELATIONSHIP BETWEEN PLASMA CITRULLINE AND PARENTERAL SUPPORT NEEDS IN PATIENTS WITH SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE RECEIVING TEDUGLUTIDE Palle Bekker Jeppesen, Denmark; S. M. Gabe; D. L. Seidner; H.-M. Lee; C. Olivier
Poster in the Spotlight
Poster of Excellence
P1287 LACTULOSE, LACTOSE AND FRUCTOSE INGESTION INDUCES SPECIFIC PATTERNS OF GASTROINTESTINAL SYMPTOMS IN CHINESE SUBJECTS WITH FUNCTIONAL DYSPEPSIA AND IRRITABLE BOWEL SYMPTOMS. Victoria Tan, Hong Kong PRC; N. H. S. Chu; C. K. Yao; P. R. Gibson P1288 PATIENTS WITH SHORT BOWEL SYNDROME STRATIFIED BY DIAGNOSIS: POST HOC ANALYSIS OF TEDUGLUTIDE ON FLUID COMPOSITE EFFECT Palle Bekker Jeppesen, Denmark; S. M. Gabe; K. Iyer; U.-F. Pape; D. L. Seidner; H.-M. Lee; C. Olivier P1289 RESULTS OF A POST HOC ANALYSIS OF BASELINE CHARACTERISTICS AND CLINICAL RESPONSE TO TEDUGLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME BASED ON RESIDUAL BOWEL ANATOMY Palle Bekker Jeppesen, Denmark; S. M. Gabe; D. L. Seidner; H.-M. Lee; C. Olivier Small intestinal neoplasia P1290 GENE EXPRESSION PROFILING OF SUPERFICIAL SPORADIC NON-AMPULLARY DUODENAL EPITHELIAL TUMORS Yoshiki Sakaguchi, Japan; N. Yamamichi; S. Tomida; C. Takeuchi; Y. Takahashi; N. Kageyama-Yahara; M. Fujishiro; K. Koike P1291 WITHDRAWN P1292 USE OF 3D COMPUTED TOMOGRAPHIC ENTEROCLYSIS TO OBTAIN INFORMATION ON THE LENGTH OF THE SMALL INTESTINE AND ON THE SIZE, SHAPE, LOCATION OF INTESTINAL NEOPLASIAS Toshiyuki Yoshikawa, Japan; K. Ohno; T. Kurokami P1293 INK TATTOOING FOR BALLOON-ASSISTED ENTEROSCOPY – TIME WELL SPENT? Christoph Römmele, Germany; A. Ebigbo; H. Messmann; S. Gölder P1294 THE ROLE OF CAPSULE ENDOSCOPY IN THE DETECTION OF SMALL BOWEL TUMOURS IN A LOW RISK POPULATION; A SINGLE CENTRE EXPERIENCE Mary Hussey, Ireland; G. Holleran; T. Nuzum; S. Crowther; D. McNamara
Clinical Case Session
205
Tuesday, October 31, 2017
P1280 PNPLA3 RS738409 POLYMORPHISM PREDICTS THE DEVELOPMENT AND THE SEVERITY OF HEPATIC STEATOSIS, BUT NOT METABOLIC SYNDROME, IN PATIENTS WITH CELIAC DISEASE Nicola Imperatore, Italy; R. Tortora; A. Rispo; A. Alisi; A. Crudele; F. Ferretti; V. Nobili; L. Miele; N. Gerbino; V. Di Martino; N. Caporaso; F. Morisco
UEG Week Final Programme : Poster Sessions
Poster Session 09:00 – 17:00 Nutrition II
Tuesday, October 31, 2017
Nutrients and gut function Hall 7
Obesity P1295 VITAMIN D PREVENTS HEPATIC STEATOSIS AND CARDIOVASCULAR DAMAGE IN A RAT MODEL OF FATTY WESTERN DIET G. Mazzone; C. Morisco; Vincenzo Lembo, Italy; G. D'Argenio; M. D'Armiento; A. Rossi; C. Del Giudice; N. Caporaso; F. Morisco P1296 WITHDRAWN P1297 ELIPSE BALLOON SYSTEM: OUR EXPERIENCE. A PRELIMINARY STUDY Eleonora Avallone, Italy; M. A. Vitale; A. De Cesare; G. Villotti; R. Urgesi; M. C. Di Paolo; L. Pallotta; M. G. Graziani Tuesday, October 31, 2017
P1298 NUTRITIONAL STATUS EVALUATION TOOL IS NOT USED AND NUTRITIONAL SUPPORT CONSULTATION IS RARELY REQUESTED BY THE TREATING PHYSICIAN IN A TERTIARY GREEK HOSPITAL G. Vlachonikolou; L. Bounou; S. Kalousios; A. Theodorou-Kanakari; E. A. Mavroeidi; M. Roma; A. Kasti; G. D. Dimitriadis; Konstantinos Triantafyllou, Greece
P1303 THE EFFECT OF A CONTROLLED GLUTEN CHALLENGE IN PATIENTS WITH SUSPECTED NON-COELIAC GLUTEN SENSITIVITY: A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED CHALLENGE Hanna Dale, Norway; J. G. Hatlebakk; N. Hovdenak; S. O. Ystad; G. A. Lied P1304 THE ROLE OF BILE ACIDS AND GUT MICROBIOTA IN CORONARY ARTERY DISEASE: RESULTS OF THE MABAC STUDY IN HUMAN (MICROBIOTA ATHEROMA AND BILE ACID IN CORONARY DISEASE) Henri Duboc, France; C. Chong Nguyen; D. Rainteau; H. Sokol; L. Humbert; P. SEKSIK; B. Coffin; O. Varenne; A. Bado; D. Duboc P1305 LOW FODMAP DIET: REINTRODUCTION PHASE DOES NOT MODIFY EFFICACY, BUT BEWARE OF REAL TRIGGER FOODS! Massimo Bellini, Italy; A. Rossi; D. Gambaccini; D. Menicucci; L. Bazzichi; B. Fani; R. Sellitri; M. G. Mumolo; N. de Bortoli; L. Ceccarelli; M. Mosca; S. Marchi P1306 EXPRESSION OF THE FRUCTOSE TRANSPORTER GLUT5 IN PATIENTS WITH FRUCTOSE MALABSORPTION. Pia Staubach, Germany; S. Krüger; A. K. Koch; J. Langhorst; C. Röcken; U. Helwig
P1299 CHANGE OF VITAMIN D AND BONE MINERAL DENSITY AFTER BARIATRIC SURGERY IN CHINESE POPULATION Ming-Lun Han, Taiwan; W.-J. Lee
P1307 BETTER RESPONSE TO LOW FODMAP DIET IN JH NEGATIVE PATIENTS WITH DISORDERS OF GUT-BRAIN INTERACTION Valeria Schindler, Switzerland; A. Zweig; A. Becker; J. Zeitz; D. Runggaldier; M. Fried; D. Pohl
P1300 INTRAGASTRIC BALLOON: A LARGE BRAZILIAN MULTICENTRIC STUDY OVER 10,000 CASES AND 20 YEARS OF EXPERIENCE Bruno Sander, Brazil; C. Marchesini; D. S. Paiva; J. Schemberk Jr.; G. Baretta; G. Cairo Nunes; J. I. B. Scarparo; E. Grecco; T. F. Souza; M. Galvao Neto
P1308 CHANGES IN GASTROINTESTINAL SYMPTOMS, SMALL INTESTINAL BACTERIA, AND DUODENAL PHYSIOLOGY FOLLOWING A LOW FIBER, HIGH SUGAR DIET George Saffouri, USA; B. Schmidt; E. J. Battaglioli; Y. Bhattarai; J. Cho; H. Lekatz; M. Grover; G. Farrugia; P. Kashyap
P1301 WEIGHT REGAIN AFTER BARIATRIC SURGERY – ARGON PLASMA COAGULATION FOR GASTROJEJUNAL ANASTOMOSIS DECREASE Bruno Sander, Brazil; D. S. Paiva; M. P. Sander; M. Galvao Neto; G. Baretta; E. Grecco; T. F. Souza; J. I. B. Scarparo
P1309 STRESS AND STRESS-RELATED PEPTIDE AMPLIFY THE ANOREXIC ACTIONS OF CHOLECYSTOKININ Naomi Yamaguchi, Japan; E. Hosomi; M. Ochiai; S. Ro; K. Chieko; K. Maezawa; S. Nagoshi; K. Takayama; K. Yakabi
P1302 EXCESS WEIGHT IN THE ELDERLY: A BRAZILIAN EXPERIENCE WITH THE INTRAGASTRIC BALLOON TREATMENT Ricardo Jose Fittipaldi Fernandez, Brazil; E. Usuy; M. Galvao Neto; C. F. Diestel; S. Barrichello; A. F. Teixeira 206
P1310 PEPTIDE TYROSINE-TYROSINE (PYY) ENHANCES EFFECTS OF CHOLECYSTOKININ (CCK) ON GASTRIC MOTILITY AND FOOD INTAKE IN RATS. Eriko Hosomi, Japan; N. Yamaguchi; K. Maezawa; M. Ochiai; S. Ro; K. Chieko; K. Takayama; K. Yakabi
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
CC082 THE UTILITY OF AN UPPER OESOPHAGEAL SPHINCTER ASSIST DEVICE ON TREATMENT OF RECURRENT ASPIRATION PNEUMONIA AFTER ESOPHAGECTOMY Dharma Sunjaya, USA; M. Halland CC083 PRIMARY FOLLICULAR LYMPHOMA OF THE DUODENUM: THERAPEUTIC APROACH WITH ENDOSCOPIC MUCOSAL RESECTION Diana Martins, Portugal; J. Pinho; P. Sousa; R. Cardoso; R. Araújo; E. Cancela; A. Castanheira; P. Ministro; A. Silva CC084 14.6 X 8 CM SUCCESSFUL WIDESPREAD ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) AND PROTECTIVE VACUUM SPONGE IMPLANTATION FOR SPARING OF WHIPPLE’S RESECTION IN IN THE SECOND AND THIRD DUODENUM Malte Hofmeyer, Germany; J. Hochberger CC085 A CASE OF EBV-POSITIVE EARLY LYMPHOEPITHELIOMA-LIKE GASTRIC CARCINOMA (LELGC) RESECTED BY ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD), INITIALLY DIAGNOSED AS A STROMAL TUMOUR. L. Shuwen; S. Zhan; D. Shi; Rui Li, China; W. Chen
CC089 TRANSVERSE MYELITIS ON THE BACKGROUND OF HEPATITIS C RESPONDING TO TREATMENT OF THE VIRUS – A CASE REPORT H. Khan; Prayman Sattianayagam, United Kingdom CC090 A RARE CAUSE OF FULMINANT ACUTE LIVER FAILURE IN A YOUNG ADULT Gonçalo Alexandrino, Portugal; S. Bernardo; P. Marcelino CC091 ADULT CAVERNOUS HEMANGIOMA MISDIAGNOSED RADIOLOGICALLY AS ATYPICAL HEPATOCELLULAR CARCINOMA :CASE REPORT. H. El Alfy; K. Farid; M. Elegezy; A. El Nakib; Ahmed Ibrahim, Egypt; M. Abd El Wahab; K. Zalata; A. Abd El Rahman; M. El-Bendary; M. El Bendary CC092 WHEN STONES DECIDE TO ROLL Ana-Maria Bucalau, Belgium; M. Arvanitakis; M. Pezzullo; M. Zalcman; E. Coppens; D. Blero; N. Nayer; J. Carro Valdes; P. Loi CC093 FISHING FOR A CAUSE OF OBSTRUCTIVE JAUNDICE Wee Khoon Ng, Singapore; R. S. Tang; J. Y. Lau Poster Session 15:45 – 17:15 E-Poster Lounge 2 Exemplary Clinical Cases III Chairs: Christopher John Hawkey, United Kingdom
CC086 PNEUMATOSIS CYSTOIDES INTESTINALIS. A CASUAL ENDOSCOPIC FINDING Pilar Ibarrola Arevalo, Spain; B. Agudo Castillo; M. Magaz Martínez; B. Oliva del Rio; L. E. Abreu García
CC094 METASTATIC CROHN'S DISEASE WITH OROFACIAL INVOLVEMENT Rui Morais, Portugal; F. Magro; R. Silva; G. Macedo
CC087 SUCCESSFUL DETECTION, CYTOLOGICAL DIAGNOSIS AND LOCAL ETHANOL ABLATION TREATMENT OF A SYMPTOMATIC 6 MM INSULINOMA IN THE PANCREATIC HEAD BY ENDOSONOGRAPHY (EUS) Dirk Brenke, Germany; T. Topalidis; L. Goßner
CC095 CROHN’S DISEASE AND ACQUIRED VON WILLEBRAND SYNDROME: A RARE DANGEROUS AFFAIR OR AN UNDERDIAGNOSED ASSOCIATION? Roberto Grassia, Italy; P. Capone; F. Pasin; S. Testa; G. P. Coppeta; F. Cereatti; E. Iiritano; K. Vjero; F. Buffoli
Poster Session 09:00 – 10:00 E-Poster Lounge 2 Exemplary Clinical Cases II Chairs: Maria Chiara Petrone, Italy Frank Tacke, Germany CC088 YELLOWISH SPUTUM: WHAT IS YOUR DIAGNOSIS ? Laura Bromberg, Belgium; M. bruyneel; A. Peeters; G. Dapri Poster in the Spotlight
Poster of Excellence
CC096 A VERY RARE FORM OF PRESENTATION OF CROHN’S DISEASE – A CASE OF DIAGNOSTIC CHALLENGE Joana Rita Carvalho, Portugal; I. Goulart; J. Tavares; P. M. dos Santos; F. Serejo; C. Ferreira; J. Velosa CC097 RESOLUTION OF ULCERATIVE COLITIS RELATED EXTRAINTESTINAL PULMONARY MANIFESTATION BY ANTI-TNF THERAPY Sarah Fischer, Germany; J. Köhler; M. F. Neurath; R. Atreya
Clinical Case Session
207
Tuesday, October 31, 2017
Poster Session 09:00 – 10:00 E-Poster Lounge 1 Exemplary Clinical Cases I Chairs: Tomer Adar, USA Bjorn Rembacken, United Kingdom
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
CC098 A COMPLEX CASE OF FEVER IN A PATIENT UNDER ANTI-TNF THERAPY Joana Veloso do Carmo, Portugal; J. Rodrigues; L. Carvalho; M. Túlio; M. Bispo; C. Chagas CC099 LABIAL ULCER IN A PATIENT WITH CROHN’S DISEASE – AN UNEXPECTED DIAGNOSIS Marco Silva, Portugal; M. Silva; A. Peixoto; S. Lopes; S. Magina; C. Lisboa; F. Magro; G. Macedo CC100 HEPATOSPLENIC T CELL LYMPHOMA : A RARE COMPLICATION OF MONOTHERAPY WITH AZATIOPRINE IN CHRON’S DISEASE Joana Carvão, Portugal; V. Magno Pereira; C. Sousa Andrade; H. Morna; F. Jacinto; M. Cordeiro; M. Pires; L. Jasmins
Tuesday, October 31, 2017
CC101 SEVERE SMALL INTESTINAL BLEEDING SECONDARY TO DIFFUSE IMMUNE MEDIATED ENTERITIS AFTER SUBTOTAL COLECTOMY FOR STEROID REFRACTORY ULCERATIVE COLITIS Rangarajan Purushothaman, Singapore; S. C. Kong; P. W. Chan; S. W. Chuah; K. H. Lim; L. T. Choong; B. H. Tan; S. J. Mesenas; G. S. Tan; B. J. Schwender CC102 AN UNUSUAL CAUSE OF CHRONIC DIARRHOEA Joyce Mak, Hong Kong PRC; Y. T. Hui; T. W. J. Lam; W. H. Li; K. H. Kwok Poster Session 09:00 – 17:00 Clinical Cases II
Hall 7
Liver / Biliary / Pancreas CC042 NOVEL HUMAN LEUCOCYTE ANTIGEN ASSOCIATION WITH AMOXICILLIN/CLAVULANATE-INDUCED FULMINANT HEPATIC FAILURE Kalaiyarasi Kaliyaperumal, Singapore; W. Griffiths; G. Aithal; A. Duckworth CC043 A CASE REPORT OF USTEKINUMAB- INDUCED ACUTE LIVER INJURY Rosa Lovero, Italy; G. Losurdo; M. Mastromauro; N. M. Castellaneta; A. Mongelli; A. Gentile; A. Di Leo
208
CC044 A RARE CASE OF JAUNDICE: HEPATIC LEPTOSPIROSIS, OBSTRUCTIVE POLYP OF DUODENAL PAPILLA IN A PATIENT WITH CHRONIC HEPATITIS B Boroka Horeanga, Romania; C. A. Dutei; M. Barbu; O. E. Balas; I. A. Husar-Sburlan; M. Ciocirlan; M. Manuc; C. M. Preda; M. Diculescu CC045 FAILURE OF PROPER ASSESSMENT OF FIBROSIS STAGE BEFORE DAAS IN THOSE WITH CONCURRENT HBV INFECTION MAY END UP WITH LIVER TRANSPLANTATION: A CASE STUDY Ahmed Kamal, Egypt CC046 LATE HEPATITIS B VIRUS REACTIVATION AFTER RITUXIMAB – HOW LONG SHOULD WE KEEP SURVEILLANCE? Joana Castela, Portugal; S. Mão de Ferro; A. Dias Pereira CC047 REVERSION OF A PREVIOUS SEROCONVERSION OF HBV AFTER RENAL TRANSPLANT Sahar Hassany, Egypt; W. Hassan CC048 REACTIVATION OF PAST HBV INFECTION AFTER SUCCESFULL HCV TREATMENT WITH SOFOSBUVIR-LEDIPASVIR IN A HCV/HIV COINFECTED PATIENT. Dina Chaaro, Spain; B. Maldonado Pérez; P. Cordero Ruiz; M. F. Guerra Veloz; I. Carmona Soria; A. Caunedo Álvarez CC049 THERAPEUTIC APHERESIS IN A PATIENT WITH THYROTOXICOSIS WITH SEVERE HEPATIC COMPLICATIONS AND LIVER CIRRHOSIS FROM CHRONIC HEPATITIS B INFECTION Everly Faith Ramos, Philippines; G. C. Floro; D. Bernardo; D. Gauiran CC050 ACUTE LIVER FAILURE SECONDARY TO DIFFUSE LIVER INFILTRATION BY OESOPHAGEAL SQUAMOUS CELL CARCINOMA – AN UNEXPECTED AND RARE MANIFESTATION. Pedro Marques Da Costa, Portugal; S. Fernandes; M. Verdelho Machado; C. Baldaia; A. Valente; R. Palma; A. Costa e Silva; J. Velosa CC051 ACUTE SICKLE CELL INTRAHEPATIC CHOLESTASIS- A RARE CAUSE OF ACUTE LIVER FAILURE Sonia Bernardo, Portugal; A. Cristino; N. Fatela; R. T. Marinho; S. Pina; A. Figueiredo; G. Alexandrino; R. Perdigoto; E. Mateus; A. Morbey; M. Mendes; H. Glória; E. Barroso; H. C. Pinto; J. Velosa
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Tuesday, October 31, 2017
Poster Sessions : UEG Week Final Programme
CC052 ATYPICAL FUNGAL INFECTION BY BIPOLARIS AND CURVULARIA IN POST LIVER TRANSPLANT PATIENT: A CASE REPORT Menahil Fatima, Pakistan; M. A. Baig; N. H. Shah; F. S. Dar CC053 A RARE CASE OF RECURRENT VARICEAL BLEEDING DUE TO NON-CIRRHOTIC PORTAL HYPERTENSION (NCPH) IN BEHÇET'S DISEASE A. Hinkson; Selena Dixon, United Kingdom; S. Moreea CC054 A RARE CAUSE OF AN ABDOMINAL MASS IN A PATIENT WITH ACUTE NECROTIZING PANCREATITIS Joana C. Branco, Portugal; L. Lourenço; A. Oliveira; L. Santos; D. Horta; J. Reis
CC057 A PATIENT WITH COLLOID CARCINOMA OF THE PANCREAS FOLLOWED FOR 13 YEARS PREOPERATIVELY AND ALIVE 10 YEARS AFTER TOTAL PANCREATECTOMY Yoshihiro Hamada, Japan; D. Kato CC058 PANCREATOBLASTOMA: AN UNUSUAL DIAGNOSIS IN A YOUNG ADULT PATIENT Gonçalo Nunes, Portugal; D. Gonçalves; R. Barosa; M. Patita; P. Pinto Marques; M. J. Brito; A. Tomaz; J. Fonseca CC059 A CASE OF MIXED ADENONEUROENDOCRINE CARCINOMA OF THE PANCREAS Fabiana Capuano, Italy; A. Amodio; P. Campagnola; S. F. Crinó; A. Brandolese; T. M. Rogger; A. Gabbrielli; L. Frulloni Surgery / Endoscopy / Imaging CC060 ATTEMPT AT ENDOSCOPIC REMOVAL OF A LESION MIMICKING APPENDIX ORIFICE CAUSED BY INGESTION OF MULTIPLE MAGNET Seung Jun Gim, Republic of Korea; H. H. Lee; H. K. Chang
CC063 RAPIDLY GROWING HAMARTOMA OF THE COLON IN AN ADULT WITH ULCERATIVE COLITIS Mamoru Ito, Japan; M. Yoshioka; M. Kaneto; S. Yabe; S. Saito; M. Fujii; S. Ishiyama; A. Fujiwara; J. Nasu; J. Shiode; K. Yamamoto CC064 RENAL TRANSPLANT IN SECONDARY AMYLOIDOSIS ASSOCIATED WITH CLINICALLY INDOLENT CROHN'S DISEASE Carlos Bernardes, Portugal; D. F. B. Carvalho; R. Loureiro; S. Santos; J. Saiote; J. Ramos CC065 MIXED ADENONEUROENDOCRINE CARCINOMA OF THE RECTUM IN A PATIENT WITH ULCERATIVE COLITIS Rui Gaspar, Portugal; J. Santos-Antunes; M. Marques; R. Liberal; D. Melo; P. Pereira; S. Lopes; G. Macedo CC066 C3 GLOMERULOPATHY AS AN EXTRA-INTESTINAL MANIFESTATION OF ULCERATIVE COLITIS – A RARE ASSOCIATION Pedro Marques Da Costa, Portugal; N. Rodrigues; H. Silva; L. Correia; L. Correia; H. Cortez-Pinto; J. Velosa CC067 ABIOTROPHIA DEFECTIVA: A RARE GUT PATHOGEN RESULTING ENDOCARDITIS IN INFLAMMATORY BOWEL DISEASE Yu Jun Wong, Singapore; B. J. Schwender CC068 RARE CAUSE IN THE DIFFERENTIAL DIAGNOSIS OF ULERATIVE COLITIS Marco Silva, Portugal; A. Peixoto; H. Cardoso; G. Macedo CC069 COLIC LEUKOCYTOCLASTIC VASCULITIS – CORTICOID RESPONSIVE COLITIS João Carlos Silva, Portugal; A. P. Silva; J. Silva; A. Ponte; J. Rodrigues; M. Sousa; R. Pinho; G. Lage; A. Furtado; J. Carvalho
Clinical Case Session
209
Tuesday, October 31, 2017
CC056 ACUTE PANCREATITIS OF INFREQUENT ETIOLOGY: ANAFILÁCTIC SHOCK AFTER KIWI'S INGESTION J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain
Poster of Excellence
CC062 ESOPHAGEAL STENTS IN AORTOESOPHAGEAL FISTULAS – ANECDOTAL EXPERIENCES OR NEW ARMAMENTARIUM? Eduardo Rodrigues-Pinto, Portugal; P. Pereira; F. Vilas-Boas; A. Peixoto; M. Silva; G. Macedo Lower GI
CC055 INFREQUEN CAUSE OF ACUTE PANCREATITIS. CURETTAGE J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain
Poster in the Spotlight
CC061 BLEEDING HEPATIC CYST – AN UNUSUAL COMPLICATION OF COLONOSCOPY L. Mlynarsky; I. Nachmany; Rafael Bruck, Israel
UEG Week Final Programme : Poster Sessions
Tuesday, October 31, 2017
CC070 SHOULD MESALAZINE PREVENT ISCHEMIC COLITIS? Deborah Costa, Italy; C. Perini; F. Capuano; S. Di Stefano; G. Vettori; C. Cusumano; L. Frulloni CC071 INTESTINAL LYMPHANGIECTASIA IN THE ADULT IN CAPSULA STUDY ENDOSCOPIC IN RELATION TO CHRONIC DIARRHEA STUDY J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain CC072 ISCHEMIC COLITIS DUE TO VENOUS COMPROMISE. Sergey Skridlevskiy, Russian Federation; V. Veselov; V. Veselov; S. Achkasov; I. Nazarov; O. Mainovskaya; I. Semenova; L. Orlova; Y. Vaganov
CC076 HAEMORRHAGE DUE TO CYTOMEGALOVIRUS OESOPHAGITIS AND DUODENITIS Luís Maia, Portugal; A. Castro; T. Moreira; T. Araujo; S. Barrias; R. Küttner Magalhães; P. S. Salgueiro; R. Marcos-Pinto; M. Rocha; M. Salgado; I. Pedroto CC077 LATE MESH MIGRATION AFTER NISSEN FUNDUPLICATION MIMICKING A GASTRIC NEOPLASM UNDER ECHOENDOSCOPIC VIEW Felipe Martínez-Alcala, Spain; A. Martinez- Alcala García; C. Martínez- Alcalá; F. Martínez Alcalá
Tuesday, October 31, 2017
Upper GI
CC078 DILATION FOR DIAGNOSE. A RARE CAUSE OF ESOPHAGEAL STENOSIS Josue Umana, Honduras; J. Suazo; R. Zelaya; F. Ramirez; V. Portillo; S. Portillo
CC073 THE OTHER SIDE OF THE COIN IN EOSINOPHILIC GASTROENTERITIS: A RARE FORM OF PRESENTATION OF THIS UNCOMMON GASTROINTESTINAL ENTITY Elisa Soares, Portugal; I. Cunha; M. Gravito-Soares; S. Mendes; L. Tomé
CC079 INTESTINAL PSEUDOPOLYPS IN A PATIENT WITH CROHN'S DISEASE AND RENAL TRANSPLANT – AN UNEXPECTED DIAGNOSIS Marco Silva, Portugal; A. Peixoto; A. C. R. Nunes; E. Rios; G. Macedo
CC074 MÉNÉTRIER´S DISEASE: A CASE OF SUCCESSFUL TREATMENT USING LONG-ACTING OCTREOTIDE Gonçalo Nunes, Portugal; R. Barosa; M. Patita; P. Pinto Marques; D. Gonçalves; C. Fonseca; A. Alves de Matos; J. Fonseca
CC080 THERE IS SOMETHING FISHY WITH THIS PANNICULITIS Laura Mans, Belgium; A.-M. Bucalau; A. Hadefi; M. Zalcman; P. Demetter; P. Eisendrath; A. Buggenhout; J. Deviere; M. Arvanitakis; M. Fernandez Y Viesca
CC075 SECONDARY ESOPHAGITIS TO THE VARICELA-ZÓSTER VIRUS ON A MALE IMMUNOCOMPETENT YOUNG J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain
CC081 STRONGYLOIDIASIS - A CHALLENGING DIAGNOSIS Carolina Simões, Portugal; D. Neves; A. C. Quadros; N. Fatela; A. Pereira; E. Vitorino; L. Carrilho Ribeiro; J. Velosa
We give your ideas green light! UEG provides a great collection of awards, fellowships and prizes to encourage research.
Find out more, visit www.ueg.eu/awards-grants
210
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
Poster Sessions by Day Wednesday, November 1, 2017 Posters in the Spotlight 08:30 – 10:00 E-Poster Lounge 1 Detecting and removing colonic lesions Chairs: Roger Leicester, United Kingdom Brian P. Saunders, United Kingdom
Posters in the Spotlight 10:30 – 12:00 E-Poster Lounge 1 Bugs and viruses causing GI diseases Chair: Tamara Matysiak Budnik, France Francis Megraud, France
P1530 WHAT IMPROVED AND WHAT REMAINS TO BE ACHIEVED IN ORDER TO COMPLY WITH THE NEW RECOMMENDATIONS OF POLYPECTOMY BY THE EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY
P1908 COMPARISON OF THE EFFICACY BETWEEN BISMUTH AND ALTERNATING RIFAXIMIN ON SECOND-LINE QUADRUPLE REGIMEN OF HELICOBACTER PYLORI ERADICATION.
P1528 MANAGEMENT OF RESECTION OF LARGE COLONIC LESIONS IN A REAL-LIFE SETTING: THE SCALP STUDY.
P1917 MANAGEMENT OF HELICOBACTER PYLORI INFECTION AT PRIMARY CARE LEVEL. THE IMPLEMENTATION OF SPECIFIC COUNSELLING IMPROVES ERADICATION RATES.
P1529 ENDOSCOPIC REMOVAL OF HIGH-RISK COLORECTAL ADENOMAS: SAFE AND EFFECTIVE?
P1907 HIGH DOSE CAM WITH VONOPRAZAN (P-CAB) PLUS AMX TRIPLE THERAPY REGIMEN IS THE STRONGEST H.PYLORI ERADICATION THERAPY EVEN IF CAM RESISTANCE.
Posters in the Spotlight 08:30 – 10:00 E-Poster Lounge 2 Clinical observations in oesophageal cancer Chairs: Teresa Macarulla, Spain Thomas Seufferlein, Germany P1866 OUTCOMES OF TREATMENT OF PATIENTS WITH EARLY-STAGE ADENOCARCINOMA OF THE ESOPHAGUS WITH INCIPIENT SUBMUCOSAL INVASION, RETROSPECTIVE ANALYSIS OF 19 CASES FROM A TERTIARY REFERRAL CENTER IN THE UK P1870 OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL PHARYNGEAL SQUAMOUS CELL CARCINOMA P1868 CLINICAL OUTCOMES OF ENDOSCOPIC RESECTION FOR ACHALASIA-ASSOCIATED SUPERFICIAL ESOPHAGEAL CANCER
P1635 ANAL CANAL HUMAN PAPILLOMAVIRUS (HPV) INFECTION IN MEN AND WOMEN UNDERGOING COLONOSCOPY: PREVALENCE AND RISK FACTORS, HIGH BURDEN IN CROHN'S DISEASE PATIENTS. P1725 ASSOCIATION OF FUSOBACTERIUM NUCLEATUM IN ORAL CAVITY AND COLORECTAL CARCINOMAS P1610 FECAL MICROBIAL DYSBIOSIS IN CHINESE PATIENTS WITH INFLAMMATORY BOWEL DISEASE Posters in the Spotlight 10:30 – 12:00 E-Poster Lounge 2 Progress in our understanding of colorectal inflammation and neoplasia Chairs: Victor Moreno, Spain Arthur Kaser, United Kingdom P1616 THE IMPACT OF THE RS8005161 POLYMORPHISM ON G PROTEIN-COUPLED RECEPTOR GPR65 (TDAG8) PH-ASSOCIATED SIGNALING IN INTESTINAL INFLAMMATION P1618 CD16 POSITIVE CELLS EXPRESS TGF? AND MEDIATES MURINE INTESTINAL FIBROSIS
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
211
Wednesday, November 1, 2017
P1534 THE INFLUENCE OF THE REAL FOLLOW-UP TIMES DURING A COLORECTAL CANCER SCREENING PROGRAM IN DAILY PRACTICE
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1619 GTS-21, ?7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ATTENUATE DSS-INDUCED COLITIS BY IMPROVING INTESTINAL MUCOSAL BARRIER FUNCTION P1623 ZIP7 INDUCES DISRUPTION OF THE INTESTINAL BARRIER THROUGH ACTIVATION OF ENDOPLASMIC RETICULUM STRESS IN INFLAMMATORY BOWEL DISEASE P1753 COLORECTAL CANCER CELLS INDUCE NEUROGENESIS IN THE ENTERIC NERVOUS SYSTEM OF THE TUMOR MICROENVIRONMENT VIA A NGF-DEPENDENT PATHWAY P1729 BACTERIOCIN PRODUCTION BY MUCOSAL BACTERIA IN COLORECTAL NEOPLASIA Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 1 Poster Champ Session: Upper gastrointestinal diseases Chairs: Pali Hungin, United Kingdom Ernst J. Kuipers, The Netherlands P1811 CLINICAL FEATURES OF DELAYED BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC NEOPLASMS IN HIGH-RISK AND LOW-RISK PATIENTS P1818 EFFECTS OF FAECAL MICROBIOTA TRANSPLANTATION ON NEUROGENIN 3, MUSAHSI 1 AND ENTEROENDOCRINE CELLS IN THE DUODENUM OF PATIENTS WITH IRRITABLE BOWEL SYNDROME P1819 THE EFFECT OF ESOPHAGEAL ACID EXPOSURE ON NMDA RECEPTOR SUBUNITS EXPRESSION AND D-SERINE IN PREFRONTAL CORTEX AND HIPPOCAMPUS
Wednesday, November 1, 2017
P1837 HIGH-RESOLUTION ESOPHAGEAL MANOMETRY: EVALUATION OF NEW SYSTEMS FOR THE ACQUISITION AND ANALYSIS. P1838 PROTON PUMP INHIBITOR THERAPY IMPROVES ESOPHAGEAL SYMPTOMS BY RESTORING A NORMAL ESOPHAGEAL PERISTALSIS IN PATIENTS WITH PROTON PUMP INHIBITOR-RESPONSE ESOPHAGEAL EOSINOPHILIA P1843 SYSTEMATIC ANALYSIS OF SUBEPITHELIAL EOSINOPHIL COUNTS INCREASES DIAGNOSTIC YIELD IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS
212
P1845 THE LOCATION OF OESOPHAGEAL MUCOSAL AFFERENT NERVES ARE MORE SUPERFICIAL IN PATIENTS WITH NERD THAN IN HEALTHY VOLUNTEERS AND PATIENTS WITH BARRETT'S OESOPHAGUS P1846 BELCHING PATTERNS IN PATIENTS WITH ISOLATED PATHOLOGICAL UPRIGHT REFLUX AND PATHOLOGICAL BIPOSITIONAL REFLUX P1928 USEFULNESS OF BULB BIOPSY SAMPLES IN CELIAC DISEASE DIAGNOSIS IN ADULTS P1940 VALIDATION OF A SCORE CHART TO PREDICT THE RISK OF CHRONIC MESENTERIC ISCHEMIA: A DISCRIMINATIVE AND USEFUL TOOL IN CLINICAL DECISION-MAKING P1959 TAUROLIDINE PREVENTS CATHETER-RELATED BLOODSTREAM INFECTIONS IN PATIENTS ON HOME PARENTERAL NUTRITION – A RANDOMIZED CONTROLLED TRIAL Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 2 Poster Champ Session: Liver, biliary and pancreatic diseases Chairs: Asbjørn Drewes, Denmark Alessio Aghemo, Italy P1399 DIGITAL, SINGLE-OPERATOR CHOLANGIOPANCREATOSCOPY IN THE DIAGNOSIS AND MANAGEMENT OF PANCREATOBILIARY DISORDERS: RESULTS FROM THE MULTICENTER CZECH AND SLOVAK NATIONAL DATABASE P1418 LONG-TERM OUTCOMES OF A FULLY COVERED SELF-EXPANDABLE METAL STENT WITH ANTIMIGRATION PROPERTIES FOR EUS-GUIDED PANCREATIC DUCT DRAINAGE P1317 BMP1-3 IN LIVER FIBROSIS P1374 EFFECT OF FIBROBLAST GROWTH FACTOR-2 AND ITS RECEPTOR GENE POLYMORPHISMS ON SURVIVAL IN PATIENTS WITH HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA P1369 HOW OFTEN DO WE FIND STEATOSIS AND SEVERE FIBROSIS IN TYPE 2 DIABETES MELLITIUS PATIENTS
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1326 METABOLOMICS IDENTIFIES PROGRESSIVE NAFLD P1383 THE EVOLUTION OF ESOPHAGEAL VARICES IN NON CIRRHOTIC PORTAL HYPERTENSION CAUSED BY PORTAL VEIN THROMBOSIS P1323 LONG-TERM COPPER EXPOSURE OF HEPATIC CELLS LACKING FUNCTIONAL ATP7B
P1423 TRYPTOPHAN DEGRADATION AS AN ALTERNATIVE ENERGY SOURCE IN PANCREATIC CANCER Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 3 Poster Champ Session: Lower gastrointestinal diseases Chairs: Arthur Kaser, United Kingdom Ibrahim Ethem Gecim, Turkey P1795 THE RISK PREDICTIVE VALUES OF ACG CLASSIFICATION IN A COHORT OF ISCHEMIC COLITIS – REFINING THE DEFINITION OF MILD DISEASE P1772 EFFICACY AND SAFETY OF TWELVE CHEMOPREVENTIVE REGIMENS FOR THE RECURRENCE OF COLORECTAL ADENOMAS: A NETWORK META-ANALYSIS P1665 GLYCEMIC CONTROL AND INSULIN RESISTANCE IN PATIENT WITH INFLAMMATORY BOWEL DISEASE – PRELIMENARY RESULTS FROM THE POLIBD STUDY. P1779 LOW UPTAKE OF PSYCHOLOGICAL THERAPIES AMONG PATIENTS WITH IRRITABLE BOWEL SYNDROME IN SECONDARY CARE.
Poster of Excellence
P1679 THE ADDITION OF AN IMMUNOSUPPRESSANT IS AN EFFECTIVE OPTIMIZATION STRATEGY AFTER LOSS OF RESPONSE TO ANTI-TNF ALPHA MONOTHERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TWO-YEAR STUDY P1698 ENDOSCOPIC SUBMUCOSAL DISSECTION OF ULCERATIVE COLITIS-ASSOCIATED DYSPLASIA: A SINGLE CENTER BASED EXPERIENCE P1704 POST-MARKETING SAFETY EXPERIENCE OF VEDOLIZUMAB IN PATIENTS WITH PRE-EXISTING VIRAL HEPATITIS P1711 REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD) Poster Champ Session 12:30 – 13:30 Scientific Centre: Terminal 4 Poster Champ Session: Surgery, endsocopy and imaging Chairs: Ioannis Papanikolaou, Greece Maria Chiara Petrone, Italy P1575 DEDICATED DIFFUSION WEIGHTED MR IMAGING FOR STAGING PERITONEAL METASTASES IN COLORECTAL CANCER; AN ACCURATE PREOPERATIVE SELECTION TOOL FOR CYTOREDUCTION SURGERY (CRS/HIPEC) CANDIDATES P1506 HIGH LEVELS OF "PRESUMED POLYP MISS RATE" AT 1 AND 3 YEARS FOLLOWING INDEX SCREENING COLONOSCOPY: NO ROOM FOR COMPLACENCY.
Clinical Case Session
213
Wednesday, November 1, 2017
P1389 THE IMPACT OF BARIATRIC SURGERY ON ACUTE CHOLANGITIS MORTALITY AND OTHER OUTCOMES: A NATIONWIDE ANALYSIS
Poster in the Spotlight
P1660 SIMPLIFIED MR ENTEROCOLONOGRAPHY CLASSIFICATION BASED ON ENDOSCOPIC FINDINGS FOR ACTIVITY ASSESSMENT OF CROHN'S DISEASE P1674 THE DIAGNOSTIC VALUE OF MIRNA-320A AS A BIOMARKER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
P1321 AUTOMATED RAPID DETECTION SYSTEM USING THE QUENCHING PROBE METHOD FOR DETECTING RS738409 POLYMORPHISM IN PNPLA3 IN NONALCOHOLIC FATTY LIVER DISEASE
P1626 PROSTACYCLIN REVERSES COLITIS THROUGH THE DOWN REGULATION OF INTESTINAL EPITHELIAL PERMEABILITY
P1631 ILEAL SULFOMUCINS PREDICT CLINICAL RECURRENCE AFTER ILEO-COLONIC RESECTION FOR CROHN'S DISEASE: A PROSPECTIVE STUDY AT 5 YEARS
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1499 MULTIPLE COLORECTAL ADENOMAS WITHOUT APC OR MUTYH GERMLINE MUTATION: A HETEROGENEOUS SUBGROUP OF PATIENTS
Poster Session 09:00 – 14:00 Liver and Biliary III
P1535 CLINICAL OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF MALIGNANT NON-PEDUNCULATED COLORECTAL LESIONS
Molecular biology, inflammation and fibrosis
P1573 HOW MANY CAPSULE ENDOSCOPY STUDIES CAN BE READ IN A GIVEN SESSION BEFORE ACCURACY IS AFFECTED? P1456 THE VALUE OF ENDOSCOPIC FULL-THICKNESS RESECTION FOR GASTRIC AND DUODENAL SUBMUCOSAL TUMORS ORIGINATING FROM THE MUSCULARIS PROPRIA LAYER P1462 CAP ASSISTED UPPER ENDOSCOPY VERSUS SIDE-VIEWING ENDOSCOPE FOR EXAMINATION OF THE MAJOR DUODENAL PAPILLA: A RANDOMIZED, BLINDED, CONTROLLED, NON-INFERIORITY CROSSOVER STUDY (CAPPA-II STUDY) P1480 TRENDS IN CERTIFICATION FOR GASTROINTESTINAL ENDOSCOPY AND VARIATIONS BETWEEN TRAINEE SPECIALTIES: RESULTS FROM THE UK TRAINEE ENDOSCOPY DATABASE P1451 EXPOSURE TO ENDOTHERAPY FOR UPPER GASTROINTESTINAL BLEEDING AT THE POINT OF GASTROSCOPY CERTIFICATION – IS IT SUFFICIENT?
Wednesday, November 1, 2017
P1487 COMPARISON BETWEEN AN ASYMMETRIC (SMALL DOSE IN THE MORNING) AND A SYMMETRIC SPLITDOSE REGIMEN OF POLYETHYLENE GLYCOL PLUS BISACODYL FOR BOWEL PREPARATION FOR SCREENING COLONOSCOPY: A RANDOMIZED NON-INFERIORITY CLINICAL TRIAL P1517 OUTCOMES OF ENDOSCOPIC RESECTION OF RECURRENT COLORECTAL LESIONS TREATED AT A UK TERTIARY REFERRAL CENTRE
Hall 7
P1311 REGULATION OF MICRORNAS BY P53 FAMILY MEMBERS IN HEPATOCELLULAR CARCINOMA Rafael Hermelink, Germany; M. Bender; L. Kaser; E. Aschenbrenner; K. Pollinger; C. Kunst; M. Müller-Schilling P1312 IGFBP2 IS REGULATED BY THE P53 FAMILY OF TRANSCRIPTION FACTORS IN HEPATOCELLULAR CARCINOMA Dana Gschwind, Germany; M. Lohse; E. Aschenbrenner; K. Pollinger; S. Schlosser; C. Kunst; M. Müller-Schilling P1313 HOW TO IMPROVE THE RELIABILITY OF LIVER FIBROSIS EVALUATION USING 2D-SWE.GE Felix Bende, Romania; I. Sporea; R. Sirli; M. Danila; S. A. Popescu P1314 MONITORING OF LIVER FUNCTION IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH METABOLIC SYNDROME Krystyna Kvit, Ukraine; E. Sklyarov; N. Kurlyak; A. Bochar P1315 IDENTIFICATION OF P73 AS A NOVEL TRANSACTIVATOR OF IGFBP4 GENE EXPRESSION IN HEPATOCELLULAR CARCINOMA D. Gschwind; Sebastian Heckel, Germany; E. Aschenbrenner; K. Pollinger; S. Schlosser; C. Kunst; M. Müller-Schilling P1316 NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH 2 TYPE DIABETES MELLITUS AND CORONARY HEART DISEASE AGAINST THE BACKGROUND OF METABOLIC SYNDROME. HOW TO DIAGNOSE? Krystyna Kvit, Ukraine; E. Sklyarov; N. Kurlyak; A. Bochar P1317 BMP1-3 IN LIVER FIBROSIS I. Grgurevic; Lovorka Grgurevic, Croatia; S. Vukicevic; I. Erjavec; I. Dumic Cule Metabolic/genetic disorders P1318 LIVER TRANSIENT ELASTOGRAPHY IN NON-ALCOHOLIC FATTY LIVER DISEASE: IS THERE ANY PREDICTIVE ROLE IN THE DEVELOPMENT OF COLORECTAL POLYPS? Marta Gravito-Soares, Portugal; E. Gravito-Soares; D. Gomes; A. Simão; L. Tomé
214
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1320 CHARACTERIZATION OF CISPLATIN RESISTANCE IN HEPATOMA CELL LINES Sarah Guttmann, Germany; G. Chandhok; S. Reinartz Groba; C. Niemietz; V. Sauer; G. Ciarimboli; U. Karst; A. Zibert; H. Schmidt P1321 AUTOMATED RAPID DETECTION SYSTEM USING THE QUENCHING PROBE METHOD FOR DETECTING RS738409 POLYMORPHISM IN PNPLA3 IN NONALCOHOLIC FATTY LIVER DISEASE Yasunori Kawaguchi, Japan; A. Nakamura; K. Shibayama; F. Koga; S. Nakashita; D. Mori P1322 EFFECT OF ORLISTAT ON TOTAL LIVER FAT QUANTIFICATION BY NOVEL MAGNETIC RESONANCE IMAGING IN OBESE PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS: INTERIM ANALYSIS OF A PROSPECTIVE, RANDOMIZED, SINGLE CENTER, OPEN-LABEL TRIAL J. Ye; W. Yanqin; H. Xuan; Zhong Bihui, China P1323 LONG-TERM COPPER EXPOSURE OF HEPATIC CELLS LACKING FUNCTIONAL ATP7B Sarah Guttmann, Germany; S. Reinartz Groba; C. Niemietz; P. Ballmaier; R. Muhmann; V. Sauer; A. Zibert; H. Schmidt P1324 THE NONALCOHOLIC FAT LIVER DISEASE FIBROSIS SCORE IN PREDICTING FIBROSIS IN MORBIDLY OBESE PATIENTS BEFORE BARIATRIC SURGERY R. G. Silva Junior; Thicianie Fauve Andrade Cavalcante, Brazil; W. R. Freitas Júnior; A. Vieira; L. A. Szutan P1325 COMPARISON OF FIBROSCAN® AND FATTY LIVER INDEX (FLI) TO SCREEN FOR FATTY LIVER DISEASE IN A LARGE COHORT OF EMPLOYEES: WHERE IS THE OPTIMAL CUT OFF? Manuela Teufelhart, Austria; C. Rabitsch; B. Mehl; R. Winker; B. Meyer; T.-M. Scherzer P1326 METABOLOMICS IDENTIFIES PROGRESSIVE NAFLD Dana Crisan, Romania; M. Grigorescu; A. Suciu; H. Stefanescu; F. Romanciuc; C. Socaciu; L. Avram; V. Donca; C. Radu
Poster in the Spotlight
Poster of Excellence
P1327 CHRONIC RENAL FAILURE IS ASSOCIATED WITH THE DEVELOPMENT OF NAFLD/NASH Sonja Gehring, Germany; P. Di Fazio; T. M. Gress; T. T. Wissniowski P1328 NONINVASIVE DIAGNOSICS OF NONALCOHOLIC FATTY LIVER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Krystyna Kvit, Ukraine; E. Sklyarov; A. Bochar P1329 NON-OBESE FATTY LIVER DISEASE IN TYPE 2 DIABETES: NOVEL CONDITION OR SIMILAR TO TYPICAL NAFLD STATE? N. Kobyliak; Natalia Bosak, Ukraine; G. Mykhalchyshyn; D. Kyriienko; O. Dynnyk P1330 CHARACTERIZATION OF LEAN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: RESULTS OF A COHORT STUDY Ahad Eshraghian, Iran; M. R. Fattahi; R. Niknam; S. A. Taghavi Cirrhosis and complications: Clinical aspects P1331 ASSESSING BAVENO VI CRITERIA WITH A NEW POINT-SHEAR WAVE ELASTOGRAPHY TECHNIQUE: THE BAVELASTPQ STUDY Matteo Garcovich, Italy; G. Gibiino; E. DI Stasio; B. E. Annicchiarico; E. Carli; M. E. Ainora; L. Riccardi; M. E. Riccioni; M. Pompili; M. Siciliano; A. Gasbarrini; M. A. Zocco P1332 PROTON PUMP INHIBITORS INTAKE NOT ASSOCIATED WITH HEPATIC ENCEPHALOPATHY IN CIRRHOTIC PATIENTS Cristina Teixeira, Portugal; A. Antunes; E. Dantas; A. M. Vaz; P. Queirós; A. L. Alves; B. Peixe; I. Cremers; H. Guerreiro; A. P. Oliveira P1333 CLINICAL IMPACT OF MULTIDRUG-RESISTANT BACTERIAL INFECTIONS IN LIVER CIRRHOSIS Ana Catarina Cunha, Portugal; A. G. Antunes; A. M. Vaz; P. Queirós; T. Gago; J. Roseira; A. R. Clara; M. S. Eusébio; B. Peixe; H. Guerreiro P1334 STATIN THERAPY IN THE REDUCTION OF PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Jose Guillain Cataluna, Philippines; J. G. Cervantes
Clinical Case Session
215
Wednesday, November 1, 2017
P1319 ‘SUBTRACTED ADULTHOOD MASS INDEX’ (SAMI)- A NEW INDEX TO PREDICT NAFLD RISK IN NON-OBESE INDIVIDUALS Ata Kıyak, Turkey; S. Elibol; M. Saruc; Ö. Saygılı; N. Tözün
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1335 IN HOW MANY PATIENTS WE WILL MISDIAGNOSE ESOFAGEAL VARICES BY USING THE BAVENO VI CRITERIA? Simona Alina Popescu, Romania; R. Lupusoru; R. Sirli; M. Danila; L. Gheorghe; A. Seicean; A.-V. Trifan; M. Curescu; A. Goldis; L. D. Sandulescu; C. Cijevschi Prelipcean; C. Stanciu; C. Brisc; S. Iacob; I. Sporea P1336 COMBINED RADIOLOGIC-BLOOD PARAMETERS AND BLOOD DERIVED NON-INVASIVE FIBROSIS SCORES IN PREDICTING OUTCOMES IN CHRONIC HEPATITIS C Ragesh Babu Thandassery, Qatar; H. Wani; S. Al Kaabi; M. Khanna P1337 A SMART APPROACH TO THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY Tatiana Nuzum, Ireland; M. Hussey; T. Khanna; E. MacGregor; J. Olaniyi; C. Tersaruolo; N. Breslin; D. McNamara P1338 MULTISPECIES PROBIOTIC ENRICHES THE MICROBIOME WITH LACTOBACILLUS AND LACTOCOCCUS AND REDUCES ENTEROCOCCUS ABUNDANCE IN PATIENTS WITH LIVER CIRRHOSIS: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL Angela Horvath, Austria; M. Durdevic; B. Leber; B. Schmerboeck; F. Rainer; P. Douschan; E. Krones; W. Spindelboeck; F. Durchschein; G. Zollner; R. Stauber; P. Fickert; P. Stiegler; V. Stadlbauer P1339 THE IMPACT OF DIABETES MELLITUS ON SHORT-TERM AND LONG-TERM OUTCOMES AFTER LIVER TRANSPLANTATION Ahad Eshraghian, Iran; S. Nikeghbalian; M. R. Fattahi; S. Ali Malek-Hosseini
Wednesday, November 1, 2017
P1340 VALIDATION OF THE BAVENO VI CRITERIA ON A COHORT OF CIRRHOTIC PATIENTS Iulia Maria Ratiu, Romania; R. Lupusoru; N. Baltes; C. Pienar; I. Sporea P1341 MORTALITY PREDICTING MODEL IN LIVER CIRRHOSIS PATIENTS Raluca Lupusoru, Romania; I. Sporea; S. A. Popescu; A.-M. Stepan; A. Pascaru; M. Danila; A. Barbulescu; I. M. Ratiu; B. Miutescu; R. Sirli P1342 BARIATRIC SURGERY IS ASSOCIATED WITH INCREASED RISK OF DEVELOPING ACUTE LIVER INJURY: A NATIONWIDE ANALYSIS Paul Thomas Kroener, USA; P. K. Wander; V. Popov; C. C. Thompson 216
Viral hepatitis B: Clinical aspects P1343 WITHDRAWN P1344 LONGITUDINAL MONITORING OF LIVER STIFFNESS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING ENTECAVIR Shengdi Wu, China; H. Ding; L. Liu; N. Xu; W. Jiang P1345 CHRONIC HEPATITIS B VIRUS INACTIVE CARRIERS – IMPACT OF METABOLIC DISORDERS IN STEATOSIS ASSESSED BY FIBROSCAN Sofia Xavier, Portugal; S. Monteiro; C. Arieira; J. Magalhães; C. Marinho; J. Cotter P1346 ANTIVIRAL EFFICACY OF UNANI HERBS (SAUSSUREA LAPPA AND ARTEMISIA ABSINTHIUM) IN CHRONIC HEPATITIS B Shabnam Ansari, India; M. A. Siddiqui; S. Malhotra; M. Maaz P1347 QUANTIFICATION OF SERUM HBSAG IS A HELPFUL MARKER TO OPTIMIZE THE MANAGEMENT OF ANTIVIRAL NUC THERAPY IN CHRONIC HBEAG-NEGATIVE HEPATITIS B. M. Guarino; M. Masarone; G. Portella; Anna Sessa, Italy; R. Bonavolta; N. Caporaso; F. Morisco P1348 IMPROVEMENTS IN CHRONIC HEPATITIS B PATIENTS AND THE ALTERATION IN GUT MICROBIOTA AFTER FECAL MICROBIOTA TRANSPLANTATION Chuanxing Xiao, China; B. Zhang; J. Ren P1349 EFFICACY OF PEGYLATED INTERFERON ALFA-2A ADD-ON THERAPY VERSUS NUCLEOSIDE ANALOGUE MONOTHERAPY IN TREATMENT-EXPERIENCED CHRONIC HEPATITIS B PATIENTS: A RANDOMISED, CONTROLLED, OPEN-LABEL TRIAL Xuan Hu, China; J. Ye; W. Yanqin; R. Li; C. Shao; Z. Bihui Viral hepatitis C: Clinical aspects P1350 HEPATITIS C IN LEBANON: BURDEN OF THE DISEASE AND VALUE OF COMPREHENSIVE SCREENING AND TREATMENT Antoine Abou Rached, Lebanon; S. Abi Kheir; J. Saba; S. Assaf; G. Kassis; Y. S. Gonzales; O. Ethgen
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1352 HEPATITIS C TREATMENT IN RENAL TRANSPLANTATION: THE EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRALS IN THE REAL LIFE. Liliana Carvalho, Portugal; J. Rodrigues; M. A. Túlio; T. Bana e Costa; L. Lebre; C. Chagas P1353 WHAT HAPPENED WITH LIVER STIFFNESS VALUES ASSESSED BY MEANS OF TRANSIENT ELASTOGRAPHY IN PATIENTS WITH HCV LIVER CIRRHOSIS AFTER DAA TREATMENT Ioan Sporea, Romania; R. Lupusoru; S. A. Popescu; A. Lazar; R. Mare; L. Gheorghe; S. Iacob; R. Sirli
Acute liver failure, transplantation/surgery P1359 IS AN ACUTE LIVER FAILURE REALLY ALWAYS AN ACUTE LIVER FAILURE? PRE-EXISTING LIVER DISEASE IS COMMON IN PATIENTS WITH ALF DIAGNOSIS Aline Gottlieb, Germany; J. P. Sowa; M. Kottmann; P. Manka; L. Bechmann; A. Canbay P1360 EFFECTS OF PREOPERATIVE TRANSARTERIAL CHEMOEMBOLIZATION ON PATIENTS’ SHORT TERM PROGNOSIS AFTER LIVER TRANSPLANTATION. Di Ma, China P1361 IMPORTANCE OF INTERFERON-GAMMA RELEASE ASSAYS IN EVALUATING CANDIDATES FOR LIVER TRANSPLANTATION IN A COUNTRY ENDEMIC FOR TUBERCULOSIS M. C. Lita; C.-C. Ester; S. Iacob; C. Pietrareanu; Razvan Cerban, Romania; C. Gheorghe; L. S. Gheorghe
P1354 ACHIEVING SVR AFTER DAA THERAPY FOR HCV DECREASES THE ACCURACY OF BAVENO VI CLASSIFICATION OF HIGH-RISK VARICES IN CIRRHOTIC PATIENTS Magda Rotaru, Romania; H. Stefanescu; A. Suciu; R. Sav; E. Pop; M. Lupsor; B. D. Procopet; A. Seicean; M. Tantau; Z. Sparchez; C. Radu
P1362 A NATIONAL STUDY OF CANCER DIAGNOSES IN IRISH LIVER TRANSPLANT RECIPIENTS WITH PRIMARY SCLEROSING CHOLANGITIS Susanne O'Reilly, Ireland; K. Hartery; M. Walshe; S. Deady; E. O'Leary; G. A. Doherty; D. Houlihan; G. Cullen; H. Mulcahy; J. Sheridan
P1355 ª MONOCYTE CHEMOATTRACTANT PROTEIN -1 CONCENTRATIONS IN SERUM DEPEND ON OVERWEIGHT IN CHRONIC HEPATITIS C PATIENTS AND INCREASE AFTER SUSTAINED VIROLOGIC RESPONSE Ivan Valkov, Bulgaria; T. Velikova; K. Tumangelova-Yuzeir; D. Kyurkchiev; K. Antonov
P1363 OUTCOME OF LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS IN CONTEXT OF HLA-DR MISMATCH: SINGLE CENTRE EXPERIENCE Pavel Drastich, Czech Republic; L. Bajer; A. Slavcev; M. Benes; P. Trunecka; J. Spicak
P1356 HLA –A02, HLA- A03 AND HLA-B15: A NEW RISK FOR HEPATIC STEATOSIS IN EGYPTIAN CHRONIC HEPATITIS C PATIENTS Raghda Farag, Egypt; M. M. Arafa; H. Elalfy; A. F. Ainin; Y. A. Mossad P1357 THE VALUE OF 2D-SWE.GE FOR THE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH HCV COMPENSATED CHRONIC HEPATOPATHIES Felix Bende, Romania; I. Sporea; S. A. Popescu; R. Sirli; M. Danila; R. Mare; A.-M. Stepan P1358 DE NOVO HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS AFTER TREATMENT WITH DIRECT ANTIVIRAL AGENTS P. Ruiz; Laura Deiss Pascual, Spain; L. Buendia; I. Erdozain; I. Esain; S. Blanco; A. Baranda; F. Menendez
Poster in the Spotlight
Poster of Excellence
P1364 GRAFT DYSFUNCTION IN POST-LIVER TRANSPLANTATION: UTILITY OF TRANSIENT ELASTOGRAPHY BY FIBROSCAN® Elisa Soares, Portugal; M. Gravito-Soares; D. Gomes; A. Simão; E. Furtado; L. Tomé P1365 NEW-ONSET DIABETES AFTER TRANSPLANT (NODAT): INCIDENCE, RISK ANALYSIS AND IMPACT ON SURVIVALNEW-ONSET DIABETES AFTER TRANSPLANT (NODAT): INCIDENCE, RISK ANALYSIS AND IMPACT ON SURVIVAL Yasir Abbas, Pakistan; K. Nawaz; M. Salih; N. Ullah; S. Saadat P1366 VITAMIN B12 AS A PROGNOSTIC MARKER IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILURE Vera Anapaz, Portugal; M. V. Machado; C. Baldaia; A. Valente
Clinical Case Session
217
Wednesday, November 1, 2017
P1351 HEPATITIS C TREATMENT IN HEMODIALYSIS PATIENTS: THE EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRALS IN THE REAL LIFE. Liliana Carvalho, Portugal; J. Rodrigues; M. A. Túlio; T. Bana e Costa; L. Lebre; C. Chagas
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1367 OUTCOMES OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA Ahad Eshraghian, Iran; S. Nikeghbalian; S. Ali Malek-Hosseini; B. Geramizadeh Imaging, radiology (incl. interventional radiology) P1368 THE ASSESSMENT OF THE ADC PREDICTIVE VALUE IN SURVIVAL OUTCOMES OF PATIENTS UNDERGOING RADIOFREQUENCY ABLATION FOR METASTATIC COLORECTAL CANCER LIVER TUMORS. Oliwia Kozak, Poland; T. Nowicki; J. M. Pienkowska; E. Izycka-Swieszewska; D. Zadrozny; E. Szurowska P1369 ª HOW OFTEN DO WE FIND STEATOSIS AND SEVERE FIBROSIS IN TYPE 2 DIABETES MELLITIUS PATIENTS I. Sporea; Ruxandra Mare, Romania; R. Sirli; S. A. Popescu; S. Nistorescu; A. Sima; R. Timar P1370 LEARNING CURVE EVALUATION USING ELASTPQ Ruxandra Mare, Romania; I. Sporea; S. A. Popescu; R. Sirli; C. Pienar P1371 ENHANCEMENT PATTERN OF HEPATOCELLULAR CARCINOMA ON CONTRAST ENHANCED ULTRASOUND EXAMINATION IN PATIENTS WITH CHRONIC LIVER DISEASE Mirela Danila, Romania; I. Sporea; R. Sirli; A. Popescu; T. V. Moga; A.-M. Stepan P1372 DIAGNOSTIC ACCURACY OF CONTRAST-ENHANCED ULTRASOUND ALGORITHM (ACR CEUS LI-RADSV 2016) FOR THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC LIVER DISEASE Ana-Maria Stepan, Romania; M. Danila; R. Sirli; S. A. Popescu; T. V. Moga; C. S. Ivascu; C. Pienar; I. Sporea Liver neoplasia: Clinical
P1375 EXTRAHEPATIC HEPATOCELLULAR CARCINOMA METASTASIS: IMPORTANCE OF AN EARLY DIAGNOSIS AND TARGETED THERAPY Rui Morais, Portugal; H. Cardoso; S. Rodrigues; R. Coelho; R. Liberal; P. Pereira; A. Albuquerque; R. Gonçalves; S. Lopes; A. M. Horta e Vale; G. Macedo P1376 MANAGEMENT OF INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA Akihiro Deguchi, Japan P1377 HEPATOCELLULAR CARCINOMA RECURRENCE RATE IN HCV INFECTED PATIENTS TREATED WITH DIRECT ANTIVIRAL AGENTS. A SINGLE CENTER EXPERIENCE G. G. Di Costanzo; R. Granata; M. Guarracino; M. Sanduzzi Zamparelli; M. Guarino; G. Cordone; G. D'Adamo; Raffaella Tortora, Italy P1378 PATTERN OF DISTANT EXTRAHEPATIC METASTASES IN PRIMARY LIVER CANCER: A SEER-BASED STUDY Wenrui Wu, China; X. He; L. Li; D. Fang; D. Shi; Y. Li; J. Ye; F. Guo P1379 TIME-DEPENDENT EFFECT OF ALFA-FETOPROTEIN AND DISEASE CONTROL ON PATIENTS’ SURVIVAL IN BCLC C STAGE HEPATOCELLULAR CARCINOMA Francesca Romana Ponziani, Italy; I. Spinelli; E. Rinninella; L. Cerrito; A. Saviano; M. Garcovich; B. E. Annicchiarico; M. Siciliano; L. Riccardi; M. A. Zocco; N. De Matthaeis; M. Biolato; F. Giuliante; R. Iezzi; A. M. De Gaetano; M. Basso; L. Miele; A. Avolio; F. Vecchio; G. L. Rapaccini; A. Grieco; A. Gasbarrini; M. Pompili P1380 WITHDRAWN Vascular diseases of the liver, bile duct or pancreas
Wednesday, November 1, 2017
P1373 DICKKOPF-1: AS A SERUM BIOMARKER FOR PREDICTION OF HEPATOCELLULAR CARCINOMA TREATMENT RESPONSE. Ahmed Sharaf, Egypt; E.-S. G. El-Badrawy; N. A. Khalifa
P1381 INTRAHEPATIC PORTAL HYPERTENSION WITHOUT CIRRHOSIS: EXPERIENCE OF A MORROCAN UNIVERSITY CENTER (33 CASES) Ibtissam Nakhcha, Morocco; I. Benelbarhdadi; F. Z. Ajana
P1374 EFFECT OF FIBROBLAST GROWTH FACTOR-2 AND ITS RECEPTOR GENE POLYMORPHISMS ON SURVIVAL IN PATIENTS WITH HEPATITIS B VIRUS–ASSOCIATED HEPATOCELLULAR CARCINOMA Jaeyoun Cheong, Republic of Korea
P1382 CONSERVATIVE MANAGEMENT OF EXTERNAL BILIARY FISTULAS COMPLICATING SURGERY OF HYDATID CYST OF THE LIVER Oussama Baraket, Tunisia; K. Ayed; W. Triki; M. A. Lahmidi; A. Itami; I. Abbassi; S. Bouchoucha
218
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
Cholestasis and gallstones: Clinical P1384 EVALUATION OF COMMON BILE DUCT CLEARANCE AFTER ENDOSCOPIC MANAGEMENT OF DIFFICULT BILIARY STONES BY DIRECT PERORAL CHOLANGIOSCOPY: PRELIMINARY RESULTS OF A PILOT STUDY. Andrea Anderloni, Italy; A. Fugazza; F. Auriemma; R. Maselli; S. Carrara; M. Di Leo; E. Ferrara; P. A. Galtieri; R. Semeraro; G. Lollo; G. Amvrosiadis; A. Repici
Biliary neoplasia: Basic P1390 WITHDRAWN P1391 PATHOLOGICAL, CLINICAL AND RADIOLOGICAL CHARACTERISTICS OF NEOPLASTIC AND NONNEOPLASTIC GALLBLADDER POLYPS Sarah Wennmacker, The Netherlands; A. Van Dijk; J. Reassens; N. Hasami; J. P. H. Drenth; C. J. H. M. van Laarhoven; P. de Reuver; I. D. Nagtegaal P1392 METFORMIN INDUCES APOPTOSIS AND MODULATES PROLIFERATION IN THE BILE DUCT CANCER CELLS. Jin Lee, Republic of Korea; J. H. Jung; D. H. Koh; S. W. Park; H. J. Jang; M. H. Choi; S.-H. Kae
P1385 LONG-TERM OUTCOMES OF PATIENTS WITH ACUTE CALCULOUS CHOLECYSTITIS AFTER SUCCESSFUL REMOVAL OF GALLBLADDER STONES WITH PERCUTANEOUS TRANSHEPATIC CHOLANGIOSCOPY: A DECADE EXPERIENCE AT A SINGLE TERTIARY CENTER Seok-Ho Dong, Republic of Korea; C. H. Oh; J. R. Moon
P1393 DEREGULATIONS IN BASE EXCISION REPAIR (BER) PATHWAY AND RESULTING OXIDATIVE STRESS AS KEY MODULATOR OF GALL BLADDER ANOMALIES AND PROGRESSION TO CARCINOGENESIS: A NORTHEAST INDIA BASED STUDY Sujoy Bose, India; N. Singh; D. Tiwari; R. Sultana; R. Borkotoky; A. K. Saikia; N. N. Das; S. N. Kazim
P1386 SINGLE DEVICE TECHNIQUE FOR ENDOSCOPIC TREATMENT OF BILE DUCT STONES Manabu Sen-yo, Japan; S. Kaino; S. Amano; S. Shinoda; I. Sakaida
P1394 THE DEVELOPMENT OF NON-INVASIVE MOLECULAR DIAGNOSIS OF GALLBLADDER CANCER BY BILE JUICE-LIQUID BIOPSY Hideaki Kinugasa, Japan; K. Nouso; S. Ako; K. Matsumoto; H. Kato; H. Okada
P1387 ACCURACY OF ASGE CRITERIA IN THE IDENTIFICATION OF PATIENTS WITH SUSPECTED CHOLEDOCHOLITHIASIS Cláudia Macedo, Portugal; N. Almeida; D. Gomes; E. Camacho; S. Mendes; L. Tomé; A. M. Ferreira P1388 DOES FIBRIN GLUE APPLIED ON THE CHOLANGIOTOMY IN LAPAROSCOPIC COMMON BILE DUCT EXPLORATION REDUCE THE RISK OF BILE LEAKAGE? A RANDOMIZED STUDY Bahman Darkahi, Sweden; G. Sandblom; T. Nordén P1389 THE IMPACT OF BARIATRIC SURGERY ON ACUTE CHOLANGITIS MORTALITY AND OTHER OUTCOMES: A NATIONWIDE ANALYSIS Paul Thomas Kroener, USA; M. S. Abougergi; V. Popov; C. C. Thompson
P1395 EFFICACY OF INTRADUCTAL RADIOFREQUENCY ABLATION USING A NOVEL ENDOLUMINAL RADIOFREQUENCY ABLATION CATHETER IN A SWINE MODEL Hyung-Keun Kim, Republic of Korea; O.-R. Shin; B.-S. Jeon; H.-H. Choi; S.-W. Kim; S.-S. Kim; H.-S. Chae Biliary neoplasia: Clinical P1396 PREDICTIVE MODEL FOR THE NEOPLASTIC POTENTIAL OF GALLBLADDER POLYPS Jong Kyun Lee, Republic of Korea P1397 COMPARISONS OUTCOMES FOR CONTROLLED PHOTODYNAMIC THERAPY IN HIGH GRADE UNRESECTABLE HILAR CHOLANGIOCARCINOMA Een Taek Park, Republic of Korea; B. C. Yun; S. U. Lee; B. H. Han P1398 IGG4-ASSOCIATED CHOLANGITIS MIMICKING PERIHILAR CHOLANGIOCARCINOMA: A PERSISTENT DILEMMA. Lowiek Hubers, The Netherlands; E. Roos; R. J. S. Coelen; J. Verheij; U. H. W. Beuers; T. M. van Gulik
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
219
Wednesday, November 1, 2017
P1383 THE EVOLUTION OF ESOPHAGEAL VARICES IN NON CIRRHOTIC PORTAL HYPERTENSION CAUSED BY PORTAL VEIN THROMBOSIS Imane Benelbarhdadi, Morocco; K. loubaris; H. Boutallaka; F. Z. Ajana
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1399 ª DIGITAL, SINGLE-OPERATOR CHOLANGIOPANCREATOSCOPY IN THE DIAGNOSIS AND MANAGEMENT OF PANCREATOBILIARY DISORDERS: RESULTS FROM THE MULTICENTER CZECH AND SLOVAK NATIONAL DATABASE Rastislav Hustak, Slovak Republic; J. Král; F. Neumann; V. Nosek; E. Skanderova; J. Usak; O. Urban; B. Bunganic; M. Zavoral; O. Shonova; P. Vitek; J. Spicak; J. Martinek P1400 DISTINCT PROGNOSTIC VALUE AND BIOLOGICAL CHARACTERISTICS OF OSTEOPONTIN IN INTRAHEPATIC CHOLANGIOCARCINOMA Kaiqian Zhou, China; F.-Y. Chen; C. Zhou; L.-S. Cheng; Z. Wang P1401 PANCREATIC STENT PLACEMENT AFTER ENDOSCOPIC RESECTION OF AMPULLARY TUMORS IS MANDATORY Pietro Gambitta, Italy; F. Iannuzzi; S. Pallotta; A. Ballerini; A. D'Alessandro; E. Bareggi; P. Fontana P1402 SERUM LEVELS OF HEAVY METALS IN CHOLANGIOCARCINOMA PATIENTS FROM THE NILE DELTA REGION OF EGYPT :A SINGLE CENTRE STUDY M. Abdel-Wahab; M. El-Bendary; Mahmoud Abdel-Wahab, Egypt; S. Abed; A. S. Shehatta; M. Salah; A.-H. El-Gilany P1403 SELF-EXPANDLE METAL STENT ARE SUPERIOR TO PLASTIC STENT FOR PREOPERATIVE BILIARY DRAINAGE IN RESECTABLE MALIGNANT DISTAL BILIARY STRICTURE: A SYSTEMATIC REVIEW AND META-ANALYSIS Alberto Tringali, Italy; M. Cintolo; L. Cristoferi; E. Forti; F. Pugliese; L. Dioscoridi; R. Manta; M. Mutignani P1404 THE EFFICACY AND SAFETY OF PREOPERATIVE BILIARY DRAINAGE IN PATIENTS WITH OBSTRUCTIVE JAUNDICE: A SYSTEMATIC REVIEW AND META-ANALYSIS. Alberto Tringali, Italy; M. Cintolo; L. Cristoferi; E. Forti; F. Pugliese; L. Dioscoridi; M. Mutignani
Poster Session 09:00 – 14:00 Pancreas III
Hall 7
Pancreatitis, acute P1405 INCREASED MORTALITY AMONG PATIENTS WITH ACUTE PANCREATITIS FROM THE MEDITERRANEAN REGION COMPARED WITH THE REST OF SPAIN Guillermo García-Rayado, Spain; F. Bolado; H. J. Canaval-Zuleta; C. Marra-López; A. I. Hernando-Alonso; A. del-Val-Antonana; H. Sternby; R. Rivera Irigoin; F. J. Grau-Garcia; L. Oms; J. Millastre-Bocos; I. Pascual-Moreno; D. Martínez-Ares; J. A. Rodriguez-Oballe; A. Lopez-Serrano; M. Ruiz-Rebollo; A. Viejo-Almanzor; P. Zapater; E. de-Madaria P1406 1-DEOXY-SPHINGOLIPIDS, NOVEL BIOMARKERS OF DIABETES, ARE CYTOTOXIC FOR EXOCRINE PANCREATIC CELLS Rong Chen, Switzerland; T. Hornemann; W. Yu; S. Camargo; R. Graf; S. Sonda P1407 ROLE OF THROMBOPHILIA IN SPLANCHNIC VENOUS THROMBOSIS IN ACUTE PANCREATITIS Sobur Uddin Ahmed, India; S. S. Rana; J. Ahluwalia; M. Kang; R. Sharma; D. K. Bhasin P1408 EVALUATION OF A PROTOCOL OF AN ENDOSCOPIC ULTRASOUND TRANSMURAL DRAINAGE OF INFECTED PANCREATIC NECROSIS (IPN) WITH LOCAL ANTIBIOTHERAPY THROUGH NASOCYSTIC CATHETER J. Lariño Noia; J. López-Díaz; Daniel De la Iglesia-García, Spain; J. Iglesias-Garcia; R. Mejuto-Fernández; F. Macias-Garcia; A. Álvarez-Castro; A. Mckenzie-Ballesteros; S. García-Rodríguez; J. Díaz-Gutiérrez; J. E. Dominguez-Muñoz
Wednesday, November 1, 2017
P1409 EUS-GUIDED PANCREATIC FLUID COLLECTION DRAINAGE WITH LUMEN-APPOSING METAL STENTS OR PLASTIC DOUBLE PIGTAIL STENTS: A MULTI-FACTORIAL ANALYSIS Nan Ge, China; S. Sun P1410 EARLY ACHIEVABLE SEVERITY (EASY) INDEX FOR SIMPLE AND ACCURATE EXPEDITE RISK STRATIFICATION IN ACUTE PANCREATITIS Balázs Kui, Hungary; S. Gódi; J. Bajor; I. Török; M. Macaria; H. Farkas; A. Mickevicius; V. Sallinen; E. R. Maldonado; M. Papp; G. Kovács; P. Sarlós; S. Galeev; B. Nemeth; A. Vincze; P. Pencik; I. Ozola-Zalite; A. Pukitis; A. Litvin; I. Kovalskaya; J. Czimmer; T. Huszár; M. Ihász; G. Pár; I. Hritz; T. Molnár; D. Illés; A. Szentesi; L. Lakatos; G. Capruso; A. V. Patai; E. Stilidi; G. Peserico; K. Zadorozhna; E. Sonmez; A. Tüzün Ince; S. Vishalkumar; M. Horibe; P. Hegyi
220
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1412 CORONARY DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE ARE NOT ASSOCIATED WITH WORSE OUTCOME IN ACUTE PANCREATITIS Joana Rita Carvalho, Portugal; P. Santos; S. Fernandes; M. Moura; T. Antunes; J. Velosa P1413 WORSE OUTCOMES IN ACUTE PANCREATITIS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS Patrícia Santos, Portugal; J. R. Carvalho; S. Fernandes; M. Moura; T. Antunes; J. Velosa P1414 ACUTE PANCREATITIS IN LIVER TRANSPLANT RECIPIENTS: INCIDENCE AND OUTCOME Peter Macinga, Czech Republic; K. Poc; P. Trunecka; J. Spicak; T. Hucl Pancreatitis, chronic (including hereditary disorders) P1415 THE IMPACT OF BILIARY SLUDGE TO DEVELOPMENT OF PAIN AND EFFICACY OF HYMECROMONE IN CHRONIC BILIARY PANCREATITIS Alexey Okhlobystin, Russian Federation; N. Ponkratova; O. Okhlobystina; S. Nasonova; M. Tatarkina; S. A. Budzinsky; V. Ivashkin P1416 RETROSPECTIVE ANALYSIS OF EXOCRINE PANCREATIC FUNCTIONALITY IN PATIENTS WITH CHRONIC PANCREATITIS Alessandro Brandolese, Italy; A. Amodio; M. C. Conti Bellocchi; S. Di Stefano; P. Campagnola; N. de Pretis; L. Bernardoni; S. F. Crinó; A. Gabbrielli; L. Frulloni P1417 ‘PAINLESS’ CHRONIC PANCREATITIS: EPIDEMIOLOGICAL, CLINICAL AND RADIOLOGICAL CHARACTERIZATION Claudia Perini, Italy; A. Amodio; L. Bernardoni; A. Gabbrielli; S. F. Crinó; P. Campagnola; D. Costa; F. Capuano; V. Framba; L. Frulloni P1418 LONG-TERM OUTCOMES OF A FULLY COVERED SELF-EXPANDABLE METAL STENT WITH ANTIMIGRATION PROPERTIES FOR EUS-GUIDED PANCREATIC DUCT DRAINAGE Dong-Wook Oh, Republic of Korea; D. H. Park; D. H. Cho; T. J. Song; S. S. Lee; D.-W. Seo; S. K. Lee; M.-H. Kim
Poster in the Spotlight
Poster of Excellence
P1419 MONITORING AND OPTIMIZATION OF PANCREATIC ENZYME REPLACEMENT THERAPY IN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCY Mila Kovacheva-Slavova, Bulgaria; S. Siminkovitch; J. Genov; B. Golemanov; R. Mitova; P. Gecov; D. Svinarov; B. Vladimirov Pancreatic cancer: Basic P1420 HUR MEDIATED POST-TRANSCRIPTIONAL REGULATION OF HO-1 AND INHIBITORS OF APOPTOSIS PROTEINS IS ASSOCIATED WITH THE POOR CLINICAL OUTCOMES AMONG PATIENTS WITH PANCREATIC CANCER Zilvinas Dambrauskas, Lithuania; A. Gulbinas; A. Jakštaite; A. Urboniene P1421 HYPOXIA INDUCED HIF1A-MEDIATED DIFFERENTIAL O-GALNAC GLYCOSYLATION DIRECTLY REGULATES SIGNALING PATHWAYS IN PANCREATIC CANCER. B. Mercanoglu; B. T. Hofmann; C. Güngör; J. R. Izbicki; M. Bockhorn; Gerrit Wolters-Eisfeld, Germany P1422 THE EXPRESSION AND FUNCTION OF MIR-195 IN PANCREATIC CANCERTHE EXPRESSION AND FUNCTION OF MIR-195 IN PANCREATIC CANCER Y. Zhang; Qiang Zhan, China P1423 TRYPTOPHAN DEGRADATION AS AN ALTERNATIVE ENERGY SOURCE IN PANCREATIC CANCER Cenap Guengoer, Germany; C. Kondziella; B. Mercanoglu; G. Wolters-Eisfeld; J. R. Izbicki; M. Bockhorn P1424 INTEGRIN α11 IS SPECIFICALLY EXPRESSED IN PANCREATIC TUMOR STROMA AND A KEY TARGET IN REGULATION OF PANCREATIC TUMOR STROMAL MYOFIBROBLASTS Jonas Schnittert, The Netherlands; R. Bansal; G. Storm; A. Östman; J. Prakash P1425 EFFECT OF ACOUSTIC CAVITATION ON A THREE-DIMENSIONAL CULTURE MODEL OF PANCREATIC ADENOCARCINOMA. Benoit Bordacahar, France; M. Camus; E. Abou Ali; J. L. Mestas; M. Lafond; I. Suarez; A. Gomes; V. Lobjois; F. Batteux; C. Lafon; F. Prat P1426 PATHOLOGICAL EVALUATION AND REPORTING OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS: THE CORRELATION AND ANALYZES OF THE HISPATHOTOLOGIC PATTERNS Carolin Nava, Brazil; R. Coudry; M. C. Cesar Machado; L. Meirelles; M. D. C. Gonçalves; G. Ferreira Paduani; J. G. Guerra; J. C. Ardengh
Clinical Case Session
221
Wednesday, November 1, 2017
P1411 EVALUATION OF LOCAL INSTILLATION OF ANTIBIOTICS IN WALLED-OFF PANCREATIC NECROSIS Mikkel Werge, Denmark; S. Roug; E. Feldager; J. D. Knudsen; L. L. Gluud; S. Novovic; P. N. Schmidt
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
Pancreatic cancer: Clinical P1427 EVALUATION OF LONG TERM SURVIVAL OF CHEMORADIOTHERAPY WITH GEMCITABINE AND S-1 COMPARED WITH CHEMOTHERAPY ALONE IN THE CASES WITH LOCALLY ADVANCED PANCREATIC CANCER Ko Tomishima, Japan; S. Ishii; T. Fujisawa; S. Takahashi; A. Suzuki; R. Kanazawa; H. Saito; H. Isayama; K. Sasai; S. Kawasaki P1428 HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) THERAPY FOR UNRESECTABLE PANCREATIC CANCER Atsushi Sofuni, Japan; Y. Asai; M. Fujita; T. Tsuchiya; S. Tsuji; R. Tanaka; R. Tonozuka; M. Honjo; S. Mukai; K. Yamamoto; Y. Matsunami; K. Kamada; T. Itoi P1429 EUS AND CT SCAN ACCURACY IN ESTABLISHING THE T STAGE IN PANCREATIC CANCER BASED ON THE UPCOMING TNM 8TH EDITION Livia Archibugi, Italy; M. C. Petrone; S. Crippa; E. Dabizzi; A. Mariani; R. Nicoletti; C. Doglioni; G. Capurso; M. Falconi; P. G. Arcidiacono P1430
RISK FACTORS AND SURVIVAL IN PANCREATIC ADENOCARCINOMA Livia Petrusel, Romania; V. L. Drug; M. Bilibou; C. Cainap; C. Pojoga; R. Seicean; A. Seicean P1431 PREVALENCE STRATIFICATION OF MALIGNANCY IN RESECTED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS INVOLVING MAIN DUCT: IS THE 10 MM WIRSUNG DIAMETER AN ADEQUATE CUTOFF? Tiago Cúrdia Gonçalves, Portugal; C. Montironi; M. Cuatrecasas; J. R. Ayuso; S. Sanchez; H. de Leon; C. Sanchez; G. Fernández-Esparrach; A. Gines; X. Molero; C. Marinho; J. Cotter; E. Vaquero
Wednesday, November 1, 2017
P1432 CLINICAL SIGNIFICANCE OF CHEMOTHERAPY FOR ELDERLY UNRESECTABLE PANCREATIC CANCER PATIENTS Seiji Kaino, Japan; M. Sen-yo; S. Shinoda; S. Amano; I. Sakaida P1433 THE USE OF A NEW CORE NEEDLE IN THE ENDOSCOPIC ULTRASOUND ASSISTED TISSUE SAMPLING FOR PANCREATIC SOLID MASSES: A MULTICENTRE PROSPECTIVE STUDY. Silvia Carrara, Italy; M. Di Leo; L. Bernardoni; D. Rahal; G. Donato; M. Massidda; A. Anderloni; S. Crinò; E. Manfrin; M. Ballare; L. Poliani; F. Auriemma; A. Fugazza; P. Occhipinti; A. Gabbrielli; A. Repici
222
P1434 A 5- YEAR TERTIARY CENTRE EXPERIENCE OF ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION FOR DIAGNOSIS OF SOLID PANCREATIC MASS LESIONS Thomas Skouras, United Kingdom; L. Bonnett`; M. Swaminathan; R. Mcgalliard; A. Metussin; J. Evans; S. Sarkar; T. Giles; A. Cullen; K. Brougham; J. Sheard P1435 CLINICAL IMPACT OF GNAS AND KRAS MOLECULAR ALTERATIONS ADDED TO CEA AND CYTOLOGY IN PANCREATIC CYSTIC FLUID OBTAINED BY EUS-FNA Sandra Faias, Portugal; M. Duarte; C. Albuquerque; R. Roque; J. Pereira da Silva; R. Fonseca; A. Dias Pereira P1436 KRAS MUTATION ASSAY ON EUS FNA SPECIMENS FROM PACIENTS WITH PANCREATIC MASS Martin Laclav, Czech Republic; B. Bunganic; T. Halkova; L. Benesova; B. Belsanova; E. Traboulsi; S. Suchanek; M. Minarik; M. Zavoral P1437 DO BILIARY STENTS REDUCE THE DIAGNOSTIC PERFORMANCE OF EUS BIOPSY IN PATIENTS WITH A MASS IN THE HEAD OF PANCREAS? Noor Bekkali, United Kingdom; M. Nayar; L. Thornton; S. J. Johnson; B. Haugk; A. Darne; J. S. Leeds; R. Charnley; K. Oppong P1438 SOLID-PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS (SPN) DOES NOT CONTRAINDICATE EUS PONCTION: ABOUT A RETROSPECTIVE SERIES OF FIFTY PATIENTS WITH PREOPERATIVE EUS-FNA (THE SPN G.R.A.P.H.E. SERIES) David Karsenti, France; S. Koch; L. Poincloux; U. Chaput; G. Vanbiervliet; F. Cholet; M. Wangermez; P. Ah-Soune; P. Bichard; Y. Le Baleur; J. Privat; E. Coron; C. Subtil; M. Palazzo Endocrine tumours of the pancreas P1439 DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMOURS USING SUREPATH CYTOLOGY AND IMMUNOHISTOCHEMISTRY WITHOUT NEED FOR EXCISION BIOPSY. Christopher Meredith, Australia; H. Dixson; P. Irandoost; P. Baird P1440 EFFECTS OF IGF2BPS ON GROWTH AND PROLIFERATION IN NEUROENDOCRINE PANCREATIC TUMOR CELL LINES Lars Nietfeld, Germany; F. Sperling; K. Theuerkorn; H. Griesmann; S. Krug; S. Hüttelmaier; P. Michl
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1442 EFFECTS OF LOW-DOSES ASPIRIN ON CLINICAL OUTCOME AND DISEASE PROGRESSION IN PATIENTS WITH GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE TUMORS: RESULTS OF A MULTICENTRIC RETROSPECTIVE STUDY. S. Massironi; S. Pusceddu; Federica Cavalcoli, Italy; A. Zilli; G. Tamagno; D. Femia; N. Prinzi; C. Ciafardini; D. Conte P1443 PANCREATIC LESIONS IN VON HIPPEL-LINDAU SYNDROME: CLINICAL AND EPIDEMIOLOGICAL DATA FROM A SINGLE CENTER L. Venezia; Pablo Cortegoso Valdivia, Italy; C. G. De Angelis P1444 IMPACT OF TUMOUR SIZE ON THE PROBABILITY OF METASTASIS AND SURVIVAL IN PATIENTS WITH PANCREATIC NEUROENDOCRINE TUMOURS (PNETS): A POPULATION BASED STUDY Yangyang Liu, China; B. Ye; X. He; S. Chen; J. Pan; L. Wang; H. Shi P1445 THE LARGEST FAMILY IN TURKEY WITH MULTIPLE ENDOCRINE NEOPLASIA-TYPE 1 AND A NOVEL MUTATION Alş Çetin, Turkey; D. G. Duman P1446 PROGNOSTIC VALUE OF THE DIFFERENT PRE-TREATMENT BIOMARKERS FOR PATIENTS WITH NEUROENDOCRINE TUMORS Raluca Roxana Grigorescu, Romania; C. Gheorghe; I. M. Stanel; A. Croitoru; I. Dinu; V. Croitoru P1447 FUNCTIONAL RELEVANCE OF THE OVEREXPRESSION OF PLAC8 IN NEUROENDOCRINE PANCREATIC TUMORS Marina Hutzler, Germany; M. Haijat; H. Schmidt; R. Lawlor; A. Scarpa; T. M. Gress; M. Buchholz Poster Session 09:00 – 14:00 Endoscopy and Imaging III
Hall 7
Endoscopy, upper GI P1448 CLINICAL OUTCOMES OF SUPERFICIAL LARYNGOPHARYNGEAL CANCER WITH LYMPHO-VASCULAR INVASION AFTER ENDOSCOPIC LARYNGO-PHARYNGEAL SURGERY HIroki Ishida, Japan; R. Nakamura; T. Omori; S. Mayanagi; K. Fukuda; K. Suda; N. Wada; H. Kawakubo; Y. Kitagawa Poster in the Spotlight
Poster of Excellence
P1449 LONG-TERM OUTCOMES OF EARLY GASTRIC CANCER WITH LATERAL MARGIN POSITIVE AFTER ENDOSCOPIC RESECTION Hyung-Kil Kim, Republic of Korea; D.-H. Yang; J.-S. Park; B. W. Bang; Y. W. Shin P1450 EFFICACY OF THE FORCED COAGULATION MODE WITH LOW HIGH-FREQUENCY POWER SETTING DURING ENDOSCOPIC SUBMUCOSAL DISSECTION Tsukasa Ishida, Japan; T. Toyonaga; Y. Ohara; R. Ariyoshi; F. Kawara; S. Tanaka; Y. Morita; E. Umegaki; N. Hoshi; T. Azuma P1451 EXPOSURE TO ENDOTHERAPY FOR UPPER GASTROINTESTINAL BLEEDING AT THE POINT OF GASTROSCOPY CERTIFICATION – IS IT SUFFICIENT? Keith Siau, United Kingdom; P. Dunckley; J. Anderson; I. Beales; R. Broughton; M. Feeney; A. Haycock; N. Hawkes; R. Valori; C. Wells; S. Thomas-Gibson; B. McKaig P1452 ELECTRONIC CHROMOENDOSCOPY WITH MAGNIFICATION IN THE DETECTION OF DYSPLASIA IN BARRETT'S ESOPHAGUS C. Carames; Juan Carlos Carames, Mexico; M.-M. Xu; M. Carames; M. Gaidhane; M. Kahaleh P1453 DOES ‘INVISIBLE’ DYSPLASIA IN BARRETT’S OESOPHAGUS REALLY EXIST? A. Antonello; D. Nucci; D. Arcidiacono; T. Morbin; M. Fassan; M. Häfner; M. Rugge; Stefano Realdon, Italy P1454 SAFETY, EFFICACY AND CLOSURE TECHNIQUES OF ENDOSCOPIC FULL THICKNESS RESECTION-INITIAL CLINICAL EXPERIENCE A. Bapaye; Tarun Bharadwaj, India; M. R. Mahadik; S. G. Vare; R. pujari; S. date; N. dubale; J. A. Bapaye; A. Kulkarni P1455 PROPHYLAXIS OF VARICEAL BLEEDING IN CIRRHOTIC PATIENTS: EFFICACY AND SAFETY OF ENDOSCOPIC VARICEAL LIGATION IN A TERTIARY CENTRE Elisa Soares, Portugal; M. Gravito-Soares; A. Henriques; N. Almeida; L. Tomé P1456 THE VALUE OF ENDOSCOPIC FULL-THICKNESS RESECTION FOR GASTRIC AND DUODENAL SUBMUCOSAL TUMORS ORIGINATING FROM THE MUSCULARIS PROPRIA LAYER Mei-Dong Xu, China; C. Zhang; Q.-L. Li
Clinical Case Session
223
Wednesday, November 1, 2017
P1441 CONCOMITANT NEUROENDOCRINE TUMOR OF THE PANCREAS AND INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM: IS THERE SOMETHING BEYOND? Ludovica Venezia, Italy; P. Cortegoso Valdivia; C. G. De Angelis
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1457 BLUE LIGHT IMAGING AND LINKED COLOR IMAGING FOR DETECTION AND CHARACTERISATION OF CHRONIC GASTRITIS Jochen Weigt, Germany; A. Link; A. Canbay; P. Malfertheiner
P1466 PER ORAL ENDOSCOPIC MYOTOMY: UPDATED RESULTS FROM A UNITED KINGDOM CASE SERIES Shraddha Gulati, United Kingdom; A. Emmanuel; H. Inoue; A. Haji; B. Hayee
P1458 LONG-TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION(ESD) FOR RELATIVE INDICATION GROUP OF EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA(EESCC) IN AGED PATIENTS Z. Qi; Y. Zhong; Ping-Hong Zhou, China
P1467 NEW CHALLENGE FOR SAFER ENDOSCOPIC SUBMUCOSAL DISSECTION USING CO2 LASER Yoshinori Morita, Japan; R. Ariyoshi
P1459 RETROSPECTIVE ANALYSIS ON SUSPICION OF FOREIGN BODY INGESTION AND FOOD IMPACTION ON GASTROENTEROLOGY EMERGENCIES. Joao Correia de Sousa, Portugal; D. Libanio; P. Lago; R. Marcos-Pinto; I. Pedroto P1460 LEARNING CURVE FOR ENDOSCOPIC SUBMUCOSAL DISSECTION OF GASTRIC NEOPLASMS; LOW-VOLUME SINGLE CENTER EXPERIENCE Seong Taeg Kim, Republic of Korea; T. H. Kim; S.-Y. Na P1461 COMPARATIVE STUDY OF ESD AND SURGICAL RESECTION FOR GASTRIC SETS ORIGINATED FROM MUSCULARISPROPRIA Chang Beom Ryu, Republic of Korea; M. S. Lee; J. Y. Bae P1462 CAP ASSISTED UPPER ENDOSCOPY VERSUS SIDE-VIEWING ENDOSCOPE FOR EXAMINATION OF THE MAJOR DUODENAL PAPILLA: A RANDOMIZED, BLINDED, CONTROLLED, NON-INFERIORITY CROSSOVER STUDY (CAPPA-II STUDY) Mohamed Abdelhafez, Germany; V. Phillip; A. Hapfelmeier; M. Elnegouly; M. Dollhopf; A. El Magid Kassem; P. Klare; M. Bajbouj; R. M. Schmid; S. Delius; F. Eckel Florian
Wednesday, November 1, 2017
P1463 (IN)ACCURACY OF CAMBRIDGE PROTOCOL FOR PATIENTS HARBOURING CHD1 MUTATION: A CONSECUTIVE SERIES Rui Castro, Portugal; D. Libânio Monteiro; T. Pinto-Pais; M. Dinis-Ribeiro; C. Brandão P1464 SINGLE CENTER CLINICAL EXPERIENCE WITH A RECENTLY DEVELOPED FULL-THICKNESS ENDOSCOPIC CLIP A. Bapaye; S. G. Vare; M. R. Mahadik; Tarun Bharadwaj, India; R. Pujari; S. Date; N. Dubale; J. A. Bapaye; A. Kulkarni P1465 ENDOSCOPIC AMPULLECTOMY OUTCOMES IN A TERTIARY ENDOSCOPY DEPARTMENT M. Tantau; A. Varciu; M. Voicu; Bogdan Miutescu, Romania; V. Ioana; C. Lidia; T. Alina 224
P1468 LONG TERM OUTCOME OF ACUTE CORROSIVE INGESTION: A PROSPECTIVE SINGLE CENTER STUDY Sudipta Dhar Chowdhury, India; B. Kumar C; R. T. Kurien; S. K. Ghatak; D. Sreekar P1469 PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY (PCLE) FOR IN VIVO DIAGNOSIS OF ESOPHAGEAL AND GASTRIC LESIONS – RESULTS OF A PROSPECTIVE, CONTROLLED, CROSS-OVER STUDY Marek Kollar, Czech Republic; J. Krajciova; J. Maluskova; M. Kment; Z. Vackova; J. Spicak; J. Martinek P1470 COMPARING RISK SCORING SYSTEMS FOR NON-VARICEAL UPPER DIGESTIVE BLEEDING IN THE GASTROENTEROLOGY DEPARTMENT Daniela Lazar, Romania; I. Sporea; D. Tornea; L. Girboni; R. Lupusoru; I. Romosan; A. Goldis P1471 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY: A SAFE PROCEDURE EVEN IN CANCER PATIENTS Juliana Pinho, Portugal; J. Lage; D. Libanio; S. Ferraz; N. Silva; M. Dinis-Ribeiro; C. Brandão P1472 A PROSPECTIVE, SINGLE-CENTER, CROSS-OVER CONTROLLED TRIAL OF CONFOCAL LASER ENDOMICROSCOPY ASSESSMENT OF PERSISTENT OR RECURRENT INTESTINAL METAPLASIA AND RECURRENCE OF NEOPLASIA AFTER ENDOSCOPIC TREATMENT OF BARRETT'S ESOPHAGUS RELATED NEOPLASIA (BORN) Jana Krajciova, Czech Republic; M. Kollar; J. Maluskova; M. Kment; Z. Vackova; J. Spicak; J. Martinek P1473 FLEXIBLE ENDOSCOPIC SEPTUM DIVISION (FESD) OF ZENKER'S DIVERTICULUM: OUTCOMES FROM A SINGLE TERTIARY CENTER USING A NEW SYMPTOMS SCORE. Roberta Maselli, Italy; G. Lollo; M. Di Leo; R. Nicoletti; E. Finati; P. A. galtieri; L. Poliani; F. Auriemma; R. Semeraro; A. Fugazza; E. C. Ferrara; A. Anderloni; S. Carrara; A. Repici P1474 HOW ACCURATE ARE THE SYMPTOMS IN PATIENTS WITH FOOD IMPACTION AND FOREIGN BODIES INGESTION? Ana Laranjo, Portugal; I. Mocanu; M. M. Carvalho; S. Pires; N. Veloso; L. Gonçalves; R. Godinho; I. Medeiros
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1476 SYMPTOMATIC RESPONSE OF PYLORIC PNEUMATIC DILATATION, BOTOX INJECTION OR COMBINATION THERAPY IN PATIENTS WITH GASTROPARESIS OR DELAYED GASTRIC EMPTYING POST-GASTRIC TRANSPOSITION Abhinav Gupta, United Kingdom; M. A. Everson; R. Haidry; M. Banks; S. Bown; D. Graham; R. Ganatra; A. Ramasubramoni; L. Lovat; R. Sweis P1477 AN ANALYSIS OF COMPLICATIONS FOLLOWING ENDOSCOPIC SUBMUCOSAL DISSECTION IN A WESTERN SETTING – MAKING THE CASE FOR A SHORTER LENGTH OF STAY Sharmila Subramaniam, United Kingdom; K. Kandiah; G. Longcroft-Wheaton; P. Bhandari P1478 PREDICTIVE FACTORS AND MANAGEMENT OF REFRACTORY BENIGN OESOPHAGEAL STRICTURES Miguel Moura, Portugal; C. Simões; C. Noronha Ferreira; P. Santos; J. P. Freire; J. Lopes; L. Carrilho Ribeiro; J. Velosa P1479 LOCAL CORTICOSTEROIDS IMPROVE EARLY CLINICAL OUTCOMES IN PATIENTS UNDERGOING ENDOSCOPIC DILATION OF BENIGN OESOPHAGEAL STRICTURES Miguel Moura, Portugal; C. Simões; C. Noronha Ferreira; P. Santos; J. P. Freire; J. Lopes; L. Carrilho Ribeiro; J. Velosa P1480 TRENDS IN CERTIFICATION FOR GASTROINTESTINAL ENDOSCOPY AND VARIATIONS BETWEEN TRAINEE SPECIALTIES: RESULTS FROM THE UK TRAINEE ENDOSCOPY DATABASE Keith Siau, United Kingdom; R. Broughton; J. Anderson; I. Beales; M. Feeney; A. Haycock; N. Hawkes; G. Johnson; B. McKaig; R. Pullan; R. Valori; C. Wells; S. Thomas-Gibson; P. Dunckley P1481 EFFICIENCY AND SAFETY OF ENDOSCOPIC PAPILLECTOMY FOR TREATMENT OF DUODENAL PAPILLA TUMORS Y. Chu; Mei-Dong Xu, China; P.-H. Zhou; C. Zhang P1482 CHANGES IN SCORING OF DIRECT OBSERVATION OF PROCEDURAL SKILLS (DOPS) FORMS IN ENDOSCOPY TRAINING AND THEIR IMPACT ON COMPETENCE ASSESSMENT Keith Siau, United Kingdom; P. Dunckley; A. Nevill; J. Anderson; I. Beales; R. Broughton; M. Feeney; A. Haycock; N. Hawkes; B. McKaig; S. Thomas-Gibson; R. Valori; C. Wells; G. Johnson Poster in the Spotlight
Poster of Excellence
P1483 WITHDRAWN P1484 PROTECTIVE VACUUM SPONGE IMPLANTATION AND CONTINUOUS EVACUATION OF BILE AND PANCREATIC JUICE FOR PREVENTION OF SECONDARY PERFORATION AFTER PRIMARY SUCCESSFUL ENDOSCOPIC RESECTION OF WIDESPREAD D2/D3 DUODENAL AND PAPILLARY ADENOMATA Jürgen Hochberger, Germany; M. Loss; C. von Heymann; C. Jung; E. Wedi; M. Hofmeyer Endoscopy, colon P1485 ENDOSCOPIC CLOSURE OF ACUTE PERFORATIONS OF THE GASTROINTESTINAL TRACT IN ANIMAL MODELS: A SYSTEMATIC REVIEW AND META-ANALYSIS Ahmed Gabr, United Kingdom; N. Ammar; M. El Houssine; M. Rutter P1486 RISK FACTORS FOR COLORECTAL POLYP IN ASYMPTOMATIC YOUNG ADULTS UNDER THE AGE OF 50 Yusik Myung, Republic of Korea P1487 COMPARISON BETWEEN AN ASYMMETRIC (SMALL DOSE IN THE MORNING) AND A SYMMETRIC SPLIT-DOSE REGIMEN OF POLYETHYLENE GLYCOL PLUS BISACODYL FOR BOWEL PREPARATION FOR SCREENING COLONOSCOPY: A RANDOMIZED NON-INFERIORITY CLINICAL TRIAL Paolo Andreozzi, Italy; C. Bezzio; G. De Nucci; S. Saibeni; M. Devani; I. Arena; R. Reati; E. Mandelli; D. Redaelli; D. Morganti; B. Omazzi; G. Manes P1488 SINGLE BALLOON OVERTUBE-GUIDED COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION; A NEW APPROACH TO MANAGEMENT OF COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION Tadateru Maehata, Japan; Y. Ochiai; T. Akimoto; Y. Mitsunaga; Y. Kiguchi; A. Fujimoto; O. Goto; T. Nishizawa; T. Uraoka; N. Yahagi P1489 SEDATION IN COLORECTAL ESD: A SYSTEMATIC REVIEW OF WESTERN CLINICAL PRACTICE Mileidis Esther San Juan Acosta, Spain; S. Beg; S. Sansone; K. Ragunath; B. Manorahan P1490 COMPUTER-AIDED POLYP MEASUREMENT OF 78 POLYPS DURING LIVE COLONOSCOPY (CAPME) : A PROSPECTIVE STUDY Christophe Allimant, France; O. Rouquette; S. Le Roux; B. Pereira; A. Abergel; A. Bartoli; C. Tilmant; L. Poincloux
Clinical Case Session
225
Wednesday, November 1, 2017
P1475 GASTROINTESTINAL ENDOSCOPY UNDER SEDATION IS ASSOCIATED WITH PNEUMONIA IN OLDER INPATIENTS – RESULTS OF A RETROSPECTIVE CASE-CONTROL STUDY. Christopher Kollmann, Germany; W. Schmiegel; T. Brechmann
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1491 USING THE MULTI-ASSISTANT RATING SCALE (MARS) FOR ENDOSCOPIC NON-TECHNICAL SKILLS PERFORMANCE AUGMENTS USE OF STANDARD KEY PERFORMANCE MEASURES IN INDEPENDENT COLONOSCOPISTS. Neil Hawkes, United Kingdom; F. Kokwara; B. Davies; J. Cornish P1492 EARLY ECONOMIC MODELLING OF EMI-137 TO IMPROVE THE DETECTION RATE OF POLYPS IN PATIENTS WITH INCREASED RISK OF COLORECTAL CANCER Bethany Shinkins, United Kingdom; A. Smith; N. King; A. Davies; I. Wilson P1493 RANDOMIZED CLINICAL TRIAL EVALUATING THE EFFECT OF A VISUAL EDUCATIONAL BOOKLET ON THE PREPARATION OF COLONOSCOPIES IN HOSPITALIZED PATIENTS. Antonio Guardiola Arévalo, Spain; A. Granja Navacerrada; F. J. Garcia-Alonso; P. Bernal Checa; M. Hernández Tejero; D. Bonillo; E. M. Andrés Esteban; A. Algaba Garcia; F. Bermejo P1494 STUDY OF ULCERATIVE COLITIS COMPLICATED BY PRIMARY SCLEROSING CHOLANGITIS Shun Murasugi, Japan; A. Ito; H. Kambayashi; M. Yonezawa; T. Ohmori; K. Tokushige P1495 COMPETENCY OF ENDOSCOPIC NON-TECHNICAL SKILLS (ENTS) DURING ENDOSCOPY TRAINING Keith Siau, United Kingdom; P. Dunckley; J. Anderson; I. Beales; R. Broughton; M. Feeney; N. Hawkes; G. Johnson; B. McKaig; R. Valori; C. Wells; S. Thomas-Gibson; A. Haycock
Wednesday, November 1, 2017
P1496 MAKING COLONOSCOPISTS MORE AWARE OF THEIR ENDOSCOPIC NON-TECHNICAL SKILLS – IMPROVING FEEDBACK FORMATS DERIVED FROM THE MULTI-ASSISTANT RATING SCALE (MARS) TOOL. Neil Hawkes, United Kingdom; F. Kokwara; B. Davies; J. Cornish P1497 OUTCOMES OF ENDOSCOPIC RESECTION OF COMPLEX COLORECTAL LESIONS REFERRED TO A TERTIARY INSTITUTION AFTER FAILED ATTEMPTS AT RESECTION OR EXTENSIVE MANIPULATION Andrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji P1498 NBI VERSUS BLI! WHICH MODALITY IS BETTER FOR OBSERVATION OF MUCOSAL BLOOD FLOW IN THE SMALL AND LARGE BOWEL USING NBI (NARROW BAND IMAGING) OR BLI (BLUE LASER IMAGING)? Mitsunori Yasuda, Japan; Y. Naito; Y. Itoh 226
P1499 MULTIPLE COLORECTAL ADENOMAS WITHOUT APC OR MUTYH GERMLINE MUTATION: A HETEROGENEOUS SUBGROUP OF PATIENTS Lupe Sanchez Mete, Italy; E. Mannisi; A. Martayan; M. Varanese; V. Stigliano P1500 EVALUATION THE RELATIONSHIP BETWEEN NUMBERS OF BIOPSIES PER CASE AND DEGREE OF FIBROSIS IN COLON Jaekook Yang, Republic of Korea; Y. Jung; I.-K. Chung; Y. S. Cho; S. J. HAN; T. H. Lee; S.-H. Park; H. Cho; Y. Hwangbo; S.-J. Kim P1501 ADVANCED NEOPLASIA YIELD IN PATIENTS UNDERGOING COLONOSCOPY AFTER SCREENING FLEXIBLE SIGMOIDOSCOPY: DOES THE DISTAL COLONIC PATHOLOGY PREDICTS THE YIELD IN PROXIMAL COLON? Rajaratnam Rameshshanker, United Kingdom; F. Purchiaroni; A. Crudeli; A. Rajendran; I. Stasinos; A. Wilson; S. Thomas-Gibson; A. Haycock; A. Humphries; N. Suzuki; B. P. Saunders P1502 LEARNING CURVE FOR OPTICAL DIAGNOSIS OF COLORECTAL POLYPS USING CUMULATIVE SUM ANALYSIS Rajaratnam Rameshshanker, United Kingdom; A. Wilson; S. Thomas-Gibson; N. Kamperidis; N. O'shea; B. P. Saunders P1503 THE CLINICAL VALUE OF ENDOSCOPIC FULL-THICKNESS RESECTION FOR THE TREATMENT OF COLORECTAL SUBMUCOSAL TUMORS ORIGINATING FROM THE MUSCULARIS PROPRIA: A PROSPECTIVE SINGLE-CENTER STUDY Mei-Dong Xu, China; C. Zhang; Q.-L. Li P1504 COLONIC ESD BY UTILIZING SHORT DOUBLE BALLOON ENDOSCOPE ~HOW TO TREAT DIFFICULT CASES IN COLONIC ESD~ Shinichi Katsuki, Japan; T. Fujita; K. Takanashi; E. Waga P1505 WITHDRAWAL TIME MONITORING AND FULL-SPECTRUM ENDOSCOPY IMPROVE ADENOMA DETECTION RATE. Germana De Nucci, Italy; P. Andreozzi; C. Bezzio; R. Reati; D. Morganti; D. Redaelli; E. Mandelli; B. Omazzi; I. Arena; S. Saibeni; G. Manes P1506 HIGH LEVELS OF “PRESUMED POLYP MISS RATE” AT 1 AND 3 YEARS FOLLOWING INDEX SCREENING COLONOSCOPY: NO ROOM FOR COMPLACENCY. Rajaratnam Rameshshanker, United Kingdom; F. Purchiaroni; A. Wilson; A. Rajendran; S. Thomas-Gibson; A. Humphries; A. Haycock; N. Suzuki; B. P. Saunders
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1507 IMPACT OF PERIODONTAL DISEASE ON PREVALENCE OF COLORECTAL NEOPLASIA IN PATIENTS UNDERGOING ROUTINE SCREENING COLONOSCOPY Angelika Dokladanska, Austria; P. Jeschek; E. Waldmann; D. Penz; B. Majcher; A. Hinterberger; G. Heinze; M. Ferlitsch
P1515 RISK OF HIGH GRADE DYSPLASIA AND SUBMUCOSAL INVASION IN DIFFERENT MORPHOLOGICAL SUB-TYPES OF LARGE COLORECTAL NEOPLASTIC LESIONS RESECTED AT A UK TERTIARY REFERRAL UNIT Andrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji
P1508 OUTCOMES OF ENDOSCOPIC RESECTIONS OF LARGE NON-POLYPOID LESIONS IN INFLAMMATORY BOWEL DISEASE: A SINGLE UNITED KINGDOM CENTRE EXPERIENCE Shraddha Gulati, United Kingdom; A. Emmanuel; M. Burt; P. Dubois; B. Hayee; A. Haji
P1516 POLYP DETECTION INCREASES WITH COLONOSCOPY WITHDRAWAL TIME Khaled Agar, Tunisia; L. Hamzaoui; M. Medhioub; B. Bouchabou; M. M. Azouz
P1509 RESEARCH ON APPLICATION OF TRANSANAL TUBE DECOMPRESSION FOR PREVENTION OF COMPLICATIONS IN COLORECTAL MUCOSAL LESIONS AFTER ESD L. Bing; Z. Qi; Yunshi Zhong, China
P1517 OUTCOMES OF ENDOSCOPIC RESECTION OF RECURRENT COLORECTAL LESIONS TREATED AT A UK TERTIARY REFERRAL CENTRE Andrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji
P1510 OUTCOMES FOLLOWING UNDERWATER ENDOSCOPIC MUCOSAL RESECTION OF >10MM COLONIC POLYPS: A PROSPECTIVE DUAL-CENTRE STUDY Keith Siau, United Kingdom; A. Yusuf; N. Suzuki; S. Ishaq
P1518 THE EFFECTIVENESS OF NEW TECHNIQUE WITH SELF-EXPANDABLE METALLIC STENT INSERTION IN TREATING RIGHT-SIDED COLONIC OBSTRUCTION Chang Beom Ryu, Republic of Korea; M. S. Lee; J. Y. Bae
P1511 WATER-AIDED COLONOSCOPY – RESEARCH FOCUS IN THE PAST DECADE AND CURRENT CLINICAL PRACTICE Felix Leung, USA
P1519 ENDOSCOPIC FULL-THICKNESS RESECTION FOR COLONIC LESIONS. INITIAL EXPERIENCE IN 3 CENTERS OF CATALONIA. Hugo Uchima Koecklin, Spain; D. Barquero; A. Fernandez-Simon; A. Mata; C. Huertas Nadal; M. Figa; M. Hombrados; J. Espinós
P1513 ENDOSCOPIC SUBMUCOSAL DISSECTION FOR COLORECTAL NEOPLASIA: THE EXPERIENCE OF A UK TERTIARY REFERRAL CENTRE Andrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji P1514 RISK OF STENOSIS AND OUTCOMES FOLLOWING ENDOSCOPIC RESECTION OF LARGE COLORECTAL LESIONS INVOLVING MORE THAN 75% OF THE LUMINAL CIRCUMFERENCE Andrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji
Poster in the Spotlight
Poster of Excellence
P1520 A META-ANALYSIS: CHROMOENDOSCOPY OR WHITE LIGHT ENDOSCOPY FOR NEOPLASIA DETECTION IN LYNCH SYNDROME O. Har-Noy; D. E. Yung; A. Koulaouzidis; U. Kopylov; Lior Katz, Israel P1521 HOT AVULSION TECHNIQUE – A FIRST LINE APPROACH FOR TREATMENT OF VISIBLE RESIDUAL NEOPLASIA DURING ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL POLYPS? Juliana Pinho, Portugal; R. Castro; D. Libanio; P. Pimentel-Nunes; T. Pinto-Pais; M. Dinis-Ribeiro; R. P. Bastos P1522 QUALITY IN BOWEL CLEANSING, PERFORMANCE MEASURES AND PATIENTS SATISFACTION USING DIFFERENT PURGATIVES IN SCREENING COLONOSCOPY Elisabeth Waldmann, Austria; D. Penz; B. Majcher; A. Dokladanska; A. Hinterberger; H. Sinkovec; G. Heinze; M. Trauner; M. Ferlitsch
Clinical Case Session
227
Wednesday, November 1, 2017
P1512 ENDOSCOPIC SUBMUCOSAL DISSECTION: RESULTS AND LEARNING CURVE OF A LARGE PROSPECTIVE SERIE OF 183 CASES IN THREE CENTERS M. Lopez Gomez; M. Hernández; C. E. González; J. Santiago; C. Bernardo; B. Conde; C. González-Lois; P. Matallanos; J. L. Calleja; L. E. Abreu García; Alberto Herreros de Tejada, Spain
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1523 DIFFERENCES BETWEEN BOWEL PREPARATION QUALITY OF SURVEILLANCE AND SCREENING COLONOSCOPY Anna Hinterberger, Austria; D. Penz; E. Waldmann; B. Majcher; A. Dokladanska; A. Szymanska; M. Trauner; M. Ferlitsch P1524 DIFFERENCES IN QUALITY OF BOWEL PREPARATION AT SCREENING COLONOSCOPIES IN PRIVATE PRACTICES AND HOSPITALS Barbara Majcher, Austria; D. Penz; E. Waldmann; A. Hinterberger; A. Dokladanska; A. Szymanska; M. Trauner; M. Ferlitsch P1525 RISK FACTORS FOR RESIDUAL NEOPLASIA AFTER ENDOSCOPIC MUCOSAL RESECTION OF LATERALLY SPREADING TUMORS Nagyia Brogyuk, Czech Republic; T. Grega; M. Voska; O. Ngo; O. Majek; M. Zavoral; S. Suchanek P1526 ENDOSCOPIC SURVEILLANCE AFTER SURGERY ON FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS: IT IS EFFECTIVE BUT INTERVALS CAN BE WIDENED Juliana Pinho, Portugal; J. Lage; M. Dinis-Ribeiro; C. Brandão P1527 BOWEL PREPARATION FOR FLEXIBLE SIGMOIDOSCOPY: COMPARISON OF POLYETHYLENE GLYCOL ELECTROLYTE SOLUTION (PEG-ES) AND PHOSPHATE ENEMA IN 4,949 PATIENTS AT TWO UK HOSPITALS Abdulkani Yusuf, United Kingdom; S. Paranahewa; A. Jeevagan; P. Mayhead
Wednesday, November 1, 2017
P1528 MANAGEMENT OF RESECTION OF LARGE COLONIC LESIONS IN A REAL-LIFE SETTING: THE SCALP STUDY. Arnaldo Amato, Italy; F. Radaelli; V. Cennamo; E. Di Giulio; L. Fuccio; G. Manes; O. Tarantino; G. Fiori; M. De Bellis; A. Buda; F. Pigò; P. Cesaro; A. Anderloni; P. Occhipinti; G. Feliciangeli; P. Dulbecco; A. Musso; G. Gullotti; M. Giardini; B. Mangiavillano; S. Paggi; C. Hassan; A. Repici P1529 ENDOSCOPIC REMOVAL OF HIGH-RISK COLORECTAL ADENOMAS: SAFE AND EFFECTIVE? Mariann Rutka, Hungary; K. Farkas; A. Fabian; R. Bor; A. Balint; Á. Milassin; Z. Szepes; T. Molnar P1530 WHAT IMPROVED AND WHAT REMAINS TO BE ACHIEVED IN ORDER TO COMPLY WITH THE NEW RECOMMENDATIONS OF POLYPECTOMY BY THE EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY Jaime Rodrigues, Portugal; R. Pinho; L. Alberto; A. Rodrigues; L. Proença; T. Freitas; A. P. Silva; S. Fernandes; S. Leite; J. Silva; A. Ponte; M. Sousa; J. C. Silva; J. Carvalho 228
P1531 ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) OF SUPERFICIAL COLORECTAL NEOPLASMS AT THE ANAL CANAL AND ILEOCECAL VALVE Federico Iacopini, Italy; Y. Saito; T. Gotoda; C. Grossi; W. Elisei; F. Montagnese; P. Rigato; A. Cefaro; G. Costamagna P1532 SELF-EXPANDABLE METALLIC STENT IN THE OCCLUSIVE COLORECTAL CANCER AS PALLIATIVE TREATMENT Tânia Gago, Portugal; A. Antunes; A. M. Vaz; P. Queirós; J. Roseira; A. C. Cunha; A. Ramos; H. Guerreiro P1533 RISK FACTORS FOR ADENOMA RECURRENCE AFTER ENDOSCOPIC MUCOSAL RESECTION OF LARGE COLORECTAL POLYPS Juliana Pinho, Portugal; D. Martins; P. Sousa; R. Araújo; A. Castanheira; E. Cancela; R. Cardoso; P. Ministro; A. Silva P1534 THE INFLUENCE OF THE REAL FOLLOW-UP TIMES DURING A COLORECTAL CANCER SCREENING PROGRAM IN DAILY PRACTICE Enrique Perez-Cuadrado-Robles, Belgium; B. Martínez-Andrés; E. A. Torrella Cortes; E. Pérez-Cuadrado-Martínez; F. Pérez-Riquelme P1535 CLINICAL OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF MALIGNANT NON-PEDUNCULATED COLORECTAL LESIONS Carl-Fredrik Rönnow, Sweden; E. Toth; H. Thorlacius P1536 ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) VS HYBRID DISSECTION: WHICH TECHNIQUE TO FAVOR IN LARGE COLORECTAL LESIONS ? Marie-Anne Guillaumot, France; S. Leblanc; H. Soliman; B. Brieau; M. Barret; R. coriat; F. Prat; S. Chaussade Endoscopy, ERCP P1537 TRENDS IN STATISTICS REGARDING ELECTIVE ERCP PROCEDURES IN THE VENETO REGION: A RETROSPECTIVE STUDY BASED ON ADMINISTRATIVE DATABASES. M. Saia; E. Rosa-Rizzotto; E. Guido; Diego Caroli, Italy; A. Frasson; B. Germaná; P. Pilati; F. De Lazzari P1538 EFFECT OF OBESITY, DYSLIPIDEMIA AND DIABETES MELLITUS ON THE RISK OF POST-ERCP PANCREATITIS Hajer Hassine, Tunisia; H. Elloumi; M. Sabbah; N. Bibani; D. Trad; D. Gargouri; A. Ouakaa; J. Kharrat
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1540 QUALITY INDICATORS AND POST OPERATIVE OUTCOME OF ERCP PERFORMED IN A LOW RESOURCE SETTING; CAN QUALITY INDICATORS FROM DEVELOPED SETTINGS BE APPLIED? I. Kongala Liyanage; E. Thalagala; Supun Kulatunge, Sri Lanka; R. Peiris; N. Nawarathne P1541 USE OF MICROCATHETERS IN ECHOENDOSCOPY-GUIDED BILIOPANCREATIC RENDEZ-VOUS – INITIAL EXPERIENCE João Pinto, Portugal; C. Saldaña Dueñas; C. Leitão; I. Fernández-Urién Sainz; J. J. Vila P1542 ERCP AND PTCD IN BILIARY TRACT COMPLICATIONS AFTER LIVER TRANSPLANTATION: PREDICTORS OF LONG-TERM OUTCOME M. Heinemann; Bita Tafrishi, Germany; S. Pischke; C. Spehr; A. W. Lohse; L. Fischer; T. Rösch; M. Sterneck; U. Denzer P1543 RESULTS OF THE FRENCH NATIONAL OBSERVATIONAL STUDY CONCERNING THE PRACTICE OF PROBE BASED CONFOCAL ENDOMICROSCOPY (CELLVIZIO®). Eid Mahfouz, France; G. Rahmi; L. Palazzo; R. Gincul; B. Napoléon; M. Giovannini; J. Moreau; M. Levy; G. Perrod; A. Vienne; E. Samaha; J.-M. Canard; F. Caillol; V. Lepilliez; T. Ponchon; E. Coron; C. Cellier P1544 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PATIENTS WITH SURGICALLY MODIFIED GASTRO-ENTERIC-BILIARY ANATOMY: RESULTS FROM A TERTIARY CENTER Elisa Soares, Portugal; M. Gravito-Soares; N. Almeida; D. Gomes; E. Camacho; S. Mendes; R. Ferreira; L. Tomé P1545 NEWLY DEVELOPED BASKET FOR DIGITAL, SINGLE-OPERATOR CHOLANGIOSCOPY FOR MANAGEMENT OF RESIDUAL STONES AFTER LITHOTRIPSY Jong Ho Moon, Republic of Korea; Y. N. Lee; H. J. Choi; H. W. Lee; T. H. Lee; M. H. Choi; S.-W. Cha; Y. D. Cho; S.-H. Park P1546 ASSOCIATION BETWEEN PREDICTIVE FACTORS AND RADIATION EXPOSURE DURING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY Seok-Ho Dong, Republic of Korea; C. H. Oh; J. R. Moon Poster in the Spotlight
Poster of Excellence
P1547 DEVELOPMENT OF AN ERCP REGISTRY FOR QUALITY CONTROL AND BENCHMARKING Dániel Pécsi, Hungary; S. Gódi; F. Pakodi; P. Nagy; T. Molnár; P. Hegyi; A. Vincze P1548 DOUBLE-BALLON ENTEROSCOPY FOR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PATIENTS WITH SURGICALLY ALTERED UPPER GASTROINTESTINAL ANATOMY Celine Ghaoui, France; E. Samaha; G. Rahmi; G. Perrod; H. Benosman; A. Vienne; C. Savale; S. Khater; L. Abbes; J.-B. Danset; G. Malamut; C. Cellier P1549 NEEDLE-KNIFE SPHINCTEROTOMY (NKS) VERSUS TRANSPANCREATIC SPHINCTEROTOMY (TPS) FOR DIFFICULT BILIARY CANNULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS Alberto Tringali, Italy; M. Cintolo; L. Cristoferi; E. Forti; F. Pugliese; L. Dioscoridi; M. Mutignani P1550 TRANSPANCREATIC SPHINCTEROTOMY: A VALUABLE TECHNIQUE FOR GAINING CBD ACCESS Shiran Esmaily, United Kingdom; M. Elzubier; D. Dwarakanath; V. Mitra; D. Majumdar; B. K. Chaudhury; J. Hancock P1551 ENDOSCOPIC REMOVAL OF BILE DUCT STONES – A RETROSPECTIVE SINGLE-CENTER STUDY Gabriel Constantinescu, Romania; O. M. Plotogea; M. Ilie; B. Ungureanu; A. Constantinescu; I. Moroi; V. Sandru P1552 DICLOFENAC AND INDOMETHACIN IN THE PREVENTION OF POST-ERCP PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE CONTROLLED TRIALS Arpad V. Patai, Hungary; N. Solymosi; L. Mohácsi; Á. Nagy; A. Patai P1553 RECTAL DICLOFENAC AND PANCREATITIS AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY Lourdes Del Olmo Martinez, Spain; B. Velayos; M. Ruiz-Rebollo P1554 WITHDRAWN P1555 A PILOT STUDY OF PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY FOR COMPUTER-AIDED DIAGNOSIS OF BILE DUCT CANCER BY USING THE DEEP LEARNING TECHNOLOGY Koichi Furukawa, Japan; N. Yokoyama; H. Hashidate
Clinical Case Session
229
Wednesday, November 1, 2017
P1539 PLACE OF ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) IN THE MANAGEMENT OF HEPATIC HYDATID DISEASE Hajer Hassine, Tunisia; M. Sabbah; N. Bibani; D. Trad; H. Elloumi; D. Gargouri; A. Ouakaa; J. Kharrat
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
Endosonography P1556 COMPARISON OF EUS-GUIDED FINE NEEDLE BIOPSY TECHNIQUES FOR CORE TISSUE ACQUISITION AND DIAGNOSTIC PERFORMANCES IN PANCREATIC SOLID LESIONS Chang-Min Cho, Republic of Korea; S. J. Yeo; A. N. Seo; H. I. Bae P1557 WITHDRAWN P1558 WITHDRAWN P1559 WITHDRAWN P1560 EUS-GUIDED GALLBLADDER DRAINAGE FOR ACUTECHOLECYSTITIS WITH A SILICONE-COVERED NITINOL SHORT FLARED ENDS STENT: A CASE SERIES. R. Manta; Claudio Zulli, Italy; F. P. Zito; A. Zullo; E. Forti; A. Tringali; L. Dioscoridi; S. Russo; M. Lupo; A. Caruso; H. Bertani; R. Conigliaro; M. Mutignani P1561 ª EFFICIENCY COMPARISON BETWEEN 22 G VERSUS 25G NEEDLES DURING ENDOSCOPIC ULTRASOUND FINE NEEDLE ASPIRATION FOR SOLID PANCREATIC MASSES ASSESSMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS BASED ON RCTS. H. G. Guedes; Ralph Duarte, Brazil; D. T. H. de Moura; S. Cheng; M. Coronel; M. E. L. dos Santos; S. E. Matuguma; D. M. Chaves; W. M. Bernardo; E. G. Hourneaux Moura P1562 OUTCOMES AND LEARNING CURVES OF EUS-GUIDED GALLBLADDER DRAINAGE WITH LUMEN APPOSING STENTS. Anthony Teoh, Hong Kong PRC; S. M. Chan; H. C. Yip; V. Wong; P. W. Y. Chiu; E. Ng
Wednesday, November 1, 2017
P1563 TECHNICAL FEASIBILITY STUDY OF EUS-GUIDED HYDROGEL MICROPARTICLE INJECTION INTO THE PANCREATIC HEAD-DUODENAL WALL INTERFACE IN A CADAVERIC MODEL S.-H. Kim; K. Ding; A. Rao; L. Rosati; A. Narang; Eun Ji Shin, USA P1564 EX-VIVO RADIOFREQUENCY ABLATION OF PORCINE LIVER: A PRELIMINARY STUDY OF EFFICACY OF A NEW SYSTEM Gemma Rossi, Italy; M. C. Petrone; E. Dabizzi; A. Mariani; S. G. G. Testoni; M. Traini; L. Archibugi; P. Magnoni; P. G. Arcidiacono
230
P1565 THROMBOEMBOLIC DISEASE DIAGNOSED BY ENDOSCOPIC ULTRASOUND IN PANCREATIC CANCER: A CASE SERIES Catarina Atalaia Martins, Portuga; P. Pinto-Marques; I. Mocanu; J. Cortez-Pinto; D. Serra P1566 THE ROLE OF EARLY ENDOSCOPIC ULTRASONOGRAPHY FOLLOWING TRANSABDOMINAL ULTRASONOGRAPHY IN PATIENTS WITH SUSPECTED BILIARY COLIC Benedetto Mangiavillano, Italy; L. Frazzoni; R. Grassia; M. Flavia Savarese; M. Bianchetti; A. Repici; L. Fuccio P1567 BILIOPANCREATIC RADIOFREQUENCY ABLATION: COMPARISON OF THE THREE CURRENTLY AVAILABLE DEVICES IN A PIG MODEL. Maximilien Barret, France; S. Leblanc; B. Bordaçahar; A. Rouquette; S. Chaussade; F. Prat P1568 ENDOSCOPIC ULTRASOUND-GUIDED RENDEZVOUS FACILITATES BILIARY CANNULATION IN CASE OF INACCESSIBLE INTRA-DIVERTICULAR PAPILLA Dimitrios Kypraios, Greece; A. Malachias; L. Theodoropoulos; S. L. Hatzinicolaou; S. Stavrinidis; N. Saribegioglou; G. Sofianidis; K. Tsamakidis; D. Dimitroulopoulos; D. Xinopoulos P1569 A RANDOMIZED CONTROL TRIAL ASSESSING THE CONTRAST ENHANCED GUIDED FINE NEEDLE ASPIRATION IN SOLID PANCREATIC NEOPLASMS Andrada Seicean, Romania; A. Samarghitan; I. Rusu; M. I. Gheorghiu; C. Pojoga; R. Seicean Capsule endoscopy P1570 EARLY CAPSULE ENDOSCOPY PROVIDES BETTER BLEEDING LOCALIZATION VALUE IN PATIENTS PRESENTING WITH NON-HEMATEMESIS GASTROINTESTINAL BLEEDING WHEN COMPARED TO CLINICAL SYMPTOMS ALONE Salmaan Jawaid, USA; N. Marya; A. Foley; C. Marshall; K. Bhattacharya; D. Cave P1571 MUCOSAL HEALING RATES INDUCED BY ADALIMUMAB IN ISOLATED SMALL BOWEL CROHN’S DISEASE: PROSPECTIVE EVALUATION BY CAPSULE ENDOSCOPY Eyal Gal, Israel; O. Ben-Bassat; Z. Levi; G. M. Fraser; Y. Snir; H. Yanai; I. Dotan; I. Avni-Biron P1572 CORRELATION BETWEEN SMALL BOWEL MRI, FAECAL CALPROTECTIN AND CAPSULE ENDOSCOPY IN THE INVESTIGATION OF INFLAMMATORY BOWEL DISEASE S. Vijayan; Diana Yung, United Kingdom; H. Suzuki; R. Makins; U. Kopylov; A. Levartovsky; B. J. F. Rosa; J. N. Plevris; A. Koulaouzidis
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1574 ª FEASIBILITY OF SAME DAY COLON CAPSULE ENDOSCOPY (CCE) IN PATIENTS WITH INCOMPLETE COLONOSCOPY Mary Hussey, Ireland; G. Holleran; C. Tersaruolo; D. McNamara Cross sectional imaging P1575 DEDICATED DIFFUSION WEIGHTED MR IMAGING FOR STAGING PERITONEAL METASTASES IN COLORECTAL CANCER; AN ACCURATE PREOPERATIVE SELECTION TOOL FOR CYTOREDUCTION SURGERY (CRS/HIPEC) CANDIDATES I. Jansen; D. M. Lambregts; S. Chandrasegaram-Shanmuganathan; N. Kok; G. L. Beets; R. G. H. Beets-Tan; A. Aalbers; Max Lahaye, The Netherlands P1576 HISTOLOGICAL PREDICTION OF COLONIC POLYPS BY COMPUTER VISION. PRELIMINARY RESULTS. Cristina Sánchez-Montes, Spain; J. Sánchez; C. Rodríguez de Miguel; H. Córdova; J. Bernal; M. López-Cerón; J. LLach; G. Fernández-Esparrach P1577 COLORECTAL LATERALLY SPREADING TUMORS DETECTED AT CT COLONOGRAPHY Masahiro Iwabuchi, Japan; M. Sugimura; S. Toda; K. Ukai P1578 ANALYSIS OF CT COLONOGRAPHY MISS RATE OF LARGE NEOPLASTIC LESIONS DETERMINED BY COLONOSCOPY ON JAPANESE NATIONAL CT COLONOGRAPHY TRIAL (JANCT). Michiaki Hirayama, Japan; T. Takayama; R. Fujii; T. Minagawa; S. Ohiwa; K. Sakata; M. Yoshida; Y. Okagawa; H. Ihara; T. Sumiyoshi; Y. Tsuji; N. Yoshizaki; H. Kondo; K. Nagata P1579 DIFFUSION-WEIGHTED MAGNETIC RESONANCE FOR ASSESSING FIBROSIS IN CROHN’S DISEASE Antonino Caruso, Italy; M. Scarpa; G. Schifano; C. Mescoli; M. Rudatis; R. D'inca; G. C. Sturniolo; C. Lacognata; I. Angriman P1580 MOLECULAR IMAGING OF C-MET IN THE CLINICAL MANAGEMENT OF GASTROINTESTINAL CANCERS N. McDonald; C. Portal; Ian Wilson, United Kingdom
Poster in the Spotlight
Poster of Excellence
Enteral dilatation and stenting (oesophagus, stomach, duodenum, colon) P1581 HOMEMADE FIXATION OF FULLY-COVERED SELF EXPANDING METAL STENT Caterina Maria Pia Simioni Pennacchi, Brazil; E. H. G. dominguez; E. Q. Mendonça; J. F. D. Oliveira; B. D. C. Martins; G. de Paulo; F. Kawaguti; C. C. Gusmon; U. Ribeiro Jr.; R. A. A. sallum; F. Maluf-Filho P1582 CLINICAL OUTCOME WHEN USING SELF EXPANDING METAL STENT IN OBSTRUCTIVE COLORECTAL CANCER IN 248 PATIENTS; 7 YEARS EXPERIENCE FROM A TERTIARY CENTER. Morteza Shafazand, Sweden; T. Radomski; L. Alkelin; N. Papachrysos P1583 ENDOSCOPIC TREATMENT OF ESOPHAGEAL FISTULAS Denisa Bucur, Romania; D. Oprisanescu; G. Constantinescu; M. Ilie; V. Sandru; D. Tabacelia P1584 LONG-TERM OUTCOME OF ENDOSCOPIC TREATMENT OF SYMPTOMATIC ENTERIC STRICTURES IN CROHN'S DISEASE Elisabeth Aichinger, Germany; M. Koch; K. Rothfuss; C. Schäfer; K. Grün; M. Schneider; J. Peveling-Oberhag; N. Lubomierski; J. Albert P1585 ENDOSCOPIC INTRALESIONAL STEROID INJECTION IS EFFECTIVE IN THE TREATMENT OF BENIGN REFRACTORY OESOPHAGEAL STRICTURE, A META-ANALYSIS László Szapáry, Hungary; N. Farkas; K. Márta; P. Hegyi; B. Eross P1586 EFFICACY AND COMPLICATIONS IN PALLITVE OESOPHAGEAL STENTING, EXPERINCES OF A TERTIARY REFERRAL CENTER IN THE UK Charles Clisby, United Kingdom; C. Gordon; B. Eross P1587 LONG-TERM RESULTS: WHEN RE-STENOSIS COMES AFTER ESOPHAGEAL STENTING? Denis Gusev, Russian Federation; S. Kashin; N. Akhapkin P1588 SELF-EXPANDABLE METAL STENTS ARE A VALID OPTION IN PATIENTS WITH LONG-TERM SURVIVAL FROM ADVANCED ESOPHAGEAL CANCER Eduardo Rodrigues-Pinto, Portugal; P. Pereira; T. H. Baron; G. Macedo
Clinical Case Session
231
Wednesday, November 1, 2017
P1573 HOW MANY CAPSULE ENDOSCOPY STUDIES CAN BE READ IN A GIVEN SESSION BEFORE ACCURACY IS AFFECTED? Sabina Beg, United Kingdom; R. Sidhu; T. R. Card; E. Wronska; K. Ragunath
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
Interventional radiology
Hepatobiliary / pancreas / spleen
P1589 NOVEL PERCUTENOUS TECHNIQUES IN MANAGEMENT OF POST-CHOLECYSTECTOMY COMPLICATIONS Mahmoud Ghalab, Egypt; A. A. Abd El Kerim; S. E. Hegab; O. S. El Aassar; M. H. Emara Elzanan; E. Emara; M. Sharaan
P1596 A RELIABLE AND ACCURATE ALGORITHM TO QUANTIFY THE TUMOR STROMA QTS AMONG TUMOR ENTITIES: HIGH INFILTRATION OF CD3+ AND CD8+ LYMPHOCYTES CORRELATES WITH IMPROVED SURVIVAL IN HEPATOCELLULAR CARCINOMA AND PANCREATIC CANCER Rainer Christoph Miksch, Germany; J. Hao; K. Dötzer; F. Schlüter; M. Weniger; S. Yin; S. Ormanns; J. G. D'Haese; M. Guba; J. Werner; B. Mayer; A. V. Bazhin; M. B. Schoenberg
P1590 WHAT IS THE ROLE OF ANGIOGRAPHY IN ACUTE COLONIC AND SMALL BOWEL BLEEDING? Rita Vale Rodrigues, Portugal; P. Amaro; M. Ferreira; M. Barros; P. Donato; L. Tomé Poster Session 09:00 – 14:00 Surgery III
Hall 7
Oesophagus / stomach / duodenum P1591 PROGNOSTIC VALUE OF CARDIOPULMONARY EXERCISE TESTING FOR MORBIDITY RISK AND SURVIVAL AFTER OESOPHAGECTOMY FOR CANCER Neil Patel, United Kingdom; J. Wheat; C. Brown; A. Powell; T. Abdelrahman; R. Davies; I. Appadurai; W. Lewis P1592 PROPENSITY SCORE ANALYSIS OF 18-FDG PET/CT ENHANCED STAGING IN PATIENTS UNDERGOING SURGERY FOR OESOPHAGEAL CANCER Neil Patel, United Kingdom; K. Foley; D. Chan; C. Brown; A. Powell; T. Abdelrahman; P. Fielding; A. Roberts; W. Lewis P1593 PREDICTION OF LYMPH NODE METASTASIS FOR SUPERFICIAL ESOPHAGEAL CANCER WITH USING RANDOM FOREST ANALYSIS Masashi Takeuchi, Japan; H. Kawakubo; K. Fukuda; R. Nakamura; K. Suda; N. Wada; Y. Kitagawa
Wednesday, November 1, 2017
P1594 PROGNOSTIC SIGNIFICANCE OF CARDIORESPIRATORY FITNESS, BODY COMPOSITION ANALYSIS, AND SYSTEMIC INFLAMMATORY RESPONSE IN UPPER GASTROINTESTINAL CANCER Neil Patel, United Kingdom; P. Blake; J. Wheat; C. Brown; A. Powell; T. Abdelrahman; W. lewis P1595 COPING AND QUALITY OF LIFE AFTER ESOPHAGECTOMY FOR CANCER E. Pinto; F. Cavallin; Luca Maria Saadeh, Italy; R. Alfieri; C. Caberlotto; M. C. Bellissimo; M. Cagol; C. Castoro; M. Scarpa
232
P1597 WITHDRAWN P1598 LIVER RESECTION IN OBESE PATIENTS WITH HEPATOCELLULAR CARCINOMA Hideaki Iwama, Japan; S. Hai; E. Hatano; T. Okada; Y. Asano; N. Uyama; K. Suzumura; M. Tada; J. Fujimoto P1599 TIMING OF ELECTIVE CHOLECYSTECTOMY AFTER ACUTE CHOLECYSTITIS – A POPULATION BASED STUDY Agnieszka Popowicz, Sweden; G. Sandblom P1600 MIXED REALITY SURGERY USING CT-BASED PATIENT-SPECIFIC IMMERSIVE 3D HOLOGRAMS ENHANCED SPATIAL AWARENESS IN HEPATO-PANCREATO-BILIARY AND GASTROINTESTINAL SURGERY Maki Sugimoto, Japan P1601 WITHDRAWN Postoperative complications P1602 EFFICACY OF DOUBLE PIGTAIL STENT FOR POST OESOGASTRIC SURGICAL LEAKS NON LINKED TO BARIATRIC SURGERY: A PILOT BI-CENTRE RETROSPECTIVE STUDY J. Jacques; Lauriane Pagnon, France; A. Taibi; R. Legros; T. Tabouret; T. Barrioz; M. Wangermez; S. Durand-Fontanier; S. Bouvier; M. Mathonnet; D. Valleix; A. Le-sidaner; H. Lepetit; V. Loustaud-Ratti; D. Sautereau P1603 ROUTINE USE OF POLYPROPYLENE MESH FOR PROPHYLAXIS OF ABDOMINAL COMPARTMENT SYNDROME FOR PATIENTS AFTER RUPTURED ABDOMINAL AORTIC ANEURYSM OPEN REPAIRING. RESULTS OF THREE YEARS FOLLOW-UP. Oksana Popova, Ukraine; O. Sergeev
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1605 CLINICAL ASSESSMENT OF THE FAILING TO REVERSE A DIVERTING ILEOSTOMY Aleksandra Sobolewska-Włodarczyk, Poland; M. Wlodarczyk; J. Włodarczyk; P. Siwiński; J. Kasprzyk; A. Dziki; Ł. Dziki P1606 BODY COMPOSITION AS A PREDICTOR OF MORBI-MORTALITY FOLLOWING BILIOPANCREATIC CANCER SURGERY Maria Pia Costa Santos, Portugal; S. Velho; C. Cunha; F. Costa; L. Agostinho; R. Cruz; R. Maio; M. Cravo Paediatric surgery P1607 GASTROSCHISIS: A 16-YEAR STUDY Ana Maria Bradeanu, Romania; L. Balanescu; I. Nenciu Poster Session 09:00 – 14:00 IBD III
Hall 7
Basic/pathogenesis/pathology P1608 ASSESSING THE EFFECT OF ETHNICITY ON URINARY METABOLIC PROFILES IN INFLAMMATORY BOWEL DISEASE. Lucy Hicks, United Kingdom; S. T. R. Powles; L. W. L. Chong; J. Swann; E. Holmes; H. R. T. Williams; T. R. Orchard P1609 EFFECTS OF ACUTE CHANGES IN FERMENTABLE FIBRE INTAKE ON REGIONAL COLONIC FERMENTATION AND TRANSIT IN PATIENTS WITH QUIESCENT ULCERATIVE COLITIS Ck Yao, Australia; R. E. Burgell; K. M. Taylor; M. G. Ward; J. S. Barrett; J. G. Muir; P. R. Gibson P1610 FECAL MICROBIAL DYSBIOSIS IN CHINESE PATIENTS WITH INFLAMMATORY BOWEL DISEASE Haiqin Ma, China; H. Zhang P1611 HYPOXIA-MEDIATED IRON UPTAKE PREVENTS INFLAMMATORY GENE EXPRESSION IN THE INTESTINAL EPITHELIUM THROUGH THE REGULATION OF NF-κB BINDING ACTIVITY S. Simmen; J. Cosin Roger; C. De Valliere; M. Scharl; J. Zeitz; S. Vavricka; G. Rogler; Pedro Ruiz-Castro, Switzerland Poster in the Spotlight
Poster of Excellence
P1612 OGR1 (GPR68) EXPRESSION IS INCREASED IN INTESTINAL INFLAMMATION AND CORRELATES WITH DISEASE ACTIVITY IN PATIENTS WITH IBD J. Cosin Roger; Katharina Baebler, Switzerland; S. Bengs; S. Lang; M. Turina; A. Rickenbacher; M. Scharl; K. Seuwen; P. A. Ruiz-Castro; B. Misselwitz; G. Rogler; C. De Valliere P1613 MICROBIAL PROFILING OF NEWLY DIAGNOSED PATIENTS WITH ULCERATIVE COLITIS DIFFERS WITH ETHNICITY; RESULTS OF AN INCEPTION COHORT TIME SERIES ANALYSIS Ravi Misra, United Kingdom; A. Perdones-Montero; N. S. Ding; D. Rees; O. Faiz; J. Marchesi; N. Arebi P1614 VITAMIN D SUPPLEMENTATION REDUCES FAECAL CALPROTECTIN AND ALTERS INTESTINAL MICROBIOTA COMPOSITION IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS M. Garg; Philip Hendy, United Kingdom; S. Shaw; N. S. Ding; G. Hold; A. Hart P1615 SUPPRESSION OF PHOSPHOLIPASE A2 OF INTESTINAL MICROBIOTA AMELIORATES MUCOSAL INFLAMMATION IN A GENETIC MOUSE MODEL OF ULCERATIVE COLITIS Wolfgang Stremmel, Germany; S. Staffer; N. C. Stuhrmann; A. Gauss; N. Burger; D. Hornuss P1616 THE IMPACT OF THE RS8005161 POLYMORPHISM ON G PROTEIN-COUPLED RECEPTOR GPR65 (TDAG8) PH-ASSOCIATED SIGNALING IN INTESTINAL INFLAMMATION I. Tcymbarevich; Katharina Baebler, Switzerland; J. Cosin Roger; N. Obialo; M. R. Spalinger; J. J. Eloranta; S. Lang; G. A. Kullak-Ublick; C. A. Wagner; M. Scharl; K. Seuwen; P. A. Ruiz-Castro; G. Rogler; B. Misselwitz; C. de Vallière P1617 B2-STRICTURING AND B3-PENETRATING PHENOTYPE IN CROHN’S DISEASE: CHARACTERIZATION OF MACROPHAGES POPULATION AND WNT SIGNALING Dolores Ortiz Masia, Spain; P. Salvador; D. Macias-Ceja; R. Alos; J. Hinojosa Del Val; F. Navarro-Vicente; J. Manyé; M. D. Barrachina; S. Calatayud P1618 CD16 POSITIVE CELLS EXPRESS TGFβ AND MEDIATES MURINE INTESTINAL FIBROSIS Pedro Salvador, Spain; D. Ortiz-Masia; D. Macias-Ceja; L. Gisbert-Ferrándiz; C. Hernández; J. V. Esplugues; M. D. Barrachina; S. Calatayud P1619 GTS-21, α7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ATTENUATE DSS-INDUCED COLITIS BY IMPROVING INTESTINAL MUCOSAL BARRIER FUNCTION Yunjuan Zhu, China; H. Zhang
Clinical Case Session
233
Wednesday, November 1, 2017
P1604 ENDOSCOPIC PERORAL DRAINAGE (EPOD) OF PERITONEAL COLLECTIONS AND ABSCESSES SECONDARY TO BARIATRIC SURGERY LEAKS: THE PARADIGM SHIFT OF SEEING PERITONEUM AS AN ORGAN AMENABLE FOR FLEXIBLE ENDOSCOPES INTERVENTIONS Alberto J. Baptista, Venezuela; A. Salinas; M. A. Guzman; A. Gelrud; D. Ramirez; W. García; A. Oropeza; H. Rass; J. F. Piñerúa Gonsálvez
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1620 EXPRESSION OF WNT10B IN M2-MACROPHAGES FROM CROHN´S DISEASE PATIENTS Dolores Ortiz Masia, Spain; D. Macias-Ceja; P. Salvador; D. Bernardo; F. Navarro-Vicente; R. Alos; L. Gisbert-Ferrándiz; C. Hernández; S. Calatayud; M. D. Barrachina P1621 ANAEMIA PREVALENCE AND TREATMENT APPROACH FOR INFLAMMATORY BOWEL DISEASE Goksel Bengi, Turkey; H. Keyvan; H. Akpınar P1622 SUCCINATE RECEPTOR (SUCNR1) MEDIATES INFLAMMATION IN A MURINE MODEL OF COLITIS. Dulce Carolina Macias Ceja, Spain; D. Ortiz-Masia; P. Salvador; L. Gisbert-Ferrándiz; S. Coll-Puig; C. Hernández; J. V. Esplugues; S. Calatayud; M. D. Barrachina P1623 ZIP7 INDUCES DISRUPTION OF THE INTESTINAL BARRIER THROUGH ACTIVATION OF ENDOPLASMIC RETICULUM STRESS IN INFLAMMATORY BOWEL DISEASE Jing Sun, China; Q. Zhan; F. An P1624 EFFECT OF T CELL ACTIVATION AND INFLAMMATION ON THE INTERACTION BETWEEN T CELLS AND ENTERIC GLIAL CELLS I. Neveu; Julie Pabois, France; T. Durand; J. Gonzales; J. A. Gonzales; M. Neunlist; P. Naveilhan P1625 ENTERIC GLIAL CELLS REACTION TO INFLAMMATION IS LOST IN CROHN’S DISEASE Malvyne Rolli-Derkinderen, France; C. Pochard; T. clairembault; N. Cenac; A. Bourreille; M. Neunlist P1626 PROSTACYCLIN REVERSES COLITIS THROUGH THE DOWN REGULATION OF INTESTINAL EPITHELIAL PERMEABILITY Camille Pochard, France; P. Aubert; C. Gesret; N. Cenac; A. Bourreille; G. Meurette; E. Coron; M. Neunlist; M. Rolli-Derkinderen Wednesday, November 1, 2017
P1627 7α-HYDROXY-4-CHOLESTEN-3-ONE FOR DIAGNOSIS AND MANAGEMENT OF BILE ACID MALABSORPTION: FIRST YEAR CLINICAL EXPERIENCE. B. Friedli; F. Brunner; C. Prost; C. Bovet; D. Kröll; A. Macpherson; Pascal Juillerat, Switzerland P1628 THE ROLE OF SEVERAL CYTOKINES IN THE PATHOGENESIS OF AUTOIMMUNE INFLAMMATION IN PATIENTS WITH ULCERATIVE COLITIS Alina Valeeva, Russian Federation; R. A. Abdulkhakov; O. V. Skorokhodkina; S. R. Abdulkhakov; S. Khaiboullina; E. Martinova; A. Rizvanov 234
P1629 ANP32E IS INVOLVED IN THE STEROID-REFRACTORY ULCERATIVE COLITIS Violeta Lorén, Spain; A. Garcia-Jaraquemada; J. E. Naves; J. Carmona; E. Cabré; M. Mañosa; J. Manyé; E. Domènech P1630 CO-HOUSING DSS TREATED MICE WITH HEALTHY MICE RESULTS IN FASTER NORMALIZATION OF THE INTESTINAL MICROBIOTA AND PROMOTES RECOVERY Marianne Rebecca Spalinger, Switzerland; L. Hering; C. Gottier; S. Lang; G. Rogler; M. Scharl Aetiology/epidemiology P1631 ILEAL SULFOMUCINS PREDICT CLINICAL RECURRENCE AFTER ILEO-COLONIC RESECTION FOR CROHN’S DISEASE: A PROSPECTIVE STUDY AT 5 YEARS Livia Biancone, Italy; M. Ascolani; C. Mescoli; G. Sica; G. Palmieri; S. Romeo; L. Albertoni; B. Neri; F. Pallone; M. Rugge P1632 IMMUNOGENICITY OF A QUADRIVALENT INFLUENZA VACCINE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE Shimpei Shirai, Japan; Y. Sakata; K. Akutagawa; K. Yamanouchi; N. Tsuruoka; H. Endo; R. Shimoda; T. Noda; N. Sugisaki; R. Iwakiri; K. Fujimoto P1633 THE INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN SEVEN ETHNICALLY DIVERSE URBAN POPULATIONS IN ENGLAND; RESULTS FROM THE UK INCEPTION COHORT EPIDEMIOLOGICAL STUDY (UNITE) Ravi Misra, United Kingdom; J. Limdi; R. Cooney; M. Brookes; E. Fogden; S. Pattni; N. Sharma; G. Young; J. Burisch; P. Munkholm; N. Arebi P1634 IBD-RELATED MALIGNANCIES AND MORTALITIES OBSERVED BETWEEN 2015-2016 – TWO YEARS’ RESULTS FROM THE PROSPECTIVE NATIONWIDE HUNGARIAN REGISTRY Tamas Molnar, Hungary; M. Rutka; F. Nagy; P. Fritz; L. Lakatos; P. Miheller; Z. Erdélyi; T. Szamosi; E. Schäfer; A. Vincze; P. Sarlós; J. Banai; Á. Kovács; J. Novák; A. Salamon; A. Szepes; N. Szigeti; M. Juhász; K. Müllner; Z. Barta; O. Kadenczki; A. Gelley; K. Palatka; M. Papp; A. Zaránd; P. L. Lakatos; G. L. Veres; A. Fabian; A. Balint; R. Bor; Z. Szepes; K. Farkas P1635 ANAL CANAL HUMAN PAPILLOMAVIRUS (HPV) INFECTION IN MEN AND WOMEN UNDERGOING COLONOSCOPY: PREVALENCE AND RISK FACTORS, HIGH BURDEN IN CROHN’S DISEASE PATIENTS. Lucine Vuitton, France; E. Jacquin; A.-L. Parmentier; F. Fein; A.-C. Dupont-Gossart; L. Plastaras; S. Koch; J.-L. Pretet; C. Mougin; S. Valmary-Degano
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1637 IS SMOKING CESSATION LINKED TO NEW ULCERATIVE COLITIS CASES? A RESTROSPECTIVE COHORT-BASED HYPOTHESIS. Maude Grueber, Switzerland; L. Biedermann; S. Vavricka; A. Schoepfer; A. Macpherson; P. Juillerat; C. Clair Willi; N. Fournier P1638 THE IMPACT OF INFLAMMATORY BOWEL DISEASE ON HARD TEETH TISSUES – PRELIMINARY RESULTS FROM POLIBD STUDY D. Piatek; I. Korona-Glowniak; A. Malm; S. Jarmakiewicz; S. Pudzianowski; A. Pekala; P. R. Kiela; Rafał Filip, Poland Diagnosis and monitoring P1639 RESTING ENERGY EXPENDITURE IN WOMEN WITH CROHN’S DISEASE: A CROSS-SECTIONAL STUDY Nicola Imperatore, Italy; I. Cioffi; R. Sammarco; A. Testa; A. Rispo; M. Marra; F. Contaldo; N. Caporaso; F. Castiglione; F. Pasanisi P1640 MAGNETIC RESONANCE CHOLANGIOGRAPHY ABNORMALITIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Arthur Belle, France; A. Lopez; V. Laurent; C. Baumann; H. Rousseau; X. Orry; J.-P. Bronowicki; L. Peyrin-Biroulet P1641 TRUECOLOURS ULCERATIVE COLITIS (TCUC): WILL PATIENTS WITH UC COMPLETE DIGITAL QUESTIONNAIRES IN REAL-TIME? Alissa Walsh, United Kingdom; M. Peters; C. Hinds; V. Sexton; A. Kormilitzin; P. Seeva; G. Collins; S. Keshav; O. Brain; H. Uhlig; A. Simmons; J. Geddes; G. Goodwin; S. Travis P1642 BODY COMPOSITION AS A PREDICTOR FACTOR OF DISEASE OUTCOME IN INFLAMMATORY BOWEL DISEASE – RESULTS OF 3-YEAR FOLLOW UP Agnes Anna Csontos, Hungary; A. Molnár; R. Hencz; D. Piri; S. Dakó; T. Ferenci; E. Pálfi; P. Miheller
Poster in the Spotlight
Poster of Excellence
P1643 CONTRAST-ENHANCED ULTRASOUND IS HELPFUL IN THERAPEUTIC DECISION MAKING IN PATIENTS WITH STRICTURING CROHN`S DISEASE Zuzana Zelinkova, Slovak Republic; B. Kadleckova; D. Podmanicky P1644 FERTILITY AND PREGNANCY IN IBD – OUR EXPERIENCES Eszter Schäfer, Hungary; K. Bursics; T. Szamosi; J. Banai; F. Zsigmond; T. Gyökeres; L. Herszényi P1645 DIAGNOSTIC DELAY AND PREDICTIVE FACTORS FOR CROHN'S DISEASE IN AN ALGERIAN POPULATION. Yacine Chelbi, Algeria; R. Boulares P1646 TUBERCULOSIS IN INFLAMMATORY BOWEL DISEASE UNDER TUMOUR NECROSIS FACTOR ALPHA ANTAGONIST – THE RISK BEYOND SCREENING Liliana Carvalho, Portugal; M. A. Túlio; J. Carmo; J. Rodrigues; T. Bana e Costa; C. Chagas P1647 CAN A PATIENT RATE THE ACTIVITY OF THEIR CROHN´S DISEASE THROUGH A MOBILE APP? THE MEDICROHN STUDY. Ana Echarri Piudo, Spain; I. Vera Mendoza; J. Guardiola; V. Ollero; B. Castro; F. Gallego; M. Aguas; M. Chaparro; D. Ceballos; C. Arajol; P. Robledo Andrés; S. Riestra; I. Marín-Jiménez; P. Nos; S. García-López P1648 HISTOLOGICAL ASSESSMENT OF REMISSION IN ULCERATIVE COLITIS: DISCREPANCIES BETWEEN DAILY PRACTICE AND EXPERT OPINION Pim Kranenburg, The Netherlands; T. E. H. Römkens; A. Van Tilburg; C. Bronkhorst; J. P. H. Drenth; I. D. Nagtegaal; F. Hoentjen P1649 EVALUATION OF MODIFIED MAYO ENDOSCOPIC SCORE AND DUBLIN, NEW ENDOSCOPIC SCORES THAT INCORPORATE ULCERATIVE COLITIS EXTENSION, IN THE PREDICTION OF RELAPSE Jaime Rodrigues, Portugal; R. Pinho; S. Fernandes; J. Silva; A. Ponte; M. Sousa; J. C. Silva; S. Leite; T. Freitas; L. Proença; A. P. Silva; L. Alberto; A. Rodrigues; J. Carvalho P1650 USEFULNESS OF MAGNETIC RESONANCE ENTEROGRAPHY ON MEDICAL DECISION-MAKING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) AFTER A 1 YEAR FOLLOW-UP: A MULTICENTER STUDY. L. Ramos; Alejandro Hernandez Camba, Spain; I. Rodríguez – Lago; M. Carrillo Palau; L. Cejas; A. Elorza; I. Alonso Abreu; M. Vela; A. Hidalgo; N. Alvarez-Builla; G. E. Rodriguez; M. Aduna; L. Diaz-Florez; Y. Rodriguez; C. Tardillo; D. Eiroa; J. A. Larena; M. S. Garrido; J. L. Cabriada; E. Quintero Carrion
Clinical Case Session
235
Wednesday, November 1, 2017
P1636 ª GUT COLONIZATION WITH EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING ENTEROBACTERIA MAY INCREASE DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASES OUT-PATIENTS: PRELIMINARY STUDY RESULTS Vita Skuja, Latvia; K. Pekarska; H. Dauvarte; E. Vasuka; L. Dobelniece; J. Malina; D. Rudzite; E. Lavrinovica; L. Piekuse; A. Kalcenaua; A. Krumina; A. Lejnieks; A. Derovs
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1651 CORRELATION BETWEEN THE LÉMANN INDEX AND THE INFLAMMATORY BOWEL DISEASE- DISABILITY INDEX IN CROHN’S DISEASE Clémentine Farré, France; M. Azahaf; M. Nachury; R. Gerard; J. Branche; P. Wils; P. Desreumaux; O. Ernst; B. Pariente
P1659 DYSBIOSIS OF THE GUT MICROBIOTA IN RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE Petr Ricanek, Norway; R. Kalla; Y. Ber; S. Vatn; M. K. Karlsson; L. Finnby; D. Bergemalm; A. Carstens; J. D. Söderholm; J. Jahnsen; F. Gomollon; J. Halfvarson; J. Satsangi; C. Casén; M. H. Vatn
P1652 COMPARISON OF CYTOKINES MRNA EXPRESSION IN INFLAMED AND NON-INFLAMED MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE Zuzana Lešková, Slovak Republic; A. Krajcovicova; K. Soltys; S. Stuchlik; I. Sturdik; T. Koller; M. Huorka; T. Hlavaty
P1660 SIMPLIFIED MR ENTEROCOLONOGRAPHY CLASSIFICATION BASED ON ENDOSCOPIC FINDINGS FOR ACTIVITY ASSESSMENT OF CROHN’S DISEASE Toshimitsu Fujii, Japan; Y. Kitazume; K. Takenaka; M. Kimura; E. Saito; K. Matsuoka; M. Nagahori; K. Ohtsuka; M. Watanabe
P1653 IMPACT OF THE BALLOON-ASSISTED ENDOSCOPY AND ENDOSCOPIC BALLOON DILATION THERAPY FOR THE SURGICAL RATE OF CROHN’S DISEASE Takayoshi Nishimoto, Japan; K. Mitsui; M. Suzuki; A. Ehara; S. Tanaka; A. Tatsuguchi; S. Fujimori; K. Iwakiri
P1661 RISK FACTORS FOR METABOLIC SYNDROME AND ITS COMPONENTS IN INFLAMMATORY BOWEL DISEASE Konstantinos Efthymakis, Italy; M. Serio; M. Fioravante; A. Milano; F. Laterza; A. Bonitatibus; M. Neri
P1654 THE RELATIONSHIP OF NEUTROPHILIC AND ENDOTHELIAL ACTIVITY MARKERS WITH THE DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE Salih Boga, Turkey; A. R. Koksal; H. Alkim; A. A. Ozagari; I. Sen; M. Sahin; C. Alkim P1655 MONITORING OF LABORATORY PARAMETERS DURING THIOPURINE MAINTENANCE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: AN UNNECESSARY BURDEN? Joany Kreijne, The Netherlands; A. C. de Vries; G. Bouma; G. Dijkstra; R. West; M. J. Pierik; D. J. De Jong; N. K. H. de Boer; C. J. van der Woude
Wednesday, November 1, 2017
P1656 ULTRASOUND ELASTICITY IMAGING PREDICTS THERAPEUTIC OUTCOMES IN PATIENTS WITH CROHN’S DISEASE TREATED WITH ANTI-TUMOR NECROSIS FACTOR ANTIBODIES Stefania Orlando, Italy; M. Fraquelli; M. Coletta; F. Branchi; A. Magarotto; C. B. Conti; S. Mazza; D. Conte; G. Basilisco; F. Caprioli P1657 CLINICAL CHARACTERISTICS OF RECTAL-SPARING ULCERATIVE COLITIS Ayumi Ito, Japan; O. Teppei; T. Katutoshi P1658 EVALUATION OF COLONIC MUCOSA WITH FLEXIBLE SPECTRAL IMAGING COLOR ENHANCEMENT (FICE) IN PATIENTS WITH LONG TERM ULCERATIVE COLITIS DURING DYSPLASIA SCREENING G. Bengi; Seda Kaya Özdinç, Turkey; H. Akpınar 236
P1662 C-REACTIVE PROTEIN / ALBUMIN RATIO IS A GOOD PREDICTOR OF RESPONSE TO INTRAVENOUS CORTICOSTEROIDS IN ACUTE SEVERE ULCERATIVE COLITIS Sara Monteiro, Portugal; T. Cúrdia Gonçalves; F. Dias de Castro; S. Leite; M. J. Moreira; J. Cotter P1663 INSUFFICIENT VARIATION OF MEDIUM CORPUSCULAR VOLUME (∆ MCV) IN INFLAMMATORY BOWEL DISEASE UNDER THYOPURINES PREDICTS DIFFICULTY IN ACHIEVING COMBINED DEEP REMISSION OUTCOME EVEN AFTER COMBINATION WITH ANTI-TNF – THE OTHER SIDE OF THE MCV FLOW STUDY Joana Roseira, Portugal; H. Tavares de Sousa; A. Marreiros; P. Queirós; A. M. Vaz; T. Gago; L. Contente; H. Guerreiro P1664 FECAL CALPROTECTIN PREDICTS SHORT-TERM RELAPSE IN INFLAMMATORY BOWEL DISEASE PATIENTS IN DEEP REMISSION Radislav Nakov, Bulgaria; V. Nakov; V. Gerova; L. Tankova; T. Kundurzhiev; B. Vladimirov P1665 GLYCEMIC CONTROL AND INSULIN RESISTANCE IN PATIENT WITH INFLAMMATORY BOWEL DISEASE – PRELIMENARY RESULTS FROM THE POLIBD STUDY. R. Filip; Joanna Sztembis, Poland; P. Kiela; A. Rybak P1666 THE ROLE OF MR IMAGING IN ASSESSMENT OF LEMANN INDEX IN THE COURSE OF CROHN’S DISEASE. J. M. Pienkowska; Oliwia Kozak, Poland; T. Nowicki; E. Szurowska
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1668 EVALUATION OF SEVERITY SCORE IN CROHN'S DISEASE Catarina Gouveia, Portugal; M. P. Santos; C. Palmela; C. Gomes; J. Torres; C. Fidalgo; L. Glória; M. Cravo P1669 ENDOSCOPIC FINDINGS AND COLONOSCOPIC PERFORATION IN MICROSCOPIC COLITIS; A SYSTEMATIC REVIEW OF THE LITERATURE W. M. Marlicz; I. Łoniewski; K. Skonieczna-Żydecka; Diana Yung, United Kingdom; A. Koulaouzidis P1670 PREVALENCE AND QUANTITATIVE ASSESSMENT OF LIVER STEATOSIS IN INFLAMMATORY BOWEL DISEASE PATIENTS D. V. Balaban; Iulia Enache, Romania; B. Macadon; M. Patrasescu; G. C. Robu; A. Zoican; S. Bucurica; R. S. Costache; P. Nuta; F. Ionita Radu; M. Jinga P1671 INTESTINAL MICROBIOTA BIOMARKERS AS A NEW TOOL TO SUPPORT IRRITABLE BOWEL SYNDROME DIAGNOSTICS Joan Amoedo, Spain; L. Torrealba; S. Ramió-Pujol; L. Oliver; A. Bahí; M. Serrano; M. Malagón; D. Busquets; P. Gilabert; J. Guardiola; M. Serra-Pagès; J. Garcia-Gil; X. Aldeguer P1672 DISTINGUISH BETWEEN ULCERATIVE COLITIS AND CROHN DISEASE USING AN ELECTRONIC NOSE AND DATA MINING: PRELIMINARY STUDY J. Pelegri-Sebastia; E. Climent; J. B. Talens; L. Torse; Ana Belen Beltran Niclos, Spain; T. Sogorb; P. Nos P1673 CZECH REGISTRY OF INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGICAL THERAPY: RESULTS FROM THE FIRST YEAR Martin Bortlík, Czech Republic; P. Falt; P. Drastich; T. Douda; M. Konecny; V. Zboril; M. Lukas P1674 THE DIAGNOSTIC VALUE OF MIRNA-320A AS A BIOMARKER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Friederike Cordes, Germany; C. Ruhs; M. Brückner; T. M. Nowacki; F. Lenze; M. A. Schmidt; C. Cichon; D. Bettenworth
P1675 COST EFFECTIVENESS OF IBDOC FAECAL CALPROTECTIN AS A SURROGATE MARKER OF MUCOSAL HEALING POST INDUCTION OF BIOLOGICAL AGENTS IN INFLAMMATORY BOWEL DISEASE Gafer El-Safi, Ireland; K. Sugrue; D. Fitzgerald; C. Byron; L. Barry; M. Farman; A. Alhanaee; M. Buckley; J. McCarthy P1676 DOSE OPTIMISATION OF INFLIXIMAB: COMPARATIVE STUDY OF A RAPID TEST AND A ESTABLISHED ELISA METHOD Ana Echarri Piudo, Spain; G. Molina; A. Lopez Insua; H. Ferreiro-Mazón; B. Fernandez Saya; J. Cid Fernandez; V. Ollero P1677 RISK FACTORS ASSOCIATED WITH A HIGH RISK OF COLORECTAL CANCER IN PATIENTS WITH ULCERATIVE COLITIS. PRELIMINARY RESULTS FROM THE IBSEN COHORT. Pasquale Klepp, Norway; M. C. Smaastuen; M. Hoivik; B. Mom; I. Study Group P1678 MANAGEMENT OF COMPLEX PERIANAL FISTULAE: WHEN TO SUSPECT INFLAMMATORY BOWEL DISEASE? Mariana Cardoso, Portugal; J. C. Branco; A. M. Oliveira; C. G. Rodrigues; L. Santos; C. Carneiro; J. Reis Treatment-medical P1679 THE ADDITION OF AN IMMUNOSUPPRESSANT IS AN EFFECTIVE OPTIMIZATION STRATEGY AFTER LOSS OF RESPONSE TO ANTI-TNF ALPHA MONOTHERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TWO-YEAR STUDY Fabio Salvatore Macaluso, Italy; C. Sapienza; M. Ventimiglia; S. Renna; G. Rizzuto; R. Orlando; M. Di Pisa; M. Affronti; E. Orlando; M. Cottone; A. Orlando P1680 CORRELATION BETWEEN EXTRA-INTESTINAL MANIFESTATIONS AND ANTI-DRUG ANTIBODIES DEVELOPMENT IN CROHN’S DISEASE PATIENTS. Mattia Crespi, Italy; G. Bodini; E. G. Giannini; V. Savarino; A. Jain; E. Savarino P1681 THE PRESENCE OF IRRITABLE BOWEL SYNDROME-TYPE SYMPTOMS IN MICROSCOPIC COLITIS IS ASSOCIATED WITH INCREASED PSYCHOLOGICAL COMORBIDITY AND IMPAIRED QUALITY OF LIFE. John Kane, United Kingdom; A. J. Irvine; Y. Derwa; O. Rotimi; A. C. Ford P1682 ANEMIA IN INFLAMMATORY BOWEL DISEASES Sonia Bernardo, Portugal; J. R. Carvalho; S. Fernandes; A. Costa; L. Branco; A. R. Gonçalves; C. Baldaia; A. Valente; P. M. Santos; A. Oliveira; L. Correia; J. Velosa
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
237
Wednesday, November 1, 2017
P1667 OPTICAL CHARACTERIZATION OF LESIONS IN IBD COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS Richard Lord, United Kingdom; N. Burr; N. Mohammed; V. Subramanian
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1683 TROUGH LEVELS AND ANTIBODIES TO USTEKINUMAB ARE NOT CORRELATED TO RESPONSE TO USTEKINUMAB TREATMENT IN CROHN’S DISEASE PATIENTS Claire Painchart, France; S. Brabant; N. Duveau; P. Wils; M. Boualit; M. Nachury; J. Branche; R. Gerard; P. Desreumaux; M. Labalette; B. Pariente
P1690 C60 FULLERENES ATTENUATE THE INTENSITY OF COLON DAMAGE AND EXTRAINTESTINAL MANIFESTATIONS ON RAT ACUTE ULCERATIVE COLITIS MODEL Halyna Kuznietsova, Ukraine; I. Byelinska; N. Dziubenko; O. Gurniak; O. Lynchak; Y. Prylutskyy; V. Rybalchenko
P1684 ECONOMIC IMPLICATIONS IN INFLAMMATORY BOWEL DISEASES: RESULTS FROM A RETROSPECTIVE ANALISYS IN AN ITALIAN CENTRE Arianna Massella, Italy; A. Variola; R. Tessari; T. Zuppini; R. Ravasio; A. Geccherle
P1691 EARLY CLINICAL REMISSION BY WEEK 2 PREDICTS GOOD SHORT- AND LONG-TERM EFFICACY OF TACROLIMUS THERAPY IN PATIENTS WITH MODERATE TO SEVERE STEROID-REFRACTORY ULCERATIVE COLITIS N. Oshima; Shunji Ishihara, Japan; K. Kawashima; H. Sonoyama; N. Yamashita; N. Fukuba; Y. Mishima; I. Moriyama; T. Yuki; Y. Kinoshita
P1685 THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): PRELIMINARY DATA ON EFFICACY OF BIOLOGICAL THERAPY Ambrogio Orlando, Italy; F. S. Macaluso; W. Fries; A. C. Privitera; M. Cappello; S. Siringo; G. Inserra; A. Magnano; R. Di Mitri; N. Belluardo; G. Scarpulla; G. Magrì; A. Trovatello; A. Carroccio; S. Genova; C. Bertolami; R. Vassallo; C. Romano; S. Pellegrino; M. Citrano; S. Accomando; M. Ventimiglia; S. Renna; R. Orlando; G. Rizzuto; E. Vinci; M. Cottone P1686 SINGLE-CENTRE EXPERIENCE WITH BIOLOGICAL TREATMENT IN BUDESONIDE-REFRACTORY MICROSCOPIC COLITIS PATIENTS N. Daferera; S. Ignatova; Andreas Münch, Sweden P1687 BENEFICIAL EFFECT OF A LOW FODMAPS DIET IN DIFFERENT GASTROINTESTINAL DISORDERS Anna Testa, Italy; N. Imperatore; A. Rispo; M. Rea; R. Tortora; O. M. Nardone; L. Lucci; G. Accarino; N. Caporaso; F. Castiglione
Wednesday, November 1, 2017
P1688 EFFICACY OF VEDOLIZUMAB ON INTESTINAL AND ARTICULAR SYMPTOMS: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD) Fabio Salvatore Macaluso, Italy; R. Orlando; W. Fries; M. Scolaro; A. Magnano; D. Pluchino; M. Cappello; G. C. Morreale; S. Siringo; A. C. Privitera; C. Ferracane; N. Belluardo; N. Alberghina; M. Ventimiglia; S. Renna; M. Di Pisa; M. Cottone; A. Orlando P1689 POSITIVE PHARMACOKINETIC EFFECT OF AZATHIOPRINE CO-MEDICATION ON INFLIXIMAB TROUGH LEVELS IS DOSE-DEPENDENT B. Kadleckova; K. Otottova; J. Lucenicova; P. Bozek; P. Mikus; Zuzana Zelinkova, Slovak Republic
238
P1692 INFLIXIMAB (IFX) IN MODERATE TO SEVERE ULCERATIVE COLITIS (UC): COMPARISON BETWEEN SCHEDULED TREATMENT STRATEGY AND BRIDGE STRATEGY Alicia Maria Sambuelli, Argentina; A. H. Gil; S. M. Negreira; M. I. Bellicoso; S. Goncalves; S. P. Huernos; P. R. Tirado; P. Chavero; A. Cabanne P1693 ILLNESS PERCEPTIONS, COPING STRATEGIES, OUTCOMES AND THEIR CHANGES OVER TIME IN IBD PATIENTS WITH ARTHROPATHIES: A 12-MONTH FOLLOW-UP STUDY Sanne Van Erp, The Netherlands; M. van der Have; H. H. Fidder; D. van der Heijde; R. Wolterbeek; D. W. Hommes; A. A. Kaptein; A. E. Van Der Meulen – De Jong P1694 INFLIXIMAB BIOSIMILAR CT-P13 THERAPY IS EFFECTIVE IN MAINTAINING ENDOSCOPIC REMISSION IN ULCERATIVE COLITIS – RESULTS FROM MULTICENTRE OBSERVATIONAL COHORT Klaudia Farkas, Hungary; A. Balint; M. Rutka; M. Kolar; M. Bortlík; D. Duricova; V. Hruba; M. Lukas; K. Mitrova; K. Malickova; M. Lukas; Z. Szepes; F. Nagy; K. Palatka; S. Lovas; Z. Vegh; Z. Kurti; A. A. Csontos; P. Miheller; R. Bor; Á. Milassin; A. Fabian; P. L. Lakatos; T. Molnar P1695 THE USE OF ANTI-TNFS IN INDUCING CLINICAL RESPONSE AND REMISSION IN ULCERATIVE COLITIS: A COMPARATIVE ANALYSIS IN THE REAL LIFE EXPERIENCE OF A SINGLE REFERRAL CENTER Barbara Scrivo, Italy; M. G. Cilluffo; G. C. Morreale; V. Calvaruso; M. Mendolaro; A. Vitello; S. Peralta; M. Cappello
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1696 REAL WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS Stefan Schreiber, Germany; A. Dignass; L. Peyrin-Biroulet; M. Mosli; G. Hather; D. Demuth; A. Blake; R. Curtis; J. M. Khalid; E. V. Loftus Jr
P1704 POST-MARKETING SAFETY EXPERIENCE OF VEDOLIZUMAB IN PATIENTS WITH PRE-EXISTING VIRAL HEPATITIS D.-C. Wu; I. N. Hilmi; S. Adsul; A. Blake; Fatima Bhayat, United Kingdom
P1697 COST-UTILITY ANALYSES OF BIOLOGICS FOR REFRACTORY ULCERATIVE COLITIS Sophia Campbell Davies, Italy; C. Inserra; R. Salerno; A. Cassinotti; G. Muserra; M. Piacenza; S. Ardizzone
P1705 AMINOSALICYLATES FOR MAINTENANCE THERAPY IN ULCERATIVE COLITIS: IS THE ADHERENCE REALLY IMPORTANT? D. Martí; Maria Pilar Ballester, Spain; M. Fullana; P. Navarro; M. M. Boscá; J. Tosca; F. Mora; M. Minguez
P1699 EVALUATION OF ADHERENCE TO INFLIXIMAB THERAPY IN IBD PATIENTS Ariadna Clos, Spain; G. Corrales; F. Cañete; T. Lobaton; M. Larrain; L. Marin; M. Mañosa; E. Cabré; E. Domènech P1700 TNF-EXPRESSION OF MONOCYTES IS A PREDICTIVE MARKER FOR RESPONSE TO INFLIXIMAB TREATMENT Donata Lissner, Germany; B. Jessen; E. Sonnenberg; F. Schmidt; A. Kuehl; B. Siegmund P1701 EVALUATION OF CONCOMITANT CORTICOSTEROID AND VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN REAL-LIFE CLINICAL PRACTICE T. Ylisaukko-oja; J. Aaltonen; S. Torvinen; A. Eberl; H. Nuutinen; T. Blomster; A. Jussila; M. Pajala; J. Jokelainen; S. Herrala; K. Tamminen; Taina Sipponen, Finland P1702 VEDOLIZUMAB TROUGH LEVELS PREDICT CLINICAL OUTCOMES IN INFLAMMATORY BOWEL DISEASE L. Guidi; Daniela Pugliese, Italy; T. Panici Tonucci; B. Tolusso; C. Felice; A. Papa; I. De Vitis; E. Gremese; A. Gasbarrini; G. L. Rapaccini; A. Armuzzi P1703 EFFICACY, SAFETY AND LONG-TERM OUTCOME OF ENDOSCOPIC DILATION THERAPY FOR PRIMARY CROHN’S DISEASE STRICTURES OF THE UPPER GASTROINTESTINAL TRACT – AN INTERNATIONAL MULTICENTER COMBINED ANALYSIS Dominik Bettenworth, Germany; M. M. Mücke; A. Singh; R. Lopez; M. Goetz; T. Matsui; J. G. Karstensen; N. S. Ding; T. B. Qui; J. Hampe; K. Matthes; P. V. Valli; G. Rogler; F. Rieder
Poster in the Spotlight
Poster of Excellence
P1706 DEVELOPMENT AND FEASIBILITY OF A WEB-BASED REGISTRY FOR MULTICENTRE SURVEILLANCE OF EFFECTIVENESS AND SAFETY OF NOVEL IBD-DRUGS IN THE THE NETHERLANDS Vince Biemans, The Netherlands; C. J. van der Woude; G. Dijkstra; A. E. Van Der Meulen – De Jong; K. H. N. (. de Boer; C. Y. Ponsioen; B. Oldenburg; F. Hoentjen; M. J. Pierik P1707 SIX-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTAINANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTS Claudio Cassieri, Italy; R. Pica; E. V. Avallone; G. Brandimarte; M. Zippi; P. Crispino; D. De Nitto; G. P. Lecca; P. Vernia; P. Paoluzi; E. S. Corazziari P1708 CLINICAL EFFICACY AND SAFETY OF ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE IN THE ELDERLY: A UK TERTIARY REFERRAL CENTRE EXPERIENCE Jonathan Digby-Bell, United Kingdom P1709 TACROLIMUS IN REFRACTORY ULCERATIVE COLITIS – 12 MONTH OUTCOME IN A SINGLE CENTRE UK DISTRICT HOSPITAL Nishani Jayasooriya, United Kingdom; L. Everson; S. Mann P1710 A REAL LIFE COMPARISON OF THE EFFICACY OF ADALIMUMAB VERSUS GOLIMUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTER EXPERIENCE FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD) Sara Renna, Italy; F. Mocciaro; M. Ventimiglia; F. S. Macaluso; R. Orlando; M. Billeci; M. Cappello; M. Mendolaro; A. C. Privitera; C. Ferracane; W. Fries; V. Pisana; A. Magnano; D. Pluchino; G. Inserra; G. Scarpulla; S. Garufi; A. Carroccio; S. Siringo; R. Dimitri; M. Cottone; A. Orlando
Clinical Case Session
239
Wednesday, November 1, 2017
P1698 ENDOSCOPIC SUBMUCOSAL DISSECTION OF ULCERATIVE COLITIS-ASSOCIATED DYSPLASIA: A SINGLE CENTER BASED EXPERIENCE Dong-Hoon Yang, Republic of Korea; S.-H. Lee; K. Chang; E. M. Song; S. W. Hwang; S. H. Park; B. D. Ye; J.-S. Byeon; S.-J. Myung; S.-K. Yang
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1711 REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD) Daniela Pugliese, Italy; A. Variola; A. C. Privitera; M. Allocca; F. Bossa; M. Cappello; G. Lorenzon; S. Mazzuoli; M. Principi; R. Sablich; A. Ferronato; S. Festa; L. Moser; G. Tapete; G. Bodini; M. Di Girolamo; L. Grossi; F. Mocciaro; C. Ricci; S. Saibeni; R. Spagnuolo; E. Capoferro; A. Armuzzi P1712 PREVALENCE OF CIPROFLOXACIN RESISTANCE IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH GUT COLONIZATION WITH EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING ENTEROBACTERIA ACCORDING TO BACTERIAL PLASMID GENES Vita Skuja, Latvia; K. Pekarska; H. Dauvarte; E. Vasuka; L. Dobelniece; J. Malina; D. Rudzite; E. Lavrinovica; L. Piekuse; A. Kalcenaua; A. Krumina; A. Lejnieks; A. Derovs P1713 PATTERNS OF ANTI-TNF USE IN CROHN’S DISEASE PATIENTS IN FRANCE: RESULTS FROM AN ANALYSIS OF A FRENCH ADMINISTRATIVE DATABASE (GENERAL SAMPLE OF HEALTH INSURANCE BENEFICIARIES) AND HOSPITAL DISCHARGE DATA. Raphael Toueg, France; I. Bureau; C. Laurendeau; L. Lamarsalle; M. Allez P1714 PREDICTIVE FACTORS OF RESPONSE TO ANTI-TNF α TREATMENT OF COMPLEX ANO-PERINEAL FISTULAS IN CROHN’S DISEASE. Maroua Hafi, Tunisia; M. Fekih; A. Laabidi; N. Ben Mustapha; J. Boubaker; A. Filali
Wednesday, November 1, 2017
P1715 COMPARISON OF ORIGINAL AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE AND MULTICENTRIC STUDY IN SPAIN Helena Martínez Lozano, Spain; J. Miranda Bautista; K. Villa; Y. González-Lama; P. López Serrano; J. L. Pérez Calle; P. Pérez Galindo; D. Carpio López; V. Matallana; M. Calvo; M. I. Vera; I. Marín-Jiménez; L. Menchén Viso P1716 DOES SEVERE ENDOSCOPIC COLITIS PREDICT STEROID REFRACTORY DISEASE IN ACUTE SEVERE COLITIS? Fadoua Er-Rabie, Morocco; S. elmahjoubi; E. M. Amine; W. Khannoussi; Z. Ismaili; G. Kharrasse
240
P1717 BASELINE CALPROTECTIN DOES NOT PREDICT RESPONSE TO BIOLOGICAL THERAPY IN ULCERATIVE COLITIS D. Storey; Thomas Skouras, United Kingdom; A. Bond; S. Dodd; S. Subramanian P1718 EIGHT YEARS EXPERIENCE OF DRUG EFFICACY IN CROHN’S DISEASE PATIENTS: A PROSPECTIVE MULTICENTER REAL LIFE STUDY Michal Lodyga, Poland; P. Eder; M. Gawron-Kiszka; M. Hartleb; J. Kierkus; M. Klopocka; M. Kukulska; M. Grzymislawski; E. Malecka-Panas; E. Poniewierka; I. Smola; T. Rawa; J. Regula; G. Rydzewska P1719 EFFICACY OF VEDOLIZUMAB INDUCTION THERAPY IN PATIENTS WITH SEVERE, THERAPEUTIC RESISTANT INFLAMMATORY BOWEL DISEASE Renáta Bor, Hungary; K. Farkas; P. Miheller; K. Palatka; T. Szamosi; P. L. Lakatos; K. B. Gecse; P. A. Golovics; A. Vincze; L. Lakner; M. Rutka; A. Balint; A. Fabian; Á. Milassin; Z. Szepes; T. Molnar P1720 WITHDRAWN Treatment-surgical P1721 CLINICAL CHARACTERISTICS AND MANAGEMENT OF CROHN'S DISEASE IN PATIENTS WITH RESIDUAL DISEASE AFTER SURGERY COMPARED WITH CURATIVE SURGERY. RESULTS FROM PRACTICROHN STUDY. Eugeni Domènech, Spain; M. D. Martín Arranz; A. Gutiérrez; M. Iborra; V. García-Sánchez; M. Barreiro-de Acosta; L. Cea-Calvo; C. Romero; B. Juliá De Páramo P1722 SEVERITY OF BILE ACID MALABSORPTION CORRELATES WITH LENGTH OF ILEAL RESECTION IN CROHN’S DISEASE Thomas Skouras, United Kingdom; Y. Prasad; S. Dodd; S. Subramanian Poster Session 09:00 – 14:00 Other Lower GI Disorders III
Hall 7
Microbiology P1723 A MICROBIAL SIGNATURE OF PSYCHOLOGICAL DISTRESS IN IRRITABLE BOWEL SYNDROME J. Peter; C. Fournier; L. Knoblich; B. Keip; Gabriele Moser, Austria
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1724 SACCHAROMYCES BOULARDII CNCM I-745 LOWERS FECAL CHOLIC ACID CONCENTRATIONS DURING ANTIBIOTHERAPY IN HEALTHY VOLUNTEERS: A NEW POTENTIAL MECHANISM IN THE PROTECTION AGAINST CLOSTRIDIUM DIFFICILE INFECTION Henri Duboc, France; C. Chong Nguyen; T. Kabbani; D. Rainteau; L. Humbert; S. Dowd; L.-J. Palmieri; B. Coffin; K. Pallav; A. Bado; C. Kelly
Lower GI bleeding
P1725 ASSOCIATION OF FUSOBACTERIUM NUCLEATUM IN ORAL CAVITY AND COLORECTAL CARCINOMAS Yasuhiko Komiya, Japan; T. Higurashi; A. Nakajima
P1734 ACCURACY OF THE NASOGASTRIC TUBE AND THE BUN/CREATININE RATIO FOR DISTINGUISHING BETWEEN UPPER AND LOWER SOURCES OF GASTROINTESTINAL BLEEDING. A SYSTEMATIC REVIEW. Salvador Machlab, Spain; E. Martinez-Bauer; P. Garcia-Iglesias; A. Lira; C. Marmol; G. Llibre; J. P. da Costa; M. Gallach; L. Melcarne; V. Puig-Divi; F. Junquera; R. Campo; E. Brullet; X. Calvet
P1727 HUMAN MILK OLIGOSACCHARIDES; A NEW STRATEGY AGAINST POST-ANTIBIOTIC CLOSTRIDIUM DIFFICILE INFECTION? Louise Vigsnaes, Denmark P1728 CHANGES IN GUT MICROBIATA ASSOCIATED WITH AGING IN OBESE INDIVIDUALS Rina Tanaka, Japan; M. Matsuzaka; S. Nakaji; Y. Sasaki P1729 BACTERIOCIN PRODUCTION BY MUCOSAL BACTERIA IN COLORECTAL NEOPLASIA Darina Kohoutova, Czech Republic; M. Forstlova; P. Moravkova; S. Rejchrt; D. Smajs; J. Bures P1730 CARBOXYLIC AND AMINO ACIDS MIXTURE IDENTICAL TO THE METABOLITES OF THE PROBIOTIC ESCHERICHIA COLI M17 INDUCES BACTERIOCIN SYNTHESIS IN PROBIOTIC LACTOBACILLUS HELVETICUS D75 AND D76 STRAINS AND ENHANCES THEIR ANTIMICROBIAL ACTIVITY AGAINST TEST PATHOGENS T. Vakhitov; V. Toropov; O. Shalaeva; S. Sitkin; Evgeniy Tkachenko, Russian Federation P1731 LONG-TERM SAFETY AND EFFECT ON GASTROINTESTINAL SYMPTOMS OF FECAL MICROBIOTA TRANSPLANTATION Perttu Arkkila, Finland; A. Hillamaa; J. Jalanka; E. Mattila; V.-J. Anttila; R. Satokari P1732 CLOSTRIDIUM DIFFICILE–ASSOCIATED DISEASE IN A PORTUGUESE HOSPITAL CENTER Tânia Gago, Portugal; A. Antunes; A. M. Vaz; P. Queirós; J. Roseira; A. C. Cunha; A. Ramos; H. Guerreiro
Poster in the Spotlight
Poster of Excellence
P1735 GLASGOW-BLACHFORD SCORE ACCURATELY PREDICTS THE NEED OF TRANSFUSION IN ACUTE LOWER GASTROINTESTINAL BLEEDING. A DIAGNOSTIC ACCURACY EVALUATION STUDY. Salvador Machlab, Spain; E. Martinez-Bauer; P. Garcia-Iglesias; A. Lira; C. Marmol; G. Llibre; J. P. da Costa; M. Gallach; L. Melcarne; V. Puig-Divi; F. Junquera; R. Campo; X. Calvet; E. Brullet P1736 ACUTE LOWER GASTROINTESTINAL BLEEDING IN PATIENTS TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED WITH WARFARIN IN CLINICAL PRACTICE: CHARACTERISTICS AND CLINICAL OUTCOME. Georgia Diamantopoulou, Greece; C. Konstantakis; G. Theocharis; V. Theopistos; G. Skroubis; C. Triantos; V. Nikolopoulou; K. Thomopoulos P1737 NOBLADS – THE NEW RISK SCORE TO PREDICT THE SEVERITY OF ACUTE LOWER GASTROINTESTINAL BLEEDING Marta Patita, Portugal; G. Nunes; R. Barosa; L. Ramos; C. Fonseca P1738 WITHDRAWN P1739 ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL POLYP IN ANTICOAGULATED PATIENTS Sayo Kobayashi, Japan; T. Nawa; K. Harada; H. Seki; Y. Noma; T. Ueki; H. Okada
Clinical Case Session
241
Wednesday, November 1, 2017
P1726 WITHDRAWN
P1733 THE EFFICACY OF SELECTIVE ARTERIAL EMBOLIZATION IN THE MANAGEMENT OF DIVERTICULAR BLEEDING Yuichi Fukami, Japan; S. Sakita; T. Mochida; C. Kamitsuma; A. Igarashi; J. Tsuchiya; K. Yasuda; M. Ike; N. Kozawa; M. Kaneshiro; H. Ikemiyagi; K. Yoshino; M. Watanabe
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
Lower GI malignant disease-epidemiology P1740 RISK OF COLORECTAL CANCER IN ASYMPTOMATIC INDIVIDUALS WHOSE FIRST DEGREE RELATIVES WERE AFFECTED BY CRC AT DIFFERENT AGES OF ONSET: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 9.28 MILLION SUBJECTS J. L. L. Huang; Martin Wong, Hong Kong PRC; C. Chan; J. Lin; W. W. Cheung; M. Liang; Y. Fang; C. Yu; D. Fung P1741 IS THERE ANY DIFFERENCE IN RISK OF COLORECTAL CANCER AMONG ASYMPTOMATIC SUBJECTS WHOSE SIBLINGS VS. PARENTS WERE AFFECTED? A SYSTEMATIC REVIEW AND META-ANALYSIS J. L. L. Huang; Martin Wong, Hong Kong PRC; C. Chan; J. Lin; W. W. Cheung; M. Liang; Y. Fang; D. Fung; C. Yu P1742 GILBERT SYNDROME IS NOT THAT INNOCENT! Nadir Arber, Israel; M. Menachem; L. Ari; G. Lior; B. Ezra; H. Gil; H. G. Amira; J.-D. Maayan; S. Shapira P1743 CHARACTERISTICS AND PREDICTORS OF INTERVAL CANCER: A CASE-CONTROL STUDY Ido Laish , Israel; J. Mizrahi; F. Konikoff P1744 THE RELATIONSHIP BETWEEN QUANTITATIVE FIT RESULTS AND NEOPLASTIC FINDINGS Jerry Shane McGrath, Canada; M. Borgaonkar; D. Pace; S. Antle; S. Stone; E. Randell; J. Quinlan P1745 METABOLIC RISK FACTORS AND THEIR IMPACT IN COLORECTAL CANCER SCREENING: MULTICENTER PROSPECTIVE STUDY Tomas Grega, Czech Republic; S. Suchanek; O. Majek; O. Ngo; P. Minarikova; B. Seifert; O. Shonova; K. Balihar; J. Cyrany; M. Benes; M. Zavoral
Wednesday, November 1, 2017
P1746 PREVALENCE OF SERRATED POLYPOSIS SYNDROME IN AVERAGE-RISK SCREENING COLONOSCOPIES IN GERMANY. Christoph Schramm, Germany; K. S. Janhsen; J. Dinter; F. Kuetting; T. Goeser; H.-M. Steffen Lower GI malignant disease, pathogenesis P1747 CONTRIBUTION OF GERMLINE MUTATIONS TO NON FAMILIAL EARLY ONSET CANCERS Alessandro Mannucci, Italy; F. Calabrese; R. A. Zuppardo; U. Elmore; F. Aleotti; M. Lemma; A. Tamburini; M. Reni; M. Ronzoni; V. Burgio; E. Mazza; M. G. Patricelli; A. Russo Raucci; R. Rosati; P. A. Testoni; G. M. Cavestro 242
P1748 IMPACT OF COLIBACTIN-PRODUCING ESCHERICHIA COLI ON IMMUNE MICROENVIRONMENT IN PRECLINICAL COLORECTAL CANCER MODELS Amélie Lopes, France; A. H. Casse; J. Veziant; E. Cardamone; D. Pezet; N. Barnich; E. Miot-Noirault; S. Naimi; E. Billard; B. Dumas; M. Bonnet P1749 INVESTIGATING THE DIRECT INTERACTION BETWEEN CD24 AND β-CATENIN IN INTESTINAL TUMORIGENESIS Nadir Arber, Israel; A. Fokra; S. Shapira; D. Kazanov; F. Bedny; B. Eli; C. Varol P1750 YM155 AS AN INHIBITOR OF CANCER STEMNESS SIMULTANEOUSLY INHIBITS AUTOPHOSPHORYLATION OF EGFR AND G9A-MEDIATED STEMNESS IN EGFR-POSITIVE CANCER CELLS C.-C. Cheng; Ai-Sheng Ho, Taiwan P1751 WITHDRAWN P1752 WITHDRAWN P1753 COLORECTAL CANCER CELLS INDUCE NEUROGENESIS IN THE ENTERIC NERVOUS SYSTEM OF THE TUMOR MICROENVIRONMENT VIA A NGF-DEPENDENT PATHWAY Farouk Drissi, France; A. Bessard; M. Touvron; H. Boudin; F. Cossais; L. Van Landeghem; M. Neunlist; E. Duchalais P1754 FGF14 IS A FUNCTIONAL TUMOR SUPPRESSOR THROUGH INHIBTING AMPK/MTOR PATHWAY IN COLORECTAL CANCER Lixia Xu, China; N. Zhang; L. Huang; X. LI; S. Peng; Z. Zeng; M. Chen P1755 CHARACTERISTICS OF HYPERMUTATOR IN DIGESTIVE SYSTEM CANCERS Hiroyuki Matsubayashi, Japan; H. Ishiwatari; N. Kawata; K. Takizawa; N. Kakushima; M. Tanaka; M. Yoshida; S. Ito; K. Imai; K. Hotta; H. Ono; Y. Kiyozumi; Y. Horiuchi; K. Urakami; M. Kusuhara P1756 UNBIASED ANALYSIS OF REGULATION OF TRANSCRIPTION FACTORS UPON ER STRESS IN THE LS174T COLORECTAL CANCER CELL LINE EXPOSES CTBP2 AS A POTENTIAL REGULATOR OF STEMNESS Bartolomeus Meijer, The Netherlands; B. F. Westendorp; J. H. M. van der Meer; W. L. Smit; J. Heijmans; V. Muncan; G. R. van den Brink
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1757 MICROBIOTA A NEW INDICATOR OF COLORECTAL CANCER (CRC) HETEROGENEITY Iradj Sobhani, France; E. Bergstein; A. Ghozlane; S. Kennedy P1758 EPIGENETIC SILENCING OF SMOC1 IS ASSOCIATED WITH DEVELOPMENT OF COLORECTAL TRADITIONAL SERRATED ADENOMAS Hironori Aoki, Japan; E. Yamamoto; A. Takasawa; T. Niinuma; H.-O. Yamano; H.-O. Matsushita; T. Harada; T. Sugai; H. Suzuki P1759 DEVELOPMENT AND VALIDATION OF PREDICTIVE MODEL FOR PARTICIPATION IN COLORECTAL CANCER SCREENING IN KOREA Joo-Won Chung, Republic of Korea; J. J. Park; J. Y. Yoon P1760 CD24 PREDICTIVE LEVELS- A SIMPLE NOVEL BLOOD TEST FOR EARLY DETECTION OF VARIOUS MALIGNANCIES Nadir Arber, Israel; S. Shapira; D. Kazanov; A. Fokra; Z. Sally; S. Zigdon; J.-D. Maayan; L. Ari; K. Roni; L. Alissa; I. Ofer; E. Liberman P1761 FACTORS ASSOCIATED WITH OPTIMIZING PREPARATION FOR COLONOSCUPOY USING SPLIT DOSE PICOLAX Elizabeth Half, Israel; R. Leiba; T. Hanania; I. Chermesh; E. Hag P1762 IMPROVED ADENOMA DETECTION WITH ELUXEO LINKED COLOR IMAGING (LCI) AS COMPARED TO CONVENTIONAL WHITE-LIGHT HIGH-DEFINITION COLONOSCOPY – A RANDOMIZED CONTROLLED TRIAL Milán Szalai, Hungary; L. Oczella; Z. Dubravcsik; A. Szepes; L. Madacsy P1763 COMPREHENSIVE ANALYSIS OF LONG NON-CODING RNAS WITH CHARACTERISTIC EXPRESSION LEVEL ALTERATION IN COLORECTAL ADENOMAS AND CANCERS Alexandra Kalmár, Hungary; Z. B. Nagy; O. Galamb; B. Wichmann; B. K. Bartak; G. Valcz; K. Szigeti; Z. Tulassay; P. Igaz; B. Molnar P1764 A1-ANTITRYPSIN (SERPIN-A1) AS A PUTATIVE BIOMARKER FOR COLORECTAL CANCER D. Kypraios; Stamatia Lydia Hatzinicolaou, Greece; A. Malachias; L. Theodoropoulos; A. Vakrakou; G. Papachristopoulou; D. Dimitroulopoulos; M. Talieri; D. Xinopoulos
Poster in the Spotlight
Poster of Excellence
P1765 DIFFERENTIATION BETWEEN NEOPLASTIC AND NON-NEOPLASTIC DIMINUTIVE COLORECTAL POLYPS WITH FUJINON ELUXEO-BLI VERSUS FICE ELECTRONIC CHROMOENDOSCOPY WITH AND WITHOUT OPTICAL MAGNIFICATION – A RANDOMIZED PROSPECTIVE STUDY Laszlo Madacsy, Hungary; M. Szalai; L. Oczella; Z. Dubravcsik; P. Novak; K. Zsobrak; A. Szepes P1766 HOW FREQUENTLY DO SECONDARY CARE CLINICIANS MISS COLORECTAL CANCER? V. Theis; S. Priestley; A. Bassi; E. Berryman; I. Vasiliadou; Bethany Richards, United Kingdom; H. Parry P1767 ENDOCYTOSCOPIC VASCULAR PATTERN FOR COLORECTAL LESION IS HELPFUL IN PREDICTING PATHOLOGICAL DIAGNOSIS. Shinei Kudo, Japan; T. Watanabe; H. Nakamura; M. Misawa; K. Matsumoto; S. Kataoka; Y. maeda; S. Matsudaira; K. Ichimasa; S. Sasanuma; N. Toyoshima; Y. Mori; T. Kudo; T. Hisayuki; K. Wakamura; T. Hayashi; T. Baba; H. Miyachi; F. Ishida; H. Inoue Lower GI malignant disease, management P1768 CONSIDERATION OF RECTAL NEUROENDOCRINE TUMOR IN OUR HOSPITAL Mitsuhiro Akita, Japan P1769 SELECTIVE ERADICATION OF K-RAS MUTATED CANCER CELLS BY DELIVERY OF BACTERIAL TOXINS Nadir Arber, Israel; B. Ilana; D. Kazanov; S. Shapira P1770 USE OF A COMBINATION OF LENTIVIRUS PARTICLES AND A SPECIFIC PEPTIDE FOR ERADICATION OF CD24-EXPRESSING Nadir Arber, Israel; F. Eynat; L. Abraham; S. Shapira P1771 ILF3 STABILIZES AND ACTIVATES EGFR-MEDIATED G9A PATHWAY FOR MAINTAINING CANCER STEMNESS PROPERTY IN EGFR-POSITIVE CANCERS C.-C. Cheng; Ai-Sheng Ho, Taiwan P1772 EFFICACY AND SAFETY OF TWELVE CHEMOPREVENTIVE REGIMENS FOR THE RECURRENCE OF COLORECTAL ADENOMAS: A NETWORK META-ANALYSIS Han Chen, China P1773 COX-2 MEDIATES RESISTANCE TO EICOSAPENTAENOIC ACID IN COLORECTAL CANCER CELLS. Milene Volpato, United Kingdom; L. Coletta; M. A. Hull
Clinical Case Session
243
Wednesday, November 1, 2017
Lower GI malignant disease, diagnosis/histopathology
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1774 PROGNOSTIC ROLE OF GLASGOW PROGNOSTIC SCORE IN PATIENTS WITH COLORECTAL CANCER: EVIDENCE FROM POPULATION STUDIES Yangyang Liu, China; X. He; J. Pan; S. Chen; L. Wang P1775 COST EFFECTIVENESS OF THE FIRST SURVEILLANCE COLONOSCOPY IN POPULATION WITH ADVANCED COLORECTAL POLYPS OR MULTIPLE POLYPS FROM COLORECTAL CANCER SCREENING PROGRAM Laura Carot, Spain; M. González; M. Batlle; A. Buron; X. Bessa Casserras; M. Andreu Garcia; A. Álvarez-Urturi P1776 OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR COLORECTAL LESIONS: A SINGLE EUROPEN CENTER EXPERIENCE Roberta Maselli, Italy; P. A. Galtieri; L. Lamonaca; M. Di Leo; R. semeraro; L. Poliani; F. Auriemma; A. Fugazza; G. Lollo; G. amvrosiadis; E. C. Ferrara; A. Anderloni; S. Carrara; A. Repici P1777 POPULATION-BASED COLORECTAL CANCER SCREENING IN THE CZECH REPUBLIC – FIRST RESULTS OF THE NEW PROGRAM SETTINGS Stepan Suchanek, Czech Republic; T. Grega; O. Majek; O. Ngo; B. Seifert; L. Dusek; M. Zavoral P1778 LONG-TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY CANCER AND HIGH GRADE DYSPLASIA IN COLORECTUM P.-H. Zhou; Tao Chen, China Lower GI motility disorders: Clinical P1779 LOW UPTAKE OF PSYCHOLOGICAL THERAPIES AMONG PATIENTS WITH IRRITABLE BOWEL SYNDROME IN SECONDARY CARE. Orla Craig, United Kingdom; C. Black; L. Houghton; A. C. Ford Wednesday, November 1, 2017
P1780 GUT SYMPTOMS AND TRANSIT DISTURBANCE IN PARKINSON’S DISEASE ARE PAN-ENTERIC BUT NOT UBIQUITOUS: A WIRELESS MOTILITY CAPSULE STUDY Valentina Passananti, United Kingdom; N. Zarate Lopez; R. Sweis; A. V. Emmanuel P1781 OUTLET DYSFUNCTION IS PREVALENT IN SEVERE FUNCTIONAL BLOATING: PRELIMINARY REPORT FROM A MULTICENTER ITALIAN STUDY Paola Iovino, Italy; M. C. Neri; L. D'Alba; S. Gallotta; G. Chiarioni
244
P1782 PATHOPHYSIOLOGY ASSESSMENT OF FECAL INCONTINENCE AND RISK FACTORS ASSOCIATED. RESULTS OF A TEN YEARS RETROSPECTIVE STUDY. L. D'Alba; Emanuela Ribichini, Italy; R. Urgesi; M. A. Vitale; L. Pallotta; M. C. Di Paolo; G. Villotti; A. De Cesare; S. Cocca; P. Zaccari; M. G. Graziani P1783 RETROSPECTIVE STUDY: ROLE OF SEHCAT TEST IN THE DIAGNOSIS OF BILE ACID MALABSORPTION AS A CAUSE OF CHRONIC DIARRHOEA AND POTENTIAL RISK FACTORS ASSOCIATED. Claudia Barber Caselles, Spain; B. Lobo Alvarez; J. L. Mosquera; S. Aguade-Bruix; F. Azpiroz; J. Santos Irritable bowel syndrome: Epidemiology P1784 INTAKE OF FERMENTABLE OLIGO-, DI- AND MONO-SACCHARIDES AND POLYOLS (FODMAPS) INCREASES THE RISK OF IRRITABLE BOWEL SYNDROME (IBS) IN INDIVIDUALS EXPOSED TO PSYCHOSOCIAL STRESS IN THE COMMUNITY: RESULTS OF A LARGE, PROSPECTIVE, POPULATION BASED STUDY Mark Fox, Switzerland; Y. Long; Y. Deng; H. Chu; X. Zheng; J. Yang; Y. Cong; Y. Yu; H. Liu; N. Dai P1785 CHARACTERIZING IBS PATIENTS WITH ANXIETY OR DEPRESSION Irina Pontén, Sweden; M. Simrén; H. Törnblom P1786 THE ASSOCIATION BETWEEN IRRITABLE BOWEL SYNDROME AND LACTOSE INTOLERANCE Reşat Dabak, Turkey; T. Arslan Kucuk; S. Tuzun; H. Cetin; E. Ahıshalı; C. Dolapcıoglu P1787 WITHDRAWN P1788 THE PREVALENCE AND IMPACT OF OVERLAPPING ROME IV FUNCTIONAL GASTROINTESTINAL DISORDERS ON SOMATISATION, QUALITY OF LIFE, AND HEALTHCARE UTILISATION: RESULTS FROM A THREE-COUNTRY GENERAL POPULATION STUDY Imran Aziz, Sweden; O. S. Palsson; H. Törnblom; A. Sperber; W. E. Whitehead; M. Simrén P1789 WITHIN-PERSON CORRELATIONS BETWEEN GASTROINTESTINAL AND PSYCHOLOGICAL FEATURES OF THE IRRITABLE BOWEL SYNDROME Egbert Clevers, Belgium; J. Tack; H. Törnblom; G. Ringström; L. Van Oudenhove; M. Simrén
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1791 HEALTH CARE UTILIZATION FOR ROME IV IRRITABLE BOWEL SYNDROME; A THREE-COUNTRY SURVEY IN THE GENERAL POPULATION Navkiran Jossan, Sweden; H. Törnblom; M. Simrén; I. Aziz; O. S. Palsson; W. E. Whitehead; A. Sperber Lower GI vascular disorders P1792 ISCHAEMIC COLITIS AND VITAMIN K DEFICIENCY: A HYPOTHESIS Achilleas Tsimperidis, Greece; I. A. Linardou; A. N. Kapsoritakis; A. K. Psychos; S. P. Potamianos P1793 WITHDRAWN P1794 ARTERIAL PH AND LACTATE HAVE SIGNIFICANT IMPACT ON THE OUTCOMES OF PATIENTS WITH ISCHEAMIC COLITIS Carolina Simões, Portugal; V. Magno Pereira; M. Silva; J. Carvão; A. Oliveira; C. Baldaia; G. Serrão; L. Jasmins; J. Velosa P1795 THE RISK PREDICTIVE VALUES OF ACG CLASSIFICATION IN A COHORT OF ISCHEMIC COLITIS – REFINING THE DEFINITION OF MILD DISEASE V. Magno Pereira; Carolina Simões, Portugal; M. Silva; J. Carvão; A. Oliveira; C. Baldaia; G. Serrão; L. Jasmins; J. Velosa Lower GI health services research P1796 HOW COST AFFECTS THE TREATMENT CHOICE FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA PATIENTS: A COST-EFFECTIVENESS ANALYSIS OF TRICYCLIC AGENTS AND RIFAXIMIN Eric Shah, USA; E. Andraska; J. Li; S. Zhang; W. D. Chey P1797 PREDICTIVE FACTORS FOR BETTER OUTCOMES IN COLONOSCOPY-ASSOCIATED PERFORATION Byungsun Kim, Republic of Korea; S. Park; M. A. Yang; S. H. Yun; Y. Lee; J. W. Kim; J. Cho
Poster in the Spotlight
Poster of Excellence
P1798 PATIENTS’ AND CLINICIANS’ VIEWS OF AND EXPERIENCE WITH A NOVEL CLINICAL PATHWAY FOR FUNCTIONAL GASTROINTESTINAL DISORDERS Ecushla Linedale, Australia; A. Mikocka-Walus; P. R. Gibson; J. M. Andrews P1799 ANNUAL FECAL IMMUNOLOGICAL TESTING IS LESS COSTLY THAN COLONOSCOPY EVERY 5 YEARS AND REDUCES MORTALITY IN FAMILIAL COLORECTAL CANCER SCREENING. David Nicolás Pérez, Spain; I. Castilla-Rodríguez; M. Salgado-Fernández; M. Ponce; J. M. Herrero-Rivas; T. Ocaña; M. P. Roncales; F. Sopeña-Biarge; J. Santiago; C. Alvarez Urturi; E. Andreu-García; O. Castaño-Fernández; P. Muñoz-Garrido; M. Rodríguez-Soler; M. Carrillo Palau; M. Llanos-Muñoz; N. González-López; J. Cubiella; F. Balaguer; L. Bujanda Fernández de Piérola; A. Lanas; A. Suárez González; A. Herreros de Tejada; R. Jover; X. Bessa Casserras; A. Gimeno Garcia; E. Quintero Carrion P1800 COMBINATION OF FOBT AND FECAL CALPROTECTIN MAY BE USEFUL FOR REDUCING UNNECESSARY COLONOSCOPIES IN SYMPTOMATIC PATIENTS Carlos Sostres, Spain; A. Lué; M. V. Barra Pardos; G. Hijos; A. Perales; J. J. Puente; A. Lanas; F. Gomollon P1801 CLINICAL PRACTICE, MONITORING, AND PATIENT SAFETY DURING PROCEDURAL SEDATION IN FIVE COUNTRIES R. Saunders; Jason Davis, Germany; R. Weissbrod; P. Kranke; J. R. Lightdale; D. Whitaker P1802 PERFORMANCE OF THE MOTUS PURE-VU SYSTEM – A NOVEL DEVICE FOR ACHIEVING ADEQUATE BOWEL PREP IN POORLY PREPPED PATIENTS P. D. Siersema; Kelly van Keulen, The Netherlands; H. Neumann; M. C. W. Spaander P1803 THE EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY KEY PERFORMANCE MEASURES FOR COLONOSCOPY IN THE POLISH COLORECTAL CANCER SCREENING PROGRAM. Marek Bugajski, Poland; P. Wieszczy; M. Rupinski; J. Regula; M. F. Kaminski P1804 WITHDRAWN P1805 VALIDATION OF THE “FAILURE TO PROVIDE ADEQUATE RELIEF” (F-PAR) SCALE IN A SPECIALIST CLINIC SETTING Valentina Passananti, United Kingdom; N. Zarate Lopez; A. V. Emmanuel
Clinical Case Session
245
Wednesday, November 1, 2017
P1790 IRRITABLE BOWEL SYNDROME WITH CONSTIPATION: IMPACT OF SYMPTOM SEVERITY ON HEALTH-RELATED QUALITY OF LIFE: A POST HOC ANALYSIS OF DATA FROM TWO PHASE 3 TRIALS OF LINACLOTIDE Anne Marciniak, United Kingdom; Y. Mo; J. Ma; J. L. Abel; R. T. Carson
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1806 ADHERENCE WITH TRANSANAL IRRIGATION USING THE NAVINA™ SYSTEM IS ASSOCIATED WITH PERSONALITY TRAITS EVEN WHEN THERE IS IMPAIRED HAND FUNCTION Valentina Passananti, United Kingdom; J. Storrie; N. Zarate Lopez; A. V. Emmanuel Poster Session 09:00 – 14:00 Hall 7 Oesophageal, Gastric and Duodenal Disorders III Microbiology P1807 THE DUODENAL MUCOSA RETAINS A DIVERSE MICROBIOTA FOLLOWING BOWEL PREPARATION Erin Shanahan, Australia; A. Shah; A. Do; P. Ghasemi; T. Hansen; N. Koloski; M. Morrison; G. Holtmann Upper GI and small intestinal bleeding P1808 PERFORMANCE OF GLASGOW-BLACTHFORD, ROCKALL AND AIMS65 SCORES TO PREDICT OUTCOMES AND TO IDENTIFY THE LOW-RISK GROUP AFTER UPPER GI BLEEDING IN PATIENTS WITH CANCER. Matheus Franco, Brazil; S. Jang; B. D. C. Martins; T. Stevens; V. Jairath; R. Lopez; J. J. Vargo; A. Barkun; F. Maluf-Filho P1809 THE EFFECTS OF ANTICOAGULANTS ON THE CLINICAL OUTCOME OF ENDOSCOPIC TREATMENT Ken Namikawa, Japan; T. Yoshio; H. Tomita; T. Yamada; J. Fujisaki P1810 ENDOSCOPIC ALLPICATION OF MUCOADHESIVE POWDER (NEXPOWDER®) FOR HEMOSTASIS IN PATIENTS WITH GASTROINTESTINAL BLEEDING Byoung Wook Bang, Republic of Korea; K. S. Kwon; H. K. Kim; Y. W. Shin; S. J. Hong; J.-S. Park; J. H. Moon; J. J. Hwang Wednesday, November 1, 2017
P1811 CLINICAL FEATURES OF DELAYED BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC NEOPLASMS IN HIGH-RISK AND LOW-RISK PATIENTS Takuya Inoue, Japan; Y. maegawa; S. Ito; T. Shimizu; Y. Yokoyama; S. Tawara; S. Ishii; Y. Haruna; T. Yakushijin; A. Inoue
246
P1812 EFFICACY AND SAFETY OF FERRIC CARBOXYMALTOSE TREATMENT IN PATIENTS HOSPITALIZED FOR ACUTE GASTROINTESTINAL BLEEDING NOT ASSOCIATED WITH PORTAL HYPERTENSION Gisela Torres-Vicente, Spain; M. Planella-de Rubinat; R. Ballester-Clau; L. López-Barroso; T. Voltà-Pardo; M. Cucala-Ramos; J. M. Reñé-Espinet P1813 NOVEL EUS-GUIDED TREATMENT OF GASTRIC VARICES WITH A LIQUID NON-ADHESIVE NEUROVASCULAR EMBOLIZATION AGENT. Alberto J. Baptista, Venezuela; M. A. Guzman; H. Rass; J. F. Piñerúa Gonsálvez; E. Richards P1814 PEPTIC ULCER BLEEDING IN THE ELDERLY: CLINICAL OUTCOMES AND IN-HOSPITAL MORTALITY Daniela Matei, Romania; I. Groza; S. Pasca; D. Negrutiu; B. Furnea; C. Bocsan; C. Cruciat; A. Seicean; M. Tantau P1815 PREDICTIVE FACTORS FOR IN-HOSPITAL MORTALITY IN PATIENTS WITH PEPTIC ULCER BLEEDING Daniela Matei, Romania; S. Pasca; I. Groza; D. Negrutiu; A. David; M. Nedal; M. Tantau P1816 ANAEMIA AND UPPER GI BLEEDING: A LOCAL EXPERIENCE Michael Ding, United Kingdom; R. Prawiradiradja; Z. Arastu; H. Sabri; M. Smith Upper GI nerve- gut and motility: Transmitters/signals/ receptors/enteric nervous system P1817 THE RELATIONS AMONG SERUM GHRELIN, MOTILIN, CIRCULATING ANTIMYENTERIC ANTIBODIES AND GASTRIC EMPTYING AND AUTONOMIC NERVOUS SYSTEM FUNCTION IN PATIENTS WITH AUTOIMMUNE GASTRITIS Ç. Kalkan; Fatih Karakaya, Turkey; I. Soykan P1818 EFFECTS OF FAECAL MICROBIOTA TRANSPLANTATION ON NEUROGENIN 3, MUSAHSI 1 AND ENTEROENDOCRINE CELLS IN THE DUODENUM OF PATIENTS WITH IRRITABLE BOWEL SYNDROME Tarek Mazzawi, Norway; M. El-Salhy; G. A. Lied; T. Hausken P1819 THE EFFECT OF ESOPHAGEAL ACID EXPOSURE ON NMDA RECEPTOR SUBUNITS EXPRESSION AND D-SERINE IN PREFRONTAL CORTEX AND HIPPOCAMPUS Weifang Zhang, China; L. Duan; K. Wang; X. Wang
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
Upper GI motility disorders: Clinical P1821 DIAGNOSTIC YIELD OF PROVOCATIVE TESTS ON ESOPHAGEAL HIGH RESOLUTION MANOMETRY (HRM) Stephen Hasak, USA; S. A. Basit; V. Naravadi; A. Lazarescu; C. P. Gyawali P1822 THE INCIDENCE AND PREVALENCE OF ACHALASIA IN ENGLAND IN TWO NATIONAL DATABASES Phil Harvey, United Kingdom; T. Thomas; J. Chandan; B. Coupland; J. Mytton; N. Bhala; P. Patel; K. Nirantharakumar; N. Trudgill P1823 ACHALASIA DESPITE NORMAL INTEGRATED RELAXATION PRESSURE WITH 5ML WATER SWALLOWS S. Sanagapalli; M. Duffy; A. V. Emmanuel; A. Raeburn; M. Banks; R. Haidry; L. Lovat; Rami Sweis, United Kingdom P1824 200ML RAPID DRINK CHALLENGE DURING HIGH RESOLUTION MANOMETRY PREDICTS OESOPHAGOGASTRIC JUNCTION OBSTRUCTION IN DYSPHAGIA, AND IS CORRELATED WITH SYMPTOM SEVERITY IN ACHALASIA Shirley Gabieta-Sonmez, United Kingdom; P. Woodland; J. Arguero; J. L. S. Ooi; K. Nakagawa; E. Glasinovic; E. Yazaki; D. Sifrim P1825 THE TIMED BARIUM ESOPHAGRAM SURFACE AREA CORRELATES WITH SYMPTOM IMPROVEMENT BETTER THAN COLUMN HEIGHT FOLLOWING TREATMENT IN ACHALASIA. S. Sanagapalli; J. Maynard; A. Plumb; A. V. Emmanuel; A. Raeburn; M. Banks; R. Haidry; L. Lovat; Rami Sweis, United Kingdom P1826 NUTRIENTS ENHANCE BELCHING AND REDUCE INTESTINAL PROPULSION OF GASTRIC GAS IN HEALTHY HUMANS Elba Noemi Caballero De Garcia, Spain; B. Benslaiman Seyid-Jebari; J. Serra Pueyo P1827 MODIFICATIONS OF THE ECKARDT SCORE PARAMETERS AFTER PERORAL ENDOSCOPIC MYOTOMY Maximilien Barret, France; S. Leblanc; M. Gaudric; M.-A. Guillaumot; A. Oudjit; M. Dhooge; V. Abitbol; A. Chryssostalis; R. Coriat; S. Chaussade; F. Prat
Poster in the Spotlight
Poster of Excellence
P1828 SUBGROUP ANALYSES OF CLINICAL TRIALS ON A HERBAL MEDICINE IN FD, STW 5 J. Müller; Olaf Kelber, Germany; B. Vinson; C. Fink; S. Rabini; K. Kraft; M. A. Storr P1829 THE TREATMENT OF ACHALASIA IN PATIENTS WITH OESOPHAGEAL VARICES: AN INTERNATIONAL CASE SERIES Cormac Magee, United Kingdom; R. Holloway; C. P. Gyawali; S. Roman; M. Pioche; E. Savarino; F. Quader; N. Zarate Lopez; A. J. Bredenoord; R. Sweis P1830 THE NATURAL HISTORY OF ACHALASIA: EVIDENCE OF A CONTINUUM – THE PATTERN-EVOLUTIVE STAGING THEORY R. Salvador; G. Voltarel; E. Pesenti; E. Savarino; G. Capovilla; A. Perazzolo; L. Nicoletti; S. Merigliano; Mario Costantini, Italy Functional upper GI disorders: Clinical P1831 ROLE OF A SERUM BIOMARKERS PANEL (GASTROPANEL®) IN NON-INVASIVE DIAGNOSIS OF UPPER GI DISEASE: DATA BY A PRIMARY CARE POPULATION OF NORTH-EST ITALY G. Baldassarre; M. Franceschi; M. P. Panozzo; Francesco Tomba, Italy; A. Ferronato; S. Grillo; D. Sella; M. Santacatterina; A. Antico; F. Di Mario P1832 SUSTAINED TREATMENT EFFECTS OF MENTHACARIN ON SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH FUNCTIONAL DYSPEPSIA 8 WEEKS AFTER THE END OF A 4-WEEK PLACEBO-CONTROLLED TRIAL Gerald J. Holtmann, Australia; B. Stracke P1833 IMPROVEMENT OF APPROPRIATENESS OF PROTON PUMP INHIBITOR (PPI) – THERAPY PRESCRIPTION WITH USE OF SEROLOGICAL MARKERS (GASTROPANEL) IN A PRIMARY CARE POPULATION M. Franceschi; M. P. Panozzo; A. Ferronato; Francesco Tomba, Italy; D. Sella; S. Landi; A. Antico; F. Di Mario; G. Baldassarre P1834 DUODENAL ACID PERFUSION INCREASES DUODENAL PERMEABILITY AND ACTIVATES THE DUODENOGASTRIC REFLEX, INDEPENDENTLY FROM MAST CELL ACTIVATION Hanne Vanheel, Belgium; R. Farré; D. Beeckmans; M. Vicario; J. Tack; T. Vanuytsel
Clinical Case Session
247
Wednesday, November 1, 2017
P1820 1.8. UPPER GI NERVE- GUT AND MOTILITY: TRANSMITTERS/SIGNALS/RECEPTORS/ENTERIC NERVOUS SYSTEM Lin Jia, China; L. Yao; C. Dong-Yun; L. Wei-Dong; X. Jian
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1835 APPROPRIATE USE OF PPI IN THE ELDERLY: EVALUATION OF ACID SECRETION AND ATROPHIC GASTRITIS BY MEANS OF A NON-INVASIVE TEST M. Franceschi; Silvia Speroni, Italy; R. De Bastiani; A. Antico; M. P. Panozzo; G. Baldassarre; S. Scida; C. Miraglia; L. Franzoni; V. Corrente; M. Rugge; F. Di Mario; C. Scarpignato; A. PILOTTO P1836 THE PSYCHOLOGICAL CHARACTERISTICS OF REFLUX HYPERSENSITIVITY-A PILOT STUDY BASED ON SCL90 QUESTIONNAIRE AND 24 HOUR PH-IMPEDANCE MONITORING K. Wang; Z. Xu; Z. Xia; Y. Ge; Liping Duan, China P1837 HIGH-RESOLUTION ESOPHAGEAL MANOMETRY: EVALUATION OF NEW SYSTEMS FOR THE ACQUISITION AND ANALYSIS. G. Capovilla; A. Costantini; G. Voltarel; E. Pesenti; A. Perazzolo; L. Nicoletti; R. Salvador; Mario Costantini, Italy Eosinophilic oesophagitis P1838 PROTON PUMP INHIBITOR THERAPY IMPROVES ESOPHAGEAL SYMPTOMS BY RESTORING A NORMAL ESOPHAGEAL PERISTALSIS IN PATIENTS WITH PROTON PUMP INHIBITOR-RESPONSE ESOPHAGEAL EOSINOPHILIA M. Della Coletta; N. de Bortoli; O. Bartolo; S. Tolone; G. Bodini; E. Marabotto; P. Zentilin; A. Mauro; R. Penagini; V. Savarino; Edoardo Savarino, Italy P1839 EOSINOPHILIC ESOPHAGITIS: MANAGEMENT IN THE DAILY CLINICAL DUTCH PRACTICE Bram Vermeulen, The Netherlands; A. Bogte; P. D. Siersema
Wednesday, November 1, 2017
P1840 IGG4 EXPRESSION IS ELEVATED IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS COMPARED TO PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE Simon Weidlich, Germany; S. Nennstiel; K. Brockow; M. Jesinghaus; J. Slotta-Huspenina; M. Bajbouj; R. M. Schmid; C. Schlag P1841 SYSTEMATIC REVIEW: HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS: MEASURE INSTRUMENTS AND DETERMINANT FACTORS Alfredo J Lucendo Villarin, Spain; L. Arias-González; J. Molina-Infante; Á. Arias
248
P1842 TREATMENT SATISFACTION OF ADULT EOSINOPHILIC ESOPHAGITIS PATIENTS Ekaterina Safroneeva, Switzerland; D. Hafner; C. Kuehni; M. Zwahlen; S. Trelle; A. Straumann; A. Schoepfer P1843 SYSTEMATIC ANALYSIS OF SUBEPITHELIAL EOSINOPHIL COUNTS INCREASES DIAGNOSTIC YIELD IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS Alain Schoepfer, Switzerland; A. Simko; C. Bussmann; E. Safroneeva; M. Zwahlen; T. Greuter; L. Biedermann; S. Vavricka; S. Godat; A. Reinhard; C. Saner; H. Maye; C. Sempoux; C. Brunel; C. Blanchard; D. Simon; H.-U. Simon; A. Straumann Reflux disease, pathogenesis P1844 GASTROESOPHAGEAL REFLUX DISEASE PATIENTS REFLUXATE TYPE INFLUENCE ON MACROPHAGE PHENOTYPE Svetlana Lyamina, Russian Federation; S. Kalish; A. Paraskevova; O. Storonova; S. Pirogov; A. Ponomarev; D. Rumyantseva; A. S. Troukhmanov; V. T. Ivashkin; I. Maev; I. Malyshev P1845 THE LOCATION OF OESOPHAGEAL MUCOSAL AFFERENT NERVES ARE MORE SUPERFICIAL IN PATIENTS WITH NERD THAN IN HEALTHY VOLUNTEERS AND PATIENTS WITH BARRETT’S OESOPHAGUS Philip Woodland, United Kingdom; J. L. S. Ooi; F. Grassi; C. Lee; J. Evans; N. Koukias; C. Triantos; S. A. C. McDonald; M. Peiris; R. Aktar; A. Blackshaw; D. Sifrim P1846 BELCHING PATTERNS IN PATIENTS WITH ISOLATED PATHOLOGICAL UPRIGHT REFLUX AND PATHOLOGICAL BIPOSITIONAL REFLUX José Maria Conchillo, The Netherlands; J. T. W. Snijkers; J. Santos Fernandez; A. A. M. Masclee P1847 IS REFLUX DURING NAPS WORSE THAN DURING NIGHT-TIME SLEEP? Carlos Teruel Sánchez-Vegazo, Spain; M. J. De Higes Ruiz; A. Albillos P1848 TREATMENT WITH PROTON PUMP INHIBITORS (PPI) DOES NOT REDUCE ACIDIC LARYNGOPHARYNGEAL REFLUX (LPR) DESPITE REDUCING DISTAL ACIDIC GASTROESOPHAGEAL REFLUX AND IMPROVING SYMPTOMS IN PATIENTS WITH LPR. Peter Banovcin, Slovak Republic; M. Ďuriček; T. Haličková; R. Hyrdel; M. Kollarik
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1850 ANALYSIS OF THE RELATIONSHIP BETWEEN GLOBUS PERCEPTION AND ACIDIC LARYNGOPHARYNGEAL REFLUX BY DUAL PHARYNGEAL AND ESOPHAGEAL 24HOUR PH/IMPEDANCE MONITORING. Lenka Bubernáková, Slovak Republic; M. Ďuriček; P. Banovcin; R. Hyrdel Reflux disease, diagnosis P1851 GASTRIN-17 AS A NON-INVASIVE MARKER FOR GERD: A PROSPECTIVE STUDY ON SAMPLE OF 777 CONSECUTIVE PATIENTS G. Masciangelo; Francesco Di Mario, Italy; L. Franzoni; M. Franceschi; S. Landi; T. B. Tene Fokam; S. Grillo; S. Scida; E. Savarino; N. de Bortoli; C. Miraglia; A. Bertelè; V. Corrente; C. Scarpignato P1852 HIGH RESOLUTION MANOMETRY SHOULD BE CONSIDERED THE BEST TEST TO DIAGNOSE SLIDING HIATAL HERNIA Irene Martinucci, Italy; N. de Bortoli; E. Savarino; S. Tolone; E. Marabotto; M. Frazzoni; L. Frazzoni; M. Bellini; V. Savarino; S. Marchi P1853 HIGH RESOLUTION MANOMETRY CAN BE PREDICTIVE OF GERD AS CONFIRMED BY IMPEDANCE-PH MONITORING: DEVELOPMENT AND INTERNAL VALIDATION OF A PREDICTIVE MODEL. Salvatore Tolone, Italy; L. Frazzoni; E. Savarino; M. Frazzoni; N. de Bortoli; I. Martinucci; G. Bodini; M. Furnari; R. Penagini; A. Mauro; V. Savarino; L. Docimo P1854 GORD PATIENTS ARE FREQUENTLY DISSATISFIED ON LONG-TERM PPI: EXPLORING THE REASON(S) AND MANAGEMENT IN ROUTINE CLINICAL CARE (LOPA II STUDY) Joachim Labenz, Germany; G. Labenz; M. Müller; D. Stephan; F. Willeke P1855 PREVALENCE AND PATHOPHYSIOLOGY OF GASTRO-ESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH AUTOIMMUNE GASTRITIS Gemma Maddalo, Italy; V. Pilotto; E. Savarino; C. Orlando; M. Fassan; D. Basso; M. Rugge; F. Farinati
Poster in the Spotlight
Poster of Excellence
Reflux disease, treatment P1856 DIET IS MORE EFFECTIVE THAN ANTACIDS IN RELIEVING REFLUX SYMPTOMS IN MILD GERD. Manuele Furnari, Italy; S. Cento; S. Tolone; M. Frazzoni; E. Savarino; L. Frazzoni; E. Marabotto; G. Bodini; V. Savarino; N. De Bortoli; S. Marchi; P. Minale P1857 INTERIM RESULTS OF A PROSPECTIVE MULTICENTER REGISTRY OF LOWER OESOPHAGEAL SPHINCTER STIMULATION FOR GORD: THE LESS-GORD REGISTRY Joachim Labenz, Germany; A. Leodolter; J. Pedersen; A. Nieponice; R. Weise; N. Bouvy; S. Schoppmann; C. Gutt; A. Madisch P1858 ANTI-REFLUX MUCOSECTOMY (ARMS) FOR REFRACTORY GERD – INITIAL CLINICAL EXPERIENCE Amol Bapaye, India; M. R. Mahadik; R. Pujari; T. K. Bharadwaj; S. G. Vare; N. Dubale; S. Date; J. A. Bapaye P1859 EFFECTIVENESS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH NON-EROSIVE REFLUX DISEASE: A RANDOMIZED TRIAL Iryna Biriuchenko, Ukraine; N. Bondarenko; A. Svintsitskyy P1860 QUALITY OF ESOPHAGEAL MUCOSAL HEALING IN EROSIVE REFLUX DISEASE: A RANDOMIZED COMPARATIVE TRIAL WITH LANSOPRAZOLE ALONE OR COMBINED WITH REBAMIPIDE Kyung-Ho Song, Republic of Korea; Y. C. Lee; S. J. Hong; S. W. Jeon Barrett's oesophagus: Clinical P1861 LONG-TERM RESULTS OF RADIOFREQUENCY ABLATION (RFA) IN PATIENTS WITH BARRETT'S ESOPHAGUS RELATED NEOPLASIA Jana Krajciova, Czech Republic; J. Maluskova; M. Kollar; Z. Vackova; J. Spicak; J. Martinek P1862 METHODS OF MEASURING BARRETT’S MUCOSAL THICKNESS WITH VOLUMETRIC LASER ENDOMICROSCOPY (VLE), AS A BIOMARKER TO GUIDE TO TREATMENT CHOICE Iris Levink, USA; G. Tearney; H. C. Wolfsen; S. Schlachter; P. D. Siersema; M. B. Wallace P1863 SEVEN-YEAR PROSPECTIVE FOLLOW-UP RESULTS OF RADIOFREQUENCY ABLATION FOR BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND EARLY CANCER. Kamar Belghazi, The Netherlands; B. L. A. M. Weusten; S. L. Meijer; J. J. G. H. M. Bergman; R. E. Pouw
Clinical Case Session
249
Wednesday, November 1, 2017
P1849 EFFECT OF L-MENTHOL ON ESOPHAGEAL PERISTALTIS AND LOWER ESOPHAGEAL SPHINCTER IN HEALTHY VOLUNTEERS Peter Banovcin, Slovak Republic; M. Ďuriček; P. Lipták; R. Hyrdel; M. Kollarik
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1864 ACTION IS REQUIRED TO IMPROVE UNDERSTANDING AND REDUCE ANXIETY LEVELS AMONGST PATIENTS IN THE BARRETT’S SURVEILLANCE PROGRAMME. Vinay Sehgal, United Kingdom; A. Kumar; D. S. Kalsi; P. Jegatheesvaran; J. Walton; J. Sadeghian; S. Murray P1865 BARRETT’S ESOPHAGUS IS ASSOCIATED WITH TOTAL SERUM ADIPONECTIN IN WOMEN, BUT NOT WITH OTHER INFLAMMATORY OR METABOLIC BIOMARKERS Manol Jovani, USA; Y. Cao; D. Feskanich; B. C. Jacobson; A. T. Chan P1866 OUTCOMES OF TREATMENT OF PATIENTS WITH EARLY-STAGE ADENOCARCINOMA OF THE ESOPHAGUS WITH INCIPIENT SUBMUCOSAL INVASION, RETROSPECTIVE ANALYSIS OF 19 CASES FROM A TERTIARY REFERRAL CENTER IN THE UK Balint Eross, United Kingdom; C. Clisby; C. Gordon Oesophageal neoplasia: Clinical P1867 THE USE OF ENDOCYSTOSCOPY FOR THE EARLY DETECTION OF ESOPHAGEAL NEOPLASM Shannon Chan, Hong Kong PRC; P. W. Y. Chiu; A. Y. B. Teoh; H. C. Yip; V. Wong; E. Ng; J. Y. Lau P1868 CLINICAL OUTCOMES OF ENDOSCOPIC RESECTION FOR ACHALASIA-ASSOCIATED SUPERFICIAL ESOPHAGEAL CANCER Yohei Nishikawa, Japan; K. Goda; S. Kono; K. Sumi; M. Ominami; Y. Ikebuchi; I. Haruo; M. Onimaru; H. Ito; H. Inoue P1869 USEFULNESS OF TRIAMCINOLONE INJECTION TO PREVENT STRICTURE AFTER CIRCUMFERENTIAL ESOPHAGEAL ESD FOR SCC AND EAC Tsuneo Oyama, Japan; A. Takahashi Wednesday, November 1, 2017
P1870 OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL PHARYNGEAL SQUAMOUS CELL CARCINOMA T. Oyama; Akiko Takahashi, Japan P1871 SHOULD ANTITHROMBOTIC AGENTS BE DISCONTINUED PRIOR TO ESOPHAGEAL ENDOSCOPIC SUBMUCOSAL DISSECTION? Noboru Kawata, Japan; M. Tanaka; K. Takizawa; N. Kakushima; M. Yoshida; S. Ito; K. Imai; K. Hotta; H. Ishiwatari; H. Matsubayashi; H. Ono
250
P1872 EXPLORATORY STUDY OF PREDICTIVE BIOMARKER FOR DEFINITIVE CHEMORADIOTHERAPY USING BIOPSY SPECIMENS OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA. Kenji Takashima, Japan; T. Yano; M. Takahashi; Y. Yoda; K. Hori; M. Komatsu; T. Kojima; H. Daiko; K. Minashi; M. Muto; H. Sasaki; S. Fujii P1873 ENDOSCOPIC TREATMENT OF PATIENTS WITH HIGHRISK EARLY ESOPHAGEAL CANCER Marek Kollar, Czech Republic; J. Krajciova; J. Maluskova; E. Honsova; A. Pazdro; T. Harustiak; D. Kodetova; Z. Vackova; J. Spicak; J. Martinek P1874 DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASONOGRAPHY FOR ESOPHAGEAL SUBMUCOSAL GLAND DUCT INVOLVEMENT ACCOMPANIED BY EARLY ESOPHAGEAL CANCER Y. Jie; Lv Ying, China P1875 PRETREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO IS NOT A PREDICTOR OF RESPONSE TO NEOADJUVANT THERAPY IN ESOPHAGEAL CANCER GiovannI Pirozzolo, Italy; S. S. Gisbertz; O. De Simoni; A. Slaman; C. Castoro; M. Scarpa; M. I. van Berge Henegouwen Acid peptic disease (includes NSAIDS, but NOT H. pylori), epidemiology P1876 CAN THE USE OF A COMPUTER DECISION SUPPORT SYSTEM PREVENT COMPLICATED ULCER AMONG PATIENTS TREATED WITH NSAID OR ASPIRIN? A RANDOMISED CONTROLLED CLUSTER TRIAL IN GENERAL PRACTICE. Johanna Martina Petersen, Denmark; D. E. Jarbøl; J. Hallas; M. R. Munch; O. B. Schaffalitzky de Muckadell; J. M. Hansen Acid peptic disease (includes NSAIDS, but NOT H. pylori), pathogenesis P1877 ACCELERATION OF HEALING OF PREEXISTING GASTRIC ULCERS BY CARBON MONOXIDE RELEASING MOLECULE -2 (CORM-2). INVOLVEMENT OF HEME OXYGENASE, OXIDATIVE STRESS AND PROINFLAMMATORY MARKERS T. Brzozowski; Katarzyna Magierowska, Poland; S. Kwiecien; M. Magierowski; M. Hubalewska-Mazgaj; D. Wojcik; R. Pajdo; A. Chmura
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1878 PROTON PUMP INHIBITORS INAPPROPRIATE USE IN PATIENTS ADMITTED IN A TERTIARY GREEK HOSPITAL CREATES SIGNIFICANT DIRECT COSTS BURDEN AND EXPOSURE OF PATIENTS TO THE RISK OF UPPER GASTROINTESTINAL COMPLICATIONS G. Vlachonicolou; L. Bounou; A. Theodorou-Kanakari; S. Kalousios; M. Roma; E. A. Mavroeidi; G. D. Dimitriadis; Konstantinos Triantafyllou, Greece P1879 CONTINUOUS INCREASE IN PREVALENCE OF FUNDIC GLAND POLYPS WITH THE LENGTH OF PROTON PUMP INHIBITORS USE. IS THERE ANY CLINICAL CONSEQUENCE? Radek Kroupa, Czech Republic; M. Dastych; S. Konecny; J. Dolina
P1885 SHORT-TERM OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER IN ELDERLY PATIENTS AND LONG-TERM OUTCOME AFTER NON-CURATIVE RESECTION Hiroya Sakaguchi, Japan; Y. Ohara; T. Toyonaga; H. Kaku; K. Matsuoka; T. Sako; R. Ariyoshi; H. Abe; F. Kawara; S. Tanaka; T. Ishida; Y. Morita; E. Umegaki P1886 GASTRIC INTESTINAL METAPLASIA OUTCOMES: RESULTS FROM A 17 YEAR TERTIARY CENTRE UPPER GI SURVEILLANCE PROGRAMME IN IRELAND Mairead Mc Nally, Ireland; I. Cretu; A. O'Connor
Gastroduodenal neoplasia: Clinical
P1887 DIFFERENT RELATIONSHIP BETWEEN STAGE OF GASTRIC CANCER AND GENOTYPE OF TGFB1 BASED ON FIRST-DEGREE RELATIVE OF GASTRIC CANCER Mingu Kwon, Republic of Korea; N. Kim; C. Yun; Y. J. Hwang; Y. J. Choi; H. Yoon; C. M. Shin; Y. S. Park; D. H. Lee
P1880 ENDOSCOPIC RESECTION OF ADVANCED AMPULLARY ADENOMAS: A SINGLE-CENTER 14 YEAR RETROSPECTIVE COHORT STUDY Sophia van der Wiel, The Netherlands; J. W. Poley; M. J. Bruno; A. D. Koch
P1888 GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH. A GENETIC STUDY OF A NEWLY DIAGNOSED FAMILY Ilja Tachecí, Czech Republic; M. Podhola; M. Leško; M. Minarik; L. Benesova; M. Kopáčová; S. Rejchrt; J. Bures
P1881 FACTORS ASSOCIATED WITH TECHNICAL DIFFICULTY OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER WHICH MET EXPANDED INDICATION CRITERIA; POST HOC ANALYSIS USING DATA OF MULTI-INSTITUTIONAL PROSPECTIVE CONFIRMATORY TRIAL. (JCOG0607) Tomonori Yano, Japan; N. Hasuike; H. Ono; N. Boku; G. Ogawa; J. MIzusawa; I. Oda; H. Doyama; S. Hori; H. Iishi; K. Takizawa; H. Fukuda; M. Muto
P1889 ENDOSCOPIC TREATMENT FOR LATERAL SPREADING SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA Hirofumi Kawakubo, Japan; T. Omori; K. Suda; R. Nakamura; N. Wada; N. Yahagi; Y. Kitagawa
P1882 COMPARATIVE EFFECTIVENESS OF NOVEL FINE-NEEDLE BIOPSY DEVICE VS CONVENTIONAL FINE-NEEDLE ASPIRATION FOR ENDOSCOPIC ULTRASOUND DIAGNOSIS OF GASTRIC SUBMUCOSAL LESIONS Meir Mizrahi, USA; E. U. Yee; I. Nasser; J. Cohen; J. Sheridan; R. Chuttani; T. Berzin; M. Sawhney; D. Pleskow P1883 A COMPARISON OF SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION AND ENDOSCOPIC FULL-THICKNESS RESECTION FOR GASTRIC FUNDUS SUBMUCOSAL TUMORS Tianying Duan, China; Y. Tan; X. Wang; L. Liang; D. Liu P1884 COMPARISON OF THE DIAGNOSTIC YIELDS OF ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION FOR DUODENAL AND GASTRIC SUBEPITHELIAL LESIONS. Kenji Nakamura, Japan Poster in the Spotlight
Poster of Excellence
P1890 DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASONOGRAPHY FOR ESOPHAGEAL SUBMUCOSAL GLAND DUCT INVOLVEMENT ACCOMPANIED BY EARLY ESOPHAGEAL CANCER Y. Jie; Lv Ying, China P1891 PEPSINOGENS AND GASTRIN-17 FOR IDENTIFICATION OF GASTRIC CANCER PRECURSOR LESIONS: THE RESULTS FROM THE GISTAR PILOT STUDY C. Robles; D. Rudzite; I. Polaka; L. Tzivian; Ilze Kikuste, Latvia; A. Vanags; S. Isajevs; I. Liepniece-Karele; S. Parshutin; J. Young Park; R. Murillo; R. Herrero; M. Leja Gastroduodenal neoplasia: Basic P1892 MIR-211 INHIBITS PROLIFERATION AND MIGRATION OF GASTRIC CANCER CELLS BY TARGETING FOXC1 Xingkang He, China; Y. Ding; Z. Jin; L. Sun; J. Si
Clinical Case Session
251
Wednesday, November 1, 2017
Acid peptic disease (includes NSAIDS, but NOT H. pylori), diagnosis and treatment
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1893 CONGENITAL OR METAPLASTIC: EVALUATION OF GASTROESOPHAGEAL NEO-JUNCTIONS TO ASSESS CARDIAC TYPE EPITHELIUM ORIGIN Joana Castela, Portugal; D. Vinha Pereira; S. Mão de Ferro; R. Casaca; R. Fonseca; P. Chaves; A. Dias Pereira P1894 ENDOSCOPIC MUCOSAL RESECTION OF NON-AMPULLARY SPORADIC DUODENAL ADENOMAS: LONG TERM RESULTS. G. Valerii; A. Tringali; I. Boskoski; P. Familiari; Vincenzo Bove, Italy; R. Landi; V. Perri; G. Costamagna P1895 CROSSTALK BETWEEN THE G PROTEIN-COUPLED RECEPTOR 39 AND RECEPTOR TYROSINE KINASES IN HUMAN GASTRIC CANCER S. Leal-López; B. Otero-Alen; C. S. Seonae-Mosteiro; L. S. Estevez-Perez; T. Garcia-Caballero; R. Gallego-Gomez; J. Enrique Dominguez-Muñoz, Spain; J. P. Perez-Camiña; Y. Pazos-Randulfe P1896 INDOMETHACIN INDUCES LYSOSOMAL DYSFUNCTION IN GASTRIC CANCER CELLS AND INCREASES THEIR SENSITIVITY TO CYTOTOXIC DRUGS J. Vallecillo-Hernández; Laura Gisbert-Ferrándiz, Spain; P. Salvador; D. Ortiz-Masia; D. C. Macias-Ceja; M. D. Barrachina; S. Calatayud; C. Hernández P1897 HOXD10 METHYLATION IN PLASMA WAS POTENTIALLY SERVED AS BIOMARKER OF GASTRIC CANCER AND PRECANCEROUS LESIONS L. Wang; Liangjing Wang, China; M. Luo P1898 ACETYLCHOLINE INDUCES CANCER STEM CELL- LIKE PHENOTYPE IN GASTRIC CANCER CELLS OF DIFFUSE TYPE P. H. Nguyen; Y. Touchefeu; E. Duchalais; T. Durand; P. Aubert; P. Girot; M. Peron; S. Bruley des Varannes; C. Varon; M. Neunlist; Tamara Matysiak Budnik, France Wednesday, November 1, 2017
P1899 SYSTEMATIC REVIEW AND META-ANALYSIS OF THE PROGNOSTIC SIGNIFICANCE OF CPG ISLAND METHYLATOR PHENOTYPE IN GASTRIC CANCER Arfon Powell, United Kingdom; S. Soul; N. Patel; C. Brown; W. Lewis
Poster Session 09:00 – 14:00 H. Pylori III
Hall 7
Diagnosis P1900 THE VALIDITY OF BREATH COLLECTION BAGS USING THE NOVEL BREATHID®HP LAB SYSTEM: A MULTICENTER CLINICAL STUDY IN 257 SUBJECTS Haim Shirin, Israel; J. Gonzalez; S. Hazan; G. Gottlieb; K. Friedenberg; D. Gatof; R. Ganeshappa; S. Delgado; D. Abramowitz; R. Hardi; A. Coates; M. Haq; N. Mehta; B. Jones; S. Moss P1901 MACHINE-LEARNING-BASED AUTOMATIC DIAGNOSIS SYSTEM FOR HELICOBACTER PYLORI INFECTION USING LINKED COLOR IMAGING Yuto Okada, Japan; N. Yagi; H. Ichikawa; H. Kitae; A. Tomie; S. Hiwa; T. Hiroyasu P1902 HELICOBACTER PYLORI DETECTION BY γ-GLUTAMYLTRANSPEPTIDASE-ACTIVATED FLUORESCENT PROBE Taro Akashi, Japan; K. Matsushima; T. Kanda; M. Nakano; M. Kamiya; Y. Akazawa; K. Ohnita; F. Takeshima; K. Nakao; Y. Urano; H. Isomoto P1903 SEROLOGICAL CHANGES AFTER EQUIVOCAL HELICOBACTER PYLORI-SEROLOGY TEST FINDINGS DEPEND ON THE GASTRIC SECRETING ABILITY Ji Hye Kim, Republic of Korea; S.-Y. Lee; S. P. Lee; J. H. Kim; I.-K. Sung; H. S. Park; C. S. Shim P1904 WE CAN JUDGE THE EXISTENCE OF PRESENT OR PAST H.PYLORI INFECTION WITH ONLY ONE ENDOSCOPIC CARDIAC IMAGES (WHALE SHARK SIGN: WSS). Takuji Yamasaki, Japan; T. Sakurai; J. Mitobe; M. Mitsunaga; Y. Amano; Y. Tokai; M. Saruta P1905 SERUM PEPSINOGEN II AS A NON-INVASIVE MARKER FOR DIAGNOSIS OF HELICOBACTER PYLORI INFECTION: A PROSPECTIVE STUDY IN A COHORT OF DYSPEPTIC PATIENTS Francesco Di Mario, Italy; C. Miraglia; S. Scida; A. Violi; M. Franceschi; G. Baldassarre; M. Rugge; P. Crafa; A. Tursi; G. Brandimarte; L. Franzoni; N. Dal Bò; R. Cannizzaro; C. Scarpignato P1906 CAN THE UREA BREATH TEST PREDICT HELICOBACTER PYLORI ERADICATION? Denise Brennan, Ireland; C. Dalton; P. Murray; J. O'Toole; H. Temperley; C. O'Morain; S. Smith; D. McNamara
252
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
P1907 HIGH DOSE CAM WITH VONOPRAZAN (P-CAB) PLUS AMX TRIPLE THERAPY REGIMEN IS THE STRONGEST H.PYLORI ERADICATION THERAPY EVEN IF CAM RESISTANCE. Takuji Yamasaki, Japan; T. Sakurai; J. Mitobe; M. Mitsunaga; Y. Amano; Y. Tokai; M. Chibai; M. Saruta P1908 COMPARISON OF THE EFFICACY BETWEEN BISMUTH AND ALTERNATING RIFAXIMIN ON SECOND-LINE QUADRUPLE REGIMEN OF HELICOBACTER PYLORI ERADICATION. Junseok Park, Republic of Korea; J. S. Lee; J.-O. Kim; S. J. Hong; H. G. Kim; T. H. Lee; S. R. Jeon; J.-H. Cho P1909 COMPARISON OF 10-DAY STANDARD TRIPLE THERAPY AND LEVOFLOXACIN BASED THERAPY FOR HELICOBACTER PYLORI ERADICATION: RANDOMIZED CONTROLLED TRIAL Min Kyu Kang, Republic of Korea; S.-H. Lee; M. C. Kim; K. H. KIM; K. O. Kim; B. I. Jang; T.-N. Kim P1910 TREATMENT OF HELICOBACTER PYLORI INFECTION: WILL TAILORING THERAPY FIRST TIME OVERCOME INCREASING FAILURE OF STANDARD TRIPLE THERAPY? Denise Brennan, Ireland; M. Hussey; D. Tighe; C. O'Morain; S. Smith; D. McNamara P1911 TREATING HELICOBACTER PYLORI INFECTION SECOND TIME ROUND: IS TAILORING THERAPY BASED ON ANTIMICROBIAL SUSCEPTIBILITY THE BEST OPTION? Denise Brennan, Ireland; M. Hussey; D. Tighe; C. O'Morain; S. Smith; D. McNamara P1912 ARE PROBIOTICS USEFUL AS ADJUVANTS IN ERADICATION THERAPY OF HELICOBACTER PYLORI INFECTION? Marta Gravito-Soares, Portugal; E. Gravito-Soares; D. Gomes; N. Almeida; L. Tomé P1913 THE IMPACT OF CLOSTRIDIUM BUTYRICUM MIYAIRI-588 ON HELICOBACTER PYLORI ERADICATION THERAPY Shun Takayama, Japan; O. Handa; R. Mukai; Y. Suyama; A. Majima; Y. Onozawa; O. Dohi; T. Okayama; N. Yoshida; K. Kamada; K. Katada; K. Uchiyama; T. Ishikawa; T. Takagi; H. Konishi; Y. Naito; Y. Itoh P1914 ª THE EFFECTS OF SACCHAROMYCES BOULARDII SUPPLEMENTATION ON HELICOBACTER PYLORI ERADICATION RATE AND SIDE EFFECTS DURING SEQUENTIAL THERAPY : A PROSPECTIVE RANDOMISED CONTROLLED STUDY Hanae Boutallaka, Morocco; H. Seddik; K. Loubaris; F. Nejjari; S. Berrag; I. Elkoti; A. Benkirane Poster in the Spotlight
Poster of Excellence
P1915 ‘CONCOMITANT’ OR ‘SEQUENTIAL’ THERAPY FOR THE ERADICATION OF HELICOBACTER PYLORI: WHICH REGIMEN COMES FIRST IN MOROCCO? Adil Ait Errami, Morocco; Z. Samlani; S. Oubaha; K. Krati P1916 PROSPECTIVE COMPARATIVE STUDY OF TWO FIRST-LINE REGIMENS FOR HELICOBACTER PYLORI ERADICATION: 14DAYS NON-BISMUTH QUADRUPLE OPTIMIZED CONCOMITANT THERAPY VERSUS 10-DAYS BISMUTH-CONTAINING QUADRUPLE THERAPY USING A THREE-IN-ONE CAPSULE. Javier Alcedo, Spain; M. Gracia; P. García-Cámara; C. Palacín; S. Frago; I. Aured; L. Luzón; S. Gallego; C. Jimeno-Ayllón; D. Pérez-Milián; D. Villafranca P1917 MANAGEMENT OF HELICOBACTER PYLORI INFECTION AT PRIMARY CARE LEVEL. THE IMPLEMENTATION OF SPECIFIC COUNSELLING IMPROVES ERADICATION RATES. Viviana Laredo, Spain; T. Arroyo Villarino; E. Alfaro; C. Sostres; A. Lanas Poster Session 09:00 – 14:00 Small Intestinal III
Hall 7
Enterocyte biology/pathology and nutrient/water transport/electrolyte transport P1918 VALPROATE AND CHIR 99201 AMELIORATES RADIATION INDUCED INTESTINAL EPITHELIAL INJURY IN MOUSE MODEL Younjoo Kim, Republic of Korea; J. S. Shin Coeliac disease (adult) P1919 PREVALENCE OF CELIAC DISEASE AMONG RELATIVES IN ALGERIA Fadila Lounes, Algeria; N. Aliarous; S. Salah; K. Belanteur; M. G. Mokhtech; Z. C. Amir; D. Hannoun; R. Ouldgougam; Y. Chikhi; S. Cheraitia; F. Asselah; H. Asselah; M. Lahcene P1920 LONG-TERM HEALTH AND LIFESTYLE OUTCOMES IN ADULT CELIAC DISEASE PATIENTS DIAGNOSED IN CHILDHOOD BECAUSE OF CLINICAL SUSPICION OR BY SCREENING Laura Kivelä, Finland; S. Alin; S. Kröger; K. Kaukinen; K. Kurppa P1921 REVIEW OF SERVICE PROVISION OF NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) RECOMMENDED QUALITY STANDARDS FOR COELIAC DISEASE AT A BIG DISTRICT GENERAL HOSPITAL Faisal Kamran Shaikh, United Kingdom; D. Vani; M. Sprakes; F. Greenhalgh
Clinical Case Session
253
Wednesday, November 1, 2017
Treatment
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1922 SERUM MICROBIAL MARKERS IN NONRESPONSIVE CELIAC DISEASE Liisa Viitasalo, Finland; K. Kurppa; H. Huhtala; M. Mäki; K. Kaukinen; S. Iltanen P1923 CORRELATION BETWEEN OXIDATIVE STRESS AND DUODENAL ATROPHY IN CELIAC DISEASE Francesca Ferretti, Italy; F. Branchi; L. Roncoroni; S. Moretti; A. Vezzoli; S. Mrakic-Sposta; V. Lombardo; D. Conte; L. Elli P1924 CIRCULATING EXTRACELLULAR VESICLES, A NOVEL MECHANISM OF ENDOCRINE CELLULAR CROSS-TALK, ARE INCREASED IN NEWLY DIAGNOSED CELIAC DISEASE PATIENTS Konstantinos Efthymakis, Italy; G. Bologna; P. Lanuti; C. Pipino; A. Milano; F. Laterza; P. Simeone; A. Bonitatibus; A. Pandolfi; M. Marchisio; S. Miscia; M. Neri P1925 COELIAC DISEASE AND REPRODUCTIVE DISORDERS : IS THERE ANY CORRELATION Hanae Boutallaka, Morocco; I. benelbarhdadi; F. Z. Ajana P1926 SEVERITY OF MUCOSAL DAMAGE AND TISSUE TRANSGLUTAMINASE ANTIBODY LEVELS CORRELATE WELL IN ADULT CELIAC DISEASE IRRESPECTIVE OF CLINICAL FEATURES R. Maxim; Anca-Victorita Trifan, Romania; A. Plesa; S. C. Oana Cristina; I. Ciortescu; I. Girleanu; C. Stanciu P1927 ASSOCIATION OF CELIAC DISEASE AND PATENT FORAMEN OVALE Mesut Sezikli, Turkey; G. Dindar; D. Karacimen; S. B. Acikgoz P1928 USEFULNESS OF BULB BIOPSY SAMPLES IN CELIAC DISEASE DIAGNOSIS IN ADULTS Daniel Vasile Balaban, Romania; A. Popp; J. Taavela; K. Laurila; M. Mäki; M. Jinga Wednesday, November 1, 2017
P1929 PROSPECTIVE MULTI-CENTER-STUDY TO EVALUATE A FINGER PRICK-BASED POINT-OF-CARE-TEST (POCT) FOR DIAGNOSIS OF COELIAC DISEASE. P. H. Tangermann; F. Branchi; W. Spitz; U. Möhler; J. Aschenbeck; S. Schubert; A. Schroeder; F. Heller; S. Trenkel; M. Schmitt; B. Siegmund; C. Bojarski; Michael Schumann, Germany P1930 QUALITY STANDARDS IN COELIAC DISEASE: A RETROSPECTIVE EVALUATION IN A SINGLE SPECIALIST CLINIC Michael FitzPatrick, United Kingdom; S. Nichols; E. Soilleux; S. Travis 254
Small intestinal bleeding P1931 MANAGEMENT OF OCCULT OBSCURE GASTROINTESTINAL BLEEDING PATIENTS BASED ON LONG-TERM OUTCOMES Sayoko Kunihara, Japan; S. Oka; S. Tanaka; A. Tsuboi; I. Otani; K. Chayama P1932 A PILOT STUDY EXPLORING THE VALUE OF FAECAL IMMUNOCHEMICAL TEST (FIT) WHEN INVESTIGATING ANAEMIA OR OCCULT GASTROINTESTINAL BLEEDING WITH SMALL BOWEL CAPSULE ENDOSCOPY Donal Tighe, Ireland; C. Judge; P. Walsh; M. Kelly; A. O'Connor; N. Breslin; B. Ryan; G. Boran; D. McNamara P1933 VIDEO CAPSULE ENDOSCOPY IN THE ASSESSMENT OF PORTAL HYPERTENSIVE ENTEROPATHY. Yasir Al-Azzawi, USA; M. Mahmoud; L. Spaho; J. Kheder; D. Cave P1934 MULTICENTER PROSPECTIVE CASE-CROSSOVER STUDY ON THE ASSOCIATION BETWEEN OVERT SMALL-BOWEL BLEEDING AND DRUGS USING CAPSULE ENDOSCOPY DATABASE IN JAPAN Naoki Ohmiya, Japan; S. Fujimori; M. Nakamura; A. Yamada; K. Maki; S. Oka; M. Esaki; A. Nakajima; T. Matsumoto; S. Tanaka; H. Goto; C. Sakamoto P1935 META-ANALYSIS REVEALS SIMILAR REBLEEDING RATES AMONG EASTERN AND WESTERN POPULATIONS UP TO FIVE YEARS AFTER INDEX VIDEO CAPSULE ENDOSCOPY EXAMINATION FOR OBSCURE GASTROINTESTINAL BLEEDING G. Tziatzios; P. Gkolfakis; G. D. Dimitriadis; Konstantinos Triantafyllou, Greece P1936 LONGTERM OUTCOMES AFTER NEGATIVE DOUBLEBALLOON ENTEROSCOPY FOR SUSPECTED OVERT SMALL BOWEL BLEEDING (OBSCURE-OVERT GASTROINTESTINAL BLEEDING) Rintaro Hashimoto, Japan; T. Matsuda; M. Nakahori P1937 DOES DISCONTINUATION OF ANTITHROMBOTIC AGENTS AFFECT DIAGNOSTIC YIELD OF SMALL BOWEL CAPSULE ENDOSCOPY IN PATIENTS WITH OBSCURE GASTROINTESTINAL BLEEDING? Toshio Watanabe, Japan; S. Shimada; Y. Nadatani; K. Otani; F. Tanaka; Y. Nagami; N. Kamata; H. Yamagami; T. Tanigawa; M. Shibatoge; T. Miyazaki; S. Nakamura; Y. Fujiwara P1938 EFFICACY OF REBAMIPIDE TO PREVENT LOW-DOSE ASPIRIN-INDUCED SMALL INTESTINAL INJURY Sergey Vyalov, Russian Federation
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
Vascular disorders P1940 VALIDATION OF A SCORE CHART TO PREDICT THE RISK OF CHRONIC MESENTERIC ISCHEMIA: A DISCRIMINATIVE AND USEFUL TOOL IN CLINICAL DECISION-MAKING Louisa van Dijk, The Netherlands; D. van Noord; R. H. Geelkerken; S. A. Berendsen; A. C. de Vries; A. Moelker; H. J. M. Verhagen; J. J. Kolkman; M. J. Bruno; on behalf of the Dutch Mesenteric Ischemia Study group (DMIS) P1941 LONG-TERM SYMPTOM RELIEF AFTER REVASCULARIZATION IN PATIENTS WITH SINGLE ARTERY CHRONIC MESENTERIC ISCHEMIA Louisa van Dijk, The Netherlands; L. M. G. Moons; D. van Noord; A. Moelker; H. J. M. Verhagen; M. J. Bruno; E. V. Rouwet P1942 UNDERUTILIZATION OF ENDOSCOPIC ARGON PLASMA COAGULATION FOR TREATMENT OF BLEEDING GASTROINTESTINAL ANGIODYSPLASIAS: AN INTERNATIONAL MULTICENTRE COHORT STUDY Karina Grooteman, The Netherlands; M. Matheeuwsen; G. Holleran; E. Van Geenen; D. McNamara; J. P. H. Drenth P1943 DIGESTIVE INVOLVEMENT IN SYSTEMIC DISEASES: A UNIVERSITY HOSPITAL EXPERIENCE Wafaa Khannoussi, Morocco; K. Chhita; H. Bachir; G. Kharrasse; A. El Mekkaoui; S. Hamaz; H. B. Alaoui; K. Serraj; Z. Ismaili Poster Session 09:00 – 14:00 Nutrition III
Hall 7
Obesity P1944 CHANGES IN LEVELS OF VITAMIN D IN OBESE PATIENTS SUBMITTED TO BARIATRIC SURGERY Ana Vaz, Portugal; R. Guerreiro; D. Sousa; P. Queirós; T. Gago; J. Roseira; H. Guerreiro P1945 WITHDRAWN Poster in the Spotlight
Poster of Excellence
P1946 INTRAGASTRIC BALLOON: A CRITICAL VIEW IN NON ELECTIVE BARIATRIC SURGERY PATIENTS Ricardo Jose Fittipaldi Fernandez, Brazil; E. Usuy; C. F. Diestel; S. Barrichello; A. F. Teixeira; M. Galvao Neto P1947 SPATZ3® ADJUSTABLE INTRAGASTRIC BALLOON TREATMENT: A BRAZILIAN MULTICENTRIC EXPERIENCE Ricardo Jose Fittipaldi Fernandez, Brazil; C. F. Diestel; M. Galvao Neto; A. F. Teixeira; E. Usuy; S. Barrichello P1948 VOMITING FREQUENCY AFTER INTRAGASTRIC BALLOON PLACEMENT AND INTRAVENOUS HYDRATION REQUIREMENT Sérgio Barrichello, Brazil; R. J. F. Fernandez; E. Usuy; A. F. Teixeira; M. Galvao Neto; T. F. Souza; E. Grecco P1949 BODY MASS IMPROVEMENT AND METABOLIC CHANGE RATE AFTER INTRAGASTRIC BALLOON TREATMENT. Sérgio Barrichello, Brazil; R. J. F. Fernandez; E. Usuy; T. F. Souza; M. Galvao Neto; A. F. Teixeira; E. Grecco P1950 A LARGE BRAZILIAN EXPERIENCE WITH THE INTRAGASTRIC BALLOON TREATMENT IN HIGH VOLUME OF PATIENTS CENTERS Ricardo Jose Fittipaldi Fernandez, Brazil; C. F. Diestel; M. Galvao Neto Nutrients and gut function P1951 FRUCTO-OLIGOSACCHARIDE EXACERBATES STRESS-INDUCED VISCERAL HYPERALGESIA AND GUT INFLAMMATION IN A MURINE MODEL Binrui Chen, China; L. Du; H. He; J. J. Kim; N. Dai P1952 GENOMIC ANALYSIS OF THE MULTISPECIES PROBIOTIC PRODUCT VSL#3 Diego Mora, Italy; W. M. de Vos; F. P. Douillard P1953 RAISING PUBLIC AWARENESS OF GASTROINTESTINAL DISEASES: AN INNOVATIVE STRATEGY FOR A NATIONAL CAMPAIGN L. Franzoni; P. Crafa; A. Bertelè; V. Corrente; S. Grillo; S. Landi; C. Miraglia; S. Scida; Francesco Di Mario, Italy P1954 ALTERED PLASMA PROFILE AND URINE EXRECTION OF AMINO ACIDS IN COELIAC DISEASE CHILDREN AFTER ADMINISTRATION OF OLIGOFRUCTOSE-ENRICHED INULIN INTO GLUTEN-FREE DIET – RESULTS OF RANDOMIZED, PLACEBO-CONTROLLED PILOT TRIAL Natalia Drabińska, Poland; E. Jarocka-Cyrta; U. Krupa-Kozak
Clinical Case Session
255
Wednesday, November 1, 2017
P1939 CAPSOCAM SV-1 VERSUS PILLCAM SB 3 IN THE DETECTION OF OBSCURE GASTROINTESTINAL BLEEDING: RESULTS OF A PROSPECTIVE RANDOMIZED COMPARATIVE MULTI-CENTER STUDY Lilli Zwinger, Germany; B. Siegmund; A. Stroux; A. Adler; W. Veltzke-Schlieker; R. Wentrup; C. Jürgensen; B. Wiedenmann; F. Wiedbrauck; S. Hollerbach; T. Liceni; C. Bojarski
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
P1955 LONG-TERM TRENDS IN HEMATOLOGICAL AND NUTRITIONAL STATUS AFTER GASTRECTOMY FOR GASTRIC CANCER. Ji-Hyun Kim, Republic of Korea P1956 EVOLUTION OF REPRODUCTIVE DISORDERS RELATED TO CELIAC DISEASE UNDER GLUTEN -FREE DIET Ayoub Aomari, Morocco; M. firwana; A. Amjahdi; I. Benelbarhdadi P1957 ROLE OF VAGAL AFFERENTS ON HIGH FAT DIET INDUCED ALTERATIONS IN RAT BEHAVIOUR AND GUT MOTILITY Yonca Öztürk, Turkey; B. Akgün; O. Çetin; H. Ö. Karataş; B. Güney; Z. N. Özdemir Kumral; D. Özbeyli; S. Arabacı Çetin; H. Zortul; İ. Peker; F. Arıcıoğlu; C. Erzik; B. Çağlayan Yeğen; N. Imeryüz Enteral and parenteral nutrition P1958 OPTIMAL NUTRITIONAL ROUTE FOLLOWING TOTAL GASTRECTOMY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Shubhangi Govil, United Kingdom; D. Chan; T. Abdelrahman; A. Foliaki; W. Lewis; G. Clark; G. Blackshaw P1959 TAUROLIDINE PREVENTS CATHETER-RELATED BLOODSTREAM INFECTIONS IN PATIENTS ON HOME PARENTERAL NUTRITION – A RANDOMIZED CONTROLLED TRIAL Yannick Wouters, The Netherlands; M. Theilla; P. Singer; S. Tribler; P. B. Jeppesen; L. Pironi; L. Vinter-Jensen; H. H. Rasmussen; F. Rahman; G. Wanten P1960 REPAIR OF DAMAGED CENTRAL VENOUS CATHETERS SUBSTANTIALLY PROLONGS DEVICE SURVIVAL IN PATIENTS ON HOME PARENTERAL NUTRITION Yannick Wouters, The Netherlands; R. Vissers; W. Kievit; G. Wanten Wednesday, November 1, 2017
P1961 LONG-TERM CLINICAL OUTCOMES OF PATIENTS ON HOME PARENTERAL NUTRITION USING TAUROLIDINE CATHETER LOCKS Yannick Wouters, The Netherlands; B. Roosenboom; W. Kievit; G. Wanten P1962 INTESTINAL DYSBIOSIS IN PATIENTS WITH SHORT BOWEL SYNDROME DEPENDENT ON TOTAL PARENTERAL NUTRITION IS REFLECTED BY ALTERED METABOLOME IN FAECES Lukas Bajer, Czech Republic; M. Kostovcik; J. Hradecky; T. David; P. Wohl; J. Spicak; P. Drastich; M. Cahova 256
P1963 COMPARING RISKS OF ADVERSE EVENTS ASSOCIATED WITH PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) PLACEMENT BETWEEN THE MODIFIED INTRODUCER TECHNIQUE AND THE OVERTUBE ASSISTED PULL TECHNIQUE. Hiroaki Matsui, Japan; H. Inomata; H. Horiuchi; N. Tamai; K. Sumiyama Poster Session 09:00 – 14:00 Clinical Cases III
Hall 7
Liver / Biliary / Pancreas CC103 FOLLICULAR LYMPHOMA IN A CIRRHOTIC PATIENT – WHEN ASCITIC FLUID IS THE ONLY CLUE Richard Azevedo, Portugal; H. Ribeiro; J. Pinto; F. Pereira; C. Leitão; A. Caldeira; R. Sousa; E. Pereira; A. Banhudo CC104 IDIOPATHIC CHYLOUS ASCITES IN A PATIENT WITH HIV INFECTION – RESPONSE TO TOTAL PARENTERAL NUTRITION AND OCTREOTIDE THERAPY Gonçalo Nunes, Portugal; R. Barosa; M. Patita; A. Gomes; J. Botas; H. Coelho; J. Fonseca; C. Fonseca CC105 RAPID-ONSET AND RECURRENT HEPATIC ENCEPHALOPATHY AFTER SPLENECTOMY: A CASE REPORT Linjie Guo, China CC106 A RARE CAUSE OF ACUTE-ON-CHRONIC LIVER FAILURE IN A PATIENT WITH SECONDARY BUDD-CHIARI SYNDROME DUE TO HEPATOCELLULAR CARCINOMA Oana Farcau, Romania; A.-M. Fit; F. Andreea; I. Rusu; P. Fischer; L. Dina; H. Stefanescu; M. Tantau; B. D. Procopet CC107 A CASE REPORT WITH (HEPATIC?) ENCEPHALOPATHY Francesca Ponziani, Italy; C. Mosoni; G. Addolorato; A. Gasbarrini; G. Gasbarrini CC108 A CHALLENGING AND UNCOMMON DIAGNOSIS OF LONG-EVOLUTION ASCITES Marta Gravito-Soares, Portugal; E. Soares; J. Pina-Cabral; J. Almeida; E. Fraga; L. Tomé CC109 A RARE CAUSE OF HIGH INTESTINAL OBSTRUCTION E.-C. Salloum-Cojocariu; M. Chiorascu; L. Stirbu; V. Fotea; Irina Girleanu, Romania
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Wednesday, November 1, 2017
Poster Sessions : UEG Week Final Programme
CC110 ACUTE HEPATITIS CAUSED BY GENOTYPE 4 HCV PRESENTED WITH A PICTURE OF THROMBOTIC THROMBOCYTOPENIC PURPURA Ahmed Kamal, Egypt CC111 DIRECT ACTING ANTIVIRALS INDUCED GRAFT INJURY AFTER LIVER TRANSPLANT Iva Košuta, Croatia; A. Skrtic; S. Gasparov; A. Mrzljak CC112 LIVER ABSCESS CAUSED BY A FISHBONE Flávio Pereira, Portugal; D. Oliveira; N. Devesa; P. Casanova
Surgery / Endoscopy / Imaging CC120 EXTRAHEPATIC BILIARY CYSTADENOMA PRESENTING WITH ASCENDING CHOLANGITIS AND OBSTRUCTIVE JAUNDICE: A CASE REPORT. Tanawat Pattarapuntakul, Thailand; B. – Ovartlanporn CC121 AGENESIS OF THE MAJOR DUODENAL PAPILLA? João Pinto, Spain; C. Saldaña Dueñas; C. Leitão; E. Albéniz Arbizu; J. J. Vila Lower GI
CC114 HIGH DIGESTIVE OBSTRUCTION SECONDARY TO BOUVERET'S SYNDROME. J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain CC115 SUCCESSFUL CLOSURE OF CHOLECYSTO-COLONIC FISTULA USING A ENDOSCOPIC DETACHABLE SNARE LIGATION Ji Hye Kim, Republic of Korea; C. S. Shim CC116 UNUSUAL FOREIGN BODY IN THE COMMON BILE DUCT Yakhlef Aissat, Algeria; H. Mahiou; M. Nakmouche; H. Saoula; A. F. Boutaleb; Y. Zmiri; R. Osmane; M. Aissaoui; A. Mitiche; N. Hamidouche; D. Nacima CC117 A CASE OF OBSTRUCTIVE JAUNDICE SECONDARY TO HEPATIC HILAR LYMPHADENITIS CAUSED BY INVASIVE TRICHOSPORONOSIS C. Tang; Linhao Zhang, China; Y. Tai; H. Tong CC118 CHOLECYSTOGASTRIC FISTULA MASQUERADING AS MALIGNANT GASTRIC OUTLET OBSTRUCTION Sajan Nagpal, USA; A. M. Egan; M. Halland CC119 SPLENIC ARTERY PSEUDOANEURYSM AS A COMPLICATION OF PANCREATIC PSEUDOCYSTS Patrícia Santos, Portugal; D. Reis; J. Martins; P. Moura dos Santos; F. Serejo; J. Velosa
CC122 SUCCESSFUL TREATMENT OF REFRACTORY INTESTINAL ULCER IN PATIENTS WITH MYELODYSPLASTIC SYNDROME. Shinichiro Henmi, Japan; Y. Osaki; T. Maruo CC123 ANTI-TNFα ANTIBODY THERAPY IS EFFECTIVE FOR EOSINOPHILIC GASTRITIS ASSOCIATED WITH ULCERATIVE COLITIS. Masao Yoshioka, Japan; M. Ito; M. Kaneto; S. Yabe; S. Saito; M. Fujii; S. Ishiyama; A. Fujiwara; J. Nasu; J. Shiode CC124 MANAGEMENT OF CROHN'S DISEASE IN YOUNG PATIENT WITH SEVERE MALNUTRITION Veronika Shcherbakha, Russian Federation; O. Okhlobystina; A. Stepanov; P. Pavlov; O. S. Shifrin; V. T. Ivashkin CC125 CROHN'S DISEASE: A CLINICAL MANIFESTATION OF COMMON VARIABLE IMMUNODEFICIENCY Cátia Arieira, Portugal; F. Dias de Castro; M. J. Moreira; J. Cotter CC126 A RARE CAUSE OF CHRONIC BLOODY DIARRHOEA Luís Maia, Portugal; Â. Rodrigues; T. Moreira; M. Loforte; M. França; R. Maia; M. Rocha; I. Pedroto CC127 LOWER GASTROINTESTINAL BLEED: LIVER RAMS INTO GUT !!! Amit Soni, India; N. S. Malhi CC128 HEMATEMESIS AND HEMATOCHEZIA IN A YOUNG MAN: A SURPRISING CAUSE Xinyi Liu, China; Y. Zhang; J. Gao; G. Zhang; Z. Wang; Y. Liu CC129 INFECTIOUS CAUSE OF ISCHEMIC COLITIS: TAKING OF AMPHETAMINES IN YOUNG PATIENT. J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
257
Wednesday, November 1, 2017
CC113 SECONDARY HEPATIC METASTASIS TO CARCINOMA OF ECRINAL GLANDS IN A UMBILICAL HERNIA. J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain
UEG Week Final Programme : Poster Sessions
Wednesday, November 1, 2017
CC130 A RARE ASSOCIATION OF TWO DISEASES Sonia Bernardo, Portugal; M. Moura; A. R. Gonçalves; E. Sousa; L. Correia; J. Velosa Upper GI
CC137 GASTRIC KAPOSI SARCOMA AFTER RENAL TRANSPLANTATION: SIROLIMUS INDUCED REMISSION Sara Santos, Portugal; C. Bernardes; R. V. Loureiro; V. P. Borges; P. Russo; D. Carvalho; J. Saiote; F. Remédio; M. Mendes
CC131 ADENOCARCINOMA ARISING FROM A GASTRIC DUPLICATION CYST Brian Chan, Canada; F. Tse
CC138 ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE: AN UNCOMMON DIAGNOSIS Rui Gaspar, Portugal; A. C. Nunes; G. Macedo
CC132 GANGLIOCYTIC PARAGANGLIOMA OF THE DUODENAL BULB: AN UNCOMMON LOCALIZATION. S. Rizza; P. Cortegoso Valdivia; L. Venezia; Claudio Giovanni De Angelis, Italy
CC139 GASTRIC MYELOID SARCOMA Pedro Marcos, Portugal; C. Atalaia-Martins; S. Barbeiro; L. Eliseu; I. Cotrim; F. Silva; C. Amado; M. F. Cunha; A. Fernandes; A. Santos; C. Gonçalves; H. Vasconcelos
CC133 A CASE OF BRUNNER GLAND ADENOMA, WHICH EXHIBITED DRAMATIC MACROSCOPIC METAMORPHOSIS WITHOUT CANCERATION Kenji Sasaki, Japan; N. Takano; N. Iwama; T. Masuda CC134 SMALL LYMPHOCYTIC LYMPHOMA CAUSING GASTTRIC OUTLET OBSTRUCTION – CHALLENGES IN DIAGNOSIS AND MANAGEMENT Pedro Marques Da Costa, Portugal; C. Ferreira; I. Távora; H. Cortez-Pinto; J. Velosa CC135 A RARE CAUSE OF GASTRIC METASTASIS Carolina Simões, Portugal; J. Monteiro; L. Carrilho Ribeiro; J. Velosa CC136 A CASE OF GASTRIC CYSTIC PROFUNDA ACCOMPANIED BY EARLY GASTRIC CANCER AND SYNCHRONOUS MULTIPLE GASTRIC NEUROENDOCRINE TUMOURS Hangbin Jin, China; J. Yang; W. Gu; X. Zhang
CC140 GLOMIC TUMOR OF THE STOMACH – A CASE REPORT Rafaela Loureiro, Portugal; S. Santos; C. Bernardes; V. Pavão Borges; M. Oliveira; D. F. B. Carvalho; J. S. Fonseca; G. Ramos; A. M. Carvalho CC141 CIRCUMFERENTIAL PYLORUS MUCOSECTOMY BY ENDOSCOPIC SUBMUCOSAL DISSECTION FOR TREATMENT OF GASTRIC ADENOCARCINOMA Liliana Carvalho, Portugal; J. Rodrigues; I. Carina; P. Barreiro; C. Chagas CC142 EARLY GASTRIC CANCER WITH GOOD RESPONSE AFTER RECTAL CANCER CHEMOTHERAPY E. Q. Mendonça; Caterina Pennacchi, Brazil; J. F. de Oliveira; A. V. Safatle-Ribeiro; B. D. C. Martins; C. C. Gusmon; E. R. Baba; F. Kawaguti; L. H. Lenz Tolentino; G. de Paulo; M. Sorbello; R. S. Uemura; S. Geiger; M. Simas de Lima; U. Ribeiro Jr.; F. Maluf-Filho
Wednesday, November 1, 2017 258
Poster in the Spotlight
Poster of Excellence
Clinical Case Session
Young Talent Group
Participation in other UEG Committees
Job Corner Online Library
Postgraduate Teaching at UEG Week Classroom Courses
Networking Events
Standards & Guidelines
Online Courses
Networking & Exchange
Education
How can we support your career?
Research Prize
Young GI Lounge at UEG Week
Travel Grants for UEG Week
Grants
International Scholarship Award
Research & Science
Abstract based Awards
Mentoring
Mentoring Programme
Guided Poster Tours
Visiting Fellowship Programme
Find out more, visit www.ueg.eu
Rising Star Award
Recognition
Your work presented in the spotlight
Journal Best Paper Award
Poster Prizes
Get ready for practice in Hall 8.0
Sat – Tue 9:00 – 18:00 Wed 9:00 – 14:00
Ultrasound Learning Area → Meet with ultrasonography experts → Take part in a 2-day basic and advanced course of ultrasonography with real-time video clips
ESGE Learning Area ESGE hands-on training in cooperation with ESGENA Take the opportunity to hone your endoscopy skills – check the programme for session details
ESGE Lecture Theatre
Surgical Learning Area Surgical hands-on training and educational modeling in GI Surgery in sync with associated disciplines
www.ueg.eu/week/programme/hands-on
Meet and learn from leading experts
ESGE eLibrary Learning Centre View latest ESGE releases
ESGE Learning Area For all delegates of UEG Week whose focus is on endoscopy the ESGE Learning Area is without a doubt the first and best place to meet and mingle. Again this year, accomplished doctors and nurses will volunteer their time and expertise to support the ESGE mission: To promote good endoscopy, to show the basics as well as the latest developments, to support training and to offer small-group teaching activities to everyone with a real interest in the how and why of current endoscopy. The ESGE Learning Area provides a unique and ideal platform for live encounter and interaction among aspiring endoscopists and renowned experts in the field. Please come and be a part of it!
UEG Week Final Programme : ESGE Learning Area
ESGE Learning Area Hall 8.0
Hands-on Training Centre Test your skills and experience the latest technology. The 90-minute training sessions in the Hands-on Theatre offer unique access to state-of-the-art endoscopic equipment and accessories. Participants will have the opportunity to look, learn, ask questions and perform techniques themselves under personal doctor and nurse tutoring. In cooperation with ESGENA, the aim of this activity is to increase the awareness of diagnostic and therapeutic techniques and to offer delegates the possibility of checking their skills. Basic and advanced training is offered. The paediatric stations on Monday are limited to doctors working in child medicine. Registration There is limited availability of tickets for the training sessions from Saturday to Monday. Please go to the ESGE desk in the Learning Area and secure your ticket (starting on Saturday at 9:00). Participation will be on a first-come, first-served basis. To maintain a high standard of teaching each workstation is limited to a maximum of eight participants. Endoscopic training on GI simulators is available on a walk-in basis throughout UEG Week as are the handson sessions on Tuesday and Wednesday.
Saturday, October 28, 2017 • EMR • Hemostasis (injection, clipping, varices ligation) • Polypectomy/colonoscopy • ERCP Session 1 14:00 – 15:30 Session 2 16:00 – 17:30 Sunday, October 29, 2017 • EMR • Hemostasis (injection, clipping, varices ligation) • Polypectomy/colonoscopy • ERCP Session 1 11:00 – 12:30 Session 2 14:00 – 15:30 Session 3 16:00 – 17:30 Monday, October 30, 2017 • EMR • Hemostasis (injection, clipping, varices ligation) • Polypectomy/colonoscopy • ERCP • FNA – fine needle aspiration • EUS – endoscopic ultrasound • Paediatric endoscopy – (Dilation, PEG, Bleeding) Session 1 10:30 – 12:00 Session 2 12:30 – 14:00 Session 3 14:30 – 16:00
262
ESGE Learning Area : UEG Week Final Programme
Tuesday, October 31, 2017 No registration required 09:30 – 11:00 • Colonoscopy – the basics • Modern clip (OTSC) treatment for bleeding, fistulae and perforations • Barrx RFA procedure for the treatment of dysplastic Barrett’s oesophagus • Hemostatic Technology 11:30 – 13:00 • Stone Management: See the difference using cholangioscopy in the treatment of stone disease • Therapy in the colon • Therapy in the oesophagus • ESD, Advanced Therapeutic Techniques 14:00 – 15:30 • Hemostatic Technology • EUS anatomy and diagnostics • Modern clip (OTSC) treatment for bleeding, fistulae and perforations 16:00 – 17:30 • The emerging role of EUS FNB vs FNA – disease states and procedural advances • Therapy in the colon • Therapy in the oesophagus • Barrx RFA procedure for the treatment of dysplastic Barrett’s oesophagus • ESD, Advanced Therapeutic Techniques
ESGE E-learning Stations The ESGE E-learning Stations offer UEG Week delegates the opportunity to view the latest training material on video screens with headphone sound transmission. The ESGE teaching units presented at the Learning Area are otherwise only available to ESGE members via the ESGE website. If you are not already a member of ESGE, this is your chance to catch a glimpse of one of the many benefits ESGE provides when you join. The ESGE teaching units are complemented by selected video submissions from ASGE and JGES. Any time you are in the Learning Area take a seat, grab a headphone and tune in to the topic of your interest. ESGE Lecture Theatre In the ESGE Lecture Theatre highly qualified and wellknown endoscopists have been invited to present their views and experience with current endoscopic procedures and techniques. Their counterparts in discussion are equally well known, in several cases more senior specialists whose role it is to moderate the talk and perhaps critically question the case at hand. The number of participants is limited to 70 in order to ensure a small-forum atmosphere where active participation is possible. Special highlights in the Lecture Theatre include a mini symposium entitled ‘How do I ensure the quality of my endoscopy?’ and an introduction of different research projects that are currently being conducted by ESGE.
Wednesday, November 1, 2017 No registration required Sunday, October 29, 2017 09:30 – 11:00 • Hot Axios: Practice placing a LAMS in a simulated pseudocyst • Therapy in the colon • Therapy in the oesophagus • Barrx RFA procedure for the treatment of dysplastic Barrett’s oesophagus 11:30 – 13:00 • Modern clip (OTSC) treatment for bleeding, fistulae and perforations • FNA – fine need aspiration • Hemostatic Technology
10:30 – 11:00 When do I do ERCP in acute pancreatitis? G. Paspatis, Greece T. Marek, Poland 12:30 – 13:00 How do I treat a recurrent polyp in the colon? L. Fuccio, Italy H. Messmann, Germany 14:00 – 14:30 What POEM do I do and why: anterior or posterior? J. Martinek, Czech Republic T. Rösch, Germany 16:30 – 17:00 When and how do I treat early esophageal or gastric neoplasia with endoscopy M. Pioche, France M. Dinis-Ribeiro, Portugal 263
UEG Week Final Programme : ESGE Learning Area
Monday, October 30, 2017 10:30 – 11:00 How do I treat pancreatic cysts and tumors with EUS? O. Mosteanu, Romania E. Santo, Israel 12:30 – 14:00 ESGE GENERAL ASSEMBLY 15:00 – 17:00 Mini Symposium: How do I ensure quality in my endoscopy? Performance measures for upper GI endoscopy Performance measures for lower GI endoscopy Performance measures for ERCP and EUS Performance measures for small bowel and endoscopy M. Rutter, United Kingdom R. Bisshops, Belgium M. Kaminski, Poland D. Domagk, Germany C. Spada, Italy R. Valori, United Kingdom
15:00 – 15:30 How do I do surveillance endoscopy in IBD patients? Z. Zelinkova, Slovakia E. Despott, United Kingdom 16:00 – 18:00 Opportunities for research in GI endoscopy Funding opportunities for GI endoscopy in H2010 Grey areas for research in GI endoscopy Upper GI Working Group research proposals Lower GI Working Group research proposals Small Bowel Working Group research proposals ERCP-EUS Working Group research proposals J. Riese, Spain L. Fuccio, Italy O. Pech, Germany R. Jover, Spain A. Koulaouzidis, United Kingdom P.A. Testoni, Italy
Tuesday, October 31, 2017
Wednesday, November 1, 2017
10:00 – 10:30 What endoscopy can I offer to my overweight patients? M. Ibrahim, Belgium P. Eisendrath, Belgium 14:00 – 14:30 How do I manage biliary cancer by endoscopy? I. Hritz, Hungary S. Lakhtakia, India
10:30 – 11:00 How do I find and treat serrated polyps? M. Pellise, Spain J. Regula, Poland 11:30 – 12:00 How do I detect dyspasia in Barrett's oesophagus? J. de Groof, The Netherlands A. Meining, Germany
ESGE Learning Area 2016
264
ULA
Ultrasound Learning Area The Ultrasound Learning Area promotes the role of a major diagnostic and interventional tool in gastroenterology: Clinical ultrasonography in the hands of the gastroenterologist. The Ultrasound Learning Area offers individual hands-on training, a basic and an advanced course on ultrasonography for the gastroenterologist, which are designed for both, the beginner and the experienced and lectures in abdominal ultrasonography in the topics Interventional US (INVUS), Elastography and Contrast Enhanced US (CEUS) presented by expert gastroenterologists. Course directors Dieter Nuernberg, Neuruppin, Germany Odd Helge Gilja, Bergen, Norway Ioan Sporea, Timisoara, Romania
Faculty members Klaus Dirks, Winnenden, Germany Gabriele Hanenberg, Düren, Germany Christian Jenssen, Strausberg-Wriezen, Germany Horst Kinkel, Düren, Germany Giovanni Maconi, Milano, Italy Thomas Mueller, Reutlingen, Germany Kim Nylund, Bergen, Norway Alina Popescu,Timisoara, Romania Adrian Saftoiu, Craiova, Romania Zeno Sparchez, Cluij, Romania Stefan Uebel, Hitachi Co., Germany Jonas Valentinas, Vilnius, Lithuania Rune Wilkens, Copenhagen, Denmark
UEG Week Final Programme : Ultrasound Learning Area
Ultrasound Learning Area Room B1 in Hall 8.0
Programme Overview
Ultrasonography for the Gastroenterologist
09:00 10:00
Saturday October 28, 2017
Sunday October 29, 2017
Monday October 30, 2017
Tuesday October 31, 2017
Wednesday November 1, 2017
PART I 09:00 – 16:00 Basic Course
PART II 09:00 – 16:00 Advanced Course
Hands-on Training C 09:00 – 11:30
Hands-on Training E 09:00 – 11:30
PART V 09:00 – 11:00 Morning Session CEUS
PART III 11:30 – 14:00 Noon Lectures INVUS
PART IV 11:30 – 14:00 Noon Lectures Elastography
Hands-on Training D 14:30 – 18:00
Hands-on Training F 14:30 – 18:00
11:00 12:00 13:00
Hands-on Training G 11:00 – 14:00
14:00 15:00 16:00
Hands-on Training A 16:00 – 18:00
Hands-on Training B 16:00 – 18:00
17:00
Saturday, October 28, 2017
Moderation:
Basic Course Part I 09:00 – 16:00
11:00 – 11:15 Examination of liver I. Sporea 11:15 – 11:30 Examination of gall bladder and bile duct H. Kinkel 11:30 – 12:30 Hands-on Training: Focus liver and biliary system Faculty 12:30 – 12:45 Physics and technique – setting up the machine and small introduction to technical details S. Uebel 12:45 – 13:00 Examination of pancreas J. Valentinas 13:00 – 14:00 Lunch Break
Basics and introduction in abdominal ultrasound examinations Moderation: I. Sporea, T. Mueller 09:00 – 09:10 Introduction and aims of the course I. Sporea 09:10 – 09:25 The view in the body – examination technique and Sonoanatomy A. Popescu 09:25 – 09:40 Abdominal vessels – landmarks T. Mueller 09:40 – 10:30 Hands-on Training: Focus abdominal vessels Faculty 10.30 – 11:00 Coffee Break 266
A. Popescu, H. Kinkel
Ultrasound Learning Area : UEG Week Final Programme
Moderation:
A. Popescu, K. Nylund
14:00 – 14:15 Examination of (abdominal) lymph nodes R. Wilkens 14:15 – 15:00 Hands-on Training: Focus pancreas and retroperitoneum Faculty 15:00 – 15:15 Where to check for free fluid and gas? A. Popescu 15:15 – 15:30 First look at stomach and bowel – typical positions K. Nylund 15:30 – 15:55 Live demonstration and QUIZZ G. Hanenberg, H. Kinkel, A. Popescu 15:55 – 16:00 Closing remarks for the first day A. Popescu, I. Sporea
Hands-on Training A 16:00 – 18:00
Ultrasonography for the gastroenterologist Sunday, October 29, 2017
Advanced Course Part II 09:00 – 16:00
Pathology and special topics in abdominal ultrasound examinations Moderation: D. Nuernberg, I. Sporea 09:00 – 09:05 Introduction and aims of the course D. Nuernberg 09:05 – 09:20 Gall bladder pathology: Stones and tumours K. Dirks 09:20 – 09:35 Pancreas pathology – focal lesions C. Jenssen 09:35 – 09:50 Liver pathology: Diffuse changes I. Sporea 09:50 – 10:30 Hands-on Training: Bile duct, liver and portal system Faculty 10:30 – 11:00 Coffee Break Moderation:
C. Jenssen, T. Mueller
11:00 – 11:10 Better examination (tips and tricks) – live demonstration D. Nuernberg 11:10 – 11:25 Focal liver lesions H. Kinkel 11:25 – 11:40 Pathology of abdominal vessels T. Mueller
11:40 – 12:25 Hands-on Training: Liver segments, abdominal vessels Faculty 12:25 – 12:45 Pathology of gastrointestinal tract R. Wilkens 12:45 – 13:00 Better examination (tips and tricks) – live demonstration – how to find the appendix? G. Maconi 13:00 – 14:00 Lunch Break Moderation:
O. H. Gilja, D. Nuernberg
14:00 – 14:15 Bile duct pathology: Causes of obstruction Z. Sparchez 14:15 – 14:30 Pancreas pathology – inflammatory changes O. H. Gilja 14:30 – 15:15 Hands-on Training: Focus pancreas and bowel Faculty 15:15 – 15:30 Other abdominal and retroperitoneal pathology interesting for gastroenterologists D. Nuernberg 15:30 – 15:55 Interesting cases – (video demonstration) Faculty 15:55 – 16:00 Closing remarks, certificates O. H. Gilja, D. Nuernberg
Hands-on Training B 16:00 – 18:00
Ultrasonography for the gastroenterologist Monday, October 30, 2017
Hands-on Training C 09:00 – 11:30
Ultrasonography for the gastroenterologist
PART III 11:30 – 14:00
Ultrasound Learning Area – noon lectures: Interventional ultrasound in gastroenterology Moderation: D. Nuernberg, T. Mueller 11:30 – 12:00 INVUS guidelines – special points C. Jenssen 12:00 – 12:30 Update Hygiene regime – recommendations of DEGUM T. Mueller 267
UEG Week Final Programme : Ultrasound Learning Area
12:30 – 13:00 Drainage of liquid collections Z. Sparchez 13:00 – 13:30 Biliary interventions D. Nuernberg 13:30 – 14:00 EUS interventions A. Saftoiu
Hands-on Training D 14:30 – 18:00
Ultrasonography for the gastroenterologist Tuesday, October 31, 2017
Hands-on Training E 09:00 – 11:30
Ultrasonography for the gastroenterologist
PART IV 11:30 – 14:00
Ultrasound Learning Area – noon lectures: Ultrasonography and elastography in gastroenterology Moderation: I. Sporea, A. Saftoiu
Hands-on Training F 14:30 – 18:00
Ultrasonography for the gastroenterologist Wednesday, November 1, 2017
PART V 09:00 – 11:00
Ultrasound Learning Area – morning session: Contrast enhanced ultrasound (CEUS) in gastroenterology Moderation: H. Kinkel, D. Nuernberg 09:00 – 09:30 What is CEUS? How does it work? H. Kinkel 09:30 – 10:00 CEUS for benign lesions D. Nuernberg 10:00 – 10:30 CEUS for malign lesions I. Sporea 10:30 – 11:00 CEUS and interventions (abscess drainage) in IBD G. Maconi 11:00 – 11:300 EUS and CEUS C. Jenssen
11:30 – 12:00 Classification of elastographic methods and actual Guidelines T. Mueller 12:00 – 12:30 Transient Elastography (TE) for the liver A. Popescu 12:30 – 13:00 Point Shear Wave Elasticity (SWE) and 2D SWE of the liver I. Sporea 13:00 – 13:30 Elastography in CED K. Nylund 13:30 – 14:00 Others applications of elastography in gastroenterology A. Saftoiu
Hands-on Training G 11:00 – 14:00
Organised and supported by EFSUMB and ISCUS
Supported by Hitachi Co., GE Co. and Bracco
268
Ultrasonography for the gastroenterologist
Surgical Learning Area Building on last year’s success, the UEG Surgical block welcomes delegates to this second offering in hands-on training and educational modeling for surgeons in GI Surgery and associated disciplines. There will be 3 courses on offer to experience live hands-on training and demonstrations involving both simulation and anatomical models. Colorectal Laparoscopic skills (LSS Grade 2), Trans Anal Microsurgery and Introduction into basic Laparoscopic skills. (Conditions apply) In addition, there will be the general education area with activities such as case based discussions, meet the expert and video sessions. The purpose of the area is to broaden the awareness within the GI community for the surgical perspective within GI Care and vice versa and attract attendees to gain a broader insight in surgical education and hands on training procedures.
Faculty members M. Adham, France A. Arezzo, Italy J. Izbicki, Germany J. Jakimowicz, The Netherlands I. Jenkins, United Kingdom M. Morino, Italy M. van Berge Henegouwen, The Netherlands Y. Vashist, Switzerland P. Ignatavicius, Lithuania O. Aziz, United Kingdom C. Thorn, United Kingdom
UEG Week Final Programme : Surgical Learning Area
Surgical Learning Area Hall 8.0 Saturday, October 28, 2017
Sunday, October 29, 2017
Information desk | Simulation demonstrations | Running videos 09:00 – 12:00 General Area Course One: Laparoscopic surgical skills grade 2 colorectal surgery hands-on course 09:15 – 17:30 Room E6 Programme 09:15 Welcome, introduction & course outline 09:30 Baseline evaluation, suturing, knot tying assessment and peer assessment 11:00 Expert session: interactive clinical based discussion: Safe use of tissue energisers Safe use of tissue approximation and stapling 13:30 Expert session: interactive clinical based discussion: Set-up for left hemicolectomy Step by step left hemicolectomy Critical steps in left hemicolectomy 14:00 Practical: bowel anastomosis Suturing anastomosis – side to side and end to end 16:30 Expert session: interactive discussions on case scenarios and video clips of left hemicolectomy 17:00 Closure of day
Simulation demonstrations | Running videos 09:00 – 12:30 General Area Basic laparoscopic skills course: Part I 09:00 – 12:00
General Area
09:00 – 09:30 Introductory lecture 09:30 – 11:30 Practical skills training 11:30 – 12:00 Practical skills assessment TEO/TEM Theory and Discussion 09:00 – 11:00
Room E5
09:00 Anatomical hints for transrectal excision (Arolfo) 09:10 Indications and Results for local excision of rectal lesions (Morino) 09:30 The instrumentation: Evolution, present standard, future development (Allaix) 09:40 The technique: Tips and tricks (Arezzo) 09:50 General or spinal anesthesia? (Morino) TEO/TEM hands-on instruction Hands-on 6 stations, 30 min per candidate 11:00 – 12:00 Room E5
S imulation demonstrations | Running videos 14:00 – 18:00 General Area
Course One: Laparoscopic surgical skills grade 2 colorectal surgery hands-on course 09:00 – 17:00 Room E6
Basic laparoscopic skills course 14:00 – 17:00
Programme 09:00 Introduction & course outline day 2 09:30 Expert session: interactive clinical based discussion: Set-up and steps of right hemicolectomy Step by step right hemicolectomy Critical steps in right hemicolectomy 11:00 Expert session: interactive clinical based discussion on right hemicolectomy: Case scenarios 11:30 Laparoscopic bowel suturing and assessment, peer assessment and self assessment session 1
14:00 – 14:30 14:30 – 16:00 16:30 – 17:00
General Area
Introductory lecture Practical skills training Practical skills assessment
General Information for Saturday and Sunday | Coffee Breaks: 10:30 – 11:00 and 15:30 – 16:00 | Lunch Break: 13:00 – 14:00
270
Surgical Learning Area : UEG Week Final Programme
Monday, October 30, 2017 13:30 Testing session: Complications in colon surgery: case scenarios: tips & tricks of trouble shouting 15:30 Laparoscopic bowel suturing assessment, peer assessment and self assessment session 2 16:30 Closure of day 2
Simulation demonstrations | Running videos 09:00 – 12:30 General Area Basic laparoscopic surgical skills: Part I 09:00 – 12:00 General Area
S imulation demonstrations | Running videos 14:00 – 18:00 General Area
09:00 – 09:30 Introductory lecture 09:30 – 11:30 Practical skills training 11:30 – 12:00 Practical skills assessment
Basic laparoscopic skills course: Part II 14:00 – 17:00 General Area
TEO/TEM Theory and discussion 09:00 – 11:00
14:00 – 14:30 14:30 – 16:00 16:30 – 17:00
09:00 Anatomical hints for transrectal excision (Arolfo) 09:10 Indications and Results for local excision of rectal lesions (Morino) 09:30 The instrumentation: Evolution, present standard, future development (Allaix) 09:40 The technique: Tips and tricks (Arezzo) 09:50 General or spinal anesthesia? (Morino)
Introductory lecture Practical skills training Practical skills assessment
TEO/TEM hands-on instruction Hands-on 6 stations, 30 min per candidate 14:00 – 18:00 Room E5
Room E5
TEO/TEM hands-on instruction Hands-on 6 stations, 30 min per candidate 11:00 – 12:00 Room E5
General Information for Monday | Coffee Breaks: 10:00 – 10:30 and 15:30 – 15:45 | Lunch Break: 12:00 – 14:00
271
UEG Week Final Programme : Surgical Learning Area
Surgical Learning Area Hall 8.0 Monday, October 30, 2017
Tuesday, October 31, 2017
Course Two: Laparoscopic surgical skills grade 2 colorectal surgery hands-on course 09:15 – 17:30 Room E6
Simulation demonstrations | Running videos 09:00 – 12:00 General Area
Programme 09:15 Welcome, introduction & course outline 09:30 Baseline evaluation, suturing, knot tying assessment and peer assessment 11:00 Expert session: interactive clinical based discussion: Safe use of tissue energisers Safe use of tissue approximation and stapling 13:30 Expert session: interactive clinical based discussion: Set-up for left hemicolectomy Step by step left hemicolectomy Critical steps in left hemicolectomy 14:00 Practical: bowel anastomosis Suturing anastomosis – side to side and end to end 16:30 Expert session: interactive discussions on case scenarios and video clips of left hemicolectomy 17:00 Closure of day
Basic laparoscopic skills course: Part I 09:00 – 12:00
Simulation demonstrations | Running videos 14:00 – 18:00 General Area Basic laparoscopic skills course: Part II 14:00 – 17:00 General Area 14:00 – 14:30 14:30 – 16:00 16:30 – 17:00
Introductory lecture Practical skills training Practical skills assessment
TEO/TEM hands-on instruction Hands-on 6 stations, 30 min per candidate 14:00 – 18:00 Room E5
09:00 – 09:30 Introductory lecture 09:30 – 11:30 Practical skills training 11:30 – 12:00 Practical skills assessment TEO/TEM hands-on instruction Hands-on 6 stations, 30 min per candidate 11:00 – 12:00 Room E5 Course Two: Laparoscopic surgical skills grade 2 colorectal surgery hands-on course 09:00 – 17:00 Room E6 Programme 09:00 Introduction & course outline day 2 09:30 Expert session: interactive clinical based discussion: Set-up and steps of right hemicolectomy Step by step right hemicolectomy Critical steps in right hemicolectomy 11:00 Expert session: interactive clinical based discussion on right hemicolectomy: Case scenarios 11:30 Laparoscopic bowel suturing and assessment, peer assessment and self assessment session 1 13:30 Testing session: Complications in colon surgery: case scenarios: tips & tricks of trouble shouting 15:30 Laparoscopic bowel suturing assessment, peer assessment and self assessment session 2 16:30 Closure of day 2
General Information for Monday and Tuesday | Coffee Breaks: 10:00 – 10:30 and 15:30 – 15:45 | Lunch Break: 12:00 – 14:00
272
General Area
Surgical Learning Area : UEG Week Final Programme
Wednesday, November 1, 2017 Simulation demonstrations | Running videos 14:00 – 18:00 General Area
Simulation demonstrations | Running videos 09:00 – 14:00 General Area
Basic laparoscopic skills course: Part II 14:00 – 17:00 General Area
Basic laparoscopic skills course 09:00 – 12:00
14:00 – 14:30 14:30 – 16:00 16:30 – 17:00
09:00 – 09:30 Introductory lecture 09:30 – 11:30 Practical skills training 11:30 – 12:00 Practical skills assessment
Introductory lecture Practical skills training Practical skills assessment
TEO/TEM hands-on instruction Hands-on 6 stations, 30 min per candidate 14:00 – 18:00 Room E5
General Area
TEO/TEM hands-on instruction Hands-on 6 stations, 30 min per candidate 09:00 – 14:00 Room E5 Course Two: Laparoscopic surgical skills grade 2 colorectal surgery hands-on course Detailed assessment, evaluation and discussion 09:00 – 14:00 Room E6
General Information for Tuesday | Coffee Breaks: 10:00 – 10:30 and 15:30 – 15:45 | Lunch Break: 12:00 – 14:00 General Information for Wednesday | Coffee Break: 10:00 – 10:30 | Lunch Break: 12:00 – 14:00
The Surgical Learning Area is run courtesy of:
And kindly supported by:
273
Classroom Courses Education from every angle
Young Investigators Meeting March 16–18, 2018 Vienna, Austria
Our classroom courses offer hands-on training in a range of medical specialities, with activities including case-based sessions, small-group discussions, workshops and lectures as well as networking events.
Basic Science Course June 27–29, 2018 Leuven, Belgium
Summer School May 24–27, 2018 Prague, Czech Republic
Evidence Based Medicine Course October 20–21, 2018 Vienna, Austria
Find out more, visit the UEG Booth in Hall 8.0 or www.ueg.eu/education
Evidence Based Medicine Course
UEG Week Final Programme : Evidence Based Medicine Course
Evidence Based Medicine Course Saturday and Sunday, October 28–29, 2017
Please note that this meeting takes place outside of the core scientific programme and attendance is by invitation only. This course, designed for junior and senior physicians alike, aims to teach Evidence Based Medicine (EBM) principles and how they can be applied in daily clinical work. The course combines interdisciplinary clinical cases with questions of diagnosis and therapy, and identifies opportunities to integrate EBM into clinical practice. Delegates will be guided by tutors and stimulated with short input lectures, they will work in break-out groups and discuss the results achieved. Faculty members Alexander Ford (Leeds, United Kingdom) Sanjiv Mahadeva (Kuala Lumpur, Malaysia) Leonardo Eusebi (Bologna, Italy) Gavin Johnson (London, United Kingdom) John Kane (Leeds, United Kingdom) Anne Lund Krarup (Aalborg, Denmark) Björn Lindkvist (Gothenburg, Sweden) Andre Mihaljevic (Heidelberg, Germany)
Programme Overview Module A Clinical questions: From clinical practice to answerable questions Exercises based on patient histories Module B Search literature databases: From the question to potentially relevant evidence Interactive lecture, hands-on exercise on the computer Module C Critical appraisal: From the papers to critically appraised new knowledge Small group work, interactive lectures Module D EBM transfer: From critically appraised new knowledge to changed practice & from learning to teaching EBM skills Small group work, theory input and video analysis
Apply for the upcoming Evidence Based Medicine Course, taking place at UEG Week Vienna 2018! Application deadline: July 13, 2018
The ʻUEG Evidence Based Medicine Courseʼ is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. The 'UEG Evidence Based Medicine Course' is designated for a maximum of 11 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. 276
21st ESGENA Conference Hosted by the Spanish Society of Endoscopy Nurses and Associates (AEEED) and the Spanish Society of Digestive Disease Nurses (AEEPD)
In Conjunction with the 25th United European Gastroenterology Week
Further information: www.esgena.org
UEG Week Final Programme : 21stESGENA Conference
21st ESGENA Conference Word of Welcome
Dear colleague, On behalf of ESGENA, the Spanish Society of Endoscopy Nurses and Associates (AEEED) and the Spanish Society of Digestive Disease Nurses (AEEPD) it is our great pleasure to welcome you to the 21st ESGENA Conference, which is being held during the 25th United European Gastroenterology Week, October 28–30, 2017, in Barcelona, Spain. Following past meetings in 2010 and 2015, this is the third time that the medical and nursing community of gastroenterology and endoscopy will meet in Barcelona. After celebrating its 20th anniversary in 2016, ESGENA will continue its established structures while also initiating new formats of interactive learning. Recent successes have already connected countries and have laid the foundation for new future projects. The three day ESGENA conference is not only an opportunity to meet colleagues from throughout Europe, but also from North and South America, Africa, Asia and Australia. The exchange with nurses from all over the world combined with the opportunity to attend the medical
278
programme of UEG Week ensures that the ESGENA conference will be an exceptional educational event. In 2017 the UEG celebrates its 25th anniversary in Barcelona, offering interesting and interactive learning formats which emphasise the multidisciplinary approach. Enjoy the warm Spanish hospitality of Barcelona, combined with the multicultural atmosphere of an international meeting. We welcome you to the 21st ESGENA Conference and 25th UEG Week in October 2017 in Barcelona. Jadranka Brljak President of ESGENA Enriqueta Hernández-Soto President of AEEED Guillermo José Garcia Sola President of AEEPD
21th ESGENA Conference : UEG Week Final Programme
Programme Overview
Saturday, October 28, 2017 Room B2
Room B3
Room E4
Room B5
ESGE Learning Area
Workshop 4 Actualización en reprocesamiento de Duodenoscopiosy control de calidad Duodenoscopereprocessing andquality control update Organised by AEEED & Olympus Spain
Workshop 5 Hands–on training on biosimulators: • Upper GI bleeding • ERCP • Colonoscopy
Workshop 10 Hands–on training on biosimulators • Upper GI bleeding • ERCP • Colonoscopy
09:00 – 10:30
Lecture Halls
13:00 – 14:00 Lunch Break
14:00 – 15:30
UEG Week Postgraduate Teaching Programme
Workshop 1 Stop the bleeding: What is the best device in which situation?
Workshop 2 Controlling the Procedure: The Nurses Role in ERCP and Infection Prevention
Workshop 3 Endoscope reprocessing: Trends, current standards, process innovations
Organised by Olympus Europa
Organised by Boston Scientific
Organised by BHT & Dr. Weigert
16:00 – 17:30
15:30 – 16:00 Coffee Break
17:30 – 19:00
09:00 – 16:00
11:00 – 13:00
10:30 – 11:00 Coffee Break
Workshop 6 Future endoscope reprocessing – A closer view into room concepts
Workshop 7 Actualización en hemostasia, técnicasmecánicas Update on hemostasis, mechanical techniques
Workshop 8 The Complete Circle of Protection
Workshop 9 Electrosurgery – Prevention of complication
Organised by Olympus
Organised by AEEED & Boston Scientific Spain
Organised by Cantel
Organised by Erbe
ESGENA Annual General Assembly
279
UEG Week Final Programme : 21st ESGENA Conference
Room B2
Room B3
09:00 – 10:30
Session 1 Free Paper I
Session 2 Liver transplantation
11:00 – 12:30
Sunday, October 29, 2017 Poster Area
Session 3 Free Paper II
10:30 – 11:00 Coffee Break
ESGE Learning Area
Poster Round I
Session 4 Education
Workshop 11 Hands-on training on bio simulators • Upper GI Bleeding • ERCP
12:30 – 15:00
Lunch Session 1 GE Endoscopy
Lunch Session 2 Hygiene and infection control
15:00 – 16:30
Session 5 Management
Session 6 Endoscopic techniques
17:00 – 18:00
13:00 – 14:00 Lunch Break
Session 7 Colo rectal cancer screening
Session 8 When unforeseen happens …
Poster Round II
Workshop 12 Hands-on training on bio simulators: • ERCP • Colonoscopy
16:30 – 17:00 Coffee Break
Monday, October 30, 2017 Room A2 08:30 – 10:00
Best Free Paper and Best Poster Award ESGENA Plenary Session: Controversial discussions in endoscopy Invitation to next conferences 10:00 – 10:30 Coffee Break
10:30 – 12:00
Visit of exhibition ESGE Learning Area UEG Week sessions 12:00 – 14:00 Lunch Break
14:00 – 15:30
Visit of exhibition ESGE Learning Area UEG Week sessions 15:30 – 15:45 Coffee Break
15:45 – 17:15
280
Visit of exhibition ESGE Learning Area UEG Week aessions
21th ESGENA Conference : UEG Week Final Programme
Scientific Programme Saturday, October 28, 2017
Workshop 1 14:00 – 15:30
Room B2
Stop the bleeding: What is the best device in which situation? This workshop is organised by OLYMPUS EUROPA SE & CO. KG Workshop language: English
Chairs:
Jens Niehaus, Germany Karina Yacoub, Germany
Aims & Content This workshop is all about hemostasis. You will learn about different endoscopic cases and their specific procedures. In addition, there will be tips and tricks useful for the nurse’s daily work. During this workshop, we will offer the opportunity to improve your skills of choosing and handling the right device to stop the bleeding. It includes a hands-on training within the broad range of the hemostasis-area under supervision and support of highly experienced tutors. After the theoretical part, an intensive hands-on will follow, where you may gain further knowledge and handling-skills about the following techniques in hemostasis: • Diathermy • Injection • Looping • Clipping Workshop 2 14:00 – 15:30
Room B3
Controlling the Procedure: The Nurses Role in ERCP and Infection Prevention This workshop is organised by Boston Scientific Workshop language: English
Chair:
Marc Ellrichmann, Germany
Aims & Content The goal of this workshop is to highlight the nurses role during an ERCP procedure from start to finish. You will learn about various tips and techniques for pre-procedure, during the procedure as well as post procedure to reduce risks to the patient.
This workshop will : • Highlight the importance of teamwork during an ERCP procedure while using single use devices • Provide an update on infection risks in endoscopy units and tips on how to provide quality control during cleaning and disinfection of reusable material • Offer hands-on experience with our RX biliary devices as well as our new infection prevention line of products Workshop 3 14:00 – 15:30
Room B3
Endoscope reprocessing: Trends, current standards, process innovations This workshop is organised by Chemische Werke Dr. Weigert and BHT Workshop language: English
Chairs:
Thomas Brümmer, Germany Stefan Stülpnagel, Germany
Aims & Content Part 1: Process chemistry: overview – trends – active substances – Cleaning & disinfection processes The individual steps for a safe reprocessing of endoscopes are defined by national and international recommendations. Different active substances and processes have been established for manual and automated reprocessing of endoscopes. This part of the workshop will answer the following questions: • What are the different active substances for manual and WD (washer disinfector) reprocessing? • How good is the cleaning performance of different active substances and how is it tested? • What impact do different process chemicals have on treatment processes? Presentations: Different active substances in the cleaning and disinfection of flexible endoscopes Markus Kamer, Germany Part 2: Process improvements in endoscope reprocessing: simpler – safer – faster – more cost-effective Automated reprocessing with WD (washer disinfectors) has become standard practice. This part of the workshop works out what has to be taken into account to make reprocessing procedures more hygienic – simpler, 281
UEG Week Final Programme : 21th ESGENA Conference
faster and cheaper. There are numerous innovations and process optimisations available: • Simpler: There are numerous approaches, which facilitate the process, e.g. documentation. • Safer: Technical solutions for enhanced safety in automated endoscope reprocessing. • Faster: Often endoscopists must wait for endoscopes. Find out how you can speed up the process incl. drying. • Low cost: The cost of reprocessing is high – especially concerning consumption of chemicals, consequential costs, damaged endoscopes and endoscope purchases. The workshop looks at possibilities to save costs Presentations: Process improvements in endoscope reprocessing: Simpler – safer – faster – more cost-effective Stefan Stülpnagel, Germany Workshop 4 14:00 – 15:30
• Reusable material and single us common in Endoscopy department • New generation scope reprocessing steps (duodenoscopes) Workshop 5 14:00 – 15:30
ESGE Learning Area
Hands-on training on bio simulators B5
Actualización en reproceso de duodenoscopios, material endoscópico y control de calidad / Update in duodenoscope reprocess, endoscopy material and quality control This workshop is organised by AEED and OLYMPUS EUROPA SE & CO. KG Workshop language: Spanish
Chairs: Montserrat Medina, Spain Silvia Carnicer, Spain Objetivo y Contenido / Aims & Content Actualización de conocimientos y desarrollo de las habilidades para fomentar las buenas prácticas en el reprocesamiento de materiales y equipos de las unidades de endoscopia digestiva. Conocer las mejoras en el reprocesamiento de los endoscopios y material reutilizable y los métodos de limpieza y esterilización disponibles. El contenido, actualización sobre riesgos de infección de las unidades de endoscopia digestiva. Limpieza y desinfección de material reutilizable y control de calidad. Workshops: • Material reutilizable y desechable usado en departamentos de endoscopia • Reprocesamiento de los nuevos endoscopios (duodenoscopios)
282
Knowledge update and Development of skills to promote good practices in the reprocessing of materials and equipment of digestive endoscopy units. To know the improvements in the reprocessing of endoscopes and reusable material and the available methods of cleaning and sterilization available The content, update on risks of infection of digestive endoscopy units. Cleaning and disinfection of reusable material and quality control. Workshops:
This workshop is organised by ESGENA Workshop language: English
Chairs: Eric Pflimlin, Switzerland Michael Ortmann, Switzerland Aims and Content Hands-on training on bio simulators (pig models) under the supervision of highly experienced tutors: Participants will have the opportunity to perform endoscopic techniques on the following topics: • OGD with Injection techniques, ligation, clipping, APC • Colonoscopy with polypectomy, EMR and APC • ERCP with stone extraction and stenting As participation will be limited, registration will be treated on a first-come, first-served basis: Tickets will be available onsite only – at the entrance of the ESGE Learning Area.
21th ESGENA Conference : UEG Week Final Programme
Workshop 6 16:00 – 17:30
Room B2
Future endoscope reprocessing – A closer view into room concepts This workshop is organised by OLYMPUS EUROPA SE & CO. KG Workshop language: English
Chairs: Holger, Biering, Germany Reinhard Blum, Germany Aims & Content During the last 15 years, reprocessing of flexible endoscopes has become an important and accepted discipline within the area of medical GI endoscopy. During that time, the workflow of endoscopes between patient examinations has become more and more standardised, automated endoscope reprocessing machines (WD) are state-of-the-art in almost every endoscopy unit. International and national guidelines have been updated or newly released, focusing on patient and user safety. In this context, guidelines often recommend to clearly separate contaminated from clean steps in the reprocessing workflow, optimally by creating separate zones or even rooms for reprocessing. This workshop will: • inform about relevant guidelines dealing with reprocessing room and workflow design • provide an overview of aspects to be considered for set-up of endoscope reprocessing rooms • give examples of latest endoscope reprocessing room designs • allow to practically experience how to set-up suitable reprocessing rooms based on real examples Workshop 7 16:00 – 17:30
Room B3
Actualización en hemostasia, técnicas mecánicas Update on hemostasis, mechanical techniques This workshop is organised by AEEED and Boston Scientific Workshop language: Spanish
Chairs: Alicia Sánchez Rubio, Spain Laura Moreno Salas, Spain Objetivo y Contenido / Aims & Content La hemostasia endoscópica, es seguras y eficaz, reduce la tasa de recidiva, la necesidad de la cirugía y la mortalidad en la HDA. En la HDB, la yatrogenia (principalmente la polipectomía) es una de las causas más frecuentes. Las técnicas mecánicas, sumadas a otro método de hemostasia endoscópica, contribuyen a potenciar la eficacia y seguridad del tratamiento de la hemorragia digestiva.
El Objetivo del taller es: • Actualizar las técnicas hemostásicas • Describir cómo aplicar las técnicas mecánicas de hemostasia y conocer diferentes dispositivos de hemostasia mecánica Endoscopic hemostasis, is safe and effective, reduces the recurrence rate, the need for surgery and mortality in upper GI Bleeding. In low digestive bleeding, iatrogenic (mainly Polypectomy) is one of the most frequent causes. Mechanical techniques, coupled with another method of endoscopic hemostasis, contribute to enhance the efficacy and safety of the treatment of digestive bleeding. The aim of the workshop is: • Update the hemostasis techniques • Describe how to apply the mechanical techniques of hemostasis and to know different devices of mechanical hemostasis. Workshop 8 16:00 – 17:30
Room E4
The ‘Complete Circle of Protection’ This workshop is organised by CANTEL Workshop language: English
Chair:
Cheri Ackert-Burr, The Netherlands
Aims & Content Delivering the ‘Complete Circle of Protection’, a full-value, proactive partnership dedicated to helping you remove risk, streamline operational efficiencies and optimize your success. This part of the workshop focuses on the 4 stages of an endoscopes journey and looks at how you can maximize efficiency and improve patient safety at each stage. • Procedure: Defendo, amplifeye and Endo Stratus – improving patient safety and outcomes • Manual clean: Scope Buddy – reducing the manual process and improving the process • Reprocessing: Pass-Through machines – improving process flow with CLEAN and DIRTY sides • Dry & store: Cleanascope carts & Endodry – protecting the scope and ensuring clear identification of clean & dirty
283
UEG Week Final Programme : 21th ESGENA Conference
Workshop 9 16:00 – 17:30
Room B5
Scientific Programme Sunday, October 29, 2017
Electrosurgery – Prevention of complication This workshop is organised by ERBE Elektromedizin GmbH Workshop language: English
Chairs: Thomas Beck, Germany Björn Fehrke, Switzerland
Session 1 09:00 – 10:30
Aims and Content Electrosurgery is a technology which is widely used during endoscopic procedures. It allows to cut and coagulate using electric current. A broad range of different modes, effects and settings is possible, depending on the planned procedure. With argon plasma coagulation (APC) tissue can be devitalized and bleedings can be treated. Elevation can be achieved with the use of a waterjet device.
Free Paper I Chairs: Irene Dunkley, United Kingdom Montse Victor, Spain Wendy Waagenes, Denmark Gerlinde Weilguny, Austria
Room B2
09:00 – 09:15 Welcome Jayne Tillett, United Kingdom
The aim of the workshop is: • To update on principles of electrosurgery • To get a deeper understanding of the use of electrosurgery and APC in endoscopic procedures • Practical demonstration of settings for different applications like Polypectomy, EMR, ESD, Papilloectomy, etc. • How to achieve maximum safety for the patient and how to prevent adverse events and complications
09:15 – 09:30 Nursing need theory potentially applied in gastrointestinal endoscopy setting Giulia Marika Futura Beorchia, Roberta Mattiola, Italy
Workshop 10 16:00 – 17:30
09:45 – 10:00 The quality of life of patients with inflammatory bowel diseases treated by biological therapy Marija Zubčić, Croatia
ESGE Learning Area
Hands-on training on bio simulators This workshop is organised by ESGENA Workshop language: English
Chair: Eric Pflimlin, Switzerland Michael Ortmann, Switzerland Aims and Content Hands-on training on bio simulators (pig models) under the supervision of highly experienced tutors: Participants will have the opportunity to perform endoscopic techniques on the following topics: • OGD with Injection techniques, ligation, clipping, APC • Colonoscopy with polypectomy, EMR and APC • ERCP with stone extraction and stenting As participation will be limited, registration will be treated on a first-come, first-served basis. Tickets will be available onsite only – at the entrance of the ESGE Learning Area.
284
09:30 – 09:45 A ‘Debriefing’ method to improve gastroenterology nursing practices Ruhama Podoler, Ian M. Gralnek, Israel
10:00 – 10:15 Straight to scope – should iron deficiency anaemia referrals go automatically to scope? Dominique McGinlay, Naismith G, United Kingdom 10:15 – 10:30 Review of the number of endoscope repairs and loans required after implementation of a new tip protection device Esther McBurney, United Kingdom
21th ESGENA Conference : UEG Week Final Programme
Session 2 09:00 – 10:30
Room B3
Liver transplantation Chairs: Jadranka Brljak, Croatia Eva Ramon Abal, Spain 09:00 – 09:10 Welcome Jadranka Brljak, Croatia 09:10 – 09:30 How to make liver transplantation a success? Jasna Brezak, Croatia 09:30 – 09:50 Acute care of patient after liver transplantation Anna Aliberch, Spain 09:50 – 10:10 Psychological aspects in the care of liver transplant patients Vlatka Rafaj, Croatia 10:10 – 10:30 Complications after liver transplantation – the endoscopic approach Jacques Deviere, Belgium Poster Round I 10:30 – 11:00 ESGENA Poster area in front of Room E4 Chairs: Joan Skovlund Christensen, Denmark Fanny Durand, France Minerva Galvez-Martin, Spain Jayne Tillett, United Kingdom Sedation P-1 The role of nurse conducted informed consent in digestive endoscopy. A case-control study Adriana-Sidela Leca, Valeria-Danuta Mihnea, Institute of Gastroenterology and Hepatology, Iasi, Romania P-2 Assessing the postal consent for upper gastroduodenal endoscopy Ama Badu, Natalia Cambon Bonet, Sarah Gibbings and Roxana Lupu, United Kingdom P-3 Conventional sedation with midazolam and sufentanil is safe and feasible for endoscopic treatment of walled-off pancreatic necrosis Sisse Rysgaard, Camilla Ramvold, Palle Nordblad Schmidt, Lise Lotte Gluud, Srdan Novovic, Denmark
P-4 Gastroenterology nurse administered dexmedetomidine for ESD. Chaya Baruchi, Galina Garberg, Dganit Daniel Avdar, Israel Session 3 11:00 – 12:30
Room B2
Free Paper II Chairs: Irene Dunkley, United Kingdom Montse Victor, Spain Wendy Waagenes, Denmark Gerlinde Weilguny, Austria 11:00 – 11:15 Awake! The effects of unsedated colonoscopy on adenoma detection rate Jane Magtoto, Jay Lardizabal, William Karnes USA 11:15 – 11:30 Gastrostomy tube tract length: Does it change with the child's growth? Rachel Leshem-Namedar, Yael Adler Batia Weiss, Israel 11:30 – 11:45 High incidence of minor adverse events after endoscopic mucosal resection or submucosal dissection for colorectal tumors Ye Lim Song, Kyung-Jo Kim, Jeong-Sik Byeon, Ji Hye Kim, Yeo Ok Kim, Dong-Hoon Yang, Sang Hyoung Park, Sung Wook Hwang, Eun Mi Song, South Korea 11:45 – 12:00 Endoluminal vacuum therapy in anastomotic leakages at rectal level. Pedro Luis Del Mazo Tomé, Alejandro Toledo Soriano, Cristina Viñuela Lobo, María Del Mar Gutiérrez García, Aida Longoria Argüelles, Spain 12:00 – 12:15 The role of endoscopy nurse in removal foreign bodies from the upper gastrointestinal tract in children Mirela Kubicz, Livia Dumitra, Valentina Vulpe, Cornelia Tudor 12:15 – 12:30 Digital, direct pancreatoscopy in chronic pancreatitis can change patient management – A case report Petra Holzky-Haselbach, Sandra Krüger, Alexander Arlt, H. Aselmann, T. Becker, Mark Ellrichmann, Germany
285
UEG Week Final Programme : 21th ESGENA Conference
Session 4 11:00 – 12:30
Room B3
Education – Different approaches in Europe Chairs: Helen Griffiths, United Kingdom Marjon de Pater, The Netherlands 11:00 – 11:15 What kind of staff is needed in Endoscopy Ulrike Beilenhoff, Germany 11:15 – 11:35 What kind of specialist education and training is needed in Endoscopy? Experience from Estonia Siiri Maasen, Estonia 11:35 – 11:55 Endoscopy diploma at university – the French experience Fanny Durand and Mikael Mochet, France 11:55 – 12:15 E-Learning, Apps and YouTube innovate communication and training – what makes sense? What infrastructure is needed? José Manuel Martínez Gonzalez, Spain 12:15 – 12:30 Nursing Education – Combining Real & Virtual Training (Boston Scientific) NN Workshop 11 11:00 – 12:30
Poster Round II 13:30 – 15:00 ESGENA Poster area in front of Room E4 Chairs: Joan Slovlund Christensen, Denmark Fanny Durand, France Minerva Galvez-Martin, Spain Jayne Tillett, United Kingdom Upper GIT P-5 Foreign bodies in the upper gastrointestinal tract Mladenka Buić Gržeta, Boris Kopić, Katarina Matošević, Kristina Bego, Merima Salešević, Croatia P-6 The comparison of pre-procedural anxiety for Esophagogastroduodenoscopy Sunghee Cho, South Korea P-7 The role of the endoscopic nurse in the management of patient with acute pancreatitis undergoing to endoscopic necrosectomy Giulia Provenzano, Italy P-8 Workload related to histological analysis in gastroscopy Cinzia Rivara, Daniela Carretto Teresa Iannone, Italy Service & quality assurance P-11 Comparison of sugared Polyethylene Glycol solution versus Polyethylene Glycol solution for colonoscopy Ok Yeon Cho, Mi Yeong Kim, Ki Young Sung, Sun Hee Nam, Jun Won Chung, South Korea
ESGE Learning Area
Hands-on training on bio simulators This workshop is organised by ESGENA Chairs: Eric Pflimlin, Switzerland Michael Ortmann, Switzerland Hands-on training on bio simulators (pig models) under the supervision of highly experienced tutors. Participants will have the opportunity to perform endoscopic techniques on the following topics: • Upper GI Bleeding • ERCP As participation will be limited, registration will be treated on a first-come, first-served basis. Ticket will be available onsite only – at the entrance of the ESGE Learning Area.
P-10 Divided dose different day and same day drug use comparison in colon cleaning Tacettin Güngör, Mahmut Atas, F. Şentürk, S.Özarabaci, M.Türkbeyler, D.Sevindik, Mahmut Caneken Agil Ağakişiyev, M. C. Savaş, Turkey P-11 Pressure on abdomen and position change during colonoscopy: A routine procedure? Tacettin Güngör, Mahmut Caneken, Mahmut Ataş, M. Sait Dağ,Nimet Yilmaz, Hakan Çam, Agil Agakişiyev, Turkey P-12 Improvement Activities for Reducing Colonic Perforation in Colonoscopy Nalae Jo, South Korea P-13 Screening for colorectal cancer: nursing intervention in intestinal preparation prior to colonoscopy. María Elena de la Torre, Nuria Rivas, María del Mar Pascual, María Jesús García, Spain
286
21th ESGENA Conference : UEG Week Final Programme
P-14 Challenges of nursing and treatment management in a case of active ulcerative colitis with an uncommon extraintestinal manifestation Carmen Dirzu, Nicoleta Melinte, Carol Stanciu, Cristina Muzica, Oana Stoica, Stefan Chiriac, Anca Trifan, Romania P-15 The influence of biological therapy on the quality of life of patients with inflammatory bowel disease Željka Pušeljić, Lidija Tomas, Maja Čebohin, Croatia P-16 The role of the nurse in the endoscopic treatment with hemorrhoidal rubber bands ligation Martín Arias MC, García Zafra B, Pérez Oltra A, Ráez Frías RM, Vilar García M. Spain
Education & management P-23 A new era for GI endoscopy nursing in Malaysia Rosalin Maria P.Sulit, Malaysia P-24 Do you prescribe professional health apps? Antonio Torrejón, Octavi Rodríguez, Miguel A. Mayer, Spain P-25 Design and implementation of a scientific update app for healthcare professionals Lorena Villa, Octavi Rodríguez, Antonio Torrejón, Spain
Liver
P-26 Transforming skills in practice. The experience of the European Endoscopy Training Center. Fabio Grilli, Anna Di Gemma, Cinzia Rivara, Davide Cordioli, Guido Costamagna, Italy
P-17 Investigation of the information levels of patients about complications of chronic HBV – HCV diseases Tacettin Güngör, Nurevşan Kuşdoğan, Esra Ekiciler, Bahadır Edizer, A .Emre Yildirim, M.Taner Gülşen, Turkey
P-27 Development of Web-based Job Training Program for Nurses in Gastrointestinal Endoscopy Unit Kwon EunJu, Jung EunJu, Lee HangMi, Kim BoKoung, KIm YoungHui, Lee YoHan, Jung KwuyIm, South Korea
P-18 Challenges of nutritional intervention in patients with liver cirrhosis in a tertiary care center from north-eastern Romania: the perspective of the nurse Ana Maria Rotaru, Valeria Dănuța, Carol Stanciu, Cristina Muzica, Irina Girleanu, Stefan Chiriac, Anca Trifan, Romania
P-28 The experience of a nurse-operated referral center for Video-capsule Endoscopy Osnat Kalnizki, Inna Brin,Jorge Liechtmann, Israel
P-19 Hepatitis B Virus (HBV) Transmission from 202 Confirmed Viraemic Patients to Gastrointestinal Endoscopes and Current Infection Prevention Procedure Evaluation Yatao Liu, Lihua Zhou, Qiong Deng, Yunchao Yang, Xiaodan Shao, China
Lunch Session 1 12:30 – 15:00
Room B2
Endoscopic techniques This lunch session is organised by ESGENA
Chairs: Sylvia Lahey, The Netherlands Daniela Burtea, Romania
Hygiene P-20 Digital manual for adequate disinfection of flexible endoscopes Anna-Karin Olsson, Violetta Engelbrektsson, Sweden P-21 The situation and quality control in the endoscopes reprocessing in China Xi Huijun, China P-22 Development and application of an instrument for cleaning endoscopes and the effect of an enzymatic cleaner on removal of biofilm from endoscopes and the level of job satisfaction InJa Yoon, South Korea
12:30 – 12:40 Personal protection equipment – the forgotten topic for health care workers in endoscopy (Boston Scientific) Andrea Sochart, Germany 12:40-12:50 Advantages of the OTSC® System in the treatment of UGIB (ovesco Endoscopy AG) Antonio Caputo, Germany 12:50-13:00 Endoscopic tissue ablation – Techniques and instruments (Miro-tech Europe) Andreas Jung, Germany
287
UEG Week Final Programme : 21th ESGENA Conference
13:00-13:10 Electrosurgery in Endoscopy – How confident are you? (Olympus Europa SE & Co. KG) Philipp Grzeskowiak, Germany 13:10-13:20 Novelties in reprocessing of duodenoscopes (KARL STORZ GmbH & Co. KG) Guido Merk, Germany 13:30-15:00 Hands-on training with the companies Lunch Session 2 12:30 – 15:00
Room B3
Hygiene and infection control
Workshop 12 14:20 – 15:00
ESGE Learning Area
Hands-on training with the companies Chairs: Eric Pflimlin, Switzerland Michael Ortmann, Switzerland Hands-on training on bio simulators (pig models) under the supervision of highly experienced tutors. Participants will have the opportunity to perform endoscopic techniques on the following topics: • Colonoscopy • ERCP As participation will be limited, registration will be treated on a first-come, first-served basis. Ticket will be available onsite only – at the entrance of the ESGE Learning Area.
This lunch session is organised by ESGENA
Chairs: Björn Fehrke, Switzerland Maja Ilijevska, Macedonia
Session 5 15:00 – 16:30
12:30-12:40 Evolution of a total green automated system for effective and safe endoscope reprocessing (CBC Europe) Monica Cimbro, Italy
Management – which structure is needed? Chairs: Enriqueta Hernandez-Soto, Spain Yuri Guriel, Israel
12:40-12:50 One Connection System = more safety, less cross contamination & faster reprocessing (Steelco) Monica Menin Ostani, Italy 12:50-13:00 Ensure the hygiene control of your endoscope reprocessing eco system to guarantee patient safety (Soluscope) David Derrien, France 13:00-13:10 Efficacy of endoscope reprocessing; what we know and what we can do about it (Pulthru) Rodolphe Hervé, United Kingdom 13:10-13:20 A step further in perfection for endoscopy pre – cleaning Ultrazonic Nancy Steenbakkers, Belgium 13:30 – 15:00 Hands-on training with the companies
288
Room B2
15:00 – 15:20 Optimising the workflow in Endoscopy Marjon de Pater, The Netherlands 15:20 – 15:40 Implementation of checklists in daily routine – benefits & difficulties Peter Sirsema, The Netherlands 15:40 – 16:00 How to assess and measure competence of the nurse assisting with endoscopic procedures? Laura Dwyer, United Kingdom 16:00 – 16:15 How to calculate staff in Endoscopy – different approaches Ulrike Beilenhoff, Germany 16:15 – 16:30 Building a comprehensive approach to medical device hygiene and infection control (Pentax) Hudson Garrett Jr., USA
21th ESGENA Conference : UEG Week Final Programme
Sessions 6 15:00 – 16:30
Room B3
Endoscopic techniques Chairs: Siiri Maasen, Estonia Lidia Gorchs, Spain 15:00-15:20 Endoscopic faecal transplantation – different ways of application Salvador Machlab, Spain 15:20-15:40 Endoscopic treatments for obesity – benefits and limitations Alba Lira, Spain 15:40-16:00 New techniques for treatment of pancreatic cysts Nadan Rustemovic, Croatia 16:00-16:15 ERCP training for nurses – a model solution (Cook Medical) Ivo Boškoski, Italy 16:15-16:30 Forthcoming Olympus innovations in Endoscopy (OLYMPUS EUROPA) Rüdiger, Tamm, Germany Session 7 17:00 – 18:30
Room B2
Colorectal cancer screening Chairs: Ingrid Karström, Sweden Päivi Muranen, Finland 17:20 – 17:20 Surveillance Colonoscopy – are we scoping the right people at the right time? Irene Dunkley, United Kingdom
17:40 – 18:00 The nurses role in colo rectal cancer screening Mireia Díaz Centeno, Spain 18:20 – 18:30 EMR, ESD – which technique for which polyp and which location? Michal Kaminski, Poland Session 8 17:00 – 18:30
Room B3
When unforeseen happens … Chairs: Christine Petersen, The Netherlands Patricia Burga, Italy 17:00 – 17:20 How to treat bleeding and perforation – benefits and limitations of traditional and new techniques Hrvoje Ivecovic, Croatia 17:20 – 17:40 Foreign body removal – routine and obscure cases in endoscopy Alexander Dechêne, Germany 17:40 – 18:00 Stentmisplacement during and after the procedure – how to solve the problem Radu Tutuian, Switzerland 18:00 – 18:20 ‘I have a dream’: Nepal after the earthquake – back to normal life Michael Ortmann, Switzerland 18.20 – 18.30 Discussion
17:20 – 17:40 Who is qualified to perform screening colonoscopies? Experience from Scandinavia Helle Roy Tilgaard, Denmark
289
UEG Week Final Programme : 21th ESGENA Conference
Scientific Programme Monday, October 30, 2017
Session 9 08:30 – 10:00
Room A2
Controversial discussions in endoscopy Chairs: Jadranka Brljak, Croatia Enriqueta Hernandez-Soto, Spain
09:10 – 09:30 Medico-legal aspects of nursing in endoscopy Enriqueta Hernandez-Soto, Spain
The winner of the best free papers – oral presentation and the best poster presentations – will be announced. Presenting authors are requested to attend this session. • Jadranka Brljak, Croatia • Enriqueta Hernandez-Soto
The main responsibility of the endoscopy team is to offer a quality service, guaranteeing the patient’s safety. Yearly about 1,000 endoscopies are performed per procedure room and the entire endoscopy team is responsible for being prepared to carry out them. Each component has its share of responsibility, yet the nurses are the professional of the team that will be most time beside patients, while supporting technically the endoscopy. What can be done to legitimize the legal dimension of endoscopy, which provides a lawful security acceptable to nurses?
08:50 – 09:10 New techniques – easy and quick to perform! Does the endoscopist still need the qualified nurse? Marjon de Pater, The Netherlands
09:30 – 09:50 Advanced roles for nurses – a mini-doctor or a maxi nurse? Helen Griffiths, United Kingsdom
Nurses have two roles during endoscopic examinations: Patient Care with monitoring, and technical assistance for the procedures. The patient care role has become complexer over the years, but technical assistance has changed from mainly taking biopsies and occasional polypectomy in the early seventies to complex assistance during therapeutic ERCP. New procedures where the endoscopist handles accessories him/herself potentially changes the role of the assistant again. The question therefore arises – do we still need qualified endoscopy nurses for the technical assistance.
Due to shortages of doctors many former medical tasks are delegated to nurses. This raises many questions: how will staff for these tasks identified, what training is needed, how is the quality of care assured (Quality Assurance), who takes the medico-legal responsibility for both nursing and delegated medical practice, and where are the boundaries between nursing and medical practice.
08:30 – 08:50 Best Free Paper and Best Poster Awards PENTAX Medical supports the ESGENA Free Paper and Poster Award
290
09:50 – 10:00 Invitation to the next ESGENA Conference 2018 in Vienna Gerlinde Weilguny, Austria
Common Interest Group Meetings
UEG Week Final Programme : Common Interest Group Meetings
Common Interest Group Meetings
Sunday, October 29, 2017 10:00 – 12:00 Healthy Stomach Initiative
Monday, October 30, 2017 B5
Upon invitation only (HSI)
The non-profit HSI, a group of GI specialists from 35 countries aiming to bring awareness to doctors & the general population on stomach health and preventive care. The HSI has been endorsed by the WGO, EAGEN, EHMSG and many National Societies, private & athlete endorsors. 13:00 – 16:00 B5 Annual meeting of the ESscD theme: intestinal biopsies in diagnosing Celiac Disease Upon invitation only (ESscD)
Discussion: What is the role of biopsy in adult and paediatric celiac disease? Working group: 2020–2025 Renaming RCD II to pr-EATL CIG Meeting including: a) report from the board b) election: president-elect, board member (paediatrician) c) budget matters 16:00 – 17:30 E2 PRO-MC collaboration – building a European registry for microscopic colitis (EMCG)
In July 2016, the ‘PRO-MC COLLABORATION: ESTABLISHMENT OF A PROSPECTIVE REGISTRY FOR MICROSCOPIC COLITIS IN EUROPE – A UEG LINK AWARD PROJECT’ has started. The ultimate aim is to improve knowledge on MC across Europe. We want to inform about the progress and give interested colleagues the chance to participate in this project. 17:00 – 19:00 B5 Normal values for esophageal pH impedance monitoring (ESNM)
292
17:30 – 19:00 B5 Faecal Microbiota Transplantation in Clinical Practice (Gut Microbiota & Health Section, ESNM, ECCO, ESPGHAN, EASL)
Loss of species diversity and microbial gene richness in the gut microbiome is commonly reported in individuals affected by chronic non-communicable diseases. Maintaining gut microbiota diversity is a novel clinical target for health promotion and disease prevention. Functional foods and microbiota transplantation are useful tools for improving host-microbial symbiosis. 17:30 – 19:30 E2 Water-aided colonoscopy (WAC) – consensus meeting (International WATER (Water Assisted Techniques Endoscopic proceduRes) – working group)
Chair: Felix Leung Co-Chair: Chris Mulder Distinction between water immersion (WI) and water exchange (WE) is important Sergio Cadoni, Italy Underwater polypectomy Sauid Ishaq, United Kingdom Where are we now and where are we going? Felix Leung, USA
Business Meetings Several business meetings – association, board and committee meetings for elected (UEG) leadership – will take place during UEG Week 2017. Please note that attendance is by invitation only.
UEG Week Final Programme : Business Meetings
Business Meetings
Please note that attendance is by invitation only.
UEG 16:00 – 20:00
Friday, October 27, 2017 Council Meeting
UEG Meeting Room 1
08:00 – 11:30 15:15 – 16:15 16:30 – 18:30 16:30 – 17:00 16:30 – 18:00
Saturday, October 28, 2017 UEG Journal Management Board Meeting National Societies Committee Meeting Public Affairs Committee Meeting Scientific Committee: Best of UEG Week Team for DDW Standards & Guidelines Task Force Meeting
UEG Meeting Room 1 UEG Meeting Room 2 UEG Meeting Room 3 UEG Meeting Room 1 UEG Meeting Room 2
12:30 – 14:15 13:00 – 15:00 16:00 – 19:00 17:30 – 19:00
Sunday, October 29, 2017 UEG Journal Editorial Board Meeting National Societies Forum Meeting of Members Scientific Committee – PGT Programme Committee
UEG Meeting Room 1 Room A2 Room A2 UEG Meeting Room 2
12:00 – 13:30 14:30 – 15:30 16:00 – 17:30 16:00 – 18:00 17:00 – 18:30 17:15 – 18:00
Monday, October 30, 2017 Press Briefing UEG - EBGH Meeting Research Board Meeting Scientific Committee - Group Coordinators' Meeting Equality & Diversity Task Force Meeting Meeting with Friends of YTG
UEG Meeting Room 2 UEG Meeting Room 1 UEG Meeting Room 1 Room 7.12 UEG Meeting Room 3 UEG Meeting Room 2
12:00 – 13:30
Tuesday, October 31, 2017 Press Briefing
UEG Meeting Room 2
Wednesday, November 1, 2017 08:00 – 10:00 Young Talent Group Meeting 10:30 – 11:45 Industry Debrief Meeting
UEG Meeting Room 1 Room B5
EAGEN 13:00 – 18:00
Saturday, October 28, 2017 EAGEN Board Meeting
Room 7.8
fEMGA 14:00 – 15:45
Sunday, October 29, 2017 fEMGA/Medical Block Association Meeting
Room 7.12
IAPWG 15:00 – 18:00
Sunday, October 29, 2017 IAPWG Consensus Meeting
Room 7.8
ISPM/EUREOS Sunday, October 29, 2017 12:00 – 14:00 EUREOS Update 2017
UEG Press Briefing Monday, October 17, 2016 Tuesday, October 18, 2016 294
Room 7.8
12:15 – 13:30 12:15 – 13:30
UEG Meeting Room 3 UEG Meeting Room 3
Industry Sponsored Symposia The programme of industry sponsored symposia is not affiliated with UEG and as of September 12, 2017.
UEG Week Final Programme : Industry Sponsored Symposia
Industry Sponsored Symposia Sunday, October 29, 2017 Industry Sponsored Symposium 16:15 – 17:45 How will we manage Crohn’s disease – in 2027? (Boehringer Ingelheim Pharma GmbH & Co KG) Chair: Stefan Schreiber, Germany
A3
Introduction Presentation and moderated panel discussion on each of the following:
• How will scientific advances influence Crohn’s disease management in 2027? •
ersonalised medicine: what will the Crohn’s P disease patients of 2027 expect from their health experts?
•
T he role of lifestyle interventions in the management of Crohn’s disease
Close Industry Sponsored Symposium 16:15 – 17:45 F2 Bridging the gap in Crohn’s disease: from clinical evidence to daily practice (Janssen) Chairs: Séverine Vermeire, Belgium Laurent Peyrin-Biroulet, France Welcome and opening of the meeting Séverine Vermeire, Belgium Targeting the IL-12/23 pathway Laurent Peyrin-Biroulet, France Challenging questions in clinical practice Séverine Vermeire, Belgium Laurent Peyrin-Biroulet, France James Lindsay, United Kingdom Conclusions and closure Séverine Vermeire, Belgium
Industry Sponsored Symposium 16:15 – 17:45 A1 A Novel Approach to Prevent Recurrent Clostridium difficile Infection (CDI) in High-Risk Patients (MSD) Chair: Mark Wilcox, United Kingdom Welcome and Introduction Mark Wilcox, United Kingdom Epidemiology and Patients at High Risk of Recurrent CDI Javier Cobo, Spain Antitoxin Mechanism of Action for Prevention of Recurrent CDI Ciaran Kelly, USA Bezlotoxumab for the Prevention of Recurrent CDI Mark Wilcox, United Kingdom Clinical and Economic Consequences of Recurrent CDI Frederic Barbut, France Q&A and Closing Remarks Mark Wilcox, United Kingdom Industry Sponsored Symposium 16:15 – 17:45 F1 Optimising infliximab therapy in IBD patients: Data, Dilemmas and Debates (Pfizer) Chair: Iris Dotan, Israel Welcome and Introduction Iris Dotan, Israel Biosimilar infliximab in IBD: Digesting the data Silvio Danese, Italy Optimising patient outcomes with infliximab: A virtual clinic 2 challenging patient cases presented by Krisztina Gecse, Netherlands Stephan Vavricka, Switzerland Take home messages for our clinical practice Iris Dotan, Israel
296
Industry Sponsored Symposia : UEG Week Final Programme
Industry Sponsored Symposium 18:00 – 19:30 Management of Diverticular Disease in the Third Millennium – Questions & Answers (Alfasigma S.p.A) Chair: Carmelo Scarpignato, Italy
E4
What is the Clinical Picture of Diverticular Disease? Lisa L. Strate, USA How Is the Gut Microbiota Altered in Patients with Diverticular Disease? Giovanni Barbara, Italy What are the Aims of Treatment? Angel Lanas, Spain Is There a Role for Diet and Nutraceuticals? Lisa L. Strate, USA Which Drugs Are Effective? Angel Lanas, Spain How Do Effective Drugs Work? Giovanni Barbara, Italy Take Home Messages Carmelo Scarpignato, Italy Industry Sponsored Symposium 18:00 – 19:30 A1 Biosimilars: Experts Discuss Real World Considerations (Amgen Inc.) Chair: Simon Travis, United Kingdom Roundtable Discussion: Addressing Questions in the Evolving Biosimilar Landscape Daniel Hommes, USA Walter Reinisch, Austria Industry Sponsored Symposium 18:00 – 19:30 E1 Functional digestive disorders and STW-5: passing the exam of evidence based medicine (Bayer Consumer Health) Chairs: Fermín Mearin, Spain Alexander Trukhmanov, Russia Introduction. Functional dyspepsia and irritable bowel syndrome: complex disorders with complex treatments Fermín Mearin, Spain FD and IBS pathophysiology: beyond ROME IV Vincenzo Stanghellini, Italy STW-5 mechanisms of action in FD and IBS: The origin of multi-target Hans-Dieter Allescher, Germany Clinical evidence of the efficacy of STW-5 in FD and IBS Peter Malfertheiner, Germany
STW-5: clinical experience in everyday practice Tatyana Lapina, Russia Open discussion Industry Sponsored Symposium 18:00 – 19:30 F1 Managing the Complexities of UC: Aligning Patient and Physician Goals (Pfizer) Chair: Laurent Peyrin-Biroulet, France Welcome, Introduction, and Patient Vignette Laurent Peyrin-Biroulet, France Better Understanding the Patient Perspective David T. Rubin, USA Physician Perspective of the Complexities of UC Management Gerhard Rogler, Switzerland Aligning the Two Perspectives Laurent Peyrin-Biroulet, France Question-and-Answer Session Panel Industry Sponsored Symposium 18:00 – 19:30 C1 Mission: Rapid Action and Lasting Remission – Focus on Disease Progression in Ulcerative Colitis (Takeda Pharmaceuticals International AG) Chair: William J. Sandborn, USA Welcome and Introduction William J. Sandborn, USA Mission Assigned: Rapid Onset and Lasting Remission in Ulcerative Colitis William J. Sandborn, USA Q&A All Faculty Mission Assessed: Challenges and Strategies to Achieve Early, Lasting Remission Geert D'Haens, The Netherlands Q&A All Faculty Mission: Remission — Optimising Rapid Onset and Long-term Outcomes With Gut-Selective Therapy Remo Panaccione, Canada Q&A All Faculty Panel Discussion William J. Sandborn, USA 297
UEG Week Final Programme : Industry Sponsored Symposia
Industry Sponsored Symposia Monday, October 30, 2017 Industry Sponsored Symposium 07:00 – 08:00 E4 Biosimilars for IBD: Patient Concerns for Now and Later (Samsung Bioepis) Chair: Geert D'Haens, The Netherlands Welcome and Introduction Geert D'Haens, The Netherlands
Welcome and Introduction Fermín Mearin, Spain
Patients' View on Biosimilars Geert D'Haens, The Netherlands The Physician's Story to the Patient: How to Optimize the Dialogue Fraser Cummings, United Kingdom Addressing Scientific Questions Regarding Biosimilars Krisztina Gecse, The Netherlands Panel Discussion and Q&A All Industry Sponsored Symposium 17:45 – 19:15 Keep CALM and Treat to Target in IBD (AbbVie) Chair: Jean-Frédéric Colombel, USA
C2
In Focus: Importance of early diagnosis and treating to target in IBD Benjamin Pariente, France
Treating to target in IBD – At what cost? Geert D’Haens, The Netherlands Discussion and audience Q&A Faculty Close Jean-Frédéric Colombel, USA
Changing the narrative in IBS: New perspectives for clinicians and patients Fermín Mearin, Spain Maura Corsetti, United Kingdom New treatments in IBS: Translating clinical evidence into real-life benefits for patients Bill Chey, USA Managing IBS in an era of rapid innovation: A casebased approach All; led by Fermín Mearin, Spain
Welcome to ‘Keep CALM and Treat to Target in IBD’ Jean-Frédéric Colombel, USA
News update: CALM study results Jean-Frédéric Colombel, USA
Industry Sponsored Symposium 17:45 – 19:15 F2 IBS – hard to ignore: Time to take a different view Innovations and advances in patient care (Allergan Pharmaceuticals International Ltd) Chair: Fermín Mearin, Spain
Summary and close Fermín Mearin, Spain Industry Sponsored Symposium 17:45 – 19:15 F1 Role of detection and characterization in advanced endoscopy (FUJIFILM) Chairs: Alessandro Repici, Italy Hironori Yamamoto, Japan Welcome and Introduction Alessandro Repici, Italy Hironori Yamamoto, Japan Role of BLI in the diagnosis of Barretts neoplasia Raf Bisschops, Belgium Predicting polyp histology with BLI: Keep it BASIC! Cesare Hassan, Italy Linked Color Imaging (LCI) – A new tool for detection of early neoplasia Hironori Yamamoto, Japan How to make ESD safe & efficient in the west Pradeep Bhandari, United Kingdom Closing remarks Alessandro Repici, Italy Hironori Yamamoto, Japan
298
Industry Sponsored Symposia : UEG Week Final Programme
Industry Sponsored Symposia Tuesday, October 31, 2017 Industry Sponsored Symposium 17:45 – 19:15 F3 Pharmacological and clinical perspectives: The evolution of the treatment landscape and personalised medicine approaches for management of UC (Pfizer) Chair: Silvio Danese, Italy Welcome and Introductions Silvio Danese, Italy Clinical Implications of the Evolving Treatment Landscape in UC Peter Irving, United Kingdom
Industry Sponsored Symposium 07:00 – 08:00 A1 How is the Future of the IBD Landscape Evolving? (Celgene Corporation) Chair: Geert D’Haens, The Netherlands Improving Patient Care and Management: What Unmet Needs do we Still Need to Address? William Sandborn, USA Beyond the Biologics: What do Future Therapies Hold? Silvio Danese, Italy
Emerging Therapies Targeting Mechanisms of UC Pathogenesis Silvio Danese, Italy
Industry Sponsored Symposium 07:00 – 08:00 A3 Probiotics effects in gut health: between art and science (Ferring International Center S.A.)
The Pharmacologist’s Perspective on Current and Emerging Treatment Options in UC Diane Mould, USA
Probiotics: understanding their beneficial effects – from FAO/WHO to WGO Practice Guidelines Francisco Guarner, Spain
Audience Q&A All
Evidence-based use of Probiotics – from IBD to IBS and Liver Diseases Giovanni Barbara, Italy
Industry Sponsored Symposium 17:45 – 19:15 C1 Targeting Mucosal Healing: Optimising Results With Early, Appropriate Therapy in Crohn’s Disease (Takeda Pharmaceuticals International AG) Chair: Julián Panés, Spain
Towards next generation Probiotics Harry Sokol, France
Welcome and Introduction Julián Panés, Spain The Case for Early Intervention in Crohn’s Disease Julián Panés, Spain Close-up on Endoscopic Healing as a Treatment Goal: What Do We Need to Know? Laurent Peyrin-Biroulet, France Meeting Evolving Treatment Goals With Gut-Selective Therapy Charlie Lees, Scotland
Industry Sponsored Symposium 07:00 – 08:00 F1 Changing perspectives in Primary Biliary Cholangitis (PBC) (Intercept Pharmaceutical Europe Ltd) Chair: Albert Parés, Spain The impact of the new European guidelines on the management of PBC Guilherme Macedo, Portugal Recent advances in PBC management: Looking beyond current therapeutic options Fredrik Nevens, Belgium
Putting Knowledge Into Practice: Approach to Patient Cases Julián Panés and Faculty Summary and Concluding Remarks Julián Panés, Spain
299
UEG Week Final Programme : Industry Sponsored Symposia
Industry Sponsored Symposium 17:45 – 19:15 C1 Addressing common challenges in IBD – practical approaches and best practice sharing (AbbVie) Chairs: Remo Panaccione, Canada James Lindsay, United Kingdom Welcome and Introduction Remo Panaccione, Canada Challenge presentation and faculty discussion Faculty Addressing day-to-day challenges in IBD management Faculty Challenge 1: Beyond the bowel – Extra-intestinal manifestations of IBD Vito Annese, UAE Challenge 2: Monitoring/tight control/treat-to-target – Who, what, how and when? Remo Panaccione, Canada Video Case Study: Ireland – Managing IBD under special circumstances Glen Doherty, Ireland
Industry Sponsored Symposium 17:45 – 19:15 F2 Going Above and Beyond: A Full Spectrum of Innovation for Personalized, Convenient, and Affordable Treatment (CELLTRION HEALTHCARE) Chair: Stefan Schreiber, Germany Exclusive to CT-P13: An Accumulation of Clinical Evidence Stefan Schreiber, Germany A Leap beyond Evidence to the Next Stage_ Personalized Treatment Walter Reinisch, Austria A Leap beyond Evidence to the Next Stage_ Convenient Treatment Stefan Schreiber, Germany A Leap beyond Evidence to the Next Stage_ Affordable Treatment László Gulácsi, Hungary Panel Discussion All
Challenge 3: Moving from paediatrics to adult care James Lindsay, United Kingdom
Industry Sponsored Symposium 17:45 – 19:15 A2 Time to Get Ulcerative Colitis Under Tight Control (MSD) Chair: Laurent Peyrin-Biroulet, France
Challenge 4: TDM – Ready for prime time? Iris Dotan, Israel
Welcome and Introduction Laurent Peyrin-Biroulet, France
Audience Q&A Chairs and faculty
The Disease Burden in UC Edouard Louis, Belgium
Key takeaways James Lindsay, United Kingdom
Q&A Can We Change the Natural Course of UC? Laurent Peyrin-Biroulet, France Q&A Patient Empowerment and Remote Monitoring in UC Pierre Michetti, Switzerland Q&A Panel Discussion Laurent Peyrin-Biroulet, France
300
Industry Sponsored Symposia : UEG Week Final Programme
Industry Sponsored Symposium 17:45 – 19:15 A3 Bowel preparation quality, ADR and patient experience: Are low volume PEG-based preparations the vital link? (Norgine) Chair: Cesare Hassan, Italy Introductions Cesare Hassan, Italy
INDUSTRY SPONSORED SYMPOSIUM
Setting up success through effective bowel preparation Ralf Kiesslich, Germany
FUNCTIONAL DIGESTIVE DISORDERS AND STW-5: PASSING THE EXAM OF EVIDENCE BASED MEDICINE
Key performance measures and the relationship with patient-related outcomes Michaeł F. Kamiński, Poland
29th October 2017, 6 p.m., Room E1
Low volume PEG-based preparations: What do the data show? Cesare Hassan, Italy Panel discussion: Low volume PEG-based preparations in relation to improving outcomes for colonoscopy – what can we learn? Cesare Hassan, Italy Summary and close Cesare Hassan, Italy
Prof. Fermín Mearin, Barcelona, Spain.
Industry Sponsored Symposium 17:45 – 19:15 A1 Optimizing the management of acid-related disorders – from diagnosis to treatment (Takeda Pharmaceuticals International AG) Chair: David Metz, USA
Prof. Vincenzo Stanghellini, Bologna, Italy.
Welcome David Metz, USA How to make a conclusive diagnosis of GERD in 2017 Daniel Sifrim, United Kingdom The evolving treatment landscape: risk/benefit ratio of PPIs David Metz, USA
Introduction: Functional dyspepsia and irritable bowel syndrome: Complex disorders with complex treatments
FD and IBS pathophysiology: Beyond ROME IV
Prof. Hans-Dieter Allescher, GarmischPartenkirchen, Germany. STW-5 mechanisms of action in FD and IBS: The origin of multi-target Prof. Peter Malfertheiner, Magdeburg, Germany. Clinical evidence of the efficacy of STW-5 in FD and IBS
Ass. Prof. Tatyana Lapina, Moscow, Russia. STW-5: Clinical experience in everyday practice
Beyond PPIs: first clinical experiences with P-CABs Ken Haruma, Japan Audience Q&A Faculty Meeting summary and close David Metz,USA
Bayer Meets the Media: “Harvesting the benefits of evidence-based phytomedicine”, 30th October 2017, 7:15 p.m., Hotel SB Plaza Europa, Barcelona:
[email protected]
This symposium is not affiliated with UEG L.ES.MA.08.2017.3195
301
Da
as
t
D i le m m a,
Optimising Infliximab Therapy in IBD patients
an
d Debates
Optimising Infliximab Therapy in IBD Patients: Data, Dilemmas and Debates An Interactive Patient Case-Led Session 16:15 to 17:45
Chair and Moderator Iris Dotan, MD l Petah Tivka, Israel
Biosimilar Infliximab in IBD: Digesting the Data Full Summary of Product Characteristics is available at the booth (42). Ficha técnica de Inflectra disponible en el stand (42) Este medicamento está sujeto a seguimiento adicional, es prioritaria la notificación de sospechas de reacciones adversas asociadas a este medicamento. This medicinal product is subject to additional monitoring, any suspected adverse reactions should be reported.
Silvio Danese, MD, PhD l Milan, Italy
Optimising Patient Outcomes with Infliximab: A Virtual Clinic – 2 Challenging Cases Krisztina Gecse, MD, PhD l Amsterdam, Netherlands Stephan Vavricka, MD l Zürich, Switzerland
Join Us for Two Informative Sessions Highlighting Emerging Trends in IBD — Sunday, 29 October 2017 — Fira de Barcelona
•
Gran Via North Entrance – Hall 8
•
Room F1
•
Barcelona, Spain
•
Food and beverages will be provided.
These symposia are not affiliated with UEG. These programmes are funded and organised by Pfizer Inc.
Managing the Complexities of UC: Aligning Patient and Physician Goals 18:00 to 19:30
Chair and Moderator Laurent Peyrin-Biroulet, MD, PhD l Vandoeuvre-lès-Nancy, France
Patient Perspective on the Burden of UC David T. Rubin, MD l Chicago, Illinois, United States
Physician Perspective on the Complexities of UC Management Gerhard Rogler, MD, PhD l Zürich, Switzerland
Panel Discussion: Aligning the Two Perspectives PP-IFA-ESP-0169 September 2017 © 2017 Pfizer Inc. All rights reserved.
Congress Information Congress Venue Fira de Barcelona – Gran Via Venue North Entrance – Hall 8 Carrer del Foc, 35 08038 Barcelona, Spain Congress Registration Counter All congress material and documentation is available at the counters located in the Entrance Foyer.
Opening Hours Friday October 27 Saturday October 28 Sunday October 29 Monday October 30 Tuesday October 31 Wednesday November 1
14:00 – 18:00 07:30 – 18:00 07:30 – 18:00 07:00 – 18:00 07:00 – 18:00 07:00 – 16:00
During these opening hours the congress registration desk can be reached at: T +43 676 845 880 704.
UEG Week Final Programme : Congress Information
Congress Information
Registration Onsite registration does not necessarily entitle the participants to receive all congress material. Registration will be handled upon a first-come, first-served basis, priority will be given to pre-registered delegates.
Barcelona’s public transportation system includes metro and bus (TMB), local train (FGC), tram (TRAM) and regional trains (Rodalies de Catalunya).
Congress Language The official language of UEG Week is English. No simultaneous translation will be provided.
Please see page 309 for a metro map of Barcelona.
Name Badges Participants are requested to wear their name badge at all times during the congress. The colours of the name badges have the following significance: Delegate of UEG Week Faculty, Officers, Organisers of UEG Week Delegate of Postgraduate Teaching Programme Delegate of UEG Week and Postgraduate Teaching Programme Delegate of ESGENA Exhibitor Press Congress Staff Guest/Common Interest Group/Business Meeting YGN Young GI Network Kindly note that when your badge is being scanned at exhibition booths or during industry sponsored symposia, as previously agreed by you, personal data, comprising of full name, address (institute/company, department, address) and email address is being passed on to the respective UEG sponsors/exhibitors for the purpose of providing marketing and information material relating to the field of digestive health as well as information on scientific events. How to get around We ask all of our visitors to think of the environment and use public transport wherever possible. Public Transportation Ticket All registered UEG Week and ESGENA delegates benefit from unlimited use of the Barcelona public transportation system valid for 3 days once activated. Public transportation tickets will be handed out at the congress material counter. 304
However, using the AEROBUS from/to the airport requires the purchase of a separate ticket.
From the airport: At Terminal 1 or 2, take the metro line L9 Sud and stop at station ‘Fira’. From the metro station ‘Fira’ it is 6-8 minutes walking distance to Fira Gran Via – North Entrance Hall 8 for UEG Week. From the city: Take the metro lines L1, L3 or L5 and change to metro line L9 Sud (direction to airport) as follows: When on metro line L1, you can change to metro line L9 Sud at station ‘Torrassa’, when on metro line L3, you can change to line L9 Sud at station ‘Zona Universitaria’ and when using metro line L5, you can change at station ‘Collblanc’. Then take the metro line L9 Sud (direction to airport) and stop at station "Fira’. From the metro station ‘Fira’ it is 6-8 minutes walking distance to Fira Gran Via – North Entrance Hall 8 for UEG Week. Taxi A taxi stand is located in front of the North Entrance – Hall 8. Taxis can be called day and night at the telephone numbers: TAXI CLASS Phone: +34 933 07 07 07 TAXI MÉS Phone: +34 933 30 03 00 RADIO TAXI Phone: +34 933 03 30 33 Abstracts The abstracts of UEG Week Barcelona 2017 will be available online in the UEG Education library and on the UEG website. Congress News and Website The UEG Week website, UEG Week 2017 Congress App and our social media channels will provide an overview of sessions and data presented each day and ‘what not to miss’ the following day along with hot topics and snapshots of the congress. For more information, visit the UEG Week website (www.ueg.eu/week)
Congress Information : UEG Week Final Programme
Live streaming of Sessions Be part of UEG Week and view 50% of all sessions of Europe’s largest GI meeting wherever you are!
UEG Members Village Meet representatives of UEG’s Member Societies in Hall 8.0.
UEG will connect everyone to its annual meeting via live stream on the UEG Week Live website. Lean back and get updated on relevant GI and liver topics free of charge, and connect with the community via the UEG Week Social Wall. Simply sign in to myUEG. For more information, please visit live.ueg.eu
UEG Young GI Lounge Join the Young GI Network in Hall 8.0. For more info please see page 21.
UEG Week 2017 App Get the UEG Week 2017 congress app for your smartphone and experience the congress at your fingertips! Send questions during sessions via the Q&A tool or quickly find your way through the most up-to-date congress schedule. Cast your vote in interactive sessions via the app. Have a look at floor plans and browse the exhibition and company profiles. Just take the congress with you! The app is free of charge for iPhone/iPad and Android smartphone users. The Q&A tool is available in the following session rooms: Hall 6, C1, C2, F1, F2, F3, A1, A2 The UEG Week 2017 App is available at:
Programme Changes UEG cannot assume liability for any changes in the conference programme due to external or unforeseen circumstances. Meet UEG Find out more about the work we do at the UEG Booth in Hall 8.0.
Opening Hours Saturday October 28 Sunday October 29 Monday October 30 Tuesday October 31 Wednesday November 1
07:30 – 18:00 07:30 – 18:00 07:00 – 18:00 07:00 – 18:00 07:30 – 14:00
Speakers Centre The Speakers Centre is located in the Entrance Foyer. Speakers are asked to hand in their CD-ROM or USB stick, containing the Power-Point Presentation (IBM format or compatible, no multisession) or video preferably one day before their presentation but at the latest 3 hours prior to the presentation. The presentation will be transferred to the central congress server and will be available afterwards on a special congress notebook in the hall of the presentation. Due to time and technical reasons we kindly ask the speakers not to use their own notebook. In the Speakers Centre there are several PCs where speakers can also work on their slides in a quiet area. Technical staff will be happy to assist.
Opening Hours Friday October 27 Saturday October 28 Sunday October 29 Monday October 30 Tuesday October 31 Wednesday November 1
14:00 – 18:00 07:30 – 18:00 07:30 – 18:00 07:00 – 18:00 07:00 – 18:00 07:00 – 14:00
Internet Centre and WiFi The Internet Centre with several terminals is located on the walkway to Halls 6/7.
Opening Hours Saturday October 28 Sunday October 29 Monday October 30 Tuesday October 31 Wednesday November 1
08:30 – 17:00 08:30 – 17:00 08:30 – 17:00 08:30 – 17:00 08:30 – 15:00
WiFi is available throughout the venue. #UEGWifi by Pfizer_5Ghz #UEGWifi by Pfizer_2.4Ghz Password: uegweek17 305
UEG Week Final Programme : Congress Information
Poster Exhibition Posters are displayed from Monday, October 30 until Wednesday, November 1 in the scientific centre in Hall 7. The posters are changed daily and are at display during the following times:
Monday Tuesday Wednesday
October 30 October 31 November 1
09:00 – 17:00 09:00 – 17:00 09:00 – 14:00
The poster presenters are asked to put up and remove their poster on the day of presentation according to the schedule below: Hanging: On the day of display 08:00 – 09:00. Removal: On the day of display 17:00 – 17:30 (Mon-Tue) and 14:00 – 14:30 (Wed). Posters that have not been removed by the respective time will be disposed of. Poster material to put up the poster is available at the poster service desk in the poster exhibition area. If you have submitted a poster for printing for UEG Week 2017 through the CTI poster printing service, please pick up your poster at the poster service desk in the poster area:
Monday Tuesday Wednesday
October 30 October 31 November 1
08:00 – 17:30 08:00 – 17:30 08:00 – 14:30
E-Posters E-posters will be available in the scientific centre in Hall 7. All poster presenters have been invited to upload their poster prior to UEG Week. All uploaded e-posters can be searched for and viewed electronically on the 6 terminals in the poster area throughout Monday, October 30 to Wednesday, November 1 during the above mentioned display times. Technical Exhibition UEG Week is accompanied by a major technical exhibition taking place in Hall 8.1. This provides an excellent opportunity for physicians, pharmacists, pharmacy assistants, nurse practitioners, physician assistants to interact with the industry and familiarise themselves with the latest advances in technology and pharmacology. For further information and floor plans please see the list of exhibitors on page 313 and following, in the UEG 306
Week 2017 Congress App as well as on the UEG website www.ueg.eu/week. Please note that according to the EU Directive 2001/83/EC promotional material related to prescription-only medicines must be distributed or provided exclusively to healthcare professionals who are authorised to prescribe or dispense them.
Opening Hours Monday October 30 Tuesday October 31 Wednesday November 1
09:00 – 17:00 09:00 – 17:00 09:00 – 14:00
Press Centre The Press Centre is located at the end of the walkway towards Halls 6 and 7. It is open from 08:00 – 18:00 (SunTue, October 29-31) and 08:00 – 16:00 (Wed, November 1). All press/media representatives are invited to attend the press briefings in UEG Meeting Room 2 (Foyer Halls 6/7): Press Briefings Monday October 30 12:15 – 13:30 Tuesday October 31 12:15 – 13:30 Local and international speakers will be available to answer questions. The Press Centre is managed by the press agency Spink. The agency’s staff is pleased to provide more detailed information related to press activities during UEG Week Barcelona 2017. Silent Room There is a room set apart for prayer. It is a quiet place where delegates may withdraw to seek divine strength and guidance. The silent room is located in Room 7.6 (Foyer Halls 6/7). Coffee Breaks and Lunch PGT Programme and ESGENA Conference (Sat – Sun) Coffee and a light sandwich snack are provided in the catering areas Hall 8.0 and Foyer Halls 6/7 for PGT Programme and ESGENA Conference delegates on Saturday, October 28 and on Sunday, October 29.
PGT Catering Times Saturday, October 28 and Sunday, October 29 Coffee Break 10:30 – 11:00 Lunch 13:00 – 14:00
Congress Information : UEG Week Final Programme
ESGENA Catering Times Saturday, October 28 Coffee Break 10:30 – 11:00 // 15:30 – 16:00 Lunch 13:00 – 14:00 Sunday, October 29 Coffee Break 10:30 – 11:00 // 16:30 – 17:00 Lunch 13:00 – 14:00
UEG Week Programme (Mon – Wed) Coffee as well as a light sandwich snack are served free of charge to all registered UEG Week participants in the designated catering stations located within the exhibition area in Hall 8.1 and in the poster exhibition area in Hall 7.
UEG Week Catering Times Monday, October 30 and Tuesday, October 31 Coffee Break 10:00 – 10:30 // 15:30 – 15:45 Lunch 12:00 – 14:00 Wednesday, November 1 Coffee Break 10:00 – 10:30 Lunch 12:00 – 14:00
Throughout the venue there will be water dispensers and catering kiosks to buy refreshments and snacks. Networking Areas The perfect meeting point to network with colleagues are our designated networking areas in the exhibition area in Hall 8.1, in Hall 7. or at the UEG Booth in Hall 8.0 where we provide charging stations for your mobile devices. The live endoscopy will also be transmitted to the networking areas on Tuesday. Congress delegates below 40 are also invited to meet other young fellows in the Young GI Lounge in Hall 8.0 where they can form new collaborations, surf the net, charge their devices and join our social media activities! Cloakroom The cloakrooms are located in the Entrance Foyer next to the registration counters and can be used free of charge from Saturday, October 28 through to Wednesday, November 1. Participants can also store their luggage there.
Emergency and First Aid In case of emergency please contact our staff. The First Aid Room is located in Room 7.7 (Foyer Halls 6/7). The attentive staff there will be pleased to help. Smoking The Fira Barcelona is a non-smoking venue. Smoking is prohibited within the congress venue. Photos, Filming and Recording of Scientific Sessions It is strictly forbidden to film, take photos or record any oral or poster presentation of UEG Week without the consent of the organiser (including smart phones, mobile devices, etc). Please note that numerous sessions will be recorded and published at www.ueg.eu/education/library immediately after the congress and will be available for all congress delegates. This archive will also include all abstracts, e-posters and the syllabus of the Postgraduate Teaching Programme. Insurance / Liability UEG does not accept any liability for damages and/or losses of any kind which may be incurred by the congress participants, during either the official activities or official UEG networking events. Delegates attend the congress at their own risk. Participants are advised to take out insurance against loss, accidents or damage that could be incurred during the congress. Safety As in all major cities and congress venues, people should always keep an eye on their personal belongings. Please be aware of pickpocketing and bag-snatching and make sure to take off your name badge and congress bag when you go sightseeing in downtown Barcelona. Wearing the name and bag identifies you as a tourist which might attract pickpockets.
307
BIOSIMILARS Sunday, 29 October 2017
Experts Discuss Real World Considerations
18:00–19:30
Fira de Barcelona Gran Via North Entrance Hall 8 – Room A1
Faculty Daniel Hommes, MD, PhD
Professor of Medicine David Geffen School of Medicine of UCLA Los Angeles, California, USA
Walter Reinisch, MD
Associate Professor of Gastroenterology Medical University Vienna Vienna, Austria
Simon Travis, DPhil, FRCP
Professor of Clinical Gastroenterology, University of Oxford Consultant Gastroenterologist, John Radcliffe Hospital Oxford, United Kingdom
Agenda
17:45–18:00 Registration 18:00–18:05 Opening Remarks and Objectives 18:05–19:30 Experts Discuss Real World Considerations
Objectives
• Discuss key questions involved in evaluating a data package for a biosimilar
• Highlight study design approaches for biosimilar clinical trials
• Clarify extrapolation, immunogenicity, and other www.AmgenBiosimilarSymposium.com considerations for biosimilar use in IBD
This symposium is not affiliated with UEG.
© 2017 Amgen Inc. All rights reserved. Not for reproduction.
Public Transportation : UEG Week Final Programme
309
UEG Week Final Programme : Acknowledgements
Acknowledgements (in alphabetical oder)
UEG gratefully acknowledges the support of the following companies: Premium Partners AbbVie
Olympus Europa SE & Co. KG
FUJIFILM
Pfizer
Janssen
Takeda Pharmaceuticals International AG
Major Partners Allergan Pharmaceuticals International Ltd
MEDTRONIC
Boehringer Ingelheim Pharma GmbH & Co KG
Norgine
CELLTRION HEALTHCARE
PENTAX EUROPE GmbH
MSD
Shire International GmbH
General Sponsors and Exhibitors 3D Matrix EMEA B.V 3D Systems Simbionix ACTIAL FARMACEUTICA SRL Alfasigma S.p.A Alton (Shanghai) Medical Instruments co., Ltd amg Amgen Ankon ANREI MEDICAL Apollo Endosurgery Bayer Consumer Health BCM Co., Ltd Bedfont Scientific Beijing Richen-Force Holdings BHT Hygienetechnik GmbH Biocodex BioGaia 310
Biohit Oyj Biomedal Boston Scientific BÜHLMANN Laboratories AG CALPRO AS Cantel CapsoVision Casen Recordati S.L CBC Group Celgene Corporation Changzhou Dahua Group/Citec Choyang Medical Cook Medical Creo Medical Ltd. Dr. Falk Pharma GmbH Dr. Henke Medical Training & Education ELLA-CS
Acknowledgements : UEG Week Final Programme
General Sponsors and Exhibitors EMcision International Inc. EMED SP. Z O. O. SP. K. EndoAid Ltd. EndoClot Plus, Inc. Endoscopic Ultrasound Journal Endoscopy / ESGE - Thieme EndoSim Europe GmbH Endotics Erbe Elektromedizin GmbH Eurospital Exalenz F. Hoffmann La Roche Ferring Pharmaceuticals Finemedix Co., Ltd Fischer Analysen Instrumente GmbH GE Healthcare Genetic Analysis AS GI Supply Gilead Sciences Grifols Hangzhou AGS MedTech Co., Ltd. Huger Medical Instrument Co., Ltd Immundiagnostik AG INFAI GMBH Innovex Medical Co. Ltd. Insitumed GmbH Intercept Pharmaceutical Europe Ltd Intromedic Co., Ltd. invendo medical GmbH Jiangsu ATE Medical Technology Co., Ltd Jinshan Science & Technology Karger Publishers KARL STORZ GMBH & CO. KG LA LETTRE DE L'HEPATO-GASTROENTEROLOGUE LABORIE Leo Medical Co., Ltd. Life Partners Europe Lumendi M.I. Tech Ltd. Mauna Kea Technologies Mayoly Spindler Mederi Therapeutics Inc. Medify Medi-Globe GmbH/ Endo-Flex GmbH MEDITALIA S.A.S. Mednova medwork GmbH
YOU THANK R Micro-Tech-Europe GmbH FOR YOU ! T MTW-Endoskopie SUPPOR NEXTBIOMEDICAL Co.,Ltd. NIKKISO Niso Biomed srl Noventure Ovesco Endoscopy AG Oxford University Press Oy Medix Biochemica Ab Peter Pflugbeil GmbH Medizinische Instrumente PrecisionBiotics Ltd Probiotics International Ltd (Protexin) Prometheus Laboratories Inc. R-Biopharm Reckitt Benckiser Robarts Clinical Trials B.V. Samsung Bioepis Sandhill Scientific Sandoz Biopharmaceuticals Shangxian Minimal Invasive Inc. SHENZHEN ZHONGHE HEADWAY BIO-SCI & TECH CO., LTD Shionogi Europe Ltd SMART Medical Systems Ltd. SOFAR SPA SOLUSCOPE SonoScape Medical Corp. Standard Sci-Tech Inc. STEELCO SPA STERIS SUMITOMO BAKELITE CO., LTD. Surgical Science Sweden AB Taewoong Medical Co., Ltd TEAC Europe GmbH The Lancet The Standard Co., Ltd Tillotts Pharma AG Tristel US Endoscopy Vital Therapies, Inc. W.L. Gore & Associates GmbH Walz Elektronik Wassenburg Medical B.V. WILSON INSTRUMENTS (SHA) CO., LTD Wilson Therapeutics AB Wisepress Ltd Zhuji Pengtian Medical Instrument Co.,Ltd
311
TAKING GIANT STRIDES FORWARD in helping to diagnose and monitor gastrointestinal diseases
Barrx™ 360 Express RFA Balloon Catheter
PillCam™ SB 3 System Advanced imaging and visualization of the small bowel with capsule endoscopy The Beacon™ EUS delivery system features interchangeable FNA and FNB needles.
IMPORTANT: Please refer to the package insert for complete instructions, contraindications, warnings and precautions. © 2017 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. ™* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. 17-uegw-program-advertisement-en-2000212
Scan the QR code to download your FREE guide to Barrx™ Radiofrequency Ablation
List of Exhibitors and Exhibition Floor Plans Technical Exhibition UEG Week is accompanied by a major technical exhibition taking place in Hall 8.1.
Opening Hours Monday October 30 09:00 – 17:00 Tuesday October 31 09:00 – 17:00 Wednesday November 1 09:00 – 14:00
UEG Week Final Programme : List of Exhibitors and Exhibition Floor Plan
List of Exhibitors (in alphabetical oder) Premium Partners
Booth No.
Major Partners
Booth No.
AbbVie 36 AbbVie 48 FUJIFILM 43 Janssen 59 Janssen 58 OLYMPUS Europa SE & Co. KG 81 Pfizer 41 Pfizer 42 TAKEDA Pharmaceuticals International AG 82 TAKEDA Pharmaceuticals International AG 93
Allergan Pharmaceuticals International Ltd 37 Boehringer Ingelheim Pharma GmbH & Co KG 55 CELLTRION HEALTHCARE 92 MEDTRONIC 24 MSD 60 Norgine 56 PENTAX EUROPE GmbH 111 Shire International GmbH 94 Shire International GmbH 40
General Exhibitors
General Exhibitors
Booth No.
3D Matrix EMEA B.V 125 3D Systems Simbionix 87 ACTIAL FARMACEUTICA SRL 71 Alfasigma S.p.A 54 Alton (Shanghai) Medical Instruments co., Ltd 53 amg 105 Ankon 63 ANREI MEDICAL 119 Apollo Endosurgery 2 BCM Co., Ltd 97 Bedfont Scientific Ltd. 45 Beijing Richen-Force Holdings 120 BHT Hygienetechnik GmbH 98 Biocodex 121 BioGaia 88 Biohit Oyj 17 Biomedal 66 Boston Scientific 23 BÜHLMANN Laboratories AG 64 CALPRO AS 103 Cantel 80 CapsoVision 117 Casen Recordati S.L 52 CBC Group 15 Celgene Corporation 112 Changzhou Dahua Group/Citec 65 Choyang Medical 139 Cook Medical 85 Creo Medical Ltd. 14 Dr. Falk Pharma GmbH 86 Dr. Henke Medical Training & Education 116 ELLA-CS 130 314
Booth No.
EMcision International Inc. 100 EMED SP. Z O. O. SP. K. 3 EndoAid Ltd. 135 EndoClot Plus, Inc. 18 Endoscopic Ultrasound Journal 8 Endoscopy / ESGE - Thieme 9 EndoSim Europe GmbH 76 Endotics 110 Erbe Elektromedizin GmbH 61 Eurospital 127 Exalenz 31 F. Hoffmann La Roche 108 Finemedix Co., Ltd 140 Fischer Analysen Instrumente GmbH 114 GE Healthcare 132 Genetic Analysis AS 90 GI Supply 32 Gilead Sciences 35 Grifols 126 Hangzhou AGS MedTech Co., Ltd. 26 HITACHI Medical System / PENTAX EUROPE GmbH 111 Huger Medical Instrument Co., Ltd 67 Immundiagnostik AG 134 INFAI GMBH 44 Innovex Medical Co. Ltd. 133 Insitumed GmbH 27 Intercept Pharmaceutical Europe Ltd 115 Intromedic Co., Ltd. 49 invendo medical GmbH 77 Jiangsu ATE Medical Technology Co., Ltd 33 Jinshan Science & Technology 74 Karger Publishers 7
List of Exhibitors and Exhibition Floor Plan : UEG Week Final Programme
General Exhibitors
Booth No.
KARL STORZ GMBH & CO. KG 47 LA LETTRE DE L'HEPATO-GASTROENTEROLOGUE 16 LABORIE 62 Leo Medical Co., Ltd. 28 Life Partners Europe 109 Lumendi 123 M.I. Tech Ltd. 57 Mauna Kea Technologies 89 Mayoly Spindler 91 Mederi Therapeutics Inc. 34 Medify 136 Medi-Globe GmbH/ Endo-Flex GmbH 39 MEDITALIA S.A.S. 19 Medix Biochemica 129 Mednova 38 medwork GmbH 46 Micro-Tech-Europe GmbH 69 MTW-Endoskopie 131 NEXTBIOMEDICAL Co.,Ltd. 68 NIKKISO 10 Niso Biomed srl 1 Noventure 13 Ovesco Endoscopy AG 124 Oxford University Press 5 Peter Pflugbeil GmbH Medizinische Instrumente 70a PrecisionBiotics Ltd 20 Probiotics International Ltd (Protexin) 72 Prometheus Laboratories Inc. 128 R-Biopharm 113 Reckitt Benckiser 84 Robarts Clinical Trials B.V. 12 Sandhill Scientific 21 Sandoz Biopharmaceuticals 50 Shangxian Minimal Invasive Inc. 122 SHENZHEN ZHONGHE HEADWAY BIO-SCI & TECH CO., LTD 138 Shionogi Europe Ltd 137 SMART Medical Systems Ltd. 75 SOFAR SPA 107 SOLUSCOPE 22 SonoScape Medical Corp. 83 Standard Sci-Tech Inc. 11 STEELCO SPA 101 STERIS 4 SUMITOMO BAKELITE CO., LTD. 78 Surgical Science 102 Taewoong Medical Co., Ltd 95 TEAC Europe GmbH 30 The Lancet 6
General Exhibitors
Booth No.
The Standard Co., Ltd 104 Tristel 96 US Endoscopy 25 Vital Therapies, Inc. 51 W.L. Gore & Associates GmbH 106 Walz Elektronik 70 Wassenburg Medical B.V. 99 WILSON INSTRUMENTS (SHA) CO., LTD 79 Wilson Therapeutics AB 29 Wisepress 118 Zhuji Pengtian Medical Instrument Co.,Ltd 73 Members Village - Hall 8.0
Booth No.
EAES MV06 EAGEN MV12 EASL MV01 ECCO MV14 EDS MV13 EFISDS MV05 EHMSG MV09 EPC MV02 ESCP MV07 ESDO MV04 ESGAR MV10 ESGE MV11 ESNM MV03 ESPCG M V 0 8 Association & Future Events Area – Hall 8.0 Booth No. 4th Athens International Symposium 2018 AFA10 Asociación Mexicana de Hepatología AFA12 EFCCA AFA14 Egypt Gastro Hep Congress AFA09 Ehlers-Danlos Society AFA15 ENDO LIVE ROMA 2018 AFA07 European Section and Board of Gastroenterology and Hepatology - ESBGH AFA05 GEEW AFA06 International Society for Diseases of the Esophagus - ISDE AFA11 Portuguese Society of Gastroenterology - SPG AFA01 Rome Foundation AFA08 Sage AFA13 Turkish Society of Gastroenterology AFA02 World Endoscopy Organization - WEO AFA03 World Gastroenterology Organisation - WGO AFA04 315
316
Press Centre
UEG Week Hotspot E-Poster Lounges Poster Exhibition
to Halls 6/7
Internet Centre
c
Catering Kiosk
64
59
60
57
61
62
74
54
55
56
75
76
77
51
50
49
80
53 52
81
78
General Exhibitors
Catering Kiosk c
Catering
58
65
66
68 63 67
69
70 70a 71 72 73
Hall 8.1
Entrance to Hall 8.1
Premium Partners / Major Partners
Escalators to Halls 6/7
79
45 44
46
47
48
83
84
41
37
36
Entrance to Hall 8.1
43
42
91
89 90
Exhibition
93
92
86
38
35
34
25
109
108
111
110
107
24
102 105 106
103 104
c Catering Kiosk
39
40
94
95
96 101
97 100
98 99
Escalators to Registration Area and Session Rooms in Hall 8.0
82
85
Catering
87 88
c Catering Kiosk
21
17 18 15
19
112
113
114
22
23
20
16
125
122 123 124
121
126
13
11
1
2
3
4
7 6 5 14
8
9
140
139
138
137
136
135
134
12
10
131
128 132 129 130
127 133
c Catering Kiosk
UEG Meeting Room 1
Meeting Rooms 8.1 – 8.30
UEG Office
Entrance to Hall 8.1
Exhibitor Service Desk Freight Forwarding
32 29 31 30
33 28
27
26
115
118 119
116 120
117
Networking & Live Streaming Area
Hall 8.1
Catering
Hall 8.1
UEG Week Final Programme : List of Exhibitors and Exhibition Floor Plan
List of Reviewers
UEG Week Final Programme : Letter of Thanks
Letter of Thanks
Dear Colleagues, On behalf of the UEG Scientific Committee, I would like to take this opportunity to thank you most sincerely for your contribution as an abstract reviewer for the original programme of the 25th UEG Week Barcelona 2017. The abstract reviewing process has been again very important this year with a number of innovations introduced to improve especially the poster abstract presentations. I know just how much time and effort reviewing abstracts takes, but without your expertise we would not have the quality that I believe we have achieved in the free paper and poster sessions, and UEG Week would not be the top international digestive diseases meeting that it has become today. Thank you! We received a number of 3,438 abstracts in total for UEG Week Barcelona 2017. In total, 2,341 abstracts were accepted, giving an acceptance rate of 68,13%. 378 abstracts will be delivered as oral presentations and 1,963 as posters. I am even more pleased to tell you that standards have again reached a very high level and we can expect to be exposed to most interesting research and great presentations.
318
This high volume and high standard confirm that UEG Week is the most important forum at which to present your best research. We have received 95 video cases which were formally evaluated by the Scientific Committee for presentation in Barcelona. As in previous years, late breaking abstracts have been scored by the Scientific Committee for presentation in Vienna. The quality of reviewing this year was excellent, but if you have any further (positive or negative) comments, please do let us know! Finally, but most importantly, thanks to all investigators both within and outside Europe who have submitted their research to the meeting, and who are clearly contributing to making the 25th UEG Week Barcelona 2017 such a great success!
Magnus Simrén Chair, UEG Scientific
List of Reviewers : UEG Week Final Programme
List of Reviewers
A Aabakken, Lars Abraldes, Juan Acalovschi, Monica Adamina, Michel Adar, Tomer Adham, Mustapha Adolph, Timon Erik Aghemo, Alessio Agréus, Lars Albano, Emanuele Algül, Hana Allez, Matthieu Almasio, Piero Luigi Almeida, Raquel Andresen, Viola Annibale, Bruno Arlt, Alexander Armengol-miro, Jose Ramon Arvanitakis, Marianna Atherton, John Azpiroz, Fernando B Baert, Filip Bahr, Matthias J. Balaguer, Francesc Barbu, Sorin Traian Basoli, Antonio Baumgart, Daniel C. Bazzoli, Franco Beaugerie, Laurent Beglinger, Christoph Beldi, Guido Benamouzig, Robert Bendtsen, Flemming Bergquist, Annika Biancone, Livia Biesiekierski, Jessica Binder, Henry J. Binek, Janek Bisschops, Raf Böcker, Ulrich Boeckxstaens, Guy E. Boermeester, Marja A.
Bor, Serhat Bories, Erwan Bornschein, Jan Bouhnik, Yoram Bourreille, Arnaud Bredenoord, Albert Jan Bruno, Marco J. Bures, Jan Burisch, Johan Burra, Patrizia Buscarini, Elisabetta Bytzer, Peter C Caca, Karel Capurso, Gabriele Cardenas, Andres Carneiro, Fatima Carter, Ross Caseiro Alves, Filipe Castiella Eguzkiza, Agustin Castro, Rui Castro, Valeria Cellier, Christophe Chamaillard, Mathias Chmiela, Magdalena Cholongitas, Evangelos Colombel, Jean-Frederic Corsetti, Maura Cortez-Pinto, Helena Costamagna, Guido Cottone, Mario Cravo, Marilia Cremers, Isabelle D D'Haese, Jan Goesta de Franchis, Roberto De Giorgio, Roberto de Knegt, Robert J. De Palma, Giovanni De Wit, Niek J. de-Madaria, Enrique Dejaco, Clemens Dekker, Evelien
Del Chiaro, Marco Delhaye, Myriam Delladetsima, Johanna Depoortere, Inge Deprez, Pierre Henri Deviere, Jacques di Pietro, Massimiliano Dignass, Axel Dinis-Ribeiro, Mario Dorta, Gian Drenth, Joost P.H. Drewes, Asbjørn Dziki, Adam E Eisendrath, Pierre El-Omar, Emad Eliakim, Rami Emmanuel, Anton Enck, Paul Ensari, Arzu Esmat, Gamal F Färkkila, Martti A. Ferenci, Peter Ferrante, Marc Ferreira, Rui M. Fewtrell, Mary Fichna, Jakub Fitzgerald, Rebecca Clare Floreani, Annarosa Fockens, Paul Ford, Alexander Charles Fox, Mark Francoz, Claire Friess, Helmut Froehlich, Florian Fujishiro, Mitsuhiro G Gangl, Alfred Gasbarrini, Antonio Gemilyan, Manik Ghaneh, Paula
Ghia, Jean-Eric Giangregorio, Francesco Gionchetti, Paolo Giovannini, Marc Gisbertz, Suzanne S. Goetz, Martin Gomes de Sousa, Rita Graf, Rolf Graziadei, Ivo Gress, Thomas M. Grgurevic, Ivica Grundy, David H Haddad, Fouad Hahnloser, Dieter Halfvarson, Jonas Hammad, Essam Hammer, Heinz Florian Handra-Luca, Adriana Hassan, Cesare Hatakeyama, Masanori Havre, Roald Flesland Hegyi, Peter Heieck, Frank Helmberger, Thomas Herszényi, László Hofer, Harald Hojsak, Iva Holleran, Grainne Hovde, Øistein Huberty, Vincent Hytiroglou, Prodromos I Iacopini, Giampaolo Ianiro, Gianluca Ibrahim, Mostafa Ilan, Yaron Ilie, Madalina Irving, Peter J Jackson, Simon Jansen, Peter L. M. Jenkins, Ian
319
UEG Week Final Programme : List of Reviewers
K Karagiannis, John Kaukinen, Katri Kelly, Paul Keszthelyi, Daniel Kida, Mitsuhiro Kleger, Alexander Knowles, Charles H. Koletzko, Berthold Koletzko, Sibylle Kolho, Kaija-Leena Koning, Frits Kori, Michal Korponay-Szabo, Ilma Rita Kramer, Ludwig Krishnadath, Kausilia K. Kuipers, Ernst J. Kurppa, Kalle L Lackner, Karoline Laghi, Andrea Laharie, David Lakatos, Peter László Lamarque, Dominique Lambregts, Doenja M. Langner, Cord Laukkarinen, Johanna Leedham, Simon Leicester, Roger Leja, Marcis Lemmers, Arnaud Lennon, Anne Marie Leroi, Anne Marie Lévy, Philippe Lindberg, Greger Lindley, Keith Lindsay, James Löhr, Matthias Lopes, Ana Isabel Louis, Hubert Louis, Edouard Lügering, Andreas Lugli, Alessandro Lundin, Knut E.A. Luzza, Francesco M Maaroos, Heidi-Ingrid Maaser, Christian Machado, Jose Carlos L.
320
Machado, Mariana Luisa Moutinho Verdelho Makristathis, Athanasios Malagelada, Juan Ramon Malagelada, Carolina Manns, Michael Manolakopoulos, Spilios Mantzaris, Gerassimos Marinho, Rui Tato Marquardt, Jens Uwe Marteau, Philippe Marti-Bonmati, Luis Martinek, Jan Masclee, Ad Mcalindon, Mark McColl, Kenneth E. L. McLaughlin, John Mearín Manrique, Fermin Megraud, Francis Meier, Peter Meining, Alexander Meisner, Soren Menu, Yves Michetti, Pierre Michl, Patrick Milashka, Mariana Milosavljevic, Tomica Mion, Francois Moehler, Markus Moeller, Soeren Morino, Mario Moschen, Alexander R. Mulder, Chris J.J. Muñoz Navas, Miguel Murray, Charles Musso, Alessandro Myrelid, Pär N Nakajima, Takeshi Nardone, Gerardo Naylor, Gregory Neesse, Albrecht Ness-Jensen, Eivind Neuberger, James Neufert, Clemens Neuhaus, Horst Neunlist, Michel Ng, Siew Chien Nielsen, Ole Haagen Nowakowska-Dulawa, Ewa
O O'Morain, Colm Odes, Shmuel Ohlsson, Bodil Öhman, Lena Okolicsanyi, Lajos Oliveira, Carla Oliveira, Claudia Öresland, Tom P Pace, Fabio Palsson, Olafur S. Papadopoulou, Alexandra Papanikolaou, Ioannis Papatheodoridis, Georgios Pár, Alajos Parola, Maurizio Pech, Oliver Peck-Radosavljevic, Markus Pedersen, Natalia Peeters, Harald Penagini, Roberto Pereira, Stephen Perez Gisbert, Francisco Javier Pérez-Miranda, Manuel Petrosillo, Nicola Peyrin-Biroulet, Laurent Plentz, Ruben Pohl, Daniel Pokrotnieks, Juris Prifti, Skerdi Püspök, Andreas Q Quante, Michael Quintero Carrion, Enrique R Racz, Istvan Ragunath, Krish Rakonczay, Zoltan Ramadori, Giuliano Rautou, Pierre-Emmanuel Rebours, Vinciane Reenaers, Catherine Regula, Jaroslaw Reif, Shimon Ricart Gomez, Elena
Ricciardiello, Luigi Riis, Lene Buhl Risio, Mauro Rodrigues, Cecília Maria Pereira Rogler, Gerhard Rokkas, Theodore Roman, Sabine Romano, Marco Ronkainen, Jukka Rösch, Thomas Rosendahl, Jonas Rossini, Francesco Paolo Rubin, Gregory Rudler, Marika Russo, Francesco Paolo Ruszniewski, Philippe S Salaga, Maciej Salupere, Riina Sanders, David Surendran Santos, Javier Sarnelli, Giovanni Savarino, Edoardo Savarino, Vincenzo Scharl, Michael Schemann, Michael Schöfl, Rainer Schölmerich, Jürgen Schoon, Erik Jan Schreiber, Stefan Schrumpf, Erik Seifert, Bohumil Sekiguchi, Masau Serag Zakaria, Khaled Serra, Jordi Seufferlein, Thomas Shamir, Raanan Sheridan, James P. Shirin, Haim Siegmund, Britta Siersema, Peter D. Sifrim, Daniel Simrén, Magnus Singh, Baljit Siveke, Jens T. Smout, André Sokol, Harry Sookoian, Silvia Spada, Cristiano Spiller, Robin
List of Reviewers : UEG Week Final Programme
Spinelli, Antonino Sporea, Ioan Staiano, Annamaria Stallmach, Andreas Stauber, Rudolf Stengel, Andreas Stieger, Bruno Stoyanova, Daniela Sung, Joseph Jao Yiu Syn, Wing-Kin T Tack, Jan Tacke, Frank Tamori, Akihiro Targarona, Eduardo Taylor, Stuart Thabut, Dominique Theodorou, Vassilia Thorlacius, Henrik Tilg, Herbert Tiniakos, Dina
Tomazic, Ales Tomlinson, Ian Törnblom, Hans Torres, Joana Tözün, Nurdan Trifan, Anca-Victorita Troncone, Riccardo Trovato, Cristina Maria Trukhmanov, Alexander Tsochatzis, Emmanuel Tulassay, Zsolt Turner, Dan Tutuian, Radu U Uranues, Selman Uraoka, Toshio V Vaira, Berardino Valantinas, Jonas Válek, Vlastimil
van Berge Henegouwen, Mark Ivo Van Cutsem, Eric van der Woude, C. Janneke van Eijck, Casper H.J. van Herwaarden, Yasmijn Van Hootegem, Philippe Van Kemseke, Catherine Van Laethem, Jean-Luc van Leerdam, Monique Van Oudenhove, Lukas Veereman, Gigi Veres, Gabor Laszlo Vermeire, Severine Vilmann, Peter Vinter-Jensen, Lars Vlachogiannakos, John Vogel, Arndt Vogel, Wolfgang von Hahn, Thomas Vucelic, Boris
W Walker, Marjorie Watson, Alastair Welsch, Christoph Whitehead, William E. Wilder-Smith, Clive Wittenburg, Henning Wolthuis, Albert Y Yamaoka, Yoshio Yao, Kenshi Z Zachou, Kalliopi Zaninotto, Giovanni Zeissig, Sebastian Zelinkova, Zuzana Zerbib, Frank Zins, Marc
Don’t wander alone – join our
Guided Poster Tours Dedicated guides will show you around their themed selection. The best opportunity to interact with the presenters! Open to all delegates, no registration is required. Meet us at the poster service desk on Mon–Wed at 12:30
321
Join us for a scientific symposium at
UEG WEEK BARCELONA 2017
Monday, 30 October
|
17:45–19:15
|
Fira de Barcelona Gran Via North Entrance – Hall 8 |
Room F3
Refreshments will be provided
PHARMACOLOGICAL AND CLINICAL PERSPECTIVES: The evolution of the treatment landscape and personalised medicine approaches for management of UC Clinical Implications of the Evolving Treatment Landscape in UC Peter Irving, MA, MD, FRCP Guy’s and St. Thomas’ Hospitals | London, United Kingdom
Emerging Therapies Targeting Mechanisms of UC Pathogenesis Silvio Danese, MD, PhD—Chair Humanitas Research Hospital | Milan, Italy
The Pharmacologist’s Perspective on Current and Emerging Treatment Options in UC Diane Mould, PhD (Pharmaceutics and Pharmaceutical Chemistry), FCP, FAAPS Projections Research, Inc. | Pennsylvania, United States
Funded and sponsored by Pfizer.
PP-GIP-EUR-1030
This symposium is not affiliated with UEG
Date of Preparation: September 2017
Index of Authors and Co-Authors
UEG Week Final Programme : Index of Authors and Co-Authors
Index of Authors and Co-Authors
A A K Silva, A............................. 173 Aabakken, L............37, 74, 99, 106 Aach, M.................................. 178 Aalbers, A...............................231 Aaltonen, J............................. 239 Aasbrenn, M............................ 52 Abalo, R..................................156 Abanades-Tercero, M...............153 Abazia, C.................................165 Abbas, Y.................................. 217 Abbassi, I................................218 Abbes, L................................. 229 Abbott, C. A.............................150 Abd El Kerim, A. A.................. 232 Abd El Rahman, A.................. 207 Abd El Wahab, M.................... 207 Abd el_Aziz, M.........................168 Abd-Elsalam, S........... 52, 115, 153 Abdalla, H................................96 Abdel Hamid, M.......................96 Abdel Rehim, A....................... 118 Abdel-Aziz, H...................150, 195 Abdel-Wahab, M.................... 220 Abdelfattah, A......................... 119 Abdelhafez, M........................ 224 Abdelkrim, Z........................... 177 Abdellah, M............................123 Abdellatif, E............................ 179 Abdellatif, Y..............................117 Abdelmoemen, G.................... 115 Abdelrahman, T........ 199, 232, 256 Abdulkhakov, R. A..............77, 234 Abdulkhakov, S. R........77, 164, 234 Abe, H............................. 181, 251 Abe, S...................78, 89, 123, 220 Abe, T................................ 61, 115 Abe, Y.....................................145 Abed, S.................................. 220 Abel, A. P................................ 187 Abel, J. L......................... 196, 245 Abellà-Ametller, C...................134 Abellán-Alfocea, P.............121, 197 Abergel, A.............................. 225 Abi Kheir, S.............................216 Abiko, S...................... 53, 128, 151 Abitbol, V.......75, 139, 185-186, 247 Aboelfotoh, A..........................123 Abols, A..................................193 Aboo, N.................................. 141 Abou Ali, E........................181, 221 Abou Rached, A......................216 Abou Saif, S............................ 115 Abougergi, M. S....71, 103, 153, 219
324
Abraham, L............................ 243 Abramowich, D........................69 Abramowitz, D....................... 252 Abreu García, L. E............. 207, 227 Abu-Taleb, H........................... 118 Abukawa, D.............................140 Accarino, A........................ 92, 145 Accarino, G............................ 238 Accomando, S........................ 238 Achkasov, S.............................210 Acikgoz, S. B.......................... 254 Adachi, S............................... 203 Adachi, T.............................79, 93 Adair, R. A...............................59 Adam, V..................................103 Adams, J.................................123 Adar, T.............................. 63, 207 Addamo, C............................... 78 Addolorato, G.................. 166, 256 Adedokun, O. J......................... 47 Aden, K............................ 135, 138 Adeoti, B................................. 127 Adinolfi, L. E........................... 119 Adler, A.................................. 255 Adler, D. G............................... 62 Adler, S. N............................... 131 Adolph, T. E..............................89 Adorini, L................................. 91 Adsul, S................................. 239 Aduna, M............................... 235 Aepli, P.................................... 72 Aerts, H. J. W. L.......................144 Afferri, M. T.............................138 Affronti, M..............................237 Afif, W..................................... 137 Afonso, J...........................187-188 Afonso, M. B............. 114, 164, 169 Afzali, A..................................139 Agar, K....................................227 Agardh, D.................................94 Agarwal, J............................... 157 Agarwal, M............................. 151 Agarwala, R............................159 Agawa, S.......................... 173, 198 Aggarwal, N............................155 Aghamohammadi, E................154 Aghemo, A.........39, 42, 77, 95, 212 Agnholt, J................................155 Agossa, K................................135 Agostinho, L............................233 Agostini, M............................200 Agranovich, I...........................153 Agrawal, A..............................126 Agréus, L..................49, 53, 61, 71
Aguade-Bruix, S..................... 244 Aguas, M............................... 235 Agudo Castillo, B.................... 207 Aguirre, E................................ 63 Agus, A................................ 71-72 Ah-Soune, P........................... 222 Ahıshalı, E............................. 244 Ahlem, B................... 138, 168, 183 Ahlenstiel, G...........................128 Ahluwalia, J........................... 220 Ahmad, T.................................80 Ahmed, A. M..................... 117, 133 Ahmed, M...............................134 Ahmed, S.................................50 Ahmed, S. U........................... 220 Ahn, C.....................................165 Ahn, D.-W...............................130 Ahn, I..................................... 127 Ahuja, N. K.............................. 62 Aichinger, E.............................231 Aida, B. S................................138 Aihara, Y................................. 167 Ainin, A. F............................... 217 Ainora, M. E............................215 Aissaoui, M......................185, 257 Aissat, Y...........................185, 257 Ait errami, A.......................... 253 Aithadad, H.............................194 Aithal, G................................ 208 Aiura, K..................................124 Aizawa, N............................... 167 Ajana, F. Z...........168, 218-219, 254 Akagi, M...........................134, 191 Akaike, K................................. 147 Akamatsu, T............................126 Akamine, E.............................126 Akao, Y....................................144 Akasaka, T......................... 85, 201 Akashi, T................................ 252 Akazawa, Y.... 93, 147, 174, 202, 252 Akgün, B................................ 256 Akhapkin, N............................231 Akhmadullina, O.....................155 Akiho, H..................................123 Akimoto, N.............................. 178 Akimoto, T...................82, 173-174, 198, 201, 225 Akinola, O............................... 176 Akita, M................................. 243 Akizue, N......................... 124, 176 Akkoc, T.................................. 114 Ako, S.....................................219 Akpınar, H....................... 234, 236 Akpinar, Z...............................148
Aktan, C..................................143 Aktar, R.................................. 248 Akutagawa, K............ 187, 193, 234 Akutsu, D................................ 191 Al Abbas, A. I........................... 52 Al Ghamry, F............................123 Al Hajjar, N..............................64 Al Kaabi, S..............................216 Al-Azzawi, Y........................... 254 Al-Batran, S.-E......................... 92 Al-Hasani, H........................... 151 Al-Tarrah, M............................135 Alaa, M................................... 181 Aladag, M...............................170 Alakkari, A..............................186 Alami, R................................... 52 Alaoui, H. B........................... 255 Alarcon, P................................136 Albadry, M..............................164 Albanese, I.............................. 187 Albéniz Arbizu, E............. 125, 175, 177-178, 257 Alberghina, N......................... 238 Albers, D.................................. 53 Albert, J................66, 88, 162, 231 Alberti, L. R.............................155 Alberto, L..................228, 234-235 Alberto, S.................................117 Albertoni, L............................ 234 Albillos, A........................116, 248 Alboraie, M................. 116-117, 164 Albouys, J.....................53, 177-178 Albrecht, H..............................148 Albrecht, P...............................195 Albuquerque, A................196, 218 Albuquerque, C................159, 222 Alcedo, J................................ 253 Aldave, A................................152 Aldeguer, X.............................237 Aleixo, M. J..............................158 Alekberzade, A........................183 Aleman, B. M..........................192 Aleman, S.......................... 38, 95 Alempijevic, T..........................165 Alenda, C................................143 Aleotti, F................................ 242 Aleshicheva, A......................... 173 Alexandrino, G.................207-208 Alexandrino, P......................... 167 Alfambra, E.............................136 Alfaro, E.............................71, 253 Alfaro-Almajano, E....................71 Alferink, L. J. M........................48 Alfieri, R.................. 182, 200, 232
Index of Authors and Co-Authors : UEG Week Final Programme
Alfthan, H................................ 91 Algaba Garcia, A.................... 226 Alguacil, J...............................143 Alguacil Cuéllar, M..................125 Algül, H.............................72, 122 Alhanaee, A............................237 Ali, A................................ 87, 205 Ali, J......................... 138, 168, 183 Ali, Y........................................ 93 Ali-Eldin, Z..............................117 Ali Malek-Hosseini, S........ 65, 165, 216, 218 Aliarous, N............................. 253 Alias, B..................................200 Alin, S.............................204, 253 Alina, T.................................. 224 Alisi, A................................... 205 Alissa, L................................. 243 Alivernini, S............................. 75 Alkaade, S...............................145 Alkelin, L.................................231 Alkim, C................................. 236 Alkim, H................................. 236 Allegretta, L........................... 203 Allen, M..................................159 Allez, M.............35, 40, 47, 63, 73, 75, 94, 100, 137, 240 Allimant, C........... 80, 83, 186, 225 Allocca, M........................ 137, 240 Alm, E...................................... 70 Almeida, J.............................. 256 Almeida, N.........219, 223, 229, 253 Aloi, M....................... 135, 190-191 Alonso, P................................. 178 Alonso Abreu, I...................... 235 Alonso Cotoner, C..................... 57 Alonso-Riaño, M..................... 127 Alos, R............................. 233-234 Alperovich, G............. 101-102, 139 Alrajhi, S................................. 137 AlSafadi, A. M......................... 133 Alsardi, L................................120 Altwegg, R.................... 73, 75-76, 80, 139, 185-186 Alustiza, J. M........................... 115 Alustiza, M.................. 63, 115, 143 Alvarado-Escobar, H...........49, 174 Alvarez, M. A.................... 125, 178 Alvarez-Builla, N.................... 235 Álvarez-Castro, A............... 71, 220 Alvarez Delgado, A............175, 178 Álvarez-Urturi, A.................... 244 Alvarez Urturi, C................63, 245 Alves, A. L...............................215 Alves de Matos, A............. 157, 210 Alvisi, P.......................97, 185, 190 Alzina-Pérez, A........................128 Alzoubaidi, D..........................148 Amado, C............................... 258 Amalou, K........................ 158-159
Amani, D.................................154 Amano, N................................198 Amano, S.........................219, 222 Amano, Y.........................252-253 Amaral, A. J.............................164 Amaro, M................................. 52 Amaro, P...................126, 166, 232 Amaryan, G............................. 157 Amata, M.................................99 Amato, A................................ 228 Amato, L.................................156 Amato, M. R............................ 174 Amer, M.-E.............................164 Amiano, P...............................143 Amigo, N................................145 Amil, M...................................185 Amine, E. M.............. 158, 177, 240 Aminian, A.............................. 197 Amiot, A................73, 75, 139, 186 Amir, Z. C........................ 185, 253 Amira, H. G............................ 242 Amjahdi, A............................. 256 Amlani, B................................136 Ammar, N........................178, 225 Amodio, A........... 121, 171, 209, 221 Amoedo, J...............................237 Amoruso, A.............................154 Amos, D..................................145 Amrani, N................................54 Amvrosiadis, G................ 219, 244 Amzolini, A.............................165 An, F............... 59, 95, 111, 118, 127, 139, 144, 148, 157, 161, 164, 187, 200, 211, 228, 233-234, 242, 256-257 An, W................................ 52, 187 Ananthakrishnan, A. N............190 Ananthanarayanan, M..............117 Anapaz, V. L............................ 217 Anderloni, A............. 156, 219, 222, 224, 228, 244 Anders, M................................ 76 Andersen, J. B.......................... 91 Andersen, N. N........................ 101 Anderson, J...............223, 225-226 Anderson, R....................... 56, 64 Anderson, S............................156 Ando, T....................................85 Andoh, A.......126, 129, 137, 171, 203 Andrade, A......... 159, 168, 188, 201 Andrae, D. A............................196 Andraska, E............................ 245 Andreasson, A.........................143 Andreea, F.............................. 256 Andreone, P............................. 91 Andreozzi, P........ 146-147, 225-226 Andrés Esteban, E. M.............. 226 Andresen, V................. 71, 154, 195 Andreu-García, E.................... 245 Andreu Garcia, M................... 244
Andrews, J. M.....64, 140, 146, 245 Andrisani, G............................ 181 Andriulli, A.................117, 167, 189 Angeletti, S...................... 124, 127 Angeli, P.................................166 Angelidou, I............................134 Angelison, L............................189 Angermann, Q.........................128 Angkathunyakul, N..................165 Angriman, I.......... 86, 141, 192, 231 Ankersen, D. V.................. 136, 138 Annareddy, D.......................... 133 Annese, V...................... 54, 67, 83 Annibale, B............... 124, 146-147, 155, 199 Annicchiarico, B. E........... 215, 218 Ansari, S.................................216 Ansell, J...................................90 Antal-Szalmas, P................61, 136 Antico, A...................113, 128, 142, 202, 241, 247-248 Antipova, M............................. 132 Antle, S.................................. 242 Antolić, M...............................183 Antonelli, G.............................166 Antonelli, M............................166 Antonello, A.....................182, 223 Antoni, M................................185 Antonini, F..............................130 Antonov, K.............................. 217 Antor, M..................................183 Anttila, V.-J.............................241 Antunes, A. G............215, 228, 241 Antunes, T...............................221 Anzai, S................................... 97 Aoki, H....................... 98, 193, 243 Aoki, T..................................... 167 Aomari, A.............................. 256 Aouattah, T.............................102 Aoucheta, D............................135 Aoyama, T......................... 69, 142 Apalset, E............................... 204 Aparicio, J. R...........................143 Apessou, D..............................125 Apicella, I................................ 174 Appadurai, I........................... 232 Appenrodt, B..........................146 Appleby, V............................... 132 Ara, N........................143, 155, 197 Arabacı Çetin, S...................... 256 Aracelia, M. P..........................188 Arafa, M. M............................. 217 Aragonés, N............................143 Arai, J.....................................142 Arai, M...................... 124, 145, 176 Arain, M..................................145 Arajol, C...........................196, 235 Arakawa, T.............................. 147 Aralica, G................................183 Arama, V................................. 116
Arampatzioglou, A..................134 Aranda, R.............................47, 61 Arantes, V. N...........................155 Arao, M....................................85 Arastu, Z................................ 246 Arau, B....................................56 Araújo, R........................ 207, 228 Araujo, T.................................210 Arbelaiz, A..........................91, 117 Arber, N.................... 181, 242-243 Archer, T..................................135 Archibugi, L........ 59, 172, 222, 230 Arcidiacono, D........................ 223 Arcidiacono, P. G..............122, 172, 222, 230 Ardanaz, E..............................143 Ardengh, J. C...........................221 Ardizzone, S..........97, 177, 185, 239 Arebi, N..................... 96, 134-135, 185, 233-234 Arechavaleta Tabuenca, S.......200 Arelaki, S................................134 Arena, I............................225-226 Arena, M.................................156 Arévalo-Rodríguez, M...............56 Argüelles-Arias, F....................189 Arguero, J......................... 69, 247 Ari, L........... 139, 149, 242-243, 248 Arias García, L.........................139 Arias-González, L............ 149, 248 Arias, Á........................... 149, 248 Aridi, H. D.......................... 52, 62 Arieira, C.................. 186, 216, 257 Arikawa, T........................ 133, 182 Arima, S........................... 121, 186 Arimoto, J...............................155 Ariño, I..............................77, 104 Arioli, S...................................156 Aripov, A. N............................. 157 Ariyoshi, R................ 223-224, 251 Arıcıoğlu, F............................. 256 Arjona Ferreira, J. C...........90, 195 Arkkila, P.................................241 Arlt, A.....................................102 Armellini, E.............................130 Armendariz-Borunda, J........... 116 Armengol-Debeir, L............76, 135 Armerding, P...........................140 Armstrong, D............................ 87 Armuzzi, A............. 49, 53, 60, 75, 80, 96-97, 100, 155, 185, 239-240 Arnelo, U................................120 Arnhard, K...............................89 Arnheim Dahlström, L..............49 Arnhold, J...............................190 Arnoletti, J. P...........................103 Aro, P........................................71 Arola, J.................................... 91 Arrigo, S.................................190
325
UEG Week Final Programme : Index of Authors and Co-Authors
Arrizabalaga, B....................... 115 Arroja, B.................................183 Arroyo Villarino, T.............136, 253 Arslan Kucuk, T....................... 244 Artesiani, M. L......................... 197 Arulmani, U............................190 Arumugam, M.................... 50, 63 Arvanitakis, M..........35-36, 54-55, 81, 107, 126, 207, 210 Asada, M................................ 167 Asadzadeh, H..........................154 Asahara, S.............................. 172 Asai, S....................................126 Asai, Y.................................... 222 Asakura, H............................... 61 Asano, N................................. 197 Asano, T..................................182 Asano, Y......................93, 167, 232 Asanuma, K............................ 197 Asayama, N....................... 69, 142 Aschenbeck, J................... 84, 254 Aschenbrenner, E............. 116, 214 Ascolani, M............................ 234 Ashall, B..................................58 Ashaye, A. O............................ 141 Aslan, F.............................84, 148 Aso, K.....................................130 Asoglu, V................................159 Asokkumar, R..........................156 Aspinall, R.............................. 116 Assaf, S...................................216 Asselah, F............................... 253 Asselah, H.............................. 253 Atalaia Martins, C.......89, 166, 230 Atanassova, A..........................186 Atarashi, K................................71 Atayan, Y.................................170 Ates, F..................................... 115 Athanasiadou, E.......................49 Atherton, J.................. 37, 105-106 Atif, E......................................169 Atreya, I..................................184 Atreya, R............ 47, 55, 60-61, 79, 94, 105, 184, 207 Atrott, K....................... 86, 97, 184 Attallah, A. M...........................117 Attwell, A................................. 62 Attwood, S........ 37, 47, 67, 101, 105 Aubele, C................................128 Aubert, P.................. 195, 234, 252 Aubourg, A....................... 73, 185 Aupiais, C............................... 191 Aured, I................................. 253 Auricchio, R.............................64 Auriemma, F..... 219, 222, 224, 244 Aussó, S................................... 97 Aust, D....................................140 Avallone, E. V.................. 206, 239 Avedano, L............................. 100 Avidan, B..........................137, 140
326
Avni-Biron, I.......................... 230 Avolio, A.................................218 Avram, L.................................215 Awadie, H.............69, 128, 175, 177 Axon, A........................ 46, 77, 104 Ay, C........................................ 51 Aya, H.....................................138 Ayed, K...................................218 Ayllón Cano, S.........................198 Ayoub, F.................................. 151 Ayoubi Khajekini, M. T............. 119 Ayuso, J. R............................. 222 Azahaf, M............................... 236 Azevedo, R....................... 84, 128, 166, 180, 256 Aziz, A........... 64, 71, 160, 182, 244 Aziz, E. M................................ 177 Aziz, I...... 64, 71, 146, 160, 244-245 Aziz, Q............................. 156, 197 Azman, A................................158 Azouz, M. M............................227 Azpiroz, F................57, 65, 80, 83, 92, 145, 244 Azuara Garcia, D....................... 97 Azuma, M................ 104, 124, 200 Azuma, T...................170, 203, 223 Azzarone, A.............................189 Azzini, A. M.............................183
B Baba, E. R................ 194, 201, 258 Baba, S...................................194 Baba, T...................... 46, 98, 126, 128, 193-194, 243 Baba, U................................... 179 Baba, Y.............................151, 175 Babenko, O.............................125 Bach, S.................................... 41 Bach, V.................................. 204 Bachir, H................................ 255 Bäckhed, F................................50 Badawi, R................................ 52 Badia Aranda, E......................139 Badía, M.................................153 Badillo, R................................198 Bado, A.................... 156, 206, 241 Badr, M....................................117 Bae, H. I.......................... 180, 230 Bae, J. Y.......................... 224, 227 Baebler, K..........................97, 233 Baeg, M. K..............................152 Baek, J.-H............................... 177 Baert, F.........................49, 55, 80 Bafutto, M......................... 49, 189 Bagnoli, S...............................190 Bagyánszki, M.........................195 Bahaz, B.................................188 Bahí, A....................................237 Bahin, F............................. 76, 177
Bai, G............................... 89, 103 Baicus, C.-R............................ 167 Baier, G....................................89 Baig, M. A....................... 129, 209 Baik, G. H............................... 173 Bailador, C.............................. 137 Bailey, Y..................................138 Baillet, P.................................186 Bair, M.-J................................. 77 Baird, P............................ 119, 222 Bajaj, J. S..................... 51, 83, 101 Bajbouj, M......................224, 248 Bajer, L.............. 158, 184, 217, 256 Bajor, J................................... 220 Bak, Y.-T..................................150 Baker, R...................................90 Baker, S..................................195 Bakers, F.................................144 Bakewell, L.............................156 Bakkali, A............................... 187 Bakulin, I................................ 119 Balaban, D. V...................237, 254 Balaguer, F........................63, 245 Balakrishnan, M...................... 127 Balanescu, L............................233 Balas, O. E............................. 208 Balázs, A.................................120 Balbaa, M............................... 118 Baldaia, C.... 167, 208, 217, 237, 245 Baldan, A................................130 Baldaque-Silva, F...................200 Baldassarre, G................ 199, 203, 247-248, 252 Baldissarro, I..................... 187, 191 Baldwin, S..............................170 Balfour, A................................140 Balihar, K............................... 242 Balint, A...........228, 234, 238, 240 Balladur, P.............................. 181 Ballare, M.............................. 222 Ballerini, A.................181-182, 220 Ballester, M. P........................ 239 Ballester-Clau, R.................... 246 Ballet, N................................. 137 Ballet, V..................................189 Ballmaier, P.............................215 Balmana, J............................... 63 Balogh, B................................. 61 Baltar-Boileve, J...................... 147 Baltes, N.................................216 Baltus, A...................................71 Bamba, H................................129 Bamba, S.............76, 126, 129, 137, 171, 180, 188 Ban, H.................61, 126, 201, 203 Bana e Costa, T................. 217, 235 Banai, J................83, 136, 234-235 Banales, J. M......... 91, 117, 165, 169 Banasiuk, M............................195 Banaszkiewicz, A.....................195
Bancil, A. S............................. 176 Bandel, W...............................183 Bando, H.................................201 Banerjee, A. K.........................122 Banerji, V...........................71, 195 Banescu, C.............................. 157 Bang, B. W...................... 223, 246 Bang, C. S............................... 173 Bang, J. Y..............72, 103, 129-130 Bang, K. B...............................194 Bang, S..........122, 169-170, 172-173 Banhudo, A............... 84, 128, 166, 180, 256 Banks, M............ 132, 148, 225, 247 Bannaga, A.............................159 Banno, S.................................. 53 Bannwart, F.............................84 Banovcin, P................69, 248-249 Bansal, R...........................61, 221 Bantleon, F.............................. 187 Banzragch, M.......................... 114 Bapaye, A........... 99, 223-224, 249 Bapaye, J. A........ 99, 223-224, 249 Baptista, A. J............ 183, 233, 246 Bar-Yoseph, H.................. 189-190 Bar, N................54, 57, 59, 61, 63, 70-72, 82, 85, 88, 99, 110, 137, 150-151, 242, 249 Baraket, O...............................218 Baranda, A.............................. 217 Barann, M................................89 Barauskas, G........................... 172 Barbara, G........ 59, 63, 70, 78, 82, 88, 90, 99, 146-147 Barbara, M..............................166 Barbaro, F...............................130 Barbaro, M. R............... 70, 78, 90 Barbeiro, S................. 89, 179, 258 Barber Caselles, C.................. 244 Barberio, B...................... 187, 189 Barbosa, M.............................166 Barbu, M............................... 208 Barbulescu, A..........................216 Bardan, E................................195 Bardella, M. T......................... 205 Bareggi, E..................181-182, 220 Baretta, G.............................. 206 Baribaud, F.............................188 Barjas, E................................. 178 Barkun, A........................ 103, 246 Barlas, İ. Ö............................. 203 Barna, G.................................143 Barnich, N.... 57, 71-72, 85, 137, 242 Baron, T. H..........49, 100, 102-104, 145, 231 Barone, M..........150, 154, 166, 203 Barosa, R........... 157-158, 176, 180, 209-210, 241, 256 Barquero, D............................227 Barra Pardos, M. V.................. 245
Index of Authors and Co-Authors : UEG Week Final Programme
Barrachina, M. D.............. 134, 233-234, 252 Barranco, L.............................153 Barreau, F................................ 92 Barreiro, P.............................. 258 Barreiro-de Acosta, M............ 185-187, 189-190, 240 Barresi, L.......................... 99, 130 Barret, M..............53, 62, 127, 129, 178, 181, 228, 230, 247 Barrett, J. S............... 141, 196, 233 Barrias, S......................... 175, 210 Barrichello, S..................206, 255 Barrioz, T............................... 232 Barrison, I................................65 Barroca, H........................ 173, 196 Barroca, R...............................145 Barros, J............................ 84, 128 Barros, M............................... 232 Barroso, E....................... 180, 208 Barry, L...................................237 Barta, B. P...............................195 Barta, Z................................. 234 Bartak, B. K............... 143, 193, 243 Barthet, M......... 40, 48, 67, 73, 81, 95, 99, 124, 152, 172, 182, 200 Bartneck, M............................. 61 Bartoli, A............................... 225 Bartolí, R.............. 83, 126, 175-176 Bartolo, O....................... 149, 248 Bartsch, D...........118, 120, 164, 168 Barturen Barroso, A............... 180 Barucca, V............................... 172 Barut, B..................................170 Baryshnikova, N. V................. 203 Barzaghi, F..............................156 Basaranoglu, M....................... 116 Basford, P................................125 Basha, J.................................. 181 Bashir, M................................ 101 Basilisco, G............................ 236 Basit, S. A...............................247 Basquill, C.............................. 175 Bassem, H...............................138 Basset, P........................... 89, 155 Bassett, P.................................89 Bassi, A......................58, 188, 243 Bassi, C............................. 85, 183 Basso, D..........................203, 249 Basso, M.................................218 Bassotti, G...............................96 Baston Rey, I............................ 72 Bastos, R. P.............................227 Bastuji-Garin, S........................50 Batista, M...............................164 Batlle, M................................ 244 Battaglioli, E. J....................... 206 Batterham, R........................... 173 Batteux, F................................221
Battistel, M............................. 116 Battmann, A............................. 92 Baudry, C................................185 Bauer, P..............102, 120, 127, 195 Bauerfeind, P.............102, 127, 195 Baumann, C........................... 235 Baumeler, S............................. 52 Baumgaertner, I.......................50 Baumgart, D. C........................140 Bayomi, H. A...........................164 Bayrhoffer, T............................190 Bazan, A.................................184 Bazhin, A. V........................... 232 Bazzichi, L.............................. 206 Bazzoli, F................................. 197 Beales, I....................223, 225-226 Beath, A. P..............................145 Beaufrand, C...........................145 Beaugerie, L......... 54, 101, 139, 185 Bech Johannesen, T..................58 Bechmann, L........................... 217 Bechstein, W............................ 92 Becker, A................................ 206 Becker, B.................................. 52 Becker, C........................... 70, 170 Becker, D.................................196 Becker, E........................... 86, 164 Becker, K. F..............................193 Becq, A................................... 181 Becx, M................................... 187 Bednarz-Misa, I.......................184 Bedny, F................................. 242 Beeckmans, D.........................247 Beer, S.....................................46 Beer-Gabel, M........................195 Beets, G. L................. 50, 144, 231 Beets-Tan, R. G. H...... 50, 144, 231 Beg, S..............................225, 231 Bège, T....................................124 Beglinger, C................. 52, 77, 104 Beiderwellen, K...................... 187 Beintaris, I..............................143 Bekal, P...................................136 Bekkali, N................................ 62 Bekkali, N. L........................... 222 Belacosa, L...............................90 Belanteur, K........................... 253 Belei, O............................104, 170 Belghanem, F................... 158-159 Belghazi, K..................76, 173, 249 Belhocine, K............................185 Bellacosa, L..............................90 Bellaiche, M............................ 191 Belle, A.................................. 235 Bellicoso, M. I........................ 238 Bellimi, H...............................188 Bellini, M....90, 198, 200, 206, 249 Bellisario, C............................ 101 Bellissimo, M. C..................... 232 Belluardo, N.......................... 238
Belostotsky, N.........................155 Belousova, L............................ 119 Belsanova, B.......................... 222 Belt, E....................... 120, 169, 237 Beltran Niclos, A. B.................237 Belyakov, N.............................139 Bemelman, W. A................ 73, 81, 104-105, 134 Ben Ameur, W.........................183 Ben-Bassat, O.................. 151, 230 Ben-Haim, L............................155 Ben-Horin, S........ 78, 137, 139-140, 189-190 Ben Mami, N.................... 133, 183 Ben Mustapha, N.................... 240 Ben-Shlomo, S......................... 72 Ben Shoham, A........................56 Ben Slama, A...................168, 183 Ben-Yehoyada, M.....................85 Benatti, E................................. 78 Benbaya, R.............................188 Bendaoud, S...........................185 Bende, F........................... 214, 217 Bender, M...............................214 Bender, P....................... 67, 73, 81 Bene, L.......... 56, 83, 136, 222, 251 Benech, N............................... 132 Benedetti, I.................. 64-65, 155 Benedikt, K..............................64 Benelbarhdadi, I.......168, 218-219, 254, 256 Benes, M....................52, 217, 242 Benesic, A................................59 Benesova, L......................222, 251 Benezech, A............. 124, 182, 200 Benfenatki, N..........................154 Bengi, G.......................... 234, 236 Bengs, S...........................86, 233 Benini, R...........................146-147 Benítez-Cantero, J. M........140, 186 Benítez Roldan, A....................139 Benito, R.................................153 Benkirane, A.......................... 253 Bennet, S. M. P........................ 141 Bennett, R...............................145 Benny, S.................................. 181 Benosman, H......................... 229 Bensaid, L.............................. 203 Benslaiman Seyid-Jebari, B.................................. 65, 247 Benson, A................................69 Benvengù, L............................168 Ber, Y..................................... 236 Bercier, S................................194 Berdah, S.......................... 99, 124 Beregova, T.............................155 Berends, S.............................. 141 Berendsen, S. A...................... 255 Bereswill, M............... 101-102, 139 Beretta, P................................156
Berg, S....................... 101-102, 139 Berg, T.........................39, 46, 154 Bergamin, I.............................. 52 Bergemalm, D........................ 236 Berger, A................................. 141 Berger, A................................. 151 Berger, A. W............................193 Berger, A.-E............................186 Berger, E.................................134 Bergillos-Meca, T.....................154 Bergman, J. J. G. H. M.... 39, 54, 67, 76, 87, 148, 173, 200-201, 249 Bergman, W.............................85 Bergonzi, M................. 64-65, 155 Bergstein, E........................... 243 Berkane, S.......................185, 188 Berkhout, D. J. C......................186 Bermejo, A..............................125 Bermejo, F.................120, 125, 226 Bernal, J........................... 128, 231 Bernal Checa, P............... 120, 226 Bernardes, C............ 159, 209, 258 Bernardo, C.............................227 Bernardo, D...............97, 208, 234 Bernardo, S........207-208, 237, 258 Bernardo, W. M............... 126, 230 Bernardoni, L................... 221-222 Bernhardt, J......................133, 174 Bernklev, T.............................. 176 Bernoux, A..............................194 Bernstein, C. N................... 89, 92 Berntsen, N. L..........................59 Berrag, S................................ 253 Berretti, D...............................122 Berroneau, A..........................188 Berrutti, M.............................. 119 Berry, N...............103, 171, 178, 187 Berryman, E........................... 243 Berstad, P................................ 176 Bertakis, V................................ 92 Bertani, H..................96, 130, 230 Bertelè, A......... 150, 198, 249, 255 Bertolami, C........................... 238 Bertucat, A..............................130 Berzin, T........................... 93, 251 Besheer, T.................. 117, 166, 168 Besherdas, K.......................... 202 Bessa Casserras, X.............63, 178, 244-245 Bessard, A....................... 195, 242 Besselink, M. G. H........ 37, 46, 66, 71, 93, 169-170 Betes Ibáñez, M. T.................. 180 Bethge, J.................................138 Bettenworth, D.....89, 135, 237, 239 Beuers, U. H. W................. 117, 219 Beukers, R..............................102 Bevan, R..................................89 Bevivino, G..............................143
327
UEG Week Final Programme : Index of Authors and Co-Authors
Beydogan, H............................49 Beyer, L....................................99 Beyna, T.............36, 40, 42, 67, 73, 76, 81, 126, 173 Bezzio, C..........................225-226 Bhagwat, A............................. 179 Bhala, N...........................142, 247 Bhandari, B. R........................140 Bhandari, P..... 53, 72, 99, 125, 225 Bharadwaj, .......................... T. K. Bhasin, D. K........................... 220 Bhatt, A............................181, 187 Bhattacharya, A....................... 187 Bhattacharya, K...................... 230 Bhattacharyya, R.....................125 Bhattarai, Y............................ 206 Bhayat, F................................ 239 Biagi, F................................... 204 Bian, S....................................189 Bianchetti, M............129, 156, 230 Bianco, M. A........................... 177 Biancone, L....97, 185, 187-188, 234 Biasci, D...................................80 Biasiolo, A.............................. 114 Biasutto, D.............................. 197 Bibani, N.........................228-229 Bichard, P............................... 222 Bideau, K................................185 Biedermann, L..........101, 235, 248 Bielich, A................................. 53 Biemans, V. B. C..................... 239 Bienfait, L...............................192 Bienvenu, J.............................. 79 Bieri, O.................................... 52 Biermann, M...........................170 Biesiekierski, J..........................65 Bieze, M.................................. 118 Bihui, Z.............................215-216 Bilibou, M.............................. 222 Billard, E........................... 71, 242 Billeci, M............................... 239 Billiauws, L.............................. 42 Billmeier, U........................79, 170 Bing, L....................................227 Bingham, R....................... 93, 129 Biolato, M...............................218 Biriuchenko, I......................... 249 Biro, E....................................136 Biró, P.....................................120 Bischoff, S......................... 87, 100 Bismuth, M.............................. 76 Bispo, M......................... 180, 208 Bisschops, R............54, 76, 87, 94, 114, 125, 173, 177 Bisseling, T. M.........................192 Björk, J....................................189 Black, C........................... 146, 244 Blackshaw, A............... 70, 79, 248 Blackshaw, G.................. 182, 256 Blad, W...................................184
328
Blake, A................................. 239 Blake, P.................................. 232 Blanc, P.................................... 76 Blancas-Valencia, J. M............. 174 Blanchard, C.......................... 248 Blanco Belver, A...................... 178 Blanco Velasco, G.................... 174 Blanco-González, J..................153 Blanco, S................................. 217 Blanpied, C.............................. 92 Blatt, A...................................189 Blauvelt, A..............................140 Blaydon, D..............................148 Blazer, D.................................183 Bleijenberg, A..........................50 Blero, D................................. 207 Bléro, D............................. 66, 88 Bloemendaal, F. M..................184 Blomster, T............................. 239 Blondeau, B............................156 Bloom, S........................... 61, 140 Blumberg, R. S......................... 79 Blümel, S................................168 Boadas, J................................. 97 Boal Carvalho, P......................166 Boarino, V...............................130 Boccia, S.................................122 Bochar, A..........................214-215 Böcher, W. O............................ 47 Bockhorn, M................ 46, 78, 221 Bocsan, C............................... 246 Boda, K.................................... 53 Bodelier, A..............................102 Bódi, N...................................195 Bodineau, L.............................156 Bodini, G........... 149, 187, 191, 199, 237, 240, 248-249 Boeckxstaens, G. E............ 50, 70, 75, 79, 94 Boecxstaens, V........................ 101 Boehm, G................................140 Boermeester, M. A........ 41, 53, 59, 142, 192 Boga, S.................................. 236 Bogie, R...................................69 Bogte, A................................. 248 Böhm, B.................................. 93 Böhm, I. T...............................120 Boix, J................... 83, 126, 175-176 Bojarski, C.......................254-255 Bojic, D...................................189 Bokemeyer, B.......................... 137 Boku, N...................................251 Bolado, F..........................170, 220 Bologna, G............................. 254 Boltin, D............................ 91, 151 Bomme Høgh, M.....................154 Bommelaer, G........79, 83, 137, 186 Bon, I.............. 36, 83, 126, 175-176 Bonavolta, R...........................216
Bond, A...........................197, 240 Bondarenko, N....................... 249 Bonder, M.-J............................ 70 Bonderup, O. K........................140 Bondue, A............................... 197 Bongers, G................................71 Boni, F....................................156 Bonifacio, C............................. 137 Bonillo, D............................... 226 Bonitatibus, A................. 236, 254 Bonnart, C............................... 92 Bonnet, M.........................85, 242 Bonnet, R.................................85 Bonnett`, L............................. 222 Bonora, E................................. 92 Bonsing, B...............................85 Bonten, M. J. M.......................103 Boo, S.-J.................................159 Booij, K. A...............................169 Bools, D..................................192 Boone, J. H.............................. 187 Boonstra, J............................... 91 Boota, N.................................142 Bor, R........ 219, 228, 234, 238, 240 Bor, S...............52, 73, 77, 104-105, 148, 197, 199 Boran, G................................ 254 Borda, A................................. 181 Bordaçahar, B............ 62, 221, 230 Bordin, D. S........................77, 104 Borgaonkar, M....................... 242 Borges, V. P............................ 258 Borgwardt, S............................ 52 Bories, E............. 62, 152, 169, 200 Borisova, E..............................153 Borizanova, A..........................159 Borkar, V. V............................. 157 Borkotoky, R............................219 Bornschein, J................ 62, 76, 161 Borralho, P..............................169 Borrelli, O................................65 Bortlík, M......................... 237-238 Bortoluzzi, F............................190 Borzan, B................................158 Borzan, V................................158 Borzio, F..................................168 Bosak, N.................................215 Boscá, M. M........................... 239 Bosch, J.............................. 38, 86 Bosch, S...................... 92, 186-187 Boschetti, E.........................79, 92 Boschetti, G..........79, 135, 137, 186 Bose, S...................................219 Boskoski, I............................. 252 Bosnar, M...............................183 Bossa, F........................... 189, 240 Bossuyt, P............... 49, 55, 80, 96 Botas, J.................................. 256 Botteri, E................................ 176 Boualit, M....................... 185, 238
Boubaker, J............................ 240 Boucekkine, T...................185, 188 Bouchabou, B.........................227 Bouchaoui, K..........................188 Boucher, A.-L........................... 83 Bouchmal, S............................. 92 Bouchnafa, S...........................159 Bouchoucha, S........................218 Boudet, J.................................189 Boudin, H....................... 195, 242 Bouguen, G.............73, 75, 83, 186 Bouhnik, Y..................... 43, 75, 86 Boulanger, T........................... 204 Boulares, R............................ 235 Boulygina, E. A......................... 77 Bouma, G.....................64, 91, 236 Bounab, N...............................185 Bounou, L....................... 206, 251 Bouras, E..........................127, 129 Boureille, A.............................185 Bourgaux, J.-F.......................... 76 Bourget, A...............................82 Bourke, M. J...... 52, 62, 68-69, 76, 99-100, 128, 175, 177 Bourner, L...............................188 Bourreille, A.............136, 186, 234 Bourrier, A........................ 75, 186 Boursier, J............................... 151 Bousquet, C................ 78, 102, 161 Bousseloub, A.................. 158-159 Boustiere, C.............................95 Boutaleb, A. F...................185, 257 Boutallaka, H............ 219, 253-254 Bouvier, S.............................. 232 Bouvy, N......................... 105, 249 Bove, V................................... 252 Bovet, C................................. 234 Bowlus, C................................. 91 Bown, S...........................132, 225 Boyanova, L.......................77, 104 Bozek, P................................. 238 Braat, A................................... 93 Brabant, S.............................. 238 Brachman, Y.............................69 Bradeanu, A. M.......................233 Bradshaw, L............................142 Braegger, C............................. 157 Brahmbhatt, B...................93, 127 Brain, O................................. 235 Bramuzzo, M....................135, 190 Branch, S................................145 Branche, J....................... 236, 238 Branchi, F.................205, 236, 254 Branco, J. C.............................237 Branco, L.................................237 Brandão, C...................... 224, 228 Brandimarte, G...............146, 199, 203, 239, 252 Brandimarte, M. A...................146 Brandolese, A........... 121, 209, 221
Index of Authors and Co-Authors : UEG Week Final Programme
Brandt, C. F.............................103 Brar, T. S................................. 151 Braun, A.................................128 Braux, J...................................135 Braverman, M..........................69 Bravo, M................................ 205 Brazier, F.................................135 Brecelj, J.................................. 79 Brechmann, T............ 175, 178, 225 Bredenoord, A. J............ 37, 67, 75, 95, 99, 101, 247 Breidert, M.............................. 53 Breilh, D.................................188 Brenke, D............................... 207 Brennan, D.......................252-253 Brenner, H...............................50 Breoni, I...................................171 Bresciani, M........................64-65 Breslin, N.................. 126, 137-138, 140, 216, 254 Bretthauer, M................58, 82, 98 Breuer, R.................................90 Breukink, S. O.........................144 Breunig, M..............................120 Brewer Gutierrez, O. I........ 62, 99, 102-103 Brezina, J................................184 Brichet, L................................185 Bridonneau, C.......................... 57 Brieau, B................... 127, 177, 228 Brind, J....................................65 Brink, L...................................126 Brisc, C............................ 116, 216 Brito, H. M. D. S......................164 Brito, M. J................. 157-158, 209 Britzen-Laurent, N....................86 Brixi, H....................... 75, 80, 186 Brixie, Z..................................194 Brøbech, P...............................103 Brocca, A................................166 Brockow, K............................. 248 Brodmerkel, C.........................188 Broers, C................................. 101 Brogan, G...............................155 Brogyuk, N............................. 228 Broide, E.................................140 Bromberg, L........................... 207 Bronkhorst, C.................. 166, 235 Bronowicki, J.-P...................... 235 Bronzwaer, M...........................50 Brookes, M.......................125, 234 Brougham, K.......................... 222 Broughton, R............223, 225-226 Brown, C............196, 199, 232, 252 Brown, G................................ 177 Brown, J..................................182 Brozzi, L............................ 121, 171 Bruck, R................................. 209 Brückner, M..................... 135, 237 Bruckner, R. S.......................... 97
Brueckner, S............................ 101 Bruijning-Verhagen, P. C. J.................................103 Bruins, M. J..............................56 Bruley Des Varannes, S.................... 82, 136, 186, 252 Brullet, E................................241 Brummer, R. J............ 56, 103, 146 Brun, P........................86, 141, 192 Brunel, C................................ 248 Brunet, J.................................. 63 Brunetti, F................................50 Bruni, B.................................. 127 Brunner, F.............................. 234 Bruno, M............................... 180 Bruno, M. J.............49, 71, 76, 107, 123, 129, 143, 150-151, 179, 192, 200, 251, 255 Bruns, T................................... 61 Brusselaers, N.......................... 77 Bruyneel, M........................... 207 Bryant, R................................ 197 Brzozowski, B......................... 204 Brzozowski, T............ 85, 104, 250 Bu, C.............. 87, 89, 93, 101, 135, 141, 169-170, 248 Bu, S..........49, 71, 97, 166, 169, 171, 198, 205, 231, 237, 250-251 Bubernáková, L...................... 249 Bucalau, A.-M..................207, 210 Buccianti, N............................189 Buchen, B................................ 70 Buchholtz, M.-L........................59 Buchholz, M.....................120, 223 Buckley, M..............................237 Bucsics, T................................ 132 Bucur, D..................................231 Bucurica, S..............................237 Buda, A.............................55, 228 Budding, A. E..........................196 Budihal, S..................124, 129, 176 Budzinsky, S. A........................221 Buendia, L.............................. 217 Buening, C.............................. 141 Buettner, S..............................169 Buffoli, F......................... 180, 207 Bugajski, M............................ 245 Bugariu, A..........................64, 73 Buggenhout, A........................210 Bugianesi, E..................48, 75, 86 Buhman, K. K...........................95 Bui, L....................................... 75 Buijs, J. G................................ 179 Buis, C. I.................................. 93 Buisson, A..............75, 79, 83, 135, 137, 139, 185-186 Bujanda Fernández de Piérola, L............. 63, 77, 91, 104, 117, 153, 245 Bukhari, M. A........ 62, 99, 102-103
Bulajic, M........................ 122, 130 Buldak, R. J.............................164 Bulla, J....................................126 Büller, N. V. J. A........................ 92 Bunganic, B.................... 220, 222 Buonocore, R. M.....................165 Burazeri, G..............................149 Burdyga, G............................... 52 Bureau, I................................ 240 Bures, J..................... 138, 241, 251 Burganova, G. R......................164 Burgell, R. E.............. 141, 195, 233 Burger, N................................233 Burgess, N. G.......................... 177 Burgess, N. J........................... 175 Burgio, V................................ 242 Burisch, J.............. 60, 92, 96, 101, 135-136, 138, 185, 234 Burke, A. L..............................140 Burns, G................................ 204 Buron, A................................ 244 Burr, N.......................132, 135, 237 Burra, P................. 54, 61, 100, 116 Burrelli Scotti, G......................138 Bursics, K............................... 235 Burt, M............................ 226-227 Burtin, P.................................. 176 Buscarini, E.............................153 Busch, O. R. C............. 93, 169-170 Buse, E...................................156 Buskens, C. J.................67, 73, 134 Busquets, D......................189, 237 Bussmann, C....................101, 248 Bustamante, M........................143 Buti, M............................... 39, 84 Butler, J...................................136 Butler, R. N............................ 204 Butt, F...................................... 72 Butt, M. O. T............................ 167 Butturini, G..............................85 Buxbaum, J. L........................... 62 Buzás, E. I...............................192 Buzás, G. M........................77, 104 Byelinska, I............................ 238 Byeon, J.-S................. 98, 175, 239 Bykova, S................................155 Byrne, S...................................90 Byron, C..................................237 Bytzer, P....................... 58, 77, 104
C C. Branco, J................117, 209, 237 Caballero, N............... 65, 126, 247 Cabanne, A............................ 238 Caberlotto, C.......................... 232 Cabib, C..................................149 Cabré, E................... 186, 234, 239 Cabriada, J. L.............140, 185, 235 Caca, K......................53, 67, 73, 81
Caccamo, L..............................130 Caccaro, R...............................189 Cadiot, G.................................186 Cadoni, S................................. 52 Caduff, R.................................195 Caetano, C...............................139 Caggiari, L...............................153 Çağlayan Yeğen, B.................. 256 Cagol, M.................. 182, 200, 232 Cahen, D. L......................... 36, 82 Cahova, M.............................. 256 Cai, B................................90, 195 Cai, F......................... 132, 152, 229 Cai, M..............................198, 201 Cai, Z......................................143 Caillo, L............................... 73, 76 Caillol, F....................152, 169, 229 Cainap, C............................... 222 Caio, G..................................... 92 Cairns, A.................................122 Cairo Nunes, G....................... 206 Calabrese, E................ 97, 185, 187 Calabrese, F............................ 242 Calatayud, M...........................139 Calatayud, S....... 134, 233-234, 252 Caldas, M................................. 77 Caldas Álvarez, M..........77, 97, 104 Caldeira, A..........84, 128, 166, 256 Caldeira, P...............................188 Calleja, J. L..............................227 Callery, M................................. 93 Calpe, S.................... 92, 150, 200 Calvaruso, V..................... 187, 238 Calvet, X...............62, 106, 139, 241 Calvo, H..................................152 Calvo, M................................. 240 Camacho, E......................219, 229 Camacho, M............................158 Camargo, S............................ 220 Camera, S................... 117-118, 167 Cameron, R.............................149 Cameron, S. J..........................184 Camila Dias, C........... 132, 188, 196 Camilleri, M................ 65, 90, 195 Caminero, A.............................56 Caminero-Fernandez, R............ 97 Cammà, C........................166, 168 Cammarota, G................... 84, 103 Campagnola, P...........171, 209, 221 Campbell Davies, S................. 239 Campello, E............................. 116 Campo, R......................... 153, 241 Camprubí-Font, C............. 134, 184 Camus, M.............127, 129, 181, 221 Canard, J.-M..................... 151, 229 Cañas, M.................................186 Canaval-Zuleta, H. J..........170, 220 Canbay, A.................. 156, 217, 224 Cancela, E....................... 207, 228 Cancelas-Navia, P.................... 127
329
UEG Week Final Programme : Index of Authors and Co-Authors
Candinas, D.............................183 Cañellas, N..............................145 Cañete, F......................... 186, 239 Cannizzaro, R........... 153, 192, 196, 198-199, 202, 252 Cano-Mollinedo, M. M.............149 Cantamessa, A........................ 180 Canto, M. I...... 54, 87, 102-103, 181 Canton, E................................192 Cantù, P..................................130 Cao, C...................................... 61 Cao, L..................................... 202 Cao, Y..................................... 250 Capalbo, C............................... 172 Capella, G...........................63, 97 Capelle, L...........................77, 104 Capelli, E...................... 70, 78, 90 Capobianco, D.........................146 Capoferro, E.................... 190, 240 Capone, P........................ 180, 207 Caporaso, N................ 64, 117-118, 167-168, 205-206, 216, 235, 238 Capovilla, G......................247-248 Cappelleri, J. C........................ 141 Cappello, G.............................155 Cappello, M........ 187, 189, 238-240 Cappon, A............................... 114 Cappuccio, R...........................190 Caprioli, F............................... 236 Capruso, G............................. 220 Capuano, F......... 159, 209-210, 221 Capurso, G............59, 68, 85, 106, 171-172, 222 Carabotti, M............... 146-147, 199 Carames, C............................. 223 Carames, J. C.......................... 223 Carames, M............................ 223 Caramia, V...............................156 Carapelle, M........................70, 78 Carballal, S.............................. 63 Carbo Perseguer, J................... 178 Carbonnel, F......36, 54, 77, 80, 104 Card, T. R................................231 Cardamone, E........................ 242 Cárdenas-Jaén, K................. 59, 71 Cárdenas-Rebollo, J. M............128 Cardin, R...........................119, 187 Cardoso, H.................116-118, 159, 196, 209, 218 Cardoso, M. F..........................237 Cardoso, R...................... 207, 228 Carey, N..................................188 Carina, I................................. 258 Carli, E....................................215 Carlotti, E................................150 Carlsson, A..............................143 Carlton, T.................................89 Carmo, J...........................234-235 Carmona Soria, I.................... 208
330
Carmona, E.............................186 Carmona, J............................. 234 Carmona, L..............................186 Carneiro, C..............................237 Carneiro, F.............97, 107, 111, 165, 168, 173, 196, 201 Carneiro, L..............................148 Caro-Maldonado, A.................. 91 Caroli, A.......................... 190, 245 Caroli, D.................... 138, 192, 228 Carot, L.................................. 244 Carpio López, D...................... 240 Carracedo, A.......................91, 117 Carrara, S.................. 85, 219, 222, 224, 244 Carrascosa del Álamo, I...........125 Carrat, F.................................. 101 Carretero-Gomez, J. F...............134 Carriere, J................................. 57 Carrilho Ribeiro, L..... 158, 167, 173, 210, 225, 258 Carrillo Palau, M........63, 235, 245 Carrington, E.................60, 81, 88 Carro Valdes, J........................ 207 Carroccio, A......................238-239 Carroll, R................................188 Carsetti, R................................96 Carson, R. T..................... 196, 245 Carstens, A............................. 236 Carter, D..................................195 Carter, R.................. 36, 53, 60, 99 Caruana, P.............................. 202 Caruntu, F. A........................... 116 Caruso, A.............. 62, 96, 230-231 Caruso, C................................155 Carvalheiro, J..........................166 Carvalho, A. E. Z......................184 Carvalho, A. M....................... 258 Carvalho, D.............. 184, 188, 258 Carvalho, D. F. B..............209, 258 Carvalho, J.................116, 131, 138, 147, 209, 228, 235 Carvalho, J. R...................159, 167, 207, 221, 237 Carvalho, L........ 208, 217, 235, 258 Carvalho, M............... 52, 224, 258 Carvalho, M. M....................... 224 Carvalho, R................ 117, 221, 237 Carvalho, S............................. 180 Carvalho, T....159, 167, 169, 207, 221 Carvão, J.........................208, 245 Casabona, S............................. 97 Casaca, R.........................159, 252 Casado, R................................189 Casals, F................................... 97 Casanova, J.-P.........................200 Casanova, M. J.........................185 Casanova, P..................... 200, 257 Casazza, G............................... 118 Caselitz, M............................... 53
Casellas, F......................... 49, 189 Casellas, J. A...........................143 Casén, C.............................71, 236 Casini, V..................................156 Casse, A. H............................. 242 Cassieri, C................ 146, 203, 239 Cassinotti, A........................... 239 Castagliuolo, I..... 86, 141, 192, 200 Castanheira, A................. 207, 228 Castaño-Fernández, O............ 245 Castaño-Vinyals, G..................143 Castela, J..... 159, 176, 178, 208, 252 Castelijn, D. A. R......................64 Castellaneta, N. M.................. 208 Castellano-Tortajada, G........... 127 Castellazzi, A. M.......................90 Castellino, F............................. 119 Castellot, A............................. 180 Castells, A................................ 63 Castera, L......................38, 48, 84 Castiella Eguzkiza, A................ 115 Castiglione, F....... 97, 185, 235, 238 Castilla-Rodríguez, I............... 245 Castillejo, A.............................. 63 Castillejo, G..............................64 Castillo Hererra, L. A................ 167 Castillo, R................................ 137 Castoro, C............. 76, 86, 141, 182, 192, 200, 232, 250 Castro Fernández, M...........77, 104 Castro Laria, L.................. 139, 189 Castro Urda, J. L....................... 167 Castro, A.................................210 Castro, B................................ 235 Castro, R..........................124, 227 Castro, R. E........ 114, 164, 169, 224 Catalano, G.............................130 Cataluna, J. G. E......................215 Catassi, G................................135 Catnach, S............................... 127 Catrinoiu, D.......................115, 153 Cats, A.............................. 98, 192 Cattan, P............................ 50, 176 Catton, J................................. 202 Caturelli, E..............................168 Cauchin, E................................82 Caulet, M.......................... 93, 168 Caunedo Álvarez, A......... 139, 208 Cavalcante, T. F. A....................215 Cavalcoli, F............................. 223 Cavallaro, F.............................. 72 Cavallaro, L. G. G......................171 Cavallin, F................ 182, 200, 232 Cave, D..................... 186, 230, 254 Cavestro, G. M................. 202, 242 Cavicchi, M........................ 50, 176 Cea Soriano, L..........................96 Cea-Calvo, L............. 186, 190, 240 Ceausu, E................................ 167 Ceballos, D................185, 189, 235
Cebolla, A......................... 56, 157 Ceccarelli, L............................ 206 Ceelen, W................................ 133 Cefaro, A................................ 228 Cejas, L.................................. 235 Cekic, C...................................148 Celikel, C. A............................. 114 Cellier, C............. 151, 154, 173, 229 Cenac, N................50, 70, 78, 234 Cennamo, V............................ 228 Cento, S................................. 249 Ceplis-Kastner, S...................... 137 Cerban, R................................ 217 Cereatti, F........................ 180, 207 Cernat, E................................. 191 Cerofolini, A............................130 Cerrito, L.................................218 Cervantes, J. G.........................215 Cerys, S................................... 127 Cesar Machado, M. C...............221 Cesario, S.........................196, 199 Cesaro, P................................ 228 Cesbron Métivier, E.................. 151 Cesna, V.................................. 172 Çetin, A.................................. 223 Cetin, H.................................. 244 Çetin, O.................................. 256 Cha, B. H................................. 119 Cha, J. H..................................201 Cha, S.-W.........................179, 229 Chaabouni, H................... 133, 183 Chaaro, D........................ 139, 208 Chae, H.-S...............................219 Chagas, C................. 180, 208, 217, 235, 258 Chai, H.............................109, 140 Chakraborty, J.......................... 151 Chamaillard, M........................ 57 Chan, A. T.............................. 250 Chan, B.................................. 258 Chan, C...................... 63, 133, 242 Chan, D.......182, 185, 199, 232, 256 Chan, E. W..........................46, 91 Chan, F. C................................. 63 Chan, F. K. L......... 82, 142, 147, 152 Chan, G.......................70, 102, 215 Chan, H.-H...............................59 Chan, P....................................142 Chan, P. W.............................. 208 Chan, S. M......................230, 250 Chan, Y....................................198 Chandan, J..............................247 Chandhok, G...........................215 Chandrakumar, L.....................195 Chandramaliteeswaran, C........ 133 Chandrasegaram Shanmuganathan, S...........231 Chandy, R................................188 Chang, D. K.................85, 193-194 Chang, H.............. 39, 124, 169, 179
Index of Authors and Co-Authors : UEG Week Final Programme
Chang, H. K............................ 209 Chang, K..............85, 193-194, 239 Chang, L............46, 60, 74, 94, 132 Change, K. J.............................98 ChaoQiang, F........................... 173 Chaouch, S.............................. 181 Chaparro, M............... 97, 185, 235 Chapelle, N..............................82 Chaput, U......................... 181, 222 Charissoux, A.......................... 177 Charles, D......................... 59, 139 Charlois, A.-L..........................135 Charnley, R............................ 222 Charpentier, C.......................... 76 Chassaing, B............ 57, 70-71, 183 Chatelain, D............................135 Chattree, A.............................. 175 Chaudhari, H............................69 Chaudhury, B. K..................... 229 Chaussade, S.........53, 62, 127, 129, 177-178, 181, 228, 230, 247 Chavan, R.................. 148, 156, 170 Chavero, P.............................. 238 Chaves, D. M.......................... 230 Chaves, P...................145, 159, 252 Chayama, K..........53, 144, 151, 254 Chazouillères, O..................53, 91 Che Ani, M. F...........................158 Checchin, D.............................190 Chedgy, F.................................125 Chelbi, Y................................. 235 Chen, B...................... 72, 148, 255 Chen, C.-C......77, 148-149, 242-243 Chen, D............................ 118, 199 Chen, F.-Y............................... 220 Chen, G............................ 122, 165 Chen, G. G............................... 114 Chen, H......................93, 136, 143, 147, 192, 243 Chen, J......................... 52, 57, 154 Chen, J.-M................................46 Chen, L...........46, 91, 147, 149, 202 Chen, L. A............................... 141 Chen, M............................46, 242 Chen, M.-H.............................136 Chen, M.-J...............................154 Chen, N........ 133, 139, 170, 192, 220 Chen, Q.................................... 72 Chen, R........................... 192, 220 Chen, S................59, 103, 114, 157, 202, 220, 223, 230, 244 Chen, T................................... 244 Chen, W.................... 170, 175, 207 Chen, W.-C...............................59 Chen, Y. I........................... 62, 103 Chen, Y.-I.....................62, 99, 102 Cheng, A. S. L..................... 91, 147 Cheng, B.................................. 72 Cheng, C.-C......................242-243
Cheng, J.-S...............................59 Cheng, L.-S......................114, 220 Cheng, S............. 59, 114, 220, 230 Cheng, Y..................................145 Cheong, J.........................168, 218 Cheong, J.-H............................201 Cheong, P................................198 Cheraitia, S............................ 253 Chermesh, I............................ 243 Chernetcova, E........................ 115 Chernov, V. M........................... 77 Chervinska, T...........................184 Chess, G................................... 52 Cheung, C. K...........................198 Cheung, K...............................142 Cheung, K. S.......................46, 91 Cheung, W. W......................... 242 Chevalier, J..............................195 Chey, W. D....................... 196, 245 Chhita, K................................ 255 Chiarion Sileni, V....................200 Chiarioni, G............................ 244 Chiba, T...................................136 Chibai, M............................... 253 Chieko, K................................ 206 Chies, G..................................166 Chikhi, Y................................. 253 Chikugo, K............ 117, 129, 171, 180 Ching, J. Y. L...................... 82, 142 Chino, A.................................. 175 Chiorascu, M.......................... 256 Chiriac, S............. 116, 131, 166-167 Chiu, C. T..........................142, 180 Chiu, H. M...............................143 Chiu, P. W. Y......152, 202, 230, 250 Chizhikov, A. V.........................158 Chliara, E................................145 Chlouverakis, G.......................125 Chmielewska, A........................64 Chmura, A.............................. 250 Cho, C.-M............................... 230 Cho, D. H....................131, 184, 221 Cho, E..................54, 169, 199, 219 Cho, H............ 56, 96, 102, 118, 121, 123, 126, 130-131, 146, 168-169, 173, 179, 184, 201, 219, 221, 226, 229, 253 Cho, I. R...............122, 169-170, 172 Cho, J........... 114, 127, 132, 148, 152, 179, 192, 197, 203, 206, 229, 245, 251 Cho, J.-H................................ 253 Cho, K. B.................................201 Cho, S.....83, 127, 132-133, 148, 155, 158, 171, 179, 183, 203, 226 Cho, Y. D..........................179, 229 Cho, Y. K..................................150 Cho, Y. S...........................133, 226 Choe, B.-H...............................56 Choe, Y. H......................... 56, 174
Choi, C. W.................. 123, 126, 131 Choi, D. H................................184 Choi, E. K................................159 Choi, H.......... 96, 102, 118, 121, 123, 126, 130-131, 146, 169, 173, 179, 184, 201, 219, 229 Choi, H. J..........................179, 229 Choi, H. S.................. 127, 132, 148, 152, 155, 203 Choi, H.-H...............................219 Choi, I.-S.................................158 Choi, J.................114, 127, 132, 148, 152, 179, 192, 197, 202-203, 229, 251 Choi, J. H...... 102, 121, 130, 169, 201 Choi, J. S................................. 179 Choi, K. H................................ 118 Choi, M. H........... 173, 179, 219, 229 Choi, M.-G....................... 150, 152 Choi, S. H..... 123, 126, 131, 146, 201 Choi, S. J....................114, 127, 132, 148, 152, 203 Choi, Y.............................150, 169 Choi, Y. H...................121, 130, 169 Choi, Y. J.............152, 192, 199, 251 Choi, Y. S................................. 133 Cholet, F............................ 72, 222 Chon, H. K............................... 118 Chong, J. N. C..........................156 Chong, L. W. L........... 184-185, 233 Chong Nguyen, C............. 206, 241 Chooklin, S...............................171 Choong, L. T........................... 208 Chow, V...................................189 Chowdhry, M...........................122 Chowers, Y................ 140, 189-190 Christodoulou, D.....................185 Christoph, J..............................86 Chrysanthopoulou, A...............134 Chryssostalis, A.......................247 Chu, E. S.................................164 Chu, H............................. 143, 244 Chu, K.-M.............................. 202 Chu, N. H. S........................... 205 Chu, Y............................. 180, 225 Chu, Y. Y................................. 180 Chuah, S. W........................... 208 Chuah, S.-K.............................166 Chueca Lapuente, E................200 Chuklin, S................................171 Chun, H. J.................. 127, 132, 148, 152, 155, 203 Chun, K. Y...............................188 Chun, W.............. 146, 168, 177, 184 Chung, I.-K............................. 226 Chung, J.-B..........122, 169-170, 172 Chung, J.-W................146, 177, 243 Chung, K. H.............................102 Chung, M. J..........122, 169-170, 172 Chur-Hansen, A.......................140
Church, N................................ 175 Chuttani, R..............................251 Ciacci, C............................. 39, 59 Ciafardini, C........................... 223 Ciarimboli, G...........................215 Cicala, M..................................90 Ciccantelli, B...........................145 Ciccarese, F..............................168 Cicenia, A................................ 147 Cichon, C.................................237 Cid Fernandez, J......................237 Cid Gómez, L............................ 63 Ciecielski, K.............................122 Cijevschi, C....................... 116, 216 Cillo, U.................................... 116 Cilluffo, M. G.................... 187, 238 Cini, G.....................................192 Cintolo, M....................... 220, 229 Ciocirlan, M................. 68, 74, 208 Cioffi, I................................... 235 Ciortescu, I............................. 254 Cipelli, R................................. 116 Ciprani, D................................183 Cipriano, M. A.........................158 Ciriza de Los Rios, C................ 101 Ciscato, C................................156 Citrano, M.............................. 238 Ciuca, I..............................157, 170 Civitelli, F................................ 191 Claesson, M. J..........................134 Clair Willi, C........................... 235 Clairembault, T....................... 234 Clara, A. R...............................215 Clark, G........................... 182, 256 Clark, S...................................189 Clark, T....................................188 Clarke, G..................................56 Claro, I............................. 159, 178 Clausen, H. R..........................155 Clavé, P.............................90, 149 Clavenzani, P............................ 92 Clayton, L......................... 125, 136 Clément, O.............................. 173 Clemons, N.............................150 Clerc, C. O...............................145 Clevers, E.......................... 71, 244 Cleynen, I.................................96 Climent, E...............................237 Clisby, C.................... 151, 231, 250 Clooney, A. G...........................134 Clos, A.............................142, 239 Cnossen, W. R.........................165 Coates, A................................ 252 Cobian, J................................. 178 Cocca, S................................. 244 Cocciolillo, S............................140 Coelen, R. J. S.................. 93, 120, 169-170, 219 Coelho, H......................... 157, 256 Coelho, R............118, 159, 188, 218
331
UEG Week Final Programme : Index of Authors and Co-Authors
Coen, S. J................................ 197 Coffin, B..................... 75, 206, 241 Cogliandro, R........................... 92 Cohen, J............................ 93, 251 Cojocariu, C...................... 116, 166 Colecchia, A...................... 78, 159 Coletta, L....................69, 149-150, 199, 243, 248 Coletta, M.............................. 236 Coll-Puig, S......................134, 234 Collij, V.................................... 70 Collins, B................................188 Collins, G............................... 235 Collins, J.................................150 Collins, K. L.............................140 Collomb, D....................... 195-196 Colombel, J.-F.......... 47, 49, 61, 80, 101-102, 136, 140-141 Colombo, M............................ 118 Colombo, S..............................156 Comer, G. M............................149 Comino, I................................ 157 Compare, D............................ 203 Concepcion-Martin, M............. 178 Conchillo, J................124, 149, 248 Concia, E.................................183 Conde, B.................................227 Conde, P.................................. 137 Cong, Y................................... 244 Conigliaro, R................62, 69, 96, 130, 230 Conio, M.................................. 62 Constantinescu, A................... 229 Constantinescu, G...... 181, 229, 231 Contaldo, F............................. 235 Conte, D................... 118, 130, 205, 223, 236, 254 Contente, L............................. 236 Conti Bellocchi, M. C................221 Conti, C. B........................ 118, 236 Conti, F.............................. 117, 167 Conti, L...................................155 Cooney, R.........................142, 234 Cooreman, M. P........................64 Coppens, E............................. 207 Coppeta, G. P.......................... 207 Coppola, C.............................. 119 Coppola, N.............................. 119 Corazza, G. R..............64, 155, 204 Corazziari, E. S................. 147, 239 Cordeiro, M............................ 208 Cordero Ruiz, P....................... 208 Cordes, F.....................89, 135, 237 Cordone, G....................... 118, 218 Córdova, H..............................231 Coriat, R........ 127, 177, 181, 228, 247 Corley, D.................................143 Cornberg, M........................61, 95 Cornillie, F...............................140 Cornish, J............................... 226
332
Coron, E..................... 82, 121, 130, 137, 222, 229, 234 Corona, G................................154 Coronel, M............................. 230 Corral, J. E................................ 52 Corrales, G............................. 239 Correale, L.............................. 101 Correia de Sousa, J. T.............. 224 Correia, A........................ 150, 224 Correia, L...........159, 209, 237, 258 Corrente, V...............196, 199, 202, 248-249, 255 Cortegoso Valdivia, P......................... 158, 223, 258 Cortés-Pérez, H........................ 175 Cortez Pinto, H.......42, 61, 85, 159, 167, 209, 258 Cortez-Pinto, J................. 114, 145, 176, 178, 230 Corvace, V...............................166 Corvinus, F..............................125 Cosin Roger, J..............97, 184, 233 Cosnes, J.................................186 Cossais, F............................... 242 Cossiga, V......................... 118, 168 Costa, A............ 208, 210, 237, 248 Costa, D............ 42, 55, 57, 60, 81, 85, 95, 118-119, 127, 158-159, 178, 208-210, 218, 221, 241, 258 Costa, F...................................233 Costa, J. M........................180, 183 Costa, J. P. V............................189 Costa, L............................. 85, 154 Costa, M. B. G.........................189 Costa, R............................157, 183 Costa e Silva, A....................... 208 Costa-Moreira, P.......................117 Costa Santos, M. P................... 178 Costabile, A.............................154 Costache, R. S.........................237 Costachescu, R........................ 157 Costamagna, G............. 55, 60, 81, 95, 130-131, 173, 228, 252 Costantini, A.......................... 248 Costantini, M........75, 105, 247-248 Costello-Goldring, E.......... 93, 102 Cotrim, I..................... 89, 179, 258 Cotter, J..............166, 186, 191, 201, 216, 222, 236, 257 Cottone, M....................... 237-239 Coudry, R................................221 Coulie, P................................... 63 Coupé, V. M. H.........................50 Coupland, B.....................103, 247 Courbette, O............................ 191 Coutinho, J..............................158 Covelli, C.................................154 Coysh, T................................. 205
Cozijnsen, M. A........................56 Crafa, P....... 196, 199, 202, 252, 255 Craig, D................................... 119 Craig, O........................... 146, 244 Cravo, M................... 178, 233, 237 Cremers, I....................54, 65, 215 Cremon, C...............70, 78, 90, 147 Crenier, L................................ 173 Crespi, M......................... 191, 237 Crespo, P..................................64 Cretu, I....................................251 Crinò, S......... 171, 121, 209, 221-222 Crippa, S...............68, 85, 161, 222 Crisan, D.................................215 Crispino, P.............................. 239 Cristino, A.............................. 208 Cristoferi, L..................... 220, 229 Critchlow, T.............................142 Croitoru, A............................. 223 Croitoru, V.............................. 223 Croner, R. S..............................86 Cronin, L.................................140 Crooks, C. J............................... 78 Crotty, P...................................159 Crowe, S........................... 89, 139 Crowe, S. E...............................54 Crowther, S............................ 205 Croxford, A. L..........................170 Cruciat, C............................... 246 Crudele, A.............................. 205 Crudeli, A............................... 226 Cruz, R....................................233 Csontos, A. A................... 235, 238 Csupor, D.................................171 Cuatrecasas, M............97, 143, 222 Cubiella, J....................... 144, 245 Cubisino, R............................ 203 Cucala-Ramos, M................... 246 Cucchiara, S......................135, 191 Cuciureanu, T..............131, 166-167 Cuenca Alarcón, F.....................65 Cui, G.-X.................................129 Cui, N..................................... 119 Cuillerier, E.............................185 Cuk, K......................................50 Čuković-Čavka, S......... 96, 135, 185 Culetto, A................................ 172 Cullen, A................................ 222 Cullen, G................................. 217 Cummins, S.............................138 Cunha, A. C...............215, 228, 241 Cunha, C...................228, 233, 241 Cunha, I..................................210 Cunha, M. F............................ 258 Cuomo, R..........................146-147 Cúrdia Gonçalves, T......................... 166, 222, 236 Curescu, M....................... 116, 216 Curtis, R.................... 141, 188, 239 Curvers, W. L...........................124
Cusumano, C.................... 159, 210 Čužić, S...................................183 Cuzzupè, C..............................135 Cyrany, J................................. 242 Czimmer, J.............................. 220
D D'Arcangelo, G........... 135, 190-191 D'Errico, F................................. 92 D'Haens, G. R........... 43, 47, 67, 73, 80, 102, 104, 141 D'Hoore, A...................56, 86, 107 D’Haens, G.........................47, 102 D’Heygere, F.............................55 D'Inca, R..................... 96, 97, 135, 185, 187, 189, 231 D´Orey, L.................................145 Da Costa, G.............................. 57 Da Costa, J. P...........................241 Da Costa, L. S. N...................... 127 Dabak, R................................ 244 Dabizzi, E..................122, 222, 230 Dąbkowski, K........................... 78 Dabrowski, A............................ 78 Dacal Rivas, A.......................... 63 Daferera, N............................ 238 Dagorn, J.-C............................. 57 Dahal-Koirala, S.......................56 Dahan, K..................................58 Dahlerup, J. F................... 96, 135, 155, 185, 189 Dai, N................148, 157, 244, 255 Dai, R.....................................142 Dai, S.-X..................................136 Dai, Y....................................... 92 Daiko, H................................. 250 Dakó, S.................................. 235 Dakour Aridi, H........................ 62 Dal Bò, N...........150, 196, 198, 252 Dale, H. F............................... 206 Dalén, E.................................. 176 Dalla, V...................................134 Dalla Gasperina, M.................. 187 Dallemagne, B........................ 173 Dallio, M......................... 165, 203 Dalmasso, G........................57, 85 Dalton, C................................ 252 Daly, K..................................... 52 Dambrauskas, Z................172, 221 Damsgaard, B.........................155 Danalıoğlu, A..................... 49, 80 Danese, S..............80, 137, 139-140 Dang, Y.................................... 57 Danila, M............168, 214, 216-218 Daniluk, J................................. 78 Daniluk, U................................ 78 Danion, P................................135 Dankó, T..................................143 Danse, E..................................182
Index of Authors and Co-Authors : UEG Week Final Programme
Danset, J.-B............................ 229 Dantas, E................................215 Daperno, M........................97, 185 Dapke, S.................................135 Dapoigny, M............................. 83 Dapri, G................................. 207 Dar, F. S.................................. 209 Dargiene, G.............................154 Darisetty, S.......................148, 156 Darkahi, B...............................219 Darne, A................................ 222 Darwish Murad, S.....................48 Darzi, A...................................155 Das, N. N................................219 Dasari, V................................. 133 Dassanayake, A. S....................164 Dassner, S...............................145 Dastych, M..............................251 Date, S................ 99, 223-224, 249 Dauvarte, H..................... 235, 240 Daveson, A. J............................64 David, A...........................139, 246 David, T.............................78, 256 Davies, A................................ 226 Davies, B................................ 226 Davies, R................................ 232 Davis, H. M............................... 47 Davis, J............................ 126, 245 Davis, M.............................. 47, 49 Dawsey, S................................201 Dayananda, B. M.....................158 De Angelis, C..... 158, 180, 223, 258 De Bastiani, R.................203, 248 De Bellis, M........................... 228 De Boer, J. P............................192 De Boer, K. H. N.........59, 186, 236 De Bortoli, N..............69, 149-150, 198-200, 206, 248-249 De Brito, L. X........................... 167 De Buck Van Overstraeten, A.........................................56 De Carlis, L..............................130 De Carolis, A...........................138 de Carvalho, K. I. L..................184 De Ceglie, A............................. 62 De Cesare, A....................206, 244 De Falco, L...............................64 de Franchis, R......................... 177 De Gaetano, A. M....................218 De Giorgio, R........... 50, 63, 70, 92 De Girolamo, V........................ 119 De Groof, J............................... 75 De Groot, W............................ 179 De Haan, M. W........................124 De Hertogh, G.................. 141, 190 De Higes Ruiz, M. J................. 248 De Jong, D................................64 De Jong, D. J........................... 236 De Jong, M..................49, 165, 187
De Jonge, J........... 93, 120, 169-170 De Juan, M. D.......................... 115 De Kleine, R. H. J......................59 De Kock, I.................................96 De Korte, C.............................. 167 De la Iglesia Garcia, D........................... 72, 180, 220 De La Morena, E......................154 De la Morena, F........................ 97 De la Ossa, N. D............83, 175-176 De la Peña, J......................175, 178 De la Santa Belda, E................153 De La Serna Higuera, C....... 99, 171 De Lange, T............................. 176 De Lazzari, F.....................192, 228 De Leon, H............................. 222 De Lima-Karagiannis, A............ 83 De Lima, M. S..........................201 De Looze, D............................. 133 De Luca, A............................... 133 De Luca, L................................ 62 De Manzini, N.........................165 De Marchi, F.............................171 De Matthaeis, N.......................218 De Meij, T. G. J..................186-187 De Meijer, V. E..........................59 De Monte, L..............................99 De Moura, D. T. H................... 230 De Moura, E. G. H....................126 De Nitto, D............................. 239 De Nucci, G......... 127, 130, 225-226 De Oca, J.................................. 97 De Oliveira, J. F................ 194, 258 De Pastena, M.........................183 De Paulo, G........194, 201, 231, 258 De Pretis, N.......................121, 221 De Re, V..................................153 De Reuver, P..................... 169, 219 De Ridder, L.............................56 De Ridder, R............... 69, 124, 149 De Roberto, G.........................156 De Silva, A. P.................... 135, 164 De Silva, H. J.................... 135, 164 De Silva, S. T...........................164 De Silva, T. M..........................135 De Simone, V......................79, 143 De Simoni, O................... 182, 250 De Stefano, G.......................... 119 De Swart, J..............................186 De Toma, D.............................. 127 De Toma, G............................. 147 De Torres, I.............................. 57 De Valliere, C..............97, 184, 233 De Vitis, I.........................155, 239 De Vos Tot Nederveen Cappel, W...................... 85, 98 De Vos, M.....................36, 49, 54, 96, 156, 255 De Vos, W. M................... 156, 255 De Vries, A. C.................. 236, 255
De Wit, N. J............ 74, 90, 103, 111 De Zorzi, M.............................153 De-Madaria, E...............59-60, 71, 106, 170, 220 Deacy, T..................................144 Deady, S.................................. 217 Deamici, M........................ 65, 155 Debourdeau, A.................124, 182 Dede, K...................................192 Deev, R...................................164 Deguchi, A..............................218 Deibert, P................................ 114 Deiss Pascual, L....................... 217 Dejaco, C................................. 137 Dejardin, E..............................170 Dejong, C. H............................. 93 Dekker, E.................39, 50, 68, 72, 84, 89, 98, 143, 192 Del Chiaro, M....... 64, 82, 120, 160 Del Giudice, C........................ 206 Del Olmo Martinez, L.............. 229 Del Pozo-García, A. J.......... 127, 175 Del Sancho-Serra, C......... 92, 200 Del Tedesco, E............. 73, 79, 135, 185-186 Del-Val-Antonana, A.........170, 220 Delacre, M............................... 57 Delanaud, S........................... 204 Delattre, H..............................194 Delconte, G.............................130 Delgado, M. D. P.......................49 Delgado, S............................. 252 Delhaye, M........... 36, 102, 113, 126 Deli, Z.....................................201 Delius, S...........................84, 224 Della Coletta, M..........69, 149-150, 199, 248 Della Scala, G..........................156 Dellaporta, E...........................134 Delle Fave, G......................171-172 Delmas, J.............................57, 71 Deloose, E......................... 65, 101 Demetter, P............... 126, 192, 210 Demir, I. E................................ 72 Demirel, U..............................170 Demuth, D.............................. 239 Denadai-Souza, A..................... 92 Deng, Y.................................. 244 Deng, Z.................................... 72 Denisov, N............................... 115 Denizot, J............................. 71-72 Dent, J...................................... 87 Denys, A.................................. 51 Denzer, U.................... 53, 95, 229 Depeint, F............................... 204 Depla, A..................................102 Deprez, P. H..............54, 67, 73, 81 Deraison, C.............................. 92 Derman, R..............................189 Derovs, A........................ 235, 240
Derrien, M............. 56, 83, 90, 141 Derwa, Y.................................237 Desai, P. N...............................130 Desideri, F............................... 127 Desomer, L............69, 128, 175, 177 Despott, E. J.................. 37, 41, 96, 131, 148 Desreumaux, P...........76, 236, 238 Dettmar, P...............................199 Devani, M........................156, 225 Devauchelle, B........................135 Devesa Medina, M. J............64-65 Devesa, N................................257 Deviere, J...........60, 67, 81, 96, 99, 126, 173, 197, 210 Dewit, O....................... 47, 55, 186 Dhaka, N..............103, 171, 178, 187 Dhar Chowdhury, S................. 224 Dhawan, M....................... 58, 122 Dhir, V.....................................150 Dhooge, M..............................247 Di Berardino, M.......................140 Di Costanzo, G. G.........118-119, 218 Di Fazio, P....................... 118, 120, 164, 168, 215 Di Fede, G...........................64-65 Di Giacomo, C.........................140 Di Giovangiulio, M............. 96, 143 Di Girolamo, M....................... 240 Di Giulio, E.......................124, 127, 155, 199, 228 Di Leo, A................... 92, 150, 154, 166, 203, 208 Di Leo, M.................. 85, 156, 219, 222, 224, 244 Di Lorenzo, C....................... 47, 55 Di Maggio, P............................ 116 Di Marco, M............................168 Di Mario, F........ 146, 150, 153, 196, 198-199, 202-203, 247-249, 252, 255 Di Martino, M..........................169 Di Martino, V.......................... 205 Di Matteo, F. M........................ 181 Di Mitri, R.............................. 238 Di Nicolantonio, F....................107 Di Palma, M........................... 205 Di Paolo, M. C.................206, 244 Di Pietro, M.......... 69, 89, 173, 200 Di Pisa, M........................ 237-238 Di Rosa, E...............................146 Di Sario, A...............................130 Di Sarno, R..............................165 DI Stasio, E..............................215 Di Stefano, M............... 64-65, 155 Di Stefano, S............. 159, 210, 221 Diamantis, E............................102 Diamantopoulou, G.................241 Diano, N.................................165 Dias de Castro, F........186, 236, 257
333
UEG Week Final Programme : Index of Authors and Co-Authors
Dias Pereira, A.... 145, 159, 176, 178, 180, 208, 222, 252 Dias, M. S............................... 167 Díaz Tasende, J. B.............. 127, 175 Díaz-Almirón, M......................188 Diaz-Florez, L......................... 235 Diaz-Guerra, A......................... 97 Díaz-Gutiérrez, J..................... 220 Díaz-Veléz, C...........................152 Díaz, G....................................189 Diaz, J..................................... 157 Dicksved, J............................... 79 Diculescu, M..............116, 167, 208 Dienethal, A............................155 Dienstmann, R........................107 Diestel, C. F.....................206, 255 Dieterich, W............................. 79 Dietrich, G................................ 92 Díez-Villanueva, A...................143 Diez, P............................... 84, 128 Digby-Bell, J........................... 239 Digby, J...................................193 Diggle, M................................142 Digiglio, L............................... 187 Dignass, A.............................. 239 Dijkgraaf, M. G. W....... 84, 93, 142 Dijkstra, G........... 70, 102, 236, 239 Dikken, J........................... 76, 182 Dikkongue, E...........................195 Dikopoulos, N................... 84, 193 Dilillo, D..................................190 DiMaio, C. J.............................. 62 Dimas, I............. 125, 129, 140, 145 Dimcevski, G............................171 Dimitri, R............................... 239 Dimitriadis, G. D............... 127, 131, 206, 251, 254 Dimitrijevic, I.......................... 133 Dimitroulopoulos, D....62, 230, 243 Dina, L................................... 256 Dindar Badem, N....................199 Dindar, G............................... 254 Ding, A...................................198 Ding, H...................................216 Ding, K................................... 230 Ding, M.................................. 246 Ding, N............... 70, 134, 233, 239 Ding, Y.......... 141, 143, 171, 201, 251 Dinis-Ribeiro, M...... 37, 46, 73, 82, 97, 106, 124, 132, 224, 227-228 Dino, P..................................... 70 Dinter, J............................. 61, 242 Dinu, I................................... 223 Dior, M.................................... 127 Dioscoridi, L............. 220, 229-230 Dirks, K.................................... 78 Disney, B.................................159 Dissanayake, V. H....................135 Dixon, S................................. 209
334
Dixson, H............................... 222 Djabarouti, S...........................188 Do, A.......... 39, 58, 60, 69, 82, 89, 92, 113, 116, 123, 128, 132, 139, 146-147, 162, 165, 168, 175, 188-189, 204, 217, 227-228, 246 Dobelniece, L.................. 235, 240 Dobos, G.......................... 187, 190 Dobrolyubova, E......................139 Docimo, L...................69, 198, 249 Dodd, S.................................. 240 Doglioni, C............................. 222 Doheim, M. F............................117 Doherty, G. A........................... 217 Dohi, O..................... 123, 174, 253 Doi, A............................... 69, 146 Doina, P.................................. 157 Dokladanska, A..........175, 227-228 Dolak, W................................. 132 Dolapcıoglu, C........................ 244 Dolin, P....................................49 Dolina, J........................... 149, 251 Dollhopf, M............................ 224 Dolwani, S..............................125 Dolz Abadia, C......................... 175 Domagk, D. L............................94 Domènech, E............186, 190, 234, 239-240 Domínguez-Flores, R................56 Dominguez-Muñoz, J. E.....................71-72, 147, 187, 190, 220, 252 Domínguez-Pino, A.................128 Dominguez-Rosales, A............ 116 Dominguez, E. H. G.................231 Dominik, L...............................84 Donato, G............................... 222 Donato, M. F............................130 Donato, P............................... 232 Donca, V..................................215 Dong-Yun, C............................247 Dong, J..................................... 52 Dong, S.-H.......................219, 229 Dong, T....................................82 Dong, Y....................... 91, 147, 202 Doorakkers, E........................... 77 Doré, J.............................. 50, 141 Doron, S.................................. 181 Dorreman, Y............................ 133 Dos Santos, M. E. L................. 230 Dos Santos, P. M...............159, 207 Doss, W....................................117 Dotan, I.........................43, 81, 91, 94, 104, 230 Dotti, I..................................... 97 Dötzer, K................................ 232 Dou, L...................................... 72 Doubkova, M...........................149 Douda, T.................................237 Douillard, F. P......................... 255
Doukas, M...............................192 Doukoure, B............................192 Douschan, P............................216 Dousset, B............................... 181 Dovbynchuk, T.................. 134, 184 Dowd, S..................................241 Downey, R. W..........................189 Dowson, G..............................188 Dowty, M. E.............................. 79 Doyama, H...... 51, 58, 142, 151, 251 Drabińska, N.................... 157, 255 Draganov, P............75, 95, 145, 151 Dragasevic, S...........................165 Dragoi, D..................................59 Dragoni, G..............................190 Drastich, P..... 52, 184, 217, 237, 256 Dray, X.................. 72, 128, 131, 181 Dreanic, J................................ 127 Drenth, J. P. H.....46, 58, 71, 86, 91, 107, 121, 136, 165-167, 169, 219, 235, 255 Drewes, A. M........37, 107, 199, 212 Drissi, F.................................. 242 Drobne, D................................ 79 Drozd, U.................................. 132 Drug, V. L............................... 222 Drukker, M..............................196 Drummond, L...........................90 Drvarov, O................................ 61 Du, H.............52, 76, 132, 155, 158, 173, 181-182, 185, 207, 212, 231, 246-247, 255, 258 Du, L........... 57, 59, 62, 72, 99, 129, 135, 137, 145, 148, 169, 178-179, 218-219, 229, 244, 246, 255, 257 Du, M....................... 133, 202, 216, 222, 247, 256 Duan, L........57, 145, 204, 246, 248 Duan, T...................................251 Duarte Rojo, A..........................71 Duarte, M............................... 222 Duarte, R. B.................... 126, 230 Dubale, N............ 99, 223-224, 249 Dubbink, H. J...........................192 Dubinsky, M. C........................140 Duboc, D................................ 206 Duboc, H......................... 206, 241 Dubois, A................................ 137 Dubois, P.................................227 Dubravcsik, Z......................... 243 Duchalais, E.................... 242, 252 Duchmann, J. C.......................130 Duckworth, A......................... 208 Duclos, B................................. 75 Ducreux, M.............. 38, 51, 75, 82 Duffy, M..................................247 Dufour, G................................. 76 Dufour, J.-F......................... 38, 42 Duijnhouwer, T........................166
Dulbecco, P............................. 228 Duman, D. G.................... 114, 223 Dumas, B............................... 242 Dumic Cule, I...........................214 Dunckley, P.......... 89, 223, 225-226 Dunn, S....................................89 Duong, C.................................150 Dupas, J.-L........................135, 137 Dupont-Gossart, A.-C............. 234 Durand-Fontanier, S............... 232 Durand-Zaleski, I......................50 Durand, T................. 195, 234, 252 Durc, P....................................149 Durchschein, F.........................216 Durdevic, M.............................216 Ďuriček, M.......... 69, 101, 248-249 Duricova, D....76, 96, 135, 185, 238 Duron, C.................................. 83 Dusek, L................................. 244 Dustmuxamedova, D. X............ 157 Dutei, C. A.............................. 208 Duvanskiy, V............................ 132 Duveau, N.............................. 238 Dvorak, J.................................184 Dwarakanath, D...................... 229 Dwyer, L. K............................... 62 Dyaczyński, M..........................164 Dynnyk, O...................101, 168, 215 Dziekiewicz, M........................195 Dziki, A...................................233 Dziki, Ł....................................233 Dziubenko, N................... 184, 238 Dzuris, J. J................................56
E Early, D................................... 179 Easler, J................................... 179 East, J. E.................. 68, 72, 89, 98 Eberl, A.................................. 239 Eberl, G................................... 57 Ebigbo, A.................. 48, 100, 205 Echarri, A................................189 Echarri Piudo, A...............235, 237 Eckel, F................................... 224 Eckersley, R............................ 205 Eckhardt, G............................. 137 Edebol-Carlman, H..................146 Edelmann, M..........................128 Eder, P................................... 240 Edir, A...................................... 92 Ee, H........................................64 Efimova, O. V...........................122 Efthymakis, K.................. 236, 254 Egan, A. M..............................257 Egan, L.........................54, 63, 162 Egoavil, C................................143 Ehara, A................................. 236 Ehlken, H................................. 76 Eiroa, D.................................. 235
Index of Authors and Co-Authors : UEG Week Final Programme
Eisele, B..................................154 Eisendrath, P........ 60, 95, 126, 210 Eissa, N.............................. 89, 92 Ejova, A........................... 145, 197 Ejstrud, P.................................199 Ekici, A..................................... 79 El Aassar, O. S........................ 232 El-Aarag, B.............................166 El-Ahwany, E........................... 118 El Alfy, H..........................168, 207 El Baz, T.................................. 118 El-Badrawy, E.-S. G.................218 El-Barber, D.............................117 El-Bendary, M..... 117, 166, 207, 220 El-Diasty, M.............................166 El Essawey, R...........................117 El Fayoumie, M.......................123 El-Gilany, A.-H....................... 220 El Hajj, I.................................. 179 El-Hanafy, E..................... 121, 168 El Houssine, M.................178, 225 El Kady, S. M...........................136 El Kassas, M.............................117 El Magid Kassem, A................ 224 El Mekkaoui, A.................178, 255 El-Mikkawy, A..........................96 El Morsy, A..............................168 El Nakeeb, A........................... 121 El Nakib, A............................. 207 El-Omar, E.........37, 83, 92, 97, 106 El-Safi, G................................237 El-Salhy, M................ 194-195, 246 El-Serafy, M.............................117 El-Setouhy, M.................... 117, 166 El Shabrawi, A........................168 El Shafie, A.............................164 Eladl, A.-H........................ 117, 166 Elalfy, H......................117, 166, 217 Elbadrawy, A...........................168 Elbadry, M.............................. 167 Elbahrawy, A.................... 123, 136 Elbe, P....................................200 Eldahshan, M..........................123 Elegezy, M.............................. 207 Elferink, M. A..........................192 Elferink, R................................117 Elfert, A................................... 52 Elhadidy, E. M......................... 115 Elhanafy, E....................... 169, 179 Eli, B...................................... 242 Eliakim, R.................... 72, 78, 131, 137, 140, 190 Elibol, S..................................215 Elisei, W................... 146, 203, 228 Eliseu, L..................... 89, 179, 258 Elizabeth, H............................ 181 Elizalde, I................................ 181 Elkholy, A................................166 Elkoti, I.................................. 253 Ell, C.................................. 76, 96
Ellakany, W. I.......................... 118 Ellazeik, Y.................................117 Elleuch, N...............................168 Elli, L..............................205, 254 Elloumi, H........................228-229 Ellul, P..................89, 96, 135, 185 Elmahjoubi, S........................ 240 Elmesseri, H............................153 Elmore, U............................... 242 Elmorsy, A. A............................117 Elmunzer, B. J................... 62, 103 Elnagar, M...............................117 Elnakeeb, A...................... 169, 179 Elnegouly, M.......................... 224 Elnoemany, K...........................117 Eloranta, J. J............................233 Elorza, A................................ 235 Elosua, A................................ 178 Elrakhawy, M. M...................... 115 Elsaeed, K................................117 Elsareef, M..............................166 Elsayed, H................................117 Elshazly, Y................................117 Eltabbakh, M............................117 Eltahan, A................................117 Elwan, N.................................. 52 Elzubier, M............................. 229 Emara Elzanan, M. H......................118, 178, 232 Emara, E.......................... 118, 232 Eminler, A. T............................ 132 Emmanuel, A............224, 226-227 Emmanuel, A. V.............40, 71, 78, 88, 195, 244-247 Emparanza, J. I........................ 115 Emura, F......................58, 82, 107 Enache, I.................................237 Endo, H.........67, 69, 77, 79, 97, 151, 163, 176-177, 187, 193-194, 198, 201, 222, 227, 234 Endo, K.................................... 76 Endo, S.............75, 87-88, 91, 125, 152, 178, 191, 224 Endoh, B.............. 117, 129, 171, 180 Enejosa, J............................ 47, 87 Engel, T...................................140 Engelen, S. M...........................50 Engjom, T.................................171 Engsbro, A. L............................58 Engstrand, L........................ 77, 79 Ennas, S..................................155 Ennio, G..................................192 Enochsson, L....................120, 183 Enomoto, H............................. 167 Epshtein, J................................69 Epstein, A................................ 72 Er-Rabie, F............................. 240 Eraković Haber, V.....................183 Erchinger, F. G..........................171 Erdélyi, Z............................... 234
Erdogan, M. A.........................170 Erdős, R..................................170 Erdozain, I.............................. 217 Ergul, B...................................199 Ergun, P..................................199 Erhardt, A................................ 53 Erhartova, D............................ 174 Erice, O...............................91, 117 Eriksson, C..............................189 Erjavec, I.................................214 Erler, N. S.................................48 Ernst, O............................212, 236 Eross, B..............151, 153, 231, 250 Errico, S..................................165 Erzik, C.................................. 256 Esain, I................................... 217 Esaka, N............................ 117, 128 Esaki, M............. 123, 152, 182, 254 Escher, J. C...................56, 83, 102 Escofet, X................................199 Eseneeva, G............................ 133 Eser, A..................................... 83 Eshraghian, A.................. 65, 165, 215-216, 218 Esmaily, S.........................89, 229 Esmat, G........................... 117, 166 Espin Basany, E........................82 Espinel, J.................................153 Espinós, J...................153, 178, 227 Espinosa, A.............................143 Esplugues, J. V.................. 233-234 Esposito, G.......... 124, 127, 155, 199 Esposito, P............................... 174 Esser, D....................................96 Esteban, R................................ 39 Ester, C.-C.........................116, 217 Esteve, M................... 56, 185, 189 Esteves, G...............................159 Estevez-Perez, L. S............ 147, 252 Eswaran, S. L.................47, 53, 83 Ethgen, O................................216 Ette, E......................................50 Eugenicos, M. P.......................146 Eusebi, L. H...................... 148, 197 Eusébio, M. S..........................215 Eutamene, H.................... 141, 145 Evans, J.................... 150, 222, 248 Evdokimova, L......................... 119 Everett, S................................ 132 Everson, L.............................. 239 Everson, M. A.......76, 132, 149, 225 Eves, K.................................... 141 Evgenya, L............................... 181 Evgrafov, P............................... 187 Evison, F........................... 103, 170 Eyal, I..................................... 131 Eynat, F.................................. 243 Ezaki, T...................................170 Ezpeleta, G.............................. 181 Ezra, B................................... 242
F Fabbri, C.................................130 Fabian, A..........228, 234, 238, 240 Fabiocchi, F.............................146 Fabisiak, A..............................134 Fabisiak, N..............................134 Facchin, S............................... 187 Fadeenko, G.......................77, 104 Fadeeva, N................. 138-139, 184 Fadgyas-Freyler, P....................138 Fahrbach, K............................. 141 Faias, S...............176, 178, 180, 222 Faiss, S.................................... 76 Faiz, O....................... 134, 189, 233 Fakheri, H.............................. 203 Falalyeyeva, T................... 101, 155 Falconi, M.........................85, 222 Falk-Paulsen, M.......................135 Falt, P......................................237 Familiari, P............................. 252 Fan, L...................................... 115 Fan, Z..................124, 173, 197-199 Fanczal, J................................120 Fang, D............................ 114, 218 Fang, F....................................198 Fang, J............................... 77, 192 Fang, Y................................... 242 Fang, Y.-J................................. 77 Fani, B................................... 206 Fantin, A.................................130 Fantini, M. C..................... 96, 187 Faraag, E. A............................ 133 Farag, A.................................. 116 Farag, R.................................. 217 Farah, K............................ 58, 122 Farcau, O.......................... 73, 256 Farges, O..................................88 Farid, A....................................117 Farid, K...................... 117, 168, 207 Farida, J..................................196 Farinati, F..... 119, 168, 171, 203, 249 Farkas, H................................ 220 Farkas, K................... 83, 136, 228, 234, 238, 240 Farkas, N.......................... 153, 231 Farkash, S............................... 181 Färkkila, M. A. A.................91, 138 Farman, M..............................237 Farmazon, A............................165 Farmer, A. D......................196-197 Faroux, R................................185 Farré, C.................................. 236 Farré, R...................................247 Farro, G................................... 79 Farrugia, G........................ 57, 206 Farthing, M......................103, 105 Fassan, M....86, 200, 203, 223, 249 Fassino, V................................138 Fatela, N................... 167, 208, 210 Fatima, M........................ 129, 209
335
UEG Week Final Programme : Index of Authors and Co-Authors
Fattahi, M. R............... 65, 215-216 Favreau, J. T............................145 Fawzi, M................................. 116 Fawzy, E. F............................... 167 Fawzy, I. M.............................. 167 Fayad, L............................ 62, 103 Fazendeiro, M.........................195 Fazio, A...................................135 Feagan, B.....................47, 56, 61, 139, 141, 190 Federico, A...................... 165, 203 Federico, F................................ 75 Fedotova, A.............................184 Fedusenko, O..........................168 Feeney, M.................223, 225-226 Fehling, H.-J.............................96 Feichtenschlager, T.................. 137 Fein, F.................................... 234 Fekih, M................................. 240 Feldager, E..............................221 Felder, M................................168 Feldhamer, I............................. 91 Felice, C................................. 239 Feliciangeli, G........................ 228 Félix, J.....................................159 Feliziani, M.............................156 Fellermann, K.......................... 53 Felt-Bersma, R. J.....................185 Femia, D................................ 223 Fennessy, S.............................126 Ferdinande, K......................... 133 Férec, C....................................46 Ferenci, T............................... 235 Ferkolj, I.................................. 79 Ferlitsch, A............................... 51 Ferlitsch, M................175, 227-228 Fernandes, A.....................89, 258 Fernandes, C...........................159 Fernandes, S............ 116, 159, 208, 221, 228, 235, 237 Fernández, E.................... 121, 140 Fernández, F......................137, 140 Fernandez, G..................... 117, 145 Fernandez, R. J. F............206, 255 Fernández-Bañares, F........56, 140 Fernandez-Barrena, M. G.........117 Fernández-Esparrach, G.............128, 175, 180, 222, 231 Fernández-Esparrach, M. G..... 175 Fernández-Fernández, E.......... 121 Fernandez-Irigoyen, J...............117 Fernández-Laso, A. B................71 Fernández Rosaenz, H.............185 Fernandez Saya, B...................237 Fernandez-Simon, A................227 Fernandez-Tome, S................... 97 Fernández-Urién Sainz, I............................131, 181, 229 Fernández-Urién, I............ 72, 131, 181, 229
336
Fernandez Y Viesca, M.............210 Ferracane, C.....................238-239 Ferraccioli, G............................ 75 Ferrández Arenas, Á.......... 84, 128 Ferrante, M............. 47, 55-56, 189 Ferrara, E................. 219, 224, 244 Ferrara, L................................ 119 Ferraz, S................................ 224 Ferrazzii, F................................ 79 Ferreira Paduani, G.................221 Ferreira, A. M..........................219 Ferreira, A. O.............. 72, 158, 178 Ferreira, C.................159, 207, 258 Ferreira, D...............................139 Ferreira, M................ 166, 219, 232 Ferreira, P............................... 167 Ferreira, R........... 72, 158, 166, 229 Ferreira, S............................... 178 Ferreira, T...............................145 Ferreiro Iglesias, R........... 187, 190 Ferreiro-Mazón, H...................237 Ferrer-Guixeras, M..................134 Ferrer-Picón, E......................... 97 Ferretti, F........................205, 254 Ferronato, A............. 203, 240, 247 Feshtali, S................................85 Feskanich, D........................... 250 Fest, J......................................85 Festa, S...................... 97, 185, 240 Festen, E. A. M......................... 70 Festi, D.................................... 78 Fetsych, T................................ 151 Fiamma, M.-N.........................156 Fichna, J......................79, 134-135, 143, 156, 184 Fickert, P.......................... 101, 216 Fidalgo, C................................237 Fidder, H. H............................ 238 Fiedorek, F. T............................65 Fielding, P.............................. 232 Figa, M...................................227 Figueiredo, A......................... 208 Figuerola, A............................139 Filali, A.................................. 240 Filho, J. R................................189 Filiberti, R................................ 62 Filip, R.............................235-236 Filippi, J....................... 75, 80, 137 Filipponi, F..............................130 Finati, E................................. 224 Fink, C....................................247 Finnby, L................................ 236 Fioravante, M......................... 236 Fiore, W...................................90 Fiori, G.................77, 104, 137, 228 Fiorini, G............................77, 104 Fiorino, G................................ 137 Firwana, M............................ 256 Fisas, D.................................... 63 Fischbach, W..................... 92, 126
Fischer, A....................53, 147, 207 Fischer, L................................ 229 Fischer, P.................... 73, 166, 256 Fischer, S............................... 207 Fisher, N. C.............................123 Fishman, S..............................155 Fit, A.-M................................ 256 Fitzel, G................................... 53 Fitzgerald, D............................237 Fitzgerald, R. C...... 81, 89, 105, 107 FitzPatrick, M......................... 254 Flamant, M...................... 136, 186 Flaquer, F. S............................184 Flavia Savarese, M.................. 230 Fletcher, L.............................. 204 Flik, C......................................90 Fliss Isacov, N.......................... 151 Floquet, E................................ 57 Floreani, A.................... 53, 68, 91 Florent, C................................ 181 Flores-Trujillo, G......................152 Florido, M...............................194 Floro, G. C.............................. 208 Florovsky, G............................ 132 Flourie, B........ 75, 79, 135, 139, 186 Flynn, H. A..............................140 Fockens, P.............. 42, 46, 60, 84, 88-89, 105 Foell, D....................................89 Fogden, E............................... 234 Fogel, E.................................. 179 Fokra, A...........................242-243 Foley, A.................................. 230 Foley, K.................................. 232 Foliaki, A........................ 182, 256 Folprecht, G............................. 92 Foncea, C. G............................168 Fondevila, C.............................38 Fonseca, C....157-158, 210, 241, 256 Fonseca, J....157-158, 209-210, 256 Fonseca, J. S........................... 258 Fonseca, R........ 145, 180, 222, 252 Fontaine, F...............................55 Fontana, P.............................. 220 Ford, A. C..........59, 67, 70, 74, 146, 188, 197, 237, 244 Forde, J. J........................... 76, 151 Foret, F....................................149 Foria, B................................... 151 Forlano, R...............................165 Fornasarig, M................... 153, 192 Fornelli, A...............................130 Forner, A...........................54, 106 Forsberg, A.............................143 Forsmark, C. E......................... 151 Forstlova, M............................241 Fortarezza, F............................154 Fortea, M................................. 57 Forti, E........130, 156, 220, 229-230 Foschi, F. G..............................168
Foss, A....................................145 Foster, P................................. 204 Fotea, V.................................. 256 Foteinogiannopoulou, K.......... 187 Fotsing Makougang, G..............80 Fouad, A..................................117 Fournier, C............................. 240 Fournier, N............................. 235 Fowler, J. F..............................140 Fox, M...... 40, 60, 80, 88, 148, 244 Fradejas Salazar, P................... 137 Fraga, E................................. 256 Fragkaki, M........ 125, 129, 140, 145 Frago, S................................. 253 Fraile González, M............ 125, 178 Framarin, L............................. 119 Framba, V...............................221 Frampas, E..............................136 França, M................................257 Frances, R................................ 73 Franceschet, I..........................190 Franceschi, M..................146, 196, 198-199, 202-203, 247-249, 252 Franchimont, D................... 47, 55 Franchina, M...........................198 Francica, G.............................. 119 Franco, M. C........................... 246 Franco, O. H.............................48 Francoz, C..................38, 100, 104 Franke, A..................... 89, 91, 138 Franke, L.................................. 70 Franzè, E........................... 96, 143 Franzoni, L........ 196, 198-199, 202, 248-249, 252, 255 Frappart, P.-O........................... 78 Fraquelli, M..................... 118, 236 Fraser, C.................................. 131 Fraser, C. G.............................193 Fraser, G. M........................... 230 Frasson, A.............................. 228 Frazzoni, L................. 69, 129-130, 198, 200, 230, 249 Frazzoni, M........ 69, 198, 200, 249 Frederking, D..........................154 Frei, P...............................86, 225 Freire, J...................................145 Freire, J. P.............................. 225 Freitas, C.................................158 Freitas, T......................... 228, 235 Freitas Júnior, W. R..................215 Frey-Wagner, I...................97, 184 Freyssinet, M...........................186 Fried, M.............. 86, 118, 195, 206 Friedenberg, K................ 140, 252 Friedli, B................................ 234 Friedman, G.......... 56, 61, 102, 140 Friedman, J.............................188 Friedrich-Rust, M.................... 118 Frieling, T................................. 53
Index of Authors and Co-Authors : UEG Week Final Programme
Fries, W.....................97, 185, 189, 238-239 Friess, H..................................168 Frigerio, I.................................85 Frigerio, M..............................156 Fritz, P.................................... 234 Fritzer-Szekeres, M................... 51 Fronek, J.................................158 Frulloni, L............ 80, 98, 121, 159, 171, 209-210, 221 Fu, J................. 51, 70, 93, 151, 167, 174-175, 232, 246 Fu, L...................... 69-70, 93, 101, 129-130, 198, 200-201, 228, 230, 249 Fuccio, L...............69, 101, 129-130, 198, 200, 228, 230 Fuchssteiner, H........................ 137 Fudim, E..........................140, 190 Fuentes Coronel, A. M............. 137 Fugang, L................................201 Fugazza, A........ 219, 222, 224, 244 Fuglsang, K. A.........................103 Fuhler, G. M............................. 79 Führer, M................................148 Fujii, M........................... 209, 257 Fujii, N................................... 203 Fujii, R............................. 178, 231 Fujii, S....................... 97, 236, 250 Fujii, T........... 76, 136, 178, 188, 236 Fujii, Y............................. 122, 153 Fujimori, S................178, 236, 254 Fujimoto, A..... 53, 82, 173-174, 225 Fujimoto, J..................93, 167, 232 Fujimoto, K.... 77, 187, 193, 197, 234 Fujimoto, Y.............................. 167 Fujino, T...........................152, 243 Fujisaki, J........51, 151, 174-175, 246 Fujisawa, T........................58, 222 Fujishiro, M................ 51, 96, 142, 151, 205 Fujita, I....................................82 Fujita, K........................... 126, 147 Fujita, M................................ 222 Fujita, T.................................. 226 Fujiwara, A............... 115, 209, 257 Fujiwara, K.............................145 Fujiwara, Y.......... 79, 115, 200, 254 Fukahori, M........................... 180 Fukami, Y........................ 203, 241 Fukata, N................................126 Fuks, D................................49, 74 Fukuba, N........................101, 238 Fukuda, H...............................251 Fukuda, K........... 183, 187, 223, 232 Fukuda, S....................71, 194, 203 Fukuda, T................................138 Fukuhara, M............................ 167 Fukui, A................................. 204 Fukui, H...................................84
Fukui, K.................................. 121 Fukumoto, A..................... 69, 142 Fukunaga, S...........................200 Fukunaga, Y............................ 175 Fukushima, H.......................... 176 Fuldeore, M............................. 87 Fullana, M.............................. 239 Fumery, M............. 75-76, 96, 135, 137, 139, 185 Fumery, O...............................135 Fumihito, H..............................58 Funaki, S.................... 175-176, 182 Funasaka, K...................... 136-137 Funato, K................................142 Fung, D.................................. 242 Furfaro, F................................ 137 Furgała, A.............................. 204 Furnari, M..................69, 198, 249 Furnea, B............................... 246 Furtado, A.............................. 209 Furtado, E............................... 217 Furudoi, A......................... 53, 144 Furukawa, K............... 136-137, 229 Furutachi, S............................201 Furutake, M............................ 176 Fuschi, D.............................70, 78 Fushimi, S............................... 132 Fust, K....................................196 Futagami, S.................82, 173, 198
G Gabbrielli, A..................... 121, 171, 209, 221-222 Gabe, S. M............................. 205 Gabieta-Sonmez, S..................247 Gabr, A................. 64-65, 178, 225 Gabriele, A..........................64-65 Gaeta, G. B.............................. 119 Gagalis, A...............................159 Gagliani, N..............................150 Gagniere, C..................50, 75, 186 Gago, T...... 215, 228, 236, 241, 255 Gahan, C. G.............................134 Gaia, S................................... 180 Gaidhane, M.......................... 223 Gaiser, T................................... 92 Gait, A....................................182 Gal, E............ 49, 131, 171, 230, 240 Galamb, O...........143, 192-193, 243 Galanko, J................................ 78 Galdona, I...............................140 Galeev, S................................ 220 Galera, A. B............................154 Gallach, M..............................241 Gallagher, C............................138 Gallart, M................................ 57 Galle, P. R................... 55, 98, 125 Gallego-Gomez, R............ 147, 252 Gallego, F............................... 235
Gallego, S.............................. 253 Galli, G..................... 124, 155, 199 Gallittu, P................................. 52 Gallmeier, E..............102, 106, 160 Galloro, G................................96 Gallotta, S.............................. 244 Galloway, D.............................158 Galloway, P............................. 132 Galtieri, P. A............. 219, 224, 244 Galvao Neto, M................ 155, 173, 206, 255 Gama-Carvalho, M..................164 Gamar, L.................................185 Gambaccini, D........................ 206 Gambitta, P................181-182, 220 Gameel, A............................... 115 Gamian, A...............................184 Gan, T. M. A............................156 Ganatra, R.............................. 225 Gandara, J...............................196 Gandolfo, C..............................99 Ganeshappa, R....................... 252 Gao, J............................... 116, 257 Gao, L.-L............................ 47, 141 Gao, N....................................170 Garau Colom, C........................ 63 Garcia, D.................... 65, 139, 247 Garcia, L. D.............................184 García, M.................. 128, 137, 220 Garcia, M. J.............................194 Garcia, S................................200 García, W................................233 García Alonso, F. J....................120 Garcia Donday, M...............77, 104 García Durán, F........................120 García Martín, L......................125 Garcia Pagan, J. C................... 100 García Ramirez, L....................188 Garcia Ramos, C...................... 167 García Rodríguez, L. A..............96 Garcia-Alonso, F. J............125, 226 García-Arribas, D......................65 Garcia-Caballero, T........... 147, 252 García-Cámara, P.................... 253 Garcia-Cortes, P.......................194 Garcia-Gil, J..................... 134, 237 García-González, M. A..... 153, 200 Garcia-Guix, M....................... 180 Garcia-Iglesias, P.....................241 Garcia-Jaraquemada, A.......... 234 García-López, S............... 189, 235 García-Mayor, M......................128 García-Puig, R..........................56 García-Rayado, G........71, 170, 220 García-Rodríguez, S............... 220 García-Sánchez, V..... 140, 185-186, 190, 240 Garcovich, M.................... 215, 218 Gardiner, P. J............................59 Garg, M.............................58, 233
Gargallo Puyuelo, C. J........................125, 136, 178 Gargari, G...............................156 Gargaté, L...............................159 Gargouri, D......................228-229 Garmanchuk, L........................134 Garret, C................................. 121 Garrido, M. S.......................... 235 Garros, A................................ 197 Gartner, J................................ 137 Garufi, S................................ 239 Garvey, T.................................158 Garzon-Benavides, M............... 63 Gasbarrini, A............37, 50, 59, 77, 87, 100, 103-104, 166, 168, 188, 215, 218, 239, 256 Gasbarrini, G.......................... 256 Gashemi, P............................. 204 Gasink, C............................ 47, 141 Gasmi, M.................................95 Gaspar, M. M...........................169 Gaspar, R............117, 165, 168, 173, 195-196, 201, 209, 258 Gasparov, S.............................257 Gaspersz, M...............120, 169-170 Gasztonyi, B...................... 83, 136 Gatof, D.................................. 252 Gatti, P.............................. 117, 167 Gatti, S....................................190 Gaudric, M..............................247 Gauiran, D............................. 208 Gaujoux, S.............................. 181 Gauss, A..................................233 Gauthier, A..............................188 Gauthier, J.-F...........................156 Gavasso, S............................... 116 Gavini, S................................. 133 Gawish, A...............................123 Gawron-Kiszka, M.................. 240 Gaya, D. R......................... 61, 190 Gazeau, F................................ 173 Gazis, T...................................148 Gazizov, I. M............................164 Gazouli, M.............................. 187 Ge, C............ 57, 59, 77-79, 117, 141, 144, 167, 234, 253 Ge, N............36-38, 51, 55-56, 58, 61-62, 64, 66-68, 71, 76, 82, 88-89, 92-94, 98-99, 102, 105-106, 118, 125, 138, 143, 155, 161-162, 168, 171-172, 174-175, 178, 184, 190, 195, 205, 211, 215, 220221, 225, 251, 254 Ge, Y..............48, 60, 88, 104, 134, 193, 214, 226, 248 Geccherle, A.................... 190, 238 Gecim, I.............................81, 213 Gecim, I. E.........................81, 213 Gecov, P..................................221
337
UEG Week Final Programme : Index of Authors and Co-Authors
Gecse, K. B..............54, 61, 70, 83, 110, 136, 138, 240 Geddes, J............................... 235 Gedgaudas, R.....................91, 142 Geelkerken, R. H.................... 255 Gehring, S...............................215 Geier, M. S............................. 204 Geiger, S.................. 194, 201, 258 Geiger, T. L..............................184 Geijo, F...................................153 Geismann, C............................102 Gelabert, J...............................194 Geller, S. I............................... 157 Gelley, A................................ 234 Gelman, S............................... 115 Gelrud, A.........................183, 233 Genc, D................................... 114 Genda, T.................................198 Gendo, Y.................................134 Geng, C..............................79, 174 Genov, J..................................221 Genova, S............................... 238 Gentile, A............................... 208 George, V................................ 137 Georgieva, A...........................186 Georgiou, E.............................183 Geramizadeh, B...............165, 218 Gerard, R........................ 236, 238 Gerardi, V................................155 Gerassy, S...............................189 Gerber, M............................... 204 Gerbes, A. L.............................59 Gerbino, N....................... 64, 205 Gerges, C..................42, 67, 73, 81 Germain, P.............................. 137 Germaná, B.......... 96, 171, 192, 228 Gerner, R. R.............................89 Gerova, V.........................159, 236 Gerß, J....................................135 Gervasi, S............................... 202 Gesret, C................................ 234 Gevers, T. J............................... 91 Gewirtz, A. T................ 57, 70, 183 Geyer, M..................................84 Ghalab, M........................ 118, 232 Ghaoui, C............................... 229 Ghasemi, P......................204, 246 Ghasiyari, H............................154 Ghatak, S. K........................... 224 Ghazi, S..................................120 Gheorghe, C............... 116, 217, 223 Gheorghe, L................116, 216-217 Gheorghiu, M. I...................... 230 Gherhardt, D.................... 168, 170 Ghia, J.-E........................... 89, 92 Ghinolfi, D...............................130 Ghosh, P..................................156 Ghosh, S.................. 47, 49, 61, 67, 88, 100, 142, 176 Ghozlane, A........................... 243
338
Giacomin, A.............................171 Giampietro, V.......................... 197 Giannakeas, N.........................165 Giannakopoulos, A..................125 Giannikaki, L.................... 125, 145 Giannini, E. G...... 168, 187, 191, 237 Giannotta, M.............. 96, 135, 185 Giannou, A..............................150 Gianquinto, E.......................... 187 Giardini, M............................. 228 Giardullo, N............................ 133 Gibiino, G...............................215 Gibson, P. R.....47, 67, 103, 141, 146, 195-196, 205, 233, 245 Gies, A.....................................50 Gil-Simon, P.............................99 Gil, A. H.......................... 238, 242 Gil, H....................... 194, 238, 242 Gil, K..................................... 204 Gil, P.................... 99, 171, 196, 237 Gilabert, P........................ 196, 237 Gilardi, D................................ 137 Giles, T................................... 222 Gilissen, L. P. L.......... 102, 124, 149 Gilja, O. H..........................77, 194 Gillespie, G....................... 61, 190 Gillet, A............................ 50, 176 Gilletta De Saint Joseph, C........ 73 Gils, A............................... 64, 189 Gim, S. J................................. 209 Gimeno Garcia, A................... 245 Gimeno García, A. Z............... 180 Gimesi-Orszagh, J....................138 Gimier, E.................................. 72 Ginard, D................................185 Gincul, R................................ 229 Giner-Calabuig, M............. 63, 143 Gines, A.......................... 180, 222 Gingold Belfer, R...................... 91 Gini, A.....................................50 Ginsberg, G. G.......................... 76 Ginter, G................................ 104 Giorda, E..................................96 Giorgetti, G.............................146 Giouleme, O.............................49 Giovannini, M....... 49, 82, 95, 122, 152, 169, 172, 200, 229 Giráldez-Montero, J. M............190 Girardin, G..............................189 Girboni, L............................... 224 Girleanu, I.... 131, 166-167, 254, 256 Girot, P................................... 252 Gisbert-Ferrándiz, L................134, 233-234, 252 Gisbert, J. P............77, 97, 104, 185 Gisbertz, S. S............... 76, 82, 250 Giuliante, F..............................218 Giuseppe, C.............................189 Giuseppe, P............................ 203 Gkolfakis, P................. 127, 131, 254
Glanemann, M........................146 Glasinovic, E..................... 69, 247 Glerup, H................................ 141 Glocker, E................................154 Gloor, B..................................183 Glória, H................................ 208 Glória, L..................................237 Gloudemans, A. K....................184 Gluck, N..............................69, 72 Gluud, L. L..............................221 Glynn, P..................................142 Glynne-Jones, R..... 38, 74, 107, 114 Gobbo, M................................186 Goda, K.................................. 250 Godat, S................................. 248 Goddard, S..............................125 Godfrey, E................................59 Gódi, S............................ 220, 229 Godin, N.................................149 Godinho, R................. 177, 179, 224 Goertz, R. S............................. 121 Goeser, T......................... 146, 242 Goess, C..................................140 Goetz, M.................... 69, 148, 239 Goetze, T. O.............................. 92 Goggins, B. J................... 184, 204 Gogov, B.................................169 Goishi, H...........................134, 191 Goldberg, Y............................. 151 Gölder, S................................ 205 Goldin, R. D............................165 Goldis, A...............77, 96, 104, 116, 135, 185, 216, 224 Goldsmith, J. D.........................56 Goldstein, K. E.................... 56, 64 Goldsworthy, M. A....................59 Golemanov, B..........................221 Golob, S................................... 79 Golovics, P. A...... 83, 136, 138, 240 Gomes, A.........................221, 256 Gomes, C......................... 178, 237 Gomes, D..................158, 214, 217, 219, 229, 253 Gomes, S................................195 Gomez, A...............63-65, 198-199 Gomez, J...................... 79, 92, 145 Gomez, V................ 91, 93, 127, 129 Gomez-Hurtado, I.................... 73 Gómez-Pastrana, I...................125 Gomez-Pinilla, P. J...............79, 92 Gómez Senent, S.....................188 Gomez-Vallejo, V...................... 91 Gomollon, F...............136, 139, 185, 236, 245 Gonçalves, A. R...............183, 188, 237, 258 Gonçalves, B.......................... 180 Gonçalves, C.........89, 179, 221, 258 Gonçalves, D............. 158, 209-210 Gonçalves, L............... 177, 179, 224
Gonçalves, M. D. C...................221 Gonçalves, R............180, 183, 188, 218, 237, 258 Goncalves, S........................... 238 Gonczi, L.....................83, 136, 138 Gonlachanvit, S.......................194 Gonzales, J...................... 195, 234 Gonzales, J. A......................... 234 Gonzales, Y. S..........................216 Gonzalez Alvarez, D. O............ 204 Gonzalez Huix, F......................125 Gonzalez Santiago, J................ 178 Gonzalez Suarez, B...................56 González-Castro, A. M.............. 57 González-Cervera, J.................149 González-Huix, F.....................153 González-Lama, Y................... 240 González-Lois, C......................227 González-López, J....................190 González-López, N.................. 245 Gonzalez-Navajas, J. M............. 73 González, C....................... 56, 227 González, C. E.........................227 Gonzalez, E......... 99, 172, 194, 200 Gonzalez, J.-M......95, 99, 124, 152, 172, 182, 200 González, M...................... 57, 244 Gonzalez, N........................56, 177 Goodrick, K........................69, 177 Goodwin, G............................ 235 Goos, K.-H..............................190 Goosey, R................................195 Gooszen, J................................ 41 Gordan, M...............................165 Gordo, I.................................. 114 Gordon, C.................. 151, 231, 250 Gordon, H...............................184 Gori, A..................................... 92 Gornals, J. B........................... 180 Gornet, J.-M..................... 185-186 Görög, M.................................120 Górska, S................................184 Gosch, I...................................134 Gospodinova, M......................159 Goßner, L............................... 207 Goto, H...................... 136-137, 254 Goto, O.................82, 173-174, 225 Goto, T................ 120-121, 123-124, 131, 151-152, 175, 228 Gotoda, T............ 123-124, 151-152, 175, 228 Gottesdiener, K.........................65 Gottier, C........................... 97, 234 Gottlieb, A............................... 217 Gottlieb, G............................. 252 Gouda, Y.................................169 Goulart, I.........................159, 207 Goulding, C.............................164 Gouma, D. J....................... 93, 169 Gourcerol, G..........39, 107, 113, 198
Index of Authors and Co-Authors : UEG Week Final Programme
Gournay, J............................... 121 Goutorbe, F....................... 83, 186 Goutte, M.................... 83, 137, 186 Gouveia, C...............................237 Goverde, A..............................192 Goverse, G..........................79, 92 Govil, S.................................. 256 Gower-Rousseau, C............76, 135 Goyal, S.................................. 121 Goze, H...................................159 Gracia, M............................... 253 Gracie, D.................................188 Gracie, D. J............................... 70 Graddy, C................................. 93 Graf, R......... 102, 140, 170-171, 220 Grafton, R...............................140 Graham, D..........132, 148, 191, 225 Graham, T...............................150 Gralnek, I. M......37, 41, 48, 88, 179 Granata, A................................99 Granata, L.............................. 203 Granata, R................... 117, 167, 218 Grande, G........... 96, 196, 199, 202 Grander, C................................89 Granja Navacerrada, A..... 120, 226 Grant, D..................................149 Grassalkovich, A......................120 Grassi, F................................. 248 Grassia, R................. 180, 207, 230 Grasso, E.................................188 Grau-Garcia, F. J...............170, 220 Graur, F....................................64 Gravina, A. G............. 165, 174, 203 Gravito-Soares, E..............214, 253 Gravito-Soares, M..... 158, 210, 214, 217, 223, 229, 253, 256 Gray, M. A...............................120 Graziani, C..............................188 Graziani, M. G.................206, 244 Grecco, E.................. 155, 206, 255 Green, J.................................. 119 Green, L........................77, 83, 125 Greenaway, J........................... 119 Greenhalf, B........................ 77, 83 Greenhalgh, F......................... 253 Grega, T...................228, 242, 244 Gregory, M. H........................... 62 Gregus, M...............................149 Greinwald, R.................... 101, 140 Gremese, E....................... 75, 239 Gress, T. M............ 66, 68, 80, 118, 120, 164, 168, 215, 223 Greuter, M................................50 Greuter, T.........................101, 248 Grgurevic, I.............................214 Grgurevic, L.............................214 Grieco, A.................................218 Griesmann, H......................... 222 Griffiths, A. M...........................56
Griffiths, W............................. 208 Grigoras, C.-A.......................... 73 Grigorescu, M..........................215 Grigorescu, R. R. R................. 223 Grigoreva, I. N.........................122 Grigoryeva, T. V........................ 77 Grillo, S............150, 196, 199, 202, 247, 249, 255 Grimaud, J.-C........................... 75 Grimminger, P.........................125 Grinevich, V............................. 115 Gringeri, E.............................. 116 Grip, O....................................189 Grobbee, E. J...........................143 Gröchenig, H. P.................137, 140 Groefsema, M..........................165 Grohmann, F...........................102 Gromov, A. A...........................144 Gronaas Farup, P...................... 52 Grønbæk, H............................. 101 Groot Koerkamp, B........... 93, 120, 169-170 Grooteman, K.................... 71, 255 Gros, B....................................186 Groselj-Strele, A...................... 101 Gross, S. A...............................69 Grossi, C................................ 228 Grossi, L................... 140, 189, 240 Grover, M.......................... 57, 206 Groza, I.................................. 246 Grueber, M............................. 235 Gruis, N...................................85 Grün, K...................................231 Grzymislawski, M................... 240 Gschwantler, M....................... 132 Gschwind, D............................214 Gu, H.-X..................................136 Gu, W................................ 91, 258 Guagnozzi, D............................ 57 Guardiola Arévalo, A........125, 226 Guardiola, J.......................97, 186, 196, 235, 237 Guarino, M.................. 42, 118-119, 168, 216, 218 Guarner Argente, C.....125, 175, 178 Guarracino, M.........................218 Guba, M................................. 232 Gubler, C.................................102 Gudkova, R..............................139 Guedes, H. G................... 126, 230 Guengoer, C............................221 Guenther, T.............................154 Guenthert, S............................155 Guerra Veloz, M. F........... 139, 208 Guerra, J. G.............................221 Guerreiro, H.............215, 228, 236, 241, 255 Guerreiro, R........................... 255 Guerrero Vinsard, D.................129 Guglielmetti, S.........................90
Gui, X..................................... 176 Guidi, G.................................200 Guidi, L...........75, 97, 155, 185, 239 Guido, E................................. 228 Guido, P.................................. 119 Guilbaud, T.............................124 Guillaumot, M.-A.............. 53, 62, 177-178, 228, 247 Guillemain, G..........................156 Guinó, E.............................97, 143 Guitton, C................................ 121 Gül Utku, Ö.............................199 Gulati, A..................................58 Gulati, S............. 148, 224, 226-227 Gulbinas, A.......................172, 221 Gullotta, R..............................156 Gullotti, G.............................. 228 Gumerova, A. A.......................164 Güney, B................................ 256 Güngör, C..................... 46, 78, 221 Gungunes, A...........................199 Günther, C....................55, 70, 170 Guo, F.....................................218 Guo, J.....................................124 Guo, L.................................... 256 Gupta, A..............102, 170-171, 225 Gupta, R................................. 181 Gupta, V...................................171 Gupte, A................................. 151 Gurianov, V.............................168 Gurniak, O.............................. 238 Gurry, T.................................... 70 Gurusamy, K. S........................169 Gusev, D..................................231 Gusmon, C. C.....194, 201, 231, 258 Gustafsson, J.-Å........................ 92 Gutberlet, K.............................. 53 Gutiérrez, A....... 125, 140, 190, 240 Gutierrez, J. P........................... 52 Gutiérrez Galiana, E. A.............49 Gutiérrez Martín, A..................125 Gutschow, C............................102 Gutt, C................................... 249 Guttmann, S............................215 Guzman, M. A.......... 183, 233, 246 Guzzardo, V............................200 Gweon, T.-G.............................96 Gyawali, C. P....... 69, 148, 198, 247 Gyimesi, J.................................64 Gyökeres, T....................... 179, 235
H H., L........ 51, 57, 59, 62, 74, 76, 80, 85, 87, 92, 95-96, 98, 101, 117, 120, 139, 146, 148, 151, 157-159, 163-164, 167, 173-174, 181, 192, 194, 196-197,201, 206, 208, 212, 216, 218-219, 227, 230-231, 234-236, 241-242, 244, 256, 258
Ha, S. M........................... 151, 252 Haag, G. M............................... 92 Haanstra, J...............................98 Haas, S...................................120 Haas, T.................................... 137 Haber, G..................................145 Haccourt, A.............................186 Hachiya, H............................... 119 Hack, M..................................128 Hadefi, A.......................... 197, 210 Haderer, M.............................. 116 Hadzic, D................................. 191 Haefner, M.............................. 127 Haf, D................................72, 248 Hafi, M................................... 240 Hafner, D................................ 248 Häfner, M............................... 223 Hag, E.................................... 243 Hagel, A. F................. 128, 148, 196 Hagström, H............................143 Hahn, H................................... 92 Hahnloser, D.......... 38, 53, 81, 100 Hai, S..........................93, 167, 232 Haidry, R....................76, 132, 148, 173, 225, 247 Haijat, M................................ 223 Haito-Chavez, Y.................. 62, 99 Haj Natour, O..........................140 Hajek, P....................................69 Haji, A............... 148, 224, 226-227 Hakimian, S............................186 Hakuta, R.................................95 Hakvoort, T. B. M.....................192 Halama, M...............................86 Hale, M. F................................189 Half, E.................................... 243 Halfvarson, J............. 96, 135, 185, 189, 236 Haličková, T.......................69, 248 Halkova, T.............................. 222 Hall, D............................... 47, 134 Hall, G...............................71, 195 Hall, M...................... 179, 207, 257 Halland, M................ 149, 207, 257 Hallas, J.......................... 154, 250 Haller, D............................ 50, 134 Hallouin, P..............................136 Hällström, P.............................49 Hama, M............................97, 186 Hamada, K...............................85 Hamada, T................... 95, 120-121 Hamada, Y...........122, 172, 181, 209 Hamamoto, H..........................186 Hamatani, S.....................128, 194 Hamaz, S............................... 255 Hamidouche, N................185, 257 Hamlin, P. J........... 61, 70, 188, 190 Hammami, E....................168, 183 Hammami, M..........................128 Hammer, H. F..................... 39, 65
339
UEG Week Final Programme : Index of Authors and Co-Authors
Hammer, J...............................148 Hammer, K..............................148 Hammer, V..............................148 Hammoud, D...........................190 Hampe, J................................ 239 Hamzaoui, L............................227 Han, B. H......................... 179, 219 Han, J. Y..................................153 Han, K. D.................................192 Han, M.-L............................... 206 Han, S.............. 47, 61, 147, 169, 179 Han, S. J................................. 226 Hanabata, N..................... 118, 194 Hanada, K...............................122 Hanafy, A. S............................ 197 Hanania, T.............................. 243 Hanaoka, N....................... 85, 201 Hanauer, S...........................47, 61 Hancock, J.............................. 229 Handa, O............123, 174, 204, 253 Hanen, J........................... 138, 183 Hann, A...................................58 Hannoun, D............................ 253 Hansen, B................................ 91 Hansen, B. E........................... 179 Hansen, C. P............................122 Hansen, J. M................... 154, 250 Hansen, K. E............................150 Hansen, T........................204, 246 Hansford, S............................. 147 Hänze, J...........................164, 168 Hao, J..................................... 232 Hao, J. Y..................................184 Hapfelmeier, A.................. 72, 224 Haq, M................................... 252 Har-Noy, O.......................140, 227 Hara, C....................................145 Hara, K.... 84, 122-123, 171, 203, 241 Harada, E.................................98 Harada, H..................123, 147, 169 Harada, K..................123, 203, 241 Harada, M...............................123 Harada, N................. 128, 194, 201 Harada, T...... 98, 122, 172, 181, 243 Haraoka, S...............................58 Harbord, M.............................184 Hardi, R................................. 252 Hardwick, J..............................98 Harkat, C................................. 141 Harki, J....................................123 Harputluoglu, M. M. M. M........................170 Harris, J. P................................ 62 Harrison, P............................... 47 Hart, A................... 40, 43, 70, 80, 185, 189, 233 Hartery, K................................ 217 Hartl, J..................................... 91 Hartleb, M....................... 164, 240 Hartman, C..............................64
340
Hartmann, D.............. 64, 101, 168 Haruna, Y............................... 246 Haruo, I................................. 250 Harustiak, T............................ 250 Harvey, P................... 103, 170, 247 Hasak, S...........................198, 247 Hasami, N...............................219 Hasan, M..............72, 103, 129-130 Hasegawa, G...........................103 Hasegawa, H.................... 126, 153 Hasegawa, K........................... 167 Hasegawa, R........................... 119 Hasegawa, S.............. 179, 182-183 Hashem, R. A........................... 61 Hashidate, H.......................... 229 Hashimoto, C..........................194 Hashimoto, R......................... 254 Hashimoto, S..............103, 121, 186 Hashimoto, Y.................... 169, 172 Hassan, C..................... 41, 48, 88, 98, 101, 228 Hassan, M..........................117-118 Hassan, W.............................. 208 Hassany, M...............................117 Hassany, S. M......................... 208 Hasse, M...................................71 Hasselblatt, P........................... 114 Hasselby, J. P...........................122 Hassine, H........................228-229 Hasui, K........................... 118, 194 Hasuike, N..............................251 Hata, M...................................182 Hatamaru, K............................ 181 Hatanaka, K........................... 203 Hatano, E....................93, 167, 232 Hatem, G.................................55 Hather, G............................... 239 Hatlebakk, J. G.......... 194-195, 206 Hatta, W........................... 152, 197 Hattori, M...............................123 Hattori, S.......................... 136-137 Hatzinicolaou, S. L......62, 230, 243 Haug, U..................................143 Haugk, B................................ 222 Hauptmann, M.........................64 Hausken, T......... 156, 194-195, 246 Hausmann, M..........................184 Hautefeuille, V................... 93, 168 Havard, T.................................199 Havre, R. F...............................122 Hawes, R.................49, 55, 64, 72, 100, 103, 129-130 Hawkes, N.................223, 225-226 Hawkey, C. J...................... 41, 207 Hayasaka, K..................... 123, 169 Hayasaki, A............................. 172 Hayashi, K........................ 123, 142 Hayashi, M..............................183 Hayashi, N..............................142 Hayashi, S.............53, 119, 121, 169
Hayashi, T............. 46, 72, 98, 126, 128, 131, 147, 183, 193-194, 202, 243 Hayashi, Y......................... 68, 123 Hayat, J................................... 101 Hayat, M................................. 179 Haycock, A.......... 89, 223, 225-226 Hayee, B............ 148, 224, 226-227 Hazama, S................................86 Hazan, S................................ 252 Hazelton, W. D.......................... 87 Hazewinkel, Y..................... 84, 89 He, H............50, 148, 151, 153-154, 158, 166, 173, 190, 222, 255 He, K................................ 173, 198 He, S.............. 69, 72, 121, 130, 158, 167-168, 175, 177, 201, 239 He, X.............. 52, 80, 114, 137, 139, 141, 143, 171, 201-202, 218, 223, 244, 251 He, X. Q..................................184 Hebert-Magee, S................72, 130 Hebristean, C..........................166 Hebuterne, X............... 80, 137, 139 Heckel, S.................................214 Hedin, C.......................63, 88, 103 Hedstrom, A.............................171 Hegab, S. E............................ 232 Hegarty, R............................... 157 Hegyi, E........................46, 76, 98 Hegyi, P.......... 59, 76, 98, 120, 153, 170-171, 220, 229, 231 Heijmans, J.......................92, 242 Heikenwälder, M.........102, 170-171 Heinemann, M....................... 229 Heinrich, H................... 40, 57, 65, 81, 94, 160 Heinrich, J...............................196 Heinrich, M.............................. 78 Heinrich, S.............................. 121 Heinze, G................................227 Heitman, S.................. 69, 175, 177 Heller, F................................. 254 Helmrath, M. A.........................96 Helsper, C................................95 Heluwaert, F............................185 Helwig, U........................ 138, 206 Hemerick, J.............................145 Hemmrich-Stanisak, G.............. 91 Hencz, R................................ 235 Hendel, J..................................69 Henderson, M.........................154 Hendy, P...................... 40, 70, 233 Henmi, S.......................... 167, 257 Henriques, A.......................... 223 Hentic, O..................................171 Heredia, M..............................194 Herichova, I.............................. 47 Hering, L................................ 234 Hermann-Kleiter, N..................89
Hermann, P. C.......................... 93 Hermelink, R...........................214 Hermsen, S. A. B......................58 Hernandez Camba, A.............. 235 Hernandez Mondragon, O. V.... 174 Hernandez Reyes, M. L............ 174 Hernández Tejero, M....... 120, 226 Hernández-Illán, E..................143 Hernández, C..... 134, 233-234, 252 Hernández, L............................ 57 Hernández, M........... 120, 226-227 Hernández, V.............. 84, 96, 128, 135, 185 Hernando-Alonso, A. I......170, 220 Herold, A.......................... 81, 104 Herraiz, M....................63, 84, 128 Herrala, S............................... 239 Herrera Rodriguez, J. C........... 204 Herrero-Rivas, J. M................. 245 Herrero, R........................ 173, 251 Herreros de Tejada, A.......175, 178, 227, 245 Herrmann, M..........................170 Hershcovici, T...........................69 Herszényi, L............................ 235 Herzog, J...................................71 Hes, F.......................................85 Hesselink, M.............................71 Hession, R............................... 137 Hessmann, E............................ 78 Hewitson, P............................. 175 Heynen, G. J............................122 Hibi, T.......................... 61, 76, 188 Hibiya, S.................................143 Hicks, L. C................. 184-185, 233 Hidaka, E................... 98, 128, 193 Hidaka, H................................. 77 Hidalgo, A.............................. 235 Hidano, S................................134 Higaki, Y.................................. 121 Higashi, R................................ 53 Higashimori, A........................ 147 Higashino, K..................... 85, 201 Higashiyama, M................ 53, 144 Higginson, A............................99 Higuchi, K...................82, 173, 198 Higueras Nafría, J.....................65 Higurashi, T.......... 63, 114, 155, 241 Hijioka, S.......................... 122, 171 Hijona, E.................................153 Hijos, G.................................. 245 Hildner, K................................. 79 Hill, C.....................................134 Hillamaa, A.............................241 Hilmi, I. N.............................. 239 Hind, J.................................... 157 Hindryckx, P.............................96 Hinds, C................................. 235 Hinkson, A............................. 209 Hinojosa Del Val, J...................233
Index of Authors and Co-Authors : UEG Week Final Programme
Hinterberger, A..........175, 227-228 Hiraga, Y.................................. 53 Hirai, H. W............................... 63 Hirai, S............................ 168, 191 Hirai, Y..................................... 53 Hirano, N................................122 Hirano, S...........................131, 182 Hirao, M.................................. 151 Hiraoka, S.............................. 203 Hirasawa, K..............................96 Hirata, N................................. 174 Hirata, Y.................... 122, 144, 182 Hirayama, K................117, 133, 231 Hirayama, M...........................231 Hirayama, T..............................171 Hirono, S.................................122 Hirooka, Y......................... 136-137 Hirose, K.................................123 Hirose, M................................ 191 Hirose, S.................................126 Hiroshima, Y............................ 191 Hirotani, A..............................169 Hiroyasu, T...................... 124, 252 Hirschmann, S..................... 61, 79 Hirth, S...................................170 Hisa, T..................61, 125, 128, 131, 176, 193-194, 243 Hisabe, T.................................125 Hisada, H................................169 Hisamatsu, T............................ 61 Hisayuki, T.....128, 131, 193-194, 243 Histace, A......................... 128, 181 Hiwa, S........................... 124, 252 Hiyama, T................................ 151 Hjelle, A. M............................ 204 Hjortswang, H.........................189 Hlavaty, T............................... 236 Ho, A.-S...........................242-243 Ho, J........ 48, 52, 76, 142, 147, 184, 204, 207, 246-247, 249, 253 Ho, K. T...................................142 Ho, R.................. 58, 102, 114, 125, 156, 164, 167, 171, 196, 247 Ho, S...................39, 47, 56, 61-62, 68, 74, 79, 91-92, 95, 114, 120, 125, 136, 152, 177, 183, 196, 202, 204-205, 241, 245, 251, 255 Hoa, P. T. L...............................117 Hoad, C. L...............................148 Hobson, A. R...........................196 Hochberger, J............ 147, 207, 225 Hodgson, D. C..........................50 Hoeffel, C................................186 Hoefnagel, S.................... 92, 200 Hoentjen, F............... 102, 235, 239 Hoepffner, N............................ 137 Hoesl, M................................. 137 Hoff, G.................................... 176 Hoffman, A...............................69
Hoffmann, M...........................170 Hofheinz, R. D.......................... 92 Hofmann, B. T.........................221 Hofmann, E............................. 118 Hofmeister, A........................... 72 Hofmeyer, M....................207, 225 Hofstra, R. M. W......................192 Högenauer, C...................... 41, 61 Hohenester, S........................... 91 Hohwieler, M.................... 93, 120 Hoibian, S...............................152 Hoisschen, A...........................165 Hoivik, M................................237 Hojo, M............................174, 202 Hokkinen, L..............................85 Hol, L......................................120 Hold, G............................185, 233 Holleman, F............................. 173 Hollenstein, M..........................40 Holler, B................................... 61 Holleran, G.............. 205, 231, 255 Hollerbach, S......................... 255 Holloway, R.............................247 Holmes, E............70, 134, 185, 233 Holota, Y.......................... 134, 184 Holster, S.......................... 56, 103 Holt, B. A................................103 Holtmann, G....................204, 246 Holtmann, G. J.........................247 Holvoet, T.................................96 Homan, M................................ 79 Homann, N.............................. 92 Hombrados, M........................227 Hombu, T................................ 177 Homma, K............................... 177 Hommes, D...................... 80, 238 Homolya, L..............................192 Hompes, R...............................82 Honda, K............................ 71, 122 Honda, Y................................. 114 Hong, J.-B............................... 115 Hong, S. J.................246, 249, 253 Hong, S. N............ 70, 85, 193-194 Hongo, H.................................140 Honing, J.................................. 76 Honjo, M................................ 222 Honsova, E............................. 250 Hontoria Bautista, G................139 Hoorn, E. J...............................48 Hopps, R.................................125 Hordonneau, C.................. 83, 186 Horeanga, B. C....................... 208 Horhat, A.......................... 64, 166 Hori, K.................95, 177, 201, 250 Hori, S.............................120, 251 Horibe, M...................120-121, 220 Horiguchi, N............................123 Horikawa, Y............................. 132 Horiki, N.................... 122, 172, 181 Horimatsu, T..................... 51, 144
Horiuchi, H............................. 256 Horiuchi, Y............................. 242 Hörmannsperger, G.................134 Hörndler, C.............................200 Hornemann, T........................ 220 Hornuss, D..............................233 Horta e Vale, A. M...................218 Horta, D.......................... 139, 209 Horvat, J.......................... 184, 204 Horvath, A........................ 101, 216 Horváth, G..............................170 Horváth, M.............................. 179 Hoshi, N.......................... 203, 223 Hoshino, S..............................183 Hosmer, A................................ 62 Hosny, A.................................. 118 Hosoda, Y................................128 Hosoi, E..................................140 Hosokawa, T............................123 Hosomi, E.............................. 206 Hosomi, S................................ 79 Hosoya, A................................. 79 Hoteya, S.................... 68, 152, 177 Hotta, K....................... 51, 84, 128, 194, 242, 250 Hou, J...................................... 52 Hough, R................................156 Houghton, L.... 57, 71, 107, 146, 244 Houlihan, D............................. 217 Hourigan, L.............................. 51 Hourneaux Moura, E. G.......... 230 Hov, J. R........................ 57, 79, 90 Hovdenak, N................... 156, 206 Hovsepyan, M......................... 157 Howarth, G. S......................... 204 Hradecky, J............................. 256 Hritz, I................................... 220 Hruba, V................................. 238 Hruz, P............................... 70, 86 Hrycek, C.................................140 Hsieh, P.-J............................... 118 Hsieh, Y.-H...............................82 Hsu, C.-N................................166 Hsu, J.-T..................................142 Hsu, P.-I............................ 59, 166 Hu, C.-T....................................82 Hu, J.-W..................................201 Hu, M..........116, 122, 138, 179, 193, 202, 216, 236, 250, 253 Hu, X......................................216 Hu, Y...........120, 125, 134, 145, 159, 193, 201, 231, 243 Huan, Y...............125, 134, 193, 201 Huang, B.............................47, 80 Huang, H................................ 191 Huang, J................................... 52 Huang, J. L. L.......................... 242 Huang, L...........................59, 242 Huang, M.-Y............................193 Huang, S.-Z.............................136
Huang, T............................ 91, 147 Huang, W................................. 72 Huang, Y................... 124-125, 129, 179, 193, 201 Hubalewska-Mazgaj, M.......... 250 Hübenthal, M........................... 91 Huber, S..................................150 Hubers, L. M...........................219 Hübner, G................................ 53 Hucl, T..................... 52, 72-73, 81, 148, 158, 174, 221 Hudson, M.............................. 116 Huelin Alvarez, P..................... 178 Huelsen, A............................... 51 Huernos, S. P.......................... 238 Huerta, A................................ 178 Huertas Nadal, C..............180, 227 Huggett, M..............................122 Hughes, J................................140 Hugot, J.-P............................... 191 Huguet, J.................................189 Huh, K............................. 169, 197 Huhtala, H.............................. 254 Hui, J....................................... 52 Hui, Y. T.................................. 208 Hull, M. A........................135, 243 Hulscher, J. B. F........................59 Humbert, L...................... 206, 241 Hume, D. A.............................. 79 Humes, D. J.............................. 78 Humphries, A................... 131, 226 Hung, J.-S........................ 148-149 Hung, T.-H..............................166 Hünger, M...............................126 Hungin, P.....................74, 80, 212 Huntsman, D........................... 147 Huorka, M.............................. 236 Hupkens, B.............................144 Hur, C...................................... 87 Hurduc, V................................ 157 Husar-Sburlan, I. A................ 208 Hüser, N............................64, 168 Hussein, M.......................193, 202 Hussey, D. J.............................150 Hussey, M...138, 205, 216, 231, 253 Hustak, R........................ 125, 220 Huszár, T................................ 220 Hüttelmaier, S........................ 222 Hutzler, M.............................. 223 Huy, N. T........................... 117, 133 Huyck, S..................................140 Huysentruyt, C. J......................124 Hwang, J. C.............................130 Hwang, J. J............................. 246 Hwang, S. W.............. 98, 175, 239 Hwang, Y. J....................... 152, 251 Hwangbo, Y............................ 226 Hyams, J. S...............................56 Hyatt, B...................................186 Hyodo, I............................ 191-192
341
UEG Week Final Programme : Index of Authors and Co-Authors
Hyrdel, R....................69, 248-249 Hyung, W. J.............................201
I Iacob, R. A.............................. 116 Iacob, S.......................116, 216-217 Iacobellis, A...................... 117, 167 Iacomino, G............................ 133 Iacopini, F........................ 127, 228 Iacorte, D................................190 Iacovou, M..............................103 Iacucci, M......................... 142, 176 Ian, G............................... 165, 181 Ianiro, G......................74, 90, 103 Iannone, A................ 150, 154, 166 Iannuzzi, F............177, 181-182, 220 Ianosi, G.................................165 Ianosi, S..................................165 Iaquinto, G.............................. 133 Iaquinto, S.............................. 133 Ibañez Beroiz, B...................... 178 Ibáñez, G................................143 Ibarrola Arevalo, P.................. 207 Ibarrola-de Andrés, C.............. 127 Iborra, M................................ 240 Iboshi, Y...........................194, 201 Ibrahim, A.............................. 207 Ibrahim, I.................................85 Ibrahim, I. M........................... 178 Ibrahim, M.............. 41, 70, 74, 88, 96, 163, 178 Ibrahim, M. E..........................136 Ichikawa, H..................... 124, 252 Ichikawa, T............................. 204 Ichimasa, K........... 46, 72, 98, 126, 128, 193-194, 243 Ida, Y......................................130 Ide, E......................................126 Ido, A............................... 121, 186 Ierardi, E...................150, 154, 203 Iezzi, R....................................218 Igarashi, A...................... 203, 241 Igarashi, S........................ 118, 194 Igaz, P.......... 143, 159, 192-193, 243 Iglesias, M. J...........................144 Iglesias Garcia, J..................... 180 Iglesias-Garcia, J...........71-72, 220 Iglesias-Flores, E.....................186 Ignatova, S............................. 238 Ignazzi, A................................ 147 Ihaddadene, F.........................188 Ihara, E............................194, 201 Ihara, H...................................231 Ihász, M................................. 220 Iiboshi, T...........................134, 191 Iida, K................................93, 167 Iida, M.....................................86 Iijima, H.................................. 167 Iijima, K........................... 167, 198
342
Iiritano, E........................ 180, 207 Iishi, H..................53, 85, 201, 251 Iizuka, T.............................68, 177 IJspeert, J.................................50 IJzermans, J. N. M............. 93, 120, 169-170 Ike, M....................... 172, 203, 241 Ikebuchi, Y............................. 250 Ikeda, F...................................166 Ikeda, G......................82, 173, 198 Ikeda, M.................................. 172 Ikeda, N.................................. 167 Ikeda, Y...................................152 Ikematsu, H...... 78, 84, 95, 177, 201 Ikemiyagi, H.................... 203, 241 Ikeura, T...................... 62, 120-121 Ikezawa, K.............................. 191 Ikram, M. A........................ 48, 85 Ilana, B.................................. 243 Ilić, K......................................183 Ilie, M............ 92, 96, 181, 229, 231 Illés, D................................... 220 Illiceto, M. T............................190 Iltanen, S............................... 254 Imaeda, H...............................126 Imagawa, H................ 175-176, 182 Imai, H........................119, 131, 181 Imai, K... 51, 84, 128, 194, 242, 250 Imai, T....................................129 Imaizumi, H............................ 119 Imajo, K.................................. 114 Imamura, K..............................69 Imaoka, H............................... 172 Imatani, A............................... 197 Imed, B. M..............................138 Imeneo, M............................. 202 Imeryüz, N............................. 256 Imhann, F................................. 70 Imondi, A................................ 119 Imperatore, N..... 64, 205, 235, 238 Inada, M................................. 121 Inadomi, J................................ 87 Inamdar, S............................... 62 Inatomi, O................. 126, 129, 137, 171, 180, 203 Ince, C....................................123 Inciuraite, R............................. 91 Inderson, A..............................85 Inokuchi, T............................. 203 Inokuma, T..............................120 Inomata, H............................. 256 Inoshita, N.............................. 177 Inoue, A........................... 171, 246 Inoue, H............ 46, 48, 75, 87, 95, 98, 122, 129, 172, 181-182, 224, 243, 250 Inoue, J.................................. 203 Inoue, M.................................124 Inoue, T.................................. 246 Inserra, C............................... 239
Inserra, G.................. 189, 238-239 Invernizzi, P.............................. 91 Ioana, V................................. 224 Iolascon, A...............................64 Ionita Radu, F..........................237 Iovanna, J. L............................. 57 Iovino, P................................. 244 Iozzi, D.....................................65 Ip, M.......................................142 Ippolito, A......................... 117, 167 Iqbal, T...................................142 Irandoost, P...................... 119, 222 Irani, S. S................................. 62 Iriarte, R.................................159 Iribarren, A............................. 115 Irie, K......................................169 Irvine, A. J...............................237 Irving, P..........61, 89, 139, 156, 190 Isajevs, S.................................251 Isaji, S.................................... 172 Isakov, V........................... 149, 156 Isayama, H..... 58, 95, 119, 144, 222 Ishaq, S................69, 123, 125, 127, 175-176, 182, 227 Ishibashi, F............................... 97 Ishibashi, R.............................182 Ishida, F................ 46, 72, 98, 126, 128, 193-194, 243 Ishida, H....................153, 191, 223 Ishida, K.............126, 167, 180, 223 Ishida, N.................................124 Ishida, R. K.............................126 Ishida, T........136-137, 194, 223, 251 Ishida, Y...........................124, 180 Ishido, K....................51, 104, 200 Ishigaki, K................................95 Ishigaki, T........................126, 194 Ishigami, H............................. 176 Ishiguro, S....................... 133, 182 Ishihara, A..............................153 Ishihara, H..............................125 Ishihara, R.................. 53, 85, 201 Ishihara, S........................101, 238 Ishii, A.................................... 167 Ishii, H....................................122 Ishii, M.................................... 76 Ishii, N.................................... 167 Ishii, S............................ 222, 246 Ishii, T.....................................169 Ishii, Y.....................................134 Ishikawa, E....................... 136-137 Ishikawa, H..................58, 84, 151 Ishikawa, S..............................58 Ishikawa, T.................123, 136-137, 174, 204, 253 Ishimura, N............................. 101 Ishiwatari, H.....................51, 128, 194, 242, 250 Ishiyama, A.......................151, 174 Ishiyama, S..................... 209, 257
Ismaili, Z............177-178, 240, 255 Isomoto, H........................58, 252 Israeli, E..................................69 Itakura, J..................................69 itami, A...................................218 Ito, A.......48, 55, 140, 191, 226, 236 Ito, C........................................84 Ito, G.................................. 96-97 Ito, H..........122, 126, 152, 203, 250 Ito, J....................................... 203 Ito, K..........................128, 130, 179 Ito, M.......... 130, 191, 209, 236, 257 Ito, R.................... 93, 167, 177, 209 Ito, S....................51, 119, 123, 128, 194, 242, 246, 250 Ito, T.............. 51, 53, 122, 169, 222 Ito, Y............. 95, 123, 129, 171, 174, 180, 194, 204, 226, 253 Itoh, F...............................152, 191 Itoh, H....................................126 Itoh, Y.........123, 174, 204, 226, 253 Itoi, H.................................... 203 Itoi, T.......................... 48, 55, 222 Itokawa, Y..................129, 171, 180 Itonaga, M..............................130 Itonaga, S...............................123 Itskoviz, D................................ 151 Ivanov, S................................. 119 Ivascu, C. S.......................168, 218 Ivashkin, K.............................. 115 Ivashkin, V..........145, 221, 248, 257 Iven, J......................................65 Iwabuchi, M.............. 144, 192, 231 Iwagami, H.............................126 Iwai, N............................. 123, 174 Iwai, T..................................... 119 Iwakiri, K...... 82, 173, 178, 198, 236 Iwakiri, R....... 77, 187, 193, 197, 234 Iwama, H....................93, 167, 232 Iwama, N............................... 258 Iwamoto, H.............................130 Iwamoto, S...............................117 Iwamura, S.............................152 Iwamuro, M......................151, 175 Iwao, Y............................. 138, 176 Iwasaki, E...............................120 Iwasaki, T..........................152-153 Iwase, H..................................128 Iwashita, A........................ 58, 125 Iwata, M.......................... 123, 126 Iwata, Y................................... 167 Iwatate, M...............................126 Iwatsu, S.................................. 93 Iwatsubo, T..............................85 Iyer, K.................................... 205 Iyo, E. Y...................................194 Izbicki, J. R............ 46, 78, 150, 221 Izquierdo Rubio, S...............64-65 Izumi, C..................................123 Izycka-Swieszewska, E.............218
Index of Authors and Co-Authors : UEG Week Final Programme
Izzo, F...................................... 119 Izzo, R.....................................143
J Jacenik, D................................143 Jacinto, F................................ 208 Jackson, A...............................123 Jacob, H...................................69 Jacobson, B. C........................ 250 Jacobstein, D...................... 47, 141 Jacques, J.......53, 100, 177-178, 232 Jacquin, E............................... 234 Jaenisch, S...................... 150, 204 Jäger, E.................................... 92 Jäghult, S................................189 Jahnsen, J............................... 236 Jain, A.............................. 187, 237 Jair Morales, V........................ 180 Jairath, V................................ 246 Jakobsson, S............................ 176 Jakštaite, A..............................221 Jalanka, J................................241 James, A.................................. 61 James, E................................. 202 James, T..................................102 Jamoul, C................................. 47 Jang, B. I................................ 253 Jang, D. K................................ 121 Jang, H. J.......................... 173, 219 Jang, H. S................................159 Jang, M. S............................... 127 Jang, M.-J................................ 119 Jang, S................ 127, 159, 181, 246 Jang, S. B................................195 Janhsen, K. S.......................... 242 Jankipersadsing, S.................... 70 Janmaat, V. T...........................150 Jansen, I........................76, 87, 231 Jansen, J. M...................... 102, 141 Jansen, M........ 76, 87, 102, 141, 150 Janssen, H. L. A........................48 Janus, C. P...............................192 Jao-yiu Sung, J........................143 Jaquez, O................................. 83 Jaquotot Herranz, M................188 Jaramillo, C. A..........................49 Jarbøl, D. E............................. 250 Jardak, S................... 133, 168, 183 Jarmakiewicz, S...................... 235 Jarmin, R.........................120, 158 Jarmuz, A................................143 Jarocka-Cyrta, E................ 157, 255 Jarry, A.-C...............................156 Jasinska, M.............................. 137 Jasmins, L.......................208, 245 Jauch-Lembach, J....................140 Jawaid, S................................ 230 Jawhari, A...............................142 Jaworek, J. M...........................120
Jayanna, M...............................69 Jayasekara, R. W......................135 Jayasooriya, N................. 202, 239 Jaziri, H...................................168 Jeen, Y. T................... 127, 132, 148, 152, 155, 203 Jeevagan, A............................ 228 Jegatheesvaran, P................... 250 Jenkins, G................................86 Jenkins, I...............35, 82, 104, 162 Jenne, D. E..............................170 Jentzsch, M....................... 89, 135 Jeon, B.-S...............................219 Jeon, S. R............................... 253 Jeon, S. W....................... 201, 249 Jeon, Y. J..........................158, 164 Jeong, G. Y..............................158 Jeong, J...................................169 Jeong, M.................................. 83 Jeong, S.............................86, 119 Jeong, S. H..............................152 Jeong, S. U..............................159 Jeppesen, P. B..........103, 205, 256 Jerie, M................................... 197 Jeschek, P................................227 Jesinghaus, M........................ 248 Jess, T.......................... 36, 86, 101 Jesse, L................................... 181 Jessen, B................................ 239 Jessen, P.................................. 137 Jewes, S..................................125 Ji, J.-S......................................96 Ji, Z.............. 152-153, 201-202, 251 Jia, H........................................82 Jia, L.......................................247 Jia, X.....................70, 116, 172, 247 Jian, C.....................................201 Jian, X............................... 70, 247 Jiang, B....................................49 Jiang, T..................................... 72 Jiang, W..................... 114, 167, 216 Jiang, X.................................... 70 JianYing, B.............................. 173 Jiao, C.....................................170 Jie, Y................................ 250-251 Jimenez, A........................ 177-178 Jimenez, M..........................97, 99 Jimenez-Agüero, R...................117 Jimenez-Gamiz, M. P................171 Jimenez-Garcia, V. A...........78, 178 Jimenez-Moleon, J. J................143 Jimenez-Palacios, M.................99 Jiménez-Rosales, R...........121, 197 Jimeno-Ayllón, C.................... 253 Jin, H.............................. 130, 258 Jin, S.......................... 99, 145, 201 Jin, Y....................................... 173 Jin, Z...................153, 201-202, 251 Jinca, C.................................. 104 Jindal, S...................................99
Jing, S.....................................145 Jinga, M...........................237, 254 Jirapinyo, P..............................103 Jo, J. H.................122, 169-170, 172 Jochum, W............................... 52 Joergensen, M. T.......................99 Joh, T......................................142 Johanns, J................................ 47 Johansson, M........................... 63 Johansson, S.-E.........................71 Johnson, G.......................225-226 Johnson, S................................49 Johnson, S. J........................... 222 Jokelainen, J........................... 239 Jokelainen, K............................ 91 Joly, F............................ 42, 87, 95 Jonaitis, L.....................77, 91, 104, 142, 146, 154 Jones, B................................. 252 Jones, M. P. P...... 145, 155, 197, 204 Jones, T. V........................102, 140 Jonkers, D. M............49, 55, 70-71, 74, 82, 187 Jordán-Castro, A......................153 Jørgensen, S. P........................155 Jose, N..........................73, 79, 161 Josefsson, A............................149 Joshi, D...................................158 Joshi, V....................................123 Jossan, N......................... 146, 245 Josson, C.................................. 79 Jouret-Mourin, A.....................102 Jovani, M................................ 250 Jovanovic, I.............................. 52 Jover, R.................63, 84, 125-126, 128, 143, 245 Joyce, S. A...............................134 Juanmartiñena, J. F.................. 181 Juárez, M................................143 Judge, C................................. 254 Juhász, M............................... 234 Juillerat, P....... 36, 55, 83, 234-235 Juliá De Páramo, B......................... 186, 190, 240 Julian Gómez, L....................... 137 Jung, C............................. 147, 225 Jung, D. H...............................201 Jung, G.................................... 63 Jung, H. I................................201 Jung, H.-Y................................150 Jung, J. H................................219 Jung, K. W............................... 197 Jung, M. K.............................. 180 Jung, Y............................ 150, 226 Jung, Y. J.................................139 Jüngst, C.................................146 Junquera, F..............................241 Junya, N........................... 130, 181 Jürgensen, C........................... 255 Jurgoš, L.................................125
Jussif, J. M................................ 79 Jussila, A................................ 239 Justin, A...................................59 Juzenas, S.......................... 91, 116 JY Sung, J..................... 63, 93, 152
K Kabbani, T...............................241 Kabbash, I................................117 Kabrawala, M..........................130 Kaczka, A.................................171 Kaczmarczyk, O...................... 204 Kaddache, N............................188 Kaddour, N..............................129 Kadenczki, O.......................... 234 Kadleckova, B.................. 235, 238 Kadota, T...........................177, 201 Kadungothayil, N.....................135 Kae, S.-H.......................... 173, 219 Kageyama-Yahara, N.............. 205 Kagramanova, A................138-139 Kahaleh, M............................ 223 Kaimakliotis, I............ 96, 135, 185 Kaino, S...........................219, 222 Kaise, M.............................82, 173 Kaisler, M................................ 175 Kaji, I......................................184 Kajihara, T.........................134, 191 Kajor, M..................................164 Kakinoki, N.............................168 Kaku, H...................................251 Kakugawa, Y............................145 Kakushima, N....................51, 128, 194, 242, 250 Kalabic, J.................... 101-102, 139 Kalaitzakis, E...........................122 Kalambakas, A........................159 Kalapala, R......... 148, 156, 170, 181 Kalcenaua, A................... 235, 240 Kaleta, C.................................138 Kalish, S................................. 248 Kaliyaperumal, A.....................189 Kaliyaperumal, K.................... 208 Kalkan, Ç......................... 144, 246 Kalla, R.................................. 236 Kalmár, A............143, 192-193, 243 Kalousios, S.................... 206, 251 Kalsi, D. S............................... 250 Kalubovila, U...........................135 Kamada, K...................... 123, 174, 204, 222, 253 Kamada, N............................... 57 Kamal, A......................... 208, 257 Kamata, K............................... 181 Kamata, N..... 76, 79, 188, 200, 254 Kambas, K...............................134 Kambayashi, H....................... 226 Kamei, A.................................169 Kamel, E..................................117
343
UEG Week Final Programme : Index of Authors and Co-Authors
Kamilova, O. T......................... 157 Kamiński, A.............................195 Kaminski, M. F..............48, 68, 89, 98, 143, 245 Kamitsuma, C.................. 203, 241 Kamiya, M.............................. 252 Kamiya, S................................ 132 Kamiyama, N.....................115, 134 Kamoshida, T..........................168 Kamperidis, N.................. 131, 226 Kanai, T.......................61, 120, 138 Kanao, H........................... 53, 144 Kanazawa, K.................... 118, 194 Kanazawa, R.......................... 222 Kanda, T............................58, 252 Kandel, P................76, 93, 127, 129 Kandiah, K...... 53, 72, 99, 125, 225 Kandler, J....................... 67, 73, 81 Kane, J. S................................237 Kanekiyo, S..............................86 Kaneko, M......................... 69, 192 Kaneko, T................... 119, 169, 191 Kanemitsu, Y...........................198 Kanesaka, T...................53, 58, 85 Kaneshiro, M................... 203, 241 Kaneto, M....................... 209, 257 Kang, B....................................56 Kang, C. D...............................184 Kang, D. H........... 123, 126, 131, 152 Kang, H............... 123, 126, 152, 179 Kang, J....................................169 Kang, J. K..........................132, 175 Kang, J. W...........102, 121, 130, 188 Kang, M.......................... 169, 220 Kang, M. K............................. 253 Kang, N...................................168 Kang, W...............91, 102, 121, 130, 143, 147, 188, 202 Kang, Y...................... 168-169, 253 Kanis, S............................. 83, 102 Kanmura, S...................... 121, 186 Kanno, T........................... 156, 197 Kanno, Y.....................128, 130, 179 Kanwar, B........................ 133, 140 Kanzaki, H.........................151, 175 Kao, J. Y....................................54 Kaplan, G. G............................ 176 Kapsoritakis, A. N................... 245 Kaptein, A. A.......................... 238 Karacimen, D.......................... 254 Karagiannis, D.........................124 Karakaya, F...................... 144, 246 Karasaki, H........................122, 172 Karashima, T............................69 Karataş, H. Ö.......................... 256 Kariv, R.............................151, 178 Karlén, P.................................189 Karlsen, T. H............ 59, 68, 74, 86 Karlsson, M. K........................ 236 Karmiris, K................ 125, 140, 145
344
Karnebeek, K...........................170 Karpus, O. N............................. 92 Karsenti, D................. 50, 176, 222 Karst, U...................................215 Karstens, K.-F.................... 78, 150 Karstensen, J. G.......... 69, 122, 239 Kartalis, N...............................120 Karunadasa, E......................... 127 Karunaratne, T. M. P. B............. 92 Kasahara, K..............................117 Kaser, A..............46-47, 70, 90-91, 105, 211, 213 Kaser, L...................................214 Kashab, M............................... 101 Kashida, H................. 89, 126, 152 Kashin, S...........................173, 231 Kashyap, P......................... 57, 206 Kasianov, A.............................184 Kasper, S............................ 86, 92 Kasprzyk, J..............................233 Kassis, G.................................216 Kasthuriratna, A......................164 Kasti, A.................................. 206 Katada, C.............51, 104, 151, 200 Katada, K................. 123, 204, 253 Katai, H....................................89 Katano, T.................................142 Kataoka, H..............................142 Kataoka, S.................. 98, 126, 243 Kataoka, Y..........................96, 151 Katicic, M...........................77, 104 Kato, D................................... 209 Kato, H.......... 65, 122, 134, 168, 219 Kato, K.............................. 89, 134 Kato, M..................51, 82, 85, 123, 126, 128, 151-152, 173 Kato, N...................... 124, 164, 176 Kato, S..............................131, 153 Kato, T..................................... 114 Kato, Y.............................. 132, 153 Katrich, A................................ 118 Katsanos, K. H................... 96, 135 Katsoula, A...............................49 Katsuki, S............................... 226 Katsuno, T...............................124 Katsurahara, M........... 122, 172, 181 Katsushima, S..........................117 Katsuyama, Y.................... 123, 169 Katutishi, T.............................. 191 Katutoshi, T............................ 236 Katz, L. H................................227 Kaufmanis, A...........................194 Kaufmann, B...........................168 Kaukinen, K.............39, 61, 94, 99, 204, 253-254 Kaul, V..................................... 62 Kaur, P....................................189 Kausilia Krishnadath, K............150 Kautiainen, H........................... 91 Kawachi, H..............................124
Kawagoe, T..................82, 173, 198 Kawaguchi, K...........................58 Kawaguchi, T............................ 76 Kawaguchi, Y.............. 119, 172, 215 Kawaguti, F........194, 201, 231, 258 Kawahara, T............................ 114 Kawahara, Y......................151, 175 Kawahira, H............................124 Kawai, M.................................. 97 Kawaji, Y................................. 181 Kawakami, K..................... 84, 126 Kawakami, T...............129, 171, 180 Kawakubo, H..............82, 174, 183, 223, 232, 251 Kawakubo, K..................... 131, 172 Kawamoto, A............................ 97 Kawamoto, H.................... 99, 122 Kawamura, T.................... 123, 126 Kawano, S.........................151, 175 Kawara, F..................194, 223, 251 Kawasaki, S............................ 222 Kawasaki, Y............................. 147 Kawashima, H................... 136-137 Kawashima, K..................101, 238 Kawashima, R........................ 204 Kawata, N.................. 51, 128, 152, 194, 242, 250 Kawauchi, J..............................89 Kawauchi, K............................123 Kawesha, A............................. 127 Kaya Özdinç, S........................ 236 Kaye, P....................................135 Kayhan, C................................ 141 Kazanov, D.......................242-243 Kazim, S. N.............................219 Kchir, H............................ 133, 183 Kecili, L............................185, 188 Kederys, A............................... 115 Keelly, S................................. 204 Keely, S.................... 155, 184, 204 Keil, C.....................................126 Keip, B................................... 240 Keku, T..................................... 78 Kelber, O................... 150, 195, 247 Keller, J........ 37, 39, 59, 67, 80, 196 Keller, J. J.......................... 84, 196 Këlliçi, I...................................149 Kelly, C............................. 141, 241 Kelly, M.................................. 254 Kelsell, D.................................148 Kempski, J...............................150 Kennedy, M.............................138 Kennedy, S............................. 243 Kent, T...................................... 93 Kermarrec, L...................... 89, 92 Keshav, S......................... 140, 235 Keshavarz, H............................50 Kessoku, T............................... 114 Kestens, C................................ 76 Keswani, R.............................. 179
Keszthelyi, D................ 71, 90, 124, 149, 196 Keum, B.................... 127, 132, 148, 152, 155, 203 Keung, C.................................123 Kevans, D................................138 Keyvan, H............................... 234 Kezzoula, D...................... 158-159 Kf Tsoi, K.................................. 63 Khaiboullina, S....................... 234 Khalid, J. M....................... 61, 239 Khalid, M. J................141, 188-189 Khalif, I................................... 187 Khalifa, N. A............................218 Khalikulov, K. G.......................183 Khaloian Sarnaghi, S...............134 Khamaysi, I............................. 179 Khan, H.................................. 207 Khan, I....................................135 Khan, N...................................102 Khan, S...................................189 Khanna, M..............................216 Khanna, T................................216 Khannoussi, W...........158, 177-178, 240, 255 Kharrasse, G...............158, 177-178, 240, 255 Kharrat, J.........................228-229 Khashab, M. A................... 62, 99, 102-103, 181 Khater, S................................ 229 Kheder, J......................... 186, 254 Khodeir, S............................... 115 Khomeriki, S...........................155 Khorovodov, A.........................153 Khorsi-Cauet, H...................... 204 Khouitar, S..............................188 Khullar, V................................ 151 Khusnutdinova, D. R................. 77 Kida, M............................ 119, 124 Kieć-Kononowicz, K.................134 Kiefte-de Jong, J. C............. 48, 85 Kiela, P.............................235-236 Kierkus, J................................ 240 Kieslichova, E..........................148 Kiesslich, R....................... 69, 176 Kievit, L...................... 96, 135, 185 Kievit, W................ 71, 76, 165, 256 Kiguchi, Y............................... 225 Kikkawa, M.............................144 Kikuchi, D.................................68 Kikuchi, E................................ 167 Kikuchi, H............................... 119 Kikuste, I.......................... 173, 251 Kim, B...............................96, 245 Kim, B. G............................... 202 Kim, C. D................... 127, 132, 148, 152, 155, 203 Kim, D. B..................................96 Kim, D. S................................. 133
Index of Authors and Co-Authors : UEG Week Final Programme
Kim, E. H................................. 174 Kim, E. J............................ 127, 177 Kim, E. R.....................85, 193-194 Kim, E. S................... 127, 132, 148, 152, 155, 203 Kim, H............ 70, 85, 127, 131-132, 146, 148, 152, 155, 165, 174, 177, 181-182, 193-194, 201-203, 221, 224, 230, 252-253 Kim, H. G............................... 253 Kim, H. J.................................123 Kim, H. K..........................179, 246 Kim, H. S....................139, 143, 192 Kim, H. U................................159 Kim, H. W................... 123, 126, 131 Kim, H. Y................................. 173 Kim, H.-I.................................201 Kim, H.-K.........................219, 223 Kim, J.............. 47, 85, 123, 126-127, 131, 142, 145-146, 148, 152-153, 175, 177, 193-194, 198, 201, 226, 255 Kim, J. H.................. 202, 252, 257 Kim, J. H................... 146, 177, 199, 202, 252, 257 Kim, J. J.....................148, 152-153, 193, 198, 255 Kim, J. W............ 139, 197, 202, 245 Kim, J.-H.................. 130, 132, 182, 201, 256 Kim, J.-O................................ 253 Kim, J.-W..........................168, 171 Kim, K............86, 98, 179, 195, 246 Kim, K. H................................ 253 Kim, K. O....................146, 177, 253 Kim, K.-J..................... 47, 142, 175 Kim, M. C............................... 253 Kim, M. K................................195 Kim, M. S................................ 197 Kim, M.-H.........................131, 221 Kim, N...................... 127, 130, 152, 192, 197, 251, 253 Kim, N. K........................... 86, 98 Kim, P.....................................152 Kim, S................. 127, 132-133, 139, 143, 148, 152, 155, 169, 203, 219 Kim, S. G......................... 150, 202 Kim, S. H............. 85, 127, 132, 148, 152, 155, 165, 172, 193-194, 203 Kim, S. J....... 123, 126, 131, 146, 201 Kim, S. T...........................159, 224 Kim, S.-H.........................181, 230 Kim, S.-I.................................184 Kim, S.-J................................ 226 Kim, S.-S.................................219 Kim, S.-W................................219 Kim, S.-Y.......................... 146, 177
Kim, T................102, 121, 130, 140, 152-153, 159, 167, 169, 179, 198 Kim, T. H.......................... 118, 224 Kim, T. J..................... 85, 152-153, 193-194, 198 Kim, T.-N................................ 253 Kim, W...........123, 126-127, 131-132, 139, 148, 152, 168, 172, 194, 197, 202-203, 219, 245 Kim, Y................. 131, 146, 173, 177, 202, 252-253, 257 Kim, Y. H..................................85 Kim, Y. J.....................146, 152, 177 Kim, Y.-H..................... 70, 193-194 Kim, Y.-T..............102, 121, 130, 169 Kimura, A..........................147, 174 Kimura, G................................ 172 Kimura, M........................136, 236 Kimura, S................................145 Kimura, T................... 140, 167, 179 Kimura, Y................................ 131 Kindlova, D..............................149 King, A.................................... 127 King, N................................... 226 King, T.....................................64 Kinoshita, S.............................. 53 Kinoshita, T...................... 133, 182 Kinoshita, Y......................101, 238 Kinugasa, H...................... 154, 219 Kioka, K.................................. 147 Kiparissi, F............................... 191 Kipcak, S.......................... 197, 199 Kirchgatterer, A....................... 137 Kirchgesner, J.....................83, 101 Kirita, K...................................198 Kirkøen, B............................... 176 Kirov, A...................................159 Kirsanov, K. V..........................158 Kirsners, A.............................. 173 Kirsten, H.................................46 Kishida, Y.........................128, 194 Kishine, K................................145 Kishiwada, M.......................... 172 Kita, R..................................... 167 Kitae, H..................... 124, 174, 252 Kitagataya, T........................... 203 Kitagawa, Y................82, 174, 183, 223, 232, 251 Kitajima, M.............................145 Kitamoto, S.............................. 57 Kitano, M......................... 130, 181 Kitano, Y..................................130 Kitazume, Y......................136, 236 Kitterer, H.-R...........................128 Kiudelis, G........... 91, 142, 146, 154 Kiurski, S................................. 133 Kivelä, L..........................204, 253 Kiyasov, A. P............................164 Kiyokawa, H............................152
Kiyota, R.................................153 Kiyozumi, Y............................. 242 Kıyak, A..................................215 Klang, E.................................. 137 Klare, P.............................84, 224 Klausen, P...............................122 Kleber, G.................................128 Kleger, A............... 78, 93, 120, 193 Kleibeuker, J.............................98 Klein, A.............................175, 179 Klein, W..................................165 Klenske, E............................... 127 Klepp, P...................................237 Klepsch, V................................89 Klevebro, F.............................. 132 Kliček, R..................................183 Klimina, K...............................184 Klopocka, M........................... 240 Kluger, A. K.............................148 Klugmann, T............................ 137 Klünder, B................................48 Kment, M............................... 224 Knabe, M........................... 76, 96 Knafelz, D................................190 Knight, D............................57, 184 Knights, D................................ 57 Knittel, T.................................190 Knoblich, L............................. 240 Knoester, I.................................71 Knowles, C. H......................59, 81 Knudsen, J. D..........................221 Knuth, A. K. R...........................86 Knyazev, O.................. 138-139, 184 Ko, C................... 62, 208, 221, 241 Ko, J. H..............................123, 131 Ko, S. J..............................115, 159 Ko, Y.................79, 82, 87, 93, 118, 124, 126, 128-129, 149, 151-152, 173, 175, 193-194, 197-198, 241 Kobayashi, K........................... 191 Kobayashi, M.................... 69, 201 Kobayashi, N........................... 151 Kobayashi, S..................... 191, 241 Kobayashi, T..........61, 76, 122, 134, 140, 170, 188, 201 Kobyliak, N..........101, 155, 168, 215 Koch, A. D............ 76, 129, 173, 251 Koch, A. K.................187, 190, 206 Koch, J. M................................145 Koch, M............................ 145, 231 Koch, R.... 70, 103, 137, 171, 178, 187 Koch, S.......................95, 222, 234 Kochhar, R...........103, 171, 178, 187 Kocsis, A.................................159 Kodaka, Y....................82, 173, 198 Kodashima, S..............96, 142, 151 Kodetova, D............................ 250 Kodisinghe, K. S......................135 Kodo, M................................. 204
Koehler, P..........................133, 174 Koelink, P. J....................... 92, 184 Koenigsmann, M...................... 92 Koens, L............................ 89, 134 Koga, F............................. 172, 215 Kogevinas, M...........................143 Kogure, H...........................95, 119 Koh, D. H.................................219 Koh, S.-J................................. 202 Köhler, J................................. 207 Köhn, N...................................183 Kohno, H.................... 175-176, 182 Kohoutova, D.................... 138, 241 Kohut, M.................................135 Koike, K.................95-96, 119, 142, 151, 182, 205 Koike, T.............................151, 197 Koike, Y...................................124 Koivogui, A.............................194 Koizumi, K............................... 172 Koizumi, W............... 104, 119, 124, 200, 204 Kojima, K......................... 142, 152 Kojima, T...................174, 201, 250 Kojima, Y.................................. 79 Kok, N.....................................231 Koksal, A. R............................ 236 Koksal, A. S............................. 132 Kokuma, S...............................140 Kokuryu, H..............................129 Kokwara, F............................. 226 Kolar, M................................. 238 Kolber, M................................125 Koletzko, S................... 47, 53, 56, 61, 64, 83, 105 Kolho, K.-L..............................138 Kolkman, J. J.......................... 255 Kollar, M.............69, 224, 248-250 Kollarik, M.................69, 248-249 Koller, T.................................. 236 Kollmann, C. M...................... 225 Koloski, N...........155, 197, 204, 246 Komai, Y..................................129 Komatsu, M............................ 250 Komatsu, S....................... 133, 182 Komaya, K........................ 133, 182 Komeda, T................................117 Komeda, Y.................. 89, 126, 152 Komekado, H........................... 167 Komisarenko, I........................ 101 Komiya, Y................................241 Komori, H........................174, 202 Komori, K......................... 133, 182 Komori, S...............................200 Komuta, M..............................102 Kondo, H.................................231 Kondo, M................................142 Kondo, Y.............................93, 197 Kondrackiene, J....................... 115 Kondziella, C...........................221
345
UEG Week Final Programme : Index of Authors and Co-Authors
Konecny, M.............................237 Konecny, S........................ 149, 251 Kong, C. Y................................. 87 Kong, S...................................182 Kong, S. C.............................. 208 Kongala Liyanage, I................ 229 König, J............................. 56, 103 König, K.................................. 132 Konijeti, G. G...........................140 Konikoff, F.............................. 242 Koning, F..................................94 Konishi, H................. 123, 174, 253 Konishi, K................................ 151 Kono, S.................................. 250 Kono, T.....................................84 Kono, Y............................. 149, 175 Konoplyannikov, A.............138-139 Konovalova, M.........................149 Konradsson, M.......................200 Konstantakis, C........................241 Konstantinov, S. R..................... 79 Koo, H.....................................169 Koo, M............................... 52, 82 Koornstra, J. J...........................98 Kooyker, A..........................41, 192 Kopáčová, M............................251 Kopczynska, M.........................125 Kopp, H.-G............................... 92 Kopylov, U................... 72, 131, 137, 140, 190, 227, 230 Korablina, N............................ 133 Kordek, R......................... 134, 143 Kore-eda, N............................182 Korenkova, V...........................143 Kormilitzin, A......................... 235 Kornienko, E............................ 157 Kornouchova, L........................ 115 Korona-Glowniak, I................ 235 Korostelev, D........................... 119 Korpela, T.................................59 Korponai, G.............................138 Korponay-Szabo, I. R................64 Koshi, A.................................. 178 Koshita, S...................128, 130, 179 Koster, J. J................................ 92 Kostovcik, M.................... 184, 256 Košuta, I..................................257 Kothari, S................................. 62 Kotsafti, A........... 86, 141, 192, 200 Kottmann, M........................... 217 Koukias, N........................ 131, 248 Kouklakis, G............................134 Koulaouzidis, A...........72, 131, 227, 230, 237 Kouno, H.................... 175-176, 182 Kouno, Y.................................. 151 Koutroubakis, I................. 185, 187 Kouyama, Y................128, 193-194 Kovacevic, B............................122 Kovacheva-Slavova, M.............221
346
Kovács, Á............................... 234 Kovács, G............................... 220 Kovacs, P..................................46 Kovalskaya, I.......................... 220 Kowalski, G.............................164 Kowalski, T............................... 62 Kozak, O...........................218, 236 Kozakai, F................................ 179 Kozawa, N....................... 203, 241 Kozelj, M.................................. 79 Kraft, K....................................247 Kraja, B...................................149 Kraja, F....................................149 Krajciova, J................ 148, 174, 197, 224, 249-250 Krajcovicova, A....................... 236 Krajewska, J. B........................135 Krajewska, W. M......................143 Král, J...............................143, 220 Kramer, L................................ 132 Kranenburg, P........................ 235 Kranke, P......................... 126, 245 Krarup, A. L.............................199 Krasnov, T................................ 151 Krati, K................................... 253 Kräuchi, S............................... 187 Kraus, T. W............................... 92 Kravchuk, Y.............................. 115 Krawczyk, M............................146 Kraynova, E............................. 173 Krdzalic, J.................................50 Kreijne, J. E............................ 236 Kreisel, W................................ 114 Krenács, T...............................192 Kressel, J.................................196 Krishnadath, K. K............... 89, 92, 150, 200 Krishnan, E.............................189 Krishnan, K.............................. 62 Kristof, T............................ 83, 136 Krivokapic, Z........................... 133 Kroeger, A...............................102 Kroener, P. T................ 52, 71, 103, 153, 216, 219 Kroep, S................................... 87 Kröger, S.........................204, 253 Krogh, K..................................155 Kröll, D.................................. 234 Kronborg, C.............................154 Krones, E................................216 Kroupa, R................................251 Kruchinin, V. N........................144 Kruchinina, M. V......................144 Krug, S................................... 222 Krüger, S................................ 206 Kruimel, J............. 71, 124, 149, 196 Kruis, W.................................. 137 Krumina, A...................... 235, 240 Krupa-Kozak, U................ 157, 255 Krylov, N.................................183
Krzysiek-Maczka, G...................85 Krzystek-Korpacka, M..............184 Ksenchyn, O............................150 Kssia, M..................................183 Ku, M.-K.................................166 Ku, Y..........................53, 144, 203 Kuban, P..................................149 Kubo, A...................................154 Kubosawa, Y............................. 53 Kubota, E................................142 Kucharzik, T................. 61, 135, 138 Kudo, A................................... 176 Kudo, M................89, 131, 152, 181 Kudo, S..................... 128, 193, 243 Kudo, S.-E.............. 46, 72, 84, 98, 126, 131, 194 Kudo, T..............46, 72, 84, 98, 113, 126-128, 131, 151, 193-194, 203, 243 Kuehl, A................................. 239 Kuehni, C............................... 248 Kuetting, F.............................. 242 Kuga, R...................................126 Kühbacher, T............................ 61 Kuhn-Sherlock, B.....................90 Kui, B..................................... 220 Kuijper, E.......................... 83, 196 Kuijvenhoven, J.......................102 Kuiper, J........... 79, 96-97, 107, 123, 135, 143, 192, 212 Kuiper, T................................... 72 Kuipers, E. J.......... 79, 97, 107, 123, 143, 192, 212 Kukla, M.................................164 Kukulska, M........................... 240 Kulatunge, S........................... 229 Kulkarni, A...........58, 122, 223-224 Kullak-Ublick, G. A..................233 Kumar C, B............................. 224 Kumar, A......................... 193, 250 Kumar, D.................................185 Kumar, L.................................126 Kumar, S.................... 135, 157, 181 Kumarasena, R. S....................135 Kumbhari, V............................. 62 Kumon, H.................................65 Kumta, N.................................. 62 Kunda, R........................... 62, 102 Kundurzhiev, T........................ 236 Kunihara, S............................ 254 Kunihiro, M....................... 53, 144 Kuno, R.................................... 97 Kuno, T.............................. 136-137 Kunst, C........................... 116, 214 Kuo, C.-J.................................142 Kupcinskas, J...... 77-78, 91, 115-116, 140, 142, 146, 154 Kupcinskas, L......... 77, 91, 96, 104, 115, 135, 142, 146, 154, 185
Kurata, T.................................193 Kurent, T.................................. 79 Kurien, R. T............................ 224 Kurihara, M............................. 151 Kurilovich, S. A........................144 Kurilshikov, A........................... 70 Kurimoto, A........................93, 167 Kurlyak, N...............................214 Kurobe, T................................ 174 Kuroda, H................................ 115 Kuroda, M...............................134 Kurokami, T............................ 205 Kurokawa, K............................142 Kuroki, K................................. 151 Kurosaki, S..............................142 Kurppa, K..................... 53, 56, 61, 204, 253-254 Kurti, Z............................ 83, 136, 138, 238 Kurumi, H................................58 Kusaka, T.................................129 Kusano, C................................123 Kusano, M...............................198 Kushiyama, Y...........................144 Kushnir, V................................. 62 Kusters, J.................................103 Kusuhara, M........................... 242 Kusumoto, K...............129, 171, 180 Kusunose, H............................ 179 Küttner Magalhães, R..............210 Kuvaev, R................................ 173 Kuwabara, K............................. 97 Kuwahara, T.............................171 Kuwai, T.................... 53, 128, 144, 175-176, 182 Kuwaki, K............................... 203 Kuwatani, M...................... 131, 179 Kuznetsova, D..........................135 Kuznietsova, H........................ 238 Kverka, M................................184 Kvit, K...............................214-215 Kwak, D. H..............................139 Kwan, V................................... 175 Kwiecien, S..................... 104, 250 Kwok, H...........................191, 208 Kwok, K. H............................. 208 Kwon, B. J.........................126, 131 Kwon, H. C............................... 83 Kwon, H. G............................. 202 Kwon, H. N..............................193 Kwon, K. A....................... 146, 177 Kwon, K. S............................. 246 Kwon, M.......................... 152, 251 Kwon, R................................... 62 Kwon, Y.-H..............................201 Kyaw, M..................................142 Kyo, R.....................................144 Kypraios, D.................62, 230, 243 Kyriienko, D...................... 101, 215 Kyurkchiev, D........................... 217
Index of Authors and Co-Authors : UEG Week Final Programme
L Laabidi, A.............................. 240 Laan, W....................................90 Labalette, M........................... 238 Labeeuw, E.............................. 92 Labenz, G............................... 249 Labenz, J................................ 249 Labiano, I................................. 91 Lacerda, A................................ 87 Lacerda, A. P....................... 47-48 Lackermeier, R. M....................128 Lackner, K..................... 38, 75, 84 Laclav, M................................ 222 Lacna, J...................................149 Lacognata, C...........................231 Lacour, J.-P..............................140 Lafon, C...................................221 Lafond, M................................221 Lafuente, I...............................140 Lage, G.................................. 209 Lage, J..................77, 132, 224, 228 Lage, P..............................176, 178 Lagergren, J.............46, 77, 87, 132 Lagergren, P............................ 132 Laghi, L...................................146 Lagin, L...................................186 Lago, P................127, 139, 188, 224 Lagoussis, P............................. 127 Laharie, D.................... 73, 75, 80, 139, 186, 188 Lahat, A................ 78, 131, 137, 140 Lahaye, M........................ 144, 231 Lahcene, M............................ 253 Lahmidi, M. A.........................218 Lahner, E................... 124, 155, 199 Lai, P. B................................... 114 Lai, S..................................... 202 Lakatos, L....... 83, 96, 135-136, 138, 185, 220, 234, 238, 240 Lakatos, P. L... 83, 96, 135-136, 138, 185, 234, 238, 240 Lakhtakia, S............................. 181 Lakner, L................................ 240 Lam, L. Y. K....................... 82, 142 Lam, M.................50, 93, 144, 231 Lam, T. W. J............................ 208 Lam, T. Y. T...............................82 Lamacchia, C...........................154 Lamarsalle, L.......................... 240 Lamas-Díaz, M. J.....................190 Lamas, B.................................. 57 Lamberts, M. P........................169 Lamboglia, F............................190 Lambrecht, G............................55 Lambregts, D. M......... 50, 144, 231 LaMere, B............................... 133 Lammert, F..............................146 Lamonaca, L........................... 244 Lamy, V..............................77, 104 Lanas, A...... 96, 135, 200, 245, 253
Landi, R................................. 252 Landi, S.............150, 196, 199, 202, 247, 249, 255 Landman, C.............................. 41 Landy, J................................... 127 Lang, A...................................140 Lang, D............................ 138, 176 Lang, S.........................86, 97, 187, 190, 233-234 Langella, P............................... 57 Langerova, L............................143 Langhah, A. A......................... 167 Langholz, E................ 96, 135, 185 Langhorst, J...............187, 190, 206 Langner, C........67, 87, 107, 156, 193 Lansdorp-Vogelaar, I..........50, 87, 143, 151, 192 Lanska, V.................................148 Lanuti, P................................. 254 Lanzlotti, V..............................165 Laoui, D................................... 79 Lapenta, R...............................194 Lapidus, A......................... 131, 179 Laquière, A.............................130 Larabi, A.................................. 57 Laranjo, A............ 52, 177, 179, 224 Laredo, V................................ 253 Larena, J. A............................ 235 Lariño Noia, J......... 71-72, 180, 220 Larmour, K...............................65 Larrain, M.............................. 239 Larsen, N.......................... 58, 156 Larsen, T.................................156 Larussa, T............................... 202 LaRusso, N...............................117 Lasch, K................................... 61 Laserna-Mendieta, E. J............134 Lass, A...............................71, 195 Laterza, F........................ 236, 254 Latif, A....................................199 Lau, J. K. C..............................164 Lau, J. Y.....................152, 207, 250 Lau, K. S................................. 202 Lauenstein, T........................... 187 Laukens, D...............................96 Laukkarinen, J..........................58 Laumen, H...............................46 Laumeyer, T.............................135 Laurberg, S..............................40 Laurendeau, C........................ 240 Laurent, V............................... 235 Lauria, A.................................189 Laurila, K............................... 254 Lavrinovica, E.................. 235, 240 Law, S. T............................ 138, 171 Lawendy, N.................61, 102, 140 Lawlor, R................................ 223 Lazar, A................114, 139, 217, 247 Lazar, D.................................. 224 Lazarescu, A............................247
Lazarescu, M........................... 157 Lazaro, A................................. 114 Le, P.-H...................................142 Le, S................... 53, 62, 70-72, 79, 122-123, 125-133, 147, 150, 152, 155, 169-172, 177-178, 181, 194, 201, 203, 221-222, 224-225, 227-228, 230, 235-236, 247, 252-253 Le Baleur, Y......................130, 222 Le Baut, G................................ 73 Le Berre, C................ 136, 186, 195 Le Beyec, J..............................156 Le Gall, M...............................156 Le Moine, O.............................126 Le Nevé, B............................... 141 Le Rhun, M...................... 121, 129 Le Roux, S.............................. 225 Le Thuaut, A............................ 121 Le-sidaner, A.......................... 232 Leach, Z..................................156 Leal, S......................... 71, 147, 252 Leal-López, S.................... 147, 252 Leber, B........................... 101, 216 Leblanc, S................... 53, 62, 127, 129-130, 177-178, 181, 228, 230, 247 Lebre, L................................... 217 Lecca, G. P........................146, 239 Lecomte, T......................... 93, 168 Lee, C...........................70, 80, 83, 174, 248-249 Lee, C. S..................................150 Lee, D. H....... 86, 119, 133, 142-143, 152, 192, 199, 251 Lee, D. S.................................. 133 Lee, E.................................86, 177 Lee, E. Y. T............................... 175 Lee, E.-J.................................. 133 Lee, H............ 86, 98, 102, 119, 121, 132-133, 142-143, 145, 152-153, 169, 172, 179, 192, 195, 198-199, 209, 226, 229, 239, 251, 253 Lee, H. H......................... 152, 209 Lee, H. J..................................201 Lee, H. S............. 122, 127, 132, 148, 152, 155, 169-170, 172, 201, 203 Lee, H. W..........................179, 229 Lee, H.-M............................... 205 Lee, J...............49, 80, 83, 133, 139, 152, 171-172, 175, 184, 194, 201, 206, 219 Lee, J. B.................................. 133 Lee, J. C....................................80 Lee, J. E................................... 172 Lee, J. H........................... 145, 152 Lee, J. K............................ 172, 219 Lee, J. M....... 127, 132, 148, 152, 203
Lee, J. S........ 123, 126, 131, 222, 253 Lee, J. Y...................................201 Lee, K. H................................. 172 Lee, K. J............................. 171, 175 Lee, K. L................................. 202 Lee, K. M....................132, 175, 182 Lee, K. T.................................. 172 Lee, K.-M.................................96 Lee, M. S.................... 62, 224, 227 Lee, R.................... 51, 69, 177, 188 Lee, S..................... 62,70, 122-123, 126-127, 131-133, 150, 152, 155, 169-170, 172, 188, 195, 201, 203, 221-222, 224, 227, 253 Lee, S. D............................140-141 Lee, S. H........ 98, 102, 121, 130, 169 Lee, S. J......... 85, 139, 172, 184, 194 Lee, S. K..................... 131, 174, 221 Lee, S. P.......................... 202, 252 Lee, S. S............................131, 221 Lee, S. U........................... 179, 219 Lee, S.-D................................. 133 Lee, S.-H......................... 239, 253 Lee, S.-W.................................96 Lee, S.-Y.......................... 202, 252 Lee, T......................... 169, 172, 175 Lee, T. H.............179, 226, 229, 253 Lee, W. J............................. 49, 80 Lee, W.-J.................... 49, 139, 206 Lee, Y................. 86, 188, 201-202, 245, 252 Lee, Y. C...........................174, 249 Lee, Y. J...................................201 Lee, Y. N..................... 62, 179, 229 Leeds, J. S.............................. 222 Leenhardt, R............................ 72 Leffler, D. A............................ 204 Lefor, A. K......................... 68, 130 Legaki, E................................. 187 Legastelois, S........................... 79 Leggett, C................................ 173 Legros, R........53, 100, 177-178, 232 Lehman, G.............................. 179 Lehoczki, V..............................159 Lei, W.-Y........................... 148-149 Lei, X.................................79, 174 Leiba, R.................................. 243 Leibovici Wiseman, Y............... 151 Leicester, R.................. 81, 104, 211 Leifeld, L................................. 137 Leigh, K...................................188 Leitão, C............. 84, 128, 166, 180, 229, 256-257 Leite, I.....................................158 Leite, S......................228, 235-236 Leitl, A.....................................59 Leja, M.............. 37, 62, 77, 91, 104, 154, 173, 193, 251 Lejnieks, A...................... 235, 240
347
UEG Week Final Programme : Index of Authors and Co-Authors
Lekatz, H........................... 57, 206 Lemab, G................................194 Lembo, V................................ 206 Lemma, M.............................. 242 Lemmens, V.............................192 Lemmens, V. E. P. P............ 76, 182 Lemmers, A.................96, 126, 197 Lemos, D................................. 147 Lenggenhager, D...............102, 171 Lenker, E..................................89 Lennon, R...............................129 Lenz Tolentino, L. H..................... 194, 201, 258 Lenze, F...................................237 Leodolter, A............................ 249 León, F.....................................56 Leonardi, C. L..........................140 Leoncini, E..............................122 Leone, N................................. 119 Lepage, P................................. 63 Lepetit, H............................... 232 Lepilliez, V............ 53, 151, 178, 229 Leppkes, M..............................170 Lerang, F............................77, 104 Lerch, M. M............. 36-37, 60, 170 Leroi, A. M..............................198 Leroyer, A...........................76, 135 Lesavre, N................................95 Lesina, M................................. 78 Leško, M..................................251 Lešková, Z.............................. 236 Letamendi, G........................... 115 Lethebe, B. C........................... 176 Letrung, T................................194 Leue, C....................................196 Leung, F. W....................... 82, 227 Leung, W. K..................46, 91, 202 Leutenegger, M........................ 97 Levartovsky, A........................ 230 Levesque, B. G.......................... 47 Levhar, N....................137, 140, 190 Levi, Z......................... 91, 151, 230 Levink, I................................. 249 Levit, R.................................... 157 Levy, M................................... 229 Lévy, P...............82, 98, 111, 171-172 Lewerenz, B............................158 Lewis, J. D...............................136 Lewis, N. R.................80, 135, 202 Lewis, S..................................136 Lewis, W............ 182-183, 196, 199, 232, 252, 256 Ley, D......................................135 Leykauf, S................................128 Li, B..................52, 71, 79, 115, 184 LI, C......... 47, 52, 59, 61, 72-73, 93, 170, 181, 203, 208, 217, 224 Li, G......................52, 68, 132, 161, 164, 174-176, 204, 242, 252, 257
348
Li, J..............59, 123, 140, 142, 156, 201, 204, 234, 242, 245 Li, K....... 65, 124, 129, 138, 179, 188 Li, K. K....................................138 Li, L...............48, 66, 70, 72-74, 79, 114-115, 119, 124, 133, 136, 143, 145-146, 150, 156, 166, 173-174, 194, 197-200, 215-216, 218, 222-223, 226, 229, 242, 245, 251-252 Li, M................... 115, 117, 132, 145, 166-167, 170, 180, 200, 242 Li, Q.-L...................... 123-124, 143, 174, 223, 226 Li, R..................52, 59, 61, 112, 117, 126, 141, 168, 175, 184, 191, 201-202, 207, 209, 216, 218, 245, 257 Li, S............. 38, 52, 59, 77, 89, 91, 93, 112, 114-115, 118, 132, 140-142, 146, 152-155, 172, 203, 208-209, 217, 221, 227 LI, W.................. 114, 124, 129, 132, 141, 177, 201-202 Li, W. H.................................. 208 Li, X..........79, 85, 118-119, 133, 143, 145, 166, 174, 202, 242 Li, Y................ 52, 72, 114, 136, 182, 187, 201, 218, 257 Li, Z..................... 52, 79, 201, 204 Li, Z. R....................................184 Lian, J.-J..................................201 Liang, C.-M.............................166 Liang, H...................................49 Liang, L...................................251 Liang, M.......................... 166, 242 Liang, P. S.............................. 202 Liautaud, A.............................194 Libânio Monteiro, D................ 224 Libanio, D.................124, 224, 227 Liberal, R................... 68, 117, 168, 201, 209, 218 Liberman, E............................ 243 Librandi, M....................... 117, 167 Licci, C................................... 203 Liceni, T.................................. 255 Lichtenstein, G. R..................... 61 Lichtner, P................................46 Liddle, R. A...................54, 68, 82 Lidia, C................................... 224 Lied, G. A.......... 156, 195, 206, 246 Lien, J. M............................... 180 Liepniece-Karele, I..................251 Liggi, M.................................... 52 Lightdale, J. R.................. 126, 245 Ligresti, D.......................... 99, 130 Lim, A. G................................. 176 Lim, D. N. F..............................192 Lim, K. H................................ 208 Lim, S. G....................132, 175, 182
Lima, A...................................102 Limbach, V..............................126 Limbert, M..............................145 Limdi, J.................................. 234 Lin, C.-J...................................142 Lin, H.-C..................................59 Lin, J.......... 140, 142, 156, 204, 242 Lin, J.-T.............................. 77, 154 Lin, K.-H..................................59 Lin, L...........................66, 70, 143, 145-146, 150, 156, 194, 200, 215, 222, 242, 245 Lin, Q.-Y..................................136 Lin, R. S..................................153 Lin, T. H.................................... 79 Lin, Z. Q..................................145 Linardou, I. A......................... 245 Linas, I..................................... 70 Lindblad, M..................... 132, 200 Lindgren, F..............................120 Lindgren, S..............................140 Lindig, U.................................. 92 Lindley, K.................................65 Lindner, V................................ 173 Lindsay, J........36, 86, 110, 140, 204 Lindsay, R. J........................... 204 Line, A....................................193 Linedale, E. C.................. 146, 245 Ling, K. L.................................156 Ling, L. X.................................145 Linghu, E................................ 132 Link, A.......... 91, 116, 154, 156, 224 Link, J.....................................156 Lior, G.................................... 242 Liou, J.-M........................... 77, 154 Liparoti, R.............................. 202 Lipinski, S................................89 Lipnitsky, E..............................183 Lipták, P................................. 249 Lira, A.............................. 139, 241 Lisboa, C................................ 208 Lishchinskaya, A................138-139 Lisowski, Z............................... 79 Lissner, D............................... 239 Lissoos, T..................................49 Liszka, Ł..................................164 Lita, M. C................................ 217 Litvin, A................................. 220 Liu, B........................... 52, 71, 169 Liu, C....................................... 52 Liu, D......................... 93, 150, 251 Liu, F........................................ 52 Liu, H..................................... 244 Liu, J................................ 125, 153 Liu, J.-Z...................................201 Liu, K..................................... 104 Liu, L.................48, 72-73, 115, 119, 124, 133, 173, 197-199, 216 Liu, S......................................152 Liu, T......................... 148-149, 166
Liu, T.-T............................ 148-149 Liu, W.............................. 124, 129 Liu, X......................................257 Liu, X. J...................................184 Liu, Y....................52, 114, 167, 201, 223, 244, 257 Liu, Y. L....... 48, 72-73, 115, 119, 133 Liu, Z.........................52, 201, 204 Liu, Z.-Q..................................124 Lizhou, D.................................201 LLach, J...................................231 Llamas, C................................190 Llanos-Muñoz, M.................... 245 Llaó, J.....................................189 Llibre, G..................................241 Llop, J...................................... 91 Llorca, J...................................143 Llort, G.................................... 63 Lloyd, J....................................165 Lo Pumo, S........................ 187, 191 Loaiza-Bonilla, A.....................139 Lobaton, T...................97, 186, 239 Lobjois, V................................221 Lobo Alvarez, B................. 57, 244 Lobo, A. J................................189 Locher, C.................................185 Lodyga, M.............................. 240 Loforte, M...............................257 Loftus Jr, E. V..........61, 87, 101-102, 139-140, 239 Logacheva, M..........................184 Logan-Ellis, H......................... 203 Logan, R. P. H......................... 203 Loguercio, C.................... 165, 203 Lohinszky, J.............................159 Löhr, J.-M................................120 Lohse, A. W................ 91, 150, 229 Lohse, M.................................214 Loi, P...................................... 207 Lojo, S.......................................71 Lolli, E.................................... 187 Lollo, G..............156, 219, 224, 244 Lombardi, G............................130 Lombardo, V........................... 254 Lomer, M.................................156 Long, G. H...............................190 Long, Y...................... 101-102, 244 Longcroft-Wheaton, G.......125, 225 Łoniewski, I.............................237 Lopes, A................................. 242 Lopes, J.................... 120, 122, 158, 173, 196, 225 Lopes, S........ 116-117, 130, 138, 173, 188, 208-209, 218 Lopetuso, L. R..........................188 Lopez, A.................... 63, 170, 220, 235, 237 Lopez, R....................181, 239, 246 López-Barroso, L.................... 246 López-Cerón, M.......................231
Index of Authors and Co-Authors : UEG Week Final Programme
López-Díaz, J.......................... 220 Lopez Fernandez, A.................. 63 López García, O. N............. 65, 199 Lopez Gomez, M......................227 Lopez Insua, A.........................237 López Ramos, C....................... 137 Lopez-Serrano, A..............170, 220 López Serrano, P..................... 240 Lopez-Siles, M.................. 134, 184 López Viedma, B......................153 Loras Alaustrey, C................... 180 Lord, R....................................237 Loreau, J.................................135 Loren, D.................. 47, 55, 62, 172 Lorén, V.................................. 234 Lorente Poyatos, R...................185 Lorenzo-Zúñiga García, V................................. 126, 136 Lorenzo-Zúñiga, V...................... 83, 136, 175-176 Lorenzo, D..............47, 55, 124, 172 Lorenzon, G..................... 189, 240 Lores, T...................................140 Lorinczy, K............................... 179 Loroño, A................................140 Loske, G..................................183 Loss, M.................................. 225 Losurdo, G................. 77, 150, 154, 203, 208 Lottrup, C................................199 Lou, Q...................................... 91 Loubaris, K.......................219, 253 Loudova, P...............................148 Louis, E................... 47, 55, 87, 190 Lounes, F................................ 253 Loureiro, J. F............................ 127 Loureiro, R............... 159, 209, 258 Lourenço, L............................ 209 Loustaud-Ratti, V.................... 232 Louvet, A.............................61, 84 Lovas, S.................................. 238 Lovasz, B. D.................83, 136, 138 Lovat, L..................... 132, 225, 247 Lövdahl, J.................................90 Lovero, R................................ 208 Low, W.................................... 197 Lowenberg, M.................... 73, 141 Lowerison, M.......................... 176 Loy, K. L..................................156 Lozano Escario, M. D.............. 180 Lozano, E.......................... 91, 240 Lu, B........................... 92, 157, 199 Lu, J. J.....................................153 Lu, L................84-85, 87, 130, 132, 193, 201, 238, 253 Lu, M..................... 49, 64, 80, 96, 123, 168, 217, 230, 237-238, 252 Lu, W...................................... 191 Lubomierski, N........................231
Lucas, C...................................85 Lucas, M.................................123 Lucci, L................................... 238 Lucendo Villarin, A. J......... 67, 101, 149, 248 Lucenicova, J.......................... 238 Lucero, J. A..............................194 Luciani, A.................................50 Lucidi, C..................................194 Ludwiczek, O........................... 137 Ludwig, K..........................133, 174 Ludwig, L.......................... 84, 193 Lué, A..............................136, 245 Luebeck, G............................... 87 Lugtenburg, P. J.......................192 Lui, R. N...........................142, 198 Luís, R....................................158 Luiza, B................................... 157 Lukas, M...............49, 80, 237-238 Lukavetskyy, N......................... 151 Luke, D. P................................135 Luketic, V................................. 91 Lukosevicius, R......................... 91 Lukosiene, J. I.................... 78, 146 Luley, K. B................................ 92 Lundell, L........................... 87, 132 Lundin, K. E. A...... 39, 56, 94, 204 Luo, K..................................... 141 Luo, M................................... 252 Luo, R..................................... 172 Lupo, M............................96, 230 Lupsor, M................................ 217 Lupusoru, R............... 216-217, 224 Luzius, A.................................135 Luzón, L................................. 253 Luzza, F.................................. 202 Lv, B................................. 145, 152 Lyamina, S............................. 248 Lydersen, S............................... 52 Lynch, S. V............................... 133 Lynchak, O.............................. 238 Lyons, P. A................................80
M Ma, C............54, 57, 59-61, 68, 73, 78-80, 86, 92, 97, 106, 117, 132, 143-144, 156-157, 166-167, 170, 175, 180-181, 192, 194, 198, 201-202, 206, 208, 210, 213, 216, 220, 222, 230-232, 241, 246, 252, 258 Ma, D..........67, 71, 74, 101, 116, 119, 122, 125, 134, 136, 138, 141, 146, 150, 152-153, 157, 165, 168-171, 176, 178, 181, 183, 190, 196, 198-199, 202-205, 210, 217-218, 220, 228-229, 233-234, 239-240, 242-243, 247-249, 252, 255
Ma, G............ 55, 76, 78, 81, 91-92, 116-118, 120, 122, 125, 130, 138, 143-144, 154, 156, 159, 165, 168, 173, 177-178, 181, 183, 187,192-197, 201, 204, 206-210, 218,225-226, 228-229, 231, 238, 242-243, 249, 258 Ma, H................. 37, 43, 46, 51, 62, 66, 69, 76, 86, 91, 96, 103, 122, 128-129, 131, 145, 151-152, 157-158, 160, 162, 164, 167, 169, 172, 178, 181-182, 184-185, 190, 194, 197, 206, 208, 214, 216, 224, 229, 233, 239, 241, 248, 250, 257 Ma, J.........56, 89, 91, 104, 117, 120, 125, 148, 156, 165-166, 170-171, 174, 184, 186, 191, 194, 197, 201, 216, 220, 224, 233-235, 240, 245, 247, 249-250, 257 Ma, M............... 49-50, 52, 56, 62, 64-65, 71, 91, 102, 104, 107, 117-118, 121-122, 124, 132-134, 136-137, 144-146, 149, 152-153, 156, 159, 165, 167, 171, 175, 179-181, 184, 186-187, 189, 196, 203, 207-209, 216, 220, 222, 229, 232, 234-235, 237, 239, 241, 248-250, 254-255 Ma, W.............................. 114, 190 Ma, Y. H............................ 76, 184 Maa, J. F..................................136 Maamouri, N.................... 133, 183 Maas, M............................50, 144 Maaser, C...........................61, 138 Maass, L. S..............................148 Maayan, J.-D............. 181, 242-243 Maaz, M..................................216 Mabe, K..................................123 Mabrouk, S.............................123 Macadon, B.............................237 Macaluso, F. S.................. 237-239 Macaria, M............................. 220 Macarri, G...............................130 Macarulla, T....................... 87, 211 Macchi, V...............................200 Macchia, L................................69 Maccioni, F..........................60, 73 MacConell, L............................ 91 MacDonald, G........................ 204 Macedo, C...............................219 Macedo, G........... 116-118, 120, 122, 130, 138, 159, 165, 168, 173, 187, 195-196, 201, 207-210, 218, 231, 258 Macfarlane, B.......................... 127 MacGregor, E..........................216 Mach, T.................................. 204 Machado, J. C. L.......... 77, 84, 104, 106, 161
Machado, M. V........................ 217 Macheiner, S............................89 Machlab, S..............................241 Macías, E................................ 181 Macias-Ceja, D.......... 134, 233-234 Macias-Garcia, F..................... 220 Macinga, P................ 158, 184, 221 Maciuca, R..............................190 Maconi, G.......................... 77, 156 Macor, D.................................165 Macpherson, A........... 70, 234-235 Macutkiewicz, C.......................59 Madacsy, L............................. 243 Madacsy, T..............................120 Maddalo, G.....................203, 249 Madero, R...............................194 Madian, A...............................136 Madisch, A.......................101, 249 Madl, C................................... 132 Madl, T.................................... 101 Maeda, S.................................169 Maeda, Y...................... 46, 72, 98, 126, 194, 243 Maegawa, Y............................ 246 Maehata, T............82, 173-174, 225 Maekawa, T..............................58 Maeng, J. H..............................86 Maeso-Sánchez, N...................184 Maestro Prada, I...................... 167 Maetani, I...............................144 Maev, I................................... 248 Maezawa, K........................... 206 Mafra, M. M............................159 Magalhães, J............ 166, 186, 191, 201, 216 Magarotto, A....................130, 236 Magaz Martínez, M................. 207 Magee, C.......................... 132, 247 Maggi, U.................................130 Maggiore, L..............................89 Magierowska, K............... 104, 250 Magierowski, M............... 104, 250 Magina, S.............................. 208 Magnano, A.....................238-239 Magno Pereira, V...... 173, 208, 245 Magnoni, P............................. 230 Magnusson, M. K..................... 141 Magrì, G................................. 238 Magris, R......................... 153, 192 Magro, F..............96, 135, 138, 185, 187-188, 207-208 Maguchi, H................ 122, 131, 172 Mahadevan, U.........................140 Mahadik, M. R..... 99, 223-224, 249 Mahajan, H..............................69 Mahesh, V. V............................99 Maheshwari, P.........................126 Mahfouz, E............................. 229 Mahiou, H........................185, 257 Mahmmod, N..........................102
349
UEG Week Final Programme : Index of Authors and Co-Authors
Mahmoud, M...................118, 254 Mahoney, P.............................145 Maia, L................139, 175, 210, 257 Maia, R...................................257 Maida, M. F....................... 93, 166 Maier, C.................................. 175 Maiero, S......................... 153, 192 Mainovskaya, O.......................210 Maio, R...................................233 Maiorano, G........................... 204 Maire, F....................................171 Maisterra, S............................196 Majcher, B.................175, 227-228 Majek, O..................228, 242, 244 Majima, A.......................204, 253 Majka, J................................. 104 Major, G....................... 52, 71, 142 Majumdar, D.................... 119, 229 Mak, J.................................... 208 Maki, K.................................. 254 Mäki, M................................. 254 Mäkinen, M. J...........................86 Makino, Y................................130 Makins, R............................... 230 Malachias, A..............62, 230, 243 Malagelada, C................... 92, 145 Malagelada, J. R......................145 Malagón, M.............................237 Malamut, G......................154, 229 Malanin, S. Y............................ 77 Maldonado Pérez, B........ 139, 208 Maldonado, E. R..................... 220 Malecka-Panas, E............ 134, 240 Maléth, J.....................120, 170-171 Malfertheiner, P............. 62, 91, 97, 106, 116, 154, 156, 224 Malhi, N. S.......................159, 257 Malhotra, S.............................216 Maliar, A..................................69 Malickova, K........................... 238 Malik, S........................... 103, 178 Malina, J......................... 235, 240 Maljaars, J. P. W......................190 Mallant, R...............................102 Malm, A................................. 235 Maluf-Filho, F..................194, 201, 231, 246, 258 Maluskova, J............. 224, 249-250 Malvik, M.................................171 Malyshev, I............................. 248 Malyuga, V.............................. 132 Mamie, C.................................86 Mamiya, T............................... 191 Mancini, C.............................. 202 Mandai, M...............................65 Mandavdhare, H. S..................159 Mandelli, E............... 130, 225-226 Mandolesi, D........................... 101 Mandorfer, M.....................51, 132
350
Manes, G.................. 130, 156, 177, 225-226, 228 Manfredi, G.............................156 Manfredi, G. F............... 64-65, 155 Manfrin, E.............................. 222 Mangas, C.................. 84, 128, 143 Mangiafico, S...........................96 Mangialavoria, L......................130 Mangiavillano, B............... 62, 96, 129, 228, 230 Mangueira, C. L. P...................184 Manka, P................................. 217 Mankodi, S..............................149 Mann, S.................... 49, 205, 239 Manne, S.................................49 Manner, H................................ 76 Manning, J..............................136 Mannisi, E.............................. 226 Manns, M............... 39, 46, 49, 54, 80, 90, 105 Mannucci, A........................... 242 Manolakis, A...........................198 Manor, U.................................190 Manorahan, B.................. 177, 225 Mañosa, M............... 186, 234, 239 Manousou, P...........................165 Mans, L...................................210 Mansell, P...............................148 Manta, R................... 96, 220, 230 Manuc, M.........................167, 208 Manuchehri, A........................ 141 Manvar, A................................ 62 Manyé, J........................... 233-234 Manz, M............................ 52, 153 Manzano Santamaría, I............125 Manzano, M............................153 Mão de Ferro, S................176, 178, 208, 252 Mapiye, A................................192 Marabotto, E............. 69, 149, 199, 248-249 Marasco, G............................... 78 Marasco, R............................. 202 Marcelino, P........................... 207 Marchegiani, G........................183 Marchesi, J.......................184, 233 Marchesini, C......................... 206 Marchi, S..................69, 198, 200, 206, 249 Marchiori, C................86, 141, 192 Marchisio, M.......................... 254 Marciani, L..............................148 Marciniak, A.............. 195-196, 245 Marcon, N. E........................... 173 Marcos-Pinto, R............... 210, 224 Marcos, P................... 89, 179, 258 Marcovici, T............................ 104 Marczak-Karpina, B................. 137 Mare, R............................. 217-218 Marena, P................................ 133
Marescaux, J.............................46 Marginean, C.......................... 157 Marginean, C. O...................... 157 Marginean, M. O..................... 157 Marginean, O................... 104, 157 Mari, L.......................96, 150, 239 Mariani, A....................... 222, 230 Marín-Gabriel, J. C............ 127, 175 Marín-Jiménez, I.............186, 189, 235, 240 Marín, A. C............................... 97 Marín, I................ 83, 126, 175-176, 186, 189, 235, 240 Marin, J. J............................91, 117 Marin, L................................. 239 Marinho, C................166, 216, 222 Marinho, R. T............. 85, 167, 208 Marini, M................................. 62 Marino, M...............................122 Marino, R................................156 Mariños, H..............................152 Markaki, A...............................59 Markelova, M. I........................ 77 Marker, D......................... 136, 138 Markiewicz, L. H...................... 157 Markovic, V............................. 133 Markus-de Kwaadsteniet, M. L...................................185 Markus, E..........................192-193 Marlicz, W. M..........................237 Marmol, C...............................241 Maroto Castellanos, M.........64-65 Marques Da Costa, P......................42, 85, 158, 178, 208-209, 258 Marques, A.............................158 Marques, I................ 145, 176, 180 Marques, M.............. 146, 159, 209 Marques, S. C......................... 180 Marques, T...................... 145, 159, 180, 209-210 Marra-López, C.................170, 220 Marra, A.................................154 Marra, M................................ 235 Marreiros, A........................... 236 Marren, A...............................140 Marseglia, G. L.................. 65, 155 Marshall, C............................ 230 Marshall, D...............................71 Marshall, L..............................189 Marsiano, N............................. 97 Márta, K........................... 153, 231 Martayan, A........................... 226 Marteau, P.............72, 75, 181, 186 Martel, M................................ 137 Martelossi, S...........................135 Martens, M.............................144 Martí, D....................125, 170, 178, 190, 220, 239-240 Martin, A.......... 67, 91, 117, 171, 210
Martin, C..........54, 57, 78, 80, 194, 201, 231, 246, 258 Martín, E............... 71, 125, 137, 171, 186, 188 Martin, J. C...............................80 Martin, S.................................. 67 Martin, V.................................143 Martín Arranz, M. D......... 190, 240 Martín Dávila, F.......................153 Martin de Carpi, J.....................56 Martín-Arranz, E.....................188 Martín-Arranz, M............. 188-189 Martín-Arriero, S.......................71 Martin-Cardona, A................. 180 Martin-Martin, N...................... 91 Martin-Ruiz, M........................156 Martineau, C...........................139 Martinek, J......... 125, 148, 174, 197, 220, 224, 249-250 Martinez, C.............................. 57 Martinez, E.................. 63-64, 241 Martínez, E..................71, 171, 186 Martinez, F..............................126 Martínez, J. F...........................143 Martínez Alcalá, F.............194, 210 Martinez de Castro, E............... 63 Martínez Feito, A.....................188 Martínez Izquierdo, G..............125 Martínez Lapiedra, M............. 180 Martínez Lozano, H................. 240 Martinez Moreno, B................ 180 Martínez- Alcalá, C...........194, 210 Martinez-Alcala García, A.................................194, 210 Martínez-Alcala, F. J.........194, 210 Martínez-Andrés, B................ 228 Martínez-Ares, D............. 125, 170, 178, 220 Martinez-Bauer, E...................241 Martinez-Cara, J. G............178, 197 Martinez-Chamorro, A..............171 Martínez-García, A..................143 Martinez-Medina, M......... 134, 184 Martínez-Moneo, E..............71, 171 Martinez-Vinson, C.................. 191 Martini, A............................... 114 Martino, M........................180-181 Martinotti, M.......................... 180 Martinova, E.......................... 234 Martins, A................................117 Martins, B. D. C...............194, 201, 231, 246, 258 Martins, D................. 132, 207, 228 Martins, J................................257 Martinucci, I....... 69, 198, 200, 249 Martorano, M......................... 203 Maruki, Y.......................... 173, 198 Marunchyn, N.........................168 Maruo, T.......................... 167, 257 Maruoka, D...................... 124, 176
Index of Authors and Co-Authors : UEG Week Final Programme
Maruy Saito, A........................ 204 Maruyama, H..........................122 Mary Beth, D........................... 141 Marya, N................................ 230 Marzio, L.................................140 Marzioni, M..... 68, 86, 91, 106, 117 Masahiro, I.............................. 181 Masarone, M....................165, 216 Masci, E..................................130 Mascialino, B..........................186 Masciangelo, G................ 196, 249 Masclee, A. A. M......... 49, 71, 124, 149, 187, 196, 248 Maselli, M. A........................... 147 Maselli, R...........101, 219, 224, 244 Masetti, C.......................... 117, 167 Maslova, G..............................165 Mason, A. J.............................156 Masotto, A..............................168 Massault, P. P.......................... 181 Massella, A............................ 238 Massidda, M....................156, 222 Massironi, S........................... 223 Masson, E................................46 Mastromarino, P......................146 Mastromatteo, A. M.................146 Mastromauro, M..................... 208 Masu, K.....................128, 130, 179 Masucci, L...............................103 Masuda, A...............................170 Masuda, D...............................122 Masuda, M............................... 62 Masuda, T.............................. 258 Masutti, F................................165 Masuy, I...................................65 Mata, A...................................227 Matallana, V........................... 240 Matallanos, P..........................227 Matalon, S...............................69 Matas-Cobos, A. M............ 121, 171 Matei, D................................. 246 Mateus, E............................... 208 Matheeuwsen, M.................... 255 Mathieu, N.........................97, 135 Mathiex-Fortunet, H................145 Mathonnet, M........................ 232 Mathot, R................................ 141 Mathou, N...............................125 Mathurin, F.............................. 73 Matono, T................................164 Matos, C............................. 53, 99 Matos, D....................157, 183, 210 Matoso, A. G. B.......................159 Matsubara, S......................95, 119 Matsubara, T........................... 121 Matsubayashi, H.........51, 128, 194, 242, 250 Matsuda, K........................128, 151 Matsuda, M.............................152 Matsuda, T.....78, 84, 143, 145, 254
Matsudaira, S.................. 126, 128, 193-194, 243 Matsueda, K...................... 69, 146 Matsueda, M...........................154 Matsui, H............................... 256 Matsui, S........................... 89, 152 Matsui, T.................... 58, 125, 239 Matsuka, L.............................. 151 Matsukawa, M.........................122 Matsukuma, S..........................86 Matsumae, T........................... 167 Matsumoto, K............ 58, 174, 202, 219, 243 Matsumoto, M............ 127, 145, 179 Matsumoto, T...................176, 254 Matsumura, T................... 124, 176 Matsunaga, T............................ 77 Matsunaka, T...........................154 Matsunami, Y......................... 222 Matsuo, Y..........................152, 191 Matsuoka, K......... 61, 136, 236, 251 Matsushima, K....................... 252 Matsushita, H.-O...............98, 243 Matsushita, M................... 136-137 Matsuura, M...........................136 Matsuura, N...................... 85, 201 Matsuura, R...................... 136-137 Matsuzaka, M..........................241 Matsuzaki, I............................123 Matsuzaki, J.............................89 Mattar, O. M...................... 117, 133 Matteoli, G..........................79, 92 Matthes, K.............................. 239 Mattila, E................................241 Mattsson, F.............................. 132 Matuguma, S. E...................... 230 Matuo, H................................. 167 Matusiewicz, M.......................184 Matysiak Budnik, T........ 37, 51, 82, 93, 107, 168, 211, 252 Maueröder, C..........................170 Maurano, A.............................. 62 Maurice, J...............................165 Mauro, A............149, 198, 248-249 Mavroeidi, E. A................ 206, 251 Mawe, G. B....................... 56, 110 Mawe, G. M...................... 56, 110 Maxim, R............................... 254 Maximov, V. N.........................122 May, A............. 48, 60, 76, 88, 96, 104, 137, 146 Mayanagi, S.....................183, 223 Mayberry, J..............................129 Maydeo, A. P...........................150 Maye, H................................. 248 Mayer, A................................. 137 Mayer, B................................ 232 Mayerle, J........... 36-37, 76, 80, 170 Mayhead, P............................ 228
Maynard, J..............................247 Mayumi, T.........................120-121 Maza, F. R...............................186 Mazilu, L...........................115, 153 Mazza, E.................. 195, 242, 246 Mazza, F.................................. 101 Mazza, S................................ 236 Mazzaferro, V..........................130 Mazzarella, G.......................... 133 Mazzawi, T...................... 195, 246 Mazzella, G.............................. 91 Mazzone, G............................ 206 Mazzuoli, S..................... 189, 240 Mc Nally, M.............................251 Mcalindon, M..................... 72, 131 McBride, J...............................190 McCallum, R. W........................65 McCarthy, J..............................237 McCartney, S.................... 140, 191 McCarville, J.............................56 McClements, D........................188 McCoy, A.................................. 78 McDonald, J............................184 McDonald, N...........................231 McDonald, S. A. C............ 150, 248 Mcgalliard, R.......................... 222 McGee, A................................ 167 McGinty, L. A...........................148 McGrath, J. S.......................... 242 McHenry, L.............................. 179 McKaig, B.......................125, 223, 225-226 Mckenzie-Ballesteros, A......... 220 McKenzie, Y......................... 47, 55 McKevitt, M.............................140 McKinney, E. F..........................80 McLain-Smith, S......................195 McLaughlin, J..........................195 McLaughlin, S.........................189 McLeod, D................................69 McLindon, J.............................188 McMahon, B. P........................199 McNamara, D............ 126, 137-138, 140, 159, 205, 216, 231, 252-255 McNicholl, A. G..................77, 104 McQuaid, K............................. 176 Mearín Manrique, F.............55, 74 Mearin Manrique, M. L.............64 Mearns, E. S........................... 204 Medeiros, I........... 52, 177, 179, 224 Medhat, E............................... 118 Medhioub, M..........................227 Medina, R...............................186 Meester, R. G. S........................50 Megía Sánchez, M...................148 Megraud, F.................... 37, 62, 77, 104, 106, 211 Mehdi, K.......................... 138, 168 Mehl, B...................................215
Mehmedović, A.......................169 Mehta, N................................ 252 Mehta, S................................. 191 Meiborg, M.............................128 Meier, B................................... 53 Meier, M.................................. 93 Meijer, B.................... 59, 192, 242 Meijer, G. A...................... 143, 192 Meijer, S. L............................. 249 Meindl, R................................ 178 Meining, A........51, 54, 58, 64, 193 Meira, T...................................188 Meireles, L..............................158 Meireles, L. C..........................159 Meirelles, L.............................221 Meisner, S................................ 92 Mejia, L. K......................... 76, 129 Mejuto-Fernández, R.............. 220 Mejuto, R.........................187, 220 Melcarne, L.............................241 Melchior, C. A..........................198 Melhem, H..............................184 Melina, R................................ 133 Melit, L. E............................... 157 Mellor, K.................................183 Mellor, S.................................192 Melo, D.................................. 209 Melo, R...................................159 Meltzer, B. A...........................149 Melum, E.................................59 Meluzinova, E.......................... 197 Mena, L...................................186 Menachem, M........................ 242 Menchén Viso, L..................... 240 Mendall, M.............................185 Mendes, M......................208, 258 Mendes, S.................210, 219, 229 Mendibil, L.............................. 115 Mendivil, E. J........................... 116 Mendl, J..................................158 Mendolaro, M........... 189, 238-239 Mendonça, E. Q...............194, 201, 231, 258 Menegaux, F............................ 181 Menendez, F............................ 217 Meng, J................................... 132 Meng, M. L..............................153 Meng, Z.................................. 174 Menicucci, D........................... 206 Mentzel, C...............................126 Mera, A................................... 187 Merah, N.................................156 Mercanoglu, B.............. 46, 78, 221 Merchan Gomez, B.............64-65, 198-199 Meredith, C...................... 119, 222 Merfort, I................................ 114 Merighi, A...............................130 Merigliano, S..........................247 Merino, V................................139
351
UEG Week Final Programme : Index of Authors and Co-Authors
Merlin, D.................................. 70 Merlo, J............................ 125, 178 Mertens, J................... 61, 102, 127 Merzlyakov, M.........................135 Mesana, L...............................188 Mescoli, C........................231, 234 Mesenas, S. J.......................... 208 Messadeg, L............................. 83 Messina, V................... 117, 119, 167 Messmann, H..............64, 82, 205 Messner, B..............................135 Mestas, J. L..............................221 Metselaar, H. J..........................48 Metussin, A............................ 222 Metz, D. C...............................150 Metzger, G............................... 118 Meucci, G....................97, 156, 185 Meurette, G............................ 234 Meyer-Gerspach, A. C........ 52, 103 Meyer, B.................................215 Mezei, D..................................195 Miceli, E............................ 64, 155 Michel, M.-L............................. 57 Michetti, P.................... 67, 75, 100 Michida, T...........................51, 53 Michigami, Y............................84 Michl, P.............................46, 222 Mickevicius, A........................ 220 Micsik, T..................................159 Middendorf, J.......................... 116 Miehlke, S............ 67, 101, 140, 154 Miehsler, W............................. 137 Miele, E..................................135 Miele, L........................... 205, 218 Mielnik, P. F............................ 204 Mifsud, S..................................89 Miguel Esteban, J................... 180 Miguel, I.................................145 Mihaly, E.................................140 Miheller, P...........83, 136, 234-235, 238, 240 Mikami, K................................58 Mikami, Y................................ 115 Mikocka-Walus, A..... 140, 146, 245 Mikolasevic, I...........................64 Miksch, R. C........................... 232 Mikus, P................................. 238 Milani, V..................................55 Milano, A........................ 236, 254 Milano, R. V............................. 76 Milashka, M.......................95, 113 Milassin, Á...............228, 238, 240 Milella, M................... 117, 167, 172 Milicic, B.................................165 Millan, M.......................... 81, 104 Millastre-Bocos, J........71, 170, 220 Miller, E.................................. 178 Milosavljevic, T............77, 104, 165 Mimori, N............................... 132 Mimura, T................................65
352
Min, G....................... 127, 132, 148, 152, 173, 203 Min, M........ 194, 201, 222, 239, 251 Minaga, K............................... 181 Minagawa, T..................... 124, 231 Minahan, K..................... 184, 204 Minale, P................................ 249 Minami, T..........................122, 177 Minamide, T............................ 177 Minamiguchi, S.......................144 Minarik, M.......................222, 251 Minarikova, P......................... 242 Minashi, K.............................. 250 Minata, M........................194, 201 Mingrone, G............................ 173 Minguez, M............................ 239 Minisola, S..............................138 Ministro, P.................188, 207, 228 Mion, F............................. 148, 197 Miot-Noirault, E..................... 242 Miraglia, C......... 146, 196, 198-199, 202-203, 248-249, 252, 255 Miranda Bautista, J................. 240 Miranda, A...................... 189, 203 Miranda, P................................ 97 Mircea, P. A.............................165 Miri, B....................................192 Mirijello, A..............................166 Miro, E....................................194 Mirones, L...............................145 Misawa, M............ 46, 72, 98, 126, 128, 131, 193-194, 243 Miscia, S................................ 254 Mishakina, N. Y.......................158 Mishima, Y.................. 71, 101, 238 Misicka, A................................ 79 Misra, R............... 70, 134, 233-234 Missale, G...............................168 Missbichler, A..........................196 Misselwitz, B......................97, 233 Mita, E....................................153 Mitiche, A........................185, 257 Mitobe, J...................201, 252-253 Mitoro, A.................................152 Mitova, R................................221 Mitra, V............................ 119, 229 Mitre, M...................................58 Mitrova, K.............................. 238 Mitsios, A................................134 Mitsui, K..........................178, 236 Mitsunaga, M............201, 252-253 Mitsunaga, S........................... 172 Mitsunaga, Y.........82, 173-174, 225 Mitsuyama, K........................... 61 Miura, H...........................122, 172 Miura, K..................................124 Miura, R..................... 175-176, 182 Miura, T............................134, 191 Miura, Y...................................68
Miutescu, B......................216, 224 Miwa, H............................ 84, 169 Miyachi, H....................... 194, 243 Miyahara, K.............................154 Miyahara, R....................... 136-137 Miyake, K................................ 173 Miyamoto, S........... 51, 62, 128, 151 Miyamoto, Y............................ 167 Miyaoka, M..............................58 Miyasako, Y................ 175-176, 182 Miyata, E................................. 119 Miyata, T................................. 181 Miyazaki, T............................. 254 Miyoshi, H................................ 62 Mizokami, Y............................. 191 Mizoshita, T.............................142 Mizrahi, J............................... 242 Mizrahi, M...................69, 93, 251 Mizukami, K..................... 134, 172 Mizukami, Y.......................122, 172 Mizumoto, T............................ 151 Mizumoto, Y...............129, 171, 180 Mizuno, C................................140 Mizuno, K.-I............................103 Mizuno, M......................... 69, 146 Mizuno, N................................171 Mizuno, S.................... 95, 119, 138 MIzusawa, J.............................251 Mizushima, T......................53, 151 Mizutamari, H......................... 132 Mizutani, Y........................ 136-137 Mlynarsky, L..............155, 178, 209 Mo, Y...............69, 72, 84, 98, 126, 128, 131, 167, 177, 186, 193-194, 196, 203, 223, 243, 245, 251 Moahammed, A. T................... 133 Mocanu, I............. 52, 177, 179-180, 224, 230 Mocciaro, F..................97, 239-240 Moccisro, F..............................185 Mocellin, S..............................182 Mochida, T...................... 203, 241 Mochizuki, K...........................128 Mochizuki, S.............................96 Modderman, S........................102 Modino, Y................................186 Moehler, M.........................38, 63 Moelker, A.............................. 255 Moenig, S. P............................. 92 Moga, T...................................168 Moga, T. V...............................218 Mohácsi, L............................. 229 Mohamed, E. M....................... 133 Mohamed, M.-E. F....................48 Mohamed, Z...........................120 Mohammed El Sayed Ahmed El Nakib, A..............168 Mohammed, N........................237 Möhler, U............................... 254
Mois, E....................................64 Mokhtech, M. G...................... 253 Mokrowiecka, A.......................134 Moleiro, J................................ 176 Molero, X............................... 222 Molina, A. J................. 77, 104, 143 Molina, C................................123 Molina, G................................237 Molina Infante, J......67, 77, 99, 101, 104, 149, 248 Molinari, A..............................139 Molinero García, M..................125 Møller, H. J.............................. 101 Molnár, A............................... 235 Molnar, B..... 143, 159, 192-193, 243 Molnár, R................................120 Molnar, T................... 83, 136, 228, 234, 238, 240 Molnár, T......................... 220, 229 Mom, B...................................237 Momoi, T................................. 176 Monast, C................................188 Mone, I...................................149 Mongelli, A............................ 208 Monica, F................................192 Moniz, E...................................117 Mönkemüller, K................. 52, 194 Montagnese, F........................ 228 Montalban-Arques, A............... 97 Montale, A..............................129 Monteiro, J............................. 258 Monteiro, S........166, 186, 216, 236 Monteleone, G............96, 143, 187 Monteleone, M........................130 Montesano, L...........................64 Montgomery, A.......................142 Montgomery, S........................189 Montironi, C........................... 222 Moodie, S. J............................ 176 Moon, J. H.................179, 229, 246 Moon, J. R........................219, 229 Moon, S. J...............................195 Mooney, L............................... 175 Moons, L. M. G................ 192, 255 Moor, M................................... 52 Moore, J..................................195 Moors, G.................................189 Mora, D........................... 156, 255 Mora, F................................... 239 Mora-Gutierrez, I..................... 97 Morabito, G.............................135 Morais, R...................117, 138, 159, 195-196, 207, 218 Moran, A. W............................. 52 Moran, C.....................55, 134, 167 Morando, F.............................. 167 Moraru, C................................. 73 Moravkova, P.................... 138, 241 Morbey, A.............................. 208 Morbin, T............................... 223
Index of Authors and Co-Authors : UEG Week Final Programme
Moreau, J................... 75, 100, 229 Moreea, S.............................. 209 Moreels, T................. 102, 178, 182 Moreira, L................................ 63 Moreira, M. J.............186, 236, 257 Moreira, T................. 175, 210, 257 Morelli, A................................150 Moreno, C...........................42, 61 Moreno, L......................... 63, 128 Moreno, V..............83, 89, 97, 126, 143, 175-176, 211 Moreno de Vega, V........... 83, 126, 175-176 Moreno-Almazán, L.................128 Moretti, S............................... 254 Morgan, S......................... 86, 192 Morganti, D......................225-226 Morgner, A..............................154 Mori, A................................... 119 Mori, D...................................215 Mori, H................ 46, 53, 124, 200 Mori, K.............46, 51, 98, 124, 126 Mori, Y....... 46, 69, 72, 84, 98, 126, 128, 131, 177, 193-194, 203, 223, 243, 251 Morimitsu, Y.............................69 Morimoto, H............................124 Morino, M............. 52, 67, 100, 105 Morinushi, T............................ 174 Morisco, C.............................. 206 Morisco, F............. 117-119, 167-168, 205-206, 216 Morita, M................................154 Morita, Y...... 177, 194, 223-224, 251 Morito, Y................................ 203 Moriya, H...............................200 Moriyama, I............... 101, 122, 238 Morna, H................................ 208 Moroi, I............................ 181, 229 Moroni, F................................146 Moroni, P................................182 Morozov, S..............................149 Morreale, G. C.................. 187, 238 Morreau, H..............................85 Morris, E.................................143 Morrison, M....................204, 246 Morrissey, S...................... 58, 122 Morsy, M. E............................. 178 Mortele, K. J............................. 93 Moryoussef, F..........................130 Mosca, D.................................156 Mosca, M........................ 102, 206 Moscariello, M........................102 Moschen, A. R..........47, 70, 89, 94 Moschetta, A........................... 101 Moser, C. E..............................103 Moser, G................................ 240 Moser, J................................... 93 Moser, L................................. 240 Moshkowitz, M.........................69
Mosinska, P.............................156 Möslein, G......................... 58, 82 Mosli, M................................. 239 Mosnier, J.-F.............................82 Mosoni, C........................ 166, 256 Mosquera, J. L........................ 244 Moss, A............................. 177, 217 Moss, A. C................................56 Moss, S.................................. 252 Mossad, Y. A............................ 217 Mössner, J...........................46, 61 Mostafa, I.................................96 Mostafa, W. A. E......................164 Mostazo Torres, J..............157-158, 209-210, 257 Mota, F. L................................ 127 Motegi, A................................201 Motokawa, Y............................ 167 Motoya, M............................... 131 Motoya, S................................140 Motta Molina, M. J...................125 Mougin, C.............................. 234 Mouhadeb, O........................... 72 Mould, D. R.............................. 83 Moura dos Santos, P................257 Moura, M...........158, 221, 225, 258 Moura, R. N............................201 Mourad, L............................... 118 Mouri, H........................... 69, 146 Mousa, A. A............................ 115 Mousa, R................................ 118 Moussa, A. M.......................... 167 Moutinho-Ribeiro, P...........................120, 130, 173 Mouzas, I................................185 Mowat, C................................193 Moy, E...................................... 79 Mpitouli, A......... 125, 129, 140, 145 Mrakic-Sposta, S.................... 254 Mramba, L...............................95 Mroß, M.................................. 137 Mrzljak, A...............................257 Mucherino, C.......................... 203 Mücke, M. M.......................... 239 Mudter, J.............................55, 79 Mueller, B...............................156 Mueller, C. T............................183 Mueller, R............................... 101 Mueller, T.......................... 96, 183 Mugica, F..........................175, 178 Muguruma, N........................... 51 Muhmann, R...........................215 Muir, J. G.............103, 141, 196, 233 Mujagic, Z..................... 70-71, 196 Mukai, K................................. 121 Mukai, R.........................204, 253 Mukai, S.................... 69, 142, 222 Mukherjee, R........................... 72 Mulak, A................................. 137 Mulcahy, H.............................. 217
Mulder, C. J. J.................... 59, 64, 123, 182, 196 Mullady, D. K...........................145 Müller, J..................................247 Müller, M.................. 116, 214, 249 Muller, N..................................171 Müller-Schilling, M.......... 116, 214 Mullish, B. H...........................165 Müllner, K.............................. 234 Mumolo, M. G........................ 206 Mun, Y. G................................152 Munakata, M.................... 118, 194 Muncan, V.................. 92, 192, 242 Münch, A................... 67, 140, 238 Munch, M. R.......................... 250 Munck, L. K.............................140 Mundet, L.........................90, 149 Munkholm, P.............. 96, 135-136, 138, 185, 234 Munoz, L. E.............................170 Munoz-Garrido, P.........91, 117, 245 Muñoz-Gómez, P.....................153 Muñoz-Jurado, G......................49 Muñoz-Suano, A............... 56, 157 Münster, T................................ 79 Munsterman, I...................165-167 Munteanu, M. A......................165 Mura, D...................... 52, 123, 169 Murabayashi, T........................ 179 Murakami, B...........................124 Murakami, D..............123, 147, 169 Murakami, K.................... 134, 147 Murakami, M.....................51, 124 Murakami, S...........................124 Murakami, T..................... 124, 147 Murasugi, S............................ 226 Murata, A................................198 Murata, Y................................ 172 Murcia, O................................143 Murillo, R......................... 173, 251 Murino, A......................... 131, 148 Murphy, I................................138 Murray, C................................ 191 Murray, D.................................90 Murray, J. A.............................149 Murray, P................................ 252 Murray, S............................... 250 Murugananthan, A..................125 Musaico, D..............................154 Musaus, J.................................80 Muscat, M................................89 Muserra, G............................. 239 Musladin, S.............................183 Musso, A................................ 228 Mustafa, A. S...........................135 Mustafajev, I. F......................... 91 Mustonen, H............................ 91 Mutaguchi, M..........................138 Mutignani, M............96, 130, 220, 229-230
Muto, M................51, 151, 250-251 Muto, S................................... 179 Mykhalchyshyn, G............. 101, 215 Myshkin, E..............................188 Mytton, J................... 103, 170, 247 Myung, S.-J.......................98, 239 Myung, Y................................ 225
N Na, H...........51, 65, 85-86, 89, 98, 102, 110, 126, 132, 136, 138, 153, 169, 177, 185, 193-195, 203, 241, 243, 246-247 Na, S.-Y............................159, 224 Nabers, D................................. 52 Nabi, Z................ 148, 156, 170, 181 Nacak, T..................................140 Nachmany, I........................... 209 Nachury, M................80, 137, 186, 236, 238 Nacima, D...............................257 Nada, R...................................159 Nadal, E..................................130 Nadatani, Y....................... 79, 254 Nadezhin, A............................ 173 Naessens, D............................188 Naftali, T.................................140 Nagahama, T............................58 Nagahara, A.............. 174, 198, 202 Nagahori, M.....................136, 236 Nagai, T....................... 79, 89, 152 Nagaishi, T............................... 79 Nagamatu, S........................... 167 Nagami, Y................. 79, 200, 254 Nagano, H................................86 Naganuma, M....................61, 138 Nagaoka, I..............................145 Nagasaka, M.................... 123, 144 Nagase, H................................ 51 Nagata, K................................231 Nagata, S..................... 53, 69, 97, 142, 144 Nagayasu, K............................145 Nageeb, A............................... 116 Nägel, A............................ 55, 127 Nagengast, F. M........................98 Nagoshi, S............................. 206 Nagpal, S. J. S.........................257 Nagtegaal, I. D............. 76, 82, 98, 219, 235 Nagy, A...............159, 192-193, 229 Nagy, F.......................83, 234, 238 Nagy, G...................................165 Nagy, P................................... 229 Nagy, Z. B................. 143, 193, 243 Nahon-Uzan, K.................. 50, 176 Nahon, S.................................185 Naidoo, A................................126 Naimi, S................................. 242
353
UEG Week Final Programme : Index of Authors and Co-Authors
Naito, Y.................... 123, 174, 180, 204, 226, 253 Nakad, A........................... 55, 182 Nakada, A...............................182 Nakadoi, K........................ 53, 144 Nakagawa, K...........................247 Nakagawa, M................... 152, 154 Nakagawa, T.......124, 144, 170, 176 Nakagawa, Y.................... 123, 144 Nakahara, R..................... 123, 169 Nakahata, Y............................. 174 Nakahira, H..............................85 Nakahori, M........................... 254 Nakai, T................................... 147 Nakai, Y.......... 95, 119, 171, 180, 182 Nakaji, S.................................241 Nakajima, A..............103, 114, 155, 241, 254 Nakajima, N............................103 Nakajima, T.............................. 78 Nakajo, K...........................95, 177 Nakamatsu, D.......................... 121 Nakamura, A...........................215 Nakamura, H............. 98, 126, 169, 177, 194, 243 Nakamura, I.......................93, 167 Nakamura, K...........................251 Nakamura, M.............122, 136-137, 172, 181, 254 Nakamura, R...... 183, 223, 232, 251 Nakamura, S................... 166, 254 Nakamura, T.................95, 97, 119, 131, 143, 182 Nakamuta, M...................194, 201 Nakanishi, Y............................182 Nakano, C............................... 167 Nakano, M............................. 252 Nakano, S................................117 Nakano, T......................... 123, 174 Nakao, K...........................93, 252 Nakase, H........................ 136, 193 Nakashima, H..........................124 Nakashita, S..................... 172, 215 Nakata, A................... 145, 147, 174 Nakata, T............................ 97, 167 Nakatani, A.............................145 Nakatani, T.............................. 167 Nakatsu, S............................... 191 Nakayama, A......................82, 173 Nakayama, T............................144 Nakazawa, S...........................123 Nakazuru, S............................153 Nakhcha, I........................168, 218 Nakmouche, M.................185, 257 Nakov, R.................... 49, 159, 236 Nakov, V...........................159, 236 Nakstad, B................................71 Nam, H. S.........................126, 131 Nam, K............................ 174, 194 Nam, S. Y................................201
354
Nam, S.-J................................184 Namgung, H............................194 Namikawa, K..............151, 174, 246 Nan, Y. H..................................86 Nanayakkara, S. D...................135 Nancey, S......................75, 79-80, 135, 137, 139, 186 Nande, K. S..............................56 Nanjo, S...................................85 Nanki, K..................................138 Napoléon, B............... 95, 129, 229 Naqeem, A.............................. 137 Narang, A.............................. 230 Narasaka, T............................. 191 Naravadi, V..............................247 Nardi, K.................................200 Nardone, G...................... 119, 203 Nardone, O. M........................ 238 Narita, A.................................182 Narita, T................................... 53 Naruse, H............................... 203 Nasi, G....................................146 Nasonova, S............................221 Nassar, A.................................. 93 Nasser, I..................................251 Nastro, F...................................64 Nastu, K..................................124 Nasu, A................................... 167 Nasu, J............................ 209, 257 Nasu, Y........................65, 121, 186 Nathan, G............................... 181 Natividad, J. M......................... 57 Natsume, S...................... 122, 182 Nava, C. D...............................221 Navajas, F. J............................. 178 Navaneethan, U.....72, 103, 129-130 Navarathne, N. M....................135 Navarro, C...............................143 Navarro, M........................ 63, 189 Navarro, P.............................. 239 Navarro-Llavat, M....................189 Navarro-Vicente, F............ 233-234 Naveilhan, P........................... 234 Naves, J. E.............................. 234 Navolokin, N...........................153 Nawa, T...................................241 Nawarathne, N....................... 229 Nawaz, K................................. 217 Nayar, M................................ 222 Nayer, N................................. 207 Nazarov, I................................210 Nduaka, C......................... 61, 140 Neagoe, D...............................165 Neamatallah, M................ 117, 166 Nebiki, H...........................147, 174 Necula, D................................. 78 Nedal, M................................ 246 Neese, A.................................. 78 Neesse, A............... 78, 85, 102, 111 Negreira, S. M........................ 238
Negrutiu, D............................ 246 Neilson, L. J....................... 89, 175 Neimark, E......................... 49, 80 Nejjari, F................................ 253 Nelson, A................................ 132 Németh, A................................ 72 Nemeth, B.........................59, 220 Nenciu, I.................................233 Nennstiel, S........................... 248 Neokosmidis, G.......................126 Neri, B.................97, 185, 188, 234 Neri, M.................... 136, 236, 254 Neri, M. C.............................. 244 Nerin de la Puerta, J. M...........136 Netinatsunton, N..................... 119 Neu, B.....................................84 Neubauer, K............................184 Neufert, C..........................79, 127 Neuhaus, H................... 39, 67, 73, 76, 81, 126, 173 Neuman, S........................137, 140 Neumann Sen, H............... 98, 125 Neumann, F............................ 220 Neumann, H....... 37, 55, 69-70, 94, 98-99, 125, 127, 245 Neumann, U. P................... 55, 66 Neunlist, M....... 195, 234, 242, 252 Neurath, M. F..... 47, 55, 61, 70, 79, 121, 127, 148, 170, 184, 207 Neuweiler, J............................. 52 Nevens, F...........................91, 165 Neves, D..................................210 Neveu, I................................. 234 Nevill, A................................. 225 Ng Kwet Shing, R............. 125, 136 Ng, D. H. L...............................156 Ng, E............. 36, 60, 94, 135, 142, 152, 202, 230, 250 Ng, S. C.................................. 180 Ng, S. C. C........ 36, 60, 82, 94, 142 Ng, S. S. M.............................. 147 Ng, W. K................................. 207 Ngamruengphong, S....62, 99, 103 Ngo, O.....................228, 242, 244 Nguang, S.-H..........................166 Nguyen-Khac, E.......................135 Nguyen, H. T. T....................57, 85 Nguyen, N. Q.....................197-198 Nguyen, P. H.......................... 252 Nichols, S............................... 254 Nicolás Pérez, D...................... 245 Nicoletti, L........................247-248 Nicoletti, R...................... 222, 224 Nicolucci, C.............................165 Nieber, K.................................190 Nieboer, D...............................143 Nielsen, K. R.............. 96, 135, 185 Niemietz, C.............................215 Nieponice, A.......................... 249 Niess, J. H................................ 70
Nietfeld, L.............................. 222 Nieto, A................................... 57 Nieto, J.............................. 62, 102 Nieto, L.....................................71 Nietsch, H. H...........................126 Nieuwdorp, M....... 74, 90, 100, 173 Nieuwenhuijzen, G. A. P.... 76, 182 Nieves, J. W.............................150 Niezychowski, W.......................56 Niida, S....................................89 Niimi, K.................51, 96, 142, 151 Niinuma, T............................. 243 Nijeboer, P...............................64 Nikaido, M............................... 51 Nikeghbalian, S.................... 65, 165, 216, 218 Nikiforova, Y............................ 119 Niknam, R...............................215 Nikolaus, S..............................138 Nikolić, P.................................183 Nikolopoulou, V.......................241 Nikonov, E............................... 173 Nilsen, J. A.............................. 176 Nilsen, R. M........................... 204 Nilsson, L................................189 Nilsson, M....................... 132, 200 Nimura, S...............................182 Ning, L....................................201 Nio, C. Y..................................170 Nion-Larmurier, I.................... 181 Nipshagen, M. D......................103 Nir, E....................................... 97 Nirantharakumar, K.................247 Niriella, M. A.................... 135, 164 Nishi, M............... 86, 122, 126, 191 Nishida, A.........................126, 137 Nishida, H..........................93, 167 Nishida, T...........................53, 121 Nishiguchi, S........................... 167 Nishijima, N............................ 167 Nishikawa, H........................... 167 Nishikawa, M..........................126 Nishikawa, T...................... 136-137 Nishikawa, Y.................... 144, 250 Nishimoto, T........................... 236 Nishimura, K....................145, 182 Nishimura, M..........................122 Nishimura, N..................... 69, 146 Nishimura, R...........................143 Nishimura, T.............. 167, 175, 182 Nishino, K........................ 124, 129 Nishino, N...............................129 Nishiumi, S.............................122 Nishiyama, M...........................86 Nishizawa, T..................... 173, 225 Nisim, M................................. 151 Nissim-Eliraz, E........................ 97 Nissinen, S...............................85 Nistorescu, S...........................218 Niubo-Carulla, L......................134
Index of Authors and Co-Authors : UEG Week Final Programme
Niv, Y......................77, 91, 104, 154 Niwa, Y........................136-137, 171 NM Dinjens, W........................192 Nobili, V................................. 205 Nobuoka, D.............................166 Noda, H......................82, 173, 198 Noda, T................ 69, 82, 154, 173, 187, 193, 234 Noda, Y............................ 130, 179 Noel, R...................................120 Nogales Rincón, O.............175, 178 Noguchi, S.............................. 115 Noh, C.-K..........................132, 175 Noh, S. H................................201 Noji, T.....................................182 Nojima, M................................ 76 Nolan, J...................................134 Noma, Y..................................241 Nonaka, S...............................124 Noor, N. M...............................80 Noordzij, I. C...........................124 Nora, C. C. V............................184 Nordén, T................................219 Nordlinger, B...................... 51, 74 Norman, G. L......................61, 136 Noronha Ferreira, C.......... 173, 225 Norsa, L................................. 205 Noruzi, A.................................102 Nos, P.......................185, 235, 237 Nosek, V................................. 220 Noser, Y................................... 116 Noskova, K..............................139 Noto, A.................................. 202 Notta, P...................................196 Nour, E............................ 138, 183 Nouso, K.................................219 Novacek, G................... 49, 80, 137 Novak, G.................................. 79 Novák, J................................. 234 Novak, P................................. 243 Novella, M..............................194 Novelli, M. R...........................149 Novovic, S...............................221 Nowacki, T. M................... 135, 237 Nowecki, S..............................170 Nowicki, T........................218, 236 Nozaki, R................................ 172 Nucci, D....... 127, 130, 223, 225-226 Nuckcheddy, T........................200 Nudo, D...................................64 Nudurupati, S.........................150 Numao, H........................ 118, 194 Numata, K...............................169 Nunes, A. C...............159, 210, 258 Nunes, G...................157-158, 180, 209-210, 241, 256 Nunes, Q. M............................. 72 Nurbhai, S........................ 89, 139 Nussbaum, D...........................183 Nuta, P....................................237
Nuutinen, H........................... 239 Nuzuki, S................................123 Nuzum, T..................138, 205, 216 Nylund, K................................. 78 Nyssen, O. P.......................77, 104
O O'Connell, R....................... 40, 88 O'Morain, N..................... 126, 138 O'Reilly, S. M........................... 217 O´Brien Andersen, L.................58 Oana Cristina, S. C.................. 254 Obayashi, Y.......................151, 175 Oberacher, H............................89 Obialo, N................................233 Obora, A................................. 174 Obritin-Guilhen, H...................186 Ocaña, T............................63, 245 Occhipinti, P..............130, 222, 228 Ochi, M.................... 145, 168, 206 Ochiai, M........................ 145, 206 Ochiai, T........................... 145, 174 Ochiai, Y.... 68, 82, 173-174, 177, 225 Ochieng, A.............................. 137 Ochiya, T..................................89 Ochoa Sangrador, C................. 137 Oczella, L............................... 243 Oda, I.......................... 89, 151, 251 Oda, M........................ 46, 98, 126 Oda, T..................................... 121 Ofer, I..................................... 243 Ogata, H..................................138 Ogata, M................................. 172 Ogata, N......... 72, 126, 128, 131, 193 Ogawa, C................................154 Ogawa, G................................251 Ogawa, T....................128, 130, 179 Ogawa, Y.......... 46, 69, 72, 98, 114, 126, 142, 194, 201 Ogihara, K.......................... 58, 93 Ogino, H.................................123 Ogita, K............................ 123, 174 Oguri, T................................... 115 Oğuz, D...................................199 Oh, C. H...........................219, 229 Oh, D...................................... 131 Oh, D.-W.................................221 Oh, H.-C.................................. 179 Oh, Y.......84, 95, 190, 194, 223, 251 Ohara, Y....................194, 223, 251 Ohashi, N................................ 119 Ohata, K...................................96 Ohda, Y....................................84 Ohira, T...................................128 Ohiwa, S.................................231 Ohki, T............................. 142, 147 Ohkubo, H...............................155 Ohkusa, T................................134 Öhman, L................................ 141
Ohmiya, N.................123, 144, 254 Ohmiya, T................................182 Ohmori, T............................... 226 Ohnishi, S................................ 53 Ohnita, K.................... 93, 152, 252 Ohno, E............................. 136-137 Ohno, K.................................. 205 Ohno, Y....................................95 Ohta, A....................................58 Ohtsu, K.......... 69, 72, 131, 136, 236 Ohtsuka, K........... 72, 131, 136, 236 Ohyama, A.......................166, 168 Oka, A................................71, 168 Oka, S..................53, 144, 151, 254 Okabe, Y...........................170, 180 Okada, H....... 53, 65, 151, 166, 168, 175, 182, 203, 219, 241 Okada, M................................130 Okada, T.......................76, 93, 167, 172, 232, 252 Okada, Y................................. 252 Okagawa, Y.............................231 Okamoto, K.............................164 Okamoto, N............................. 177 Okamoto, R........................97, 143 Okamoto, T..............................124 Okamoto, Y....................... 142, 175 Okamura, K.............................182 Okanobu, H....................... 53, 144 Okawara, A.............................168 Okayama, T........123, 174, 204, 253 Okazaki, K................................ 62 Oke, S.....................................185 Okhlobystin, A.........................221 Okhlobystina, O................221, 257 Okhotina, A............................. 118 Okimoto, K....................... 124, 176 Okimoto, T...............................134 Oksala, N.................................85 Oksanen, P................. 96, 135, 185 Okubo, M................................123 Okubo, S................................. 132 Okuda, N.................................169 Okuda, Y..................................144 Okugawa, T..............................84 Okumura, T.............................128 Okuno, N..................................171 Okuse, H...........................122, 172 Okuwaki, K.............................. 119 Okuzono, T..............................169 Olaniyi, J.................................216 Olariu, L................................. 104 Olbjørn, C.................................71 Oldenburg, B....................102, 239 Oleas-Narea, R.........................49 Oliva, S................................... 191 Oliva del Rio, B...................... 207 Oliveira, A................ 209, 237, 245 Oliveira, A. M..........................237 Oliveira, A. P............................215
Oliveira, C................... 83, 147, 189 Oliveira, D................ 194, 201, 231, 257-258 Oliveira, E. C..................... 49, 189 Oliveira, J. F. D....194, 201, 231, 258 Oliveira, M.......................237, 258 Oliveira, P..........................147, 215 Olivencia Palomar, P................153 Oliver, L...................................237 Olivier, C......................... 106, 205 Olivier, N.................................125 Ollero, V...........................235, 237 Ollivier, J.................................188 Olmedo Camacho, J.................153 Olmos, C..................................65 Olson, A...............................47, 61 Omae, M................................200 Omar, A.................................. 118 Omari, T..................................198 Omatsu, T................................ 174 Omazzi, B.........................225-226 Omidvari, A.-H......................... 87 Ominami, M................... 200, 250 Omori, T..............124, 151, 223, 251 Omori, Y..................................122 Omoto, S...........................122, 181 Omran, D...........................117-118 Omran, M.................................117 Oms, L.............................170, 220 Omura, A................................154 On, W................................ 38, 188 Onali, S................................... 187 Onimaru, M............................ 250 Onishi, H.................................166 Önnerhag, K............................143 Ono, A....................................126 Ono, H................ 51, 124, 128, 194, 203, 242, 250-251 Ono, M............................. 131, 203 Ono, S.................. 96, 128, 142, 151 Ono, Y.......... 58, 122, 172, 204, 253 Onozawa, Y.....................204, 253 Ooi, J..................101, 148, 247-248 Ooi, M.................126, 197-198, 203 Oom, R...................................145 Oono, I.................................... 172 Oono, Y.............................177, 201 Ooshima, S..............................143 Ooshiro, T................................182 Oostenbrug, L. E......................102 Oota, S.....................................171 Oppong, K.............................. 222 Oprisanescu, D........................231 Oproiu, A................................ 167 Orbán-Szilágyi, Á.................... 179 Orchard, T. R........36, 184-185, 233 Orel, R..................................... 79 Orfanoudaki, E........................ 187 Orlandini, B............................190 Orlando, A........... 97, 185, 237-239
355
UEG Week Final Programme : Index of Authors and Co-Authors
Orlando, C.......................203, 249 Orlando, E...............................237 Orlando, R....................... 237-239 Orlando, S.............................. 236 Orlova, L.......................... 187, 210 Orman, S..........................159, 232 Ormando, V. M........................ 174 Ormanns, S............................ 232 Oropeza, A.......................183, 233 Orry, X................................... 235 Orsic Fric, V.............................158 Ortega, O..........................90, 149 Ortega, S. P.............................194 Ortega-Suazo, E................121, 197 Orth-Höller, D........................... 70 Ortiz Fernandez-Sordo, J......................................... 173 Ortiz Masia, D............ 134, 233-234 Oruc, N...................................143 Osada, T..................................140 Osaki, Y............................ 167, 257 Osera, S.................................. 176 Oshima, N........................101, 238 Oshima, T.................................84 Oshiro, T................................. 133 Osmane, R.......................185, 257 Osoegawa, T.....................194, 201 Ospina, A................................183 Ospina, J............................49, 174 Osredkar, J............................... 79 Ostapchenko, L........................155 Osterman, M. T........................139 Östman, A...............................221 Osugi, N.................................. 121 Oswald, F................................193 Ota, H.....................................128 Ota, Y......................................130 Otake, S..................................130 Otani, I................................... 254 Otani, K.............................79, 254 Otazua, P................................. 115 Otero-Alen, B................... 147, 252 Otero-Alen, M......................... 147 Otete, H. E................................ 78 Othman, A. A...........................48 Othman, H.......................120, 158 Otlu, B....................................170 Otottova, K............................. 238 Otsuka, H.......................... 136-137 Otsuka, T..........................172, 203 Otsuki, A................................ 203 Ouakaa, A........................228-229 Ouazzani, S.............................126 Oubaha, S.............................. 253 Ouchi, A........................... 133, 182 Oudjit, A.................................247 Ouldgougam, R...................... 253 Oumnia, N..............................154 Oussi, N..................................183 Ouwendijk, R. J.......................102
356
Ovartlanporn, B....................... 119 Overbeek, L. I. H.......................64 Overwater, A..........................200 Oyama, A.................................65 Oyama, T......................... 152, 250 Oyamada, J.............................169 Oza, N..................................... 172 Ozagari, A. A.......................... 236 Ozaki, T...................................134 Ozawa, E.................................. 93 Ozawa, M................................152 Ozbek, M.................................170 Özbeyli, D............................... 256 Özdemir Kumral, Z. N............. 256 Ozeki, K...................................142 Ozola-Zalite, I......................... 220 Öztürk, Y................................ 256 Ozutemiz, O.............................143
P Pablo Fernández Navarro, P........................................143 Pabois, J................................. 234 Pace, D................................... 242 Pace, F...............................146-147 Pachofszky, T........................... 132 Pacou, M.................................188 Padro, D................................... 91 Padula, S. J............................... 47 Paese, P..................................189 Pagadala, N............................ 133 Pagani, E........................... 64, 155 Pagano, I..................................90 Paggi, S................................. 228 Pagnon, L............................... 232 Paiella, S........................... 85, 183 Paik, N. Y.................................193 Paik, W. H.........................121, 130 Painchart, C........................... 238 Paiva, D. S....................... 155, 206 Pajala, M................................ 239 Pajdo, R................................. 250 Pak, S...............................175, 217 Pakodi, F................................ 229 Pal, P.......................... 120, 171, 181 Palacín, C............................... 253 Palatka, K.....83, 136, 234, 238, 240 Palazuelos, C...........................143 Palazzo, L............................... 229 Palazzo, M.............................. 222 Pálfi, E................................... 235 Paliy, I.....................................150 Pallagi, P...........................120, 171 Pallav, K..................................241 Pallone, F................... 97, 185, 234 Pallotta, L................. 147, 206, 244 Pallotta, S............177, 181-182, 220 Palma, R................................ 208 Palmela, C........................ 178, 237
Palmieri, G...................... 188, 234 Palmieri, L.-J...........................241 Palmisano, S...........................165 Palos Cuellar, R....................... 174 Palsson, O. S............... 71, 90, 146, 149, 244-245 Palviainen, M..........................193 Pan, A......43, 46, 73, 77, 87, 94-95, 102, 105, 140, 156, 158, 163, 179, 181, 186, 209, 254 Pan, J................47, 56, 69, 97, 102, 148, 184, 189, 223, 244 Pan, W. H................................138 Pan, Y.......................................82 Panaccione, R.................... 49, 80, 101-102, 139, 176 Panadero, A............................186 Pandolfi, A............................. 254 Pandolfi, M............................. 181 Pandolfino, J..................... 69, 148 Panek-Jeziorna, M................... 137 Panés, J..............43, 47, 56, 73, 94, 97, 102, 105, 140, 189 Pang, T....................................156 Pang, Y. H................................184 Pangan, A........................... 47, 87 Panic, N..................................122 Panici Tonucci, T..................... 239 Panis, Y.........................38, 43, 86 Panozzo, M. P............202, 247-248 Panteleev-Ivlev, J.....................184 Paoluzi, P............................... 239 Paone, G.................................130 Papa, A............................155, 239 Papachristopoulou, G............. 243 Papachristou, G. I......................71 Papachrysos, N........................231 Papadia, C...............................155 Papadopoulou, A...................... 67 Papanikolaou, I.......... 42, 106, 213 Papastergiou, V.......................125 Papatheodoridis, G............. 39, 64 Papay, P.................................. 137 Pape, S...............................46, 91 Pape, U.-F.............................. 205 Papi, C...............................97, 185 Papp, M........................61, 72, 83, 136, 220, 234 Pappalardo, B..........................49 Pár, G..................................... 220 Paranahewa, S....................... 228 Paranandi, B...........................122 Paraskeva, K............................125 Paraskevova, A....................... 248 Pardeiro Pertega, R................. 178 Pardo Balteiro, A.................... 180 Pardo-Camacho, C.................... 57 Paremal, S...............................89 Parepa, I. R.......................115, 153 Parfenov, A......... 138-139, 155, 184
Pariente, B............. 75-76, 135, 137, 185, 236, 238 Parihar, V......................... 126, 159 Parisi, I......................140, 149, 191 Park, B. H.................................98 Park, D. G................................194 Park, D. H..........................131, 221 Park, D. K......................... 146, 177 Park, E. T................................. 179 Park, H.......... 98, 131, 142, 175, 179, 193, 201, 221, 226, 229, 239 Park, H. S........................ 202, 252 Park, J................ 174, 201, 243, 253 Park, J. J.......................... 201, 243 Park, J. K...........................172, 197 Park, J. M.........................152, 184 Park, J. Y...............122, 169-170, 172 Park, J.-S................... 119, 223, 246 Park, K. S................................201 Park, S.............. 152, 188, 201-202, 223, 245-246, 251-252 Park, S. C................................184 Park, S. H......98, 142, 175, 193, 239 Park, S.-H.................179, 226, 229 Park, S. W................. 122, 169-170, 172, 177, 219 Park, Y. S.......................... 152, 251 Parker, H. L.............................148 Parkes, G.................................156 Parkes, M.................................80 Parkinson, D............................196 Parlak, E................................. 132 Parmentier, A.-L..................... 234 Parniczky, A..............................59 Parodi, A.................................. 62 Parolova, N............................. 157 Parry, H.................................. 243 Parry, S. D...............................144 Parra Villanueva, F. J................125 Parra-Blanco, A....................... 177 Parshutin, S..................... 173, 251 Parsi, M.................................. 181 Parzanese, I............................130 Pasanisi, F.............................. 235 Pasca, S................................. 246 Pascale, V................................ 147 Pascaru, A...............................216 Paschos, P................................49 Pascual-Moreno, I.................. 220 Pascual-Salcedo, D..................188 Pasin, F.................................. 207 Paskauskas, S.......................... 172 Paspatis, G......... 125, 129, 140, 145 Pasqual-Moreno, I...................170 Pasquale, L...............................96 Pasquer, A............................... 132 Passananti, V................... 244-246 Passigato, N............................159 Pastorelli, L............................. 127 Patai, A...................... 83, 136, 229
Index of Authors and Co-Authors : UEG Week Final Programme
Patai, A. V................. 159, 192-193, 220, 229 Patch, D.................................. 131 Patcharatrakul, T......................194 Patel, A..........69, 141, 188-189, 193 Patel, H......................141, 188-189 Patel, N..............196, 199, 232, 252 Patel, P................103, 170, 176, 247 Patel, R. N...............................193 Paternostro, R.......................... 51 Pathmakanthan, S...................142 Pathmeswaran, A....................164 Patita, M................... 157-159, 180, 209-210, 241, 256 Patrasescu, M..........................237 Patricelli, M. G....................... 242 Patrick, V. B.............................. 62 Patrlj, L...................................183 Pattarapuntakul, T............ 119, 257 Patterson, J............................. 175 Patti, R....................................165 Pattni, S................................. 234 Patturelli, M............................189 Paul, C.............................. 92, 170 Paul, S.................79, 170, 186, 190 Pauligk, C................................. 92 Paulo, S..................................190 Paulus, S.................................170 Pauwels, A....................... 101, 198 Pauza, A. G.............................. 78 Pauziene, N....................... 78, 146 Pavão Borges, V............... 159, 258 Pavelets, K.............................. 132 Pavelets, M.............................. 132 Pavey, D..................................150 Pavlenko, A............................. 133 Pavlenko, V.............................. 133 Pavlov, P..................................257 Pavlovic Markovic, A................ 133 Paye, F.................................... 181 Pazdro, A............................... 250 Pazos-Randulfe, Y............. 147, 252 Pearlman, A............................145 Pecere, S................................. 131 Pech, O.......58, 60, 76, 87, 163, 173 Peck-Radosavljevic, M.............. 51 Pécsi, D.................................. 229 Pedersen, J............................. 249 Pedersen, N............... 96, 135, 185 Pedersen, R.............................102 Pedersen, S..............................90 Pediconi, C..............................136 Pedro, A. J............................... 167 Pedroni, C...........................64-65 Pedroto, I.....139, 175, 210, 224, 257 Peek, N. M. S...........................190 Peery, A................... 59, 67, 78, 88 Peeters, A.............................. 207 Pefkianaki, I............................185 Peiris, M................................ 248
Peiris, R................................. 229 Peiró, R...................................143 Peixe, B...................................215 Peixoto, A............ 116-118, 120, 122, 130, 173, 195, 208-210 Pekala, A................................ 235 Pekarska, K..................... 235, 240 Peker, İ................................... 256 Pelaez, J..................................152 Pelegri-Sebastia, J...................237 Pelizzaro, F.............................. 119 Pellegatta, G........................... 187 Pellegrino, S.....................135, 238 Pellet, G...................................80 Pellisé Urquiza, M............. 63, 84, 125, 128, 178 Pellisé, M....................63, 84, 125, 128, 153, 178 Peltec, S. E..............................144 Penagini, R..................... 130, 149, 198, 248-249 Pencik, P................................ 220 Penenberg, D.......................47, 61 Penez, L................................... 70 Peng, S.................................. 242 Penna, A................................ 203 Pennacchi, C.......194, 201, 231, 258 Pennazio, M............................ 131 Penney, N................................155 Penz, D......................175, 227-228 Peppelenbosch, M. P.............................. 79, 150 Perales, A............................... 245 Peralta, S............................... 238 Perazzolo, A.....................247-248 Perbtani, Y.........................95, 151 Perdigao, F............................... 62 Perdigoto, R........................... 208 Perdones-Montero, A......... 70, 233 Perea Amarillo, R....................139 Pereira, A........... 145, 159, 176, 178, 180, 208, 210, 222, 252 Pereira, B............. 83, 137, 186, 225 Pereira, E.....84, 128, 166, 180, 256 Pereira, F................... 84, 128, 166, 180, 256-257 Pereira, P................. 120, 122, 145, 209, 218, 231 Pereira, S................................ 178 Pereira da Silva, J............ 145, 176, 178, 222 Pereira Silva, J........................ 180 Perek, S.................................. 181 Perez, M. C..............................150 Perez, R.............................51, 107 Pérez-Aísa, Á............... 77, 104, 153 Pérez Arellano, E.....................154 Pérez Calle, J. L....................... 240 Perez de la Serna, J.......... 198-199 Perez Ferrer, M........................ 167
Pérez Galindo, P..................... 240 Pérez-Berezo, T........................ 57 Perez-Camiña, J. P............ 147, 252 Pérez-Cuadrado-Martínez, E....................................... 228 Perez-Cuadrado-Robles, E................... 102, 178, 182, 228 Pérez-Gómez, B.......................143 Perez-Lasala, J....................77, 104 Pérez-Milián, D...................... 253 Perez-Miranda, M............... 99, 171 Pérez-Pampín, E...................... 187 Pérez-Riquelme, F.................. 228 Pérez-Rodríguez, F. J...............128 Perini, C.................... 159, 210, 221 Perk, L........................93, 142, 193 Perkhofer, L.................. 78, 93, 193 Perminow, G.............................71 Permpoon, V........................... 177 Péron, M.....................82, 121, 252 Perren, A.................................102 Perren, B................................. 176 Perretta, S............................... 173 Perri, V................................... 252 Perrod, G...................151, 173, 229 Persico, M........................ 119, 165 Perugini, B.............................. 133 Perugorría, M. J...................91, 117 Pesatori, E. V................ 64-65, 155 Pesenti, C......................... 152, 169 Pesenti, E.........................247-248 Peserico, G....................... 119, 220 Pessegueiro Miranda, H...........196 Pestman, W.............................. 76 Peter, J..................49, 80, 101-102, 139, 192, 240 Peter, L.........................55, 66, 170 Peter, S...................................148 Péterfia, B...............................193 Peterli, R.................................. 52 Peters, A............................. 49, 61 Peters, M............................... 235 Peters, P.-G............................. 137 Peters, Y................................... 76 Petersen, A.............................. 61 Petersen, A. H.........................103 Petersen, B..............................89 Petersen, B. T.................... 62, 145 Petersen, E. J...........................192 Petersen, F..............................138 Petersen, J. H..........................103 Petersen, J. M......................... 250 Petersson, J..... 49, 80, 101-102, 139 Petito, V..................................188 Petkevicius, V....................142, 154 Petrenkiene, V......................... 115 Petricca, L................................ 75 Petrone, M. C...................98, 106, 207, 213, 222, 230 Petrov, B................................. 179
Petrov, P.................................. 179 Petrowsky, H............................86 Petrusel, L........................ 172, 222 Petruzziello, L..........................126 Peveling-Oberhag, J.................231 Pevere, S.................................122 Peyrin-Biroulet, L..... 49, 73, 75-76, 80, 87, 135, 137, 139, 185, 190, 235, 239 Pezet, D.............................85, 242 Pezzilli, R.................................85 Pezzolla, F............................... 147 Pezzullo, M............................ 207 Pezzuto, F................................154 Pfeifer, L................................. 121 Pfister, A.................................. 70 Pfisterer, N.............................. 132 Pham, K. D.-C..........................122 Pham, P................................... 57 Phelip, J. M...................... 185-186 Philip, G...........................140, 233 Phillip, V........................... 72, 224 Phillips, A................................ 74 Phillips, W...............................150 Phuwapraisirisan, S................. 133 Piacenza, M............................ 239 Piano, S..................................166 Piatek, D................................ 235 Piazuelo, E...................... 153, 200 Piazuelo, M. B.......................... 97 Pica, R................................... 239 Picard, O.................... 78, 140, 190 Picchio, M....................... 146, 203 Piciocchi, M.......................119, 187 Pico Sala, M. D......................... 63 Pidhirnyy, B..............................171 Pidial, L.................................. 173 Piekuse, L........................ 235, 240 Pienar, C........59, 157, 170, 216, 218 Pienkowska, J. M..............218, 236 Pieper, D................................. 141 Pierik, M. J....49, 102, 187, 236, 239 Piessevaux, H............ 102, 178, 182 Pietrareanu, C...................116, 217 Pietri, O.................................. 181 Pietruszka, P............................135 Pigò, F.................................... 228 Pigrau Pastor, M....................... 57 Pigrau, M................................. 57 Pilati, P............................192, 228 Pilipenko, V.............................156 Pillay, L...................................128 Pillet, S...................................185 Pilotto, A................................ 248 Pilotto, V.........................203, 249 Pilozzi, E.................................199 Pilutti, C..................................166 Pimentel-Nunes, P..... 124, 132, 227 Pin, N...........51, 144, 224, 227-228 Pina, S................................... 208
357
UEG Week Final Programme : Index of Authors and Co-Authors
Pina-Cabral, J......................... 256 Pinazo Martínez, I. L................158 Pineda, M................................ 63 Piñerúa Gonsálvez, J. F....................... 183, 233, 246 Pinese, E.................................122 Pineton de Chambrun, G............................76, 139, 185 Pinheiro, H.............................. 147 Pinho, J.............. 207, 224, 227-228 Pinho, R.............131, 209, 228, 235 Piñol, V.................................... 63 Pinto Marques, P.............159, 180, 209-210, 230 Pinto-Lopes, P......................... 187 Pinto-Pais, T.................... 224, 227 Pinto, E............................159, 232 Pinto, H. C.............................. 208 Pinto, J...................... 84, 128, 166, 180, 229, 256-257 Pioche, M............. 52-53, 100, 132, 151, 177-178, 247 Pipino, C................................ 254 Pique Becerra, R.....................120 Pires Caldeira, A. I. L.............. 180 Pires, M................................. 208 Pires, S.......................52, 132, 177, 179, 224 Piri, D.................................... 235 Pirogov, S............................... 248 Pironi, L..................... 87, 100, 256 Pirozzolo, G.......................76, 250 Pirvulescu, I............................ 116 Pisana, V................................ 239 Pisani, A........................... 96, 130 Piscaglia, F..............................168 Pischke, S.......................... 39, 229 Pita, I................................ 117, 138 Pitanga-Lukashok, H...........49, 174 Pither, C..................................156 Pizarro Moreno, Á. E....63, 84, 128 Pizarro, T. T.............................188 Pizzi, M............................181, 203 Pizzicannella, M...................... 181 Planchais, J........................57, 134 Planche, K............................... 131 Planell, N................................. 97 Planella-de Rubinat, M........... 246 Plastaras, L................ 73, 185, 234 Plat, J......................................170 Platzer, R................................ 137 Plaza Roig, P...........................125 Plesa, A................................. 254 Pleskow, D........................ 93, 251 Plevris, J. N................. 72, 131, 230 Plotogea, O. M.................. 181, 229 Pluchino, D......................238-239 Plumb, A.........51, 60, 107, 143, 247 Plut, S...................................... 79 Poc, K.....................................221
358
Pochapin, M. B.........................69 Pochard, C............................. 234 Pockros, P................................. 91 Poddar, U................................ 157 Podhola, M.............................251 Podmanicky, D........................ 235 Poh, B. Y.................................156 Pohl, D......................... 39, 55, 74, 195, 206 Pohl, M.................................... 92 Poincloux, L.................... 222, 225 Pojoga, C..................172, 222, 230 Pokojova, E.............................149 Polak, L...................................193 Polak, W.....................120, 169-170 Polaka, I........................... 173, 251 Polanco, I.................................64 Poley, J. W........................120, 251 Poliani, L..................222, 224, 244 Pollán, M................................143 Poller, D...................................99 Pollinger, K...................... 116, 214 Polte, S. C. H...........................164 Pomej, K.................................. 51 Pompili, M....................... 215, 218 Ponce, M.............. 63, 84, 128, 245 Poncet, G................................ 132 Ponchon, T.......36, 48, 53, 67, 100, 106, 177-178, 229 Pongpirul, K............................ 177 Poniewierka, E....................... 240 Poniewierska-Baran, A............. 78 Ponkina, O.............................. 118 Ponkratova, N..........................221 Ponomarev, A......................... 248 Ponsioen, C. Y...............72-73, 239 Ponte, A.....................116, 131, 138, 209, 228, 235 Pontén, I................................ 244 Pontisso, P............................... 114 Ponziani, F. R.................. 218, 256 Poo, S.....................................189 Pop, C. S................................. 167 Pop, E......................... 46, 52, 217, 233, 244 Pop, L............................... 68, 157 Popescu, A................ 157, 168, 170, 214, 216-218 Popescu, C. P........................... 167 Popescu, M.............................165 Popescu, S. A............ 157, 168, 170, 214, 216-218 Popov, V................71, 153, 216, 219 Popova, O............................... 232 Popovic, D...............................165 Popowicz, A........................... 232 Popp, A.................................. 254 Poprom, N.............................. 133 Poropat, G................................59 Portal, C..................................231
Porte, R. J................................. 93 Portella, G...............................216 Portillo, S................................210 Portillo, V................................210 Portillo Villares, I............... 84, 128 Portune, K................................ 73 Porzionato, A...... 86, 141, 192, 200 Posada Restrepo, A.................125 Posch, W.................................. 70 Potamianos, S. P..................... 245 Potter, M.................................155 Pouderoux, P............................ 76 Poulin, L. F............................... 57 Poullenot, F.............................188 Pourhosseingholi, M. A...........154 Pouw, R. E..................76, 173, 249 Poves, C................................... 63 Powell, A...........183, 196, 232, 252 Powles, S. T. R........... 184-185, 233 Poza Cordon, J.........................188 Pozzan, C......................... 119, 190 Pozzetto, B..............................185 Pozzi, R...................................120 Prakash, G................ 159, 188, 197 Prakash, J...........................78, 221 Pranculis, A............................. 115 Pranzo, G................................189 Prasad, K................................ 187 Prasad, Y................................ 240 Prasada, R........................ 171, 187 Prasnikar, N............................. 92 Prat, F............ 53, 62, 127, 129-130, 177-178, 181, 221, 228, 230, 247 Prawiradiradja, R................... 246 Preda, C. M......................167, 208 Pressman, S............................189 Preston, S. L............................150 Pretet, J.-L.............................. 234 Prevoo, W................................. 93 Pribic, T..............................57, 145 Pribolšan, L.............................183 Priestley, S........................58, 243 Priestnall, L.............................182 Prieto, J....................................117 Prieux-Klotz, C................... 93, 168 Prifti, S....................................149 Principi, M............... 150, 154, 166, 189, 203, 240 Prinzi, N................................. 223 Privat, J.................................. 222 Privitera, A. C............189, 238-240 Probert, C...................61, 156, 190 Probst, S.................................. 92 Proca, D.................................. 167 Procopet, B. D....................64, 73, 166, 217, 256 Procter, H................................ 132 Proença, L..................116, 131, 138, 228, 235
Prohic, D.................................169 Prost, C.................................. 234 Protchenkov, M........................ 132 Protopapas, A.........................126 Prudnikova, I.................... 114, 144 Prudnikova, Y. I.......................144 Prybytko, I...............................155 Prylutskyy, Y........................... 238 Prysiazhniuk, A.......................134 Przybylska-Feluś, M................ 204 Przytulski, K.......................77, 104 Psychos, A. K.......................... 245 Ptak-Belowska, A.....................85 Pudzianowski, S..................... 235 Puente, J. J............................. 245 Puga-Tejada, M..................49, 174 Pugliese, D................. 75, 239-240 Pugliese, F....................... 220, 229 Puhalović, A............................169 Puig, O....................................196 Puig-Divi, V.............................241 Pujada, A................................. 70 Pujari, R.............. 99, 223-224, 249 Pukitis, A.......................... 72, 220 Pullan, R................................ 225 Pullmann, D............................126 Pulsombat, A..........................148 Puolanne, A.-M.......................138 Purchiaroni, F......................... 226 Purkayastha, S.........................155 Purushothaman, R.................. 208 Pusceddu, S........................... 223 Putter, H...................................85
Q Qi, R........................................ 52 Qi, X........................................ 52 Qi, Z............................... 224, 227 Qian, D.................................... 121 Qian, J.....................................199 Qian, Y.............................143, 202 Qiang, Z..................................145 Qin, W..............................125, 201 Qiu, X.....................................134 Quader, F.................................247 Quadros, A. C................... 159, 210 Quaia, M.................................192 Quan, Y..............................57, 193 Quante, M...............................193 Quehenberger, P....................... 51 Queirós, P................215, 228, 236, 241, 255 Quentin, V...............................185 Qui, T. B................................. 239 Quinlan, J............................... 242 Quintero Carrion, E........... 84, 128, 153, 235, 245 Quirke, P.................................. 70 Quondamcarlo, C.....................194
Index of Authors and Co-Authors : UEG Week Final Programme
R Rábai, K.................................. 179 Rabb, N.................................. 132 Rabbitt, L................................164 Rabbitt, P.................................90 Rabekova, Z..................... 148, 174 Rabeneck, L.................54, 66, 143 Rabini, S.................................247 Rabitsch, C..............................215 Radaelli, F.............................. 228 Radice, S................................. 137 Radomski, T............................231 Radu, C............................ 215, 217 Radulovic, K............................. 70 Radwan, M. I.......................... 178 Raeburn, A..............................247 Raedler, K...............................193 Rafat, M. N..............................136 Raftopoulos, S......................... 177 Ragheb, A...................... 67, 73, 81 Ragino, Y. I..............................122 Ragunath, K...... 40, 54, 64, 72, 76, 87, 173, 177, 225, 231 Rahal, D................................. 222 Rahman, F............98, 125, 191, 256 Rahmi, G...............72, 151, 173, 229 Rai, R. R.................................. 52 Raijman, I................................ 62 Raimondo, M.............. 93, 127, 129 Raine, T...............................36, 75 Rainer, F........................... 101, 216 Rainteau, D..................... 206, 241 Raithel, M................. 128, 148, 196 Rajapakshe, N.........................135 Rajar, P.................................... 79 Rajasekhar, P. T........................89 Rajendra, S.............................150 Rajendran, A.....................89, 226 Rajilic-Stojanovic, M..... 50, 56, 90 Rakonczay, Z...............120, 170-171 Raksha, A. P............................158 Raluy Callado, M.............. 141, 188 Ramalho, F.............................. 167 Ramalho, M............................158 Ramalho, R.............................196 Ramas, M...........................77, 104 Ramasubramoni, A................. 225 Ramchandani, M........148, 156, 181 Rameshshanker, R.......89, 131, 226 Ramió-Pujol, S........................237 Ramirez, D..............................233 Ramirez, F...............................210 Ramirez, G..............................139 Ramiro, R. S............................ 114 Ramon y Cajal, T....................... 63 Ramos, A.........................228, 241 Ramos, E. F............................ 208 Ramos, F............. 125, 128, 175, 178 Ramos, G............................... 258 Ramos, J......................... 188, 209
Ramos, L..........................235, 241 Ramos-Zabala, F.........128, 175, 178 Rana, F.................................... 119 Rana, S. S.............................. 220 Ranaldo, N..............................150 Ranasinghe, A. G.....................164 Ranazzi, G...............................199 Randall, C...............................140 Randell, E.............................. 242 Rando, M. M...........................166 Rangel, I.................................146 Rantanen, T..............................85 Rao, A.................................... 230 Rao, B............................... 58, 122 Rao, G. V................................. 181 Rao, S..................... 40, 59, 81, 88 Rapaccini, G............................155 Rapaccini, G. L.... 75, 168, 218, 239 Rascarachi, G.......................... 137 Rasch, C................................... 53 Raselli, T..................................86 Rasmussen, H. H.................... 256 Rass, H.................... 183, 233, 246 Ratajczak, M. Z......................... 78 Rath, E....................................134 Rath, S....................................138 Rath, T......................... 55, 79, 127 Ratiu, I. M...............................216 Ratnakumaran, R. P.......... 188, 197 Ratone, J. P.................152, 169, 172 Rattan, A................................200 Ratziu, V.......................48, 75, 86 Rauwers, A. W......................... 179 Rauws, E. A. J.................... 93, 169 Ravasio, R.............................. 238 Ravaux, A................................154 Ravelli, A................................190 Ravelli, P........................... 62, 130 Rawa, T.................................. 240 Raza, A.................................... 62 Rázga, Z........................... 120, 170 Razumov, A.............................135 Rea, M............................ 150, 238 Rea, R................. 181, 217, 225-226 Read, M..................................150 Realdon, S......................200, 223 Reassens, J..............................219 Reati, R............................225-226 Rebiha, A................................188 Rebours, V.......66, 76, 80, 106, 171 Redaelli, A. E..........................156 Redaelli, D.......................225-226 Reddy, D. N..................49, 60, 69, 148, 156, 170, 181 Reddy, P. M............................. 181 Reddy, S. R..............................190 Redero Brioso, L.......................64 Reding, T.....................102, 170-171 Redondo Cerezo, E............178, 197 Redondo-González, O..............149
Reenaers, C................ 79, 186, 190 Rees, C. J..................... 72, 89, 175 Rees, D...................................233 Reeves, H................ 48, 54, 75, 86 Reggiani, P..............................130 Regula, J.........50, 63, 91, 240, 245 Rehbehn, K.-U........................140 Rehman, A..............................138 Reiberger, T..........51, 100, 104, 132 Reichert, M. C.........................146 Reicht, G................................. 137 Reider, S. J............................... 70 Reig, M.............................. 55, 95 Reignier, J............................... 121 Reimers, B.............................. 137 Reims, H. M.............................56 Reimund, J.-M......................... 83 Reinartz Groba, S....................215 Reinhard, A............................ 248 Reinhardt, H. C......................... 78 Reinisch, W.................. 49, 56, 67, 79-80, 83, 101-102, 136, 139-141, 189 Reis, D............................. 173, 257 Reis, J............................. 209, 237 Rejchrt, S......................... 241, 251 Rembacken, B................... 46, 84, 98, 114, 207 Remédio, F............................. 258 Remedios, D............................144 Remes-Troche, J. M..............60, 81 Ren, H. X................................ 133 Ren, J..........................114-115, 216 Ren, Z..............................125, 201 Reñé-Espinet, J. M.................. 246 Rengarajan, A................... 69, 148 Reni, M.................................. 242 Renman, P...............................183 Renna, S.............. 97, 185, 237-239 Repetto, O...............................153 Repici, A..................... 37, 60, 101, 103-104, 119, 129, 136, 156, 219, 222, 224, 228, 230, 244 Repiso Ortega, A..................... 178 Repp, M................................... 53 Repsilber, D............................103 Requile, M............................. 204 Rescigno, M............................ 116 Reszec, J.................................. 78 Reviglio, C. C. S. O...................189 Rey, E...... 64-65, 148, 174, 198-199 Rey, J. W...................................69 Reyes Larriba, M. J..................125 Reyes, J............................125, 194 Reymond, M...................... 83, 186 Reynolds, L.............................164 Rezgui, G................................ 181 Rhazi, L.................................. 204 Rhee, P.-L...............................150
Ribeiro Jr., U......194, 201, 231, 258 Ribeiro, H.....84, 128, 158, 166-167, 173, 180, 210, 225, 256, 258 Ribeiro, M...............................195 Ribeiro, R................................ 178 Ribes Koninckx, C.....................64 Ribichini, E............................ 244 Ribiere, S................................ 127 Ricanek, P.............................. 236 Riccardi, L........................ 215, 218 Ricci, C............................ 189, 240 Ricciardelli, C..........................189 Ricciardiello, L.................... 58, 66 Riccioni, M. E..........................215 Riccò, M....................196, 199, 202 Richard, M. L............................ 57 Richards, B............................ 243 Richards, E............................. 246 Richards, S. M.......................... 97 Richmond, E............................ 87 Richter-Schrag, H.-J................. 147 Rickenbacher, A.................86, 233 Ridge, A..................................138 Rieder, F................................. 239 Riedl, F.................................... 132 Riegler, G...........................97, 185 Rieker, R. J..............................196 Riemann, J. F...........................126 Riera-Ponsati, M.....................143 Riestra Menéndez, S................185 Riestra, S........................ 185, 235 Rift, C. V..................................122 Rigato, P................................ 228 Rigo, A............................. 187, 189 Rigter, L. S..............................192 Rimmani, H. H......................... 52 Rindom Krogsgaard, L..............58 Ringström, G..............90, 176, 244 Rinja, E................................... 181 Rinninella, E...........................218 Rios, E....................................210 Riphaus, A....................... 126, 175 Risnes, L. F...............................56 Rispo, A...... 64, 189, 205, 235, 238 Rist, F...................................... 175 Ritis, K....................................134 Ritter, J.............................. 89, 139 Rivas, L.................................... 63 Riveline, J.-P............................156 Rivera Irigoin, R...............170, 220 Rivera-Bermudez, M................145 Rivero Sánchez, L...............63, 178 Rivero Tirado, M......................185 Riverso, M. B........................... 151 Rivière, P..................................56 Rivory, J......... 53, 100, 132, 177-178 Rizopoulos, D...................151, 200 Rizvanov, A............................ 234 Rizza, S........................... 158, 258
359
UEG Week Final Programme : Index of Authors and Co-Authors
Rizzo, A............................. 96, 143 Rizzo, G. L.............................. 203 Rizzo, L. V................................184 Rizzuto, G........................ 237-238 Ro, S.......... 56, 60, 69, 116-117, 127, 137, 139, 148, 157, 165, 171, 188, 194, 196-197, 206, 218, 221, 234, 247 Roberti, M. F...........................199 Roberts, A.............................. 232 Roberts, K...............................139 Robertson, D...........................143 Robin, F..................................129 Robinson, A. M............ 47, 49, 80, 101-102, 136, 139 Robinson, J.................89, 139, 192 Robinson, K............................189 Robinson, R. J.........................192 Robinson, S..............................171 Robledo Andrés, P........... 185, 235 Robles-Diaz, G..........................71 Robles, C................................251 Robles-Medranda, C...........49, 174 Roblin, X....75, 79-80, 135, 185-186 Robu, G. C...............................237 Rocco, A................................. 203 Rocco, P................................. 203 Rocha, M................... 52, 139, 175, 178, 210, 257 Rochberger, S...........................69 Röcken, C............................... 206 Rodella, L................................130 Rodiño Janeiro, B. K................. 57 Rodrigo, L..........................77, 104 Rodrigues, A.............131, 139, 228, 257, 235 Rodrigues, B........................... 167 Rodrigues, C. G.......................237 Rodrigues, C. M. P..... 114, 164, 169 Rodrigues, J...............116, 131, 138, 208-209, 217, 235, 258 Rodrigues, J. P................. 228, 235 Rodrigues, M. S.......................139 Rodrigues, N.......................... 209 Rodrigues, P. M......... 114, 164, 169 Rodrigues, S.................... 117, 139, 165, 196, 218 Rodrigues-Pinto, E.... 117, 120, 122, 196, 209, 231 Rodríguez, A.....................140, 175 Rodriguez, C...... 152, 185, 194, 231 Rodriguez, G. E...................... 235 Rodríguez, L..................... 173, 189 Rodríguez, S..................... 127, 137 Rodriguez, Y........................... 235 Rodríguez de Miguel, C........................................231 Rodriguez Garcia, M. I.............154 Rodriguez Moranta, F...........63, 97
360
Rodriguez Tellez, M.......... 125, 178 Rodríguez-Alcalde, D................ 63 Rodriguez-Alonso, L................196 Rodríguez-Artalejo, F...............185 Rodríguez-Gil, Y...................... 127 Rodriguez-Herrera, A........ 56, 157 Rodriguez-Justo, M........... 149-150 Rodriguez-Moranta, F..............196 Rodríguez-Muñoz, S................ 127 Rodriguez-Nicolas, A................171 Rodriguez-Oballe, J. A......170, 220 Rodríguez-Pascual, J...............128 Rodríguez-Pescador, A.............140 Rodríguez-San Pedro, L...........189 Rodriguez-Sanchez, J..............153 Rodríguez-Soler, M..........143, 245 Rodriguez-Ulloa, C..................152 Roelens, K............................... 133 Roelofs, J. J. T. H....................... 92 Roelsgaard, K..........................190 Roesink, J. M...........................192 Rofes, L.............................90, 149 Rogai, F.......................97, 185, 190 Rogger, T. M........................... 209 Rogler, G..................... 86, 97, 184, 233-234, 239 Rogoveanu, I........................... 116 Roine, A...................................85 Rojas Galarza, R..................... 204 Rojas-Perez, P.........................152 Rokkas, T............................77, 104 Rolim, F..................................194 Rolland, C................................ 92 Rolland-Fourcade, C................. 92 Rolli-Derkinderen, M.............. 234 Roma, M.....165, 174, 203, 206, 251 Romain, O........................ 128, 181 Roman, S.......... 37, 40, 69, 75, 80, 88, 148, 197, 247 Romanciuc, F...........................215 Romańczyk, T..........................140 Romano, A.......................155, 166 Romano, C................135, 190, 238 Romano, M............... 165, 174, 203 Romanova, T. I........................122 Romberg Camps, M.......... 102, 187 Romeo, S........................ 188, 234 Romero, C................ 186, 190, 240 Romero Gómez, M...................139 Romito, M. R.......................... 203 Römkens, T. E. H.................... 235 Rommel, N............ 40, 88, 113, 198 Römmele, C........................... 205 Romosan, I............................ 224 Ron, Y..................................... 131 Roncales, M. P........................ 245 Roncoroni, L........................... 254 Rondonotti, E..................... 72, 131 Roni, K................................... 243 Ronkainen, J. M.........................71
Rönnow, C.-F.......................... 228 Ronzoni, M............................ 242 Roos, E................93, 120, 170, 219 Roosenboom, B...................... 256 Roque, R................................ 222 Rosa, B. J. F............................ 230 Rosa, I............... 145, 178, 185, 188 Rosa, R............................130, 242 Rosa-Rizzotto, E...............192, 228 Rosati, L................................. 230 Rosati, R........ 80, 87, 104, 107, 242 Rösch, T.....53, 75-76, 101, 150, 229 Roscio, F.................................. 133 Rose, A............. 46, 61, 71, 85, 190 Roseira, J........................215, 228, 236, 241, 255 Rosenberg, L............................56 Rosendahl, J.............. 46, 71-72, 85 Rosenstiel, P.................85, 89-90, 96, 135, 138 Rosinach, M.............................56 Roslan, E. J.............................120 Rosmorduc, O...................55, 106 Rosner, G.................................85 Ross, D....................................145 Rosseto, E. A...........................184 Rossi, A...................... 97, 185, 206 Rossi, G................................. 230 Rossi, G. E...............................130 Rossi, M.......................... 156, 230 Rossi, P...................................143 Rössler, A................................138 Rostami-Nejad, M...................154 Rostami, K..............................154 Rotaru, M. I............................. 217 Roth, H...................................126 Rothfuss, K..............................231 Rotimi, O................................237 Rotondi Aufiero, V................... 133 Rotondo, A...............................65 Rotter, I....................................59 Roug, S...................................221 Roul, M...................................154 Roumans, C. A. M.............151, 200 Rouquette, A.......................... 230 Rouquette, O.......................... 225 Rousseau, H........................... 235 Rouvelas, I...................... 132, 200 Rouwet, E. V........................... 255 Roviello, F............................... 147 Rozendorn, N.......................... 137 Rubenstein, J. H....................... 87 Rubin, D. T....................... 141, 190 Rubin, G.................................107 Ruchkina, I................. 138-139, 184 Rucktaeschel, F........................183 Rudatis, M..............................231 Rudzite, D................ 235, 240, 251 Rueffer, A......................... 187, 190 Ruemmele, F. M.......................56
Ruess, D. A. A....................78, 122 Ruffa, A.......................97, 185, 188 Ruffert, C.................................46 Ruffini, M................................ 121 Ruffle, J. K............................... 197 Rugge, M.............. 86, 89, 97, 196, 198-200, 202-203, 223, 234, 248-249, 252 Ruhs, C...................................237 Ruiter, R...................................85 Ruiz, A.............. 143, 148, 184, 194, 198-199, 233 Ruiz, F. A.................................143 Ruiz, P. A...................184, 217, 233 Ruiz Cerulla, A........................196 Ruiz-Cabello, F.........................171 Ruiz-Castro, P. A......................233 Ruiz de León, A......... 148, 198-199 Ruiz-Rebollo, M....... 170, 220, 229 Rullan, M................................ 178 Rumyantseva, D...................... 248 Rundquist, S...........................189 Rune Stensvold, C....................58 Runggaldier, D....................... 206 Rupinski, M............................ 245 Rupniewska, E........................189 Rusanov, D.............................. 132 Rusnakova, V...........................143 Russell, A. K.............................56 Russell, R. K.............................56 Russo Raucci, A...................... 242 Russo, G.................................. 97 Russo, M. I.............................. 174 Russo, N.................................140 Russo, P................................. 258 Russo, S............................96, 230 Rustamova, M......................... 157 Rusu, I......................172, 230, 256 Ruszniewski, P..........................171 Rutenberg, J............................155 Rutgeerts, P................. 56, 80, 136 Rutka, M................... 83, 136, 228, 234, 238, 240 Rutter, C..................................156 Rutter, M........ 48, 94, 175, 178, 225 Ryabin, N................................ 118 Ryan, B..................... 126, 137-138, 140, 186, 254 Rybak, A...........................65, 236 Rybalchenko, V....................... 238 Rydzewska, G......................... 240 Ryffel, B................................... 57 Ryhlander, J............................ 176 Ryoma, M............................... 118 Rysevaite-Kyguoliene, K............ 78 Ryu, C. B......................... 224, 227 Ryu, D. G...........................126, 131 Ryu, J. K..............102, 121, 130, 169 Ryu, K.................102, 121, 130, 169 Ryu, S. W................................201
Index of Authors and Co-Authors : UEG Week Final Programme
S Sá, A.......................... 63, 158, 198 Saad, H. M..............................136 Saadat, S................................ 217 Saadeh, L. M............ 182, 200, 232 Saba, J....................................216 Sabado, F................................ 178 Sabagh, L. C............................183 Sabbah, M.......................228-229 Sabbek, A...............................168 Sabelnikova, E.........................155 Sablich, R.............................. 240 Sabri, H................................. 246 Sacchi, M. C............................155 Sacco, R........................... 168, 177 Sacharczuk, M.......................... 79 Sachi, N..................................134 Sadeghian, J........................... 250 Sadek, A................................. 119 Sadoogh, A............................ 203 Sadr-Azodi, O...........................59 Saeb-Parsy, K...........................59 Sáenz, M. Á............................200 Saez-Royuela Gonzalo, F..........139 Saez, E.....................................117 Safadi, B.................................. 52 Safatle-Ribeiro, A. V..................... 194, 201, 258 Saffouri, G......................... 57, 206 Safina, D. D.............................. 77 Safroneeva, E...................101, 248 Sagatova, M............................153 Sagawa, T................................ 51 Sahar, N.................................. 151 Sahin-Toth, M..................... 46, 59 Sahin, M..................... 46, 59, 236 Saia, M......................171, 192, 228 Saibeni, S................ 225-226, 240 Saida, Y...................................144 Saidkhanov, B. A.....................183 Saidkhanova, D. B...................183 Saif, S......................................117 Saiki, H...............................51, 53 Saikia, A. K.............................219 Saini, N...................................196 Saiote, J................... 159, 209, 258 Saito, D...................................140 Saito, E.................................. 236 Saito, H.................................. 222 Saito, I............................. 142, 151 Saito, K................. 95, 119, 191-192 Saito, M............................ 136-137 Saito, S..................... 114, 144, 167, 175, 209, 257 Saito, T................133, 147, 182, 202 Saito, Y..... 78, 84, 89, 133, 145, 228 Saitoh, Y............................ 191-192 Sakae, H...........................151, 175 Sakaguchi, H...........................251 Sakaguchi, M...........................65
Sakaguchi, Y.............. 151, 205, 251 Sakai, A..................................170 Sakai, C. M..............................126 Sakai, P...................................126 Sakai, T................................... 179 Sakai, Y............................ 144, 167 Sakaida, I.........................219, 222 Sakaki, N................................124 Sakakibara, Y...........................153 Sakamoto, A............................ 167 Sakamoto, C........................... 254 Sakamoto, E............................144 Sakamoto, H...................... 68, 89 Sakamoto, K.............................86 Sakamoto, N.................... 53, 123, 128, 131, 151 Sakamoto, T...................... 78, 142 Sakao, M.................................. 62 Sakata, K.................................231 Sakata, Y.......147, 174, 187, 193, 234 Sakaue, T............................... 180 Sakemi, R................................69 Sakita, S.......................... 203, 241 Sakitani, K..............................198 Sakizlis, G...............................124 Sako, T....................................251 Sakuno, T................... 122, 172, 181 Sakuraba, A............................140 Sakurai, K............................... 179 Sakurai, T......89, 152, 201, 252-253 Sakuyama, N...........................145 Saladino, V..............................156 Saladzinskas, Z......................... 78 Sałaga, M................................184 Salah, A.................................. 118 Salah, M...........................117, 220 Salah, S.......................... 188, 253 Salameh, J..............................186 Salamon, A................ 83, 136, 234 Salas, A................................... 97 Salazar, E................................156 Salazar, R................................107 Salces, I................................... 63 Saldaña Dueñas, C.......... 229, 257 Salem, A............. 119, 136, 138, 183 Salem, M. A..................... 136, 183 Salem, O. E.............................136 Salerno, R........................156, 239 Salgado-Fernández, M........... 245 Salgado, M................ 175, 210, 245 Salgueiro, P. S.........................210 Saliakellis, E............................65 Salih, M........................... 129, 217 Salimon, M....................... 93, 168 Salinas, A.........................183, 233 Salizzoni, M............................130 Sallinen, V.............................. 220 Salloum-Cojocariu, E.-C......... 256 Sallum, R. A. A........................231 Sally, Z................................... 243
Salman, Z...............................194 Salmon, I................................192 Salmoral, R.............................153 Salomone Megna, A................ 119 Salteniene, V.................91, 115-116 Salupere, R................ 96, 135, 185 Salvador, E.............................. 115 Salvador, J...............................164 Salvador, P......... 134, 233-234, 252 Salvador, R................233, 247-248 Salvia, R..................................183 Salvo Romero, E....................... 57 Samaha, E........................ 151, 229 Samama, J........................ 50, 176 Samanta, J........................ 171, 187 Samanta, S..............................193 Samarghitan, A...................... 230 Sambaiah, P............................ 119 Sambuelli, A. M..................... 238 Sami, S.................................... 41 Samlani, Z............................. 253 Sammarco, R.......................... 235 Sampath, K..............................99 Sampaziotis, F..........................59 Samsom, K............................... 93 Samsonova, T. V...................... 187 Samuel, S................................ 72 Samyn, M................................ 191 San Juan Acosta, M. E............. 225 San Juan, M............................ 177 San, L...................71, 117, 122, 153, 181, 209, 237 Sanaei, O.......................... 62, 103 Sanagapalli, S.........................247 Sanborn, W. J........................... 47 Sánchez, A. B........................... 63 Sanchez, C.......................194, 222 Sánchez, J........................ 128, 231 Sanchez, S............................. 222 Sánchez García, A..................... 63 Sanchez Mete, L..................... 226 Sánchez Pernaute, A................198 Sanchez Yague, A...... 125, 175, 180 Sanchez-Contador, C................194 Sanchez-Lloansi, M.................139 Sánchez-Montes, C.... 128, 180, 231 Sanchez-Ocana, R....................99 Sanchez-Pastor, E....................196 Sandblom, G............. 120, 219, 232 Sandborn, W.......... 47, 61, 102, 136 Sandborn, W. J............. 47, 56, 80, 140-141 Sander, B. Q.................... 155, 206 Sander, M. P.................... 155, 206 Sanders, D. S................. 39, 53, 64 Sandler, R................................ 78 Sandoval-Rodriguez, A............ 116 Sandru, V.................. 181, 229, 231 Sands, B. E........................ 56, 102 Sanduleanu, S.............69, 143, 176
Sandulescu, L. D......................216 Sanduzzi Zamparelli, M...........218 Saner, C................................. 248 Sanga, K.................................169 Sanguinetti, M........................103 Sanjuan, X............................... 97 Sanni, L..................................122 Sano, I.................................... 131 Sano, K.............................147, 174 Sano, T.......................122, 133, 182 Sano, Y..............................126, 151 Sanomura, Y............................ 151 Sansoè, G................................ 119 Sansone, S....................... 177, 225 Santacatterina, M....................247 Santamaria, E..........................117 Santana Rocamora, E........ 84, 128 Santander, C......................97, 136 Santantonio, T................... 117, 167 Santare, D...............................193 Santi, G...................................130 Santi, S....................................69 Santiago, J..........125, 178, 227, 245 Santo, E............................ 85, 155 Santolaria, S...........................153 Santos, A........ 89, 91, 114, 117, 258 Santos, J.....................57, 165, 168, 201, 209, 244, 248 Santos, L....................117, 209, 237 Santos, M. P.....................233, 237 Santos, P................... 158-159, 173, 221, 225, 237, 257 Santos, P. M............................237 Santos, S.........................209, 258 Santos-Antunes, J............165, 168, 201, 209 Santos Fernandez, J................ 248 Santos-Laso, A....................91, 117 Sanui, M...........................120-121 Sanz, Y..................................... 73 São José, C.............................. 147 Saoula, H.........................185, 257 Saperas Franch, E...............63, 178 Sapienza, C.............................237 Saracco, G.............................. 180 Sarafian, M....................... 70, 134 Sarafov, S................................159 Saray, A..................................169 Sargur, R.................................189 Saribegioglou, N.................... 230 Sarici, B..................................170 Sarigianni, M...........................49 Saripoulos, P...........................159 Sarkar, A.................................. 62 Sarkar, S................................ 222 Sarlós, P.......................... 220, 234 Sarmento, J. A.........................195 Sarna, V. K...............................56 Sarter, H............................76, 135 Sartor, R. B...............................71
361
UEG Week Final Programme : Index of Authors and Co-Authors
Saruc, M.................................215 Saruta, M..................201, 252-253 Sasahira, N..............................95 Sasai, K.................................. 222 Sasajima, J.............................. 172 Sasaki, E...........................147, 174 Sasaki, F........................... 121, 186 Sasaki, H................................ 250 Sasaki, K................................ 258 Sasaki, M.................. 120-121, 126, 137, 172-173 Sasaki, R................................. 179 Sasaki, Y...........................194, 241 Sasanuma, S............... 72, 131, 243 Satarasinghe, R. L...................158 Sato, C....................................124 Sato, D.................................... 177 Sato, H.............................103, 180 Sato, S............................. 132, 198 Sato, T...................95, 116, 119, 145 Sato, Y............ 51, 103, 129, 152, 191 Satokari, R..............................241 Satou, D..................................201 Satsangi, J........... 101-102, 139, 236 Sattianayagam, P.................... 207 Sauer, V..................................215 Saunders, B. P....................48, 81, 106, 211, 226 Saunders, J.............................145 Saunders, R.................... 126, 245 Saurin, J. C..................72, 100, 132 Sautel, C.................................. 83 Sautereau, D.........53, 177-178, 232 Sauvanet, P..............................85 Sav, R..................................... 217 Savale, C................................ 229 Savarino, E............ 68-69, 88, 100, 148-150, 187, 189, 191, 198-200, 203, 237, 247-249 Savarino, V...........69, 149, 187, 191, 198-200, 237, 248-249 Saviano, A...............................218 Savoye, G...................... 75-76, 135 Sawada, M.............................. 119 Sawada, T......................... 136-137 Sawahara, H..................... 65, 168 Sawai, T..................................130 Sawai, Y.................................. 167 Sawano, H........................120-121 Sawhney, M...................... 93, 251 Sawiak, S.................................59 Saygılı, Ö................................215 Sazhin, A. V.............................158 Scacchi, G...............................156 Scaioli, E.................................. 78 Scaldaferri, F.......... 57, 72, 112, 188 Scandroglio, I.......................... 133 Scanzi, J................................... 83 Scapa, E...................................85
362
Scarpa, A............................... 223 Scarpa, M.......76, 86, 141, 182, 192, 200, 231-232, 250 Scarparo, J. I. B............... 155, 206 Scarpignato, C....146, 196, 198-199, 202, 248-249, 252 Scarpulla, G.....................238-239 Scatton, O................................ 62 Schachschal, G......................... 76 Schäfer, C................................231 Schäfer, E.........................234-235 Schäfer, M................................38 Schaffalitzky de Muckadell, O. B.......... 154, 250 Schaffner, D............................. 114 Scharl, M.............. 86, 97, 233-234 Schaubeck, M..........................134 Schellekens, A.........................165 Schemberk Jr., J...................... 206 Schembri, E. L..........................89 Schepp, W...............................158 Scherbaum, N......................... 175 Scherl, A.................................190 Scherzer, T.-M.........................215 Schett, G.................................170 Schiepatti, A........................... 204 Schierenberg, A.......................103 Schifano, G..............................231 Schildhauer, T. A..................... 178 Schindler, P............................. 116 Schindler, V............................ 206 Schlachter, S.......................... 249 Schlag, C..........................101, 248 Schlitzer, A............................... 70 Schlosser, S...................... 116, 214 Schlüter, F.............................. 232 Schmalenberg, H...................... 92 Schmerboeck, B............... 101, 216 Schmid, R. M..................224, 248 Schmidt, A................. 53, 120, 237 Schmidt, B........................ 57, 206 Schmidt, F.............................. 239 Schmidt, M. A.........................237 Schmidt, P. N...........................221 Schmidt, S................................58 Schmied, B.............................183 Schmiegel, W.......92, 175, 178, 225 Schmitt, A................................ 78 Schmitt, H................................ 79 Schmitt, M............................. 254 Schneider, M....... 102, 126, 187, 231 Schneider-Koriath, S..........133, 174 Schnittert, J........................78, 221 Schnúr, A.................................171 Schoen, R................................143 Schoenberg, M. B................... 232 Schoepfer, A..............101, 235, 248 Scholdei, M..............................171 Scholz, D.................................. 53 Scholz, M.................................46
Schöniger-Hekele, M............... 132 Schoon, E. J................. 72, 124, 173 Schoppmann, S...................... 249 Schorsch, T..............................183 Schoufour, J. D.........................48 Schramm, C.......... 61, 91, 146, 242 Schreiber, S............ 80, 83, 89, 96, 102, 138-140, 239 Schreuder, A. M.......................169 Schreuders, E..........................143 Schröder, J. O..........................138 Schroeder, A.......................... 254 Schroeder, S............................154 Schrotz-King, P.........................50 Schubert, S......................101, 254 Schuck, E................................140 Schuler, M................................ 92 Schultz, B................................126 Schulz, C................................. 116 Schumacher, B......................... 53 Schumann, M.........56, 61, 94, 254 Schuppan, D.............................56 Schürle, S...............................128 Schuster, B.............................. 132 Schuster, T............................... 187 Schwab, M............................... 72 Schwabl, P.........................51, 132 Schwartz, A............................. 131 Schwartz, D................ 96, 135, 185 Schwartz, N............................. 181 Schwarzinger, M...................... 101 Schwender, B. J............... 208-209 Schwerdel, D...........................193 Schwingel, G............................ 52 Scicluna, B.............................200 Scida, S..............146, 196, 198-199, 202-203, 248-249, 252, 255 Scirocco, A.............................. 147 Scolaro, M.............................. 238 Scott, M................................... 81 Scribano, M. L....................97, 185 Scrivo, B.......................... 187, 238 Scurry, B.................................148 Scutti, J...................................145 Sebastian, S...................... 61, 190 Sebestyén, A...........................143 Sebkova, L...............................189 Secher, T.................................. 57 Seclaman, E............................ 157 Sedda, S.................................143 Seddik, H............................... 253 Seeva, P................................. 235 Seewald, S........55, 66, 76, 88, 163 Segal, J............................185, 189 Segú-Roig, A...........................184 Segura, V................................ 157 Sehgal, V................................ 250 Seicean, A............116, 172, 216-217, 222, 230, 246 Seicean, R.................172, 222, 230
Seidler, U...........................47, 140 Seidner, D. L........................... 205 Seifert, B.........................242, 244 Sejpal, D. V.............................. 62 Seki, H....................................241 Seki, M...................................142 Sekiguchi, M...........................145 Sekizuka, T..............................134 Seksik, P............... 73, 137, 186, 206 Seleznik, G. M.............102, 170-171 Selinger, C...................47, 137, 188 Selinger, L........................140, 190 Sella, D...................................247 Sellitri, R................................ 206 Seltsam, K................................46 Selvendran, S. S......................155 Semela, D................................ 52 Semenova, I............................210 Semeraro, R............. 219, 224, 244 Sempere, L..............................140 Sempoux, C............................ 248 Semyachkina-Glushkovskaya, O........................................153 Sen-yo, M........................219, 222 Sen, I.... 64, 112, 114, 204, 236, 252 Senda, Y........................... 122, 182 Seno, H............................. 51, 144 Senz, J.................................... 147 Senzolo, M.............................. 116 Seo, A. N......................... 180, 230 Seo, D. W..........................131, 221 Seo, J. B...................................98 Seo, S...............................83, 252 Seoane, A......................... 84, 128 Seol, S. Y.................................150 Seonae-Mosteiro, C. S............ 252 Sepe, A...................................140 Serejo, F.............. 159, 167, 207, 257 Sergeev, O.............................. 232 Serhiychuk, T...........................184 Serio, M................................. 236 Serkova, M.............................. 119 Serone, A................................ 141 Serra Pueyo, J................... 65, 247 Serra-Pagès, M........................237 Serra, D................................. 230 Serra, K........................... 196, 255 Serra, M............................ 63, 237 Serraj, K................................. 255 Serrano Falcón, B....................148 Serrano, M..............................237 Serrão, G............................... 245 Serrero, M................................ 75 Sessa, A..................................216 Sestito, L.................................166 Sethi, A................................... 101 Setia, A.................................... 52 Setoyama, T.............................. 51 Seufferlein, T..... 38, 51, 68, 78, 93, 105-106, 120, 193, 211
Index of Authors and Co-Authors : UEG Week Final Programme
Seuwen, K..........................97, 233 Sevdalis, N...............................89 Sever, N..................... 79, 103, 121, 170, 212, 218 Severi, C................................. 147 Sevilla Mantilla, C............ 198-199 Sevo Spahiu, S........................125 Sevrin, G...................................71 Seward, E............................... 191 Sexton, V................................ 235 Sezgin, O................................ 203 Sezikli, M............................... 254 Sfarti, C...................................166 Sgambato, D................... 165, 203 Sgarro, C.................................189 Sha, W....................................136 Shachar, E......................... 69, 140 Shafazand, M.................... 177, 231 Shah, A.............. 62, 149, 204, 246 Shah, E. D....................... 196, 245 Shah, N. H...................... 129, 209 Shah, R...................................150 Shah, R. J.......................... 62, 145 Shah, Y....................................102 Shaheen, N. J.......................... 173 Shahini, E...............................166 Shahinyan, T........................... 157 Shaib, Y.................................... 52 Shaikh, F. K............................ 253 Shaini, E.................................189 Shalaby, S............................... 116 Shalaeva, O.............................241 Sham, P. C.............................. 202 Shamir, R.......................... 64, 154 Shan, H.................................... 72 Shanahan, E....................204, 246 Shanahan, F............................134 Shao, C...................................216 Shapina, M............................. 187 Shapira, S........................242-243 Shapiro, D................................ 91 Sharaan, M............................ 232 Sharaf, A. L.............................218 Sharara, A. I............................. 52 Shariati, F................................123 Sharkey, K. A...................... 50, 70 Sharma, A............. 52, 99, 121, 165 Sharma, D................................171 Sharma, K........................ 103, 178 Sharma, M.................. 99, 121, 130 Sharma, N........................142, 234 Sharma, P..........................87, 150 Sharma, R.............................. 220 Sharma, V...............................159 Sharp, L.................................. 175 Sharp, T.................................. 151 Shashkov, M. V........................144 Shaw, S...................................233 Shayto, R. H............................. 52 Shcherbakha, V. S....................257
Shcherbakova, A......................150 Sheard, J................................ 222 Sheehan, D.............................134 Shehata, M. A. H.....................153 Shehatta, A. S........................ 220 Sheibani-Tezerji, R..................135 Sheibani, R....................... 96, 135 Shen, S................................... 114 Shen, W................................. 104 Shen, Z..............................57, 193 Sheppard, D.............................86 Sheridan, J........................217, 251 Sherif, N. A..............................117 Sherman, S.................62, 145, 179 Shetty, S............................ 84, 125 Shi, D........................114, 175, 188, 194, 207, 218 Shi, H.................... 65, 69, 97, 121, 166, 168, 183, 223 Shi, N........................139, 151, 226 Shi, Q......................................201 Shi, R...... 77, 88, 122, 130, 152, 155, 172, 182, 187-188, 219, 234 Shiba, M.............79, 154, 200, 254 Shibamoto, A.......................... 167 Shibata, C...............................142 Shibata, M............................... 51 Shibata, T......................... 123, 144 Shibatoge, M................... 154, 254 Shibayama, K................... 172, 215 Shibuya, T........................ 119, 140 Shichinohe, T..........................182 Shidrawi, R.............................155 Shiffman, M............................. 91 Shifrin, O. S.............................257 Shigita, K................................142 Shili, S.....................................80 Shim, C. S................ 202, 252, 257 Shimada, K.............................182 Shimada, S............................ 254 Shimada, Y..............................198 Shimakawa, M........................ 114 Shimakoshi, H......................... 121 Shimamoto, F..........................144 Shimatani, M.............. 62, 84, 126 Shimaya, K....................... 118, 194 Shimizu, A..............................122 Shimizu, H............................... 97 Shimizu, R....................... 122, 130 Shimizu, T.................123, 169, 246 Shimizu, Y..................53, 122, 128, 133, 151, 182 Shimoda, A............................. 121 Shimoda, M.......................53, 173 Shimoda, R.... 77, 152, 187, 193, 234 Shimoda, Y................146, 193, 203 Shimodate, Y..................... 69, 146 Shimogama, T..........................117 Shimohara, Y..................... 69, 142 Shimosegawa, T............... 152, 197
Shimpoh, T..............................182 Shimura, T.......................142, 144 Shin, C. M.................. 152, 197, 251 Shin, D.............................188, 194 Shin, D. W........................ 143, 192 Shin, E. J..........................181, 230 Shin, H. D...............................194 Shin, J. E.................................194 Shin, J. S................................ 253 Shin, O.-R...............................219 Shin, S. J...........................132, 175 Shin, S. K................................ 174 Shin, W. C............................... 197 Shin, W. G............................... 173 Shin, Y. W........................ 223, 246 Shinji, Y..................................123 Shinkai, K...............................153 Shinkins, B............................. 226 Shinmura, K...................... 95, 201 Shinoda, S.......................219, 222 Shinohara, T..................... 122, 176 Shinozaki, S.............................68 Shintani, S..............................129 Shinzaki, S........................ 76, 188 Shiode, J......................... 209, 257 Shiomi, H................................170 Shiomi, Y.................................170 Shiraha, H.................. 65, 166, 168 Shirai, S................77, 187, 193, 234 Shirasaki, T.............................143 Shirazi-Beechey, S. P................ 52 Shirin, H...........................69, 252 Shirlow, K............................... 187 Shivaji, U................................142 Shiwaku, H.......................182-183 Shnell, M.......................... 69, 155 Shnitenkova, A........................153 Shoji, A...................................153 Shonova, O...................... 220, 242 Shousha, H............................. 118 Shpak, B..................................69 Shpigel, N. Y............................ 97 Shums, Z................................136 Shushunova, N........................153 Shutkever, O............................. 70 Shuwen, L.............................. 207 Shvets, O............................77, 104 Si-Salah, L..............................188 Si, G..................... 52, 82, 118, 162, 188, 207, 209, 215, 234 Si, J.....................116, 131, 138, 143, 170-171, 195, 201-202, 209, 228, 235, 251 Siau, K................114, 123, 125, 127, 182, 197, 223, 225-227 Sibley, C..................................156 Sica, G................................... 234 Sichijo, S..................................85 Sicília Aladrén, B.............. 139, 185 Siciliano, M...................... 215, 218
Siddique, I..............................135 Siddique, N............................. 151 Siddiqui, A. A.................... 62, 102 Siddiqui, M. A.........................216 Sidhu, M............................99, 177 Sidhu, R............................131, 231 Siegel, C.................................140 Siegmund, B..........43, 73, 81, 100, 239, 254-255 Siersema, P. D........ 55, 69, 76, 80, 88, 245, 248-249 Sifrim, D............47, 69, 73, 94, 101, 105, 247-248 Signorelli, S............................. 62 Signoretti, M..................... 85, 172 Silina, T. L...............................158 Siljander, P..............................193 Silva Junior, R. G.....................215 Silva, A........................... 207, 228 Silva, A. P.................209, 228, 235 Silva, F................................... 258 Silva, G. L. R............................126 Silva, H.................................. 209 Silva, J................116, 131, 138, 195, 209, 228, 235 Silva, J. C....................116, 131, 138, 209, 228, 235 Silva, K. T. P. E.........................189 Silva, M........ 116-118, 120, 130, 164, 173, 195, 208-210, 245 Silva, N.................................. 224 Silva, R.............. 126, 132, 180, 207 Silva, S..................................... 52 Sima, A...................................218 Simantov, R..............................69 Simão, A.......................... 214, 217 Simão, A. L.......................164, 169 Simão Ferreira, M...................159 Simas de Lima, M............ 194, 258 Simeone, P............................. 254 Siminkovitch, S........................221 Simioni, P................................ 116 Simionov, I.............................. 116 Simko, A................................ 248 Simmen, S.......................184, 233 Simmons, A........................... 235 Simões, C..........210, 225, 245, 258 Simon, D....................79, 143, 182, 248, 250 Simon, H.-U........................... 248 Simon, M..................... 73, 75, 185 Simon, P..................................171 Simon, V................................. 179 Simonelli, C............................103 Simrén, M..........46, 71, 77, 80, 90, 99, 141, 146, 149, 176, 244-245 Şimşek, H...........................77, 104 Simsek, M................................59 Singeap, A. M..............131, 166-167
363
UEG Week Final Programme : Index of Authors and Co-Authors
Singer, P................................. 256 Singh, A................................. 239 Singh, H..................................143 Singh, J...................................170 Singh, N..................................219 Singh, R...................... 58, 122, 177 Singh, S............................ 58, 122 Singh, V................................... 62 Singh, V. K...................71, 102-103 Sinha, A..................................135 Sinha, R.................................. 175 Sinha, S. K...........103, 171, 178, 187 Siniagina, M. N........................ 77 Sinkovec, H.............................227 Sipeki, N............................61, 136 Sipos, B................................... 78 Sipponen, T............................ 239 Siribumrungwong, B............... 133 Siringo, S.........................238-239 Sirli, R..........116, 168, 214, 216-218 Sitkin, S..................................241 Sivard, B.................................186 Siwiński, P...............................233 Six, A....................................... 57 Sjöblom, S.............................. 176 Skanderova, E........................ 220 Skendros, P.............................134 Skieceviciene, J............ 91, 116, 154 Skinazi, F.................................185 Sklyarov, E........................214-215 Skodje, G. I..............................56 Sköldberg, F............................143 Skolnick, B. E........................... 47 Skonieczna-Żydecka, K.............237 Skorokhodkina, O. V................ 234 Skouras, T....................... 222, 240 Skrickova, J..............................149 Skridlevskiy, S.........................210 Skroubis, G.............................241 Skrtic, A..................................257 Skrypnyk, I..............................165 Skuja, V........................... 235, 240 Skup, M............................ 49, 139 Slaman, A.............................. 250 Slavcev, A................................ 217 Sloan, S........................... 141, 188 Sloth, S....................................69 Slotta-Huspenina, J......... 193, 248 Slottje, M................................126 Slyskova, J...............................143 Smaastuen, M. C.....................237 Smajs, D.................................241 Småstuen, M. C.........................71 Smecuol, E.......................... 49, 61 Smedile, A........................ 117, 167 Smeets, X........................... 71, 121 Smid, A.................................... 79 Smit, W. L....................... 192, 242 Smith, A................................. 226 Smith, A. M..............................59
364
Smith, C..................................135 Smith, K. G...............................80 Smith, M...........................59, 246 Smith, S..............137, 140, 252-253 Smith, T..................................156 Smits, M. J. M..........................150 Smits, S..................................125 Smola, I................................. 240 Smoot Malecha, E.................... 91 Smout, A..................37, 73, 80, 90 Smrekar, N............................... 79 Snaebjornsson, P.....................192 Sneh Arbib, O........................... 91 Snel, C..................................... 92 Snijkers, J. T. W...................... 248 Snir, Y............................... 91, 230 So, I. T.....................................201 Soaita, A.................................. 47 Soares, E...................158, 210, 217, 223, 229, 256 Soares, J. B...............180, 183, 188 Sobhani, I..................50, 194, 243 Sobolewska-Włodarczyk, A........................................233 Socaciu, C...................73, 166, 215 Söderholm, J. D...................... 236 Soerjomataram, I..................... 87 Sofianidis, G......................62, 230 Sofuni, A................................ 222 Sogorb, T................................237 Soh, J. S..................................142 Sohn, K. M.......................158, 164 Soilleux, E.............................. 254 Sokol, H.............. 41, 46, 57, 77, 91, 105, 134, 139, 206 Sokoll, R................................. 187 Sokolova, A............................. 132 Sokolova, A. S.........................144 Sola Tapias, N.......................... 92 Soliman, G. M. M.................... 147 Soliman, H....................... 177, 228 Solito, S..................................122 Sollid, L...................................56 Soltys, K................................. 236 Solymosi, N............................ 229 Somani, P.................... 99, 121, 130 Son, Y. G.................................201 Soncini, M...............................156 Sonda, S..........................170, 220 Song, B.-C..............................159 Song, E. M................. 98, 175, 239 Song, K...................................169 Song, K.-H............................. 249 Song, K. Y......................... 142, 152 Song, S. Y.............122, 169-170, 172 Song, T. J...........................131, 221 Song, X...................................139 Song, Y....... 48, 72-73, 115, 122, 133, 142, 152, 169-170, 172, 175 Song, Z...................................164
Soni, A.............................159, 257 Sonmez, E.............................. 220 Sonnenberg, E....................... 239 Sonoda, A...............................134 Sonoyama, H....................101, 238 Sopeña-Biarge, F..............153, 245 Sorbello, M.............. 194, 201, 258 Soria, M....................... 49, 96, 174 Soriani, P................................ 127 Soriano Izquierdo, A................. 63 Soriano-Gabarró, M.................96 Sorrentino, D...................... 54, 63 Sorribas Olivera, M.................. 116 Sostres, C........................ 245, 253 Soto, J. L........................... 63, 143 Sou, S...............................69, 252 Soualah, K..............................188 Soul, S................................... 252 Sousa Andrade, C................... 208 Sousa, C..................... 56, 157, 208 Sousa, D....................116, 131, 138, 224, 236, 255 Sousa, E.......................... 188, 258 Sousa, M....................116, 131, 138, 209, 228, 235 Sousa, P....................188, 207, 228 Sousa, R......84, 128, 166, 180, 256 Souza, T. F................ 155, 206, 255 Sowa, J. P................................ 217 Soykan, I......................... 144, 246 Soylu, A. R..............................159 Spaan, C. N.............................192 Spaander, M. C. W.........37, 48, 79, 143, 150-151, 192, 200, 245 Spada, C..................... 94, 126, 131 Spadoni, I............................... 116 Spagnuolo, R.................. 189, 240 Spaho, L................................. 254 Spalinger, M. R....... 70, 86, 96-97, 184, 233-234 Sparchez, Z............................. 217 Spehr, C................................. 229 Spence, S. C.............................65 Sperber, A.................. 71, 146, 149, 244-245 Sperling, F.............................. 222 Speroni, S................ 150, 199, 248 Spicak, J....... 52, 125, 143, 148, 158, 174, 184, 197, 217, 220-221, 224, 249-250, 256 Spiceland, C. M........................ 62 Spielmann, P...........................184 Spiller, R.....56, 60, 74, 88, 94, 142 Spina, L..............................97, 185 Spindelboeck, W......................216 Spinelli, A........................... 73, 81 Spinelli, I................................218 Spisák, S.................................192 Spitz, W................................. 254
Spivak, E................................. 157 Sporea, I.............116, 157, 168, 170, 214, 216-218, 224 Sprakes, M............................. 253 Sprange, K..............................142 Squire, M................................150 Sreekar, D.............................. 224 Srivastava, A........................... 157 Stabuc, B................................. 79 Stack, R...................................138 Stadlbauer, V.................... 101, 216 Staffer, S.................................233 Stafylidou, M...........................159 Staiano, T................................130 Stakenborg, M.....................79, 92 Stålhammar, J..........................49 Stallmach, A............................ 141 Stanciu, C..... 116, 131, 166, 216, 254 Stanco, M................................166 Stanel, I. M............................ 223 Stanghellini, V......... 70, 78, 90, 92 Stanley, H...............................188 Starostina, T. N........................158 Starzynska, T............................ 78 Stasinos, I........................ 131, 226 Staubach, P............................ 206 Stauber, R...............................216 Staun, M.................................103 Stavrinidis, S.....................62, 230 Steel, A...................................185 Steele, R.................................193 Stefanescu, C............... 75, 80, 186 Stefanescu, H..............64, 73, 166, 215, 217, 256 Stefanovic, M........................... 72 Steffen, H..........................133, 174 Steffen, H.-M.......................... 242 Stehlikova, Z...........................184 Steijlen, P.................................49 Stein, J....................................155 Steiner, P................................. 137 Steiner, S.................................171 Steinert, A................................ 70 Stengel, S.................................89 Stengel, S. T............................135 Stepan, A.-M.....................216-218 Stepanov, A.............................257 Stephan, D............................. 249 Sternby, H........................170, 220 Sterneck, M............................ 229 Stetska, V................................184 Steube, A................................ 141 Steurer, S................................150 Stevens, T............................... 246 Steyerberg, E. W...............151, 200 Sticova, E................................158 Stieger, B................................ 118 Stiegler, P......................... 101, 216 Stiewe, T.................................164 Stigaard, T................................69
Index of Authors and Co-Authors : UEG Week Final Programme
Stigliano, S........................171-172 Stigliano, V............................. 226 Stilidi, E................................. 220 Stirand, P......................... 148, 174 Stirbu, L................................. 256 Stoica, O.................................166 Stojkovic, M..................... 133, 165 Stolfi, C...................................143 Stone, S................................. 242 Storey, D................................ 240 Storm, A. C..............................102 Storm, G.................................221 Stornello, C............................. 172 Storonova, O................... 145, 248 Storr, M. A..............................247 Storrie, J................................ 246 Stotzer, P.-O............................ 176 Stournaras, E..........................126 Strachan, J. A..........................193 Stracke, B................................247 Strand, D. S.............................. 62 Strasser, S................................ 91 Straub, D........................... 92, 150 Straumann, A...................101, 248 Strehle, K.................................84 Streleckiene, G...................91, 154 Stremmel, W...........................233 Stricker, B. H............................85 Strid, H...................................189 Strijbos, D........................124, 149 Strik, A............................... 73, 141 Strisciuglio, C..........................135 Strnisa, L.................................. 79 Strobel, D................................ 121 Stroux, A................................ 255 Struijs, E................................. 187 Strunk, M................................153 Stryszak, P...............................140 Strzalka, M...............................85 Stuchlik, S.............................. 236 Study Group, I..................237, 255 Stuhrmann, N. C......................233 Sturdik, I................................ 236 Sturgess, R............................... 62 Sturm, A............................ 97, 141 Sturniolo, G. C...... 55, 187, 189, 231 Stürzl, M..................................86 Su, C.........38, 50, 56, 61, 102, 140, 169, 188, 207, 222, 256 Su, L............53, 68, 72, 79, 96, 99, 117, 125, 127, 141, 143, 171, 178, 201, 225, 251 Su, M.-Y..................................142 Su, T................. 38, 47, 52, 62, 69, 76, 85, 92, 98, 103, 112, 119, 121, 125, 128-129, 131, 134-135, 147, 157, 161, 171, 174, 180, 200, 206, 219, 229-232, 237, 243, 255 Su, X....................................... 141
Sualeh Muhammad, J...............85 Suarez, I.................................221 Suarez, J..................................95 Suárez Ferrer, C.......................188 Suárez González, A.....84, 128, 245 Suazo, J...................................210 Subramaniam, S........... 53, 72, 99, 125, 225 Subramanian, V..........135, 176, 237 Súbtil Íñigo, J. C..................... 180 Subtil, C................................. 222 Suceveanu, A. P.................115, 153 Suceveanu, A.-I.................115, 153 Suchanek, S......222, 228, 242, 244 Suciu, A........................... 215, 217 Suda, K........ 82, 183, 223, 232, 251 Sudo, K............................. 89, 124 Suehiro, S..................123, 147, 169 Suekane, T........................147, 174 Sueoka, H..........................93, 167 Suga, B...................................136 Sugahara, A............................ 147 Sugai, T.............................98, 243 Sugaya, T................................. 76 Sugihara, Y............................. 203 Sugimori, K.............................169 Sugimoto, A............................ 121 Sugimoto, M...... 126, 137, 203, 232 Sugimoto, S................ 61, 138, 169 Sugimura, M............. 144, 192, 231 Sugimura, N............................. 79 Sugisaki, N....................... 197, 234 Sugitani, A.............................. 172 Sugiura, R............................... 131 Sugiyama, T...................... 85, 134 Sugrue, K................................237 Suh, J. H.................................139 Suharoschi, R.......................... 172 Suissa, A................................. 179 Sujendran, V..........................200 Suker, M.................................123 Sukovas, A.............................. 172 Sulaiman, R............................135 Sultana, R...............................219 Sultankhodjaeva, S. S.............. 157 Sumi, K.................... 175, 250, 256 Sumida, Y.............93, 144, 175-176, 182, 194, 201 Sumiyama, K.......................... 256 Sumiyoshi, T............................231 Šumskienė, J........................... 115 Sun, B...................................... 72 Sun, G..................................... 132 Sun, J................... 63, 93, 122, 140, 146, 152, 165, 234 Sun, L........... 141, 143, 171, 201, 251 Sun, Q.....................................145 Sun, S............................. 180, 220 Sun, W. C.................................59 Sunada, K................................68
Sunata, Y.................................. 53 Sundin, J.....................92, 141, 146 Sundy, J..................................140 Sung, I.-K....................... 202, 252 Sung, J. J. Y.......... 63, 142, 147, 192 Sunjaya, D. B......................... 207 Suo, J. B..................................153 Suo, M..............................147, 174 Suraci, E................................ 202 Suri, V.....................................159 Surmiak, M............................ 104 Sutton, R.................................. 72 Suvorov, A.............................. 203 Suvorova, T. S..........................122 Suyama, Y.......................204, 253 Suzuki, A.............129, 171, 180, 222 Suzuki, H....... 85, 98, 124, 136-137, 191-193, 230, 243 Suzuki, K........................ 61, 97-98 Suzuki, M........................ 180, 236 Suzuki, N.............86, 198, 226-227 Suzuki, S..................... 85, 123-124 Suzuki, T....................129, 171, 180 Suzuki, Y.................................. 61 Suzumura, K...............93, 167, 232 Svecová, H............................... 197 Svegl, P.................................... 79 Svegliati Baroni, G...................168 Svinarov, D..............................221 Svintsitskyy, A........................ 249 Swallow, K..............................189 Swaminathan, M.................... 222 Swan, M.................................123 Swann, J..........................185, 233 Swanson, L.............................145 Swanström, L..........................198 Sweis, R......132, 149, 225, 244, 247 Swinkels, D. W........................165 Symonds, E..............................90 Szachniewicz, M....................... 61 Szajewska, H................. 64, 74, 92 Szalai, M................................ 243 Szalai, Z..................................195 Szállási, Z...............................192 Szamosi, T.... 83, 136, 234-235, 240 Szapáry, L...............................231 Szapary, P................................ 47 Szarvas-Jones, S......................192 Szatmary, P.............................. 72 Szczyrk, U.................................85 Székely, H................................159 Szentesi, A............................. 220 Szepes, A........................ 234, 243 Szepes, Z.................. 83, 136, 228, 234, 238, 240 Szigeti, K.............143, 192-193, 243 Szigeti, N.........................192, 234 Szillat, P...................................64 Szlachcic, A............................ 104 Sztembis, J............................. 236
Szurowska, E....................218, 236 Szutan, L. A.............................215 Szymanska, A...................175, 228
T Taavela, J............................... 254 Tabacelia, D............................231 Tabouret, T............................. 232 Taccone, F. S............................ 133 Tachecí, I.................................251 Tack, J................39, 59, 65, 71, 83, 90, 94, 101, 195, 198, 244, 247 Tacke, F........... 48, 61, 84, 104, 207 Tada, K....................................126 Tada, M........... 93, 95, 119, 167, 232 Tadbiri, S................................. 75 Tafrishi, B.............................. 229 Tag-Adeen, M.......................... 93 Tagawa, K...............................142 Taghavi, S. A..................... 65, 215 Tagzout, D...............................154 Tahara, T.......................... 123, 144 Tahora, M...............................136 Tai, W.-C.................................166 Tai, Y................................. 59, 257 Taibi, A.................................. 232 Taira, K.................................... 79 Taira, T................................... 180 Taiymi, A................................. 178 Takada, J.................................152 Takada, R................................122 Takagi, M................................152 Takagi, R..................................98 Takagi, T............123, 174, 204, 253 Takahara, M........................... 203 Takahara, N.................95, 119, 182 Takahashi, A................... 152, 250 Takahashi, H..................... 58, 172 Takahashi, J............................. 97 Takahashi, K...............58, 103, 121, 130-131, 250 Takahashi, M.......................... 250 Takahashi, S.................... 203, 222 Takahashi, Y........................... 205 Takaki, A.................................166 Takaki, Y...................................58 Takami, M...............................169 Takanashi, K........................... 226 Takano, N............................... 258 Takaoka, A.............................. 137 Takaoka, M............................... 62 Takara, Y.................................. 77 Takasago, T................ 175-176, 182 Takasawa, A........................... 243 Takashima, K...............95, 177, 250 Takashima, S.......................... 203 Takashima, T........................... 167 Takata, R................................. 167
365
UEG Week Final Programme : Index of Authors and Co-Authors
Takatalo-Laine, M....................193 Takatori, Y................................ 53 Takats, Z.................................184 Takayama, H...........................146 Takayama, K........................... 206 Takayama, S.......123, 174, 204, 253 Takayama, T............................231 Takeda, K........ 46, 72, 98, 126, 194 Takeda, S.................................86 Takeda, T...................... 69, 95, 119 Takeda, Y...................... 51, 58, 142 Takei, D.................................. 203 Takei, Y...................... 122, 172, 181 Takemura, K............................142 Takenaka, K......................136, 236 Takenaka, M...................... 131, 181 Takeno, S................................183 Takeshima, F.......................... 252 Takeshita, F..............................89 Takeuchi, C..................... 124, 205 Takeuchi, H...................... 174, 232 Takeuchi, M............................ 232 Takeuchi, T........................122, 172 Takeuchi, Y.......53, 84-85, 126, 201 Takezawa, R.............................69 Taki, M.................................... 167 Takihara, H..............................194 Takikawa, Y............................. 115 Takimoto, K..............................96 Takizawa, K................51, 124, 128, 151-152, 194, 242, 250-251 Takizawa, S..............................89 Takumi, K............................... 180 Talaat, M................................. 118 Talaat, R.................................153 Talas, D....................................171 Talens, J. B..............................237 Talieri, M............................... 243 Talley, N. J......71, 149, 155, 197, 204 Tamada, K...............................130 Tamagno, G............................ 223 Tamai, N.......................... 84, 256 Tamaki, H................................154 Tamaki, Y................................130 Tamari, H.......................... 69, 142 Tamaru, Y................................144 Tamary, H............................... 151 Tamburini, A.......................... 242 Tamegai, Y.............................. 175 Tamelis, A......................... 78, 146 Tamminen, K.......................... 239 Tamura, T...................130, 144, 181 Tan, A. C................................. 121 Tan, B. H................................ 208 Tan, G. S................................ 208 Tan, J..........48, 72-73, 115, 133, 192 Tan, L. B..................................156 Tan, V.............................. 156, 205 Tan, W. K...............................200
366
Tan, Y...................98, 114, 120, 251 Tanabe, H............. 51, 58, 125, 129 Tanabe, S......51, 104, 124, 151, 200 Tanaka, F................... 79, 200, 254 Tanaka, H................... 76, 140, 188 Tanaka, K..... 76, 122, 126, 129, 134, 152, 171-172, 180-182, 191 Tanaka, M..................51, 128, 145, 194, 242, 250 Tanaka, R....................57, 222, 241 Tanaka, S............ 53, 122, 144, 151, 153, 194, 223, 236, 251, 254 Tanaka, T................... 134, 191, 203 Tanaka, Y...................... 57, 98, 114 Tandan, M............................... 181 Tang, C................ 59, 116, 172, 257 Tang, J....................................192 Tang, K...................................193 Tang, P.-L.................................59 Tang, R. S.............................. 207 Tang, S........................59, 116, 207 Tang, W...................................142 Tang, X.............................128-130 Tangermann, P. H................... 254 Tanida, S.................................142 Tanigawa, T............... 79, 200, 254 Taniguchi, Y.............................120 Tanino, M................................122 Tanke, G.................................. 167 Tankova, L........................159, 236 Tannapfel, A............................. 92 Tanoue, S......................... 121, 186 Tantau, M........... 54-55, 64, 73-74, 166, 217, 224, 246, 256 Tanzi, G.................................. 180 Tao, K........................ 175-176, 182 Tao, Z.....................................142 Tap, J...................................... 141 Tapete, G............................... 240 Tarabar, D................................56 Tarani, F.................................. 191 Tarantino, I....................... 99, 130 Tarantino, O........................... 228 Tardillo, C.............................. 235 Tardón, A................................143 Targan, S. R............................ 141 Targosz, A................................85 Tarli, C....................................166 Tashiro, T................................153 Tasset, C............................. 47, 141 Tata, A....................................188 Tatarkina, M............................221 Tate, D. J......... 69, 99, 128, 175, 177 Tatro, A...................................190 Tatsuguchi, A......................... 236 Tatsumi, N..........................51, 53 Tavani, R.................................140 Tavares de Sousa, H................ 236 Tavares Sousa, M. H................188
Tavares, D............................... 178 Tavares, J............................... 207 Távora, I................................. 258 Tawara, S............................... 246 Taya, Y.................................... 179 Taylor-Robinson, S..................165 Taylor, A. J.............................. 204 Taylor, K. M............... 141, 196, 233 Taylor, L. J................................ 62 Taylor, M.............. 70, 141, 196, 233 Taylor, S................80, 86, 163, 165 Tcymbarevich, I..................97, 233 te Morsche, R. H. M.................165 Tearney, G.............................. 249 Tebaibia, A..............................154 Techapaitoon, S....................... 177 Teggiachi, M...........................139 Teich, N..................................140 Teixeira, A. F....................206, 255 Teixeira, C...............................215 Tekin, F...................................143 Telegin, A................................153 Tell, G. S................................ 204 Tellian, A................................194 Telliez, J.-B.............................. 79 Temma, T................................169 Temperley, H.......................... 252 Ten Hove, A..............................59 Tenca, A................................... 91 Tene Fokam, T. B............. 199, 249 Teniente, A..............................186 Teoh, A. Y................................152 Teoh, A. Y. B....................230, 250 Tepeš, B.............................77, 104 Teppei, O......................... 191, 236 Terabe, H.................................69 Terai, S..............................61, 103 Teramoto, T............................. 178 Teramukai, S...........................126 Terán Lantarón, Á................... 180 Terasaki, K....................... 123, 174 Terasaki, M.............................. 53 Teresa Marzia, R.......................171 Termite, A......................... 117, 167 Terracciano, L........................... 70 Terreehorst, I. T.......................149 Tersaruolo, C.................... 216, 231 Teruel Sánchez-Vegazo, C....... 248 Terveer, E. M...........................196 Terzic, S................................... 79 Tessari, R............................... 238 Tesselaar, M............................. 93 Testa, A....................205, 235, 238 Testa, G...................................155 Testa, S.................................. 207 Testelin, S...............................135 Testoni, P. A......................69, 242 Testoni, S. G. G....................... 230 Teubner, D...............................69 Teufelhart, M..........................215
Tezel, H. A...............................159 Thabut, D........35, 38, 84, 100, 106 Thakar, K.................................194 Thakkar, R.......................... 49, 80 Thakkar, R. B............................80 Thakkar, S......................... 58, 122 Thakkinstian, A........................ 133 Thakral, A............................... 157 Thalagala, E........................... 229 Thaler, J................................... 51 Thandassery, R. B....................216 Thangarajah, D.................. 157, 191 Thapaliya, S............................164 Thapar, N........................... 50, 65 Tharsis, G.......................... 50, 176 Theilla, M............................... 256 Theis, V......................58, 188, 243 Thelin Schmidt, P.....................143 Theocharis, G..........................241 Theodoraki, E.......................... 187 Theodoropoulos, L........... 230, 243 Theodoropoulou, A.... 125, 129, 145 Theodorou-Kanakari, A... 206, 251 Theodorou, V.................... 141, 145 Theopistos, V...........................241 Theuerkorn, K........................ 222 Thiele, M..................................38 Thieringer, F...................... 98, 125 Thiis-Evensen, E........................71 Thijs, W. J................................102 Thijssen, J. M.......................... 167 Thomas-Gibson, S........ 81, 89, 94, 223, 225-226 Thomas, T...............................247 Thomassen, B.........................142 Thomopoulos, K......................241 Thompson, A...........................190 Thompson, C. C...........71, 102-103, 153, 216, 219 Thomson, C.............................153 Thorlacius, H.......................... 228 Thornton, L............................ 222 Thorpe, A. J....................... 61, 140 Thumshirn, M.......................... 52 Thursz, M................................165 Thuss-Patience, P...................... 92 Tiako-Meyo, M.................. 93, 168 Tian, J...................................... 52 Tian, W...................................144 Ticlete, I................................... 83 Tierney, M...............................156 Tighe, D....... 137-138, 140, 253-254 Tilg, H............35, 42, 70, 77, 87, 89 Tilmant, C.............................. 225 Timar, R..................................218 Tiniakos, D.................... 42, 48, 75 Tinmouth, J.............................143 Tirado, P. R............................. 238 Tirgar Fakheri, S..................... 203 Tiribelli, C...............................165
Index of Authors and Co-Authors : UEG Week Final Programme
Tischkowitz, M......................... 83 Titó, L.....................................153 Titova, M. A.............................164 Tiwari, D.................................219 Tjora, E....................................171 Tjwa, E..............................165-167 Tkachenko, E...........................241 To, K. F............................... 91, 147 To, N............ 38, 50, 60-61, 63-64, 67-68, 73, 81-83, 95, 102, 111-113, 115, 120-122, 124, 126-128, 132, 134, 138, 142, 149, 153, 162, 166, 175, 183, 187-188, 190, 193-194, 201, 203, 207, 211, 219, 228, 233, 240, 242-243, 246, 252, 256, 258 Tobin, A. M.............................138 Toda, N...................................142 Toda, S............................. 144, 231 Todesca, P............................... 119 Todorov, T...............................159 Todorova, A.............................159 Toes-Zoutendijk, E...................192 Toka, B.................................... 132 Tokai, Y............................252-253 Tokuda, Y................................. 51 Tokuhara, M............................. 62 Tokuhisa, Y...............................86 Tokumitsu, Y.............................86 Tokushige, K........................... 226 Toldi, A...................................156 Toleikiene, R...........................193 Tollenaar, R..............................85 Tolnai-Kriston, C......................143 Tolone, S............ 69, 149, 198-200, 248-249 Tolstanova, G.................... 134, 184 Tolusso, B......................... 75, 239 Tomaz, A................................ 209 Tomba, C..........................156, 247 Tomba, F.................................247 Tomczyk, D..............................135 Tomé, L............. 158, 166, 210, 214, 217, 219, 223, 229, 232, 253, 256 Tomeno, W.............................. 114 Tomida, S............................... 205 Tomie, A................... 124, 174, 252 Tominaga, K............................144 Tomishima, K...................198, 222 Tomita, H............................... 246 Tomita, M................................144 Tomita, R................................ 121 Tomita, T..................................84 Tomita, Y..................................85 Tomlinson, I....................... 58, 85 Tomochika, S............................86 Tomonori, M...........................194 Tomooka, F.............................. 167 Tomori, A................................ 176
Tong, H...................................257 Tong, T. S............................... 202 Tong, W. J.................................85 Tonon, M.................................166 Tonozuka, R........................... 222 Tontini, G. E..... 55, 72, 98, 125, 127 Topalidis, T............................. 207 Topazian, M............................. 62 Tops, S....................................189 Tordjman, G...................... 50, 176 Torimura, T............................. 180 Tornai, I................................... 61 Tornai, T................................... 61 Törnblom, H............ 39, 55, 71, 90, 141, 146, 149, 244-245 Tornea, D............................... 224 Török, G..................................192 Török, I.................................. 220 Toropov, V...............................241 Torralba-Gallego, A...................71 Torrano, V................................117 Torre, C............................. 65, 155 Torrealba, L.............................237 Torrella Cortes, E. A......... 185, 228 Torres-Vicente, G.................... 246 Torres, J..................................237 Torres, T..................................139 Torrie, R..................................125 Torroni, F.................................55 Torse, L...................................237 Tortora, R....................64, 118-119, 205, 218, 238 Torvinen, S............................. 239 Tosca, J.................................. 239 Toth, E...........72, 126, 131, 170, 228 Toth, G. T........................... 83, 136 Tóth, K.....................................171 Touchefeu, Y......... 82, 93, 168, 252 Toueg, R................................ 240 Tougeron, D...................... 93, 168 Tounai, Y..................................85 Tounigand, C............................50 Tournev, I................................159 Touvron, M............................. 242 Tov, N. L..................................122 Tova, R.................................... 181 Tovar Doncel, M. S...................123 Toxværd, A..............................122 Toya, Y..................................... 76 Toyonaga, H.....................120, 194 Toyonaga, T...............194, 223, 251 Toyoshima, N.................. 126, 128, 193-194, 243 Tozawa, K.................................84 Tözün, N.................................215 Traboulsi, E............................ 222 Trad, D.............................228-229 Traina, M.......................... 99, 130 Traini, M................................ 230
Traini, S............................ 84, 130 Tran, F............................... 89, 135 Tranesh, G................................ 93 Trang, C................ 73, 75, 136, 186 Trauner, M........ 51, 53, 68, 86, 91, 132, 175, 227-228 Travancinha, C.........................145 Travis, S..............80, 139, 235, 254 Trebeschi, S.............................144 Trebicka, J....................... 104, 106 Treling, A...............................200 Trelle, S................................. 248 Trenkel, S............................... 254 Treohan, A...............................64 Tretter, L..................................170 Trevisani, F..............................168 Triantafyllou, K................. 127, 131, 206, 251, 254 Triantos, C....................... 241, 248 Tribl, B.................................... 132 Tribler, S......................... 103, 256 Trifan, A.-V...........116, 131, 166-167, 216, 254 Triki, W...................................218 Tringali, A....................36, 40, 66, 88, 130, 220, 229-230, 252 Trishkina, I..............................153 Trivedi, C.................................102 Trojan, J................................... 92 Troncone, R..............................64 Troukhmanov, A. S................. 248 Trovatello, A........................... 238 Trudgill, N................. 103, 170, 247 Trukhmanov, A........................145 Trunecka, P................. 158, 217, 221 Truong, D. H.............................117 Tsai, W.-L.................................59 Tsamakidis, K......................... 230 Tsapas, A.................................49 Tschurtschenthaler, M...............90 Tse, F...................................... 258 Tsegai-Eh, E............................128 Tseng, C.-W..............................82 Tseng, J.................................... 93 Tseng, K.-L..............................166 Tsimperidis, A. G.................... 245 Tsipouras, M...........................165 Tsuboi, A................................ 254 Tsuboi, M................................182 Tsuchida, T........................151, 174 Tsuchikawa, T..........................182 Tsuchiya, J....................... 203, 241 Tsuchiya, K.........................97, 143 Tsuchiya, T............................. 222 Tsuda, M.............. 53, 122, 128, 151 Tsuda, T.................................. 151 Tsudome, M............................ 147 Tsugawa, N.............................. 79 Tsuji, S................................... 222
Tsuji, T.................................... 121 Tsuji, Y................. 96, 142, 151, 231 Tsukamoto, Y........................... 179 Tsumura, T.............................. 167 Tsunedomi, R...........................86 Tsunematsu, S......................... 179 Tsuru, H..................................194 Tsuruoka, N............... 187, 193, 234 Tsuruta, O.............................. 180 Tsuyama, S.............................. 147 Tsuzura, H...............................198 Tsvang, E..................................69 Tsyryuk, O...............................155 Tu, Q....................................... 172 Tubergen, A.............................49 Tuccillo, C...............................165 Tuck, C. J.................................196 Tucker, E.................................148 Tulassay, Z..........143, 192-193, 243 Túlio, M................................. 208 Túlio, M. A....................... 217, 235 Tumangelova-Yuzeir, K............ 217 Tumino, E............................... 177 Tun, G. S. Z.............................189 Tundia, N................................. 87 Tundo, P............................ 117, 167 Tuomisto, A..............................86 Turato, C................................. 114 Turcan, S.................... 96, 135, 185 Turck, D...................................135 Turculeanu, A..........................165 Turina, M..........................86, 233 Turner, D..................................56 Tursi, A.................... 146, 189, 199, 203, 252 Tutuian, R............37, 47, 69, 73, 75 Tüzün Ince, A......................... 220 Tuzun, S................................. 244 Tye-Din, J. A.............................56 Tye, M.....................................148 Tynan, S..................................188 Tysoe, O...................................59 Tytgat, G.................................. 87 Tzallas, A................................165 Tzatzagou, G...........................159 Tziatzios, G................. 127, 131, 254 Tzimas, D................................. 62 Tzivian, L.................................251
U Ucbilek, E............................... 203 Uchida, D.......................... 65, 168 Uchida, G.......................... 136-137 Uchida, K................................. 62 Uchima Koecklin, H.................227 Uchino, R................................ 119 Uchita, K........................... 58, 152 Uchiyama, K.................... 123, 174, 204, 253
367
UEG Week Final Programme : Index of Authors and Co-Authors
Uebel, P..................................125 Ueda, T............................ 123, 174 Uedo, N.......... 53, 58, 85, 126, 201 Uejima, M............................... 167 Ueki, N........................82, 173, 198 Ueki, T....................... 58, 125, 241 Uemura, R.......................194, 201 Uemura, R. S.......................... 258 Ueno, M.................................. 175 Ueno, T....................................86 Ueo, T......................................58 Ueyama, H.......................174, 202 Ugurlu, M. U........................... 114 Uhlig, H................................. 235 Uhmann, A............................... 92 Ujihara, T......................... 123, 169 Ukai, K...................... 144, 192, 231 Ulanova, M..............................153 Ullah, N.................................. 217 Ulloa, C. P................................49 Ulrich-Merzenich, G................150 Umana, J.................................210 Umar, S...................................122 Umeda, Y................................166 Umegaki, E...............194, 223, 251 Umemoto, K............................ 172 Umeno, J.................................. 76 Ümit, H...................................159 Umutlu, L................................ 187 Ungar, B.................... 140, 189-190 Ungureanu, B................... 181, 229 Uno, K.................................... 180 Unsal, B..................................148 Ünsal, G..................................159 Unzicker, C..............................126 Upponi, S.................................59 Urabe, Y.................................. 151 Urakami, K............................. 242 Urano, Y................................. 252 Uraoka, T..................... 53, 82, 173, 176-177, 225 Urba, M..................................142 Urban, O................................ 220 Urbanski, S............................. 176 Urboniene, A...........................221 Ureshino, N............................. 172 Urgesi, R.........................206, 244 Urlep, D................................... 79 Urreta, I.................................. 115 Urusova, F............................... 133 Usak, J................................... 220 Ushijima, T........................85, 180 Ushio, J...................................130 Uslan, M. I.............................. 132 Uspenskiy, Y. P........................ 203 Usuda, H................................. 114 Usuy, E............................206, 255 Uyama, N....................93, 167, 232 Uyar Alpaslan, N.................... 203 Uzzan, M.................................. 97
368
V Vackova, Z................ 125, 148, 174, 197, 224, 249-250 Vadala, S.................................122 Vadamalayan, B...................... 191 Vadan, R................................. 116 Vadillo-Calles, F....................... 121 Vaganov, Y...............................210 Vaiarello, V..............................138 Vaillant, J. C............................ 181 Vaiphei, K..................103, 178, 187 Vaira, B..............................77, 104 Vaishnavi, C............................ 187 Vakhitov, T...............................241 Vakrakou, A............................ 243 Valantiene, I............................ 115 Valats, J.-C............................... 76 Valcz, G...............143, 192-193, 243 Valdivielso Cortazar, E............. 178 Vale Rodrigues, R................... 232 Valean, S.................................165 Valeeva, A.............................. 234 Valente, A.......... 158, 208, 217, 237 Valente, A. S........................... 147 Valente, R...............................120 Valerii, G................................ 252 Valero Torres, A......................200 Valero, M...........................49, 174 Valestrand, L............................59 Valeur, J..................................195 Valitutti, F.................................65 Valk, G..................................... 93 Valkov, I.................................. 217 Valle-Muñoz, J........................153 Vallecillo-Hernández, J........... 252 Valleix, D............................... 232 Valli, P. V.............102, 127, 195, 239 Vallier, L...................................59 Valmary-Degano, S................ 234 Valori, R.................... 94, 143, 223, 225-226 Valpiani, D................. 96, 135, 185 Valvano, M. R....... 117, 167-168, 189 Valverde López, F...............121, 197 Valvo, B............................ 64, 155 Van Aerts, R............................165 Van Amesfoort, J.....................134 Van Assche, G................... 56, 189 Van Baar, A............................. 173 Van Berge Henegouwen, M. I.........................76, 80, 82, 87, 182, 250 Van Beurden, Y. H...................196 Van Bodegraven, A. A..............185 Van Brunschot, S.......... 60, 71, 162 Van Cutsem, E............... 63, 74, 80 Van de Graaf, S.......................150 Van de Laarschot, L. F. M... 58, 165 Van De Winkel, A...................... 79 Van Delden, O. M.............. 93, 169
Van Delft, S.............................103 Van den Brand, F. F................... 91 Van den Brink, G. R.......... 92, 184, 192, 242 Van den Burg, S. P...................190 Van der Aa, A..................... 47, 141 Van der Have, M..................... 238 Van der Heijde, D................... 238 Van der Horst, D......................185 Van der Leij, C.........................124 Van der Maazen, R. W.............192 Van der Meer, J. H. M...... 192, 242 Van der Post, C.........................84 Van der Sande, M....................144 Van der Weiden, M. M.............192 Van der Werf, L. R............. 76, 182 Van der Wiel, S. E............. 129, 251 Van der Willik, E....................... 76 Van der Woude, C. J......46, 65, 83, 92, 102, 105, 236, 239 Van Dijk, A................ 142, 166, 219 Van Dijk, A.-B.........................102 Van Dijk, L. J. D................123, 255 Van Dijk, S...................... 142, 255 Van Dop, W. A.......................... 92 Van Eeden, S............................ 72 Van Eijck, C. H. J...........85, 93, 123 Van Erp, S. J. H....................... 238 Van Erpecum, K........................ 91 Van Gaal, N.......................186-187 Van Geenen, E............. 71, 121, 255 Van Gils, T................................64 Van Ginderachter, J................... 79 Van Goor, H...............................71 Van Gossum, A.............. 42, 87, 95 Van Griethuysen, J. J.................50 Van Griethuysen, J. J. M...........144 Van Gulik, T. M...........93, 118, 120, 169-170, 219 Van Herk, E. H.......................... 97 Van Herwaarden, Y....... 58, 74, 112 Van Hooft, J. E............... 55, 67, 95 Van Hootegem, P................ 55, 90 Van Keulen, K......................... 245 Van Kimmenade, R..................166 Van Klaveren, D.......................170 Van Laarhoven, C. J. H. M..................... 169, 219 Van Laethem, J.-L...........37-38, 68 Van Landeghem, L.................. 242 Van Leerdam, M. E....... 41, 75, 192 Van Leeuwen, F. E............. 64, 192 Van Lienden, K. P.....................169 Van Lijnschoten, I....................124 Van Loveren, H......................... 74 Van Mil, A................................85 Van Munster, S.................200-201 Van Nieuwkerk, C. M................ 91 Van Noord, D....................123, 255
Van Os, J.................................196 Van Oudenhove, L.........65, 71, 74, 92, 197, 244 Van Rongen, I.........................142 Van Rood, Y. R..........................90 Van Rosmalen, B..................... 118 Van Santvoort, H......53, 58, 60, 71 Van Tilburg, A........................ 235 Van Veenendaal, L.................... 93 Van Vugt, J. L. A.........120, 169-170 Van Wijnen, L. E.......................49 Van Woerden, V........................ 93 Vanags, A................................251 Vanásek, T.......................... 49, 80 Vanbiervliet, G..... 88, 95, 102, 222 Vanden Berghe, P.....................50 Vanden Branden, S...................55 Vandenbroucke-Grauls, C. M. J. E............................196 Vangravs, R.............................193 Vanheel, H..............................247 Vanhoutvin, S...........................98 Vani, D................................... 253 Vanuytsel, T.................. 39, 41, 96, 101, 247 Vaquero, E............................. 222 Vaquero, J................................117 Varadarajulu, S.....72, 103, 129-130 Varanese, M........................... 226 Varciu, A................................ 224 Vardas, E.................. 125, 129, 145 Vare, S. G............ 99, 223-224, 249 Vareniuk, I..............................134 Varenne, O............................. 206 Varga, G...................................89 Vargas, V.................................. 91 Vargo, J. J.........................181, 246 Variola, A........................238, 240 Varol, C............................. 72, 242 Varon, C................................. 252 Vasconcelos, H........... 89, 179, 258 Vasen, H............................ 85, 98 Vasilakis, T.......................128, 196 Vasiliadou, I........................... 243 Vasilyev, I. Y............................. 77 Vásquez-Guerrero, J................128 Vassallo, G. A..........................166 Vassallo, R............................. 238 Vasuka, E........................ 235, 240 Vatn, M. H..........................71, 236 Vatn, S................................... 236 Vavassori, S............................. 127 Vavin, G..................................135 Vavricka, S............ 36, 40, 86, 101, 184, 233, 235, 248 Vavrova, J................................138 Vaysse, T............................75, 139 Vaz, A........ 215, 228, 236, 241, 255 Vazeille, E............................... 137 Vazquez Sequeiros, E.......122, 180
Index of Authors and Co-Authors : UEG Week Final Programme
Vecchi, M......................55, 97, 127 Vecchio, F................................218 Vecchione, V............................140 Vedel Nielsen, H.......................58 Veenendaal, R. A......................85 Vega, P....................................144 Vega, R...................................140 Vegh, Z.................83, 96, 135-136, 138, 185, 238 Veijola, L............................77, 104 Veitch, A.................................125 Vela, M.................................. 235 Velasco Guardado, A. J........... 180 Velayos, B.............................. 229 Velea, P.-I...............................170 Velho, S..................................233 Velikova, T............................... 217 Velosa, J...............85, 158-159, 167, 173, 207-210, 221, 225, 237, 245, 257-258 Veloso do Carmo, J.......... 180, 208 Veloso, N............. 52, 177, 179-180, 208, 224 Veltzke-Schlieker, W............... 255 Venâncio, J..............................145 Venerito, M........................77, 104 Venezia, A............................... 133 Venezia, F.......................... 50, 176 Venezia, L................ 158, 223, 258 Venglovecz, V...........................171 Venselaar, H............................165 Ventimiglia, M.................. 237-239 Ver Loren van Themaat, E......... 92 Vera Mendoza, I..................... 235 Vera, M. I............................... 240 Verbeek, W............................... 93 Verbeke, C............68, 102, 120, 170 Verdelho Machado, M...... 158, 208 Verdu, E...................................56 Veres, G. L........................136, 234 Vergnolle, N..................57, 70, 92, 107, 110 Verhagen, H. J. M................... 255 Verheij, J.......................... 118, 219 Vermeire, S...................47, 56, 61, 96, 141, 189 Vermeulen, B......................... 248 Vernia, P..........................138, 239 Verónica Dávila-Batista, V........143 Verset, L..................................192 Versteeg, R.............................. 92 Verstockt, B.............................189 Verter, E..................................123 Verwey, M. H........................... 187 Veselov, V................................210 Vetter, M.................................128 Vettorato, M. G........................ 187 Vettore, E................................166 Vettori, G.........................159, 210 Veziant, J................................ 242
Vezzoli, A............................... 254 Viala, J.................................... 191 Viale, E....................................69 Vicario, M..........................57, 247 Vicente, R................................189 Vich Vila, A............................... 70 Vieceli, F................................. 121 Vieira, A...........................188, 215 Viejo-Almanzor, A............170, 220 Viel, A.....................................192 Vienne, A.................. 129, 151, 229 Viennois, E............................... 70 Viennot, S...................73, 139, 186 Vierling, J.....................54, 61, 100 Vieth, M........................54-55, 79, 81, 87, 101 Vieujean, S..............................190 Viggiani, M. T..........................166 Vignolo, P................................ 173 Vigsnaes, L. K..........................241 Viitasalo, L. M........................ 254 Vijayan, S............................... 230 Vijayasingam, A...................... 197 Vila, J. J..................... 181, 229, 257 Vilallonga, R.....................68, 100 Vilardell, N..............................149 Vilas-Boas, F............. 120, 122, 130, 173, 209 Vilchez Jaimez, M.............157-158, 209-210, 257 Vilkin, A..............................69, 91 Villa, K................................... 240 Villafranca, D.......................... 253 Villas-Boas, R..........................166 Villoria, A................................139 Villotti, G.........................206, 244 Vilmann, P....................36, 69, 122 Vincelet, C...............................194 Vincent, C................................. 91 Vinci, E........................... 189, 238 Vincze, A................... 83, 136, 220, 229, 234, 240 Vinet, O................................... 132 Vinha Pereira, D..................... 252 Vinson, B................................247 Vinter-Jensen, L...................... 256 Viola, F.................................... 191 Violi, A................................... 252 Virdone, R...............................168 Virgili, A................................... 63 Virginijus Jonaitis, L.................. 77 Visciola, G.............................. 203 Visentin, M.............................. 118 Vishalkumar, S....................... 220 Vissers, R............................... 256 Vissiennon, C..........................190 Visvanathan, S.......................... 47 Vitagliano, M........................... 187 Vital, M................................... 141 Vitalba, A................................190
Vitale, M. A.....................206, 244 Vitali, F.................................... 121 Vitalis, Z.................................. 61 Vitek, P................................... 220 Vitello, A................................ 238 Vitiello, A.......................... 118-119 Vitorino, E........................158, 210 Viviano, F................................ 191 Vjero, K........................... 180, 207 Vlachonikolou, G............. 206, 251 Vlachou, E............................... 131 Vladimirov, B............ 159, 221, 236 Vladimirova, V. I......................158 Vlasova, A...............................156 Vleugels, J. L. A.............72, 84, 89 Vliegen, R. F. A........................144 Vodicka, P...............................143 Vodoleev, A............................. 132 Voest, E...................................144 Vogel, A...................................54 Vogelsang, H........................... 137 Voicu, M................................ 224 Voinea, F...........................115, 153 Voinea, F. F..............................153 Voiosu, T................................. 167 Vojtech, Z................................ 197 Volkers, A. G........................... 141 Vollebregt, P. F........................185 Vollert, J.................................. 175 Vologzhanina, L..................77, 104 Volpato, M............................. 243 Voltà-Pardo, T........................ 246 Volta, U......................... 47, 92, 99 Voltarel, G........................247-248 Von Arnim, U.......................... 101 Von Boehmer, L........................86 Von Figura, G....................64, 168 Von Heymann, C..................... 225 Von Wagner, C......................... 175 Voor in ’t holt, A. F.................. 179 Vora, A. A................................186 Vork, L...............................71, 196 Vos, M. C................................. 179 Voska, M................................ 228 Votto, M.................................. 191 Voudoukis, E.................... 129, 145 Vreugdenhil, A........................170 Vriens, M................................. 93 Vriezinga, S..............................64 Vrolijk, J. M.............................. 91 Vugts, J............................120, 169 Vuik, F. E. R.............................. 79 Vuitton, L.............. 73, 75, 186, 234 Vujasinovic, M.........................120 Vukicevic, S.............................214 Vukova, T................................ 179 Vumma, R...............................146 Vutukuru, V............................. 133 Vyalov, S. S.............. 165, 203, 254 Vymazal, J............................... 197
W Wächter, L............................... 116 Wada, K........................... 114, 130 Wada, M.................................194 Wada, N............. 183, 223, 232, 251 Wada, T..................... 96, 104, 200 Wafy, W................................... 119 Waga, E................................. 226 Wagner, A...................97, 192, 233 Wagner, C. A......................97, 233 Wahib, A. A............................. 147 Waisman, A.............................170 Waizbard, A.............................69 Wakamura, K............... 46, 72, 98, 126, 128, 131, 193-194, 243 Wakatsuki, T............................201 Wakayama, M......................... 191 Waldhör, T............................... 137 Waldmann, E.......50, 175, 227-228 Waldner, M. J...................... 61, 79 Waldschmitt, N...................57, 134 Waldthaler, A...........................171 Walji, F....................................182 Walker, M. M...............71, 148-149, 155, 184, 204 Wall, R....................................146 Wallace, K...........................47, 80 Wallace, M. B.............. 93, 98, 127, 129, 173, 249 Walsh, A................................ 235 Walsh, P................................. 254 Walshe, M............................... 217 Walter, B..................................58 Walter, B. M.............................84 Walters, J...................... 67, 82, 88 Walters, T. D.............................56 Walton, J................................ 250 Waluga, M..............................164 Wander, P. K............................216 Wanders, L. K........................... 72 Wang, A. Y.........................62, 147 Wang, A.-J.............................. 115 Wang, B.............. 64, 150, 168, 199 Wang, C.............................79, 174 Wang, G............................ 72, 201 Wang, J.................72, 133, 197, 199 Wang, J.-W..............................166 Wang, K................... 140, 145, 173, 204, 246, 248 Wang, L............... 52, 79, 174, 202, 223, 244, 252 Wang, M...... 173, 197-199, 222, 232 Wang, N...............114-115, 133, 152, 174, 197, 202, 252 Wang, Q............................114, 191 Wang, R...................................85 Wang, S...................................56 Wang, S.-Q.............................. 114 Wang, W..................... 61, 114, 166
369
UEG Week Final Programme : Index of Authors and Co-Authors
Wang, X................ 57, 87, 132, 145, 152, 173, 175, 191, 193, 197-199, 246, 251 Wang, X.-Y..............................136 Wang, Y....................... 62, 136, 147 Wang, Y. T...............................156 Wang, Z....................132, 220, 257 Wangermez, M................ 222, 232 Wani, H...................................216 Wani, S................................... 179 Wanten, G.........................95, 256 Wanzel, M...............................164 Ward, M. G....................... 141, 233 Warner, M................................ 92 Warren, N...............................125 Warschkow, R.........................183 Warusavitarne, J....... 43, 67, 73, 131 Waschina, S............................138 Waschkies, C...........................102 Wasilewski, A........................... 79 Wasmann, K............................134 Wassef, W................................ 62 Wasser, M................................85 Watabe, T................................. 79 Watanabe, D................... 126, 203 Watanabe, K............... 61, 124, 147, 172, 174 Watanabe, M.................65, 79, 97, 136, 143, 236, 241 Watanabe, N...........................128 Watanabe, O..................... 136-137 Watanabe, S.............. 143, 174, 202 Watanabe, T..............79, 145, 200, 243, 254 Watari, J...................................84 Watfah, J.................................. 41 Watkins, J................................ 179 Watson, D...............................150 Weber, A.............................72, 86 Weber, J.................................. 187 Weber, S. N.............................146 Webster, G............................... 62 Wedemeyer, H...................86, 106 Wedi, E............................ 147, 225 Weerasinghe, K.......................158 Weersma, R. K......................... 70 Weerts, Z. Z. R. M.....................71 Wegener, M.............................. 53 Wei, H.................................... 204 Wei, J.................................52, 116 Wei-Dong, L............................247 Weidlich, S............................. 248 Weigt, J............................ 116, 224 Weijers, G........................ 165, 167 Weiler, N................................. 118 Weimers, P....................... 136, 138 Weinhage, T.............................89 Weise, R................................. 249 Weiss, F. U................................46 Weissbrod, R................... 126, 245
370
Wells, C.....................223, 225-226 Wen, S.-H...............................149 Wendt, E. R............................. 133 Wenger, R. H...........................184 Weniger, M............................ 232 Wennmacker, S. Z............. 169, 219 Wentrup, R............................. 255 Wenzl, H. H............................. 137 Werge, M................................221 Werkstetter, K...........................64 Werlang, M. E......................... 127 Werner, J................................ 232 Wessels, H. J............................58 West, J..................................... 78 West, M............................ 89, 139 West, R.............. 102, 135, 139, 236 Westendorp, B. F...............92, 242 Westera, L...............................184 Westerveld, D.......................... 151 Westhoff, A.............................188 Westhovens, R.........................139 Wetzka, J..................................96 Weusten, B. L. A. M......55, 64, 76, 90, 173, 200-201, 249 Whale, G........................... 89, 139 Wheat, J................................. 232 Wheeler, C........................ 61, 190 Whelan, K...............................156 Whitaker, D..................... 126, 245 Whitcomb, D. C............76, 82, 106 White, J. R...............................148 Whitehead, W. E......... 71, 146, 149, 244-245 Whitley, L......................... 140, 191 Whitsey, H...............................192 Whorwell, P..............................90 Wichmann, B.............192-193, 243 Wickramasinghe, A. R..............164 Widlak, M. M............................ 81 Wiedbrauck, F......................... 255 Wiedbrauck, T.......................... 53 Wiedenmann, B..................... 255 Wieser, M................................ 187 Wiest, R.................................. 116 Wieszczy, P............................. 245 Wieten, E......................... 114, 143 Wifi, M.-N..........................116-117 Wiggers, J. K............................ 93 Wijmenga, C............................ 70 Wijnants, T. F............................58 Wijnhoven, B. P. L............. 76, 182 Wilasrusmee, C....................... 133 Wilcox, C. M............................103 Wilcox, M......................... 103, 141 Wild, G............................. 187, 189 Wildenberg, M. E.............. 92, 184 Wilder-Smith, C........................46 Wildner-Christensen, M...........154 Wildner, D.........................121, 170
Wilflingseder, D........................ 70 Wilhelm, C.............................. 173 Willeke, F............................... 249 Willemssen, F. E. J. A.................120, 169-170 Williams, E. J...........................144 Williams, H. R. T........ 184-185, 233 Williams, L. J...................... 56, 64 Williams, S.............................. 177 Williams, S. C. R...................... 197 Williet, N....................135, 185-186 Wills, E. S.................................58 Wils, P................. 75, 139, 236, 238 Wilson, A................... 40, 89, 100, 226, 231 Wilson, B................................156 Wilson, I..........................226, 231 Winkens, B.............................. 187 Winker, R................................215 Winstanley, A..........................158 Winter, D. C.........................81, 88 Wintjens, D. S. J....................... 187 Wirtz, S............................. 70, 170 Wiseman, G............................196 Wissniowski, T. T...... 118, 120, 164, 168, 215 Withoff, S.................................94 Witt, H.............................. 46, 120 Włodarczyk, J..........................233 Wlodarczyk, M.........................233 Wohl, P.................................. 256 Wojcik, D......................... 104, 250 Wojtowicz, A. M....................... 61 Wolf, D. C................................. 61 Wolfsen, H. C......................... 249 Wölnerhanssen, B. K................ 52 Wolterbeek, R........................ 238 Wolters-Eisfeld, G...............46, 78, 150, 221 Wolters, A................................49 Wolthuis, A..............................56 Wong, A. Y..........................46, 91 Wong, C. C.................. 91, 93, 143, 147, 192, 202 Wong, I. C...........................46, 91 Wong, I. O................................46 Wong, M. C............................ 242 Wong, S..................................142 Wong, S. H........................ 82, 142 Wong, S. K..............................152 Wong, V................... 152, 230, 250 Wong, Y. J............................... 209 Woo, H. S................................146 Wood, H................................... 70 Wood, L. D...............................66 Woodcock, A...........................199 Woodland, P........101, 148, 247-248 Woodward, J............................ 39 Woodward, T............... 93, 127, 129 Woodworth, D..........................56
Woolcott, J.............................. 141 Worni, M.................................183 Wouters, Y.............................. 256 Wright, A................................189 Wright, N................................150 Wronska, E..............................231 Wu, B.....................................199 Wu, C.-K.................................166 Wu, D.-C..........................166, 239 Wu, J...................................... 104 Wu, J. C..................... 142, 152, 198 Wu, J.-L...................................143 Wu, M.-S........................... 77, 154 Wu, N.........................48, 123, 133 Wu, Q.-N.................................123 Wu, R.-C.................................142 Wu, S...............57, 77, 154, 193, 216 Wu, W..............91-92, 114, 141-143, 171, 201, 218 Wu, X...................................... 118 Wu, Y................................ 85, 166 Wu, Y.-K..................................136 Wu, Z...................... 72-73, 115, 133 Wuestenberghs, F....................198 Wunsch, E................................ 91 Wurm Johansson, G.................. 72 Wurm, P........................... 124, 192 Würzner, R............................... 70 Wynter, E.................................69
X Xavier, R.................................. 70 Xavier, S................... 166, 186, 191, 201, 216 Xia, M.............................. 118, 144 Xia, X...................................... 173 Xia, Z......................... 93, 173, 248 Xiang, Y.................................... 52 Xiao, C....................................216 Xiao, H.-Y................................ 115 Xiaofeng, Z.............................. 93 Xiaoxue, S...............................195 Xie, Y. F...................................184 Xin, Y...................................... 173 Xing, T.-S................................136 Xinopoulos, D.............62, 230, 243 Xiong, S................................... 76 Xiong, W.................................. 52 Xu, C................................ 128-129 Xu, G....................................... 72 Xu, H.............................. 200, 215 Xu, J..................48, 72-73, 115, 133, 143, 198, 202 Xu, L.................. 118, 201-202, 242 Xu, M.-D...................223, 225-226 Xu, M.-M............................... 223 Xu, N...................... 200, 216, 223, 225-226 Xu, X.-Y...................................143
Index of Authors and Co-Authors : UEG Week Final Programme
Xu, Y..........................141, 143, 153 Xu, Z................................. 47, 248 Xuan, H...................................215 Xuan, W..................................150 Xudong, L...............................201 Xudoyorova, Z. S..................... 157 Xue, L.....................................201 Xue, M................................... 202 Xue, P..................................... 173 Xue, Q............................... 85, 133 Xue, Y.....................................153 Xuereb, F.................................188
Y Yaacob, N. Y............................120 Yaari, S....................................69 Yabe, S............................ 209, 257 Yablecovich, D...................137, 140 Yachha, S. K............................ 157 Yadav, T....................................171 Yadlapati, R....................... 69, 148 Yagawa, Y.........................126, 194 Yagel, S.................................... 97 Yagi, N...................... 124, 174, 252 Yagi, T............................... 65, 166 Yagioka, H................................95 Yagüe, C................................... 63 Yahagi, N.............. 53, 82, 173-174, 225, 251 Yahiaoui, F....................... 158-159 Yair, M.....................................69 Yakabi, K................................ 206 Yakushijin, T........................... 246 Yalchin, M.......................202, 205 Yamada, A................. 76, 188, 254 Yamada, H..............................123 Yamada, K................... 136-137, 172 Yamada, M...................78, 172, 177 Yamada, R........... 122, 144, 172, 181 Yamada, S.........................152, 177 Yamada, T.......... 90, 128, 144, 153, 176, 191, 195, 246 Yamagami, H............. 79, 200, 254 Yamaguchi, A............. 175-176, 182 Yamaguchi, N....... 48, 87, 201, 206 Yamaguchi, R..........................144 Yamaguchi, T.............. 175-176, 182 Yamaguchi, Y...........................194 Yamairi, H.............................. 203 Yamakawa, R..........................123 Yamakita, K....................... 130-131 Yamamichi, N.............96, 142, 205 Yamamoto, E.............. 98, 193, 243 Yamamoto, H.......... 48, 68-69, 87, 100, 130, 146, 152, 191 Yamamoto, K............... 51, 53, 128, 147, 151, 174, 177, 187, 209, 222
Yamamoto, M.....................53, 121 Yamamoto, N...........................95 Yamamoto, S.......... 85-86, 177, 201 Yamamoto, Y.................... 177, 203 Yamamura, M............. 147, 169, 174 Yamamura, T..................... 136-137 Yamano, H..............................193 Yamano, H.-O....................98, 243 Yamanouchi, K................. 187, 234 Yamanouchi, T......................... 151 Yamao, K................................. 181 Yamasaki, K..................... 125, 174 Yamasaki, T............... 84, 174, 201, 252-253 Yamasaki, Y.......... 53, 85, 124, 203 Yamashina, T..................... 68, 167 Yamashita, H....................128, 201 Yamashita, K...... 144, 182-183, 200 Yamashita, M.............152, 183, 191 Yamashita, N....................101, 238 Yamashita, S............................85 Yamashita, T............................ 121 Yamato, M............................... 147 Yamauchi, A............................126 Yamauchi, H......................119, 123 Yamauchi, K............................ 151 Yamaue, H..............................122 Yamawaki, H...............82, 173, 198 Yamazaki, T....................... 69, 147 Yan, E. X.................................153 Yan, K........................98, 201, 239 Yan, L......................................168 Yan, X............72, 124, 129, 153, 179 Yanagisawa, A.........................122 Yanai, H........................... 131, 230 Yanai, Y..............................76, 147 Yang, D........................ 76, 95, 151 Yang, D.-H.......... 98, 175, 223, 239 Yang, J.................91, 129-130, 188, 226, 244, 258 Yang, M. A............................. 245 Yang, M. J...............................130 Yang, S................................... 127 Yang, S.-C...............................166 Yang, S.-K.........................98, 239 Yang, T....................................150 Yang, W...................................59 Yang, X.................................... 72 Yang, Y......................... 52, 87, 132 Yang, Z.........................57, 87, 193 Yano, T..........68, 95, 104, 124, 130, 151, 177, 200-201, 250-251 Yanqin, W.........................215-216 Yao, C. K...................141, 205, 233 Yao, G....................................200 Yao, K.................58, 125, 201, 205 Yao, L......................................247 Yao, R.....................................140 Yao, T.........................147, 174, 202 Yao, W.......................124, 129, 179
Yaraş, S.................................. 203 Yashima, K...............................58 Yassin, K. A............................. 179 Yasuda, H..........................152, 191 Yasuda, K........................ 203, 241 Yasuda, M.............................. 226 Yasuda, T................................. 174 Yasui, Y.............................147, 174 Yasumoto, M.......................... 180 Yasunaka, T.............................166 Yasutomi, E............................ 203 Yavuz, S..................................199 Yavzori, M.................. 78, 140, 190 Yazaki, E.................................247 Yazbeck, R....................... 150, 204 Yazumi, S................................122 Ye, B...................................... 223 Ye, B. D...................... 98, 139, 239 Ye, C........................................59 Ye, J....................215-216, 218, 230 Ye, X.......................................125 Yee, E. U........................... 56, 251 Yee, M....................................165 Yen, C.-L................................. 118 Yener, O..................................170 Yeo, C. W.................... 123, 126, 131 Yeo, S. J.......................... 180, 230 Yep-Gamarra, V.......................152 Yeung, K. F...............................46 Yeung, R.................................102 Yeung, R. C. P..........................182 Yew, A....................................125 Yi, C.-H............................ 148-149 Yi, S.-W...................................152 Yiannakou, Y...........................195 Yin, S..................................... 232 Ying, L............................. 250-251 Yingyongthawat, W..................148 Yip, H. C................... 152, 230, 250 Yip, W. M................................138 Ylisaukko-oja, T...................... 239 Yo, K...............84, 86, 98, 122, 127, 130, 132, 148, 152, 167, 174, 203, 205, 241 Yoda, Y.................95, 177, 201, 250 Yojiro, S..................................154 Yokota, I..................................126 Yokota, Y.................................129 Yokoyama, A.....................123, 151 Yokoyama, K...........................130 Yokoyama, N..................... 61, 229 Yokoyama, T............................ 151 Yokoyama, Y......................76, 246 Yoneda, M............................... 114 Yoneyama, H............................ 61 Yonezawa, M.......................... 226 Yoo, B. M......................... 130, 132 Yoo, D. H.................................139 Yoo, H. G.................................195 Yoo, I. K....... 127, 132, 148, 152, 203
Yoon, H..................... 152, 192, 251 Yoon, J. Y................................ 243 Yoon, K. C.............................. 203 Yoshida, H............................... 167 Yoshida, M.......... 51, 122, 124, 128, 194, 203, 231, 242, 250 Yoshida, N.......... 123, 174, 180, 253 Yoshida, R...............................166 Yoshida, S........................144, 182 Yoshifuku, Y.............................152 Yoshihuku, Y............................ 151 Yoshii, T.................................. 151 Yoshikawa, K.................... 98, 205 Yoshikawa, M..........................123 Yoshikawa, T.......................... 205 Yoshimizu, S........................... 174 Yoshimura, F...........................182 Yoshimura, K...................... 84, 86 Yoshimura, N........................... 61 Yoshino, K....................... 203, 241 Yoshino, S................................86 Yoshino, T......................... 76, 188 Yoshio, T....................151, 174, 246 Yoshioka, M.................... 209, 257 Yoshitaka, N.....................129, 180 Yoshizaki, N............................231 Yoshizawa, N.....................122, 172 Yosry, A....................................117 You, M. S................................142 Youd, P.................................... 176 Youk, E. G............................... 133 Youn, Y. H...............................201 Younes, Z................................140 Young Park, J.................... 173, 251 Young, C.................................. 70 Young, E. J..............................198 Young, G.................... 90, 143, 234 Yousry, M................................ 147 Ystad, S. O....................... 156, 206 Yu, C.......59, 141, 179, 219, 242, 251 Yu, H.-C...................................59 Yu, J...................... 91, 93, 114, 143, 147, 164, 192, 202 Yu, L....................................... 147 Yu, T................... 119, 121, 145-146, 166, 194, 238 Yu, W......................... 57, 193, 220 Yu, Y................................ 167, 244 Yuan, L. T. E............................166 Yuan, W.............................57, 193 Yuen, K...................................198 Yuki, T.................................... 238 Yumura, T................................ 119 Yun, B. C.......................... 179, 219 Yun, C...........141, 152, 179, 219, 251 Yun, S. H................................ 245 Yung, D. E......72, 131, 227, 230, 237 Yunoki, S.................................. 53 Yuri, Y..................................... 167 Yurtlu, D. A.............................148
371
UEG Week Final Programme : Index of Authors and Co-Authors
Yusuf, A........................... 227-228 Yzet, C.....................................135
Z Zaanan, A......................... 93, 168 Zaballa, M...............................153 Zabana, Y.................................56 Zaccari, P............................... 244 Zacharioudaki, V....................... 57 Zachou, K.................................68 Zada, S................................... 118 Zadorozhna, K........................ 220 Zadrozny, D.............................218 Zaharie, T................................ 172 Zahi, I.....................................158 Zahran, M...............................166 Zaika, S...................................150 Zakaria, C. M. B.......................158 Zakordonets, L........................184 Zalata, K..........................168, 207 Zalcman, M......................207, 210 Zali, M. R................................154 Zaltzhendler, M........................68 Zanati, S................................. 177 Zandberga, E...........................193 Zanella, C................................ 191 Zanetto, A............................... 116 Zaninotto, G..................55, 69, 80 Zanoni, P.................................156 Zapata, E................................ 115 Zapater, P.............73, 143, 170, 220 Zaránd, A............................... 234 Zarate Lopez, N................ 244-247 Zataraín Valles, A....................199 Zatorski, H....................... 143, 184 Zavoral, M............... 220, 222, 228, 242, 244 Zayed, R...................................117 Zazour, A................................ 178 Zboril, V..................................237 Zdrhova, L...............................148
372
Zeitz, J..................... 184, 206, 233 Zelaya, R.................................210 Zelber-Sagi, S....................75, 178 Zelinkova, Z.................... 235, 238 Zemmour, C............................169 Zenda, S..................................201 Zeng, Z.................................. 242 Zenlea, T..................................56 Zentilin, P..................149, 199, 248 Zerbi, A....................................85 Zerbib, F............37, 47, 73, 105, 188 Zeuner, R................................138 Zeuzem, S............................... 118 Zevallos, V. F............................56 Zevit, N................................... 151 Zgradic, S................................165 Zhan, Q.............. 118, 144, 221, 234 Zhan, S...................... 78, 207, 245 Zhang, B...........................115, 216 Zhang, C...... 123-124, 223, 225-226 Zhang, D.................... 128-129, 175 Zhang, F.......... 48, 73, 115, 133, 136 Zhang, G..............57, 166, 168, 257 Zhang, H..................... 56, 61, 134, 139, 184, 233 Zhang, J..................57, 91, 141, 147 Zhang, L................57, 82, 116, 145, 199, 202, 257 Zhang, N...................118, 129, 145, 189, 202, 242, 246 Zhang, Q.-F.............................136 Zhang, S........................... 78, 245 Zhang, T.................................. 114 Zhang, W........57, 83, 144-145, 246 Zhang, X....... 91, 128-130, 164, 258 Zhang, X.-C.......................123-124 Zhang, Y........ 72, 119, 122, 124, 129, 141, 147, 165, 179, 201, 221, 257 Zhang, Z.................................201 Zhao, D....................................65 Zhao, G............................118, 202
Zhao, J................................ 47, 52 Zhao, L.................. 93, 173, 197-199 Zhao, S...................................140 Zhao, X......................139, 172, 184 Zhao, Y............................... 52, 88 Zheng, W......................... 171, 204 Zheng, X................................ 244 Zheng, X.-L............................. 115 Zheng, Z.-W............................136 Zhernakova, A.......................... 70 Zhong, S..................................64 Zhong, Y.......................... 224, 227 ZhongLi, L............................... 173 Zhou, C.................................. 220 Zhou, J..................................... 52 Zhou, K.................................. 220 Zhou, P...................................125 Zhou, P.-H.............51, 95, 123-124, 143, 174, 198, 201, 224-225, 244 Zhou, Q...............................47, 80 Zhou, Y.............................. 91, 147 Zhou, Y. L................................153 Zhu, B.-Q................................201 Zhu, C................................57, 193 Zhu, C.-L.................................146 Zhu, J................................132, 174 Zhu, S................................57, 148 Zhu, X..................................... 115 Zhu, Y.........................52, 174, 233 Zhurov, A................................184 Zibandeh, N............................ 114 Zibert, A.................................215 Zielińska, M.............. 134, 143, 184 Zigdon, S............................... 243 Zilli, A.................................... 223 Zilli, M............................. 122, 130 Zimmer, C................................46 Zimmer, V...............................146 Zimmermann, J.......................138 Zippi, M................................. 239 Zito, F. P............................96, 230
Zizer, E....................................193 Zlatar, I...................................183 Zmiri, Y............................185, 257 Zocco, M. A...................... 215, 218 Zoheiry, M............................... 118 Zoican, A.................................237 Zoli, M....................................168 Zollner, G................................216 Zonoozi, S.............................. 202 Zopf, S.................................... 127 Żorniak, M..............................164 Zortul, H................................ 256 Zorzano, A..............................164 Zorzi, F..............................187-188 Zou, D.....................................199 Zou, F....................................... 76 Zou, X............................... 78, 199 Zsigmond, F..................... 179, 235 Zsobrak, K.............................. 243 Zubcevic, N.............................169 Zubiaurre, L............................ 115 Zubillaga de Diego, A..............125 Zucconi, F................................190 Zuffada, M............................. 204 Zuhdi, Z..................................158 Zuin, G....................................190 Zulli, C..............................62, 230 Zullo, A.................................. 230 Zumpano, L. E.........................159 Zundler, S...............................184 Zuñiga-Ramos, L..................... 116 Zuppardo, R. A....................... 242 Zuppini, T............................... 238 Zur, D.......................................68 Zuurbier, R.............................. 187 Zwahlen, M............................ 248 Zweig, A................................ 206 Zwinger, L. L.......................... 255 Zwolinska-Wcislo, M.............. 204 Zykov, P................................... 157
Floor Plans Fira Gran Via North Entrance Hall 8
Overview
Main Entrance (North)
700m
Metro Station „Fira“ – L9 Sud
sharing the future of digestive health
Vienna, Austria
October 20–24, 2018 Venue: Austria Center Vienna Europe’s Leading Gastroenterology Meeting Young GI Network Postgraduate Teaching Programme Awards and Grants Live Endoscopy Guidelines in Clinical Practice Abstracts on Fire: Frontiers in Research Advances in Clinical GI & Hepatology Endoscopic Hands-on Training Translational/Basic Science Clinical Case Sessions Poster Sessions Surgical Learning Area Technical Exhibition World-Renowned Experts Therapy Updates Controversial Debates Ultrasound Learning Area
Find out more, visit www.ueg.eu/week
Registration 18 starts Jan. 22, 20 and includes free UEG Week 24/7 access Abstract Submission Deadline: April 20, 2018
Floor Plans Fira Gran Via : UEG Week Final Programme
Venue Overview
Fira Gran Via – North Entrance
Scientific Centre
to Halls 6/7
Hall 7
Hall 6 Hall 8.1
Exhibition
Hall 8.1 Hall 8.1
Hall 8.0 Hall 8.0 Speakers Centre
Hall 8.1
Hall 8.0 Registration
Fira Gran Via – North Entrance
375
* RTD – Round Table Discussion
Speakers Centre
Young GI Lounge
Core Programme
A1
Round Table Discussions
A3
Core Programme
A2 ESGENA
RTD*
Cloakroom
25th UEG Week Anniversary Area
UEG Booth & Members Village
Association and Future Events Area
Core Programme
B1 B2
Registration
E2
E3
RTD*
B5
Core Progr.
ESGENA
B3
NORT H ENT RANCE
e
ESGENA
E4
Surgical Learning Area
Core Core Core Programme Programme Progr.
Escalators to Hall 6, Hall 7, Hall 8.1 (Exhibition, Catering)
E1
Core
RTD* Progr.
c Catering Kiosk (Mon–Wed)
(Sat/Sun)
PGT & ESGENA Catering
Core Programme
e
Core Progr.
ESGE Learning Area
Ultrasound Learning Area
Hall 8.0
Lecture Theatre
376 ESGENA
Hall 8.0
c Catering Kiosk
Cloakroom
Core Programme
F1
Core Programme
F2
Core Programme
C1
Core Programme
F3
Core Programme
C2
UEG Week Final Programme : Floor Plans Fira Gran Via
Hall 8.0
Congress Material
Press Centre
UEG Week Hotspot E-Poster Lounges Poster Exhibition
to Halls 6/7
Internet Centre
c
Catering Kiosk
64
59
60
57
61
62
74
54
55
56
75
76
77
51
50
49
80
53 52
81
78
General Exhibitors
Catering Kiosk c
Catering
58
65
66
68 63 67
69
70 70a 71 72 73
Hall 8.1
Entrance to Hall 8.1
Premium Partners / Major Partners
Escalators to Halls 6/7
79
45 44
46
47
48
83
84
41
37
36
Entrance to Hall 8.1
43
42
91
Exhibition
93
92
86
89 90
38
35
34
25
109
108
111
110
107
24
102 105 106
103 104
c Catering Kiosk
39
40
94
95
96 101
97 100
98 99
Escalators to Registration Area and Session Rooms in Hall 8.0
82
85
Catering
87 88
c Catering Kiosk
21
17 18 15
19
112
113
114
22
23
20
16
115
125
122 123 124
121
126
13
11
1
2
3
4
7 6 5 14
8
9
140
139
138
137
136
135
134
12
10
131
128 132 129 130
127 133
c Catering Kiosk
UEG Meeting Room 1
Meeting Rooms 8.1 – 8.30
UEG Office
Entrance to Hall 8.1
Exhibitor Service Desk Freight Forwarding
32 29 31 30
33 28
27
26
116 120
118 117 119
Networking & Live Streaming Area
Hall 8.1
Catering
Hall 8.1
Floor Plans Fira Gran Via : UEG Week Final Programme
377
E-Poster Lounge 2
Catering & Networking Area
378
E-Poster Lounge 1
Posters Lower GI
UEG Week Hotspot
Scientific Centre
Hall 7
Posters Surgery / Endoscopy / Imaging
Posters Upper GI
Posters Liver / Biliary / Pancreas
Posters Clinical Cases
CC7
7.15
Entrance to Meeting Rooms 7.7 – 7.15
Room 7.1
Meeting Rooms
Catering Kiosk (Mon – Wed)
c
PGT Catering (Sat/Sun)
Foyer Halls 6/7
to Hall 8.0 and 8.1
e
Core Programme
UEG Meeting Room 2
Silent Room
First Aid
7.12
UEG Meeting 7.6 Room 3
7.7
7.14 7.13
7.11
7.10 7.9 7.8
Halls 6/7
Core Programme
Hall 6
UEG Week Final Programme :Floor Plans Fira Gran Via
Halls 6/7
Poster Service Desk
Working together to advance science and patient care
Visit Pfizer at booths 41 and 42
PP-GIP-EUR-1157-01 | September 2017
© 2017 Pfizer Inc.
All rights reserved.
UEG gratefully acknowledges the support of this year's Premium Partners:
Final Programme available for download www.ueg.eu/week
